Psyllid ID: psy5063
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 681 | 2.2.26 [Sep-21-2011] | |||||||
| Q8IR79 | 1257 | LIM domain kinase 1 OS=Dr | yes | N/A | 0.719 | 0.389 | 0.332 | 4e-62 | |
| Q8QFP8 | 662 | LIM domain kinase 1 OS=Ga | yes | N/A | 0.242 | 0.249 | 0.531 | 2e-48 | |
| P53668 | 647 | LIM domain kinase 1 OS=Mu | yes | N/A | 0.221 | 0.233 | 0.551 | 2e-48 | |
| P53669 | 647 | LIM domain kinase 1 OS=Ra | yes | N/A | 0.221 | 0.233 | 0.551 | 3e-48 | |
| P53667 | 647 | LIM domain kinase 1 OS=Ho | yes | N/A | 0.221 | 0.233 | 0.551 | 4e-48 | |
| O42565 | 615 | LIM domain kinase 1 OS=Xe | N/A | N/A | 0.236 | 0.261 | 0.534 | 8e-48 | |
| P53670 | 638 | LIM domain kinase 2 OS=Ra | no | N/A | 0.237 | 0.253 | 0.518 | 4e-45 | |
| P53671 | 638 | LIM domain kinase 2 OS=Ho | no | N/A | 0.239 | 0.255 | 0.515 | 7e-45 | |
| O54785 | 638 | LIM domain kinase 2 OS=Mu | no | N/A | 0.237 | 0.253 | 0.513 | 1e-44 | |
| Q32L23 | 638 | LIM domain kinase 2 OS=Bo | no | N/A | 0.237 | 0.253 | 0.513 | 3e-44 |
| >sp|Q8IR79|LIMK1_DROME LIM domain kinase 1 OS=Drosophila melanogaster GN=LIMK1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 240 bits (612), Expect = 4e-62, Method: Compositional matrix adjust.
Identities = 197/592 (33%), Positives = 286/592 (48%), Gaps = 102/592 (17%)
Query: 64 NGKYGEACQNC-GQMMSGP----VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSIL 118
+G + C +C GQ++ P VM +G ++H +CF+C S C G ++ +L
Sbjct: 26 SGGHSPLCAHCRGQLLPHPEEPIVMALG-QQWHCDCFRC---SVCEGHLHNWYFEREGLL 81
Query: 119 YCGLCYKRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAPPVFS 178
YC Y GR DA C+ ++ G + + P F
Sbjct: 82 YCREDY------YGRFGDAC------QQCMAVI---------TGPVMVAGEHKFHPECFC 120
Query: 179 NLCISEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLS--------G 230
+ E+ V +LY + +P ++ + ++G S
Sbjct: 121 CTACGSFIGEGESYALVERSKLYCGQCYGKRSCQPADAKARITTAGKPMHSIRLVEIPKD 180
Query: 231 SCKGLMAE-IALGNNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRAD 289
+ GL + +AL + + + L + S+ + C G R+D +
Sbjct: 181 ATPGLRVDGVALDDGCPTVRITDLFCNFFLWLTSMAE----QCCGAPY-----RID--VN 229
Query: 290 LMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERF 349
L +LH+GDRILEVNGTPV D +++++ LIR + + +LQ + + ++VC
Sbjct: 230 LTNLHIGDRILEVNGTPVSDSSVEQIDKLIR-SNEKMLQLTVEHD------PVQVCR--- 279
Query: 350 SCS-VEVKQMLCVVSPFCWLFLAPLRLGEGNMR-RQEAVEWRVKPLSLKTLTVIGTVMIN 407
SCS ++++ + + L + + G R + E K L+ T N
Sbjct: 280 SCSQADIQRAMSASTLILPLSTSASSVEVGRERLYKTPGEQGTKARKLRQAT-------N 332
Query: 408 LGQNIQVVLGTTIGCYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPAC-DLSRTRSRS 466
I G T + + R S D + + S P DLSRT+S
Sbjct: 333 ASTTIPPAAGAT-----AMTQLKEKERCSSLSKLLDEQHQAQQHSAHPQLYDLSRTQS-- 385
Query: 467 FRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLK 526
RV RIFRA+DLV G LG+GFFG+V++VTHR++GEVMVLKEL+R DEEA++NF+K
Sbjct: 386 CRVVQKPQRIFRATDLVIGEKLGEGFFGKVFKVTHRQSGEVMVLKELHRADEEAQRNFIK 445
Query: 527 ESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 586
E VAVLR L H +V++FIGVLYKD+KL++VTEY+AG
Sbjct: 446 E-------------------------VAVLRLLDHRHVLKFIGVLYKDKKLHMVTEYVAG 480
Query: 587 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G LKEL+ DP Q LPW QRV ARDIA GM+YLHSMN+IHRDLNS NCLVRE
Sbjct: 481 GCLKELIHDPAQVLPWPQRVRLARDIACGMSYLHSMNIIHRDLNSMNCLVRE 532
|
Protein kinase which regulates actin filament dynamics. Phosphorylates and inactivates the actin binding/depolymerizing factor tsr/cofilin, thereby stabilizing the actin cytoskeleton. Modulation of actin cytoskeleton dynamics may be essential for imaginal disk morphogenesis and axon guidance. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q8QFP8|LIMK1_CHICK LIM domain kinase 1 OS=Gallus gallus GN=LIMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (493), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 102/192 (53%), Positives = 126/192 (65%), Gaps = 27/192 (14%)
Query: 463 RSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK 522
RS S RV + RIFR SDL+ G +LG+G FGQ +VTHRETGEVMV+KEL R DEE ++
Sbjct: 327 RSESLRVVSRAHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR 386
Query: 523 NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 582
FLKE V V+R L H NV++FIGVLYK+++LN +TE
Sbjct: 387 TFLKE-------------------------VKVMRCLEHPNVLKFIGVLYKEKRLNFITE 421
Query: 583 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642
YI GGTL+ L++ PW QRV+FA+DIAAGM YLHSMN+IHRDLNS NCLVRE S
Sbjct: 422 YIKGGTLRGLIKSMDSHYPWSQRVSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVRENKSV 481
Query: 643 F--DFHLGQIYL 652
DF L ++ +
Sbjct: 482 VVADFGLARLMV 493
|
Protein kinase which regulates actin filament dynamics. Phosphorylates and inactivates the actin binding/depolymerizing factor cofilin, thereby stabilizing the actin cytoskeleton. Required for motility of the axon growth cone. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53668|LIMK1_MOUSE LIM domain kinase 1 OS=Mus musculus GN=Limk1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 194 bits (492), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 97/176 (55%), Positives = 119/176 (67%), Gaps = 25/176 (14%)
Query: 463 RSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK 522
RS S RV RIFR SDL+ G +LG+G FGQ +VTHRETGEVMV+KEL R DEE ++
Sbjct: 320 RSESLRVVCRPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR 379
Query: 523 NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 582
FLKE V V+R L H NV++FIGVLYKD++LN +TE
Sbjct: 380 TFLKE-------------------------VKVMRCLEHPNVLKFIGVLYKDKRLNFITE 414
Query: 583 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
YI GGTL+ ++++ PW QRV+FA+DIA+GM YLHSMN+IHRDLNS NCLVRE
Sbjct: 415 YIKGGTLRGIIKNMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE 470
|
Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways. Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop. LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin-2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton. In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation. Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly. Stimulates axonal outgrowth and may be involved in brain development. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53669|LIMK1_RAT LIM domain kinase 1 OS=Rattus norvegicus GN=Limk1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 193 bits (491), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 97/176 (55%), Positives = 118/176 (67%), Gaps = 25/176 (14%)
Query: 463 RSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK 522
RS S RV RIFR SDL+ G +LG+G FGQ +VTHRETGEVMV+KEL R DEE ++
Sbjct: 320 RSESLRVVCRPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR 379
Query: 523 NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 582
FLKE V V+R L H NV++FIGVLYKD++LN +TE
Sbjct: 380 TFLKE-------------------------VKVMRCLEHPNVLKFIGVLYKDKRLNFITE 414
Query: 583 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
YI GGTL+ +++ PW QRV+FA+DIA+GM YLHSMN+IHRDLNS NCLVRE
Sbjct: 415 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE 470
|
Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways. Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop. LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin-2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton. In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation. Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly. Stimulates axonal outgrowth and may be involved in brain development. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53667|LIMK1_HUMAN LIM domain kinase 1 OS=Homo sapiens GN=LIMK1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 4e-48, Method: Compositional matrix adjust.
Identities = 97/176 (55%), Positives = 118/176 (67%), Gaps = 25/176 (14%)
Query: 463 RSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK 522
RS S RV RIFR SDL+ G +LG+G FGQ +VTHRETGEVMV+KEL R DEE ++
Sbjct: 320 RSESLRVVCRPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR 379
Query: 523 NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE 582
FLKE V V+R L H NV++FIGVLYKD++LN +TE
Sbjct: 380 TFLKE-------------------------VKVMRCLEHPNVLKFIGVLYKDKRLNFITE 414
Query: 583 YIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
YI GGTL+ +++ PW QRV+FA+DIA+GM YLHSMN+IHRDLNS NCLVRE
Sbjct: 415 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE 470
|
Serine/threonine-protein kinase that plays an essential role in the regulation of actin filament dynamics. Acts downstream of several Rho family GTPase signal transduction pathways. Activated by upstream kinases including ROCK1, PAK1 and PAK4, which phosphorylate LIMK1 on a threonine residue located in its activation loop. LIMK1 subsequently phosphorylates and inactivates the actin binding/depolymerizing factors cofilin-1/CFL1, cofilin-2/CFL2 and destrin/DSTN, thereby preventing the cleavage of filamentous actin (F-actin), and stabilizing the actin cytoskeleton. In this way LIMK1 regulates several actin-dependent biological processes including cell motility, cell cycle progression, and differentiation. Phosphorylates TPPP on serine residues, thereby promoting microtubule disassembly. Stimulates axonal outgrowth and may be involved in brain development. Isoform 3 has a dominant negative effect on actin cytoskeletal changes. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O42565|LIMK1_XENLA LIM domain kinase 1 OS=Xenopus laevis GN=limk1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 192 bits (488), Expect = 8e-48, Method: Compositional matrix adjust.
Identities = 100/187 (53%), Positives = 122/187 (65%), Gaps = 26/187 (13%)
Query: 455 PACDL-SRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKEL 513
P+C +RS S R RIFR SDL+ G +LG+G FGQ +VTHR TGEVMV+KEL
Sbjct: 286 PSCSRRDMSRSESVRTVTGVHRIFRPSDLIPGEVLGRGCFGQAIKVTHRVTGEVMVMKEL 345
Query: 514 YRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYK 573
R DEE ++ FLKE V V+R L H +V++FIGVLYK
Sbjct: 346 IRFDEETQRTFLKE-------------------------VKVMRCLEHPHVLKFIGVLYK 380
Query: 574 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
D++LN +TEYI GGTL+ +++ PW QRV+FARDIAAGMTYLHSMN+IHRDLNS N
Sbjct: 381 DKRLNFITEYIPGGTLRRVIKSMDTHCPWNQRVSFARDIAAGMTYLHSMNIIHRDLNSHN 440
Query: 634 CLVREVG 640
CLVRE G
Sbjct: 441 CLVREDG 447
|
Protein kinase which regulates actin filament dynamics. Phosphorylates and inactivates the actin binding/depolymerizing factor cofilin, thereby stabilizing the actin cytoskeleton. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53670|LIMK2_RAT LIM domain kinase 2 OS=Rattus norvegicus GN=Limk2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 183 bits (465), Expect = 4e-45, Method: Compositional matrix adjust.
Identities = 99/191 (51%), Positives = 125/191 (65%), Gaps = 29/191 (15%)
Query: 450 PKSLRPACDLSR--TRSRSFRVEASKSR-IFRASDLVRGPLLGQGFFGQVYRVTHRETGE 506
P S + LSR +RS S R +S S+ IFR DL+ G +LG+GFFGQ +VTH+ TG+
Sbjct: 296 PSSPKEPLLLSRDISRSESLRCSSSYSQQIFRPCDLIHGEVLGKGFFGQAIKVTHKATGK 355
Query: 507 VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIR 566
VMV+KEL R DEE +K FL E V V+RSL H NV++
Sbjct: 356 VMVMKELIRCDEETQKTFLTE-------------------------VKVMRSLDHPNVLK 390
Query: 567 FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626
FIGVLYKD+KLNL+TEYI GGTLK+ L++ P PW Q+V FA+ IA+GM YLHSM +IH
Sbjct: 391 FIGVLYKDKKLNLLTEYIEGGTLKDFLRN-VDPFPWQQKVRFAKGIASGMAYLHSMCIIH 449
Query: 627 RDLNSQNCLVR 637
RDLNS NCL++
Sbjct: 450 RDLNSHNCLIK 460
|
Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P53671|LIMK2_HUMAN LIM domain kinase 2 OS=Homo sapiens GN=LIMK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (462), Expect = 7e-45, Method: Compositional matrix adjust.
Identities = 99/192 (51%), Positives = 126/192 (65%), Gaps = 29/192 (15%)
Query: 447 NSPPKSLRPACDLSRTRSRSFRVEASKSR-IFRASDLVRGPLLGQGFFGQVYRVTHRETG 505
+SP + L + D+SR S S R +S S+ IFR DL+ G +LG+GFFGQ +VTH+ TG
Sbjct: 297 SSPKEPLLFSRDISR--SESLRCSSSYSQQIFRPCDLIHGEVLGKGFFGQAIKVTHKATG 354
Query: 506 EVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVI 565
+VMV+KEL R DEE +K FL E V V+RSL H NV+
Sbjct: 355 KVMVMKELIRCDEETQKTFLTE-------------------------VKVMRSLDHPNVL 389
Query: 566 RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 625
+FIGVLYKD+KLNL+TEYI GGTLK+ L+ P PW Q+V FA+ IA+GM YLHSM +I
Sbjct: 390 KFIGVLYKDKKLNLLTEYIEGGTLKDFLRS-MDPFPWQQKVRFAKGIASGMAYLHSMCII 448
Query: 626 HRDLNSQNCLVR 637
HRDLNS NCL++
Sbjct: 449 HRDLNSHNCLIK 460
|
Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O54785|LIMK2_MOUSE LIM domain kinase 2 OS=Mus musculus GN=Limk2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 98/191 (51%), Positives = 124/191 (64%), Gaps = 29/191 (15%)
Query: 450 PKSLRPACDLSR--TRSRSFRVEASKSR-IFRASDLVRGPLLGQGFFGQVYRVTHRETGE 506
P S + LSR +RS S R +S S+ IFR DL+ G +LG+GFFGQ +VTH+ TG+
Sbjct: 296 PSSPKEPLLLSRDISRSESLRCSSSYSQQIFRPCDLIHGEVLGKGFFGQAIKVTHKATGK 355
Query: 507 VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIR 566
VMV+KEL R DEE +K FL E V V+RSL H NV++
Sbjct: 356 VMVMKELIRCDEETQKTFLTE-------------------------VKVMRSLDHPNVLK 390
Query: 567 FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626
FIGVLYKD+KLNL+TEYI GGTLK+ L+ P PW Q+V FA+ I++GM YLHSM +IH
Sbjct: 391 FIGVLYKDKKLNLLTEYIEGGTLKDFLRS-VDPFPWQQKVRFAKGISSGMAYLHSMCIIH 449
Query: 627 RDLNSQNCLVR 637
RDLNS NCL++
Sbjct: 450 RDLNSHNCLIK 460
|
Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q32L23|LIMK2_BOVIN LIM domain kinase 2 OS=Bos taurus GN=LIMK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (457), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 98/191 (51%), Positives = 124/191 (64%), Gaps = 29/191 (15%)
Query: 450 PKSLRPACDLSR--TRSRSFRVEASKSR-IFRASDLVRGPLLGQGFFGQVYRVTHRETGE 506
P S + LSR +RS S R +S S+ IFR DL+ G +LG+GFFGQ +VTH+ TG+
Sbjct: 296 PSSPKEPLLLSRDISRSESLRCSSSCSQQIFRPCDLIHGEVLGKGFFGQAIKVTHKATGK 355
Query: 507 VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIR 566
VMV+ EL R DEE +K FL E V V+RSL H NV++
Sbjct: 356 VMVMNELIRCDEETQKTFLTE-------------------------VKVMRSLDHPNVLK 390
Query: 567 FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626
FIGVLYKD+KLNL+TEYI GGTLK+ L++ P PW Q+V FA+ IA+GM YLHSM +IH
Sbjct: 391 FIGVLYKDKKLNLLTEYIEGGTLKDFLRN-VDPFPWQQKVRFAKGIASGMAYLHSMCIIH 449
Query: 627 RDLNSQNCLVR 637
RDLNS NCL++
Sbjct: 450 RDLNSHNCLIK 460
|
Displays serine/threonine-specific phosphorylation of myelin basic protein and histone (MBP) in vitro. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 681 | ||||||
| 328776829 | 1194 | PREDICTED: LIM domain kinase 1 [Apis mel | 0.741 | 0.422 | 0.474 | 1e-145 | |
| 307177067 | 1316 | LIM domain kinase 1 [Camponotus floridan | 0.741 | 0.383 | 0.471 | 1e-145 | |
| 307202433 | 1201 | LIM domain kinase 1 [Harpegnathos saltat | 0.728 | 0.412 | 0.468 | 1e-144 | |
| 350407332 | 1188 | PREDICTED: LIM domain kinase 1-like isof | 0.734 | 0.420 | 0.460 | 1e-143 | |
| 340717605 | 1188 | PREDICTED: LIM domain kinase 1-like isof | 0.734 | 0.420 | 0.458 | 1e-143 | |
| 350407329 | 1321 | PREDICTED: LIM domain kinase 1-like isof | 0.734 | 0.378 | 0.460 | 1e-143 | |
| 340717609 | 1321 | PREDICTED: LIM domain kinase 1-like isof | 0.734 | 0.378 | 0.458 | 1e-143 | |
| 383855916 | 1190 | PREDICTED: LIM domain kinase 1-like [Meg | 0.734 | 0.420 | 0.459 | 1e-141 | |
| 332025854 | 1225 | LIM domain kinase 1 [Acromyrmex echinati | 0.725 | 0.403 | 0.452 | 1e-137 | |
| 198470704 | 1302 | GA14953 [Drosophila pseudoobscura pseudo | 0.750 | 0.392 | 0.391 | 1e-103 |
| >gi|328776829|ref|XP_396603.4| PREDICTED: LIM domain kinase 1 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1340), Expect = e-145, Method: Compositional matrix adjust.
Identities = 309/651 (47%), Positives = 376/651 (57%), Gaps = 146/651 (22%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E+ LTCAGCLN I EDE++QAL+QEWH DCFRCSACD+ L WYFEKDGLLFCK+DY
Sbjct: 13 ESSGTLTCAGCLNAIDEDEFIQALNQEWHIDCFRCSACDIGLSTWYFEKDGLLFCKDDYW 72
Query: 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
YGEACQ CGQ+++GPVM+ GDHKFHPECF C SC IGDGESYALVERS LYCG CY
Sbjct: 73 AAYGEACQGCGQIITGPVMLAGDHKFHPECFACNSCGAFIGDGESYALVERSKLYCGSCY 132
Query: 125 KRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSA---HCSQGIKLALDTSQPAPPVFSNLC 181
KRQMQP+ RA + +P RKPH IRLVEI P+ +GIKL LDT+ P+P
Sbjct: 133 KRQMQPINRAPN--YPFTRKPHSIRLVEIPPNTSDPEKQRGIKLTLDTT-PSP------- 182
Query: 182 ISEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIAL 241
R C +R+ ++ R + G L+A
Sbjct: 183 ----------RNCGALLRISELM---------------------RNVRGKISKLLA---- 207
Query: 242 GNNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILE 301
S+++V +R C +N+ RL+ +DL+SLH+GDRILE
Sbjct: 208 ---------------------SVMEVLFRLCCHFSNH----RLNMSSDLISLHIGDRILE 242
Query: 302 VNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQMLCV 361
VNGTPV+D+P++ +E LI+ +DTVLQ I + + R + S ML
Sbjct: 243 VNGTPVKDQPIENIENLIQ-YSDTVLQLTIEHD-------PDTVSRRLTYSSPSAAMLTS 294
Query: 362 VSPFCWLFLAPLRLGEGNMRRQEAVEWRVKPLSLKTLTVIGTVMINLGQNIQVVLGTTIG 421
+S RL + RR E + GT L +
Sbjct: 295 ISNSKTSPENKERLFK---RRDEGY-------------ISGTRSRQLRR----------- 327
Query: 422 CYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASD 481
+ P+ SS +R S P +L CDLSRT RSFRVE RIFRASD
Sbjct: 328 -----TRDPMHKERSSSMSR--LLDGSSPTNL--TCDLSRT--RSFRVEPKNQRIFRASD 376
Query: 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
LV+G LLG GFFGQV++VTHR+T EVMVLKELYRVDEEA+KNFLKE
Sbjct: 377 LVKGELLGTGFFGQVFKVTHRDTNEVMVLKELYRVDEEAQKNFLKE-------------- 422
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D + LP
Sbjct: 423 -----------VAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDTNEILP 471
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQI 650
W QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVRE + DF L +I
Sbjct: 472 WEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARI 522
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307177067|gb|EFN66335.1| LIM domain kinase 1 [Camponotus floridanus] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1340), Expect = e-145, Method: Compositional matrix adjust.
Identities = 307/651 (47%), Positives = 376/651 (57%), Gaps = 146/651 (22%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E+ L CAGCLN I EDE++QAL+QEWH DCFRCSACD+ L +WYFEKDGLLFCK+DY
Sbjct: 146 ESGGTLICAGCLNAIDEDEFIQALNQEWHIDCFRCSACDIGLSSWYFEKDGLLFCKDDYW 205
Query: 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
YGEACQ CGQ+++GPVM+ GDHKFHPECF CTSC IGDGESYALVERS LYCG+CY
Sbjct: 206 AAYGEACQGCGQIITGPVMLAGDHKFHPECFACTSCGAFIGDGESYALVERSKLYCGVCY 265
Query: 125 KRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSA---HCSQGIKLALDTSQPAPPVFSNLC 181
KRQMQPL R A +P RKPH IRLVEI PS +GIKL LDT+ P+P
Sbjct: 266 KRQMQPLNRT--ANYPFARKPHSIRLVEIPPSTTDPDKQRGIKLTLDTA-PSP------- 315
Query: 182 ISEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIAL 241
R+C +R+ ++ R + G L+A
Sbjct: 316 ----------RSCGALLRISELM---------------------RNVRGKISKLLA---- 340
Query: 242 GNNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILE 301
S+++V +R C +N+ RL+ +DL+SLH+GDRILE
Sbjct: 341 ---------------------SVMEVLFRLCCHFSNH----RLNMSSDLISLHIGDRILE 375
Query: 302 VNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQMLCV 361
+NGTPV+D+P++ +E LI+ +DTVLQ I + V CS + CV
Sbjct: 376 INGTPVKDQPVENIENLIQ-YSDTVLQLTIEHDPDA------VSRRPTFCSPSSTMLTCV 428
Query: 362 VSPFCWLFLAPLRLGEGNMRRQEAVEWRVKPLSLKTLTVIGTVMINLGQNIQVVLGTTIG 421
+P +P RR E + L+
Sbjct: 429 GNPRT----SPENKERLFKRRDEGYMSGARSRQLRR------------------------ 460
Query: 422 CYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASD 481
+ P+ SS +R S P + P DLSRT RSFRVE RIFRASD
Sbjct: 461 -----TRDPMHKERSSSMSR--LLDGSSPTN--PTYDLSRT--RSFRVEPKNQRIFRASD 509
Query: 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
LV+G LLG+GFFGQV++VTHR+T EVMVLKELYRVDE+A+KNFLKE
Sbjct: 510 LVKGELLGKGFFGQVFKVTHRDTDEVMVLKELYRVDEDAQKNFLKE-------------- 555
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D +PLP
Sbjct: 556 -----------VAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDTNEPLP 604
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQI 650
W QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVRE + DF L +I
Sbjct: 605 WEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARI 655
|
Source: Camponotus floridanus Species: Camponotus floridanus Genus: Camponotus Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307202433|gb|EFN81853.1| LIM domain kinase 1 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1335), Expect = e-144, Method: Compositional matrix adjust.
Identities = 309/660 (46%), Positives = 375/660 (56%), Gaps = 164/660 (24%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E+ L CAGCLN I EDE++QAL+QEWH DCFRCSACD+ L +WYFEKDGLLFCK+DY
Sbjct: 13 ESGGTLICAGCLNAIDEDEFIQALNQEWHIDCFRCSACDIGLSSWYFEKDGLLFCKDDYW 72
Query: 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
YGEACQ CGQ+++GPVM+ GDHKFHPECF CTSC IGDGESYALVERS LYCG+CY
Sbjct: 73 AAYGEACQGCGQIITGPVMLAGDHKFHPECFACTSCGAFIGDGESYALVERSKLYCGVCY 132
Query: 125 KRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSA---HCSQGIKLALDTSQPAPPVFSNLC 181
KRQMQPL R A +P RKPH IRLVEI PS +GIKL LDT+ P+P
Sbjct: 133 KRQMQPLNRT--ANYPFARKPHSIRLVEIPPSTTDPDKQRGIKLTLDTA-PSP------- 182
Query: 182 ISEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIAL 241
R+C +R+ ++ R + G L+A
Sbjct: 183 ----------RSCGALLRISELM---------------------RNVRGKISKLLA---- 207
Query: 242 GNNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILE 301
S+++V +R C +N+ RL+ +DL+SLH+GDRILE
Sbjct: 208 ---------------------SVMEVLFRLCCHFSNH----RLNMSSDLISLHIGDRILE 242
Query: 302 VNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQML-C 360
VNGTPV+D+P++ +E LI+ +DTVLQ I + + R + S ML C
Sbjct: 243 VNGTPVKDQPVESIENLIQ-YSDTVLQLTIEHD-------PDAVSRRPTFSSPSSAMLTC 294
Query: 361 VVSPFCWLFLAPLRLGEGNMRRQEAVEWRVKPLSLKTLTVIGTVMINLGQNIQVVLGTTI 420
V SP +P RR E
Sbjct: 295 VGSPRT----SPEGKERLFKRRDE------------------------------------ 314
Query: 421 GCYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSR--------TRSRSFRVEAS 472
G I G AR R RD + S+ D S +R+RSFRVE
Sbjct: 315 ----GYISG---ARSRQLRRTRDPMHKERSSSMSRLLDGSSPMNPTCDLSRTRSFRVEPK 367
Query: 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGL 532
RIFRASDLV+G LLG+GFFGQV++VTHR+T EVMVLKELYRVDE+A+KNFLKE
Sbjct: 368 NQRIFRASDLVKGELLGKGFFGQVFKVTHRDTDEVMVLKELYRVDEDAQKNFLKE----- 422
Query: 533 IYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL 592
VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ L
Sbjct: 423 --------------------VAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRAL 462
Query: 593 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQI 650
L D +PLPW QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVRE + DF L +I
Sbjct: 463 LHDTNEPLPWEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARI 522
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350407332|ref|XP_003488056.1| PREDICTED: LIM domain kinase 1-like isoform 2 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1330), Expect = e-143, Method: Compositional matrix adjust.
Identities = 302/656 (46%), Positives = 372/656 (56%), Gaps = 156/656 (23%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E+ LTCAGCLN I EDE++QAL+QEWH DCFRCSACDV L WYFEKDGLLFCK+DY
Sbjct: 13 ESGGTLTCAGCLNAIDEDEFIQALNQEWHIDCFRCSACDVGLSTWYFEKDGLLFCKDDYG 72
Query: 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
YGEACQ CGQ+++GPVM+ GDHKFHPECF C SC IGDGESYALVERS LYCG CY
Sbjct: 73 AAYGEACQGCGQIITGPVMLAGDHKFHPECFACNSCGAFIGDGESYALVERSKLYCGSCY 132
Query: 125 KRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSA---HCSQGIKLALDTSQPAPPVFSNLC 181
KRQMQP+ R A P RKPH IRLVEI P++ +GIKL LDT+ P P
Sbjct: 133 KRQMQPINRT--ANCPFSRKPHSIRLVEIPPNSSDPEKQRGIKLTLDTT-PNP------- 182
Query: 182 ISEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIAL 241
R C +R+ ++ R + G L+A
Sbjct: 183 ----------RNCGALLRISELM---------------------RNVRGKISKLLA---- 207
Query: 242 GNNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILE 301
S+++V +R C +N+ RL+ +DL+SLH+GDRILE
Sbjct: 208 ---------------------SVMEVLFRLCCHFSNH----RLNMSSDLISLHIGDRILE 242
Query: 302 VNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQMLCV 361
+NGTPV+D+P++ +E LI+++ D ++++ +E +V +
Sbjct: 243 INGTPVKDQPIESIENLIQHS----------------DTVLQLTIEHDPDAVSRRPAYSS 286
Query: 362 VSPFCWLFLAPLRLGEGNM-----RRQEAVEWRVKPLSLKTLTVIGTVMINLGQNIQVVL 416
+ +A R N RR E + GT L +
Sbjct: 287 PTAAMLTSIASPRTSPENKERLFKRRDEGY-------------ISGTRSRQLRR------ 327
Query: 417 GTTIGCYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRI 476
+ P+ SS +R S P + P CDLSRTRS FRVE RI
Sbjct: 328 ----------TRDPMHKERSSSMSR--LLDGSSPTN--PTCDLSRTRS--FRVEPKNQRI 371
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
FRASDLV+G LLG GFFGQV++VTHR+T EVMVLKELYRVDEEA+KNFLKE
Sbjct: 372 FRASDLVKGELLGTGFFGQVFKVTHRDTNEVMVLKELYRVDEEAQKNFLKE--------- 422
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D
Sbjct: 423 ----------------VAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDT 466
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQI 650
+ LPW QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVRE + DF L +I
Sbjct: 467 NEILPWEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARI 522
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340717605|ref|XP_003397271.1| PREDICTED: LIM domain kinase 1-like isoform 1 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 516 bits (1328), Expect = e-143, Method: Compositional matrix adjust.
Identities = 301/656 (45%), Positives = 372/656 (56%), Gaps = 156/656 (23%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E+ LTCAGCLN I EDE++QAL+QEWH DCFRCSACD+ L WYFEKDGLLFCK+DY
Sbjct: 13 ESGGTLTCAGCLNAIDEDEFIQALNQEWHIDCFRCSACDIGLSTWYFEKDGLLFCKDDYG 72
Query: 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
YGEACQ CGQ+++GPVM+ GDHKFHPECF C SC IGDGESYALVERS LYCG CY
Sbjct: 73 AAYGEACQGCGQIITGPVMLAGDHKFHPECFACNSCGAFIGDGESYALVERSKLYCGSCY 132
Query: 125 KRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSA---HCSQGIKLALDTSQPAPPVFSNLC 181
KRQMQP+ R A P RKPH IRLVEI P++ +GIKL LDT+ P P
Sbjct: 133 KRQMQPINRT--ANCPFSRKPHSIRLVEIPPNSSDPEKQRGIKLTLDTT-PNP------- 182
Query: 182 ISEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIAL 241
R C +R+ ++ R + G L+A
Sbjct: 183 ----------RNCGALLRISELM---------------------RNVRGKISKLLA---- 207
Query: 242 GNNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILE 301
S+++V +R C +N+ RL+ +DL+SLH+GDRILE
Sbjct: 208 ---------------------SVMEVLFRLCCHFSNH----RLNMSSDLISLHIGDRILE 242
Query: 302 VNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQMLCV 361
+NGTPV+D+P++ +E LI+++ D ++++ +E +V +
Sbjct: 243 INGTPVKDQPIESIENLIQHS----------------DTVLQLTIEHDPDAVSRRPAYSS 286
Query: 362 VSPFCWLFLAPLRLGEGNM-----RRQEAVEWRVKPLSLKTLTVIGTVMINLGQNIQVVL 416
+ +A R N RR E + GT L +
Sbjct: 287 PTAAMLTSIASPRTSPENKERLFKRRDEGY-------------ISGTRSRQLRR------ 327
Query: 417 GTTIGCYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRI 476
+ P+ SS +R S P + P CDLSRTRS FRVE RI
Sbjct: 328 ----------TRDPMHKERSSSMSR--LLDGSSPTN--PTCDLSRTRS--FRVEPKNQRI 371
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
FRASDLV+G LLG GFFGQV++VTHR+T EVMVLKELYRVDEEA+KNFLKE
Sbjct: 372 FRASDLVKGELLGTGFFGQVFKVTHRDTNEVMVLKELYRVDEEAQKNFLKE--------- 422
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D
Sbjct: 423 ----------------VAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDT 466
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQI 650
+ LPW QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVRE + DF L +I
Sbjct: 467 NEILPWEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARI 522
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350407329|ref|XP_003488055.1| PREDICTED: LIM domain kinase 1-like isoform 1 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1325), Expect = e-143, Method: Compositional matrix adjust.
Identities = 302/656 (46%), Positives = 372/656 (56%), Gaps = 156/656 (23%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E+ LTCAGCLN I EDE++QAL+QEWH DCFRCSACDV L WYFEKDGLLFCK+DY
Sbjct: 146 ESGGTLTCAGCLNAIDEDEFIQALNQEWHIDCFRCSACDVGLSTWYFEKDGLLFCKDDYG 205
Query: 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
YGEACQ CGQ+++GPVM+ GDHKFHPECF C SC IGDGESYALVERS LYCG CY
Sbjct: 206 AAYGEACQGCGQIITGPVMLAGDHKFHPECFACNSCGAFIGDGESYALVERSKLYCGSCY 265
Query: 125 KRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSA---HCSQGIKLALDTSQPAPPVFSNLC 181
KRQMQP+ R A P RKPH IRLVEI P++ +GIKL LDT+ P P
Sbjct: 266 KRQMQPINRT--ANCPFSRKPHSIRLVEIPPNSSDPEKQRGIKLTLDTT-PNP------- 315
Query: 182 ISEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIAL 241
R C +R+ ++ R + G L+A
Sbjct: 316 ----------RNCGALLRISELM---------------------RNVRGKISKLLA---- 340
Query: 242 GNNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILE 301
S+++V +R C +N+ RL+ +DL+SLH+GDRILE
Sbjct: 341 ---------------------SVMEVLFRLCCHFSNH----RLNMSSDLISLHIGDRILE 375
Query: 302 VNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQMLCV 361
+NGTPV+D+P++ +E LI+++ D ++++ +E +V +
Sbjct: 376 INGTPVKDQPIESIENLIQHS----------------DTVLQLTIEHDPDAVSRRPAYSS 419
Query: 362 VSPFCWLFLAPLRLGEGNM-----RRQEAVEWRVKPLSLKTLTVIGTVMINLGQNIQVVL 416
+ +A R N RR E + GT L +
Sbjct: 420 PTAAMLTSIASPRTSPENKERLFKRRDEGY-------------ISGTRSRQLRR------ 460
Query: 417 GTTIGCYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRI 476
+ P+ SS +R S P + P CDLSRTRS FRVE RI
Sbjct: 461 ----------TRDPMHKERSSSMSR--LLDGSSPTN--PTCDLSRTRS--FRVEPKNQRI 504
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
FRASDLV+G LLG GFFGQV++VTHR+T EVMVLKELYRVDEEA+KNFLKE
Sbjct: 505 FRASDLVKGELLGTGFFGQVFKVTHRDTNEVMVLKELYRVDEEAQKNFLKE--------- 555
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D
Sbjct: 556 ----------------VAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDT 599
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQI 650
+ LPW QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVRE + DF L +I
Sbjct: 600 NEILPWEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARI 655
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340717609|ref|XP_003397273.1| PREDICTED: LIM domain kinase 1-like isoform 3 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 514 bits (1323), Expect = e-143, Method: Compositional matrix adjust.
Identities = 301/656 (45%), Positives = 372/656 (56%), Gaps = 156/656 (23%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E+ LTCAGCLN I EDE++QAL+QEWH DCFRCSACD+ L WYFEKDGLLFCK+DY
Sbjct: 146 ESGGTLTCAGCLNAIDEDEFIQALNQEWHIDCFRCSACDIGLSTWYFEKDGLLFCKDDYG 205
Query: 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
YGEACQ CGQ+++GPVM+ GDHKFHPECF C SC IGDGESYALVERS LYCG CY
Sbjct: 206 AAYGEACQGCGQIITGPVMLAGDHKFHPECFACNSCGAFIGDGESYALVERSKLYCGSCY 265
Query: 125 KRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSA---HCSQGIKLALDTSQPAPPVFSNLC 181
KRQMQP+ R A P RKPH IRLVEI P++ +GIKL LDT+ P P
Sbjct: 266 KRQMQPINRT--ANCPFSRKPHSIRLVEIPPNSSDPEKQRGIKLTLDTT-PNP------- 315
Query: 182 ISEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIAL 241
R C +R+ ++ R + G L+A
Sbjct: 316 ----------RNCGALLRISELM---------------------RNVRGKISKLLA---- 340
Query: 242 GNNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILE 301
S+++V +R C +N+ RL+ +DL+SLH+GDRILE
Sbjct: 341 ---------------------SVMEVLFRLCCHFSNH----RLNMSSDLISLHIGDRILE 375
Query: 302 VNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQMLCV 361
+NGTPV+D+P++ +E LI+++ D ++++ +E +V +
Sbjct: 376 INGTPVKDQPIESIENLIQHS----------------DTVLQLTIEHDPDAVSRRPAYSS 419
Query: 362 VSPFCWLFLAPLRLGEGNM-----RRQEAVEWRVKPLSLKTLTVIGTVMINLGQNIQVVL 416
+ +A R N RR E + GT L +
Sbjct: 420 PTAAMLTSIASPRTSPENKERLFKRRDEGY-------------ISGTRSRQLRR------ 460
Query: 417 GTTIGCYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRI 476
+ P+ SS +R S P + P CDLSRTRS FRVE RI
Sbjct: 461 ----------TRDPMHKERSSSMSR--LLDGSSPTN--PTCDLSRTRS--FRVEPKNQRI 504
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
FRASDLV+G LLG GFFGQV++VTHR+T EVMVLKELYRVDEEA+KNFLKE
Sbjct: 505 FRASDLVKGELLGTGFFGQVFKVTHRDTNEVMVLKELYRVDEEAQKNFLKE--------- 555
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D
Sbjct: 556 ----------------VAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDT 599
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQI 650
+ LPW QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVRE + DF L +I
Sbjct: 600 NEILPWEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARI 655
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383855916|ref|XP_003703456.1| PREDICTED: LIM domain kinase 1-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 510 bits (1313), Expect = e-141, Method: Compositional matrix adjust.
Identities = 297/646 (45%), Positives = 371/646 (57%), Gaps = 146/646 (22%)
Query: 10 LTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGE 69
LTCAGCLN I EDE++QAL+QEWH DCFRCSACD+ L +WYFEKDGLLFCK+DY YGE
Sbjct: 18 LTCAGCLNAIDEDEFIQALNQEWHIDCFRCSACDIGLSSWYFEKDGLLFCKDDYWAAYGE 77
Query: 70 ACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129
ACQ CGQ+++GPVM+ GDHKFHPECF C SC IGDGESYALVERS LYCG CYKRQMQ
Sbjct: 78 ACQGCGQIITGPVMLAGDHKFHPECFACNSCGAFIGDGESYALVERSKLYCGSCYKRQMQ 137
Query: 130 PLGRAKDAAFPMMRKPHCIRLVEIQPSAHC---SQGIKLALDTSQPAPPVFSNLCISEWK 186
P+ R A +P RKPH IRLVEI P++ +GIKL +DT+ P P
Sbjct: 138 PINRI--ANYPFTRKPHSIRLVEIPPNSSDPAKQRGIKLTVDTT-PNP------------ 182
Query: 187 LREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIALGNNHA 246
R C +R+ ++ R + G L+A
Sbjct: 183 -----RNCGALLRISELM---------------------RNVRGKISKLLA--------- 207
Query: 247 LLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILEVNGTP 306
S+++V +R C +N+ RL+ +DL+SLH+GDRILEVNGTP
Sbjct: 208 ----------------SVMEVLFRLCCHFSNH----RLNMSSDLISLHIGDRILEVNGTP 247
Query: 307 VRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQMLCVVSPFC 366
V+D+P++ +E LI+ D ++++ +E +V + SP
Sbjct: 248 VKDQPIENIENLIQ----------------YSDTVLQLTIEHDPDAVSRQPTFS--SPSA 289
Query: 367 WLFLAPLRLGEGNMRRQEAVEWRVKPLSLKTLTVIGTVMINLGQNIQVVLGTTIGCYRGL 426
+ + V R P + + L + + + T
Sbjct: 290 AMLTS-------------IVNPRTSPENKERL---------FKRRDEGYISGTRSRQLRR 327
Query: 427 IKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGP 486
K P+ SS +R S P + CDLSRTRS FRVE RIFRASDLV+G
Sbjct: 328 TKDPMHKERSSSMSR--LLDGSSPTNA--TCDLSRTRS--FRVEPKNQRIFRASDLVKGE 381
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LLG GFFGQV++VTHR+T E+MVLKELYRVDEEA+KNFLKE
Sbjct: 382 LLGTGFFGQVFKVTHRDTNEIMVLKELYRVDEEAQKNFLKE------------------- 422
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+ LL D + LPW QR+
Sbjct: 423 ------VAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRALLHDTSETLPWEQRM 476
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQI 650
+FA+DIAAGM YLHSMN+IHRDLNS NCLVRE + DF L +I
Sbjct: 477 SFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLARI 522
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332025854|gb|EGI66010.1| LIM domain kinase 1 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1272), Expect = e-137, Method: Compositional matrix adjust.
Identities = 299/661 (45%), Positives = 372/661 (56%), Gaps = 167/661 (25%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E+ L CA CLN I EDE++QAL+QEWH DCFRCSACD+ L +WYFEKDGLLFCK+DY
Sbjct: 59 ESRGTLICASCLNAI-EDEFIQALNQEWHIDCFRCSACDIGLSSWYFEKDGLLFCKDDYW 117
Query: 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
YGEACQ+CGQ+++GPVM+ GDHKFHPECF CTSC IGDGESYALVERS LYCG+CY
Sbjct: 118 AAYGEACQDCGQIITGPVMLAGDHKFHPECFACTSCGAFIGDGESYALVERSKLYCGICY 177
Query: 125 KRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSA---HCSQGIKLALDTSQPAPPVFSNLC 181
KRQMQPL RA A +P RKPH IRLVEI PS +GIKL LDT P+P
Sbjct: 178 KRQMQPLNRA--ANYPFARKPHSIRLVEIPPSTTDPDKQRGIKLTLDTV-PSP------- 227
Query: 182 ISEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIAL 241
R+C +R+ ++ R + G L+A
Sbjct: 228 ----------RSCGALLRISELM---------------------RNIRGKISKLLA---- 252
Query: 242 GNNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILE 301
S+++V +R C +N+ RL+ +DL+SLH+GDRILE
Sbjct: 253 ---------------------SVMEVLFRLCCHFSNH----RLNMSSDLISLHIGDRILE 287
Query: 302 VNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQMLCV 361
VNGTPV+D+P++ +E LI+ +DTVLQ L IE + V +
Sbjct: 288 VNGTPVKDQPVENIENLIQ-YSDTVLQ-----------LTIEHDPD------AVSRRPTF 329
Query: 362 VSPFCWLFLAPLRLGEGNMRRQEAVEWRVKPLSLKTLTVIGTVMINLGQNIQVVLGTTIG 421
SP S LT +GT I+ ++ G
Sbjct: 330 SSP-----------------------------SSAMLTYVGTPRISPESKERLFKRRDEG 360
Query: 422 CYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFR--- 478
G AR R RD + S+ + S + ++ + S++R FR
Sbjct: 361 YISG-------ARSRQLRRTRDPMHKERSSSMSRLLEGSSPTNPTY--DLSRTRSFRVEP 411
Query: 479 -------ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQG 531
ASDLV+G LLG+GFFGQV++VTHR+T EVMVLKELYRVDE+A+KNFLKE
Sbjct: 412 KNQRIFRASDLVKGELLGKGFFGQVFKVTHRDTNEVMVLKELYRVDEDAQKNFLKE---- 467
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
VAVLRSLHH+NV+RFIGVLYKD+KL+LVTEYIAGGTL+
Sbjct: 468 ---------------------VAVLRSLHHNNVLRFIGVLYKDKKLHLVTEYIAGGTLRA 506
Query: 592 LLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQ 649
LL D +PLPW QR +FA+DIAAGM YLHSMN+IHRDLNS NCLVRE + DF L +
Sbjct: 507 LLHDTNEPLPWEQRTSFAKDIAAGMAYLHSMNIIHRDLNSHNCLVREDKTVVVADFGLAR 566
Query: 650 I 650
I
Sbjct: 567 I 567
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|198470704|ref|XP_001355371.2| GA14953 [Drosophila pseudoobscura pseudoobscura] gi|198145581|gb|EAL32429.2| GA14953 [Drosophila pseudoobscura pseudoobscura] | Back alignment and taxonomy information |
|---|
Score = 381 bits (978), Expect = e-103, Method: Compositional matrix adjust.
Identities = 255/651 (39%), Positives = 330/651 (50%), Gaps = 140/651 (21%)
Query: 12 CAGCLNNIV----EDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKY 67
C C + ++ E V AL Q+WH DCFRCS CD L NWYFE++GLL+C+EDY ++
Sbjct: 32 CGHCHDQLLPHQEEAPIVMALGQQWHCDCFRCSVCDSHLHNWYFEREGLLYCREDYYARF 91
Query: 68 GEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY-KR 126
G+ACQ C +++GPVMV G+HKFHPECF CT+C IG+GESYALVERS LYCG CY KR
Sbjct: 92 GDACQQCTAVITGPVMVAGEHKFHPECFCCTACGSFIGEGESYALVERSKLYCGHCYGKR 151
Query: 127 QMQPLGRAKDAAFPMMRKP-HCIRLVEIQPSAHCSQGIKL---ALDTSQPAPPVFSNLCI 182
QP+ A KP H IRLVEI A + G+++ +LD P+
Sbjct: 152 SCQPMPADAKARITTAGKPMHSIRLVEIPKDA--TPGLRVDGVSLDDGCPS--------- 200
Query: 183 SEWKLREETRTCVFYVRLYLVLSVIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIALG 242
+R C FY G M E
Sbjct: 201 ----VRITDLICNFY------------------------------------GRMGE---- 216
Query: 243 NNHALLWLWSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILEV 302
HA WL S+ +C G ++ R+D +L +LH+GDRILEV
Sbjct: 217 --HAFAWLSSVA---------------DHCCG-----AIYRID--VNLTNLHIGDRILEV 252
Query: 303 NGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIEVCLERFSCSVEVKQMLCVV 362
NGTPV D +++++ LIR + + +LQ + + ++VC SCS Q C
Sbjct: 253 NGTPVSDSSVEQIDKLIR-SNEKMLQLTVEHD------PVQVCR---SCSQADIQRACSA 302
Query: 363 SPFCWLFLAPLRLGEGNMRRQE--------AVEWRVKPLSLK------TLTVIGTVMINL 408
S E R +E E K L+ + T I +
Sbjct: 303 STLVLPLSTSASSVEVGGRERERLYKSSGTGAEQSAKARKLRQATNATSSTTITKPAAAV 362
Query: 409 GQNIQVVLGTTIGCYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPAC-DLSRTRSRSF 467
+ + + R S D + + S P DLSRT+S
Sbjct: 363 PAAVPAAEAEAATATAHMTQFKDKERCSSMSKLLDDQHTAQQHSAHPQLYDLSRTQS--C 420
Query: 468 RVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKE 527
RV RIFRASDLV G LG+GFFG+V++VTHR +GEVMVLKEL+R DEEA++NF+KE
Sbjct: 421 RVVQKPQRIFRASDLVIGEKLGEGFFGKVFKVTHRLSGEVMVLKELHRADEEAQRNFIKE 480
Query: 528 SKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 587
VAVLR L H +V++FIGVLYKD+KL++VTEY+AGG
Sbjct: 481 -------------------------VAVLRLLDHQHVLKFIGVLYKDKKLHMVTEYVAGG 515
Query: 588 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
LKEL+ D + L W QRV ARDIA GM+YLHSMN+IHRDLNS NCLVRE
Sbjct: 516 CLKELIHDSSESLSWPQRVCLARDIACGMSYLHSMNIIHRDLNSMNCLVRE 566
|
Source: Drosophila pseudoobscura pseudoobscura Species: Drosophila pseudoobscura Genus: Drosophila Family: Drosophilidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 681 | ||||||
| FB|FBgn0041203 | 1257 | LIMK1 "LIM-kinase1" [Drosophil | 0.243 | 0.132 | 0.528 | 2.6e-102 | |
| ZFIN|ZDB-GENE-061212-3 | 648 | limk1a "LIM domain kinase 1a" | 0.233 | 0.245 | 0.484 | 3.7e-94 | |
| MGI|MGI:104572 | 647 | Limk1 "LIM-domain containing, | 0.249 | 0.262 | 0.450 | 5.3e-93 | |
| RGD|62055 | 647 | Limk1 "LIM domain kinase 1" [R | 0.249 | 0.262 | 0.445 | 2.1e-92 | |
| UNIPROTKB|P53669 | 647 | Limk1 "LIM domain kinase 1" [R | 0.249 | 0.262 | 0.445 | 2.1e-92 | |
| UNIPROTKB|I3LHP5 | 638 | LIMK1 "Uncharacterized protein | 0.245 | 0.261 | 0.447 | 2.6e-92 | |
| UNIPROTKB|E1BC64 | 647 | LIMK1 "Uncharacterized protein | 0.249 | 0.262 | 0.441 | 2.7e-92 | |
| UNIPROTKB|P53667 | 647 | LIMK1 "LIM domain kinase 1" [H | 0.249 | 0.262 | 0.445 | 2.7e-92 | |
| UNIPROTKB|E9PC47 | 677 | LIMK1 "LIM domain kinase 1" [H | 0.245 | 0.246 | 0.447 | 1.8e-91 | |
| UNIPROTKB|E2RQT0 | 647 | LIMK1 "Uncharacterized protein | 0.249 | 0.262 | 0.439 | 7.3e-91 |
| FB|FBgn0041203 LIMK1 "LIM-kinase1" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 2.6e-102, Sum P(4) = 2.6e-102
Identities = 94/178 (52%), Positives = 117/178 (65%)
Query: 12 CAGCLNNIV---EDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYG 68
CA C ++ E+ V AL Q+WH DCFRCS C+ L NWYFE++GLL+C+EDY G++G
Sbjct: 33 CAHCRGQLLPHPEEPIVMALGQQWHCDCFRCSVCEGHLHNWYFEREGLLYCREDYYGRFG 92
Query: 69 EACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY-KRQ 127
+ACQ C +++GPVMV G+HKFHPECF CT+C IG+GESYALVERS LYCG CY KR
Sbjct: 93 DACQQCMAVITGPVMVAGEHKFHPECFCCTACGSFIGEGESYALVERSKLYCGQCYGKRS 152
Query: 128 MQPLGRAKDAAFPMMRKP-HCIRLVEIQPSAHCSQGIKL---ALDTSQPAPPVFSNLC 181
QP AK A KP H IRLVEI A + G+++ ALD P + C
Sbjct: 153 CQPAD-AK-ARITTAGKPMHSIRLVEIPKDA--TPGLRVDGVALDDGCPTVRITDLFC 206
|
|
| ZFIN|ZDB-GENE-061212-3 limk1a "LIM domain kinase 1a" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 426 (155.0 bits), Expect = 3.7e-94, Sum P(4) = 3.7e-94
Identities = 79/163 (48%), Positives = 102/163 (62%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 71
C+GC I +D+Y+QALS +WHT C RC C L +WY+EKDG LFCK+DY K+GE C
Sbjct: 27 CSGCGQQIYDDQYLQALSSDWHTLCCRCCECGSSLSHWYYEKDGRLFCKKDYWAKFGELC 86
Query: 72 QNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130
C + +S G +MV G+ K+HPECF C SC IGDG++YALVERS LY G CY R +
Sbjct: 87 HGCSEPISTGLIMVAGEQKYHPECFSCLSCGAFIGDGDTYALVERSKLYSGHCYYRSIVT 146
Query: 131 LGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALD-TSQP 172
D+ P R PH + LV I S +G +++D S P
Sbjct: 147 PVSLPDS--PCSRIPHTVTLVSIPASTDGKRGFSVSIDQASSP 187
|
|
| MGI|MGI:104572 Limk1 "LIM-domain containing, protein kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 418 (152.2 bits), Expect = 5.3e-93, Sum P(4) = 5.3e-93
Identities = 78/173 (45%), Positives = 106/173 (61%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E E+ CA C I + +Y+QAL+ +WH DCFRC C V L + Y+EKDG LFCK+DY
Sbjct: 18 EGSELPVCASCGQRIYDGQYLQALNADWHADCFRCCECSVSLSHQYYEKDGQLFCKKDYW 77
Query: 65 GKYGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
+YGE+C C + ++ G VMV G+ K+HPECF C +C IGDG++Y LVE S LYCG C
Sbjct: 78 ARYGESCHGCSEHITKGLVMVAGELKYHPECFICLACGNFIGDGDTYTLVEHSKLYCGQC 137
Query: 124 YKRQM-QPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAPP 175
Y + + P+ P PH + LV I SAH +G+ +++D PP
Sbjct: 138 YYQTVVTPVIEQILPDSPGSHLPHTVTLVSIPASAHGKRGLSVSIDPPH-GPP 189
|
|
| RGD|62055 Limk1 "LIM domain kinase 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 2.1e-92, Sum P(4) = 2.1e-92
Identities = 77/173 (44%), Positives = 106/173 (61%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E E+ CA C +I + +Y+QAL+ +WH DCFRC C L + Y+EKDG LFCK+DY
Sbjct: 18 EGSELPVCASCSQSIYDGQYLQALNADWHADCFRCCECSTSLSHQYYEKDGQLFCKKDYW 77
Query: 65 GKYGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
+YGE+C C + ++ G VMV G+ K+HPECF C +C IGDG++Y LVE S LYCG C
Sbjct: 78 ARYGESCHGCSEHITKGLVMVGGELKYHPECFICLACGNFIGDGDTYTLVEHSKLYCGQC 137
Query: 124 YKRQM-QPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAPP 175
Y + + P+ P PH + LV I SAH +G+ +++D PP
Sbjct: 138 YYQTVVTPVIEQILPDSPGSHLPHTVTLVSIPASAHGKRGLSVSIDPPH-GPP 189
|
|
| UNIPROTKB|P53669 Limk1 "LIM domain kinase 1" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 2.1e-92, Sum P(4) = 2.1e-92
Identities = 77/173 (44%), Positives = 106/173 (61%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E E+ CA C +I + +Y+QAL+ +WH DCFRC C L + Y+EKDG LFCK+DY
Sbjct: 18 EGSELPVCASCSQSIYDGQYLQALNADWHADCFRCCECSTSLSHQYYEKDGQLFCKKDYW 77
Query: 65 GKYGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
+YGE+C C + ++ G VMV G+ K+HPECF C +C IGDG++Y LVE S LYCG C
Sbjct: 78 ARYGESCHGCSEHITKGLVMVGGELKYHPECFICLACGNFIGDGDTYTLVEHSKLYCGQC 137
Query: 124 YKRQM-QPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAPP 175
Y + + P+ P PH + LV I SAH +G+ +++D PP
Sbjct: 138 YYQTVVTPVIEQILPDSPGSHLPHTVTLVSIPASAHGKRGLSVSIDPPH-GPP 189
|
|
| UNIPROTKB|I3LHP5 LIMK1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 413 (150.4 bits), Expect = 2.6e-92, Sum P(4) = 2.6e-92
Identities = 76/170 (44%), Positives = 104/170 (61%)
Query: 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKY 67
E+ CA C I + +Y+QAL+ +WH DCFRC C L + Y+EKDG LFCK+DY +Y
Sbjct: 12 ELPVCASCGQRIYDGQYLQALNADWHADCFRCCECSASLSHQYYEKDGQLFCKKDYWARY 71
Query: 68 GEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKR 126
GE+C C + ++ G VMV G+ K+HPECF C +C IGDG++Y LVE S LYCG CY +
Sbjct: 72 GESCHGCSEHITKGLVMVAGELKYHPECFICLTCGTFIGDGDTYTLVEHSKLYCGHCYYQ 131
Query: 127 QM-QPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAPP 175
+ P+ P PH + LV I SAH +G+ +++D PP
Sbjct: 132 TVVTPVIEQILPDSPGSHLPHTVTLVSIPASAHGKRGLSVSIDPPH-GPP 180
|
|
| UNIPROTKB|E1BC64 LIMK1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 2.7e-92, Sum P(4) = 2.7e-92
Identities = 76/172 (44%), Positives = 104/172 (60%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E E+ CA C I + +Y+QAL+ +WH DCFRC C L + Y+EKDG LFCK+DY
Sbjct: 18 EGSELPVCASCGQRIYDGQYLQALNADWHADCFRCCECSASLSHQYYEKDGQLFCKKDYW 77
Query: 65 GKYGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
+YGE+C C + ++ G VMV G+ K+HPECF C +C IGDG++Y LVE S LYCG C
Sbjct: 78 ARYGESCHGCSEHITKGLVMVAGELKYHPECFICLTCGTFIGDGDTYTLVEHSKLYCGHC 137
Query: 124 YKRQM-QPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAP 174
Y + + P+ P PH + LV I SAH +G+ +++D P
Sbjct: 138 YYQTVVTPVIEQILPDSPGSHLPHTVTLVSIPASAHGKRGLSVSIDPPHGLP 189
|
|
| UNIPROTKB|P53667 LIMK1 "LIM domain kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 414 (150.8 bits), Expect = 2.7e-92, Sum P(4) = 2.7e-92
Identities = 77/173 (44%), Positives = 104/173 (60%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E E+ CA C I + +Y+QAL+ +WH DCFRC C L + Y+EKDG LFCK+DY
Sbjct: 18 EGSELPVCASCGQRIYDGQYLQALNADWHADCFRCCDCSASLSHQYYEKDGQLFCKKDYW 77
Query: 65 GKYGEACQNCG-QMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
+YGE+C C Q+ G VMV G+ K+HPECF C +C IGDG++Y LVE S LYCG C
Sbjct: 78 ARYGESCHGCSEQITKGLVMVAGELKYHPECFICLTCGTFIGDGDTYTLVEHSKLYCGHC 137
Query: 124 YKRQM-QPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAPP 175
Y + + P+ P PH + LV I S+H +G+ +++D PP
Sbjct: 138 YYQTVVTPVIEQILPDSPGSHLPHTVTLVSIPASSHGKRGLSVSIDPPH-GPP 189
|
|
| UNIPROTKB|E9PC47 LIMK1 "LIM domain kinase 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 412 (150.1 bits), Expect = 1.8e-91, Sum P(4) = 1.8e-91
Identities = 76/170 (44%), Positives = 103/170 (60%)
Query: 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKY 67
E+ CA C I + +Y+QAL+ +WH DCFRC C L + Y+EKDG LFCK+DY +Y
Sbjct: 51 ELPVCASCGQRIYDGQYLQALNADWHADCFRCCDCSASLSHQYYEKDGQLFCKKDYWARY 110
Query: 68 GEACQNCG-QMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKR 126
GE+C C Q+ G VMV G+ K+HPECF C +C IGDG++Y LVE S LYCG CY +
Sbjct: 111 GESCHGCSEQITKGLVMVAGELKYHPECFICLTCGTFIGDGDTYTLVEHSKLYCGHCYYQ 170
Query: 127 QM-QPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAPP 175
+ P+ P PH + LV I S+H +G+ +++D PP
Sbjct: 171 TVVTPVIEQILPDSPGSHLPHTVTLVSIPASSHGKRGLSVSIDPPH-GPP 219
|
|
| UNIPROTKB|E2RQT0 LIMK1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 401 (146.2 bits), Expect = 7.3e-91, Sum P(4) = 7.3e-91
Identities = 76/173 (43%), Positives = 104/173 (60%)
Query: 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYN 64
E E+ CA C I + +Y+QAL+ +WH DCFR C+ L + Y++KDG LFCK DY
Sbjct: 18 EGSELPMCASCGQRIYDGQYLQALNADWHADCFRGCECNASLSHPYYQKDGQLFCKRDYW 77
Query: 65 GKYGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
+YGEAC C + ++ G VMV G+ K+HPECF C +C IGDG++Y LVE S LYCG C
Sbjct: 78 ARYGEACHGCSEHITKGLVMVAGELKYHPECFICLTCGTFIGDGDTYTLVEHSKLYCGHC 137
Query: 124 YKRQM-QPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAPP 175
Y + + P P R PH + LV I S H +G+ +++D + PP
Sbjct: 138 YYQTVVTPAIEQVLPDSPGSRLPHTVTLVSIPASPHGKRGLSVSIDPAH-GPP 189
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 681 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-33 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-31 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-29 | |
| cd09365 | 54 | cd09365, LIM2_LIMK, The second LIM domain of LIMK | 4e-27 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-27 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-26 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-26 | |
| cd09364 | 53 | cd09364, LIM1_LIMK, The first LIM domain of LIMK ( | 1e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-22 | |
| cd09465 | 59 | cd09465, LIM2_LIMK2, The second LIM domain of LIMK | 4e-22 | |
| cd09462 | 74 | cd09462, LIM1_LIMK1, The first LIM domain of LIMK1 | 4e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-17 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-17 | |
| cd09464 | 55 | cd09464, LIM2_LIMK1, The second LIM domain of LIMK | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-16 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-15 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-15 | |
| cd09463 | 53 | cd09463, LIM1_LIMK2, The first LIM domain of LIMK2 | 3e-15 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-15 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-15 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-14 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-14 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 9e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-13 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-13 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-13 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-12 | |
| cd08368 | 53 | cd08368, LIM, LIM is a small protein-protein inter | 1e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-12 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-11 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-10 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-10 | |
| pfam00412 | 58 | pfam00412, LIM, LIM domain | 3e-10 | |
| cd09329 | 52 | cd09329, LIM3_abLIM, The third LIM domain of actin | 3e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-09 | |
| cd09369 | 54 | cd09369, LIM1_Lhx2_Lhx9, The first LIM domain of L | 2e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-09 | |
| smart00132 | 54 | smart00132, LIM, Zinc-binding domain present in Li | 8e-09 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-09 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-09 | |
| cd08368 | 53 | cd08368, LIM, LIM is a small protein-protein inter | 1e-08 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-08 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd09336 | 53 | cd09336, LIM1_Paxillin_like, The first LIM domain | 2e-08 | |
| cd09386 | 55 | cd09386, LIM1_LMO4, The first LIM domain of LMO4 ( | 2e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-08 | |
| cd09466 | 56 | cd09466, LIM1_Lhx3a, The first LIM domain of Lhx3a | 2e-08 | |
| cd09469 | 64 | cd09469, LIM1_Lhx2, The first LIM domain of Lhx2 | 3e-08 | |
| cd09470 | 54 | cd09470, LIM1_Lhx9, The first LIM domain of Lhx9 | 3e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-08 | |
| cd00992 | 82 | cd00992, PDZ_signaling, PDZ domain found in a vari | 5e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-07 | |
| cd09468 | 52 | cd09468, LIM1_Lhx4, The first LIM domain of Lhx4 | 1e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd09467 | 55 | cd09467, LIM1_Lhx3b, The first LIM domain of Lhx3b | 1e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd09368 | 52 | cd09368, LIM1_Lhx3_Lhx4, The first LIM domain of L | 1e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-07 | |
| cd09367 | 52 | cd09367, LIM1_Lhx1_Lhx5, The first LIM domain of L | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd09338 | 53 | cd09338, LIM3_Paxillin_like, The third LIM domain | 2e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-07 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd09388 | 55 | cd09388, LIM1_LMO1_LMO3, The first LIM domain of L | 5e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-07 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 9e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-06 | |
| cd09396 | 53 | cd09396, LIM_DA1, The Lim domain of DA1 | 1e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-06 | |
| cd09371 | 53 | cd09371, LIM1_Lmx1b, The first LIM domain of Lmx1b | 1e-06 | |
| cd09372 | 53 | cd09372, LIM2_FBLP-1, The second LIM domain of the | 2e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-06 | |
| pfam00412 | 58 | pfam00412, LIM, LIM domain | 3e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-06 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-06 | |
| cd09330 | 56 | cd09330, LIM4_abLIM, The fourth LIM domain of acti | 3e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-06 | |
| cd09409 | 53 | cd09409, LIM3_Paxillin, The third LIM domain of pa | 5e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-06 | |
| cd09340 | 58 | cd09340, LIM1_Testin_like, The first LIM domain of | 7e-06 | |
| cd09378 | 55 | cd09378, LIM2_Lmx1a_Lmx1b, The second LIM domain o | 7e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-06 | |
| cd09362 | 52 | cd09362, LIM2_Enigma_like, The second LIM domain o | 8e-06 | |
| smart00228 | 85 | smart00228, PDZ, Domain present in PSD-95, Dlg, an | 8e-06 | |
| smart00132 | 54 | smart00132, LIM, Zinc-binding domain present in Li | 1e-05 | |
| cd09394 | 55 | cd09394, LIM1_Rga, The first LIM domain of Rga GTP | 1e-05 | |
| cd09366 | 55 | cd09366, LIM1_Isl, The first LIM domain of Isl, a | 1e-05 | |
| cd09406 | 55 | cd09406, LIM1_Leupaxin, The first LIM domain of Le | 1e-05 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-05 | |
| cd09337 | 52 | cd09337, LIM2_Paxillin_like, The second LIM domain | 1e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-05 | |
| cd09361 | 52 | cd09361, LIM1_Enigma_like, The first LIM domain of | 1e-05 | |
| cd09370 | 52 | cd09370, LIM1_Lmx1a, The first LIM domain of Lmx1a | 2e-05 | |
| cd09363 | 54 | cd09363, LIM3_Enigma_like, The third LIM domain of | 2e-05 | |
| cd09374 | 55 | cd09374, LIM2_Isl, The second LIM domain of Isl, a | 2e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-05 | |
| cd09392 | 53 | cd09392, LIM2_Lrg1p_like, The second LIM domain of | 2e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-05 | |
| cd09376 | 56 | cd09376, LIM2_Lhx3_Lhx4, The second LIM domain of | 3e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-05 | |
| cd09327 | 52 | cd09327, LIM1_abLIM, The first LIM domain of actin | 4e-05 | |
| cd09401 | 53 | cd09401, LIM_TLP_like, The LIM domains of thymus L | 4e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-05 | |
| cd09457 | 52 | cd09457, LIM2_ENH, The second LIM domain of the En | 5e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-05 | |
| cd09361 | 52 | cd09361, LIM1_Enigma_like, The first LIM domain of | 6e-05 | |
| cd09840 | 54 | cd09840, LIM2_CRP2, The second LIM domain of Cyste | 6e-05 | |
| cd09392 | 53 | cd09392, LIM2_Lrg1p_like, The second LIM domain of | 7e-05 | |
| cd09375 | 56 | cd09375, LIM2_Lhx1_Lhx5, The second LIM domain of | 7e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-05 | |
| cd09334 | 54 | cd09334, LIM4_PINCH, The fourth LIM domain of prot | 9e-05 | |
| cd09456 | 52 | cd09456, LIM2_Enigma, The second LIM domain of Eni | 9e-05 | |
| cd09410 | 53 | cd09410, LIM3_Leupaxin, The third LIM domain of Le | 1e-04 | |
| cd09452 | 52 | cd09452, LIM1_Enigma, The first LIM domain of Enig | 1e-04 | |
| cd09453 | 52 | cd09453, LIM1_ENH, The first LIM domain of the Eni | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd09341 | 56 | cd09341, LIM2_Testin_like, The second LIM domain o | 1e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-04 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-04 | |
| cd00136 | 70 | cd00136, PDZ, PDZ domain, also called DHR (Dlg hom | 2e-04 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-04 | |
| cd09403 | 54 | cd09403, LIM2_CRP, The second LIM domain of Cystei | 2e-04 | |
| cd09384 | 56 | cd09384, LIM1_LMO2, The first LIM domain of LMO2 ( | 2e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-04 | |
| cd09461 | 54 | cd09461, LIM3_Enigma_like_1, The third LIM domain | 2e-04 | |
| cd09482 | 54 | cd09482, LIM2_CRP3, The second LIM domain of Cyste | 2e-04 | |
| cd09373 | 54 | cd09373, LIM1_AWH, The first LIM domain of Arrowhe | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 2e-04 | |
| pfam00595 | 80 | pfam00595, PDZ, PDZ domain (Also known as DHR or G | 2e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-04 | |
| cd09335 | 54 | cd09335, LIM5_PINCH, The fifth LIM domain of prote | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-04 | |
| cd09408 | 52 | cd09408, LIM2_Leupaxin, The second LIM domain of L | 5e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-04 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-04 | |
| cd09407 | 52 | cd09407, LIM2_Paxillin, The second LIM domain of p | 5e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-04 | |
| cd09360 | 52 | cd09360, LIM_ALP_like, The LIM domain of ALP (acti | 5e-04 | |
| cd09416 | 56 | cd09416, LIM2_Testin, The second LIM domain of Tes | 6e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-04 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 8e-04 | |
| cd09473 | 56 | cd09473, LIM2_Lhx4, The second LIM domain of Lhx4 | 9e-04 | |
| cd09374 | 55 | cd09374, LIM2_Isl, The second LIM domain of Isl, a | 0.001 | |
| cd09414 | 58 | cd09414, LIM1_LIMPETin, The first LIM domain of pr | 0.001 | |
| cd00988 | 85 | cd00988, PDZ_CTP_protease, PDZ domain of C-termina | 0.001 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 0.001 | |
| cd09424 | 58 | cd09424, LIM2_FHL1, The second LIM domain of Four | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.001 | |
| cd09332 | 52 | cd09332, LIM2_PINCH, The second LIM domain of prot | 0.001 | |
| cd09405 | 54 | cd09405, LIM1_Paxillin, The first LIM domain of pa | 0.001 | |
| cd09387 | 55 | cd09387, LIM2_LMO4, The second LIM domain of LMO4 | 0.001 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.002 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 | |
| cd09460 | 55 | cd09460, LIM3_ZASP_Cypher, The third LIM domain of | 0.002 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.002 | |
| cd09353 | 60 | cd09353, LIM2_Zyxin, The second LIM domain of Zyxi | 0.002 | |
| cd09328 | 56 | cd09328, LIM2_abLIM, The second LIM domain on acti | 0.002 | |
| cd09328 | 56 | cd09328, LIM2_abLIM, The second LIM domain on acti | 0.002 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd09355 | 53 | cd09355, LIM2_Ajuba_like, The second LIM domain of | 0.002 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 0.002 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.002 | |
| cd09433 | 58 | cd09433, LIM4_FHL2, The fourth LIM domain of Four | 0.002 | |
| cd09452 | 52 | cd09452, LIM1_Enigma, The first LIM domain of Enig | 0.003 | |
| cd09459 | 55 | cd09459, LIM3_ENH, The third LIM domain of the Eni | 0.003 | |
| cd09413 | 58 | cd09413, LIM1_Testin, The first LIM domain of Test | 0.003 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 0.003 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.003 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| cd09326 | 53 | cd09326, LIM_CRP_like, The LIM domains of Cysteine | 0.003 | |
| cd09393 | 56 | cd09393, LIM3_Lrg1p_like, The third LIM domain of | 0.004 | |
| cd09352 | 54 | cd09352, LIM1_Ajuba_like, The first LIM domain of | 0.004 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 0.004 | |
| cd09339 | 52 | cd09339, LIM4_Paxillin_like, The fourth LIM domain | 0.004 | |
| cd09415 | 59 | cd09415, LIM1_Prickle, The first LIM domain of Pri | 0.004 | |
| cd09395 | 53 | cd09395, LIM2_Rga, The second LIM domain of Rga GT | 0.004 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.004 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.004 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-33
Identities = 55/162 (33%), Positives = 78/162 (48%), Gaps = 34/162 (20%)
Query: 482 LVRGPLLGQGFFGQVYRVTHRETGE-------VMVLKELYRVDEEAEKNFLKESKQGLIY 534
L G LG+G FG+VY+ T + GE V LKE EE + FL+E
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA--SEEEREEFLEE------- 51
Query: 535 LIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ 594
++++ L H N++R +GV + L +VTEY+ GG L + L+
Sbjct: 52 ------------------ASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR 93
Query: 595 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
G+ L + A IA GM YL S N +HRDL ++NCLV
Sbjct: 94 KHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLV 135
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-31
Identities = 47/168 (27%), Positives = 77/168 (45%), Gaps = 29/168 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKN-FLKESKQGLIYLIDLGSHGLINN 546
LG+G FG VY ++TG+ + +K + + D + L+E
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLRE------------------- 41
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+ +L+ L+H N+++ GV + L LV EY GG+LK+LL++ L + +
Sbjct: 42 ------IEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL 95
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF---DFHLGQIY 651
I G+ YLHS +IHRDL +N L+ DF L ++
Sbjct: 96 RILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLL 143
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 51/156 (32%), Positives = 74/156 (47%), Gaps = 34/156 (21%)
Query: 488 LGQGFFGQVYR---VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
LG+G FG+VY+ +V V LKE E+ + FL+E++
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKE--DASEQQIEEFLREAR----------- 53
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL 600
++R L H NV++ +GV ++ L +V EY+ GG L L+ L
Sbjct: 54 --------------IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL 99
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
++FA IA GM YL S N IHRDL ++NCLV
Sbjct: 100 SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 135
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 54/159 (33%), Positives = 80/159 (50%), Gaps = 35/159 (22%)
Query: 488 LGQGFFGQVYRVTHRETG---EVMV----LKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
LG+G FG+VY+ T + G EV V LKE E+ + FL+E++
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKE--DASEQQIEEFLREAR----------- 53
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQP 599
++R L H N+++ +GV ++ L +V EY+ GG L + L+ +
Sbjct: 54 --------------IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE 99
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L ++FA IA GM YL S N IHRDL ++NCLV E
Sbjct: 100 LSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGE 138
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|188751 cd09365, LIM2_LIMK, The second LIM domain of LIMK (LIM domain Kinase ) | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-27
Identities = 39/54 (72%), Positives = 45/54 (83%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
C C Q+++GPVMV GDHKFHPECF C+SC IGDG+SYALVERS LYCG+CY
Sbjct: 1 CHGCSQIITGPVMVAGDHKFHPECFSCSSCKAFIGDGDSYALVERSKLYCGVCY 54
|
The second LIM domain of LIMK (LIM domain Kinase ): LIMK protein family is comprised of two members LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerization. LIMKs can function in both cytoplasm and nucleus and are expressed in all tissues. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. However, LIMK1 and LIMk2 have different cellular locations. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The LIM domains of LIMK have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (276), Expect = 6e-27
Identities = 54/165 (32%), Positives = 77/165 (46%), Gaps = 41/165 (24%)
Query: 488 LGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
LG+G FG+VY+ + ++ V LKE EE K+FLKE++
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEAR------------ 48
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ------- 594
V++ L H NV+R +GV ++ L LV EY+ GG L + L+
Sbjct: 49 -------------VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFP 95
Query: 595 -DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L ++FA IA GM YL S +HRDL ++NCLV E
Sbjct: 96 SPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGE 140
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 27/151 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
LG+G FG+VY ++TG+++ +K + + ++ + L+E
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILRE------------------ 47
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
+ +L+ L H N++R V + KL LV EY GG L +LL+ G L +
Sbjct: 48 -------IKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEA 99
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ R I + + YLHS ++HRDL +N L+
Sbjct: 100 RFYLRQILSALEYLHSKGIVHRDLKPENILL 130
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 24/159 (15%)
Query: 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
LG G FG VY+ H+ TG+++ +K L + E+++K+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA--------------- 45
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
++ +LR L H N++R I L LV EY GG L + L G PL
Sbjct: 46 --------RREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGGPLS 96
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ A I G+ YLHS +IHRDL +N L+ E G
Sbjct: 97 EDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENG 135
|
Length = 260 |
| >gnl|CDD|188750 cd09364, LIM1_LIMK, The first LIM domain of LIMK (LIM domain Kinase ) | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 1e-23
Identities = 33/52 (63%), Positives = 41/52 (78%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
CAGC I++ +YVQAL+Q+WH DCFRCS C L NWYFEKDG L+C++DY
Sbjct: 1 CAGCRGKILDSQYVQALNQDWHCDCFRCSVCSDSLSNWYFEKDGKLYCRKDY 52
|
The first LIM domain of LIMK (LIM domain Kinase ): LIMK protein family is comprised of two members LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerisation. LIMKs can function in both cytoplasm and nucleus and are expressed in all tissues. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. However, LIMK1 and LIMk2 have different cellular locations. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The LIM domains of LIMK have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 6e-23
Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 25/154 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G FG+VY+ H+ TG+ + +K + +E ++ + E
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINE-------------------- 47
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ +L+ H N++++ G K +L +V E+ +GG+LK+LL+ Q L Q
Sbjct: 48 -----IQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY 102
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+++ G+ YLHS +IHRD+ + N L+ G
Sbjct: 103 VCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE 136
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 2e-22
Identities = 52/162 (32%), Positives = 79/162 (48%), Gaps = 26/162 (16%)
Query: 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
+ RG LLG+G FG VY ++TGE+M +K + E + +E +
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSV-----ELSGDSEEELEA---------- 45
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIAGGTLKELLQDPGQ 598
L ++ +L SL H N++R+ G + K LN+ EY++GG+L LL+ G
Sbjct: 46 ------LE--REIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG- 96
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
LP + R I G+ YLHS ++HRD+ N LV G
Sbjct: 97 KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG 138
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|188849 cd09465, LIM2_LIMK2, The second LIM domain of LIMK2 (LIM domain Kinase 2) | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 4e-22
Identities = 32/59 (54%), Positives = 43/59 (72%)
Query: 66 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
K+GE C C +M+GP MV G++K+HPECF C SC I DG++YALV+ + LYCG C+
Sbjct: 1 KFGELCHGCSLLMTGPAMVAGEYKYHPECFACMSCKVIIEDGDTYALVQHTTLYCGKCH 59
|
The second LIM domain of LIMK2 (LIM domain Kinase 2): LIMK2 is a member of the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, altering the rate of actin depolymerisation. LIMK activity is activated by phosphorylation of a threonine residue within the activation loop of the kinase by p21-activated kinases 1 and 4 and by Rho kinase. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK2 is expressed in all tissues. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The activity of LIM kinase 2 to regulate cofilin phosphorylation is inhibited by the direct binding of Par-3. LIMK2 activation promotes cell cycle progression. The phenotype of Limk2 knockout mice shows a defect in spermatogenesis. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 59 |
| >gnl|CDD|188846 cd09462, LIM1_LIMK1, The first LIM domain of LIMK1 (LIM domain Kinase 1) | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 4e-20
Identities = 31/63 (49%), Positives = 42/63 (66%)
Query: 1 MEDSETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCK 60
M + E + CA C +I + +Y+QAL+ +WH DCFRC C L +WY+EKDG LFCK
Sbjct: 11 MGEEEGNVLPVCASCGQSIYDGQYLQALNSDWHADCFRCCECGASLSHWYYEKDGRLFCK 70
Query: 61 EDY 63
+DY
Sbjct: 71 KDY 73
|
The first LIM domain of LIMK1 (LIM domain Kinase 1): LIMK1 belongs to the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerization. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK1 is expressed in all tissues and is localized to focal adhesions in the cell. LIMK1 can form homodimers upon binding of HSP90 and is activated by Rho effector Rho kinase and MAPKAPK2. LIMK1 is important for normal central nervous system development, and its deletion has been implicated in the development of the human genetic disorder Williams syndrome. Moreover, LIMK1 up-regulates the promoter activity of urokinase type plasminogen activator and induces its mRNA and protein expression in breast cancer cells. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 74 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 2e-19
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 30/152 (19%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKE--LYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G FG+VY V + G++ VLKE L + E+ ++ L E
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNE----------------- 49
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLP 601
V +L+ L+H N+I++ + KL +V EY GG L + ++ G+P P
Sbjct: 50 --------VKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFP 101
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
Q +++ + + YLHS ++HRD+ QN
Sbjct: 102 EEQILDWFVQLCLALKYLHSRKILHRDIKPQN 133
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 29/154 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE--KNFLKESKQGLIYLIDLGSHGLI 544
+G+G FG VY+ + EV V + R + + FL+E++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAV--KTCRSTLPPDLKRKFLQEAE--------------- 44
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+L+ H N+++ IGV + + + +V E + GG+L L+ L +
Sbjct: 45 ----------ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKK 94
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ + D AAGM YL S N IHRDL ++NCLV E
Sbjct: 95 LLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGE 128
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 21/160 (13%)
Query: 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLK--ELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
++G L+G G FG VY + +GE+M +K EL V ++ K+ ++ +
Sbjct: 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDR-----KRSMLDALA--- 54
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL 600
++A+L+ L H N+++++G LN+ EY+ GG++ LL + G
Sbjct: 55 ----------REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA-F 103
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
NF R I G+ YLH+ +IHRD+ N LV G
Sbjct: 104 EETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG 143
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 52/160 (32%), Positives = 81/160 (50%), Gaps = 30/160 (18%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
SDL R +LGQG G VY+V H+ TG++ LK+++ +E + KQ
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFR------KQ--------- 45
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
L+ L LRS V++ G YK+ ++++V EY+ GG+L +LL+ G
Sbjct: 46 ---LLRELK------TLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG-- 94
Query: 600 LPWGQRV--NFARDIAAGMTYLHSM-NLIHRDLNSQNCLV 636
+ V AR I G+ YLH+ ++IHRD+ N L+
Sbjct: 95 -KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI 133
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-18
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 30/155 (19%)
Query: 488 LGQGFFGQVYRVTHR----ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
LG+G FG+V + TGE + +K L EE ++ +
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER---------------- 55
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLP 601
++ +LR+L H N++++ GV K R L L+ EY+ G+L++ LQ +
Sbjct: 56 --------EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQIN 107
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + F+ I GM YL S IHRDL ++N LV
Sbjct: 108 LKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV 142
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 21/153 (13%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
+G LLG G FG VY + + G+ +KE+ D+
Sbjct: 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQT------------------GQEA 45
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
+ L ++A+L L H N+++++G ++ L + E + GG+L +LL+ G P
Sbjct: 46 VKQLE--QEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEP 102
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ R I G+ YLH N +HRD+ N LV
Sbjct: 103 VIRLYTRQILLGLEYLHDRNTVHRDIKGANILV 135
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 31/172 (18%)
Query: 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
+L G +G+G FG V +R G+ + +K L A+ FL E+
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQA-FLAEAS----------- 52
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QP 599
V+ +L H N+++ +GV+ + L +VTEY+A G+L + L+ G
Sbjct: 53 --------------VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAV 98
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--VGSGFDFHLGQ 649
+ Q++ FA D+ GM YL N +HRDL ++N LV E V DF L +
Sbjct: 99 ITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 49/154 (31%), Positives = 74/154 (48%), Gaps = 32/154 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMV--LKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
LG G FG+V+ T T +V V LK + EA FL+E+
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKP-GTMSPEA---FLQEA----------------- 52
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQ 604
+++ L H +++ V ++ + +VTEY++ G+L + L+ G+ L Q
Sbjct: 53 --------QIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQ 104
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
V+ A IA GM YL S N IHRDL ++N LV E
Sbjct: 105 LVDMAAQIAEGMAYLESRNYIHRDLAARNILVGE 138
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|188848 cd09464, LIM2_LIMK1, The second LIM domain of LIMK1 (LIM domain Kinase 1) | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-17
Identities = 31/55 (56%), Positives = 38/55 (69%), Gaps = 1/55 (1%)
Query: 71 CQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
C C + ++ G VMV G+ K+HPECF C C IGDG++YALVE S LYCG CY
Sbjct: 1 CHGCSETITTGLVMVAGEQKYHPECFSCLRCGAFIGDGDTYALVEHSKLYCGHCY 55
|
The second LIM domain of LIMK1 (LIM domain Kinase 1): LIMK1 belongs to the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, and altering the rate of actin depolymerization. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK1 is expressed in all tissues and is localized to focal adhesions in the cell. LIMK1 can form homodimers upon binding of HSP90 and is activated by Rho effector Rho kinase and MAPKAPK2. LIMK1 is important for normal central nervous system development, and its deletion has been implicated in the development of the human genetic disorder Williams syndrome. Moreover, LIMK1 up-regulates the promoter activity of urokinase type plasminogen activator and induces its mRNA and protein expression in breast cancer cells. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 33/155 (21%)
Query: 488 LGQGFFGQVYRVTHRETGE------VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
+G G FG+V R + G+ + LK ++ +FL E+
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEAS------------ 57
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
++ H N+IR GV+ K R + ++TEY+ G+L + L++
Sbjct: 58 -------------IMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT 104
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
GQ V R IA+GM YL MN +HRDL ++N LV
Sbjct: 105 VGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV 139
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 9e-17
Identities = 36/149 (24%), Positives = 72/149 (48%), Gaps = 26/149 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G G+VY+ T R TG+ + +K++ R+ ++ ++ + E
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINE-------------------- 65
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ +++ H N++ + +L +V EY+ GG+L +++ + Q
Sbjct: 66 -----ILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY 120
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
R++ G+ YLHS N+IHRD+ S N L+
Sbjct: 121 VCREVLQGLEYLHSQNVIHRDIKSDNILL 149
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 82.1 bits (201), Expect = 1e-16
Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 28/158 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG+G FG+VY R+ + VL + + + FL+E +
Sbjct: 7 KLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQ----------------- 49
Query: 547 LHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ--PLPWG 603
+L SL+H N+++ + L LV EY+ GG+L++LL+ G+ PL
Sbjct: 50 --------ILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSES 101
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ + I + + YLHS +IHRD+ +N L+ G
Sbjct: 102 EALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR 139
|
Length = 384 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 49/152 (32%), Positives = 73/152 (48%), Gaps = 25/152 (16%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LLG+G FG+V++ T ++ V V + +E + FL E++
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEAR----------------- 44
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+L+ H N+++ IGV + + + +V E + GG L+ L Q V
Sbjct: 45 --------ILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLV 96
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
FA D AAGM YL S N IHRDL ++NCLV E
Sbjct: 97 KFALDAAAGMAYLESKNCIHRDLAARNCLVGE 128
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 28/159 (17%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLK--ELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
G L+G+G FG VY+ + ETG+ + +K L ++ EEA K+ ++E IDL
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQE--------IDL---- 52
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
L++L H N++++IG + L ++ EY G+L+++++ G P P
Sbjct: 53 -------------LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG-PFPE 98
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ + G+ YLH +IHRD+ + N L + G
Sbjct: 99 SLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV 137
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 30/152 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE---KNFLKESKQGLIYLIDLGSHGLI 544
LG+G +G VY+ ++TGE++ LK++ R+D E E L+E
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALRE----------------- 48
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+++L+ L H N+++ + V++ +RKL LV EY LK+ L PL
Sbjct: 49 --------ISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL 99
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + G+ Y HS ++HRDL QN L+
Sbjct: 100 IKSIMYQLLRGLAYCHSHRILHRDLKPQNILI 131
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 7e-16
Identities = 41/154 (26%), Positives = 79/154 (51%), Gaps = 16/154 (10%)
Query: 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
V+G L+G+G +G+VY + TGE+M +K++ A ++ ++ ++ +
Sbjct: 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRH--DSRQKDMVKALR----- 56
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
S++ L+ L H N+++++G + L++ EY+ GG++ L+ G+
Sbjct: 57 --------SEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ 108
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
R F + G+ YLHS ++HRDL + N LV
Sbjct: 109 LVR-FFTEQVLEGLAYLHSKGILHRDLKADNLLV 141
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 27/154 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG+G +G VY+ H+ETG+V+ +K + V+E+ + +KE I +
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQ-EIIKE--------ISI-------- 51
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
L+ ++++ G +K+ L +V EY G++ ++++ + L +
Sbjct: 52 ---------LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIA 102
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
G+ YLHS IHRD+ + N L+ E G
Sbjct: 103 AILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG 136
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 27/152 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G+FG+V+ + V + K L D +++F KE
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAI-KILKSDDLLKQQDFQKE-------------------- 52
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRV 606
V L+ L H ++I V + ++TE + G+L L+ P GQ LP +
Sbjct: 53 -----VQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI 107
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ A +A GM YL N IHRDL ++N LV E
Sbjct: 108 DMACQVAEGMAYLEEQNSIHRDLAARNILVGE 139
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 27/160 (16%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
+D+ LG G +G+VY ++ + +K L + D + FLKE+
Sbjct: 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEA----------- 53
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-Q 598
AV++ + H N+++ +GV ++ ++TE++ G L + L++ Q
Sbjct: 54 --------------AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 99
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ + A I++ M YL N IHRDL ++NCLV E
Sbjct: 100 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 139
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|188847 cd09463, LIM1_LIMK2, The first LIM domain of LIMK2 (LIM domain Kinase 2) | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-15
Identities = 22/52 (42%), Positives = 32/52 (61%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
C GC I + + + + + WH CF+CS C +L NWY+EKDG L+C + Y
Sbjct: 1 CTGCGGRIQDSFHYRVVQEAWHNSCFQCSVCQDLLTNWYYEKDGKLYCHKHY 52
|
The first LIM domain of LIMK2 (LIM domain Kinase 2): LIMK2 is a member of the LIMK protein family, which comprises LIMK1 and LIMK2. LIMK contains two LIM domains, a PDZ domain, and a kinase domain. LIMK is involved in the regulation of actin polymerization and microtubule disassembly. LIMK influences architecture of the actin cytoskeleton by regulating the activity of the cofilin family proteins cofilin1, cofilin2, and destrin. The mechanism of the activation is to phosphorylates cofilin on serine 3 and inactivates its actin-severing activity, altering the rate of actin depolymerization. LIMK activity is activated by phosphorylation of a threonine residue within the activation loop of the kinase by p21-activated kinases 1 and 4 and by Rho kinase. LIMKs can function in both cytoplasm and nucleus. Both LIMK1 and LIMK2 can act in the nucleus to suppress Rac/Cdc42-dependent cyclin D1 expression. LIMK2 is expressed in all tissues. While LIMK1 localizes mainly at focal adhesions, LIMK2 is found in cytoplasmic punctae, suggesting that they may have different cellular functions. The activity of LIM kinase 2 to regulate cofilin phosphorylation is inhibited by the direct binding of Par-3. LIMK2 activation promotes cell cycle progression. The phenotype of Limk2 knockout mice shows a defect in spermatogenesis. The LIM domains have been shown to play an important role in regulating kinase activity and likely also contribute to LIMK function by acting as sites of protein-to-protein interactions. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 28/159 (17%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELY--RVDEEAEKNFLKESKQGLIYLIDLGSHG 542
+G+G G V++ RETGE + LK++ R++ L+E K
Sbjct: 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIK------------- 51
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
L++ H V++ + V LV EY+ L E+L+D +PLP
Sbjct: 52 ------------ALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPE 98
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
Q ++ R + G+ Y+H+ ++HRDL N L+ G
Sbjct: 99 AQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV 137
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 51/194 (26%), Positives = 80/194 (41%), Gaps = 42/194 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G FG+VY+ H+ETG K + EE ++F+ E ID
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE--------ID---------- 54
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+L H N++ + + KL ++ E+ GG L ++ + + L Q
Sbjct: 55 -------ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY 107
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKTK 667
R + + +LHS +IHRDL + N L+ G V F +SAK K
Sbjct: 108 VCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD-------------VKLADFGVSAKNK 154
Query: 668 KTYYPNILKKASFI 681
T + K+ +FI
Sbjct: 155 ST----LQKRDTFI 164
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 31/156 (19%)
Query: 487 LLGQGFFGQV----YRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
LG+G FG V Y TGEV+ +K+L E ++F +E
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFERE--------------- 55
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPL 600
+ +L+SL H N++++ GV Y R L LV EY+ G+L++ LQ + L
Sbjct: 56 ----------IEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL 105
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + +A I GM YL S +HRDL ++N LV
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 52/163 (31%), Positives = 77/163 (47%), Gaps = 33/163 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETG--EVMV----LKELYRVDEEAEKNFLKESKQGLI 533
S + + ++G G FG+V+R + G EV V LK Y E+ ++FL E+
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEA----- 57
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
+++ HHN+IR GV+ K + ++TEY+ G L + L
Sbjct: 58 --------------------SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL 97
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+D Q V R IAAGM YL MN +HRDL ++N LV
Sbjct: 98 RDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV 140
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 7e-15
Identities = 42/147 (28%), Positives = 61/147 (41%), Gaps = 24/147 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G FG V++V + V +K+ IDL
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQ-----------------------IDLSKMNRRERE 44
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRV 606
+ VL L +IR+ KLN+V EY G L +LL+ G+PLP Q
Sbjct: 45 EAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW 104
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQN 633
F I G+ +LHS ++HRD+ S N
Sbjct: 105 RFFIQILLGLAHLHSKKILHRDIKSLN 131
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 43/163 (26%), Positives = 75/163 (46%), Gaps = 34/163 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
++G+G +G+VY+ H++TG+++ +K + + E+ E+ +E N
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEE----------------YNI 55
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKEL---LQDPG 597
L +S +H N+ F G K D +L LV E GG++ +L L+ G
Sbjct: 56 LRKYS--------NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG 107
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ L R+ G+ YLH +IHRD+ QN L+ +
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA 150
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 45/162 (27%), Positives = 74/162 (45%), Gaps = 25/162 (15%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
D LG G FG+V V H+ +G+ LK L K + + KQ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL-------SKAKIVKLKQ-----VE-- 46
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ- 598
H ++ +L+S+ H ++ G D L LV EY+ GG L L+ G+
Sbjct: 47 --------HVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRF 98
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
P P + +A + + YLHS+++++RDL +N L+ G
Sbjct: 99 PEPVARF--YAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 54/167 (32%), Positives = 75/167 (44%), Gaps = 36/167 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G FG+VY+ GE+ E A K LKE+ + +
Sbjct: 13 LGEGAFGKVYK------GELTGPNERLSATSVAIKT-LKENAEPKVQ------------- 52
Query: 548 HCFSQVAVLRS-LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL------QDPG--- 597
F Q A L S L H N++ +GV K++ ++ EY+A G L E L D G
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 598 ------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L ++ A IAAGM YL S + +HRDL ++NCLV E
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 21/152 (13%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
RG LLGQG FG+VY +TG + +K++ F +S +
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQV---------PFDPDSP-------ETKKE-- 47
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
+N L C ++ +L++L H ++++ G L D L++ EY+ GG++K+ L+ G L
Sbjct: 48 VNALEC--EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTET 104
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ R I G+ YLHS ++HRD+ N L
Sbjct: 105 VTRKYTRQILEGVEYLHSNMIVHRDIKGANIL 136
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 25/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G +G VY+ TGE++ +K + + + +E
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQE-------------------- 50
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+++L+ H N++ + G + KL +V EY GG+L+++ Q PL Q
Sbjct: 51 -----ISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAY 105
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R+ G+ YLH IHRD+ N L+ E G
Sbjct: 106 VCRETLKGLAYLHETGKIHRDIKGANILLTEDG 138
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 8e-14
Identities = 32/91 (35%), Positives = 50/91 (54%)
Query: 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 609
+ V+ L H +++ GV K R + +VTEY++ G L L++ G+ Q +
Sbjct: 47 IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106
Query: 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+D+ GM YL S IHRDL ++NCLV + G
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQG 137
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 28/152 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G FG+V+ T V V K L + K+FL E++
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAV-KTL-KPGTMDPKDFLAEAQ------------------ 53
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRV 606
+++ L H +I+ V + + +VTE + G+L E LQ G+ L Q +
Sbjct: 54 -------IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI 106
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ A +A+GM YL + N IHRDL ++N LV E
Sbjct: 107 DMAAQVASGMAYLEAQNYIHRDLAARNVLVGE 138
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 9e-14
Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 26/170 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +G V++ +RET E++ LK + R+D++ E G+ ++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDE--------------------GVPSS- 45
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ +L+ L H N++R VL+ D+KL LV EY K G P + +
Sbjct: 46 -ALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVK-S 103
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS--GFDFHLGQIYLIYV 655
F + G+ + HS N++HRDL QN L+ + G DF L + + I V
Sbjct: 104 FMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 44/179 (24%), Positives = 69/179 (38%), Gaps = 42/179 (23%)
Query: 476 IFRASDLVRGPLLGQGFFGQVYR------VTHRETGEVMVLKELYRVDEEAEK-NFLKES 528
+ LGQG FG VY V V + K + E+ FL E+
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAI-KTVNENASMRERIEFLNEA 60
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGT 588
+V++ + H+V+R +GV+ + +V E +A G
Sbjct: 61 -------------------------SVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGD 95
Query: 589 LKELLQ---------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
LK L+ P + + A +IA GM YL + +HRDL ++NC+V E
Sbjct: 96 LKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 3/101 (2%)
Query: 538 LGSHGLINNLHCFSQ-VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
L S L + + F + A++ SL H N+IR GV+ L +VTE G+L + L+
Sbjct: 31 LKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKD 89
Query: 597 GQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
++A IA GM YL S IHRDL ++N L+
Sbjct: 90 ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL 130
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLIN 545
+G+G FG+VY+ + T +V+ +K +D EEAE I I
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKV---IDLEEAEDE---------IEDIQQ------- 48
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
++ L + ++ G K KL ++ EY GG+ +LL+ PG L
Sbjct: 49 ------EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK-PG-KLDETYI 100
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R++ G+ YLH IHRD+ + N L+ E G
Sbjct: 101 AFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG 135
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 24/152 (15%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
RG +G G FG+VY + +TGE+M +KE+ D +
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---------------------PKT 42
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
I + ++ VL L H N++++ GV K+ + EY +GGTL+ELL+ G+ L
Sbjct: 43 IKEIA--DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEH 99
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ + G+ YLHS ++HRD+ N
Sbjct: 100 VIRVYTLQLLEGLAYLHSHGIVHRDIKPANIF 131
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 40/154 (25%), Positives = 78/154 (50%), Gaps = 23/154 (14%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +G VY+ ++ TGEV+ LK++ R+D E E G+ +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETE--------------------GVPST- 45
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++++L+ L+H N+++ + V++ + KL LV E++ K + P +P +
Sbjct: 46 -AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS 104
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ + G+ + HS ++HRDL QN L+ G+
Sbjct: 105 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA 138
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (173), Expect = 2e-13
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 33/153 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G FG+V V ++TG++ +K L +K + + K+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL-------KKKKIIKRKE---------------VE 38
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQ-PLPW 602
H ++ +L ++H FI L+ + KL LV EY GG L L G+
Sbjct: 39 HTLTERNILSRINH----PFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER 94
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ +A +I + YLHS+ +I+RDL +N L
Sbjct: 95 ARF--YAAEIVLALEYLHSLGIIYRDLKPENIL 125
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 49/173 (28%), Positives = 78/173 (45%), Gaps = 39/173 (22%)
Query: 482 LVRGPLLGQGFFGQVYR--VTHRETGEV---MVLKELYRV-DEEAEKNFLKESKQGLIYL 535
L+R LG G FG+VY R+ V + +K L E+ E +FL E+
Sbjct: 10 LLRA--LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA------- 60
Query: 536 IDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
++ +H N++R IGV ++ ++ E +AGG LK L++
Sbjct: 61 ------------------LIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRE 102
Query: 596 ----PGQPLPWGQR--VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642
P +P + + ARD+A G YL + IHRD+ ++NCL+ G G
Sbjct: 103 NRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPG 155
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 48/160 (30%), Positives = 82/160 (51%), Gaps = 23/160 (14%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
RG LLGQG FG+VY +TG + K++ + D E+ + SK+
Sbjct: 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQV-QFDPESPET----SKE------------- 47
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
++ L C ++ +L++L H ++++ G L ++ L + EY+ GG++K+ L+ G L
Sbjct: 48 VSALEC--EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LT 104
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ R I GM+YLHS ++HRD+ N L G+
Sbjct: 105 ESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN 144
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 52/186 (27%), Positives = 77/186 (41%), Gaps = 51/186 (27%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRE--------TGEVMVLKELYRVDEEAEKNFLKES 528
L G LG+G FGQV + T V +LK D+ EK+
Sbjct: 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK-----DDATEKD----- 58
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGG 587
L DL S++ +++ + H N+I +GV ++ L +V EY A G
Sbjct: 59 ------LSDL-----------VSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHG 101
Query: 588 TLKELLQD---------------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632
L++ L+ P + L V+FA +A GM +L S IHRDL ++
Sbjct: 102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161
Query: 633 NCLVRE 638
N LV E
Sbjct: 162 NVLVTE 167
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 10/96 (10%)
Query: 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-----DPG-----QPL 600
+V +L L N+ R +GV D L ++ EY+ G L + LQ G + L
Sbjct: 68 KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSL 127
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + A IA+GM YL S+N +HRDL ++NCLV
Sbjct: 128 SFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 42/194 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G FG+VY+ ++ETG + K + EE ++++ E
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-------------------- 59
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ +L + +H +++ +G Y D KL ++ E+ GG + ++ + + L Q
Sbjct: 60 -----IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 114
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKTK 667
R + + YLHSM +IHRDL + N L+ G D L F +SAK
Sbjct: 115 ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG---DIKLAD----------FGVSAKNV 161
Query: 668 KTYYPNILKKASFI 681
KT + ++ SFI
Sbjct: 162 KT----LQRRDSFI 171
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 48/182 (26%), Positives = 72/182 (39%), Gaps = 48/182 (26%)
Query: 476 IFRASDLVRGPLLGQGFFGQVYRVT--HRETGE------VMVLKELYRVDEEAEKNFLKE 527
+ +V LG+G FG+V+ H E V LKE +A K+F +E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFERE 58
Query: 528 SKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 587
+L + H N+++F GV + +V EY+ G
Sbjct: 59 -------------------------AELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93
Query: 588 TLKELLQDPG-------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634
L + L+ G L Q + A IA+GM YL S + +HRDL ++NC
Sbjct: 94 DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNC 153
Query: 635 LV 636
LV
Sbjct: 154 LV 155
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 54/174 (31%), Positives = 86/174 (49%), Gaps = 33/174 (18%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
L G ++G+G FG V + + TG+ + +K + + D A+ FL+E+
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNI-KCDVTAQA-FLEET----------- 50
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
AV+ LHH N++R +GV+ + L +V E ++ G L L+ G+
Sbjct: 51 --------------AVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRA 95
Query: 600 L-PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--VGSGFDFHLGQI 650
L Q + F+ D+A GM YL S L+HRDL ++N LV E V DF L ++
Sbjct: 96 LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARV 149
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 4e-13
Identities = 31/90 (34%), Positives = 57/90 (63%), Gaps = 2/90 (2%)
Query: 551 SQVAVLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPGQPLPWGQR-VNF 608
++ +V+ L H N+++ +GV+ +++ L +VTEY+A G+L + L+ G+ + G + F
Sbjct: 48 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 609 ARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ D+ M YL + N +HRDL ++N LV E
Sbjct: 108 SLDVCEAMEYLEANNFVHRDLAARNVLVSE 137
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-13
Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 44/177 (24%)
Query: 481 DLVRGPLLGQGFFGQVY-----RVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYL 535
D+V LG+G FG+V+ + + ++ +K L E A ++F +E++
Sbjct: 6 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAE------ 59
Query: 536 IDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
+L L H +++RF GV + R L +V EY+ G L L+
Sbjct: 60 -------------------LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRS 100
Query: 596 PGQ--------------PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G L GQ + A IA+GM YL S++ +HRDL ++NCLV +
Sbjct: 101 HGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQ 157
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-12
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 35/157 (22%)
Query: 487 LLGQGFFGQVYRVTHRETGE------VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
++G G FG+V R + G+ + LK Y E+ ++FL E+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEA------------ 56
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL-QDPGQP 599
+++ H N+I GV+ K R + ++TE++ G L L Q+ GQ
Sbjct: 57 -------------SIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQ- 102
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
Q V R IAAGM YL MN +HRDL ++N LV
Sbjct: 103 FTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV 139
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|188711 cd08368, LIM, LIM is a small protein-protein interaction domain, containing two zinc fingers | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 1e-12
Identities = 22/53 (41%), Positives = 33/53 (62%), Gaps = 1/53 (1%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDY 63
CAGC I E ++AL ++WH +CF+CS C L ++EKDG +C++ Y
Sbjct: 1 CAGCGKPIEGRELLRALGKKWHPECFKCSVCGKPLGGDSFYEKDGKPYCEKCY 53
|
LIM domains are identified in a diverse group of proteins with wide variety of biological functions, including gene expression regulation, cell fate determination, cytoskeleton organization, tumor formation and development. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. They perform their functions through interactions with other protein partners. LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. The consensus sequence of LIM domain has been defined as C-x(2)-C-x(16,23)-H-x(2)-[CH]-x(2)-C-x(2)-C-x(16, 21)-C-x(2,3)-[CHD] (where X denotes any amino acid). Length = 53 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 27/160 (16%)
Query: 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDL 538
S+L LG G FG V+ R G++ V ++ R +E +F++E+K
Sbjct: 3 PSELTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGAMSEDDFIEEAK--------- 51
Query: 539 GSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ 598
V+ L H N+++ GV K R + +VTEY+A G L L++
Sbjct: 52 ----------------VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG 95
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L ++ D+ M YL S IHRDL ++NCLV E
Sbjct: 96 KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 30/155 (19%)
Query: 488 LGQGFFGQV----YRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
LG+G FG+V Y TGE + +K L ES G+H
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----------PESG---------GNH-- 49
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLP 601
I +L ++ +LR+L+H N++++ G+ +D + L+ E++ G+LKE L +
Sbjct: 50 IADLK--KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN 107
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
Q++ +A I GM YL S +HRDL ++N LV
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV 142
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 32/162 (19%)
Query: 488 LGQGFFGQVYRVTHRE--TGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
LGQG FG VY R+ GE + V+E A L+E + L
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS---LRERIEFL------------- 57
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ--------DPG 597
++ +V++ H+V+R +GV+ K + +V E +A G LK L+ +PG
Sbjct: 58 -----NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112
Query: 598 QPLP-WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+P P + + A +IA GM YL++ +HRDL ++NC+V
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 30/157 (19%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLI 544
++G+G +G V + ++ TGE++ +K+ DE+ +K L+E
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALRE----------------- 50
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWG 603
V VLR L H N++ + +L LV EY+ L+ L P G P
Sbjct: 51 --------VKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAV 102
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ + + + Y HS N+IHRD+ +N LV E G
Sbjct: 103 RSYIW--QLLQAIAYCHSHNIIHRDIKPENILVSESG 137
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 34/156 (21%)
Query: 488 LGQGFFGQV----YRVTHRETGEVMVLKELYR-VDEEAEKNFLKESKQGLIYLIDLGSHG 542
LG+G FG+V Y + TGE++ +K L R ++ + KE
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKE--------------- 56
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPL 600
+ +L++L+H N++++ G + + L L+ EY+ G+L++ L P L
Sbjct: 57 ----------INILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL--PKHKL 104
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
Q + FA+ I GM YLHS + IHRDL ++N L+
Sbjct: 105 NLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL 140
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 35/175 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR-VDEEAEKNFLKESKQGLIYLIDL 538
DL LG G G V +V HR TG++M +K + ++E +K L+E
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELD--------- 51
Query: 539 GSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ 598
+L + ++ F G Y + +++ EY+ GG+L ++L++
Sbjct: 52 ----------------ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQG 95
Query: 599 PLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREVGSGFDFHLGQIYL 652
+P A + G+TYLH +IHRD+ N LV GQI L
Sbjct: 96 RIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN--------SRGQIKL 142
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-12
Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 23/159 (14%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G LLGQG FG+VY +TG + +K++ E E SK+ +
Sbjct: 7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPET-----SKE-------------V 48
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
N L C ++ +L++L H ++++ G L +R L++ E++ GG++K+ L+ G L
Sbjct: 49 NALEC--EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTE 105
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ R I G++YLHS ++HRD+ N L VG+
Sbjct: 106 NVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN 144
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 35/171 (20%)
Query: 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE-------VMVLKELYRVDEEAEKNFLK 526
RI + ++L + +LG G FG VY+ GE + VL+E +A K L
Sbjct: 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE--ETSPKANKEILD 58
Query: 527 ESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAG 586
E+ V+ S+ H +V+R +G+ + + L+T+ +
Sbjct: 59 EAY-------------------------VMASVDHPHVVRLLGICLSSQ-VQLITQLMPL 92
Query: 587 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
G L + +++ + +N+ IA GM+YL L+HRDL ++N LV+
Sbjct: 93 GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK 143
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 31/84 (36%), Positives = 47/84 (55%)
Query: 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 614
+L+ H N++R IGV + + + +V E + GG L+ G L + + + AA
Sbjct: 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAA 105
Query: 615 GMTYLHSMNLIHRDLNSQNCLVRE 638
GM YL S + IHRDL ++NCLV E
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTE 129
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 46/159 (28%), Positives = 85/159 (53%), Gaps = 23/159 (14%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G LLG+G FG+VY +TG + +K++ D ++++ SK+ +
Sbjct: 7 GKLLGRGAFGEVYLCYDADTGRELAVKQV-PFDPDSQET----SKE-------------V 48
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
N L C ++ +L++L H ++++ G L +++KL++ EY+ GG++K+ L+ G L
Sbjct: 49 NALEC--EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTE 105
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ R I G++YLHS ++HRD+ N L G+
Sbjct: 106 NVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN 144
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 46/168 (27%), Positives = 77/168 (45%), Gaps = 42/168 (25%)
Query: 488 LGQGFFGQV-----YRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
LG+G FG+V Y + + ++ +K L + A K+F +E++
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE------------- 59
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-------- 594
+L +L H ++++F GV + L +V EY+ G L + L+
Sbjct: 60 ------------LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVL 107
Query: 595 ----DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ L Q ++ A+ IAAGM YL S + +HRDL ++NCLV E
Sbjct: 108 MAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 38/157 (24%), Positives = 63/157 (40%), Gaps = 35/157 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+G+G FG V +V + G+++V KE+ Y E EK L
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL--------------------- 46
Query: 547 LHCFSQVAVLRSLHHHNVIRFIG--VLYKDRKLNLVTEYIAGGTLKELLQ---DPGQPLP 601
S+V +LR L H N++R+ + ++ L +V EY GG L +L+Q + +
Sbjct: 47 ---VSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE 103
Query: 602 WGQRVNFARDIAAGMTYLH-----SMNLIHRDLNSQN 633
+ + H ++HRDL N
Sbjct: 104 EEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPAN 140
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 38/165 (23%), Positives = 65/165 (39%), Gaps = 29/165 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG+G +G VY+V + LKE +DLGS
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKE-----------------------VDLGSMSQKER 43
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQPLPWG 603
+++ +L S++H N+I + KL +V EY G L + + + + +P
Sbjct: 44 EDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ 103
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLG 648
+ + G+ LH ++HRDL S N L+ + +G
Sbjct: 104 EIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIG 145
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 5e-12
Identities = 41/157 (26%), Positives = 73/157 (46%), Gaps = 20/157 (12%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
+G LG G F Y+ +TG +M +K++ V +N E ++ + L
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYV-----RNTSSEQEEVVEALRK------ 52
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
++ ++ L+H ++IR +G +D NL E++AGG++ LL G
Sbjct: 53 --------EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEA 103
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+N+ + G++YLH +IHRD+ N L+ G
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTG 140
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 43/159 (27%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +G VY+ R T E + LK++ R+++E E G+ +
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKI-RLEQEDE--------------------GVPST- 47
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++++L+ + H N++R V++ +++L LV EY+ K + P +
Sbjct: 48 -AIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSP----------D 96
Query: 608 FARD----------IAAGMTYLHSMNLIHRDLNSQNCLV 636
FA++ I G+ Y HS ++HRDL QN L+
Sbjct: 97 FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI 135
|
Length = 294 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-12
Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 26/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G FG+V++ T +V+ +K +D E ++ +++ +Q
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQ----------------- 51
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ VL V ++ G KD KL ++ EY+ GG+ +LL+ PG PL Q
Sbjct: 52 ----EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PG-PLDETQIAT 105
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R+I G+ YLHS IHRD+ + N L+ E G
Sbjct: 106 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHG 138
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 9e-12
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 24/149 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +G V++ +RETG+++ A K F++ +I I L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIV-----------AIKKFVESEDDPVIKKIAL--------- 48
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ +L+ L H N++ I V + RKL+LV EY L EL ++P + +P
Sbjct: 49 ---REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNP-RGVPEHLIKK 104
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + H N IHRD+ +N L+
Sbjct: 105 IIWQTLQAVNFCHKHNCIHRDVKPENILI 133
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 9e-12
Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 27/160 (16%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLK--ELYRVDEEA-EKNFLKESKQGLIYLIDLGS 540
+G +LG+G +G VY G+++ +K EL + A EK + K
Sbjct: 4 KGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEK-------------- 48
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL 600
L +V +L+SL H N+++++G D +++ E++ GG++ +L G PL
Sbjct: 49 ------LQ--EEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PL 99
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
P + + I G+ YLH+ ++HRD+ N ++ G
Sbjct: 100 PEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG 139
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 45/179 (25%), Positives = 82/179 (45%), Gaps = 35/179 (19%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
L+G+G +G V + H+ETG+++ +K+ +++ +
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKI--------------------- 46
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQR 605
++ +L+ L H N++ I V + ++L LV E++ L +L + P G ++
Sbjct: 47 --AMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK 104
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS------GFDFHL---GQIYLIYV 655
F I G+ + HS N+IHRD+ +N LV + G GF L G++Y YV
Sbjct: 105 YLF--QILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 1e-11
Identities = 41/160 (25%), Positives = 72/160 (45%), Gaps = 44/160 (27%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +GQVY+ +++TGE++ LK++ R++ E K+G
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI-RMENE---------KEG---------------- 40
Query: 548 HCFSQVAV-----LRSLHHHNVIRFIGVLYKDRKLN--LVTEYI----AGGTLKELLQDP 596
F A+ L+ L H N++R ++ K + +V EY+ G LL P
Sbjct: 41 --FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSP 93
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
Q + + + G+ YLHS ++HRD+ N L+
Sbjct: 94 EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI 133
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 29/150 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G FG+V+ T +V V + + + ++FL+E++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAV--KTLKPGTMSPESFLEEAQ------------------ 53
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRV 606
+++ L H +++ V+ + + +VTEY++ G+L + L+D G+ L V
Sbjct: 54 -------IMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV 105
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ A +AAGM Y+ MN IHRDL S N LV
Sbjct: 106 DMAAQVAAGMAYIERMNYIHRDLRSANILV 135
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 30/85 (35%), Positives = 52/85 (61%), Gaps = 1/85 (1%)
Query: 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRVNFARDIA 613
++++L H ++R V+ K+ + ++TEY+A G+L + L+ D G + + ++F+ IA
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 614 AGMTYLHSMNLIHRDLNSQNCLVRE 638
GM Y+ N IHRDL + N LV E
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVSE 138
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 26/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G FG+VY+ T EV+ +K +D E ++ +++ +Q
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIK---IIDLEEAEDEIEDIQQ----------------- 51
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ VL + R+ G K KL ++ EY+ GG+ +LL+ PG PL
Sbjct: 52 ----EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PG-PLEETYIAT 105
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R+I G+ YLHS IHRD+ + N L+ E G
Sbjct: 106 ILREILKGLDYLHSERKIHRDIKAANVLLSEQG 138
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
+G LG+G + VY+ +ETG ++ +K++ ++ E KE+K G+
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKI-KLGER------KEAKDGI---------- 45
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
N ++ +L+ L H N+I + V +NLV E++ L+++++D L
Sbjct: 46 ---NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTP 101
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
++ G+ YLHS ++HRDL N L+ G
Sbjct: 102 ADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG 139
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 29/152 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE---KNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G VY+ + TGE++ LK++ R++ E E ++E
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-RLETEDEGVPSTAIRE----------------- 48
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+++L+ L+H N++R + V++ + KL LV E++ K + P L
Sbjct: 49 --------ISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPL 100
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
++ + G+ Y HS ++HRDL QN L+
Sbjct: 101 IKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI 132
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 4e-11
Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 29/152 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LGQG FG+V+ T T V + + + + + FL+E++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAI--KTLKPGTMSPEAFLQEAQ------------------ 53
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRV 606
V++ L H +++ V+ + + +VTEY++ G+L + L+ + G+ L Q V
Sbjct: 54 -------VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 105
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ A IA+GM Y+ MN +HRDL + N LV E
Sbjct: 106 DMAAQIASGMAYVERMNYVHRDLRAANILVGE 137
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 4e-11
Identities = 43/169 (25%), Positives = 66/169 (39%), Gaps = 39/169 (23%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFL-KESKQGLIYLIDLGSHGL 543
G ++G+G F V +ET + +K L +K L KE K + +
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKIL-------DKRQLIKEKKVKYVKI-------- 50
Query: 544 INNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
+ VL L+ H +I+ + L V EY G L + ++ G L
Sbjct: 51 --------EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LD- 100
Query: 603 GQRVNFARDIAA----GMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHL 647
R AA + YLHS +IHRDL +N L+ + D H+
Sbjct: 101 ---EKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDK-----DMHI 141
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-11
Identities = 43/171 (25%), Positives = 84/171 (49%), Gaps = 26/171 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +G VY+ +++TG+++ +K++ R++ E E G+ +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEE--------------------GVPST- 45
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRV 606
++++L+ L H N++ VL ++ +L L+ E+++ K L P GQ +
Sbjct: 46 -AIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVK 104
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG--SGFDFHLGQIYLIYV 655
++ I G+ + HS ++HRDL QN L+ G DF L + + I V
Sbjct: 105 SYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 5e-11
Identities = 31/87 (35%), Positives = 47/87 (54%)
Query: 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 609
S+ +++ H N+I GV+ K + + +VTEY+ G+L L+ Q V
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGML 112
Query: 610 RDIAAGMTYLHSMNLIHRDLNSQNCLV 636
R IA+GM YL M +HRDL ++N LV
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILV 139
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 44/173 (25%), Positives = 73/173 (42%), Gaps = 41/173 (23%)
Query: 482 LVRGPLLGQGFFGQVY--RVTHRETGEVMVLKELYRVDEEAEKN---FLKESKQGLIYLI 536
L G +LG+G FG V +++ + ++ V + ++D FL E+
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEA-------- 52
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLK 590
A ++ H NV++ IGV ++ L ++ ++ G L
Sbjct: 53 -----------------ACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLH 95
Query: 591 ELL-----QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L + LP + F DIA GM YL + N IHRDL ++NC++RE
Sbjct: 96 SFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRE 148
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 50/175 (28%), Positives = 73/175 (41%), Gaps = 51/175 (29%)
Query: 488 LGQGFFGQVYRVTHRETGE-------------VMVLKELYRVD--EEAEKNFLKESKQGL 532
LG+G FG+V+ E V+V ++ R D + A +FLKE K
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK--- 69
Query: 533 IYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL 592
++ L + N+IR +GV D L ++TEY+ G L +
Sbjct: 70 ----------------------IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQF 107
Query: 593 LQD--------PGQPLPWGQRVNF---ARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
L +P N A IA+GM YL S+N +HRDL ++NCLV
Sbjct: 108 LSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV 162
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 7e-11
Identities = 47/159 (29%), Positives = 74/159 (46%), Gaps = 32/159 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
L+G G +GQVY+ H +TG++ +K + +E E E KQ IN
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-----EIKQE------------INM 55
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQD-PGQP 599
L +S HH N+ + G K D +L LV E+ G++ +L+++ G
Sbjct: 56 LKKYS--------HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 107
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L R+I G+++LH +IHRD+ QN L+ E
Sbjct: 108 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 146
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 32/159 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
++G G +GQVY+ H +TG++ +K + V E+ E+ E IN
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLE----------------INM 65
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQD-PGQP 599
L +S HH N+ + G K D +L LV E+ G++ +L+++ G
Sbjct: 66 LKKYS--------HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA 117
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L R+I G+ +LH+ +IHRD+ QN L+ E
Sbjct: 118 LKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTE 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-10
Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 18/105 (17%)
Query: 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---------------DP 596
+V +L L N+IR +GV + L ++TEY+ G L + L P
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 597 GQPLP---WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
LP + ++ A IA+GM YL S+N +HRDL ++NCLV E
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE 173
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 35/161 (21%), Positives = 65/161 (40%), Gaps = 30/161 (18%)
Query: 480 SDLVRGPLLGQGFFGQVYR-VTHRETGEVM-VLKELYRVDEEAEK--NFLKESKQGLIYL 535
D+ G +G+G FG VY+ V E + V + + FL+E+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEA------- 58
Query: 536 IDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
++R H ++++ IGV+ + + +V E G L+ LQ
Sbjct: 59 ------------------YIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQV 99
Query: 596 PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
L + ++ ++ + YL S +HRD+ ++N LV
Sbjct: 100 NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV 140
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 33/178 (18%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
F LV G LG+G FGQV R E Y +D+ + + L
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRA------------EAYGIDKSRPD---QTVTVAVKMLK 53
Query: 537 DLGSHGLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
D + + +L S++ +++ + H N+I +GV ++ L ++ EY A G L+E L+
Sbjct: 54 DNATDKDLADL--ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRA 111
Query: 596 ---------------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
P + L + V+ A +A GM YL S IHRDL ++N LV E
Sbjct: 112 RRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTE 169
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 29/95 (30%), Positives = 48/95 (50%), Gaps = 10/95 (10%)
Query: 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQP-------LP 601
++ ++ L N+IR + V L ++TEY+ G L + L + +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + A IA+GM YL S+N +HRDL ++NCLV
Sbjct: 129 YSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 51/181 (28%), Positives = 77/181 (42%), Gaps = 42/181 (23%)
Query: 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
+LV G LG+G FG+V + T LK A K + + L DL
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFR------LKGRAGYTTVAVKMLKENASS--SELRDL-- 50
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD----- 595
S+ +L+ ++H +VI+ G +D L L+ EY G+L+ L++
Sbjct: 51 ---------LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVG 101
Query: 596 -----------------PG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
P + L G ++FA I+ GM YL M L+HRDL ++N LV
Sbjct: 102 PSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA 161
Query: 638 E 638
E
Sbjct: 162 E 162
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 47/156 (30%), Positives = 69/156 (44%), Gaps = 29/156 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEK--NFLKESKQGLIYLIDLGSHGLI 544
+G G FG VY T+ T EV+ +K++ Y + EK + +KE
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKE----------------- 71
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
V L+ L H N I + G K+ LV EY G + +LL+ +PL +
Sbjct: 72 --------VKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVE 122
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
G+ YLHS N+IHRD+ + N L+ E G
Sbjct: 123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG 158
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 28/155 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA--EKNFLKESKQGLIYLIDLGSHGLIN 545
+G+G +G VY+ + TGE++ +K++ E K L+E K
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIK---------------- 50
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
+L+ L+H N+I+ + V L LV E++ L +L++D + LP
Sbjct: 51 ---------LLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLI 100
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
++ + G+ + HS ++HRDL +N L+ G
Sbjct: 101 KSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG 135
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-10
Identities = 49/174 (28%), Positives = 76/174 (43%), Gaps = 37/174 (21%)
Query: 476 IFRASDLVRGPLLGQGFFGQVY----RVTHRETGEVMVL-KELYRVDEEAEKNFLKESKQ 530
F S+L LG+G FG+V+ + E GE +VL K L + +E N E ++
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE---NLQSEFRR 57
Query: 531 GLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLK 590
++ + R L H NV+R +G+ + ++ EY G LK
Sbjct: 58 ---------------------ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLK 96
Query: 591 ELLQ--------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ L+ PL Q+V IA GM +L + +HRDL ++NCLV
Sbjct: 97 QFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV 150
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 28/87 (32%), Positives = 47/87 (54%), Gaps = 1/87 (1%)
Query: 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFA 609
++ VL+ L H N+I + +D+ L +V EY GGTL E +Q L ++F
Sbjct: 48 NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFF 107
Query: 610 RDIAAGMTYLHSMNLIHRDLNSQNCLV 636
I + ++H+ ++HRDL +QN L+
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILL 134
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 39/164 (23%), Positives = 72/164 (43%), Gaps = 43/164 (26%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
S+L R +G G G VY+V HR TG + LK +Y E+ + +
Sbjct: 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR------------ 121
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
++ +LR ++H NV++ + + ++ ++ E++ GG+L+
Sbjct: 122 ------------EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE--------- 160
Query: 600 LPWGQRVN-------FARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
G + AR I +G+ YLH +++HRD+ N L+
Sbjct: 161 ---GTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI 201
|
Length = 353 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 21/110 (19%)
Query: 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-------------- 595
+ A++ H N+++ +GV + + L+ EY+A G L E L+
Sbjct: 56 QREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTS 115
Query: 596 -----PGQPLPWG--QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
PLP +++ A+ +AAGM YL +HRDL ++NCLV E
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE 165
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 40/168 (23%)
Query: 487 LLGQGFFGQVYRVTHRE-----TGEVMV-LKELYR--VDEEAEKNFLKESKQGLIYLIDL 538
LG G FG+VY T + +G + V +K L + D+E +K FLKE+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEA---------- 50
Query: 539 GSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD--- 595
++ + +H N+++ +GV + ++ E + GG L L+D
Sbjct: 51 ---------------HLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARV 95
Query: 596 ---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L + ++ D+A G YL M+ IHRDL ++NCLV E G
Sbjct: 96 ERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKG 143
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-10
Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 45/176 (25%)
Query: 481 DLVRGPLLGQGFFGQV-----YRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYL 535
D+V LG+G FG+V Y ++ + ++ +K L A K+F +E++
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE------ 59
Query: 536 IDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
+L +L H ++++F GV L +V EY+ G L + L+
Sbjct: 60 -------------------LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA 100
Query: 596 ---------PGQP------LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
GQP L Q ++ A IA+GM YL S + +HRDL ++NCLV
Sbjct: 101 HGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 156
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|215907 pfam00412, LIM, LIM domain | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 3e-10
Identities = 27/58 (46%), Positives = 35/58 (60%), Gaps = 2/58 (3%)
Query: 12 CAGCLNNIVEDEYVQ-ALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYNGKY 67
CAGC I + E V+ AL + WH +CFRC+ C L +FEKDG L+CK DY +
Sbjct: 1 CAGCGKPIYDRELVRRALGKVWHPECFRCAVCGKPLGPGDFFEKDGKLYCKHDYFKLF 58
|
This family represents two copies of the LIM structural domain. Length = 58 |
| >gnl|CDD|188715 cd09329, LIM3_abLIM, The third LIM domain of actin binding LIM (abLIM) proteins | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-10
Identities = 21/52 (40%), Positives = 29/52 (55%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
CAGC I + + AL ++WH CF+C C +L Y KDG +C+ DY
Sbjct: 1 CAGCGQEIKNGQALLALDKQWHVWCFKCKECGKVLTGEYMGKDGKPYCERDY 52
|
The third LIM domain of actin binding LIM (abLIM) proteins: Three homologous members of the abLIM protein family have been identified; abLIM-1, abLIM-2 and abLIM-3. The N-terminal of abLIM consists of four tandem repeats of LIM domains and the C-terminal of acting binding LIM protein is a villin headpiece domain, which has strong actin binding activity. The abLIM-1, which is expressed in retina, brain, and muscle tissue, has been indicated to function as a tumor suppressor. AbLIM-2 and -3, mainly expressed in muscle and neuronal tissue, bind to F-actin strongly. They may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription. It has shown that LIM domains of abLIMs interact with STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. All LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 36/162 (22%), Positives = 66/162 (40%), Gaps = 37/162 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKE-LYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG+G G V + + TG + LK + + +K L+E
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRE------------------- 49
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTL----KELLQDPGQPL 600
+ + +S ++++ G + + EY GG+L K++ + G+
Sbjct: 50 ------LEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI- 102
Query: 601 PWGQRV--NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
G++V A + G++YLHS +IHRD+ N L+ G
Sbjct: 103 --GEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG 142
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 33/154 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMV--LKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
LG G FG+V+ + +V + LK+ + EA FL E+
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSMSPEA---FLAEA----------------- 52
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQ 604
NL ++ L H ++R V+ ++ + ++TEY+ G+L + L+ P G L +
Sbjct: 53 NL--------MKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINK 103
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
++ A IA GM ++ N IHRDL + N LV E
Sbjct: 104 LIDMAAQIAEGMAFIERKNYIHRDLRAANILVSE 137
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 5e-10
Identities = 40/161 (24%), Positives = 75/161 (46%), Gaps = 30/161 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG-SHGLINN 546
LGQG FG VY E K +K+ + + + + + +
Sbjct: 14 LGQGSFGMVY--------------------EGIAKGVVKDEPETRVAIKTVNEAASMRER 53
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ--------DPGQ 598
+ ++ +V++ + H+V+R +GV+ + + ++ E + G LK L+ +P Q
Sbjct: 54 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQ 113
Query: 599 -PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
P + + A +IA GM YL++ +HRDL ++NC+V E
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 154
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 7e-10
Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G + VY+ +R TGE++ LKE++ EE +
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPS------------------------ 43
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ--PLPWGQR 605
++++++ L H N++R V++ + KL LV EY+ LK+ + G L
Sbjct: 44 TAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTV 102
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG--SGFDFHLGQIYLIYV 655
+F + G+ + H ++HRDL QN L+ + G DF L + + I V
Sbjct: 103 KSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 49/194 (25%), Positives = 82/194 (42%), Gaps = 42/194 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G FG+VY+ ++ETG + K + EE ++++ E
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE-------------------- 52
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ +L S H N+++ + Y + L ++ E+ AGG + ++ + +PL Q
Sbjct: 53 -----IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV 107
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKTK 667
+ + YLH +IHRDL + N L G D L F +SAK
Sbjct: 108 VCKQTLEALNYLHENKIIHRDLKAGNILFTLDG---DIKLAD----------FGVSAKNT 154
Query: 668 KTYYPNILKKASFI 681
+T I ++ SFI
Sbjct: 155 RT----IQRRDSFI 164
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 51/181 (28%), Positives = 85/181 (46%), Gaps = 35/181 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G F +V + R+TG+ +K + K K +Q +NNL
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM--------KKHFKSLEQ-------------VNNL 45
Query: 548 HCFSQVAVLRSLHHH-NVIRFIGVLYKDRK---LNLVTEYIAGGTLKELLQDPGQPLPWG 603
++ LR L H N++R I VL+ DRK L LV E + L EL++ +PLP
Sbjct: 46 ---REIQALRRLSPHPNILRLIEVLF-DRKTGRLALVFE-LMDMNLYELIKGRKRPLPEK 100
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-EVGSGFDFHLGQIYLIYV--PYTLF 660
+ ++ + + ++H + HRD+ +N L++ ++ DF G IY PYT +
Sbjct: 101 RVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDILKLADF--GSCRGIYSKPPYTEY 158
Query: 661 I 661
I
Sbjct: 159 I 159
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 30/164 (18%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LL +G FG+++ + E +EE F+K K H
Sbjct: 11 SDLLQEGTFGRIFYGILID--------EKPGKEEEV---FVKTVKD----------HASE 49
Query: 545 NNLHCFSQVA-VLRSLHHHNVIRFIGVLYKDRKLNLVTE-YIAGGTLKELLQDP------ 596
+ Q + +L L H N++ + V +D + V Y+ G LK LQ
Sbjct: 50 IQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEAN 109
Query: 597 -GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639
Q L Q V+ A IA GM+YLH +IH+D+ ++NC++ E
Sbjct: 110 NPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE 153
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 31/158 (19%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
L+G+G +G VYR H TG V+ LK + ++ + +E
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQRE------------------ 49
Query: 546 NLHCFSQVAVLRSLHHH---NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
VA+L L N+ ++ G K +L ++ EY GG+++ L++ P+
Sbjct: 50 -------VALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK--AGPIAE 100
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R++ + Y+H + +IHRD+ + N LV G
Sbjct: 101 KYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG 138
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 1e-09
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 27/159 (16%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
S+L +G G FG V+ E +V + + R +E++F++E++
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAI--KTIREGAMSEEDFIEEAQ---------- 51
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
V+ L H +++ GV + + LV E++ G L + L+
Sbjct: 52 ---------------VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK 96
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ D+ GM YL S N+IHRDL ++NCLV E
Sbjct: 97 FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|188755 cd09369, LIM1_Lhx2_Lhx9, The first LIM domain of Lhx2 and Lhx9 family | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-09
Identities = 22/54 (40%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWY--FEKDGLLFCKEDY 63
CAGC I + Y+ A+ ++WH C +C C + LD+ F +DG ++CKEDY
Sbjct: 1 CAGCGEKIQDRFYLLAVDRQWHASCLKCCECRLPLDSELSCFSRDGNIYCKEDY 54
|
The first LIM domain of Lhx2 and Lhx9 family: Lhx2 and Lhx9 are highly homologous LHX regulatory proteins. They belong to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Although Lhx2 and Lhx9 are highly homologous, they seems to play regulatory roles in different organs. In animals, Lhx2 plays important roles in eye, cerebral cortex, limb, the olfactory organs, and erythrocyte development. Lhx2 gene knockout mice exhibit impaired patterning of the cortical hem and the telencephalon of the developing brain, and a lack of development in olfactory structures. Lhx9 is expressed in several regions of the developing mouse brain , the spinal cord, the pancreas, in limb mesenchyme, and in the urogenital region. Lhx9 plays critical roles in gonad development. Homozygous mice lacking functional Lhx9 alleles exhibit numerous urogenital defects, such as gonadal agenesis, infertility, and undetectable levels of testosterone and estradiol coupled with high FSH levels. Lhx9 null mice are phenotypically female, even those that are genotypically male. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 54 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 41/173 (23%), Positives = 76/173 (43%), Gaps = 35/173 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELY---RVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G F VY+ G V+ LK++ +D +A ++ LKE IDL
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE--------IDL------ 55
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQPLP 601
L+ L H NVI+++ ++ +LN+V E G L ++ + + +P
Sbjct: 56 -----------LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP 104
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS---GFDFHLGQIY 651
+ + + + ++HS ++HRD+ N + G G D LG+ +
Sbjct: 105 ERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLG-DLGLGRFF 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 44/166 (26%), Positives = 79/166 (47%), Gaps = 31/166 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G FG+V+ T+ + +V V + + + + FL E+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAV--KTMKPGSMSVEAFLAEAN------------------ 53
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRV 606
V+++L H +++ V+ K+ + ++TE++A G+L + L+ D G P + +
Sbjct: 54 -------VMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI 105
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--VGSGFDFHLGQI 650
+F+ IA GM ++ N IHRDL + N LV V DF L ++
Sbjct: 106 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 151
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 2e-09
Identities = 40/154 (25%), Positives = 64/154 (41%), Gaps = 33/154 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLK----ELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
LG G FG VY ++ETGE++ +K + Y +E L+E K
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVK-------------- 49
Query: 544 INNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
LR L+ H N+++ V ++ +L V EY+ G + + G+P
Sbjct: 50 -----------SLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSE 98
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ I G+ ++H HRDL +N LV
Sbjct: 99 SVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV 132
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 47/168 (27%)
Query: 488 LGQGFFGQVYRVTHRETGE---VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G+VY+VT+++ G V +L + VDEE E +
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEY-------------------- 69
Query: 545 NNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQ 598
+L+SL +H NV++F G+ YK KL LV E GG++ EL++
Sbjct: 70 ---------NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGL-- 118
Query: 599 PLPWGQRVNFA------RDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L GQR++ A G+ +LH+ +IHRD+ N L+ G
Sbjct: 119 -LICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG 165
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 26/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G FG+V++ T +V+ +K +D E ++ +++ +Q
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKI---IDLEEAEDEIEDIQQ----------------- 51
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ VL V ++ G K KL ++ EY+ GG+ +LL+ P Q
Sbjct: 52 ----EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR--AGPFDEFQIAT 105
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
++I G+ YLHS IHRD+ + N L+ E G
Sbjct: 106 MLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG 138
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 41/157 (26%), Positives = 67/157 (42%), Gaps = 30/157 (19%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMV---LKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHG 542
++G+G FG VY T ++ + +K L R+ D E + FLKE G
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKE--------------G 47
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT-EYIAGGTLKELLQDPGQPLP 601
+I ++ H NV+ +G+ LV Y+ G L+ ++
Sbjct: 48 II-----------MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPT 96
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ F +A GM YL S +HRDL ++NC++ E
Sbjct: 97 VKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE 133
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 33/173 (19%)
Query: 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
LV G LG+G FGQV V+ E +D+E + +K + L +
Sbjct: 20 LVLGKPLGEGCFGQV------------VMAEAIGLDKEKPN---RVTKVAVKMLKSDATE 64
Query: 542 GLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ------ 594
+++L S++ +++ + H N+I +G +D L ++ EY + G L+E L+
Sbjct: 65 KDLSDL--ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122
Query: 595 ---------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
P + L + V+ A +A GM YL S IHRDL ++N LV E
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 175
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 13/134 (9%)
Query: 520 AEKNFLKESKQGLIYLIDLG-------------SHGLINNLHCFSQVAVLRSLHHHNVIR 566
+E F+KE G ++ LG + G ++ + V+ L H +++
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQ 63
Query: 567 FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626
GV + + L +VTE++ G L L+ L ++ +D+ GM YL + IH
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 627 RDLNSQNCLVREVG 640
RDL ++NCLV G
Sbjct: 124 RDLAARNCLVSSTG 137
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 36/149 (24%), Positives = 63/149 (42%), Gaps = 28/149 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKE--LYRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
LG+G FG+ E ++V KE L R+ E+ ++ L E
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNE------------------ 49
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE-LLQDPGQPLPWGQ 604
+ +L L H N+I + D L + EY GGTL + +++ GQ
Sbjct: 50 -------IVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM 102
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
+ + I + ++Y+H ++HRD+ + N
Sbjct: 103 VLWYLFQIVSAVSYIHKAGILHRDIKTLN 131
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 47/178 (26%), Positives = 80/178 (44%), Gaps = 33/178 (18%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
F L G LG+G FGQV V+ E +D++ K + + + L
Sbjct: 12 FSRDKLTLGKPLGEGCFGQV------------VMAEALGIDKDKPKEAVTVAVK---MLK 56
Query: 537 DLGSHGLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
D + +++L S++ +++ + H N+I +G +D L ++ EY + G L+E L+
Sbjct: 57 DDATEKDLSDL--VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA 114
Query: 596 ---------------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
P + + + V+ +A GM YL S IHRDL ++N LV E
Sbjct: 115 RRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE 172
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 4e-09
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 29/152 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LGQG FG+V+ T T +V + + + + FL+E++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAI--KTLKPGTMMPEAFLQEAQ------------------ 53
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRV 606
+++ L H ++ V+ + + +VTE++ G+L + L++ G+ L Q V
Sbjct: 54 -------IMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV 105
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ A IA GM Y+ MN IHRDL + N LV +
Sbjct: 106 DMAAQIADGMAYIERMNYIHRDLRAANILVGD 137
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 41/163 (25%), Positives = 73/163 (44%), Gaps = 21/163 (12%)
Query: 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIY 534
RI + ++L R +LG G FG VY+ GE + + ++ E
Sbjct: 2 RILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNE--------------- 46
Query: 535 LIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ 594
+ G N+ + ++ S+ H +++R +GV + LVT+ + G L + +
Sbjct: 47 -----TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVH 100
Query: 595 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
+ + +N+ IA GM YL L+HRDL ++N LV+
Sbjct: 101 EHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK 143
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 57/197 (28%), Positives = 82/197 (41%), Gaps = 38/197 (19%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
+D+ ++G+G FGQV + ++ G M + R+ E A K+ ++ L L LG
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLG 65
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ----- 594
HH N+I +G L L EY G L + L+
Sbjct: 66 --------------------HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 105
Query: 595 --DPG--------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--VGSG 642
DP L Q ++FA D+A GM YL IHRDL ++N LV E V
Sbjct: 106 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 165
Query: 643 FDFHLGQIYLIYVPYTL 659
DF L + +YV T+
Sbjct: 166 ADFGLSRGQEVYVKKTM 182
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 11/100 (11%)
Query: 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELL-----QDPGQ 598
S+ ++ H NV+R IGV + + ++ ++ G L L D Q
Sbjct: 48 LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ 107
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
LP V F DIA+GM YL S + IHRDL ++NC++ E
Sbjct: 108 YLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNE 147
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 27/154 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+GQG G VY TG+ + +K++ N ++ K+ LI IN
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM---------NLQQQPKKELI----------IN-- 65
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ V+R H N++ ++ +L +V EY+AGG+L +++ + + GQ
Sbjct: 66 ----EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAA 119
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
R+ + +LHS +IHRD+ S N L+ GS
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 153
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 6e-09
Identities = 39/165 (23%), Positives = 65/165 (39%), Gaps = 47/165 (28%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G FG+V V + LK + + V+ ++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQE---------------------- 38
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWG 603
H FS+ +L +H +++ +KD+K + ++ EY GG L +L+D
Sbjct: 39 ---HIFSEKEILEECNHPFIVKLYRT-FKDKKYIYMLMEYCLGGELWTILRD-------- 86
Query: 604 QRVNFARDIA----AGMT----YLHSMNLIHRDLNSQNCLVREVG 640
R F A A + YLH+ +I+RDL +N L+ G
Sbjct: 87 -RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG 130
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 29/171 (16%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
L+ G +G VY V H+ET + +K K +KQ LI L N
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMK--------------KINKQNLI---------LRNQ 44
Query: 547 LH-CFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ- 604
+ F + +L + V+ R L +V EY+ GG LL++ G LP
Sbjct: 45 IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMA 103
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG--SGFDFHLGQIYLI 653
R+ FA + A + YLH+ ++HRDL N L+ +G DF L +I L+
Sbjct: 104 RMYFAETVLA-LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|214528 smart00132, LIM, Zinc-binding domain present in Lin-11, Isl-1, Mec-3 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 8e-09
Identities = 23/53 (43%), Positives = 32/53 (60%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDE-YVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKED 62
CAGC I E ++AL + WH +CF+C+ C L +FEKDG L+CK+
Sbjct: 2 CAGCGKPIYGTERVLRALGKVWHPECFKCATCGKPLSGDTFFEKDGKLYCKDC 54
|
Zinc-binding domain family. Some LIM domains bind protein partners via tyrosine-containing motifs. LIM domains are found in many key regulators of developmental pathways. Length = 54 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 8e-09
Identities = 45/174 (25%), Positives = 74/174 (42%), Gaps = 34/174 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G FG+VY+ +TG V+ LK++ + K G +
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKI----------LMHNEKDGF-------------PI 52
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLY-----KDRKLN---LVTEYIAGGTLKELLQDPGQP 599
++ +L+ L H NV+ I + RK +VT Y+ L LL++P
Sbjct: 53 TALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVK 111
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG--SGFDFHLGQIY 651
L Q + + G+ YLH +++HRD+ + N L+ G DF L + Y
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 44/194 (22%), Positives = 84/194 (43%), Gaps = 43/194 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G +G VY+ + TGE+ +K + +++ + +++
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIK-VIKLEPGEDFAVVQQ-------------------- 55
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ +++ H N++ + G + KL + E+ GG+L+++ G PL Q
Sbjct: 56 ----EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAY 110
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKTK 667
+R+ G+ YLHS +HRD+ N L+ + G +V F +SA+
Sbjct: 111 VSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-------------HVKLADFGVSAQIT 157
Query: 668 KTYYPNILKKASFI 681
T I K+ SFI
Sbjct: 158 AT----IAKRKSFI 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|188711 cd08368, LIM, LIM is a small protein-protein interaction domain, containing two zinc fingers | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-08
Identities = 20/55 (36%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 71 CQNCGQMMSG-PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
C CG+ + G ++ K+HPECFKC+ C +G G+S+ + YC CY
Sbjct: 1 CAGCGKPIEGRELLRALGKKWHPECFKCSVCGKPLG-GDSFYEKDGKP-YCEKCY 53
|
LIM domains are identified in a diverse group of proteins with wide variety of biological functions, including gene expression regulation, cell fate determination, cytoskeleton organization, tumor formation and development. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. They perform their functions through interactions with other protein partners. LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. The consensus sequence of LIM domain has been defined as C-x(2)-C-x(16,23)-H-x(2)-[CH]-x(2)-C-x(2)-C-x(16, 21)-C-x(2,3)-[CHD] (where X denotes any amino acid). Length = 53 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 49/166 (29%), Positives = 72/166 (43%), Gaps = 33/166 (19%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G +LG+G FG V RE +L D +K +K K + D+
Sbjct: 4 GRMLGKGEFGSV-----REA-------QLKSEDGSFQKVAVKMLKADIFSSSDIE----- 46
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELL----- 593
+ A ++ H NVI+ IGV + R ++ ++ G L L
Sbjct: 47 ---EFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI 103
Query: 594 -QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
++P LP V F DIA+GM YL S N IHRDL ++NC++ E
Sbjct: 104 GEEPFT-LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNE 148
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 25/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G + V++ + T ++ LKE+ EE
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP------------------------C 49
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+V++L+ L H N++ +++ D+ L LV EY+ LK+ + D G +
Sbjct: 50 TAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKI 108
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F I G+ Y H ++HRDL QN L+ E G
Sbjct: 109 FLYQILRGLAYCHRRKVLHRDLKPQNLLINERG 141
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 33/178 (18%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
+ L G LG+G FGQV V+ E +D++ K + L
Sbjct: 9 LSRTRLTLGKPLGEGCFGQV------------VMAEAIGIDKDKPN---KPVTVAVKMLK 53
Query: 537 DLGSHGLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
D + +++L S++ +++ + H N+I +G +D L ++ EY + G L+E L+
Sbjct: 54 DDATDKDLSDL--VSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRA 111
Query: 596 ---------------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
P + L + V+ A +A GM YL S IHRDL ++N LV E
Sbjct: 112 RRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE 169
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 1/89 (1%)
Query: 549 CF-SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
F ++ L H N++R GV+ + + +VTEY++ G L L+ L GQ +
Sbjct: 52 GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG 111
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+A+GM YL M +H+ L + LV
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLV 140
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 46/159 (28%), Positives = 67/159 (42%), Gaps = 35/159 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEK--NFLKESKQGLIYLIDLGSHGLI 544
+G G FG VY T EV+ +K++ Y + EK + +KE
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKE----------------- 65
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
V L+ L H N I + G ++ LV EY G + ++L+ +PL Q
Sbjct: 66 --------VRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPL---Q 113
Query: 605 RVNFA---RDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
V A G+ YLHS IHRD+ + N L+ E G
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG 152
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/195 (29%), Positives = 77/195 (39%), Gaps = 48/195 (24%)
Query: 487 LLGQGFFGQVYRVTHRETGEVM-----VLKELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
++G+G FGQV R ++ G M +LKE E ++F E L L LG
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGE----LEVLCKLG-- 60
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ------- 594
HH N+I +G L + EY G L + L+
Sbjct: 61 ------------------HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLET 102
Query: 595 DPG--------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--VGSGFD 644
DP L Q + FA D+A GM YL IHRDL ++N LV E D
Sbjct: 103 DPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIAD 162
Query: 645 FHLGQIYLIYVPYTL 659
F L + +YV T+
Sbjct: 163 FGLSRGEEVYVKKTM 177
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 49/168 (29%), Positives = 77/168 (45%), Gaps = 37/168 (22%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LLG+G G+V+ V + TG++ LK L + E ++N +K
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDK-KEMIKRNKVK-------------------- 46
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQ-DPGQPLP 601
++ +L +L H F+ LY + L LV +Y GG L LLQ PG+ L
Sbjct: 47 -RVLTEQEILATLDH----PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLS 101
Query: 602 WGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG----SGFD 644
+ F A ++ + YLH + +++RDL +N L+ E G S FD
Sbjct: 102 -EEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFD 148
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 23/153 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G FG VY T EV+ +K++ +++ E Q +I
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQS-----NEKWQDII-------------- 73
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+V L+ + H N I + G ++ LV EY G + +LL+ +PL +
Sbjct: 74 ---KEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA 129
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
G+ YLHS N+IHRD+ + N L+ E G
Sbjct: 130 ITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|188722 cd09336, LIM1_Paxillin_like, The first LIM domain of the paxillin like protein family | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-08
Identities = 21/54 (38%), Positives = 31/54 (57%), Gaps = 2/54 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYN 64
CA C IV + V AL + WH + F C+ C L +FE+DG +C++DY+
Sbjct: 1 CAACKKPIV-GQVVTALGKTWHPEHFVCAECKTELGTKNFFERDGQPYCEKDYH 53
|
The first LIM domain of the paxillin like protein family: This family consists of paxillin, leupaxin, Hic-5 (ARA55), and other related proteins. There are four LIM domains in the C-terminal of the proteins and leucine-rich LD-motifs in the N-terminal region. Members of this family are adaptor proteins to recruit key components of signal-transduction machinery to specific sub-cellular locations. Paxillin is found at the interface between the plasma membrane and the actin cytoskeleton. Paxillin serves as a platform for the recruitment of numerous regulatory and structural proteins that together control the dynamic changes in cell adhesion, cytoskeletal reorganization and gene expression that are necessary for cell migration and survival. Leupaxin is a cytoskeleton adaptor protein, which is preferentially expressed in hematopoietic cells. It associates with focal adhesion kinases PYK2 and pp125FAK and identified to be a component of the osteoclast pososomal signaling complex. Hic-5 controls cell proliferation, migration and senescence by functioning as coactivator for steroid receptors such as androgen receptor, glucocorticoid receptor and progesterone receptor. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|188772 cd09386, LIM1_LMO4, The first LIM domain of LMO4 (LIM domain only protein 4) | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-08
Identities = 21/55 (38%), Positives = 28/55 (50%), Gaps = 3/55 (5%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW---YFEKDGLLFCKEDY 63
CAGC IV+ + AL + WH C +CS C L + K G++ CK DY
Sbjct: 1 CAGCGGKIVDRFLLHALDRYWHNGCLKCSCCQAQLGEIGSSCYTKGGMILCKNDY 55
|
The first LIM domain of LMO4 (LIM domain only protein 4): LMO4 is a nuclear protein that plays important roles in transcriptional regulation and development. LMO4 is involved in various functions in tumorigenesis and cellular differentiation. LMO4 proteins regulate gene expression by interacting with a wide variety of transcription factors and cofactors to form large transcription complexes. It can interact with Smad proteins, and associate with the promoter of the PAI-1 (plasminogen activator inhibitor-1) gene in a TGFbeta (transforming growth factor beta)-dependent manner. LMO4 can also form a complex with transcription regulator CREB (cAMP response element-binding protein) and interact with CLIM1 and CLIM2. In breast tissue, LMO4 interacts with multiple proteins, including the cofactor CtIP [CtBP (C-terminal binding protein)-interacting protein], the breast and ovarian tumor suppressor BRCA1 (breast-cancer susceptibility gene 1) and the LIM-domain-binding protein LDB1. Functionally, LMO4 is shown to repress BRCA1-mediated transcription activation, thus invoking a potential role for LMO4 as a negative regulator of BRCA1 in sporadic breast cancer. LMO4 also forms complex to both ERa (oestrogen receptor alpha), MTA1 (metastasis tumor antigen 1), and HDACs (histone deacetylases), implying that LMO4 is also a component of the MTA1 corepressor complex. Over-expressed LMO4 represses ERa transactivation functions in an HDAC-dependent manner, and contributes to the process of breast cancer progression by allowing the development of Era-negative phenotypes. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 23/153 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G FG VY EV+ +K++ +++ E Q +I
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQS-----NEKWQDII-------------- 63
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+V L+ L H N I++ G ++ LV EY G + +LL+ +PL +
Sbjct: 64 ---KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAA 119
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
G+ YLHS N+IHRD+ + N L+ E G
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 152
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 50/194 (25%), Positives = 79/194 (40%), Gaps = 43/194 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G +G VY+ + TGE+ +K +I L LI
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVK--------------------IIKLEPGDDFSLIQQ- 55
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ +++ H N++ + G KL + EY GG+L+++ G PL Q
Sbjct: 56 ----EIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAY 110
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKTK 667
R+ G+ YLHS +HRD+ N L+ + G D L F ++AK
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLTDNG---DVKLAD----------FGVAAKIT 157
Query: 668 KTYYPNILKKASFI 681
T I K+ SFI
Sbjct: 158 AT----IAKRKSFI 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|188850 cd09466, LIM1_Lhx3a, The first LIM domain of Lhx3a | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-08
Identities = 18/55 (32%), Positives = 30/55 (54%)
Query: 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
I CAGC + I + ++ + WH+ C +C C L + F + G ++CKED+
Sbjct: 1 IPKCAGCDHPIFDRFILKVQDKPWHSKCLKCVDCQAQLTDKCFSRGGQVYCKEDF 55
|
The first LIM domain of Lhx3a: Lhx3a is a member of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Lhx3a is one of the two isoforms of Lhx3. The Lhx3 gene is expressed in the ventral spinal cord, the pons, the medulla oblongata, and the pineal gland of the developing nervous system during mouse embryogenesis, and transcripts are found in the emergent pituitary gland. Lhx3 functions in concert with other transcription factors to specify interneuron and motor neuron fates during development. Lhx3 proteins have been demonstrated to directly bind to the promoters of several pituitary hormone gene promoters. The Lhx3 gene encodes two isoforms, LHX3a and LHX3b that differ in their amino-terminal sequences, where Lhx3a has longer N-terminal. They show differential activation of pituitary hormone genes and distinct DNA binding properties. In human, Lhx3a trans-activated the alpha-glycoprotein subunit promoter and genes containing a high-affinity Lhx3 binding site more effectively than the hLhx3b isoform. In addition, hLhx3a induce transcription of the TSHbeta-subunit gene by acting on pituitary POU domain factor, Pit-1, while hLhx3b does not. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 56 |
| >gnl|CDD|188853 cd09469, LIM1_Lhx2, The first LIM domain of Lhx2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-08
Identities = 22/54 (40%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWY--FEKDGLLFCKEDY 63
CAGC I + Y+ A+ ++WH C +C C + L++ F KDG ++CKEDY
Sbjct: 11 CAGCGGKISDRYYLLAVDKQWHMRCLKCCECKLNLESELTCFSKDGSIYCKEDY 64
|
The first LIM domain of Lhx2: Lhx2 belongs to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. In animals, Lhx2 plays important roles in eye, cerebral cortex, limb, the olfactory organs, and erythrocyte development. Lhx2 gene knockout mice exhibit impaired patterning of the cortical hem and the telencephalon of the developing brain, and a lack of development in olfactory structures. The Lhx2 protein has been shown to bind to the mouse M71 olfactory receptor promoter. Similar to other LIM domains, this domain family is 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 64 |
| >gnl|CDD|188854 cd09470, LIM1_Lhx9, The first LIM domain of Lhx9 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-08
Identities = 22/54 (40%), Positives = 33/54 (61%), Gaps = 2/54 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWY--FEKDGLLFCKEDY 63
CAGC I + Y+ A+ ++WH C +C C + L++ F KDG ++CKEDY
Sbjct: 1 CAGCGGKISDRYYLLAVDKQWHLRCLKCCECKLALESELTCFAKDGSIYCKEDY 54
|
The first LIM domain of Lhx9: Lhx9 belongs to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Lhx9 is highly homologous to Lhx2. It is expressed in several regions of the developing mouse brain, the spinal cord, the pancreas, in limb mesenchyme, and in the urogenital region. Lhx9 plays critical roles in gonad development. Homozygous mice lacking functional Lhx9 alleles exhibit numerous urogenital defects, such as gonadal agenesis, infertility, and undetectable levels of testosterone and estradiol coupled with high FSH levels. Lhx9 null mice have reduced levels of the Sf1 nuclear receptor that is required for gonadogenesis, and recent studies have shown that Lhx9 is able to activate the Sf1/FtzF1 gene. Lhx9 null mice are phenotypically female, even those that are genotypically male. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 54 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 39/153 (25%), Positives = 65/153 (42%), Gaps = 25/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G + VY+ + T ++ LKE+ EE
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAP------------------------C 49
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+V++L+ L H N++ +++ ++ L LV EY+ LK+ L D G +
Sbjct: 50 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKL 108
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F + G+ Y H ++HRDL QN L+ E G
Sbjct: 109 FLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG 141
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 38/164 (23%), Positives = 75/164 (45%), Gaps = 21/164 (12%)
Query: 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLI 533
+RI + ++L + LLG G FG V++ G+ + + + ++ + +Q
Sbjct: 1 ARILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD------RSGRQTFQ 54
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
+ D H + + SL H ++R +G+ L LVT+ G+L + +
Sbjct: 55 EITD----------HMLA----MGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHV 99
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
+ L + +N+ IA GM YL ++HR+L ++N L++
Sbjct: 100 RQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK 143
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 4e-08
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 25/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G + V++ + T ++ LKE+ EE
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAP------------------------C 48
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+V++L++L H N++ +++ +R L LV EY+ LK+ L + G +
Sbjct: 49 TAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKI 107
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F + G++Y H ++HRDL QN L+ E G
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG 140
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 4e-08
Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 33/166 (19%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGE-----VMVLKELYRVDEEAEKNFLKESKQGLIY 534
DL R +G G FG+V+ V R + VM + E+ R+ +E
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQ-------------- 46
Query: 535 LIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ 594
H ++ VL+ + H +IR + R L ++ EY+ GG L L+
Sbjct: 47 -------------HVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLR 93
Query: 595 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ G+ + +A +I + YLHS +++RDL +N L+ + G
Sbjct: 94 NSGR-FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG 138
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|238492 cd00992, PDZ_signaling, PDZ domain found in a variety of Eumetazoan signaling molecules, often in tandem arrangements | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 5e-08
Identities = 17/39 (43%), Positives = 23/39 (58%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L +GDRILEVNG V +E L++N+ D V
Sbjct: 39 AERGGLRVGDRILEVNGVSVEGLTHEEAVELLKNSGDEV 77
|
May be responsible for specific protein-protein interactions, as most PDZ domains bind C-terminal polypeptides, and binding to internal (non-C-terminal) polypeptides and even to lipids has been demonstrated. In this subfamily of PDZ domains an N-terminal beta-strand forms the peptide-binding groove base, a circular permutation with respect to PDZ domains found in proteases. Length = 82 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 51/166 (30%)
Query: 489 GQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESK--QGLIYLIDLGSHGL 543
G+G FG+V V R+T ++ +K + + + + +N L E + Q L +H
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-------NHPF 61
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPGQPLPW 602
+ NL +S ++D + LV + + GG L+ L
Sbjct: 62 LVNLW-YS--------------------FQDEENMYLVVDLLLGGDLRYHLS-------- 92
Query: 603 GQRVNFARD--------IAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
Q+V F+ + I + YLHS +IHRD+ N L+ E G
Sbjct: 93 -QKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG 137
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 50/185 (27%), Positives = 79/185 (42%), Gaps = 39/185 (21%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL-IN 545
+G+G +G VY+ TG + LK++ + L G+ ++
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV---------------------RVPLSEEGIPLS 44
Query: 546 NLHCFSQVAVLRSL---HHHNVIRFIGVLYKDR-----KLNLVTEYIAG--GTLKELLQD 595
L ++A+L+ L H N++R + V + R KL LV E++ T
Sbjct: 45 TLR---EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK 101
Query: 596 PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLI 653
PG LP + R + G+ +LHS ++HRDL QN LV G DF L +IY
Sbjct: 102 PG--LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159
Query: 654 YVPYT 658
+ T
Sbjct: 160 EMALT 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 53/203 (26%), Positives = 84/203 (41%), Gaps = 35/203 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +G+V++ + G V + RV E G+ L
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--------------------GM--PL 46
Query: 548 HCFSQVAVLRSLH---HHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPGQP 599
+VAVLR L H NV+R V R KL LV E++ L + P
Sbjct: 47 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 106
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS--GFDFHLGQIYLIYVPY 657
+P + + G+ +LHS ++HRDL QN LV G DF L +IY +
Sbjct: 107 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 166
Query: 658 TLFILSAKTKKTYYPNILKKASF 680
T +++ + P +L ++S+
Sbjct: 167 TSVVVTLWYRA---PEVLLQSSY 186
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-08
Identities = 31/103 (30%), Positives = 53/103 (51%), Gaps = 16/103 (15%)
Query: 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL------QDPG-------- 597
+ +++ LHH N++ +GV+ +++ + ++ EY+ G L E L D G
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 598 --QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L G ++ A IAAGM YL S +H+DL ++N L+ E
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE 159
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 41/168 (24%), Positives = 73/168 (43%), Gaps = 47/168 (27%)
Query: 488 LGQGFFGQVYRVTHRETGE---VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G+V++V +++ G V +L ++ +DEE E +
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEY-------------------- 65
Query: 545 NNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQ 598
+L++L H NV++F G+ YK N LV E GG++ +L++
Sbjct: 66 ---------NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF-- 114
Query: 599 PLPWGQRVN------FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L G+R+ + G+ +LH IHRD+ N L+ G
Sbjct: 115 -LKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG 161
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 27/154 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+GQG G V+ TG+ + +K++ N K+ K+ LI
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI---------NLQKQPKKELI-------------- 63
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+++ V++ L + N++ F+ +L +V EY+AGG+L +++ + + Q
Sbjct: 64 --INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAA 119
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
R+ + +LH+ +IHRD+ S N L+ GS
Sbjct: 120 VCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS 153
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 30/155 (19%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+G G +G V + TG + +K++ V ++ LI+
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDD-----------------------LIDA 43
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQPLP 601
++ +LR L H N+I + +L + +VTE L ++++ P QPL
Sbjct: 44 KRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METDLHKVIKSP-QPLT 101
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
F I G+ YLHS N+IHRDL N LV
Sbjct: 102 DDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV 136
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|188852 cd09468, LIM1_Lhx4, The first LIM domain of Lhx4 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-07
Identities = 18/52 (34%), Positives = 32/52 (61%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
CAGC +I++ ++ L + WH+ C +C+ C + L F + G ++CKED+
Sbjct: 1 CAGCNQHILDKFILKVLDRHWHSSCLKCADCQMQLAERCFSRAGNVYCKEDF 52
|
The first LIM domain of Lhx4. Lhx4 belongs to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. LHX4 plays essential roles in pituitary gland and nervous system development. In mice, the lhx4 gene is expressed in the developing hindbrain, cerebral cortex, pituitary gland, and spinal cord. LHX4 shows significant sequence similarity to LHX3, particularly to isoforms Lhx3a. In gene regulation experiments, the LHX4 protein exhibits regulation roles towards pituitary genes, acting on their promoters/enhancers. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 52 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 1e-07
Identities = 39/154 (25%), Positives = 72/154 (46%), Gaps = 27/154 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+GQG G VY TG+ + +K++ N ++ K+ LI
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM---------NLQQQPKKELI-------------- 63
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+++ V+R + N++ ++ +L +V EY+AGG+L +++ + + GQ
Sbjct: 64 --INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAA 119
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
R+ + +LHS +IHRD+ S N L+ GS
Sbjct: 120 VCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS 153
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 39/172 (22%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
++ SD G LG G FG+V H+ TGE +K L +K + + KQ +
Sbjct: 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCL-------KKREILKMKQ-----V 62
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
H + ++L L H ++ + + ++ + E++ GG L L+
Sbjct: 63 Q----------HVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA 112
Query: 597 GQPLPWGQRVNFARDIAA--------GMTYLHSMNLIHRDLNSQNCLVREVG 640
G+ F D+A YLHS ++I+RDL +N L+ G
Sbjct: 113 GR---------FPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG 155
|
Length = 329 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 25/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G + VY+ + G+++ LK + R+ EE F
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALK-VIRLQEEEGTPFT---------------------- 49
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ ++L+ L H N++ +++ L LV EY+ + + + PG P ++
Sbjct: 50 -AIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL- 107
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F + G++Y+H ++HRDL QN L+ + G
Sbjct: 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG 140
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|188851 cd09467, LIM1_Lhx3b, The first LIM domain of Lhx3b | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-07
Identities = 19/55 (34%), Positives = 31/55 (56%)
Query: 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
I CAGC +IV+ ++ L + WH+ C +CS C L F + ++CK+D+
Sbjct: 1 IPLCAGCNQHIVDRFILKVLDRHWHSKCLKCSDCQTQLAEKCFSRGDSVYCKDDF 55
|
The first LIM domain of Lhx3b. Lhx3b is a member of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Lhx3b is one of the two isoforms of Lhx3. The Lhx3 gene is expressed in the ventral spinal cord, the pons, the medulla oblongata, and the pineal gland of the developing nervous system during mouse embryogenesis, and transcripts are found in the emergent pituitary gland. Lhx3 functions in concert with other transcription factors to specify interneuron and motor neuron fates during development. Lhx3 proteins have been demonstrated to directly bind to the promoters of several pituitary hormone gene promoters. The Lhx3 gene encodes two isoforms, LHX3a and LHX3b that differ in their amino-terminal sequences, where Lhx3a has longer N-terminal. They show differential activation of pituitary hormone genes and distinct DNA binding properties. In human, Lhx3a trans-activated the alpha-glycoprotein subunit promoter and genes containing a high-affinity Lhx3 binding site more effectively than the hLhx3b isoform. In addition, hLhx3a induce transcription of the TSHbeta-subunit gene by acting on pituitary POU domain factor, Pit-1, while hLhx3b does not. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 55 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 1e-07
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 27/152 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+LG+G +G VY T + +KE+ D + +E I L S+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEE--------IALHSY----- 61
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG-QR 605
L H N+++++G ++ + E + GG+L LL+ PL Q
Sbjct: 62 ------------LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQT 109
Query: 606 VNF-ARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ F + I G+ YLH ++HRD+ N LV
Sbjct: 110 IIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV 141
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 56/190 (29%), Positives = 79/190 (41%), Gaps = 38/190 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
++G+G FGQV + ++ G M + R+ E A K+ ++ L L LG
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMD-AAIKRMKEYASKDDHRDFAGELEVLCKLG------- 53
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-------DPG-- 597
HH N+I +G L L EY G L + L+ DP
Sbjct: 54 -------------HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFA 100
Query: 598 ------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE--VGSGFDFHLGQ 649
L Q ++FA D+A GM YL IHRDL ++N LV E V DF L +
Sbjct: 101 IANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
Query: 650 IYLIYVPYTL 659
+YV T+
Sbjct: 161 GQEVYVKKTM 170
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|188754 cd09368, LIM1_Lhx3_Lhx4, The first LIM domain of Lhx3 and Lhx4 family | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-07
Identities = 16/52 (30%), Positives = 31/52 (59%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
C GC +I++ ++ L + WH C +C+ C L + F ++G ++CK+D+
Sbjct: 1 CGGCQEHILDRFILKVLDRTWHAKCLKCNDCGAQLTDKCFARNGHVYCKDDF 52
|
The first LIM domain of Lhx3-Lhx4 family: Lhx3 and Lhx4 belong to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. The LHX3 and LHX4 LIM-homeodomain transcription factors play essential roles in pituitary gland and nervous system development. Although LHX3 and LHX4 share marked sequence homology, the genes have different expression patterns. They play overlapping, but distinct functions during the establishment of the specialized cells of the mammalian pituitary gland and the nervous system. Lhx3 proteins have been demonstrated the ability to directly bind to the promoters/enhancers of several pituitary hormone gene promoters to cause increased transcription. Lhx3a and Lhx3b, whose mRNAs have distinct temporal expression profiles during development, are two isoforms of Lhx3. LHX4 plays essential roles in pituitary gland and nervous system development. In mice, the lhx4 gene is expressed in the developing hindbrain, cerebral cortex, pituitary gland, and spinal cord. LHX4 shows significant sequence similarity to LHX3, particularly to isoforms Lhx3a. In gene regulation experiments, the LHX4 protein exhibits regulation roles towards pituitary genes, acting on their promoters/enhancers. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 52 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 38/154 (24%), Positives = 72/154 (46%), Gaps = 27/154 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+GQG G VY TG+ + ++++ N ++ K+ LI
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM---------NLQQQPKKELI-------------- 64
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+++ V+R + N++ ++ +L +V EY+AGG+L +++ + + GQ
Sbjct: 65 --INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAA 120
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
R+ + +LHS +IHRD+ S N L+ GS
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 154
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|188753 cd09367, LIM1_Lhx1_Lhx5, The first LIM domain of Lhx1 (also known as Lim1) and Lhx5 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-07
Identities = 17/52 (32%), Positives = 27/52 (51%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
CAGC I++ + L + WH C +C C L F ++G L+C+ D+
Sbjct: 1 CAGCDRPILDKFLLNVLDRAWHAKCVQCCDCKCPLTEKCFSREGKLYCRNDF 52
|
The first LIM domain of Lhx1 (also known as Lim1) and Lhx5. Lhx1 and Lhx5 are closely related members of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Lhx1 is required for regulating the vertebrate head organizer, the nervous system, and female reproductive tract development. During embryogenesis in the mouse, Lhx1 is expressed early in mesodermal tissue, then later during urogenital, kidney, liver, and nervous system development. In the adult, expression is restricted to the kidney and brain. A mouse embryos with Lhx1 gene knockout cannot grow normal anterior head structures, kidneys, and gonads, but with normally developed trunk and tail morphology. In the developing nervous system, Lhx1 is required to direct the trajectories of motor axons in the limb. Lhx1 null female mice lack the oviducts and uterus. Lhx5 protein may play complementary or overlapping roles with Lhx1. The expression of Lhx5 in the anterior portion of the mouse neural tube suggests a role in patterning of the forebrain. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 38/163 (23%), Positives = 69/163 (42%), Gaps = 24/163 (14%)
Query: 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLID 537
+A D ++G+G FG+V V H+ T +V +K L + + +K S +
Sbjct: 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE------MIKRSDSAFFW--- 91
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
+ ++ + V++ DR L +V EY+ GG L L+ +
Sbjct: 92 -------------EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 138
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
P W + + ++ + +HSM IHRD+ N L+ + G
Sbjct: 139 VPEKWARF--YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 179
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|188724 cd09338, LIM3_Paxillin_like, The third LIM domain of the paxillin like protein family | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 2e-07
Identities = 21/53 (39%), Positives = 30/53 (56%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDY 63
C GC I+E Y+ AL+ +WH +CF C C N +FE +GL +C+ Y
Sbjct: 1 CGGCNKPILE-NYISALNTQWHPECFVCRECHKPFINGSFFEHEGLPYCETHY 52
|
The third LIM domain of the paxillin like protein family: This family consists of paxillin, leupaxin, Hic-5 (ARA55), and other related proteins. There are four LIM domains in the C-terminal of the proteins and leucine-rich LD-motifs in the N-terminal region. Members of this family are adaptor proteins to recruit key components of signal-transduction machinery to specific sub-cellular locations. Paxillin is found at the interface between the plasma membrane and the actin cytoskeleton. Paxillin serves as a platform for the recruitment of numerous regulatory and structural proteins that together control the dynamic changes in cell adhesion, cytoskeletal reorganization and gene expression that are necessary for cell migration and survival. Leupaxin is a cytoskeleton adaptor protein, which is preferentially expressed in hematopoietic cells. It associates with focal adhesion kinases PYK2 and pp125FAK and identified to be a component of the osteoclast pososomal signaling complex. Hic-5 controls cell proliferation, migration and senescence by functioning as coactivator for steroid receptors such as androgen receptor, glucocorticoid receptor and progesterone receptor. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 34/149 (22%), Positives = 62/149 (41%), Gaps = 23/149 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+ +G +G+V+ + TG++ +K + K D+ ++ +
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVI--------------KKA------DMIRKNQVDQV 40
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ +L V++ + L LV EY+ GG L LL++ G L
Sbjct: 41 --LTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARI 97
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ +I + YLHS +IHRDL N L+
Sbjct: 98 YIAEIVLALEYLHSNGIIHRDLKPDNILI 126
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 43/176 (24%), Positives = 77/176 (43%), Gaps = 35/176 (19%)
Query: 470 EASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKE 527
+ +K R+ +A D ++G+G FG+V V H+ + +V +K L + + + ++ F E
Sbjct: 34 KITKLRM-KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 528 SKQGLIYLIDLGSHG---LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 584
+ D+ +H I LH Q D+ L +V EY+
Sbjct: 93 ER-------DIMAHANSEWIVQLHYAFQ--------------------DDKYLYMVMEYM 125
Query: 585 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
GG L L+ + P W + + ++ + +HSM IHRD+ N L+ + G
Sbjct: 126 PGGDLVNLMSNYDIPEKWARF--YTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 179
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 43/153 (28%), Positives = 63/153 (41%), Gaps = 31/153 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMV---LKELYRVDEEA-EKNFLKESKQGLIYLIDLGSHGL 543
LG G FG V + + V +K L + A +K FL+E+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREAS-------------- 48
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
V+ L H ++R IGV K L LV E G L + L+ + +P
Sbjct: 49 -----------VMAQLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLLKYLKKRRE-IPVS 95
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
A +A GM YL S + +HRDL ++N L+
Sbjct: 96 DLKELAHQVAMGMAYLESKHFVHRDLAARNVLL 128
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 42/187 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKE-LYRVDEEA-EKNFLKESKQGLIYLIDLGSHGLIN 545
+G+G +G+VY+ + TG+++ LK+ +DEE L+E
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALRE------------------ 50
Query: 546 NLHCFSQVAVLRSLHHHN-VIRFIGVLYKDRK-----LNLVTEYIAGGTLKELL----QD 595
+++L+ L ++R + V + + K L LV EY+ LK+ + +
Sbjct: 51 -------ISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG 102
Query: 596 PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF---DFHLGQIYL 652
PG+PLP +F + G+ + H ++HRDL QN LV + D LG+ +
Sbjct: 103 PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162
Query: 653 IYV-PYT 658
I V YT
Sbjct: 163 IPVKSYT 169
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 24/154 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G FG+V H+ G+ +K L + K LK+ +Q I + L+ N+
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQK------KAILKKKEQKHIMA---ERNVLLKNV 53
Query: 548 -HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
H F L LH+ KL V +Y+ GG L LQ + P +
Sbjct: 54 KHPF-----LVGLHYS--------FQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRAR 99
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+A +IA+ + YLHS+N+I+RDL +N L+ G
Sbjct: 100 FYAAEIASALGYLHSLNIIYRDLKPENILLDSQG 133
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 47/176 (26%), Positives = 74/176 (42%), Gaps = 29/176 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +G VYR +GE++ LK++ R+D E + G+ +
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKV-RMDNE---------RDGI-------------PI 51
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDR--KLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
++ +L +L H N++ V+ + LV EY L LL + P Q
Sbjct: 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQV 110
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG--SGFDFHLGQIY-LIYVPYT 658
+ G+ YLH +IHRDL N L+ + G DF L + Y L P T
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 25/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G + VY+ R G+++ LK + EE G+ +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEE-----------GVPFT------------ 49
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ ++L+ L H N++ +++ L V EY+ + ++Q PG P+ R+
Sbjct: 50 -AIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL- 107
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F + G+ Y+H +++HRDL QN L+ +G
Sbjct: 108 FMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG 140
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 39/162 (24%), Positives = 73/162 (45%), Gaps = 30/162 (18%)
Query: 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDL 538
D+V+ ++G+G FG+V V H+ + +V +K L + + + ++ F E + ++
Sbjct: 46 DVVK--VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD----IMAF 99
Query: 539 GSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ 598
+ + L C Q D+ L +V EY+ GG L L+ +
Sbjct: 100 ANSPWVVQLFCAFQ--------------------DDKYLYMVMEYMPGGDLVNLMSNYDV 139
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
P W + + ++ + +HSM LIHRD+ N L+ + G
Sbjct: 140 PEKWAKF--YTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG 179
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|188774 cd09388, LIM1_LMO1_LMO3, The first LIM domain of LMO1 and LMO3 (LIM domain only protein 1 and 3) | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-07
Identities = 21/55 (38%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML---DNWYFEKDGLLFCKEDY 63
CAGC I + ++AL Q WH DC +C+ CD L + + K L+ C+ DY
Sbjct: 1 CAGCNRKIKDRYLLKALDQYWHEDCLKCACCDCRLGEVGSTLYTKANLILCRRDY 55
|
The first LIM domain of LMO1 and LMO3 (LIM domain only protein 1 and 3): LMO1 and LMO3 are highly homologous and belong to the LMO protein family. LMO1 and LMO3 are nuclear protein that plays important roles in transcriptional regulation and development. As LIM domains lack intrinsic DNA-binding activity, nuclear LMOs are involved in transcriptional regulation by forming complexes with other transcription factors or cofactors. For example, LMO1 interacts with the the bHLH domain of bHLH transcription factor, TAL1 (T-cell acute leukemia1)/SCL (stem cell leukemia) . LMO1 inhibits the expression of TAL1/SCL target genes. LMO3 facilitates p53 binding to its response elements, which suggests that LMO3 acts as a co-repressor of p53, suppressing p53-dependent transcriptional regulation. In addition, LMO3 interacts with neuronal transcription factor, HEN2, and acts as an oncogene in neuroblastoma. Another binding partner of LMO3 is calcium- and integrin-binding protein CIB, which binds via the second LIM domain (LIM2) of LMO3. One role of the CIB/LMO3 complex is to inhibit cell proliferation. Although LMO1 and LMO3 are highly homologous proteins, they play different roles in the regulation of the pituitary glycoprotein hormone alpha-subunit (alpha GSU) gene. Alpha GSU promoter activity was markedly repressed by LMO1 but activated by LMO3. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 37/154 (24%), Positives = 69/154 (44%), Gaps = 24/154 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G FG++Y + E V+KE +D KE+ +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKE---IDLTKMPVKEKEASK----------------- 47
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL-KELLQDPGQPLPWGQRV 606
+V +L + H N++ F ++ +L +V EY GG L K + + G Q +
Sbjct: 48 ---KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
++ I+ G+ ++H ++HRD+ SQN + + G
Sbjct: 105 SWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNG 138
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 7e-07
Identities = 47/174 (27%), Positives = 74/174 (42%), Gaps = 33/174 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G +G VY+ +G + LK + RV + ++ GL L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV-RV---------QTNEDGL-------------PL 44
Query: 548 HCFSQVAVLRSLH---HHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPGQP 599
+VA+L+ L H N++R + V R K+ LV E++ L + P
Sbjct: 45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG 104
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIY 651
LP + R G+ +LH+ ++HRDL +N LV G DF L +IY
Sbjct: 105 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 43/154 (27%), Positives = 67/154 (43%), Gaps = 37/154 (24%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+G+G +G+V V HR G+ V+K+L R E+ ++ Q
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQ---------------- 51
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYK------DRKLNLVTEYIAGGTL-KELLQDPGQP 599
+L L H N+ V Y+ D L +V + GG L +L + G+
Sbjct: 52 --------LLSQLKHPNI-----VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL 98
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
LP Q V + IA + YLH +++HRDL +QN
Sbjct: 99 LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQN 132
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 24/105 (22%), Positives = 47/105 (44%), Gaps = 16/105 (15%)
Query: 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL-----LQDPGQPLPWGQ 604
F++V ++R H N++ +L +V E++ GG L ++ + + Q
Sbjct: 64 FNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEE-------Q 116
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG----SGFDF 645
+ +++LH+ +IHRD+ S + L+ G S F F
Sbjct: 117 IATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 8e-07
Identities = 45/176 (25%), Positives = 78/176 (44%), Gaps = 36/176 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +GQVY+ ++TGE++ LK++ R+D E K+G +
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV-RLDNE---------KEGF-------------PI 51
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVL--------YKDRKLN--LVTEYIAGGTLKELLQDPG 597
++ +LR L+H N++ ++ +K K LV EY+ L LL+
Sbjct: 52 TAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGL 110
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIY 651
+F + + G+ Y H N +HRD+ N L+ G DF L ++Y
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 9e-07
Identities = 35/156 (22%), Positives = 68/156 (43%), Gaps = 25/156 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G F +VYR T G + LK++ D L+D +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFD-----------------LMDAKARA----- 47
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQPLPWGQ 604
C ++ +L+ L+H NVI++ +D +LN+V E G L ++ + + +P
Sbjct: 48 DCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKT 107
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ + + + ++HS ++HRD+ N + G
Sbjct: 108 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG 143
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 9e-07
Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 36/161 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKEL------YRVDEEAEKNFLKESKQGLIYLIDLGSH 541
+G+G FG+ V +E G+ V+KE+ + EE+ K
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRK------------------- 48
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL-KELLQDPGQPL 600
+VAVL ++ H N++++ ++ L +V +Y GG L K++ G
Sbjct: 49 ----------EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLF 98
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
P Q +++ I + ++H ++HRD+ SQN + + G+
Sbjct: 99 PEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT 139
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 34/153 (22%)
Query: 490 QGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNF----LKESKQGLIYLIDLGSHGLIN 545
+G +G VYR ++TGE++ LK+L ++++E E F L+E IN
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKL-KMEKEKE-GFPITSLRE----------------IN 56
Query: 546 NLHCFSQVAVLRSLHHHNV--IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
+L L H N+ ++ + V K+ +V EY+ LK L++ QP
Sbjct: 57 ---------ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS 106
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + +G+ +LH ++HRDL + N L+
Sbjct: 107 EVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|188782 cd09396, LIM_DA1, The Lim domain of DA1 | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 1e-06
Identities = 15/32 (46%), Positives = 19/32 (59%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACD 43
CAGC + I ++ AL WH +CFRC AC
Sbjct: 1 CAGCKSEIGHGRFLSALGAVWHPECFRCHACR 32
|
The Lim domain of DA1: DA1 contains one copy of LIM domain and a domain of unknown function. DA1 is predicted as an ubiquitin receptor, which sets final seed and organ size by restricting the period of cell proliferation. The LIM domain is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 38/162 (23%), Positives = 70/162 (43%), Gaps = 34/162 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL-INN 546
+GQG FG+V++ H++T +++ LK++ ++ E E G I
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKV-LMENEKE--------------------GFPITA 58
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLY-KDRKLN-------LVTEYIAGGTLKELLQDPGQ 598
L ++ +L+ L H NV+ I + K N LV E+ L LL +
Sbjct: 59 LR---EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNV 114
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ + + G+ Y+H ++HRD+ + N L+ + G
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG 156
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-06
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 39/162 (24%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G +G VY+V HR TG M +KE+ R++ L ESK
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEI-RLE-------LDESK------------------ 42
Query: 548 HCFSQVAV-LRSLHHHN---VIRFIGVLYKDRKLNLVTEYIAGGTLKEL----LQDPGQP 599
F+Q+ + L LH ++ F G + + + + EY+ G+L +L + G P
Sbjct: 43 --FNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIP 100
Query: 600 LPWGQRVNFARDIAAGMTYL-HSMNLIHRDLNSQNCLVREVG 640
+R+ +A + G+ +L N+IHRD+ N LV G
Sbjct: 101 EDVLRRITYA--VVKGLKFLKEEHNIIHRDVKPTNVLVNGNG 140
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|188757 cd09371, LIM1_Lmx1b, The first LIM domain of Lmx1b | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-06
Identities = 18/52 (34%), Positives = 28/52 (53%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
CAGC I + ++ + WH +C +CS C L + +D L+CK+DY
Sbjct: 1 CAGCQRPISDRYLLRVNERSWHEECLQCSVCQQPLTTSCYFRDRKLYCKQDY 52
|
The first LIM domain of Lmx1b: Lmx1b belongs to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. In mouse, Lmx1b functions in the developing limbs and eyes, the kidneys, the brain, and in cranial mesenchyme. The disruption of Lmx1b gene results kidney and limb defects. In the brain, Lmx1b is important for generation of mesencephalic dopamine neurons and the differentiation of serotonergic neurons. In the mouse eye, Lmx1b regulates anterior segment (cornea, iris, ciliary body, trabecular meshwork, and lens) development. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|188758 cd09372, LIM2_FBLP-1, The second LIM domain of the filamin-binding LIM protein-1 (FBLP-1) | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-06
Identities = 17/50 (34%), Positives = 29/50 (58%), Gaps = 1/50 (2%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYC 120
C C +++ ++ +HP CF C +C IGD ES+A+ E++ +YC
Sbjct: 1 CAKCQGVITEHIIRALGKGYHPPCFTCVTCGRRIGD-ESFAVDEQNEVYC 49
|
The second LIM domain of the filamin-binding LIM protein-1 (FBLP-1): Fblp-1 contains a proline-rich domain near its N terminus and two LIM domains at its C terminus. FBLP-1 mRNA was detected in a variety of tissues and cells including platelets and endothelial cells. FBLP-1 binds to Filamins. The association between filamin B and FBLP-1 may play an unknown role in cytoskeletal function, cell adhesion, and cell motility. As in other LIM domains, this domain family is 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 43/171 (25%), Positives = 66/171 (38%), Gaps = 34/171 (19%)
Query: 490 QGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549
+G FG VY R TG+ +K L + D A+ + N+
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQ--------------------VTNVK- 44
Query: 550 FSQVAVLRSLHHHNVIRFIGVLY-----KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
A + ++ LY KD L LV EY+ GG L++ G LP
Sbjct: 45 ----AERAIMMIQGESPYVAKLYYSFQSKDY-LYLVMEYLNGGDCASLIKTLG-GLPEDW 98
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG--SGFDFHLGQIYLI 653
+ ++ G+ LH +IHRD+ +N L+ + G DF L + L
Sbjct: 99 AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE 149
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 30/104 (28%), Positives = 48/104 (46%), Gaps = 9/104 (8%)
Query: 552 QVAVLRSLHHHNVIRFI--GVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 609
+ A+ L+H N++ + G L V EY+ G TL+E+L G LP G+
Sbjct: 28 ETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADG-ALPAGETGRLM 85
Query: 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-----FDFHLG 648
+ + H+ ++HRDL QN +V + G DF +G
Sbjct: 86 LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|215907 pfam00412, LIM, LIM domain | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-06
Identities = 17/60 (28%), Positives = 26/60 (43%), Gaps = 4/60 (6%)
Query: 71 CQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQM 128
C CG+ + V +HPECF+C C +G G+ + + LYC Y +
Sbjct: 1 CAGCGKPIYDRELVRRALGKVWHPECFRCAVCGKPLGPGDFFEKDGK--LYCKHDYFKLF 58
|
This family represents two copies of the LIM structural domain. Length = 58 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 16/103 (15%)
Query: 550 FSQVAVLRS-LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL------QDPGQ---- 598
F A++RS L H N++ +GV+ K++ L+++ Y + L E L D G
Sbjct: 55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114
Query: 599 -----PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
L V+ IAAGM +L S +++H+DL ++N LV
Sbjct: 115 KTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV 157
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 28/155 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G G V++V+H+ +G +M K LI L I N
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARK-----------------------LIHLEIKPAIRN- 48
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRV 606
++ VL + ++ F G Y D ++++ E++ GG+L ++L+ G+ P +V
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 108
Query: 607 NFARDIAAGMTYLHSMN-LIHRDLNSQNCLVREVG 640
+ A + G+TYL + ++HRD+ N LV G
Sbjct: 109 SIA--VIKGLTYLREKHKIMHRDVKPSNILVNSRG 141
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 37/150 (24%), Positives = 71/150 (47%), Gaps = 24/150 (16%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
++G+G +G V + H+ET E++ +K+ ++ EE E+ +KE+
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK-FKDSEENEE--VKETT----------------- 47
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
++ +LR+L N++ + KL LV EY+ L+ L + P P R
Sbjct: 48 ---LRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRS 104
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ I A + + H +++HRD+ +N L+
Sbjct: 105 YIYQLIKA-IHWCHKNDIVHRDIKPENLLI 133
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|188716 cd09330, LIM4_abLIM, The fourth LIM domain of actin binding LIM (abLIM) proteins | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-06
Identities = 13/38 (34%), Positives = 22/38 (57%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGE 108
C+ C + ++G V+ G +HP C +C+ C G+GE
Sbjct: 1 CEACDKFITGKVLEAGGKHYHPTCARCSRCGQMFGEGE 38
|
The fourth LIM domain of actin binding LIM (abLIM) proteins: Three homologous members of the abLIM protein family have been identified; abLIM-1, abLIM-2 and abLIM-3. The N-terminal of abLIM consists of four tandem repeats of LIM domains and the C-terminal of acting binding LIM protein is a villin headpiece domain, which has strong actin binding activity. The abLIM-1, which is expressed in retina, brain, and muscle tissue, has been indicated to function as a tumor suppressor. AbLIM-2 and -3, mainly expressed in muscle and neuronal tissue, bind to F-actin strongly. They may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription. It has shown that LIM domains of abLIMs interact with STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. All LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 56 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 38/174 (21%), Positives = 64/174 (36%), Gaps = 49/174 (28%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLK-----ELYRVDEEA----EKNFLKESKQ 530
D ++G+G FG+V+ V ++TG+V +K ++ + ++ A E++ L ++
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 531 GLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLK 590
I L+ Q + L LV EY+ GG L
Sbjct: 61 PWI-----------VKLYYSFQ--------------------DEEHLYLVMEYMPGGDLM 89
Query: 591 ELLQDPGQPLPWGQRVNFARDIAAGMT----YLHSMNLIHRDLNSQNCLVREVG 640
LL AR A + +H + IHRD+ N L+ G
Sbjct: 90 NLLIRKDV-----FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG 138
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 22/150 (14%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
++G+G FG+V + G +K L + K LK+ +Q N+
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQK------KTILKKKEQ--------------NH 41
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+ V +L++L H ++ KL V +Y+ GG L LQ L R
Sbjct: 42 IMAERNV-LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARF 100
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+A ++A+ + YLHS+N+I+RDL +N L+
Sbjct: 101 -YAAEVASAIGYLHSLNIIYRDLKPENILL 129
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 25/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G + VY+ + TG+++ LKE+ R++ E F
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFT---------------------- 49
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ ++L+ L H N++ +++ + L LV EY+ LK+ + D G L
Sbjct: 50 -AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL 107
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F + G+ Y H ++HRDL QN L+ E G
Sbjct: 108 FLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG 140
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|188793 cd09409, LIM3_Paxillin, The third LIM domain of paxillin | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-06
Identities = 21/54 (38%), Positives = 30/54 (55%), Gaps = 2/54 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYN 64
C GC I+E+ Y+ AL+ WH +CF C C N +FE DG +C+ Y+
Sbjct: 1 CGGCARAILEN-YISALNTLWHPECFVCRECFTPFVNGSFFEHDGQPYCEAHYH 53
|
The third LIM domain of paxillin: Paxillin is an adaptor protein, which recruits key components of the signal-transduction machinery to specific sub-cellular locations to respond to environmental changes rapidly. The C-terminal region of paxillin contains four LIM domains which target paxillin to focal adhesions, presumably through a direct association with the cytoplasmic tail of beta-integrin. The N-terminal of paxillin is leucine-rich LD-motifs. Paxillin is found at the interface between the plasma membrane and the actin cytoskeleton. The binding partners of paxillin are diverse and include protein tyrosine kinases, such as Src and FAK, structural proteins, such as vinculin and actopaxin, and regulators of actin organization. Paxillin recruits these proteins to their function sites to control the dynamic changes in cell adhesion, cytoskeletal reorganization and gene expression. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 32/161 (19%), Positives = 68/161 (42%), Gaps = 29/161 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G +G+V + TG+++ +K +V N + + +Q +G G+ +
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIK---KVKIIEISNDVTKDRQ------LVGMCGI--HF 65
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ ++ + H N++ + V + +NLV + +A LK+++ ++
Sbjct: 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR---------KIR 115
Query: 608 FA--------RDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
I G+ LH +HRDL+ N + G
Sbjct: 116 LTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG 156
|
Length = 335 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 27/92 (29%), Positives = 48/92 (52%), Gaps = 2/92 (2%)
Query: 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD--PGQPLPWGQRVNFA 609
+V + +H NV+++ +L LV Y++GG+L ++++ P L
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+++ G+ YLHS IHRD+ + N L+ E GS
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS 140
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 40/163 (24%), Positives = 73/163 (44%), Gaps = 21/163 (12%)
Query: 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIY 534
RI + ++ + +LG G FG VY+ GE + + + EA K +K+ L
Sbjct: 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP--KANKEIL-- 57
Query: 535 LIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ 594
+ V+ S+ + +V R +G+ + L+T+ + G L + ++
Sbjct: 58 ----------------DEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVR 100
Query: 595 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
+ + +N+ IA GM YL L+HRDL ++N LV+
Sbjct: 101 EHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK 143
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 7e-06
Identities = 30/106 (28%), Positives = 45/106 (42%), Gaps = 37/106 (34%)
Query: 552 QVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEY-------------------IAGGTLK 590
++A+LR L H NV+ + V + D+ + L+ +Y I +K
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111
Query: 591 ELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
LL W Q +N G+ YLHS ++HRDL N LV
Sbjct: 112 SLL--------W-QILN-------GVHYLHSNWVLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 7e-06
Identities = 35/153 (22%), Positives = 61/153 (39%), Gaps = 23/153 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G FG VY V + + E LKE I +G +
Sbjct: 8 LGKGSFGTVYLVKDK------------KAVAEERLKVLKE--------IPVGELNPNETV 47
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQ 604
+ +L L H +++F + ++TEY G L L++ G+ L Q
Sbjct: 48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ 107
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
+ + G+ Y+H ++HRDL ++N ++
Sbjct: 108 VCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK 140
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|188726 cd09340, LIM1_Testin_like, The first LIM domain of Testin-like family | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 7e-06
Identities = 20/58 (34%), Positives = 24/58 (41%), Gaps = 6/58 (10%)
Query: 12 CAGCLNNIVEDEY-VQAL----SQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDY 63
C C I E V A WH CF C C+ +L D YF DG ++C Y
Sbjct: 1 CEKCKEPINPGEVAVFAERAGEDACWHPGCFVCETCNELLVDLIYFYHDGKIYCGRHY 58
|
The first LIM domain of Testin_like family: This family includes testin, prickle, dyxin and LIMPETin. Structurally, testin and prickle proteins contain three LIM domains at C-terminal; LIMPETin has six LIM domains; and dyxin presents only two LIM domains. However, all members of the family contain a PET protein-protein interaction domain. Testin is a cytoskeleton associated focal adhesion protein that localizes along actin stress fibers, at cell-cell-contact areas, and at focal adhesion plaques. Testin interacts with a variety of cytoskeletal proteins, including zyxin, mena, VASP, talin, and actin and it is involved in cell motility and adhesion events. Prickles have been implicated in roles of regulating tissue polarity or planar cell polarity (PCP). Dyxin involves in lung and heart development by interaction with GATA6 and blocking GATA6 activated target genes. LIMPETin might be the recombinant product of genes coding testin and four and half LIM proteins and its function is not well understood. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 58 |
| >gnl|CDD|188764 cd09378, LIM2_Lmx1a_Lmx1b, The second LIM domain of Lmx1a and Lmx1b | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 7e-06
Identities = 22/55 (40%), Positives = 29/55 (52%), Gaps = 3/55 (5%)
Query: 12 CAGCLNNIVEDEYV-QALSQEWHTDCFRCSACDVMLD--NWYFEKDGLLFCKEDY 63
C+GCL I E V +AL +H CF C C+ L + + K+G L CK DY
Sbjct: 1 CSGCLEKIAPSELVMRALENVYHLRCFCCCVCERQLQKGDEFVLKEGQLLCKSDY 55
|
The second LIM domain of Lmx1a and Lmx1b: Lmx1a and Lmx1b belong to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs such as the pituitary gland and the pancreas. Mouse Lmx1a is expressed in multiple tissues, including the roof plate of the neural tube, the developing brain, the otic vesicles, the notochord, and the pancreas. In mouse, mutations in Lmx1a result in failure of the roof plate to develop. Lmx1a may act upstream of other roof plate markers such as MafB, Gdf7, Bmp6, and Bmp7. Further characterization of these mice reveals numerous defects including disorganized cerebellum, hippocampus, and cortex; altered pigmentation; female sterility, skeletal defects, and behavioral abnormalities. In the mouse, Lmx1b functions in the developing limbs and eyes, the kidneys, the brain, and in cranial mesenchyme. The disruption of Lmx1b gene results kidney and limb defects. In the brain, Lmx1b is important for generation of mesencephalic dopamine neurons and the differentiation of serotonergic neurons. In the mouse eye, Lmx1b regulates anterior segment (cornea, iris, ciliary body, trabecular meshwork, and lens) development. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 55 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 23/154 (14%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G FG+V + TG++ K+L +K LK+ ++G + L ++ +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL-------DKKRLKK-RKG--EQMALNEKKILEKV 50
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP-LPWGQRV 606
V++ + KD L LV + GG LK + + G+P P + +
Sbjct: 51 SSRFIVSLAYAFET-----------KD-DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAI 98
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+A I G+ +LH +++RDL +N L+ + G
Sbjct: 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG 132
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|188748 cd09362, LIM2_Enigma_like, The second LIM domain of Enigma-like family | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 8e-06
Identities = 22/53 (41%), Positives = 30/53 (56%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFE-KDGLLFCKEDY 63
CA C I+ E + AL Q WH CF C+AC + N F +DG +C++DY
Sbjct: 1 CARCHKKIL-GEVMHALKQTWHVSCFVCAACKQPIGNSLFHMEDGEPYCEKDY 52
|
The second LIM domain of Enigma-like family: The Enigma LIM domain family is comprised of three members: Enigma, ENH, and Cypher (mouse)/ZASP (human). These subfamily members contain a single PDZ domain at the N-terminus and three LIM domains at the C-terminus. Enigma was initially characterized in humans and is expressed in multiple tissues, such as skeletal muscle, heart, bone and brain. The third LIM domain specifically interacts with the insulin receptor and the second LIM domain interacts with the receptor tyrosine kinase Ret and the adaptor protein APS. Thus Enigma is implicated in signal transduction processes, such as mitogenic activity, insulin related actin organization, and glucose metabolism. The second member, ENH protein, was first identified in rat brain. It has been shown that ENH interacts with protein kinase D1 (PKD1) via its LIM domains and forms a complex with PKD1 and the alpha1C subunit of cardiac L-type voltage-gated calcium channel in rat neonatal cardiomyocytes. The N-terminal PDZ domain interacts with alpha-actinin at the Z-line. ZASP/Cypher is required for maintenance of Z-line structure during muscle contraction, but not required for Z-line assembly. In heart, Cypher/ZASP plays a structural role through its interaction with cytoskeletal Z-line proteins. In addition, there is increasing evidence that Cypher/ZASP also performs signaling functions. Studies reveal that Cypher/ZASP interacts with and directs PKC to the Z-line, where PKC phosphorylates downstream signaling targets. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|214570 smart00228, PDZ, Domain present in PSD-95, Dlg, and ZO-1/2 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 8e-06
Identities = 15/39 (38%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L +GD ILEVNGT V E L++ V
Sbjct: 39 AAKAGLRVGDVILEVNGTSVEGLTHLEAVDLLKKAGGKV 77
|
Also called DHR (Dlg homologous region) or GLGF (relatively well conserved tetrapeptide in these domains). Some PDZs have been shown to bind C-terminal polypeptides; others appear to bind internal (non-C-terminal) polypeptides. Different PDZs possess different binding specificities. Length = 85 |
| >gnl|CDD|214528 smart00132, LIM, Zinc-binding domain present in Lin-11, Isl-1, Mec-3 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-05
Identities = 17/55 (30%), Positives = 28/55 (50%), Gaps = 4/55 (7%)
Query: 71 CQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
C CG+ + G V+ +HPECFKC +C + G+++ + + YC C
Sbjct: 2 CAGCGKPIYGTERVLRALGKVWHPECFKCATCGKPLS-GDTFFEKDGKL-YCKDC 54
|
Zinc-binding domain family. Some LIM domains bind protein partners via tyrosine-containing motifs. LIM domains are found in many key regulators of developmental pathways. Length = 54 |
| >gnl|CDD|188780 cd09394, LIM1_Rga, The first LIM domain of Rga GTPase-Activating Proteins | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-05
Identities = 13/36 (36%), Positives = 16/36 (44%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD 47
C GC +I E + WH CF+C CD L
Sbjct: 1 CVGCKESITEGHAYELGGDRWHIHCFKCYKCDKKLS 36
|
The first LIM domain of Rga GTPase-Activating Proteins: The members of this family contain two tandem repeats of LIM domains and a Rho-type GTPase activating protein (RhoGap) domain. Rga activates GTPases during polarized morphogenesis. In yeast, a known regulating target of Rga is CDC42p, a small GTPase. The LIM domain is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 55 |
| >gnl|CDD|188752 cd09366, LIM1_Isl, The first LIM domain of Isl, a member of LHX protein family | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 1e-05
Identities = 21/56 (37%), Positives = 29/56 (51%), Gaps = 5/56 (8%)
Query: 12 CAGCLNNIVEDEYVQALSQ--EWHTDCFRCSACDVMLDN--WYFEKDGLLFCKEDY 63
C GC I D+Y+ ++ EWH C +C+ C LD F +DG +CK DY
Sbjct: 1 CVGCGGKI-HDQYILRVAPDLEWHAACLKCAECGQYLDETCTCFVRDGKTYCKRDY 55
|
The first LIM domain of Isl: Isl is a member of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Isl1 and Isl2 are the two conserved members of this family. Proteins in this group are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Isl-1 is one of the LHX proteins isolated originally by virtue of its ability to bind DNA sequences from the 5'-flanking region of the rat insulin gene in pancreatic insulin-producing cells. Mice deficient in Isl-1 fail to form the dorsal exocrine pancreas and islet cells fail to differentiate. On the other hand, Isl-1 takes part in the pituitary development by activating the gonadotropin-releasing hormone receptor gene together with LHX3 and steroidogenic factor 1. Mouse Is l2 is expressed in the retinal ganglion cells and the developing spinal cord where it plays a role in motor neuron development. Same as Isl1, Isl2 may also be able to bind to the insulin gene enhancer to promote gene activation. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|188790 cd09406, LIM1_Leupaxin, The first LIM domain of Leupaxin | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-05
Identities = 21/54 (38%), Positives = 30/54 (55%), Gaps = 2/54 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYN 64
CA C I + V AL Q WH + F C C L + +FE++G +C+EDY+
Sbjct: 3 CASCQKPIA-GQVVTALGQTWHPEHFVCCQCGKELGSRPFFERNGQAYCEEDYH 55
|
The first LIM domain of Leupaxin: Leupaxin is a cytoskeleton adaptor protein, which is preferentially expressed in hematopoietic cells. Leupaxin belongs to the paxillin focal adhesion protein family. Same as other members of the family, it has four leucine-rich LD-motifs in the N-terminus and four LIM domains in the C-terminus. It may function in cell type-specific signaling by associating with interaction partners PYK2, FAK, PEP and p95PKL. When expressed in human leukocytic cells, leupaxin significantly suppressed integrin-mediated cell adhesion to fibronectin and the tyrosine phosphorylation of paxillin. These findings indicate that leupaxin may negatively regulate the functions of paxillin during integrin signaling. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 41/172 (23%), Positives = 70/172 (40%), Gaps = 37/172 (21%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGE--------VMVLKELYRVDEEAEKNFLKES 528
F ++L G LG G FG+V T + V +LK E
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE---------- 81
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGG 587
++ L+ S++ ++ L +H N++ +G + ++TEY G
Sbjct: 82 REALM-----------------SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124
Query: 588 TLKELLQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L L+ + L ++F+ +A GM +L S N IHRDL ++N L+
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTH 176
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|188723 cd09337, LIM2_Paxillin_like, The second LIM domain of the paxillin like protein family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 1e-05
Identities = 22/53 (41%), Positives = 30/53 (56%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDY 63
CA C N + D+ V AL + WH + F C+ C D + EKDG +C+EDY
Sbjct: 1 CAYC-NGPILDKCVTALDKTWHPEHFFCAQCGKPFGDEGFHEKDGKPYCREDY 52
|
The second LIM domain of the paxillin like protein family: This family consists of paxillin, leupaxin, Hic-5 (ARA55), and other related proteins. There are four LIM domains in the C-terminal of the proteins and leucine-rich LD-motifs in the N-terminal region. Members of this family are adaptor proteins to recruit key components of signal-transduction machinery to specific sub-cellular locations. Paxillin is found at the interface between the plasma membrane and the actin cytoskeleton. Paxillin serves as a platform for the recruitment of numerous regulatory and structural proteins that together control the dynamic changes in cell adhesion, cytoskeletal reorganization and gene expression that are necessary for cell migration and survival. Leupaxin is a cytoskeleton adaptor protein, which is preferentially expressed in hematopoietic cells. It associates with focal adhesion kinases PYK2 and pp125FAK and identified to be a component of the osteoclast pososomal signaling complex. Hic-5 controls cell proliferation, migration and senescence by functioning as coactivator for steroid receptors such as androgen receptor, glucocorticoid receptor and progesterone receptor. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 39/162 (24%), Positives = 61/162 (37%), Gaps = 42/162 (25%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G +GQV +TG + +K+L R + A K +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI--HAKRT------------------- 61
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIA---GGTLK-ELLQDPG 597
+ ++ +L+ + H NVI + V L LVT + +K + L D
Sbjct: 62 --YRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSD-- 117
Query: 598 QPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ F I G+ Y+HS +IHRDL N V E
Sbjct: 118 ------DHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNE 153
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 28/152 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQGLIYLIDLGSHGL 543
+LG+G FG+V + T E+ +K L + + ++ + + E + L G H
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKR----VLALAGKHPF 57
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
+ LH Q KDR L V EY+ GG L +Q G+
Sbjct: 58 LTQLHSCFQT-------------------KDR-LFFVMEYVNGGDLMFHIQRSGR-FDEP 96
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ +A +I G+ +LH +I+RDL N L
Sbjct: 97 RARFYAAEIVLGLQFLHERGIIYRDLKLDNVL 128
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|188747 cd09361, LIM1_Enigma_like, The first LIM domain of Enigma-like family | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 1e-05
Identities = 18/53 (33%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDY 63
CA C N ++ ++ AL + WH + F CS C L + + E+ G L+C+ Y
Sbjct: 1 CAHC-NQVIRGPFLVALGRSWHPEEFTCSHCHCSLAEIGFVEEKGSLYCELCY 52
|
The first LIM domain of Enigma-like family: The Enigma LIM domain family is comprised of three members: Enigma, ENH, and Cypher (mouse)/ZASP (human). These subfamily members contain a single PDZ domain at the N-terminus and three LIM domains at the C-terminus. Enigma was initially characterized in humans and is expressed in multiple tissues, such as skeletal muscle, heart, bone, and brain. The third LIM domain specifically interacts with the insulin receptor and the second LIM domain interacts with the receptor tyrosine kinase Ret and the adaptor protein APS. Thus Enigma is implicated in signal transduction processes, such as mitogenic activity, insulin related actin organization, and glucose metabolism. The second member, ENH protein, was first identified in rat brain. It has been shown that ENH interacts with protein kinase D1 (PKD1) via its LIM domains and forms a complex with PKD1 and the alpha1C subunit of cardiac L-type voltage-gated calcium channel in rat neonatal cardiomyocytes. The N-terminal PDZ domain interacts with alpha-actinin at the Z-line. ZASP/Cypher is required for maintenance of Z-line structure during muscle contraction, but not required for Z-line assembly. In heart, Cypher/ZASP plays a structural role through its interaction with cytoskeletal Z-line proteins. In addition, there is increasing evidence that Cypher/ZASP also performs signaling functions. Studies reveal that Cypher/ZASP interacts with and directs PKC to the Z-line, where PKC phosphorylates downstream signaling targets. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188756 cd09370, LIM1_Lmx1a, The first LIM domain of Lmx1a | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-05
Identities = 19/53 (35%), Positives = 32/53 (60%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQE-WHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY 63
C GC N +++D ++ ++ WH C +C++C L+ F +D L+CKEDY
Sbjct: 1 CEGC-NRVIQDRFLLRVNDSLWHERCLQCASCKEPLETTCFYRDKKLYCKEDY 52
|
The first LIM domain of Lmx1a: Lmx1a belongs to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Mouse Lmx1a is expressed in multiple tissues, including the roof plate of the neural tube, the developing brain, the otic vesicles, the notochord, and the pancreas. Human Lmx1a can be found in pancreas, skeletal muscle, adipose tissue, developing brain, mammary glands, and pituitary. The functions of Lmx1a in the developing nervous system were revealed by studies of mutant mouse. In mouse, mutations in Lmx1a result in failure of the roof plate to develop. Lmx1a may act upstream of other roof plate markers such as MafB, Gdf7, Bmp 6, and Bmp7. Further characterization of these mice reveals numerous defects including disorganized cerebellum, hippocampus, and cortex; altered pigmentation; female sterility; skeletal defects; and behavioral abnormalities. Within pancreatic cells, the Lmx1a protein interacts synergistically with the bHLH transcription factor E47 to activate the insulin gene enhancer/promoter. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 52 |
| >gnl|CDD|188749 cd09363, LIM3_Enigma_like, The third LIM domain of Enigma-like family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-05
Identities = 18/51 (35%), Positives = 25/51 (49%), Gaps = 2/51 (3%)
Query: 12 CAGCLNNI-VEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCK 60
C GC I D +++AL WH CF C+ C V L+ ++ K CK
Sbjct: 1 CHGCDFPIEAGDRFLEALGHTWHDTCFVCAVCHVNLEGQTFYSKKDKPLCK 51
|
The third LIM domain of Enigma-like family: The Enigma LIM domain family is comprised of three members: Enigma, ENH, and Cypher (mouse)/ZASP (human). These subfamily members contain a single PDZ domain at the N-terminus and three LIM domains at the C-terminus. Enigma was initially characterized in humans and is expressed in multiple tissues, such as skeletal muscle, heart, bone, and brain. The third LIM domain specifically interacts with the insulin receptor and the second LIM domain interacts with the receptor tyrosine kinase Ret and the adaptor protein APS. Thus Enigma is implicated in signal transduction processes, such as mitogenic activity, insulin related actin organization, and glucose metabolism. The second member, ENH protein, was first identified in rat brain. It has been shown that ENH interacts with protein kinase D1 (PKD1) via its LIM domains and forms a complex with PKD1 and the alpha1C subunit of cardiac L-type voltage-gated calcium channel in rat neonatal cardiomyocytes. The N-terminal PDZ domain interacts with alpha-actinin at the Z-line. ZASP/Cypher is required for maintenance of Z-line structure during muscle contraction, but not required for Z-line assembly. In heart, Cypher/ZASP plays a structural role through its interaction with cytoskeletal Z-line proteins. In addition, there is increasing evidence that Cypher/ZASP also performs signaling functions. Studies reveal that Cypher/ZASP interacts with and directs PKC to the Z-line, where PKC phosphorylates downstream signaling targets. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|188760 cd09374, LIM2_Isl, The second LIM domain of Isl, a member of LHX protein family | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-05
Identities = 22/56 (39%), Positives = 34/56 (60%), Gaps = 5/56 (8%)
Query: 12 CAGCLNNIVEDEYV-QALSQEWHTDCFRCSACDVML---DNWYFEKDGLLFCKEDY 63
CA C + ++++V +A ++ +H +CFRCSAC L D + DG LFCK D+
Sbjct: 1 CAKCQQSFSKNDFVMRARTKIYHIECFRCSACSRQLIPGDEFALRDDG-LFCKADH 55
|
The second LIM domain of Isl: Isl is a member of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Isl1 and Isl2 are the two conserved members of this family. Proteins in this group are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Isl-1 is one of the LHX proteins isolated originally by virtue of its ability to bind DNA sequences from the 5'-flanking region of the rat insulin gene in pancreatic insulin-producing cells. Mice deficient in Isl-1 fail to form the dorsal exocrine pancreas and islet cells fail to differentiate. On the other hand, Isl-1 takes part in the pituitary development by activating the gonadotropin-releasing hormone receptor gene together with LHX3 and steroidogenic factor 1. Mouse Isl2 is expressed in the retinal ganglion cells and the developing spinal cord where it plays a role in motor neuron development. Same as Isl1, Isl2 may also be able to bind to the insulin gene enhancer to promote gene activation. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 31/157 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+GQG +GQV+ ++TGE++ LK + K+ L++ ++ H L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRM---------------KKSLLFKLNEVRHVL---- 49
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ +L + +++ + D L L EY+ GG + LL + G +
Sbjct: 50 ---TERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-----LSED 101
Query: 608 FARDIAAGM----TYLHSMNLIHRDLNSQNCLVREVG 640
AR A M LH + IHRDL +N L+ G
Sbjct: 102 HARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG 138
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|188778 cd09392, LIM2_Lrg1p_like, The second LIM domain of Lrg1p, a LIM and RhoGap domain containing protein | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-05
Identities = 15/54 (27%), Positives = 28/54 (51%), Gaps = 3/54 (5%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML--DNWYFEKDGLLFCKEDY 63
C C + Y+ AL +++H + F CS C + ++ Y+E +G ++C Y
Sbjct: 1 CFKC-GGALRGSYITALGRKYHVEHFTCSVCPTVFGPNDSYYEHEGKIYCHYHY 53
|
The second LIM domain of Lrg1p, a LIM and RhoGap domain containing protein: The members of this family contain three tandem repeats of LIM domains and a Rho-type GTPase activating protein (RhoGap) domain. Lrg1p is a Rho1 GTPase-activating protein required for efficient cell fusion in yeast. Lrg1p-GAP domain strongly and specifically stimulates the GTPase activity of Rho1p, a regulator of beta (1-3)-glucan synthase in vitro. The LIM domain is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 24/155 (15%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
++G+G FG+V H+ ++ Y V +K LK+ ++
Sbjct: 2 VIGKGSFGKVLLARHKAE------EKFYAVKVLQKKAILKKKEEK--------------- 40
Query: 547 LHCFSQVAVL-RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
H S+ VL +++ H ++ KL V +YI GG L LQ L R
Sbjct: 41 -HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR 99
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+A +IA+ + YLHS+N+++RDL +N L+ G
Sbjct: 100 F-YAAEIASALGYLHSLNIVYRDLKPENILLDSQG 133
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 32/103 (31%), Positives = 49/103 (47%), Gaps = 8/103 (7%)
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ----- 594
S + + + RSL H N+++ +G + LV E+ G LK L+
Sbjct: 33 SASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKA 92
Query: 595 DPGQPLPWG-QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ P P QR+ A +IA G+ +LH N IH DL +NCL+
Sbjct: 93 ELMTPDPTTLQRM--ACEIALGLLHLHKNNFIHSDLALRNCLL 133
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 35/170 (20%)
Query: 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGE-------VMVLKELYRVDEEAEKNFLKE 527
RI + ++L + +LG G FG VY+ GE + VL+E +A K L E
Sbjct: 2 RILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE--NTSPKANKEILDE 59
Query: 528 SKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 587
+ V+ + V R +G+ + LVT+ + G
Sbjct: 60 A-------------------------YVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYG 93
Query: 588 TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
L + +++ + +N+ IA GM+YL + L+HRDL ++N LV+
Sbjct: 94 CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK 143
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 40/168 (23%), Positives = 66/168 (39%), Gaps = 34/168 (20%)
Query: 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELY-RVDEEAEKNFLKESKQGLIYLI 536
R DL LG G G V +V H TG VM K ++ K L+E
Sbjct: 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRE--------- 53
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHN---VIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
L+ +H ++ F G + + + E++ G+L +
Sbjct: 54 -------------------LQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIY 94
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMN-LIHRDLNSQNCLVREVG 640
+ G P+P A + G+TYL++++ ++HRD+ N LV G
Sbjct: 95 KKGG-PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG 141
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 4/92 (4%)
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+ ++ +L+ L H N+I + + + VTE + G L LL +PL
Sbjct: 55 RTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTE-LLGTDLHRLLT--SRPLEKQFIQ 111
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
F I G+ Y+HS ++HRDL N L+ E
Sbjct: 112 YFLYQILRGLKYVHSAGVVHRDLKPSNILINE 143
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 37/159 (23%), Positives = 73/159 (45%), Gaps = 31/159 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELY---RVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G F +VYR T + + LK++ +D +A ++ +KE IDL
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKE--------IDL------ 55
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQPLP 601
L+ L+H NVI+++ +D +LN+V E G L +++ + + +P
Sbjct: 56 -----------LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP 104
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ + + + ++HS ++HRD+ N + G
Sbjct: 105 ERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG 143
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|188762 cd09376, LIM2_Lhx3_Lhx4, The second LIM domain of Lhx3-Lhx4 family | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-05
Identities = 21/56 (37%), Positives = 28/56 (50%), Gaps = 4/56 (7%)
Query: 12 CAGCLNNIVEDEYVQ-ALSQEWHTDCFRCSACDVML---DNWYFEKDGLLFCKEDY 63
CAGC I + V+ A +H +CF C C L D +Y +D L CK+DY
Sbjct: 1 CAGCDEGIPPTQVVRRAQDNVYHLECFACFMCKRQLETGDEFYLMEDDRLVCKKDY 56
|
The second LIM domain of Lhx3-Lhx4 family: Lhx3 and Lhx4 belong to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. The LHX3 and LHX4 LIM-homeodomain transcription factors play essential roles in pituitary gland and nervous system development. Although LHX3 and LHX4 share marked sequence homology, the genes have different expression patterns. They play overlapping, but distinct functions during the establishment of the specialized cells of the mammalian pituitary gland and the nervous system. Lhx3 proteins have been demonstrated the ability to directly bind to the promoters/enhancers of several pituitary hormone gene promoters to cause increased transcription.Lhx3a and Lhx3b, whose mRNAs have distinct temporal expression profiles during development, are two isoforms of Lhx3. LHX4 plays essential roles in pituitary gland and nervous system development. In mice, the lhx4 gene is expressed in the developing hindbrain, cerebral cortex, pituitary gland, and spinal cord. LHX4 shows significant sequence similarity to LHX3, particularly to isoforms Lhx3a. In gene regulation experiments, the LHX4 protein exhibits regulation roles towards pituitary genes, acting on their promoters/enhancers. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 56 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 42/159 (26%), Positives = 67/159 (42%), Gaps = 32/159 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR----VDEEAEKNFLKESKQGLIYLIDLGSHG 542
+LG+G FG+V + T E+ +K L + D++ E +++ L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKR-----VLALQDKPP 61
Query: 543 LINNLH-CFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
+ LH CF V DR L V EY+ GG L +Q G+
Sbjct: 62 FLTQLHSCFQTV--------------------DR-LYFVMEYVNGGDLMYHIQQVGK-FK 99
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
Q V +A +I+ G+ +LH +I+RDL N ++ G
Sbjct: 100 EPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG 138
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|188713 cd09327, LIM1_abLIM, The first LIM domain of actin binding LIM (abLIM) proteins | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 4e-05
Identities = 17/50 (34%), Positives = 23/50 (46%), Gaps = 2/50 (4%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYC 120
C CG+ G V+ V D FH +CF C C C + + V+ YC
Sbjct: 1 CYKCGKKCKGEVLRVQDKYFHIKCFTCKVCGCDL--AQGGFFVKEGEYYC 48
|
The first LIM domain of actin binding LIM (abLIM) proteins: Three homologous members of the abLIM protein family have been identified; abLIM-1, abLIM-2 and abLIM-3. The N-terminal of abLIM consists of four tandem repeats of LIM domains and the C-terminal of acting binding LIM protein is a villin headpiece domain, which has strong actin binding activity. The abLIM-1, which is expressed in retina, brain, and muscle tissue, has been indicated to function as a tumor suppressor. AbLIM-2 and -3, mainly expressed in muscle and neuronal tissue, bind to F-actin strongly. They may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription. It has shown that LIM domains of abLIMs interact with STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. All LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188785 cd09401, LIM_TLP_like, The LIM domains of thymus LIM protein (TLP) | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 4e-05
Identities = 15/53 (28%), Positives = 23/53 (43%), Gaps = 1/53 (1%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDY 63
C C + E +L ++WH C RC C L + E +G +C + Y
Sbjct: 1 CPKCGKPVYFAEKKTSLGRDWHKPCLRCEKCKKTLTPGQHSEHEGKPYCNKCY 53
|
The LIM domain of thymus LIM protein (TLP) like proteins: This family includes the LIM domains of TLP and CRIP (Cysteine-Rich Intestinal Protein). TLP is the distant member of the CRP family of proteins. TLP has two isomers (TLP-A and TLP-B) and sharing approximately 30% with each of the three other CRPs. Like CRP1, CRP2 and CRP3/MLP, TLP has two LIM domains, connected by a flexible linker region. Unlike the CRPs, TLP lacks the nuclear targeting signal (K/R-K/R-Y-G-P-K) and is localized solely in the cytoplasm. TLP is specifically expressed in the thymus in a subset of cortical epithelial cells. TLP has a role in development of normal thymus and in controlling the development and differentiation of thymic epithelial cells. CRIP is a short LIM protein with only one LIM domain. CRIP gene is developmentally regulated and can be induced by glucocorticoid hormones during the first three postnatal weeks. The domain shows close sequence homology to LIM domain of thymus LIM protein. However, unlike the TLP proteins which have two LIM domains, the members of this family have only one LIM domain. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 27/153 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G G V T + TG+ + +K++ + K+ ++ L+
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKM---------DLRKQQRRELL-------------- 66
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
F++V ++R HH NV+ +L +V E++ GG L +++ + Q
Sbjct: 67 --FNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAT 122
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ ++YLH+ +IHRD+ S + L+ G
Sbjct: 123 VCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG 155
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (110), Expect = 4e-05
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 41/170 (24%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+G G FG+V+ V H+ T E K + YR +E EK+ L
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQL--------------------- 59
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+V V+R L H N++R+I ++KL ++ E+ G L +Q + +
Sbjct: 60 ---VIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIE 116
Query: 605 R---VNFARDIAAGMTYLHSMN-------LIHRDLNSQNCL----VREVG 640
V+ R + + Y H++ ++HRDL QN +R +G
Sbjct: 117 EHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166
|
Length = 1021 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 4e-05
Identities = 39/158 (24%), Positives = 71/158 (44%), Gaps = 21/158 (13%)
Query: 487 LLGQGFFGQVYRVTHRETGE-VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
LG G FG VY+V + G+ ++ LKE+ V A +E + + ++
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEIN-VHNPAFGKDKRERDKSIGDIV--------- 56
Query: 546 NLHCFSQVAVLR-SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL---LQDPGQPLP 601
S+V +++ L H N++R+ ++ +L +V + I G L E L++ Q
Sbjct: 57 -----SEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT 111
Query: 602 WGQRVNFARDIAAGMTYLH-SMNLIHRDLNSQNCLVRE 638
+ N + + YLH ++HRDL N ++ E
Sbjct: 112 EERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGE 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|188841 cd09457, LIM2_ENH, The second LIM domain of the Enigma Homolog (ENH) family | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 5e-05
Identities = 21/53 (39%), Positives = 27/53 (50%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFE-KDGLLFCKEDY 63
C C I+ E + AL Q WH CF C AC + N F +DG +C+ DY
Sbjct: 1 CGRCQRKIL-GEVINALKQTWHVSCFVCVACHNPIRNNVFHLEDGEPYCETDY 52
|
The second LIM domain of the Enigma Homolog (ENH) family: ENH was initially identified in rat brain. Same as enigma, it contains three LIM domains at the C-terminus and a PDZ domain at N-terminus. ENH is implicated in signal transduction processes involving protein kinases. It has also been shown that ENH interacts with protein kinase D1 (PKD1) via its LIM domains and forms a complex with PKD1 and the alpha1C subunit of cardiac L-type voltage-gated calcium channel in rat neonatal cardiomyocytes. The N-terminal PDZ domain interacts with alpha-actinin at the Z-line. ENH is expressed in multiple tissues, such as skeletal muscle, heart, bone, and brain. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 35/155 (22%), Positives = 70/155 (45%), Gaps = 17/155 (10%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G Q+Y G + Y+ D+E + K+ + L L +L
Sbjct: 3 LGRGTRTQIY------AGILN-----YKDDDEDDGY--SYEKEIKVILKVLDPSHRDISL 49
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL--PWGQR 605
F +++R + H +++ GV +D + +V E++ G L + L PW +
Sbjct: 50 AFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--K 107
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
A+ +A+ ++YL +L+H ++ ++N L+ G
Sbjct: 108 FKVAKQLASALSYLEDKDLVHGNVCTKNILLAREG 142
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 40/161 (24%), Positives = 70/161 (43%), Gaps = 40/161 (24%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELY-RVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG G G V +V HR +G +M K ++ + ++E
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRE------------------- 49
Query: 547 LHCFSQVAVLRSLHHHN---VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPW 602
L+ LH N ++ F G Y D ++++ E++ GG+L ++L+ G+ P
Sbjct: 50 ---------LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENI 100
Query: 603 GQRVNFARDIAAGMTYL---HSMNLIHRDLNSQNCLVREVG 640
+++ A + G+TYL H ++HRD+ N LV G
Sbjct: 101 LGKISIA--VLRGLTYLREKHK--IMHRDVKPSNILVNSRG 137
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|188747 cd09361, LIM1_Enigma_like, The first LIM domain of Enigma-like family | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 6e-05
Identities = 21/55 (38%), Positives = 30/55 (54%), Gaps = 4/55 (7%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALV-ERSILYCGLCY 124
C +C Q++ GP +V +HPE F C+ C C + + V E+ LYC LCY
Sbjct: 1 CAHCNQVIRGPFLVALGRSWHPEEFTCSHCHCSLAEI---GFVEEKGSLYCELCY 52
|
The first LIM domain of Enigma-like family: The Enigma LIM domain family is comprised of three members: Enigma, ENH, and Cypher (mouse)/ZASP (human). These subfamily members contain a single PDZ domain at the N-terminus and three LIM domains at the C-terminus. Enigma was initially characterized in humans and is expressed in multiple tissues, such as skeletal muscle, heart, bone, and brain. The third LIM domain specifically interacts with the insulin receptor and the second LIM domain interacts with the receptor tyrosine kinase Ret and the adaptor protein APS. Thus Enigma is implicated in signal transduction processes, such as mitogenic activity, insulin related actin organization, and glucose metabolism. The second member, ENH protein, was first identified in rat brain. It has been shown that ENH interacts with protein kinase D1 (PKD1) via its LIM domains and forms a complex with PKD1 and the alpha1C subunit of cardiac L-type voltage-gated calcium channel in rat neonatal cardiomyocytes. The N-terminal PDZ domain interacts with alpha-actinin at the Z-line. ZASP/Cypher is required for maintenance of Z-line structure during muscle contraction, but not required for Z-line assembly. In heart, Cypher/ZASP plays a structural role through its interaction with cytoskeletal Z-line proteins. In addition, there is increasing evidence that Cypher/ZASP also performs signaling functions. Studies reveal that Cypher/ZASP interacts with and directs PKC to the Z-line, where PKC phosphorylates downstream signaling targets. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188871 cd09840, LIM2_CRP2, The second LIM domain of Cysteine Rich Protein 2 (CRP2) | Back alignment and domain information |
|---|
Score = 40.9 bits (95), Expect = 6e-05
Identities = 17/53 (32%), Positives = 30/53 (56%), Gaps = 1/53 (1%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYF-EKDGLLFCKEDY 63
C+ C +++ E + + WH +CFRC+ C L++ EK+G ++CK Y
Sbjct: 1 CSRCGDSVYAAEKIMGAGKPWHKNCFRCAKCGKSLESTTLTEKEGEIYCKGCY 53
|
The second LIM domain of Cysteine Rich Protein 2 (CRP2): Cysteine-rich proteins (CRPs) are characterized by the presence of two LIM domains linked to short glycine-rich repeats (GRRs). The CRP family members include CRP1, CRP2, CRP3/MLP and TLPCRP1, CRP2 and CRP3 share a conserved nuclear targeting signal (K/R-K/R-Y-G-P-K), which supports the fact that these proteins function not only in the cytoplasm but also in the nucleus. CRPs control regulatory pathways during cellular differentiation, and involve in complex transcription circuits, and the organization as well as the arrangement of the myofibrillar/cytoskeletal network.CRP3 also called Muscle LIM Protein (MLP), which is a striated muscle-specific factor that enhances myogenic differentiation. The second LIM domain of CRP3/MLP interacts with cytoskeletal protein beta-spectrin. CRP3/MLP also interacts with the basic helix-loop-helix myogenic transcription factors MyoD, myogenin, and MRF4 thereby increasing their affinity for specific DNA regulatory elements. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|188778 cd09392, LIM2_Lrg1p_like, The second LIM domain of Lrg1p, a LIM and RhoGap domain containing protein | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 7e-05
Identities = 17/50 (34%), Positives = 22/50 (44%), Gaps = 1/50 (2%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYC 120
C CG + G + K+H E F C+ C G +SY E I YC
Sbjct: 1 CFKCGGALRGSYITALGRKYHVEHFTCSVCPTVFGPNDSYYEHEGKI-YC 49
|
The second LIM domain of Lrg1p, a LIM and RhoGap domain containing protein: The members of this family contain three tandem repeats of LIM domains and a Rho-type GTPase activating protein (RhoGap) domain. Lrg1p is a Rho1 GTPase-activating protein required for efficient cell fusion in yeast. Lrg1p-GAP domain strongly and specifically stimulates the GTPase activity of Rho1p, a regulator of beta (1-3)-glucan synthase in vitro. The LIM domain is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|188761 cd09375, LIM2_Lhx1_Lhx5, The second LIM domain of Lhx1 (also known as Lim1) and Lhx5 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 7e-05
Identities = 19/56 (33%), Positives = 27/56 (48%), Gaps = 4/56 (7%)
Query: 12 CAGCLNNIVEDEYV-QALSQEWHTDCFRCSACDVML---DNWYFEKDGLLFCKEDY 63
CAGC I ++ V +A + +H +CF C C L + Y + CKEDY
Sbjct: 1 CAGCDQGISPNDLVRRARDKVFHLNCFTCMVCRKQLSTGEELYILDENKFICKEDY 56
|
The second LIM domain of Lhx1 (also known as Lim1) and Lhx5. Lhx1 and Lhx5 are closely related members of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Lhx1 is required for regulating the vertebrate head organizer, the nervous system, and female reproductive tract development. During embryogenesis in the mouse, Lhx1 is expressed early in mesodermal tissue, then later during urogenital, kidney, liver, and nervous system development. In the adult, expression is restricted to the kidney and brain. A mouse embryos with Lhx1 gene knockout cannot grow normal anterior head structures, kidneys, and gonads, but with normally developed trunk and tail morphology. In the developing nervous system, Lhx1 is required to direct the trajectories of motor axons in the limb. Lhx1 null female mice lack the oviducts and uterus. Lhx5 protein may play complementary or overlapping roles with Lhx1. The expression of Lhx5 in the anterior portion of the mouse neural tube suggests a role in patterning of the forebrain. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 56 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 25/82 (30%), Positives = 40/82 (48%), Gaps = 1/82 (1%)
Query: 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 614
++ L + ++R IGV + L LV E +GG L + L + V ++
Sbjct: 48 IMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM 106
Query: 615 GMTYLHSMNLIHRDLNSQNCLV 636
GM YL N +HRDL ++N L+
Sbjct: 107 GMKYLEGKNFVHRDLAARNVLL 128
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 31/154 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG G G VY+ H T ++ +K + + E +K +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM--------------------- 47
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
S++ +L +I F G + + ++++ TE++ GG+L + P L R+
Sbjct: 48 ----SELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVL---GRI 100
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
A + G+TYL S+ ++HRD+ N LV G
Sbjct: 101 AVA--VVKGLTYLWSLKILHRDVKPSNMLVNTRG 132
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|188720 cd09334, LIM4_PINCH, The fourth LIM domain of protein PINCH | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 9e-05
Identities = 19/54 (35%), Positives = 28/54 (51%), Gaps = 2/54 (3%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDV-MLDNWYFEKDGLLFCKEDY 63
C C I E V AL + WH + F C+ C+ L + ++EK GL +C+ Y
Sbjct: 2 ICGACRRPI-EGRVVTALGKHWHVEHFVCAKCEKPFLGHRHYEKKGLAYCETHY 54
|
The fourth LIM domain of protein PINCH: PINCH plays a pivotal role in the assembly of focal adhesions (FAs), regulating diverse functions in cell adhesion, growth, and differentiation through LIM-mediated protein-protein interactions. PINCH comprises an array of five LIM domains that interact with integrin-linked kinase (ILK), Nck2 (also called Nckbeta or Grb4) and other interaction partners. These interactions are essential for triggering the FA assembly and for relaying diverse mechanical and biochemical signals between Cell-extracellular matrix and the actin cytoskeleton. The PINCH LIM4 domain recognizes the third SH3 domain of another adaptor protein, Nck2. This step is an important component of integrin signaling event. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assem bly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|188840 cd09456, LIM2_Enigma, The second LIM domain of Enigma | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 9e-05
Identities = 18/53 (33%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDY 63
CA C + E + AL WH CF C+AC + N ++ ++G +C+ DY
Sbjct: 1 CAKC-KKKITGEIMHALKMTWHVHCFTCAACKTPIRNRAFYMEEGAPYCERDY 52
|
The second LIM domain of Enigma: Enigma was initially characterized in humans as a protein containing three LIM domains at the C-terminus and a PDZ domain at N-terminus. The third LIM domain specifically interacts with the insulin receptor and the second LIM domain interacts with the receptor tyrosine kinase Ret and the adaptor protein APS. Thus Enigma is implicated in signal transduction processes, such as mitogenic activity, insulin related actin organization, and glucose metabolism. Enigma is expressed in multiple tissues, such as skeletal muscle, heart, bone and brain. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188794 cd09410, LIM3_Leupaxin, The third LIM domain of Leupaxin | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 1e-04
Identities = 20/54 (37%), Positives = 29/54 (53%), Gaps = 2/54 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSAC-DVMLDNWYFEKDGLLFCKEDYN 64
C+GC V++ Y+ A + WH +CF CS C D +FE DG C+ Y+
Sbjct: 1 CSGC-GRPVKENYLSAANGVWHPECFVCSDCLKPFTDGSFFELDGRPLCELHYH 53
|
The third LIM domain of Leupaxin: Leupaxin is a cytoskeleton adaptor protein, which is preferentially expressed in hematopoietic cells. Leupaxin belongs to the paxillin focal adhesion protein family. Same as other members of the family, it has four leucine-rich LD-motifs in the N-terminus and four LIM domains in the C-terminus. It may function in cell type-specific signaling by associating with interaction partners PYK2, FAK, PEP and p95PKL. When expressed in human leukocytic cells, leupaxin significantly suppressed integrin-mediated cell adhesion to fibronectin and the tyrosine phosphorylation of paxillin. These findings indicate that leupaxin may negatively regulate the functions of paxillin during integrin signaling. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|188836 cd09452, LIM1_Enigma, The first LIM domain of Enigma | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 1e-04
Identities = 21/53 (39%), Positives = 31/53 (58%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDY 63
CA C N I+ Y+ AL + +H + F CS C +LD +FE+ G +FC + Y
Sbjct: 1 CAQC-NKIIRGRYLVALGRSYHPEEFTCSQCKKVLDEGGFFEEKGSIFCPKCY 52
|
The first LIM domain of Enigma: Enigma was initially characterized in humans as a protein containing three LIM domains at the C-terminus and a PDZ domain at N-terminus. The third LIM domain specifically interacts with the insulin receptor and the second LIM domain interacts with the receptor tyrosine kinase Ret and the adaptor protein APS. Thus Enigma is implicated in signal transduction processes such as mitogenic activity, insulin related actin organization, and glucose metabolism. Enigma is expressed in multiple tissues, such as skeletal muscle, heart, bone and brain. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188837 cd09453, LIM1_ENH, The first LIM domain of the Enigma Homolog (ENH) family | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 1e-04
Identities = 18/54 (33%), Positives = 26/54 (48%), Gaps = 2/54 (3%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
C C Q++ GP +V +HPE F C C + + E+ LYC +CY
Sbjct: 1 CATCNQVIRGPFLVALGKSWHPEEFNCAHCKSSM--AYIGFVEEKGALYCEICY 52
|
The first LIM domain of the Enigma Homolog (ENH) family: ENH was initially identified in rat brain. Same as enigma, it contains three LIM domains at the C-terminus and a PDZ domain at N-terminus. ENH is implicated in signal transduction processes involving protein kinases. It has also been shown that ENH interacts with protein kinase D1 (PKD1) via its LIM domains and forms a complex with PKD1 and the alpha1C subunit of cardiac L-type voltage-gated calcium channel in rat neonatal cardiomyocytes. The N-terminal PDZ domain interacts with alpha-actinin at the Z-line. ENH is expressed in multiple tissues, such as skeletal muscle, heart, bone, and brain. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 24/87 (27%), Positives = 44/87 (50%), Gaps = 1/87 (1%)
Query: 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA 614
+L++++H +VIR L +V + + L L +PLP Q + + I
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILE 168
Query: 615 GMTYLHSMNLIHRDLNSQNCLVREVGS 641
G+ YLH+ +IHRD+ ++N + +V
Sbjct: 169 GLRYLHAQRIIHRDVKTENIFINDVDQ 195
|
Length = 357 |
| >gnl|CDD|188727 cd09341, LIM2_Testin_like, The second LIM domain of Testin-like family | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 1e-04
Identities = 15/35 (42%), Positives = 16/35 (45%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML 46
CA C I EY QA + WH F C CD L
Sbjct: 3 CAACDELIFSGEYTQAEGKNWHLKHFCCFQCDEPL 37
|
The second LIM domain of Testin-like family: This family includes testin, prickle, dyxin and LIMPETin. Structurally, testin and prickle proteins contain three LIM domains at C-terminal; LIMPETin has six LIM domains; and dyxin presents only two LIM domains. However, all members of the family contain a PET protein-protein interaction domain. Testin is a cytoskeleton associated focal adhesion protein that localizes along actin stress fibers, at cell-cell-contact areas, and at focal adhesion plaques. Testin interacts with a variety of cytoskeletal proteins, including zyxin, mena, VASP, talin, and actin and it is involved in cell motility and adhesion events. Prickles have been implicated in roles of regulating tissue polarity or planar cell polarity (PCP). Dyxin involves in lung and heart development by interaction with GATA6 and blocking GATA6 activated target genes. LIMPETin might be the recombinant product of genes coding testin and four and half LIM proteins and its function is not well understood. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 56 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 23/155 (14%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G FG+V V + TG++ K+L +K LK+ + L++ +N+
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKL-------DKKRLKKKSGEKMALLEKEILEKVNSP 53
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRV 606
+ S H L LV + GG LK + + G+ L + +
Sbjct: 54 FIVNLAYAFESKTH---------------LCLVMSLMNGGDLKYHIYNVGERGLEMERVI 98
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+++ I G+ +LHSM++++RD+ +N L+ + G+
Sbjct: 99 HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN 133
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 38/159 (23%), Positives = 62/159 (38%), Gaps = 38/159 (23%)
Query: 488 LGQGFFGQV-----YRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
+G G+FG+V +R + V L+ DE+ FL+E
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL--FLQE--------------- 45
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-----PG 597
V R L+H NV++ +G + LV E+ G LK L+
Sbjct: 46 ----------VQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQ 95
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ A ++A+G+ +LH + IH DL +NC +
Sbjct: 96 MAQKDVLQ-RMACEVASGLLWLHQADFIHSDLALRNCQL 133
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|238080 cd00136, PDZ, PDZ domain, also called DHR (Dlg homologous region) or GLGF (after a conserved sequence motif) | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 2e-04
Identities = 19/60 (31%), Positives = 27/60 (45%), Gaps = 5/60 (8%)
Query: 273 TGMTNNP----SVPRLDPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQ 328
G T SV P A+ L GD IL VNGT V++ L++V L++ +
Sbjct: 8 RGGTEGGVVVLSVEPGSP-AERAGLQAGDVILAVNGTDVKNLTLEDVAELLKKEVGEKVT 66
|
Many PDZ domains bind C-terminal polypeptides, though binding to internal (non-C-terminal) polypeptides and even to lipids has been demonstrated. Heterodimerization through PDZ-PDZ domain interactions adds to the domain's versatility, and PDZ domain-mediated interactions may be modulated dynamically through target phosphorylation. Some PDZ domains play a role in scaffolding supramolecular complexes. PDZ domains are found in diverse signaling proteins in bacteria, archebacteria, and eurkayotes. This CD contains two distinct structural subgroups with either a N- or C-terminal beta-strand forming the peptide-binding groove base. The circular permutation placing the strand on the N-terminus appears to be found in Eumetazoa only, while the C-terminal variant is found in all three kingdoms of life, and seems to co-occur with protease domains. PDZ domains have been named after PSD95(post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1, a mammalian tight junction protein. Length = 70 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 26/93 (27%), Positives = 44/93 (47%), Gaps = 1/93 (1%)
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
H FS+ +L ++H + G + L LV E++ GG L+ + P
Sbjct: 77 HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCF 135
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+A I YL S+N+++RDL +N L+ + G
Sbjct: 136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG 168
|
Length = 340 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 41/153 (26%), Positives = 64/153 (41%), Gaps = 31/153 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVD----EEAEKNFLKESKQGLIYLI-DLGSHG 542
LG+G FG+V +++TGE+ +K L + D +E E L K+ I+ + H
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVES--LMCEKR--IFETANSERHP 62
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
+ NL Q + + F V EY AGG L + P
Sbjct: 63 FLVNLFACFQTE--------DHVCF------------VMEYAAGGDLMMHIHTDVFSEP- 101
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ V +A + G+ YLH +++RDL N L
Sbjct: 102 -RAVFYAACVVLGLQYLHENKIVYRDLKLDNLL 133
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|188787 cd09403, LIM2_CRP, The second LIM domain of Cysteine Rich Protein (CRP) | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 2e-04
Identities = 17/53 (32%), Positives = 28/53 (52%), Gaps = 1/53 (1%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYF-EKDGLLFCKEDY 63
C C ++ E + + WH +CFRC+ C L++ +KDG ++CK Y
Sbjct: 1 CPRCGKSVYAAEKIIGAGKPWHKNCFRCAKCGKSLESTTLADKDGEIYCKGCY 53
|
The second LIM domain of Cysteine Rich Protein (CRP): Cysteine-rich proteins (CRPs) are characterized by the presence of two LIM domains linked to a short glycine-rich repeats (GRRs). The CRP family members include CRP1, CRP2, CRP3/MLP. CRP1, CRP2 and CRP3 share a conserved nuclear targeting signal (K/R-K/R-Y-G-P-K), which supports the fact that these proteins function not only in the cytoplasm but also in the nucleus. CRPs control regulatory pathways during cellular differentiation, and involve in complex transcription control, and the organization as well as the arrangement of the myofibrillar/cytoskeletal network. It is evident that CRP1, CRP2, and CRP3/MLP are involved in promoting protein assembly along the actin-based cytoskeleton. Although members of the CRP family share common binding partners, they are also capable of recognizing different and specific targets. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residu es, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|188770 cd09384, LIM1_LMO2, The first LIM domain of LMO2 (LIM domain only protein 2) | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 2e-04
Identities = 19/55 (34%), Positives = 26/55 (47%), Gaps = 3/55 (5%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML---DNWYFEKDGLLFCKEDY 63
C GC NI + +++A+ Q WH DC C C L + K G C+ DY
Sbjct: 1 CGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDY 55
|
The first LIM domain of LMO2 (LIM domain only protein 2): LMO2 is a nuclear protein that plays important roles in transcriptional regulation and development. The two tandem LIM domains of LMO2 support the assembly of a crucial cell-regulatory complex by interacting with both the TAL1-E47 and GATA1 transcription factors to form a DNA-binding complex that is capable of transcriptional activation. LMOs have also been shown to be involved in oncogenesis. LMO1 and LMO2 are activated in T-cell acute lymphoblastic leukemia by distinct chromosomal translocations. LMO2 was also shown to be involved in erythropoiesis and is required for the hematopoiesis in the adult animals. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 56 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 35/157 (22%), Positives = 65/157 (41%), Gaps = 28/157 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
L+G+G FG+V V + TG++ +K + + + + +F +E + ++ + + I
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERD----ILSISNSPWI 63
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWG 603
L Q A ++D+ L LV EY GG L LL
Sbjct: 64 PQL----QYA-----------------FQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDED 102
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ ++ + +H M +HRD+ +N L+ G
Sbjct: 103 MAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG 139
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|188845 cd09461, LIM3_Enigma_like_1, The third LIM domain of an Enigma subfamily with unknown function | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 2e-04
Identities = 19/51 (37%), Positives = 29/51 (56%), Gaps = 2/51 (3%)
Query: 12 CAGCLNNI-VEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCK 60
C C I D +V+AL+ +H+ CF C+ C+V L+ ++ K G FCK
Sbjct: 1 CVSCGFPIEAGDRWVEALNNNYHSQCFNCTRCNVNLEGQSFYAKGGRPFCK 51
|
The third LIM domain of an Enigma subfamily with unknown function: The Enigma LIM domain family is comprised of three characterized members: Enigma, ENH, and Cypher (mouse)/ZASP (human). These subfamily members contain a single PDZ domain at the N-terminus and three LIM domains at the C-terminus. They serve as adaptor proteins, where the PDZ domain tethers the protein to the cytoskeleton and the LIM domains, recruit signaling proteins to implement corresponding functions. The members of the enigma family have been implicated in regulating or organizing cytoskeletal structure, as well as involving multiple signaling pathways. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|188866 cd09482, LIM2_CRP3, The second LIM domain of Cysteine Rich Protein 3 (CRP3/MLP) | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 2e-04
Identities = 19/53 (35%), Positives = 27/53 (50%), Gaps = 1/53 (1%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYF-EKDGLLFCKEDY 63
C C ++ E V + WH CFRC+ C L++ +KDG L+CK Y
Sbjct: 1 CPRCGKSVYAAEKVMGGGKPWHKTCFRCAICGKSLESTTVTDKDGELYCKVCY 53
|
The second LIM domain of Cysteine Rich Protein 3 (CRP3/MLP): Cysteine-rich proteins (CRPs) are characterized by the presence of two LIM domains linked to short glycine-rich repeats (GRRs). The CRP family members include CRP1, CRP2, CRP3/MLP and TLPCRP1, CRP2 and CRP3 share a conserved nuclear targeting signal (K/R-K/R-Y-G-P-K), which supports the fact that these proteins function not only in the cytoplasm but also in the nucleus. CRPs control regulatory pathways during cellular differentiation, and involve in complex transcription circuits, and the organization as well as the arrangement of the myofibrillar/cytoskeletal network.CRP3 also called Muscle LIM Protein (MLP), which is a striated muscle-specific factor that enhances myogenic differentiation. The second LIM domain of CRP3/MLP interacts with cytoskeletal protein beta-spectrin. CRP3/MLP also interacts with the basic helix-loop-helix myogenic transcription factors MyoD, myogenin, and MRF4 thereby increasing their affinity for specific DNA regulatory elements. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|188759 cd09373, LIM1_AWH, The first LIM domain of Arrowhead (AWH) | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 2e-04
Identities = 17/54 (31%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWY--FEKDGLLFCKEDY 63
C GC I + ++ + WH C RC C L+ F +D ++CK DY
Sbjct: 1 CTGCGEPITDRFLLKVSGRSWHVSCLRCCVCQTPLERQPSCFTRDRQIYCKADY 54
|
The first LIM domain of Arrowhead (AWH): Arrowhead belongs to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. During embryogenesis of Drosophila, Arrowhead is expressed in each abdominal segment and in the labial segment. Late in embryonic development, expression of arrowhead is refined to the abdominal histoblasts and salivary gland imaginal ring cells themselves. The Arrowhead gene required for establishment of a subset of imaginal tissues: the abdominal histoblasts and the salivary gland imaginal rings. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 54 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 38/152 (25%), Positives = 62/152 (40%), Gaps = 26/152 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLI 544
++G+G FG+V V + TG+V +K L + + + AE +E + L+ G I
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN----GDRRWI 63
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
NLH Q + L LV +Y GG L LL LP
Sbjct: 64 TNLHYAFQ--------------------DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM 103
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ ++ + +H + +HRD+ N L+
Sbjct: 104 ARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL 135
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 24/75 (32%), Positives = 35/75 (46%), Gaps = 14/75 (18%)
Query: 579 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+V EYI G LK+L+ G +R+I + LHS +IH DL + N ++
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEELE-----LSREIGRLVGKLHSAGIIHGDLTTSNMILSG 130
Query: 639 VGSGFDFHLGQIYLI 653
G+IYLI
Sbjct: 131 ---------GKIYLI 136
|
Length = 211 |
| >gnl|CDD|201332 pfam00595, PDZ, PDZ domain (Also known as DHR or GLGF) | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 2e-04
Identities = 11/42 (26%), Positives = 18/42 (42%)
Query: 285 DPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L GDRIL +NG + + E ++ + V
Sbjct: 34 GGAAEAGGLQEGDRILSINGQDLENLSHDEAVLALKGSGGEV 75
|
PDZ domains are found in diverse signaling proteins. Length = 80 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 12/108 (11%)
Query: 521 EKNFLKESKQGLIYLIDLGSHGL------INNLHCF--SQVAVLRSLHHHNVIRFIGVLY 572
E+N + K+G Y +G+ IN+++ S++A + L H N+++ IG+
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCR 753
Query: 573 KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH 620
++ L+ EYI G L E+L++ L W +R A IA + +LH
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLH 797
|
Length = 968 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 23/87 (26%), Positives = 42/87 (48%), Gaps = 2/87 (2%)
Query: 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 609
F++V ++R H NV+ +L ++ E++ GG L +++ L Q
Sbjct: 66 FNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVC 123
Query: 610 RDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + YLHS +IHRD+ S + L+
Sbjct: 124 ESVLQALCYLHSQGVIHRDIKSDSILL 150
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 33/156 (21%), Positives = 65/156 (41%), Gaps = 27/156 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
++G+G FG+ V H + + +KE+ A ++ KE+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEA----------------- 49
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQ 604
+L + H N++ F D L +V EY GG L + ++ G+ P
Sbjct: 50 --------VLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDT 101
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ + + G+ ++H ++HRD+ S+N + + G
Sbjct: 102 ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG 137
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 39/155 (25%), Positives = 68/155 (43%), Gaps = 28/155 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G G V +V H+ +G +M K LI L I N
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARK-----------------------LIHLEIKPAIRN- 48
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRV 606
++ VL + ++ F G Y D ++++ E++ GG+L ++L++ + P +V
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 108
Query: 607 NFARDIAAGMTYLHSMN-LIHRDLNSQNCLVREVG 640
+ A + G+ YL + ++HRD+ N LV G
Sbjct: 109 SIA--VLRGLAYLREKHQIMHRDVKPSNILVNSRG 141
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 42/155 (27%), Positives = 66/155 (42%), Gaps = 23/155 (14%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+LG+G FG+V R TG++ K L EK +K+ K G +N
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKRL-------EKKRIKKRK---------GESMALN- 49
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+ +L ++ V+ L LV + GG LK + + G P +R
Sbjct: 50 -----EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA 104
Query: 607 NF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F A +I G+ LH N ++RDL +N L+ + G
Sbjct: 105 LFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG 139
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|188721 cd09335, LIM5_PINCH, The fifth LIM domain of protein PINCH | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 3e-04
Identities = 20/54 (37%), Positives = 30/54 (55%), Gaps = 3/54 (5%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACD--VMLDNWYFEKDGLLFCKEDY 63
C C N ++E + V AL++ W D F CS CD + L + ++E D CK+ Y
Sbjct: 1 CYHC-NQVIEGDVVSALNKTWCVDHFSCSFCDTKLTLKSKFYEFDMKPVCKKCY 53
|
The fifth LIM domain of protein PINCH: PINCH plays pivotal roles in the assembly of focal adhesions (FAs), regulating diverse functions in cell adhesion, growth, and differentiation through LIM-mediated protein-protein interactions. PINCH comprises an array of five LIM domains that interact with integrin-linked kinase (ILK), Nck2 (also called Nckbeta or Grb4) and other interaction partners. These interactions are essential for triggering the FA assembly and for relaying diverse mechanical and biochemical signals between Cell-extracellular matrix and the actin cytoskeleton. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 40/152 (26%), Positives = 61/152 (40%), Gaps = 25/152 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G+FG+V +L E+Y D + +KE K +
Sbjct: 3 IGNGWFGKV------------LLSEIY-TDTGVARVVVKELK---------ANASSKEQN 40
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
Q R L H N+++ +G + LV EY G LK L Q +
Sbjct: 41 EFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL 100
Query: 608 FAR---DIAAGMTYLHSMNLIHRDLNSQNCLV 636
R +IAAG+T++H N +H DL +NC +
Sbjct: 101 LQRMACEIAAGVTHMHKHNFLHSDLALRNCFL 132
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 32/159 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR----VDEEAEKNFLKESKQGLIYLIDLGSHG 542
+LG+G FG+V + T E+ +K L + D++ E +++ L G
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLAL-----PGKPP 61
Query: 543 LINNLH-CFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
+ LH CF + DR L V EY+ GG L +Q G+
Sbjct: 62 FLTQLHSCFQTM--------------------DR-LYFVMEYVNGGDLMYHIQQVGK-FK 99
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
V +A +IA G+ +LHS +I+RDL N ++ G
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG 138
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|188792 cd09408, LIM2_Leupaxin, The second LIM domain of Leupaxin | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 5e-04
Identities = 18/53 (33%), Positives = 29/53 (54%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSAC-DVMLDNWYFEKDGLLFCKEDY 63
CA C I+ + A+ Q WH + F CS C ++ D + E+DG +C+ D+
Sbjct: 1 CAYCAGPIL-QNVLTAMDQTWHPEHFFCSHCGELFGDEGFLERDGKPYCRRDF 52
|
The second LIM domain of Leupaxin: Leupaxin is a cytoskeleton adaptor protein, which is preferentially expressed in hematopoietic cells. Leupaxin belongs to the paxillin focal adhesion protein family. Same as other members of the family, it has four leucine-rich LD-motifs in the N-terminus and four LIM domains in the C-terminus. It may function in cell type-specific signaling by associating with interaction partners PYK2, FAK, PEP and p95PKL. When expressed in human leukocytic cells, leupaxin significantly suppressed integrin-mediated cell adhesion to fibronectin and the tyrosine phosphorylation of paxillin. These findings indicate that leupaxin may negatively regulate the functions of paxillin during integrin signaling. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 32/159 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR----VDEEAEKNFLKESKQGLIYLIDLGSHG 542
+LG+G FG+V + T E+ +K L + D++ E +++ L G
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALS-----GKPP 61
Query: 543 LINNLH-CFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
+ LH CF + DR L V EY+ GG L +Q G+
Sbjct: 62 FLTQLHSCFQTM--------------------DR-LYFVMEYVNGGDLMYQIQQVGR-FK 99
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
V +A +IA G+ +LHS +I+RDL N ++ G
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG 138
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 31/153 (20%), Positives = 67/153 (43%), Gaps = 27/153 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G G V T + +G+++ +K++ + K+ ++ L+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKM---------DLRKQQRRELL-------------- 64
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
F++V ++R H NV+ +L +V E++ GG L +++ + Q
Sbjct: 65 --FNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAA 120
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ ++ LH+ +IHRD+ S + L+ G
Sbjct: 121 VCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG 153
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|188791 cd09407, LIM2_Paxillin, The second LIM domain of paxillin | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 5e-04
Identities = 19/53 (35%), Positives = 28/53 (52%), Gaps = 2/53 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD-NWYFEKDGLLFCKEDY 63
C C N + D+ V AL + WH + F C+ C + EKDG +C++DY
Sbjct: 1 CYYC-NGPILDKVVTALDRTWHPEHFFCAQCGAFFGPEGFHEKDGKAYCRKDY 52
|
The second LIM domain of paxillin: Paxillin is an adaptor protein, which recruits key components of the signal-transduction machinery to specific sub-cellular locations to respond to environmental changes rapidly. The C-terminal region of paxillin contains four LIM domains which target paxillin to focal adhesions, presumably through a direct association with the cytoplasmic tail of beta-integrin. The N-terminal of paxillin is leucine-rich LD-motifs. Paxillin is found at the interface between the plasma membrane and the actin cytoskeleton. The binding partners of paxillin are diverse and include protein tyrosine kinases, such as Src and FAK, structural proteins, such as vinculin and actopaxin, and regulators of actin organization. Paxillin recruits these proteins to their function sites to control the dynamic changes in cell adhesion, cytoskeletal reorganization and gene expression. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 32/123 (26%), Positives = 52/123 (42%), Gaps = 26/123 (21%)
Query: 548 HCFSQVAVLRSLHHHNVIRF--------------IGVLYKDRKLNLVTEYIAGGTLKELL 593
H ++ ++R L H N+++ +G L + + +V EY+ L
Sbjct: 48 HALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE 107
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC------LVREVGSGFDFHL 647
Q PL F + G+ Y+HS N++HRDL N LV ++G DF L
Sbjct: 108 Q---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG---DFGL 161
Query: 648 GQI 650
+I
Sbjct: 162 ARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|188746 cd09360, LIM_ALP_like, The LIM domain of ALP (actinin-associated LIM protein) family | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 5e-04
Identities = 13/30 (43%), Positives = 15/30 (50%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSC 100
C CG + G V+ D HPECF C C
Sbjct: 1 CDKCGNGIVGVVVKARDKNRHPECFVCADC 30
|
This family represents the LIM domain of ALP (actinin-associated LIM protein) family. Four proteins: ALP, CLP36, RIL, and Mystique have been classified into the ALP subfamily of LIM domain proteins. Each member of the subfamily contains an N-terminal PDZ domain and a C-terminal LIM domain. Functionally, these proteins bind to alpha-actinin through their PDZ domains and bind or other signaling molecules through their LIM domains. ALP proteins have been implicated in cardiac and skeletal muscle structure, function and disease, platelet, and epithelial cell motility. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188800 cd09416, LIM2_Testin, The second LIM domain of Testin | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 6e-04
Identities = 17/35 (48%), Positives = 20/35 (57%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML 46
CAGC I +EY QA +Q WH F C CD +L
Sbjct: 3 CAGCDELIFSNEYTQAENQNWHLKHFCCFDCDNIL 37
|
The second LIM domain of Testin: Testin contains three C-terminal LIM domains and a PET protein-protein interaction domain at the N-terminal. Testin is a cytoskeleton associated focal adhesion protein that localizes along actin stress fibers, at cell-cell-contact areas, and at focal adhesion plaques. Testin interacts with a variety of cytoskeletal proteins, including zyxin, mena, VASP, talin, and actin and it is involved in cell motility and adhesion events. Knockout mice experiments reveal that tumor repressor function of testin. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 56 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-04
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 28/157 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQGLIYLIDLGSHGL 543
++G+G FG+V + G+ +K L + ++ + +K+ + E L+ H
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERN----VLLKNVKHPF 57
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
+ LH Q KL V +++ GG L LQ + P
Sbjct: 58 LVGLHYSFQTT--------------------EKLYFVLDFVNGGELFFHLQRE-RSFPEP 96
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ +A +IA+ + YLHS+N+++RDL +N L+ G
Sbjct: 97 RARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG 133
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 6e-04
Identities = 34/155 (21%), Positives = 69/155 (44%), Gaps = 25/155 (16%)
Query: 488 LGQGFFGQVYRVTHRETG---EVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LGQG F ++++ RE G E+ + L +V +++ +N+ ES
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNY-SES---------------- 45
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
F +++ L H +++ GV + +V EY+ G+L L+ +
Sbjct: 46 ----FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW 101
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV-RE 638
++ A+ +A + +L L H ++ ++N L+ RE
Sbjct: 102 KLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 38/158 (24%), Positives = 69/158 (43%), Gaps = 30/158 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR----VDEEAEKNFLKESKQGLIYLIDLGSHG 542
+LG+G FG+V + GE +K L + +D++ E +++ L + +
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAW-----ENP 56
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
+ +L+C Q K+ L V E++ GG L +QD G+
Sbjct: 57 FLTHLYCTFQT-------------------KEH-LFFVMEFLNGGDLMFHIQDKGR-FDL 95
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ +A +I G+ +LHS +I+RDL N ++ G
Sbjct: 96 YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG 133
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 8e-04
Identities = 33/149 (22%), Positives = 64/149 (42%), Gaps = 17/149 (11%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LGQG F +Y+ R + ++ + L LGS ++L
Sbjct: 3 LGQGTFTNIYKGVLRVQSD--------------LDIVGP-GQEVSVVLKVLGS-DHRDSL 46
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
F +++ L H ++++ GV +D + +V EY+ G L L + +++
Sbjct: 47 AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLD 105
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
A+ +A+ + YL L+H ++ +N LV
Sbjct: 106 VAKQLASALHYLEDKKLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 8e-04
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 28/157 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G FGQVY+V ++T + +K L SK+ ++ ++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL--------------SKKEIVAKKEVA-------- 38
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYK---DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
H + +L +G+ + D L LVT+Y++GG L LQ G+
Sbjct: 39 HTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FS-ED 96
Query: 605 RVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R F ++ + +LH ++++RDL +N L+ G
Sbjct: 97 RAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG 133
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|188857 cd09473, LIM2_Lhx4, The second LIM domain of Lhx4 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 9e-04
Identities = 21/56 (37%), Positives = 26/56 (46%), Gaps = 4/56 (7%)
Query: 12 CAGCLNNIVEDEYV-QALSQEWHTDCFRCSACDVML---DNWYFEKDGLLFCKEDY 63
C C I + V +A +H CF C C L D +Y +DG L CKEDY
Sbjct: 1 CTACQQGIPPTQVVRKAQDFVYHLHCFACIICSRQLATGDEFYLMEDGRLVCKEDY 56
|
The second LIM domain of Lhx4. Lhx4 belongs to the LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Members of LHX family are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. LHX4 plays essential roles in pituitary gland and nervous system development. In mice, the lhx4 gene is expressed in the developing hindbrain, cerebral cortex, pituitary gland, and spinal cord. LHX4 shows significant sequence similarity to LHX3, particularly to isoforms Lhx3a. In gene regulation experiments, the LHX4 protein exhibits regulation roles towards pituitary genes, acting on their promoters/enhancers. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 56 |
| >gnl|CDD|188760 cd09374, LIM2_Isl, The second LIM domain of Isl, a member of LHX protein family | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.001
Identities = 18/53 (33%), Positives = 27/53 (50%), Gaps = 3/53 (5%)
Query: 71 CQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCG 121
C C Q S VM +H ECF+C++CS + G+ +AL + L+C
Sbjct: 1 CAKCQQSFSKNDFVMRARTKIYHIECFRCSACSRQLIPGDEFALRDDG-LFCK 52
|
The second LIM domain of Isl: Isl is a member of LHX protein family, which features two tandem N-terminal LIM domains and a C-terminal DNA binding homeodomain. Isl1 and Isl2 are the two conserved members of this family. Proteins in this group are found in the nucleus and act as transcription factors or cofactors. LHX proteins are critical for the development of specialized cells in multiple tissue types, including the nervous system, skeletal muscle, the heart, the kidneys, and endocrine organs, such as the pituitary gland and the pancreas. Isl-1 is one of the LHX proteins isolated originally by virtue of its ability to bind DNA sequences from the 5'-flanking region of the rat insulin gene in pancreatic insulin-producing cells. Mice deficient in Isl-1 fail to form the dorsal exocrine pancreas and islet cells fail to differentiate. On the other hand, Isl-1 takes part in the pituitary development by activating the gonadotropin-releasing hormone receptor gene together with LHX3 and steroidogenic factor 1. Mouse Isl2 is expressed in the retinal ganglion cells and the developing spinal cord where it plays a role in motor neuron development. Same as Isl1, Isl2 may also be able to bind to the insulin gene enhancer to promote gene activation. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|188798 cd09414, LIM1_LIMPETin, The first LIM domain of protein LIMPETin | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.001
Identities = 18/58 (31%), Positives = 25/58 (43%), Gaps = 6/58 (10%)
Query: 12 CAGCLNNIVEDEYVQALSQE-----WHTDCFRCSACDVML-DNWYFEKDGLLFCKEDY 63
C GC + E + WH CFRCS C+ +L D Y D ++C+ Y
Sbjct: 1 CGGCSEPLKYGELAVTAPKFGESLLWHPACFRCSTCEELLVDLTYCVHDDQIYCERHY 58
|
The first LIM domain of protein LIMPETin: LIMPETin contains 6 LIM domains at the C-terminal and an N-terminal PET domain. Four of the six LIM domains are highly homologous to the four and half LIM domain protein family and two of them show sequence similarity to the LIM domains of the Testin family. Thus, LIMPETin may be the recombinant product of genes coding testin and FHL proteins. In Schistosoma mansoni, where LIMPETin was first identified, LIMPETin is down regulated in sexually mature adult Schistosoma females compared to sexually immature adult females and adult male. Its differential expression indicates that it is a transcription regulator. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 58 |
| >gnl|CDD|238488 cd00988, PDZ_CTP_protease, PDZ domain of C-terminal processing-, tail-specific-, and tricorn proteases, which function in posttranslational protein processing, maturation, and disassembly or degradation, in Bacteria, Archaea, and plant chloroplasts | Back alignment and domain information |
|---|
Score = 38.0 bits (89), Expect = 0.001
Identities = 12/38 (31%), Positives = 19/38 (50%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDT 325
A + GD I+ ++G PV L++V L+R T
Sbjct: 26 AAKAGIKAGDIIVAIDGEPVDGLSLEDVVKLLRGKAGT 63
|
May be responsible for substrate recognition and/or binding, as most PDZ domains bind C-terminal polypeptides, and binding to internal (non-C-terminal) polypeptides and even to lipids has been demonstrated. In this subfamily of protease-associated PDZ domains a C-terminal beta-strand forms the peptide-binding groove base, a circular permutation with respect to PDZ domains found in Eumetazoan signaling proteins. Length = 85 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 34/160 (21%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR----VDEEAEKNFLKESKQGLIYLIDLGSHG 542
+LG+G FG+V+ + T + +K L + +D++ E +++ L + H
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW-----EHP 56
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLP 601
+ +L+C Q L V EY+ GG L +Q + LP
Sbjct: 57 FLTHLYCTFQT--------------------KENLFFVMEYLNGGDLMFHIQSCHKFDLP 96
Query: 602 WGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R F A +I G+ +LHS +++RDL N L+ G
Sbjct: 97 ---RATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG 133
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|188808 cd09424, LIM2_FHL1, The second LIM domain of Four and a half LIM domains protein 1 (FHL1) | Back alignment and domain information |
|---|
Score = 37.0 bits (86), Expect = 0.001
Identities = 18/58 (31%), Positives = 27/58 (46%), Gaps = 2/58 (3%)
Query: 12 CAGCLNNIVE-DEYVQALSQEWHTDCFRCSAC-DVMLDNWYFEKDGLLFCKEDYNGKY 67
C GC +I+ D+ V+ WH DCF CS C + +F K +C + K+
Sbjct: 1 CKGCYKDILAGDQNVEYKGNVWHKDCFTCSNCKQPIGTKSFFPKGEDFYCVPCHEKKF 58
|
The second LIM domain of Four and a half LIM domains protein 1 (FHL1): FHL1 is heavily expressed in skeletal and cardiac muscles. It plays important roles in muscle growth, differentiation, and sarcomere assembly by acting as a modulator of transcription factors. Defects in FHL1 gene are responsible for a number of Muscular dystrophy-like muscle disorders. It has been detected that FHL1 binds to Myosin-binding protein C, regulating myosin filament formation and sarcomere assembly. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 58 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 24/92 (26%), Positives = 48/92 (52%), Gaps = 1/92 (1%)
Query: 550 FSQVAVLRSLHHHNVIRFI-GVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF 608
F + A L S H + F+ GV + + +V E++ G L L+ +P ++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122
Query: 609 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
A+ +A+ ++YL NL+H ++ ++N L+ +G
Sbjct: 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLG 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|188718 cd09332, LIM2_PINCH, The second LIM domain of protein PINCH | Back alignment and domain information |
|---|
Score = 36.9 bits (86), Expect = 0.001
Identities = 12/36 (33%), Positives = 22/36 (61%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGD 106
C CG+ + G V+ ++ +HP+CF+C C+ + D
Sbjct: 1 CGKCGEFVIGRVIKAMNNNWHPDCFRCEICNKELAD 36
|
The second LIM domain of protein PINCH: PINCH plays a pivotal role in the assembly of focal adhesions (FAs), regulating diverse functions in cell adhesion, growth, and differentiation through LIM-mediated protein-protein interactions. PINCH comprises an array of five LIM domains that interact with integrin-linked kinase (ILK), Nck2 (also called Nckbeta or Grb4) and other interaction partners. These interactions are essential for triggering the FA assembly and for relaying diverse mechanical and biochemical signals between Cell-extracellular matrix and the actin cytoskeleton. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188789 cd09405, LIM1_Paxillin, The first LIM domain of paxillin | Back alignment and domain information |
|---|
Score = 36.9 bits (85), Expect = 0.001
Identities = 17/54 (31%), Positives = 30/54 (55%), Gaps = 2/54 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSAC-DVMLDNWYFEKDGLLFCKEDYN 64
C C I + V A+ + WH + F C+ C + + +FE+DG +C++DY+
Sbjct: 2 CGACKKPIA-GQVVTAMGKTWHPEHFVCTHCQEEIGSRNFFERDGQPYCEKDYH 54
|
The first LIM domain of paxillin: Paxillin is an adaptor protein, which recruits key components of the signal-transduction machinery to specific sub-cellular locations to respond to environmental changes rapidly. The C-terminal region of paxillin contains four LIM domains which target paxillin to focal adhesions, presumably through a direct association with the cytoplasmic tail of beta-integrin. The N-terminal of paxillin is leucine-rich LD-motifs. Paxillin is found at the interface between the plasma membrane and the actin cytoskeleton. The binding partners of paxillin are diverse and include protein tyrosine kinases, such as Src and FAK, structural proteins, such as vinculin and actopaxin, and regulators of actin organization. Paxillin recruits these proteins to their function sites to control the dynamic changes in cell adhesion, cytoskeletal reorganization and gene expression. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight cons erved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 54 |
| >gnl|CDD|188773 cd09387, LIM2_LMO4, The second LIM domain of LMO4 (LIM domain only protein 4) | Back alignment and domain information |
|---|
Score = 36.7 bits (85), Expect = 0.001
Identities = 15/50 (30%), Positives = 25/50 (50%), Gaps = 2/50 (4%)
Query: 71 CQNCGQMM--SGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSIL 118
C CGQ + S VM + +H +CF C++C + G+ + V S+
Sbjct: 1 CSACGQSIPASELVMRAQGNVYHLKCFTCSTCHNQLVPGDRFHYVNGSLF 50
|
The second LIM domain of LMO4 (LIM domain only protein 4): LMO4 is a nuclear protein that plays important roles in transcriptional regulation and development. LMO4 is involved in various functions in tumorigenesis and cellular differentiation. LMO4 proteins regulate gene expression by interacting with a wide variety of transcription factors and cofactors to form large transcription complexes. It can interact with Smad proteins, and associate with the promoter of the PAI-1 (plasminogen activator inhibitor-1) gene in a TGFbeta (transforming growth factor beta)-dependent manner. LMO4 can also form a complex with transcription regulator CREB (cAMP response element-binding protein) and interact with CLIM1 and CLIM2. In breast tissue, LMO4 interacts with multiple proteins, including the cofactor CtIP [CtBP (C-terminal binding protein)-interacting protein], the breast and ovarian tumor suppressor BRCA1 (breast-cancer susceptibility gene 1) and the LIM-domain-binding protein LDB1. Functionally, LMO4 is shown to repress BRCA1-mediated transcription activation, thus invoking a potential role for LMO4 as a negative regulator of BRCA1 in sporadic breast cancer. LMO4 also forms complex to both ERa (oestrogen receptor alpha), MTA1 (metastasis tumor antigen 1), and HDACs (histone deacetylases), implying that LMO4 is also a component of the MTA1 corepressor complex. Over-expressed LMO4 represses ERa transactivation functions in an HDAC-dependent manner, and contributes to the process of breast cancer progression by allowing the development of Era-negative phenotypes. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 40/165 (24%), Positives = 70/165 (42%), Gaps = 30/165 (18%)
Query: 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLG 539
DL LG+G +G V ++ H TG +M +K + V+ + +K L +DL
Sbjct: 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLL----------MDLD 51
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---DP 596
+RS+ + F G L+++ + + E + +L + + D
Sbjct: 52 --------------ISMRSVDCPYTVTFYGALFREGDVWICME-VMDTSLDKFYKKVYDK 96
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREVG 640
G +P A I + YLHS +++IHRD+ N L+ G
Sbjct: 97 GLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG 141
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 20/62 (32%), Positives = 33/62 (53%)
Query: 575 RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634
R+ YI E+L++ L ++F+ +A GM++L S N IHRDL ++N
Sbjct: 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245
Query: 635 LV 636
L+
Sbjct: 246 LL 247
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|188844 cd09460, LIM3_ZASP_Cypher, The third LIM domain of ZASP/Cypher family | Back alignment and domain information |
|---|
Score = 36.6 bits (84), Expect = 0.002
Identities = 22/54 (40%), Positives = 32/54 (59%), Gaps = 6/54 (11%)
Query: 12 CAGCLNNIVE--DEYVQALSQEWHTDCFRCSACDVMLDN--WYFEKDGLLFCKE 61
C GC + VE D++++AL WH CF C+ C V L+ +Y +KD L CK+
Sbjct: 1 CHGC-DFPVEAGDKFIEALGHTWHDTCFICAVCHVNLEGQPFYSKKDKPL-CKK 52
|
The third LIM domain of ZASP/Cypher family: ZASP was identified in human heart and skeletal muscle and Cypher is a mice ortholog of ZASP. ZASP/Cyppher contains three LIM domains at the C-terminus and a PDZ domain at N-terminus. ZASP/Cypher is required for maintenance of Z-line structure during muscle contraction, but not required for Z-line assembly. In heart, Cypher/ZASP plays a structural role through its interaction with cytoskeletal Z-line proteins. In addition, there is increasing evidence that Cypher/ZASP also performs signaling functions. Studies reveal that Cypher/ZASP interacts with and directs PKC to the Z-line, where PKC phosphorylates downstream signaling targets. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 36/162 (22%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G +G+G +G VY+ R D + ++++ + +G G+
Sbjct: 6 GCKVGRGTYGHVYKAK--------------RKDGKDDRDYALKQIEGT---------GI- 41
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVL--YKDRKLNLVTEY--------IAGGTLKELLQ 594
++ ++A+LR L H NVI V + DRK+ L+ +Y I + +
Sbjct: 42 -SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK 100
Query: 595 DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
P Q LP G + I G+ YLH+ ++HRDL N LV
Sbjct: 101 KPVQ-LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 141
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|188739 cd09353, LIM2_Zyxin, The second LIM domain of Zyxin | Back alignment and domain information |
|---|
Score = 36.8 bits (85), Expect = 0.002
Identities = 17/60 (28%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130
C C Q ++ ++ +HP+CF C C C + +GES+ + + + +C Y R+ P
Sbjct: 1 CAVCDQKITDRMLKATGKSYHPQCFTCVVCKCPL-EGESFIVDQANQPHCVNDYHRRYAP 59
|
The second LIM domain of Zyxin: Zyxin exhibits three copies of the LIM domain, an extensive proline-rich domain and a nuclear export signal. Localized at sites of cellsubstratum adhesion in fibroblasts, Zyxin interacts with alpha-actinin, members of the cysteine-rich protein (CRP) family, proteins that display Src homology 3 (SH3) domains and Ena/VASP family members. Zyxin and its partners have been implicated in the spatial control of actin filament assembly as well as in pathways important for cell differentiation. In addition to its functions at focal adhesion plaques, recent work has shown that zyxin moves from the sites of cell contacts to the nucleus, where it directly participates in the regulation of gene expression. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors o r scaffolds to support the assembly of multimeric protein. Length = 60 |
| >gnl|CDD|188714 cd09328, LIM2_abLIM, The second LIM domain on actin binding LIM (abLIM) proteins | Back alignment and domain information |
|---|
Score = 36.6 bits (85), Expect = 0.002
Identities = 11/33 (33%), Positives = 17/33 (51%)
Query: 68 GEACQNCGQMMSGPVMVVGDHKFHPECFKCTSC 100
G C +C + G V+ +HP+CF C+ C
Sbjct: 1 GTKCDSCQDFVEGEVVSALGKTYHPKCFVCSVC 33
|
The second LIM domain of actin binding LIM (abLIM) proteins: Three homologous members of the abLIM protein family have been identified; abLIM-1, abLIM-2 and abLIM-3. The N-terminal of abLIM consists of four tandem repeats of LIM domains and the C-terminal of acting binding LIM protein is a villin headpiece domain, which has strong actin binding activity. The abLIM-1, which is expressed in retina, brain, and muscle tissue, has been indicated to function as a tumor suppressor. AbLIM-2 and -3, mainly expressed in muscle and neuronal tissue, bind to F-actin strongly. They may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription. It has shown that LIM domains of abLIMs interact with STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. All LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 56 |
| >gnl|CDD|188714 cd09328, LIM2_abLIM, The second LIM domain on actin binding LIM (abLIM) proteins | Back alignment and domain information |
|---|
Score = 36.6 bits (85), Expect = 0.002
Identities = 14/31 (45%), Positives = 17/31 (54%), Gaps = 1/31 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSAC 42
C C + VE E V AL + +H CF CS C
Sbjct: 4 CDSC-QDFVEGEVVSALGKTYHPKCFVCSVC 33
|
The second LIM domain of actin binding LIM (abLIM) proteins: Three homologous members of the abLIM protein family have been identified; abLIM-1, abLIM-2 and abLIM-3. The N-terminal of abLIM consists of four tandem repeats of LIM domains and the C-terminal of acting binding LIM protein is a villin headpiece domain, which has strong actin binding activity. The abLIM-1, which is expressed in retina, brain, and muscle tissue, has been indicated to function as a tumor suppressor. AbLIM-2 and -3, mainly expressed in muscle and neuronal tissue, bind to F-actin strongly. They may serve as a scaffold for signaling modules of the actin cytoskeleton and thereby modulate transcription. It has shown that LIM domains of abLIMs interact with STARS (striated muscle activator of Rho signaling), which directly binds actin and stimulates serum-response factor (SRF)-dependent transcription. All LIM domains are 50-60 amino acids in size and share two characteristic highly conserved zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 56 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 43/169 (25%), Positives = 68/169 (40%), Gaps = 41/169 (24%)
Query: 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
DL +G G GQVY++ ++TG VM +K++ R + E + L+DL
Sbjct: 16 DLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRI---------LMDL-- 64
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL 600
V VL+S +++ G D + + E + L +LL+ P+
Sbjct: 65 -----------DV-VLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPI 111
Query: 601 PWGQRVNFARDIAAGMTY-----LHSM----NLIHRDLNSQNCLVREVG 640
P DI MT LH + +IHRD+ N L+ G
Sbjct: 112 P--------EDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG 152
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 42/173 (24%), Positives = 70/173 (40%), Gaps = 59/173 (34%)
Query: 487 LLGQGFFGQVY---RVTHRETGEVMVLKELY--------RVDEEAEKNFLKESKQGLIYL 535
+LGQG FG+V+ ++T + G++ +K L RV + E++ L E
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------- 55
Query: 536 IDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
+H I LH Q + KL L+ +++ GG L L
Sbjct: 56 ----NHPFIVKLHYAFQT--------------------EGKLYLILDFLRGGDLFTRLS- 90
Query: 596 PGQPLPWGQRVNFARD--------IAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ V F + +A + +LHS+ +I+RDL +N L+ E G
Sbjct: 91 --------KEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG 135
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|188741 cd09355, LIM2_Ajuba_like, The second LIM domain of Ajuba-like proteins | Back alignment and domain information |
|---|
Score = 36.2 bits (84), Expect = 0.002
Identities = 20/54 (37%), Positives = 31/54 (57%), Gaps = 3/54 (5%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYF--EKDGLLFCKEDY 63
CA C + I+E +QAL + +H CFRC C+ LD F + + ++C +DY
Sbjct: 1 CAVCGHLIME-MILQALGKSYHPGCFRCCVCNECLDGVPFTVDVENNIYCVKDY 53
|
The second LIM domain of Ajuba-like proteins: Ajuba like LIM protein family includes three highly homologous proteins Ajuba, Limd1, and WTIP. Members of the family contain three tandem C-terminal LIM domains and a proline-rich N-terminal region. This family of proteins functions as scaffolds, participating in the assembly of numerous protein complexes. In the cytoplasm, Ajuba binds Grb2 to modulate serum-stimulated ERK activation. Ajuba also recruits the TNF receptor-associated factor 6 (TRAF6) to p62 and activates PKCKappa activity. Ajuba interacts with alpha-catenin and F-actin to contribute to the formation or stabilization of adheren junctions by linking adhesive receptors to the actin cytoskeleton. Although Ajuba is a cytoplasmic protein, it can shuttle into the nucleus. In nucleus, Ajuba functions as a corepressor for the zinc finger-protein Snail. It binds to the SNAG repression domain of Snail through its LIM region. Arginine methyltransferase-5 (Prmt5), a protein in the complex, is recruited to Snai l through an interaction with Ajuba. This ternary complex functions to repress E-cadherin, a Snail target gene. In addition, Ajuba contains functional nuclear-receptor interacting motifs and selectively interacts with retinoic acid receptors (RARs) and rexinoid receptor (RXRs) to negatively regulate retinoic acid signaling. Wtip, the Wt1-interacting protein, was originally identified as an interaction partner of the Wilms tumour protein 1 (WT1). Wtip is involved in kidney and neural crest development. Wtip interacts with the receptor tyrosine kinase Ror2 and inhibits canonical Wnt signaling. LIMD1 was reported to inhibit cell growth and metastases. The inhibition may be mediated through an interaction with the protein barrier-to-autointegration (BAF), a component of SWI/SNF chromatin-remodeling protein; or through the interaction with retinoblastoma protein (pRB), resulting in inhibition of E2F-mediated transcription, and expression of the majority of genes with E2F1- responsive elements. Recently, Limd1 was shown to interact with the p62/sequestosome protein and influence IL-1 and RANKL signaling by facilitating the assembly of a p62/TRAF6/a-PKC multi-protein complex. The Limd1-p62 interaction affects both NF-kappaB and AP-1 activity in epithelial cells and osteoclasts. Moreover, LIMD1 functions as tumor repressor to block lung tumor cell line in vitro and in vivo. Recent studies revealed that LIM proteins Wtip, LIMD1 and Ajuba interact with components of RNA induced silencing complexes (RISC) as well as eIF4E and the mRNA m7GTP cap-protein complex and are required for microRNA-mediated gene silencing. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 40/155 (25%), Positives = 67/155 (43%), Gaps = 23/155 (14%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+LG+G FG+V R TG++ K+L EK +K+ K + L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKGEAMAL----------- 48
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
++ +L ++ V+ L LV + GG LK + + G P +R
Sbjct: 49 ----NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERA 104
Query: 607 NF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F A +I G+ LH +++RDL +N L+ + G
Sbjct: 105 VFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG 139
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 34/179 (18%)
Query: 467 FRVEASKSRIFRASDLVRGPL-LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFL 525
+R E +K+ I+ D R +G G +G V R TG + +K+LYR + + F
Sbjct: 2 YRQEVNKT-IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS--ELFA 58
Query: 526 KESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY-- 583
K + + ++ +L+ + H NVI + V D L+ ++
Sbjct: 59 KRA---------------------YRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97
Query: 584 ---IAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G L +L++ + L R+ F + G+ Y+H+ +IHRDL N V E
Sbjct: 98 VMPFMGTDLGKLMKH--EKLS-EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNE 153
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|188817 cd09433, LIM4_FHL2, The fourth LIM domain of Four and a half LIM domains protein 2 (FHL2) | Back alignment and domain information |
|---|
Score = 36.5 bits (84), Expect = 0.002
Identities = 21/55 (38%), Positives = 28/55 (50%), Gaps = 6/55 (10%)
Query: 12 CAGCLNNIVE---DEYVQALSQEWHTDCFRCSACDVMLDNWYF--EKDGLLFCKE 61
CAGC N I +Y+ ++WH DCF C C + L F E+D +L C E
Sbjct: 1 CAGCTNPISGLGGTKYISFEERQWHNDCFNCKKCSLSLVGRGFLTERDDIL-CPE 54
|
The fourth LIM domain of Four and a half LIM domains protein 2 (FHL2): FHL2 is one of the best studied FHL proteins. FHL2 expression is most abundant in the heart, and in brain, liver and lung to a lesser extent. FHL2 participates in a wide range of cellular processes, such as transcriptional regulation, signal transduction, and cell survival by binding to various protein partners. FHL2 has shown to interact with more than 50 different proteins, including receptors, structural proteins, transcription factors and cofactors, signal transducers, splicing factors, DNA replication and repair enzymes, and metabolic enzymes. Although FHL2 is abundantly expressed in heart, the fhl2 null mice are viable and had no detectable abnormal cardiac phenotype. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to s upport the assembly of multimeric protein complexes. Length = 58 |
| >gnl|CDD|188836 cd09452, LIM1_Enigma, The first LIM domain of Enigma | Back alignment and domain information |
|---|
Score = 35.9 bits (83), Expect = 0.003
Identities = 15/54 (27%), Positives = 27/54 (50%), Gaps = 2/54 (3%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
C C +++ G +V +HPE F C+ C + +G + E+ ++C CY
Sbjct: 1 CAQCNKIIRGRYLVALGRSYHPEEFTCSQCKKVLDEGGFFE--EKGSIFCPKCY 52
|
The first LIM domain of Enigma: Enigma was initially characterized in humans as a protein containing three LIM domains at the C-terminus and a PDZ domain at N-terminus. The third LIM domain specifically interacts with the insulin receptor and the second LIM domain interacts with the receptor tyrosine kinase Ret and the adaptor protein APS. Thus Enigma is implicated in signal transduction processes such as mitogenic activity, insulin related actin organization, and glucose metabolism. Enigma is expressed in multiple tissues, such as skeletal muscle, heart, bone and brain. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188843 cd09459, LIM3_ENH, The third LIM domain of the Enigma Homolog (ENH) family | Back alignment and domain information |
|---|
Score = 36.1 bits (83), Expect = 0.003
Identities = 19/52 (36%), Positives = 25/52 (48%), Gaps = 2/52 (3%)
Query: 12 CAGCLNNI-VEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKE 61
C GC I D +++AL WH CF CS C L+ +F K CK+
Sbjct: 1 CHGCEFPIEAGDRFLEALGHTWHDTCFVCSVCCESLEGQTFFSKKDKPLCKK 52
|
The third LIM domain of the Enigma Homolog (ENH) family: ENH was initially identified in rat brain. Same as enigma, it contains three LIM domains at the C-terminus and a PDZ domain at N-terminus. ENH is implicated in signal transduction processes involving protein kinases. It has also been shown that ENH interacts with protein kinase D1 (PKD1) via its LIM domains and forms a complex with PKD1 and the alpha1C subunit of cardiac L-type voltage-gated calcium channel in rat neonatal cardiomyocytes. The N-terminal PDZ domain interacts with alpha-actinin at the Z-line. ENH is expressed in multiple tissues, such as skeletal muscle, heart, bone, and brain. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 55 |
| >gnl|CDD|188797 cd09413, LIM1_Testin, The first LIM domain of Testin | Back alignment and domain information |
|---|
Score = 36.3 bits (84), Expect = 0.003
Identities = 15/33 (45%), Positives = 21/33 (63%), Gaps = 1/33 (3%)
Query: 32 WHTDCFRCSAC-DVMLDNWYFEKDGLLFCKEDY 63
WH CF CS C ++++D YF K+G L+C Y
Sbjct: 26 WHPACFVCSTCGELLVDMIYFWKNGKLYCGRHY 58
|
The first LIM domain of Testin: Testin contains three C-terminal LIM domains and a PET protein-protein interaction domain at the N-terminal. Testin is a cytoskeleton associated focal adhesion protein that localizes along actin stress fibers, at cell-cell-contact areas, and at focal adhesion plaques. Testin interacts with a variety of cytoskeletal proteins, including zyxin, mena, VASP, talin, and actin and it is involved in cell motility and adhesion events. Knockout mice experiments reveal that tumor repressor function of Testin. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 58 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 40/189 (21%), Positives = 76/189 (40%), Gaps = 54/189 (28%)
Query: 458 DLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD 517
D++R+ ++S+++ G ++G G FG VY +T E + +K++ +
Sbjct: 59 DINRSPNKSYKL---------------GNIIGNGSFGVVYEAICIDTSEKVAIKKV--LQ 101
Query: 518 EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLY----- 572
+ KN ++ ++++L+H N+I Y
Sbjct: 102 DPQYKN---------------------------RELLIMKNLNHINIIFLKDYYYTECFK 134
Query: 573 KDRK---LNLVTEYIAGGTLKEL--LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 627
K+ K LN+V E+I K + LP ++ + + Y+HS + HR
Sbjct: 135 KNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHR 194
Query: 628 DLNSQNCLV 636
DL QN L+
Sbjct: 195 DLKPQNLLI 203
|
Length = 440 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 0.003
Identities = 38/164 (23%), Positives = 67/164 (40%), Gaps = 53/164 (32%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELY---RVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG+G +G V++ R T EV+ LK+++ R +A++ F
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-------------------- 54
Query: 545 NNLHCFSQVAVLRSLHHH-NVIRFIGVLYK---DRKLNLVTEY--------IAGGTLKEL 592
++ L+ L H N+++ + V K D+ + LV EY I L+++
Sbjct: 55 ------REIMFLQELGDHPNIVKLLNV-IKAENDKDIYLVFEYMETDLHAVIRANILEDV 107
Query: 593 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + + Y+HS N+IHRDL N L+
Sbjct: 108 -----------HKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL 140
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.003
Identities = 18/52 (34%), Positives = 30/52 (57%), Gaps = 1/52 (1%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKE 527
F A DL +G+G FG V ++ H+ +G +M +K + VDE+ +K L +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMD 52
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.003
Identities = 27/79 (34%), Positives = 39/79 (49%), Gaps = 9/79 (11%)
Query: 579 LVTEYIAGGTLKELLQDPG---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
LV EY+ GG +K LL G + + V + ++A + YLH +IHRDL N L
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMA----VKYISEVALALDYLHRHGIIHRDLKPDNML 136
Query: 636 VREVG--SGFDFHLGQIYL 652
+ G DF L ++ L
Sbjct: 137 ISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 33/156 (21%), Positives = 69/156 (44%), Gaps = 26/156 (16%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
++G+G + +V V ++T + +K + + V+++ + ++++ K
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEK--------------- 46
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
H F Q + +H ++ + +L V EY+ GG L +Q + LP
Sbjct: 47 ---HVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEH 97
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
++ +I+ + YLH +I+RDL N L+ G
Sbjct: 98 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG 133
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|188712 cd09326, LIM_CRP_like, The LIM domains of Cysteine Rich Protein (CRP) family | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.003
Identities = 16/39 (41%), Positives = 22/39 (56%), Gaps = 1/39 (2%)
Query: 23 EYVQALSQEWHTDCFRCSACDVMLDNWYF-EKDGLLFCK 60
E V A + WH CF C+ C+ LD+ E DG ++CK
Sbjct: 12 EEVIAAGKSWHKSCFTCAVCNKRLDSTTLAEHDGEIYCK 50
|
The LIM domains of Cysteine Rich Protein (CRP) family: Cysteine-rich proteins (CRPs) are characterized by the presence of two LIM domains linked to a short glycine-rich repeats (GRRs). The known CRP family members include CRP1, CRP2, and CRP3/MLP. CRP1, CRP2 and CRP3 share a conserved nuclear targeting signal (K/R-K/R-Y-G-P-K), which supports the fact that these proteins function not only in the cytoplasm but also in the nucleus. CRPs control regulatory pathways during cellular differentiation, and involve in complex transcription control, and the organization as well as the arrangement of the myofibrillar/cytoskeletal network. CRP1, CRP2, and CRP3/MLP are involved in promoting protein assembly along the actin-based cytoskeleton. All LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 53 |
| >gnl|CDD|188779 cd09393, LIM3_Lrg1p_like, The third LIM domain of Lrg1p, a LIM and RhoGap domain containing protein | Back alignment and domain information |
|---|
Score = 35.8 bits (83), Expect = 0.004
Identities = 18/55 (32%), Positives = 25/55 (45%), Gaps = 6/55 (10%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACD-----VMLDNWYFEKDGLLFCKE 61
CA C +I EDE ++ + WH CF CS C + D + KD + C
Sbjct: 1 CASCGKSI-EDECIKFEDKRWHLKCFTCSRCHREISSELSDAAFNNKDQRILCSN 54
|
The third LIM domain of Lrg1p, a LIM and RhoGap domain containing protein: The members of this family contain three tandem repeats of LIM domains and a Rho-type GTPase activating protein (RhoGap) domain. Lrg1p is a Rho1 GTPase-activating protein required for efficient cell fusion in yeast. Lrg1p-GAP domain strongly and specifically stimulates the GTPase activity of Rho1p, a regulator of beta (1-3)-glucan synthase in vitro. The LIM domain is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 56 |
| >gnl|CDD|188738 cd09352, LIM1_Ajuba_like, The first LIM domain of Ajuba-like proteins | Back alignment and domain information |
|---|
Score = 35.9 bits (83), Expect = 0.004
Identities = 15/39 (38%), Positives = 23/39 (58%), Gaps = 1/39 (2%)
Query: 26 QALSQEWHTDCFRCSACDVMLDNWYFEK-DGLLFCKEDY 63
QA+ +HT+CF C +C L F +G ++C+EDY
Sbjct: 16 QAMGNLYHTNCFTCCSCGRTLRGKAFYNVNGKVYCEEDY 54
|
The first LIM domain of Ajuba-like proteins: Ajuba like LIM protein family includes three highly homologous proteins Ajuba, Limd1, and WTIP. Members of the family contain three tandem C-terminal LIM domains and a proline-rich N-terminal region. This family of proteins functions as scaffolds, participating in the assembly of numerous protein complexes. In the cytoplasm, Ajuba binds Grb2 to modulate serum-stimulated ERK activation. Ajuba also recruits the TNF receptor-associated factor 6 (TRAF6) to p62 and activates PKCKappa activity. Ajuba interacts with alpha-catenin and F-actin to contribute to the formation or stabilization of adheren junctions by linking adhesive receptors to the actin cytoskeleton. Although Ajuba is a cytoplasmic protein, it can shuttle into the nucleus. In nucleus, Ajuba functions as a corepressor for the zinc finger-protein Snail. It binds to the SNAG repression domain of Snail through its LIM region. Arginine methyltransferase-5 (Prmt5), a protein in the complex, is recruited to Snai l through an interaction with Ajuba. This ternary complex functions to repress E-cadherin, a Snail target gene. In addition, Ajuba contains functional nuclear-receptor interacting motifs and selectively interacts with retinoic acid receptors (RARs) and rexinoid receptor (RXRs) to negatively regulate retinoic acid signaling. Wtip, the Wt1-interacting protein, was originally identified as an interaction partner of the Wilms tumour protein 1 (WT1). Wtip is involved in kidney and neural crest development. Wtip interacts with the receptor tyrosine kinase Ror2 and inhibits canonical Wnt signaling. LIMD1 was reported to inhibit cell growth and metastases. The inhibition may be mediated through an interaction with the protein barrier-to-autointegration (BAF), a component of SWI/SNF chromatin-remodeling protein; or through the interaction with retinoblastoma protein (pRB), resulting in inhibition of E2F-mediated transcription, and expression of the majority of genes with E2F1- responsive elements. Recently, Limd1 was shown to interact with the p62/sequestosome protein and influence IL-1 and RANKL signaling by facilitating the assembly of a p62/TRAF6/a-PKC multi-protein complex. The Limd1-p62 interaction affects both NF-kappaB and AP-1 activity in epithelial cells and osteoclasts. Moreover, LIMD1 functions as tumor repressor to block lung tumor cell line in vitro and in vivo. Recent studies revealed that LIM proteins Wtip, LIMD1 and Ajuba interact with components of RNA induced silencing complexes (RISC) as well as eIF4E and the mRNA m7GTP cap-protein complex and are required for microRNA-mediated gene silencing. As in other LIM domains, this domain family is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 54 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 34/157 (21%), Positives = 56/157 (35%), Gaps = 42/157 (26%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LL G +VY + E VLK E + +E
Sbjct: 5 LLKGGLTNRVYLLG--TKDEDYVLK--INPSREKGADRERE------------------- 41
Query: 547 LHCFSQVAVLRSLHHHNVI--RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
VA+L+ L + + + D L+ E+I G TL E+ ++ +
Sbjct: 42 ------VAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEE--------E 87
Query: 605 RVNFARDIAAGMTYLHSMN---LIHRDLNSQNCLVRE 638
+ + A +A + LH + L H DL+ N LV +
Sbjct: 88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 38/155 (24%), Positives = 66/155 (42%), Gaps = 25/155 (16%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LLG+G FG+V V + +G+ +K L K+ +I D +H L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKIL---------------KKEVIIAKDEVAHTL--- 43
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
++ VL++ H + +L V EY+ GG L + + R
Sbjct: 44 ----TESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRT 97
Query: 607 NF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F +I + + YLHS +++RDL +N ++ + G
Sbjct: 98 RFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG 132
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|188725 cd09339, LIM4_Paxillin_like, The fourth LIM domain of the Paxillin-like protein family | Back alignment and domain information |
|---|
Score = 35.8 bits (83), Expect = 0.004
Identities = 12/30 (40%), Positives = 16/30 (53%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSC 100
C CG+ ++G + KFHPE F C C
Sbjct: 1 CAGCGKPITGRCITAMGRKFHPEHFVCAFC 30
|
The fourth LIM domain of the Paxillin like protein family: This family consists of paxillin, leupaxin, Hic-5 (ARA55), and other related proteins. There are four LIM domains in the C-terminal of the proteins and leucine-rich LD-motifs in the N-terminal region. Members of this family are adaptor proteins to recruit key components of signal-transduction machinery to specific sub-cellular locations. Paxillin is found at the interface between the plasma membrane and the actin cytoskeleton. Paxillin serves as a platform for the recruitment of numerous regulatory and structural proteins that together control the dynamic changes in cell adhesion, cytoskeletal reorganization and gene expression that are necessary for cell migration and survival. Leupaxin is a cytoskeleton adaptor protein, which is preferentially expressed in hematopoietic cells. It associates with focal adhesion kinases PYK2 and pp125FAK and identified to be a component of the osteoclast pososomal signaling complex. Hic-5 controls cell proliferation, migration and senescence by functioning as coactivator for steroid receptors such as androgen receptor, glucocorticoid receptor and progesterone receptor. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 52 |
| >gnl|CDD|188799 cd09415, LIM1_Prickle, The first LIM domain of Prickle | Back alignment and domain information |
|---|
Score = 35.7 bits (83), Expect = 0.004
Identities = 14/29 (48%), Positives = 18/29 (62%), Gaps = 1/29 (3%)
Query: 32 WHTDCFRCSACDVML-DNWYFEKDGLLFC 59
WH CF CS C +L D YF +DG ++C
Sbjct: 26 WHPACFVCSTCKELLVDLIYFYQDGKVYC 54
|
The first LIM domain of Prickle: Prickle contains three C-terminal LIM domains and a N-terminal PET domain. Prickles have been implicated in roles of regulating tissue polarity or planar cell polarity (PCP). PCP establishment requires the conserved Frizzled/Dishevelled PCP pathway. Prickle interacts with Dishevelled, thereby modulating Frizzled/Dishevelled activity and PCP signaling. Four forms of prickles have been identified: prickle 1-4. The best characterized is prickle 1 and prickle 2 which are differentially expressed. While prickle 1 is expressed in fetal heart and hematological malignancies, prickle 2 is found in fetal brain, adult cartilage, pancreatic islet, and some types of timorous cells. Mutations in prickle 1 have been linked to progressive myoclonus epilepsy. LIM domains are 50-60 amino acids in size and share two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein complexes. Length = 59 |
| >gnl|CDD|188781 cd09395, LIM2_Rga, The second LIM domain of Rga GTPase-Activating Proteins | Back alignment and domain information |
|---|
Score = 35.5 bits (82), Expect = 0.004
Identities = 18/55 (32%), Positives = 30/55 (54%), Gaps = 3/55 (5%)
Query: 71 CQNCGQMMSG-PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
C+NCG+ + +++ D + +CF+C CS I D YA +R L+C C+
Sbjct: 1 CKNCGKKIDDTAILLSSDEAYCSDCFRCRRCSRDITD-LKYAKTKRG-LFCMSCH 53
|
The second LIM domain of Rga GTPase-Activating Proteins: The members of this family contain two tandem repeats of LIM domains and a Rho-type GTPase activating protein (RhoGap) domain. Rga activates GTPases during polarized morphogenesis. In yeast, a known regulating target of Rga is CDC42p, a small GTPase. The LIM domain is 50-60 amino acids in size and shares two characteristic zinc finger motifs. The two zinc fingers contain eight conserved residues, mostly cysteines and histidines, which coordinately bond to two zinc atoms. LIM domains function as adaptors or scaffolds to support the assembly of multimeric protein. Length = 53 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.004
Identities = 35/152 (23%), Positives = 61/152 (40%), Gaps = 26/152 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL--YRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
++G+G FG+V V + +V +K L + + + AE +E + L+ G + I
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN----GDNQWI 63
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
LH Q + L LV +Y GG L LL LP
Sbjct: 64 TTLHYAFQ--------------------DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM 103
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ ++ + +H ++ +HRD+ N L+
Sbjct: 104 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 135
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 34/166 (20%), Positives = 70/166 (42%), Gaps = 34/166 (20%)
Query: 487 LLGQGFFGQ--VYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
L+G+ F V+ H+ T ++ +K+ +D ++++ L+
Sbjct: 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKK-INLDSCSKEDLK-----------------LL 46
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLP 601
++ R L H N++ ++ D +L +V+ +A G+ ++LL+ G LP
Sbjct: 47 -----QQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LP 99
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG----SGF 643
+D+ + Y+HS IHR + + + L+ G SG
Sbjct: 100 ELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 18/40 (45%), Positives = 23/40 (57%)
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
GQPL +F I G+ Y+HS N++HRDL N LV
Sbjct: 99 GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV 138
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 681 | |||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0575|consensus | 592 | 99.98 | ||
| KOG0581|consensus | 364 | 99.98 | ||
| KOG0616|consensus | 355 | 99.97 | ||
| KOG0600|consensus | 560 | 99.97 | ||
| KOG0192|consensus | 362 | 99.97 | ||
| KOG0659|consensus | 318 | 99.97 | ||
| KOG0592|consensus | 604 | 99.97 | ||
| KOG0593|consensus | 396 | 99.97 | ||
| KOG0583|consensus | 370 | 99.97 | ||
| KOG0661|consensus | 538 | 99.97 | ||
| KOG0605|consensus | 550 | 99.97 | ||
| KOG0611|consensus | 668 | 99.96 | ||
| KOG1701|consensus | 468 | 99.96 | ||
| KOG0597|consensus | 808 | 99.96 | ||
| KOG0591|consensus | 375 | 99.96 | ||
| KOG0663|consensus | 419 | 99.96 | ||
| KOG0585|consensus | 576 | 99.96 | ||
| KOG0594|consensus | 323 | 99.96 | ||
| KOG1187|consensus | 361 | 99.96 | ||
| KOG0588|consensus | 786 | 99.96 | ||
| KOG0198|consensus | 313 | 99.96 | ||
| KOG0197|consensus | 468 | 99.96 | ||
| KOG0694|consensus | 694 | 99.95 | ||
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.95 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.95 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.95 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.95 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.95 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.95 | |
| KOG0582|consensus | 516 | 99.95 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.95 | |
| KOG3653|consensus | 534 | 99.95 | ||
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0194|consensus | 474 | 99.95 | ||
| KOG0580|consensus | 281 | 99.95 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.94 | |
| KOG0578|consensus | 550 | 99.94 | ||
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.94 | |
| KOG0032|consensus | 382 | 99.94 | ||
| KOG0193|consensus | 678 | 99.94 | ||
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.94 | |
| KOG0610|consensus | 459 | 99.94 | ||
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.94 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.94 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.94 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.94 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.94 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.94 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.94 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.94 | |
| KOG1026|consensus | 774 | 99.94 | ||
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0586|consensus | 596 | 99.94 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0589|consensus | 426 | 99.93 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.93 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.93 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.93 | |
| KOG0033|consensus | 355 | 99.93 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.93 | |
| KOG0658|consensus | 364 | 99.93 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| KOG0201|consensus | 467 | 99.93 | ||
| KOG0662|consensus | 292 | 99.93 | ||
| KOG0986|consensus | 591 | 99.93 | ||
| KOG0574|consensus | 502 | 99.93 | ||
| KOG0577|consensus | 948 | 99.93 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.93 | |
| KOG1095|consensus | 1025 | 99.93 | ||
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG0599|consensus | 411 | 99.93 | ||
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.93 | |
| KOG2052|consensus | 513 | 99.93 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.93 | |
| KOG0612|consensus | 1317 | 99.93 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4236|consensus | 888 | 99.93 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.92 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG4717|consensus | 864 | 99.92 | ||
| KOG4250|consensus | 732 | 99.92 | ||
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.92 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0690|consensus | 516 | 99.92 | ||
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.92 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0660|consensus | 359 | 99.92 | ||
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.92 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.92 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.92 | |
| KOG4721|consensus | 904 | 99.92 | ||
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.92 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.92 | |
| KOG0667|consensus | 586 | 99.92 | ||
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.92 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG0196|consensus | 996 | 99.92 | ||
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.92 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.92 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.92 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.92 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.92 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.92 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.92 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.92 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.92 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.92 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.92 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.92 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.91 | |
| KOG1094|consensus | 807 | 99.91 | ||
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.91 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.91 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.91 | |
| KOG0579|consensus | 1187 | 99.91 | ||
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.91 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.91 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.91 | |
| KOG1152|consensus | 772 | 99.91 | ||
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.91 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.91 | |
| KOG0666|consensus | 438 | 99.91 | ||
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.91 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.91 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.91 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.91 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.91 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.91 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.91 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.91 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.91 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.91 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.91 | |
| KOG4279|consensus | 1226 | 99.91 | ||
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.91 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.91 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG0608|consensus | 1034 | 99.91 | ||
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.91 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.9 | |
| KOG0607|consensus | 463 | 99.9 | ||
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.9 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.9 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.9 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.9 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.9 | |
| KOG4577|consensus | 383 | 99.9 | ||
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.9 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.9 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.9 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.9 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.9 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.9 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.9 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.9 | |
| KOG1035|consensus | 1351 | 99.9 | ||
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.9 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.9 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.9 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.9 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.9 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.9 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.9 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.9 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.9 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.9 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.9 | |
| KOG0696|consensus | 683 | 99.9 | ||
| PTZ00284 | 467 | protein kinase; Provisional | 99.9 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.9 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.9 | |
| KOG0584|consensus | 632 | 99.9 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.9 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.9 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.89 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.89 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.89 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.89 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.89 | |
| KOG4278|consensus | 1157 | 99.89 | ||
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG4645|consensus | 1509 | 99.89 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.89 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.89 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.89 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.89 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.89 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.89 | |
| KOG4257|consensus | 974 | 99.89 | ||
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| KOG0587|consensus | 953 | 99.89 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.89 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.89 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.89 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.89 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.89 | |
| KOG0695|consensus | 593 | 99.89 | ||
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.89 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.89 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.89 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.89 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.89 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.89 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.89 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.88 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.88 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.88 | |
| KOG0669|consensus | 376 | 99.88 | ||
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.88 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.88 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.88 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.88 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.88 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.88 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.88 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.88 | |
| KOG1989|consensus | 738 | 99.88 | ||
| KOG0604|consensus | 400 | 99.88 | ||
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.88 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.88 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.88 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.87 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0984|consensus | 282 | 99.87 | ||
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.87 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.87 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.87 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.87 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.87 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.87 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.87 | |
| KOG2345|consensus | 302 | 99.87 | ||
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.87 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.86 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.86 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.86 | |
| KOG0596|consensus | 677 | 99.86 | ||
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.86 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.86 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.86 | |
| KOG1025|consensus | 1177 | 99.86 | ||
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.86 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.86 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.86 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.86 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.85 | |
| KOG0199|consensus | 1039 | 99.85 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.85 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| KOG0200|consensus | 609 | 99.85 | ||
| KOG0983|consensus | 391 | 99.84 | ||
| KOG0614|consensus | 732 | 99.84 | ||
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.84 | |
| KOG1006|consensus | 361 | 99.84 | ||
| KOG0576|consensus | 829 | 99.83 | ||
| KOG1151|consensus | 775 | 99.83 | ||
| KOG0664|consensus | 449 | 99.83 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.81 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.8 | |
| KOG0671|consensus | 415 | 99.8 | ||
| KOG0668|consensus | 338 | 99.79 | ||
| KOG1044|consensus | 670 | 99.79 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.78 | |
| KOG0603|consensus | 612 | 99.78 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.78 | |
| KOG1027|consensus | 903 | 99.77 | ||
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG2272|consensus | 332 | 99.75 | ||
| KOG1345|consensus | 378 | 99.75 | ||
| KOG1701|consensus | 468 | 99.74 | ||
| KOG0665|consensus | 369 | 99.74 | ||
| KOG1167|consensus | 418 | 99.72 | ||
| KOG1163|consensus | 341 | 99.7 | ||
| KOG0670|consensus | 752 | 99.7 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.7 | |
| KOG1165|consensus | 449 | 99.69 | ||
| KOG1164|consensus | 322 | 99.69 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG2272|consensus | 332 | 99.66 | ||
| KOG1024|consensus | 563 | 99.65 | ||
| KOG1290|consensus | 590 | 99.64 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.64 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.62 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.61 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.6 | |
| KOG1703|consensus | 479 | 99.6 | ||
| KOG1703|consensus | 479 | 99.57 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.55 | |
| KOG0590|consensus | 601 | 99.53 | ||
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.53 | |
| KOG1166|consensus | 974 | 99.53 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| KOG4158|consensus | 598 | 99.48 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.47 | |
| KOG0603|consensus | 612 | 99.37 | ||
| KOG0195|consensus | 448 | 99.29 | ||
| KOG1044|consensus | 670 | 99.29 | ||
| PF00412 | 58 | LIM: LIM domain; InterPro: IPR001781 Zinc finger ( | 99.25 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.25 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.15 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.14 | |
| KOG0590|consensus | 601 | 99.13 | ||
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.05 | |
| KOG0606|consensus | 1205 | 99.03 | ||
| PF00412 | 58 | LIM: LIM domain; InterPro: IPR001781 Zinc finger ( | 99.02 | |
| KOG1240|consensus | 1431 | 98.98 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.98 | |
| KOG1023|consensus | 484 | 98.97 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.96 | |
| KOG1700|consensus | 200 | 98.87 | ||
| KOG3087|consensus | 229 | 98.84 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.78 | |
| KOG1033|consensus | 516 | 98.73 | ||
| KOG0601|consensus | 524 | 98.67 | ||
| KOG0601|consensus | 524 | 98.6 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.58 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.35 | |
| KOG3741|consensus | 655 | 98.32 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.3 | |
| KOG0490|consensus | 235 | 98.28 | ||
| KOG0606|consensus | 1205 | 98.22 | ||
| smart00132 | 39 | LIM Zinc-binding domain present in Lin-11, Isl-1, | 98.21 | |
| KOG1243|consensus | 690 | 98.19 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.17 | |
| smart00132 | 39 | LIM Zinc-binding domain present in Lin-11, Isl-1, | 98.13 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.98 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.88 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.83 | |
| KOG1266|consensus | 458 | 97.74 | ||
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.7 | |
| KOG4577|consensus | 383 | 97.6 | ||
| PF00595 | 81 | PDZ: PDZ domain (Also known as DHR or GLGF) Coordi | 97.52 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.39 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.35 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.31 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.29 | |
| KOG0576|consensus | 829 | 97.27 | ||
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.25 | |
| KOG1235|consensus | 538 | 97.22 | ||
| cd00136 | 70 | PDZ PDZ domain, also called DHR (Dlg homologous re | 96.96 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.87 | |
| PF14685 | 88 | Tricorn_PDZ: Tricorn protease PDZ domain; PDB: 1N6 | 96.84 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 96.71 | |
| KOG1700|consensus | 200 | 96.64 | ||
| KOG1702|consensus | 264 | 96.64 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.53 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.34 | |
| cd00988 | 85 | PDZ_CTP_protease PDZ domain of C-terminal processi | 96.19 | |
| cd00992 | 82 | PDZ_signaling PDZ domain found in a variety of Eum | 96.07 | |
| cd00989 | 79 | PDZ_metalloprotease PDZ domain of bacterial and pl | 95.9 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.89 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.89 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.78 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.73 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.69 | |
| cd00986 | 79 | PDZ_LON_protease PDZ domain of ATP-dependent LON s | 95.41 | |
| PF13180 | 82 | PDZ_2: PDZ domain; PDB: 2L97_A 1Y8T_A 2Z9I_A 1LCY_ | 95.32 | |
| smart00228 | 85 | PDZ Domain present in PSD-95, Dlg, and ZO-1/2. Als | 95.2 | |
| cd00991 | 79 | PDZ_archaeal_metalloprotease PDZ domain of archaea | 95.03 |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=314.31 Aligned_cols=173 Identities=24% Similarity=0.461 Sum_probs=152.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
..+|...+.||+|+||+||+|+++.++..||||.+.+. ....++...+ |+++|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~-------------------------Ei~iL 63 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLS-------------------------EIKIL 63 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHH-------------------------HHHHH
Confidence 46899999999999999999999999999999999654 3334443444 59999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++|||||.|+++..+++.+|||||||.||||.+|++..+ .+++..++.|+.||+.||++||+++||||||||+||||
T Consensus 64 kel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLL 142 (429)
T KOG0595|consen 64 KELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILL 142 (429)
T ss_pred HhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEe
Confidence 99999999999999999999999999999999999999875 49999999999999999999999999999999999999
Q ss_pred ecC-CC---e----EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REV-GS---G----FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~-g~---~----~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.. +. + +|||+||.+... ....+.+|++.|||||++...+|
T Consensus 143 s~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~Y 191 (429)
T KOG0595|consen 143 STTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQY 191 (429)
T ss_pred ccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccc
Confidence 875 32 2 999999998743 33456889999999999987777
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=298.24 Aligned_cols=180 Identities=27% Similarity=0.390 Sum_probs=156.8
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
....+||+..++||+|+||+||.++.++|++.||+|.+++..-...+ | ..+...|..+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~----e------------------~~~~~~Er~I 78 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKK----E------------------VRHTKAERNI 78 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhh----h------------------HHHHHHHHHH
Confidence 35578999999999999999999999999999999998654322111 1 1134567999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
|..++||+||+++..|++...+|||+||+.||.|+..|++.+ .+++..+..|+.+|+.||.|||++|||||||||+|||
T Consensus 79 L~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENIL 157 (357)
T KOG0598|consen 79 LSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENIL 157 (357)
T ss_pred HHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHee
Confidence 999999999999999999999999999999999999998765 4999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++|.+ +||||++...... ....+.+||+.|||||++.++.|
T Consensus 158 Ld~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy 202 (357)
T KOG0598|consen 158 LDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGY 202 (357)
T ss_pred ecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCC
Confidence 9999999 9999999766443 23345899999999999999887
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.28 Aligned_cols=180 Identities=21% Similarity=0.313 Sum_probs=151.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+.|...+.||+|+||.|-+|..+.||+.||||++.+........ .........+|+++|++
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~------------------~~~~~~~v~~EieILkk 232 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR------------------AIAKTRDVQNEIEILKK 232 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc------------------cccchhhhHHHHHHHHh
Confidence 356788899999999999999999999999999996532211111 00111234578999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
|+|||||+++++|..++..||||||++||+|.+++-.+. .+.+...+.+++|++.|+.|||++||+||||||+|||+..
T Consensus 233 L~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~ 311 (475)
T KOG0615|consen 233 LSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSN 311 (475)
T ss_pred cCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEecc
Confidence 999999999999999999999999999999999998754 4888888999999999999999999999999999999998
Q ss_pred CCCe-----EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG-----FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~-----~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+... +|||||+.... ...+.+.+||+.|.|||||.++.+
T Consensus 312 ~~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~ 355 (475)
T KOG0615|consen 312 DAEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGV 355 (475)
T ss_pred CCcceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCe
Confidence 7432 99999998763 355678999999999999987653
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=297.84 Aligned_cols=176 Identities=29% Similarity=0.423 Sum_probs=153.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
..|+.++.||+|+|+.||++++.++|+.||+|++.+........ ++ ...+||++.+.|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~--re--------------------Kv~~EIeIHr~L 75 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQ--RE--------------------KVLNEIEIHRSL 75 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcch--HH--------------------HHHHHHHHHHhc
Confidence 46999999999999999999999999999999997633221111 11 234679999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|||||+|+++|++.+++|||+|+|+.|+|..+++. .+++++.++..|++||+.||.|||+++|||||||..|+||+++
T Consensus 76 ~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~ 154 (592)
T KOG0575|consen 76 KHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNEN 154 (592)
T ss_pred CCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCc
Confidence 999999999999999999999999999999999984 5679999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++ +|||||.....+. ....+.+||+.|.|||||.++.+
T Consensus 155 ~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gH 195 (592)
T KOG0575|consen 155 MNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGH 195 (592)
T ss_pred CcEEecccceeeeecCcc--cccceecCCCcccChhHhccCCC
Confidence 988 9999999887543 33456899999999999987653
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=283.28 Aligned_cols=175 Identities=30% Similarity=0.523 Sum_probs=156.1
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeec-cCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR-VDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~-~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.+..++++.+++||+|..|+|||++|+.|++.+|+|.+.. .+....++..+ |++
T Consensus 75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~r-------------------------El~ 129 (364)
T KOG0581|consen 75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILR-------------------------ELE 129 (364)
T ss_pred ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHH-------------------------HHH
Confidence 3566799999999999999999999999999999999943 34444454444 599
Q ss_pred HHHhCCCCceeeEEEEEEeCC-eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCC
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQ 632 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~-~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~ 632 (681)
+++..+||+||.+||+|+.++ .++++||||.+|+|.+++...+ .+++....+++.++++||.|||+ ++||||||||+
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPs 208 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPS 208 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHH
Confidence 999999999999999999998 5999999999999999998754 59999999999999999999996 99999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||||+..|.+ +|||.++.+... ...+++||..|||||-+.+..|
T Consensus 209 NlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Y 254 (364)
T KOG0581|consen 209 NLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESY 254 (364)
T ss_pred HeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcC
Confidence 9999999999 999999887643 4567889999999999999887
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=270.48 Aligned_cols=176 Identities=26% Similarity=0.408 Sum_probs=156.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...+||+..+.||.|+||+|.+++++.+|..||+|++.+......++. .|..+|..+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQv----------------------eH~~nEk~vL 98 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQV----------------------EHTHNEKRVL 98 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHH----------------------HHHhhHHHHH
Confidence 556799999999999999999999999999999999866443332221 1345789999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.+.||+++++++.+.+.+.+||||||++||.|+.+|++.+ .+++..+..++.||+.||+|||+++|++|||||+||||
T Consensus 99 ~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl 177 (355)
T KOG0616|consen 99 KAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL 177 (355)
T ss_pred hhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee
Confidence 99999999999999999999999999999999999999865 49999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.+|.. +|||+|+.... ...+-+||+.|+|||++..++|
T Consensus 178 D~~G~iKitDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~y 218 (355)
T KOG0616|consen 178 DQNGHIKITDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGY 218 (355)
T ss_pred ccCCcEEEEeccceEEecC-----cEEEecCCccccChHHhhcCCC
Confidence 999998 99999998763 2446789999999999999987
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=289.82 Aligned_cols=177 Identities=27% Similarity=0.425 Sum_probs=152.4
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...+.|+..+.||+|+||+|||+++..||+.||+|++.-...+. ...+...|||.+|
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-----------------------~~~~t~~REI~IL 170 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-----------------------GFPITAIREIKIL 170 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-----------------------cchHHHHHHHHHH
Confidence 34567899999999999999999999999999999985432111 1123446789999
Q ss_pred HhCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 557 RSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
++|+||||++|.+...+. ..+|||+|||++ ||.-++...+-.|++.+++.||+|++.||+|+|++||+|||||.+||
T Consensus 171 r~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNi 249 (560)
T KOG0600|consen 171 RRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNI 249 (560)
T ss_pred HhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccce
Confidence 999999999999999876 789999999976 99999988777799999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||.+|.. +|||||+++..... ..+...+.|..|.|||+|+|+
T Consensus 250 Lidn~G~LKiaDFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~ 294 (560)
T KOG0600|consen 250 LIDNNGVLKIADFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGA 294 (560)
T ss_pred EEcCCCCEEeccccceeeccCCCC-cccccceEEeeccChHHhcCC
Confidence 99999998 99999998876542 224446679999999999887
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=284.31 Aligned_cols=179 Identities=35% Similarity=0.530 Sum_probs=149.8
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeE-EEEEEeeccCHHH--HHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEV-MVLKELYRVDEEA--EKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~-vAiK~l~~~~~~~--~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
..+.+..+++...+.||+|+||+||+|.++ |+. ||+|.+...+... .+.|.+
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~----------------------- 88 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRR----------------------- 88 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHH-----------------------
Confidence 444555667777888999999999999998 555 9999987643222 334444
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCC-eEEEEEeccCCCCHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccc
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMN-LIH 626 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~-~l~LV~Ey~~gGsL~~~L~~-~~~~l~~~~~~~i~~QIa~gL~yLHs~~-IIH 626 (681)
|+.+|++++|||||+|+|++.+.. .+.+||||+++|+|.+++.. ....+++..++.++.||++||.|||+++ |||
T Consensus 89 --E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIH 166 (362)
T KOG0192|consen 89 --EASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIH 166 (362)
T ss_pred --HHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeee
Confidence 599999999999999999999887 79999999999999999987 3567999999999999999999999999 999
Q ss_pred cCCCCCcEEEecCC-Ce--EEeeeeeEeeecccceeeeecCCCccccchhhcc--CCCC
Q psy5063 627 RDLNSQNCLVREVG-SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK--KASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g-~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~--~~~Y 680 (681)
|||||+||||+.++ .+ +|||+++...... .......||..|||||+|. +.+|
T Consensus 167 rDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~ 223 (362)
T KOG0192|consen 167 RDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPY 223 (362)
T ss_pred cccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcC
Confidence 99999999999998 55 9999999877532 2222367999999999999 4455
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=264.21 Aligned_cols=174 Identities=24% Similarity=0.349 Sum_probs=152.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|...+.||+|.||.||+|++..||+.||||+++..... ...+..++|||..|+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-----------------------dGi~~talREIK~Lqel 58 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-----------------------DGINRTALREIKLLQEL 58 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-----------------------cCccHHHHHHHHHHHHc
Confidence 4677888999999999999999999999999999654211 12234567889999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+.|+++|-..+.+.||+|||+. +|...+++....++..+++.|+.++++|++|||++.|+||||||.|+|++.+
T Consensus 59 ~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~ 137 (318)
T KOG0659|consen 59 KHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD 137 (318)
T ss_pred cCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC
Confidence 999999999999999999999999965 9999999988889999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|.. +|||||+.+.... ..+..++-|..|.|||+|.|.+
T Consensus 138 g~lKiADFGLAr~f~~p~--~~~~~~V~TRWYRAPELLfGsr 177 (318)
T KOG0659|consen 138 GQLKIADFGLARFFGSPN--RIQTHQVVTRWYRAPELLFGSR 177 (318)
T ss_pred CcEEeecccchhccCCCC--cccccceeeeeccChHHhccch
Confidence 998 9999999998543 2233346799999999998763
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=280.70 Aligned_cols=180 Identities=24% Similarity=0.349 Sum_probs=156.4
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.....||..++.||+|+|++|++|+.+++++.||||++.+ +.+.+|.|...+ -+|-.+
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K------~~Iike~KvkYV----------------~~Ek~~ 126 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDK------RYIIKEKKVKYV----------------TREKEA 126 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhH------HHHHhhcccchh----------------hHHHHH
Confidence 5667899999999999999999999999999999998843 445566543332 356788
Q ss_pred HHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 LRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
|..| .||.|++|+-.|.++..+|+|+||+++|+|.++|++.+ .|++..+..|+.||+.||+|||++|||||||||+||
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~GIIHRDlKPENI 205 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENI 205 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence 8888 89999999999999999999999999999999999876 499999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccc---------eee--eecCCCccccchhhccCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPY---------TLF--ILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~---------~~~--~~~~gt~~Y~APEvL~~~ 678 (681)
|||+||.+ +|||-|+.+...... ... .+++||..|.+||+|.+.
T Consensus 206 LLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~ 262 (604)
T KOG0592|consen 206 LLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS 262 (604)
T ss_pred eEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCC
Confidence 99999999 999999998642211 222 457899999999999765
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=271.02 Aligned_cols=175 Identities=22% Similarity=0.404 Sum_probs=146.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|+.+..+|+|+||.||||++++||+.||||++....... ..++ .++|||.+|+.|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~---~VkK--------------------IAlREIrmLKqL 58 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDP---VVKK--------------------IALREIRMLKQL 58 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccH---HHHH--------------------HHHHHHHHHHhc
Confidence 45777889999999999999999999999999986543221 1111 235679999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+|+|.|+++|.....++||+||++.. +.+-|+.....++...+++++.|++.|+.|+|++++|||||||+||||+.+
T Consensus 59 kH~NLVnLiEVFrrkrklhLVFE~~dhT-vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~ 137 (396)
T KOG0593|consen 59 KHENLVNLIEVFRRKRKLHLVFEYCDHT-VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN 137 (396)
T ss_pred ccchHHHHHHHHHhcceeEEEeeecchH-HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC
Confidence 9999999999999999999999999874 444455544559999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC-CC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA-SF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~-~Y 680 (681)
|.+ +|||+||.+.. +...+...+-|..|.|||+|.+. +|
T Consensus 138 gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqY 179 (396)
T KOG0593|consen 138 GVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQY 179 (396)
T ss_pred CcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcC
Confidence 999 99999999873 22333446779999999999873 44
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=279.16 Aligned_cols=181 Identities=27% Similarity=0.398 Sum_probs=153.1
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...+.|.+++.||+|+||.|+.|++..+++.||+|.+.+........ .....+.+|+.+|
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~--------------------~~~~~i~rEi~~~ 73 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQ--------------------KLDELIKREISIL 73 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhccccccc--------------------ccchhhHHHHHHH
Confidence 34578999999999999999999999999999999664431000000 0011223689999
Q ss_pred HhCC-CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++ ||||+++++++.....+|+||||+.||+|.+++.+ ...+.+..+..+++|++.|++|+|++||+||||||+|||
T Consensus 74 ~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENil 152 (370)
T KOG0583|consen 74 RRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENIL 152 (370)
T ss_pred HHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEE
Confidence 9998 99999999999999999999999999999999998 556999999999999999999999999999999999999
Q ss_pred EecC-CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC-C
Q psy5063 636 VREV-GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS-F 680 (681)
Q Consensus 636 l~~~-g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~-Y 680 (681)
++.+ +++ +|||++.... .......+.+||+.|+|||+|.+.. |
T Consensus 153 ld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y 199 (370)
T KOG0583|consen 153 LDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTY 199 (370)
T ss_pred ecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCc
Confidence 9999 888 9999999884 2223445688999999999999987 7
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=284.44 Aligned_cols=176 Identities=26% Similarity=0.368 Sum_probs=153.3
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..+.|...+.||.|+||.||+|+.+.+|+.||||++++.-.. .++ ..-+||+..|
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee-----------------------~~nLREvksL 62 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEE-----------------------CMNLREVKSL 62 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHH-----------------------HHHHHHHHHH
Confidence 3456788999999999999999999999999999987542211 111 1236789999
Q ss_pred HhCC-CCceeeEEEEEEeCC-eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 557 RSLH-HHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 557 ~~L~-HpnIV~l~g~~~~~~-~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
++|+ |||||+|.+++.+.+ .+|+|||||+. +|+++++.++..|++..+..|+.||++||+|+|.+|+.|||||||||
T Consensus 63 ~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENi 141 (538)
T KOG0661|consen 63 RKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENI 141 (538)
T ss_pred HhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhhe
Confidence 9998 999999999998877 99999999955 99999999999999999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+..+..+ +||||||......||+. .+.|..|.|||+|++..|
T Consensus 142 Li~~~~~iKiaDFGLARev~SkpPYTe---YVSTRWYRAPEvLLrs~~ 186 (538)
T KOG0661|consen 142 LISGNDVIKIADFGLAREVRSKPPYTE---YVSTRWYRAPEVLLRSGY 186 (538)
T ss_pred EecccceeEecccccccccccCCCcch---hhhcccccchHHhhhccc
Confidence 99976655 99999999988877776 467899999999987755
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=278.72 Aligned_cols=181 Identities=22% Similarity=0.319 Sum_probs=154.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..+||+.+++||+|+||.||+|+.+.||+.+|+|++++.......+ ..|+..|-.+|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Q----------------------v~hV~aERdiL 195 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQ----------------------VEHVRAERDIL 195 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhh----------------------HHHHHHHHHHh
Confidence 46789999999999999999999999999999999997754333221 22445678889
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
...++|+||+|+..|.+..++||||||++|||+..+|...+ .|++..+..++.+++.|++-||..|+|||||||+|+||
T Consensus 196 ~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi 274 (550)
T KOG0605|consen 196 AEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI 274 (550)
T ss_pred hhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee
Confidence 99999999999999999999999999999999999998765 59999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeee-----------------------cccc----------------------eeeeecCCCccc
Q psy5063 637 REVGSG--FDFHLGQIYLI-----------------------YVPY----------------------TLFILSAKTKKT 669 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~-----------------------~~~~----------------------~~~~~~~gt~~Y 669 (681)
|..|.+ +||||+.-+.. +.+. ......+|||.|
T Consensus 275 D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDY 354 (550)
T KOG0605|consen 275 DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDY 354 (550)
T ss_pred cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccc
Confidence 999999 99999854321 0000 011135699999
Q ss_pred cchhhccCCCC
Q psy5063 670 YYPNILKKASF 680 (681)
Q Consensus 670 ~APEvL~~~~Y 680 (681)
||||||.++.|
T Consensus 355 iAPEVll~kgY 365 (550)
T KOG0605|consen 355 IAPEVLLGKGY 365 (550)
T ss_pred cchHHHhcCCC
Confidence 99999999988
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-31 Score=274.45 Aligned_cols=176 Identities=23% Similarity=0.399 Sum_probs=156.2
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
...|++.+.||+|+||+|-+++....|+.||||.+.+..-.....+ .++.|||++|+.
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDl----------------------vhIRREIeIMSs 109 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDL----------------------VHIRREIEIMSS 109 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHH----------------------HHHHHHHHHHhh
Confidence 3568889999999999999999999999999998865433333222 234678999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
|+||||+.+|++|++.+.+.|||||..+|.|+||+...+ .+++.++..|++||.+|+.|+|.++++|||||.+|||+|.
T Consensus 110 LNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~ 188 (668)
T KOG0611|consen 110 LNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQ 188 (668)
T ss_pred cCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecC
Confidence 999999999999999999999999999999999998865 4999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++++ +||||+..+..+.- ..+++|++-|.+||++.+.+|
T Consensus 189 N~NiKIADFGLSNly~~~kf---LqTFCGSPLYASPEIvNG~PY 229 (668)
T KOG0611|consen 189 NNNIKIADFGLSNLYADKKF---LQTFCGSPLYASPEIVNGTPY 229 (668)
T ss_pred CCCeeeeccchhhhhccccH---HHHhcCCcccCCccccCCCCC
Confidence 9998 99999998876432 235899999999999999998
|
|
| >KOG1701|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-32 Score=282.62 Aligned_cols=158 Identities=25% Similarity=0.631 Sum_probs=145.5
Q ss_pred CccccccccccccCc-eEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccccCCccccCeEEec
Q psy5063 9 ILTCAGCLNNIVEDE-YVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVG 86 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~-~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~ 86 (681)
+.+|++|++.|..++ .+.||++.||..||+|..|++.|.+ .||..|+++||+.||.... +||..|+++|.+++++|.
T Consensus 274 ~~iC~~C~K~V~g~~~ac~Am~~~fHv~CFtC~~C~r~L~Gq~FY~v~~k~~CE~cyq~tl-ekC~~Cg~~I~d~iLrA~ 352 (468)
T KOG1701|consen 274 FGICAFCHKTVSGQGLAVEAMDQLFHVQCFTCRTCRRQLAGQSFYQVDGKPYCEGCYQDTL-EKCNKCGEPIMDRILRAL 352 (468)
T ss_pred hhhhhhcCCcccCcchHHHHhhhhhcccceehHhhhhhhccccccccCCcccchHHHHHHH-HHHhhhhhHHHHHHHHhc
Confidence 358999999998664 5999999999999999999999976 7999999999999998775 999999999999999999
Q ss_pred CccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC-CcCCCCCCCCCCceeEEEeeCCCcCCC-----
Q psy5063 87 DHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR-AKDAAFPMMRKPHCIRLVEIQPSAHCS----- 160 (681)
Q Consensus 87 ~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~-~~~~~~p~~~~~~~v~lv~~~~~~~~~----- 160 (681)
|+.||+.||+|.+|.+.| ||..|+++.++++||..||+++|||+|. |..++.|..+..++||+|+|+++||-.
T Consensus 353 GkayHp~CF~Cv~C~r~l-dgipFtvd~~n~v~Cv~dfh~kfAPrCs~C~~PI~P~~G~~etvRvvamdr~fHv~CY~CE 431 (468)
T KOG1701|consen 353 GKAYHPGCFTCVVCARCL-DGIPFTVDSQNNVYCVPDFHKKFAPRCSVCGNPILPRDGKDETVRVVAMDRDFHVNCYKCE 431 (468)
T ss_pred ccccCCCceEEEEecccc-CCccccccCCCceeeehhhhhhcCcchhhccCCccCCCCCcceEEEEEccccccccceehh
Confidence 999999999999999999 8999999999999999999999999986 789999999999999999999999863
Q ss_pred -CCeeEEec
Q psy5063 161 -QGIKLALD 168 (681)
Q Consensus 161 -~~~~~~~~ 168 (681)
=|+-||+|
T Consensus 432 DCg~~LS~e 440 (468)
T KOG1701|consen 432 DCGLLLSSE 440 (468)
T ss_pred hcCcccccc
Confidence 34555544
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=277.79 Aligned_cols=172 Identities=28% Similarity=0.449 Sum_probs=152.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|.+.+.||+|+||.||||+.+.|.+.||+|.+.+... ...+... +|+++++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~-------------------------~ev~i~r 56 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLR-------------------------QEVRILR 56 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHH-------------------------HHHHHHH
Confidence 578888999999999999999999999999999866432 2223333 4599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++|||||.++++|++...+|+|+||+.| +|+.+|...+ .++++.+..++.|++.||.|||+++|+|||+||.|||++
T Consensus 57 ~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~ 134 (808)
T KOG0597|consen 57 SLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLE 134 (808)
T ss_pred hcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeec
Confidence 99999999999999999999999999977 9999998765 499999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
..|.+ +|||+||.+..+. .....-.||+-|||||++.+.+|
T Consensus 135 ~~~~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~py 177 (808)
T KOG0597|consen 135 KGGTLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPY 177 (808)
T ss_pred CCCceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCCCc
Confidence 99998 9999999887543 44455679999999999999888
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-31 Score=266.57 Aligned_cols=176 Identities=22% Similarity=0.394 Sum_probs=150.7
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeec--cCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~--~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
...+|++.+.||+|.||.|||+.+..+|+.+|.|.+.- .+....... ..|+.+
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~-------------------------v~Ei~l 71 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDC-------------------------VKEISL 71 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHH-------------------------HHHHHH
Confidence 34689999999999999999999999999999998852 222223333 445999
Q ss_pred HHhCCCCceeeEEE-EEEeCCe-EEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccc
Q psy5063 556 LRSLHHHNVIRFIG-VLYKDRK-LNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHS--MN--LIH 626 (681)
Q Consensus 556 L~~L~HpnIV~l~g-~~~~~~~-l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs--~~--IIH 626 (681)
|+.|+|||||++++ .|..++. ++||||||.+|||.+.++. ....+++..+++++.|+++||.++|+ .+ |+|
T Consensus 72 LkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmH 151 (375)
T KOG0591|consen 72 LKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMH 151 (375)
T ss_pred HHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceee
Confidence 99999999999998 5666666 9999999999999998863 34579999999999999999999999 45 999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||.||+|+.+|.+ .||||++.+.... +...+.+|||.||+||.+.+.+|
T Consensus 152 RDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y 205 (375)
T KOG0591|consen 152 RDIKPANIFLTANGVVKLGDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGY 205 (375)
T ss_pred ccCcchheEEcCCCceeeccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCC
Confidence 9999999999999999 9999999988654 33346789999999999999888
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=261.75 Aligned_cols=175 Identities=25% Similarity=0.337 Sum_probs=152.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.|++|+||.||+|+++.|++.||+|+++... | .....+..+|||.+|.+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek---------e--------------k~GFPItsLREIniLl~ 131 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK---------E--------------KEGFPITSLREINILLK 131 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc---------c--------------cCCCcchhHHHHHHHHh
Confidence 467889999999999999999999999999999985432 1 12345677899999999
Q ss_pred CCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 559 LHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 559 L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
++|||||.+-.+..- -+.+|+||||++. ||..++....++|...+++.++.|+++|++|||.+.|+|||||++|+|+
T Consensus 132 ~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm 210 (419)
T KOG0663|consen 132 ARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL 210 (419)
T ss_pred cCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee
Confidence 999999999998863 4679999999976 9999999888889999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
...|.. +||||||.+... ...+...+.|..|.|||+|.+.+
T Consensus 211 ~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~ 253 (419)
T KOG0663|consen 211 SHKGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAK 253 (419)
T ss_pred ccCCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCc
Confidence 999988 999999998754 22333456799999999998863
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=265.80 Aligned_cols=188 Identities=26% Similarity=0.370 Sum_probs=151.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++|++++.||+|.||+|.++++..+++.||||++.+.....+..+..+. .........+.+||++|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~-----------a~~~~~~ekv~~EIail 162 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQP-----------AMKLMPIEKVRREIAIL 162 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhccccccc-----------ccccCcHHHHHHHHHHH
Confidence 3468999999999999999999999999999999999765443333332221 11122334668899999
Q ss_pred HhCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 557 RSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~-l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++++|||||+|+++..+. +.+|||+|||..|.+...-.+ .+ +++.++++|+++++.||+|||.+|||||||||+|
T Consensus 163 Kkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d--~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN 240 (576)
T KOG0585|consen 163 KKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD--KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN 240 (576)
T ss_pred HhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC--cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence 999999999999999764 689999999999988654333 34 8999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeec---ccceeeeecCCCccccchhhccC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIY---VPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~---~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+||+++|.+ +|||.+..+... ..........||+.|||||...+
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence 999999999 999999877322 11112234679999999999876
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=259.48 Aligned_cols=175 Identities=29% Similarity=0.438 Sum_probs=150.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
...|...+.||+|+||.||+|+.+.+|+.||+|++.....+ | ....+.+||+.+|+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-------E----------------G~P~taiREisllk~ 66 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-------E----------------GVPSTAIREISLLKR 66 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-------c----------------CCCchhhHHHHHHHH
Confidence 45677888899999999999999999999999998543221 1 124456789999999
Q ss_pred CCCCc-eeeEEEEEEeCC------eEEEEEeccCCCCHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 559 LHHHN-VIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDPG---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 559 L~Hpn-IV~l~g~~~~~~------~l~LV~Ey~~gGsL~~~L~~~~---~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
++|+| |+.|++++.+.+ .+++|+||+.. +|.+++.... ..++...++.+++||++||+|||+++|+|||
T Consensus 67 L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRD 145 (323)
T KOG0594|consen 67 LSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRD 145 (323)
T ss_pred hCCCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 99999 999999999887 89999999955 9999998765 3588889999999999999999999999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||.||||+++|.. +|||+|+.+... ...+....+|..|.|||+|.+..
T Consensus 146 LKPQNlLi~~~G~lKlaDFGlAra~~ip--~~~yt~evvTlWYRaPEvLlGs~ 196 (323)
T KOG0594|consen 146 LKPQNLLISSSGVLKLADFGLARAFSIP--MRTYTPEVVTLWYRAPEVLLGST 196 (323)
T ss_pred CCcceEEECCCCcEeeeccchHHHhcCC--cccccccEEEeeccCHHHhcCCC
Confidence 99999999999998 999999977643 33455677899999999998874
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=269.03 Aligned_cols=168 Identities=30% Similarity=0.494 Sum_probs=143.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|.....||+|+||.||+|...+ |..||||++........++|..| +++|.++
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~E-------------------------i~~ls~l 128 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNE-------------------------VEILSRL 128 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHH-------------------------HHHHhcC
Confidence 678778899999999999999875 48999997755432213335555 9999999
Q ss_pred CCCceeeEEEEEEeCC-eEEEEEeccCCCCHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCcE
Q psy5063 560 HHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARDIAAGMTYLHSMN---LIHRDLNSQNC 634 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~-~l~LV~Ey~~gGsL~~~L~~~~~-~l~~~~~~~i~~QIa~gL~yLHs~~---IIHRDLKp~NI 634 (681)
+|||+|+|+|||.+.+ ...||+|||++|+|.+.|..... +++|..+++|+.++|+||+|||... ||||||||+||
T Consensus 129 ~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 129 RHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred CCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 9999999999999988 59999999999999999988665 8999999999999999999999853 99999999999
Q ss_pred EEecCCCe--EEeeeeeEeee-cccceeeeec-CCCccccchhhcc
Q psy5063 635 LVREVGSG--FDFHLGQIYLI-YVPYTLFILS-AKTKKTYYPNILK 676 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~-~~~~~~~~~~-~gt~~Y~APEvL~ 676 (681)
|||++.++ +|||||+.... .. ..... .||.+|+|||++.
T Consensus 209 LLD~~~~aKlsDFGLa~~~~~~~~---~~~~~~~gt~gY~~PEy~~ 251 (361)
T KOG1187|consen 209 LLDEDFNAKLSDFGLAKLGPEGDT---SVSTTVMGTFGYLAPEYAS 251 (361)
T ss_pred eECCCCCEEccCccCcccCCcccc---ceeeecCCCCccCChhhhc
Confidence 99999998 99999976654 22 11222 7999999999985
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=275.49 Aligned_cols=176 Identities=28% Similarity=0.427 Sum_probs=155.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+-|++|+.||+|+-|.|.+|++..||+.+|||++.+...- .......+.+||.+|+.
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~----------------------s~s~~~~IerEIviMkL 68 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSEL----------------------SSSQPAGIEREIVIMKL 68 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeecccccc----------------------ccccccchhhhhHHHHH
Confidence 35689999999999999999999999999999999654311 11122344678999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
|.||||+++|++|++..++|+|+||++||.|+++|-..+ ++++.++.++++||+.|+.|+|..+|+||||||+|+|||.
T Consensus 69 i~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~ 147 (786)
T KOG0588|consen 69 IEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV 147 (786)
T ss_pred hcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc
Confidence 999999999999999999999999999999999998765 5999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+++ +|||+|.+-..+ ..-.+.+|++.|.|||++.|.+|
T Consensus 148 ~~nIKIADFGMAsLe~~g---klLeTSCGSPHYA~PEIV~G~pY 188 (786)
T KOG0588|consen 148 KNNIKIADFGMASLEVPG---KLLETSCGSPHYAAPEIVSGRPY 188 (786)
T ss_pred ccCEeeeccceeecccCC---ccccccCCCcccCCchhhcCCCC
Confidence 9988 999999876543 34556899999999999999998
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=258.77 Aligned_cols=174 Identities=28% Similarity=0.488 Sum_probs=145.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
..++..++.||+|+||.||++.+.++|+.+|+|.+...+....+.+. +|+.+|+.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~-------------------------~Ei~iL~~ 70 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLE-------------------------REIRILSR 70 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHH-------------------------HHHHHHHh
Confidence 45688899999999999999999999999999998655322222222 45999999
Q ss_pred CCCCceeeEEEEEEeCC--eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 559 LHHHNVIRFIGVLYKDR--KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~--~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
++|||||+++|...... .+++.|||+++|+|.+++.+.+..+++..++.+.+||+.||.|||++|||||||||+||||
T Consensus 71 l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl 150 (313)
T KOG0198|consen 71 LNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL 150 (313)
T ss_pred CCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE
Confidence 99999999999854444 6999999999999999999866469999999999999999999999999999999999999
Q ss_pred ec-CCCe--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccC
Q psy5063 637 RE-VGSG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 637 ~~-~g~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+. +|.+ +|||+++....... ........||+.|||||++..
T Consensus 151 ~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 151 DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC
Confidence 99 6777 99999987764111 112234569999999999973
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=270.16 Aligned_cols=181 Identities=29% Similarity=0.396 Sum_probs=151.8
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
...+.+.++.+.+.+.||+|.||.||.|.++. ...||+|.++.... ....|++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m-~~~~f~~------------------------- 250 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM-SPEAFLR------------------------- 250 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc-ChhHHHH-------------------------
Confidence 45667778888999999999999999999974 34789998864321 2233444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~-~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+.+|++|+|+|||+|+|++..++.+|||||||+.|+|.++|+. .+..+...+.+.|+.|||.||+||+++++|||||.
T Consensus 251 Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLA 330 (468)
T KOG0197|consen 251 EAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLA 330 (468)
T ss_pred HHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhh
Confidence 59999999999999999999999999999999999999999997 45678999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++||||++++.+ +|||||| ...+..|.......-...|+|||.|....|
T Consensus 331 ARNiLV~~~~~vKIsDFGLAr-~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F 381 (468)
T KOG0197|consen 331 ARNILVDEDLVVKISDFGLAR-LIGDDEYTASEGGKFPIKWTAPEALNYGKF 381 (468)
T ss_pred hhheeeccCceEEEccccccc-ccCCCceeecCCCCCCceecCHHHHhhCCc
Confidence 999999999987 9999999 433444554444445678999999976655
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=273.41 Aligned_cols=177 Identities=22% Similarity=0.313 Sum_probs=151.0
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
..+..++|.+.++||+|.||+|+++..+.+++.||||.+++... +..+....
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~------------------------- 417 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMC------------------------- 417 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHH-------------------------
Confidence 45778999999999999999999999999999999999987532 22222223
Q ss_pred HHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 552 QVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 552 Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|..++... +||.+++|+..|.+.+++|+||||+.||++..+.+. ..+++..+..|+..++.||+|||++|||+||||
T Consensus 418 EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlK 495 (694)
T KOG0694|consen 418 EKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLK 495 (694)
T ss_pred HHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhcCceeeecc
Confidence 34455544 799999999999999999999999999995444432 459999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+|||||.+|.+ +||||++...... ....+.+||+.|||||+|.+..|
T Consensus 496 LdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Y 545 (694)
T KOG0694|consen 496 LDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSY 545 (694)
T ss_pred hhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcc
Confidence 999999999999 9999999876443 34567999999999999999988
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-28 Score=260.78 Aligned_cols=178 Identities=21% Similarity=0.334 Sum_probs=146.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||++.+..+++.||+|++.+........ .. .+.+|+.+++.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~---------------------~~~~E~~il~~~ 58 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQ-VG---------------------HIRAERDILVEA 58 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhH-HH---------------------HHHHHHHHHHhC
Confidence 47889999999999999999999999999999986532211111 11 123468899999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++.+.+...+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 59 ~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~ 137 (363)
T cd05628 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSK 137 (363)
T ss_pred CCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCC
Confidence 99999999999999999999999999999999997654 59999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccc---------------------------------eeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPY---------------------------------TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~---------------------------------~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.+ +|||+++........ .......||+.|+|||++.+..|
T Consensus 138 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 213 (363)
T cd05628 138 GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 213 (363)
T ss_pred CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC
Confidence 988 999999764321100 00123469999999999987654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=261.01 Aligned_cols=149 Identities=24% Similarity=0.354 Sum_probs=128.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|+..+.||+|+||.||+|++..+++.||+|++.+........ .. ++.+|+.+|+.+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~-~~---------------------~~~~E~~il~~l 58 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ-VA---------------------HVKAERDILAEA 58 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHH-HH---------------------HHHHHHHHHHhc
Confidence 36888999999999999999999999999999986533211111 11 123468999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 59 ~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~ 137 (381)
T cd05626 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLD 137 (381)
T ss_pred CCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCC
Confidence 99999999999999999999999999999999997654 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEe
Q psy5063 640 GSG--FDFHLGQIY 651 (681)
Q Consensus 640 g~~--~DFGLa~~~ 651 (681)
|.+ +|||+++.+
T Consensus 138 ~~~kL~DFGl~~~~ 151 (381)
T cd05626 138 GHIKLTDFGLCTGF 151 (381)
T ss_pred CCEEEeeCcCCccc
Confidence 988 999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=255.40 Aligned_cols=176 Identities=24% Similarity=0.406 Sum_probs=148.8
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++|+..+.||+|+||.||+|+++.+++.||+|.+.+......+. .. .+.+|+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~---------------------~~~~E~~~l 72 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQ---------------------HVAQEKSIL 72 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhh-HH---------------------HHHHHHHHH
Confidence 45678999999999999999999999999999999986532111110 00 124569999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++..++..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 73 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll 151 (329)
T PTZ00263 73 MELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL 151 (329)
T ss_pred HhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE
Confidence 99999999999999999999999999999999999998654 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+|.+ +|||+++...... ....||+.|+|||++.+..|
T Consensus 152 ~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~ 192 (329)
T PTZ00263 152 DNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGH 192 (329)
T ss_pred CCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCC
Confidence 999988 9999998764322 12468999999999977654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=260.13 Aligned_cols=149 Identities=23% Similarity=0.374 Sum_probs=128.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||++.+..+++.||+|.+.+....... ... .+.+|+++|+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~-~~~---------------------~~~~E~~il~~l 58 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKD-QLA---------------------HVKAERDVLAES 58 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhH-HHH---------------------HHHHHHHHHHhC
Confidence 4788899999999999999999999999999998653211111 111 123468999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++.+++.+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 59 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~ 137 (377)
T cd05629 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRG 137 (377)
T ss_pred CCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCC
Confidence 9999999999999999999999999999999999764 458999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEe
Q psy5063 640 GSG--FDFHLGQIY 651 (681)
Q Consensus 640 g~~--~DFGLa~~~ 651 (681)
|.+ +|||+++.+
T Consensus 138 ~~~kl~DfGla~~~ 151 (377)
T cd05629 138 GHIKLSDFGLSTGF 151 (377)
T ss_pred CCEEEeeccccccc
Confidence 988 999999743
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=258.39 Aligned_cols=150 Identities=22% Similarity=0.381 Sum_probs=130.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||++++..+++.||+|++.+........ .. .+.+|+.+|+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~---------------------~~~~E~~il~~l 58 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VA---------------------HVRAERDILAEA 58 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH-HH---------------------HHHHHHHHHHhC
Confidence 47899999999999999999999999999999986532111111 00 123469999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++.+++.+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~ 137 (364)
T cd05599 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAK 137 (364)
T ss_pred CCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 99999999999999999999999999999999997654 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEee
Q psy5063 640 GSG--FDFHLGQIYL 652 (681)
Q Consensus 640 g~~--~DFGLa~~~~ 652 (681)
|.+ +|||+++.+.
T Consensus 138 ~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 138 GHIKLSDFGLCTGLK 152 (364)
T ss_pred CCEEEeecccceecc
Confidence 988 9999997653
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=258.49 Aligned_cols=148 Identities=26% Similarity=0.380 Sum_probs=128.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|+..+.||+|+||.||+|++..+++.+|+|.+.+........ .. .+.+|+.+|+.+
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~-~~---------------------~~~~E~~il~~~ 58 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQ-VA---------------------HVKAERDILAEA 58 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHH-HH---------------------HHHHHHHHHHhC
Confidence 35888999999999999999999999999999986532111111 11 123569999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++.+.+++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~ 137 (382)
T cd05625 59 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRD 137 (382)
T ss_pred CCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999999999999999999999999999999997653 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeE
Q psy5063 640 GSG--FDFHLGQI 650 (681)
Q Consensus 640 g~~--~DFGLa~~ 650 (681)
|.+ +|||+++.
T Consensus 138 g~~kL~DFGla~~ 150 (382)
T cd05625 138 GHIKLTDFGLCTG 150 (382)
T ss_pred CCEEEeECCCCcc
Confidence 988 99999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=253.22 Aligned_cols=170 Identities=24% Similarity=0.327 Sum_probs=141.1
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCcee
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVI 565 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV 565 (681)
++||+|+||.||+++++.+|+.||+|.+.+.......... +..+|+.+|+.++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~----------------------~~~~e~~~l~~l~hp~i~ 58 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVA----------------------HTLTESRVLQNTRHPFLT 58 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHH----------------------HHHHHHHHHHhCCCCCCC
Confidence 4699999999999999999999999998653211111111 124569999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--E
Q psy5063 566 RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--F 643 (681)
Q Consensus 566 ~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~ 643 (681)
++++++..++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+ +
T Consensus 59 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~ 137 (323)
T cd05571 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKIT 137 (323)
T ss_pred CEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEe
Confidence 99999999999999999999999999987644 58999999999999999999999999999999999999999988 9
Q ss_pred EeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 644 DFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 644 DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++...... .......||+.|||||++.+..|
T Consensus 138 DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 172 (323)
T cd05571 138 DFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDY 172 (323)
T ss_pred eCCCCcccccCC--CcccceecCccccChhhhcCCCC
Confidence 999998643221 11223568999999999977654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=258.13 Aligned_cols=148 Identities=24% Similarity=0.364 Sum_probs=128.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||++++..+++.||+|.+.+........ . ..+.+|+++|+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~-~---------------------~~~~~E~~il~~l 58 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQ-A---------------------AHVKAERDILAEA 58 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhh-H---------------------HHHHHHHHHHHhC
Confidence 47899999999999999999999999999999885432111110 0 1224579999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++.+..++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~ 137 (376)
T cd05598 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRD 137 (376)
T ss_pred CCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCC
Confidence 99999999999999999999999999999999997654 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeE
Q psy5063 640 GSG--FDFHLGQI 650 (681)
Q Consensus 640 g~~--~DFGLa~~ 650 (681)
+.+ +|||+|..
T Consensus 138 ~~ikL~DFG~a~~ 150 (376)
T cd05598 138 GHIKLTDFGLCTG 150 (376)
T ss_pred CCEEEEeCCCCcc
Confidence 988 99999853
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=254.90 Aligned_cols=176 Identities=24% Similarity=0.348 Sum_probs=146.3
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCC-eEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETG-EVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg-~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
...++|...+.||+|+||.||+|.+..++ ..||+|.+.+......+. .. .+.+|+.+
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~-~~---------------------~~~~E~~~ 84 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQ-VD---------------------HVFSERKI 84 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhh-HH---------------------HHHHHHHH
Confidence 45678999999999999999999977655 789999886432111110 00 12456999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
|+.++||||+++++++.+++..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIL 163 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLL 163 (340)
T ss_pred HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE
Confidence 999999999999999999999999999999999999997654 5899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+|.+ +|||+++..... .....||+.|||||++.+..|
T Consensus 164 l~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 205 (340)
T PTZ00426 164 LDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGH 205 (340)
T ss_pred ECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCC
Confidence 9999988 999999875422 123568999999999976544
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-27 Score=249.36 Aligned_cols=178 Identities=21% Similarity=0.284 Sum_probs=151.4
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH-HHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA-EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~-~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+....++|++.++||.|.-++||+|+...+++.||||++.-..... ...+. +|+
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~-------------------------kE~ 75 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALR-------------------------KEV 75 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHH-------------------------HHH
Confidence 3456789999999999999999999999999999999985433222 23333 359
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
..|+.++||||++++..|..+..+|+||.||.+|++.++++.. ...+++..+..+.+++++||.|||.+|.||||||+.
T Consensus 76 ~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAg 155 (516)
T KOG0582|consen 76 QTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAG 155 (516)
T ss_pred HHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccc
Confidence 9999999999999999999999999999999999999999753 334899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeeccccee--eeecCCCccccchhhccC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTL--FILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~--~~~~~gt~~Y~APEvL~~ 677 (681)
||||+.+|.+ +|||.+..+........ +.+..||+.|||||+|..
T Consensus 156 nILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q 204 (516)
T KOG0582|consen 156 NILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ 204 (516)
T ss_pred cEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh
Confidence 9999999999 99998877665332222 245689999999999643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=254.34 Aligned_cols=181 Identities=25% Similarity=0.352 Sum_probs=143.0
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
+.+..++|++++.||+|+||.||+|.+. .+++.||+|.+.... ......+.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------- 58 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALM----------------------- 58 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHH-----------------------
Confidence 4466788999999999999999999853 345789999886432 22223333
Q ss_pred chHHHHHHHhC-CCCceeeEEEEEEeC-CeEEEEEeccCCCCHHHHHhCCC-----------------------------
Q psy5063 549 CFSQVAVLRSL-HHHNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQDPG----------------------------- 597 (681)
Q Consensus 549 ~~~Ei~iL~~L-~HpnIV~l~g~~~~~-~~l~LV~Ey~~gGsL~~~L~~~~----------------------------- 597 (681)
+|+.+|+.+ +||||+++++++... +.+++||||+++|+|.+++....
T Consensus 59 --~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (338)
T cd05102 59 --SELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRR 136 (338)
T ss_pred --HHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccc
Confidence 458999999 899999999988764 46899999999999999986421
Q ss_pred --------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--E
Q psy5063 598 --------------------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--F 643 (681)
Q Consensus 598 --------------------------------~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~ 643 (681)
.++++..+..++.||+.||+|||+++|+||||||+|||++.++.+ +
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~ 216 (338)
T cd05102 137 IEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKIC 216 (338)
T ss_pred cccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEe
Confidence 247788889999999999999999999999999999999999988 9
Q ss_pred EeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 644 DFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 644 DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++...............++..|||||++.+..|
T Consensus 217 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 253 (338)
T cd05102 217 DFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253 (338)
T ss_pred ecccccccccCcchhcccCCCCCccccCcHHhhcCCC
Confidence 9999987643322222222345678999999877654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=250.46 Aligned_cols=173 Identities=25% Similarity=0.364 Sum_probs=145.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||++.+..+++.+|+|.+........+.. . .+.+|+++|+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-~---------------------~~~~E~~~l~~l 58 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQE-Q---------------------HVHNEKRVLKEV 58 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHH-H---------------------HHHHHHHHHHhC
Confidence 468889999999999999999999999999999864322111110 0 123469999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++.+++..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 59 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~ 137 (291)
T cd05612 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE 137 (291)
T ss_pred CCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC
Confidence 99999999999999999999999999999999997654 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.+ +|||+++...... ....||+.|+|||++.+..|
T Consensus 138 ~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~ 175 (291)
T cd05612 138 GHIKLTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGH 175 (291)
T ss_pred CCEEEEecCcchhccCCc-----ccccCChhhcCHHHHcCCCC
Confidence 988 9999998764321 22458999999999977654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=255.77 Aligned_cols=170 Identities=27% Similarity=0.411 Sum_probs=146.2
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
...+.+.++||+|.||.||||... ++.||||++. .+....|..|. +|--+-.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp---~~~kqs~~~Ek-----------------------~Iy~lp~ 260 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFP---EQEKQSFQNEK-----------------------NIYSLPG 260 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecC---HHHHHHHHhHH-----------------------HHHhccC
Confidence 556778889999999999999987 6999999884 33445566662 2444456
Q ss_pred CCCCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------Ccc
Q psy5063 559 LHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM---------NLI 625 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~---------~II 625 (681)
++|+||++|+++-.... ..|||+||.+.|+|.+||+.+ .++|....+++..+++||+|||+. .|+
T Consensus 261 m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia 338 (534)
T KOG3653|consen 261 MKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA 338 (534)
T ss_pred ccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence 79999999999876544 899999999999999999875 489999999999999999999973 599
Q ss_pred ccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 626 HRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||||+.||||.+|++. +|||||..+....+......++||.+|||||+|.+.
T Consensus 339 HRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 339 HRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred cccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 99999999999999998 999999999987777777789999999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=252.06 Aligned_cols=173 Identities=23% Similarity=0.399 Sum_probs=146.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|++.+.||+|+||.||+|++..+++.||+|++.+........ .+ .+.+|+++|+.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-~~---------------------~~~~e~~~l~~~ 58 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VR---------------------HVLTERDILTTT 58 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhH-HH---------------------HHHHHHHHHHhC
Confidence 47889999999999999999999999999999986532111110 00 124569999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++..++..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 59 ~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 137 (333)
T cd05600 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS 137 (333)
T ss_pred CCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCC
Confidence 99999999999999999999999999999999997644 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++.... ......||+.|+|||++.+..|
T Consensus 138 ~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~ 175 (333)
T cd05600 138 GHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGY 175 (333)
T ss_pred CCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCC
Confidence 988 99999986653 1223458999999999987654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=245.09 Aligned_cols=174 Identities=20% Similarity=0.249 Sum_probs=144.2
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
|...+.||+|+||.||++.+..+++.||+|.+.+......... ..+.+|+.+|+.++|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~----------------------~~~~~E~~il~~l~~ 59 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGE----------------------AMALNEKRILEKVNS 59 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhH----------------------HHHHHHHHHHHhcCC
Confidence 6678899999999999999999999999998864322211110 012356999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
+||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+++++
T Consensus 60 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~ 139 (285)
T cd05631 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG 139 (285)
T ss_pred CcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC
Confidence 99999999999999999999999999999887543 33589999999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||+++...... ......||..|||||++.+..|
T Consensus 140 ~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~ 178 (285)
T cd05631 140 HIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKY 178 (285)
T ss_pred CEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCC
Confidence 88 9999998754322 1233568999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-27 Score=254.14 Aligned_cols=178 Identities=21% Similarity=0.341 Sum_probs=145.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||++.+..+++.||+|.+.......... .. .+.+|+.++..+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~---------------------~~~~e~~~l~~l 58 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQ-VA---------------------HIRAERDILVEA 58 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhh-HH---------------------HHHHHHHHHHhC
Confidence 47888999999999999999999999999999986432111111 11 123468899999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++.+.+++.+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 59 ~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~ 137 (360)
T cd05627 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK 137 (360)
T ss_pred CCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCC
Confidence 99999999999999999999999999999999997654 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccc---------------------------------eeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPY---------------------------------TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~---------------------------------~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.+ +|||+++........ .......||+.|+|||++.+..|
T Consensus 138 ~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 213 (360)
T cd05627 138 GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY 213 (360)
T ss_pred CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC
Confidence 988 999998754321100 00113468999999999987665
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=261.14 Aligned_cols=182 Identities=34% Similarity=0.523 Sum_probs=152.9
Q ss_pred ccccceecCCCeeecceecccCcEEEEEEEEcCCCe---E-EEEEEeec---cCHHHHHHHHHHhhccceeeeccCCCCc
Q psy5063 471 ASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE---V-MVLKELYR---VDEEAEKNFLKESKQGLIYLIDLGSHGL 543 (681)
Q Consensus 471 ~~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~---~-vAiK~l~~---~~~~~~~~~~~E~k~~~~~~~~~~~~~~ 543 (681)
....|++.-++..+++.||+|+||.||+|+.+..+. . ||+|..+. ...+..+++++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~E---------------- 211 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKE---------------- 211 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHH----------------
Confidence 456688889999999999999999999999875432 3 89998764 234455555555
Q ss_pred cccccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy5063 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 623 (681)
Q Consensus 544 ~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~ 623 (681)
.++|+.++|||||+|||+...+..+++|||+|+||+|.++|++....++..+...++.|.+.||+|||+++
T Consensus 212 ---------ArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~ 282 (474)
T KOG0194|consen 212 ---------ARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN 282 (474)
T ss_pred ---------HHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC
Confidence 99999999999999999999999999999999999999999987767999999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeee-ecCCCccccchhhccCCCC
Q psy5063 624 LIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFI-LSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 624 IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~-~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||||.++|||+..++.+ +||||++.... +.... ...-...|+|||.+...-|
T Consensus 283 ~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~ 339 (474)
T KOG0194|consen 283 CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIF 339 (474)
T ss_pred CcchhHhHHHheecCCCeEEeCccccccCCcc---eeeccccccCcceecChhhhccCcc
Confidence 9999999999999998886 99999987652 22211 1124678999999976544
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=240.80 Aligned_cols=180 Identities=21% Similarity=0.336 Sum_probs=153.3
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
..+..+||++++.||+|.||.||.|+.+.++-.+|+|++.+........ .-...||++
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v----------------------~~qlrREiE 74 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQV----------------------EHQLRREIE 74 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcc----------------------hhhhhheeE
Confidence 4466789999999999999999999999999999999996643221110 012346799
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
+-+.|+||||+++|++|.++..+||++||.++|+|+..|... ...+++..+..++.|+|.||.|+|.++||||||||+|
T Consensus 75 Iqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpen 154 (281)
T KOG0580|consen 75 IQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPEN 154 (281)
T ss_pred eecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHH
Confidence 999999999999999999999999999999999999999843 3469999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|++.+|.. +|||-+-.... ..-.+.+||..|.+||+..+..|
T Consensus 155 lLlg~~~~lkiAdfGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~h 199 (281)
T KOG0580|consen 155 LLLGSAGELKIADFGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGH 199 (281)
T ss_pred hccCCCCCeeccCCCceeecCC----CCceeeecccccCCHhhcCCCCc
Confidence 999999988 99999865542 33445789999999999887654
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-27 Score=248.82 Aligned_cols=168 Identities=24% Similarity=0.355 Sum_probs=139.8
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeE
Q psy5063 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRF 567 (681)
Q Consensus 488 LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l 567 (681)
||+|+||.||++++..+++.||+|.+.+.......... ...+|+.+|+.++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~----------------------~~~~E~~~l~~l~h~~iv~~ 58 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVT----------------------HTLAERTVLAQVNCPFIVPL 58 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHH----------------------HHHHHHHHHHhCCCCcEece
Confidence 69999999999999999999999998643211111110 12356899999999999999
Q ss_pred EEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEe
Q psy5063 568 IGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDF 645 (681)
Q Consensus 568 ~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DF 645 (681)
++++..++..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.+|.+ +||
T Consensus 59 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Df 137 (312)
T cd05585 59 KFSFQSPEKLYLVLAFINGGELFHHLQREG-RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDF 137 (312)
T ss_pred eeEEecCCeEEEEEcCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEEC
Confidence 999999999999999999999999997644 58999999999999999999999999999999999999999988 999
Q ss_pred eeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 646 HLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 646 GLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+++....... ......||+.|+|||++.+..|
T Consensus 138 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 170 (312)
T cd05585 138 GLCKLNMKDDD--KTNTFCGTPEYLAPELLLGHGY 170 (312)
T ss_pred cccccCccCCC--ccccccCCcccCCHHHHcCCCC
Confidence 99986433221 1233568999999999987654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=248.54 Aligned_cols=175 Identities=21% Similarity=0.241 Sum_probs=145.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||++++..+++.||+|.+.+......... . .+..|+.+++.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-~---------------------~~~~e~~~l~~~ 58 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAET-A---------------------CFREERNVLVNG 58 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHH-H---------------------HHHHHHHHHHhC
Confidence 478999999999999999999999999999999864321111100 0 112358889999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++++.+++..|+||||+++|+|.+++......+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 59 ~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~ 138 (331)
T cd05624 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN 138 (331)
T ss_pred CCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC
Confidence 99999999999999999999999999999999998755568999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|.+ +|||+++....... .......||+.|||||++.+
T Consensus 139 ~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 139 GHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred CCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhc
Confidence 988 99999987654322 11223568999999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=261.26 Aligned_cols=172 Identities=25% Similarity=0.398 Sum_probs=150.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
..|..-+.||+|+-|.||.++...+++.||+|.+........+-. ++|+.+|+..
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLi-------------------------lnEi~Vm~~~ 327 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELL-------------------------LNEILVMRDL 327 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhh-------------------------HHHHHHHHhc
Confidence 456666789999999999999999999999999865433332222 4569999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+|||++++.|.-.+.+|+|||||+||+|.|++... .+++.++..+.++++.||+|||.+||||||||.+|||++.+
T Consensus 328 ~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~ 405 (550)
T KOG0578|consen 328 HHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMD 405 (550)
T ss_pred cchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccC
Confidence 9999999999999999999999999999999999864 49999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.+ .|||++..+....+. -.+-.||+.|||||++..+.|
T Consensus 406 g~vKltDFGFcaqi~~~~~K--R~TmVGTPYWMAPEVvtrk~Y 446 (550)
T KOG0578|consen 406 GSVKLTDFGFCAQISEEQSK--RSTMVGTPYWMAPEVVTRKPY 446 (550)
T ss_pred CcEEEeeeeeeeccccccCc--cccccCCCCccchhhhhhccc
Confidence 999 999999988765542 234679999999999999887
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=253.89 Aligned_cols=177 Identities=23% Similarity=0.332 Sum_probs=146.6
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++|+..+.||+|+||.||++++..+++.+|+|.+.+........ . ..+.+|+.++
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~--~--------------------~~~~~e~~i~ 97 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD--S--------------------AFFWEERDIM 97 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhh--H--------------------HHHHHHHHHH
Confidence 34568999999999999999999999999999999986422111100 0 0123458899
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+++.+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl 175 (370)
T cd05621 98 AFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL 175 (370)
T ss_pred HhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence 9999999999999999999999999999999999999753 48899999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+++|.+ +|||+++...... ........||+.|||||++.+.
T Consensus 176 ~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 176 DKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred CCCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhcc
Confidence 999988 9999998764322 1122345699999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=249.35 Aligned_cols=170 Identities=24% Similarity=0.344 Sum_probs=140.7
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCcee
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVI 565 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV 565 (681)
+.||+|+||.||++++..+++.||+|++.+......... . .+.+|+.+|+.++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~-~---------------------~~~~E~~~l~~l~hp~iv 58 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEV-A---------------------HTLTESRVLKNTRHPFLT 58 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-H---------------------HHHHHHHHHHhCCCCCCc
Confidence 469999999999999999999999999865321111111 0 124568999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--E
Q psy5063 566 RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--F 643 (681)
Q Consensus 566 ~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~ 643 (681)
++++++..++.+++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+ +
T Consensus 59 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~ 137 (328)
T cd05593 59 SLKYSFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKIT 137 (328)
T ss_pred ceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEe
Confidence 99999999999999999999999999887643 58999999999999999999999999999999999999999988 9
Q ss_pred EeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 644 DFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 644 DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++...... .......||+.|+|||++.+..|
T Consensus 138 DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 172 (328)
T cd05593 138 DFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDY 172 (328)
T ss_pred cCcCCccCCCcc--cccccccCCcCccChhhhcCCCC
Confidence 999998643222 12233568999999999977654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=249.31 Aligned_cols=170 Identities=24% Similarity=0.321 Sum_probs=140.6
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCcee
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVI 565 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV 565 (681)
+.||+|+||.||++++..+|+.||+|.+.+.......... ...+|+.+|+.++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~----------------------~~~~E~~~l~~l~hp~i~ 58 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVA----------------------HTVTESRVLQNTRHPFLT 58 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHH----------------------HHHHHHHHHHhCCCCCCc
Confidence 4699999999999999999999999998653211111111 123568999999999999
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--E
Q psy5063 566 RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--F 643 (681)
Q Consensus 566 ~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~ 643 (681)
++++++..++.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+ +
T Consensus 59 ~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~ 137 (323)
T cd05595 59 ALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKIT 137 (323)
T ss_pred ceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEec
Confidence 99999999999999999999999999887644 58999999999999999999999999999999999999999988 9
Q ss_pred EeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 644 DFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 644 DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++...... .......||+.|+|||++.+..|
T Consensus 138 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 172 (323)
T cd05595 138 DFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDY 172 (323)
T ss_pred ccHHhccccCCC--CccccccCCcCcCCcccccCCCC
Confidence 999988643221 12233568999999999977654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=243.56 Aligned_cols=179 Identities=28% Similarity=0.428 Sum_probs=143.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcC----------------CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccC
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRE----------------TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLG 539 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~----------------tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~ 539 (681)
+..++|...+.||+|+||.||+|.+.. ++..||+|.+.... ......+.+
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------- 68 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK------------- 68 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHH-------------
Confidence 345788999999999999999998643 34579999886532 222333433
Q ss_pred CCCccccccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC------------------CCCC
Q psy5063 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG------------------QPLP 601 (681)
Q Consensus 540 ~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~------------------~~l~ 601 (681)
|+.+|+.++||||+++++++.+.+..++||||+++|+|.+++.... ..++
T Consensus 69 ------------E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (304)
T cd05096 69 ------------EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAIS 136 (304)
T ss_pred ------------HHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccccccccccccccccc
Confidence 5999999999999999999999999999999999999999985421 2367
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 602 ~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+..+..++.||+.||.|||+++|+||||||+|||++.++.+ +|||+++...............++..|||||++.+..
T Consensus 137 ~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 137 YSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence 88899999999999999999999999999999999999988 9999998765433222222334578899999987654
Q ss_pred C
Q psy5063 680 F 680 (681)
Q Consensus 680 Y 680 (681)
|
T Consensus 217 ~ 217 (304)
T cd05096 217 F 217 (304)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=246.67 Aligned_cols=170 Identities=25% Similarity=0.328 Sum_probs=140.1
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCcee
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVI 565 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV 565 (681)
+.||+|+||.||++++..+++.||+|.+.+.......... ...+|+++++.++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~----------------------~~~~e~~~l~~~~hp~i~ 58 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVA----------------------HTLTENRVLQNSRHPFLT 58 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHH----------------------HHHHHHHHHHhCCCCCCC
Confidence 4699999999999999999999999998653211111111 123468899999999999
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCCe--
Q psy5063 566 RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 566 ~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NILl~~~g~~-- 642 (681)
++++++..++.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ ++|+||||||+|||++.+|.+
T Consensus 59 ~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL 137 (325)
T cd05594 59 ALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKI 137 (325)
T ss_pred ceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEE
Confidence 99999999999999999999999999887643 58999999999999999999997 799999999999999999988
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++...... .......||+.|||||++.+..|
T Consensus 138 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (325)
T cd05594 138 TDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDY 173 (325)
T ss_pred ecCCCCeecCCCC--cccccccCCcccCCHHHHccCCC
Confidence 9999998644222 11223468999999999977654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=248.13 Aligned_cols=174 Identities=22% Similarity=0.286 Sum_probs=144.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|++.+.||+|+||.||++++..+++.||+|.+.+........ .+ .+..|+.+++.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~---------------------~~~~e~~~l~~~ 58 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAE-TA---------------------CFREERDVLVNG 58 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhh-HH---------------------HHHHHHHHHHhC
Confidence 47889999999999999999999999999999986422111110 00 112458889999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++++.+++.+|+||||+++|+|.+++......+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~ 138 (331)
T cd05597 59 DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN 138 (331)
T ss_pred CCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC
Confidence 99999999999999999999999999999999997655569999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
|.+ +|||+++........ ......||+.|||||++.
T Consensus 139 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~ 176 (331)
T cd05597 139 GHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQ 176 (331)
T ss_pred CCEEEEECCceeecCCCCCc-cccceeccccccCHHHHh
Confidence 988 999999776532211 112245899999999986
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=253.42 Aligned_cols=176 Identities=23% Similarity=0.341 Sum_probs=151.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
...|++++.||+|.||.||+++.+.||+.+|+|.+.+........ ...+.+|+++|+.
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~----------------------~~~v~~Ev~il~~ 91 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKED----------------------REDVRREVAILQQ 91 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhcccccc----------------------HHHHHHHHHHHHh
Confidence 457889999999999999999999999999999997643322110 0123467999999
Q ss_pred CC-CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
+. |||||.++++|.+...+++|||++.||.|++.+... .+++..+..+++|++.|+.|||+.||+||||||+|+|+.
T Consensus 92 l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~ 169 (382)
T KOG0032|consen 92 LSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLA 169 (382)
T ss_pred ccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeec
Confidence 98 999999999999999999999999999999999876 399999999999999999999999999999999999997
Q ss_pred cCC----Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCCC
Q psy5063 638 EVG----SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASFI 681 (681)
Q Consensus 638 ~~g----~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y~ 681 (681)
... .+ +|||+|..... .......+||+.|+|||++.+.+|.
T Consensus 170 ~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~ 216 (382)
T KOG0032|consen 170 SKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYG 216 (382)
T ss_pred cccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCC
Confidence 653 34 99999998875 2345568899999999999988774
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-27 Score=257.57 Aligned_cols=177 Identities=27% Similarity=0.393 Sum_probs=153.4
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
..|.+..+++.++..||+|.||+||+|+|.. .||||.+...+ .+..+.|..|
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnE----------------------- 438 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNE----------------------- 438 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHH-----------------------
Confidence 5677788889999999999999999999963 48999986543 3444555554
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++++-+|.||+-|.|++.++.. .+|+.+|+|.+|+.+|+.....|+......|++||++||.|||.++|||||||
T Consensus 439 --Va~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLK 515 (678)
T KOG0193|consen 439 --VAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLK 515 (678)
T ss_pred --HHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhcc
Confidence 999999999999999999998877 99999999999999998877779999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.||++.+++++ .||||+..-.............|..-|||||+++.+
T Consensus 516 SnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmq 565 (678)
T KOG0193|consen 516 SNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQ 565 (678)
T ss_pred ccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhc
Confidence 999999999998 999999877655444455567789999999998643
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=246.06 Aligned_cols=172 Identities=22% Similarity=0.285 Sum_probs=146.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
++|...+.||+|+||.||++.+..+++.+|+|.+...... ..+.+ .+|+.++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-------------------------~~e~~i~ 55 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFF-------------------------EEERDIL 55 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHH-------------------------HHHHHHH
Confidence 4688899999999999999999999999999998653221 11112 2358899
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++|+||+++++++.+.+..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll 135 (330)
T cd05601 56 SISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135 (330)
T ss_pred HhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE
Confidence 99999999999999999999999999999999999998765579999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+.+|.+ +|||+++........ ......+|+.|+|||++..
T Consensus 136 ~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 136 DRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred CCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhcc
Confidence 999988 999999876543322 2234568999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=251.99 Aligned_cols=177 Identities=21% Similarity=0.326 Sum_probs=146.3
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..+.||+|+||.||++++..+++.+|+|.+.+......... ..+.+|+.+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~----------------------~~~~~e~~il 97 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS----------------------AFFWEERDIM 97 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhH----------------------HHHHHHHHHH
Confidence 456789999999999999999999999999999999864321111000 0123468999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+++..|+||||+++|+|.+++... .+++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 98 ~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl 175 (370)
T cd05596 98 AHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (370)
T ss_pred HhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9999999999999999999999999999999999998753 48889999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.+|.+ +|||+++....... .......||+.|||||++.+.
T Consensus 176 ~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~ 218 (370)
T cd05596 176 DKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred cCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccC
Confidence 999998 99999987643221 112235689999999998654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=250.95 Aligned_cols=177 Identities=23% Similarity=0.337 Sum_probs=146.7
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..+.||+|+||.||++.++.+++.+|+|.+.+........ .+ .+.+|+.++
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~--~~--------------------~~~~e~~i~ 97 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD--SA--------------------FFWEERDIM 97 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHH--HH--------------------HHHHHHHHH
Confidence 44579999999999999999999999999999999986432111110 00 123458899
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+++.+|+||||+++|+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 98 ~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll 175 (371)
T cd05622 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (371)
T ss_pred HhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 9999999999999999999999999999999999999753 48889999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.+|.+ +|||+++...... ........||+.|||||++.+.
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~ 218 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQ 218 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhcc
Confidence 999988 9999998764322 1112345699999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=244.44 Aligned_cols=172 Identities=24% Similarity=0.288 Sum_probs=142.5
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
+|+..+.||+|+||.||+|++..+++.||+|.+.+... .....+ ..|+.++.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~-------------------------~~e~~~l~ 55 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECT-------------------------MVEKRVLA 55 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHH-------------------------HHHHHHHH
Confidence 57888999999999999999999999999999865321 111122 34578888
Q ss_pred hCCC-CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 558 SLHH-HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 558 ~L~H-pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
.++| ++|+++++++...+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 56 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 134 (324)
T cd05587 56 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134 (324)
T ss_pred hcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 8865 568889999999999999999999999999987654 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 178 (324)
T cd05587 135 DAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPY 178 (324)
T ss_pred cCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCC
Confidence 999988 9999987543222 12334568999999999987654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=241.68 Aligned_cols=172 Identities=27% Similarity=0.414 Sum_probs=144.3
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
..++|+..+.||+|+||.||+|++..+++.||+|.+...... ... ...+|+.++
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~-------------------------~~~~E~~~l 57 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC-------------------------TAIREVSLL 57 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcch-------------------------hHHHHHHHH
Confidence 356899999999999999999999999999999988543211 111 123569999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++..++..++||||+++ +|.+++......+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 58 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~ 136 (288)
T cd07871 58 KNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI 136 (288)
T ss_pred HhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 999999999999999999999999999975 9999987666568999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+.++.+ +|||+++...... .......+++.|+|||++.+
T Consensus 137 ~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 137 NEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred CCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcC
Confidence 999988 9999998654322 12233457899999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-26 Score=244.95 Aligned_cols=174 Identities=21% Similarity=0.268 Sum_probs=144.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||+++++.+++.+|+|.+.+........ .+ .+..|+.++..+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~--~~--------------------~~~~e~~~l~~~ 58 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE--TA--------------------CFREERDVLVNG 58 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhH--HH--------------------HHHHHHHHHhhC
Confidence 47889999999999999999999999999999985422111110 00 122458889999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++++.+++.+|+||||+++|+|.+++......+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~ 138 (332)
T cd05623 59 DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN 138 (332)
T ss_pred CCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC
Confidence 99999999999999999999999999999999998755568999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+.+ +|||+++....... .......||+.|||||++.
T Consensus 139 ~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~ 176 (332)
T cd05623 139 GHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQ 176 (332)
T ss_pred CCEEEeecchheecccCCc-ceecccccCccccCHHHHh
Confidence 988 99999976543221 1222356899999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=245.82 Aligned_cols=156 Identities=27% Similarity=0.361 Sum_probs=137.0
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
....+..++|++.+.||.|.-|.||+++.+.++..+|+|++.+......+...+. ..|
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra----------------------~tE 127 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRA----------------------QTE 127 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHH----------------------HHH
Confidence 3445667889999999999999999999999999999999976554443333222 346
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
-+||+.++||.++.||..|..+...+|+||||+||+|..++++. ++.+++..+..|+.+++.||+|||.+|||.|||||
T Consensus 128 ~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKP 207 (459)
T KOG0610|consen 128 REILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKP 207 (459)
T ss_pred HHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCc
Confidence 88999999999999999999999999999999999999998764 46799999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeE
Q psy5063 632 QNCLVREVGSG--FDFHLGQI 650 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~ 650 (681)
+||||.++|.+ +||+|+..
T Consensus 208 ENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 208 ENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred ceeEEecCCcEEeeecccccc
Confidence 99999999999 99998754
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=249.04 Aligned_cols=178 Identities=22% Similarity=0.363 Sum_probs=147.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||+|++..+++.||+|++.+........ .. .+..|+.+|+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~---------------------~~~~e~~~l~~~ 58 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IA---------------------HVRAERDILADA 58 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccH-HH---------------------HHHHHHHHHHhc
Confidence 47889999999999999999999999999999986532111000 00 123458999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++.+++.+++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~ 137 (350)
T cd05573 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD 137 (350)
T ss_pred CCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence 9999999999999999999999999999999999875 459999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecc---------------------------cceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYV---------------------------PYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~---------------------------~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++...... .........||+.|+|||++.+..|
T Consensus 138 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (350)
T cd05573 138 GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY 207 (350)
T ss_pred CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC
Confidence 988 9999998765322 0011223558999999999987654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.7e-26 Score=242.30 Aligned_cols=173 Identities=23% Similarity=0.366 Sum_probs=144.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||+|++..+++.+|+|.+......... ....+|+.+|+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~------------------------~~~~~E~~~l~~ 59 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTP------------------------FTAIREASLLKG 59 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccc------------------------hhHHHHHHHHhh
Confidence 46899999999999999999999999999999988543211100 112356999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++.++...++||||++ ++|.+++......+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 60 l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 138 (303)
T cd07869 60 LKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD 138 (303)
T ss_pred CCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 999999999999999999999999995 6888888766566899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|.+ +|||+++...... .......++..|+|||++.+.
T Consensus 139 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 178 (303)
T cd07869 139 TGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGS 178 (303)
T ss_pred CCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCC
Confidence 9988 9999997654221 222335578999999998654
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-26 Score=243.88 Aligned_cols=175 Identities=23% Similarity=0.284 Sum_probs=142.6
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL- 559 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L- 559 (681)
||...+.||+|+||.||+|++..+++.+|+|.+.+.......... ....|..++..+
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~----------------------~~~~e~~~l~~~~ 58 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVE----------------------CTMVEKRVLALSG 58 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHH----------------------HHHHHHHHHHhcc
Confidence 578889999999999999999999999999998653211111110 112346677666
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|++|+++++++...+.+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~ 137 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE 137 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCC
Confidence 68999999999999999999999999999999987654 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 138 ~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 178 (323)
T cd05616 138 GHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPY 178 (323)
T ss_pred CcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCC
Confidence 988 9999998644222 11223568999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-26 Score=243.69 Aligned_cols=168 Identities=24% Similarity=0.391 Sum_probs=137.7
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
++||+|+||+||++++..+|+.+|+|++.+... .....+..| +..+++.++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e------------------------~~~~l~~~~hp 56 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAE------------------------RNVLLKNVKHP 56 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH------------------------HHHHHHhCCCC
Confidence 469999999999999999999999999865321 111222222 12357789999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
||+++++++..++..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.+|.+
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~ 135 (325)
T cd05604 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHV 135 (325)
T ss_pred CCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCE
Confidence 99999999999999999999999999999887643 58999999999999999999999999999999999999999988
Q ss_pred --EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 --FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 --~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++....... ......||+.|||||++.+..|
T Consensus 136 kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 173 (325)
T cd05604 136 VLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPY 173 (325)
T ss_pred EEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCC
Confidence 99999976432221 1223568999999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=244.31 Aligned_cols=170 Identities=19% Similarity=0.317 Sum_probs=139.3
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CCCce
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHNV 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 564 (681)
++||+|+||.||++++..+++.||+|.+.+........ .. .+.+|+.+++.+ +||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~-~~---------------------~~~~e~~il~~~~~hp~I 58 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDED-ID---------------------WVQTEKHVFETASNHPFL 58 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhH-HH---------------------HHHHHHHHHHhccCCCCC
Confidence 46999999999999999999999999986532111110 00 112458888888 79999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++++.+++.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 59 v~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL 137 (329)
T cd05588 59 VGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKL 137 (329)
T ss_pred CceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEE
Confidence 99999999999999999999999999988754 359999999999999999999999999999999999999999988
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++...... .......||+.|+|||++.+..|
T Consensus 138 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (329)
T cd05588 138 TDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDY 173 (329)
T ss_pred CcCccccccccCC--CccccccCCccccCHHHHcCCCC
Confidence 9999997543221 12233568999999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-26 Score=243.27 Aligned_cols=167 Identities=25% Similarity=0.323 Sum_probs=137.3
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh-CCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS-LHH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-L~H 561 (681)
++||+|+||.||+|++..+++.||+|.+..... ...... ..|..++.. .+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------~~e~~~l~~~~~h 55 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECT-------------------------MVERRVLALAWEH 55 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHH-------------------------HHHHHHHHhccCC
Confidence 469999999999999999999999999865321 111111 223555554 489
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
|||+++++++...+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 56 p~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~ 134 (316)
T cd05592 56 PFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH 134 (316)
T ss_pred CCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC
Confidence 999999999999999999999999999999987654 5899999999999999999999999999999999999999998
Q ss_pred e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 642 G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 135 ~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (316)
T cd05592 135 IKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKY 173 (316)
T ss_pred EEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCC
Confidence 8 9999998654322 22234568999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-26 Score=243.54 Aligned_cols=176 Identities=20% Similarity=0.314 Sum_probs=142.6
Q ss_pred CeeecceecccCcEEEEEEEEc---CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
+|++.+.||+|+||.||+++.. .+++.+|+|.+.+..........+ ...+|+.+++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~---------------------~~~~e~~~l~ 59 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVE---------------------HTRTERNVLE 59 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHH---------------------HHHHHHHHHH
Confidence 5788999999999999998864 578999999986532211111111 1234688999
Q ss_pred hC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 558 SL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 558 ~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
.+ +|+||+++++++..++.+++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili 138 (332)
T cd05614 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138 (332)
T ss_pred hccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE
Confidence 99 59999999999999999999999999999999987643 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+.+|.+ +|||+++........ ......||..|||||++.+..
T Consensus 139 ~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 182 (332)
T cd05614 139 DSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKG 182 (332)
T ss_pred CCCCCEEEeeCcCCccccccCCC-ccccccCCccccCHHHhcCCC
Confidence 999988 999999875433211 122356899999999987643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=243.24 Aligned_cols=170 Identities=22% Similarity=0.292 Sum_probs=138.3
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CCCce
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHNV 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 564 (681)
++||+|+||.||+|++..+++.||+|.+.+.......... ....|.+++..+ +||||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~----------------------~~~~e~~il~~~~~hp~i 58 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVD----------------------CTMTEKRILALAAKHPFL 58 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHH----------------------HHHHHHHHHHhccCCCCc
Confidence 4699999999999999999999999998653211111100 112357777765 89999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++++..++.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.+|.+
T Consensus 59 ~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL 137 (321)
T cd05591 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKL 137 (321)
T ss_pred cceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEE
Confidence 999999999999999999999999999987654 58999999999999999999999999999999999999999988
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++...... .......||+.|+|||++.+..|
T Consensus 138 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (321)
T cd05591 138 ADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEY 173 (321)
T ss_pred eecccceecccCC--ccccccccCccccCHHHHcCCCC
Confidence 9999998654322 12233568999999999977654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=250.12 Aligned_cols=184 Identities=25% Similarity=0.385 Sum_probs=146.8
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCC-----eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETG-----EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg-----~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
...+.+..++|+.++.||+|+||.||++++..+| +.||+|.+.... ......+.
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-------------------- 89 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALM-------------------- 89 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHH--------------------
Confidence 4456677889999999999999999999865443 579999986533 22222333
Q ss_pred cccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------------------
Q psy5063 546 NLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--------------------------- 597 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--------------------------- 597 (681)
+|+++|+.+ +|+||+++++++...+..++||||+++|+|.+++....
T Consensus 90 -----~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (374)
T cd05106 90 -----SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEK 164 (374)
T ss_pred -----HHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhc
Confidence 359999999 89999999999999999999999999999999885321
Q ss_pred ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 598 ------------------------------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 598 ------------------------------------------~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
.++++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil 244 (374)
T cd05106 165 KYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVL 244 (374)
T ss_pred ccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEE
Confidence 24788889999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+++++.+ +|||+++...............++..|||||++.+..|
T Consensus 245 ~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 291 (374)
T cd05106 245 LTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVY 291 (374)
T ss_pred EeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCC
Confidence 9998877 99999987654332222222335567999999876544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-26 Score=236.59 Aligned_cols=169 Identities=22% Similarity=0.309 Sum_probs=139.2
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeE
Q psy5063 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRF 567 (681)
Q Consensus 488 LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l 567 (681)
||+|+||+||++.++.+++.+|+|.+.+........+. .+..|+.+|+.++|+||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~----------------------~~~~E~~il~~l~~~~i~~~ 58 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYE----------------------GAMVEKRILAKVHSRFIVSL 58 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHH----------------------HHHHHHHHHHhCCCCcEeee
Confidence 69999999999999999999999998643222111111 12346899999999999999
Q ss_pred EEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 568 IGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 568 ~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
.+++..+...++||||+++|+|.+++.. ....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 59 ~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l 138 (280)
T cd05608 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRI 138 (280)
T ss_pred eEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999988743 23458999999999999999999999999999999999999999888
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++....... ......||+.|+|||++.+..|
T Consensus 139 ~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~ 174 (280)
T cd05608 139 SDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEY 174 (280)
T ss_pred eeCccceecCCCCc--cccccCCCcCccCHHHhcCCCC
Confidence 99999987654321 1223468999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-26 Score=255.14 Aligned_cols=176 Identities=22% Similarity=0.253 Sum_probs=146.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCC-CeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRET-GEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~t-g~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
..|.+.+.||+|+||.||++....+ ++.+|+|.+...+......+. +|+.+|+.
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~-------------------------~E~~~l~~ 121 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYAR-------------------------SELHCLAA 121 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHH-------------------------HHHHHHHh
Confidence 3488899999999999999998877 788888876544433333333 35999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++||||+++++++..++.+||||||+++|+|.+++.. ...++++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 122 l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIl 201 (478)
T PTZ00267 122 CDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201 (478)
T ss_pred CCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEE
Confidence 9999999999999999999999999999999988754 2346889999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||+++.+.............||+.|+|||++.+..|
T Consensus 202 l~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 248 (478)
T PTZ00267 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248 (478)
T ss_pred ECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCC
Confidence 9999988 99999987654332222334568999999999977654
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=243.49 Aligned_cols=175 Identities=23% Similarity=0.297 Sum_probs=141.5
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
+|...++||+|+||.||++.++.+|+.||+|.+.+......... + ....|..+++.+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-~---------------------~~~~e~~~l~~~~ 58 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDV-E---------------------CTMVEKRVLALQD 58 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-H---------------------HHHHHHHHHHhcc
Confidence 46778899999999999999999999999999865321111110 0 1123577787774
Q ss_pred -CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 561 -HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 561 -HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
|++|+++++++..++.+|+||||+++|+|.+++.... .+++.++..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~ 137 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE 137 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence 6788889999999999999999999999999987644 59999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 138 ~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 178 (323)
T cd05615 138 GHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPY 178 (323)
T ss_pred CCEEEeccccccccCCCC--ccccCccCCccccCHHHHcCCCC
Confidence 988 9999998643322 12233558999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-26 Score=243.46 Aligned_cols=170 Identities=21% Similarity=0.309 Sum_probs=138.4
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CCCce
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHNV 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 564 (681)
++||+|+||.||+++++.+++.||+|.+.+.......... ....|+.++..+ +||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~----------------------~~~~e~~~l~~~~~h~~i 58 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVE----------------------CTMTEKRILSLARNHPFL 58 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHH----------------------HHHHHHHHHHhccCCCch
Confidence 4699999999999999999999999998643211111100 113457777766 79999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++++...+.+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||++.++.+
T Consensus 59 v~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL 137 (320)
T cd05590 59 TQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKL 137 (320)
T ss_pred hceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEE
Confidence 999999999999999999999999999987654 59999999999999999999999999999999999999999988
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++...... .......||+.|+|||++.+..|
T Consensus 138 ~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (320)
T cd05590 138 ADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLY 173 (320)
T ss_pred eeCCCCeecCcCC--CcccccccCccccCHHHHcCCCC
Confidence 9999988643221 11233568999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=242.72 Aligned_cols=168 Identities=27% Similarity=0.407 Sum_probs=137.7
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
++||+|+||.||++++..+|+.||+|.+.+.... ....+..| +..+++.++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e------------------------~~~~~~~l~hp 56 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAE------------------------RNVLLKNVKHP 56 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHH------------------------HHHHHhhCCCC
Confidence 4699999999999999999999999998653211 11122222 13356789999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
||+++++++...+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~ 135 (323)
T cd05575 57 FLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHV 135 (323)
T ss_pred CCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcE
Confidence 99999999999999999999999999999987643 58999999999999999999999999999999999999999988
Q ss_pred --EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 --FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 --~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++...... .......||+.|+|||++.+..|
T Consensus 136 kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (323)
T cd05575 136 VLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPY 173 (323)
T ss_pred EEeccCCCcccccCC--CccccccCChhhcChhhhcCCCC
Confidence 9999997643222 11223468999999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=262.61 Aligned_cols=184 Identities=33% Similarity=0.459 Sum_probs=155.2
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
.....+.+++++..+.||+|.||+||+|+.. .....||||.++..... .+..|.+|
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~RE------------------ 539 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRRE------------------ 539 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHH------------------
Confidence 3455678899999999999999999999854 23468999999876554 66666665
Q ss_pred cccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------CC----CCCHHHHHHHHHHH
Q psy5063 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------GQ----PLPWGQRVNFARDI 612 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------~~----~l~~~~~~~i~~QI 612 (681)
+++|..|+|||||+|+|++..++.+++|+|||..|||.+||... +. +++..+.+.|+.||
T Consensus 540 -------aeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QI 612 (774)
T KOG1026|consen 540 -------AELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQI 612 (774)
T ss_pred -------HHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999632 12 38889999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 613 AAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 613 a~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.||+||-++.+|||||..+|+||.++-.+ +||||+|..-..+.|......--..+||+||.+...+|
T Consensus 613 AaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF 682 (774)
T KOG1026|consen 613 AAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF 682 (774)
T ss_pred HHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc
Confidence 999999999999999999999999999888 99999998766554443323345778999999987665
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-26 Score=243.17 Aligned_cols=173 Identities=24% Similarity=0.328 Sum_probs=140.6
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
|.+.+.||+|+||.||++.+..+++.||+|.+.+.... ..+.+..| .+++..++.
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e----------------------~~~~~~~~~ 58 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCE----------------------KRIFETANS 58 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHH----------------------HHHHHhccc
Confidence 56678999999999999999999999999998753211 11222222 122445567
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++...+..|+||||+++|+|..++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 59 l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~ 136 (324)
T cd05589 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDT 136 (324)
T ss_pred cCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECC
Confidence 8899999999999999999999999999999988865 35999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|.+ +|||+++...... .......|++.|||||++.+..|
T Consensus 137 ~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~ 178 (324)
T cd05589 137 EGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSY 178 (324)
T ss_pred CCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCC
Confidence 9988 9999987543221 11223568999999999977654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-26 Score=242.74 Aligned_cols=168 Identities=26% Similarity=0.362 Sum_probs=137.4
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH---HHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA---EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~---~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
+.||+|+||.||++++..+++.+|+|.+.+..... ...+..| +..+++.++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e------------------------~~~~l~~~~h~ 56 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSE------------------------RNVLLKNVKHP 56 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHH------------------------HHHHHHhCCCC
Confidence 46999999999999999999999999986532111 1111221 13357888999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
||+++++++..++..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+|.+
T Consensus 57 ~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~ 135 (325)
T cd05602 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 135 (325)
T ss_pred CCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCE
Confidence 99999999999999999999999999999997644 48888999999999999999999999999999999999999988
Q ss_pred --EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 --FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 --~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++....... ......||+.|||||++.+..|
T Consensus 136 kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 173 (325)
T cd05602 136 VLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQPY 173 (325)
T ss_pred EEccCCCCcccccCCC--CcccccCCccccCHHHHcCCCC
Confidence 99999986443221 1223568999999999987654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-26 Score=248.98 Aligned_cols=183 Identities=25% Similarity=0.324 Sum_probs=146.0
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEE-----cCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTH-----RETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINN 546 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~-----~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~ 546 (681)
..+.+..++|..++.||+|+||.||+|++ .+++..||+|.+.... ....+.+
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~---------------------- 85 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREAL---------------------- 85 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHH----------------------
Confidence 34556778899999999999999999974 3557789999886432 1222223
Q ss_pred ccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC----------------------------
Q psy5063 547 LHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------------------- 597 (681)
Q Consensus 547 ~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------------------- 597 (681)
.+|+.+|+.+ +||||+++++++...+..++||||+++|+|.+++....
T Consensus 86 ---~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (375)
T cd05104 86 ---MSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSC 162 (375)
T ss_pred ---HHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccc
Confidence 3459999999 89999999999999999999999999999999986421
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 598 ----------------------------------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 598 ----------------------------------------------~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
..+++..+..++.||+.||.|||+++|+||||||
T Consensus 163 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 242 (375)
T cd05104 163 DSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAA 242 (375)
T ss_pred hhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCch
Confidence 2478888999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++.+ +|||+++...............++..|+|||++.+..|
T Consensus 243 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 293 (375)
T cd05104 243 RNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVY 293 (375)
T ss_pred hhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCC
Confidence 99999998877 99999987654332222222334567999999977654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=250.66 Aligned_cols=176 Identities=24% Similarity=0.348 Sum_probs=153.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
...|.+.+.||+|.|+.|.++++..|+..||||.+.+........ . ++.+|+++|+.
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~-~----------------------k~~rev~imk~ 111 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKR-Q----------------------KLGREVDIMKS 111 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHH-H----------------------HHHHHHHHHHh
Confidence 356888899999999999999999999999999986644332211 1 12567999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|||||+++.+...+..+|+||||+.+|.+++++.+.+. +.+..+..++.|+.+|++|||+++|+|||||++||||+.
T Consensus 112 l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~ 190 (596)
T KOG0586|consen 112 LNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDE 190 (596)
T ss_pred cCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccc
Confidence 9999999999999999999999999999999999998764 666899999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASFI 681 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y~ 681 (681)
+.++ +|||++..+... ....+.+|++.|.|||++.+.+|.
T Consensus 191 ~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~ 232 (596)
T KOG0586|consen 191 NMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYD 232 (596)
T ss_pred ccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccC
Confidence 9977 999999998743 334568899999999999999884
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=235.89 Aligned_cols=175 Identities=22% Similarity=0.279 Sum_probs=144.2
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
.|+..++||+|+||.||++.+..+++.||+|++.......... . ..+.+|+.+++.++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~--------------------~~~~~E~~~l~~l~ 58 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG--E--------------------AMALNEKQILEKVN 58 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhh--H--------------------HHHHHHHHHHHhcC
Confidence 3677889999999999999999999999999986432211110 0 01235699999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
||||+++++.+..++.+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++++
T Consensus 59 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 59 SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred CCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 999999999999999999999999999999888643 3458999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++....... .....|+..|+|||++.+..|
T Consensus 139 ~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 178 (285)
T cd05605 139 GHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERY 178 (285)
T ss_pred CCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCC
Confidence 988 99999987643221 123468999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=241.09 Aligned_cols=180 Identities=25% Similarity=0.365 Sum_probs=146.4
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeE----EEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEV----MVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~----vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
+++...+|+..+.||+|+||.||+|.+..+++. ||+|.+.... ....+.+..
T Consensus 2 ~~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~----------------------- 58 (316)
T cd05108 2 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD----------------------- 58 (316)
T ss_pred cccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHH-----------------------
Confidence 356678999999999999999999998766664 8999885432 233333433
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
|+.+++.++||||++++|++..+ ..++++||+++|+|.+++......+++..+..++.||+.||+|||+++|+||||
T Consensus 59 --e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dl 135 (316)
T cd05108 59 --EAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDL 135 (316)
T ss_pred --HHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence 48899999999999999998764 578999999999999999876666899999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.++.+ +|||+++................+..|||||++.+..|
T Consensus 136 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 188 (316)
T cd05108 136 AARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY 188 (316)
T ss_pred chhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCC
Confidence 9999999999988 99999998764433222222334668999999876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=241.58 Aligned_cols=168 Identities=25% Similarity=0.366 Sum_probs=137.4
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH---HHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA---EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~---~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
++||+|+||.||++++..+++.+|+|.+.+..... ...+..| +..+++.++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e------------------------~~~~l~~~~h~ 56 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAE------------------------RNVLLKNLKHP 56 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHH------------------------HHHHHHhCCCC
Confidence 46999999999999999999999999986532211 1122222 13467889999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
||+++++++.+.+..|+||||+++|+|.+.+... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+|.+
T Consensus 57 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 135 (321)
T cd05603 57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHV 135 (321)
T ss_pred CccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE
Confidence 9999999999999999999999999999888754 358899999999999999999999999999999999999999988
Q ss_pred --EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 --FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 --~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++...... .......||+.|+|||++.+..|
T Consensus 136 kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (321)
T cd05603 136 VLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPY 173 (321)
T ss_pred EEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCC
Confidence 9999987643221 12233568999999999977654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.5e-27 Score=252.43 Aligned_cols=175 Identities=23% Similarity=0.364 Sum_probs=153.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|..++++|+|+||.++.++++..++.+|+|++.-... ...... ..|+.++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A-------------------------~~E~~li 57 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSA-------------------------IQEMDLL 57 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHH-------------------------HHHHHHH
Confidence 4688999999999999999999999999999999864322 222222 3459999
Q ss_pred HhCCCCceeeEEEEEEeCCe-EEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~-l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
++++|||||.+.+.|..++. ++|||+|++||+|.+.+.... ..+++..+..|+.|++.|+.|||+++|+|||||+.||
T Consensus 58 s~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Ni 137 (426)
T KOG0589|consen 58 SKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANI 137 (426)
T ss_pred HhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhh
Confidence 99999999999999999888 999999999999999997654 6799999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+++.++.+ .|||+|+.+.... ....+..||+.||.||++.+.+|
T Consensus 138 fltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pY 183 (426)
T KOG0589|consen 138 FLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPY 183 (426)
T ss_pred hccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCC
Confidence 99999999 9999999988654 23445789999999999999998
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.6e-26 Score=241.36 Aligned_cols=171 Identities=24% Similarity=0.353 Sum_probs=138.6
Q ss_pred ceecccCcEEEEEEEEc---CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 486 PLLGQGFFGQVYRVTHR---ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
+.||+|+||.||+++.. .+++.||+|.+.+.......... ....+|+.+|+.++||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~---------------------~~~~~E~~il~~l~hp 60 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDT---------------------AHTKAERNILEAVKHP 60 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhH---------------------HHHHHHHHHHHhCCCC
Confidence 57999999999999864 56889999998653221111100 0123569999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
||+++++++..++..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.+|.+
T Consensus 61 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 139 (323)
T cd05584 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHV 139 (323)
T ss_pred chhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCE
Confidence 99999999999999999999999999999997654 58888999999999999999999999999999999999999988
Q ss_pred --EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 --FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 --~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++....... ......||+.|+|||++.+..|
T Consensus 140 kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 177 (323)
T cd05584 140 KLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGH 177 (323)
T ss_pred EEeeCcCCeecccCCC--cccccCCCccccChhhccCCCC
Confidence 99999986443221 1223468999999999876543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=240.21 Aligned_cols=174 Identities=22% Similarity=0.370 Sum_probs=147.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
+..++|+..+.||+|+||.||++++..++..+|+|.+.... ......+ .+|+++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~-------------------------~~E~~~ 56 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI-------------------------IRELQV 56 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHH-------------------------HHHHHH
Confidence 34678999999999999999999999999999999886432 2222233 345999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~-~IIHRDLKp~NI 634 (681)
|+.++||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Ni 135 (331)
T cd06649 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNI 135 (331)
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhE
Confidence 999999999999999999999999999999999999997644 589999999999999999999986 699999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.++.+ +|||+++...... .....++..|+|||++.+..|
T Consensus 136 l~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~ 179 (331)
T cd06649 136 LVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY 179 (331)
T ss_pred EEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCC
Confidence 99999988 9999998664322 223458999999999987654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=241.62 Aligned_cols=167 Identities=22% Similarity=0.301 Sum_probs=138.4
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~H 561 (681)
+.||+|+||.||++++..+++.+|+|.+.+... .....+ .+|+.++..+ +|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-------------------------~~E~~~l~~~~~h 55 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWV-------------------------QTEKHVFEQASNH 55 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHH-------------------------HHHHHHHHhcCCC
Confidence 469999999999999999999999999875321 111222 2347777766 89
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
|||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||++.++.
T Consensus 56 p~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~ 134 (329)
T cd05618 56 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH 134 (329)
T ss_pred CcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC
Confidence 999999999999999999999999999999887643 5999999999999999999999999999999999999999998
Q ss_pred e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 642 G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+ +|||+++...... .......||..|+|||++.+..|
T Consensus 135 ~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (329)
T cd05618 135 IKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDY 173 (329)
T ss_pred EEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCC
Confidence 8 9999997643221 11223568999999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=240.74 Aligned_cols=167 Identities=23% Similarity=0.310 Sum_probs=137.5
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh-CCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS-LHH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-L~H 561 (681)
++||+|+||.||+++++.+|+.||+|.+.+.... ..... ..|..++.. ++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~-------------------------~~e~~~l~~~~~~ 55 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECT-------------------------MVEKRVLALAWEN 55 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHH-------------------------HHHHHHHHhccCC
Confidence 4699999999999999999999999998653211 11111 234666665 489
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
|||+++++++.+++.+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||++.+|.
T Consensus 56 ~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~ 134 (316)
T cd05620 56 PFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH 134 (316)
T ss_pred CCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC
Confidence 999999999999999999999999999999987643 5899999999999999999999999999999999999999998
Q ss_pred e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 642 G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+ +|||+++...... .......||..|+|||++.+..|
T Consensus 135 ~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (316)
T cd05620 135 IKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKY 173 (316)
T ss_pred EEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCC
Confidence 8 9999987543221 12234568999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=239.97 Aligned_cols=167 Identities=23% Similarity=0.321 Sum_probs=137.8
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh-CCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS-LHH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-L~H 561 (681)
+.||+|+||.||+|++..+++.||+|.+.+... ...... ..|..+++. ++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------~~e~~~l~~~~~h 55 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECT-------------------------MVEKRVLSLAWEH 55 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHH-------------------------HHHHHHHHhccCC
Confidence 469999999999999999999999999865321 111111 234666765 499
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
|||+++++++.+.+.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 56 p~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~ 134 (316)
T cd05619 56 PFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH 134 (316)
T ss_pred CcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC
Confidence 99999999999999999999999999999999764 35899999999999999999999999999999999999999998
Q ss_pred e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 642 G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+ +|||+++...... .......||..|+|||++.+..|
T Consensus 135 ~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (316)
T cd05619 135 IKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKY 173 (316)
T ss_pred EEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCC
Confidence 8 9999997643222 12234568999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=233.62 Aligned_cols=177 Identities=23% Similarity=0.343 Sum_probs=143.7
Q ss_pred cCCCeeecceecccCcEEEEEEEEc---CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
..++|...+.||+|+||.||+|+++ ..+..+|+|.+.... ......+. +|+
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~-------------------------~e~ 57 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFL-------------------------AEA 57 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHH-------------------------HHH
Confidence 4567899999999999999999875 446789999886532 22222333 458
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+|+.++||||+++++++..++..++||||+++|+|.+++......+++..+..++.|++.||+|||+++++||||||+|
T Consensus 58 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~n 137 (266)
T cd05064 58 LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHK 137 (266)
T ss_pred HHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhh
Confidence 99999999999999999999999999999999999999998755568999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.++.. +|||++......... ......++..|+|||++.+..|
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~ 185 (266)
T cd05064 138 VLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHF 185 (266)
T ss_pred EEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCc
Confidence 999999887 899987654332211 1112335678999999876554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-28 Score=239.53 Aligned_cols=177 Identities=24% Similarity=0.301 Sum_probs=148.1
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++|.+-++||+|.|+.||++.++.||+.+|+|.+........ .+. ...+|+.+-
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e----------------------~l~rEarIC 64 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQ----------------------KLEREARIC 64 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHH----------------------HHHHHHHHH
Confidence 345788899999999999999999999999999997743211111 111 124679999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.|+||||++|.+.+.++...|||+|+|.|++|..-+-.+ ..+++..+..+++||+.+|.|+|.++|||||+||+|+|+
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllL 143 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLL 143 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheee
Confidence 9999999999999999999999999999999996554433 458889999999999999999999999999999999999
Q ss_pred ecCCCe-----EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG-----FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~-----~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
....+. +|||+|..... ...+...+|||.|||||++++++|
T Consensus 144 ASK~~~A~vKL~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy 189 (355)
T KOG0033|consen 144 ASKAKGAAVKLADFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPY 189 (355)
T ss_pred eeccCCCceeecccceEEEeCC---ccccccccCCCcccCHHHhhcCCC
Confidence 765443 99999998873 345667899999999999999988
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=235.53 Aligned_cols=174 Identities=20% Similarity=0.350 Sum_probs=143.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||+++++.+++.+|+|++...... ..+. ..+|+++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~-------------------------~~~E~~~l~ 55 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKET-------------------------TLRELKMLR 55 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhh-------------------------HHHHHHHHH
Confidence 4688999999999999999999999999999988643211 1112 234699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++..++..|+||||++++.+..+... ...+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~ 134 (287)
T cd07848 56 TLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134 (287)
T ss_pred hCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 99999999999999999999999999998877655543 34589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||+++....... .......++..|+|||++.+..|
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 178 (287)
T cd07848 135 HNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPY 178 (287)
T ss_pred CCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCC
Confidence 99988 99999987643221 12223458999999999977654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=239.10 Aligned_cols=170 Identities=20% Similarity=0.290 Sum_probs=139.3
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CCCce
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHNV 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 564 (681)
+.||+|+||.||++.+..+++.+|+|.+.+......... + .+.+|+.++..+ +||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~-~---------------------~~~~e~~~~~~~~~~~~i 58 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDI-D---------------------WVQTEKHVFEQASSNPFL 58 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHH-H---------------------HHHHHHHHHHhhcCCCCE
Confidence 469999999999999999999999999875322111110 0 112457788777 79999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+.+++++...+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl 137 (327)
T cd05617 59 VGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKL 137 (327)
T ss_pred eeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEE
Confidence 999999999999999999999999999887543 59999999999999999999999999999999999999999988
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++...... .......||+.|+|||++.+..|
T Consensus 138 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 173 (327)
T cd05617 138 TDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEY 173 (327)
T ss_pred eccccceeccCCC--CceecccCCcccCCHHHHCCCCC
Confidence 9999998543221 12234568999999999987654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=243.15 Aligned_cols=168 Identities=26% Similarity=0.435 Sum_probs=140.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
...++|+..+.||+|+||.||++++..+++.||+|.+...... ....+ .+|+++
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~E~~~ 125 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQI-------------------------CREIEI 125 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHH-------------------------HHHHHH
Confidence 3457888899999999999999999999999999998654322 22223 345999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
|+.++|+||+++++++..++.+++||||+++|+|.+.. ..++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 126 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 200 (353)
T PLN00034 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLL 200 (353)
T ss_pred HHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEE
Confidence 99999999999999999999999999999999986532 3567788899999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+++++.+ +|||+++...... .......||..|+|||++.
T Consensus 201 l~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 201 INSAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERIN 241 (353)
T ss_pred EcCCCCEEEcccccceeccccc--ccccccccCccccCccccc
Confidence 9999988 9999998765322 1122356899999999974
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=241.79 Aligned_cols=166 Identities=27% Similarity=0.417 Sum_probs=139.1
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
.|...+++|.|+||.||+|...++++.+|||++....... =+|+.+|+.++
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-----------------------------nrEl~im~~l~ 75 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-----------------------------NRELQIMRKLD 75 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-----------------------------cHHHHHHHhcC
Confidence 3666789999999999999999999999999885432211 14699999999
Q ss_pred CCceeeEEEEEEeC--C---eEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 561 HHNVIRFIGVLYKD--R---KLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 561 HpnIV~l~g~~~~~--~---~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
|||||+|.-+|... . .+.|||||||. +|.++++. .+..++.-.++-++.||++||.|||+.||+||||||.
T Consensus 76 HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPq 154 (364)
T KOG0658|consen 76 HPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQ 154 (364)
T ss_pred CcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChh
Confidence 99999998888643 2 45699999976 99998874 2456888899999999999999999999999999999
Q ss_pred cEEEecC-CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 633 NCLVREV-GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 633 NILl~~~-g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|+|+|.+ |.. +|||-|+.+..+.+... ...|..|.|||++.+..
T Consensus 155 NlLvD~~tg~LKicDFGSAK~L~~~epniS---YicSRyYRaPELifga~ 201 (364)
T KOG0658|consen 155 NLLVDPDTGVLKICDFGSAKVLVKGEPNIS---YICSRYYRAPELIFGAT 201 (364)
T ss_pred eEEEcCCCCeEEeccCCcceeeccCCCcee---EEEeccccCHHHHcCcc
Confidence 9999998 444 99999999987776654 34688999999998864
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=238.82 Aligned_cols=169 Identities=22% Similarity=0.336 Sum_probs=139.4
Q ss_pred ceecccCcEEEEEEEE---cCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 486 PLLGQGFFGQVYRVTH---RETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~---~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
+.||+|+||.||++++ ..+|+.+|+|++.+........ . ...+|+++|+.++||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~-~----------------------~~~~E~~~l~~l~h~ 58 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDR-V----------------------RTKMERDILAEVNHP 58 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhH-H----------------------HHHHHHHHHHhCCCC
Confidence 5799999999999886 4678999999986532211110 0 123568999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
||+++++++..++.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 59 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 137 (318)
T cd05582 59 FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 137 (318)
T ss_pred CcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcE
Confidence 99999999999999999999999999999997643 58999999999999999999999999999999999999999988
Q ss_pred --EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 --FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 --~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++...... .......|++.|+|||++.+..|
T Consensus 138 kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~ 175 (318)
T cd05582 138 KLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGH 175 (318)
T ss_pred EEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCC
Confidence 9999998654332 12234568999999999876543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-27 Score=249.19 Aligned_cols=175 Identities=26% Similarity=0.382 Sum_probs=150.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
...|...+.||+|.||.||||.+..+++.||+|++.-...+..-+. +..|+.+|..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIed------------------------iqqei~~Ls~ 67 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIED------------------------IQQEISVLSQ 67 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHH------------------------HHHHHHHHHh
Confidence 3456667889999999999999999999999999854322221111 1235999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++++||.++|+.|..+..+|++|||+.||++.++|+... .+++..+.-++++++.||.|||+++.+|||||+.|||+..
T Consensus 68 ~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~ 146 (467)
T KOG0201|consen 68 CDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSE 146 (467)
T ss_pred cCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhcceecccccccceeEec
Confidence 999999999999999999999999999999999998643 4588888889999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|.+ +|||.+-.+....... .++.||+.||||||+.+..|
T Consensus 147 ~g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y 188 (467)
T KOG0201|consen 147 SGDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGY 188 (467)
T ss_pred cCcEEEEecceeeeeechhhcc--ccccccccccchhhhccccc
Confidence 9998 9999999888655333 56889999999999998776
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=220.23 Aligned_cols=173 Identities=28% Similarity=0.402 Sum_probs=150.0
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
+|...+.||+|.||+|||++.+++++.||+|.+...+. .....-..+||+-+|+.++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-----------------------degvpssalreicllkelk 59 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-----------------------DEGVPSSALREICLLKELK 59 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-----------------------CCCCcHHHHHHHHHHHHhh
Confidence 45667889999999999999999999999998854221 1122334567799999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|.|||+++++...++.+-+|+|||.. +|.++....+..++.+.+.+++.|+++||.|+|++++.||||||.|.||+.+|
T Consensus 60 hknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng 138 (292)
T KOG0662|consen 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG 138 (292)
T ss_pred hcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC
Confidence 99999999999999999999999954 99999988777899999999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.. +||||||.+... ..-+.....|..|..|.+|.+.+
T Consensus 139 elkladfglarafgip--vrcysaevvtlwyrppdvlfgak 177 (292)
T KOG0662|consen 139 ELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_pred cEEecccchhhhcCCc--eEeeeceeeeeeccCcceeeeee
Confidence 98 999999988753 34556677899999999998764
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-26 Score=245.23 Aligned_cols=179 Identities=22% Similarity=0.288 Sum_probs=152.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...+.|..-++||+|+||.||-++.+.||+-||+|.+.+. .++.++.+. ..++|-.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KK-------RiKkr~ge~---------------maLnEk~iL 239 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKK-------RIKKRKGET---------------MALNEKQIL 239 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHH-------HHHHhhhhH---------------HhhHHHHHH
Confidence 3345677788999999999999999999999999977321 122222211 235678899
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
..++.+.||.+-.+|++.+.++|||..|.||+|...|.+.+ ..+++..++.++.+|+.||++||+.+||.|||||+|||
T Consensus 240 ~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNIL 319 (591)
T KOG0986|consen 240 EKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENIL 319 (591)
T ss_pred HHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhhee
Confidence 99999999999999999999999999999999998887754 35999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|+.|.+ +|.|||-.+....+.. ..+||.+|||||++..+.|
T Consensus 320 LDd~GhvRISDLGLAvei~~g~~~~---~rvGT~GYMAPEvl~ne~Y 363 (591)
T KOG0986|consen 320 LDDHGHVRISDLGLAVEIPEGKPIR---GRVGTVGYMAPEVLQNEVY 363 (591)
T ss_pred eccCCCeEeeccceEEecCCCCccc---cccCcccccCHHHHcCCcc
Confidence 9999999 9999999887655433 3589999999999998877
|
|
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-27 Score=241.64 Aligned_cols=171 Identities=23% Similarity=0.411 Sum_probs=149.1
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
-|.+.+.||+|+||.|||+.|+++|+++|||++.-.. ...+..+ |+.+|+..+
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIK-------------------------EISIMQQC~ 86 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIK-------------------------EISIMQQCK 86 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHH-------------------------HHHHHHHcC
Confidence 3567788999999999999999999999999885321 2233344 499999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
.|++|++||.|.....+|+|||||..|+..|+++.+++++.+.++..++++.+.||+|||...-||||||..|||++.+|
T Consensus 87 S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G 166 (502)
T KOG0574|consen 87 SKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG 166 (502)
T ss_pred CchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc
Confidence 99999999999999999999999999999999999889999999999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||.|-.+.... ..-.+..||+.||||||+..-.|
T Consensus 167 ~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY 206 (502)
T KOG0574|consen 167 IAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGY 206 (502)
T ss_pred hhhhhhccccchhhhhH--HhhCccccCcccccHHHHHHhcc
Confidence 88 9999998765422 22334569999999999976655
|
|
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-27 Score=253.87 Aligned_cols=165 Identities=29% Similarity=0.391 Sum_probs=145.3
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
|..++.||.|+||.||-+++..+.++||||++.-... +.+..+++ |+..|+.
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlK-------------------------EVrFL~~ 82 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILK-------------------------EVRFLRQ 82 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHH-------------------------HHHHHHh
Confidence 5567889999999999999999999999999865443 33444444 4999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|||++.+.|+|..+...||||||| -|+-.|++.-..+++.+..+..|..+.+.||.|||+.+.||||||+.|||+.+
T Consensus 83 l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse 161 (948)
T KOG0577|consen 83 LRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSE 161 (948)
T ss_pred ccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecC
Confidence 99999999999999999999999999 56888888777778999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.|.+ +|||-|.+... ..+++|||.||||||+..+
T Consensus 162 ~g~VKLaDFGSAsi~~P------AnsFvGTPywMAPEVILAM 197 (948)
T KOG0577|consen 162 PGLVKLADFGSASIMAP------ANSFVGTPYWMAPEVILAM 197 (948)
T ss_pred CCeeeeccccchhhcCc------hhcccCCccccchhHheec
Confidence 9999 99999977642 3457899999999998654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=239.90 Aligned_cols=166 Identities=25% Similarity=0.366 Sum_probs=134.5
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC---CCCce
Q psy5063 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL---HHHNV 564 (681)
Q Consensus 488 LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpnI 564 (681)
||+|+||.||+|++..+++.||+|.+.+........... ...|..++... +||||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~----------------------~~~e~~~l~~~~~~~~p~i 58 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAH----------------------TIGERNILVRTLLDESPFI 58 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHH----------------------HHHHHHHHHHhccCCCCcC
Confidence 799999999999999999999999986432221111111 12345555544 79999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++++..++..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl 137 (330)
T cd05586 59 VGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIAL 137 (330)
T ss_pred cceEEEEecCCeEEEEEcCCCCChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEE
Confidence 999999999999999999999999999987644 58999999999999999999999999999999999999999988
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|||+++...... .......||..|||||++.+.
T Consensus 138 ~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~ 171 (330)
T cd05586 138 CDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDE 171 (330)
T ss_pred ecCCcCcCCCCCC--CCccCccCCccccCHHHHcCC
Confidence 9999997643222 112235689999999998654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=267.59 Aligned_cols=179 Identities=30% Similarity=0.454 Sum_probs=151.4
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCe-----EEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGE-----VMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~-----~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
+.....++++.||+|.||.||+|...+... .||+|.+.+. +.+....|++|
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~E----------------------- 745 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKE----------------------- 745 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHH-----------------------
Confidence 557788999999999999999999765433 4899998764 45566667776
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP------GQPLPWGQRVNFARDIAAGMTYLHSMNL 624 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~------~~~l~~~~~~~i~~QIa~gL~yLHs~~I 624 (681)
..+|+.++|||||+++|++.+....++++|||+||||..||++. ...+.....+.++.|||+||.||+++++
T Consensus 746 --a~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~f 823 (1025)
T KOG1095|consen 746 --ALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHF 823 (1025)
T ss_pred --HHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCC
Confidence 88999999999999999999999999999999999999999886 5678899999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 625 IHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||..+||||++...+ +||||||.+.....|...........|||||.|.+..|
T Consensus 824 vHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF 881 (1025)
T KOG1095|consen 824 VHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF 881 (1025)
T ss_pred cCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhccc
Confidence 999999999999999887 99999995554443333222234578999999987554
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=245.40 Aligned_cols=170 Identities=19% Similarity=0.249 Sum_probs=143.6
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+...+|...+.||+|+||.||++.+..+++.||+|.... ..+ .+|+++|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~-------------------------~~E~~il 137 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGT-------------------------ATEAHIL 137 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhh-------------------------HHHHHHH
Confidence 455789999999999999999999999999999996421 112 3469999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++..+...++|||++. ++|..++.... .+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 138 ~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll 215 (391)
T PHA03212 138 RAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI 215 (391)
T ss_pred HhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE
Confidence 99999999999999999999999999995 78988887643 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++.+ +|||+|+...... ........||+.|+|||++.+..|
T Consensus 216 ~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 260 (391)
T PHA03212 216 NHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPY 260 (391)
T ss_pred cCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCC
Confidence 999988 9999997543211 112233569999999999987665
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=238.01 Aligned_cols=170 Identities=19% Similarity=0.338 Sum_probs=139.2
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|++.+.||+|+||.||+|++..+++.||+|++.... ...... +.+|+++|+.
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~~E~~~l~~ 55 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR-------------------------ILREIKLLRL 55 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHH-------------------------HHHHHHHHHh
Confidence 4788899999999999999999999999999885321 111112 2356999999
Q ss_pred CCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 559 LHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++||||+++++++... ..+|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 56 l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 133 (338)
T cd07859 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKN 133 (338)
T ss_pred CCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 9999999999988643 35899999995 68999987654 58999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~ 677 (681)
||++.+|.+ +|||+++......... ......+|+.|+|||++.+
T Consensus 134 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 134 ILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred eEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc
Confidence 999999988 9999998754332221 2233568999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=238.15 Aligned_cols=170 Identities=24% Similarity=0.307 Sum_probs=138.8
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CCCce
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHNV 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpnI 564 (681)
+.||+|+||.||++++..+++.||+|.+.+.......... ...+|+++++.+ +||||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~----------------------~~~~e~~il~~~~~h~~i 58 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVE----------------------CTMTEKRVLALAGKHPFL 58 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHH----------------------HHHHHHHHHHhccCCCCc
Confidence 4699999999999999999999999998753211111110 112357778777 79999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++++...+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+++++.+
T Consensus 59 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl 137 (318)
T cd05570 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKI 137 (318)
T ss_pred cceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEe
Confidence 999999999999999999999999999987654 59999999999999999999999999999999999999999988
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++....... ......|+..|+|||++.+..|
T Consensus 138 ~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~ 173 (318)
T cd05570 138 ADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPY 173 (318)
T ss_pred cccCCCeecCcCCC--cccceecCccccCHHHhcCCCC
Confidence 99999976432221 1223458999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=233.10 Aligned_cols=175 Identities=23% Similarity=0.289 Sum_probs=149.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC----HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD----EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~----~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
..|...++||+|..+.|.++.++.+|+.+|+|++.... .+...+.+.+ ..+|+.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~Ea---------------------T~~Ev~I 75 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREA---------------------TRQEISI 75 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHH---------------------HHHHHHH
Confidence 46777889999999999999999999999999985422 1122222222 2568999
Q ss_pred HHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 LRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
|+++ .||+|+++.++|.++..+++|+|+|+.|.|+|+|...- .+++....++|+|++.|++|||.++||||||||+||
T Consensus 76 LRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENI 154 (411)
T KOG0599|consen 76 LRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENI 154 (411)
T ss_pred HHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhe
Confidence 9998 79999999999999999999999999999999998754 489999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|++++.++ +|||+|..+..+.. .+..+||++|.|||.+.-.-
T Consensus 155 Llddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m 198 (411)
T KOG0599|consen 155 LLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSM 198 (411)
T ss_pred eeccccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeec
Confidence 99999998 99999998875443 34478999999999986543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=245.74 Aligned_cols=184 Identities=24% Similarity=0.320 Sum_probs=147.8
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCC-----CeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRET-----GEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t-----g~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
...+.+..++|++++.||+|+||.||+|++... +..||+|.+...... ....+
T Consensus 29 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~--------------------- 87 (400)
T cd05105 29 DSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQAL--------------------- 87 (400)
T ss_pred CCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHH---------------------
Confidence 456677888999999999999999999987533 347999988643322 22233
Q ss_pred cccchHHHHHHHhCC-CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------------------
Q psy5063 546 NLHCFSQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--------------------------- 597 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--------------------------- 597 (681)
.+|+++|+.++ ||||+++++++...+..||||||+++|+|.+++....
T Consensus 88 ----~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (400)
T cd05105 88 ----MSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADEST 163 (400)
T ss_pred ----HHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccc
Confidence 34599999996 9999999999999999999999999999999875321
Q ss_pred --------------------------------------------------------------------CCCCHHHHHHHH
Q psy5063 598 --------------------------------------------------------------------QPLPWGQRVNFA 609 (681)
Q Consensus 598 --------------------------------------------------------------------~~l~~~~~~~i~ 609 (681)
..+++..+..++
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~ 243 (400)
T cd05105 164 RSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFT 243 (400)
T ss_pred cchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHH
Confidence 237788889999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 610 ~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.|++.||.|||+++|+||||||+|||++.++.+ +|||+++...............++..|||||++.+..|
T Consensus 244 ~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 316 (400)
T cd05105 244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY 316 (400)
T ss_pred HHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC
Confidence 999999999999999999999999999998877 99999987654333322233446778999999876543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=238.79 Aligned_cols=169 Identities=30% Similarity=0.420 Sum_probs=139.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
..++.+.+.||+|.||.||+|.++ |+.||||++...++.. +.+| .||---..
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~S---WfrE-----------------------tEIYqTvm 261 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERS---WFRE-----------------------TEIYQTVM 261 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEecccchhh---hhhH-----------------------HHHHHHHH
Confidence 468889999999999999999998 9999999997665443 3333 13444456
Q ss_pred CCCCceeeEEEEEEeC----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------Cccc
Q psy5063 559 LHHHNVIRFIGVLYKD----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--------NLIH 626 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~--------~IIH 626 (681)
|+|+||+.|++.-..+ .++|||+||.+.|||+|||... .++....++++..+|.||+|||.. .|.|
T Consensus 262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH 339 (513)
T KOG2052|consen 262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH 339 (513)
T ss_pred hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence 7999999999886554 3799999999999999999873 489999999999999999999963 4999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccc--eeeeecCCCccccchhhccC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPY--TLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~--~~~~~~~gt~~Y~APEvL~~ 677 (681)
||||+.||||.++|.. +|+|||-....+... ......+||..|||||+|..
T Consensus 340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 9999999999999998 999999888764311 12234669999999999965
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=238.55 Aligned_cols=173 Identities=23% Similarity=0.408 Sum_probs=146.2
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
..++|+..+.||+|+||.||++.+..+++.+|+|.+... .......+. +|+++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~-------------------------~E~~~l 57 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII-------------------------RELQVL 57 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHH-------------------------HHHHHH
Confidence 457899999999999999999999999999999987643 222222333 459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~-~IIHRDLKp~NIL 635 (681)
+.++||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 58 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nil 136 (333)
T cd06650 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136 (333)
T ss_pred HHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEE
Confidence 99999999999999999999999999999999999997644 589999999999999999999985 7999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+|.+ +|||+++...... .....++..|+|||++.+..|
T Consensus 137 i~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 179 (333)
T cd06650 137 VNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY 179 (333)
T ss_pred EcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCC
Confidence 9999988 9999997654321 122458999999999977654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.5e-27 Score=269.91 Aligned_cols=176 Identities=25% Similarity=0.336 Sum_probs=152.4
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
+..+||.+.++||+|+||.|..++++.|+++||+|++.+...- ....+..| |-.
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~E------------------------ERD 127 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFRE------------------------ERD 127 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHH------------------------HhH
Confidence 5578999999999999999999999999999999998663211 12222222 467
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+|..-+.+-|+.|+-+|.+++++|+|||||+||||..+|.+.. .+|+..+.+|+..|+.||+-||++|+|||||||+||
T Consensus 128 imv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNv 206 (1317)
T KOG0612|consen 128 IMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNV 206 (1317)
T ss_pred HHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCccee
Confidence 8888889999999999999999999999999999999999877 799999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||..|.+ +|||-+-.+..+. ...-...+|||.|.+||+|...
T Consensus 207 Lld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~ 251 (1317)
T KOG0612|consen 207 LLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQ 251 (1317)
T ss_pred EecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhh
Confidence 99999999 9999887766443 3444677899999999999653
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=229.93 Aligned_cols=168 Identities=24% Similarity=0.358 Sum_probs=138.1
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeE
Q psy5063 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRF 567 (681)
Q Consensus 488 LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l 567 (681)
||+|+||.||+++.+.+|+.||+|.+......... .+ .....|+++|+.++||||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~---~~-------------------~~~~~E~~il~~l~hp~i~~~ 58 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS---GE-------------------KMALLEKEILEKVNSPFIVNL 58 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcch---hh-------------------HHHHHHHHHHHhcCCCcEEEE
Confidence 69999999999999999999999988542211100 00 011346899999999999999
Q ss_pred EEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EE
Q psy5063 568 IGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FD 644 (681)
Q Consensus 568 ~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~D 644 (681)
++++.++...++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+++++.+ +|
T Consensus 59 ~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~D 138 (277)
T cd05607 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSD 138 (277)
T ss_pred EEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEee
Confidence 99999999999999999999999887543 3358899999999999999999999999999999999999999988 99
Q ss_pred eeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 645 FHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 645 FGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++....... ......++..|+|||++.+..|
T Consensus 139 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 171 (277)
T cd05607 139 LGLAVELKDGK---TITQRAGTNGYMAPEILKEEPY 171 (277)
T ss_pred ceeeeecCCCc---eeeccCCCCCccCHHHHccCCC
Confidence 99998765432 1233568999999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-25 Score=242.09 Aligned_cols=169 Identities=25% Similarity=0.399 Sum_probs=144.1
Q ss_pred ecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 484 ~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
..++||+|.||+||-|.++.+|+.||||.+.+.. ...+..+. +|+++|+.++|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR-------------------------~EVaILq~l~H 622 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLR-------------------------NEVAILQNLHH 622 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHH-------------------------HHHHHHHhcCC
Confidence 3578999999999999999999999999996532 22222222 35999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
|.||.|...|++.+++++|||-+.|.-|..+|......+++...+.++.||+.||.|||.++|+|.||||+|||+.....
T Consensus 623 PGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~ 702 (888)
T KOG4236|consen 623 PGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASP 702 (888)
T ss_pred CCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCC
Confidence 99999999999999999999999776677777766667999999999999999999999999999999999999987643
Q ss_pred e-----EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 642 G-----FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 642 ~-----~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
- +|||+||+..... .-++..||+.|.|||+|+.+.|
T Consensus 703 FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGy 743 (888)
T KOG4236|consen 703 FPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGY 743 (888)
T ss_pred CCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccc
Confidence 2 9999999987532 2345679999999999999887
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.9e-25 Score=229.94 Aligned_cols=171 Identities=23% Similarity=0.290 Sum_probs=142.8
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
|+..++||+|+||.||++.+..+++.+|+|.+...... ....+ ..|+.+++.
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~-------------------------~~E~~il~~ 56 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA-------------------------LNEKQILEK 56 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHH-------------------------HHHHHHHHh
Confidence 66778899999999999999999999999988643211 11112 345899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++|+||+.+++.+.+++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+||||||+|||++
T Consensus 57 l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~ 136 (285)
T cd05630 57 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD 136 (285)
T ss_pred CCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC
Confidence 99999999999999999999999999999999988543 23589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||++........ .....|+..|||||++.+..|
T Consensus 137 ~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~ 178 (285)
T cd05630 137 DHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERY 178 (285)
T ss_pred CCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCC
Confidence 99888 99999976543221 123468999999999977654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-25 Score=228.83 Aligned_cols=174 Identities=22% Similarity=0.263 Sum_probs=142.8
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
|+..+.||+|+||.||++.+..+++.+|+|.+........... . ...+|+++|+.++|
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~-~---------------------~~~~E~~il~~l~~ 59 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGE-S---------------------MALNEKQILEKVNS 59 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHH-H---------------------HHHHHHHHHHHcCC
Confidence 5667889999999999999999999999998854321111100 0 12346999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
+||+.+++.+..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||+++++
T Consensus 60 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~ 139 (285)
T cd05632 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG 139 (285)
T ss_pred cCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC
Confidence 99999999999999999999999999999888643 33599999999999999999999999999999999999999998
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||+++...... ......|+..|+|||++.+..|
T Consensus 140 ~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~ 178 (285)
T cd05632 140 HIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRY 178 (285)
T ss_pred CEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCC
Confidence 88 9999997654322 1223468999999999876554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.9e-25 Score=232.71 Aligned_cols=172 Identities=27% Similarity=0.414 Sum_probs=143.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|...+.||+|+||.||+|+++.+++.+|+|.+...... .... ..+|+++++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~-------------------------~~~E~~~l~ 59 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT-------------------------AIREVSLLK 59 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchh-------------------------HHHHHHHHH
Confidence 46799999999999999999999999999999988643211 1111 234699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++..++..++||||+++ +|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 60 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~ 138 (309)
T cd07872 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN 138 (309)
T ss_pred hCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 99999999999999999999999999975 88888876655689999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.++.+ +|||+++...... .......++..|+|||++.+.
T Consensus 139 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 179 (309)
T cd07872 139 ERGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGS 179 (309)
T ss_pred CCCCEEECccccceecCCCc--cccccccccccccCCHHHhCC
Confidence 99988 9999998654322 122234578999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-25 Score=248.37 Aligned_cols=177 Identities=20% Similarity=0.251 Sum_probs=145.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|.+.+.||+|+||.||++++..+++.||+|.+.... ......+ .+|+.+|
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~-------------------------~~Ei~~l 85 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA-------------------------QAEVCCL 85 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHH-------------------------HHHHHHH
Confidence 468999999999999999999999999999999986432 2222222 2458899
Q ss_pred HhCCCCceeeEEEEEEeCC--------eEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy5063 557 RSLHHHNVIRFIGVLYKDR--------KLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLI 625 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~--------~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~II 625 (681)
..++|+||+++++.+.... .+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+
T Consensus 86 ~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~Ii 165 (496)
T PTZ00283 86 LNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMI 165 (496)
T ss_pred hcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 9999999999988775432 378999999999999998642 34689999999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 626 HRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||||||+|||++.++.+ +|||+++.+.............||+.|+|||++.+..|
T Consensus 166 HrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 222 (496)
T PTZ00283 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY 222 (496)
T ss_pred cCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCC
Confidence 99999999999999988 99999987654332222334568999999999987665
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=241.49 Aligned_cols=174 Identities=24% Similarity=0.341 Sum_probs=151.6
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
=|.+.+.||+|.|.+|-+++|.-||+.||||++.+...+.... -+.+.|+..|+.++
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st-----------------------~hlfqEVRCMKLVQ 75 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST-----------------------GHLFQEVRCMKLVQ 75 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh-----------------------hHHHHHHHHHHHhc
Confidence 4667789999999999999999999999999997644332211 12344599999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec-C
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-V 639 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~-~ 639 (681)
|||||+||++...+..+|||+|+-.+|+|+||+.+....+.+..+.+|+.||+.|+.|+|...+|||||||+|+.+-+ .
T Consensus 76 HpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl 155 (864)
T KOG4717|consen 76 HPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL 155 (864)
T ss_pred CcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec
Confidence 999999999999999999999999999999999888778999999999999999999999999999999999998765 4
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.+ .|||++..+..... ..+.+|+..|-|||+|.+..|
T Consensus 156 GlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsY 195 (864)
T KOG4717|consen 156 GLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSY 195 (864)
T ss_pred CceEeeeccccccCCCcch---hhcccchhhccCchhhhcCcc
Confidence 666 99999988875443 445899999999999999988
|
|
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.9e-26 Score=251.90 Aligned_cols=172 Identities=24% Similarity=0.435 Sum_probs=142.8
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.|...+.||+|+||.||+|+++.+|+.+|||.+.+.. ....+.. -+|+++|+++
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~-------------------------~~EieilkKL 68 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERW-------------------------CREIEILKKL 68 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHH-------------------------HHHHHHHHHc
Confidence 4556678999999999999999999999999886532 1112222 3569999999
Q ss_pred CCCceeeEEEEEEeCC------eEEEEEeccCCCCHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 560 HHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~------~l~LV~Ey~~gGsL~~~L~~~--~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+|+|||+++++=.+.. ...+|||||.||||+.+|++. ...+++.+.+.+..++..||.|||++||+||||||
T Consensus 69 nh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP 148 (732)
T KOG4250|consen 69 NHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKP 148 (732)
T ss_pred CchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCC
Confidence 9999999998865443 567999999999999999864 34599999999999999999999999999999999
Q ss_pred CcEEEec--CCCe----EEeeeeeEeeecccceeeeecCCCccccchhhccC-CCC
Q psy5063 632 QNCLVRE--VGSG----FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK-ASF 680 (681)
Q Consensus 632 ~NILl~~--~g~~----~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~-~~Y 680 (681)
.||++-. +|+. +|||.||....+. .+.+..||..|++||++.. +.|
T Consensus 149 ~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y 201 (732)
T KOG4250|consen 149 GNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKY 201 (732)
T ss_pred CcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCc
Confidence 9999864 4544 9999999887655 4566889999999999985 444
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=224.62 Aligned_cols=176 Identities=27% Similarity=0.381 Sum_probs=144.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcCC---CeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRET---GEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~t---g~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.++|+..+.||+|+||.||+|.+..+ ...+|+|.+.... ......+.. |+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~-------------------------e~~ 57 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLT-------------------------EAS 57 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHH-------------------------HHH
Confidence 46789999999999999999998654 4578999875432 223333443 488
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+++.++||||+++++++...+..+++|||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 58 IMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred HHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 99999999999999999999999999999999999999987655799999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|+++++.+ +|||+++...............++..|+|||.+.+..
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 184 (266)
T cd05033 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184 (266)
T ss_pred EEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCC
Confidence 99999887 9999999875222111112233567899999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.9e-25 Score=223.44 Aligned_cols=170 Identities=27% Similarity=0.416 Sum_probs=138.1
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCce
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNV 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 564 (681)
+.||+|+||.||+|++..+++.+|+|.+... ..+....+.+ |+++++.++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~-------------------------e~~~l~~l~h~~i 55 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ-------------------------EARILKQYSHPNI 55 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHH-------------------------HHHHHHhCCCCCc
Confidence 3699999999999999999999999987543 2333333443 4889999999999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++++...+..++||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl 135 (252)
T cd05084 56 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKI 135 (252)
T ss_pred ceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEE
Confidence 999999999999999999999999999997655568999999999999999999999999999999999999999987
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+++................+..|+|||.+.+..|
T Consensus 136 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 173 (252)
T cd05084 136 SDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173 (252)
T ss_pred CccccCcccccccccccCCCCCCceeecCchhhcCCCC
Confidence 99999876542211111111123456999999876543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-26 Score=233.95 Aligned_cols=182 Identities=24% Similarity=0.304 Sum_probs=155.6
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
......++|..+++||+|.||+|.+++.+.+|+.||+|++++.-..... ...|.+.|-
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakd----------------------EVAHTlTE~ 219 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKD----------------------EVAHTLTEN 219 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehH----------------------HhhhhhhHH
Confidence 3445678999999999999999999999999999999988653211111 122345568
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+|+..+||.+..|-..|...+++++||||+.||.|+..|.... .+++..+..+..+|+.||.|||+++||.||||.+|
T Consensus 220 RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLEN 298 (516)
T KOG0690|consen 220 RVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLEN 298 (516)
T ss_pred HHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhh
Confidence 89999999999999999999999999999999999999887644 59999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|+|.+|.+ +||||.+....+. ....+++||+.|.|||||.+..|
T Consensus 299 LlLDkDGHIKitDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDY 345 (516)
T KOG0690|consen 299 LLLDKDGHIKITDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDY 345 (516)
T ss_pred heeccCCceEeeecccchhccccc--ceeccccCChhhcCchhhccccc
Confidence 999999998 9999998765433 34467899999999999988776
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=228.04 Aligned_cols=180 Identities=22% Similarity=0.336 Sum_probs=142.3
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeE----EEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEV----MVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~----vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
+++..++|+..+.||+|+||.||+|.+..+++. +++|.+..... .....+
T Consensus 2 ~~~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~------------------------- 56 (279)
T cd05111 2 RILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI------------------------- 56 (279)
T ss_pred CcCCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHH-------------------------
Confidence 456678999999999999999999999877764 56666532211 111122
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
..|+..++.++||||+++++++. +...++++||+++|+|.+++......+++..+..++.|++.||.|||+++++||||
T Consensus 57 ~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dl 135 (279)
T cd05111 57 TDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNL 135 (279)
T ss_pred HHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecccc
Confidence 23477889999999999999875 45688999999999999999876667999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||+++++.+ +|||+++...............++..|+|||++.+..|
T Consensus 136 kp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 188 (279)
T cd05111 136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188 (279)
T ss_pred CcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCc
Confidence 9999999999987 99999987653322222223446778999999876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=226.18 Aligned_cols=179 Identities=26% Similarity=0.370 Sum_probs=144.5
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCe----EEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGE----VMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~----~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
++..++|+..+.||+|+||.||+|++..+++ .||+|.+.... ......+.+
T Consensus 3 ~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~------------------------ 58 (279)
T cd05109 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILD------------------------ 58 (279)
T ss_pred ccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHH------------------------
Confidence 4667899999999999999999999877776 47999886432 222333333
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+.+++.++||||+++++++.. ...++++||+++|+|.+++......+++..+..++.|++.||.|||+++|+|||||
T Consensus 59 -e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlk 136 (279)
T cd05109 59 -EAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLA 136 (279)
T ss_pred -HHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 4888999999999999999875 45789999999999999998755569999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||+++++.+ +|||+++...............++..|+|||++.+..|
T Consensus 137 p~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (279)
T cd05109 137 ARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188 (279)
T ss_pred cceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCC
Confidence 999999998888 99999987754322212222334678999999876543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-25 Score=232.84 Aligned_cols=173 Identities=23% Similarity=0.332 Sum_probs=140.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
..|...+.||+|+||.|..+.++.+|+.||+|++.+.- ...... .+.+||+.+|+.+
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~a---------------------kRtlRElklLr~~ 78 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDA---------------------KRTLRELKLLRHL 78 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHH---------------------HHHHHHHHHHHHh
Confidence 34555789999999999999999999999999885321 111111 1236779999999
Q ss_pred CCCceeeEEEEEEe-----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 560 HHHNVIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 560 ~HpnIV~l~g~~~~-----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+|+||+.+.+++.. -+.+|+|+|+| +.+|.++++... .++...+..++.||++||.|+|+.+|+||||||.|+
T Consensus 79 ~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNl 156 (359)
T KOG0660|consen 79 RHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNL 156 (359)
T ss_pred cCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcccccccccchhhe
Confidence 99999999999876 35799999999 569999998753 499999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|++.+... +||||||...............-|..|.|||++..
T Consensus 157 l~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~ 201 (359)
T KOG0660|consen 157 LLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN 201 (359)
T ss_pred eeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhc
Confidence 99999888 99999999864311222234457899999999743
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=255.02 Aligned_cols=176 Identities=22% Similarity=0.263 Sum_probs=144.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
++|+..+.||+|+||.||+|++..+++.||+|++.... ....+.+ .+|++++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rf-------------------------lrEi~IL 56 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRF-------------------------LREAKIA 56 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHH-------------------------HHHHHHH
Confidence 57899999999999999999999999999999986421 1122233 3459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP----------GQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~----------~~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
+.++||||+++++++.+++..|+||||++||+|.+++... ...+++..+..++.||+.||+|||+++|+|
T Consensus 57 s~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIH 136 (932)
T PRK13184 57 ADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLH 136 (932)
T ss_pred HhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 9999999999999999999999999999999999998631 123567788899999999999999999999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeeccc----------------ceeeeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVP----------------YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~----------------~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||+|||++.+|.+ +|||+++....... ........||+.|||||++.+..|
T Consensus 137 RDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~ 208 (932)
T PRK13184 137 RDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA 208 (932)
T ss_pred cCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC
Confidence 9999999999999988 99999987622110 001112358999999999987654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-25 Score=224.07 Aligned_cols=169 Identities=28% Similarity=0.470 Sum_probs=144.6
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
|+.++.||+|+||.||++.+..+++.+|+|.+............. .+|+.+++.++|
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~-----------------------~~e~~~~~~l~~ 57 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREEN-----------------------IREIKILRRLRH 57 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHH-----------------------HHHHHHHHHHTB
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchh-----------------------hhhhhccccccc
Confidence 678899999999999999999999999999998765544332111 235889999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
|||+++++++..+...++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||+++++.
T Consensus 58 ~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~ 136 (260)
T PF00069_consen 58 PNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE 136 (260)
T ss_dssp TTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE
T ss_pred cccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999983 245899999999999999999999999999999999999999888
Q ss_pred e--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 642 G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+ +|||++.... ..........++..|+|||++.
T Consensus 137 ~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 137 VKLIDFGSSVKLS--ENNENFNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp EEESSGTTTEEST--STTSEBSSSSSSGGGSCHHHHT
T ss_pred ccccccccccccc--cccccccccccccccccccccc
Confidence 8 8999998652 1123334566899999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=225.71 Aligned_cols=177 Identities=32% Similarity=0.476 Sum_probs=142.8
Q ss_pred CCCeeecceecccCcEEEEEEEE----cCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTH----RETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~----~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
..+|+..+.||+|+||.||++.. ..+++.||+|.+........+.+.+ |++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~-------------------------e~~ 57 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER-------------------------EIE 57 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHH-------------------------HHH
Confidence 45788899999999999999984 4568899999987655444444444 489
Q ss_pred HHHhCCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 555 VLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
+++.++||||+++++++.. ...+++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus 58 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ 137 (284)
T cd05081 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137 (284)
T ss_pred HHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence 9999999999999998754 35789999999999999999765556899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceee-eecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLF-ILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~-~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++++.+ +|||+++........... ....++..|+|||++.+..|
T Consensus 138 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 188 (284)
T cd05081 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188 (284)
T ss_pred hEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCc
Confidence 9999999988 999999876543322111 11223456999999876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.9e-25 Score=226.96 Aligned_cols=178 Identities=29% Similarity=0.404 Sum_probs=144.1
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCC-----eEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETG-----EVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg-----~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
..++|+..+.||+|+||.||+|.+...+ ..+|+|.+..... .....+. +
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~-------------------------~ 57 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR-------------------------Q 57 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHH-------------------------H
Confidence 3468899999999999999999986655 6899998864332 2222333 3
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHHHHHHHHHHH
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGM 616 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~i~~QIa~gL 616 (681)
|+.+|+.++||||+++++++...+..+++|||+++|+|.+++.... ..+++..+..++.|++.||
T Consensus 58 ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al 137 (283)
T cd05048 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGM 137 (283)
T ss_pred HHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 5899999999999999999999999999999999999999986531 3478889999999999999
Q ss_pred HHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 617 TYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 617 ~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.|||+++++||||||+|||+++++.+ +|||+++.......+.......++..|+|||++.+..|
T Consensus 138 ~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 203 (283)
T cd05048 138 EYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF 203 (283)
T ss_pred HHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC
Confidence 99999999999999999999999887 89999987643322222233446788999999866543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.2e-26 Score=246.28 Aligned_cols=170 Identities=28% Similarity=0.374 Sum_probs=147.1
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
...|.+..+.+..++-||.|+-|.||+|+.+ ++.||||+++. ++| -
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e---------lkE-----------------------T 161 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE---------LKE-----------------------T 161 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh---------hhh-----------------------h
Confidence 4455666666666778999999999999987 88999997632 222 1
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+|+-|++|+||||+.|.|+|.+...++||||||+.|-|..+|+... .+.....+.|..+||.||.|||.+.|||||||+
T Consensus 162 dIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKS 240 (904)
T KOG4721|consen 162 DIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKS 240 (904)
T ss_pred hHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCC
Confidence 3888999999999999999999999999999999999999998754 588899999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
-||||..+..+ +|||.++..... .....++||..|||||+++.++
T Consensus 241 PNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrneP 287 (904)
T KOG4721|consen 241 PNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEP 287 (904)
T ss_pred CceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCC
Confidence 99999998888 999999876543 4456789999999999998875
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=226.72 Aligned_cols=172 Identities=28% Similarity=0.421 Sum_probs=135.0
Q ss_pred CCeeecceecccCcEEEEEEEEcC-CCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRE-TGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~-tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
++|+..+.||+|+||.||+|++.. +++.+|+|.+...... ....+. +|++++
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------------------------~e~~~l 55 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI-------------------------REVAVL 55 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHH-------------------------HHHHHH
Confidence 368888999999999999999854 4688999988543211 111222 235555
Q ss_pred Hh---CCCCceeeEEEEEE-----eCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy5063 557 RS---LHHHNVIRFIGVLY-----KDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 627 (681)
Q Consensus 557 ~~---L~HpnIV~l~g~~~-----~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHR 627 (681)
+. ++||||+++++++. ....+++||||++ ++|.+++... ...+++..+..++.|++.||.|||+++|+||
T Consensus 56 ~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~ 134 (290)
T cd07862 56 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR 134 (290)
T ss_pred HhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence 54 57999999999985 2456999999996 6999988653 3458999999999999999999999999999
Q ss_pred CCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 628 DLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 628 DLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||||+|||++.++.+ +|||+++...... ......+|..|+|||++.+..|
T Consensus 135 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 186 (290)
T cd07862 135 DLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSY 186 (290)
T ss_pred CCCHHHEEEcCCCCEEEccccceEeccCCc---ccccccccccccChHHHhCCCC
Confidence 999999999999988 9999998765321 2223558999999999876554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.7e-25 Score=237.76 Aligned_cols=171 Identities=27% Similarity=0.391 Sum_probs=140.7
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+.++.||+|+||.||++.+..+++.||+|++.... ....+.+ .+|+++|+.
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~~E~~~l~~ 55 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV-------------------------FRELKMLCF 55 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHH-------------------------HHHHHHHHh
Confidence 5778899999999999999999999999999885431 1222222 346999999
Q ss_pred CCCCceeeEEEEEEeCC-----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 559 LHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~-----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++|+||+++++++...+ .+|+||||+. ++|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 56 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~N 133 (372)
T cd07853 56 FKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGN 133 (372)
T ss_pred CCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHH
Confidence 99999999999998776 8999999996 5888887654 359999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||++.++.+ +|||+++....... .......++..|+|||++.+..
T Consensus 134 ili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~ 180 (372)
T cd07853 134 LLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSR 180 (372)
T ss_pred EEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCC
Confidence 999999988 99999987643221 1122345788999999987643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=234.93 Aligned_cols=170 Identities=21% Similarity=0.313 Sum_probs=139.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|+..+.||+|+||.||++.+..+|+.+|+|++.+.. ......+ .+|+.++
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-------------------------~~E~~~l 74 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA-------------------------YRELVLL 74 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHH-------------------------HHHHHHH
Confidence 478999999999999999999999999999999986432 1222222 3458999
Q ss_pred HhCCCCceeeEEEEEEeCC------eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~------~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++.... ..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||+++|+|||||
T Consensus 75 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlk 150 (359)
T cd07876 75 KCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 150 (359)
T ss_pred HhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9999999999999986543 57999999965 66666643 37889999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.+|.+ +|||+++...... ......+|..|+|||++.+..|
T Consensus 151 p~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~ 199 (359)
T cd07876 151 PSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGY 199 (359)
T ss_pred HHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCCCCCchhccCCCC
Confidence 999999999988 9999998654322 1123457899999999987655
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=244.65 Aligned_cols=170 Identities=22% Similarity=0.243 Sum_probs=143.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
...|.+.+.||+|+||.||++.+..+++.||+|.... ..+ .+|+++|+.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~-------------------------~~E~~iL~~ 216 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASS-------------------------VHEARLLRR 216 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCH-------------------------HHHHHHHHH
Confidence 4578889999999999999999999999999995321 111 246999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+||+++++++..++..++|||++. ++|.+++......+++.+++.++.|++.||.|||+++|+||||||+|||++.
T Consensus 217 L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~ 295 (461)
T PHA03211 217 LSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295 (461)
T ss_pred CCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC
Confidence 999999999999999999999999994 7999988765557999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...............||..|||||++.+..|
T Consensus 296 ~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 339 (461)
T PHA03211 296 PEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY 339 (461)
T ss_pred CCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCC
Confidence 9888 99999987654322222223568999999999987654
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=229.47 Aligned_cols=183 Identities=27% Similarity=0.376 Sum_probs=145.3
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEc-------CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHR-------ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLI 544 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-------~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~ 544 (681)
..+.+..++|.+++.||+|+||.||++++. ..+..+|+|.+.... ......+
T Consensus 8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~-------------------- 67 (304)
T cd05101 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-------------------- 67 (304)
T ss_pred CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHH--------------------
Confidence 345566788999999999999999999753 234578999875432 1222223
Q ss_pred ccccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------------CCCCCHHHHHHH
Q psy5063 545 NNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNF 608 (681)
Q Consensus 545 ~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------------~~~l~~~~~~~i 608 (681)
.+|+.+++.+ +||||+++++++..+...|+||||+++|+|.+++... ...+++..+..+
T Consensus 68 -----~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 142 (304)
T cd05101 68 -----VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142 (304)
T ss_pred -----HHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHH
Confidence 3458899999 8999999999999999999999999999999998653 134788889999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 609 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 609 ~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.||+.||.|||++||+||||||+|||++.++.+ +|||+++...............++..|+|||++.+..|
T Consensus 143 ~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 216 (304)
T cd05101 143 TYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY 216 (304)
T ss_pred HHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC
Confidence 9999999999999999999999999999999887 89999987754332222223345678999999876554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=226.25 Aligned_cols=177 Identities=24% Similarity=0.354 Sum_probs=142.8
Q ss_pred cCCCeeecceecccCcEEEEEEEEc----CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHR----ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~----~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..++|+..+.||+|+||.||+|... .++..+|+|.+.... ......+. +|
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~E 57 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQ-------------------------QE 57 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHH-------------------------HH
Confidence 3468889999999999999999853 456789999886432 22223333 35
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC----------------CCCCCHHHHHHHHHHHHHHH
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP----------------GQPLPWGQRVNFARDIAAGM 616 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~----------------~~~l~~~~~~~i~~QIa~gL 616 (681)
+++++.++||||+++++++..+...|+||||+++|+|.+++... ...+++..+..++.|++.||
T Consensus 58 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 137 (283)
T cd05090 58 ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGM 137 (283)
T ss_pred HHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 89999999999999999999999999999999999999998522 12478889999999999999
Q ss_pred HHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 617 TYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 617 ~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.|||+++++||||||+|||+++++.+ +|||+++...............++..|+|||++.+..
T Consensus 138 ~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05090 138 EYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK 202 (283)
T ss_pred HHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC
Confidence 99999999999999999999999888 9999998765433222223344567899999987554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=222.27 Aligned_cols=170 Identities=24% Similarity=0.366 Sum_probs=143.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|++..+++.+|+|.+..........+. +|+.+++.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~-------------------------~e~~~l~~ 62 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQ-------------------------QEIFMVKE 62 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHH-------------------------HHHHHHHh
Confidence 46899999999999999999999999999999988644322222222 35889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+||+++.
T Consensus 63 ~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~ 141 (267)
T cd06646 63 CKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred cCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 999999999999999999999999999999999987543 5899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
++.+ +|||+++...... .......++..|+|||++.
T Consensus 142 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~ 179 (267)
T cd06646 142 NGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred CCCEEECcCccceeecccc--cccCccccCccccCHhHcc
Confidence 9988 9999998764322 1112345788999999984
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=243.28 Aligned_cols=168 Identities=24% Similarity=0.412 Sum_probs=143.3
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
.|++.++||+|+||+|.+|++..|++.||||++++.... ..+. ..|+.+|..|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-----~~Q~---------------------~~Ei~iL~~ln 240 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-----LRQA---------------------QIEIRILELLN 240 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-----HHHH---------------------HHHHHHHHHHh
Confidence 789999999999999999999999999999998654322 2221 23577887775
Q ss_pred -C-----CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 561 -H-----HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 561 -H-----pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
| -|+|+++++|...++++||+|+++ -+|+++|+.+. ..++...+..|+.||+.||.+||+.+|||.||||||
T Consensus 241 ~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPEN 319 (586)
T KOG0667|consen 241 KHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPEN 319 (586)
T ss_pred ccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhh
Confidence 3 499999999999999999999995 59999998753 468999999999999999999999999999999999
Q ss_pred EEEecCCCe----EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG----FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~----~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||.+.+.. +|||.|....... + +...+..|.|||||.|.+|
T Consensus 320 ILL~~~~r~~vKVIDFGSSc~~~q~v----y-tYiQSRfYRAPEVILGlpY 365 (586)
T KOG0667|consen 320 ILLKDPKRSRIKVIDFGSSCFESQRV----Y-TYIQSRFYRAPEVILGLPY 365 (586)
T ss_pred eeeccCCcCceeEEecccccccCCcc----e-eeeeccccccchhhccCCC
Confidence 999887754 9999998766432 2 4567999999999999998
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=226.84 Aligned_cols=177 Identities=28% Similarity=0.432 Sum_probs=144.1
Q ss_pred cCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
...+|.+.+.||+|+||.||++... .++..+|+|.+........+.+.. |
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------e 57 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR-------------------------E 57 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHH-------------------------H
Confidence 4568899999999999999999853 345678999886554444444444 4
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG------------QPLPWGQRVNFARDIAAGMTYLH 620 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~------------~~l~~~~~~~i~~QIa~gL~yLH 620 (681)
+++|+.++||||+++++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||+|||
T Consensus 58 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH 137 (288)
T cd05093 58 AELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA 137 (288)
T ss_pred HHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999999999986432 24899999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 621 SMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 621 s~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++++||||||+|||+++++.+ +|||+++...............++..|+|||++.+..
T Consensus 138 ~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 198 (288)
T cd05093 138 SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 198 (288)
T ss_pred hCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC
Confidence 9999999999999999999987 9999998654322212222233567899999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=218.51 Aligned_cols=172 Identities=21% Similarity=0.316 Sum_probs=144.1
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+|+..+.||+|+||.||++.+..+++.+|+|.+.... ....+.+. .|+.+++.+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-------------------------~e~~~l~~l 55 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR-------------------------KEAVLLAKM 55 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHH-------------------------HHHHHHHhC
Confidence 5778899999999999999999999999999885432 22222222 358899999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~-~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
+|+||+++++.+..++.+|++|||+++|+|.+++.. ....+++..+..++.|++.||.|||+++|+|+||||+|||+++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~ 135 (255)
T cd08219 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQ 135 (255)
T ss_pred CCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECC
Confidence 999999999999999999999999999999998865 3345889999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.+ +|||+++....... ......++..|+|||++.+..
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~ 176 (255)
T cd08219 136 NGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMP 176 (255)
T ss_pred CCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCC
Confidence 9988 99999987654221 122355888999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=220.46 Aligned_cols=178 Identities=27% Similarity=0.446 Sum_probs=145.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHH-HHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE-KNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~-~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|..++.||+|+||.||++.+..+++.+|+|.+........ ....+ .+.+|+++++.
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~---------------------~~~~e~~~l~~ 60 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVN---------------------ALECEIQLLKN 60 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHH---------------------HHHHHHHHHHh
Confidence 468899999999999999999999999999998864322111 11111 12456999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..++..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+|+||||+|+||++++
T Consensus 61 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 61 LQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred CCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999999999987643 5889999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.+ +|||+++......... ......++..|+|||++.+..
T Consensus 140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (263)
T cd06625 140 AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183 (263)
T ss_pred CCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC
Confidence 9988 9999998654321111 112344778899999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=235.01 Aligned_cols=181 Identities=25% Similarity=0.335 Sum_probs=142.5
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
+.|..++|.+.+.||+|+||.||+|.+. .+++.||+|.+.... ......+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~------------------------ 57 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL------------------------ 57 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHH------------------------
Confidence 5677889999999999999999999853 457899999986432 2222223
Q ss_pred chHHHHHHHhC-CCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCCC-----------------------------
Q psy5063 549 CFSQVAVLRSL-HHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPG----------------------------- 597 (681)
Q Consensus 549 ~~~Ei~iL~~L-~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~~----------------------------- 597 (681)
.+|+++|..+ +||||+++++++.. +..++++|||+++|+|.+++....
T Consensus 58 -~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (343)
T cd05103 58 -MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKR 136 (343)
T ss_pred -HHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhh
Confidence 3458999999 78999999998865 457899999999999999986421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 598 -------------------------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 598 -------------------------------------~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
..+++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 216 (343)
T cd05103 137 RLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN 216 (343)
T ss_pred hccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC
Confidence 2367888899999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||+++...............++..|+|||++.+..|
T Consensus 217 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 258 (343)
T cd05103 217 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258 (343)
T ss_pred cEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCC
Confidence 88 99999987643322222222335677999999866543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=246.41 Aligned_cols=180 Identities=27% Similarity=0.402 Sum_probs=152.4
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCC---eEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETG---EVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg---~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
+.+..+...+.++||.|.||.|++|+.+..| ..||||.++....+ .+..|+.|
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~E----------------------- 680 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSE----------------------- 680 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhh-----------------------
Confidence 4466778888999999999999999998766 47999999765433 34445555
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
..+|.+++||||++|.|+......+.+|+|||++|+|..||+.+...|++.+.+.+.+.|+.||.||-++++|||||.
T Consensus 681 --AsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLA 758 (996)
T KOG0196|consen 681 --ASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLA 758 (996)
T ss_pred --hhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhh
Confidence 999999999999999999999999999999999999999999988889999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecC--CCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSA--KTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~--gt~~Y~APEvL~~~~Y 680 (681)
++||||+.+-.+ +||||+|.+..+. ...+.+.. ....|-|||.+.--+|
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKF 811 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKF 811 (996)
T ss_pred hhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhccc
Confidence 999999998766 9999999776544 33333332 3467999999865544
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=235.27 Aligned_cols=181 Identities=25% Similarity=0.355 Sum_probs=143.1
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
|.+..++|++.++||+|+||.||+|.+.. +++.||+|.+.... ....+.+.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~----------------------- 58 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALM----------------------- 58 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHH-----------------------
Confidence 45667789999999999999999997543 45789999886432 12222233
Q ss_pred chHHHHHHHhC-CCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCCC-----------------------------
Q psy5063 549 CFSQVAVLRSL-HHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPG----------------------------- 597 (681)
Q Consensus 549 ~~~Ei~iL~~L-~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~~----------------------------- 597 (681)
+|+.+++.+ +|+||+++++++.. +..++++|||+++|+|.+++....
T Consensus 59 --~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (337)
T cd05054 59 --TELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSV 136 (337)
T ss_pred --HHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccC
Confidence 358899999 89999999998864 467899999999999999985321
Q ss_pred -------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EE
Q psy5063 598 -------------------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FD 644 (681)
Q Consensus 598 -------------------------------~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~D 644 (681)
..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+ +|
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~D 216 (337)
T cd05054 137 SSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICD 216 (337)
T ss_pred CccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEec
Confidence 258899999999999999999999999999999999999999888 99
Q ss_pred eeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 645 FHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 645 FGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+++...............++..|||||++.+..|
T Consensus 217 fG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 252 (337)
T cd05054 217 FGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252 (337)
T ss_pred cccchhcccCcchhhccCCCCCccccCcHHhcCCCC
Confidence 999987654332222223345678999999876654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=222.69 Aligned_cols=174 Identities=27% Similarity=0.402 Sum_probs=141.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||++.++. +..+|+|.+..... ....+. +|+++|+.
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~-~~~~~~-------------------------~e~~~l~~ 55 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM-SEEDFI-------------------------EEAKVMMK 55 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc-cHHHHH-------------------------HHHHHHHH
Confidence 4678889999999999999998864 56789998753321 122333 35899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 56 l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred CCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 99999999999999999999999999999999999765456899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...... ........++..|+|||++.+..|
T Consensus 136 ~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd05114 136 TGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKY 178 (256)
T ss_pred CCeEEECCCCCccccCCCc-eeccCCCCCchhhCChhhcccCcc
Confidence 9887 8999998654322 111122234567999999876543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=239.06 Aligned_cols=184 Identities=25% Similarity=0.363 Sum_probs=146.1
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccCHHH-HHHHHHHhhccceeeeccCCCCccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVDEEA-EKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~~~~-~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
...+.+..++|.+++.||+|+||.||+|++. .+++.||+|.+....... ...+.
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~-------------------- 88 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALM-------------------- 88 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHH--------------------
Confidence 3446677788999999999999999999964 345789999986532221 22233
Q ss_pred cccchHHHHHHHhCC-CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------------------
Q psy5063 546 NLHCFSQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--------------------------- 597 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--------------------------- 597 (681)
+|+.+|..+. ||||+++++++...+..++||||+++|+|.+++....
T Consensus 89 -----~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (401)
T cd05107 89 -----SELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQ 163 (401)
T ss_pred -----HHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccc
Confidence 4599999997 9999999999999999999999999999999985421
Q ss_pred ----------------------------------------------------------------------CCCCHHHHHH
Q psy5063 598 ----------------------------------------------------------------------QPLPWGQRVN 607 (681)
Q Consensus 598 ----------------------------------------------------------------------~~l~~~~~~~ 607 (681)
..+++..+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 243 (401)
T cd05107 164 RKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVG 243 (401)
T ss_pred cccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHH
Confidence 1367778889
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 608 i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.|++.||.|||+++|+||||||+|||+++++.+ +|||+++...............++..|||||++.+..|
T Consensus 244 ~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 318 (401)
T cd05107 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318 (401)
T ss_pred HHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC
Confidence 99999999999999999999999999999998877 99999987654322222222346788999999876543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=234.28 Aligned_cols=177 Identities=20% Similarity=0.285 Sum_probs=142.5
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
........++|...+.||+|+||.||++.+..+++.+|+|.+.... ......+
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~------------------------- 63 (355)
T cd07874 9 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA------------------------- 63 (355)
T ss_pred CchhhhhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHH-------------------------
Confidence 3333344578999999999999999999999999999999886532 1222222
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 623 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~ 623 (681)
.+|+.+|+.++||||+++++++... ...|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++|
T Consensus 64 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g 139 (355)
T cd07874 64 YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAG 139 (355)
T ss_pred HHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3458999999999999999998643 357999999965 67777653 4888999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 624 LIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 624 IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+||||||+|||++.++.+ +|||+++...... ......+|..|+|||++.+..|
T Consensus 140 ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~ 195 (355)
T cd07874 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGY 195 (355)
T ss_pred cccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCC
Confidence 9999999999999999988 9999998654321 1223458999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=225.38 Aligned_cols=171 Identities=25% Similarity=0.348 Sum_probs=147.2
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|++.+.||+|+||.||++.+..+++.+|+|.+........+.+..| +++++.
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e-------------------------~~~l~~ 58 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-------------------------IDILSE 58 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHH-------------------------HHHHHh
Confidence 4578899999999999999999998999999999876554444444444 899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..+...|+||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~ 138 (280)
T cd06611 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL 138 (280)
T ss_pred CCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECC
Confidence 99999999999999999999999999999999999876667999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
++.. +|||++....... .......++..|+|||++.
T Consensus 139 ~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 139 DGDVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVA 176 (280)
T ss_pred CCCEEEccCccchhhcccc--cccceeecchhhcCHHHHh
Confidence 9988 8999987654322 1122345888999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=221.12 Aligned_cols=173 Identities=21% Similarity=0.376 Sum_probs=144.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
++|++.+.||+|+||.||+|++..+++.+|+|.+.... ......+. +|++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~-------------------------~e~~~l 56 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCV-------------------------KEIDLL 56 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHH-------------------------HHHHHH
Confidence 57899999999999999999999999999999875422 22222333 459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
+.++||||+++++++...+..+++|||+++|+|.+++.. ....+++..+..++.|++.||.|||+++++||||||+|
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~n 136 (267)
T cd08228 57 KQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPAN 136 (267)
T ss_pred HhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHH
Confidence 999999999999999999999999999999999988853 23458899999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||++.++.+ +|||+++....... ......++..|+|||++.+..
T Consensus 137 il~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~ 182 (267)
T cd08228 137 VFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred EEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCC
Confidence 999999988 99999987654321 112345788999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=240.90 Aligned_cols=168 Identities=23% Similarity=0.337 Sum_probs=135.7
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
...+|..++.||+|+||.||+|.+..+++.||+|++...... . .+|+.+|+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~----~-------------------------~~Ei~il~ 114 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQY----K-------------------------NRELLIMK 114 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcch----H-------------------------HHHHHHHH
Confidence 346799999999999999999999999999999988542211 1 13589999
Q ss_pred hCCCCceeeEEEEEEeC--------CeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 558 SLHHHNVIRFIGVLYKD--------RKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~--------~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
.++||||+++++++... ..+++||||+++ +|.+++.. ....+++..+..++.||+.||.|||+++|+|
T Consensus 115 ~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiH 193 (440)
T PTZ00036 115 NLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICH 193 (440)
T ss_pred hcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 99999999999987542 257799999975 77766642 3456899999999999999999999999999
Q ss_pred cCCCCCcEEEecCCC-e--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 627 RDLNSQNCLVREVGS-G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 627 RDLKp~NILl~~~g~-~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||||+|||++.++. + +|||+|+........ ....+|+.|||||++.+.
T Consensus 194 rDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 194 RDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS---VSYICSRFYRAPELMLGA 245 (440)
T ss_pred CCcCHHHEEEcCCCCceeeeccccchhccCCCCc---ccCCCCcCccCHHHhcCC
Confidence 999999999997663 4 999999876543221 234579999999998764
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=223.75 Aligned_cols=178 Identities=25% Similarity=0.373 Sum_probs=144.8
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCe----EEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGE----VMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~----~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
++...+|...+.||+|+||.||+|.++.+|+ .+|+|.+..... .....+.
T Consensus 3 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~------------------------- 57 (279)
T cd05057 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEIL------------------------- 57 (279)
T ss_pred ccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHH-------------------------
Confidence 4567889999999999999999999877665 588887754432 2223333
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+|+.+|+.++||||+++++++.. ...++||||+++|+|.+++......+++..+..++.|++.||+|||+++++|||||
T Consensus 58 ~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~ 136 (279)
T cd05057 58 DEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLA 136 (279)
T ss_pred HHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccC
Confidence 45899999999999999999887 78999999999999999998766669999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|+|||++.++.+ +|||+++...............++..|+|||.+....
T Consensus 137 p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (279)
T cd05057 137 ARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187 (279)
T ss_pred cceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCC
Confidence 999999998887 9999998766433222211222356799999886543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=222.28 Aligned_cols=170 Identities=24% Similarity=0.389 Sum_probs=144.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||++.+..+++.+|+|.+..........+. +|+.+++.
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~-------------------------~e~~~~~~ 62 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQ-------------------------QEIIMMKD 62 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHH-------------------------HHHHHHHh
Confidence 45788889999999999999999999999999988654333222232 34889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++.+..++..|+||||+++++|.+++...+ .+++.++..++.|++.||.|||+++++||||||+||+++.
T Consensus 63 l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~ 141 (267)
T cd06645 63 CKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred CCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 999999999999999999999999999999999987654 5899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
++.+ +|||++....... .......|+..|+|||++.
T Consensus 142 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 142 NGHVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred CCCEEECcceeeeEccCcc--cccccccCcccccChhhhc
Confidence 9988 9999987664321 1122346899999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=224.75 Aligned_cols=178 Identities=24% Similarity=0.374 Sum_probs=140.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
...++|+..+.||+|+||.||+|.+.. ++..+|+|.+.... ......+ .
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~-------------------------~ 57 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEF-------------------------L 57 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHH-------------------------H
Confidence 345789999999999999999998652 35689999875432 1222223 3
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHh
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------QPLPWGQRVNFARDIAAGMTYLHS 621 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------~~l~~~~~~~i~~QIa~gL~yLHs 621 (681)
+|+.+++.++||||+++++++......++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+
T Consensus 58 ~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (277)
T cd05062 58 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA 137 (277)
T ss_pred HHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45889999999999999999999999999999999999999986522 235778889999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 622 MNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 622 ~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.+++||||||+|||+++++.+ +|||+++...............++..|||||++.+..
T Consensus 138 ~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05062 138 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 197 (277)
T ss_pred CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC
Confidence 999999999999999999988 9999998654332222111233567899999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=224.67 Aligned_cols=183 Identities=28% Similarity=0.375 Sum_probs=145.8
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCC-----eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETG-----EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINN 546 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg-----~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~ 546 (681)
....+..++|...+.||+|+||.||++.+.... ..+|+|.+.... ......+
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~---------------------- 62 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL---------------------- 62 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHH----------------------
Confidence 344566778999999999999999999986443 789999876432 1222222
Q ss_pred ccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------------CCCCCHHHHHHHHH
Q psy5063 547 LHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFAR 610 (681)
Q Consensus 547 ~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------------~~~l~~~~~~~i~~ 610 (681)
.+|+.+++.+ +|+||+++++++..++..+++|||+++|+|.+++... ...+++..+..++.
T Consensus 63 ---~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 139 (293)
T cd05053 63 ---VSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139 (293)
T ss_pred ---HHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 3458899999 8999999999999999999999999999999998532 34588999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 611 DIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 611 QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.||.|||+++|+||||||+|||++.++.+ +|||+++...............++..|+|||++.+..|
T Consensus 140 qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 211 (293)
T cd05053 140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY 211 (293)
T ss_pred HHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc
Confidence 99999999999999999999999999999987 99999987654322222222334567999999866543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-24 Score=217.28 Aligned_cols=173 Identities=25% Similarity=0.397 Sum_probs=145.8
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|...+.||+|+||.||++++..+++.+++|.+... .......+. +|+++++.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-------------------------DEARVLAK 55 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHH-------------------------HHHHHHHh
Confidence 577888999999999999999999999999988643 222333333 35889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++||||+++++++..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~ 135 (256)
T cd08529 56 LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD 135 (256)
T ss_pred cCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe
Confidence 99999999999999999999999999999999999764 45689999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||+++...... .......+++.|+|||++.+..|
T Consensus 136 ~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 178 (256)
T cd08529 136 AYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCEDKPY 178 (256)
T ss_pred CCCCEEEcccccceeccCcc--chhhccccCccccCHHHhcCCCC
Confidence 99988 8999998765432 22233457889999999876543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=224.57 Aligned_cols=172 Identities=27% Similarity=0.384 Sum_probs=145.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||++.+..+++.+|+|.+.+......+... .+.+|+++|+.+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~----------------------~~~~e~~~l~~l 58 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVE----------------------HVLNEKRILQSI 58 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHH----------------------HHHHHHHHHHhC
Confidence 4788899999999999999999999999999988653221111110 123569999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||+|+|||++.+
T Consensus 59 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~ 137 (290)
T cd05580 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSD 137 (290)
T ss_pred CCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCC
Confidence 9999999999999999999999999999999999765 358999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|.+ +|||+++..... .....+++.|+|||.+.+..
T Consensus 138 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 174 (290)
T cd05580 138 GYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKG 174 (290)
T ss_pred CCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCC
Confidence 987 999999876543 22345889999999986553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=224.41 Aligned_cols=178 Identities=28% Similarity=0.386 Sum_probs=144.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCC----------------eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccC
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETG----------------EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLG 539 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg----------------~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~ 539 (681)
+..++|++.+.||+|+||.||++.+..++ ..+|+|.+.... ....+.+.
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~-------------- 67 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFL-------------- 67 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHH--------------
Confidence 34568899999999999999999876544 467999876432 22233333
Q ss_pred CCCccccccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC----------CCCCHHHHHHHH
Q psy5063 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG----------QPLPWGQRVNFA 609 (681)
Q Consensus 540 ~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~----------~~l~~~~~~~i~ 609 (681)
+|+++|+.++||||+++++++..++..+++|||+++++|.+++.... ..+++..+..++
T Consensus 68 -----------~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (296)
T cd05051 68 -----------KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMA 136 (296)
T ss_pred -----------HHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHH
Confidence 35999999999999999999999999999999999999999987543 258999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 610 ~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.|++.||.|||+++|+||||||+|||++.++.+ +|||+++...............++..|||||++.+..
T Consensus 137 ~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (296)
T cd05051 137 TQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK 208 (296)
T ss_pred HHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC
Confidence 999999999999999999999999999999888 9999998764332222222344677899999987644
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=225.08 Aligned_cols=178 Identities=28% Similarity=0.406 Sum_probs=144.2
Q ss_pred cCCCeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
..++|.+.+.||+|+||.||+|.+.. +++.+|+|.+...... ..+.+.+
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------------------- 57 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER------------------------- 57 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHH-------------------------
Confidence 34678888999999999999998753 3678999988654332 3334444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-------------CCCCHHHHHHHHHHHHHHHHH
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-------------QPLPWGQRVNFARDIAAGMTY 618 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-------------~~l~~~~~~~i~~QIa~gL~y 618 (681)
|+++|+.++|+||+++++++......++||||+++|+|.+++...+ ..+++..+..++.|++.|+.|
T Consensus 58 e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~ 137 (280)
T cd05049 58 EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVY 137 (280)
T ss_pred HHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHH
Confidence 4899999999999999999999999999999999999999996432 347889999999999999999
Q ss_pred HHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 619 LHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 619 LHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+++++||||||+|||++.++.+ +|||+++...............++..|+|||++.+..|
T Consensus 138 lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05049 138 LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF 201 (280)
T ss_pred HhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCc
Confidence 999999999999999999999988 99999986543222111122335678999999876654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-24 Score=226.37 Aligned_cols=171 Identities=23% Similarity=0.365 Sum_probs=144.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|...+.||+|+||.||++.+..++..+|+|.+.... ......+ .+|+++++.
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~-------------------------~~E~~~l~~ 55 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI-------------------------IRELKVLHE 55 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHH-------------------------HHHHHHHHh
Confidence 46888999999999999999999999999999875432 2222223 345999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NILl~ 637 (681)
++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+|||++
T Consensus 56 l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~ 134 (308)
T cd06615 56 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN 134 (308)
T ss_pred CCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe
Confidence 99999999999999999999999999999999999765 458999999999999999999998 5899999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||+++...... .....++..|+|||++.+..|
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~ 175 (308)
T cd06615 135 SRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY 175 (308)
T ss_pred cCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCC
Confidence 99888 9999987654321 123468899999999876543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=224.02 Aligned_cols=173 Identities=25% Similarity=0.384 Sum_probs=147.4
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...+.|+..+.||+|+||.||+|.+..+++.+|+|.+........+.+..| +.++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e-------------------------~~~l 63 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-------------------------IEIL 63 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHH-------------------------HHHH
Confidence 344678899999999999999999999999999999876655544444444 8899
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++|+||+++++.+..++..++||||+++++|..++.+....+++..+..++.|++.||.|||+++++||||||+||++
T Consensus 64 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili 143 (292)
T cd06644 64 ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143 (292)
T ss_pred HhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE
Confidence 99999999999999999999999999999999998887655568999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+.++.+ +|||++....... .......++..|+|||++.
T Consensus 144 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 144 TLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVM 183 (292)
T ss_pred cCCCCEEEccCccceeccccc--cccceecCCccccCceeec
Confidence 998888 9999987643221 1122345788999999985
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=235.39 Aligned_cols=169 Identities=24% Similarity=0.334 Sum_probs=143.6
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
....+|...+.||+|+||.||+|++..+++.||+|...... ...|+.++
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~-------------------------------~~~E~~~l 111 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT-------------------------------TLIEAMLL 111 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc-------------------------------cHHHHHHH
Confidence 34457999999999999999999999999999999642211 12458899
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++...+..++||||+. ++|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 112 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill 190 (357)
T PHA03209 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI 190 (357)
T ss_pred HhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 99999999999999999999999999995 68999887766679999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++.+ +|||+++...... ......||..|+|||++.+..|
T Consensus 191 ~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 233 (357)
T PHA03209 191 NDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKY 233 (357)
T ss_pred CCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCC
Confidence 999988 9999997543221 1223568999999999987655
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=222.09 Aligned_cols=176 Identities=27% Similarity=0.376 Sum_probs=142.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCe---EEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGE---VMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~---~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+.... ....+.+. +|+.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~e~~ 57 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-------------------------SEAS 57 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHH-------------------------HHHH
Confidence 4578889999999999999999865443 78999875432 22223333 3589
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+++.++||||+++++++..++..++||||+++++|.+++......+++..+..++.|++.||.|||+++++||||||+||
T Consensus 58 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 58 IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred HHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 99999999999999999999999999999999999999987656689999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeeccccee-eeecCCCccccchhhccCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTL-FILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~-~~~~~gt~~Y~APEvL~~~~ 679 (681)
|++.++.+ +|||+++.......... .....++..|+|||++.+..
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 185 (267)
T cd05066 138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185 (267)
T ss_pred EECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCc
Confidence 99999887 89999987654321111 11122356799999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.4e-24 Score=221.90 Aligned_cols=167 Identities=23% Similarity=0.401 Sum_probs=140.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|+..++||+|+||.||+|.+..+++.+|+|.+... .......+.. |+++++.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-------------------------E~~~l~~ 55 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMS-------------------------ELEILYK 55 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHH-------------------------HHHHHHh
Confidence 3677889999999999999999999999999988643 2222333333 4889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..++..++||||+++++|..+. .+++..+..++.|++.||.|||+++|+|+||||+|||++.
T Consensus 56 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~ 130 (279)
T cd06619 56 CDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNT 130 (279)
T ss_pred CCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECC
Confidence 99999999999999999999999999999997552 3788889999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||++...... ......++..|+|||++.+..|
T Consensus 131 ~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~ 170 (279)
T cd06619 131 RGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQY 170 (279)
T ss_pred CCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCC
Confidence 9988 999999865432 1223468999999999876543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=221.73 Aligned_cols=177 Identities=28% Similarity=0.422 Sum_probs=143.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCe---EEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGE---VMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~---~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.++|...+.||+|+||.||+|.+..+++ .||+|.+... .......+.. |+.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------e~~ 57 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-------------------------EAS 57 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHH-------------------------HHH
Confidence 4578889999999999999999887665 6999988643 2333334444 489
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+++.++||||+++++++.+++..++||||+++|+|.+++......+++.++..++.|++.||.|||+++++||||||+||
T Consensus 58 ~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 58 IMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred HHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 99999999999999999999999999999999999999987656689999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecC---CCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSA---KTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~---gt~~Y~APEvL~~~~Y 680 (681)
|++.++.+ +|||+++............... .+..|+|||++.+..|
T Consensus 138 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 188 (269)
T cd05065 138 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188 (269)
T ss_pred EEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcc
Confidence 99998887 8999998665432211111111 2357999999876543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=226.54 Aligned_cols=172 Identities=27% Similarity=0.412 Sum_probs=143.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH-HHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA-EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~-~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|...+.||+|+||.||+|++..+++.||+|.+....... ...+ .+|+.+++
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~E~~~l~ 59 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA-------------------------IREVSLLK 59 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHH-------------------------HHHHHHHH
Confidence 468999999999999999999999999999999885432111 1112 34699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++..++..++||||++ ++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 60 ~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~ 138 (301)
T cd07873 60 DLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN 138 (301)
T ss_pred hcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC
Confidence 9999999999999999999999999997 599998877666689999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.++.+ +|||+++...... .......++..|+|||++.+.
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~ 179 (301)
T cd07873 139 ERGELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGS 179 (301)
T ss_pred CCCcEEECcCcchhccCCCC--CcccccceeecccCcHHHhCC
Confidence 99988 9999997654322 122234568899999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-24 Score=221.55 Aligned_cols=168 Identities=24% Similarity=0.377 Sum_probs=143.4
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
|+..+.||+|+||.||++.+..++..+++|.+........+.+.. |+++++.++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-------------------------e~~~l~~l~h 61 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-------------------------EIDILASCDH 61 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHH-------------------------HHHHHHHCCC
Confidence 567788999999999999999999999999886555444444444 4889999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
|||+++++++..++..++||||+++++|..++.....++++..+..++.|++.||.|||+.+++||||||+|||++.++.
T Consensus 62 ~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~ 141 (282)
T cd06643 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD 141 (282)
T ss_pred CCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC
Confidence 99999999999999999999999999999988765567999999999999999999999999999999999999999998
Q ss_pred e--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 642 G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+ +|||+++...... .......++..|+|||++.
T Consensus 142 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 176 (282)
T cd06643 142 IKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVM 176 (282)
T ss_pred EEEccccccccccccc--cccccccccccccCHhhcc
Confidence 8 9999987654321 1122345889999999984
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=231.52 Aligned_cols=171 Identities=19% Similarity=0.285 Sum_probs=140.1
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
..++|...+.||+|+||.||++.+..+++.+|+|++.... ......+ .+|+.+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~~E~~~ 76 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA-------------------------YRELVL 76 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHH-------------------------HHHHHH
Confidence 3578999999999999999999999999999999886432 1222222 345899
Q ss_pred HHhCCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 556 LRSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
++.++||||+++++++... ...|+||||+++ +|.+++.. .+++..+..++.|++.||.|||+++|+||||
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dl 152 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 152 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCC
Confidence 9999999999999988643 357999999965 77777753 3788999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.++.+ +|||+++...... ......+|..|+|||++.+..|
T Consensus 153 kp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~ 202 (364)
T cd07875 153 KPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGY 202 (364)
T ss_pred CHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCC
Confidence 9999999999988 9999998654321 1223468999999999987654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=225.52 Aligned_cols=179 Identities=27% Similarity=0.406 Sum_probs=141.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCC--------------eEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCC
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETG--------------EVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSH 541 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg--------------~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~ 541 (681)
+..++|++.+.||+|+||.||++++..++ ..||+|.+... .......+.
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------- 65 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL---------------- 65 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHH----------------
Confidence 34568999999999999999999875432 35899988543 222233333
Q ss_pred CccccccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-----------CCCCHHHHHHHHH
Q psy5063 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-----------QPLPWGQRVNFAR 610 (681)
Q Consensus 542 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-----------~~l~~~~~~~i~~ 610 (681)
+|+++|+.++|+||+++++++..++..++||||+++++|.+++.... ..+++..+..++.
T Consensus 66 ---------~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 136 (295)
T cd05097 66 ---------KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAV 136 (295)
T ss_pred ---------HHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHH
Confidence 35999999999999999999999999999999999999999986431 1368889999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 611 DIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 611 QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.||.|||+++++||||||+|||+++++.+ +|||+++...............++..|+|||++.+..|
T Consensus 137 ~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 208 (295)
T cd05097 137 QIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF 208 (295)
T ss_pred HHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc
Confidence 99999999999999999999999999998877 99999986543322221122334678999999866543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-25 Score=238.68 Aligned_cols=179 Identities=28% Similarity=0.399 Sum_probs=154.3
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.|.++.+..++.||+|-||.|.+|.... +..||+|.++..+.. ..+.|.+| ++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kE-------------------------Ik 587 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKE-------------------------IK 587 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHH-------------------------HH
Confidence 4677888899999999999999999763 689999999765433 34666666 99
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCC-CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL-PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l-~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
+|.+++||||++|+|+|..++.+++|+|||++|+|.+|+..+..+. .-...++++.||++||+||.+.++|||||.++|
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rN 667 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRN 667 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccc
Confidence 9999999999999999999999999999999999999998764333 556677899999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.++++ +|||++|-+.....|.......-...|||||.+.-.+|
T Consensus 668 cLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkF 716 (807)
T KOG1094|consen 668 CLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKF 716 (807)
T ss_pred eeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccc
Confidence 999999998 99999998877777777667777899999999765443
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=220.58 Aligned_cols=178 Identities=26% Similarity=0.352 Sum_probs=143.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCC-----eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETG-----EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg-----~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
+..++|...+.||+|+||.||++.+...+ ..+|+|.+.... ......+.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~------------------------- 57 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFL------------------------- 57 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHH-------------------------
Confidence 45678999999999999999999986443 789999875432 22222233
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHHHHHh
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------GQPLPWGQRVNFARDIAAGMTYLHS 621 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------~~~l~~~~~~~i~~QIa~gL~yLHs 621 (681)
+|+.+|+.++||||+++++++......++||||+++|+|.+++... ...+++..+..++.|++.||.|||+
T Consensus 58 ~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~ 137 (277)
T cd05032 58 NEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA 137 (277)
T ss_pred HHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4589999999999999999999999999999999999999998642 1236888999999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 622 MNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 622 ~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++|+||||||+|||++.++.+ +|||+++.......+.......++..|+|||++.+..
T Consensus 138 ~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05032 138 KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV 197 (277)
T ss_pred CCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC
Confidence 999999999999999999998 8999998665433222222334577899999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=222.70 Aligned_cols=179 Identities=30% Similarity=0.461 Sum_probs=144.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
+..++|...++||+|+||.||++... .++..+|+|.+..........+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~------------------------- 56 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR------------------------- 56 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHH-------------------------
Confidence 34568889999999999999999743 346789999876655444444444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC--------------CCCCHHHHHHHHHHHHHHHH
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--------------QPLPWGQRVNFARDIAAGMT 617 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--------------~~l~~~~~~~i~~QIa~gL~ 617 (681)
|+++++.++|+||+++++++......+++|||+++|+|.+++.... ..+++..+..++.|++.||.
T Consensus 57 e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 136 (280)
T cd05092 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMV 136 (280)
T ss_pred HHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHH
Confidence 4899999999999999999999999999999999999999986532 24789999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 618 YLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 618 yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++++||||||+|||+++++.+ +|||+++.......+.......++..|+|||++.+..|
T Consensus 137 ~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05092 137 YLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 201 (280)
T ss_pred HHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc
Confidence 9999999999999999999999888 89999986653322222222335678999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-24 Score=220.73 Aligned_cols=171 Identities=28% Similarity=0.451 Sum_probs=145.4
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|++.+.||+|+||.||+|.+..+|+.+|+|++.... ......+. +|+.+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQAL-------------------------REIKALQA 55 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHH-------------------------HHHHHHHh
Confidence 4788899999999999999999999999999986543 22222333 45899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..+...++||||+ +++|.+++......+++..+..++.|++.||.|||+++++|+||||+||+++.
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~ 134 (286)
T cd07832 56 CQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISA 134 (286)
T ss_pred CCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcC
Confidence 99999999999999999999999999 99999999766667999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++.+ +|||++........ .......++..|+|||++.+.
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07832 135 DGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGA 175 (286)
T ss_pred CCcEEEeeeeecccccCCCC-CccccccCcccccCceeeecc
Confidence 9887 99999987754321 122345688999999998654
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=221.17 Aligned_cols=166 Identities=26% Similarity=0.323 Sum_probs=130.3
Q ss_pred eecccCcEEEEEEEEcC--CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc
Q psy5063 487 LLGQGFFGQVYRVTHRE--TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN 563 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~~--tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 563 (681)
.||+|+||.||+|.... ....+|+|.+.... ......+.+ |+.+++.++|+|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~-------------------------e~~~~~~l~h~n 56 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQ-------------------------EVQPYRELNHPN 56 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHH-------------------------HHHHHHhCCCCC
Confidence 58999999999997543 34578888765432 222233333 488999999999
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG----QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~----~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
|+++++.+...+..++||||+++|+|.+++.... ...++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 57 ii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~ 136 (269)
T cd05042 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD 136 (269)
T ss_pred cceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC
Confidence 9999999999999999999999999999997532 224677888999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+.+ +|||+++...............++..|+|||++..
T Consensus 137 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 137 LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176 (269)
T ss_pred CcEEEeccccccccccchheeccCCCCCcccccCHHHHhh
Confidence 988 99999876443221222222345677999999753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=225.60 Aligned_cols=183 Identities=28% Similarity=0.363 Sum_probs=143.3
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcC-------CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRE-------TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLI 544 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~-------tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~ 544 (681)
+.+....++|.+++.||+|+||.||++.+.. +...+|+|.+.... ......+
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~-------------------- 70 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDL-------------------- 70 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHH--------------------
Confidence 3445556789999999999999999998653 23569999886432 2222222
Q ss_pred ccccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHHH
Q psy5063 545 NNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNF 608 (681)
Q Consensus 545 ~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~i 608 (681)
.+|+++++.+ +||||+++++++..++..|+||||+++|+|.+++.... ..+++.++..+
T Consensus 71 -----~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 145 (307)
T cd05098 71 -----ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145 (307)
T ss_pred -----HHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence 3458899999 79999999999999999999999999999999997532 24889999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 609 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 609 ~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.|++.||+|||+++++||||||+|||++.++.+ +|||+++...............++..|||||++.+..|
T Consensus 146 ~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 219 (307)
T cd05098 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 219 (307)
T ss_pred HHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC
Confidence 9999999999999999999999999999999988 99999876543221111111224568999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=216.68 Aligned_cols=173 Identities=25% Similarity=0.379 Sum_probs=147.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||++.+..+++.+++|.+........+.+.+ |+++++.
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------e~~~l~~ 56 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ-------------------------EISMLKE 56 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHH-------------------------HHHHHHh
Confidence 468899999999999999999999999999999987654443333333 4899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++...+.+|++|||+++++|.+++......+++..+..++.|++.||.|||+++|+|+||||+||+++.
T Consensus 57 ~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 136 (262)
T cd06613 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTE 136 (262)
T ss_pred CCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECC
Confidence 99999999999999999999999999999999999876456999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++.+ +|||++....... .......++..|+|||++...
T Consensus 137 ~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 137 DGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVE 176 (262)
T ss_pred CCCEEECccccchhhhhhh--hccccccCCccccCchhhccc
Confidence 9988 9999987654321 112234578889999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=220.34 Aligned_cols=176 Identities=27% Similarity=0.402 Sum_probs=145.3
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+...+|...+.||+|+||.||+|.++.+++.+|+|.+..... ....+. +|++++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~-------------------------~e~~~l 56 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFL-------------------------KEAAVM 56 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch-HHHHHH-------------------------HHHHHH
Confidence 445678889999999999999999999999999998764322 223333 358999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++|+||+++++++..++..+++|||+++++|.+++... ...+++..+..++.|++.||.|||+++++||||||+|||
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil 136 (263)
T cd05052 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 136 (263)
T ss_pred HhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence 9999999999999999999999999999999999998753 345899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++++.+ +|||+++...... .........+..|+|||++.+..
T Consensus 137 ~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 181 (263)
T cd05052 137 VGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNK 181 (263)
T ss_pred EcCCCcEEeCCCccccccccce-eeccCCCCCccccCCHHHhccCC
Confidence 9999988 9999998765422 11111222456799999987654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=224.39 Aligned_cols=177 Identities=25% Similarity=0.304 Sum_probs=141.6
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCC-----CeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRET-----GEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~t-----g~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
..++|.+.+.||+|+||.||+|.+..+ ++.+|+|.+...... ....+. .
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~ 57 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFK-------------------------H 57 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHH-------------------------H
Confidence 345678889999999999999987543 578999988643322 122232 3
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------------CCCCCHHHHHHHHHHHHHHH
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAAGM 616 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------------~~~l~~~~~~~i~~QIa~gL 616 (681)
|+.+++.++||||+++++++......++++||+++++|.+++... ...+++..+..++.|++.||
T Consensus 58 e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL 137 (283)
T cd05091 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGM 137 (283)
T ss_pred HHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHH
Confidence 588999999999999999999999999999999999999998521 12478888999999999999
Q ss_pred HHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 617 TYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 617 ~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.|||+++|+||||||+|||+++++.+ +|||+++...............+++.|+|||++.+..
T Consensus 138 ~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05091 138 EFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK 202 (283)
T ss_pred HHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC
Confidence 99999999999999999999998887 9999988765433222223344577899999986544
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=219.80 Aligned_cols=174 Identities=30% Similarity=0.369 Sum_probs=141.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
..+|...+.||+|+||.||++.++ ++..+|+|.+.+.... ...+. +|+++++.
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~-~~~~~-------------------------~e~~~l~~ 55 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS-EDDFI-------------------------EEAKVMMK 55 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC-HHHHH-------------------------HHHHHHHh
Confidence 457888999999999999999886 4668999987543221 12233 34899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++...+..++||||+++++|.+++......+++..+..++.|++.||.|||+++++||||||+||++++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05059 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135 (256)
T ss_pred CCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC
Confidence 99999999999999999999999999999999999765556899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++....... .......++..|+|||++.+..|
T Consensus 136 ~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~ 178 (256)
T cd05059 136 DNVVKVSDFGLARYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRF 178 (256)
T ss_pred CCcEEECCcccceecccccc-cccCCCCCCccccCHHHhccCCC
Confidence 9988 99999987653221 11111223457999999876544
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-26 Score=246.30 Aligned_cols=170 Identities=24% Similarity=0.343 Sum_probs=148.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+-|.+...||.|+||.||++..++++-..|.|.+.....+....++-| |++|...
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVE-------------------------IeILa~C 86 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVE-------------------------IEILAEC 86 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhh-------------------------hhhhhcC
Confidence 345667789999999999999999999999998876666555555555 9999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||+||+|++.|+-++.+|++.|||.||-...++-..+..+.+.++..+.+|++.||.|||+++|||||||+.|||++.+
T Consensus 87 dHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld 166 (1187)
T KOG0579|consen 87 DHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD 166 (1187)
T ss_pred CChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec
Confidence 99999999999999999999999999999999988878889999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
|.+ +|||.+...... ...-.++.||+.||||||..
T Consensus 167 GdirLADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvm 203 (1187)
T KOG0579|consen 167 GDIRLADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVM 203 (1187)
T ss_pred CcEeeecccccccchhH--HhhhccccCCcccccchhee
Confidence 999 999998654432 22334678999999999964
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=222.79 Aligned_cols=178 Identities=26% Similarity=0.377 Sum_probs=139.8
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
...++|++.+.||+|+||.||+|.+++ .+..+|+|.+..... .....+ .
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------------------------~ 57 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEF-------------------------L 57 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHH-------------------------H
Confidence 456789999999999999999997653 355899998754321 111222 3
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------CCCCHHHHHHHHHHHHHHHHHHHh
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------QPLPWGQRVNFARDIAAGMTYLHS 621 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------~~l~~~~~~~i~~QIa~gL~yLHs 621 (681)
+|+.+++.++||||+++++++...+..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+
T Consensus 58 ~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 137 (288)
T cd05061 58 NEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA 137 (288)
T ss_pred HHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45899999999999999999999999999999999999999996421 234667888999999999999999
Q ss_pred CCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 622 MNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 622 ~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++|+||||||+|||++.++.+ +|||+++...............++..|+|||.+.+..
T Consensus 138 ~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 197 (288)
T cd05061 138 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV 197 (288)
T ss_pred CCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCC
Confidence 999999999999999999988 9999998654322211111223467799999987654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=223.64 Aligned_cols=178 Identities=28% Similarity=0.411 Sum_probs=144.0
Q ss_pred cCCCeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
...+|.+.+.||+|+||.||++.+.. ++..+++|.+........+.+.+ |
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-------------------------e 57 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR-------------------------E 57 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHH-------------------------H
Confidence 45678899999999999999998643 45678888876554444444444 4
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHH
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMT 617 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~i~~QIa~gL~ 617 (681)
+++++.++|+||+++++++...+..++||||+++++|.+++.... ..+++..+..++.||+.||.
T Consensus 58 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 137 (291)
T cd05094 58 AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV 137 (291)
T ss_pred HHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999999999999986431 24789999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 618 YLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 618 yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++|+||||||+|||++.++.+ +|||+++...............++..|+|||++.+..|
T Consensus 138 ~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 202 (291)
T cd05094 138 YLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 202 (291)
T ss_pred HHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC
Confidence 9999999999999999999999987 99999976543221111222345778999999876543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=215.17 Aligned_cols=174 Identities=20% Similarity=0.391 Sum_probs=145.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
++|...+.||+|+||.||+|.+..+|+.+|+|.+.... ....+.+ .+|++++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~-------------------------~~ei~~l 56 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDC-------------------------LKEIDLL 56 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHH-------------------------HHHHHHH
Confidence 57889999999999999999999999999999885422 2222223 3459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
+.++|+||+++++++..++..++||||+++|+|.+++.. ....+++.++..++.|++.||.|||+.+|+||||||+|
T Consensus 57 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~n 136 (267)
T cd08224 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPAN 136 (267)
T ss_pred HhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhh
Confidence 999999999999999999999999999999999999864 23458999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+++.++.. +|||+++....... ......++..|+|||++.+..|
T Consensus 137 il~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~ 183 (267)
T cd08224 137 VFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGY 183 (267)
T ss_pred EEECCCCcEEEeccceeeeccCCCc--ccceecCCccccCHHHhccCCC
Confidence 999999988 99999987653321 1223457889999999876544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.8e-24 Score=231.94 Aligned_cols=170 Identities=19% Similarity=0.242 Sum_probs=141.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcC--CCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRE--TGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~--tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
..+|...+.||+|+||.||++.... +++.+|+|.+.... .. .+|+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~-------------------------~~E~~il 140 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TP-------------------------GREIDIL 140 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cH-------------------------HHHHHHH
Confidence 4579999999999999999998643 46788999774321 11 2459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++......++||||+. ++|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 141 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill 218 (392)
T PHA03207 141 KTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL 218 (392)
T ss_pred HhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 99999999999999999999999999995 6898888543 469999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++.+ +|||+++...............||..|+|||++.+..|
T Consensus 219 ~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 264 (392)
T PHA03207 219 DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY 264 (392)
T ss_pred cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCC
Confidence 999988 99999987654332222234568999999999987655
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=219.86 Aligned_cols=170 Identities=26% Similarity=0.445 Sum_probs=140.7
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+..+.||+|+||.||+|++..+++.||+|.+...... ..+. ..+|+.+++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~-------------------------~~~e~~~l~~ 55 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPST-------------------------AIREISLLKE 55 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHH-------------------------HHHHHHHHHh
Confidence 578889999999999999999999999999988542211 1112 2346999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~--~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
++||||+++++++..++..|+||||++ ++|.+++... +..+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~ 134 (285)
T cd07861 56 LQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134 (285)
T ss_pred cCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE
Confidence 999999999999999999999999997 6898888643 2468999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.+|.+ +|||+++..... ........++..|+|||++.+.
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd07861 135 DNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGS 176 (285)
T ss_pred cCCCcEEECcccceeecCCC--cccccCCcccccccChHHhcCC
Confidence 999988 999999865432 1222334568899999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=219.43 Aligned_cols=176 Identities=22% Similarity=0.378 Sum_probs=145.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||++.+..+++.+|+|.+...+....+.. . .+.+|+.+++.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~-~---------------------~~~~e~~~l~~~ 59 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-A---------------------DCIKEIDLLKQL 59 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHH-H---------------------HHHHHHHHHHHc
Confidence 578888999999999999999999999999998865332111110 0 123459999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+|+||+++++++..++..+++|||+++++|.+++.. ....+++..+..++.|++.||.|||+++++|+||||+||++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 139 (267)
T cd08229 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred cCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 999999999999999999999999999999998863 23458999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+.++.+ +|||+++....... ......++..|+|||++.+..
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~ 182 (267)
T cd08229 140 TATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG 182 (267)
T ss_pred cCCCCEEECcchhhhccccCCc--ccccccCCcCccCHHHhcCCC
Confidence 999988 99999987654322 122345888999999986654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=224.19 Aligned_cols=181 Identities=24% Similarity=0.351 Sum_probs=145.1
Q ss_pred ceecCCCeeecceecccCcEEEEEEEE-----cCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTH-----RETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~-----~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
+.+..++|...+.||+|+||.||++.+ ..++..+|+|.+..... ...+.+.
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------- 86 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALM----------------------- 86 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHH-----------------------
Confidence 345567899999999999999999985 33456899998765432 2222333
Q ss_pred chHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 549 CFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 549 ~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
+|+++++.+ +||||+++++++...+..|+||||+++|+|.+++.... ..+++.++..++.|++.||.|||+++|+|
T Consensus 87 --~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH 164 (302)
T cd05055 87 --SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIH 164 (302)
T ss_pred --HHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeh
Confidence 358999999 89999999999999999999999999999999997533 34899999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+||||+|||++.++.+ +|||+++...............++..|+|||++.+..|
T Consensus 165 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 220 (302)
T cd05055 165 RDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY 220 (302)
T ss_pred hhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCC
Confidence 9999999999998877 89999987654332222222345678999999876543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=221.80 Aligned_cols=171 Identities=26% Similarity=0.423 Sum_probs=135.1
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH-
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR- 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~- 557 (681)
+|+..+.||+|+||.||+|+++.+++.+|+|.+...... ...... +|+++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV-------------------------REVALLKR 55 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHH-------------------------HHHHHHHH
Confidence 477888999999999999999999999999988542111 111122 2345444
Q ss_pred --hCCCCceeeEEEEEEe-----CCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 558 --SLHHHNVIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 558 --~L~HpnIV~l~g~~~~-----~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
.++||||+++++++.. ....+++|||+++ +|.+++.... ..+++..+..++.|++.||.|||+++|+||||
T Consensus 56 l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~di 134 (288)
T cd07863 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDL 134 (288)
T ss_pred hhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 4579999999999864 3468999999974 8988886532 34899999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.++.+ +|||+++....... .....+|..|+|||++.+..|
T Consensus 135 kp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 184 (288)
T cd07863 135 KPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTY 184 (288)
T ss_pred CHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCC
Confidence 9999999999988 99999987653221 122457889999999976654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=236.85 Aligned_cols=183 Identities=22% Similarity=0.339 Sum_probs=155.0
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
-..++|...+.+|+|+||+|+.|.++.+...|++|.+.+.. --...+.+.++-+ ++-.||++|
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeR-IL~DtWvrDrkLG----------------tVp~EIqIl 620 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKER-ILVDTWVRDRKLG----------------TVPSEIQIL 620 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhh-hhhhhhhcccccC----------------ccchhHHHH
Confidence 34568999999999999999999999999999999886532 1222333332211 334689999
Q ss_pred HhCC---CCceeeEEEEEEeCCeEEEEEecc-CCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 557 RSLH---HHNVIRFIGVLYKDRKLNLVTEYI-AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 557 ~~L~---HpnIV~l~g~~~~~~~l~LV~Ey~-~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
..++ |+||++++++|+++++.||+||-- +|-+|++++.... .+++.++..|++|++.|+++||++||||||||-+
T Consensus 621 a~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikde 699 (772)
T KOG1152|consen 621 ATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDE 699 (772)
T ss_pred HHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCceecccccc
Confidence 9997 999999999999999999999974 5679999998654 4999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASFI 681 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y~ 681 (681)
|+.++.+|-+ +|||-|.... ...+..+.||..|.|||+|.+++|.
T Consensus 700 nvivd~~g~~klidfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~ 746 (772)
T KOG1152|consen 700 NVIVDSNGFVKLIDFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYL 746 (772)
T ss_pred cEEEecCCeEEEeeccchhhhc----CCCcceeeeeccccchhhhCCCccC
Confidence 9999999988 9999987655 3457788999999999999999993
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=221.44 Aligned_cols=176 Identities=29% Similarity=0.417 Sum_probs=141.6
Q ss_pred CCeeecceecccCcEEEEEEEE----cCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTH----RETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~----~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.-|+..+.||+|+||.||++.. ..+++.+|+|.+.... ......+. +|++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~-------------------------~e~~ 58 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-------------------------KEIE 58 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHH-------------------------HHHH
Confidence 3467788999999999999984 4568899999886442 22222333 3589
Q ss_pred HHHhCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 555 VLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
+++.++||||+++++++... ...++||||+++++|.+++......+++..+..++.|++.||.|||+++++||||||+
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~ 138 (284)
T cd05079 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 138 (284)
T ss_pred HHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchh
Confidence 99999999999999998775 6789999999999999999765556899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccc-eeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPY-TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~-~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||++.++.+ +|||+++........ .......++..|+|||++.+..|
T Consensus 139 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 189 (284)
T cd05079 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF 189 (284)
T ss_pred eEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCC
Confidence 9999999888 899999876543221 11223446778999999876543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=222.18 Aligned_cols=172 Identities=23% Similarity=0.372 Sum_probs=145.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.+|...+.||+|+||.||++.+..+++.+|+|.+..........+. +|+.+++.+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~e~~~l~~~ 73 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII-------------------------NEILVMREN 73 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHH-------------------------HHHHHHHhC
Confidence 5788899999999999999999999999999998654433333333 348899999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++++..++..++||||+++++|.+++.+. .+++.++..++.|++.||.|||+.+++||||||+|||++.+
T Consensus 74 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~ 151 (297)
T cd06656 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMD 151 (297)
T ss_pred CCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 9999999999999999999999999999999998753 48899999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||++......... .....+++.|+|||.+.+..|
T Consensus 152 ~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 192 (297)
T cd06656 152 GSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAY 192 (297)
T ss_pred CCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCC
Confidence 988 999999865433211 123457889999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=224.79 Aligned_cols=182 Identities=29% Similarity=0.400 Sum_probs=143.3
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcC-------CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccc
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRE-------TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~-------tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
.+.+..++|.+++.||+|+||.||++++.. ....+|+|.+.... ......+.
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-------------------- 65 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLI-------------------- 65 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHH--------------------
Confidence 345666789999999999999999998642 34578999876432 22222233
Q ss_pred cccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------------CCCCCHHHHHHHH
Q psy5063 546 NLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFA 609 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------------~~~l~~~~~~~i~ 609 (681)
+|+.+++.+ +||||+++++++..++..|++|||+++|+|.+++... ...+++..+..++
T Consensus 66 -----~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (314)
T cd05099 66 -----SEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCA 140 (314)
T ss_pred -----HHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHH
Confidence 358899999 6999999999999999999999999999999999652 1348899999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 610 ~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.|++.||.|||++|++||||||+|||++.++.+ +|||+++...............++..|||||++.+..|
T Consensus 141 ~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (314)
T cd05099 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY 213 (314)
T ss_pred HHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc
Confidence 999999999999999999999999999999987 99999986653222221112234567999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=222.07 Aligned_cols=171 Identities=23% Similarity=0.364 Sum_probs=144.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.+|+..+.||+|+||.||++.+..+++.+|+|.+..........+.. |+.+++.+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~-------------------------e~~~l~~~ 74 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-------------------------EILVMREN 74 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHH-------------------------HHHHHHhC
Confidence 57888899999999999999999999999999886544333333333 48899999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++.+..+...++||||+++++|.+++... .+++.++..++.|++.||.|||+++|+||||||+|||++.+
T Consensus 75 ~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~ 152 (296)
T cd06654 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152 (296)
T ss_pred CCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCC
Confidence 9999999999999999999999999999999998753 48899999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+.+ +|||+++....... ......+++.|+|||.+.+..
T Consensus 153 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 192 (296)
T cd06654 153 GSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKA 192 (296)
T ss_pred CCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCC
Confidence 987 99999886543221 112345888999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.8e-24 Score=226.96 Aligned_cols=183 Identities=27% Similarity=0.363 Sum_probs=144.0
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCC-------CeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRET-------GEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLI 544 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t-------g~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~ 544 (681)
+.+.+...+|++++.||+|+||.||++.+... +..+|+|.+.... ....+.+.
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~------------------- 65 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV------------------- 65 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHH-------------------
Confidence 44556667899999999999999999986432 2368999775422 22223333
Q ss_pred ccccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------------CCCCCHHHHHHH
Q psy5063 545 NNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNF 608 (681)
Q Consensus 545 ~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------------~~~l~~~~~~~i 608 (681)
+|+++++.+ +||||+++++++..++..+++|||+++|+|.+++... ...+++..+..+
T Consensus 66 ------~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 139 (334)
T cd05100 66 ------SEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139 (334)
T ss_pred ------HHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHH
Confidence 358899999 8999999999999999999999999999999998642 124788899999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 609 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 609 ~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.|++.||.|||+++|+||||||+|||++.++.+ +|||+++...............++..|||||++.+..|
T Consensus 140 ~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 213 (334)
T cd05100 140 AYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY 213 (334)
T ss_pred HHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc
Confidence 9999999999999999999999999999999987 99999987654322222222234567999999876654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=222.90 Aligned_cols=169 Identities=18% Similarity=0.268 Sum_probs=136.3
Q ss_pred CCCeeec--ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRG--PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~--~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.+++... ..||+|++|.||+|.+ +|+.||+|.+....... +.+.+ .+.+|+.+|
T Consensus 17 ~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~-~~~~~---------------------~~~~E~~~l 72 (283)
T PHA02988 17 SDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGH-KVLID---------------------ITENEIKNL 72 (283)
T ss_pred HHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEecccccccc-HHHHH---------------------HHHHHHHHH
Confidence 3444444 5799999999999998 58999999986543221 11111 123569999
Q ss_pred HhCCCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCC
Q psy5063 557 RSLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNS 631 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp 631 (681)
+.++||||++++|++.+ ...+++||||+++|+|.+++.... .+++.....++.|++.||.|||+ .+++||||||
T Consensus 73 ~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp 151 (283)
T PHA02988 73 RRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS 151 (283)
T ss_pred HhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCCh
Confidence 99999999999999877 357899999999999999998654 58999999999999999999998 4999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||+++++.+ +|||+++...... ....++..|+|||++.+
T Consensus 152 ~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 152 VSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLND 194 (283)
T ss_pred hhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhh
Confidence 99999999988 9999998654321 12457899999999865
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-25 Score=225.60 Aligned_cols=179 Identities=25% Similarity=0.356 Sum_probs=143.0
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCe----EEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGE----VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~----~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
-....|+....||+|+||.|||+...++.. .+|+|+++... .+......+.||
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k-----------------------d~tGiS~SAcRE 77 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK-----------------------DGTGISMSACRE 77 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC-----------------------CCCCcCHHHHHH
Confidence 334578888999999999999997655432 56666553221 122334456789
Q ss_pred HHHHHhCCCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDP----GQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 627 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~----~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHR 627 (681)
+.+++.++||||+.|..+|.+ +..+||++||.+. +|..+++-. ...++...+++++.||+.|+.|||++-|+||
T Consensus 78 iaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHR 156 (438)
T KOG0666|consen 78 IALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHR 156 (438)
T ss_pred HHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeec
Confidence 999999999999999999987 8899999999977 888888632 3468999999999999999999999999999
Q ss_pred CCCCCcEEEecC----CCe--EEeeeeeEeeecc-cceeeeecCCCccccchhhccCCC
Q psy5063 628 DLNSQNCLVREV----GSG--FDFHLGQIYLIYV-PYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 628 DLKp~NILl~~~----g~~--~DFGLa~~~~~~~-~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||||.||||..+ |.+ +||||||.+.... +.......+.|..|.|||+|.+..
T Consensus 157 DLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~ 215 (438)
T KOG0666|consen 157 DLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGAR 215 (438)
T ss_pred cCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccc
Confidence 999999999998 666 9999999987643 222223344688999999999875
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-23 Score=213.31 Aligned_cols=172 Identities=23% Similarity=0.363 Sum_probs=146.0
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+..++||+|+||.||.++...+++.+++|.+.... ....+.+. +|+++|+.
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-------------------------NEIVILSL 55 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHH-------------------------HHHHHHHh
Confidence 4788899999999999999999999999999886432 22333333 35999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++|+||+++++++.+.+.++++|||+++|+|.+++... ...+++..+..++.|++.||.|||+.+++|+||||+||+++
T Consensus 56 ~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~ 135 (256)
T cd08221 56 LQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT 135 (256)
T ss_pred CCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe
Confidence 99999999999999999999999999999999999764 34589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++.+ +|||+++....... ......+++.|+|||++.+..
T Consensus 136 ~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~ 177 (256)
T cd08221 136 KAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVK 177 (256)
T ss_pred CCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCC
Confidence 99988 99999987754331 223345889999999986653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=217.65 Aligned_cols=175 Identities=27% Similarity=0.394 Sum_probs=143.1
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..+.||+|+||.||+|... ++..+|+|.+..... ..+.+. +|+.++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~-~~~~~~-------------------------~e~~~l 55 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM-SVQAFL-------------------------EEANLM 55 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch-hHHHHH-------------------------HHHHHH
Confidence 55678999999999999999999975 466799998754332 222333 358999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++|+||+++++.+..++..+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+++++||||||+||+
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil 135 (261)
T cd05072 56 KTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL 135 (261)
T ss_pred HhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE
Confidence 9999999999999999999999999999999999998653 345889999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.++.+ +|||+++...... ........++..|+|||++.+..
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 180 (261)
T cd05072 136 VSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGS 180 (261)
T ss_pred ecCCCcEEECCCccceecCCCc-eeccCCCccceecCCHHHhccCC
Confidence 9999987 9999998765322 11122233567899999986654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=216.82 Aligned_cols=175 Identities=27% Similarity=0.356 Sum_probs=142.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|...+.||+|+||.||+|.+.. ++.+|+|.+..... ..+.+. +|+.++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~-~~~~~~-------------------------~e~~~l 55 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM-DPKDFL-------------------------AEAQIM 55 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc-cHHHHH-------------------------HHHHHH
Confidence 456789999999999999999999754 57899998854322 222333 358999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++||||+++++++...+..+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||+
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 135 (261)
T cd05068 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVL 135 (261)
T ss_pred HHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEE
Confidence 99999999999999999999999999999999999997643 45899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++++.+ +|||+++...... .........+..|+|||++.+..
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 180 (261)
T cd05068 136 VGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNR 180 (261)
T ss_pred EcCCCCEEECCcceEEEccCCc-ccccCCCcCceeccCccccccCC
Confidence 9999988 9999998876322 11111122345799999986644
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=217.35 Aligned_cols=177 Identities=29% Similarity=0.427 Sum_probs=142.8
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCe---EEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGE---VMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~---~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
..++|...+.||+|+||.||+|+...+++ .+|+|.+.... ......+.. |+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~-------------------------e~ 57 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-------------------------EA 57 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHH-------------------------HH
Confidence 34678888999999999999999876654 78999875432 222333333 48
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++++.++|+||+++++++...+..++||||+++++|.+++......+++..+..++.|++.||+|||+.+++||||||+|
T Consensus 58 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N 137 (268)
T cd05063 58 SIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARN 137 (268)
T ss_pred HHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhh
Confidence 89999999999999999999999999999999999999998765668999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceee-eecCCCccccchhhccCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLF-ILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~-~~~~gt~~Y~APEvL~~~~ 679 (681)
||++.++.. +|||+++........... .....+..|+|||++....
T Consensus 138 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (268)
T cd05063 138 ILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186 (268)
T ss_pred EEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCC
Confidence 999999887 999999876543211111 1112345799999987654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-24 Score=218.13 Aligned_cols=174 Identities=31% Similarity=0.459 Sum_probs=142.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||++.+.. +..+|+|.+..... ....+. +|+.+++.
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~-------------------------~e~~~l~~ 55 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFI-------------------------EEAKVMMK 55 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHH-------------------------HHHHHHhc
Confidence 4678899999999999999998764 45699998754322 222333 34899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++...+..++||||+++|+|.+++......+++..+..++.|++.||.|||+.+++|+||||+|||++.
T Consensus 56 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred CCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 99999999999999889999999999999999999765556899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...... ........++..|++||++.+..|
T Consensus 136 ~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~ 178 (256)
T cd05113 136 QGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKF 178 (256)
T ss_pred CCCEEECCCccceecCCCc-eeecCCCccChhhCCHHHHhcCcc
Confidence 9988 9999998664322 222222335677999999875543
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=216.29 Aligned_cols=177 Identities=27% Similarity=0.436 Sum_probs=141.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.+|..++.||+|+||.||++.+..+++.||+|.+...... ..+. .+ .+.+|+.+++
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~-~~---------------------~~~~E~~~l~ 59 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VN---------------------ALECEIQLLK 59 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHH-HH---------------------HHHHHHHHHH
Confidence 5788999999999999999999999999999987532111 1110 00 1234689999
Q ss_pred hCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 558 SLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
.++||||+++++++.+. ..++++|||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+|||
T Consensus 60 ~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil 138 (265)
T cd06652 60 NLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANIL 138 (265)
T ss_pred hcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 99999999999998763 57889999999999999987643 4888999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecc-cceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYV-PYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~-~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.++.+ +|||+++...... .........++..|+|||++.+..
T Consensus 139 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (265)
T cd06652 139 RDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185 (265)
T ss_pred ecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCC
Confidence 9999988 8999998654311 111122345788999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=217.24 Aligned_cols=173 Identities=28% Similarity=0.386 Sum_probs=136.8
Q ss_pred eeecceecccCcEEEEEEEEcCC---CeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRET---GEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~t---g~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
|.+++.||+|+||.||+|....+ +..+|+|.+.... ......+. +|+..|
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------~e~~~l 55 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-------------------------SEAACM 55 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHH-------------------------HHHHHH
Confidence 45678999999999999997653 4789999886432 12222333 458899
Q ss_pred HhCCCCceeeEEEEEEeCCe------EEEEEeccCCCCHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy5063 557 RSLHHHNVIRFIGVLYKDRK------LNLVTEYIAGGTLKELLQDP-----GQPLPWGQRVNFARDIAAGMTYLHSMNLI 625 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~------l~LV~Ey~~gGsL~~~L~~~-----~~~l~~~~~~~i~~QIa~gL~yLHs~~II 625 (681)
+.++||||+++++++..... .+++|||+++|+|..++... ...+++..+..++.|++.||.|||+++++
T Consensus 56 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~ 135 (273)
T cd05035 56 KDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFI 135 (273)
T ss_pred HhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99999999999998866544 79999999999999988432 23589999999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 626 HRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||||||+||++++++.+ +|||+++.......+........+..|+|||++.+..
T Consensus 136 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 191 (273)
T cd05035 136 HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV 191 (273)
T ss_pred ccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCC
Confidence 99999999999999887 9999998775433222222233567899999986554
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-24 Score=219.67 Aligned_cols=174 Identities=29% Similarity=0.420 Sum_probs=145.2
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
..+|...+.||+|+||.||+|.+.. ++.+|+|.+..........+.. |+.+++.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~-------------------------e~~~l~~ 58 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQK-------------------------EVQALKR 58 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHH-------------------------HHHHHhc
Confidence 4578899999999999999999987 8899999886654433333333 4889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++|+||+++++++...+..++||||+++|+|.+++.+. ...+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 59 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~ 138 (261)
T cd05148 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138 (261)
T ss_pred CCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc
Confidence 99999999999999999999999999999999999763 34589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||++....... .......++..|+|||++.+..|
T Consensus 139 ~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~ 181 (261)
T cd05148 139 EDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTF 181 (261)
T ss_pred CCceEEEccccchhhcCCcc--ccccCCCCceEecCHHHHccCCC
Confidence 99888 8999998764322 11123345678999999876543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=220.32 Aligned_cols=160 Identities=21% Similarity=0.289 Sum_probs=127.9
Q ss_pred eecccCcEEEEEEEEcCCC------------------------eEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCC
Q psy5063 487 LLGQGFFGQVYRVTHRETG------------------------EVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~~tg------------------------~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~ 542 (681)
.||+|+||.||+|....++ ..+|+|.+..........+.
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~----------------- 64 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFF----------------- 64 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHH-----------------
Confidence 5899999999999854222 35777877443222222233
Q ss_pred ccccccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy5063 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM 622 (681)
Q Consensus 543 ~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~ 622 (681)
+|+.+++.++||||+++++++..+...++||||+++|+|.+++......+++..+..++.|++.||+|||++
T Consensus 65 --------~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 136 (274)
T cd05076 65 --------ETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK 136 (274)
T ss_pred --------HHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC
Confidence 348899999999999999999999999999999999999999976555689999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCC-------e--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 623 NLIHRDLNSQNCLVREVGS-------G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~~g~-------~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|+||||||+|||++..+. + +|||++...... ....++..|+|||.+.+
T Consensus 137 ~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 137 NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPG 194 (274)
T ss_pred CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcC
Confidence 9999999999999987542 2 799987654321 12346788999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-23 Score=212.40 Aligned_cols=172 Identities=24% Similarity=0.366 Sum_probs=142.5
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+..+.||+|+||.||++.+..+++.+|+|.+.... ....+.+ .+|+++++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-------------------------~~e~~~l~~ 55 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAA-------------------------EQEAQLLSQ 55 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHH-------------------------HHHHHHHHh
Confidence 4788999999999999999999999999999985432 1222222 235889999
Q ss_pred CCCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 559 LHHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 559 L~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
++|+|++++++.+.. +..++++|||+++++|.+++... ...+++.++..++.|++.|+.|||+++++||||||+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~ 135 (257)
T cd08223 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL 135 (257)
T ss_pred CCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE
Confidence 999999999998864 45789999999999999998763 3458999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+.++.+ +|||+++...... .......+++.|+|||++.+..
T Consensus 136 ~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 178 (257)
T cd08223 136 TRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKP 178 (257)
T ss_pred ecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcCCC
Confidence 999988 9999998765322 2223455789999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-24 Score=223.76 Aligned_cols=178 Identities=25% Similarity=0.373 Sum_probs=142.7
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCe----EEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGE----VMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~----~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
++..++|+..+.||+|+||.||++.+..+++ .+|+|.+..... .....+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~------------------------- 57 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFM------------------------- 57 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHH-------------------------
Confidence 4667889999999999999999999987776 467887654322 2222233
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+|+.+++.++||||+++++++... ..++++||+++|+|.+++......+++..+..++.|++.||.|||+++|+|||||
T Consensus 58 ~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dik 136 (303)
T cd05110 58 DEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLA 136 (303)
T ss_pred HHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccc
Confidence 358899999999999999998754 5779999999999999998765568999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|+|||++.++.+ +|||+++...............++..|+|||++.+..
T Consensus 137 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (303)
T cd05110 137 ARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187 (303)
T ss_pred cceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCC
Confidence 999999998887 9999998765432221222233567899999987654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=214.28 Aligned_cols=169 Identities=33% Similarity=0.470 Sum_probs=142.1
Q ss_pred ceecccCcEEEEEEEEcCC---CeEEEEEEeeccCHHH-HHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRET---GEVMVLKELYRVDEEA-EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~t---g~~vAiK~l~~~~~~~-~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
+.||+|+||.||++.+... +..+++|.+....... .+.+. +|+++++.++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~e~~~l~~~~~ 55 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFL-------------------------KEARVMKKLGH 55 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHH-------------------------HHHHHHhhcCC
Confidence 4699999999999999866 8899999886543322 22233 35899999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~--------~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
+||+++++++..+...++||||+++++|.+++... ...+++..+..++.|++.||.|||+++++||||||+|
T Consensus 56 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~n 135 (262)
T cd00192 56 PNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARN 135 (262)
T ss_pred CChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcce
Confidence 99999999999999999999999999999999875 4569999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|+++.++.+ +|||+++...............++..|+|||.+....
T Consensus 136 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (262)
T cd00192 136 CLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183 (262)
T ss_pred EEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCC
Confidence 999999988 9999998876543222233455788999999987643
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-24 Score=223.63 Aligned_cols=175 Identities=28% Similarity=0.421 Sum_probs=139.1
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeE--EEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEV--MVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~--vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+..++|+..+.||+|+||.||+|.++.++.. +|+|.+.... ......+. +|+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~Ei 58 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFA-------------------------GEL 58 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHH-------------------------HHH
Confidence 4457899999999999999999999877764 4667654322 22222333 358
Q ss_pred HHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHH
Q psy5063 554 AVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMT 617 (681)
Q Consensus 554 ~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~i~~QIa~gL~ 617 (681)
+++..+ +|+||+++++++..++..|+||||+++|+|.+++.... ..+++..+..++.|++.||+
T Consensus 59 ~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ 138 (303)
T cd05088 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 138 (303)
T ss_pred HHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHH
Confidence 899999 89999999999999999999999999999999986432 24789999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 618 YLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 618 yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||+++|+||||||+|||++.++.+ +|||+++..... ........+..|+|||++.+..
T Consensus 139 ~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~ 199 (303)
T cd05088 139 YLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSV 199 (303)
T ss_pred HHHhCCccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccC
Confidence 9999999999999999999999988 999998643211 1111123456799999986654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-24 Score=221.75 Aligned_cols=171 Identities=32% Similarity=0.505 Sum_probs=138.0
Q ss_pred eecceecccCcEEEEEEEEc----CCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 483 VRGPLLGQGFFGQVYRVTHR----ETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~----~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.+.+.||.|.||.||+|.+. ..+..|++|.+... .....+.+.+| ++.|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e-------------------------~~~l~ 56 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNE-------------------------IQILR 56 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHH-------------------------HHHHH
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeec-------------------------ccccc
Confidence 45678999999999999998 45678999999543 33345555555 89999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
.++||||++++|++...+..++||||+++|+|.++|... ...+++..+..++.||+.||.|||+++++|+||+++|||+
T Consensus 57 ~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill 136 (259)
T PF07714_consen 57 KLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL 136 (259)
T ss_dssp THSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999888899999999999999999876 4569999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.++.+ +|||+++...................|+|||++.+.
T Consensus 137 ~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 180 (259)
T PF07714_consen 137 DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG 180 (259)
T ss_dssp ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc
Confidence 999988 999999877332222222334477889999998654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-24 Score=219.85 Aligned_cols=177 Identities=28% Similarity=0.417 Sum_probs=141.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
.++|.+.+.||+|+||.||+|.+.. ++..+|+|.+.... ......+.+ |
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~-------------------------e 59 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-------------------------E 59 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHH-------------------------H
Confidence 4678889999999999999999987 77899999875432 223333444 4
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG------QPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~------~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
+.+++.++|+||+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.||+.||+|||+++++|
T Consensus 60 ~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 139 (277)
T cd05036 60 ALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIH 139 (277)
T ss_pred HHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 899999999999999999999999999999999999999986532 24889999999999999999999999999
Q ss_pred cCCCCCcEEEecCCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||+|||++.++. + +|||+++................+..|+|||++.+..|
T Consensus 140 ~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05036 140 RDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF 198 (277)
T ss_pred cccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCc
Confidence 999999999997663 3 99999987632211111111223567999999865543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.9e-24 Score=229.16 Aligned_cols=166 Identities=23% Similarity=0.330 Sum_probs=138.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||++.+..+++.||+|.+.+.... ..+. ..+|+.+|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------------------------~~~E~~~l 68 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR-------------------------TYRELRLL 68 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHH-------------------------HHHHHHHH
Confidence 36788899999999999999999999999999988643211 1111 23469999
Q ss_pred HhCCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++... ...|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||+++|+|||||
T Consensus 69 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdik 145 (343)
T cd07878 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLK 145 (343)
T ss_pred HhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCC
Confidence 999999999999988543 4579999988 7899988864 349999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|+|||++.++.+ +|||+++...... ....+|..|+|||++.+
T Consensus 146 p~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 146 PSNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLN 189 (343)
T ss_pred hhhEEECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcC
Confidence 999999999988 9999998754321 23458999999999876
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.6e-24 Score=218.41 Aligned_cols=167 Identities=26% Similarity=0.268 Sum_probs=132.2
Q ss_pred ceecccCcEEEEEEEEc--CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 486 PLLGQGFFGQVYRVTHR--ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~--~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
+.||+|+||.||+|... .++..+|+|.+.... ......+. +|+.+++.++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-------------------------~E~~~l~~l~h~ 55 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFL-------------------------EEAQPYRSLQHS 55 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHH-------------------------HHHHHHHhCCCC
Confidence 36899999999999864 345679999875433 22222333 358999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP----GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~----~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
||+++++++.+....++||||+++|+|.+++... ....++..+..++.|++.||+|||+++++||||||+||+++.
T Consensus 56 ~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~ 135 (269)
T cd05087 56 NLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTA 135 (269)
T ss_pred CEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcC
Confidence 9999999999999999999999999999998642 124567788899999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++.+ +|||+++.......+.......++..|+|||++.+
T Consensus 136 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05087 136 DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176 (269)
T ss_pred CCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcc
Confidence 9888 99999975443222121122346788999999854
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-24 Score=216.68 Aligned_cols=160 Identities=22% Similarity=0.332 Sum_probs=131.6
Q ss_pred ceecccCcEEEEEEEEcCCC----------eEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 486 PLLGQGFFGQVYRVTHRETG----------EVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg----------~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+. +|+.+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~-------------------------~e~~~ 54 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFF-------------------------ETASL 54 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHH-------------------------HHHHH
Confidence 46899999999999998776 34777765433222 23333 34889
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
|+.++||||+++++++.. ...++||||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 55 l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nil 133 (259)
T cd05037 55 MSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNIL 133 (259)
T ss_pred HHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEE
Confidence 999999999999999888 7789999999999999999875546899999999999999999999999999999999999
Q ss_pred EecCC-------Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 636 VREVG-------SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 636 l~~~g-------~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++.++ .+ +|||+++.... .....++..|+|||++.+.
T Consensus 134 l~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 134 VARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNG 179 (259)
T ss_pred EecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCC
Confidence 99887 34 99999987543 1123467789999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=239.05 Aligned_cols=164 Identities=26% Similarity=0.451 Sum_probs=143.3
Q ss_pred eecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceee
Q psy5063 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIR 566 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~ 566 (681)
+||+|+||+||.|+++.|....|||.+...+.........| |++.+.|+|.|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEE-------------------------IaLH~~LrHkNIVr 636 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEE-------------------------IALHSTLRHKNIVR 636 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHH-------------------------HHHHHHHhhHhHHH
Confidence 79999999999999999999999999976554444444444 99999999999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec-CCCe-
Q psy5063 567 FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL--PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-VGSG- 642 (681)
Q Consensus 567 l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l--~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~-~g~~- 642 (681)
++|.+.+++.+-+.||-+|||+|.++|+..-+++ .+..+-.+.+||+.||.|||++.|||||||-+|+||+. .|.+
T Consensus 637 YLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlK 716 (1226)
T KOG4279|consen 637 YLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLK 716 (1226)
T ss_pred HhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEE
Confidence 9999999999999999999999999999877777 78889999999999999999999999999999999986 4444
Q ss_pred -EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 643 -FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 643 -~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||.++.+..-.| ...++.||..|||||++..
T Consensus 717 ISDFGTsKRLAginP--~TETFTGTLQYMAPEvIDq 750 (1226)
T KOG4279|consen 717 ISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDQ 750 (1226)
T ss_pred ecccccchhhccCCc--cccccccchhhhChHhhcc
Confidence 99999988765443 3456889999999999854
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=220.22 Aligned_cols=172 Identities=26% Similarity=0.404 Sum_probs=142.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|..+.+++.||+|.+........ .....+|+++++.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~------------------------~~~~~~E~~~l~~ 59 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA------------------------PFTAIREASLLKD 59 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCC------------------------chhHHHHHHHHhh
Confidence 4689999999999999999999998999999998854321110 0112356999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+||+++++++.+++..++||||+++ +|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 60 l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~ 138 (291)
T cd07844 60 LKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE 138 (291)
T ss_pred CCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC
Confidence 9999999999999999999999999975 999998766557899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|.+ +|||+++...... .......++..|+|||++.+
T Consensus 139 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 139 RGELKLADFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCCEEECccccccccCCCC--ccccccccccccCCcHHhhc
Confidence 9988 9999987543211 11122346788999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=217.88 Aligned_cols=161 Identities=19% Similarity=0.284 Sum_probs=130.2
Q ss_pred ceecccCcEEEEEEEEcCC------------CeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 486 PLLGQGFFGQVYRVTHRET------------GEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~t------------g~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+.||+|+||.||+|+.... ...+++|.+..........+.+ |+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~-------------------------~~ 55 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFE-------------------------TA 55 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHH-------------------------HH
Confidence 3689999999999985422 2357888765433333333333 48
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+++.++||||+++++++..+...++||||+++|+|..++......+++..+..++.||+.||+|||+++|+||||||+|
T Consensus 56 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 135 (262)
T cd05077 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKN 135 (262)
T ss_pred HHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCccc
Confidence 89999999999999999999999999999999999999987665669999999999999999999999999999999999
Q ss_pred EEEecCCC-------e--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 634 CLVREVGS-------G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 634 ILl~~~g~-------~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||++.++. + +|||++...... ....++..|+|||++.+
T Consensus 136 ill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~ 182 (262)
T cd05077 136 ILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVED 182 (262)
T ss_pred EEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcC
Confidence 99987764 3 799998765421 12347889999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=223.51 Aligned_cols=167 Identities=28% Similarity=0.399 Sum_probs=130.3
Q ss_pred cceecccCcEEEEEEEEc--CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 485 GPLLGQGFFGQVYRVTHR--ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~--~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
++.||+|+||.||+|+++ .+++.+|+|.+...... .. ..+|+++|+.++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~--~~-------------------------~~~E~~~l~~l~h~ 58 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MS-------------------------ACREIALLRELKHP 58 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc--HH-------------------------HHHHHHHHHhcCCC
Confidence 568999999999999976 36789999988543211 11 23469999999999
Q ss_pred ceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 563 NVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDP--------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 563 nIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~--------~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
||+++++++.. +...|++|||++ ++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+
T Consensus 59 niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~ 137 (317)
T cd07868 59 NVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPA 137 (317)
T ss_pred CCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHH
Confidence 99999999864 467899999995 5888887531 225889999999999999999999999999999999
Q ss_pred cEEEe----cCCCe--EEeeeeeEeeecc-cceeeeecCCCccccchhhccCCC
Q psy5063 633 NCLVR----EVGSG--FDFHLGQIYLIYV-PYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 633 NILl~----~~g~~--~DFGLa~~~~~~~-~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||++ .++.+ +|||+++...... +........+|+.|+|||++.+..
T Consensus 138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 191 (317)
T cd07868 138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 191 (317)
T ss_pred HEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCC
Confidence 99994 44555 9999998765322 112223356899999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-23 Score=215.28 Aligned_cols=171 Identities=24% Similarity=0.391 Sum_probs=140.3
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
++..-..||+|+||.||+|.+..++..+|+|.+........+.+.+ |+.+++.++
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~-------------------------e~~~l~~l~ 63 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE-------------------------EIALHSYLK 63 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHH-------------------------HHHHHHhcC
Confidence 3333457999999999999999999999999887655444444444 488999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL--PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l--~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
|+||+++++++..++..++|+||+++++|.+++......+ ++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 64 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~ 143 (268)
T cd06624 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNT 143 (268)
T ss_pred CCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcC
Confidence 9999999999999999999999999999999998654445 88889999999999999999999999999999999987
Q ss_pred -CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 -VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 -~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++.+ +|||++........ ......++..|+|||++.+.
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~ 184 (268)
T cd06624 144 YSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKG 184 (268)
T ss_pred CCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccc
Confidence 4555 99999986543221 12234578999999998543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-24 Score=235.56 Aligned_cols=181 Identities=23% Similarity=0.314 Sum_probs=151.4
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...+-|..++.||-|+||+|.++...+|...||+|.+.+.+.-...+ ..|...|-.||
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQ----------------------vaHVKAERDIL 683 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQ----------------------VAHVKAERDIL 683 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhh----------------------hhhhhhhhhhH
Confidence 44567889999999999999999999999999999987655433322 12334567899
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
...+++-||+||-.|.+.+.+|+||||++||++..+|...+ .|++..+.+|+.++..|+++.|.+|+|||||||+||||
T Consensus 684 AEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI 762 (1034)
T KOG0608|consen 684 AEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI 762 (1034)
T ss_pred hhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE
Confidence 99999999999999999999999999999999999998766 49999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeee---------cc-------------------------------cceeeeecCCCccccchhh
Q psy5063 637 REVGSG--FDFHLGQIYLI---------YV-------------------------------PYTLFILSAKTKKTYYPNI 674 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~---------~~-------------------------------~~~~~~~~~gt~~Y~APEv 674 (681)
|.+|.+ .||||..-+.= +. ........+||+.|+||||
T Consensus 763 DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapev 842 (1034)
T KOG0608|consen 763 DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEV 842 (1034)
T ss_pred ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHH
Confidence 999999 99999765431 00 0001123459999999999
Q ss_pred ccCCCC
Q psy5063 675 LKKASF 680 (681)
Q Consensus 675 L~~~~Y 680 (681)
|.+..|
T Consensus 843 l~r~g~ 848 (1034)
T KOG0608|consen 843 LARTGY 848 (1034)
T ss_pred hcccCc
Confidence 988766
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=221.09 Aligned_cols=178 Identities=26% Similarity=0.397 Sum_probs=140.7
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcC----------------CCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccC
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRE----------------TGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLG 539 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~----------------tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~ 539 (681)
|..++|++.+.||+|+||.||++.+.. ++..+|+|.+... .......+..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~------------- 68 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK------------- 68 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHH-------------
Confidence 445689999999999999999986542 3457899988643 2223333444
Q ss_pred CCCccccccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC----------CCCCHHHHHHHH
Q psy5063 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG----------QPLPWGQRVNFA 609 (681)
Q Consensus 540 ~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~----------~~l~~~~~~~i~ 609 (681)
|+++|+.++|+||+++++++..++..++||||+++|+|.+++.... ..+++..+..++
T Consensus 69 ------------E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (296)
T cd05095 69 ------------EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMA 136 (296)
T ss_pred ------------HHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHH
Confidence 4899999999999999999999999999999999999999986532 236778899999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 610 ~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.|++.||+|||+++++||||||+|||++.++.+ +|||+++................+..|+|||+..+..
T Consensus 137 ~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 208 (296)
T cd05095 137 TQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK 208 (296)
T ss_pred HHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC
Confidence 999999999999999999999999999998887 9999998664332212122233467899999876544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=216.53 Aligned_cols=173 Identities=28% Similarity=0.378 Sum_probs=135.4
Q ss_pred eecceecccCcEEEEEEEEcCCCe--EEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGE--VMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~--~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+++.||+|+||.||+|.+..++. .+|+|.+.... ......+. +|+++|+.
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~-------------------------~E~~~l~~ 56 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFL-------------------------SEAVCMKE 56 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHH-------------------------HHHHHHHh
Confidence 467889999999999999887775 58999875432 22233333 35889999
Q ss_pred CCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy5063 559 LHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQD-----PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 627 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~-----~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHR 627 (681)
++|+||+++++++... ...+++|||+++|+|.+++.. ....+++..+..++.|++.||.|||+++|+||
T Consensus 57 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 136 (272)
T cd05075 57 FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR 136 (272)
T ss_pred CCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 9999999999987532 357899999999999988742 22358899999999999999999999999999
Q ss_pred CCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 628 DLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 628 DLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||||+|||+++++.+ +|||+++...............++..|+|||++.+..|
T Consensus 137 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 191 (272)
T cd05075 137 DLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY 191 (272)
T ss_pred ccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCc
Confidence 999999999999988 99999987654332222222345678999999876543
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=223.51 Aligned_cols=170 Identities=18% Similarity=0.251 Sum_probs=134.2
Q ss_pred ecceeccc--CcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 484 RGPLLGQG--FFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 484 ~~~~LG~G--~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
+.++||+| +||.||+++++.+|+.||+|.+..... .....+++ +|+.+++.++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------------------~e~~~l~~l~ 57 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQ------------------------GELHVSKLFN 57 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHH------------------------HHHHHHHhcC
Confidence 45789999 789999999999999999999854321 11112222 3588999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
||||+++++++..++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 58 hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~ 137 (327)
T cd08227 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137 (327)
T ss_pred CCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC
Confidence 999999999999999999999999999999998653 3458999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccce-----eeeecCCCccccchhhccC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYT-----LFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~-----~~~~~~gt~~Y~APEvL~~ 677 (681)
+.+ .||+............ ......++..|+|||++.+
T Consensus 138 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 138 GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred CcEEEcccchhhccccccccccccccccccccceecccChHHhhc
Confidence 987 6776543322111000 0112346778999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=215.43 Aligned_cols=178 Identities=27% Similarity=0.437 Sum_probs=142.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH-HHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA-EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~-~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+|+.++.||+|+||.||++.+..++..+|+|.+....... ...... .+.+|+.+++.
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~---------------------~~~~e~~~l~~ 60 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVS---------------------ALECEIQLLKN 60 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHH---------------------HHHHHHHHHHH
Confidence 47888999999999999999999999999999886432111 000000 12346899999
Q ss_pred CCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 559 LHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 559 L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
++||||+++++++.. +..+++++||+++++|.+++.... .+++.....++.|++.||.|||+++|+||||||+||++
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~ 139 (266)
T cd06651 61 LQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR 139 (266)
T ss_pred cCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 999999999999875 467899999999999999997644 48999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecc-cceeeeecCCCccccchhhccCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYV-PYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~-~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+.++.+ +|||+++...... .........++..|+|||++.+..
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (266)
T cd06651 140 DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185 (266)
T ss_pred CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCC
Confidence 999887 9999998654211 111122345788999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=215.90 Aligned_cols=178 Identities=24% Similarity=0.451 Sum_probs=143.0
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+.++.||+|+||.||++....+++.+|+|.+...... ......+ .+.+|+++++.
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~---------------------~~~~e~~~l~~ 59 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE---------------------ALRKEIRLMAR 59 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHH---------------------HHHHHHHHHHH
Confidence 467788999999999999999999999999988643211 1111111 12356999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+||+++++++.+.+..++||||+++++|.+++.... ++++..+..++.|++.||.|||+++++||||||+||+++.
T Consensus 60 l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~ 138 (268)
T cd06630 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS 138 (268)
T ss_pred cCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 999999999999999999999999999999999997643 5899999999999999999999999999999999999988
Q ss_pred CCC-e--EEeeeeeEeeecccce--eeeecCCCccccchhhccCCCC
Q psy5063 639 VGS-G--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~-~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++. + +|||++.......... ......++..|+|||++.+..|
T Consensus 139 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~ 185 (268)
T cd06630 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY 185 (268)
T ss_pred CCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCC
Confidence 775 3 9999998765431110 1112347889999999876543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=212.71 Aligned_cols=172 Identities=23% Similarity=0.399 Sum_probs=147.1
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||++.+..+++.+++|.+..... ...+.+ |+++++.
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~-------------------------e~~~~~~ 54 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIK-------------------------EISILKQ 54 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHH-------------------------HHHHHHh
Confidence 4678899999999999999999998899999998854322 233333 4889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+||+++++++..+...|+++||+++++|.+++......+++..+..++.|++.||.|||+.+++||||+|+||+++.
T Consensus 55 l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~ 134 (256)
T cd06612 55 CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134 (256)
T ss_pred CCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC
Confidence 99999999999999999999999999999999999876667999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.+ +|||++........ ......++..|+|||++.+..
T Consensus 135 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~ 175 (256)
T cd06612 135 EGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIG 175 (256)
T ss_pred CCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCC
Confidence 9988 99999987654321 122344788999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.7e-25 Score=223.87 Aligned_cols=165 Identities=22% Similarity=0.377 Sum_probs=140.5
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CCCc
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHN 563 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~Hpn 563 (681)
.+.||+|+|+.|--+....+|..||||++.+......... +||++++... .|+|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~Rv-------------------------fREVe~f~~Cqgh~n 137 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRV-------------------------FREVETFYQCQGHKN 137 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHH-------------------------HHHHHHHHHhcCCcc
Confidence 4689999999999999999999999999976644444433 4569999888 6999
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe-
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG- 642 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~- 642 (681)
|+.|+++|+++.++|||||-|.||+|...+.++. .|++.++..+.++|+.||+|||.+||.||||||+|||-.....+
T Consensus 138 ilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vs 216 (463)
T KOG0607|consen 138 ILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVS 216 (463)
T ss_pred HHHHHHHhcccceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcC
Confidence 9999999999999999999999999999998754 59999999999999999999999999999999999999987766
Q ss_pred ----EEeeeeeEeeecccc-----eeeeecCCCccccchhhc
Q psy5063 643 ----FDFHLGQIYLIYVPY-----TLFILSAKTKKTYYPNIL 675 (681)
Q Consensus 643 ----~DFGLa~~~~~~~~~-----~~~~~~~gt~~Y~APEvL 675 (681)
+||.|+.-.....+- ....+++|+..|||||+.
T Consensus 217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVV 258 (463)
T KOG0607|consen 217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV 258 (463)
T ss_pred ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHH
Confidence 899988765432221 222356799999999985
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=215.32 Aligned_cols=181 Identities=27% Similarity=0.433 Sum_probs=144.0
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHH-HHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKN-FLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~-~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
|..++.||+|+||.||+|.+..+++.+|+|.+.......... ...+. ...+.+|+.+++.++
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~-----------------~~~~~~e~~~l~~l~ 64 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSM-----------------LDALAREIALLKELQ 64 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHH-----------------HHHHHHHHHHHHhcC
Confidence 567789999999999999999899999999886533221110 00000 002345799999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+++++||||+|+|||+++++
T Consensus 65 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~ 143 (267)
T cd06628 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG 143 (267)
T ss_pred CCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC
Confidence 999999999999999999999999999999999765 3589999999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccce----eeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYT----LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~----~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||+++......... ......++..|+|||++.+..|
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~ 189 (267)
T cd06628 144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY 189 (267)
T ss_pred CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCC
Confidence 87 9999998775321111 1112347889999999876543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-24 Score=221.25 Aligned_cols=173 Identities=28% Similarity=0.437 Sum_probs=142.1
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
+|+..+.||+|+||.||++++..+|+.+|+|.+........ ....+.+|+++++.++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~-----------------------~~~~~~~ei~~l~~l~ 57 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-----------------------VPSSALREICLLKELK 57 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccccc-----------------------CccchhHHHHHHHhcC
Confidence 36778899999999999999999999999998854211100 0112345799999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
||||+++++++.+....++|+||++ ++|.+++......+++..+..++.||+.||.|||+++|+||||||+||+++.++
T Consensus 58 h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~ 136 (284)
T cd07839 58 HKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG 136 (284)
T ss_pred CCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC
Confidence 9999999999999999999999996 588888876555699999999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.+ +|||+++...... .......++..|+|||++.+..
T Consensus 137 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 175 (284)
T cd07839 137 ELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAK 175 (284)
T ss_pred cEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCc
Confidence 88 9999998654321 2223345788999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=218.89 Aligned_cols=175 Identities=25% Similarity=0.402 Sum_probs=142.7
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
+|...+.||+|+||.||+|.+..+++.||+|.+............. ..+..|+++++.++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~--------------------~~~~~e~~~l~~~~ 60 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN--------------------FTALREIKLLQELK 60 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhh--------------------HHHHHHHHHHhhcC
Confidence 3677889999999999999999999999999986543221000000 01234689999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|+||+++++++.+.+..++||||+ +|+|.+++......+++..+..++.||+.||.|||+++|+|+||||+|||++.+|
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~ 139 (298)
T cd07841 61 HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG 139 (298)
T ss_pred CCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC
Confidence 999999999999999999999999 9999999987554699999999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.+ +|||+++...... .......++..|+|||++.+.
T Consensus 140 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 177 (298)
T cd07841 140 VLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGA 177 (298)
T ss_pred CEEEccceeeeeccCCC--ccccccccceeeeCHHHHhCC
Confidence 88 9999998765432 112234467889999998553
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=219.04 Aligned_cols=177 Identities=25% Similarity=0.426 Sum_probs=142.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||++.+..+++.||+|.+.......... .. .+.+|+++++.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~-~~---------------------~~~~e~~~l~~~ 58 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQ-IQ---------------------QVFVERDILTFA 58 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHH-HH---------------------HHHHHHHHHHhC
Confidence 46888899999999999999999999999999886543211111 00 123458999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++.+..++.+++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|||++.+
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~ 137 (305)
T cd05609 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSM 137 (305)
T ss_pred CCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCC
Confidence 99999999999999999999999999999999997654 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccce-------------eeeecCCCccccchhhccCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYT-------------LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~-------------~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|.+ +|||+++......... ......++..|+|||.+.+..
T Consensus 138 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 192 (305)
T cd05609 138 GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG 192 (305)
T ss_pred CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCC
Confidence 988 9999987532111000 001234678899999986654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=214.33 Aligned_cols=167 Identities=25% Similarity=0.364 Sum_probs=132.6
Q ss_pred eecccCcEEEEEEEEc--CCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc
Q psy5063 487 LLGQGFFGQVYRVTHR--ETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN 563 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~--~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 563 (681)
.||+|+||.||+|.+. .++..+|+|.+..... ...+.+. +|+.+++.++|||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~-------------------------~E~~~l~~l~h~~ 56 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMM-------------------------REAEIMHQLDNPY 56 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHH-------------------------HHHHHHHhcCCCC
Confidence 4899999999999875 4466799998854322 2222333 4589999999999
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe-
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG- 642 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~- 642 (681)
|+++++++. ....++||||+++|+|.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++.+
T Consensus 57 ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~k 135 (257)
T cd05115 57 IVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAK 135 (257)
T ss_pred eEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEE
Confidence 999999875 457899999999999999997655679999999999999999999999999999999999999999887
Q ss_pred -EEeeeeeEeeecccce-eeeecCCCccccchhhccCCC
Q psy5063 643 -FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 643 -~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||+++......... ......++..|+|||++....
T Consensus 136 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05115 136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174 (257)
T ss_pred eccCCccccccCCccceeccCCCCCCcccCCHHHHccCC
Confidence 9999998654332211 111122356899999986554
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=213.51 Aligned_cols=170 Identities=31% Similarity=0.489 Sum_probs=142.7
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..+.||+|+||.||++... |+.+|+|.+..... ..+.+. +|+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~-------------------------~e~~~l 54 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFL-------------------------AEASVM 54 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHH-------------------------HHHHHH
Confidence 45678899999999999999999875 78999999865433 233333 458999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++|+||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+
T Consensus 55 ~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nil 134 (256)
T cd05039 55 TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVL 134 (256)
T ss_pred HhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEE
Confidence 99999999999999999999999999999999999997643 25899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.++.. +|||+++....... ....+..|+|||++....
T Consensus 135 i~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~ 175 (256)
T cd05039 135 VSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKK 175 (256)
T ss_pred EeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCc
Confidence 9999987 99999987643221 233466799999986543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=219.62 Aligned_cols=169 Identities=24% Similarity=0.414 Sum_probs=142.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|+..+.||+|+||.||++.+..+++.+|+|.+... .......+. +|+.+++.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII-------------------------MELDILHK 55 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHH-------------------------HHHHHHHh
Confidence 4688899999999999999999999999999988643 222223333 34889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~--~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NIL 635 (681)
++|+||+++++.+..++..|+||||+++++|..++... ...+++..+..++.|++.||.|||+ .+|+||||||+|||
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 135 (286)
T cd06622 56 AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVL 135 (286)
T ss_pred cCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEE
Confidence 99999999999999999999999999999999998763 2368999999999999999999997 59999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++.++.+ +|||+++...... .....++..|+|||++.+
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 175 (286)
T cd06622 136 VNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYMAPERIKS 175 (286)
T ss_pred ECCCCCEEEeecCCcccccCCc----cccCCCccCccCcchhcC
Confidence 9998887 9999997654322 223457889999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-24 Score=219.10 Aligned_cols=162 Identities=20% Similarity=0.303 Sum_probs=131.3
Q ss_pred ceecccCcEEEEEEEEcCCCe-------EEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 486 PLLGQGFFGQVYRVTHRETGE-------VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~-------~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+.||+|+||.||+|.++.++. .+|+|.+........+.+. .|+.+|+.
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFF-------------------------EAASMMSQ 55 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHH-------------------------HHHHHHHh
Confidence 369999999999999876544 3777766433322223333 34889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..+...++||||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 56 ~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~ 135 (258)
T cd05078 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIR 135 (258)
T ss_pred CCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEec
Confidence 99999999999999999999999999999999999876556899999999999999999999999999999999999988
Q ss_pred CCC--------e--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGS--------G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~--------~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++. + +|||++..... .....++..|+|||++.+.
T Consensus 136 ~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~ 179 (258)
T cd05078 136 EEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENP 179 (258)
T ss_pred ccccccCCCceEEecccccccccCC------chhccccCCccCchhccCC
Confidence 764 2 78888765432 1224578899999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=219.26 Aligned_cols=172 Identities=22% Similarity=0.375 Sum_probs=145.2
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.+|...+.||.|+||.||++.+..+++.+|+|.+........+.+. +|+++++.+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~-------------------------~e~~~l~~l 73 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELII-------------------------NEILVMKEL 73 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHH-------------------------HHHHHHHhc
Confidence 4688999999999999999999999999999988654333333333 358899999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++...+..|+|+||+++++|.+++... .+++.++..++.|++.||.|||+++++||||||+||+++.+
T Consensus 74 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~ 151 (296)
T cd06655 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD 151 (296)
T ss_pred CCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 9999999999999999999999999999999998753 48999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++........ .....++..|+|||.+.+..|
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~ 192 (296)
T cd06655 152 GSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAY 192 (296)
T ss_pred CCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCC
Confidence 988 999998865433211 122457889999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=215.57 Aligned_cols=170 Identities=25% Similarity=0.408 Sum_probs=142.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||++.++.+++.+|+|++..... ...+.+ .+|+.+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-------------------------~~e~~~l~ 55 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-------------------------LREIRMLK 55 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHH-------------------------HHHHHHHH
Confidence 368888999999999999999999999999998854321 111222 34599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++|+||+++++++..+...++||||++++.|..++.... .+++..+..++.|++.||.|||+++++||||||+||+++
T Consensus 56 ~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~ 134 (286)
T cd07847 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT 134 (286)
T ss_pred hCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc
Confidence 9999999999999999999999999999998888776543 589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
.++.+ +|||++........ ......++..|+|||++.+
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 135 KQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVG 174 (286)
T ss_pred CCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhC
Confidence 99988 99999987654321 1223457888999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG4577|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-26 Score=226.46 Aligned_cols=126 Identities=30% Similarity=0.719 Sum_probs=116.7
Q ss_pred CCCccccccccccccCceEEecCccccccCcccccCcCccCCceEeeCCeeeeccccccccCCcccccCCccccC-e-EE
Q psy5063 7 PEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGP-V-MV 84 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~g~-~-~~ 84 (681)
.++|+|++|.+.|.+.+++.++++.||..|++|+.|..+|..++|.++|.+||+.||+++||.||.+|.+.|... + -.
T Consensus 31 ~eip~CagC~q~IlDrFilKvl~R~wHs~CLkCs~C~~qL~drCFsR~~s~yCkedFfKrfGTKCsaC~~GIpPtqVVRk 110 (383)
T KOG4577|consen 31 VEIPICAGCDQHILDRFILKVLDRHWHSSCLKCSDCHDQLADRCFSREGSVYCKEDFFKRFGTKCSACQEGIPPTQVVRK 110 (383)
T ss_pred cccccccchHHHHHHHHHHHHHhhhhhhhhcchhhhhhHHHHHHhhcCCceeehHHHHHHhCCcchhhcCCCChHHHHHH
Confidence 367899999999999999999999999999999999999999999999999999999999999999999998654 3 34
Q ss_pred ecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 85 VGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 85 a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
|.+..||.+||.|..|++.|..|++|++.++.++.|+.+|+...+.-+
T Consensus 111 Aqd~VYHl~CF~C~iC~R~L~TGdEFYLmeD~rLvCK~DYE~Ak~k~~ 158 (383)
T KOG4577|consen 111 AQDFVYHLHCFACFICKRQLATGDEFYLMEDARLVCKDDYETAKQKHC 158 (383)
T ss_pred hhcceeehhhhhhHhhhcccccCCeeEEeccceeehhhhHHHHHhccc
Confidence 899999999999999999999999999999999999999998655433
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=218.15 Aligned_cols=174 Identities=30% Similarity=0.406 Sum_probs=138.5
Q ss_pred CeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
+|++.+.||+|+||.||+|+... ....+++|.+..... .....+. +|+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-------------------------~E~~ 55 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLL-------------------------SEFN 55 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHH-------------------------HHHH
Confidence 46788899999999999998753 235788887754322 2222333 4589
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-----------------------CCCCCHHHHHHHHHH
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-----------------------GQPLPWGQRVNFARD 611 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-----------------------~~~l~~~~~~~i~~Q 611 (681)
+++.++||||+++++.+..++..+++|||+++|+|.+++... ...+++..+..++.|
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ 135 (290)
T cd05045 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQ 135 (290)
T ss_pred HHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHH
Confidence 999999999999999999999999999999999999998532 124788999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 612 IAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 612 Ia~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.||.|||+++++||||||+|||+++++.+ +|||+++.......+.......++..|+|||++.+..
T Consensus 136 i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 205 (290)
T cd05045 136 ISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI 205 (290)
T ss_pred HHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC
Confidence 9999999999999999999999999999888 8999998764433222222334567899999876554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=218.66 Aligned_cols=178 Identities=26% Similarity=0.411 Sum_probs=143.0
Q ss_pred cCCCeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
..++|+..+.||+|+||.||++.+.. ++..+|+|.+.... ....+.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~------------------------- 57 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR------------------------- 57 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHH-------------------------
Confidence 45688999999999999999998753 67899999886432 222333333
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------------CCCCHHHHHHHHH
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------------QPLPWGQRVNFAR 610 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------------~~l~~~~~~~i~~ 610 (681)
|+.+++.++||||+++++++..+...++||||+++|+|.+++.... ..+++..+..++.
T Consensus 58 ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 137 (288)
T cd05050 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAK 137 (288)
T ss_pred HHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHH
Confidence 4899999999999999999999999999999999999999986321 2477888999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 611 DIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 611 QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.||.|||+++++||||||+|||++.++.. +|||+++................+..|+|||++.+..|
T Consensus 138 ~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (288)
T cd05050 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY 209 (288)
T ss_pred HHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC
Confidence 99999999999999999999999999999987 99999986643322222222334667999999876554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=215.17 Aligned_cols=180 Identities=25% Similarity=0.392 Sum_probs=143.5
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHH--HHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK--NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~--~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.|...+.||+|+||.||+|....+|+.+|+|.+......... ...++. ...+.+|+.+++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~-----------------~~~~~~e~~~l~~ 64 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDM-----------------VKALRSEIETLKD 64 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHH-----------------HHHHHHHHHHHHh
Confidence 477888999999999999999999999999987532211111 000000 0022457999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||+|+||+++.
T Consensus 65 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~ 143 (272)
T cd06629 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDA 143 (272)
T ss_pred cCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcC
Confidence 999999999999999999999999999999999998754 5899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++.+ +|||+++...............++..|+|||++...
T Consensus 144 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 185 (272)
T cd06629 144 DGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185 (272)
T ss_pred CCeEEEeeccccccccccccccccccccCCccccCHHHhccc
Confidence 9988 999999865432211112234578899999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=215.42 Aligned_cols=169 Identities=25% Similarity=0.411 Sum_probs=138.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHH-HHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA-VLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~-iL~ 557 (681)
++|+..+.||+|+||.||++.+..+|+.||+|.+.... ......+..| +. .++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e-------------------------~~~~~~ 55 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMD-------------------------LDISMR 55 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHH-------------------------HHHHHH
Confidence 47888999999999999999999999999999886532 2222333333 44 467
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQN 633 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~-~IIHRDLKp~N 633 (681)
.++||||+++++++..++..|++|||++ |+|.+++.. ....+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 56 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~n 134 (283)
T cd06617 56 SVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSN 134 (283)
T ss_pred HcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHH
Confidence 7899999999999999999999999996 688887754 234689999999999999999999997 99999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||++.++.+ +|||+++....... .....++..|+|||++.+
T Consensus 135 il~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 135 VLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINP 177 (283)
T ss_pred EEECCCCCEEEeecccccccccccc---cccccCCccccChhhcCC
Confidence 999999988 99999987643221 122457889999999864
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=217.02 Aligned_cols=176 Identities=26% Similarity=0.412 Sum_probs=141.7
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCC-----CeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRET-----GEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~t-----g~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
..++|...+.||+|+||.||+|+.+.+ .+.+++|.+...... ....+. +
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-------------------------~ 57 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR-------------------------R 57 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHH-------------------------H
Confidence 457888999999999999999997643 467898877543322 223333 3
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--------QPLPWGQRVNFARDIAAGMTYLHSMN 623 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--------~~l~~~~~~~i~~QIa~gL~yLHs~~ 623 (681)
|+++++.++|+||+++++++...+..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++
T Consensus 58 E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~ 137 (275)
T cd05046 58 ELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR 137 (275)
T ss_pred HHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC
Confidence 5899999999999999999999899999999999999999997543 15899999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 624 LIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 624 IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|+||||||+|||++.++.. +|||+++...... ........++..|+|||.+.+..
T Consensus 138 i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~ 194 (275)
T cd05046 138 FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDD 194 (275)
T ss_pred cccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCC
Confidence 9999999999999999988 8999987543221 22222334567799999986543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=214.07 Aligned_cols=176 Identities=22% Similarity=0.356 Sum_probs=140.9
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCC---CeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRET---GEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~t---g~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
..++|...+.||+|+||.||+|.+... ...+|+|...... ....+.+.. |+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~-------------------------e~ 58 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ-------------------------EA 58 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHH-------------------------HH
Confidence 346788899999999999999997654 3468889775443 333333433 48
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+++.++||||+++++++.+ ...|+||||+++|+|.+++......+++..+..++.|++.||.|||+.+++||||||+|
T Consensus 59 ~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~n 137 (270)
T cd05056 59 YIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARN 137 (270)
T ss_pred HHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChhe
Confidence 99999999999999998865 56789999999999999998755568999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.++.+ +|||+++.......+. .....++..|+|||.+....|
T Consensus 138 ili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~ 185 (270)
T cd05056 138 VLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRF 185 (270)
T ss_pred EEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCC
Confidence 999999888 9999998765432211 112234567999999865543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=215.03 Aligned_cols=177 Identities=31% Similarity=0.468 Sum_probs=143.1
Q ss_pred cCCCeeecceecccCcEEEEEEEEc----CCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHR----ETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~----~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
...+|...+.||+|+||.||++.+. .+++.+|+|.+...... ....+.+ |
T Consensus 2 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~-------------------------e 56 (284)
T cd05038 2 EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFER-------------------------E 56 (284)
T ss_pred chhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHH-------------------------H
Confidence 3457788899999999999999865 34889999998654433 2333333 4
Q ss_pred HHHHHhCCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+++++.++|+||+++++++.. ....+++|||+++++|.+++......+++..+..++.|++.||+|||+++++|||||
T Consensus 57 i~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~ 136 (284)
T cd05038 57 IEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLA 136 (284)
T ss_pred HHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 889999999999999999877 567999999999999999998765569999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccc-eeeeecCCCccccchhhccCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPY-TLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~-~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|+|||++.++.+ +|||+++........ .......++..|+|||.+.+..
T Consensus 137 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 188 (284)
T cd05038 137 ARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK 188 (284)
T ss_pred HHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCC
Confidence 999999999888 999999877633221 1111223456799999886543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=214.69 Aligned_cols=169 Identities=27% Similarity=0.424 Sum_probs=139.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|...+.||+|+||.||+|.+..+++.+|+|.+...... ...+. +|+.+++.+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~-------------------------~e~~~l~~~ 59 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIK-------------------------QEINMLKKY 59 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc-HHHHH-------------------------HHHHHHHHh
Confidence 4577788999999999999999999999999988654321 22222 348888888
Q ss_pred -CCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 560 -HHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 560 -~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+|+||+++++++... ...|++|||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||
T Consensus 60 ~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~ 139 (272)
T cd06637 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 139 (272)
T ss_pred cCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCH
Confidence 799999999998753 4689999999999999998763 34589999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+||++++++.+ +|||+++...... .......|+..|+|||++.
T Consensus 140 ~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 140 QNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred HHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhc
Confidence 99999999988 9999998654322 2223355889999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-23 Score=218.75 Aligned_cols=178 Identities=25% Similarity=0.368 Sum_probs=144.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||++.+..+++.+|+|.+.......... .+ .+..|+++++.+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~-~~---------------------~~~~e~~~l~~l 58 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VK---------------------RVLTEQEILATL 58 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHH-HH---------------------HHHHHHHHHHhC
Confidence 36888999999999999999999999999999986543221111 11 123458999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
+|+||+++++.+..+...++||||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++||||||+||+++.
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 138 (316)
T cd05574 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138 (316)
T ss_pred CCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence 9999999999999999999999999999999998753 346899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccce---------------------------eeeecCCCccccchhhccCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYT---------------------------LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~---------------------------~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.+ +|||++.......... ......|+..|+|||++.+..
T Consensus 139 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 208 (316)
T cd05574 139 SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG 208 (316)
T ss_pred CCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC
Confidence 9988 9999987654321100 011234788899999987654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=219.24 Aligned_cols=173 Identities=30% Similarity=0.445 Sum_probs=137.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCe--EEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGE--VMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~--~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
++|...++||+|+||.||+|....++. .+++|.+... .....+.+. +|++++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~E~~~l 56 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFA-------------------------GELEVL 56 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHH-------------------------HHHHHH
Confidence 578899999999999999999887765 4688877532 222223333 348889
Q ss_pred HhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHH
Q psy5063 557 RSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLH 620 (681)
Q Consensus 557 ~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~i~~QIa~gL~yLH 620 (681)
+.+ +||||+++++++...+..|++|||+++|+|.+++.... ..+++..+..++.|++.||+|||
T Consensus 57 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH 136 (297)
T cd05089 57 CKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS 136 (297)
T ss_pred HhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 888 79999999999999999999999999999999986421 24888999999999999999999
Q ss_pred hCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 621 SMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 621 s~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+++|+||||||+|||++.++.+ +|||++....... .......+..|+|||++.+..|
T Consensus 137 ~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 195 (297)
T cd05089 137 EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVY 195 (297)
T ss_pred HCCcccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCC
Confidence 9999999999999999998887 9999986432111 1111223457999999876654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=215.06 Aligned_cols=174 Identities=29% Similarity=0.398 Sum_probs=139.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+ .+|++++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~-------------------------~~E~~~l 55 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAF-------------------------LQEAQVM 55 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHH-------------------------HHHHHHH
Confidence 4456799999999999999999998765 4589998864322 11223 3458999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++||||+++++++. +...++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++++||||||+|||
T Consensus 56 ~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nil 134 (262)
T cd05071 56 KKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 134 (262)
T ss_pred HhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEE
Confidence 9999999999999874 45689999999999999999753 345789999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++++.+ +|||+++...... ........++..|+|||++.+..
T Consensus 135 l~~~~~~~L~dfg~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~ 179 (262)
T cd05071 135 VGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR 179 (262)
T ss_pred EcCCCcEEeccCCceeeccccc-cccccCCcccceecCHhHhccCC
Confidence 9999987 9999998664322 11222234567899999986543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=216.84 Aligned_cols=171 Identities=23% Similarity=0.352 Sum_probs=139.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||+|.+..+++.+|+|.+......... ....+|+.+++.+
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~------------------------~~~~~e~~~l~~l 60 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP------------------------FTAIREASLLKGL 60 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCc------------------------HHHHHHHHHHHhc
Confidence 5788999999999999999999999999999988543211110 1123468999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++++..++..|+||||++ ++|.+++......+++..+..++.|++.||.|||+.+|+||||||+|||++.+
T Consensus 61 ~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~ 139 (291)
T cd07870 61 KHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL 139 (291)
T ss_pred CCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC
Confidence 99999999999999999999999995 67777766544558888999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+.+ +|||+++...... .......++..|+|||++.+
T Consensus 140 ~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 177 (291)
T cd07870 140 GELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLG 177 (291)
T ss_pred CcEEEeccccccccCCCC--CCCCCccccccccCCceeec
Confidence 988 9999998654321 11223457889999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-23 Score=213.70 Aligned_cols=171 Identities=23% Similarity=0.365 Sum_probs=145.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|+..+.||.|+||.||++.+..+++.+|+|.+.... ......+. +|+.+++.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQ-------------------------QEIQFLSQ 55 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHH-------------------------HHHHHHHH
Confidence 36788889999999999999999999999999885432 22222222 45899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+||+++++++..+...|+|+||+++++|.+++... .+++..+..++.|++.||.|||+++++||||+|+||++++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (274)
T cd06609 56 CRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSE 133 (274)
T ss_pred cCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECC
Confidence 99999999999999999999999999999999999764 6899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.+ +|||+++...... .......++..|+|||++.+..
T Consensus 134 ~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 174 (274)
T cd06609 134 EGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSG 174 (274)
T ss_pred CCCEEEcccccceeecccc--cccccccCCccccChhhhccCC
Confidence 9988 9999998876432 1122345788899999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=209.94 Aligned_cols=168 Identities=29% Similarity=0.502 Sum_probs=142.3
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-----HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-----EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-----~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
|+..+.||+|+||+||+|....+++.+++|.+..... +..+.+ .+|+.++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~-------------------------~~e~~~l 56 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQL-------------------------EQEIALL 56 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHH-------------------------HHHHHHH
Confidence 5677899999999999999998899999998865331 122222 3458999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++|+||+++++++..+...++++||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+|+|+||+|+||++
T Consensus 57 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~ 135 (258)
T cd06632 57 SKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV 135 (258)
T ss_pred HhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 99999999999999999999999999999999999997653 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.++.+ +|||++....... ......++..|++||.+...
T Consensus 136 ~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~ 176 (258)
T cd06632 136 DTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQ 176 (258)
T ss_pred CCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCC
Confidence 999988 9999988765432 22335588899999998654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=250.43 Aligned_cols=177 Identities=24% Similarity=0.337 Sum_probs=141.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+||+..++||+||||.|||++++-+|..||||++.... ..+...+ +++|+.+|.+
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~sk----------------------I~rEVk~LAr 533 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSK----------------------ILREVKLLAR 533 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHH----------------------HHHHHHHHhh
Confidence 468999999999999999999999999999999996543 2222222 3567999999
Q ss_pred CCCCceeeEEEEEEeC----------------------------------------------------------------
Q psy5063 559 LHHHNVIRFIGVLYKD---------------------------------------------------------------- 574 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~---------------------------------------------------------------- 574 (681)
|+|||||+++..|.+.
T Consensus 534 LnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~ 613 (1351)
T KOG1035|consen 534 LNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYE 613 (1351)
T ss_pred cCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCcccccccccccccc
Confidence 9999999998664210
Q ss_pred -------------------------------------------------------CeEEEEEeccCCCCHHHHHhCCCCC
Q psy5063 575 -------------------------------------------------------RKLNLVTEYIAGGTLKELLQDPGQP 599 (681)
Q Consensus 575 -------------------------------------------------------~~l~LV~Ey~~gGsL~~~L~~~~~~ 599 (681)
..+||-||||+...|++++..+...
T Consensus 614 ~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~ 693 (1351)
T KOG1035|consen 614 SSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN 693 (1351)
T ss_pred ccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc
Confidence 1168899999998888888765421
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeee----------------cccceeee
Q psy5063 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLI----------------YVPYTLFI 661 (681)
Q Consensus 600 l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~----------------~~~~~~~~ 661 (681)
-.....+++++||+.||.|+|++|||||||||.||++++++.+ .|||+|..... ..+.....
T Consensus 694 ~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~T 773 (1351)
T KOG1035|consen 694 SQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLT 773 (1351)
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccc
Confidence 1467889999999999999999999999999999999999998 99999998220 11112334
Q ss_pred ecCCCccccchhhccCCC
Q psy5063 662 LSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 662 ~~~gt~~Y~APEvL~~~~ 679 (681)
...||..|+|||++.+..
T Consensus 774 s~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 774 SQVGTALYVAPELLSDTS 791 (1351)
T ss_pred cccceeeeecHHHhcccc
Confidence 567999999999997764
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=212.32 Aligned_cols=170 Identities=29% Similarity=0.435 Sum_probs=138.6
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+...+|...+.||+|+||.||++... |..+|+|.+.... ..+.+. +|+.++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~-------------------------~e~~~l 53 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFL-------------------------AEASVM 53 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHH-------------------------HHHHHH
Confidence 44568899999999999999999765 7889999875322 122333 358899
Q ss_pred HhCCCCceeeEEEEEE-eCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 557 RSLHHHNVIRFIGVLY-KDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~-~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+.++|+|++++++++. .++..+++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||
T Consensus 54 ~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 133 (256)
T cd05082 54 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNV 133 (256)
T ss_pred HhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheE
Confidence 9999999999999764 4567999999999999999997643 3488999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++++++.+ +|||+++...... .....+..|+|||++.+..|
T Consensus 134 l~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 176 (256)
T cd05082 134 LVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF 176 (256)
T ss_pred EEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCC
Confidence 99999988 9999998654322 12234668999999876543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=214.77 Aligned_cols=170 Identities=23% Similarity=0.362 Sum_probs=144.8
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
+|+..+.||.|+||.||++.+..+++.+|+|.+.+... ...+.+ .+|+++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~-------------------------~~e~~~l~ 55 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNV-------------------------LNERRILQ 55 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHH-------------------------HHHHHHHH
Confidence 47888999999999999999999999999999865322 122222 34589999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++.+..+...++|+||+++++|.+++... .++++..+..++.|++.||.|||+++++|+||+|+||+++
T Consensus 56 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~ 134 (258)
T cd05578 56 ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD 134 (258)
T ss_pred hCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc
Confidence 999999999999999999999999999999999999765 4689999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++.. +|||++....... ......++..|+|||++....
T Consensus 135 ~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~ 175 (258)
T cd05578 135 EQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQG 175 (258)
T ss_pred CCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccC
Confidence 99988 9999988765432 223355888999999986543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.8e-23 Score=210.78 Aligned_cols=170 Identities=33% Similarity=0.491 Sum_probs=141.1
Q ss_pred eecceecccCcEEEEEEEEcCCC----eEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETG----EVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg----~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++.+.||+|+||.||++.+..++ ..+|+|.+...... ..+.+.. |+.+++
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------e~~~l~ 56 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLR-------------------------EARIMR 56 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHH-------------------------HHHHHH
Confidence 45678999999999999998766 89999998654322 2333333 489999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~-l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
.++|+||+++++++..++..+++|||+++++|.+++...... +++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 57 ~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 57 KLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred hcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 999999999999999999999999999999999999765433 8999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.++.+ +|||+++.......+... ...++..|+|||.+.+.
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~ 179 (258)
T smart00219 137 GENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDG 179 (258)
T ss_pred ccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccC
Confidence 999977 999999887654222211 23367889999988543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=209.73 Aligned_cols=167 Identities=33% Similarity=0.458 Sum_probs=135.3
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCce
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNV 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 564 (681)
++||+|+||.||+|... ++..+|+|.+.... ......+. +|+++++.++||||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~-------------------------~e~~~l~~l~h~~i 54 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFL-------------------------SEARILKQYDHPNI 54 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHH-------------------------HHHHHHHhCCCCCc
Confidence 36899999999999865 58889999876432 22222333 35889999999999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++++...+..++||||+++++|.+++......+++..+..++.|++.||.|||+++++||||||+||+++.++.+
T Consensus 55 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l 134 (250)
T cd05085 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKI 134 (250)
T ss_pred CeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEE
Confidence 999999999999999999999999999997655568999999999999999999999999999999999999999987
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||+++...... ........++..|+|||++.+..
T Consensus 135 ~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 170 (250)
T cd05085 135 SDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGR 170 (250)
T ss_pred CCCccceeccccc-cccCCCCCCcccccCHHHhccCC
Confidence 9999997644321 11111223456799999986543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=214.18 Aligned_cols=171 Identities=23% Similarity=0.371 Sum_probs=139.8
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|+..+.||+|+||.||++.+..+++.+|+|.+...... ...+. +|+.+++
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~-------------------------~e~~~l~ 69 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-DEEIE-------------------------AEYNILK 69 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch-HHHHH-------------------------HHHHHHH
Confidence 357899999999999999999999999999999987542211 12222 3478888
Q ss_pred hC-CCCceeeEEEEEE-----eCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 558 SL-HHHNVIRFIGVLY-----KDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 558 ~L-~HpnIV~l~g~~~-----~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
.+ +||||+++++++. .++..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++|+|||
T Consensus 70 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 149 (286)
T cd06638 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRD 149 (286)
T ss_pred HHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence 88 7999999999874 34679999999999999998753 234588999999999999999999999999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
|||+||+++.++.+ +|||+++...... .......++..|+|||++.
T Consensus 150 lkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 150 VKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred CCHHhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhc
Confidence 99999999999988 9999998765322 1122345899999999985
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=211.47 Aligned_cols=169 Identities=30% Similarity=0.372 Sum_probs=137.7
Q ss_pred ceecccCcEEEEEEEEcC-CC--eEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRE-TG--EVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~-tg--~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
++||+|+||.||+|.+.. .+ ..+|+|.+..... ...+.+. +|+.+++.++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~e~~~l~~l~h 55 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFL-------------------------KEAAIMHSLDH 55 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHH-------------------------HHHHHHhhcCC
Confidence 468999999999999865 33 3689998866444 2333333 35999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|||+++++++.. ...++||||+++|+|.+++.+.. ..+++..+..++.|++.||+|||+++++||||||+|||++.++
T Consensus 56 ~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~ 134 (257)
T cd05040 56 ENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD 134 (257)
T ss_pred CCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC
Confidence 999999999988 89999999999999999997754 4689999999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||+++....... +.......++..|+|||.+.+..|
T Consensus 135 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~ 177 (257)
T cd05040 135 KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177 (257)
T ss_pred EEEeccccccccccccccceecccCCCCCceecCHHHhcccCc
Confidence 88 99999988754321 122223446788999999876543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-23 Score=211.09 Aligned_cols=178 Identities=25% Similarity=0.418 Sum_probs=141.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+|.+++.||+|+||.||++.+..+++.+|+|.+...... ....... .+.+|+++++.
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~---------------------~~~~ei~~l~~ 60 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVN---------------------ALECEIQLLKN 60 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHH---------------------HHHHHHHHHHH
Confidence 5789999999999999999999999999999987432110 0111011 12346999999
Q ss_pred CCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 559 LHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
++|+||+++++++.+. +.++++|||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||++
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i 139 (264)
T cd06653 61 LRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR 139 (264)
T ss_pred cCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE
Confidence 9999999999998764 56899999999999999987644 48899999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+.++.. +|||+++....... ........++..|+|||++.+..
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (264)
T cd06653 140 DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185 (264)
T ss_pred cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCC
Confidence 999887 89999986542111 11112345788999999987653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=214.01 Aligned_cols=170 Identities=29% Similarity=0.463 Sum_probs=140.8
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+|+..+.||+|+||.||+|++..+|+.+|+|.+...... ....+ .+|+++++.+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~-------------------------~~E~~~l~~l 55 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA-------------------------IREISLMKEL 55 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHH-------------------------HHHHHHHHhh
Confidence 478889999999999999999999999999988643221 11222 3458999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
+|+||+++++++...+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+++++||||||+||+++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~ 134 (284)
T cd07836 56 KHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN 134 (284)
T ss_pred cCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC
Confidence 999999999999999999999999985 8988886543 4589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+++.+ +|||+++...... .......++..|++||++.+.
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~ 175 (284)
T cd07836 135 KRGELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGS 175 (284)
T ss_pred CCCcEEEeecchhhhhcCCc--cccccccccccccChHHhcCC
Confidence 99988 9999997654321 122234568889999998654
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=215.38 Aligned_cols=164 Identities=23% Similarity=0.312 Sum_probs=132.6
Q ss_pred eecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc
Q psy5063 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN 563 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 563 (681)
.||+|+||.||++.+..+++.+|+|.+.+.... ....+..+. ....++...+|||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~ 58 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER----------------------IMLSLVSTGDCPF 58 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHH----------------------HHHHHHhhCCCCc
Confidence 489999999999999999999999988653211 111122220 0133455568999
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe-
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG- 642 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~- 642 (681)
|+.+++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||+++++.+
T Consensus 59 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~ 137 (279)
T cd05633 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137 (279)
T ss_pred EeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEE
Confidence 9999999999999999999999999999987654 59999999999999999999999999999999999999999988
Q ss_pred -EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 643 -FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 643 -~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||++....... .....++..|+|||++..
T Consensus 138 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 138 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQK 169 (279)
T ss_pred EccCCcceeccccC----ccCcCCCcCccCHHHhcC
Confidence 9999997654322 123468999999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=216.50 Aligned_cols=172 Identities=23% Similarity=0.358 Sum_probs=144.6
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
..++|+..+.||+|+||.||++.+..+++.+|+|.+.... ....+.+. +|++++
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~-------------------------~E~~~l 57 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQIL-------------------------RELQIM 57 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHH-------------------------HHHHHH
Confidence 3568889999999999999999999999999999876432 22233333 459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NIL 635 (681)
+.++||||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .+++||||||+||+
T Consensus 58 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 136 (284)
T cd06620 58 HECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136 (284)
T ss_pred HHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE
Confidence 9999999999999999999999999999999999998764 358999999999999999999997 68999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++++.+ +|||+++...... .....++..|+|||++.+..
T Consensus 137 ~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~ 178 (284)
T cd06620 137 VNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPERIQGGK 178 (284)
T ss_pred ECCCCcEEEccCCcccchhhhc----cCccccCcccCCHHHHccCC
Confidence 9999988 9999987553221 12245899999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=213.74 Aligned_cols=166 Identities=25% Similarity=0.294 Sum_probs=129.2
Q ss_pred eecccCcEEEEEEEEcCCC--eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc
Q psy5063 487 LLGQGFFGQVYRVTHRETG--EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN 563 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~~tg--~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 563 (681)
.||+|+||.||++.....+ ..+++|.+.... ....+.+.+ |+.+++.++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~-------------------------e~~~~~~l~h~~ 56 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQ-------------------------QGDPYRILQHPN 56 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHH-------------------------HHHHHhccCCcc
Confidence 5999999999999754332 356667665432 223333444 488999999999
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|+++++.+......++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++++||||||+|||++.++
T Consensus 57 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~ 136 (268)
T cd05086 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL 136 (268)
T ss_pred hhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc
Confidence 999999999999999999999999999998753 23466777889999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
.+ +|||++................++..|+|||++..
T Consensus 137 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 137 TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175 (268)
T ss_pred cEEecccccccccCcchhhhcccCCcCcccccCchhccc
Confidence 88 99999864332211111223457889999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.7e-23 Score=214.28 Aligned_cols=178 Identities=24% Similarity=0.291 Sum_probs=141.9
Q ss_pred cCCCeeecceecccCcEEEEEEEEcC----CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRE----TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~----tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..++|...++||+|+||.||+|.+.. ++..+++|.+.... ......+. +|
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~-------------------------~e 58 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLL-------------------------QE 58 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHH-------------------------HH
Confidence 45788999999999999999999876 35788999876432 22223233 35
Q ss_pred HHHHHhCCCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPG-------QPLPWGQRVNFARDIAAGMTYLHSMNL 624 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~~-------~~l~~~~~~~i~~QIa~gL~yLHs~~I 624 (681)
+.+|+.++|+||+++++++.. +...++++||+++|+|.+++.... ..+++..+..++.|++.||+|||++++
T Consensus 59 ~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i 138 (280)
T cd05043 59 SCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGV 138 (280)
T ss_pred HHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 889999999999999998765 578899999999999999986531 358899999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 625 IHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+||||||+|||+++++.+ +|||+++.+.............++..|+|||++.+..|
T Consensus 139 ~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~ 196 (280)
T cd05043 139 IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY 196 (280)
T ss_pred eecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC
Confidence 999999999999999887 89999986643322111122335678999999876543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-23 Score=208.88 Aligned_cols=171 Identities=23% Similarity=0.327 Sum_probs=142.6
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+..+.||+|+||.||++.+..+++.+|+|.+.... ......+ .+|+++++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~~e~~~l~~ 55 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAA-------------------------QNECQVLKL 55 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHH-------------------------HHHHHHHhh
Confidence 4778899999999999999999999999999986532 1122222 345999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++||||+++++.+..++..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++++|+||||+||+++
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~ 135 (256)
T cd08220 56 LSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD 135 (256)
T ss_pred CCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 99999999999999999999999999999999999764 34589999999999999999999999999999999999998
Q ss_pred cCCCe---EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 638 EVGSG---FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 638 ~~g~~---~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.++.. +|||+++....... .....++..|+|||.+.+..
T Consensus 136 ~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~ 177 (256)
T cd08220 136 KHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYISPELCEGKP 177 (256)
T ss_pred CCCCEEEEccCCCceecCCCcc---ccccccCCcccCchhccCCC
Confidence 76643 89999987654321 12245788999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=216.55 Aligned_cols=171 Identities=25% Similarity=0.452 Sum_probs=142.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||+|.+..+++.+|+|.+...... ..+.+ .+|+++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-------------------------~~e~~~l~ 55 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIA-------------------------MREIRMLK 55 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHH-------------------------HHHHHHHH
Confidence 3688889999999999999999999999999987542211 11222 34589999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++..++..++||||+++++|..+..... .+++..+..++.|++.||.|||+.+++|+||+|+||+++
T Consensus 56 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~ 134 (286)
T cd07846 56 QLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS 134 (286)
T ss_pred hcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 9999999999999999999999999999999988776543 489999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+++.+ +|||+++...... .......++..|+|||++.+.
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 175 (286)
T cd07846 135 QSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGD 175 (286)
T ss_pred CCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccc
Confidence 99988 9999998764322 222234578899999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=220.11 Aligned_cols=170 Identities=22% Similarity=0.336 Sum_probs=141.6
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
.|.....||+|+||.||++.+..+++.+|+|.+........+.+. +|+.+++.++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~e~~~l~~l~ 77 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF-------------------------NEVVIMRDYH 77 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHH-------------------------HHHHHHHhCC
Confidence 444566799999999999999999999999988654333333333 3588999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|+||+++++.+..++..++||||+++++|.+++... .+++..+..++.||+.||.|||+++|+||||||+||++++++
T Consensus 78 h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~ 155 (292)
T cd06658 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG 155 (292)
T ss_pred CCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC
Confidence 999999999999999999999999999999988653 488999999999999999999999999999999999999998
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.+ +|||++........ ......++..|+|||++.+..
T Consensus 156 ~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~ 194 (292)
T cd06658 156 RIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLP 194 (292)
T ss_pred CEEEccCcchhhcccccc--cCceeecCccccCHHHHccCC
Confidence 88 99999876543222 112345788999999986644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.4e-23 Score=216.15 Aligned_cols=173 Identities=26% Similarity=0.400 Sum_probs=143.2
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||+|.+..+++.+|+|.+........ +. ....+|+.+++.+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~---------------------~~~~~e~~~l~~l 61 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG--FP---------------------ITSLREINILLKL 61 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccccc--ch---------------------hhHHHHHHHHHhc
Confidence 578888999999999999999999999999999864322110 00 1123568999999
Q ss_pred CCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 560 HHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
+||||+++++++..+ +..|+||||++ ++|.+++......+++..+..++.|++.||+|||+++++||||||+|||++
T Consensus 62 ~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~ 140 (293)
T cd07843 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN 140 (293)
T ss_pred CCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEEC
Confidence 999999999999877 89999999997 599999876555699999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.++.+ +|||+++...... .......++..|+|||++.+.
T Consensus 141 ~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~ 181 (293)
T cd07843 141 NRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGA 181 (293)
T ss_pred CCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCC
Confidence 99988 9999998766432 122234578889999998654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=210.55 Aligned_cols=175 Identities=28% Similarity=0.350 Sum_probs=143.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|.+.+.||+|+||.||++.+.. ++.+|+|.+..... ..+.+. +|+.++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~-------------------------~e~~~l 55 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFL-------------------------QEAQIM 55 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHH-------------------------HHHHHH
Confidence 456789999999999999999999764 57799998864322 122233 358999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++|+||+++++++..+...++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nil 135 (261)
T cd05034 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL 135 (261)
T ss_pred hhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEE
Confidence 99999999999999999899999999999999999997643 46899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.++.+ +|||+++....... ........+..|+|||.+.+..
T Consensus 136 i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~ 180 (261)
T cd05034 136 VGENLVCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGR 180 (261)
T ss_pred EcCCCCEEECccccceeccchhh-hhhhccCCCccccCHHHhccCC
Confidence 9999988 89999987653221 1111223456899999987654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=209.25 Aligned_cols=168 Identities=28% Similarity=0.402 Sum_probs=136.9
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCce
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNV 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 564 (681)
++||+|+||.||++.+.. ++.+|+|.+...... ....+.+ |+++++.++|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~-------------------------e~~~l~~l~~~~i 54 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQ-------------------------EAEILKQYDHPNI 54 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHH-------------------------HHHHHHhCCCCCe
Confidence 469999999999999987 999999987654332 2333333 4899999999999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++++......++||||+++++|.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++.+
T Consensus 55 ~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l 134 (251)
T cd05041 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKI 134 (251)
T ss_pred EEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEE
Confidence 999999999999999999999999999997655568899999999999999999999999999999999999999988
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||+++................+..|+|||++.+..
T Consensus 135 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 171 (251)
T cd05041 135 SDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171 (251)
T ss_pred eeccccccccCCcceeccccCcceeccCChHhhccCC
Confidence 9999998654221111111122356799999986654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=227.56 Aligned_cols=176 Identities=24% Similarity=0.322 Sum_probs=149.7
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC----HHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD----EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~----~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.++..||....+||+|+||+|.++..+.+.+.||||++++.- ...+-. ..
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvect--------------------------m~ 398 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECT--------------------------MV 398 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccce--------------------------eh
Confidence 577889999999999999999999999999999999886521 111100 12
Q ss_pred HHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 552 QVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 552 Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|-++|... +-|.+++++..|.+.+++|+||||+.||+|.-.++.-++ +.+..++.++.+|+-||-|||++|||.||||
T Consensus 399 EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh~kgIiYRDLK 477 (683)
T KOG0696|consen 399 EKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLK 477 (683)
T ss_pred hhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhhcCCeeeeecc
Confidence 34455554 678999999999999999999999999999988887654 8899999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+|||+|.+|.+ +|||+++...-+ .....+.+||+.|+|||++.-++|
T Consensus 478 LDNvmLd~eGHiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPY 527 (683)
T KOG0696|consen 478 LDNVMLDSEGHIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPY 527 (683)
T ss_pred ccceEeccCCceEeeecccccccccC--CcceeeecCCCcccccceEEeccc
Confidence 999999999998 999999865543 345567999999999999988887
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-22 Score=228.99 Aligned_cols=170 Identities=16% Similarity=0.246 Sum_probs=133.8
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|++.++||+|+||.||+|++..+++.||||++...... ...... |+.+++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~-~~~~~~-------------------------e~~~l~ 180 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKY-TRDAKI-------------------------EIQFME 180 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhh-HHHHHH-------------------------HHHHHH
Confidence 457899999999999999999999999999999998643211 111222 244444
Q ss_pred hC------CCCceeeEEEEEEeC-CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCC
Q psy5063 558 SL------HHHNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDL 629 (681)
Q Consensus 558 ~L------~HpnIV~l~g~~~~~-~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDL 629 (681)
.+ +|.+++++++++..+ ...++|||++ +++|.+++...+ .+++..+..++.||+.||+|||+ .|||||||
T Consensus 181 ~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDl 258 (467)
T PTZ00284 181 KVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTELHLMHTDL 258 (467)
T ss_pred HHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCC
Confidence 44 456799999998764 5789999988 778998887653 59999999999999999999998 59999999
Q ss_pred CCCcEEEecCCC----------------e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGS----------------G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~----------------~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.++. + +|||++..... ......||+.|||||++.+..|
T Consensus 259 KP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~ 322 (467)
T PTZ00284 259 KPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGW 322 (467)
T ss_pred CHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCC
Confidence 999999998763 4 89998764321 1223568999999999988765
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.8e-23 Score=210.65 Aligned_cols=177 Identities=23% Similarity=0.460 Sum_probs=141.4
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+.++.||+|+||.||+|.. .+++.+|+|.+..... ........ .+.+|+++++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~---------------------~~~~e~~~l~~ 58 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYE---------------------KLQEEVDLLKS 58 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHH---------------------HHHHHHHHHHh
Confidence 577889999999999999986 4788999998864321 11111111 12456999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+||+++++++.+.+..+++|||+++++|.+++.+.. .+++..+..++.|++.||+|||+.+|+|+||+|+||++++
T Consensus 59 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~ 137 (265)
T cd06631 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP 137 (265)
T ss_pred cCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC
Confidence 999999999999999999999999999999999997644 5899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecc---c-ceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYV---P-YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~---~-~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...... . ........++..|+|||++.+..|
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~ 185 (265)
T cd06631 138 NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY 185 (265)
T ss_pred CCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCC
Confidence 9988 8999987643210 0 111123457889999999876543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=210.57 Aligned_cols=170 Identities=25% Similarity=0.401 Sum_probs=132.6
Q ss_pred ceecccCcEEEEEEEEcC---CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRE---TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~---tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
+.||+|+||.||+|.+.. ....+|+|.+.... ....+.+.. |+.+++.++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-------------------------e~~~l~~l~h 55 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLK-------------------------EGIIMKDFSH 55 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHH-------------------------HHHHHccCCC
Confidence 468999999999998754 34579999875432 223333333 4889999999
Q ss_pred CceeeEEEEEE-eCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 562 HNVIRFIGVLY-KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 562 pnIV~l~g~~~-~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|||+++++++. .++..+++|||+++|+|.+++......+++..+..++.|++.||.|||+++++||||||+|||++.++
T Consensus 56 ~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~ 135 (262)
T cd05058 56 PNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF 135 (262)
T ss_pred CCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC
Confidence 99999999775 45678999999999999999976555577888899999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccce--eeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||+++......... ......++..|+|||++.+..|
T Consensus 136 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 179 (262)
T cd05058 136 TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179 (262)
T ss_pred cEEECCccccccccCCcceeecccccCcCCccccChhHhccCcc
Confidence 88 8999998654321111 1112335678999999866543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-23 Score=217.55 Aligned_cols=166 Identities=27% Similarity=0.373 Sum_probs=128.8
Q ss_pred cceecccCcEEEEEEEEcC--CCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 485 GPLLGQGFFGQVYRVTHRE--TGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~--tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
+..||+|+||.||+|+++. ++..+|+|.+...... ..+ .+|+++|+.++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~--~~~-------------------------~~E~~~l~~l~h~ 58 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSA-------------------------CREIALLRELKHP 58 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc--HHH-------------------------HHHHHHHHhCCCC
Confidence 4679999999999999764 5678999987543211 112 3469999999999
Q ss_pred ceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 563 NVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQD--------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 563 nIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~--------~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
||+++++++.. +...++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+++|+||||||+
T Consensus 59 niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~ 137 (317)
T cd07867 59 NVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPA 137 (317)
T ss_pred CeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHH
Confidence 99999999854 568899999986 478777642 1234889999999999999999999999999999999
Q ss_pred cEEEe----cCCCe--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccCC
Q psy5063 633 NCLVR----EVGSG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 633 NILl~----~~g~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||+. .++.+ +|||+++....... ........+|..|+|||++.+.
T Consensus 138 Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07867 138 NILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred HEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCC
Confidence 99994 44555 99999987654321 1122234578999999998764
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=237.06 Aligned_cols=166 Identities=28% Similarity=0.430 Sum_probs=137.0
Q ss_pred ecceecccCcEEEEEEEEcCCCeEEEEEEeeccC----HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD----EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 484 ~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~----~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
...+||+|+|-+||||.+..+|..||.-.++..+ ..... .+++|+++|+.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~le-------------------------R~~~Ev~lLKsL 98 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELE-------------------------RLYSEVHLLKSL 98 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHH-------------------------HHHHHHHHHccC
Confidence 3468999999999999999999999865443211 11112 235679999999
Q ss_pred CCCceeeEEEEEEeCCe--EEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcEE
Q psy5063 560 HHHNVIRFIGVLYKDRK--LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCL 635 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~--l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~--IIHRDLKp~NIL 635 (681)
+||||++||.+|.+... +.+|+|++..|+|+.|+++.+. +....++.|++||++||.|||++. |||||||-+||+
T Consensus 99 ~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIF 177 (632)
T KOG0584|consen 99 KHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIF 177 (632)
T ss_pred CCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEE
Confidence 99999999999987655 8899999999999999987654 899999999999999999999985 999999999999
Q ss_pred EecC-CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREV-GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~-g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+.+ |.+ .|+|||....... ...-.|||.|||||++. +.|
T Consensus 178 inG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~Y 220 (632)
T KOG0584|consen 178 VNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENY 220 (632)
T ss_pred EcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhc
Confidence 9854 666 9999999887432 23356999999999986 444
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=213.53 Aligned_cols=167 Identities=23% Similarity=0.311 Sum_probs=137.4
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeE
Q psy5063 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRF 567 (681)
Q Consensus 488 LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l 567 (681)
||+|+||.||++.+..+|+.+|+|.+........... ..+.+|+++|+.++||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~----------------------~~~~~e~~~l~~l~~~~i~~~ 58 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGE----------------------QMALNEKKILEKVSSRFIVSL 58 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhh----------------------HHHHHHHHHHHhCCCCCEeee
Confidence 6899999999999999999999998864321111100 012346999999999999999
Q ss_pred EEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EE
Q psy5063 568 IGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FD 644 (681)
Q Consensus 568 ~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~D 644 (681)
++++...+..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||+++++||||+|+|||+++++.+ +|
T Consensus 59 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~d 138 (277)
T cd05577 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISD 138 (277)
T ss_pred eeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcc
Confidence 999999999999999999999999987643 358999999999999999999999999999999999999999988 99
Q ss_pred eeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 645 FHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 645 FGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||+++..... .......++..|+|||++.+..
T Consensus 139 fg~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~ 170 (277)
T cd05577 139 LGLAVELKGG---KKIKGRAGTPGYMAPEVLQGEV 170 (277)
T ss_pred CcchhhhccC---CccccccCCCCcCCHHHhcCCC
Confidence 9998765432 1222345788999999986654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=211.10 Aligned_cols=174 Identities=29% Similarity=0.399 Sum_probs=138.6
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|++.+.||+|+||.||++.+. .+..+|+|.+..... ....+. +|+.++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~-------------------------~E~~~l 55 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFL-------------------------EEAQIM 55 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHH-------------------------HHHHHH
Confidence 34568899999999999999999876 466789998864322 112233 458999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++|+||+++++++. +...+++|||+++++|.+++... ...+++..+..++.|++.||.|||+++|+||||||+||+
T Consensus 56 ~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nil 134 (260)
T cd05070 56 KKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANIL 134 (260)
T ss_pred HhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEE
Confidence 9999999999999875 55689999999999999998753 345899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++++.+ +|||+++...... ........++..|+|||++.+..
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 179 (260)
T cd05070 135 VGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR 179 (260)
T ss_pred EeCCceEEeCCceeeeeccCcc-cccccCCCCCccccChHHHhcCC
Confidence 9999887 8999998764322 11111223456799999986543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=219.78 Aligned_cols=170 Identities=22% Similarity=0.348 Sum_probs=141.0
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
|.....||+|+||.||++.+..+++.+|+|.+........+.+ .+|+.+++.++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~-------------------------~~e~~~l~~l~h 77 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELL-------------------------FNEVVIMRDYQH 77 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHH-------------------------HHHHHHHHhCCC
Confidence 3344579999999999999998999999999854332222223 345889999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
|||+++++++..++..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++||||||+|||++.++.
T Consensus 78 p~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~ 155 (297)
T cd06659 78 QNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR 155 (297)
T ss_pred CchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc
Confidence 9999999999999999999999999999998865 34899999999999999999999999999999999999999998
Q ss_pred e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 642 G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+ +|||+++....... ......++..|+|||++.+..|
T Consensus 156 ~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 194 (297)
T cd06659 156 VKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPY 194 (297)
T ss_pred EEEeechhHhhcccccc--cccceecCccccCHHHHccCCC
Confidence 8 99999876543221 1223458899999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=242.82 Aligned_cols=172 Identities=25% Similarity=0.387 Sum_probs=139.9
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
..++|++.+.||+|+||.||++++..+++.+|+|.+.... ......+ .+|+.+
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~-------------------------~~EI~I 65 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQL-------------------------VIEVNV 65 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHH-------------------------HHHHHH
Confidence 3568999999999999999999999999999999886432 2222233 345999
Q ss_pred HHhCCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhC-------C
Q psy5063 556 LRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSM-------N 623 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~-------~ 623 (681)
|+.|+||||++++++|.. ...+||||||+++|+|.++|... ...+++..++.|+.||+.||.|||+. +
T Consensus 66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 999999999999999865 35799999999999999998642 24699999999999999999999984 4
Q ss_pred ccccCCCCCcEEEecCC-----------------Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 624 LIHRDLNSQNCLVREVG-----------------SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 624 IIHRDLKp~NILl~~~g-----------------~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||||||||+||||+.+. .+ +|||+++...... ......||+.|+|||++.+
T Consensus 146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhc
Confidence 99999999999997531 23 8999998764322 1223468999999999864
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=210.80 Aligned_cols=171 Identities=25% Similarity=0.375 Sum_probs=143.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
..|+..+.||+|+||.||+|.+..+++.+|+|.+.... ......+. +|+.+++.
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 58 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ-------------------------QEITVLSQ 58 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHH-------------------------HHHHHHHh
Confidence 35667788999999999999999999999999886433 22222233 45899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+||+++++++.+++..++||||+++|+|.+++.. .++++.++..++.|++.||+|||+++++|+||+|+||+++.
T Consensus 59 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~ 136 (277)
T cd06640 59 CDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred CCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcC
Confidence 9999999999999999999999999999999999875 35889999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.. +|||++........ ......++..|+|||++.+..
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~ 177 (277)
T cd06640 137 QGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSA 177 (277)
T ss_pred CCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCC
Confidence 9888 99999987653221 122245788899999986654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=212.93 Aligned_cols=172 Identities=27% Similarity=0.435 Sum_probs=146.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|+..+.||+|+||.||++.++.+++.+|+|.+.... ......+. +|+++++.
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQIL-------------------------RELDILHK 55 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHH-------------------------HHHHHHHH
Confidence 36778889999999999999999999999999886543 22333333 35899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NILl~ 637 (681)
++||||+++++.+..++..++++||+++++|.+++......+++..+..++.|++.||.|||+ .+++|+||||+||+++
T Consensus 56 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~ 135 (265)
T cd06605 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN 135 (265)
T ss_pred CCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC
Confidence 999999999999999999999999999999999998754678999999999999999999999 9999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+++.+ +|||++......... ...++..|+|||++.+..|
T Consensus 136 ~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~ 176 (265)
T cd06605 136 SRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDY 176 (265)
T ss_pred CCCCEEEeecccchhhHHHHhh----cccCChhccCHHHHcCCCC
Confidence 99887 999998766432211 1557889999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=207.35 Aligned_cols=172 Identities=24% Similarity=0.387 Sum_probs=143.3
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+..+.||+|+||.||+++...+++.+|+|.+.... ....+.+ .+|+.+++.
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~~e~~~l~~ 55 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-------------------------RKEVAVLSN 55 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHH-------------------------HHHHHHHHh
Confidence 4778899999999999999999999999999986432 2222223 345899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++||||+++++++...+..++||||+++++|.+++... ...+++.++..++.|++.||.|||+++++|+||+|+|||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~ 135 (256)
T cd08218 56 MKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT 135 (256)
T ss_pred CCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc
Confidence 99999999999999999999999999999999998753 33588999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.++.+ +|||++......... .....++..|+|||++.+..
T Consensus 136 ~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~ 177 (256)
T cd08218 136 KDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRP 177 (256)
T ss_pred CCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCC
Confidence 98888 999999876432211 12244788899999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=239.68 Aligned_cols=169 Identities=23% Similarity=0.319 Sum_probs=143.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.++|.+.+.||+|+||.||+|++..+++.||+|++..... .....+ ..|+.+
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~-------------------------~~E~~~ 57 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQV-------------------------QAERDA 57 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHH-------------------------HHHHHH
Confidence 4689999999999999999999999999999999865321 111222 245888
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++.++||||+++++++...+.+|+||||+++++|.+++.... .+++..++.++.||+.||+|||+++||||||||+|||
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NIL 136 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNML 136 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEE
Confidence 999999999999999999999999999999999999997644 5899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhc
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNIL 675 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL 675 (681)
|+.++.+ +|||+++....... ......+|+.|++||..
T Consensus 137 l~~~g~vkL~DFGls~~~~~~~~--~~~~~~~t~~~~~pe~~ 176 (669)
T cd05610 137 ISNEGHIKLTDFGLSKVTLNREL--NMMDILTTPSMAKPKND 176 (669)
T ss_pred EcCCCCEEEEeCCCCccccCCcc--cccccccCccccCcccc
Confidence 9999988 99999997654321 22235688889999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=208.39 Aligned_cols=174 Identities=22% Similarity=0.288 Sum_probs=144.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|+.++.||.|+||.||+|....++..+|+|.+..... .....+. +|+++|+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELR-------------------------KEVQAMSQ 55 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHH-------------------------HHHHHHHh
Confidence 478899999999999999999998999999998854322 1222333 35889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~--~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
++|+||+++++.+..++..|+||||+++++|.+++... ...+++..+..++.|++.||.|||+++++||||||+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~ 135 (267)
T cd06610 56 CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL 135 (267)
T ss_pred cCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE
Confidence 99999999999999999999999999999999999753 2358999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccce--eeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~~ 678 (681)
++++.. +|||++..+....... ......++..|+|||++...
T Consensus 136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 136 GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccc
Confidence 999887 9999988766432221 11233578899999998654
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.5e-23 Score=212.87 Aligned_cols=172 Identities=26% Similarity=0.418 Sum_probs=142.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||+|.+..+++.||+|.+.... ....+.+ .+|+++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~-------------------------~~e~~~l~ 55 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA-------------------------LREVKVLR 55 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHH-------------------------HHHHHHHH
Confidence 36888999999999999999999999999999875421 1112222 34599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++|+||+++++++..++..++||||++++.+..+.... ..+++..+..++.|++.||.|||+++++||||+|+||+++
T Consensus 56 ~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~ 134 (288)
T cd07833 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS 134 (288)
T ss_pred hcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC
Confidence 999999999999999999999999999987777666543 4589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+++.+ +|||++........ .......++..|+|||++.+.
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 135 ESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred CCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCC
Confidence 99988 99999987664332 122234578889999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.4e-23 Score=211.68 Aligned_cols=167 Identities=29% Similarity=0.445 Sum_probs=132.4
Q ss_pred ceecccCcEEEEEEEEcCCCe--EEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGE--VMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~--~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~H 561 (681)
++||+|+||.||+|++..++. .+++|.+... .......+.+ |+++++.+ +|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~-------------------------E~~~l~~l~~h 55 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG-------------------------ELEVLCKLGHH 55 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHH-------------------------HHHHHHhhccC
Confidence 368999999999999988776 4588877542 2233333333 48899999 89
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
|||+++++++...+..++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+++++|
T Consensus 56 ~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H 135 (270)
T cd05047 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIH 135 (270)
T ss_pred CCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence 999999999999999999999999999999986432 24789999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||+|||+++++.+ +|||+++..... ........+..|+|||++....|
T Consensus 136 ~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~ 188 (270)
T cd05047 136 RDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY 188 (270)
T ss_pred cccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCC
Confidence 9999999999999987 999998643211 11111223567999999866543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.1e-24 Score=231.67 Aligned_cols=180 Identities=28% Similarity=0.421 Sum_probs=154.0
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
...|.+.+.|+.....||-|.||.||.|.|+.-.-.||||.++. +.-...+|++|
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkE------------------------ 313 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKE------------------------ 313 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHH------------------------
Confidence 36678888999999999999999999999999999999998843 33344566666
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
.++|+.++|||+|+|+|+|..+..+|||+|||..|+|.+||+..+ ..++.-..+.++.||.+||+||..+++|||||.
T Consensus 314 -AAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA 392 (1157)
T KOG4278|consen 314 -AAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA 392 (1157)
T ss_pred -HHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence 999999999999999999999999999999999999999998754 346677778899999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.+|+|+.++..+ +||||+|++..+. |+..-...-...|-|||-|.-.
T Consensus 393 ARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyN 441 (1157)
T KOG4278|consen 393 ARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYN 441 (1157)
T ss_pred hhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCccccccc
Confidence 999999998887 9999999988654 4544344456779999987543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=208.30 Aligned_cols=174 Identities=26% Similarity=0.390 Sum_probs=141.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||++.+.. +..+|+|.+...... ...+. +|+++++.
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~-~~~~~-------------------------~e~~~l~~ 55 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS-EEDFI-------------------------EEAQVMMK 55 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC-HHHHH-------------------------HHHHHHHh
Confidence 4678889999999999999998864 678999987543221 12233 35899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++......++||||+++++|.+++......+++..+..++.|++.||.|||+.+++||||||+||+++.
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred CCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 99999999999999999999999999999999999876556899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...... ........++..|+|||++.+..|
T Consensus 136 ~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~ 178 (256)
T cd05112 136 NQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKY 178 (256)
T ss_pred CCeEEECCCcceeecccCc-ccccCCCccchhhcCHhHhccCCc
Confidence 8877 9999998664322 111122335678999999876543
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-24 Score=252.77 Aligned_cols=175 Identities=26% Similarity=0.408 Sum_probs=144.8
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
++..+..||.|.||.||-+.+.+||+.+|+|.+.-.+.. .+. .+ .+.+|+.++..++
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~-~~---------------------~i~eEm~vlE~ln 1292 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKT-FK---------------------LIAEEMKVLEGLN 1292 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-ccc-Cc---------------------chHHHHHHHHhcc
Confidence 456678899999999999999999999999988654333 111 11 1235799999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|||+|+++|+-..++..+|.||||++|+|.++++.. .-.++....-+..|++.|+.|||++|||||||||+||||+.+|
T Consensus 1293 HpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~g-ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g 1371 (1509)
T KOG4645|consen 1293 HPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHG-RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG 1371 (1509)
T ss_pred CccccccCceeecHHHHHHHHHHhccCcHHHHHHhc-chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC
Confidence 999999999999999999999999999999999764 3477777888999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccce--eeeecCCCccccchhhccCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.+ .|||.|.......... .-....||+.|||||++.+..
T Consensus 1372 ~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~ 1414 (1509)
T KOG4645|consen 1372 LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK 1414 (1509)
T ss_pred cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccc
Confidence 87 9999999887542100 011345999999999998753
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=212.13 Aligned_cols=164 Identities=23% Similarity=0.296 Sum_probs=134.0
Q ss_pred eecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc
Q psy5063 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN 563 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 563 (681)
+||+|+||.||++.+..+++.||+|.+.+.... ....+..+ ...+..++..+|||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~ 58 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE----------------------RIMLSLVSTGDCPF 58 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHH----------------------HHHHHHHHhCCCCc
Confidence 489999999999999999999999988653211 11112222 11244566678999
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe-
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG- 642 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~- 642 (681)
|+.+++++...+..++||||++||+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 59 i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~k 137 (278)
T cd05606 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVR 137 (278)
T ss_pred EeeeeeeeecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEE
Confidence 999999999999999999999999999998764 459999999999999999999999999999999999999999988
Q ss_pred -EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 643 -FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 643 -~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||+++...... .....|+..|+|||++.+
T Consensus 138 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~ 169 (278)
T cd05606 138 ISDLGLACDFSKKK----PHASVGTHGYMAPEVLQK 169 (278)
T ss_pred EccCcCccccCccC----CcCcCCCcCCcCcHHhcC
Confidence 9999987654322 123468999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=210.49 Aligned_cols=168 Identities=26% Similarity=0.436 Sum_probs=141.0
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.|+..+.||+|+||.||+|.+..+++.+|+|.+.... ......+. +|+++++.+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-------------------------~e~~~l~~l 56 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ-------------------------REVALLSQL 56 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHH-------------------------HHHHHHHHh
Confidence 4677789999999999999999999999999885432 22222233 347788887
Q ss_pred C---CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 560 H---HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 560 ~---HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+ |||++++++++..+...++||||+++++|.+++... .+++..+..++.|++.||.|||+.+|+|+||+|+||++
T Consensus 57 ~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i 134 (277)
T cd06917 57 RQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV 134 (277)
T ss_pred ccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE
Confidence 6 999999999999999999999999999999998763 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+.++.+ +|||++....... .......++..|+|||.+.+
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06917 135 TNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITE 175 (277)
T ss_pred cCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhcc
Confidence 999988 9999998776433 12223458889999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=211.88 Aligned_cols=171 Identities=29% Similarity=0.427 Sum_probs=135.4
Q ss_pred eeecceecccCcEEEEEEE----EcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 482 LVRGPLLGQGFFGQVYRVT----HRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~----~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
|...+.||+|+||+||++. ...++..+|+|.+..... .....+. +|+++|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~E~~~l 60 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK-------------------------KEINIL 60 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHH-------------------------HHHHHH
Confidence 3778899999999998765 345678999998865322 2223333 358999
Q ss_pred HhCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 557 RSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+.++||||+++++++... ...+++|||+++|+|.+++... .+++.++..++.|++.||.|||+++|+||||||+||
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni 138 (283)
T cd05080 61 KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV 138 (283)
T ss_pred HhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence 999999999999987653 4689999999999999999763 489999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeeccccee-eeecCCCccccchhhccCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTL-FILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~-~~~~~gt~~Y~APEvL~~~~ 679 (681)
|+++++.+ +|||+++.......... .....++..|+|||++.+..
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 186 (283)
T cd05080 139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK 186 (283)
T ss_pred EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccC
Confidence 99999887 99999987654221111 11223466799999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=207.84 Aligned_cols=172 Identities=28% Similarity=0.422 Sum_probs=144.4
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|...+.||+|+||.||++.+..+++.+|+|.+...... ..+.+ .+|+.+++.
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~~e~~~~~~ 55 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEI-------------------------ADEMKVLEL 55 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHH-------------------------HHHHHHHHh
Confidence 467788999999999999999989999999998754432 22222 345899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+||+++++++...+..++|+||+++++|.+++.... .+++..+..++.|++.||.|||+.+|+|+||+|+||++++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~ 134 (264)
T cd06626 56 LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH 134 (264)
T ss_pred CCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 999999999999999999999999999999999997643 4889999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeeccccee--eeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTL--FILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~--~~~~~gt~~Y~APEvL~~~ 678 (681)
++.+ +|||++........... .....++..|++||++.+.
T Consensus 135 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 178 (264)
T cd06626 135 NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178 (264)
T ss_pred CCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCC
Confidence 9888 99999987754322111 1234578899999998754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=206.89 Aligned_cols=171 Identities=32% Similarity=0.509 Sum_probs=145.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|+..+.||+|+||.||++.+..+++.+|+|++..... .....+. +|+..++.
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL-------------------------RELKTLRS 55 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHH-------------------------HHHHHHHh
Confidence 468888999999999999999999999999998865443 2223333 35889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NILl~ 637 (681)
++|+||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ++++||||+|+||+++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~ 134 (264)
T cd06623 56 CESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLIN 134 (264)
T ss_pred cCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEEC
Confidence 99999999999999999999999999999999999765 458999999999999999999999 9999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.++.+ +|||++.......... ....++..|+|||.+.+.
T Consensus 135 ~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 135 SKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGE 175 (264)
T ss_pred CCCCEEEccCccceecccCCCcc--cceeecccccCHhhhCCC
Confidence 99988 9999998775433221 124478899999998655
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=213.77 Aligned_cols=171 Identities=27% Similarity=0.406 Sum_probs=142.2
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.|...+.||+|+||.||+|.+..+++.+|+|.+.... ....+.+ .+|+++++.+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~e~~~l~~l 59 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDI-------------------------QQEITVLSQC 59 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHH-------------------------HHHHHHHHcC
Confidence 4666788999999999999999999999999876433 2222222 3458999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++..++..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+++++|+||+|+||+++++
T Consensus 60 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~ 137 (277)
T cd06642 60 DSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQ 137 (277)
T ss_pred CCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCC
Confidence 999999999999999999999999999999999865 358999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++...... .......++..|+|||++.+..|
T Consensus 138 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 178 (277)
T cd06642 138 GDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAY 178 (277)
T ss_pred CCEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCCC
Confidence 988 9999998665322 11122457888999999876543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=213.99 Aligned_cols=171 Identities=24% Similarity=0.371 Sum_probs=143.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||++....+++.+|+|.+..........+ .+|+.+++.+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~-------------------------~~e~~~l~~l 73 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELI-------------------------INEILVMREN 73 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHH-------------------------HHHHHHHhhc
Confidence 578888999999999999999988899999998754332222233 3458899999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++..++..|+|+||+++++|.+++.+. .+++..+..++.|++.||.|||+++++||||||+||+++.+
T Consensus 74 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~ 151 (293)
T cd06647 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 151 (293)
T ss_pred CCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC
Confidence 9999999999999999999999999999999998753 47899999999999999999999999999999999999998
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+.+ +|||++........ ......++..|+|||++.+..
T Consensus 152 ~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~ 191 (293)
T cd06647 152 GSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKA 191 (293)
T ss_pred CCEEEccCcceeccccccc--ccccccCChhhcCchhhccCC
Confidence 887 99999876543221 112235788899999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=223.95 Aligned_cols=177 Identities=25% Similarity=0.403 Sum_probs=149.3
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCC--C--eEEEEEEeec-cCHHHHHHHHHHhhccceeeeccCCCCccccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRET--G--EVMVLKELYR-VDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t--g--~~vAiK~l~~-~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~ 547 (681)
....+.+..+++.+.||+|.||.||+|....- | -.||||..+. ...+..+.|+.|
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqE-------------------- 441 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQE-------------------- 441 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHH--------------------
Confidence 34456667778889999999999999986433 2 3688898876 455666677776
Q ss_pred cchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy5063 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 627 (681)
Q Consensus 548 ~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHR 627 (681)
..+|+.++||||++|+|++.+ ...|+|||+++.|.|..||+.+...++......++.||..||.|||+.++|||
T Consensus 442 -----a~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHR 515 (974)
T KOG4257|consen 442 -----ASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHR 515 (974)
T ss_pred -----HHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhh
Confidence 889999999999999999865 57999999999999999999887789999999999999999999999999999
Q ss_pred CCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 628 DLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 628 DLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
||..+|||+....-+ +||||+|.+..+..|.. ....-...|||||.+.
T Consensus 516 DIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYka-S~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 516 DIAARNILVSSPQCVKLADFGLSRYLEDDAYYKA-SRGKLPIKWMAPESIN 565 (974)
T ss_pred hhhhhheeecCcceeeecccchhhhccccchhhc-cccccceeecCccccc
Confidence 999999999987766 99999998876654444 3445677899999874
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=206.19 Aligned_cols=172 Identities=25% Similarity=0.364 Sum_probs=142.2
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+..+.||.|+||.||++.+..+++.+|+|.+.... ....+.+. .|+.+++.
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLV-------------------------SEVNILRE 55 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHH-------------------------HHHHHHHh
Confidence 4778889999999999999999999999999886432 22222233 35899999
Q ss_pred CCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccC
Q psy5063 559 LHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLH-----SMNLIHRD 628 (681)
Q Consensus 559 L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLH-----s~~IIHRD 628 (681)
++|+||+++++++.. ....+++|||+++++|.+++... ...+++..+..++.|++.||.||| +.+++|+|
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~d 135 (265)
T cd08217 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRD 135 (265)
T ss_pred cCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecC
Confidence 999999999998764 45789999999999999998653 456899999999999999999999 89999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||+||+++.++.+ +|||++........ ......++..|+|||++.+..
T Consensus 136 l~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~ 186 (265)
T cd08217 136 LKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMS 186 (265)
T ss_pred CCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCC
Confidence 99999999999988 99999987754331 122345889999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-23 Score=211.37 Aligned_cols=169 Identities=27% Similarity=0.424 Sum_probs=133.7
Q ss_pred ceecccCcEEEEEEEEcCCC------eEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 486 PLLGQGFFGQVYRVTHRETG------EVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg------~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+.||+|+||.||+|++.+.. +.+|+|.+..... .....+ .+|+.+++.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~-------------------------~~e~~~l~~ 55 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEF-------------------------LKEAHLMSN 55 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHH-------------------------HHHHHHHHh
Confidence 36899999999999986544 6889997754321 222223 345899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP------GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~------~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
++||||+++++++..++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++++|+||||+
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 135 (269)
T cd05044 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAAR 135 (269)
T ss_pred cCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 99999999999999999999999999999999998642 234788999999999999999999999999999999
Q ss_pred cEEEecCC-----Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 633 NCLVREVG-----SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 633 NILl~~~g-----~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||++.++ .+ +|||+++...............++..|+|||++.+..
T Consensus 136 nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (269)
T cd05044 136 NCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK 189 (269)
T ss_pred eEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCC
Confidence 99999877 44 9999998665332222222234567899999987654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=207.78 Aligned_cols=163 Identities=22% Similarity=0.311 Sum_probs=138.1
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCce
Q psy5063 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNV 564 (681)
Q Consensus 488 LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 564 (681)
||.|+||.||++++..+++.+|+|.+.+.... ..+.+ .+|+.+++.++||||
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~-------------------------~~e~~~l~~l~h~~i 55 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHI-------------------------FSEKEILEECNHPFI 55 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHH-------------------------HHHHHHHHhCCCCCE
Confidence 69999999999999999999999998653321 22223 345889999999999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++.+.+++..+++|||+++++|.+++.+.. .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+
T Consensus 56 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l 134 (262)
T cd05572 56 VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKL 134 (262)
T ss_pred eeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEE
Confidence 999999999999999999999999999997653 48999999999999999999999999999999999999999988
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||+++...... ......++..|++||++.+..
T Consensus 135 ~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~ 168 (262)
T cd05572 135 VDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKG 168 (262)
T ss_pred eeCCcccccCccc---ccccccCCcCccChhHhcCCC
Confidence 9999998775432 112245788999999986654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=229.93 Aligned_cols=172 Identities=27% Similarity=0.404 Sum_probs=144.1
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+.|++.++||+|.+|+||+++++.+++.+|+|++...... ..+.. .|.++|+.
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE-------------------------~eynil~~ 71 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIE-------------------------LEYNMLKK 71 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHH-------------------------HHHHHHHh
Confidence 45678889999999999999999999999999987543222 12211 23777887
Q ss_pred C-CCCceeeEEEEEEe-----CCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 559 L-HHHNVIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 559 L-~HpnIV~l~g~~~~-----~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
. +|||++.++|+|.. ++++|||||||.+|+..|++++. +..+.|..+..|.+.++.|+.+||.+.+||||+|-
T Consensus 72 ~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG 151 (953)
T KOG0587|consen 72 YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKG 151 (953)
T ss_pred ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccC
Confidence 7 79999999999974 57899999999999999998763 45689999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.|||++.+|.+ .|||++....... ..-.+..||+.||||||+.-+
T Consensus 152 ~NiLLT~e~~VKLvDFGvSaQldsT~--grRnT~iGtP~WMAPEViac~ 198 (953)
T KOG0587|consen 152 QNVLLTENAEVKLVDFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACD 198 (953)
T ss_pred ceEEEeccCcEEEeeeeeeeeeeccc--ccccCcCCCcccccceeeecc
Confidence 99999999999 9999998776433 333467899999999998543
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=206.90 Aligned_cols=165 Identities=25% Similarity=0.343 Sum_probs=134.5
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH-HHHhCCCCce
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA-VLRSLHHHNV 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpnI 564 (681)
+.||+|+||.||+|.+..+++.+|+|.+.+............ ..|.. .....+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~----------------------~~e~~~~~~~~~~~~i 59 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNV----------------------KAERAIMMIQGESPYV 59 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHH----------------------HHHHHHHhhcCCCCCe
Confidence 568999999999999999999999998865432222111111 11233 3445589999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++++..++..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+|||+++++.+
T Consensus 60 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l 138 (260)
T cd05611 60 AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKL 138 (260)
T ss_pred eeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEE
Confidence 999999999999999999999999999997643 58999999999999999999999999999999999999999888
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||+++.... .....++..|+|||.+.+..
T Consensus 139 ~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~ 169 (260)
T cd05611 139 TDFGLSRNGLE------NKKFVGTPDYLAPETILGVG 169 (260)
T ss_pred eecccceeccc------cccCCCCcCccChhhhcCCC
Confidence 99999886543 12345788999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=214.67 Aligned_cols=175 Identities=25% Similarity=0.390 Sum_probs=142.3
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|+..+.||+|+||.||+|.+..+|+.||+|.+........ ......+|+.+++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-----------------------~~~~~~~E~~~l~ 61 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDG-----------------------IPISSLREITLLL 61 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCC-----------------------CcchhhHHHHHHH
Confidence 45789999999999999999999999999999998853221100 0112245799999
Q ss_pred hCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 558 SLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
.++|+||+++++++... +..++||||++ ++|.+++......+++.++..++.|++.||.|||+.+++||||||+|||
T Consensus 62 ~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 140 (309)
T cd07845 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140 (309)
T ss_pred hCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 99999999999998755 57899999996 4898888765567999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+++++.+ +|||+++....... ......++..|+|||++.+.
T Consensus 141 ~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 183 (309)
T cd07845 141 LTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGC 183 (309)
T ss_pred ECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCC
Confidence 9999988 99999987754321 11223357789999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=211.01 Aligned_cols=171 Identities=20% Similarity=0.329 Sum_probs=143.1
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
+|...+.||+|+||.||++.+..+++.+++|.+........+.+. +|+.+++.++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~-------------------------~e~~~l~~~~ 74 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLF-------------------------NEVVIMRDYQ 74 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHH-------------------------HHHHHHHHcC
Confidence 344456899999999999999989999999988654433333333 3488999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
||||+++++++...+..++++||+++++|.+++.. ..+++..+..++.|++.||.|||+++|+||||+|+||+++.++
T Consensus 75 h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 152 (285)
T cd06648 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG 152 (285)
T ss_pred CCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC
Confidence 99999999999999999999999999999999977 3589999999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||+++......+ ......++..|+|||++.+..|
T Consensus 153 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 192 (285)
T cd06648 153 RVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPY 192 (285)
T ss_pred cEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCC
Confidence 88 99999876554322 1223458899999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=206.62 Aligned_cols=167 Identities=27% Similarity=0.372 Sum_probs=133.3
Q ss_pred ceecccCcEEEEEEEEcCCC---eEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETG---EVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg---~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
+.||+|+||.||+|.+..++ ..+|+|.+...... ..+.+. +|+.+|+.++|
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-------------------------~e~~~l~~l~h 55 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFL-------------------------REASVMAQLDH 55 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHH-------------------------HHHHHHHhcCC
Confidence 46999999999999876554 78999988644322 222333 45899999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
+||+++++++. .+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++++||||||+|||++.++.
T Consensus 56 ~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~ 133 (257)
T cd05060 56 PCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ 133 (257)
T ss_pred CCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc
Confidence 99999999875 557899999999999999998654 5899999999999999999999999999999999999999998
Q ss_pred e--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCC
Q psy5063 642 G--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+ +|||+++......... ......++..|+|||.+.+..
T Consensus 134 ~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05060 134 AKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174 (257)
T ss_pred EEeccccccceeecCCcccccccCccccccccCHHHhcCCC
Confidence 7 9999998775433211 111122346799999986554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=207.97 Aligned_cols=166 Identities=23% Similarity=0.331 Sum_probs=132.0
Q ss_pred eecccCcEEEEEEEE--cCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 487 LLGQGFFGQVYRVTH--RETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~--~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
.||+|+||.||+|.+ ..+++.+|+|.+.... ....+.+. +|+.+++.++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-------------------------~e~~~l~~l~h~ 56 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELL-------------------------REANVMQQLDNP 56 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHH-------------------------HHHHHHHhCCCC
Confidence 589999999999965 4567899999875432 22222333 358999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
||+++++++. .+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+++++.+
T Consensus 57 ~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~ 134 (257)
T cd05116 57 YIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYA 134 (257)
T ss_pred CcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeE
Confidence 9999999875 457799999999999999997643 58999999999999999999999999999999999999998877
Q ss_pred --EEeeeeeEeeecccce-eeeecCCCccccchhhccCCC
Q psy5063 643 --FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 643 --~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||+++......... ......++..|||||.+....
T Consensus 135 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05116 135 KISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK 174 (257)
T ss_pred EECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCC
Confidence 9999998765432211 111222457899999986543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=211.96 Aligned_cols=174 Identities=21% Similarity=0.310 Sum_probs=140.4
Q ss_pred CeeecceecccCcEEEEEEEEc---CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
+|+..+.||+|+||.||+++.. .+|+.||+|.+............+ ++.+|+.+++
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~---------------------~~~~e~~~l~ 59 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTE---------------------HTRTERQVLE 59 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHH---------------------HHHHHHHHHH
Confidence 4678889999999999999874 478999999886532211111111 1234689999
Q ss_pred hC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 558 SL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 558 ~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
.+ +|+||+++++.+..+...++||||+++++|.+++.... .+++..+..++.|++.||.|||+++++||||||+|||+
T Consensus 60 ~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~ 138 (290)
T cd05613 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL 138 (290)
T ss_pred hcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE
Confidence 99 69999999999999999999999999999999997643 58899999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+.++.+ +|||+++....... .......++..|+|||++.+
T Consensus 139 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 139 DSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred CCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccC
Confidence 999988 99999987643221 11223458889999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=214.13 Aligned_cols=176 Identities=22% Similarity=0.383 Sum_probs=140.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||++.+..+++.||+|.+......... .....+|+++++.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-----------------------~~~~~~e~~~l~~ 67 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGF-----------------------PITALREIKILQL 67 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCc-----------------------hhHHHHHHHHHHh
Confidence 45789999999999999999999999999999988543211000 0112346999999
Q ss_pred CCCCceeeEEEEEEeCC--------eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 559 LHHHNVIRFIGVLYKDR--------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~--------~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
++||||+++++++...+ ..++||||+. ++|.+++......+++..+..++.|++.||.|||+++++|+|||
T Consensus 68 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~ 146 (310)
T cd07865 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMK 146 (310)
T ss_pred CCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 99999999999987653 4599999996 58888887665568999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccc--eeeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPY--TLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~--~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|+|||++.++.+ +|||++......... .......++..|+|||++.+.
T Consensus 147 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 198 (310)
T cd07865 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198 (310)
T ss_pred HHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCC
Confidence 999999999988 999999876542211 111223467889999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=208.77 Aligned_cols=169 Identities=27% Similarity=0.397 Sum_probs=140.8
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
-|...+.||+|+||.||+|.+..+++.+|+|.+..... .....+. +|+.+++.+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-------------------------~e~~~l~~l 59 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-------------------------QEITVLSQC 59 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHH-------------------------HHHHHHHhc
Confidence 35677889999999999999998999999998754322 2222222 358899999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++..++..|+||||+++++|.+++... .+++..+..++.|++.||.|||+.+++|+||||+||+++.+
T Consensus 60 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~ 137 (277)
T cd06641 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 137 (277)
T ss_pred CCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCC
Confidence 9999999999999999999999999999999998753 58999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.+ +|||+++...... .......++..|+|||.+.+.
T Consensus 138 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~ 176 (277)
T cd06641 138 GEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQS 176 (277)
T ss_pred CCEEEeecccceecccch--hhhccccCCccccChhhhccC
Confidence 988 9999988765322 112234578889999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=208.08 Aligned_cols=174 Identities=26% Similarity=0.393 Sum_probs=139.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..++||+|+||.||+|... +++.+|+|.+...... ...+ .+|+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~-~~~~-------------------------~~E~~~l 55 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS-PEAF-------------------------LAEANLM 55 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc-HHHH-------------------------HHHHHHH
Confidence 45678999999999999999999865 4778999988643321 1223 3458999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++|+||+++++++. ++..+++|||+++|+|.+++... +..+++.++..++.|++.||+|||+.+++||||||+||+
T Consensus 56 ~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~ 134 (260)
T cd05067 56 KQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134 (260)
T ss_pred HhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEE
Confidence 9999999999999874 56799999999999999998653 346899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++++.+ +|||+++...... ........++..|+|||++....
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~ 179 (260)
T cd05067 135 VSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGT 179 (260)
T ss_pred EcCCCCEEEccCcceeecCCCC-cccccCCcccccccCHHHhccCC
Confidence 9999988 9999998765322 11112233567899999986543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=201.84 Aligned_cols=171 Identities=26% Similarity=0.452 Sum_probs=146.4
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
+|...+.||+|+||.||++.+..+++.+++|++..........+. +|+++++.++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~-------------------------~e~~~l~~l~ 55 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKII-------------------------NEIQILKKCK 55 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHH-------------------------HHHHHHHhCC
Confidence 577888999999999999999989999999998665443333333 3489999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|+||+++++.+..+...++++||+++++|.+++......+++..+..++.|++.||.|||+++++|+||+|+||++++++
T Consensus 56 ~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~ 135 (253)
T cd05122 56 HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG 135 (253)
T ss_pred CCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC
Confidence 99999999999999999999999999999999987645699999999999999999999999999999999999999998
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.+ +|||++........ .....++..|++||++.+..
T Consensus 136 ~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~ 173 (253)
T cd05122 136 EVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKP 173 (253)
T ss_pred eEEEeecccccccccccc---ccceecCCcccCHHHHcCCC
Confidence 87 99999987664332 22345788999999986543
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-23 Score=216.74 Aligned_cols=179 Identities=21% Similarity=0.286 Sum_probs=150.6
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc---CHHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV---DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~---~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
++-+..+||.++++||+|+|.+|..++++.|.+.||+|++++. +.+...-...
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqt------------------------ 299 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQT------------------------ 299 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHh------------------------
Confidence 3446678999999999999999999999999999999988642 1111111111
Q ss_pred HHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 551 SQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 551 ~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
|-.+.... +||.+|.|+.+|.++.++++|.||++||+|...++...+ +|+..+..+..+|..||.|||++|||.|||
T Consensus 300 -ek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh~rgiiyrdl 377 (593)
T KOG0695|consen 300 -EKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLHERGIIYRDL 377 (593)
T ss_pred -hHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHhhcCeeeeec
Confidence 23344444 799999999999999999999999999999988887654 999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.+|+|+|..|.+ .|+|+.+...... ....+++||+.|.|||+|+++.|
T Consensus 378 kldnvlldaeghikltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeey 428 (593)
T KOG0695|consen 378 KLDNVLLDAEGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEY 428 (593)
T ss_pred cccceEEccCCceeecccchhhcCCCCC--cccccccCCCcccchhhhccccc
Confidence 9999999999998 9999998765433 33457899999999999999987
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-22 Score=202.80 Aligned_cols=170 Identities=25% Similarity=0.456 Sum_probs=144.7
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+..+.||+|+||.||++++..+++.+++|.+..... .....+ .+|+++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~~e~~~l~~ 55 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSI-------------------------MQEIDLLKN 55 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHH-------------------------HHHHHHHHh
Confidence 47788999999999999999999999999999865443 222222 345999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+|++++++++.+++..+++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 134 (254)
T cd06627 56 LKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK 134 (254)
T ss_pred CCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECC
Confidence 99999999999999999999999999999999999765 45899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++.+ +|||++......... .....++..|+|||.+.+.
T Consensus 135 ~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~ 174 (254)
T cd06627 135 DGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMS 174 (254)
T ss_pred CCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCC
Confidence 8887 999999877643321 2234578899999998654
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=207.95 Aligned_cols=173 Identities=29% Similarity=0.391 Sum_probs=137.1
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|.+.+.||+|+||.||++.+..++ .+|+|.+..... ....+. +|+.+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~-~~~~~~-------------------------~E~~~l~ 56 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM-MPEAFL-------------------------QEAQIMK 56 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc-cHHHHH-------------------------HHHHHHH
Confidence 3467888899999999999999887654 588998754321 122233 3589999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
.++|+|++++++++. .+..+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 57 ~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill 135 (260)
T cd05069 57 KLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV 135 (260)
T ss_pred hCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE
Confidence 999999999999875 56789999999999999999753 3458899999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++++.+ +|||+++...... ........++..|+|||++.+..
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~ 179 (260)
T cd05069 136 GDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGR 179 (260)
T ss_pred cCCCeEEECCCccceEccCCc-ccccCCCccchhhCCHHHhccCC
Confidence 999988 8999998764322 11112233567899999886543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=220.05 Aligned_cols=162 Identities=20% Similarity=0.270 Sum_probs=123.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcC-CCeEEEEEEeecc-----CHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRE-TGEVMVLKELYRV-----DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~-tg~~vAiK~l~~~-----~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
.++|..++.||+|+||+||+|.++. +++.+|+|++... .......+ .+|
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~-------------------------~~E 71 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLA-------------------------ARE 71 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHH-------------------------HHH
Confidence 4679999999999999999999876 6788899986432 11112222 356
Q ss_pred HHHHHhCCCCceee-EEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-C
Q psy5063 553 VAVLRSLHHHNVIR-FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL-N 630 (681)
Q Consensus 553 i~iL~~L~HpnIV~-l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL-K 630 (681)
+++|+.++|+|++. +++ .+..|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| |
T Consensus 72 ~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~K 139 (365)
T PRK09188 72 IRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAGITHNDLAK 139 (365)
T ss_pred HHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCC
Confidence 99999999999985 443 2468999999999999732 21 11 1467899999999999999999999 9
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeeccccee------eeecCCCccccchhhccC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTL------FILSAKTKKTYYPNILKK 677 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~------~~~~~gt~~Y~APEvL~~ 677 (681)
|+|||++.++.+ +|||+|+.+........ .....++..|+|||++.-
T Consensus 140 P~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 140 PQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999999988877 99999998764321111 123457888999999864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=208.82 Aligned_cols=167 Identities=25% Similarity=0.379 Sum_probs=136.1
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL- 559 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L- 559 (681)
|...+.||+|+||.||++.+..+++.+|+|.+...... .... .++|+.+++.+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~-------------------------~~~e~~~l~~l~ 55 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVN-------------------------NLREIQALRRLS 55 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhh-------------------------HHHHHHHHhhcC
Confidence 45678899999999999999999999999987543111 1111 13458888888
Q ss_pred CCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 560 HHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
+|+||+++++++.++ +.+++||||++ |+|.+++......+++..+..++.|++.||.|||+.+++||||||+||+++
T Consensus 56 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~ 134 (282)
T cd07831 56 PHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK 134 (282)
T ss_pred CCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc
Confidence 499999999999987 89999999997 588888876555689999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
. +.+ +|||+++......+.. ...++..|+|||++...
T Consensus 135 ~-~~~kl~dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~ 173 (282)
T cd07831 135 D-DILKLADFGSCRGIYSKPPYT---EYISTRWYRAPECLLTD 173 (282)
T ss_pred C-CCeEEEecccccccccCCCcC---CCCCCcccCChhHhhcC
Confidence 9 777 9999998765433222 24478899999987543
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=210.96 Aligned_cols=172 Identities=27% Similarity=0.422 Sum_probs=136.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||+|.+..+++.||+|.+........ ....+.+|+.+++.+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l 57 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEG-----------------------IPPTALREISLLQML 57 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccC-----------------------CchHHHHHHHHHHHc
Confidence 368888999999999999999999999999998743211100 011234568999999
Q ss_pred -CCCceeeEEEEEEeCCe-----EEEEEeccCCCCHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 560 -HHHNVIRFIGVLYKDRK-----LNLVTEYIAGGTLKELLQDP----GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 560 -~HpnIV~l~g~~~~~~~-----l~LV~Ey~~gGsL~~~L~~~----~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
+||||+++++++...+. .|+||||+++ +|.+++... ...+++..+..++.||+.||.|||+++|+||||
T Consensus 58 ~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl 136 (295)
T cd07837 58 SESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDL 136 (295)
T ss_pred cCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 56999999999987665 8999999985 898887542 235899999999999999999999999999999
Q ss_pred CCCcEEEec-CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 630 NSQNCLVRE-VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 630 Kp~NILl~~-~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||+||+++. ++.+ +|||+++.+.... .......+++.|+|||++.+
T Consensus 137 ~~~nil~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~ 185 (295)
T cd07837 137 KPQNLLVDKQKGLLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLG 185 (295)
T ss_pred ChHHEEEecCCCeEEEeecccceecCCCc--cccCCcccccCCCChHHhhC
Confidence 999999998 6666 9999998664321 12223346888999998865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=213.17 Aligned_cols=175 Identities=24% Similarity=0.402 Sum_probs=141.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|.++.+|+.+|+|.+......... .....+|+++++.
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~-----------------------~~~~~~e~~~~~~ 62 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGF-----------------------PITAIREIKILRQ 62 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCc-----------------------hHHHHHHHHHHHh
Confidence 46788999999999999999999999999999988643211100 0112356999999
Q ss_pred CCCCceeeEEEEEEeCC----------eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 559 LHHHNVIRFIGVLYKDR----------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~----------~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
++||||+++++++.+.. .+++|+||+++ +|.+++......+++..+..++.|++.||.|||+++|+|||
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~d 141 (302)
T cd07864 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRD 141 (302)
T ss_pred CCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999987654 79999999976 78777776555689999999999999999999999999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||+||++++++.+ +|||+++....... ..+....++..|+|||++.+.
T Consensus 142 l~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~ 192 (302)
T cd07864 142 IKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGE 192 (302)
T ss_pred CCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCC
Confidence 99999999999988 99999987654331 112223457789999988643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-22 Score=203.05 Aligned_cols=173 Identities=27% Similarity=0.481 Sum_probs=146.0
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|...+.||+|+||.||++.+..+++.+|+|.+..... ...+.+. +|+++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDAL-------------------------NEVKILKK 55 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHH-------------------------HHHHHHHh
Confidence 47778899999999999999999999999999865432 2333333 34889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++|+|++++++.+..+...++|+||+++++|.+++... ...+++..+..++.|++.||.|||+++++|+||+|+||+
T Consensus 56 l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil 135 (258)
T cd08215 56 LNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIF 135 (258)
T ss_pred cCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeE
Confidence 99999999999999999999999999999999999764 356999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||++....... .......+++.|+|||.+.+..+
T Consensus 136 ~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~ 180 (258)
T cd08215 136 LTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPY 180 (258)
T ss_pred EcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCC
Confidence 9998888 8999998765432 12233457889999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=206.85 Aligned_cols=171 Identities=25% Similarity=0.420 Sum_probs=141.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|.+..+++.+++|.+...... ...+.. |+.+++.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~-------------------------e~~~l~~ 58 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKE-------------------------EYNILRK 58 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-HHHHHH-------------------------HHHHHHH
Confidence 36889999999999999999999989999999988654332 223333 4888999
Q ss_pred C-CCCceeeEEEEEEeCC------eEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 559 L-HHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 559 L-~HpnIV~l~g~~~~~~------~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
+ +|+||+++++++.... ..|+||||+++++|.+++... +..+++..+..++.|++.||.|||+++++|+|
T Consensus 59 ~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~ 138 (275)
T cd06608 59 YSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRD 138 (275)
T ss_pred hcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCC
Confidence 8 7999999999997644 589999999999999988642 35689999999999999999999999999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|+|+||+++.++.+ +|||++....... .......++..|+|||++..
T Consensus 139 l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 187 (275)
T cd06608 139 IKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIAC 187 (275)
T ss_pred CCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcc
Confidence 99999999999888 9999988654322 11223458889999999854
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=217.66 Aligned_cols=170 Identities=21% Similarity=0.311 Sum_probs=139.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||++.+..+++.+|+|.+.+. .......+ .+|+.++
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~~E~~~l 69 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRA-------------------------YRELVLM 69 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHH-------------------------HHHHHHH
Confidence 46799999999999999999999999999999988542 22222222 3458999
Q ss_pred HhCCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++|+||+++++++... ...|+||||+. ++|.+.+... +++..+..++.|++.||+|||++||+|||||
T Consensus 70 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk 145 (353)
T cd07850 70 KLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 145 (353)
T ss_pred HhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCC
Confidence 999999999999998644 35799999995 5888887642 8889999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.++.+ +|||+++....... .....++..|+|||++.+..|
T Consensus 146 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 194 (353)
T cd07850 146 PSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGY 194 (353)
T ss_pred HHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCC
Confidence 999999999988 99999987643221 223457889999999977654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-22 Score=208.21 Aligned_cols=172 Identities=22% Similarity=0.384 Sum_probs=141.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|+..+.||.|+||.||++.+..+++.+|+|.+..... .....+. +|+++++.
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQIL-------------------------RELEINKS 55 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHH-------------------------HHHHHHHh
Confidence 467888999999999999999999999999998865432 2223333 45999999
Q ss_pred CCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 559 LHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++||||+++++++... +.+++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+++|+||+|+|
T Consensus 56 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~n 135 (287)
T cd06621 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSN 135 (287)
T ss_pred CCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 9999999999998653 479999999999999988653 23458899999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++++++.+ +|||++........ ....++..|+|||.+.+..|
T Consensus 136 il~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~ 180 (287)
T cd06621 136 ILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTSFYMAPERIQGKPY 180 (287)
T ss_pred EEEecCCeEEEeecccccccccccc----ccccCCccccCHHHhcCCCC
Confidence 999999888 99999876543221 12447888999999876543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=207.34 Aligned_cols=168 Identities=33% Similarity=0.507 Sum_probs=136.4
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|++.+.||+|+||.||++.. +++.+|+|.+.... ....+. +|+.++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~-------------------------~e~~~l 53 (254)
T cd05083 3 LNLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFL-------------------------EETAVM 53 (254)
T ss_pred ccHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHH-------------------------HHHHHH
Confidence 3456889999999999999999874 58889999875322 112233 358999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++||||+++++++..+ ..+++|||+++|+|.+++.... ..+++..+..++.|++.||.|||+++++||||||+|||
T Consensus 54 ~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nil 132 (254)
T cd05083 54 TKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132 (254)
T ss_pred HhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE
Confidence 999999999999998654 5799999999999999997543 35889999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.++.+ +|||+++...... .....+..|+|||++.+..
T Consensus 133 i~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~ 173 (254)
T cd05083 133 VSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKK 173 (254)
T ss_pred EcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCC
Confidence 9999988 9999997654221 1123456799999986554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=211.36 Aligned_cols=171 Identities=26% Similarity=0.455 Sum_probs=140.5
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+..+.||+|+||.||+|++..+++.+|+|.+...... ... .+.+|+++++.
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~-------------------------~~~~E~~~l~~ 55 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPS-------------------------TAIREISLLKE 55 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccch-------------------------HHHHHHHHHHh
Confidence 477888999999999999999999999999987532211 111 22356999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++||||+++++++.+++..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+++++||||+|+||+++
T Consensus 56 l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~ 134 (284)
T cd07860 56 LNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN 134 (284)
T ss_pred cCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 999999999999999999999999996 6898888653 34589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.++.+ +|||+++...... .......++..|+|||++.+..
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~ 176 (284)
T cd07860 135 TEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCK 176 (284)
T ss_pred CCCCEEEeeccchhhcccCc--cccccccccccccCCeEEecCC
Confidence 99988 9999987654321 2222344688899999986643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=205.27 Aligned_cols=174 Identities=26% Similarity=0.392 Sum_probs=139.6
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|.+.+.||+|+||.||++.+. .+..+|+|.+.... .....+. +|+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~-------------------------~e~~~ 54 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFL-------------------------AEANV 54 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHH-------------------------HHHHH
Confidence 345678999999999999999999865 45668999875432 2222333 35899
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
++.++|+||+++++++.. ...+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+.+++||||||+||
T Consensus 55 l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni 133 (260)
T cd05073 55 MKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 133 (260)
T ss_pred HHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceE
Confidence 999999999999999877 7889999999999999999753 34578899999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+++.++.+ +|||+++...... ........++..|+|||++...
T Consensus 134 ~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~ 178 (260)
T cd05073 134 LVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFG 178 (260)
T ss_pred EEcCCCcEEECCCcceeeccCCC-cccccCCcccccccCHhHhccC
Confidence 99999888 8999998654321 1111223355679999998654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=209.06 Aligned_cols=171 Identities=26% Similarity=0.391 Sum_probs=137.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||+|.+..+++.||+|.+..... .....+ .+|+++++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-------------------------~~e~~~l~ 56 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA-------------------------IREISLLK 56 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHH-------------------------HHHHHHHH
Confidence 578899999999999999999999999999998754321 111122 34589999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
.++||||+++++++..++..|+||||++ ++|.+++.... ..+++..+..++.||+.||+|||+++++||||||+||++
T Consensus 57 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill 135 (294)
T PLN00009 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLI 135 (294)
T ss_pred hccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEE
Confidence 9999999999999999999999999996 57887775433 336788888999999999999999999999999999999
Q ss_pred ecCC-Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVG-SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g-~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.++ .+ +|||+++...... .......++..|+|||++.+.
T Consensus 136 ~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~ 178 (294)
T PLN00009 136 DRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGS 178 (294)
T ss_pred ECCCCEEEEcccccccccCCCc--cccccCceeecccCHHHHhCC
Confidence 9655 33 9999997654321 112234568899999998654
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=205.64 Aligned_cols=172 Identities=22% Similarity=0.337 Sum_probs=142.0
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|...+.||+|+||.||++..+.+|..+|+|.+..... ...+.+ .+|+.+++.
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~~E~~~l~~ 55 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-------------------------KKEVILLAK 55 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHH-------------------------HHHHHHHHh
Confidence 47788999999999999999999999999998854321 111222 245899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++|+||+++++.+..++..++|+||+++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||||+||+++
T Consensus 56 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~ 135 (257)
T cd08225 56 MKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS 135 (257)
T ss_pred CCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc
Confidence 999999999999999999999999999999999987543 3579999999999999999999999999999999999999
Q ss_pred cCCCe---EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 638 EVGSG---FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 638 ~~g~~---~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+++.. +|||++........ ......++..|+|||++.+..
T Consensus 136 ~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~ 178 (257)
T cd08225 136 KNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRP 178 (257)
T ss_pred CCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCC
Confidence 88753 99999987653221 122345888999999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=210.56 Aligned_cols=165 Identities=26% Similarity=0.372 Sum_probs=138.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
..|...+.||+|+||.||++.+..+++.||+|.+..... ...+.+ .+|++++
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~-------------------------~~Ei~~l 69 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-------------------------IKEVRFL 69 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHH-------------------------HHHHHHH
Confidence 347778899999999999999999999999998864322 222223 3458999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++..++..++||||++ |+|.+++......+++..+..++.|++.||.|||+++|+||||+|+||++
T Consensus 70 ~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~ 148 (307)
T cd06607 70 QQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL 148 (307)
T ss_pred HhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE
Confidence 99999999999999999999999999996 57877776545569999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+.++.+ +|||+++..... ....++..|+|||++.
T Consensus 149 ~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 149 TEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVIL 184 (307)
T ss_pred CCCCCEEEeecCcceecCCC------CCccCCccccCceeee
Confidence 999988 999998765422 2245788999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-25 Score=217.64 Aligned_cols=178 Identities=21% Similarity=0.365 Sum_probs=146.3
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..+.|+....||+|.||.||+++.+.+|+.||+|++ +....| ..-.++.++|+.+|.
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkv----------lmeneK-------------eGfpitalreikiL~ 71 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKV----------LMENEK-------------EGFPITALREIKILQ 71 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHH----------HHhccc-------------cCCcHHHHHHHHHHH
Confidence 345677888999999999999999999999888754 111111 123456788999999
Q ss_pred hCCCCceeeEEEEEEe--------CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 558 SLHHHNVIRFIGVLYK--------DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~--------~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
.|+|+|++.+++.+.. ...+|+||++|+. +|.-+|.+....++...+.+++.+++.||.|+|++.|+|||+
T Consensus 72 ~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDm 150 (376)
T KOG0669|consen 72 LLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDM 150 (376)
T ss_pred HhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcc
Confidence 9999999999888743 2459999999976 999999888777999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecc--cceeeeecCCCccccchhhccCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYV--PYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~--~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||+|+||+.+|.. +|||+||.+.... ....+...+.|..|..||.|.+..
T Consensus 151 KaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r 204 (376)
T KOG0669|consen 151 KAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR 204 (376)
T ss_pred cHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhccc
Confidence 9999999999998 9999999887532 222333445689999999998763
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=207.55 Aligned_cols=171 Identities=27% Similarity=0.398 Sum_probs=139.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||++....+++.+|+|.+...... ...+. +|+.+++.
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~-~~~~~-------------------------~e~~~l~~ 74 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIE-------------------------AEYNILQS 74 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH-HHHHH-------------------------HHHHHHHH
Confidence 56799999999999999999999999999999988543211 12222 34778888
Q ss_pred C-CCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 559 L-HHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 559 L-~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
+ +||||+++++++... +..++||||+++|+|.++++. ....+++..+..++.|++.||.|||+.+++||||
T Consensus 75 l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dl 154 (291)
T cd06639 75 LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDV 154 (291)
T ss_pred hcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 8 899999999998753 368999999999999998863 2346899999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||+||+++.++.+ +|||+++....... ......++..|+|||++..
T Consensus 155 kp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 202 (291)
T cd06639 155 KGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIAC 202 (291)
T ss_pred CHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcC
Confidence 9999999999987 99999886543221 1123457889999999754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=212.92 Aligned_cols=171 Identities=23% Similarity=0.350 Sum_probs=136.4
Q ss_pred eeecceecccCcEEEEEEEEcC--CCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRE--TGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~--tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
|...+.||+|+||.||+|.+.. +++.||+|.+.... ...... ..+|+.++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~-------------------------~~~e~~~l 56 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQS-------------------------ACREIALL 56 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHH-------------------------HHHHHHHH
Confidence 6677889999999999999988 89999999986532 111111 23468999
Q ss_pred HhCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDP----GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~----~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++... ..+++||||+++ +|.+++... ...+++..+..++.|++.||.|||+++|+|||||
T Consensus 57 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlk 135 (316)
T cd07842 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLK 135 (316)
T ss_pred HhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 999999999999999988 889999999975 777766432 2258899999999999999999999999999999
Q ss_pred CCcEEEec----CCCe--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVRE----VGSG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~----~g~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|+|||++. ++.+ +|||+++....... ........++..|+|||++.+.
T Consensus 136 p~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (316)
T cd07842 136 PANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190 (316)
T ss_pred HHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCC
Confidence 99999999 7777 99999987643321 1111233468889999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=206.28 Aligned_cols=169 Identities=24% Similarity=0.402 Sum_probs=138.2
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeE
Q psy5063 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRF 567 (681)
Q Consensus 488 LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l 567 (681)
||+|+||.||++++..+|+.+|+|.+.......... .. .+.+|+++++.++||||+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~-~~---------------------~~~~e~~~l~~~~h~~i~~~ 58 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQ-VD---------------------QVLTERDILSQAQSPYVVKL 58 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhH-HH---------------------HHHHHHHHHHhCCCcchhHH
Confidence 689999999999999999999999886543321111 11 12346899999999999999
Q ss_pred EEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEe
Q psy5063 568 IGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDF 645 (681)
Q Consensus 568 ~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DF 645 (681)
++.+..+...|++|||+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||++++++.+ +||
T Consensus 59 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~df 137 (265)
T cd05579 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDF 137 (265)
T ss_pred HHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEec
Confidence 999999999999999999999999998654 58999999999999999999999999999999999999999988 999
Q ss_pred eeeeEeeeccc------ceeeeecCCCccccchhhccCCC
Q psy5063 646 HLGQIYLIYVP------YTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 646 GLa~~~~~~~~------~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|++........ ........++..|+|||++.+..
T Consensus 138 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 177 (265)
T cd05579 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG 177 (265)
T ss_pred ccchhcccCcccccccccccccCcccCccccCHHHhcCCC
Confidence 99886543311 01222344788899999986543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=206.97 Aligned_cols=169 Identities=25% Similarity=0.425 Sum_probs=140.6
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
|+..+.||+|+||.||+|.+..+++.+|+|.+.... ......+ .+|+++++.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~-------------------------~~e~~~l~~l 55 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA-------------------------IREIKLLQKL 55 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHH-------------------------HHHHHHHHhc
Confidence 456788999999999999999999999999987542 1112222 3458999999
Q ss_pred CCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 560 HHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
+|+|++++++++... +..++||||+++ +|.+++......+++..+..++.|++.||.|||+++++|+||||+|||++
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~ 134 (287)
T cd07840 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN 134 (287)
T ss_pred cCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc
Confidence 999999999999888 899999999975 89999877655699999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+++.+ +|||+++....... .......++..|+|||.+.+
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 135 NDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLG 175 (287)
T ss_pred CCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEc
Confidence 99988 99999987764321 11223446788999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=199.98 Aligned_cols=172 Identities=31% Similarity=0.485 Sum_probs=145.6
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|...+.||+|+||.||+|.+..+++.+++|.+..... ...+.+. +|+++++.
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 55 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALE-------------------------REIRILSS 55 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHH-------------------------HHHHHHHH
Confidence 46778899999999999999999999999998865432 2222233 45999999
Q ss_pred CCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 559 LHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
++|+||+++++.+... ...++++||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||++
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i 134 (260)
T cd06606 56 LQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV 134 (260)
T ss_pred cCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 9999999999999988 89999999999999999998755 69999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.++.+ +|||.+................++..|++||.+.+.
T Consensus 135 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~ 178 (260)
T cd06606 135 DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178 (260)
T ss_pred cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCC
Confidence 998888 999999887754321112335688899999998655
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=207.79 Aligned_cols=170 Identities=26% Similarity=0.424 Sum_probs=138.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+.|+..+.||+|+||.||+|.+..+++.+|+|.+..... ....+. .|+.+++.
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~-------------------------~e~~~l~~ 68 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIK-------------------------LEINMLKK 68 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHH-------------------------HHHHHHHH
Confidence 3577888899999999999999999999999998754322 122222 34778888
Q ss_pred C-CCCceeeEEEEEEe------CCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 559 L-HHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 559 L-~HpnIV~l~g~~~~------~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+ +|+||+++++++.. .+..+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+|||||
T Consensus 69 ~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~ 148 (282)
T cd06636 69 YSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIK 148 (282)
T ss_pred hcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 7 79999999999853 46789999999999999998753 3458888899999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
|+||++++++.+ +|||+++...... .......++..|+|||++.
T Consensus 149 ~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 149 GQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred HHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcC
Confidence 999999999988 9999987654221 1122345888999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=210.32 Aligned_cols=166 Identities=20% Similarity=0.321 Sum_probs=139.2
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCce
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNV 564 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 564 (681)
...||+|+||.||++....+++.+|+|++..........+. +|+.+++.++|+||
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~-------------------------~e~~~l~~l~h~~i 79 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF-------------------------NEVVIMRDYQHENV 79 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHH-------------------------HHHHHHHhcCCcch
Confidence 46799999999999999999999999987543333333333 45889999999999
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-- 642 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-- 642 (681)
+++++.+..++..++||||+++++|.+++... .+++..+..++.|++.||.|||+++++|+||+|+||++++++..
T Consensus 80 v~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l 157 (292)
T cd06657 80 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKL 157 (292)
T ss_pred hheeeEEEeCCEEEEEEecCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999999999999999999999988653 48999999999999999999999999999999999999999888
Q ss_pred EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 643 FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 643 ~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||++........ ......++..|+|||++.+..
T Consensus 158 ~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~ 192 (292)
T cd06657 158 SDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLP 192 (292)
T ss_pred cccccceecccccc--cccccccCccccCHHHhcCCC
Confidence 89999876654321 122345788999999986544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=215.03 Aligned_cols=171 Identities=24% Similarity=0.360 Sum_probs=138.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .....+ .+|+.+++
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~E~~~l~ 58 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-------------------------LREIKILR 58 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHH-------------------------HHHHHHHH
Confidence 3689999999999999999999999999999998854221 111222 34599999
Q ss_pred hCCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 558 SLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.++|+||+++++++... ...++|+||++ ++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+
T Consensus 59 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~ 135 (336)
T cd07849 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPS 135 (336)
T ss_pred hCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 99999999999987644 35899999996 588888865 35899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeeccccee-eeecCCCccccchhhccC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTL-FILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~-~~~~~gt~~Y~APEvL~~ 677 (681)
|||++.++.. +|||+++.......... .....++..|+|||++.+
T Consensus 136 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 136 NLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred HEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC
Confidence 9999999988 99999987654322111 122457889999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-22 Score=206.11 Aligned_cols=163 Identities=23% Similarity=0.281 Sum_probs=132.9
Q ss_pred Ceeecce--ecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPL--LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~--LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|...+. ||+|+||.||++..+.++..+|+|.+........ |+.....
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------------------------------e~~~~~~ 64 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------------------------------EPMVHQL 64 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------------------------------hHHHHHH
Confidence 4444444 5999999999999999999999998754211100 1222222
Q ss_pred C-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 L-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
+ +||||+++++.+..++..++||||+++|+|.+++.... .+++..+..++.|+++||.|||+.+++||||||+||+++
T Consensus 65 ~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 65 MKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143 (267)
T ss_pred hhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe
Confidence 2 79999999999999999999999999999999997654 699999999999999999999999999999999999999
Q ss_pred cCC-Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVG-SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g-~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++ .+ +|||+++..... ....++..|+|||++.+..|
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~ 183 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNY 183 (267)
T ss_pred CCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCC
Confidence 988 66 999998765422 12357899999999977654
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=208.92 Aligned_cols=173 Identities=25% Similarity=0.333 Sum_probs=144.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
++|...+.||+|+||.||++....+++.+|+|.+.+... ..... ..+|++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~~~e~~~~ 55 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKY-------------------------VKIEKEVL 55 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHH-------------------------HHHHHHHH
Confidence 478899999999999999999999999999998854221 11112 23458899
Q ss_pred HhCC-CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++ |+||+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+
T Consensus 56 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~ 134 (280)
T cd05581 56 TRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENIL 134 (280)
T ss_pred HhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence 9998 9999999999999999999999999999999998754 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccc------------------eeeeecCCCccccchhhccCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPY------------------TLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~------------------~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++.+|.+ +|||++......... .......++..|+|||++.+.
T Consensus 135 i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 197 (280)
T cd05581 135 LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK 197 (280)
T ss_pred ECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCC
Confidence 9999988 999999876543211 112233468899999987654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=226.98 Aligned_cols=189 Identities=19% Similarity=0.228 Sum_probs=135.1
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCe-EEEEEEeecc---CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGE-VMVLKELYRV---DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~-~vAiK~l~~~---~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.++|.+.+.||+|+||.||++..+.... ..+.|.+... .....+...+..+. .......+.+|+.
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-----------~~~~~~~~~~Ei~ 215 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-----------GSRAAIQLENEIL 215 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-----------chHHHHHHHHHHH
Confidence 4689999999999999999998764433 2333322111 11111111111000 0001123457899
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG----QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~----~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+|+.++||||+++++++...+..|+|+|++. ++|.+++.... .......+..++.||+.||.|||+++|||||||
T Consensus 216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK 294 (501)
T PHA03210 216 ALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK 294 (501)
T ss_pred HHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9999999999999999999999999999995 57777765321 123456677899999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.+|.+ +|||+++.+...... ......||..|+|||++.+..|
T Consensus 295 P~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 345 (501)
T PHA03210 295 LENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGY 345 (501)
T ss_pred HHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCC
Confidence 999999999988 999999876543211 1223468999999999987765
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=206.67 Aligned_cols=173 Identities=24% Similarity=0.383 Sum_probs=145.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+.|+..+.||+|+||.||++.+..+++.+++|.+..... ....+. +|+++++.
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~-------------------------~e~~~l~~ 71 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELII-------------------------NEILIMKD 71 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHH-------------------------HHHHHHHH
Confidence 3567788899999999999999998899999999865443 223333 34889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|+||+++++.+..++..|+|+||+++++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 72 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~ 151 (286)
T cd06614 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK 151 (286)
T ss_pred CCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC
Confidence 99999999999999999999999999999999999876546999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.+ +|||++....... .......++..|++||++.+..
T Consensus 152 ~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~ 192 (286)
T cd06614 152 DGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKD 192 (286)
T ss_pred CCCEEECccchhhhhccch--hhhccccCCcccCCHhHhcCCC
Confidence 9888 9999887554322 1112334788899999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=231.02 Aligned_cols=174 Identities=24% Similarity=0.378 Sum_probs=141.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+...++++.++|.+|||+.||.+.+...|..||+|++.-.++...+...+| |.+|
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~E-------------------------I~~M 88 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKRE-------------------------IDIM 88 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHH-------------------------HHHH
Confidence 334556778899999999999999998889999999988777776665555 9999
Q ss_pred HhCC-CCceeeEEEE-EEe------CCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Q psy5063 557 RSLH-HHNVIRFIGV-LYK------DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMN--LI 625 (681)
Q Consensus 557 ~~L~-HpnIV~l~g~-~~~------~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~--II 625 (681)
+.|+ |+|||.+++. ... ..+.+|.||||+||.|-|++..+ ...|++.++++|+.|+++|+.+||... ||
T Consensus 89 K~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiI 168 (738)
T KOG1989|consen 89 KLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPII 168 (738)
T ss_pred HHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccc
Confidence 9996 9999999993 221 13688999999999999999753 234999999999999999999999997 99
Q ss_pred ccCCCCCcEEEecCCCe--EEeeeeeEeeecccce-------eeeecCCCccccchhhc
Q psy5063 626 HRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYT-------LFILSAKTKKTYYPNIL 675 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~-------~~~~~~gt~~Y~APEvL 675 (681)
|||||-|||||..+|.. ||||-|..-....... ..+...-|+.|.|||++
T Consensus 169 HRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMI 227 (738)
T KOG1989|consen 169 HRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMI 227 (738)
T ss_pred hhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHH
Confidence 99999999999999977 9999886543211000 11123369999999997
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-23 Score=210.24 Aligned_cols=169 Identities=26% Similarity=0.363 Sum_probs=139.1
Q ss_pred CCCeeec-ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRG-PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~-~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.+||.+. ++||-|-.|.|..+.++.||+.+|+|++..... . .+|+++.-
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~K-----A-------------------------RrEVeLHw 109 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSPK-----A-------------------------RREVELHW 109 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCHH-----H-------------------------HhHhhhhh
Confidence 3566654 689999999999999999999999998743211 1 23466544
Q ss_pred hC-CCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 558 SL-HHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 558 ~L-~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
.. .|||||+++++|.+ ...+.+|||.|+||.|+..+++++ ..|++.++..|++||..|+.|||+++|.||||||
T Consensus 110 ~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKp 189 (400)
T KOG0604|consen 110 MASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKP 189 (400)
T ss_pred hhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCCh
Confidence 44 79999999999865 357899999999999999998764 4699999999999999999999999999999999
Q ss_pred CcEEEecCCCe-----EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG-----FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~-----~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|+|....+.- +|||+|+.-.. .....+.+-|+.|.|||+|..++|
T Consensus 190 ENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKy 240 (400)
T KOG0604|consen 190 ENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKY 240 (400)
T ss_pred hheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhc
Confidence 99999876542 89999987653 233456778999999999988877
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=214.27 Aligned_cols=171 Identities=24% Similarity=0.371 Sum_probs=139.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||+|.+..+++.+|+|++.... ...... ..+|+.+++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~-------------------------~~~E~~~l~ 61 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR-------------------------TFREIMFLQ 61 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhh-------------------------hhHHHHHHH
Confidence 57888999999999999999999899999999885421 111111 234699999
Q ss_pred hC-CCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 558 SL-HHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 558 ~L-~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
.+ +||||+++++++... ...|+||||++ ++|.+++... .+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 62 ~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ni 138 (337)
T cd07852 62 ELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNI 138 (337)
T ss_pred HhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 99 999999999998643 46899999997 5999988764 588999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccc---eeeeecCCCccccchhhccCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPY---TLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~---~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|++.+|.+ +|||+++........ .......++..|+|||++.+.
T Consensus 139 ll~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 187 (337)
T cd07852 139 LLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGS 187 (337)
T ss_pred EEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeecc
Confidence 99999988 999999876543211 122234578899999988653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.6e-22 Score=203.35 Aligned_cols=181 Identities=24% Similarity=0.343 Sum_probs=140.3
Q ss_pred CeeecceecccCcEEEEEEEEcC-CCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh-
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRE-TGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS- 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~-tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~- 558 (681)
+|+..+.||+|+||.||++.+.. +++.+|+|.+........+.. ++ ..........|+.+++.
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~-~~--------------~~~~~~~~~~e~~~l~~~ 65 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDK-RE--------------RDKSIGDIVSEVTIIKEQ 65 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeecccccccccc-cc--------------chHHHHHHHHHHHHHhhc
Confidence 46778899999999999999987 688999998854321111000 00 00000112456777765
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNC 634 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NI 634 (681)
++||||+++++++..++..+++|||+++++|.+++.. ....+++..++.++.|++.||.|||+ .+++|+||||+||
T Consensus 66 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ni 145 (269)
T cd08528 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNI 145 (269)
T ss_pred CCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHE
Confidence 7999999999999999999999999999999988743 34468999999999999999999996 7899999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|++.++.+ +|||++....... ......++..|+|||++.+..
T Consensus 146 l~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~ 189 (269)
T cd08528 146 MLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEP 189 (269)
T ss_pred EECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCC
Confidence 99999988 9999998765432 223456888999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=201.63 Aligned_cols=171 Identities=22% Similarity=0.335 Sum_probs=143.9
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|+..+.||+|+||.||++.+..+++.+|+|.+..... .....+ .+|+.+++.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~~e~~~l~~ 55 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDA-------------------------VNEIRILAS 55 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHH-------------------------HHHHHHHHh
Confidence 47778899999999999999999999999998865322 112222 245899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++|+||+++++++......++||||+++++|.+++... ...+++..+..++.|++.||.|||+++++|+||+|+||+
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~ 135 (256)
T cd08530 56 VNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANIL 135 (256)
T ss_pred CCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEE
Confidence 99999999999999999999999999999999998652 245899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.. +|||+++..... ......++..|++||.+.+..|
T Consensus 136 ~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~ 178 (256)
T cd08530 136 LVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPY 178 (256)
T ss_pred EecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCC
Confidence 9998887 999999877643 1223457889999999876654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=242.86 Aligned_cols=161 Identities=22% Similarity=0.390 Sum_probs=135.0
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
++...++||+|+||.||+|++..++..||+|++....... ..|++.|+.++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------------------~~~~~~l~~l~ 741 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----------------------------SSEIADMGKLQ 741 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc-----------------------------HHHHHHHhhCC
Confidence 4556678999999999999999899999999875432111 12477899999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCcEEEe
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH---SMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLH---s~~IIHRDLKp~NILl~ 637 (681)
||||++++|++.+++..|+||||+++|+|.++++. ++|..+..++.|++.||+||| +.+|+||||||+|||++
T Consensus 742 HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~ 817 (968)
T PLN00113 742 HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817 (968)
T ss_pred CCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC
Confidence 99999999999999999999999999999999963 899999999999999999999 66999999999999999
Q ss_pred cCCCe-EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG-FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~-~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.. ..||++...... ....+|..|||||++.+..|
T Consensus 818 ~~~~~~~~~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~ 855 (968)
T PLN00113 818 GKDEPHLRLSLPGLLCTD------TKCFISSAYVAPETRETKDI 855 (968)
T ss_pred CCCceEEEeccccccccC------CCccccccccCcccccCCCC
Confidence 98877 677776544321 12357899999999987655
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=9e-22 Score=212.25 Aligned_cols=166 Identities=25% Similarity=0.378 Sum_probs=137.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||++.+..+++.||+|++.+.. ......+ .+|+++|
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-------------------------~~E~~~l 68 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRA-------------------------YRELRLL 68 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHH-------------------------HHHHHHH
Confidence 457999999999999999999999999999999885422 1111222 3469999
Q ss_pred HhCCCCceeeEEEEEEeCC------eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~------~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++..+. ..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+++|+|||||
T Consensus 69 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlk 145 (343)
T cd07880 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLK 145 (343)
T ss_pred HhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9999999999999987653 468999999 7799988865 358999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|+|||++.++.+ +|||+++...... ....++..|+|||++.+
T Consensus 146 p~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 146 PGNLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILN 189 (343)
T ss_pred HHHEEEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhC
Confidence 999999999988 9999998654321 22357889999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.5e-22 Score=207.27 Aligned_cols=185 Identities=17% Similarity=0.182 Sum_probs=132.7
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCC---CeEEEEEEeeccCHHH--HHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRET---GEVMVLKELYRVDEEA--EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~t---g~~vAiK~l~~~~~~~--~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..++|.+.+.||+|+||.||+|.+..+ +..+|+|......... +....+.. .......+
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~----------------~~~~~~~~ 73 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNI----------------YDIDKIAL 73 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhh----------------hhHHHHHH
Confidence 346899999999999999999999877 6677777543222111 11111110 00111233
Q ss_pred HHHHHhCCCCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
...+..++|+||+++++...... ..++++|++. .++.+++... ...++..+..++.|++.||+|||+++|+|||
T Consensus 74 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrD 151 (294)
T PHA02882 74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGD 151 (294)
T ss_pred HHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 55667789999999998765543 4578888874 4777776643 2367888999999999999999999999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccc-----eeeeecCCCccccchhhccCCCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPY-----TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~-----~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+|||++.++.+ +|||+|+.+...... .......||+.|+|||++.+..|
T Consensus 152 iKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~ 210 (294)
T PHA02882 152 IKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV 210 (294)
T ss_pred CCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC
Confidence 99999999998888 999999887532211 11123458999999999887654
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.6e-22 Score=206.28 Aligned_cols=169 Identities=27% Similarity=0.438 Sum_probs=138.6
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
|+..+.||+|++|.||+|.+..+|+.||+|++...... ....+ .+|+++++.+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~~E~~~l~~l 55 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA-------------------------IREISLLKEL 55 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHH-------------------------HHHHHHHHhc
Confidence 45677899999999999999999999999988543211 11122 3459999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
+||||+++++++.+++..+++|||++ ++|.+++.... ..+++..+..++.|++.||.|||+++++||||+|+||+++.
T Consensus 56 ~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~ 134 (283)
T cd07835 56 NHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDR 134 (283)
T ss_pred CCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcC
Confidence 99999999999999999999999995 68999987643 35899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++.+ +|||+++...... .......++..|+|||++.+.
T Consensus 135 ~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~ 174 (283)
T cd07835 135 EGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGS 174 (283)
T ss_pred CCcEEEeecccccccCCCc--cccCccccccCCCCCceeecC
Confidence 9888 9999997654221 122233468889999988654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=207.95 Aligned_cols=164 Identities=27% Similarity=0.382 Sum_probs=138.1
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.|...+.||+|+||.||++++..+++.+|+|.+...... ....+ .+|+++++
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~-------------------------~~e~~~l~ 80 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI-------------------------IKEVKFLQ 80 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHH-------------------------HHHHHHHH
Confidence 366788899999999999999999999999988643222 22223 34599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++|||++++++++..+...++||||++ |+|.+++.....++++.++..++.|++.||.|||+++|+||||+|+||+++
T Consensus 81 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~ 159 (317)
T cd06635 81 RIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT 159 (317)
T ss_pred hCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC
Confidence 9999999999999999999999999996 588888766556799999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
.++.+ +|||++...... ....++..|+|||++.
T Consensus 160 ~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 160 EPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVIL 194 (317)
T ss_pred CCCCEEEecCCCccccCCc------ccccCCccccChhhhh
Confidence 99888 999998754321 2345788999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=4e-22 Score=194.15 Aligned_cols=174 Identities=23% Similarity=0.412 Sum_probs=143.5
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeec-cCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR-VDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~-~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
-....+++..+..||+|+||+|-+-++..+|..+|+|.+.. .....+++.+.+ +
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~d-------------------------l 95 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMD-------------------------L 95 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHh-------------------------h
Confidence 55667888899999999999999999999999999999854 233334444444 5
Q ss_pred H-HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccC
Q psy5063 554 A-VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---DPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRD 628 (681)
Q Consensus 554 ~-iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~---~~~~~l~~~~~~~i~~QIa~gL~yLHs~-~IIHRD 628 (681)
. .++...-|.+|.|||.+......|+.||.|. -||..+.+ +.+..+++..+-+++..+..||.|||++ .+||||
T Consensus 96 di~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRD 174 (282)
T KOG0984|consen 96 DIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRD 174 (282)
T ss_pred hhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhcc
Confidence 4 4566689999999999999999999999995 48877654 2456699999999999999999999986 899999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+||+|||++.+|.+ +|||++-.+.+..- ...++|-..|||||.+..
T Consensus 175 vKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt~daGCkpYmaPEri~~ 222 (282)
T KOG0984|consen 175 VKPSNILINYDGQVKICDFGISGYLVDSIA---KTMDAGCKPYMAPERINP 222 (282)
T ss_pred CCcceEEEccCCcEEEcccccceeehhhhH---HHHhcCCCccCChhhcCc
Confidence 99999999999999 99999987764322 223678999999998754
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=206.03 Aligned_cols=175 Identities=21% Similarity=0.316 Sum_probs=140.1
Q ss_pred CeeecceecccCcEEEEEEEEc---CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
+|...+.||+|+||.||+++.. .+++.+|+|.+.+........... ...+|+++++
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~---------------------~~~~E~~~l~ 59 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAE---------------------HTRTERQVLE 59 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHH---------------------HHHHHHHHHH
Confidence 4778889999999999999864 467899999886532211111111 1235689999
Q ss_pred hC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 558 SL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 558 ~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
.+ +||||+++++.+..+...++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 60 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~ 138 (288)
T cd05583 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138 (288)
T ss_pred hccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 99 69999999999999999999999999999999987643 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.++.+ +|||+++....... .......++..|+|||.+.+.
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~ 181 (288)
T cd05583 139 DSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGG 181 (288)
T ss_pred CCCCCEEEEECccccccccccc-cccccccCCccccCHHHhcCC
Confidence 999887 99999987654321 111224578899999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=203.70 Aligned_cols=173 Identities=29% Similarity=0.396 Sum_probs=134.0
Q ss_pred eeecceecccCcEEEEEEEEc---CCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
|...++||+|+||.||+|.+. .+++.+|+|.+... .....+.+. +|+.+|
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-------------------------~E~~~l 55 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFL-------------------------REAACM 55 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHH-------------------------HHHHHH
Confidence 456788999999999999865 35789999988542 222233333 458999
Q ss_pred HhCCCCceeeEEEEEEeCC------eEEEEEeccCCCCHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy5063 557 RSLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDP-----GQPLPWGQRVNFARDIAAGMTYLHSMNLI 625 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~------~l~LV~Ey~~gGsL~~~L~~~-----~~~l~~~~~~~i~~QIa~gL~yLHs~~II 625 (681)
+.++||||+++++++.... ..++++||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+
T Consensus 56 ~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~ 135 (273)
T cd05074 56 KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFI 135 (273)
T ss_pred hcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 9999999999999886532 347899999999998886421 22478899999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 626 HRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||||||+|||++.++.+ +|||+++.......+.......++..|++||.+.+..
T Consensus 136 H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 191 (273)
T cd05074 136 HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV 191 (273)
T ss_pred ecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc
Confidence 99999999999998888 8999998765432222222234567899999986554
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=206.52 Aligned_cols=171 Identities=21% Similarity=0.342 Sum_probs=136.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|...+.||+|+||.||++.+..+++.+|+|.+.... ......+. +|+.++.
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-------------------------~e~~~l~ 57 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLL-------------------------MDLDVVM 57 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHH-------------------------HHHHHHH
Confidence 457777889999999999999999999999999886432 22222333 3488888
Q ss_pred hCC-CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHh----CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q psy5063 558 SLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ----DPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNS 631 (681)
Q Consensus 558 ~L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~----~~~~~l~~~~~~~i~~QIa~gL~yLHs~-~IIHRDLKp 631 (681)
.+. |+||+++++++..++..+++|||+.. +|.++.. .....+++..+..++.|++.||+|||+. +++||||||
T Consensus 58 ~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp 136 (288)
T cd06616 58 RSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKP 136 (288)
T ss_pred HhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCH
Confidence 885 99999999999999999999999864 6555432 1235689999999999999999999975 999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|||++.++.+ +|||+++........ ....++..|+|||++.+.
T Consensus 137 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 137 SNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPS 182 (288)
T ss_pred HHEEEccCCcEEEeecchhHHhccCCcc---ccccCccCccCHHHhccc
Confidence 99999999887 999999765432211 223578899999998765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.3e-22 Score=210.66 Aligned_cols=181 Identities=21% Similarity=0.295 Sum_probs=139.7
Q ss_pred ecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHH-HHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK-NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 484 ~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~-~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
+.+.||+|+||.||++.+..+++.||+|++......... ...+.. ........+.+|+++++.++|+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~E~~~l~~l~h~ 80 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLV------------GMCGIHFTTLRELKIMNEIKHE 80 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhh------------cccccchhHHHHHHHHHhCCCc
Confidence 457899999999999999999999999988643221110 000000 0001112346789999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
||+++++++..++..++||||++ |+|.+++.... .+++.....++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~ 158 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGIC 158 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCE
Confidence 99999999999999999999996 69999987643 48999999999999999999999999999999999999999988
Q ss_pred --EEeeeeeEeeecc------------cceeeeecCCCccccchhhccCC
Q psy5063 643 --FDFHLGQIYLIYV------------PYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 643 --~DFGLa~~~~~~~------------~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|||+++...... .........++..|+|||++.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred EECCccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 9999998765110 00111123467789999998664
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=205.44 Aligned_cols=167 Identities=29% Similarity=0.413 Sum_probs=138.6
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
|...+.||+|+||.||+|....+++.+|+|.+...... ..... .+|+..++.++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~-------------------------~~e~~~l~~~~ 55 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN-------------------------LREVKSLRKLN 55 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHH-------------------------HHHHHHHHhcc
Confidence 56778899999999999999999999999987543211 11111 24588899998
Q ss_pred -CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 561 -HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 561 -HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
|+||+++++++..++..++||||+ +|+|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.
T Consensus 56 ~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~ 134 (283)
T cd07830 56 EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSG 134 (283)
T ss_pred CCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC
Confidence 999999999999999999999999 889999887653 46899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++.+ +|||+++........ ....++..|+|||++.+
T Consensus 135 ~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~ 172 (283)
T cd07830 135 PEVVKIADFGLAREIRSRPPY---TDYVSTRWYRAPEILLR 172 (283)
T ss_pred CCCEEEeecccceeccCCCCc---CCCCCcccccCceeeec
Confidence 9888 999999876543221 22457888999998854
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=209.36 Aligned_cols=168 Identities=19% Similarity=0.232 Sum_probs=130.0
Q ss_pred ceeccc--CcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 486 PLLGQG--FFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 486 ~~LG~G--~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
..||+| +||+||++++..+|+.||+|.+.... ....+.+. +|+.+++.++|
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------~e~~~~~~l~h 58 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQ-------------------------NEVVLSHFFRH 58 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHH-------------------------HHHHHHHhCCC
Confidence 356666 99999999999999999999886432 22222222 35888899999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|||+++++++..++..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++.++
T Consensus 59 ~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~ 138 (328)
T cd08226 59 PNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG 138 (328)
T ss_pred CCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC
Confidence 99999999999999999999999999999998754 23589999999999999999999999999999999999999988
Q ss_pred Ce--EEeeeeeEeeecc-cc----eeeeecCCCccccchhhccCC
Q psy5063 641 SG--FDFHLGQIYLIYV-PY----TLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~-~~----~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.. .||+.+....... .. .......++..|||||++.+.
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 139 LVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred cEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCC
Confidence 87 6665432221110 00 000112356679999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=205.42 Aligned_cols=176 Identities=23% Similarity=0.339 Sum_probs=142.1
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
...+..++|...+.||+|+||.||++.+..+++.+|+|.+..... .....+.. |
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~-------------------------e 63 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM-------------------------D 63 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHH-------------------------H
Confidence 344567889999999999999999999999999999999865432 22222333 3
Q ss_pred HHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCC
Q psy5063 553 VAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLN 630 (681)
Q Consensus 553 i~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLK 630 (681)
+.++... +|+||+++++++.++...|++|||++ ++|.+++......+++..+..++.|++.||.|||+ .+|+||||+
T Consensus 64 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~ 142 (296)
T cd06618 64 LDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVK 142 (296)
T ss_pred HHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCc
Confidence 5555555 59999999999999999999999985 58888776655579999999999999999999997 599999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|+||++++++.+ +|||++......... ....++..|+|||++.+.
T Consensus 143 p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 143 PSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPP 189 (296)
T ss_pred HHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCC
Confidence 999999999888 999998765432211 223478899999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.5e-22 Score=208.10 Aligned_cols=176 Identities=27% Similarity=0.418 Sum_probs=139.2
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|.+.+.||+|+||.||++.++.+++.+|+|.+......... .....+|+++++.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~-----------------------~~~~~~e~~~l~~ 63 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGF-----------------------PITALREIKILKK 63 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCc-----------------------chhHHHHHHHHHh
Confidence 47899999999999999999999999999999988543211100 0112356999999
Q ss_pred CCCCceeeEEEEEEeC--------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 559 LHHHNVIRFIGVLYKD--------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~--------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
++||||+++++++... ..+++||||+.+ +|...+......+++..+..++.|++.||.|||+++|+|||||
T Consensus 64 l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~ 142 (311)
T cd07866 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIK 142 (311)
T ss_pred cCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9999999999987543 357999999965 7877776655569999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccce---------eeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYT---------LFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~---------~~~~~~gt~~Y~APEvL~~~ 678 (681)
|+|||+++++.+ +|||+++......... .+....++..|+|||++.+.
T Consensus 143 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 201 (311)
T cd07866 143 AANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE 201 (311)
T ss_pred HHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCC
Confidence 999999999988 9999998765322111 11122457789999987653
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.1e-22 Score=211.37 Aligned_cols=171 Identities=22% Similarity=0.323 Sum_probs=139.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||++....+++.||+|.+..... ...+. +.+|+.+|+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~-------------------------~~~e~~~l~ 59 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKR-------------------------TLRELKILR 59 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHH-------------------------HHHHHHHHH
Confidence 678888999999999999999999999999998854321 11112 234699999
Q ss_pred hCCCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 558 SLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.++||||+++++++.. ...+++||||+. |+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 60 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 137 (334)
T cd07855 60 HFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSN 137 (334)
T ss_pred hcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 9999999999998763 357899999995 68999987644 49999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccc--eeeeecCCCccccchhhccC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPY--TLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~--~~~~~~~gt~~Y~APEvL~~ 677 (681)
||++++|.+ +|||+++........ .......++..|+|||++.+
T Consensus 138 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred EEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcC
Confidence 999999988 999999876543211 11123457889999999855
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-22 Score=201.23 Aligned_cols=182 Identities=21% Similarity=0.270 Sum_probs=150.8
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.....++.++|.+.+.||+|||+.||.++...+++.||+|++.-...+..+..++
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~r------------------------- 67 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALR------------------------- 67 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHH-------------------------
Confidence 4445577889999999999999999999999999999999997665555554444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMN 623 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~ 623 (681)
|++..++++||||++++++...+ ...||+++|...|+|.+.++. .+..+++.+++.|+.++++||++||+..
T Consensus 68 Eid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~ 147 (302)
T KOG2345|consen 68 EIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE 147 (302)
T ss_pred HHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC
Confidence 49999999999999998876443 359999999999999998864 3446999999999999999999999998
Q ss_pred --ccccCCCCCcEEEecCCCe--EEeeeeeEeeecccce-------eeeecCCCccccchhhccCC
Q psy5063 624 --LIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYT-------LFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 624 --IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~-------~~~~~~gt~~Y~APEvL~~~ 678 (681)
++||||||.|||+.+++.+ .|||-++......... .+.....|..|.|||++.-+
T Consensus 148 ~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk 213 (302)
T KOG2345|consen 148 PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK 213 (302)
T ss_pred CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc
Confidence 9999999999999998888 9999988776432111 12234479999999998644
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.8e-21 Score=208.57 Aligned_cols=166 Identities=25% Similarity=0.338 Sum_probs=136.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||++.+..+++.||+|++.+.... ..+.+ .+|+.++
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~~Ei~~l 70 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------------------------YRELRLL 70 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHH-------------------------HHHHHHH
Confidence 47799999999999999999999999999999988653211 11222 3469999
Q ss_pred HhCCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++... ...+++++++ +++|.+++... .+++..+..++.|++.||.|||+++|+|||||
T Consensus 71 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 147 (345)
T cd07877 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 147 (345)
T ss_pred HHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 999999999999988643 3478888887 78999888653 48999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|+||+++.+|.+ +|||+++..... .....++..|+|||++.+
T Consensus 148 p~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 148 PSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN 191 (345)
T ss_pred hHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhC
Confidence 999999999988 999998865322 122357889999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=210.12 Aligned_cols=169 Identities=23% Similarity=0.336 Sum_probs=138.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..|...+.||+|+||.||++++..+++.||+|.+.... ...... ..+|+.+++
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~~E~~~l~ 59 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKR-------------------------TLREIKLLR 59 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHH-------------------------HHHHHHHHH
Confidence 46888999999999999999999999999999885431 111112 234689999
Q ss_pred hCCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 558 SLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.++|+||+++++++... ...|+|+||+. ++|.+++.... .+++..+..++.|++.||.|||+++++||||||+
T Consensus 60 ~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~ 137 (337)
T cd07858 60 HLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPS 137 (337)
T ss_pred hcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 99999999999988644 35899999995 68999887654 5999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|||++.++.+ +|||+++...... .......++..|+|||++.+
T Consensus 138 Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 138 NLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred HEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhc
Confidence 9999999988 9999998765321 11223457889999998864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=219.50 Aligned_cols=189 Identities=17% Similarity=0.235 Sum_probs=138.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEc----------------CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCC
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHR----------------ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~----------------~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~ 540 (681)
+..++|...++||+|+||.||+|... ..++.||+|++........+.|+++....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~--------- 212 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLA--------- 212 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhh---------
Confidence 34678999999999999999999752 23467999998665544555565542110
Q ss_pred CCccccccchHHHHHHHhCCCCce-----eeEEEEEEe--------CCeEEEEEeccCCCCHHHHHhCCC----------
Q psy5063 541 HGLINNLHCFSQVAVLRSLHHHNV-----IRFIGVLYK--------DRKLNLVTEYIAGGTLKELLQDPG---------- 597 (681)
Q Consensus 541 ~~~~~~~~~~~Ei~iL~~L~HpnI-----V~l~g~~~~--------~~~l~LV~Ey~~gGsL~~~L~~~~---------- 597 (681)
.........|+.++..++|.++ +++++++.. .+..||||||+++|+|.+++....
T Consensus 213 --~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~ 290 (507)
T PLN03224 213 --KGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEF 290 (507)
T ss_pred --hcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHH
Confidence 0011123457778888876654 677777653 356899999999999999886421
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeee
Q psy5063 598 -------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFIL 662 (681)
Q Consensus 598 -------------~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~ 662 (681)
..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+ +|||+++......... ...
T Consensus 291 l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~ 369 (507)
T PLN03224 291 MMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLY 369 (507)
T ss_pred HhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccc
Confidence 124567788999999999999999999999999999999999887 9999997654322111 112
Q ss_pred cCCCccccchhhccC
Q psy5063 663 SAKTKKTYYPNILKK 677 (681)
Q Consensus 663 ~~gt~~Y~APEvL~~ 677 (681)
..+++.|+|||++..
T Consensus 370 g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 370 GMLDPRYSPPEELVM 384 (507)
T ss_pred cCCCcceeChhhhcC
Confidence 235789999999854
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=210.32 Aligned_cols=171 Identities=25% Similarity=0.357 Sum_probs=136.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||.|+||.||+|.+..+++.||+|++........+.+. +|+++|+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~-------------------------~Ei~~l~~ 58 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-------------------------REIKIIRR 58 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHH-------------------------HHHHHHHh
Confidence 36789999999999999999999999999999998665443333333 35899999
Q ss_pred CCCCceeeEEEEEEeC--------------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy5063 559 LHHHNVIRFIGVLYKD--------------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 624 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~--------------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~I 624 (681)
++||||+++++++... ...|+||||++ ++|.+++... .+++..+..++.||+.||.|||++||
T Consensus 59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~gi 135 (342)
T cd07854 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSANV 135 (342)
T ss_pred cCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 9999999999876543 35899999997 5999888643 48999999999999999999999999
Q ss_pred cccCCCCCcEEEecCCC-e--EEeeeeeEeeecccce-eeeecCCCccccchhhccC
Q psy5063 625 IHRDLNSQNCLVREVGS-G--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~-~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~ 677 (681)
+||||||+|||++.++. + +|||+++......... ......++..|+|||++.+
T Consensus 136 vH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 136 LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred ccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhC
Confidence 99999999999986553 3 8999998654321111 1112346888999998754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=212.82 Aligned_cols=177 Identities=19% Similarity=0.232 Sum_probs=149.7
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEee--ccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELY--RVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~--~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.+....|++.+.||+||.+.||++...+ ...||+|++. ..+......+..| +
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nE-------------------------I 410 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNE-------------------------I 410 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHH-------------------------H
Confidence 3566789999999999999999998754 4566766553 2444555555555 9
Q ss_pred HHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
++|.+| .|.+||+|++|-..++.+||||||- .-+|.++|+.....++...++.+..|++.++.++|..||||-||||.
T Consensus 411 ~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPA 489 (677)
T KOG0596|consen 411 ALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPA 489 (677)
T ss_pred HHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcc
Confidence 999999 6999999999999999999999987 45999999887655554478899999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|+-. |.. +|||+|.....+........++||..||+||.|....|
T Consensus 490 NFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s 538 (677)
T KOG0596|consen 490 NFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSS 538 (677)
T ss_pred cEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccc
Confidence 999987 555 99999999999888788889999999999999987764
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=199.48 Aligned_cols=169 Identities=29% Similarity=0.416 Sum_probs=135.2
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh-
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS- 558 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~- 558 (681)
|...+.||+|+||.||+++++.+++.+|+|.+...... ....+. +|+.+++.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-------------------------~e~~~l~~l 55 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTL-------------------------REIALLKQL 55 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHH-------------------------HHHHHHHHh
Confidence 46678899999999999999988999999998643211 111122 23555544
Q ss_pred --CCCCceeeEEEEEEeCCe-----EEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 559 --LHHHNVIRFIGVLYKDRK-----LNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 559 --L~HpnIV~l~g~~~~~~~-----l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
++|+||+++++++...+. .+++|||+++ +|.+++.... ..+++..+..++.|++.||.|||+++++|+||+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~ 134 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLK 134 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 469999999999988776 9999999974 8998887533 358999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|+||+++.++.+ +|||+++........ ....++..|+|||++.+..
T Consensus 135 ~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~ 182 (287)
T cd07838 135 PQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSS 182 (287)
T ss_pred hhhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCC
Confidence 999999999988 999999877543221 2234788899999987654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=201.56 Aligned_cols=169 Identities=25% Similarity=0.422 Sum_probs=140.5
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
|...+.||+|++|.||++.+..+++.+++|.+...... ....+ .+|+++|+.+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~-------------------------~~e~~~l~~l 55 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-------------------------LREIKLLKEL 55 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHH-------------------------HHHHHHHHHh
Confidence 34567899999999999999999999999988653322 22222 3458999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++++..++..++||||+++ +|.+++......+++..+..++.|++.||.|||+++|+|+||||+||+++.+
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~ 134 (283)
T cd05118 56 NHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTE 134 (283)
T ss_pred cCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCC
Confidence 999999999999999999999999975 8888887755579999999999999999999999999999999999999998
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.+ +|||.+....... .......++..|+|||.+.+.
T Consensus 135 ~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 135 GVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred CcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcC
Confidence 888 9999998776432 112234577889999998654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=203.11 Aligned_cols=166 Identities=28% Similarity=0.403 Sum_probs=136.3
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
|...+.||+|+||.||+|++..+++.+|+|.+............ .+.+|+++++.++|
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~----------------------~~~~E~~~l~~l~h 80 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ----------------------DIIKEVKFLQQLKH 80 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHH----------------------HHHHHHHHHHhCCC
Confidence 44566799999999999999999999999988643221111110 11345899999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
||++++++++.++...|+||||+. |+|.+++.....++++..+..++.|++.||.|||+++++||||+|+||+++.++.
T Consensus 81 ~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~ 159 (313)
T cd06633 81 PNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ 159 (313)
T ss_pred CCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC
Confidence 999999999999999999999995 5888888765567999999999999999999999999999999999999999988
Q ss_pred e--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 642 G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+ +|||++..... .....++..|+|||++.
T Consensus 160 ~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~ 190 (313)
T cd06633 160 VKLADFGSASKSSP------ANSFVGTPYWMAPEVIL 190 (313)
T ss_pred EEEeecCCCcccCC------CCCccccccccChhhcc
Confidence 8 99999864321 12345788999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=208.34 Aligned_cols=171 Identities=26% Similarity=0.365 Sum_probs=141.4
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+|...+.||+|+||.||+|.+..+++.+|+|.+.... ....+.+ .+|+.+++.
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-------------------------~~e~~~l~~ 55 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRI-------------------------LREIKLLRH 55 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhH-------------------------HHHHHHHHh
Confidence 4778899999999999999999999999999886532 2222223 345999999
Q ss_pred CCCCceeeEEEEEEeCC-----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 559 LHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~-----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++|+||+++++++.... .+|++|||++ ++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~n 133 (330)
T cd07834 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSN 133 (330)
T ss_pred cCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 99999999999988765 7999999997 58999987654 69999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccc-eeeeecCCCccccchhhccCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPY-TLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~-~~~~~~~gt~~Y~APEvL~~~ 678 (681)
||++.++.+ +|||++......... .......++..|+|||++.+.
T Consensus 134 ili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 134 ILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred EEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecc
Confidence 999999988 899999887643210 112234578889999998765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=227.86 Aligned_cols=183 Identities=27% Similarity=0.387 Sum_probs=150.6
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCe----EEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCcccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE----VMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINN 546 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~----~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~ 546 (681)
..-+++....+...++||+|+||.||||.+...|+ +||+|++... ..+...+++.|
T Consensus 688 ~~lrI~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~Lde------------------- 748 (1177)
T KOG1025|consen 688 ALLRILKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDE------------------- 748 (1177)
T ss_pred hheeechhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHH-------------------
Confidence 34455666677788999999999999999876665 6788887543 33444555554
Q ss_pred ccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 547 ~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
+-+|.+++|||+++|+|++..+. +-||++|+++|+|.|+++.....+..+..+.|..||++||.|||.++++|
T Consensus 749 ------Al~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVH 821 (1177)
T KOG1025|consen 749 ------ALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVH 821 (1177)
T ss_pred ------HHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhh
Confidence 88999999999999999997665 88999999999999999988888999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||..+||||.+...+ .|||+|+....+..........-.+.|||=|.+..-+|
T Consensus 822 rdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~ 877 (1177)
T KOG1025|consen 822 RDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKY 877 (1177)
T ss_pred hhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCC
Confidence 9999999999998888 99999999876543333333344667898888776555
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=201.94 Aligned_cols=169 Identities=29% Similarity=0.457 Sum_probs=140.3
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
|+..+.||+|+||.||+|+...+++.+|+|.+.... ....+.+ ..|+.+++.+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-------------------------~~e~~~l~~~ 55 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA-------------------------LREISLLKEL 55 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHH-------------------------HHHHHHHHhc
Confidence 455678999999999999999999999999886543 1111222 3458999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|+||+++++++...+..++||||++ ++|.+++......+++..+..++.|++.||.|||+++|+||||+|+||+++++
T Consensus 56 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~ 134 (282)
T cd07829 56 KHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRD 134 (282)
T ss_pred CCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCC
Confidence 99999999999999999999999997 59999998764569999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.+ +|||+++...... .......++..|+|||++.+.
T Consensus 135 ~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 135 GVLKLADFGLARAFGIPL--RTYTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred CCEEEecCCcccccCCCc--cccCccccCcCcCChHHhcCC
Confidence 888 9999998765422 122234467789999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.4e-21 Score=202.73 Aligned_cols=164 Identities=27% Similarity=0.384 Sum_probs=137.6
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.|...+.||+|+||.||+|++..+++.+|+|.+.... ......+. +|+++++
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~-------------------------~e~~~l~ 70 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII-------------------------KEVRFLQ 70 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHH-------------------------HHHHHHH
Confidence 3666778999999999999999999999999886422 12222233 3589999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++|+|++++++++..+...++||||+. |+|.+++.....++++..+..++.|++.||.|||+++++||||||+|||++
T Consensus 71 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~ 149 (308)
T cd06634 71 KLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 149 (308)
T ss_pred hCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC
Confidence 9999999999999999999999999996 688887765556689999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
.++.+ +|||++...... ....++..|+|||++.
T Consensus 150 ~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 150 EPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVIL 184 (308)
T ss_pred CCCcEEECCcccceeecCc------ccccCCccccCHHHHh
Confidence 99888 999998765432 1235788999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=203.16 Aligned_cols=167 Identities=20% Similarity=0.263 Sum_probs=130.6
Q ss_pred ecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 484 ~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
+++.+|.| |.||.++...+++.||+|++... .....+.+. +|+++|+.++|
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~-------------------------~Ei~~l~~l~h 58 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ-------------------------QEIITSRQLQH 58 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHH-------------------------HHHHHHHhcCC
Confidence 33444444 45566666668999999998653 222333333 35999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
+||+++++++..++..+++|||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||++.+|
T Consensus 59 ~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~ 138 (314)
T cd08216 59 PNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG 138 (314)
T ss_pred cchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC
Confidence 99999999999999999999999999999999753 34588999999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeeccc-----ceeeeecCCCccccchhhccC
Q psy5063 641 SG--FDFHLGQIYLIYVP-----YTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~-----~~~~~~~~gt~~Y~APEvL~~ 677 (681)
.+ +|||.+........ ........++..|+|||++.+
T Consensus 139 ~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 139 KVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred ceEEecCccceeeccccccccccccccccccccccccCHHHhcC
Confidence 88 99998876643211 111123446778999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-21 Score=204.96 Aligned_cols=166 Identities=27% Similarity=0.382 Sum_probs=136.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||++.+..+++.+|+|++.+.. ....+.+ .+|++++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~~E~~~l 63 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRT-------------------------YRELKLL 63 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHH-------------------------HHHHHHH
Confidence 467999999999999999999999999999999875421 1111222 3459999
Q ss_pred HhCCCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++||||+++++++.. ....+++|||+ +++|.+++... .+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 64 ~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil 140 (328)
T cd07856 64 KHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL 140 (328)
T ss_pred HhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe
Confidence 99999999999999875 56799999998 56999888753 4788889999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+++++.+ +|||+++..... .....++..|+|||++.+
T Consensus 141 i~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 141 INENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred ECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeec
Confidence 9999888 999998754321 122346888999998755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=205.15 Aligned_cols=170 Identities=25% Similarity=0.317 Sum_probs=134.2
Q ss_pred CeeecceecccCcEEEEEEEEcCC--CeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRET--GEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~t--g~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+|...+.||+|+||.||++++..+ +..+|+|.+.... ....+.+ .+|++++
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-------------------------~~E~~~l 55 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA-------------------------LRELKLL 55 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHH-------------------------HHHHHHH
Confidence 467788999999999999999988 8999999875321 1112222 3458889
Q ss_pred HhC-CCCceeeEEEEEEeC----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 557 RSL-HHHNVIRFIGVLYKD----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 557 ~~L-~HpnIV~l~g~~~~~----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.+ +||||+++++..... ...|+++||++ ++|.+++... ..+++..+..++.||+.||.|||+++|+||||||
T Consensus 56 ~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp 133 (332)
T cd07857 56 RHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKP 133 (332)
T ss_pred HHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 988 699999999875432 46889999985 6899988754 4589999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccc--eeeeecCCCccccchhhccC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPY--TLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~--~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||++.++.+ +|||+++........ .......++..|+|||++.+
T Consensus 134 ~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 134 GNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred HHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhC
Confidence 99999999988 999999876532211 11122357889999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=197.08 Aligned_cols=153 Identities=18% Similarity=0.163 Sum_probs=127.2
Q ss_pred cCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeEEEE
Q psy5063 491 GFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGV 570 (681)
Q Consensus 491 G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~ 570 (681)
|.||.||++++..+++.||+|.+...... .. |...+....||||++++++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~-----~~-------------------------~~~~~~~~~~~~i~~~~~~ 53 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEY-----SR-------------------------ERLTIIPHCVPNMVCLHKY 53 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhh-----hh-------------------------HHHHHHhcCCCceeehhhh
Confidence 89999999999999999999998653211 11 1333445579999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeee
Q psy5063 571 LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLG 648 (681)
Q Consensus 571 ~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa 648 (681)
+...+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||+||+++.++.. +|||++
T Consensus 54 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~ 132 (237)
T cd05576 54 IVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRW 132 (237)
T ss_pred eecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccch
Confidence 999999999999999999999987643 58999999999999999999999999999999999999999988 999988
Q ss_pred eEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 649 QIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 649 ~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
...... .....++..|+|||++.+..
T Consensus 133 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~ 158 (237)
T cd05576 133 SEVEDS-----CDGEAVENMYCAPEVGGISE 158 (237)
T ss_pred hccccc-----cccCCcCccccCCcccCCCC
Confidence 665432 12234677899999986554
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=200.34 Aligned_cols=176 Identities=22% Similarity=0.345 Sum_probs=137.0
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
.|.+.+.||+|+||.||++.+..++..+++|.++.......... ......+|+.+++.++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~e~~~l~~l~ 60 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPN--------------------ETVQANQEAQLLSKLD 60 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcc--------------------hHHHHHHHHHHHHhCC
Confidence 36778899999999999999988777777776643221100000 0011234588999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
||||+++++++.+....++||||+++++|.+++.. ....+++..+..++.|++.||.|||+++++|+||||+||+++
T Consensus 61 h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~ 140 (260)
T cd08222 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK 140 (260)
T ss_pred CCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee
Confidence 99999999999999999999999999999998853 334689999999999999999999999999999999999998
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.+ .+ +|||+++....... ......++..|+|||.+.+..
T Consensus 141 ~~-~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~ 181 (260)
T cd08222 141 NN-LLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQG 181 (260)
T ss_pred cC-CEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCC
Confidence 64 45 99999987654321 222345788999999986544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=193.86 Aligned_cols=166 Identities=27% Similarity=0.398 Sum_probs=137.4
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeE
Q psy5063 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRF 567 (681)
Q Consensus 488 LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l 567 (681)
||+|+||.||++.+..+++.+|+|.+.+........ .. .+.+|+.+++.++|+||+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~-~~---------------------~~~~e~~~l~~l~h~~i~~~ 58 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE-VE---------------------HTLTERNILSRINHPFIVKL 58 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHH-HH---------------------HHHHHHHHHHHcCCCcHHHH
Confidence 699999999999999889999999886543211110 00 12345889999999999999
Q ss_pred EEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEe
Q psy5063 568 IGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDF 645 (681)
Q Consensus 568 ~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DF 645 (681)
++.+..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.+ +||
T Consensus 59 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~ 137 (250)
T cd05123 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDF 137 (250)
T ss_pred HHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeec
Confidence 999999999999999999999999998654 58999999999999999999999999999999999999999988 999
Q ss_pred eeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 646 HLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 646 GLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|++........ ......++..|++||.+.+.
T Consensus 138 ~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~ 168 (250)
T cd05123 138 GLAKELSSEGS--RTNTFCGTPEYLAPEVLLGK 168 (250)
T ss_pred CcceecccCCC--cccCCcCCccccChHHhCCC
Confidence 99987654321 12234578899999998654
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=216.85 Aligned_cols=183 Identities=25% Similarity=0.316 Sum_probs=150.0
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCC-Ce--EEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRET-GE--VMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNL 547 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t-g~--~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~ 547 (681)
...-.+..+++.+.++||+|.||.|++|.|... |+ .||||.+...... ....|
T Consensus 102 ~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddf----------------------- 158 (1039)
T KOG0199|consen 102 DLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDF----------------------- 158 (1039)
T ss_pred CcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHH-----------------------
Confidence 445567778899999999999999999998743 33 6899988654333 23334
Q ss_pred cchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 548 ~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~-~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
++|+.+|-+|+|+|+++|||+..+ ..+.||||+++.|+|.+.|.+ ....|.......|+.|||.||.||.++++||
T Consensus 159 --lrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvH 235 (1039)
T KOG0199|consen 159 --LREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVH 235 (1039)
T ss_pred --HHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhh
Confidence 445999999999999999999987 688999999999999999987 4456888888999999999999999999999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCC-ccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKT-KKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt-~~Y~APEvL~~~~Y 680 (681)
|||..+|+||.....+ +||||.|.+..+..+..+...... ..|-|||.|+.-+|
T Consensus 236 RDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF 292 (1039)
T KOG0199|consen 236 RDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF 292 (1039)
T ss_pred hhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccc
Confidence 9999999999998877 999999999877655544433333 34678999977655
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=205.18 Aligned_cols=164 Identities=24% Similarity=0.389 Sum_probs=133.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|...+.||+|+||.||+|++..+|+.+|+|.+.+... ..... +.+|+.+++
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~~e~~~l~ 69 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR-------------------------AYRELTLLK 69 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhH-------------------------HHHHHHHHH
Confidence 578889999999999999999999999999998864321 11111 235699999
Q ss_pred hCCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 558 SLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
.++||||+++++++... ...++|+||+.. +|..++. ..+++..+..++.|++.||.|||+++|+||||||
T Consensus 70 ~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp 145 (342)
T cd07879 70 HMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKP 145 (342)
T ss_pred hcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 99999999999998754 356999999964 7877653 2489999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||++.++.+ +|||+++...... ....++..|+|||++.+
T Consensus 146 ~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 146 GNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILN 188 (342)
T ss_pred HHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcC
Confidence 99999999988 9999987643211 12346888999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.1e-21 Score=220.68 Aligned_cols=171 Identities=25% Similarity=0.289 Sum_probs=121.2
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCC----CeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRET----GEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t----g~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.+..++|...+.||+|+||.||+|++..+ +..||+|++...... +.+..+
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e------------------------ 181 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE------------------------ 181 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH------------------------
Confidence 35678999999999999999999999988 899999987543211 111111
Q ss_pred HHHHHHhCCCCceeeEEEE------EEeCCeEEEEEeccCCCCHHHHHhCCCCCC-------------------CHHHHH
Q psy5063 552 QVAVLRSLHHHNVIRFIGV------LYKDRKLNLVTEYIAGGTLKELLQDPGQPL-------------------PWGQRV 606 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~------~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l-------------------~~~~~~ 606 (681)
.++...+.++..+... ...+...++||||+++++|.+++.....++ ....+.
T Consensus 182 ---~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~ 258 (566)
T PLN03225 182 ---RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQ 258 (566)
T ss_pred ---HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHH
Confidence 0111111222211111 235678999999999999999987543211 123456
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCcEEEec-CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 607 ~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~-~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
.++.|++.||+|||+++|+||||||+|||++. ++.+ +|||+|+.+.....+. .....+++.|||||.+.
T Consensus 259 ~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 259 TIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYI 330 (566)
T ss_pred HHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhh
Confidence 79999999999999999999999999999996 4555 9999998765432222 12356899999999764
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-21 Score=221.10 Aligned_cols=181 Identities=29% Similarity=0.379 Sum_probs=148.6
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcC-------CCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccc
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRE-------TGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~-------tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
.+.+..+++.+.+.||+|.||+|++|.... ....||+|.++..... ..+.+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~-------------------- 349 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLM-------------------- 349 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHH--------------------
Confidence 777888888888999999999999998431 1457999988654333 233333
Q ss_pred cccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHHHH
Q psy5063 546 NLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFA 609 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~i~ 609 (681)
.|+++|+.+ +|+||+.++|++.+++.+++|+||++.|+|.++|+... ..++....++++
T Consensus 350 -----~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa 424 (609)
T KOG0200|consen 350 -----SELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFA 424 (609)
T ss_pred -----HHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHH
Confidence 359999999 79999999999999999999999999999999998765 348889999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecC--CCccccchhhccCCCC
Q psy5063 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSA--KTKKTYYPNILKKASF 680 (681)
Q Consensus 610 ~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~--gt~~Y~APEvL~~~~Y 680 (681)
.||+.||+||++.++|||||..+|||+.++..+ +||||||.......|... ... -...|||||.+.+..|
T Consensus 425 ~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~f 498 (609)
T KOG0200|consen 425 YQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVF 498 (609)
T ss_pred HHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcc
Confidence 999999999999999999999999999998777 999999977655544422 222 2345999999988665
|
|
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-21 Score=195.68 Aligned_cols=176 Identities=22% Similarity=0.325 Sum_probs=145.2
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.......++++....||.|+-|+|++++.+.+|..+|||.+.+.+ .+..+.++..
T Consensus 85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmD------------------------ 140 (391)
T KOG0983|consen 85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMD------------------------ 140 (391)
T ss_pred cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHh------------------------
Confidence 334455678888889999999999999999999999999998754 3444444443
Q ss_pred HHHHHHh-CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCC
Q psy5063 552 QVAVLRS-LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDL 629 (681)
Q Consensus 552 Ei~iL~~-L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDL 629 (681)
+.++.. -+-|.||+.+|+|..+...++.||.|. ..+..+++...+++++..+-++...+++||.||.+ ++|||||+
T Consensus 141 -ldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDv 218 (391)
T KOG0983|consen 141 -LDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV 218 (391)
T ss_pred -hhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeeccc
Confidence 555444 468999999999999999999999994 47777777767789999999999999999999986 57999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||+|||+|+.|++ +|||++-.+.... .....+|-+.|||||-|.-
T Consensus 219 KPSNILlDe~GniKlCDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp 265 (391)
T KOG0983|consen 219 KPSNILLDERGNIKLCDFGISGRLVDSK---AHTRSAGCAAYMAPERIDP 265 (391)
T ss_pred CccceEEccCCCEEeecccccceeeccc---ccccccCCccccCccccCC
Confidence 9999999999999 9999998876433 2345779999999998753
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-22 Score=218.43 Aligned_cols=177 Identities=23% Similarity=0.267 Sum_probs=151.0
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++++....||-|+||.|-++........+|+|.+++......+ .. .|+++|-.+|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtk--Qq--------------------eHv~sEr~Im 474 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTK--QQ--------------------EHVFSERNIM 474 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchh--HH--------------------HHHHhHHHHH
Confidence 3456888888999999999999988765556898887653221111 11 2557788999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
...+.|.||++|..|.++.++|+.||-|-||.|...|++++ .|+...+..++.-++.|++|||++|||.|||||+|+|+
T Consensus 475 ~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL 553 (732)
T KOG0614|consen 475 MECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL 553 (732)
T ss_pred HhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee
Confidence 99999999999999999999999999999999999999876 49999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+.+|.+ .|||+|+...... ...+++||+.|.|||++..+.
T Consensus 554 d~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKG 595 (732)
T KOG0614|consen 554 DNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKG 595 (732)
T ss_pred ccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccC
Confidence 999999 9999999887644 334689999999999997654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-21 Score=204.96 Aligned_cols=166 Identities=26% Similarity=0.346 Sum_probs=138.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||+|++..+++.+|+|.+.... ....+.+ .+|+.++
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-------------------------~~E~~~l 68 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT-------------------------YRELRLL 68 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHH-------------------------HHHHHHH
Confidence 467999999999999999999999999999999875421 1111222 3458999
Q ss_pred HhCCCCceeeEEEEEEeCCe------EEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKDRK------LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~------l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++..++. .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||++||+|||||
T Consensus 69 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlk 145 (343)
T cd07851 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLK 145 (343)
T ss_pred HhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 99999999999998876554 89999999 6799999875 358999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|+||++++++.+ +|||++...... .....++..|+|||++.+
T Consensus 146 p~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 146 PSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred HHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhC
Confidence 999999999988 999999876432 122357888999999854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.8e-22 Score=200.50 Aligned_cols=176 Identities=22% Similarity=0.366 Sum_probs=144.7
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
.....|..++++....||.|+||.|+|-.++.+|+.+|||++... ....+++++.|
T Consensus 56 ~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e----------------------- 112 (361)
T KOG1006|consen 56 AHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLME----------------------- 112 (361)
T ss_pred ccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHH-----------------------
Confidence 445668888999999999999999999999999999999999754 34556666665
Q ss_pred HHHH-HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q psy5063 551 SQVA-VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD----PGQPLPWGQRVNFARDIAAGMTYLHS-MNL 624 (681)
Q Consensus 551 ~Ei~-iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~----~~~~l~~~~~~~i~~QIa~gL~yLHs-~~I 624 (681)
.+ +|+.-+-||||+|||+...++..|+-||+|. -||..+.+. ....+++...-.+..-++.||+||-+ .+|
T Consensus 113 --~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lki 189 (361)
T KOG1006|consen 113 --HDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKI 189 (361)
T ss_pred --HHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhh
Confidence 33 5777789999999999999999999999994 477665432 23458888888888888999999986 589
Q ss_pred cccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 625 IHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
||||+||+|||++..|.+ +|||++-.+... ......+|-..|||||-+.
T Consensus 190 IHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 190 IHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERID 240 (361)
T ss_pred hhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccC
Confidence 999999999999999999 999998766532 2234577999999999874
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-22 Score=221.09 Aligned_cols=170 Identities=25% Similarity=0.392 Sum_probs=146.4
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..+||++...+|.|+||.|||++++.+++..|+|.++......-+...+| +-+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqe-------------------------i~~~~ 67 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQE-------------------------IGMLR 67 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccc-------------------------eeeee
Confidence 35789999999999999999999999999999999876544433333333 66788
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
..+||||+.++|.+...+.+|+.||||.+|+|.+...-. .++++.++....+..++||.|||++|-+|||||-.|||++
T Consensus 68 dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt 146 (829)
T KOG0576|consen 68 DCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT 146 (829)
T ss_pred cCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec
Confidence 899999999999999999999999999999999987654 4699999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhc
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNIL 675 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL 675 (681)
+.|.+ +|||.+-.+.... ..-..+.||+.|||||+-
T Consensus 147 d~gDvklaDfgvsaqitati--~KrksfiGtpywmapEva 184 (829)
T KOG0576|consen 147 DEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVA 184 (829)
T ss_pred ccCceeecccCchhhhhhhh--hhhhcccCCccccchhHH
Confidence 99999 9999987665432 223357799999999985
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-21 Score=204.56 Aligned_cols=178 Identities=21% Similarity=0.243 Sum_probs=140.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|.++.+||+|+|+.|||+.+....+.||+|+-.... .+..|.+... ..++.||..+.+.|
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK-----~WrdEKKeNY-------------hKHAcREyrIHKeL 524 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNK-----NWRDEKKENY-------------HKHACREYRIHKEL 524 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhcc-----chhhHhhhhH-------------HHHHHHHHhhhhcc
Confidence 45677889999999999999999889999999643211 1111111100 23567899999999
Q ss_pred CCCceeeEEEEEE-eCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCcEEE
Q psy5063 560 HHHNVIRFIGVLY-KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--NLIHRDLNSQNCLV 636 (681)
Q Consensus 560 ~HpnIV~l~g~~~-~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~--~IIHRDLKp~NILl 636 (681)
+||.||++|++|. +.+.++-|+|||+|.+|..||+... .+++.++.+|+-||+.||.||.+. .|||-||||.||||
T Consensus 525 DHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILL 603 (775)
T KOG1151|consen 525 DHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILL 603 (775)
T ss_pred CcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEE
Confidence 9999999999996 4567899999999999999998754 599999999999999999999986 49999999999999
Q ss_pred ecCCC---e--EEeeeeeEeeecccc-----eeeeecCCCccccchhhcc
Q psy5063 637 REVGS---G--FDFHLGQIYLIYVPY-----TLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 637 ~~~g~---~--~DFGLa~~~~~~~~~-----~~~~~~~gt~~Y~APEvL~ 676 (681)
-.... + .||||++++..+... ....-.+||..|..||.|.
T Consensus 604 v~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 604 VNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred ecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceee
Confidence 76433 2 899999998764322 2233456899999999873
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-22 Score=202.88 Aligned_cols=171 Identities=27% Similarity=0.429 Sum_probs=138.7
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
|++..+.||-|+||.||.+++..+|+.+|+|++...-. ...+ .+++|+++|..
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~k-------------------------rvFre~kmLcf 108 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCK-------------------------RVFREIKMLSS 108 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHH-------------------------HHHHHHHHHHh
Confidence 44455679999999999999999999999998854321 1122 34567999999
Q ss_pred CCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 559 LHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++|.|++..++..... .++|+++|+| ..+|.+++-.. ..++...++-+..||++||.|||+.+|.||||||.|
T Consensus 109 FkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGN 186 (449)
T KOG0664|consen 109 FRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGN 186 (449)
T ss_pred hccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCcc
Confidence 9999999999887654 3578999999 45898888764 458889999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.|++.+... +||||||....+.... +.....|..|.|||+|.+..
T Consensus 187 LLVNSNCvLKICDFGLARvee~d~~~h-MTqEVVTQYYRAPEiLMGaR 233 (449)
T KOG0664|consen 187 LLVNSNCILKICDFGLARTWDQRDRLN-MTHEVVTQYYRAPELLMGAR 233 (449)
T ss_pred EEeccCceEEecccccccccchhhhhh-hHHHHHHHHhccHHHhhcch
Confidence 999998877 9999999877654332 23345688899999998864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.1e-19 Score=176.68 Aligned_cols=168 Identities=32% Similarity=0.513 Sum_probs=140.5
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
|...+.||+|+||.||++.+..+++.+|+|.+...... ..+.+. +|++.++.++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~-------------------------~e~~~~~~~~ 55 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFL-------------------------REIRILKKLK 55 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHH-------------------------HHHHHHHhCC
Confidence 45667899999999999999988999999998654433 233333 3588999999
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|+|++++++++......++++||+++++|.+++......+++.....++.|++.++.|||+++++|+||+|+||+++.++
T Consensus 56 ~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~ 135 (225)
T smart00221 56 HPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG 135 (225)
T ss_pred CCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 99999999999999999999999999999999986543388999999999999999999999999999999999999988
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhc
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNIL 675 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL 675 (681)
.+ +|||++.......+. ......++..|++||.+
T Consensus 136 ~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~ 171 (225)
T smart00221 136 LVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVL 171 (225)
T ss_pred CEEEeeCceeeEecCcccc-cccceeccCCcCCHhHh
Confidence 87 999999887653211 12234577889999997
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.1e-18 Score=169.69 Aligned_cols=164 Identities=31% Similarity=0.524 Sum_probs=137.5
Q ss_pred ecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceee
Q psy5063 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIR 566 (681)
Q Consensus 488 LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~ 566 (681)
||+|.+|.||++....+++.+++|.+...... ....+. +|+..++.++|++|++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~-------------------------~e~~~~~~l~~~~i~~ 55 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELL-------------------------REIEILKKLNHPNIVK 55 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHH-------------------------HHHHHHHhcCCCCeee
Confidence 68999999999999888999999998655433 122233 3589999999999999
Q ss_pred EEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec-CCCe--E
Q psy5063 567 FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-VGSG--F 643 (681)
Q Consensus 567 l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~-~g~~--~ 643 (681)
+++++......++++||+++++|.+++......+++..+..++.++++++.|||+.+++|+||+|.||+++. ++.. +
T Consensus 56 ~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~ 135 (215)
T cd00180 56 LYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLA 135 (215)
T ss_pred EeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEe
Confidence 999999999999999999999999999865345899999999999999999999999999999999999999 6776 9
Q ss_pred EeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 644 DFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 644 DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||.+........ ......+...|++||.+...
T Consensus 136 d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~ 168 (215)
T cd00180 136 DFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGK 168 (215)
T ss_pred cCCceEEccCCcc--hhhcccCCCCccChhHhccc
Confidence 9999987654321 12234578889999998653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.9e-20 Score=191.26 Aligned_cols=170 Identities=21% Similarity=0.318 Sum_probs=138.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
...|...+.+|+|+||+|-++.+..++..||+|+++..+...+.. ..|+++|+.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa--------------------------~iEi~vLqk 141 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAA--------------------------LIEIEVLQK 141 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHH--------------------------HHHHHHHHH
Confidence 456788899999999999999999999999999886543322211 235888998
Q ss_pred CCCC------ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 559 LHHH------NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 559 L~Hp------nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.+. -++.+.++|.-.++.++|+|.+ |-|++++|.+++ .+++..++..++.|++.++.|||+.+++|-||||
T Consensus 142 i~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKP 220 (415)
T KOG0671|consen 142 INESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKP 220 (415)
T ss_pred HHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCCh
Confidence 8322 3678889999999999999998 669999998754 5789999999999999999999999999999999
Q ss_pred CcEEEecCC--------------------Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVG--------------------SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g--------------------~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||+-+.. .+ +|||-|+....+.+. -+.|..|.|||++.+-.|
T Consensus 221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~-----iVsTRHYRAPEViLgLGw 286 (415)
T KOG0671|consen 221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHST-----IVSTRHYRAPEVILGLGW 286 (415)
T ss_pred heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcce-----eeeccccCCchheeccCc
Confidence 999995421 11 899999887655422 347999999999998765
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.4e-20 Score=181.62 Aligned_cols=167 Identities=20% Similarity=0.349 Sum_probs=138.6
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|++.+.+|+|.|+.||.|....+.+.++||+++.... +. +.||+.+|.
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kK-------------------------IkREikIL~ 87 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KK-------------------------IKREIKILQ 87 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HH-------------------------HHHHHHHHH
Confidence 45789999999999999999999999999999999865422 22 235699999
Q ss_pred hCC-CCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 558 SLH-HHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 558 ~L~-HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
.|. ||||++|+++..++ ....||+||+.+.+...+... ++...+..++.|++.||+|+|++||+|||+||.|+
T Consensus 88 nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNv 163 (338)
T KOG0668|consen 88 NLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNV 163 (338)
T ss_pred hccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhcCcccccCCccee
Confidence 995 99999999999765 457799999999998877653 67778899999999999999999999999999999
Q ss_pred EEecCCCe---EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 635 LVREVGSG---FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 635 Ll~~~g~~---~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+||....- +|.|||-++-....|+. ...+..|-.||+|-+.+
T Consensus 164 mIdh~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~ 208 (338)
T KOG0668|consen 164 MIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQ 208 (338)
T ss_pred eechhhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeech
Confidence 99987655 99999998876665554 34455556699987654
|
|
| >KOG1044|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-20 Score=202.84 Aligned_cols=117 Identities=35% Similarity=0.907 Sum_probs=109.4
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCCceEeeCCeeeeccccccccCCcccccCCccccCeEEecC
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGD 87 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~~ 87 (681)
+...|++|++.|..++.+.|+++.||..||+|..|+..|.+.|+.+||.+||++||.+.|+.+|..|.+.|.|.++.|+|
T Consensus 132 ~ps~cagc~~~lk~gq~llald~qwhv~cfkc~~c~~vL~gey~skdg~pyce~dy~~~fgvkc~~c~~fisgkvLqag~ 211 (670)
T KOG1044|consen 132 GPSTCAGCGEELKNGQALLALDKQWHVSCFKCKSCSAVLNGEYMSKDGVPYCEKDYQAKFGVKCEECEKFISGKVLQAGD 211 (670)
T ss_pred CCccccchhhhhhccceeeeeccceeeeeeehhhhcccccceeeccCCCcchhhhhhhhcCeehHHhhhhhhhhhhhccC
Confidence 34579999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCceecCCCCcccCCCCceeeecCCeeeeccchh
Q psy5063 88 HKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYK 125 (681)
Q Consensus 88 ~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~ 125 (681)
++|||.|-+|..|+..+++|++.++.... ++-..|-+
T Consensus 212 kh~HPtCARCsRCgqmF~eGEEMYlQGs~-iWHP~C~q 248 (670)
T KOG1044|consen 212 KHFHPTCARCSRCGQMFGEGEEMYLQGSE-IWHPDCKQ 248 (670)
T ss_pred cccCcchhhhhhhccccccchheeecccc-ccCCcccc
Confidence 99999999999999999999999987544 66666653
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.4e-19 Score=177.24 Aligned_cols=161 Identities=17% Similarity=0.113 Sum_probs=106.6
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHH--HHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK--NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~--~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
...||+|+||.||+|.+. +|+.||+|.+......... .+.... .....................+|++.|..+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGE-FRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCC-chhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 357999999999999997 8999999998653211100 000000 000000000000000011223588999999877
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCcEEEecCCC
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYL-HSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yL-Hs~~IIHRDLKp~NILl~~~g~ 641 (681)
++.....+... ..+|||||++++++...+... ..++...+..++.|++.+|.|+ |+.||+||||||+|||+++ +.
T Consensus 80 ~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~~ 155 (190)
T cd05147 80 GIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-GK 155 (190)
T ss_pred CCCCCcEEEec--CCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-Cc
Confidence 76443322222 238999999998776553322 4589999999999999999999 7999999999999999985 55
Q ss_pred e--EEeeeeeEe
Q psy5063 642 G--FDFHLGQIY 651 (681)
Q Consensus 642 ~--~DFGLa~~~ 651 (681)
+ +|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 6 999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=173.68 Aligned_cols=158 Identities=32% Similarity=0.510 Sum_probs=133.8
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeeccCHHH-HHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeEEEE
Q psy5063 492 FFGQVYRVTHRETGEVMVLKELYRVDEEA-EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGV 570 (681)
Q Consensus 492 ~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~-~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~ 570 (681)
+||.||++.+..+++.+|+|.+....... .+.+.. |++.++.++|+||+++++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~-------------------------e~~~~~~l~~~~i~~~~~~ 55 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILR-------------------------EISILKKLKHPNIVRLYDV 55 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHH-------------------------HHHHHHhCCCCcHHHHHhh
Confidence 58999999999889999999986543332 333333 4889999999999999999
Q ss_pred EEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeee
Q psy5063 571 LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLG 648 (681)
Q Consensus 571 ~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa 648 (681)
+..+...++++||+++++|.+++..... +++..+..++.+++.++.|||+.+++|+||+|+||+++.++.. +|||++
T Consensus 56 ~~~~~~~~l~~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~ 134 (244)
T smart00220 56 FEDEDKLYLVMEYCDGGDLFDLLKKRGR-LSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLA 134 (244)
T ss_pred eeeCCEEEEEEeCCCCCCHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccce
Confidence 9999999999999999999999976543 8999999999999999999999999999999999999999887 999999
Q ss_pred eEeeecccceeeeecCCCccccchhhccCC
Q psy5063 649 QIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 649 ~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
....... ......++..|++||.+.+.
T Consensus 135 ~~~~~~~---~~~~~~~~~~~~~pE~~~~~ 161 (244)
T smart00220 135 RQLDPGG---LLTTFVGTPEYMAPEVLLGK 161 (244)
T ss_pred eeecccc---ccccccCCcCCCCHHHHccC
Confidence 8876432 22335578899999988643
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-19 Score=199.56 Aligned_cols=167 Identities=19% Similarity=0.275 Sum_probs=138.3
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|+....+|.|+|+.|..+.+..+++..++|++.+...+.. +|+.++.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~-----------------------------~e~~~~~ 370 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQ-----------------------------DEIPISL 370 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccccc-----------------------------cccchhh
Confidence 35678888889999999999999999999999999865422211 1244443
Q ss_pred -hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 558 -SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 558 -~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
.-+||||+++.+++.++.+.|+|||++.||-|.+.+..... +. .++..|+.||+.|+.|||++|||||||||+|||+
T Consensus 371 ~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~ 448 (612)
T KOG0603|consen 371 LVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILL 448 (612)
T ss_pred hhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheee
Confidence 34899999999999999999999999999988887765432 33 7788899999999999999999999999999999
Q ss_pred -ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 -REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 -~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+..|.+ +|||.++..... ..+.+-|..|.|||++....|
T Consensus 449 ~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~y 490 (612)
T KOG0603|consen 449 DGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEY 490 (612)
T ss_pred cCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCC
Confidence 588877 999999877643 344567999999999987666
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=172.29 Aligned_cols=159 Identities=18% Similarity=0.163 Sum_probs=109.8
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeecc---CCCCccccccchHHHHHHHhC
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDL---GSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~---~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.+.||+|+||+||+|.+. +|+.||+|.+...... ....+....+ ..... ............+|.+.+..+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDP----RFRSRYSKSNPRKLVFAWAEKEFRNLKRL 76 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCc----ccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 467999999999999987 8999999998754221 0011110000 00000 000000011224688999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHH-HhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEe
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL-LQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVR 637 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~-L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NILl~ 637 (681)
.|+++.....+.... .+|||||++|+++... +.. ..++......++.|++.+|.++|+ +||+||||||+|||++
T Consensus 77 ~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~ 152 (190)
T cd05145 77 YEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH 152 (190)
T ss_pred HhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE
Confidence 999875544443332 4899999998865433 433 347888899999999999999999 9999999999999999
Q ss_pred cCCCe--EEeeeeeEeee
Q psy5063 638 EVGSG--FDFHLGQIYLI 653 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~ 653 (681)
++.+ +|||+++....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 6776 99999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.7e-19 Score=199.93 Aligned_cols=165 Identities=25% Similarity=0.321 Sum_probs=128.2
Q ss_pred eecceecccCcEE-EEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-C
Q psy5063 483 VRGPLLGQGFFGQ-VYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-H 560 (681)
Q Consensus 483 ~~~~~LG~G~FG~-Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~ 560 (681)
...+++|.|+-|. ||+|... |+.||||.+-..-. . .+.|||..|+.- +
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~---~-------------------------~A~rEi~lL~eSD~ 561 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFF---D-------------------------FAQREIQLLQESDE 561 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHhH---H-------------------------HHHHHHHHHHhccC
Confidence 3456799999885 8999986 88999997632111 1 113568888776 7
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCC---HHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP---WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~---~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
|||||++++.-.++..+|+..|+|. -+|.++++.....+. .........|++.||++||+.+||||||||.||||.
T Consensus 562 H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~ 640 (903)
T KOG1027|consen 562 HPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILIS 640 (903)
T ss_pred CCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEE
Confidence 9999999999999999999999995 599999987311111 133467889999999999999999999999999999
Q ss_pred c---CCCe----EEeeeeeEeeeccc-ceeeeecCCCccccchhhccCC
Q psy5063 638 E---VGSG----FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~---~g~~----~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
. +++. +|||+++....+.. ........||.+|+|||+|.+.
T Consensus 641 ~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~ 689 (903)
T KOG1027|consen 641 VPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRED 689 (903)
T ss_pred ccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcc
Confidence 8 4644 89999998876532 2233456699999999999765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-18 Score=172.12 Aligned_cols=136 Identities=18% Similarity=0.296 Sum_probs=103.0
Q ss_pred eecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC---
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL--- 559 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L--- 559 (681)
...++||+|+||.||. +..++.. +||++........+.+ .+|+.+++.+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~-------------------------~rEi~~l~~L~~~ 56 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEI-------------------------RRELKYYAHLSRR 56 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHH-------------------------HHHHHHHHHhhcc
Confidence 3456899999999995 7666665 6888765432222223 3568999988
Q ss_pred --CCCceeeEEEEEEeCC---eEE-EEEec--cCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCC
Q psy5063 560 --HHHNVIRFIGVLYKDR---KLN-LVTEY--IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGM-TYLHSMNLIHRDLN 630 (681)
Q Consensus 560 --~HpnIV~l~g~~~~~~---~l~-LV~Ey--~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL-~yLHs~~IIHRDLK 630 (681)
+||||++++|++.++. .++ +|+|| +++|+|.+++.+. .+++. ..++.|++.++ +|||+++|+|||||
T Consensus 57 ~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlK 132 (210)
T PRK10345 57 LIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNRIVTMELK 132 (210)
T ss_pred CCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCCEeecCCC
Confidence 6799999999998873 434 78999 5589999999763 36655 35688888888 99999999999999
Q ss_pred CCcEEEecCC----Ce--EE-eeeeeE
Q psy5063 631 SQNCLVREVG----SG--FD-FHLGQI 650 (681)
Q Consensus 631 p~NILl~~~g----~~--~D-FGLa~~ 650 (681)
|+|||++..+ .+ +| ||.+..
T Consensus 133 p~NILl~~~~~~~~~~~LiDg~G~~~~ 159 (210)
T PRK10345 133 PQNILCQRISESEVIPVVCDNIGESTF 159 (210)
T ss_pred HHHEEEeccCCCCCcEEEEECCCCcce
Confidence 9999998543 34 99 555444
|
|
| >KOG2272|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.5e-20 Score=181.79 Aligned_cols=119 Identities=25% Similarity=0.675 Sum_probs=108.2
Q ss_pred CCCCccccccccccccCceEEecCccccccCcccccCcCcc-CCceEeeCCeeeeccccccccCCcccccCCccccCeEE
Q psy5063 6 TPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMV 84 (681)
Q Consensus 6 ~~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L-~~~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~ 84 (681)
+-+.|+|..|.++|. +..+.|||+.||.++|+|+.|.+|. +...|++.|..||+.+|.++||..|..|+.+|.|.++.
T Consensus 192 ~mgipiCgaC~rpIe-ervi~amgKhWHveHFvCa~CekPFlGHrHYEkkGlaYCe~h~~qLfG~~CF~C~~~i~G~vv~ 270 (332)
T KOG2272|consen 192 KMGIPICGACRRPIE-ERVIFAMGKHWHVEHFVCAKCEKPFLGHRHYEKKGLAYCETHYHQLFGNLCFICNRVIGGDVVS 270 (332)
T ss_pred ccCCcccccccCchH-HHHHHHhccccchhheeehhcCCcccchhhhhhcCchhHHHHHHHHhhhhheecCCccCccHHH
Confidence 356799999999995 6889999999999999999999987 56899999999999999999999999999999999999
Q ss_pred ecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhh
Q psy5063 85 VGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKR 126 (681)
Q Consensus 85 a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~ 126 (681)
|.++.|.++||.|+.|.+.|...+.|+.. +-+|.|++||++
T Consensus 271 al~KawCv~cf~Cs~Cdkkl~~K~Kf~E~-DmkP~CKkCy~r 311 (332)
T KOG2272|consen 271 ALNKAWCVECFSCSTCDKKLTQKNKFYEF-DMKPVCKKCYDR 311 (332)
T ss_pred Hhhhhhccccccccccccccccccceeee-ccchHHHHHHhh
Confidence 99999999999999999999777777544 456899999985
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.2e-18 Score=175.77 Aligned_cols=165 Identities=23% Similarity=0.362 Sum_probs=131.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+.|.+.+.||+|.||.+-+++|+.+...+|+|.+.+. ....+.|.+|- ..--.
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEf-------------------------hY~~~ 76 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREF-------------------------HYSFF 76 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHh-------------------------cccee
Confidence 46788889999999999999999999999999988654 33456677762 21122
Q ss_pred C-CCCceeeEEEE-EEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 559 L-HHHNVIRFIGV-LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 559 L-~HpnIV~l~g~-~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
| .|.||+.-|++ |...+...+++||+|.|+|..-+...+ +.+...+.++.|+++|++|+|++++||||||.+||||
T Consensus 77 Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLi 154 (378)
T KOG1345|consen 77 LSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILI 154 (378)
T ss_pred eccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEE
Confidence 3 68999987765 667788889999999999998877643 8888999999999999999999999999999999999
Q ss_pred ecCC--Ce--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 637 REVG--SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 637 ~~~g--~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
-... .+ +|||+.+.......+ ..-+..|-+||+..
T Consensus 155 f~~df~rvKlcDFG~t~k~g~tV~~-----~~~~~~y~~pe~~~ 193 (378)
T KOG1345|consen 155 FDADFYRVKLCDFGLTRKVGTTVKY-----LEYVNNYHAPELCD 193 (378)
T ss_pred ecCCccEEEeeecccccccCceehh-----hhhhcccCCcHHHh
Confidence 6543 23 999998866533222 23577888898864
|
|
| >KOG1701|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.3e-19 Score=187.12 Aligned_cols=119 Identities=29% Similarity=0.718 Sum_probs=101.6
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccCCceE--eeCCeeeeccccccccCCcccccCCccccC-----
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYF--EKDGLLFCKEDYNGKYGEACQNCGQMMSGP----- 81 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~--~~dg~~yC~~cY~~~f~~~C~~C~~~I~g~----- 81 (681)
+..|..|++.|. +.+++|+|+.||+.||+|..|++.|++.-| ..++++||-.||+++|+++|+.|+++|...
T Consensus 334 lekC~~Cg~~I~-d~iLrA~GkayHp~CF~Cv~C~r~ldgipFtvd~~n~v~Cv~dfh~kfAPrCs~C~~PI~P~~G~~e 412 (468)
T KOG1701|consen 334 LEKCNKCGEPIM-DRILRALGKAYHPGCFTCVVCARCLDGIPFTVDSQNNVYCVPDFHKKFAPRCSVCGNPILPRDGKDE 412 (468)
T ss_pred HHHHhhhhhHHH-HHHHHhcccccCCCceEEEEeccccCCccccccCCCceeeehhhhhhcCcchhhccCCccCCCCCcc
Confidence 456999999996 689999999999999999999999998655 567999999999999999999999999431
Q ss_pred --eEEecCccCCCCceecCCCCcccC----CCCceeeecCCeeeeccchhhhcCC
Q psy5063 82 --VMVVGDHKFHPECFKCTSCSCCIG----DGESYALVERSILYCGLCYKRQMQP 130 (681)
Q Consensus 82 --~~~a~~~~yH~~CF~C~~C~~~l~----~g~~~~l~~~~~lyC~~Cy~~~~~p 130 (681)
.|+++|+.||.+|++|..|+..|. +...|-| ++.++|+.|+-+.+..
T Consensus 413 tvRvvamdr~fHv~CY~CEDCg~~LS~e~e~qgCyPl--d~HllCk~Ch~~Rl~~ 465 (468)
T KOG1701|consen 413 TVRVVAMDRDFHVNCYKCEDCGLLLSSEEEGQGCYPL--DGHLLCKTCHLKRLQA 465 (468)
T ss_pred eEEEEEccccccccceehhhcCccccccCCCCcceec--cCceeechhhhhhhcc
Confidence 467999999999999999999986 2234555 5779999999876554
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-18 Score=180.16 Aligned_cols=171 Identities=20% Similarity=0.294 Sum_probs=137.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
...|...+.+|.|.- .|-.+-+.-+++.||+|++... |.. ........+|..+|..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-------f~n----------------~~~akra~rel~l~~~ 71 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-------FQN----------------QTHAKRAYRELKLMKC 71 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-------ccc----------------Cccchhhhhhhhhhhh
Confidence 345677778888887 6777888888999999987543 100 1123345678999999
Q ss_pred CCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 559 LHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
++|+||++++.+|... ...|+||||| .++|...+.. .++...+.+++.|++.|+.|||+.||+||||||+
T Consensus 72 v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPs 147 (369)
T KOG0665|consen 72 VNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPS 147 (369)
T ss_pred hcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCcc
Confidence 9999999999999754 3589999999 4599888773 3788899999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++..++.. .|||+|+....+.. ......|..|.|||++.+..|
T Consensus 148 nivv~~~~~lKi~dfg~ar~e~~~~~---mtpyVvtRyyrapevil~~~~ 194 (369)
T KOG0665|consen 148 NIVVNSDCTLKILDFGLARTEDTDFM---MTPYVVTRYYRAPEVILGMGY 194 (369)
T ss_pred cceecchhheeeccchhhcccCcccc---cCchhheeeccCchheeccCC
Confidence 9999999988 99999998765422 222457889999999998876
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.4e-18 Score=179.30 Aligned_cols=140 Identities=23% Similarity=0.425 Sum_probs=121.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcC---CCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRE---TGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~---tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+.|...+.||+|.|+.||++++.. ..+.||+|.+.....- ..+..|+++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---------------------------~ri~~El~~ 87 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---------------------------SRILNELEM 87 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---------------------------hHHHHHHHH
Confidence 4578888999999999999999887 7889999988653211 123456888
Q ss_pred HHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 LRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
|..+ .+.||+++.+++...+...+||||++..+..+++.. ++..++..+++.++.||.++|.+||||||+||.|+
T Consensus 88 L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNF 163 (418)
T KOG1167|consen 88 LYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNF 163 (418)
T ss_pred HHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccc
Confidence 9888 699999999999999999999999999999999875 67889999999999999999999999999999999
Q ss_pred EEecCCC---eEEeeeee
Q psy5063 635 LVREVGS---GFDFHLGQ 649 (681)
Q Consensus 635 Ll~~~g~---~~DFGLa~ 649 (681)
|.+..-. ..|||||.
T Consensus 164 L~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 164 LYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred ccccccCCceEEechhHH
Confidence 9987533 39999998
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=4e-17 Score=162.57 Aligned_cols=170 Identities=19% Similarity=0.227 Sum_probs=135.8
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
..++....|.+.+.||.|+||.+|.|....+|+.||||.=..... .-+...|.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~---------------------------hpqL~yEs 61 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK---------------------------HPQLLYES 61 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC---------------------------CcchhHHH
Confidence 345677899999999999999999999999999999996422111 11223456
Q ss_pred HHHHhCCC-CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSLHH-HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L~H-pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.+.+.|++ ..|..+..+..+..+-.+|||+. |-+|.+++.-....++...++.++-|++.-++|+|.+++|||||||+
T Consensus 62 kvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPd 140 (341)
T KOG1163|consen 62 KVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPD 140 (341)
T ss_pred HHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCcc
Confidence 77777754 56777777777888889999999 78999998765566899999999999999999999999999999999
Q ss_pred cEEEecCCCe-----EEeeeeeEeee-----cccceeeeecCCCccccc
Q psy5063 633 NCLVREVGSG-----FDFHLGQIYLI-----YVPYTLFILSAKTKKTYY 671 (681)
Q Consensus 633 NILl~~~g~~-----~DFGLa~~~~~-----~~~~~~~~~~~gt~~Y~A 671 (681)
|.|..-+-.. +|||||+.+.. ..++.....-.||..|.+
T Consensus 141 NFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYAS 189 (341)
T KOG1163|consen 141 NFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYAS 189 (341)
T ss_pred ceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehh
Confidence 9999765433 99999998864 344555555668888875
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-17 Score=180.12 Aligned_cols=171 Identities=21% Similarity=0.283 Sum_probs=141.2
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+.|.+....|+|-|+.|.+|.+...|..||||+|.. .+...+.-++ |+++|+.
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~-------------------------EleiLkK 484 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLK-------------------------ELEILKK 484 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhH-------------------------HHHHHHH
Confidence 4567788889999999999999999999999998854 3334444444 4899998
Q ss_pred CC------CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 559 LH------HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 559 L~------HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+ --|+++|+..|...++++||+|-+ .-+|.++|++.+ -.|....+..|+.|+..||..|-..||+|.|||
T Consensus 485 L~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIK 563 (752)
T KOG0670|consen 485 LNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIK 563 (752)
T ss_pred hhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccC
Confidence 84 348899999999999999999988 459999998653 347788899999999999999999999999999
Q ss_pred CCcEEEecCCCe---EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG---FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~---~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+||||++..++ +|||-|.....+.-.. .-.+.+|.|||++.|.+|
T Consensus 564 PDNiLVNE~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~y 612 (752)
T KOG0670|consen 564 PDNILVNESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPY 612 (752)
T ss_pred ccceEeccCcceeeeccCccccccccccccH----HHHHHhccCcceeecCcc
Confidence 999999998887 9999998776543111 124678999999999988
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.6e-16 Score=161.01 Aligned_cols=168 Identities=30% Similarity=0.474 Sum_probs=137.5
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH---HHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA---EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~---~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
|...+.||.|+||.||++.+. ..+++|.+....... ...+ .+|+.+++.
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~-------------------------~~e~~~~~~ 53 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERF-------------------------LREIQILAS 53 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHH-------------------------HHHHHHHHH
Confidence 567788999999999999987 778888885433221 2223 345889999
Q ss_pred CCCC-ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 559 LHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L~Hp-nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.|+ +|+++.+.+......+++++|+.++++.+++.... ..++......++.|++.++.|+|+.+++|||+||+|||
T Consensus 54 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil 133 (384)
T COG0515 54 LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENIL 133 (384)
T ss_pred ccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence 9888 79999999988888999999999999998877654 25889999999999999999999999999999999999
Q ss_pred EecCC-Ce--EEeeeeeEeeecccce----eeeecCCCccccchhhccC
Q psy5063 636 VREVG-SG--FDFHLGQIYLIYVPYT----LFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 636 l~~~g-~~--~DFGLa~~~~~~~~~~----~~~~~~gt~~Y~APEvL~~ 677 (681)
++..+ .. +|||+++......... ......++..|+|||.+.+
T Consensus 134 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 134 LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred ecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcC
Confidence 99988 34 9999998665433211 2355679999999999876
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.9e-17 Score=166.02 Aligned_cols=167 Identities=19% Similarity=0.277 Sum_probs=134.3
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+-.-.|.+|+.||+|+||+.+.|+..-+++.||||.=.+..+.. ++.. |....
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP--QLrd-------------------------EYr~Y 77 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP--QLRD-------------------------EYRTY 77 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcc--hHHH-------------------------HHHHH
Confidence 34457999999999999999999999999999999643322111 1111 24445
Q ss_pred HhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.| .-++|...|-+-..+.+-.||||++ |-+|.|+..-.+..|+...+..++.|++.-++|+|++.+|.|||||+|+|
T Consensus 78 KlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFL 156 (449)
T KOG1165|consen 78 KLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFL 156 (449)
T ss_pred HHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCcccee
Confidence 555 5688888877666677778999999 78999998877777999999999999999999999999999999999999
Q ss_pred EecCCCe-------EEeeeeeEeeec-----ccceeeeecCCCccccc
Q psy5063 636 VREVGSG-------FDFHLGQIYLIY-----VPYTLFILSAKTKKTYY 671 (681)
Q Consensus 636 l~~~g~~-------~DFGLa~~~~~~-----~~~~~~~~~~gt~~Y~A 671 (681)
|...++. +|||+|+.+... .||.......||..||+
T Consensus 157 IGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMS 204 (449)
T KOG1165|consen 157 IGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMS 204 (449)
T ss_pred ecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeE
Confidence 9887653 899999998753 44555556779999997
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.7e-16 Score=170.34 Aligned_cols=171 Identities=19% Similarity=0.181 Sum_probs=130.5
Q ss_pred CeeecceecccCcEEEEEEEEcCCC-eEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETG-EVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg-~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.|.+.+.||+|+||.||++.+..++ +.+|+|............ ...|+.+|..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~-------------------------l~~E~~vl~~l 73 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSV-------------------------LKIEIQVLKKL 73 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCcc-------------------------chhHHHHHHHH
Confidence 7999999999999999999988775 678888764432111111 12357777777
Q ss_pred CC----CceeeEEEEE-EeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 560 HH----HNVIRFIGVL-YKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 560 ~H----pnIV~l~g~~-~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.. +++..+++.. ..+..-|+||+++ |.+|.++..... ..++...+..++.|++.+|++||+.|++||||||+|
T Consensus 74 ~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N 152 (322)
T KOG1164|consen 74 EKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPEN 152 (322)
T ss_pred hhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHH
Confidence 52 6889999888 4778899999988 889999886543 679999999999999999999999999999999999
Q ss_pred EEEecCC-----Ce--EEeeeee--Eeeecccc-----ee-eeecCCCccccchhhccC
Q psy5063 634 CLVREVG-----SG--FDFHLGQ--IYLIYVPY-----TL-FILSAKTKKTYYPNILKK 677 (681)
Q Consensus 634 ILl~~~g-----~~--~DFGLa~--~~~~~~~~-----~~-~~~~~gt~~Y~APEvL~~ 677 (681)
+++...+ .+ .|||+|+ .+...... .. .....||..|.++.+-.+
T Consensus 153 ~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~ 211 (322)
T KOG1164|consen 153 FVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG 211 (322)
T ss_pred eeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC
Confidence 9998764 23 9999999 43332211 11 123448999998876544
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.7e-16 Score=155.68 Aligned_cols=139 Identities=23% Similarity=0.330 Sum_probs=109.8
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
+.||+|++|.||+|.+ .|..+++|...... .........+ ...+|++++..+.|+
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~--------------------~~~~E~~~l~~l~~~ 59 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRE--------------------RTRREARIMSRARKA 59 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHH--------------------HHHHHHHHHHHHHHC
Confidence 5799999999999987 47788889764321 1111111111 234678999999999
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
+|.....++......+++|||++|++|.+++.... + ....++.+++.+|.++|+.+++|+|++|+|||++ ++.+
T Consensus 60 ~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~ 133 (211)
T PRK14879 60 GVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKI 133 (211)
T ss_pred CCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCE
Confidence 98877777777788999999999999999986532 2 7788999999999999999999999999999999 5666
Q ss_pred --EEeeeeeEee
Q psy5063 643 --FDFHLGQIYL 652 (681)
Q Consensus 643 --~DFGLa~~~~ 652 (681)
+|||+++...
T Consensus 134 ~liDf~~a~~~~ 145 (211)
T PRK14879 134 YLIDFGLAEFSK 145 (211)
T ss_pred EEEECCcccCCC
Confidence 9999988643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=161.85 Aligned_cols=161 Identities=20% Similarity=0.152 Sum_probs=109.2
Q ss_pred CeeecceecccCcEEEEEEE-EcCCCeEEEEEEeeccCHHH--HHHHHHHhhccceeeeccCCCCc--cccccchHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVT-HRETGEVMVLKELYRVDEEA--EKNFLKESKQGLIYLIDLGSHGL--INNLHCFSQVAV 555 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~-~~~tg~~vAiK~l~~~~~~~--~~~~~~E~k~~~~~~~~~~~~~~--~~~~~~~~Ei~i 555 (681)
.|.+.+.||+|+||.||+|. +..+|+.||+|.+....... ......... .. .+..... .......+|+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDF-RF----KYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccch-hh----ccCCCCHHHHHHHHHHHHHHH
Confidence 56778899999999999999 66789999999986533211 000000000 00 0000000 000123468999
Q ss_pred HHhCCCC--ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCC
Q psy5063 556 LRSLHHH--NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN-LIHRDLNSQ 632 (681)
Q Consensus 556 L~~L~Hp--nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~-IIHRDLKp~ 632 (681)
++.+.+. .+.+.++. ...++||||++|++|....... ..+....+..++.|++.++.+||++| |+||||||+
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~ 178 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY 178 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence 9999753 23444432 2358999999998887664332 23566667889999999999999999 999999999
Q ss_pred cEEEecCCCe--EEeeeeeEee
Q psy5063 633 NCLVREVGSG--FDFHLGQIYL 652 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~ 652 (681)
|||++ ++.+ +|||++....
T Consensus 179 NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hEEEE-CCCEEEEEChhhhccC
Confidence 99999 6666 9999988654
|
|
| >KOG2272|consensus | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.2e-18 Score=168.80 Aligned_cols=117 Identities=24% Similarity=0.715 Sum_probs=104.7
Q ss_pred ccccccccccccC-ceEEecCccccccCcccccCcCcc-CCceEeeCCeeeeccccccccCCcccccCCccccCeEEecC
Q psy5063 10 LTCAGCLNNIVED-EYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGD 87 (681)
Q Consensus 10 ~~C~~C~~~I~~~-~~v~a~~~~wH~~CF~C~~C~~~L-~~~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~~ 87 (681)
..|.+|....... .++...+..||..||.|++|-.++ ++.||+-+|+.||+.||..+|+|.|+.|++.|.|+++.|++
T Consensus 13 ~~C~RC~~gF~~~e~~vns~ge~wH~~CFvCAQCf~pf~~g~~~efEgRkYCEhDF~~LfaPcC~kC~EFiiGrVikamn 92 (332)
T KOG2272|consen 13 MVCERCRDGFEPAEKIVNSNGELWHEQCFVCAQCFRPFPDGIFYEFEGRKYCEHDFHVLFAPCCGKCGEFIIGRVIKAMN 92 (332)
T ss_pred HHHHHHhccCCchhhhhccCchhhHHHHHHHHHhcCcCCCceeEEecCcccccccchhhhchhhcccccchhhHHHHhhc
Confidence 4699998887654 467778899999999999999999 56999999999999999999999999999999999999999
Q ss_pred ccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhc
Q psy5063 88 HKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQM 128 (681)
Q Consensus 88 ~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~ 128 (681)
.+|||.||+|..|.+.|.+.. ++..+++..|..|.++..
T Consensus 93 nSwHp~CF~Cd~Cn~~Lad~g--f~rnqgr~LC~~Cn~k~K 131 (332)
T KOG2272|consen 93 NSWHPACFRCDLCNKHLADQG--FYRNQGRALCRECNQKEK 131 (332)
T ss_pred cccCcccchhHHHHHHHhhhh--hHhhcchHHhhhhhhhhc
Confidence 999999999999999997655 456678889999997743
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.65 E-value=3e-16 Score=165.08 Aligned_cols=184 Identities=24% Similarity=0.281 Sum_probs=136.3
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
...++....++-+|.||.||.|.+++.... . ..+..+.+..++.. +.+.....+.|--.+.
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~------n----~~q~v~vKTvk~~A---------S~iQv~~~L~es~lly 342 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTY------N----DCQEVLVKTVKQHA---------SQIQVNLLLQESMLLY 342 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCc------c----hHHHHHHHHHHhcc---------cHHHHHHHHHHHHHHh
Confidence 345677777899999999999988743221 1 11112222211100 0111123345677788
Q ss_pred hCCCCceeeEEEEEEeC-CeEEEEEeccCCCCHHHHHh-----CC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 558 SLHHHNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQ-----DP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~-~~l~LV~Ey~~gGsL~~~L~-----~~--~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
.+.|||+....++..++ ...++++.++.-|+|+.+|. +. ...++..+.+.++.|++.||+|||+++|||.||
T Consensus 343 ~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDi 422 (563)
T KOG1024|consen 343 GASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDI 422 (563)
T ss_pred cCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchh
Confidence 89999999999998764 67788899999999999997 22 234777889999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
..+|++||+.-.+ +|-.|+|.+-.......-........||+||.|..+.|
T Consensus 423 AaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y 475 (563)
T KOG1024|consen 423 AARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY 475 (563)
T ss_pred hhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh
Confidence 9999999999887 89999998775544444445557889999999988766
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=164.21 Aligned_cols=137 Identities=20% Similarity=0.378 Sum_probs=112.8
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.|....|.+.++||-|-|++||++++..+.+.||+|+++..... .+.. +.||.+
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaA-------------------------lDEIkl 127 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAA-------------------------LDEIKL 127 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHH-------------------------HHHHHH
Confidence 36668899999999999999999999999999999988543222 2222 345888
Q ss_pred HHhCC-----C---CceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy5063 556 LRSLH-----H---HNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSM 622 (681)
Q Consensus 556 L~~L~-----H---pnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~ 622 (681)
|+.++ | ..||+|++.|.- +.+++||+|++ |.+|..+|... .+.++...++.|++||+.||.|||+.
T Consensus 128 L~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e 206 (590)
T KOG1290|consen 128 LQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE 206 (590)
T ss_pred HHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh
Confidence 88772 2 379999999974 45899999999 77888888754 35699999999999999999999975
Q ss_pred -CccccCCCCCcEEEecC
Q psy5063 623 -NLIHRDLNSQNCLVREV 639 (681)
Q Consensus 623 -~IIHRDLKp~NILl~~~ 639 (681)
||||-||||+|||+...
T Consensus 207 cgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 207 CGIIHTDLKPENVLLCST 224 (590)
T ss_pred cCccccCCCcceeeeecc
Confidence 99999999999999765
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=151.82 Aligned_cols=135 Identities=24% Similarity=0.315 Sum_probs=102.7
Q ss_pred eecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc
Q psy5063 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN 563 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 563 (681)
.||+|+||.||++.+ ++..+++|...... .........+ ...+|+++++.++|++
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~--------------------~~~~E~~~l~~l~~~~ 58 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRE--------------------RTRNEARLLSRARKAG 58 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHH--------------------HHHHHHHHHHHHHHCC
Confidence 489999999999985 47788889764321 1111111111 2245799999998887
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe-
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG- 642 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~- 642 (681)
+.....++...+..++||||++|++|.+++.... . .++.|++.+|.+||+.+++|+|++|+|||++ ++.+
T Consensus 59 i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~ 129 (199)
T TIGR03724 59 VNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLY 129 (199)
T ss_pred CCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEE
Confidence 6555555556677899999999999999876421 1 7889999999999999999999999999999 6666
Q ss_pred -EEeeeeeEee
Q psy5063 643 -FDFHLGQIYL 652 (681)
Q Consensus 643 -~DFGLa~~~~ 652 (681)
.|||+++...
T Consensus 130 liDfg~a~~~~ 140 (199)
T TIGR03724 130 LIDFGLGKYSD 140 (199)
T ss_pred EEECCCCcCCC
Confidence 9999988754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.5e-15 Score=174.12 Aligned_cols=138 Identities=22% Similarity=0.304 Sum_probs=105.7
Q ss_pred eecceecccCcEEEEEEEEcCCCeEEEEEEee-cc-C-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELY-RV-D-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~-~~-~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
...+.||+|+||.||++.+... .+++|+.. +. . .........+ .+.+|+++|+.+
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~--------------------~~~~E~~~l~~l 393 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTE--------------------RTRAEARLLSEA 393 (535)
T ss_pred CccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHH--------------------HHHHHHHHHHhh
Confidence 4578899999999999987643 34444322 11 1 1111111111 234679999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|++++....+.......++||||++|++|.+++. ....++.|++.+|.|||+.+++||||||+|||++ +
T Consensus 394 ~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~ 463 (535)
T PRK09605 394 RRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-D 463 (535)
T ss_pred cccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-C
Confidence 99999988877777778899999999999999885 3467899999999999999999999999999994 5
Q ss_pred CCe--EEeeeeeEee
Q psy5063 640 GSG--FDFHLGQIYL 652 (681)
Q Consensus 640 g~~--~DFGLa~~~~ 652 (681)
+.+ +|||+++...
T Consensus 464 ~~~~liDFGla~~~~ 478 (535)
T PRK09605 464 DRLYLIDFGLGKYSD 478 (535)
T ss_pred CcEEEEeCcccccCC
Confidence 555 9999998754
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=153.16 Aligned_cols=147 Identities=13% Similarity=0.103 Sum_probs=110.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...++||.|+||.||+... ++..+|+|.+.......+..+..-.+ .-...+|+..+..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~----------------g~~~e~Ea~~l~r 91 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVK----------------GDYYENLIVQTDR 91 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhh----------------hHHHHHHHHHHHH
Confidence 57899999999999999999655 36689999886433222221111000 0012356889999
Q ss_pred CCCCceeeEEEEEEeC--------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 559 LHHHNVIRFIGVLYKD--------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~--------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.|++|....+++... +..+|+|||++|.+|.++.. ++. ....+++.+|..+|+.|++|||+|
T Consensus 92 L~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dik 162 (232)
T PRK10359 92 VRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPH 162 (232)
T ss_pred HHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCC
Confidence 9999999998886643 35899999999999988742 332 245699999999999999999999
Q ss_pred CCcEEEecCCCe-EEeeeeeEee
Q psy5063 631 SQNCLVREVGSG-FDFHLGQIYL 652 (681)
Q Consensus 631 p~NILl~~~g~~-~DFGLa~~~~ 652 (681)
|+|++++.+|-. +|||..+...
T Consensus 163 p~Nili~~~gi~liDfg~~~~~~ 185 (232)
T PRK10359 163 KGNFIVSKNGLRIIDLSGKRCTA 185 (232)
T ss_pred hHHEEEeCCCEEEEECCCccccc
Confidence 999999999833 9999887654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=6e-15 Score=147.87 Aligned_cols=134 Identities=22% Similarity=0.226 Sum_probs=99.7
Q ss_pred ecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC-CC
Q psy5063 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH-HH 562 (681)
Q Consensus 484 ~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp 562 (681)
....|++|+||+||.+.. .+..++.+.+..........+.. .+.+|+++|+.|+ |+
T Consensus 6 ~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~---------------------l~~rE~~iL~~L~~~~ 62 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWW---------------------LARREALALRQLDGLP 62 (218)
T ss_pred cceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHH---------------------HHHHHHHHHHhcCCCC
Confidence 356799999999997665 46777766654332211111000 1235699999994 58
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCcEEEecCCC
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL-NSQNCLVREVGS 641 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL-Kp~NILl~~~g~ 641 (681)
+|++++++ +..+++|||+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.
T Consensus 63 ~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~ 130 (218)
T PRK12274 63 RTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS 130 (218)
T ss_pred CCCEEEEE----cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC
Confidence 89999886 457999999999998764321 1 1357889999999999999999999 799999999998
Q ss_pred e--EEeeeeeEee
Q psy5063 642 G--FDFHLGQIYL 652 (681)
Q Consensus 642 ~--~DFGLa~~~~ 652 (681)
+ +|||+|....
T Consensus 131 i~LIDFG~A~~~~ 143 (218)
T PRK12274 131 PAVIDFQLAVRGN 143 (218)
T ss_pred EEEEECCCceecC
Confidence 7 9999998544
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.8e-15 Score=147.75 Aligned_cols=151 Identities=22% Similarity=0.183 Sum_probs=105.4
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHH--H---HHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE--K---NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~--~---~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
|...+.||+|+||.||++.+. +|+.+|+|.+........ . ......+ ....-........+|..++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRK--------HASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccc--------cchhHHHhHHHHHHHHHHH
Confidence 556788999999999999875 799999998754321100 0 0000000 0000000111245678889
Q ss_pred HhCCCCc--eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 557 RSLHHHN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 557 ~~L~Hpn--IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
..+.|++ +...++ ....++||||++|++|.++... .....++.+++.++.++|+.+|+||||||+||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Ni 156 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNI 156 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccE
Confidence 8887774 444443 2456899999999999776431 23457889999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEee
Q psy5063 635 LVREVGSG--FDFHLGQIYL 652 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~ 652 (681)
++++++.+ +|||++....
T Consensus 157 ll~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 157 LVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred EEcCCCcEEEEECCccccCC
Confidence 99998877 9999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1703|consensus | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.4e-16 Score=177.55 Aligned_cols=122 Identities=25% Similarity=0.567 Sum_probs=109.4
Q ss_pred ccccccccccccCceEEecCccccccCcccccCcCcc-CCceEeeCCeeeeccccccccCCcccccCCccccCeEEecCc
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDH 88 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L-~~~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~~~ 88 (681)
+.|..|++.|.+...+.++++.||+.||.|..|...+ .+.+.+.+|++||..||.+.+.++|.+|+++|.+.+|.|.++
T Consensus 304 p~c~~c~~~i~~~~~i~~~~~~~h~~~~~c~~~~~~~~~~~~~~~~g~~~c~~~~~~~~~p~C~~C~~~i~~~~v~a~~~ 383 (479)
T KOG1703|consen 304 PLCLSCNQKIRSVKVIVALGKEWHPEHFSCEVCAIVILDGGPRELDGKILCHECFHAPFRPNCKRCLLPILEEGVCALGR 383 (479)
T ss_pred ccccccccCcccceeEeeccccccccceeeccccccccCCCccccCCCccHHHHHHHhhCccccccCCchHHhHhhhccC
Confidence 7899999999754899999999999999999999988 457789999999999999999999999999999999999999
Q ss_pred cCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 89 KFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 89 ~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
.||++||.|..|.+.+..+.+| . .++.+||..||++.+.+++.
T Consensus 384 ~wH~~cf~C~~C~~~~~~~~~~-~-~~~~pyce~~~~~~~~~~~~ 426 (479)
T KOG1703|consen 384 LWHPECFVCADCGKPLKNSSFF-E-SDGEPYCEDHYKKLFTTKCD 426 (479)
T ss_pred eechhceeeecccCCCCCCccc-c-cCCccchhhhHhhhccccch
Confidence 9999999999999998655534 3 35679999999999887653
|
|
| >KOG1703|consensus | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.1e-16 Score=175.69 Aligned_cols=114 Identities=27% Similarity=0.663 Sum_probs=100.7
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccccCCccc--cCeEE
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCGQMMS--GPVMV 84 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~--g~~~~ 84 (681)
..+.|++|+++|. ++.+.|+++.||++||.|..|++++.+ .||+.||.+||+.||+++|..+|..|..++. +..+.
T Consensus 362 ~~p~C~~C~~~i~-~~~v~a~~~~wH~~cf~C~~C~~~~~~~~~~~~~~~pyce~~~~~~~~~~~~~~~~p~~~~~~~ie 440 (479)
T KOG1703|consen 362 FRPNCKRCLLPIL-EEGVCALGRLWHPECFVCADCGKPLKNSSFFESDGEPYCEDHYKKLFTTKCDYCKKPVEFGSRQIE 440 (479)
T ss_pred hCccccccCCchH-HhHhhhccCeechhceeeecccCCCCCCcccccCCccchhhhHhhhccccchhccchhHhhhhHhh
Confidence 3578999999996 678999999999999999999999965 7999999999999999999999999999885 78899
Q ss_pred ecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccch
Q psy5063 85 VGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124 (681)
Q Consensus 85 a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy 124 (681)
+.+..||.+||+|..|.+.+. +..|+. ..++++|..|+
T Consensus 441 ~~~~~~h~~~F~c~~c~~~l~-~~~~~~-~~~~p~c~~~~ 478 (479)
T KOG1703|consen 441 ADGSPFHGDCFRCANCMKKLT-KKTFFE-TLDKPLCQKHF 478 (479)
T ss_pred ccCccccccceehhhhhcccc-CCceee-cCCccccccCC
Confidence 999999999999999999995 444443 35568999986
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.3e-15 Score=180.20 Aligned_cols=124 Identities=16% Similarity=0.164 Sum_probs=94.3
Q ss_pred HHhCCC-CceeeEEEEE-------EeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy5063 556 LRSLHH-HNVIRFIGVL-------YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 627 (681)
Q Consensus 556 L~~L~H-pnIV~l~g~~-------~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHR 627 (681)
.+.++| +||.+++++| .....++++|||+ +++|.++|......+++.+++.++.||+.||.|||++||+||
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 455667 6888899987 3345688889988 669999998765669999999999999999999999999999
Q ss_pred CCCCCcEEEec-------------------CCCe--EEeeeeeEeeecc-------------cc-eeeeecCCCccccch
Q psy5063 628 DLNSQNCLVRE-------------------VGSG--FDFHLGQIYLIYV-------------PY-TLFILSAKTKKTYYP 672 (681)
Q Consensus 628 DLKp~NILl~~-------------------~g~~--~DFGLa~~~~~~~-------------~~-~~~~~~~gt~~Y~AP 672 (681)
||||+||||+. ++.+ +|||+++...... +. .......||+.||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 2333 7888877532100 00 001123578889999
Q ss_pred hhccCCCC
Q psy5063 673 NILKKASF 680 (681)
Q Consensus 673 EvL~~~~Y 680 (681)
|++.+.+|
T Consensus 185 E~~~~~~~ 192 (793)
T PLN00181 185 EEDNGSSS 192 (793)
T ss_pred hhhccCCC
Confidence 99988766
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.7e-15 Score=171.77 Aligned_cols=175 Identities=25% Similarity=0.303 Sum_probs=135.6
Q ss_pred eecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
....++|.|+||.|+........+.++.|..... ..+....+... +..|..+-..+.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~---------------------i~sE~~i~~~l~ 379 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYN---------------------ITSEFCIGSSLS 379 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhh---------------------hhhheeeccccc
Confidence 4567899999998888877766666666644310 11111111110 223456667889
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g 640 (681)
|+|++..+..+.+....+-+|||+++ +|+.++.... .+....+-.++.|++.|+.|+|++||.|||||++|+|+..+|
T Consensus 380 h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g 457 (601)
T KOG0590|consen 380 HPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG 457 (601)
T ss_pred CCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC
Confidence 99998887777766666666999999 9999998753 488889999999999999999999999999999999999999
Q ss_pred Ce--EEeeeeeEeeecccc--eeeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPY--TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~--~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||.+..+...... .......|+..|+|||++.+..|
T Consensus 458 ~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~y 501 (601)
T KOG0590|consen 458 ILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEY 501 (601)
T ss_pred ceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccccc
Confidence 88 999999998876544 44556779999999999999887
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.53 E-value=4e-14 Score=138.97 Aligned_cols=152 Identities=22% Similarity=0.205 Sum_probs=98.3
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH--HHHHH--HHhhccceeeeccCCCC---ccccccchHHHHHHH
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA--EKNFL--KESKQGLIYLIDLGSHG---LINNLHCFSQVAVLR 557 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~--~~~~~--~E~k~~~~~~~~~~~~~---~~~~~~~~~Ei~iL~ 557 (681)
++.||+|+||.||++.+. +++.||+|.+....... ..... ... ....+. .........|...+.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~e~~~l~ 72 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYR--------FGRKKSNWRYLSRLWAEKEFRNLK 72 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHH--------hccCCcchhhhhhHHHHHHHHHHH
Confidence 467999999999999986 78999999886532211 11110 000 000000 001111234566666
Q ss_pred hCCCC--ceeeEEEEEEeCCeEEEEEeccCCCCHHH-HHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCc
Q psy5063 558 SLHHH--NVIRFIGVLYKDRKLNLVTEYIAGGTLKE-LLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQN 633 (681)
Q Consensus 558 ~L~Hp--nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~-~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~N 633 (681)
.+.+. .+.+.++. ...++||||++++.+.. .+.... .. ..+..++.+++.++.++|. .+|+||||||+|
T Consensus 73 ~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 73 RLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred HHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 66443 34445443 24689999999955432 122111 11 5677899999999999999 999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeee
Q psy5063 634 CLVREVGSG--FDFHLGQIYLI 653 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~ 653 (681)
|+++ ++.+ +|||.+.....
T Consensus 146 ili~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 146 ILVD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EEEE-CCcEEEEECcccccccC
Confidence 9999 6666 99999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.53 E-value=3.3e-14 Score=167.87 Aligned_cols=176 Identities=20% Similarity=0.243 Sum_probs=137.3
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
..+....|.+.+.||+|+||+||+|...+ |+.+|+|.-+...... ++--.+
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE----------------------------fYI~~q 743 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE----------------------------FYICLQ 743 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee----------------------------eeehHH
Confidence 34556778889999999999999999987 9999999764432110 001133
Q ss_pred HHHhCC---CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 555 VLRSLH---HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 555 iL~~L~---HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+|.+|+ -+-|+++..++.-.+.-+||+||.+.|+|.+++.. .+.++|...+.|..|++.-++.||.++|||+||||
T Consensus 744 ~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKP 822 (974)
T KOG1166|consen 744 VMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKP 822 (974)
T ss_pred HHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCc
Confidence 344444 23444455555556778899999999999999984 45699999999999999999999999999999999
Q ss_pred CcEEEecC-----CCe----EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREV-----GSG----FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~-----g~~----~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|+||... +.. +|||-+-.+..-...+.+....+|..+-.+|++.+.+|
T Consensus 823 DNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpW 880 (974)
T KOG1166|consen 823 DNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW 880 (974)
T ss_pred ceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCC
Confidence 99999642 111 99999988887666678888889999999999998875
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.6e-13 Score=139.85 Aligned_cols=147 Identities=24% Similarity=0.289 Sum_probs=103.1
Q ss_pred ceec-ccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCce
Q psy5063 486 PLLG-QGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNV 564 (681)
Q Consensus 486 ~~LG-~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI 564 (681)
.+|| .|+.|.||++... +..+|+|.+.+...-. + +.+... ...........+|++++..|+|++|
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~-k-v~~~~~----------~~~~~~~~r~~rE~~ll~~L~~~gi 102 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIG-K-LSKDRY----------LFTGLERTRAFAEFRLLAQLYEAGL 102 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHH-h-hhhhcc----------cccchhhhHHHHHHHHHHHHHhCCC
Confidence 4677 7888888888775 7788999885432110 0 100000 0000011234578999999988875
Q ss_pred --eeEEEEEEeC-C---eEEEEEeccCC-CCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 565 --IRFIGVLYKD-R---KLNLVTEYIAG-GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 565 --V~l~g~~~~~-~---~l~LV~Ey~~g-GsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
+..+++.... . ..++||||++| .+|.+++... .++.. .+.|++.+|.+||++||+||||||+|||++
T Consensus 103 ~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~ 176 (239)
T PRK01723 103 PVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLD 176 (239)
T ss_pred CCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEc
Confidence 6777764432 2 23599999997 6999988653 35543 357899999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEee
Q psy5063 638 EVGSG--FDFHLGQIYL 652 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~ 652 (681)
.++.+ +|||.++...
T Consensus 177 ~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 177 PDGKFWLIDFDRGELRT 193 (239)
T ss_pred CCCCEEEEECCCcccCC
Confidence 88877 9999988754
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.6e-14 Score=152.63 Aligned_cols=116 Identities=23% Similarity=0.245 Sum_probs=89.0
Q ss_pred CCCceeeEEEEEEeC---------------------------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHH
Q psy5063 560 HHHNVIRFIGVLYKD---------------------------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDI 612 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~---------------------------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QI 612 (681)
+|||||++.++|.+. ..+|+||.-++. +|..++..+. .+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 699999999988642 248999998855 9999997654 5566677788999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEEecCC--Ce----EEeeeeeEeee---cccceeeeecC-CCccccchhhccCC
Q psy5063 613 AAGMTYLHSMNLIHRDLNSQNCLVREVG--SG----FDFHLGQIYLI---YVPYTLFILSA-KTKKTYYPNILKKA 678 (681)
Q Consensus 613 a~gL~yLHs~~IIHRDLKp~NILl~~~g--~~----~DFGLa~~~~~---~~~~~~~~~~~-gt~~Y~APEvL~~~ 678 (681)
++|+.|||.+||.|||||++||||.-+. -. +|||.+-.-.. ..+|..+..+. |...-||||+....
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999999999999999996543 22 99998754332 34555554444 56678999998654
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.47 E-value=2e-13 Score=126.72 Aligned_cols=131 Identities=26% Similarity=0.282 Sum_probs=104.9
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC--C
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH--H 562 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--p 562 (681)
.+.||+|.++.||++.... ..+++|....... ...+.. |+.+++.++| .
T Consensus 3 ~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~-------------------------e~~~~~~l~~~~~ 53 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADRER-------------------------EVAILQLLARKGL 53 (155)
T ss_pred ceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHH-------------------------HHHHHHHHHHcCC
Confidence 4579999999999999853 7789998754332 222333 4778888865 5
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCcEEEecC
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM---NLIHRDLNSQNCLVREV 639 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~---~IIHRDLKp~NILl~~~ 639 (681)
++++++++...++..+++|||++++.+..+ +......++.+++.+|.++|.. +++|+|++|+|||+++.
T Consensus 54 ~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~ 125 (155)
T cd05120 54 PVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG 125 (155)
T ss_pred CCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECC
Confidence 899999988888899999999998877654 4556677889999999999985 69999999999999987
Q ss_pred CCe--EEeeeeeEee
Q psy5063 640 GSG--FDFHLGQIYL 652 (681)
Q Consensus 640 g~~--~DFGLa~~~~ 652 (681)
+.+ .|||+++...
T Consensus 126 ~~~~l~Df~~~~~~~ 140 (155)
T cd05120 126 KILGIIDWEYAGYGP 140 (155)
T ss_pred cEEEEEecccccCCC
Confidence 766 9999987543
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.5e-14 Score=156.06 Aligned_cols=160 Identities=22% Similarity=0.310 Sum_probs=129.7
Q ss_pred eecccCcEEEEEEE---EcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC-CC
Q psy5063 487 LLGQGFFGQVYRVT---HRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH-HH 562 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~---~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp 562 (681)
++|+|+||.|++++ -.+.|..+|+|.+++........- +...|..++...+ ||
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-----------------------~t~~er~il~~~~~~~ 57 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-----------------------HTKQERIILAFVHNTP 57 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-----------------------ccccHHHHHhhccCCC
Confidence 47999999999754 345688999998865432211100 1223466778886 99
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
.++++...+..+..++++++|..||+|...+.+... +.+.....+...++.|++++|+.+|+|||+|++||+++.+|.+
T Consensus 58 f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi 136 (612)
T KOG0603|consen 58 FLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM-FDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHI 136 (612)
T ss_pred ceeeeeeeeccccchhHhhhhcccchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCcc
Confidence 999999999999999999999999999988877543 6777777888899999999999999999999999999999966
Q ss_pred --EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 643 --FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 643 --~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
.|||+++....... .+||..|||||++.
T Consensus 137 ~~tdfglske~v~~~~------~cgt~eymApEI~~ 166 (612)
T KOG0603|consen 137 KLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN 166 (612)
T ss_pred ccCCchhhhHhHhhhh------cccchhhhhhHhhh
Confidence 99999998764332 27999999999987
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=9e-13 Score=133.50 Aligned_cols=171 Identities=24% Similarity=0.340 Sum_probs=127.7
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
-+..+++.+..+|.+...|..|+|++. |..++.|++.-.+ ....+.|..| .
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfnee-------------------------f 238 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEE-------------------------F 238 (448)
T ss_pred CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcchhhcchhhhh-------------------------C
Confidence 345566777778999999999999998 4445557663322 1122223333 5
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCC
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLN 630 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~--IIHRDLK 630 (681)
-.|+-+.||||+.++|.+.+...+.++..||+.|+|+.+|.... ...+..++++++.++++||.|||+.. |..--|.
T Consensus 239 p~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~ln 318 (448)
T KOG0195|consen 239 PALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLN 318 (448)
T ss_pred cceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcc
Confidence 56777899999999999999999999999999999999998753 34678899999999999999999974 4444688
Q ss_pred CCcEEEecCCCe-EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 631 SQNCLVREVGSG-FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 631 p~NILl~~~g~~-~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+..+++|++-++ ...+-+++...... ..-.+.||+||.|.+++
T Consensus 319 s~hvmidedltarismad~kfsfqe~g------r~y~pawmspealqrkp 362 (448)
T KOG0195|consen 319 SKHVMIDEDLTARISMADTKFSFQEVG------RAYSPAWMSPEALQRKP 362 (448)
T ss_pred cceEEecchhhhheecccceeeeeccc------cccCcccCCHHHHhcCc
Confidence 999999999877 44443333322221 22478999999998764
|
|
| >KOG1044|consensus | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.8e-13 Score=143.62 Aligned_cols=119 Identities=25% Similarity=0.569 Sum_probs=94.3
Q ss_pred cccccccccCceEEecCccccccCcccccCcCcc-CC-ceEeeCCeeeecccccc--------ccCCcccccCCcc-ccC
Q psy5063 13 AGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DN-WYFEKDGLLFCKEDYNG--------KYGEACQNCGQMM-SGP 81 (681)
Q Consensus 13 ~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L-~~-~~~~~dg~~yC~~cY~~--------~f~~~C~~C~~~I-~g~ 81 (681)
..|+.-+ .++++.++|+.||+.||.|+.|+.+. .+ +.-.-+....|+.|-.- .....|++|++.| .|.
T Consensus 69 ~~c~~~~-~gevvsa~gktyh~~cf~cs~ck~pf~~g~~vt~~gk~~~c~~c~~~~~~~p~~~~~ps~cagc~~~lk~gq 147 (670)
T KOG1044|consen 69 DDCRAFV-EGEVVSTLGKTYHPKCFSCSTCKSPFKSGDKVTFSGKECLCQTCSQPMPVSPAESYGPSTCAGCGEELKNGQ 147 (670)
T ss_pred cchhhhc-cceeEecccceeccccceecccCCCCCCCCeeeecchhhhhhhhcCcccCCcccccCCccccchhhhhhccc
Confidence 3454444 57899999999999999999999988 33 44444555678888532 1234699999766 889
Q ss_pred eEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCCCc
Q psy5063 82 VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGRAK 135 (681)
Q Consensus 82 ~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~~~ 135 (681)
.+.|.++.||..||+|..|...| .|+ ++..++.+||..||+++|.-+|..+
T Consensus 148 ~llald~qwhv~cfkc~~c~~vL-~ge--y~skdg~pyce~dy~~~fgvkc~~c 198 (670)
T KOG1044|consen 148 ALLALDKQWHVSCFKCKSCSAVL-NGE--YMSKDGVPYCEKDYQAKFGVKCEEC 198 (670)
T ss_pred eeeeeccceeeeeeehhhhcccc-cce--eeccCCCcchhhhhhhhcCeehHHh
Confidence 99999999999999999999998 566 4566788999999999998887543
|
|
| >PF00412 LIM: LIM domain; InterPro: IPR001781 Zinc finger (Znf) domains are relatively small protein motifs which contain multiple finger-like protrusions that make tandem contacts with their target molecule | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.8e-12 Score=101.69 Aligned_cols=56 Identities=39% Similarity=0.949 Sum_probs=50.9
Q ss_pred ccccccccccCceE-EecCccccccCcccccCcCccCC-ceEeeCCeeeecccccccc
Q psy5063 12 CAGCLNNIVEDEYV-QALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKY 67 (681)
Q Consensus 12 C~~C~~~I~~~~~v-~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f 67 (681)
|++|+++|.+++.+ .++|+.||++||+|..|+++|.+ .|+..||++||+.||.++|
T Consensus 1 C~~C~~~I~~~~~~~~~~~~~~H~~Cf~C~~C~~~l~~~~~~~~~~~~~C~~c~~~~f 58 (58)
T PF00412_consen 1 CARCGKPIYGTEIVIKAMGKFWHPECFKCSKCGKPLNDGDFYEKDGKPYCKDCYQKRF 58 (58)
T ss_dssp BTTTSSBESSSSEEEEETTEEEETTTSBETTTTCBTTTSSEEEETTEEEEHHHHHHHT
T ss_pred CCCCCCCccCcEEEEEeCCcEEEccccccCCCCCccCCCeeEeECCEEECHHHHhhhC
Confidence 89999999877765 79999999999999999999965 5899999999999998875
|
Some of these domains bind zinc, but many do not; instead binding other metals such as iron, or no metal at all. For example, some family members form salt bridges to stabilise the finger-like folds. They were first identified as a DNA-binding motif in transcription factor TFIIIA from Xenopus laevis (African clawed frog), however they are now recognised to bind DNA, RNA, protein and/or lipid substrates [, , , , ]. Their binding properties depend on the amino acid sequence of the finger domains and of the linker between fingers, as well as on the higher-order structures and the number of fingers. Znf domains are often found in clusters, where fingers can have different binding specificities. There are many superfamilies of Znf motifs, varying in both sequence and structure. They display considerable versatility in binding modes, even between members of the same class (e.g. some bind DNA, others protein), suggesting that Znf motifs are stable scaffolds that have evolved specialised functions. For example, Znf-containing proteins function in gene transcription, translation, mRNA trafficking, cytoskeleton organisation, epithelial development, cell adhesion, protein folding, chromatin remodelling and zinc sensing, to name but a few []. Zinc-binding motifs are stable structures, and they rarely undergo conformational changes upon binding their target. This entry represents LIM-type zinc finger (Znf) domains. LIM domains coordinate one or more zinc atoms, and are named after the three proteins (LIN-11, Isl1 and MEC-3) in which they were first found. They consist of two zinc-binding motifs that resemble GATA-like Znf's, however the residues holding the zinc atom(s) are variable, involving Cys, His, Asp or Glu residues. LIM domains are involved in proteins with differing functions, including gene expression, and cytoskeleton organisation and development [, ]. Protein containing LIM Znf domains include: Caenorhabditis elegans mec-3; a protein required for the differentiation of the set of six touch receptor neurons in this nematode. C. elegans. lin-11; a protein required for the asymmetric division of vulval blast cells. Vertebrate insulin gene enhancer binding protein isl-1. Isl-1 binds to one of the two cis-acting protein-binding domains of the insulin gene. Vertebrate homeobox proteins lim-1, lim-2 (lim-5) and lim3. Vertebrate lmx-1, which acts as a transcriptional activator by binding to the FLAT element; a beta-cell-specific transcriptional enhancer found in the insulin gene. Mammalian LH-2, a transcriptional regulatory protein involved in the control of cell differentiation in developing lymphoid and neural cell types. Drosophila melanogaster (Fruit fly) protein apterous, required for the normal development of the wing and halter imaginal discs. Vertebrate protein kinases LIMK-1 and LIMK-2. Mammalian rhombotins. Rhombotin 1 (RBTN1 or TTG-1) and rhombotin-2 (RBTN2 or TTG-2) are proteins of about 160 amino acids whose genes are disrupted by chromosomal translocations in T-cell leukemia. Mammalian and avian cysteine-rich protein (CRP), a 192 amino-acid protein of unknown function. Seems to interact with zyxin. Mammalian cysteine-rich intestinal protein (CRIP), a small protein which seems to have a role in zinc absorption and may function as an intracellular zinc transport protein. Vertebrate paxillin, a cytoskeletal focal adhesion protein. Mus musculus (Mouse) testin which should not be confused with rat testin which is a thiol protease homologue (see IPR000169 from INTERPRO). Helianthus annuus (Common sunflower) pollen specific protein SF3. Chicken zyxin. Zyxin is a low-abundance adhesion plaque protein which has been shown to interact with CRP. Yeast protein LRG1 which is involved in sporulation []. Saccharomyces cerevisiae (Baker's yeast) rho-type GTPase activating protein RGA1/DBM1. C. elegans homeobox protein ceh-14. C. elegans homeobox protein unc-97. S. cerevisiae hypothetical protein YKR090w. C. elegans hypothetical proteins C28H8.6. These proteins generally contain two tandem copies of the LIM domain in their N-terminal section. Zyxin and paxillin are exceptions in that they contain respectively three and four LIM domains at their C-terminal extremity. In apterous, isl-1, LH-2, lin-11, lim-1 to lim-3, lmx-1 and ceh-14 and mec-3 there is a homeobox domain some 50 to 95 amino acids after the LIM domains. LIM domains contain seven conserved cysteine residues and a histidine. The arrangement followed by these conserved residues is: C-x(2)-C-x(16,23)-H-x(2)-[CH]-x(2)-C-x(2)-C-x(16,21)-C-x(2,3)-[CHD] LIM domains bind two zinc ions []. LIM does not bind DNA, rather it seems to act as an interface for protein-protein interaction. More information about these proteins can be found at Protein of the Month: Zinc Fingers [].; GO: 0008270 zinc ion binding; PDB: 2CO8_A 2EGQ_A 2CUR_A 3IXE_B 1CTL_A 1B8T_A 1X62_A 2DFY_C 1IML_A 2CUQ_A .... |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.7e-11 Score=135.46 Aligned_cols=164 Identities=19% Similarity=0.128 Sum_probs=102.1
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHH---HHh----hccceeeeccC--------CCCccccccch
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFL---KES----KQGLIYLIDLG--------SHGLINNLHCF 550 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~---~E~----k~~~~~~~~~~--------~~~~~~~~~~~ 550 (681)
+.||.|++|+||+|+.+ +|+.||||+....-......-+ +.. ..........+ .......+.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999986 6899999988653322111100 000 00000000000 00111223455
Q ss_pred HHHHHHHhC----CCCceeeEEEEEE-eCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q psy5063 551 SQVAVLRSL----HHHNVIRFIGVLY-KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA-GMTYLHSMNL 624 (681)
Q Consensus 551 ~Ei~iL~~L----~HpnIV~l~g~~~-~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~-gL~yLHs~~I 624 (681)
+|...+..+ +|.+-+.+-.++. -....+|||||++|++|.++........+ ...++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence 676666655 2333344433432 23457999999999999887653211122 2345666655 4788999999
Q ss_pred cccCCCCCcEEEecCCCe--EEeeeeeEeee
Q psy5063 625 IHRDLNSQNCLVREVGSG--FDFHLGQIYLI 653 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~~--~DFGLa~~~~~ 653 (681)
+|+|++|.||+++.+|.+ .|||++..+..
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999988 99999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.5e-11 Score=135.90 Aligned_cols=166 Identities=16% Similarity=0.118 Sum_probs=101.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHH----------HHHhhcc--cee---eeccCCCCcc
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNF----------LKESKQG--LIY---LIDLGSHGLI 544 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~----------~~E~k~~--~~~---~~~~~~~~~~ 544 (681)
.+|.. +.||.|++|+||+|+.+++|+.||||++.+.-....+.- +...... ... +.+--.....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35555 689999999999999998899999999865422211100 0000000 000 0000000111
Q ss_pred ccccchHHHHHHHhC----CCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHH--HhCCCC---CCCHHHHHHHHHHHHH
Q psy5063 545 NNLHCFSQVAVLRSL----HHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKEL--LQDPGQ---PLPWGQRVNFARDIAA 614 (681)
Q Consensus 545 ~~~~~~~Ei~iL~~L----~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~--L~~~~~---~l~~~~~~~i~~QIa~ 614 (681)
..+.+.+|...+..+ .+.+.+.+-.++.+ ....+|||||++|+++.++ +...+. .+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 223455666655554 35555555555543 4567899999999999875 332221 13333344444444
Q ss_pred HHHHHHhCCccccCCCCCcEEEecCC----Ce--EEeeeeeEeee
Q psy5063 615 GMTYLHSMNLIHRDLNSQNCLVREVG----SG--FDFHLGQIYLI 653 (681)
Q Consensus 615 gL~yLHs~~IIHRDLKp~NILl~~~g----~~--~DFGLa~~~~~ 653 (681)
...|++|+|+||.||+++.+| .. .|||+...+..
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 468999999999999999988 55 99999987754
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=5.9e-11 Score=124.72 Aligned_cols=181 Identities=23% Similarity=0.314 Sum_probs=101.3
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.+..++.||.|+|+.||.+++.+|++.+|+|........ ..+.+.+|.- .... -.+..+..++.+....|.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l----~~~~--~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQL----AITL--FPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHH----GGGG--STT--SHHHHHHHH-B--
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHH----Hhhh--hccCCCHHHHHHhceEEe
Confidence 467788999999999999999999999999988643322 2333333311 0000 011112222222222222
Q ss_pred hCCCCceeeEE---EEEEeC---C-----eEEEEEeccCCCCHHHHHhC---CC---CCCCHHHHHHHHHHHHHHHHHHH
Q psy5063 558 SLHHHNVIRFI---GVLYKD---R-----KLNLVTEYIAGGTLKELLQD---PG---QPLPWGQRVNFARDIAAGMTYLH 620 (681)
Q Consensus 558 ~L~HpnIV~l~---g~~~~~---~-----~l~LV~Ey~~gGsL~~~L~~---~~---~~l~~~~~~~i~~QIa~gL~yLH 620 (681)
-+ -++++- .++... . +.+++|+-+ .+||.+++.. .. ..+.......+..|+++.+++||
T Consensus 87 P~---d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh 162 (288)
T PF14531_consen 87 PL---DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH 162 (288)
T ss_dssp -S---EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ee---EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh
Confidence 11 122211 011111 1 346777777 5689888642 11 11333444566789999999999
Q ss_pred hCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 621 SMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 621 s~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+.|++|+||||+|+|++.+|.+ .||+-...... .......+..|.+||+..
T Consensus 163 ~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 163 SYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELES 215 (288)
T ss_dssp HTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHH
T ss_pred hcceEecccceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhh
Confidence 9999999999999999999999 88876554332 111134567788899763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=1e-10 Score=113.22 Aligned_cols=81 Identities=17% Similarity=0.061 Sum_probs=70.3
Q ss_pred CCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCeEEeeeeeEeeecccceeeeecCCC
Q psy5063 587 GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKT 666 (681)
Q Consensus 587 GsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~~DFGLa~~~~~~~~~~~~~~~~gt 666 (681)
|+|.+++...+.++++.++..++.|++.||.|||+++ ||+|||++.++.+..||+++...... ..||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~fG~~~~~~~~~-------~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKLDGSVAFKTPEQ-------SRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceeeccceEeecccc-------CCCc
Confidence 7899999876667999999999999999999999998 99999999999884499998765322 2589
Q ss_pred ccccchhhccCCCC
Q psy5063 667 KKTYYPNILKKASF 680 (681)
Q Consensus 667 ~~Y~APEvL~~~~Y 680 (681)
+.|||||++.+..|
T Consensus 68 ~~y~aPE~~~~~~~ 81 (176)
T smart00750 68 PYFMAPEVIQGQSY 81 (176)
T ss_pred ccccChHHhcCCCC
Confidence 99999999988766
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.13 E-value=7.1e-12 Score=144.80 Aligned_cols=179 Identities=18% Similarity=0.240 Sum_probs=136.5
Q ss_pred CCCeeecceecccCcEEEEEEEEc-CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHR-ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~-~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
...|...+.||+|+|+.|-..... .....+|.|.+.... ....+... +-.|..+-+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~---------------------i~~e~~~~~ 75 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEH---------------------IDTETDIQK 75 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--Cccchhhh---------------------cCccccccc
Confidence 345666677999999999887764 334566666664433 00111111 112244445
Q ss_pred hCC-CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHH-hCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcE
Q psy5063 558 SLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL-QDPGQPLPWGQRVNFARDIAAGMTYLH-SMNLIHRDLNSQNC 634 (681)
Q Consensus 558 ~L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L-~~~~~~l~~~~~~~i~~QIa~gL~yLH-s~~IIHRDLKp~NI 634 (681)
.+. |+|++++++...+.+..++++||..||++.+.+ .......+...+..++.|+..|+.|+| ..++.|||+||+|.
T Consensus 76 ~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~ 155 (601)
T KOG0590|consen 76 KLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNS 155 (601)
T ss_pred cccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccc
Confidence 554 999999999999999999999999999999988 443325777788899999999999999 99999999999999
Q ss_pred EEecCC-Ce--EEeeeeeEeee-cccceeeeecCC-CccccchhhccCCCC
Q psy5063 635 LVREVG-SG--FDFHLGQIYLI-YVPYTLFILSAK-TKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g-~~--~DFGLa~~~~~-~~~~~~~~~~~g-t~~Y~APEvL~~~~Y 680 (681)
+++..+ .. +|||+|..+.. ...........| ++.|+|||.+.+..|
T Consensus 156 ~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~ 206 (601)
T KOG0590|consen 156 LLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAY 206 (601)
T ss_pred hhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhh
Confidence 999999 55 99999999887 554555566778 999999999987543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.6e-10 Score=108.05 Aligned_cols=127 Identities=22% Similarity=0.176 Sum_probs=89.1
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCce-
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNV- 564 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnI- 564 (681)
+.|+.|.++.||+++.. ++.+++|....... ....+ .+|+.+++.+.+.++
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~-------------------------~~E~~~l~~l~~~~~~ 55 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINR-------------------------ENEAENSKLAAEAGIG 55 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCH-------------------------HHHHHHHHHHHHhCCC
Confidence 56889999999999875 78899997643221 01111 235777777754443
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCcEEEecC
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL-----IHRDLNSQNCLVREV 639 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~I-----IHRDLKp~NILl~~~ 639 (681)
.+++... ...-++||||++|.++.+. . . ....++.+++.+|..||+.++ +|+|++|.||+++ +
T Consensus 56 P~~~~~~--~~~~~lv~e~i~G~~l~~~--~----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~ 123 (170)
T cd05151 56 PKLYYFD--PETGVLITEFIEGSELLTE--D----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D 123 (170)
T ss_pred CceEEEe--CCCCeEEEEecCCCccccc--c----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C
Confidence 4455443 2345899999999887643 0 1 113456799999999999985 9999999999999 4
Q ss_pred CCe--EEeeeeeEee
Q psy5063 640 GSG--FDFHLGQIYL 652 (681)
Q Consensus 640 g~~--~DFGLa~~~~ 652 (681)
+.+ +|||.+....
T Consensus 124 ~~~~liDf~~a~~~~ 138 (170)
T cd05151 124 GRLWLIDWEYAGMND 138 (170)
T ss_pred CeEEEEecccccCCC
Confidence 455 9999987543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-10 Score=135.64 Aligned_cols=140 Identities=28% Similarity=0.438 Sum_probs=102.0
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|..+++|..|+||.||.++|+.+.+.+|+|+- +... .++ .++.
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~l-----ilR---------------------------nilt 127 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL-----ILR---------------------------NILT 127 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccc-ccch-----hhh---------------------------cccc
Confidence 357899999999999999999999999999999532 2110 000 0233
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
...+|.+| ||-..+++..+ +++... +.+++|||+.+|+|||+||+|.||+
T Consensus 128 ~a~npfvv---------------------gDc~tllk~~g-~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT 177 (1205)
T KOG0606|consen 128 FAGNPFVV---------------------GDCATLLKNIG-PLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLIT 177 (1205)
T ss_pred ccCCccee---------------------chhhhhcccCC-CCcchh--------hHHhHhhccCCeecCCCCCCcceee
Confidence 33445444 67777777654 344332 7789999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccce-------------eeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYT-------------LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~-------------~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.-|.+ .||||++......... .....+||+.|.||||+..+.|
T Consensus 178 ~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy 235 (1205)
T KOG0606|consen 178 SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY 235 (1205)
T ss_pred ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc
Confidence 99988 9999998765421111 1112369999999999988766
|
|
| >PF00412 LIM: LIM domain; InterPro: IPR001781 Zinc finger (Znf) domains are relatively small protein motifs which contain multiple finger-like protrusions that make tandem contacts with their target molecule | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.3e-10 Score=91.39 Aligned_cols=56 Identities=32% Similarity=0.849 Sum_probs=47.1
Q ss_pred ccccCCccccCeE--EecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhc
Q psy5063 71 CQNCGQMMSGPVM--VVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQM 128 (681)
Q Consensus 71 C~~C~~~I~g~~~--~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~ 128 (681)
|++|+++|.+..+ .+.|+.||++||+|..|++.|.++. |+.. ++++||..||.++|
T Consensus 1 C~~C~~~I~~~~~~~~~~~~~~H~~Cf~C~~C~~~l~~~~-~~~~-~~~~~C~~c~~~~f 58 (58)
T PF00412_consen 1 CARCGKPIYGTEIVIKAMGKFWHPECFKCSKCGKPLNDGD-FYEK-DGKPYCKDCYQKRF 58 (58)
T ss_dssp BTTTSSBESSSSEEEEETTEEEETTTSBETTTTCBTTTSS-EEEE-TTEEEEHHHHHHHT
T ss_pred CCCCCCCccCcEEEEEeCCcEEEccccccCCCCCccCCCe-eEeE-CCEEECHHHHhhhC
Confidence 8899999976543 5999999999999999999997766 5444 56899999998865
|
Some of these domains bind zinc, but many do not; instead binding other metals such as iron, or no metal at all. For example, some family members form salt bridges to stabilise the finger-like folds. They were first identified as a DNA-binding motif in transcription factor TFIIIA from Xenopus laevis (African clawed frog), however they are now recognised to bind DNA, RNA, protein and/or lipid substrates [, , , , ]. Their binding properties depend on the amino acid sequence of the finger domains and of the linker between fingers, as well as on the higher-order structures and the number of fingers. Znf domains are often found in clusters, where fingers can have different binding specificities. There are many superfamilies of Znf motifs, varying in both sequence and structure. They display considerable versatility in binding modes, even between members of the same class (e.g. some bind DNA, others protein), suggesting that Znf motifs are stable scaffolds that have evolved specialised functions. For example, Znf-containing proteins function in gene transcription, translation, mRNA trafficking, cytoskeleton organisation, epithelial development, cell adhesion, protein folding, chromatin remodelling and zinc sensing, to name but a few []. Zinc-binding motifs are stable structures, and they rarely undergo conformational changes upon binding their target. This entry represents LIM-type zinc finger (Znf) domains. LIM domains coordinate one or more zinc atoms, and are named after the three proteins (LIN-11, Isl1 and MEC-3) in which they were first found. They consist of two zinc-binding motifs that resemble GATA-like Znf's, however the residues holding the zinc atom(s) are variable, involving Cys, His, Asp or Glu residues. LIM domains are involved in proteins with differing functions, including gene expression, and cytoskeleton organisation and development [, ]. Protein containing LIM Znf domains include: Caenorhabditis elegans mec-3; a protein required for the differentiation of the set of six touch receptor neurons in this nematode. C. elegans. lin-11; a protein required for the asymmetric division of vulval blast cells. Vertebrate insulin gene enhancer binding protein isl-1. Isl-1 binds to one of the two cis-acting protein-binding domains of the insulin gene. Vertebrate homeobox proteins lim-1, lim-2 (lim-5) and lim3. Vertebrate lmx-1, which acts as a transcriptional activator by binding to the FLAT element; a beta-cell-specific transcriptional enhancer found in the insulin gene. Mammalian LH-2, a transcriptional regulatory protein involved in the control of cell differentiation in developing lymphoid and neural cell types. Drosophila melanogaster (Fruit fly) protein apterous, required for the normal development of the wing and halter imaginal discs. Vertebrate protein kinases LIMK-1 and LIMK-2. Mammalian rhombotins. Rhombotin 1 (RBTN1 or TTG-1) and rhombotin-2 (RBTN2 or TTG-2) are proteins of about 160 amino acids whose genes are disrupted by chromosomal translocations in T-cell leukemia. Mammalian and avian cysteine-rich protein (CRP), a 192 amino-acid protein of unknown function. Seems to interact with zyxin. Mammalian cysteine-rich intestinal protein (CRIP), a small protein which seems to have a role in zinc absorption and may function as an intracellular zinc transport protein. Vertebrate paxillin, a cytoskeletal focal adhesion protein. Mus musculus (Mouse) testin which should not be confused with rat testin which is a thiol protease homologue (see IPR000169 from INTERPRO). Helianthus annuus (Common sunflower) pollen specific protein SF3. Chicken zyxin. Zyxin is a low-abundance adhesion plaque protein which has been shown to interact with CRP. Yeast protein LRG1 which is involved in sporulation []. Saccharomyces cerevisiae (Baker's yeast) rho-type GTPase activating protein RGA1/DBM1. C. elegans homeobox protein ceh-14. C. elegans homeobox protein unc-97. S. cerevisiae hypothetical protein YKR090w. C. elegans hypothetical proteins C28H8.6. These proteins generally contain two tandem copies of the LIM domain in their N-terminal section. Zyxin and paxillin are exceptions in that they contain respectively three and four LIM domains at their C-terminal extremity. In apterous, isl-1, LH-2, lin-11, lim-1 to lim-3, lmx-1 and ceh-14 and mec-3 there is a homeobox domain some 50 to 95 amino acids after the LIM domains. LIM domains contain seven conserved cysteine residues and a histidine. The arrangement followed by these conserved residues is: C-x(2)-C-x(16,23)-H-x(2)-[CH]-x(2)-C-x(2)-C-x(16,21)-C-x(2,3)-[CHD] LIM domains bind two zinc ions []. LIM does not bind DNA, rather it seems to act as an interface for protein-protein interaction. More information about these proteins can be found at Protein of the Month: Zinc Fingers [].; GO: 0008270 zinc ion binding; PDB: 2CO8_A 2EGQ_A 2CUR_A 3IXE_B 1CTL_A 1B8T_A 1X62_A 2DFY_C 1IML_A 2CUQ_A .... |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=98.98 E-value=1e-10 Score=136.79 Aligned_cols=170 Identities=21% Similarity=0.242 Sum_probs=126.2
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++...+.||++.|=+|.++++.+ |. +++|++.+.+ ......+.++ +.|+. ...+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qr----------------------L~~ik-~~l~ 78 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQR----------------------LEEIK-FALM 78 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHH----------------------HHHHH-HHhh
Confidence 57778899999999999999874 55 8889987655 3334444443 23355 6667
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|||++.+.-+...+...|||-+|.. .+|+|.|.-+. .+...+.+-|+.|++.||.-+|+.||.|+|||.+||||+.=
T Consensus 79 ~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW 156 (1431)
T KOG1240|consen 79 KAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW 156 (1431)
T ss_pred cCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee
Confidence 99999999888888888999999994 59999997654 36677777899999999999999999999999999999986
Q ss_pred CCe--EEeeeeeEeee--cc--cce-eeeecCCCccccchhhccC
Q psy5063 640 GSG--FDFHLGQIYLI--YV--PYT-LFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 640 g~~--~DFGLa~~~~~--~~--~~~-~~~~~~gt~~Y~APEvL~~ 677 (681)
+-+ +||.--+.--. +. .++ .+.+...-.-|.|||-|-.
T Consensus 157 NW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 157 NWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred chhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhc
Confidence 665 77764443221 11 111 1233344556999998754
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.2e-09 Score=102.90 Aligned_cols=138 Identities=24% Similarity=0.293 Sum_probs=99.9
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEee-c--cCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELY-R--VDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~-~--~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
..+++|+=+.+|.+.+. |..+++|.-. + ..++-.....++ ...+|..++..++--
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~--------------------Rt~~Earil~~a~~~ 59 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRE--------------------RTRREARILAKAREA 59 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHH--------------------HHHHHHHHHHHHHHc
Confidence 35789999999998775 5456666532 2 123333333333 235788888887544
Q ss_pred ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe
Q psy5063 563 NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642 (681)
Q Consensus 563 nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~ 642 (681)
.|.--+=+..+.+...|+|||++|-.|.+++... ...+++.+-.-+.-||..||+|+||.++||++...+..
T Consensus 60 GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~i~ 131 (204)
T COG3642 60 GVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGRIY 131 (204)
T ss_pred CCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCcEE
Confidence 4444444455677889999999999999998764 13466667777888999999999999999999987766
Q ss_pred -EEeeeeeEeee
Q psy5063 643 -FDFHLGQIYLI 653 (681)
Q Consensus 643 -~DFGLa~~~~~ 653 (681)
+||||+.....
T Consensus 132 ~IDfGLg~~s~~ 143 (204)
T COG3642 132 FIDFGLGEFSDE 143 (204)
T ss_pred EEECCccccccc
Confidence 99999986543
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.5e-10 Score=125.28 Aligned_cols=124 Identities=29% Similarity=0.401 Sum_probs=103.9
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCcE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL-IHRDLNSQNC 634 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~I-IHRDLKp~NI 634 (681)
|+.+.|.|+.+|+|.+.++...++|.+|++.|+|.|.+......+++.....++++|+.||.|||+..| .|+.|++.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 356889999999999999999999999999999999999877779999999999999999999999877 9999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++|..-.+ +|||+.........+..........-|.|||++++..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~ 127 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGAL 127 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccc
Confidence 99998877 9999988774311111111222455688999998753
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.4e-09 Score=107.02 Aligned_cols=155 Identities=18% Similarity=0.168 Sum_probs=99.8
Q ss_pred ceecccCcEEEEEEEEcC------CCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCC---CccccccchHHHH
Q psy5063 486 PLLGQGFFGQVYRVTHRE------TGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSH---GLINNLHCFSQVA 554 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~------tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~---~~~~~~~~~~Ei~ 554 (681)
..||.|.=+.||.|...+ .+..+|+|..+..... .....++. . ......... -....+.+.+|..
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~---~-~rf~~~~~k~~~~~~~~~wa~kE~r 78 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKD---D-YRFKDRFSKLNPRKIIRMWAEKEMH 78 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccC---C-cccccCcCCCCHHHHHHHHHHHHHH
Confidence 468999999999998653 3578999987542211 11111110 0 000000000 0112233457999
Q ss_pred HHHhCCC--CceeeEEEEEEeCCeEEEEEeccCCCCHHH-HHhCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCC
Q psy5063 555 VLRSLHH--HNVIRFIGVLYKDRKLNLVTEYIAGGTLKE-LLQDPGQPLPWGQRVNFARDIAAGMTYL-HSMNLIHRDLN 630 (681)
Q Consensus 555 iL~~L~H--pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~-~L~~~~~~l~~~~~~~i~~QIa~gL~yL-Hs~~IIHRDLK 630 (681)
.|+.+.. -++...+++ ..-+|||||+.++.+.. .+++ ..++......+..|++.+|..+ |+.||||+||+
T Consensus 79 ~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 79 NLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9998843 466677764 46789999997654422 2332 1355556677889999999998 89999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEe
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIY 651 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~ 651 (681)
+.|||+++ |.+ +|||.+-..
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeC
Confidence 99999985 445 999977543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1700|consensus | Back alignment and domain information |
|---|
Probab=98.87 E-value=3.1e-10 Score=113.60 Aligned_cols=116 Identities=28% Similarity=0.674 Sum_probs=92.3
Q ss_pred ccccccccccccCceEEecCccccccCcccccCcCccC-CceEeeCCeeeeccccccccC--------------------
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD-NWYFEKDGLLFCKEDYNGKYG-------------------- 68 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~-~~~~~~dg~~yC~~cY~~~f~-------------------- 68 (681)
..|..|++.++-.+.++..|..||..||+|..|...|+ +.+..+++.+||+.||...++
T Consensus 8 ~kc~~c~k~vy~~e~~~~~g~~~hk~c~~c~~~~k~l~~~~~~~~e~~~yc~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 87 (200)
T KOG1700|consen 8 DKCNACGKTVYFVEKVQKDGVDFHKECFKCEKCKKTLTLSGYSEHEGVPYCKNCHVAQFGPKGGGFGKGFQKAGGLGKDG 87 (200)
T ss_pred chhhhccCcchHHHHHhccCcchhhhHHhccccccccccccccccccccccccchHhhhCcccccccccccccCCCCccc
Confidence 47999999998777788999999999999999999995 478889999999997654443
Q ss_pred ---------------------CcccccCCcccc-CeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhh
Q psy5063 69 ---------------------EACQNCGQMMSG-PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKR 126 (681)
Q Consensus 69 ---------------------~~C~~C~~~I~g-~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~ 126 (681)
..|..|.+.+.. +.+.+.+..||..||+|+.|+..|..+ .|...+ +.+||...+.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~g~~~~c~~c~k~vy~~Ek~~~~~~~~hk~cfrc~~~~~~ls~~-~~~~~~-g~l~~~~~~~~ 165 (200)
T KOG1700|consen 88 KSLNESKPNQSAKFQVFAGEKEKCARCQKTVYPLEKVTGNGLEFHKSCFRCTHCGKKLSPK-NYAALE-GVLYCKHHFAQ 165 (200)
T ss_pred ccccccccccchhHHhhhccccccccccceeeehHHHhhhhhhhhhhheeecccccccCCc-chhhcC-Cccccchhhhe
Confidence 359999987754 345577889999999999999999654 454444 44666666655
Q ss_pred h
Q psy5063 127 Q 127 (681)
Q Consensus 127 ~ 127 (681)
+
T Consensus 166 ~ 166 (200)
T KOG1700|consen 166 L 166 (200)
T ss_pred e
Confidence 4
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.84 E-value=2.8e-08 Score=96.90 Aligned_cols=147 Identities=21% Similarity=0.287 Sum_probs=101.6
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeecc---CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRV---DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~---~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
..+|-+|+-+.|+++.+. |+.++||.-... .+.-.....+. ....|..+|.++.-
T Consensus 12 l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~--------------------Rt~~Ear~l~k~~~ 69 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRK--------------------RTKQEARLLAKCRA 69 (229)
T ss_pred ceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHH--------------------HHHHHHHHHHHHHH
Confidence 456889999999999886 888888864221 11111111111 23456777777654
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCC-CCHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAG-GTLKELLQDPGQ-PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~g-GsL~~~L~~~~~-~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
-.|.--.=++.+...-.|+|||++| .++.+++..... .........++++|-+.+.-||.++|||+||..+||+|..+
T Consensus 70 ~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~ 149 (229)
T KOG3087|consen 70 LGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSD 149 (229)
T ss_pred hCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecC
Confidence 4444333455566677899999977 477888765322 22233336788999999999999999999999999999988
Q ss_pred CCe-----EEeeeeeEeee
Q psy5063 640 GSG-----FDFHLGQIYLI 653 (681)
Q Consensus 640 g~~-----~DFGLa~~~~~ 653 (681)
|.. +||||+.....
T Consensus 150 ~~~~~~~lIdfgls~~s~~ 168 (229)
T KOG3087|consen 150 GNQITPILIDFGLSSVSRL 168 (229)
T ss_pred CCcCceEEEeecchhcccC
Confidence 764 89999876543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.3e-08 Score=99.98 Aligned_cols=138 Identities=23% Similarity=0.243 Sum_probs=98.6
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC--C
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH--H 562 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--p 562 (681)
+.|+.|.++.||+++..+ |+.+++|........ .... ..+|.++++.+.+ .
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~-------------------------~~~E~~~~~~l~~~~~ 57 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHD-------------------------VAREYRVLRALAGTGV 57 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCccccc-------------------------HHHHHHHHHHhhCCCC
Confidence 468999999999998754 678999976433211 1111 2345888888865 3
Q ss_pred ceeeEEEEEEeC---CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q psy5063 563 NVIRFIGVLYKD---RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS------------------ 621 (681)
Q Consensus 563 nIV~l~g~~~~~---~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs------------------ 621 (681)
++.+++.+.... +..++||||++|.++.+.+.. ..++......++.+++.+|.+||+
T Consensus 58 ~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~ 135 (223)
T cd05154 58 PVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYL 135 (223)
T ss_pred CCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchH
Confidence 456777766543 367899999999988775532 236677777778888888888873
Q ss_pred --------------------------------------CCccccCCCCCcEEEec--CCCe--EEeeeeeEe
Q psy5063 622 --------------------------------------MNLIHRDLNSQNCLVRE--VGSG--FDFHLGQIY 651 (681)
Q Consensus 622 --------------------------------------~~IIHRDLKp~NILl~~--~g~~--~DFGLa~~~ 651 (681)
..++|+|++|.|||++. ++.. +||+.+...
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 136 ERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 13699999999999998 4543 899988654
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.2e-09 Score=116.98 Aligned_cols=103 Identities=19% Similarity=0.195 Sum_probs=87.6
Q ss_pred CeEEEEEeccCCCCHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeE
Q psy5063 575 RKLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQI 650 (681)
Q Consensus 575 ~~l~LV~Ey~~gGsL~~~L~~~--~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~ 650 (681)
.++|+.|+++...+|.++|..+ ....++...+.++.|++.|++| ++.+|||+||.||+...+..+ .||||...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 3589999999999999999643 3457788899999999999999 999999999999999888866 99999887
Q ss_pred eeecc----cceeeeecCCCccccchhhccCCCC
Q psy5063 651 YLIYV----PYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 651 ~~~~~----~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
..... .........||..||+||.|.+..|
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y 439 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY 439 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhh
Confidence 76544 3444556779999999999998877
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.67 E-value=9.9e-09 Score=114.87 Aligned_cols=175 Identities=19% Similarity=0.127 Sum_probs=132.5
Q ss_pred CCeeecceecc--cCcEEEEEEEE--cCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 480 SDLVRGPLLGQ--GFFGQVYRVTH--RETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 480 ~d~~~~~~LG~--G~FG~Vyk~~~--~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
..+...+.+|. |.+|.||.+.. ..++..+|+|.-+..-...... ++-++|...
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~-----------------------~~k~~~~~s 170 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS-----------------------KRKLREFLS 170 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc-----------------------ccccchhhc
Confidence 34455667899 99999999998 8889999998743221111111 111234555
Q ss_pred HHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCC
Q psy5063 556 LRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAA----GMTYLHSMNLIHRDLN 630 (681)
Q Consensus 556 L~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~----gL~yLHs~~IIHRDLK 630 (681)
.+.+ .|+|.++.+..+...+.+|+-+|++ +.+|..+.......++...++....+..+ ||.++|+.+++|-|+|
T Consensus 171 ~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~k 249 (524)
T KOG0601|consen 171 HHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLK 249 (524)
T ss_pred ccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccc
Confidence 5556 5999999999999999999999999 47888888776666888899999999999 9999999999999999
Q ss_pred CCcEEEecC-CCe--EEeeeeeEeeeccc---ceeeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVREV-GSG--FDFHLGQIYLIYVP---YTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~~-g~~--~DFGLa~~~~~~~~---~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|+||++..+ ... .|||+...+....- ........+...|++||++.+.
T Consensus 250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l 303 (524)
T KOG0601|consen 250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL 303 (524)
T ss_pred hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc
Confidence 999999999 444 89999887765321 1111233578889999998653
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.6e-08 Score=110.49 Aligned_cols=152 Identities=20% Similarity=0.209 Sum_probs=117.6
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEc-CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHR-ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
......+|.....||.|.|+.|++...+ .++..|++|.+.+.-...... +..+.|+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-----------------------i~sl~ev 316 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-----------------------IFSLGEV 316 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-----------------------hcchhhh
Confidence 4455678888999999999999998866 678899999875432211111 1113345
Q ss_pred HHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
-+...+ .|.+++.++..|....+.|+-.||++++++...+.- ...+++...+.+..|++.++.++|++.++|+|+||+
T Consensus 317 ~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~ps 395 (524)
T KOG0601|consen 317 ILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPS 395 (524)
T ss_pred hHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhccccccc
Confidence 555555 689999999999888899999999999988766522 234677788899999999999999999999999999
Q ss_pred cEEEecCCCe---EEeeeeeE
Q psy5063 633 NCLVREVGSG---FDFHLGQI 650 (681)
Q Consensus 633 NILl~~~g~~---~DFGLa~~ 650 (681)
||++..+|-. .|||++..
T Consensus 396 ni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 396 NILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred ceeeccchhhhhccccccccc
Confidence 9999997533 89998865
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.4e-06 Score=91.42 Aligned_cols=102 Identities=19% Similarity=0.170 Sum_probs=74.0
Q ss_pred chHHHHHHHhCCCCc--eeeEEEEEEe-----CCeEEEEEeccCCC-CHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHH
Q psy5063 549 CFSQVAVLRSLHHHN--VIRFIGVLYK-----DRKLNLVTEYIAGG-TLKELLQDP-GQPLPWGQRVNFARDIAAGMTYL 619 (681)
Q Consensus 549 ~~~Ei~iL~~L~Hpn--IV~l~g~~~~-----~~~l~LV~Ey~~gG-sL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yL 619 (681)
+.+|...+..+..-+ .+..+++... ...-+||||++++- +|.+++... ..+.+......++.+++..+.-|
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L 154 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM 154 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 456677666663222 2334444432 23578999999886 899998632 23355667778999999999999
Q ss_pred HhCCccccCCCCCcEEEecC-------CCe--EEeeeeeE
Q psy5063 620 HSMNLIHRDLNSQNCLVREV-------GSG--FDFHLGQI 650 (681)
Q Consensus 620 Hs~~IIHRDLKp~NILl~~~-------g~~--~DFGLa~~ 650 (681)
|..||+|+||++.|||++.+ +.+ +||+.++.
T Consensus 155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999999999999999852 333 89998864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=8e-07 Score=88.43 Aligned_cols=148 Identities=20% Similarity=0.137 Sum_probs=82.3
Q ss_pred EEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhc-cc-eeeeccCCCCccccccchHHHHHHHhCCCC--ceeeEEEE
Q psy5063 495 QVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQ-GL-IYLIDLGSHGLINNLHCFSQVAVLRSLHHH--NVIRFIGV 570 (681)
Q Consensus 495 ~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~-~~-~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--nIV~l~g~ 570 (681)
.||.|... .|..+|+|..........+ ..+.... .. .........-........+|.+.|..+..- ++.+.+++
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~-~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~ 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKR-RKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-H-HHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEE-eeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE
Confidence 38888874 4789999977542211111 1111000 00 000000011122234556799999999765 56667655
Q ss_pred EEeCCeEEEEEeccC--CCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCcEEEecCCCe-EEee
Q psy5063 571 LYKDRKLNLVTEYIA--GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTY-LHSMNLIHRDLNSQNCLVREVGSG-FDFH 646 (681)
Q Consensus 571 ~~~~~~l~LV~Ey~~--gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~y-LHs~~IIHRDLKp~NILl~~~g~~-~DFG 646 (681)
. .-.|||||++ |..+..+.... ++......++.+++..+.. +|+.||+|+||.+.|||+++++-. +|||
T Consensus 79 ~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~~~~iIDf~ 151 (188)
T PF01163_consen 79 N----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDGKVYIIDFG 151 (188)
T ss_dssp E----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETTCEEE--GT
T ss_pred e----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecceEEEEecC
Confidence 3 3479999998 65555443321 2234456677888886665 579999999999999999998444 9999
Q ss_pred eeeEe
Q psy5063 647 LGQIY 651 (681)
Q Consensus 647 La~~~ 651 (681)
.+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 87644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=98.32 E-value=3.4e-06 Score=93.36 Aligned_cols=132 Identities=24% Similarity=0.256 Sum_probs=99.4
Q ss_pred CcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeEEEEE
Q psy5063 492 FFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVL 571 (681)
Q Consensus 492 ~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~ 571 (681)
.-...||++...+|..|++|++.-........... =++.++++.|+|||.|.++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~-------------------------lve~wkkl~h~NvV~frevf 342 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTS-------------------------LVEAWKKLCHTNVVPFREVF 342 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchH-------------------------HHHHHHHhccCceeehhhhh
Confidence 34468999999999999999883211110000001 17789999999999999998
Q ss_pred Ee----CCeEEEEEeccCC-CCHHHHHhC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 572 YK----DRKLNLVTEYIAG-GTLKELLQD--------------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 572 ~~----~~~l~LV~Ey~~g-GsL~~~L~~--------------~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.. +..+.+|++|.|+ ++|.++.-. .+...++..++.|+.|+..||.++|+.|+.-+-|.+.
T Consensus 343 ~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~ 422 (655)
T KOG3741|consen 343 LTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLK 422 (655)
T ss_pred hhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHh
Confidence 73 5679999999985 577776421 1224678999999999999999999999999999999
Q ss_pred cEEEecCCCeEEeeee
Q psy5063 633 NCLVREVGSGFDFHLG 648 (681)
Q Consensus 633 NILl~~~g~~~DFGLa 648 (681)
+||++.+..+.-+|++
T Consensus 423 kIlv~G~~RIriS~C~ 438 (655)
T KOG3741|consen 423 KILVTGKMRIRISGCG 438 (655)
T ss_pred HeEeeCcceEEEeccc
Confidence 9999987666444433
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.30 E-value=3.5e-06 Score=84.98 Aligned_cols=102 Identities=25% Similarity=0.242 Sum_probs=76.2
Q ss_pred hHHHHHHHhCCCC--ceeeEEEEEEeC----CeEEEEEeccCCC-CHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy5063 550 FSQVAVLRSLHHH--NVIRFIGVLYKD----RKLNLVTEYIAGG-TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM 622 (681)
Q Consensus 550 ~~Ei~iL~~L~Hp--nIV~l~g~~~~~----~~l~LV~Ey~~gG-sL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~ 622 (681)
.+|...+..+..- ...+.+++.... ..-+||+|++++. +|.+++..... .+......++.+++..+.-||.+
T Consensus 59 ~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~lH~~ 137 (206)
T PF06293_consen 59 KREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKLHDA 137 (206)
T ss_pred HHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHHHHC
Confidence 4455555555322 234455555442 2468999999884 89999886433 66677788999999999999999
Q ss_pred CccccCCCCCcEEEecCC---Ce--EEeeeeeEee
Q psy5063 623 NLIHRDLNSQNCLVREVG---SG--FDFHLGQIYL 652 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~~g---~~--~DFGLa~~~~ 652 (681)
||+|+|+++.|||++.++ .+ +||+-++...
T Consensus 138 gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 138 GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999999999999987 33 8999877654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0490|consensus | Back alignment and domain information |
|---|
Probab=98.28 E-value=8.2e-08 Score=98.14 Aligned_cols=113 Identities=26% Similarity=0.607 Sum_probs=99.2
Q ss_pred ccccccccCceEEecCccccccCcccccCcCccC--CceEeeCCeeeecccccc--ccCCcccccCCcc--ccCeEEecC
Q psy5063 14 GCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD--NWYFEKDGLLFCKEDYNG--KYGEACQNCGQMM--SGPVMVVGD 87 (681)
Q Consensus 14 ~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~--~~~~~~dg~~yC~~cY~~--~f~~~C~~C~~~I--~g~~~~a~~ 87 (681)
+|+..|.+...+.+.+..||..|..|..|...|. ..+|.++|..||..+|.. .+..+|.+|...+ .+.++.+..
T Consensus 1 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~~d~~~~~~~~~rr~rt~~~~~ql~~ler~f~ 80 (235)
T KOG0490|consen 1 GCGRQILDRYLLRVLDRYWHASCLKCAECDNPLGVGDTCFSKDGSIYCKRDYQREFKFSKRCARCKFTISQLDELERAFE 80 (235)
T ss_pred CCCccccchHHhhcccHHHHHHHHhhhhhcchhccCCCcccCCCcccccccchhhhhccccccCCCCCcCHHHHHHHhhc
Confidence 4888888777788889999999999999999997 677777999999999998 8889999999887 456777888
Q ss_pred ccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhh
Q psy5063 88 HKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQ 127 (681)
Q Consensus 88 ~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~ 127 (681)
+. |..||.|..|...+..++++.+..+.+.+|.+.+.+.
T Consensus 81 ~~-h~Pd~~~r~~la~~~~~~e~rVqvwFqnrrak~r~~~ 119 (235)
T KOG0490|consen 81 KV-HLPCFACRECLALLLTGDEFRVQVWFQNRRAKDRKEE 119 (235)
T ss_pred CC-CcCccchHHHHhhcCCCCeeeeehhhhhhcHhhhhhh
Confidence 77 9999999999999889999999988788899888653
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=98.22 E-value=4.1e-07 Score=107.20 Aligned_cols=178 Identities=19% Similarity=0.100 Sum_probs=120.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+++.+.+-+-+|.|+.++.+.-..+|...+.|.....+.-. +...+. ..++-.++-.
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-~~~~~s---------------------~r~~s~~~i~ 860 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-TNDYES---------------------IRSKSNILIT 860 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhc-cccccc---------------------cCCccCcccc
Confidence 456777778889999999998888888666666443222110 000000 0111112222
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
-+||.++...-.+......+|+++|+.+++|...|++.+ ..+..-+..+...+..+++|||+..++|||++|.|.|...
T Consensus 861 p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~ 939 (1205)
T KOG0606|consen 861 PRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAY 939 (1205)
T ss_pred CCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcc
Confidence 356777766555556788999999999999999998765 3566666777888999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeec-----------------------------ccceeeeecCCCccccchhhccCCC
Q psy5063 639 VGSG--FDFHLGQIYLIY-----------------------------VPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~-----------------------------~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|.. +|||+......- ..........+|+.|.|||.+.+..
T Consensus 940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~ 1011 (1205)
T KOG0606|consen 940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR 1011 (1205)
T ss_pred cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc
Confidence 9877 888732221110 0001122345899999999987753
|
|
| >smart00132 LIM Zinc-binding domain present in Lin-11, Isl-1, Mec-3 | Back alignment and domain information |
|---|
Probab=98.21 E-value=8.8e-07 Score=64.28 Aligned_cols=37 Identities=41% Similarity=0.934 Sum_probs=33.6
Q ss_pred cccccccccccC-ceEEecCccccccCcccccCcCccC
Q psy5063 11 TCAGCLNNIVED-EYVQALSQEWHTDCFRCSACDVMLD 47 (681)
Q Consensus 11 ~C~~C~~~I~~~-~~v~a~~~~wH~~CF~C~~C~~~L~ 47 (681)
.|.+|+++|.++ ..+.++++.||++||+|..|+.+|.
T Consensus 1 ~C~~C~~~i~~~~~~~~~~~~~~H~~Cf~C~~C~~~L~ 38 (39)
T smart00132 1 KCAGCGKPIRGGELVLRALGKVWHPECFKCSKCGKPLG 38 (39)
T ss_pred CccccCCcccCCcEEEEeCCccccccCCCCcccCCcCc
Confidence 489999999876 7788999999999999999999885
|
Zinc-binding domain family. Some LIM domains bind protein partners via tyrosine-containing motifs. LIM domains are found in many key regulators of developmental pathways. |
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.9e-06 Score=93.00 Aligned_cols=120 Identities=23% Similarity=0.308 Sum_probs=93.0
Q ss_pred EEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCceeeEEEEEEeCCeE
Q psy5063 498 RVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKL 577 (681)
Q Consensus 498 k~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l 577 (681)
.|..+.++.++.+........+......+. ++-|+.++||||+++++.+..++.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A-------------------------~k~lKtlRHP~Il~yL~t~e~~~~~ 84 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRA-------------------------VKRLKTLRHPNILSYLDTTEEEGTL 84 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHH-------------------------HHHhhhccCchhhhhhhhhcccCce
Confidence 466777888888888776555222222222 6779999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEecCCCe--EEeeee
Q psy5063 578 NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH-SMNLIHRDLNSQNCLVREVGSG--FDFHLG 648 (681)
Q Consensus 578 ~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLH-s~~IIHRDLKp~NILl~~~g~~--~DFGLa 648 (681)
|||+|-+ -.|..+++..+ .....--+.||+.||.||| +.+++|.+|.-+.|+|++.|.- .+|-+.
T Consensus 85 ylvTErV--~Pl~~~lk~l~----~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v 152 (690)
T KOG1243|consen 85 YLVTERV--RPLETVLKELG----KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV 152 (690)
T ss_pred EEEeecc--ccHHHHHHHhH----HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence 9999988 46777777633 4455556789999999998 5689999999999999999987 444444
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=6.2e-06 Score=85.38 Aligned_cols=150 Identities=24% Similarity=0.276 Sum_probs=97.2
Q ss_pred eecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCC--ccccccchHHHHHHHhCC
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG--LINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~--~~~~~~~~~Ei~iL~~L~ 560 (681)
.++..||-|.=+.||.|... .|..+|+|. .+.... .|.+.... ...+.+-.-.+ ....+.+.+|.++|..|.
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKf-HR~Grt---sFrkvk~~-R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~ 167 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKF-HRLGRT---SFRKVKRN-RDYLADKEHGSWLYVSRLAAEREFEALQRLY 167 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEE-eecCch---hhhhhcch-hhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence 35678999999999999986 588899994 332211 11111100 00000111111 234556678999999996
Q ss_pred CC--ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 561 HH--NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 561 Hp--nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
.. .|.+-+++ ++-.+||||++|-.|...- ++......++..|+.-+.-+-..||||+|+.+=|||+++
T Consensus 168 ~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~ 237 (304)
T COG0478 168 PEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237 (304)
T ss_pred hcCCCCCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence 55 56655543 5678999999997665432 123334445556666666566899999999999999999
Q ss_pred CCCe--EEeeee
Q psy5063 639 VGSG--FDFHLG 648 (681)
Q Consensus 639 ~g~~--~DFGLa 648 (681)
+|.+ +||--+
T Consensus 238 dg~~~vIDwPQ~ 249 (304)
T COG0478 238 DGDIVVIDWPQA 249 (304)
T ss_pred CCCEEEEeCccc
Confidence 9877 777543
|
|
| >smart00132 LIM Zinc-binding domain present in Lin-11, Isl-1, Mec-3 | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.5e-06 Score=63.07 Aligned_cols=36 Identities=39% Similarity=0.971 Sum_probs=32.3
Q ss_pred cccccCCcccc--CeEEecCccCCCCceecCCCCcccC
Q psy5063 70 ACQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIG 105 (681)
Q Consensus 70 ~C~~C~~~I~g--~~~~a~~~~yH~~CF~C~~C~~~l~ 105 (681)
+|..|+++|.+ ..+.+.++.||++||+|..|+++|.
T Consensus 1 ~C~~C~~~i~~~~~~~~~~~~~~H~~Cf~C~~C~~~L~ 38 (39)
T smart00132 1 KCAGCGKPIRGGELVLRALGKVWHPECFKCSKCGKPLG 38 (39)
T ss_pred CccccCCcccCCcEEEEeCCccccccCCCCcccCCcCc
Confidence 58999999977 5778899999999999999999883
|
Zinc-binding domain family. Some LIM domains bind protein partners via tyrosine-containing motifs. LIM domains are found in many key regulators of developmental pathways. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=2.8e-05 Score=88.49 Aligned_cols=164 Identities=17% Similarity=0.121 Sum_probs=96.2
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHH-------HHHHhhccceee-eccC--------CCCccccccc
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKN-------FLKESKQGLIYL-IDLG--------SHGLINNLHC 549 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~-------~~~E~k~~~~~~-~~~~--------~~~~~~~~~~ 549 (681)
+.|+.++-|+||+|+.++ |+.||||+....-.+.... +.+-.+. .... ..+. .......+..
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~-~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKR-LPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHH-cCCccccCChHHHHHHHHHHHHHHhCH
Confidence 578999999999999975 9999999876532221111 1110000 0000 0000 0011122344
Q ss_pred hHHHHHHHhC----CCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy5063 550 FSQVAVLRSL----HHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 624 (681)
Q Consensus 550 ~~Ei~iL~~L----~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~I 624 (681)
.+|...+..+ +...=+.+-.++.+ ...-.|+|||++|-.+.++.......++...+.....++ -+.-+=..|+
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgf 286 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCc
Confidence 5566666554 23333444444433 467789999999999888743222335533332222111 1223334899
Q ss_pred cccCCCCCcEEEecCCCe--EEeeeeeEeee
Q psy5063 625 IHRDLNSQNCLVREVGSG--FDFHLGQIYLI 653 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~~--~DFGLa~~~~~ 653 (681)
+|.|..|.||+++.+|.. .|||+...+..
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999998 99999877653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00018 Score=73.08 Aligned_cols=146 Identities=18% Similarity=0.169 Sum_probs=89.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
..+|...+++-......|.+... .|+.+++|.........++.|..-.+.. ...+++..+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~----------------~~~~l~~~~~~ 91 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGS----------------EYSRLINNTDK 91 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccH----------------HHHHHHHHHHH
Confidence 45666666666666666666554 3788888876554444444433221111 11223333333
Q ss_pred CCC---CceeeEEEEEEe-----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 559 LHH---HNVIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 559 L~H---pnIV~l~g~~~~-----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.. .....++-+... ....+|+|||++|..|.++.. +++ .+...+..+|.-||+.|+.|+|..
T Consensus 92 i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~h 162 (229)
T PF06176_consen 92 IRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPH 162 (229)
T ss_pred HHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCC
Confidence 322 222232222221 234668999999988876542 332 244567778999999999999999
Q ss_pred CCcEEEecCCCe-EEeeeeeEe
Q psy5063 631 SQNCLVREVGSG-FDFHLGQIY 651 (681)
Q Consensus 631 p~NILl~~~g~~-~DFGLa~~~ 651 (681)
|.|++++.++.. .||+..+..
T Consensus 163 pgNFlv~~~~i~iID~~~k~~~ 184 (229)
T PF06176_consen 163 PGNFLVSNNGIRIIDTQGKRMS 184 (229)
T ss_pred cCcEEEECCcEEEEECcccccc
Confidence 999999987765 999877653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00019 Score=72.59 Aligned_cols=141 Identities=18% Similarity=0.194 Sum_probs=90.5
Q ss_pred cccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc--eee
Q psy5063 489 GQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN--VIR 566 (681)
Q Consensus 489 G~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn--IV~ 566 (681)
|+||-+-|+..... |+.+-+|.-...-.... .+++ ...++.+|...+..+..-+ +.+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~------------------r~P~-g~ptf~rE~~~L~~L~~~GvPVP~ 85 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSV------------------RYPF-GRPTIVREVAVIKELERAGVIVPK 85 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccc------------------cCCC-CchHHHHHHHHHHHHHHcCCCCCc
Confidence 56777788887765 44677776431100000 0011 1223445566666663222 444
Q ss_pred EEEEEE---e--CCeEEEEEeccCC-CCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 567 FIGVLY---K--DRKLNLVTEYIAG-GTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 567 l~g~~~---~--~~~l~LV~Ey~~g-GsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
.. ++. . .-+-+||+|-+++ -+|.+++.+.. .+.+......++.+++..+.-||+.|+.|+|+.+.|||++.+
T Consensus 86 pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~ 164 (216)
T PRK09902 86 IV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE 164 (216)
T ss_pred cc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC
Confidence 43 222 1 1247899997753 58988886532 245677778899999999999999999999999999999977
Q ss_pred CC--e--EEeeeeeEe
Q psy5063 640 GS--G--FDFHLGQIY 651 (681)
Q Consensus 640 g~--~--~DFGLa~~~ 651 (681)
|. + +||--++..
T Consensus 165 g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 165 GKAEAGFLDLEKSRRR 180 (216)
T ss_pred CCeeEEEEEhhccchh
Confidence 76 3 677655543
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=97.74 E-value=7.8e-06 Score=85.99 Aligned_cols=87 Identities=25% Similarity=0.473 Sum_probs=74.1
Q ss_pred HHhCCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cc
Q psy5063 556 LRSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMN--LI 625 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~--II 625 (681)
|-.+.|.|||+++.||.+. .+..+++|||+.|+|.++|++. ...+......+|..||++||.|||+.. |+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4456799999999998654 4578999999999999999752 345777788899999999999999974 99
Q ss_pred ccCCCCCcEEEecCCCe
Q psy5063 626 HRDLNSQNCLVREVGSG 642 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~ 642 (681)
|+++.-+-|++..+|-+
T Consensus 201 hgnlTc~tifiq~ngLI 217 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLI 217 (458)
T ss_pred cCCcchhheeecCCceE
Confidence 99999999999988766
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00082 Score=67.52 Aligned_cols=142 Identities=20% Similarity=0.292 Sum_probs=91.6
Q ss_pred CCeeecceecccCc-EEEEEEEEcCCCeEEEEEEeeccC---H-HHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 480 SDLVRGPLLGQGFF-GQVYRVTHRETGEVMVLKELYRVD---E-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 480 ~d~~~~~~LG~G~F-G~Vyk~~~~~tg~~vAiK~l~~~~---~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.+++..+.||.|.- |.||+++.. |+.||+|...... . .....+.+... .+ .........+..|.+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~----~~----~~~~~y~~PF~~ECR 106 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHET----SL----STPAHYADPFNCECR 106 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCcccccccccccc----cc----chhhhhcChHHHHHH
Confidence 78999999999999 999999986 8899999843211 1 11111111100 00 000111224556666
Q ss_pred HHHhC---CCCce--eeEEEEEEeC------------------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHH
Q psy5063 555 VLRSL---HHHNV--IRFIGVLYKD------------------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 611 (681)
Q Consensus 555 iL~~L---~HpnI--V~l~g~~~~~------------------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~Q 611 (681)
...+| .+.++ |+.+||+.-. ...-||.||++... .+. ..-+.+
T Consensus 107 AfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~----~~~~~~ 172 (207)
T PF13095_consen 107 AFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ----IRDIPQ 172 (207)
T ss_pred hhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----hhHHHH
Confidence 65555 45566 8889997422 12357778776533 122 234567
Q ss_pred HHHHHHHHHhCCccccCCCCCcEEEecCCCeEEeeee
Q psy5063 612 IAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLG 648 (681)
Q Consensus 612 Ia~gL~yLHs~~IIHRDLKp~NILl~~~g~~~DFGLa 648 (681)
|.+-|..+|..||+=+|+|+.|.. +|..+|||.+
T Consensus 173 ~~~dl~~~~k~gI~~~Dv~~~ny~---~G~lvDfs~~ 206 (207)
T PF13095_consen 173 MLRDLKILHKLGIVPRDVKPRNYR---GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHCCeeeccCcccccc---CCEEEecccC
Confidence 788899999999999999999986 6777999853
|
|
| >KOG4577|consensus | Back alignment and domain information |
|---|
Probab=97.60 E-value=5.1e-06 Score=84.57 Aligned_cols=71 Identities=21% Similarity=0.456 Sum_probs=57.2
Q ss_pred cCCcccccCCccccC-eEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCCCcCCCCC
Q psy5063 67 YGEACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGRAKDAAFP 140 (681)
Q Consensus 67 f~~~C~~C~~~I~g~-~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~~~~~~~p 140 (681)
--++|++|.+.|.++ ++.+.+++||..|.+|+.|+.+|.+ ..+.. .+.+||+.+|-+.|..+|..|.-..|
T Consensus 32 eip~CagC~q~IlDrFilKvl~R~wHs~CLkCs~C~~qL~d--rCFsR-~~s~yCkedFfKrfGTKCsaC~~GIp 103 (383)
T KOG4577|consen 32 EIPICAGCDQHILDRFILKVLDRHWHSSCLKCSDCHDQLAD--RCFSR-EGSVYCKEDFFKRFGTKCSACQEGIP 103 (383)
T ss_pred ccccccchHHHHHHHHHHHHHhhhhhhhhcchhhhhhHHHH--HHhhc-CCceeehHHHHHHhCCcchhhcCCCC
Confidence 348999999999887 4569999999999999999999954 33344 45589999999999999876554333
|
|
| >PF00595 PDZ: PDZ domain (Also known as DHR or GLGF) Coordinates are not yet available; InterPro: IPR001478 PDZ domains are found in diverse signalling proteins in bacteria, yeasts, plants, insects and vertebrates [, ] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00011 Score=62.46 Aligned_cols=40 Identities=35% Similarity=0.576 Sum_probs=36.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (681)
.|++||+|++|||.++++++.+++..+++ .....++|+|+
T Consensus 42 gl~~GD~Il~INg~~v~~~~~~~~~~~l~-~~~~~v~L~V~ 81 (81)
T PF00595_consen 42 GLKVGDRILEINGQSVRGMSHDEVVQLLK-SASNPVTLTVQ 81 (81)
T ss_dssp TSSTTEEEEEETTEESTTSBHHHHHHHHH-HSTSEEEEEEE
T ss_pred ccchhhhhheeCCEeCCCCCHHHHHHHHH-CCCCcEEEEEC
Confidence 49999999999999999999999999999 56668988875
|
PDZ domains can occur in one or multiple copies and are nearly always found in cytoplasmic proteins. They bind either the carboxyl-terminal sequences of proteins or internal peptide sequences []. In most cases, interaction between a PDZ domain and its target is constitutive, with a binding affinity of 1 to 10 microns. However, agonist-dependent activation of cell surface receptors is sometimes required to promote interaction with a PDZ protein. PDZ domain proteins are frequently associated with the plasma membrane, a compartment where high concentrations of phosphatidylinositol 4,5-bisphosphate (PIP2) are found. Direct interaction between PIP2 and a subset of class II PDZ domains (syntenin, CASK, Tiam-1) has been demonstrated. PDZ domains consist of 80 to 90 amino acids comprising six beta-strands (beta-A to beta-F) and two alpha-helices, A and B, compactly arranged in a globular structure. Peptide binding of the ligand takes place in an elongated surface groove as an anti-parallel beta-strand interacts with the beta-B strand and the B helix. The structure of PDZ domains allows binding to a free carboxylate group at the end of a peptide through a carboxylate-binding loop between the beta-A and beta-B strands.; GO: 0005515 protein binding; PDB: 3AXA_A 1WF8_A 1QAV_B 1QAU_A 1B8Q_A 1MC7_A 2KAW_A 1I16_A 1VB7_A 1WI4_A .... |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.002 Score=64.44 Aligned_cols=78 Identities=33% Similarity=0.401 Sum_probs=50.6
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC--
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-- 562 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-- 562 (681)
.+.|+.|..+.||++.... ..+++|..... ........ |.++++.+...
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~-------------------------e~~~~~~l~~~~~ 52 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRR-------------------------EAAVLRQLAEHGI 52 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHH-------------------------HHHHHHHHHHTTS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHH-------------------------HHHHHHHHHhcCC
Confidence 3568999999999999875 47888876433 22233333 36666666322
Q ss_pred ceeeEEEEEE---eCCeEEEEEeccCCCCHHH
Q psy5063 563 NVIRFIGVLY---KDRKLNLVTEYIAGGTLKE 591 (681)
Q Consensus 563 nIV~l~g~~~---~~~~l~LV~Ey~~gGsL~~ 591 (681)
.+.+++.... .....+++|++++|..+..
T Consensus 53 pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 53 PVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp BS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred CCceEEeecccccccccceEEEEEeccccccc
Confidence 3556665443 2346799999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0014 Score=67.10 Aligned_cols=136 Identities=13% Similarity=0.147 Sum_probs=77.1
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc--
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN-- 563 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-- 563 (681)
..||+|..+.||+. .+..+++|........ ... .+|.++|+.+..-.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~--~~i-------------------------~~E~~~l~~l~~~glp 55 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDK--ETI-------------------------KREFDASRKVFSLGIP 55 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCH--HHH-------------------------HHHHHHHHHHHHcCCC
Confidence 56899999999983 2445777866432211 111 23477777764332
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCC-HHHHH---------------------hCCC-CCCCHHH-HHHHHHH--------
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGT-LKELL---------------------QDPG-QPLPWGQ-RVNFARD-------- 611 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGs-L~~~L---------------------~~~~-~~l~~~~-~~~i~~Q-------- 611 (681)
+.+.+++....+...+|||+++|.+ +...+ +... ...+... ...+..+
T Consensus 56 vP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~ 135 (226)
T TIGR02172 56 TPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVP 135 (226)
T ss_pred CCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCC
Confidence 3566777777778899999999863 21111 1100 0011111 0011111
Q ss_pred --HHH-HHHHHHh----CCccccCCCCCcEEEecCCCe-EEeeeeeEee
Q psy5063 612 --IAA-GMTYLHS----MNLIHRDLNSQNCLVREVGSG-FDFHLGQIYL 652 (681)
Q Consensus 612 --Ia~-gL~yLHs----~~IIHRDLKp~NILl~~~g~~-~DFGLa~~~~ 652 (681)
+.. ...+|.+ ..++|+|+.|.||++++++.. +||+.+....
T Consensus 136 ~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~~~iIDwe~a~~Gd 184 (226)
T TIGR02172 136 KDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKGTYWIDLGDFGYGN 184 (226)
T ss_pred HHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCCcEEEechhcCcCC
Confidence 111 1223322 236899999999999998844 9999876543
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0015 Score=79.20 Aligned_cols=79 Identities=18% Similarity=0.223 Sum_probs=51.7
Q ss_pred cceecccCcEEEEEEEEcCCC--eEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC-
Q psy5063 485 GPLLGQGFFGQVYRVTHRETG--EVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH- 560 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg--~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~- 560 (681)
.+.|+.|.++.+|+......+ ..+++|+...... .....+ .+|.++|+.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~-------------------------~rE~~~l~~L~~ 97 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAV-------------------------EREYQVLRALGE 97 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHH-------------------------HHHHHHHHHHhh
Confidence 356889999999998765432 4677776533211 111122 34588888885
Q ss_pred CCce--eeEEEEEEeC---CeEEEEEeccCCCC
Q psy5063 561 HHNV--IRFIGVLYKD---RKLNLVTEYIAGGT 588 (681)
Q Consensus 561 HpnI--V~l~g~~~~~---~~l~LV~Ey~~gGs 588 (681)
|+++ .+.+.++.+. +..|+||||++|..
T Consensus 98 ~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~ 130 (822)
T PLN02876 98 HTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI 130 (822)
T ss_pred cCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence 6665 7777776654 46889999998864
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0017 Score=66.61 Aligned_cols=75 Identities=21% Similarity=0.161 Sum_probs=48.1
Q ss_pred ecccCc-EEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC-CCcee
Q psy5063 488 LGQGFF-GQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH-HHNVI 565 (681)
Q Consensus 488 LG~G~F-G~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV 565 (681)
|-.|.+ ..||+.... +..+++|...... .... .+|+++++.+. +--+.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~-------------------------~~E~~~l~~l~~~~~vP 55 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYEL-------------------------EREAERLRWLAGKLPVP 55 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccch-------------------------HHHHHHHHHHHhcCCCC
Confidence 444555 679998754 4567778764432 1111 23466666662 34466
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHH
Q psy5063 566 RFIGVLYKDRKLNLVTEYIAGGTLKEL 592 (681)
Q Consensus 566 ~l~g~~~~~~~l~LV~Ey~~gGsL~~~ 592 (681)
+++++...++..++|||+++|.+|...
T Consensus 56 ~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 56 EVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred eEEEEEecCCccEEEEEeeCCccHhHh
Confidence 777777766778999999999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0016 Score=67.17 Aligned_cols=156 Identities=21% Similarity=0.158 Sum_probs=93.0
Q ss_pred eecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCC-CCccccccchHHHHHHHhCC--CCc
Q psy5063 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS-HGLINNLHCFSQVAVLRSLH--HHN 563 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~-~~~~~~~~~~~Ei~iL~~L~--Hpn 563 (681)
.|..|.=+.||+|.. .++..+|+|+.........+. .+-. .+......+.. .-.........|..-|+.+. +-.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~-~~Yi-~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRI-RRYI-QGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhH-HHHH-hcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 677888889999887 358899999886543322210 0000 00000001110 01111223345677777763 444
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCC-HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEEEecCCC
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGT-LKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGs-L~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NILl~~~g~ 641 (681)
+.+-+++. .-.|||||+.... -.-.|++ -++....+..+..++++.|.-|-. .++||.||..=|||+. +|.
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD--v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD--VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc--CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 55555554 3469999995531 1112222 123344677788899999998766 8999999999999999 455
Q ss_pred e--EEeeeeeEee
Q psy5063 642 G--FDFHLGQIYL 652 (681)
Q Consensus 642 ~--~DFGLa~~~~ 652 (681)
+ +|||-|-...
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 4 9998775443
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.27 E-value=6e-05 Score=85.51 Aligned_cols=156 Identities=15% Similarity=0.103 Sum_probs=107.6
Q ss_pred eecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc-ee
Q psy5063 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN-VI 565 (681)
Q Consensus 487 ~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn-IV 565 (681)
-+++|++++++|.+...+.... .+.+... +...-++++|.+.+||| .+
T Consensus 249 ~fvK~altknpKkRptaeklL~-h~fvs~~------------------------------l~~rl~~eLLdK~n~P~~~v 297 (829)
T KOG0576|consen 249 NFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------------------------------LSRRLAIELLDKVNNPNPVV 297 (829)
T ss_pred HHHHHHhcCCCccCCChhhhee-ceeeccc------------------------------hhhHHHHHHHHHccCCCCcc
Confidence 3688999999998876544433 4443221 01122488999999999 77
Q ss_pred eEEEEEEeCCeEEEEEeccCCC-CHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe-E
Q psy5063 566 RFIGVLYKDRKLNLVTEYIAGG-TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG-F 643 (681)
Q Consensus 566 ~l~g~~~~~~~l~LV~Ey~~gG-sL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~-~ 643 (681)
..++-+..+...+++++++.+| +-..........+...+...+.+.-+++++|+|+..=+||| |||..+.... .
T Consensus 298 ~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~~~~~~~ 373 (829)
T KOG0576|consen 298 RYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSEEEVKLL 373 (829)
T ss_pred cccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccccccccc
Confidence 7777777788999999999887 32222221112233444555667778899999998888999 8888875554 8
Q ss_pred EeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 644 DFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 644 DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+....+.... ..++..+++.++|||+.....|
T Consensus 374 ~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~ 407 (829)
T KOG0576|consen 374 DFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTI 407 (829)
T ss_pred cccCCcccCccc---ccccCCCCCCCCCchhhccccc
Confidence 999887665432 2345679999999998776544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0046 Score=62.19 Aligned_cols=136 Identities=23% Similarity=0.289 Sum_probs=84.3
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC--
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-- 559 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-- 559 (681)
...||+|+.-.||.- .. .....||+....... ..+.+.+.... ....-...+|+.....+
T Consensus 6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~------------~~~~~~~~~E~~~y~~l~~ 70 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRP------------KSRYRQNRRELRYYKQLSL 70 (199)
T ss_pred CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcc------------cchhHHHHHHHHHHHHHhh
Confidence 456999999999963 22 344566877554300 01111111000 00011123344443333
Q ss_pred ----CCCceeeEEEEEEeCCeEEEEEeccCC------CCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 560 ----HHHNVIRFIGVLYKDRKLNLVTEYIAG------GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 560 ----~HpnIV~l~g~~~~~~~l~LV~Ey~~g------GsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
.+.+|.+++|+..++-.+.+|+|.+-. -+|.+++.+. .++. .. ...+-.-..||-+.+|+.+||
T Consensus 71 ~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl 144 (199)
T PF10707_consen 71 RRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-EL---RQALDEFKRYLLDHHIVIRDL 144 (199)
T ss_pred ccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HH---HHHHHHHHHHHHHcCCeecCC
Confidence 488999999999999999999998642 3688888653 3554 22 233334456888999999999
Q ss_pred CCCcEEEecCCC
Q psy5063 630 NSQNCLVREVGS 641 (681)
Q Consensus 630 Kp~NILl~~~g~ 641 (681)
+|.||++...+.
T Consensus 145 ~~~NIv~~~~~~ 156 (199)
T PF10707_consen 145 NPHNIVVQRRDS 156 (199)
T ss_pred CcccEEEEecCC
Confidence 999999987654
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0015 Score=74.61 Aligned_cols=163 Identities=17% Similarity=0.145 Sum_probs=90.7
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHH------HHHHHHhhccceeeeccC--------CCCccccccchH
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE------KNFLKESKQGLIYLIDLG--------SHGLINNLHCFS 551 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~------~~~~~E~k~~~~~~~~~~--------~~~~~~~~~~~~ 551 (681)
+.||.-+.|+||+++.+. |+.||||+-+..-.... -.++.+.-.... .+.+ .......+.+..
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~--p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFF--PDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhC--cCCchhhHHHHHHhhhHhhcchHH
Confidence 468999999999999987 99999997654211110 000000000000 0000 001223344555
Q ss_pred HHHHHH----hCCCCc---eeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy5063 552 QVAVLR----SLHHHN---VIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 623 (681)
Q Consensus 552 Ei~iL~----~L~Hpn---IV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~ 623 (681)
|.+-.. .+.|-+ =|..-.++.+ .....|+||||+|..+.|+-.-....++...+..-+.++..- -|=..|
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~--qIf~~G 321 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLE--QIFKTG 321 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHH--HHHhcC
Confidence 555433 334555 1223333322 346789999999987766532222236655544444333222 233467
Q ss_pred ccccCCCCCcEEEecC----CCe--EEeeeeeEeee
Q psy5063 624 LIHRDLNSQNCLVREV----GSG--FDFHLGQIYLI 653 (681)
Q Consensus 624 IIHRDLKp~NILl~~~----g~~--~DFGLa~~~~~ 653 (681)
++|.|-.|.|||++.+ +.. .|||+......
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 9999999999999954 233 89999876653
|
|
| >cd00136 PDZ PDZ domain, also called DHR (Dlg homologous region) or GLGF (after a conserved sequence motif) | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0014 Score=53.74 Aligned_cols=40 Identities=33% Similarity=0.531 Sum_probs=35.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQI 331 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (681)
.|++||+|++|||.++.+++.+++..++++..++.++|++
T Consensus 30 gl~~GD~I~~Ing~~v~~~~~~~~~~~l~~~~g~~v~l~v 69 (70)
T cd00136 30 GLQAGDVILAVNGTDVKNLTLEDVAELLKKEVGEKVTLTV 69 (70)
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHhhCCCCeEEEEE
Confidence 6999999999999999999999999999966667888876
|
Many PDZ domains bind C-terminal polypeptides, though binding to internal (non-C-terminal) polypeptides and even to lipids has been demonstrated. Heterodimerization through PDZ-PDZ domain interactions adds to the domain's versatility, and PDZ domain-mediated interactions may be modulated dynamically through target phosphorylation. Some PDZ domains play a role in scaffolding supramolecular complexes. PDZ domains are found in diverse signaling proteins in bacteria, archebacteria, and eurkayotes. This CD contains two distinct structural subgroups with either a N- or C-terminal beta-strand forming the peptide-binding groove base. The circular permutation placing the strand on the N-terminus appears to be found in Eumetazoa only, while the C-terminal variant is found in all three kingdoms of life, and seems to co-occur with protease domains. PDZ domains have been named after PSD95(pos |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0066 Score=59.66 Aligned_cols=128 Identities=20% Similarity=0.154 Sum_probs=81.4
Q ss_pred eecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 562 (681)
...+.||+|++|.||+|.+. |..+|+|.-... .....+.+| .++|..++-.
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kE-------------------------akiLeil~g~ 75 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKE-------------------------AKILEILAGE 75 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHH-------------------------HHHHHHhhhc
Confidence 34567999999999999987 668888865332 233444454 6777777655
Q ss_pred ceee-EEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCcEEEecCC
Q psy5063 563 NVIR-FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN-SQNCLVREVG 640 (681)
Q Consensus 563 nIV~-l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK-p~NILl~~~g 640 (681)
++-. ++.+- ..++.|||+.|-.|.+.-... +..+. ..++..---|-..||-|..|. |...+|..++
T Consensus 76 ~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~~----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~ 143 (201)
T COG2112 76 GVTPEVYFYG----EDFIRMEYIDGRPLGKLEIGG----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR 143 (201)
T ss_pred CCCceEEEec----hhhhhhhhhcCcchhhhhhcc----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCC
Confidence 5533 33332 344569999998887765421 22222 334444444567899998886 4444444444
Q ss_pred Ce--EEeeeeeEe
Q psy5063 641 SG--FDFHLGQIY 651 (681)
Q Consensus 641 ~~--~DFGLa~~~ 651 (681)
.+ +||.-|+.-
T Consensus 144 ~~~iIDFd~At~k 156 (201)
T COG2112 144 DVYIIDFDSATFK 156 (201)
T ss_pred cEEEEEccchhhc
Confidence 54 999998843
|
|
| >PF14685 Tricorn_PDZ: Tricorn protease PDZ domain; PDB: 1N6F_D 1N6D_C 1N6E_C 1K32_A | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.003 Score=55.04 Aligned_cols=67 Identities=19% Similarity=0.232 Sum_probs=43.4
Q ss_pred eeEEEeEeeecCCCCCCCCCccCCCCCcc---ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 263 SLVQVTYRYCTGMTNNPSVPRLDPRADLM---SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
...+|+ |+..|+.-+|... ||-.. .+++||.|++|||.|+. +-..+..++.|.+++...|++...++
T Consensus 12 ~~y~I~-~I~~gd~~~~~~~----sPL~~pGv~v~~GD~I~aInG~~v~--~~~~~~~lL~~~agk~V~Ltv~~~~~ 81 (88)
T PF14685_consen 12 GGYRIA-RIYPGDPWNPNAR----SPLAQPGVDVREGDYILAINGQPVT--ADANPYRLLEGKAGKQVLLTVNRKPG 81 (88)
T ss_dssp TEEEEE-EE-BS-TTSSS-B-----GGGGGS----TT-EEEEETTEE-B--TTB-HHHHHHTTTTSEEEEEEE-STT
T ss_pred CEEEEE-EEeCCCCCCcccc----CCccCCCCCCCCCCEEEEECCEECC--CCCCHHHHhcccCCCEEEEEEecCCC
Confidence 467777 7888886554443 22222 58999999999999995 44567788999999999999999884
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0043 Score=61.85 Aligned_cols=95 Identities=21% Similarity=0.260 Sum_probs=74.2
Q ss_pred HHHHHHHhCCC-CceeeEEEEEEeCCeEEEEEeccCCCCHHHH---HhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q psy5063 551 SQVAVLRSLHH-HNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL---LQDPGQPLPWGQRVNFARDIAAGMTYLHS---MN 623 (681)
Q Consensus 551 ~Ei~iL~~L~H-pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~---L~~~~~~l~~~~~~~i~~QIa~gL~yLHs---~~ 623 (681)
.|.-+|+.+++ +++.+++|+|- -++|.||.+.+++... +... ...+|..+.+++.+++..+++|+. ..
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 36778888866 69999999993 3678999987766422 1111 136899999999999999999987 34
Q ss_pred ccccCCCCCcEEEecCCCe--EEeeeeeE
Q psy5063 624 LIHRDLNSQNCLVREVGSG--FDFHLGQI 650 (681)
Q Consensus 624 IIHRDLKp~NILl~~~g~~--~DFGLa~~ 650 (681)
+.-.|++++|+-++++|.+ .|.+.+-.
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 7889999999999999888 77765443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1700|consensus | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0004 Score=69.79 Aligned_cols=58 Identities=31% Similarity=0.711 Sum_probs=51.1
Q ss_pred ccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeecccccccc
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKY 67 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f 67 (681)
..|..|++.+++.+-+.+.+..||..||+|+.|+..|+. .|-..+|.+||+..+...+
T Consensus 109 ~~c~~c~k~vy~~Ek~~~~~~~~hk~cfrc~~~~~~ls~~~~~~~~g~l~~~~~~~~~~ 167 (200)
T KOG1700|consen 109 EKCARCQKTVYPLEKVTGNGLEFHKSCFRCTHCGKKLSPKNYAALEGVLYCKHHFAQLF 167 (200)
T ss_pred cccccccceeeehHHHhhhhhhhhhhheeecccccccCCcchhhcCCccccchhhheee
Confidence 569999999998888999999999999999999999975 6778899999998776544
|
|
| >KOG1702|consensus | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.00024 Score=69.51 Aligned_cols=58 Identities=26% Similarity=0.608 Sum_probs=50.3
Q ss_pred ccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeecccccccc
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKY 67 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f 67 (681)
+-|..|++.++.-+-+..+++.||..||+|..|+..|.- .|-.-|.++||..+|.+..
T Consensus 5 ~n~~~cgk~vYPvE~v~cldk~whk~cfkce~c~mtlnmKnyKgy~kkpycn~hYpkq~ 63 (264)
T KOG1702|consen 5 CNREDCGKTVYPVEEVKCLDKVWHKQCFKCEVCGMTLNMKNYKGYDKKPYCNPHYPKQV 63 (264)
T ss_pred chhhhhccccccHHHHhhHHHHHHHHhheeeeccCChhhhhccccccCCCcCcccccce
Confidence 468899999988888999999999999999999999976 4445789999999997653
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.015 Score=63.74 Aligned_cols=162 Identities=16% Similarity=0.191 Sum_probs=102.0
Q ss_pred eecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CC
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HH 561 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~H 561 (681)
..++.||+|+-+.+|-.-.- +..|| |+......-.+.....+ |... .|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VA-KIYh~Pppa~~aqk~a~----------------------------la~~p~~ 62 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVA-KIYHAPPPAAQAQKVAE----------------------------LAATPDA 62 (637)
T ss_pred CCCccccCCccceeeecchh--hchhh-eeecCCCchHHHHHHHH----------------------------hccCCCC
Confidence 45778999999999964322 22333 76655444333322222 2222 44
Q ss_pred CceeeEEEE----E---EeCCeEEEEEeccCCC-CHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 562 HNVIRFIGV----L---YKDRKLNLVTEYIAGG-TLKELLQDP-----GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 562 pnIV~l~g~----~---~~~~~l~LV~Ey~~gG-sL~~~L~~~-----~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
|-+..=+.+ . ..+..+.+.|..+++. ...+++... -....|...++.++.++.+..-||..|.+-+|
T Consensus 63 p~~~~rvaWPqa~L~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGD 142 (637)
T COG4248 63 PLLNYRVAWPQATLHGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGD 142 (637)
T ss_pred cchhhhhcccHHHhhCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccc
Confidence 433220111 0 0122367788877664 333443211 12367999999999999999999999999999
Q ss_pred CCCCcEEEecCCCeEEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 629 LNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 629 LKp~NILl~~~g~~~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
++++|+|+.+++.+.-.|- ..+........+....|...|..||.=.
T Consensus 143 Vn~~~~lVsd~~~V~LVds-Dsfqi~~ng~~~~cpVg~~eftPPElQ~ 189 (637)
T COG4248 143 VNQNSFLVSDDSKVVLVDS-DSFQINANGTLHLCPVGVSEFTPPELQT 189 (637)
T ss_pred cCccceeeecCceEEEEcc-cceeeccCCceEecccCccccCCHHHhc
Confidence 9999999999999822221 2233334456677788999999999743
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.013 Score=60.09 Aligned_cols=30 Identities=27% Similarity=0.205 Sum_probs=24.2
Q ss_pred CccccCCCCCcEEEecCCCe--EEeeeeeEee
Q psy5063 623 NLIHRDLNSQNCLVREVGSG--FDFHLGQIYL 652 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~ 652 (681)
.++|+|+.+.|||++.++.. +||+.+....
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~gD 196 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGVGD 196 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccCcCC
Confidence 48999999999999876533 8999876543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd00988 PDZ_CTP_protease PDZ domain of C-terminal processing-, tail-specific-, and tricorn proteases, which function in posttranslational protein processing, maturation, and disassembly or degradation, in Bacteria, Archaea, and plant chloroplasts | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.0098 Score=50.64 Aligned_cols=43 Identities=26% Similarity=0.485 Sum_probs=38.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
-|++||+|+.|||.++.+++.+++..++++..++.+.++++++
T Consensus 30 gl~~GD~I~~vng~~i~~~~~~~~~~~l~~~~~~~i~l~v~r~ 72 (85)
T cd00988 30 GIKAGDIIVAIDGEPVDGLSLEDVVKLLRGKAGTKVRLTLKRG 72 (85)
T ss_pred CCCCCCEEEEECCEEcCCCCHHHHHHHhcCCCCCEEEEEEEcC
Confidence 6999999999999999998889998888755677899999887
|
May be responsible for substrate recognition and/or binding, as most PDZ domains bind C-terminal polypeptides, and binding to internal (non-C-terminal) polypeptides and even to lipids has been demonstrated. In this subfamily of protease-associated PDZ domains a C-terminal beta-strand forms the peptide-binding groove base, a circular permutation with respect to PDZ domains found in Eumetazoan signaling proteins. |
| >cd00992 PDZ_signaling PDZ domain found in a variety of Eumetazoan signaling molecules, often in tandem arrangements | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.01 Score=50.01 Aligned_cols=39 Identities=33% Similarity=0.526 Sum_probs=33.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQI 331 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (681)
.|++||+|++|||.++.+.+.+++..+++ .....++|++
T Consensus 43 gl~~GD~I~~ing~~i~~~~~~~~~~~l~-~~~~~v~l~v 81 (82)
T cd00992 43 GLRVGDRILEVNGVSVEGLTHEEAVELLK-NSGDEVTLTV 81 (82)
T ss_pred CCCCCCEEEEECCEEcCccCHHHHHHHHH-hCCCeEEEEE
Confidence 69999999999999999999999999999 4544666665
|
May be responsible for specific protein-protein interactions, as most PDZ domains bind C-terminal polypeptides, and binding to internal (non-C-terminal) polypeptides and even to lipids has been demonstrated. In this subfamily of PDZ domains an N-terminal beta-strand forms the peptide-binding groove base, a circular permutation with respect to PDZ domains found in proteases. |
| >cd00989 PDZ_metalloprotease PDZ domain of bacterial and plant zinc metalloprotases, presumably membrane-associated or integral membrane proteases, which may be involved in signalling and regulatory mechanisms | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.013 Score=49.11 Aligned_cols=42 Identities=21% Similarity=0.433 Sum_probs=34.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+ .+++..++.+..+..+.+++.++.
T Consensus 29 gl~~GD~I~~ing~~i~~--~~~~~~~l~~~~~~~~~l~v~r~~ 70 (79)
T cd00989 29 GLKAGDRILAINGQKIKS--WEDLVDAVQENPGKPLTLTVERNG 70 (79)
T ss_pred CCCCCCEEEEECCEECCC--HHHHHHHHHHCCCceEEEEEEECC
Confidence 599999999999999974 578888887555677888887765
|
May be responsible for substrate recognition and/or binding, as most PDZ domains bind C-terminal polypeptides, and binding to internal (non-C-terminal) polypeptides and even to lipids has been demonstrated. In this subfamily of protease-associated PDZ domains a C-terminal beta-strand forms the peptide-binding groove base, a circular permutation with respect to PDZ domains found in Eumetazoan signaling proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.057 Score=56.98 Aligned_cols=30 Identities=27% Similarity=0.277 Sum_probs=25.0
Q ss_pred CCccccCCCCCcEEEecCCCe--EEeeeeeEe
Q psy5063 622 MNLIHRDLNSQNCLVREVGSG--FDFHLGQIY 651 (681)
Q Consensus 622 ~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~ 651 (681)
.+++|+|+.|.|+|++.++.. .||+.+...
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 369999999999999987753 899887654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.054 Score=55.07 Aligned_cols=29 Identities=28% Similarity=0.305 Sum_probs=23.5
Q ss_pred CccccCCCCCcEEEec-CCCe--EEeeeeeEe
Q psy5063 623 NLIHRDLNSQNCLVRE-VGSG--FDFHLGQIY 651 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~-~g~~--~DFGLa~~~ 651 (681)
.++|+|+.+.|||++. ++.+ +||..|...
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~ 202 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN 202 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence 5899999999999998 4545 899877643
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.1 Score=58.04 Aligned_cols=77 Identities=16% Similarity=0.155 Sum_probs=48.8
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccC-------HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-------EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-------~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.+.||.|.+..||++...+.++.+++|.-.... ....... ..|.+.|+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~-------------------------~~Eae~L~ 85 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRA-------------------------RIEAEALK 85 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHH-------------------------HHHHHHHH
Confidence 356899999999999986544688999743110 0011122 23355555
Q ss_pred hC---CCCceeeEEEEEEeCCeEEEEEeccCCCC
Q psy5063 558 SL---HHHNVIRFIGVLYKDRKLNLVTEYIAGGT 588 (681)
Q Consensus 558 ~L---~HpnIV~l~g~~~~~~~l~LV~Ey~~gGs 588 (681)
.+ ...++.+++.+ +...-++||||+++..
T Consensus 86 ~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 86 IQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred HHHhhCCCCCCeEEEE--CCCCCEEEEecCCCcc
Confidence 54 23467777766 4456789999998643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.11 Score=55.65 Aligned_cols=30 Identities=27% Similarity=0.258 Sum_probs=24.4
Q ss_pred CCccccCCCCCcEEEecCCCe--EEeeeeeEe
Q psy5063 622 MNLIHRDLNSQNCLVREVGSG--FDFHLGQIY 651 (681)
Q Consensus 622 ~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~ 651 (681)
.+++|+|+.|.|||++.+... +||+.+...
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~~ 218 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACND 218 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccCC
Confidence 379999999999999966543 999987644
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.042 Score=56.96 Aligned_cols=29 Identities=21% Similarity=0.265 Sum_probs=24.5
Q ss_pred CccccCCCCCcEEEecCCCe-EEeeeeeEe
Q psy5063 623 NLIHRDLNSQNCLVREVGSG-FDFHLGQIY 651 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~~g~~-~DFGLa~~~ 651 (681)
.++|+|+.|.|||++.++.. +||..|...
T Consensus 147 ~l~H~Dl~~~Nil~~~~~~~lIDwE~a~~g 176 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQGLKLIDWEYASDG 176 (256)
T ss_pred eeecCCCCcCcEEEeCCCCEEEeccccCcC
Confidence 47999999999999988855 899877654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd00986 PDZ_LON_protease PDZ domain of ATP-dependent LON serine proteases | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.046 Score=46.09 Aligned_cols=42 Identities=24% Similarity=0.485 Sum_probs=34.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhc-CCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRN-TTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 335 (681)
.|++||.|+.|||.++.+ .+++..++.+ ..++.+.+++.++-
T Consensus 24 gL~~GD~I~~Ing~~v~~--~~~~~~~l~~~~~~~~v~l~v~r~g 66 (79)
T cd00986 24 KLKAGDHIIAVDGKPFKE--AEELIDYIQSKKEGDTVKLKVKREE 66 (79)
T ss_pred CCCCCCEEEEECCEECCC--HHHHHHHHHhCCCCCEEEEEEEECC
Confidence 599999999999999974 6778877773 45667888888765
|
Most PDZ domains bind C-terminal polypeptides, though binding to internal (non-C-terminal) polypeptides and even to lipids has been demonstrated. In this bacterial subfamily of protease-associated PDZ domains a C-terminal beta-strand is thought to form the peptide-binding groove base, a circular permutation with respect to PDZ domains found in Eumetazoan signaling proteins. |
| >PF13180 PDZ_2: PDZ domain; PDB: 2L97_A 1Y8T_A 2Z9I_A 1LCY_A 2PZD_B 2P3W_A 1VCW_C 1TE0_B 1SOZ_C 1SOT_C | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.029 Score=47.78 Aligned_cols=42 Identities=24% Similarity=0.521 Sum_probs=34.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhh-hcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLI-RNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|+.|||.+| ...+++..++ +...++.++|++.++-
T Consensus 31 Gl~~GD~I~~ing~~v--~~~~~~~~~l~~~~~g~~v~l~v~R~g 73 (82)
T PF13180_consen 31 GLQPGDIILAINGKPV--NSSEDLVNILSKGKPGDTVTLTVLRDG 73 (82)
T ss_dssp TS-TTEEEEEETTEES--SSHHHHHHHHHCSSTTSEEEEEEEETT
T ss_pred CCCCCcEEEEECCEEc--CCHHHHHHHHHhCCCCCEEEEEEEECC
Confidence 4999999999999999 4557777666 5577889999999976
|
... |
| >smart00228 PDZ Domain present in PSD-95, Dlg, and ZO-1/2 | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.04 Score=46.37 Aligned_cols=42 Identities=33% Similarity=0.463 Sum_probs=35.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
-|.+||+|+.|||.++.+.+..+....+++ ....+.|++.++
T Consensus 43 gl~~GD~I~~In~~~v~~~~~~~~~~~~~~-~~~~~~l~i~r~ 84 (85)
T smart00228 43 GLKVGDVILEVNGTSVEGLTHLEAVDLLKK-AGGKVTLTVLRG 84 (85)
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHh-CCCeEEEEEEeC
Confidence 399999999999999999988888888774 455888888764
|
Also called DHR (Dlg homologous region) or GLGF (relatively well conserved tetrapeptide in these domains). Some PDZs have been shown to bind C-terminal polypeptides; others appear to bind internal (non-C-terminal) polypeptides. Different PDZs possess different binding specificities. |
| >cd00991 PDZ_archaeal_metalloprotease PDZ domain of archaeal zinc metalloprotases, presumably membrane-associated or integral membrane proteases, which may be involved in signalling and regulatory mechanisms | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.046 Score=46.31 Aligned_cols=42 Identities=31% Similarity=0.538 Sum_probs=34.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 335 (681)
-|+.||.|++|||.++. .++++..++.+. .++.+.+++.++-
T Consensus 27 GL~~GDiI~~Ing~~v~--~~~d~~~~l~~~~~g~~v~l~v~r~g 69 (79)
T cd00991 27 VLHTGDVIYSINGTPIT--TLEDFMEALKPTKPGEVITVTVLPST 69 (79)
T ss_pred CCCCCCEEEEECCEEcC--CHHHHHHHHhcCCCCCEEEEEEEECC
Confidence 59999999999999997 567888888854 3677888888765
|
May be responsible for substrate recognition and/or binding, as most PDZ domains bind C-terminal polypeptides, and binding to internal (non-C-terminal) polypeptides and even to lipids has been demonstrated. In this subfamily of protease-associated PDZ domains a C-terminal beta-strand forms the peptide-binding groove base, a circular permutation with respect to PDZ domains found in Eumetazoan signaling proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 681 | ||||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-47 | ||
| 1x6a_A | 81 | Solution Structures Of The Second Lim Domain Of Hum | 5e-18 | ||
| 2rgt_A | 169 | Crystal Structure Of Lhx3 Lim Domains 1 And 2 With | 9e-15 | ||
| 2jtn_A | 182 | Nmr Solution Structure Of A Ldb1-Lid:lhx3-Lim Compl | 1e-14 | ||
| 3mmk_A | 169 | The Structural Basis For Partial Redundancy In A Cl | 7e-13 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-12 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-11 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-11 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 7e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 8e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-10 | ||
| 2dj7_A | 80 | Solution Structure Of 3rd Lim Domain Of Actin-Bindi | 5e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 9e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-09 | ||
| 2xjy_A | 131 | Crystal Structure Of The Lmo2:ldb1-Lid Complex, P21 | 2e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-09 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-09 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-09 | ||
| 2dfy_X | 195 | Crystal Structure Of A Cyclized Protein Fusion Of L | 5e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-09 | ||
| 1rut_X | 188 | Complex Of Lmo4 Lim Domains 1 And 2 With The Ldb1 L | 6e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 8e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 8e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-08 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-08 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-08 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 6e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-08 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-07 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-07 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-07 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-07 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-07 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-07 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-07 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 8e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-06 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-06 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-06 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-06 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-06 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 8e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-06 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-06 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 9e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-06 | ||
| 2xqn_T | 126 | Complex Of The 2nd And 3rd Lim Domains Of Tes With | 9e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 5e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-05 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-05 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-05 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 7e-05 | ||
| 2l4z_A | 123 | Nmr Structure Of Fusion Of Ctip (641-685) To Lmo4-L | 7e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-05 | ||
| 1m3v_A | 122 | Flin4: Fusion Of The Lim Binding Domain Of Ldb1 And | 8e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-04 | ||
| 1cxx_A | 113 | Mutant R122a Of Quail Cysteine And Glycine-Rich Pro | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-04 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-04 | ||
| 2yub_A | 118 | Solution Structure Of The Pdz Domain From Mouse Lim | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-04 | ||
| 1qli_A | 113 | Quail Cysteine And Glycine-Rich Protein, Nmr, 15 Mi | 3e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 3e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-04 | ||
| 1j2o_A | 114 | Structure Of Flin2, A Complex Containing The N-Term | 5e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-04 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-04 | ||
| 1x3h_A | 80 | Solution Structure Of The Lim Domain Of Human Leupa | 8e-04 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 8e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 9e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 9e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 9e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-04 |
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1X6A|A Chain A, Solution Structures Of The Second Lim Domain Of Human Lim- Kinase 2 (limk2) Length = 81 | Back alignment and structure |
|
| >pdb|2RGT|A Chain A, Crystal Structure Of Lhx3 Lim Domains 1 And 2 With The Binding Domain Of Isl1 Length = 169 | Back alignment and structure |
|
| >pdb|2JTN|A Chain A, Nmr Solution Structure Of A Ldb1-Lid:lhx3-Lim Complex Length = 182 | Back alignment and structure |
|
| >pdb|3MMK|A Chain A, The Structural Basis For Partial Redundancy In A Class Of Transcription Factors, The Lim-Homeodomain Proteins, In Neural Cell Type Specification Length = 169 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2DJ7|A Chain A, Solution Structure Of 3rd Lim Domain Of Actin-Binding Lim Protein 3 Length = 80 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XJY|A Chain A, Crystal Structure Of The Lmo2:ldb1-Lid Complex, P21 Crystal Form Length = 131 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2DFY|X Chain X, Crystal Structure Of A Cyclized Protein Fusion Of Lmo4 Lim Domains 1 And 2 With The Lim Interacting Domain Of Ldb1 Length = 195 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1RUT|X Chain X, Complex Of Lmo4 Lim Domains 1 And 2 With The Ldb1 Lid Domain Length = 188 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XQN|T Chain T, Complex Of The 2nd And 3rd Lim Domains Of Tes With The Evh1 Domain Of Mena And The N-Terminal Domain Of Actin-Like Protein Arp7a Length = 126 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2L4Z|A Chain A, Nmr Structure Of Fusion Of Ctip (641-685) To Lmo4-Lim1 (18-82) Length = 123 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1M3V|A Chain A, Flin4: Fusion Of The Lim Binding Domain Of Ldb1 And The N- Terminal Lim Domain Of Lmo4 Length = 122 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1CXX|A Chain A, Mutant R122a Of Quail Cysteine And Glycine-Rich Protein, Nmr, Minimized Structure Length = 113 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2YUB|A Chain A, Solution Structure Of The Pdz Domain From Mouse Lim Domain Kinase Length = 118 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1QLI|A Chain A, Quail Cysteine And Glycine-Rich Protein, Nmr, Minimized Average Structure Length = 113 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1J2O|A Chain A, Structure Of Flin2, A Complex Containing The N-Terminal Lim Domain Of Lmo2 And Ldb1-Lid Length = 114 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1X3H|A Chain A, Solution Structure Of The Lim Domain Of Human Leupaxin Length = 80 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 5e-62
Identities = 92/168 (54%), Positives = 114/168 (67%), Gaps = 25/168 (14%)
Query: 471 ASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQ 530
+ RIFR SDL+ G +LG+G FGQ +VTHRETGEVMV+KEL R DEE ++ FLKE
Sbjct: 1 SMPHRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE--- 57
Query: 531 GLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLK 590
V V+R L H NV++FIGVLYKD++LN +TEYI GGTL+
Sbjct: 58 ----------------------VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLR 95
Query: 591 ELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+++ PW QRV+FA+DIA+GM YLHSMN+IHRDLNS NCLVRE
Sbjct: 96 GIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRE 143
|
| >2jtn_A LIM domain-binding protein 1, LIM/homeobox protein LHX3; intramolecular (fusion) protein-protein complex, protein binding/transcription complex; NMR {Mus musculus} Length = 182 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-41
Identities = 42/131 (32%), Positives = 64/131 (48%), Gaps = 2/131 (1%)
Query: 1 MEDSETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCK 60
M TPEI CAGC +I++ ++AL + WH+ C +CS C V L F + ++CK
Sbjct: 52 MGSGGTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAERCFSRGESVYCK 111
Query: 61 EDYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSIL 118
+D+ ++G C C + V D +H CF C C + G+ + L+E S L
Sbjct: 112 DDFFKRFGTKCAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRL 171
Query: 119 YCGLCYKRQMQ 129
C Y+ Q
Sbjct: 172 VCKADYETAKQ 182
|
| >2jtn_A LIM domain-binding protein 1, LIM/homeobox protein LHX3; intramolecular (fusion) protein-protein complex, protein binding/transcription complex; NMR {Mus musculus} Length = 182 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-09
Identities = 14/91 (15%), Positives = 29/91 (31%), Gaps = 4/91 (4%)
Query: 38 RCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSG-PVMVVGDHKFHPECFK 96
R N ++ G C C Q + ++ D +H +C K
Sbjct: 30 RLENTQFDAANGIDDEGGSGGHMGSGGTPEIPMCAGCDQHILDRFILKALDRHWHSKCLK 89
Query: 97 CTSCSCCIGDGESYALVERSILYCGLCYKRQ 127
C+ C + + + +YC + ++
Sbjct: 90 CSDCHVPLAE-RCF--SRGESVYCKDDFFKR 117
|
| >2rgt_A Fusion of LIM/homeobox protein LHX3, linker, INSU enhancer protein ISL-1; protein-protein complex, LIM domain, Zn finger, activator, D binding; 2.05A {Mus musculus} PDB: 3mmk_A Length = 169 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-41
Identities = 41/128 (32%), Positives = 64/128 (50%), Gaps = 2/128 (1%)
Query: 6 TPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNG 65
TPEI CAGC +I++ ++AL + WH+ C +CS C V L F + ++CK+D+
Sbjct: 3 TPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAERCFSRGESVYCKDDFFK 62
Query: 66 KYGEACQNCGQMM--SGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
++G C C + + V D +H CF C C + G+ + L+E S L C
Sbjct: 63 RFGTKCAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKAD 122
Query: 124 YKRQMQPL 131
Y+ Q
Sbjct: 123 YETAKQGG 130
|
| >2rgt_A Fusion of LIM/homeobox protein LHX3, linker, INSU enhancer protein ISL-1; protein-protein complex, LIM domain, Zn finger, activator, D binding; 2.05A {Mus musculus} PDB: 3mmk_A Length = 169 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 3e-22
Identities = 24/94 (25%), Positives = 30/94 (31%), Gaps = 4/94 (4%)
Query: 12 CAGCLNNI-VEDEYVQALSQEWHTDCFRCSACDVML---DNWYFEKDGLLFCKEDYNGKY 67
CA C I +A +H CF C C L D +Y +D L CK DY
Sbjct: 68 CAACQLGIPPTQVVRRAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYETAK 127
Query: 68 GEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCS 101
G G MV + H +
Sbjct: 128 QGGSGGSGGSGGGTPMVAASPERHDGGLQANPVE 161
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-40
Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 36/190 (18%)
Query: 455 PACDLSRTRSRSFRVEASKSRIFRA------SDLVRGPLLGQGFFGQVYRVTHRETGEVM 508
P +LS +RSF +AS++ IF L G L+G+G FGQVY GEV
Sbjct: 2 PEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVA 59
Query: 509 VLKELY--RVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIR 566
+ + + R +E+ K F +E V R H NV+
Sbjct: 60 I-RLIDIERDNEDQLKAFKRE-------------------------VMAYRQTRHENVVL 93
Query: 567 FIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626
F+G L ++T G TL +++D L + A++I GM YLH+ ++H
Sbjct: 94 FMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILH 153
Query: 627 RDLNSQNCLV 636
+DL S+N
Sbjct: 154 KDLKSKNVFY 163
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 37/171 (21%), Positives = 77/171 (45%), Gaps = 24/171 (14%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
+++ +G+G FG V++ + V+ +K L D E E +++ ++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQE--------- 69
Query: 540 SHGLINNLHCFSQ-VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ 598
F + V ++ +L+H N+++ G+++ +V E++ G L L D
Sbjct: 70 ----------FQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAH 117
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVREVGSGFDFHL 647
P+ W ++ DIA G+ Y+ + N ++HRDL S N ++ +
Sbjct: 118 PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-36
Identities = 44/161 (27%), Positives = 65/161 (40%), Gaps = 31/161 (19%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELY--RVDEEAEKNFLKESKQGLIYLID 537
+ G +G G FG VY+ G+V V K L + + F E
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWH--GDVAV-KMLNVTAPTPQQLQAFKNE---------- 70
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
V VLR H N++ F+G + L +VT++ G +L L
Sbjct: 71 ---------------VGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASE 114
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ ++ AR A GM YLH+ ++IHRDL S N + E
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHE 155
|
| >2xjy_A Rhombotin-2; oncoprotein, T-cell leukemia, proto-oncogene, transcription, developmental protein; 2.40A {Homo sapiens} PDB: 2xjz_A Length = 131 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 40/131 (30%), Positives = 58/131 (44%), Gaps = 8/131 (6%)
Query: 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN---WYFEKDGLLFCKEDYNG 65
+LTC GC NI + +++A+ Q WH DC C C L + K G C+ DY
Sbjct: 2 LLTCGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLR 61
Query: 66 KYG--EACQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCG 121
+G C +C + + M V D +H ECFKC +C G+ Y L+ S + C
Sbjct: 62 LFGQDGLCASCDKRIRAYEMTMRVKDKVYHLECFKCAACQKHFCVGDRYLLIN-SDIVCE 120
Query: 122 LCYKRQMQPLG 132
+ G
Sbjct: 121 QDIYEWTKING 131
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 33/163 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLID 537
DL +G G FG V+R + +V V K L D E FL+E
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWHGS-DVAV-KILMEQDFHAERVNEFLRE---------- 84
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL--QD 595
VA+++ L H N++ F+G + + L++VTEY++ G+L LL
Sbjct: 85 ---------------VAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129
Query: 596 PGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLV 636
+ L +R++ A D+A GM YLH+ N ++HR+L S N LV
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV 172
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 7e-34
Identities = 48/173 (27%), Positives = 68/173 (39%), Gaps = 34/173 (19%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEV---MVLKELYRVDEEAEKNFLKESKQGLIYLI 536
++L ++G G FG+VYR EV + + +N +E
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQE--------- 56
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
+ L H N+I GV K+ L LV E+ GG L +L
Sbjct: 57 ----------------AKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-- 98
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHSMN---LIHRDLNSQNCLVREVGSGFDFH 646
G+ +P VN+A IA GM YLH +IHRDL S N L+ + D
Sbjct: 99 GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLS 151
|
| >1rut_X Flinc4, fusion protein of LMO4 protein and LIM domain- binding protein 1; B-tandem zipper, protein binding; 1.30A {Mus musculus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 2dfy_X 2xjz_I 2xjy_B Length = 188 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-33
Identities = 36/161 (22%), Positives = 65/161 (40%), Gaps = 8/161 (4%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW---YFEKDGLLFCKEDYNGKY 67
CAGC I + + A+ WH+ C +CS+C L + + K G++ C+ DY +
Sbjct: 7 RCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLF 66
Query: 68 GEA--CQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
G + C CGQ + VM + +H +CF C++C + G+ + + S L+C
Sbjct: 67 GNSGACSACGQSIPASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGS-LFCEHD 125
Query: 124 YKRQMQPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIK 164
+ + + +V G +
Sbjct: 126 RPTALINGHLNSGGSGGSGGSGGDVMVVGEPTLMGGEFGDE 166
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-32
Identities = 31/164 (18%), Positives = 62/164 (37%), Gaps = 34/164 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELY--RVDEEAEKNFLKESKQGLIYLID 537
L L + G++++ + +++V K L ++F +E
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQGN-DIVV-KVLKVRDWSTRKSRDFNEE---------- 57
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNL--VTEYIAGGTLKELLQD 595
LR H NV+ +G + +T ++ G+L +L +
Sbjct: 58 ---------------CPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE 102
Query: 596 -PGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLV 636
+ Q V FA D+A GM +LH++ + LNS++ ++
Sbjct: 103 GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI 146
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 36/162 (22%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
++ ++G+G FG V + R +V + K++ E K F+ E
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWRAK-DVAI-KQIE--SESERKAFIVE------------ 51
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL--QDPG 597
+ L ++H N+++ G + LV EY GG+L +L +P
Sbjct: 52 -------------LRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPL 96
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMN---LIHRDLNSQNCLV 636
+++ + G+ YLHSM LIHRDL N L+
Sbjct: 97 PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL 138
|
| >2xqn_T Testin, TESS; metal-binding protein, cytoskeleton, focal adhesion, acrosom; 2.62A {Homo sapiens} Length = 126 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 40/130 (30%), Positives = 57/130 (43%), Gaps = 10/130 (7%)
Query: 4 SETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKED 62
SE P CAGC I +EY QA +Q WH F C CD +L Y + CK
Sbjct: 1 SEKPR---CAGCDELIFSNEYTQAENQNWHLKHFCCFDCDSILAGEIYVMVNDKPVCKPC 57
Query: 63 YNGKYGEACQNCGQMMSGPVMVV--GDHKFHP--ECFKCTSCSCCIGDGESYALVERSIL 118
Y + CQ C + V V + +H ECF C+ CS C+ + + +
Sbjct: 58 YVKNHAVVCQGCHNAIDPEVQRVTYNNFSWHASTECFLCSCCSKCLIGQKFMPVEGM--V 115
Query: 119 YCGLCYKRQM 128
+C + K++M
Sbjct: 116 FCSVECKKRM 125
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 35/174 (20%)
Query: 472 SKSRIFRASDLVRGPLLGQGFFGQVYR---VTHRETGEVMV----LKELYRVDEEAEKNF 524
+ RI + ++ + +LG G FG VY+ + E ++ V L+E +A K
Sbjct: 7 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEI 64
Query: 525 LKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 584
L E V+ S+ + +V R +G+ + L+T+ +
Sbjct: 65 LDE-------------------------AYVMASVDNPHVCRLLGICLTST-VQLITQLM 98
Query: 585 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G L + +++ + +N+ IA GM YL L+HRDL ++N LV+
Sbjct: 99 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-29
Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 30/162 (18%)
Query: 480 SDLVRGPLLGQGFFGQVYR-VTHRETGEVMV--LKELYRVDEEAEKNFLKESKQGLIYLI 536
DLV G +G+G FG+V+ + V V +E + + + FL+E
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE--TLPPDLKAKFLQE--------- 162
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
+L+ H N++R IGV + + + +V E + GG L+
Sbjct: 163 ----------------ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE 206
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G L + D AAGM YL S IHRDL ++NCLV E
Sbjct: 207 GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTE 248
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 43/159 (27%), Positives = 66/159 (41%), Gaps = 27/159 (16%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
++ LG G FG V + +V V K + + +E F +E
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAV-KMI-KEGSMSEDEFFQE------------ 53
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
+ L H +++F GV K+ + +VTEYI+ G L L+ G+
Sbjct: 54 -------------AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKG 100
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L Q + D+ GM +L S IHRDL ++NCLV
Sbjct: 101 LEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDR 139
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 35/205 (17%)
Query: 453 LRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKE 512
L + +D+ LG G +G+VY ++ + +K
Sbjct: 193 LHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT 252
Query: 513 LYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLY 572
L + D + FLKE+ V++ + H N+++ +GV
Sbjct: 253 L-KEDTMEVEEFLKEAA-------------------------VMKEIKHPNLVQLLGVCT 286
Query: 573 KDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631
++ ++TE++ G L + L++ Q + + A I++ M YL N IHR+L +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA 346
Query: 632 QNCLVRE-----VGSGFDFHLGQIY 651
+NCLV E V DF L ++
Sbjct: 347 RNCLVGENHLVKVA---DFGLSRLM 368
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 31/170 (18%)
Query: 475 RIFRASDLVRGPLLGQGFFGQVYR---VTHRETGEVMV-LKELYRVDEEAEKNFLKESKQ 530
IF L LG+G FG V + +V +K+L + +++F +E
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE--- 74
Query: 531 GLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIAGGT 588
+ +L++LH ++++ GV Y + L LV EY+ G
Sbjct: 75 ----------------------IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 112
Query: 589 LKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L++ LQ L + + ++ I GM YL S +HRDL ++N LV
Sbjct: 113 LRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES 162
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 43/165 (26%), Positives = 66/165 (40%), Gaps = 33/165 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLI 533
S + ++G G G+V + +V V LK Y E ++FL E
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSE------ 100
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
+++ H N+IR GV+ + R +VTEY+ G+L L
Sbjct: 101 -------------------ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ Q V R + AGM YL + +HRDL ++N LV
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDS 186
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 42/159 (26%), Positives = 67/159 (42%), Gaps = 27/159 (16%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
DL LG G FG V R +V + K + + +E F++E
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAI-KMI-KEGSMSEDEFIEE------------ 69
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
V+ +L H +++ GV K R + ++TEY+A G L L++
Sbjct: 70 -------------AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR 116
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
Q + +D+ M YL S +HRDL ++NCLV +
Sbjct: 117 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 155
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 31/174 (17%)
Query: 471 ASKSRIFRASDLVRGPLLGQGFFGQVYR----VTHRETGEVMVLKELYRVDEEAEKNFLK 526
S F L LG+G FG V TGEV+ +K+L EE ++F +
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 527 ESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYI 584
E + +L+SL H N++++ GV Y + L L+ EY+
Sbjct: 61 E-------------------------IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 585 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G+L++ LQ + + + + + I GM YL + IHRDL ++N LV
Sbjct: 96 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVEN 149
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 44/173 (25%), Positives = 71/173 (41%), Gaps = 36/173 (20%)
Query: 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGE-------VMVLKELYRVDEEAEKNFLKE 527
F L R LG+G FG+V + G+ V LK + KE
Sbjct: 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKE 73
Query: 528 SKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIA 585
+ +LR+L+H N++++ G+ +D + L+ E++
Sbjct: 74 -------------------------IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 586 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G+LKE L + Q++ +A I GM YL S +HRDL ++N LV
Sbjct: 109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 161
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 40/159 (25%), Positives = 66/159 (41%), Gaps = 27/159 (16%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
S+L +G G FG V+ +V + K + R +E++F++E
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAI-KTI-REGAMSEEDFIEE------------ 53
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
V+ L H +++ GV + + LVTE++ G L + L+
Sbjct: 54 -------------AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL 100
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ D+ GM YL +IHRDL ++NCLV E
Sbjct: 101 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 139
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 46/187 (24%), Positives = 78/187 (41%), Gaps = 31/187 (16%)
Query: 458 DLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE---VMV-LKEL 513
+L + E F L LG+G FG V + + +V +K+L
Sbjct: 19 NLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL 78
Query: 514 YRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYK 573
EE ++F +E + +L+SL H N++++ GV Y
Sbjct: 79 QHSTEEHLRDFERE-------------------------IEILKSLQHDNIVKYKGVCYS 113
Query: 574 DRK--LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631
+ L L+ EY+ G+L++ LQ + + + + + I GM YL + IHRDL +
Sbjct: 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLAT 173
Query: 632 QNCLVRE 638
+N LV
Sbjct: 174 RNILVEN 180
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 52/166 (31%), Positives = 75/166 (45%), Gaps = 34/166 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYR---VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGL 532
S + R ++G G FG+VY+ T EV V LK Y E+ +FL E
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGE----- 96
Query: 533 IYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL 592
++ HHN+IR GV+ K + + ++TEY+ G L +
Sbjct: 97 --------------------AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136
Query: 593 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L++ Q V R IAAGM YL +MN +HRDL ++N LV
Sbjct: 137 LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNS 182
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 9e-28
Identities = 44/177 (24%), Positives = 80/177 (45%), Gaps = 37/177 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
L LG G FG+V+ T+ + +V V K + + + + FL E+
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAV-KTM-KPGSMSVEAFLAEAN---------- 235
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQ 598
V+++L H +++ V+ K+ + ++TE++A G+L + L+ G
Sbjct: 236 ---------------VMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGS 279
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----VGSGFDFHLGQI 650
P + ++F+ IA GM ++ N IHRDL + N LV + DF L ++
Sbjct: 280 KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIA---DFGLARV 333
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-28
Identities = 45/166 (27%), Positives = 72/166 (43%), Gaps = 33/166 (19%)
Query: 479 ASDLVRGPLLGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGL 532
A+++ ++G G FG+V + E+ V LK Y E+ ++FL E
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGE----- 96
Query: 533 IYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL 592
+++ H N+IR GV+ K + + +VTEY+ G+L
Sbjct: 97 --------------------ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 593 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L+ Q V R IA+GM YL M +HRDL ++N L+
Sbjct: 137 LRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINS 182
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 34/169 (20%), Positives = 64/169 (37%), Gaps = 34/169 (20%)
Query: 477 FRASDLVRGPLLGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQ 530
+ + ++G+G FG VY + + ++ L + D FL E
Sbjct: 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTE--- 76
Query: 531 GLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGV-LYKDRKLNLVTEYIAGGTL 589
+++ H NV+ +G+ L + +V Y+ G L
Sbjct: 77 ----------------------GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL 114
Query: 590 KELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ +++ + F +A GM YL S +HRDL ++NC++ E
Sbjct: 115 RNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE 163
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 41/174 (23%), Positives = 74/174 (42%), Gaps = 35/174 (20%)
Query: 472 SKSRIFRASDLVRGPLLGQGFFGQVYR---VTHRETGEVMV----LKELYRVDEEAEKNF 524
+ RI + ++ + +LG G FG VY+ + E ++ V L+E +A K
Sbjct: 7 ALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEI 64
Query: 525 LKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 584
L E V+ S+ + +V R +G+ + L+T+ +
Sbjct: 65 LDE-------------------------AYVMASVDNPHVCRLLGICLTS-TVQLITQLM 98
Query: 585 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G L + +++ + +N+ IA GM YL L+HRDL ++N LV+
Sbjct: 99 PFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 152
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 33/164 (20%), Positives = 66/164 (40%), Gaps = 32/164 (19%)
Query: 480 SDLVRGPLLGQGFFGQVYR------VTHRETGEVMV-LKELYRVDEEAEKNFLKESKQGL 532
DL+ LGQG F ++++ + + E V LK L + ++F +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA----- 62
Query: 533 IYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL 592
+++ L H +++ GV + LV E++ G+L
Sbjct: 63 --------------------ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102
Query: 593 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
L+ + ++ A+ +AA M +L LIH ++ ++N L+
Sbjct: 103 LKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 43/173 (24%), Positives = 72/173 (41%), Gaps = 38/173 (21%)
Query: 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGE-------VMVLKELYRVDEEAEKNFLKE 527
+F L + LG+G FG+V + T + V LK + + +E
Sbjct: 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKA--DAGPQHRSGWKQE 83
Query: 528 SKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK--LNLVTEYIA 585
+ +LR+L+H ++I++ G L LV EY+
Sbjct: 84 -------------------------IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 586 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G+L++ L + Q + FA+ I GM YLH+ + IHRDL ++N L+
Sbjct: 119 LGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDN 169
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 37/209 (17%), Positives = 72/209 (34%), Gaps = 34/209 (16%)
Query: 437 SSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQV 496
S + + + DLS + + + ++G+G FG V
Sbjct: 46 SLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCV 105
Query: 497 YR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550
Y + + ++ L + D FL E
Sbjct: 106 YHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEG---------------------- 141
Query: 551 SQVAVLRSLHHHNVIRFIGV-LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFA 609
+++ H NV+ +G+ L + +V Y+ G L+ +++ + F
Sbjct: 142 ---IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198
Query: 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+A GM +L S +HRDL ++NC++ E
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDE 227
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 48/188 (25%), Positives = 73/188 (38%), Gaps = 46/188 (24%)
Query: 477 FRASDLVRGPLLGQGFFGQVYR----VTHRETGEVMV----LKELYRVDEEAEKNFLKES 528
++ LG G FG+VY + + V L E+ E+ E +FL E
Sbjct: 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLME- 124
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGT 588
++ +H N++R IGV + ++ E +AGG
Sbjct: 125 ------------------------ALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGD 160
Query: 589 LKELLQ------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642
LK L+ L ++ ARDIA G YL + IHRD+ ++NCL+ G G
Sbjct: 161 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 220
Query: 643 F-----DF 645
DF
Sbjct: 221 RVAKIGDF 228
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 49/174 (28%), Positives = 68/174 (39%), Gaps = 32/174 (18%)
Query: 471 ASKSRIFRASDLVRGPLLGQGFFGQVYR----VTHRETGEVMV--LKELYRVDEEAEKNF 524
S + + DL LG G FG V R +T V V LK EA +F
Sbjct: 9 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 525 LKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 584
++E V + SL H N+IR GV+ + +VTE
Sbjct: 69 IRE-------------------------VNAMHSLDHRNLIRLYGVVLTP-PMKMVTELA 102
Query: 585 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G+L + L+ G +A +A GM YL S IHRDL ++N L+
Sbjct: 103 PLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT 156
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 37/174 (21%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
L LGQG FG+V+ T T V + K L + + + FL+E++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAI-KTL-KPGTMSPEAFLQEAQ---------- 231
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQ 598
V++ L H +++ V+ ++ +VTEY++ G+L + L+ G+
Sbjct: 232 ---------------VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGK 275
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----VGSGFDFHL 647
L Q V+ A IA+GM Y+ MN +HRDL + N LV E V DF L
Sbjct: 276 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA---DFGL 326
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 47/188 (25%), Positives = 73/188 (38%), Gaps = 46/188 (24%)
Query: 477 FRASDLVRGPLLGQGFFGQVYR----VTHRETGEVMV----LKELYRVDEEAEKNFLKES 528
++ LG G FG+VY + + V L E+ +E + FL E
Sbjct: 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD--FLME- 83
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGT 588
++ +H N++R IGV + ++ E +AGG
Sbjct: 84 ------------------------ALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGD 119
Query: 589 LKELLQD------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642
LK L++ L ++ ARDIA G YL + IHRD+ ++NCL+ G G
Sbjct: 120 LKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPG 179
Query: 643 F-----DF 645
DF
Sbjct: 180 RVAKIGDF 187
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 37/174 (21%), Positives = 77/174 (44%), Gaps = 35/174 (20%)
Query: 472 SKSRIFRASDLVRGPLLGQGFFGQVYR---VTHRETGEVMV----LKELYRVDEEAEKNF 524
+RIF+ ++L + +LG G FG V++ + E+ ++ V +++ ++ +
Sbjct: 5 VLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAV 62
Query: 525 LKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI 584
+ + SL H +++R +G+ L LVT+Y+
Sbjct: 63 TDH-------------------------MLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYL 96
Query: 585 AGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
G+L + ++ L +N+ IA GM YL ++HR+L ++N L++
Sbjct: 97 PLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKS 150
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 42/205 (20%), Positives = 76/205 (37%), Gaps = 43/205 (20%)
Query: 446 YNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETG 505
Y P +SLR + S++ + R A + +G+G +G+V+ R
Sbjct: 4 YIPPGESLRDLIEQSQSSGSGSGLPLLVQRTI-AKQIQMVKQIGKGRYGEVWMGKWRGE- 61
Query: 506 EVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVI 565
+V V K E ++ +E++ + + H N++
Sbjct: 62 KVAV-KVF---FTTEEASWFRETE-----------------------IYQTVLMRHENIL 94
Query: 566 RFIGVLYKDRKLN----LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS 621
FI K L+T+Y G+L + L+ L + A +G+ +LH+
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 622 MNL--------IHRDLNSQNCLVRE 638
HRDL S+N LV++
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKK 177
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-27
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 37/174 (21%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
L LGQG FG+V+ T T V + K L + + + FL+E++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAI-KTL-KPGTMSPEAFLQEAQ---------- 314
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQ 598
V++ L H +++ V+ ++ + +VTEY++ G+L + L+ G+
Sbjct: 315 ---------------VMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGK 358
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----VGSGFDFHL 647
L Q V+ A IA+GM Y+ MN +HRDL + N LV E V DF L
Sbjct: 359 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA---DFGL 409
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 35/166 (21%), Positives = 67/166 (40%), Gaps = 34/166 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLI 533
++G+G FG VY + + L + + + + FL+E
Sbjct: 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREG----- 73
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGV-LYKDRKLNLVTEYIAGGTLKEL 592
++R L+H NV+ IG+ L + +++ Y+ G L +
Sbjct: 74 --------------------LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQF 113
Query: 593 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
++ P + ++F +A GM YL +HRDL ++NC++ E
Sbjct: 114 IRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDE 159
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 42/172 (24%)
Query: 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDL 538
A D+ +G+G +G+V+R + + V V K EK++ +E++
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQGE-NVAV-KIF---SSRDEKSWFRETE--------- 52
Query: 539 GSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN----LVTEYIAGGTLKELLQ 594
+ L H N++ FI R + L+T Y G+L + LQ
Sbjct: 53 --------------LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ 98
Query: 595 DPGQPLPWGQRVNFARDIAAGMTYLHS--------MNLIHRDLNSQNCLVRE 638
L + IA+G+ +LH + HRDL S+N LV++
Sbjct: 99 L--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKK 148
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 42/175 (24%), Positives = 70/175 (40%), Gaps = 42/175 (24%)
Query: 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDL 538
A +V +G+G FG+V+R R EV V K E+++ +E++
Sbjct: 41 ARTIVLQESIGKGRFGEVWRGKWRGE-EVAV-KIF---SSREERSWFREAE--------- 86
Query: 539 GSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN----LVTEYIAGGTLKELLQ 594
+ L H N++ FI KD LV++Y G+L + L
Sbjct: 87 --------------IYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 132
Query: 595 DPGQPLPWGQRVNFARDIAAGMTYLHS--------MNLIHRDLNSQNCLVREVGS 641
+ + A A+G+ +LH + HRDL S+N LV++ G+
Sbjct: 133 R--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 185
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 35/179 (19%), Positives = 68/179 (37%), Gaps = 27/179 (15%)
Query: 460 SRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE 519
R+ + + +LG+G +G VY + +KE
Sbjct: 2 MRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKE------- 54
Query: 520 AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNL 579
I LH ++A+ + L H N+++++G ++ + +
Sbjct: 55 ----------------IPERDSRYSQPLH--EEIALHKHLKHKNIVQYLGSFSENGFIKI 96
Query: 580 VTEYIAGGTLKELLQDPGQPLPWGQRV--NFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
E + GG+L LL+ PL ++ + + I G+ YLH ++HRD+ N L+
Sbjct: 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 37/177 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
L LG G FG+V+ + +V V K L + + FL E+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAV-KSL-KQGSMSPDAFLAEAN---------- 60
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQ 598
+++ L H ++R V+ ++ ++TEY+ G+L + L+ P G
Sbjct: 61 ---------------LMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGI 104
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----VGSGFDFHLGQI 650
L + ++ A IA GM ++ N IHRDL + N LV + + DF L ++
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIA---DFGLARL 158
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 33/165 (20%), Positives = 62/165 (37%), Gaps = 34/165 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLI 533
+ G +G+G FG V++ E + V K + + FL+E
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQE------ 66
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
+R H ++++ IGV+ ++ ++ E G L+ L
Sbjct: 67 -------------------ALTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL 106
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
Q L + +A ++ + YL S +HRD+ ++N LV
Sbjct: 107 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 151
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 33/163 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYR-VTHRETGEVMV--LKELYRVDEEAEKNFLKESKQGLIYLI 536
+D+ LG G +G+VY V + + V V LKE D + FLKE
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKE--------- 59
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
AV++ + H N+++ +GV ++ ++TE++ G L + L++
Sbjct: 60 ----------------AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC 103
Query: 597 -GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
Q + + A I++ M YL N IHRDL ++NCLV E
Sbjct: 104 NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 146
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-26
Identities = 47/180 (26%), Positives = 76/180 (42%), Gaps = 43/180 (23%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMV--LKELYRVDEEAEKNFLKESKQGLIY 534
+L +G+G FG V +R +V V +K + + FL E
Sbjct: 190 LNMKELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKN-----DATAQAFLAE------- 236
Query: 535 LIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELL 593
+V+ L H N+++ +GV+ +++ L +VTEY+A G+L + L
Sbjct: 237 ------------------ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 278
Query: 594 QDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE-----VGSGFDFHL 647
+ L + F+ D+ M YL N +HRDL ++N LV E V DF L
Sbjct: 279 RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVS---DFGL 335
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 37/195 (18%), Positives = 67/195 (34%), Gaps = 26/195 (13%)
Query: 443 DAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHR 502
+ + P+ + + S T + F+ R LG G +G+V++V +
Sbjct: 21 QSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQ-QSFQRLSRLGHGSYGEVFKVRSK 79
Query: 503 ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH 562
E G + +K G + ++V + H
Sbjct: 80 EDGRLYAVKR-----------------------SMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 563 -NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS 621
+R + L L TE G +L++ + G LP Q + RD + +LHS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 622 MNLIHRDLNSQNCLV 636
L+H D+ N +
Sbjct: 176 QGLVHLDVKPANIFL 190
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 35/163 (21%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMV--LKELYRVDEEAEKNFLKESKQGLIYLID 537
+L +G+G FG V +R +V V +K + + FL E
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCIKN-----DATAQAFLAE---------- 64
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDP 596
+V+ L H N+++ +GV+ +++ L +VTEY+A G+L + L+
Sbjct: 65 ---------------ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 109
Query: 597 -GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L + F+ D+ M YL N +HRDL ++N LV E
Sbjct: 110 GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSE 152
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 37/165 (22%), Positives = 71/165 (43%), Gaps = 34/165 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLI 533
D+V +LG+GFFG+VY T+ + ++ V K+ + ++ F+ E
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSE------ 63
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
++++L H ++++ IG++ ++ ++ E G L L
Sbjct: 64 -------------------AVIMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYL 103
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ L V ++ I M YL S+N +HRD+ +N LV
Sbjct: 104 ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVAS 148
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 44/176 (25%)
Query: 480 SDLVRGPLLGQGFFGQVYR----VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQG 531
+ LGQG FG VY ++ E V + E FL E
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE--AASMRERIEFLNE---- 78
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
+V++ + H+V+R +GV+ + + ++ E + G LK
Sbjct: 79 ---------------------ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 592 LLQ---------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L+ P + + A +IA GM YL++ +HRDL ++NC+V E
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 173
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 30/159 (18%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
+G+G F VY+ ET + EL ++ K +Q
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCEL------QDRKLTKSERQRFK---------- 73
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIG----VLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
+ +L+ L H N++RF + + + LVTE + GTLK L+
Sbjct: 74 -------EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-V 125
Query: 600 LPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLV 636
+ ++ R I G+ +LH+ +IHRDL N +
Sbjct: 126 MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 35/176 (19%), Positives = 63/176 (35%), Gaps = 33/176 (18%)
Query: 471 ASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKE--LYRVDEEAEKNFLKES 528
KSR ++ +G G FG V++ R G + +K E+N L+E
Sbjct: 4 GMKSRY--TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALRE- 60
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGG 587
V L H +V+R+ +D + + EY GG
Sbjct: 61 ------------------------VYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 96
Query: 588 TLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+L + + + + + + G+ Y+HSM+L+H D+ N +
Sbjct: 97 SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTS 152
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 36/156 (23%), Positives = 60/156 (38%), Gaps = 33/156 (21%)
Query: 488 LGQGFFGQVYR-VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
LG G FG V + V ++ V LK+ ++ + ++E
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMRE--------------- 60
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
++ L + ++R IGV + L LV E GG L + L + +P
Sbjct: 61 ----------AQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV 109
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
++ GM YL N +HRDL ++N L+
Sbjct: 110 SNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVN 145
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 52/214 (24%), Positives = 83/214 (38%), Gaps = 50/214 (23%)
Query: 447 NSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYR----VTHR 502
+ P + + + + D+V LG+G FG+V+
Sbjct: 8 SLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLP 67
Query: 503 ETGEVMV----LKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558
E +++V LKE E A ++F +E +L
Sbjct: 68 EQDKMLVAVKALKE---ASESARQDFQRE-------------------------AELLTM 99
Query: 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ--------------DPGQPLPWGQ 604
L H +++RF GV + R L +V EY+ G L L+ PL GQ
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ A +AAGM YL ++ +HRDL ++NCLV +
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 33/165 (20%), Positives = 63/165 (38%), Gaps = 34/165 (20%)
Query: 480 SDLVRGPLLGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLI 533
+ G +G+G FG V++ E + V K + + FL+E+
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEA----- 442
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
+R H ++++ IGV+ ++ ++ E G L+ L
Sbjct: 443 --------------------LTMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFL 481
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
Q L + +A ++ + YL S +HRD+ ++N LV
Sbjct: 482 QVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 526
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-25
Identities = 43/190 (22%), Positives = 68/190 (35%), Gaps = 50/190 (26%)
Query: 472 SKSRIFRASDLVRGPLLGQGFFGQVYR----VTHRETGEVMV----LKELYRVDEEAEKN 523
K + S + LG+ FG+VY+ V LK+ + +
Sbjct: 1 GKLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREE 58
Query: 524 FLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 583
F E + L H NV+ +GV+ KD+ L+++ Y
Sbjct: 59 FRHE-------------------------AMLRARLQHPNVVCLLGVVTKDQPLSMIFSY 93
Query: 584 IAGGTLKELLQ---------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628
+ G L E L L V+ IAAGM YL S +++H+D
Sbjct: 94 CSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKD 153
Query: 629 LNSQNCLVRE 638
L ++N LV +
Sbjct: 154 LATRNVLVYD 163
|
| >2cup_A Skeletal muscle LIM-protein 1; four and half LIM domains protein 1, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 Length = 101 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-25
Identities = 22/94 (23%), Positives = 36/94 (38%), Gaps = 4/94 (4%)
Query: 11 TCAGCLNNIVEDEY-VQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYNGKYG 68
C C I D V ++ WH CFRC+ C L + + KD + C + +
Sbjct: 7 GCVECRKPIGADSKEVHYKNRFWHDTCFRCAKCLHPLANETFVAKDNKILCNKCTTREDS 66
Query: 69 EACQNCGQMMSGP--VMVVGDHKFHPECFKCTSC 100
C+ C + + + +H +CF S
Sbjct: 67 PKCKGCFKAIVAGDQNVEYKGTVWHKDCFSGPSS 100
|
| >2cup_A Skeletal muscle LIM-protein 1; four and half LIM domains protein 1, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 Length = 101 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-06
Identities = 12/63 (19%), Positives = 23/63 (36%), Gaps = 4/63 (6%)
Query: 66 KYGEACQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
C C + + + + +H CF+C C + + E++ + I C C
Sbjct: 3 SGSSGCVECRKPIGADSKEVHYKNRFWHDTCFRCAKCLHPLAN-ETFVAKDNKI-LCNKC 60
Query: 124 YKR 126
R
Sbjct: 61 TTR 63
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 51/185 (27%)
Query: 477 FRASDLVRGPLLGQGFFGQVYR----VTHRETGEVMV----LKELYRVDEEAEKNFLKES 528
+ D+V LG+G FG+V+ +++V LK+ A K+F +E
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD---PTLAARKDFQRE- 67
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGT 588
+L +L H ++++F GV L +V EY+ G
Sbjct: 68 ------------------------AELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 103
Query: 589 LKELLQ---------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
L + L+ L Q ++ A IA+GM YL S + +HRDL ++N
Sbjct: 104 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRN 163
Query: 634 CLVRE 638
CLV
Sbjct: 164 CLVGA 168
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 38/175 (21%), Positives = 68/175 (38%), Gaps = 33/175 (18%)
Query: 469 VEASKSRIFRASDLVRGPLLGQGFFGQVYR-VTHRETGEVMV----LKELYRVDEEAEKN 523
++ K + R + L+ LG G FG V + V ++ V LK+ ++ +
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEE 382
Query: 524 FLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEY 583
++E ++ L + ++R IGV + L LV E
Sbjct: 383 MMRE-------------------------AQIMHQLDNPYIVRLIGVC-QAEALMLVMEM 416
Query: 584 IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
GG L + L + +P ++ GM YL N +HR+L ++N L+
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVN 471
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 44/176 (25%), Positives = 66/176 (37%), Gaps = 43/176 (24%)
Query: 480 SDLVRGPLLGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLI 533
G +LG+G FG V + + V V LK + E+ FL+E
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLRE------ 75
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGV------LYKDRKLNLVTEYIAGG 587
A ++ H +V + +GV + ++ ++ G
Sbjct: 76 -------------------AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG 116
Query: 588 TLKELLQ-----DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L L + LP V F DIA GM YL S N IHRDL ++NC++ E
Sbjct: 117 DLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAE 172
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 42/175 (24%)
Query: 480 SDLVRGPLLGQGFFGQVYR--VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQGLI 533
+ L+ G +LG+G FG V + + + V +K E E+ FL E
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSE------ 86
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGT 588
A ++ H NVIR +GV + K ++ ++ G
Sbjct: 87 -------------------AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 589 LKELLQ-----DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L L + +P + F DIA GM YL + N +HRDL ++NC++R+
Sbjct: 128 LHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD 182
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 45/183 (24%), Positives = 69/183 (37%), Gaps = 48/183 (26%)
Query: 477 FRASDLVRGPLLGQGFFGQVYR-VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQG 531
+D+ ++G+G FGQV + ++ + +KE ++ ++F E
Sbjct: 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGE---- 75
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLK 590
+ VL L HH N+I +G L L EY G L
Sbjct: 76 ---------------------LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 114
Query: 591 ELLQ---------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ L+ L Q ++FA D+A GM YL IHRDL ++N L
Sbjct: 115 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 174
Query: 636 VRE 638
V E
Sbjct: 175 VGE 177
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 35/176 (19%), Positives = 68/176 (38%), Gaps = 44/176 (25%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
F++ L + +G FG V++ V V K + ++++ E +
Sbjct: 21 FQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAV-KIF---PIQDKQSWQNEYE------- 68
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN----LVTEYIAGGTLKEL 592
V L + H N+++FIG + ++ L+T + G+L +
Sbjct: 69 ----------------VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112
Query: 593 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL----------IHRDLNSQNCLVRE 638
L+ + W + + A +A G+ YLH HRD+ S+N L++
Sbjct: 113 LK--ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKN 166
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 33/156 (21%), Positives = 67/156 (42%), Gaps = 31/156 (19%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELY---RVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
+G+G F +VYR G + LK++ +D +A + +KE
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKE---------------- 82
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPL 600
+ +L+ L+H NVI++ +D +LN+V E G L +++ + +
Sbjct: 83 ---------IDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 133
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
P + + + + ++HS ++HRD+ N +
Sbjct: 134 PERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 169
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 43/190 (22%), Positives = 74/190 (38%), Gaps = 58/190 (30%)
Query: 480 SDLVRGPLLGQGFFGQVYR----VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQG 531
+++ +G+G FG+V++ MV LKE + + +F +E
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQRE---- 100
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
A++ + N+++ +GV + + L+ EY+A G L E
Sbjct: 101 ---------------------AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 592 LLQ-----------------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628
L+ PL +++ AR +AAGM YL +HRD
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199
Query: 629 LNSQNCLVRE 638
L ++NCLV E
Sbjct: 200 LATRNCLVGE 209
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 34/153 (22%), Positives = 65/153 (42%), Gaps = 28/153 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKE--LYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G FG+ V E G V+KE + R+ + + +E
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRRE----------------- 73
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWG 603
VAVL ++ H N++++ ++ L +V +Y GG L + + G
Sbjct: 74 --------VAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQED 125
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
Q +++ I + ++H ++HRD+ SQN +
Sbjct: 126 QILDWFVQICLALKHVHDRKILHRDIKSQNIFL 158
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 36/168 (21%), Positives = 58/168 (34%), Gaps = 33/168 (19%)
Query: 476 IFRASDLVRGPLLGQGFFGQVYR-VTHRETGEVMV----LKELYRVDEEAEKNFLKESKQ 530
+ R + LG G FG V + + V LK D + L E
Sbjct: 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAE--- 68
Query: 531 GLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLK 590
V++ L + ++R IG+ + LV E G L
Sbjct: 69 ----------------------ANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLN 105
Query: 591 ELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ LQ + + + ++ GM YL N +HRDL ++N L+
Sbjct: 106 KYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 152
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 43/173 (24%), Positives = 63/173 (36%), Gaps = 44/173 (25%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
+L L+G+G +G VY+ + E V V K +NF+ E IY
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSLDER-PVAV-K---VFSFANRQNFINEKN---IYR---- 60
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQ 594
+ + H N+ RFI + + LV EY G+L + L
Sbjct: 61 ----------------VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS 104
Query: 595 DPGQPLPWGQRVNFARDIAAGMTYLHSMNL---------IHRDLNSQNCLVRE 638
W A + G+ YLH+ HRDLNS+N LV+
Sbjct: 105 L--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 32/157 (20%), Positives = 56/157 (35%), Gaps = 32/157 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG+G F V V G LK + +++ + +E
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE------------------- 76
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQ---DPGQP 599
+ R +H N++R + ++R + L+ + GTL ++ D G
Sbjct: 77 ------ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
L Q + I G+ +H+ HRDL N L+
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL 167
|
| >1x6a_A LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 81 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-22
Identities = 35/75 (46%), Positives = 47/75 (62%)
Query: 57 LFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERS 116
+DY GK+GE C C +M+GP MV G+ K+HPECF C SC I DG++YALV+ +
Sbjct: 4 GSSGKDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHA 63
Query: 117 ILYCGLCYKRQMQPL 131
LYCG C+ +
Sbjct: 64 TLYCGKCHNEVVSGP 78
|
| >1x6a_A LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 81 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 7e-11
Identities = 14/64 (21%), Positives = 28/64 (43%), Gaps = 4/64 (6%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML---DNWYFEKDGLLFCKEDYNGKYG 68
C GC + ++ A ++H +CF C +C V++ D + + L+C + +N
Sbjct: 18 CHGCSLLMTG-PFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLYCGKCHNEVVS 76
Query: 69 EACQ 72
Sbjct: 77 GPSS 80
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 44/185 (23%), Positives = 70/185 (37%), Gaps = 53/185 (28%)
Query: 480 SDLVRGPLLGQGFFGQVYR------VTHRETGEVMV----LKELYRVDEEAEKNFLKESK 529
L G LG+G FGQV + V V LK+ E+ + + E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSE-- 90
Query: 530 QGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGT 588
+ +++ + H N+I +G +D L ++ EY + G
Sbjct: 91 -----------------------MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 127
Query: 589 LKELLQ---------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
L+E L+ P + + + V+ +A GM YL S IHRDL ++N
Sbjct: 128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187
Query: 634 CLVRE 638
LV E
Sbjct: 188 VLVTE 192
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 39/210 (18%), Positives = 80/210 (38%), Gaps = 32/210 (15%)
Query: 433 ARVLSSRNRRDAWYNSPPKSLRP-ACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQG 491
A L+S + + ++ + L P D + P +G+G
Sbjct: 10 AHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRG 69
Query: 492 FFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551
FG+V+R+ ++TG +K+ V L+ +
Sbjct: 70 SFGEVHRMKDKQTGFQCAVKK---VR-------LEVFRV--------------------E 99
Query: 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARD 611
++ L ++ G + + +N+ E + GG+L +L++ G LP + + +
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQ 158
Query: 612 IAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
G+ YLH+ ++H D+ + N L+ GS
Sbjct: 159 ALEGLEYLHTRRILHGDVKADNVLLSSDGS 188
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 43/170 (25%), Positives = 62/170 (36%), Gaps = 39/170 (22%)
Query: 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDL 538
ASD +LGQG FGQV + + +K++ R EE L E
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSE----------- 52
Query: 539 GSHGLINNLHCFSQVAVLRSLHHHNVIRFIGV-------------LYKDRKLNLVTEYIA 585
V +L SL+H V+R+ + K L + EY
Sbjct: 53 --------------VMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCE 98
Query: 586 GGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
GTL +L+ + R I ++Y+HS +IHRDL N
Sbjct: 99 NGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF 148
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 44/185 (23%), Positives = 70/185 (37%), Gaps = 53/185 (28%)
Query: 480 SDLVRGPLLGQGFFGQVYR------VTHRETGEVMV----LKELYRVDEEAEKNFLKESK 529
L G LG+G FGQV + V V LK+ E+ + + E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKD--DATEKDLSDLVSE-- 136
Query: 530 QGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGT 588
+ +++ + H N+I +G +D L ++ EY + G
Sbjct: 137 -----------------------MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173
Query: 589 LKELLQ---------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
L+E L+ P + + + V+ +A GM YL S IHRDL ++N
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233
Query: 634 CLVRE 638
LV E
Sbjct: 234 VLVTE 238
|
| >1j2o_A FLIN2, fusion of rhombotin-2 and LIM domain-binding protein 1; LIM-interaction-domain (LID), metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 114 | Back alignment and structure |
|---|
Score = 90.9 bits (225), Expect = 5e-22
Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 7/101 (6%)
Query: 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN---WYFEKDGLLFCKEDYNG 65
+LTC GC NI + +++A+ Q WH DC C C L + K G C+ DY
Sbjct: 3 LLTCGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLR 62
Query: 66 KYGEACQNCGQMM----SGPVMVVGDHKFHPECFKCTSCSC 102
G P ++ G+ E +
Sbjct: 63 LGGSGGHMGSGGDVMVVGEPTLMGGEFGDEDERLITRLENT 103
|
| >1j2o_A FLIN2, fusion of rhombotin-2 and LIM domain-binding protein 1; LIM-interaction-domain (LID), metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 114 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 8e-06
Identities = 15/73 (20%), Positives = 23/73 (31%), Gaps = 1/73 (1%)
Query: 71 CQNCGQ-MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129
C C Q + + D +H +C C C C +G+ + C Y R
Sbjct: 6 CGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLRLGG 65
Query: 130 PLGRAKDAAFPMM 142
G M+
Sbjct: 66 SGGHMGSGGDVMV 78
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-22
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 25/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G FG+VY+ ++ETG + K + EE ++++ E
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE-------------------- 66
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ +L + H +++ +G Y D KL ++ E+ GG + ++ + + L Q
Sbjct: 67 -----IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R + + +LHS +IHRDL + N L+ G
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG 154
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 50/190 (26%), Positives = 73/190 (38%), Gaps = 58/190 (30%)
Query: 480 SDLVRGPLLGQGFFGQVYRVT----HRETGEVMV----LKELYRVDEEAEKNFLKESKQG 531
+LV G LG+G FG+V + T G V LKE ++ L E
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE--NASPSELRDLLSE---- 76
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
VL+ ++H +VI+ G +D L L+ EY G+L+
Sbjct: 77 ---------------------FNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 592 LLQ-----------------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628
L+ + L G ++FA I+ GM YL M L+HRD
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175
Query: 629 LNSQNCLVRE 638
L ++N LV E
Sbjct: 176 LAARNILVAE 185
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 8e-22
Identities = 46/185 (24%), Positives = 70/185 (37%), Gaps = 53/185 (28%)
Query: 480 SDLVRGPLLGQGFFGQVYR------VTHRETGEVMV----LKELYRVDEEAEKNFLKESK 529
LV G LG+G FGQV + V LK + ++ + E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD--LISE-- 124
Query: 530 QGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGT 588
+ +++ + H N+I +G +D L ++ EY + G
Sbjct: 125 -----------------------MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 589 LKELLQ---------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
L+E LQ +P + L V+ A +A GM YL S IHRDL ++N
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARN 221
Query: 634 CLVRE 638
LV E
Sbjct: 222 VLVTE 226
|
| >2dj7_A Actin-binding LIM protein 3; LIM domain, Zn binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-21
Identities = 23/69 (33%), Positives = 36/69 (52%)
Query: 3 DSETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKED 62
+ CAGC I + + AL ++WH CF+C C V+L Y KDG+ +C+ D
Sbjct: 9 PIKIRGPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQTCSVILTGEYISKDGVPYCESD 68
Query: 63 YNGKYGEAC 71
Y+ ++G
Sbjct: 69 YHAQFGSGP 77
|
| >2dj7_A Actin-binding LIM protein 3; LIM domain, Zn binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-07
Identities = 16/67 (23%), Positives = 25/67 (37%), Gaps = 4/67 (5%)
Query: 62 DYNGKYGEACQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYC 120
+ C C + G ++ D ++H CFKC +CS + Y + YC
Sbjct: 9 PIKIRGPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQTCSVILTG--EYISKDGVP-YC 65
Query: 121 GLCYKRQ 127
Y Q
Sbjct: 66 ESDYHAQ 72
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 41/164 (25%), Positives = 62/164 (37%), Gaps = 46/164 (28%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
L+G G FGQV++ HR G+ V+K V EK +E
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNNEK-AERE------------------- 54
Query: 547 LHCFSQVAVLRSLHHHNVIRFIG----------------VLYKDRKLNLVTEYIAGGTLK 590
V L L H N++ + G K + L + E+ GTL+
Sbjct: 55 ------VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 591 ELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
+ ++ G+ L + I G+ Y+HS LI+RDL N
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSN 152
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 30/235 (12%), Positives = 46/235 (19%), Gaps = 17/235 (7%)
Query: 429 GPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRAS----DLVR 484
G R L R Y PA + + + A + S L
Sbjct: 7 GDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKL 66
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELY---RVDEEAEKNFLKESKQGLIYLIDLGSH 541
L G V+ V E E LK + + L+
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEA-TFAAARLLGESPE 125
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN--LVTEYIAG--GTLKELLQDP- 596
+ + + N L+ + L L
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY 185
Query: 597 --GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHL 647
+ L S L+H N + G D
Sbjct: 186 VFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 30/193 (15%), Positives = 65/193 (33%), Gaps = 32/193 (16%)
Query: 448 SPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEV 507
+ + DL A++ + +G G +V++V + E ++
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQI 82
Query: 508 MVLKE--LYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN-- 563
+K L D + ++ E +A L L H+
Sbjct: 83 YAIKYVNLEEADNQTLDSYRNE-------------------------IAYLNKLQQHSDK 117
Query: 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN 623
+IR D+ + +V E L L+ + +R ++ +++ + +H
Sbjct: 118 IIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 624 LIHRDLNSQNCLV 636
++H DL N L+
Sbjct: 176 IVHSDLKPANFLI 188
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-21
Identities = 41/183 (22%), Positives = 76/183 (41%), Gaps = 28/183 (15%)
Query: 460 SRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR-VDE 518
R R +F + K + D + LG G G V++V+H+ +G VM K ++ +
Sbjct: 13 QRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP 72
Query: 519 EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN 578
++E + VL + ++ F G Y D +++
Sbjct: 73 AIRNQIIRE-------------------------LQVLHECNSPYIVGFYGAFYSDGEIS 107
Query: 579 LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVR 637
+ E++ GG+L ++L+ G +P + + G+TYL ++HRD+ N LV
Sbjct: 108 ICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 166
Query: 638 EVG 640
G
Sbjct: 167 SRG 169
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 29/156 (18%), Positives = 59/156 (37%), Gaps = 28/156 (17%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+LGQG V+R H++TG++ +K
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQ------------ 54
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN--LVTEYIAGGTLKELLQDPGQPLPW 602
+ VL+ L+H N+++ + + + L+ E+ G+L +L++P
Sbjct: 55 -----MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109
Query: 603 GQRV--NFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ RD+ GM +L ++HR++ N +
Sbjct: 110 PESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMR 145
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-21
Identities = 29/162 (17%), Positives = 52/162 (32%), Gaps = 40/162 (24%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
LG+G FG V+ ++ +K + E A + ++E
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMRE------------------ 53
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGV------------LYKDRKLNLVTEYIAGGTLKELL 593
V L L H ++R+ L + + LK+ +
Sbjct: 54 -------VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM 106
Query: 594 --QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
+ + ++ IA + +LHS L+HRDL N
Sbjct: 107 NGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSN 148
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 8e-21
Identities = 31/162 (19%), Positives = 59/162 (36%), Gaps = 37/162 (22%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKE--LYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G G +G+ ++ + G+++V KE + E ++ + E
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSE----------------- 55
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIG--VLYKDRKLNLVTEYIAGGTLKELLQD---PGQP 599
V +LR L H N++R+ + + L +V EY GG L ++ Q
Sbjct: 56 --------VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNL-----IHRDLNSQNCLV 636
L + + + H + +HRDL N +
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 9e-21
Identities = 40/181 (22%), Positives = 65/181 (35%), Gaps = 49/181 (27%)
Query: 480 SDLVRGPLLGQGFFGQVYRVT----HRETGEVMV----LKELYRVDEEAEKNFLKESKQG 531
++L G LG G FG+V T +E + V LK DE+ + E K
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA--LMSELK-- 101
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLK 590
++ L H N++ +G + ++TEY G L
Sbjct: 102 -----------------------IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 591 ELLQD-------------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
L+ ++F+ +A GM +L S N IHRD+ ++N L+
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 638 E 638
Sbjct: 199 N 199
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 36/155 (23%), Positives = 72/155 (46%), Gaps = 29/155 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG+G +G VY+ H+ETG+++ +K+ V E + +KE
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQ---VPVESDLQEIIKE------------------- 74
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+++++ +V+++ G +K+ L +V EY G++ ++++ + L +
Sbjct: 75 ------ISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ G+ YLH M IHRD+ + N L+ G
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH 163
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 41/185 (22%), Positives = 63/185 (34%), Gaps = 53/185 (28%)
Query: 480 SDLVRGPLLGQGFFGQVYRVT----HRETGEVMV----LKELYRVDEEAEKNFLKESKQG 531
+ L G LG G FG+V T + + V LK + + E
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP--SAHLTEREALMSE---- 76
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLK 590
+ VL L +H N++ +G ++TEY G L
Sbjct: 77 ---------------------LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLL 115
Query: 591 ELLQ-----------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
L+ D L ++F+ +A GM +L S N IHRDL ++N
Sbjct: 116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175
Query: 634 CLVRE 638
L+
Sbjct: 176 ILLTH 180
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQG 531
SK R + D G LG+G FG VY +++ ++ LK L++ + EK ++
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFK--AQLEKAGVEH---- 54
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
+V + L H N++R G + ++ L+ EY GT+
Sbjct: 55 ----------------QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 98
Query: 592 LLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
LQ + + ++A ++Y HS +IHRD+ +N L+
Sbjct: 99 ELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 142
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 30/162 (18%), Positives = 60/162 (37%), Gaps = 28/162 (17%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+LGQG V+R H++TG++ +K
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQ------------ 54
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN--LVTEYIAGGTLKELLQDPGQPLPW 602
+ VL+ L+H N+++ + + + L+ E+ G+L +L++P
Sbjct: 55 -----MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109
Query: 603 GQRV--NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG 642
+ RD+ GM +L ++HR++ N + G
Sbjct: 110 PESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDG 151
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 2e-20
Identities = 37/236 (15%), Positives = 70/236 (29%), Gaps = 12/236 (5%)
Query: 417 GTTIGCYRGLIKGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRI 476
+RG G V L +R + + A L T +
Sbjct: 13 NLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESE 72
Query: 477 F--RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIY 534
R LVRG +LGQ T +ETGE + Y + + ++ L
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 535 LIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI----AGGTLK 590
+ G + + + I V +R + +++ + L+
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 591 ELLQ------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ + L R+ + + LH L+H L + ++ + G
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 248
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 27/157 (17%), Positives = 57/157 (36%), Gaps = 32/157 (20%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKE--LYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
+G G +V++V + E ++ +K L D + ++ E
Sbjct: 13 ILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNE-------------- 57
Query: 542 GLINNLHCFSQVAVLRSLHHHN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
+A L L H+ +IR D+ + +V E L L+
Sbjct: 58 -----------IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-S 104
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ +R ++ +++ + +H ++H DL N L+
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 141
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 27/157 (17%), Positives = 57/157 (36%), Gaps = 32/157 (20%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKE--LYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
+G G +V++V + E ++ +K L D + ++ E
Sbjct: 32 ILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNE-------------- 76
Query: 542 GLINNLHCFSQVAVLRSLHHHN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
+A L L H+ +IR D+ + +V E L L+
Sbjct: 77 -----------IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-S 123
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ +R ++ +++ + +H ++H DL N L+
Sbjct: 124 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI 160
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 36/156 (23%), Positives = 56/156 (35%), Gaps = 28/156 (17%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQGLIYLIDLGS 540
G LLG+G F VYR TG + +K + + + E
Sbjct: 15 VGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE------------- 61
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL 600
V + L H +++ + LV E G + L++ +P
Sbjct: 62 ------------VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPF 109
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ +F I GM YLHS ++HRDL N L+
Sbjct: 110 SENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL 145
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 39/184 (21%), Positives = 60/184 (32%), Gaps = 52/184 (28%)
Query: 480 SDLVRGPLLGQGFFGQVYRVT----HRETGEVMV----LKELYRVDEEAEKNFLKESKQG 531
L G LG+G FGQV + V LKE + + E
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE--GATHSEHRALMSE---- 80
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGV-LYKDRKLNLVTEYIAGGTL 589
+ +L + HH NV+ +G L ++ E+ G L
Sbjct: 81 ---------------------LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL 119
Query: 590 KELLQ---------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634
L+ L + ++ +A GM +L S IHRDL ++N
Sbjct: 120 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 635 LVRE 638
L+ E
Sbjct: 180 LLSE 183
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 90.8 bits (225), Expect = 9e-20
Identities = 34/188 (18%), Positives = 61/188 (32%), Gaps = 12/188 (6%)
Query: 463 RSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK 522
+ FRVE+ R LVRG +LGQ T +ETGE + Y +
Sbjct: 58 TGQPFRVESELGE--RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115
Query: 523 NFLKESKQGLIYLIDLG---SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNL 579
+ ++ L + G +L +++ +IR L+
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 580 VTEY-IAGGTLKELLQD------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632
Y L+ + + L R+ + + LH L+H L
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 633 NCLVREVG 640
+ ++ + G
Sbjct: 236 DIVLDQRG 243
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 40/190 (21%), Positives = 65/190 (34%), Gaps = 58/190 (30%)
Query: 480 SDLVRGPLLGQGFFGQVYRVT----HRETGEVMV----LKELYRVDEEAEKNFLKESKQG 531
+L G +LG G FG+V T + + V LKE + D + + E K
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELK-- 100
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLK 590
++ L H N++ +G + L+ EY G L
Sbjct: 101 -----------------------MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLL 137
Query: 591 ELL----------------------QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628
L ++ L + + FA +A GM +L + +HRD
Sbjct: 138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197
Query: 629 LNSQNCLVRE 638
L ++N LV
Sbjct: 198 LAARNVLVTH 207
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 27/154 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+GQG G VY TG+ + ++++ + ++ + E
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE-------------------- 67
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ V+R + N++ ++ +L +V EY+AGG+L +++ + + GQ
Sbjct: 68 -----ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAA 120
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
R+ + +LHS +IHRD+ S N L+ GS
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS 154
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 35/155 (22%), Positives = 62/155 (40%), Gaps = 25/155 (16%)
Query: 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
+ + +LG G FGQV++ TG + K + + ++ E
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNE------------- 136
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPL 600
++V+ L H N+I+ + LV EY+ GG L + + D L
Sbjct: 137 ------------ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNL 184
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ F + I G+ ++H M ++H DL +N L
Sbjct: 185 TELDTILFMKQICEGIRHMHQMYILHLDLKPENIL 219
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 13/151 (8%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G +G+V + +K + +K+ + + H I
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVI-------KKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
N ++++L+SL H N+I+ V + LVTE+ GG L E + + +
Sbjct: 94 YN-----EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDECD 147
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
N + I +G+ YLH N++HRD+ +N L
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENIL 178
|
| >1m3v_A FLIN4, fusion of the LIM interacting domain of LDB1 and the N-terminal LIM domain of LMO4...; fusion protein, LMO proteins, metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 122 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 3e-19
Identities = 22/122 (18%), Positives = 38/122 (31%), Gaps = 16/122 (13%)
Query: 6 TPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW---YFEKDGLLFCKED 62
+ CAGC I + + A+ WH+ C +CS+C L + + K G++ C+ D
Sbjct: 2 SLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRND 61
Query: 63 YNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGL 122
Y +G + G + + L L
Sbjct: 62 YIRLFGNSGAGGSG------------GHMGSGGDVMVVGEPTLMGGEFGDEDER-LITRL 108
Query: 123 CY 124
Sbjct: 109 EN 110
|
| >1m3v_A FLIN4, fusion of the LIM interacting domain of LDB1 and the N-terminal LIM domain of LMO4...; fusion protein, LMO proteins, metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 122 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-07
Identities = 15/60 (25%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 68 GEACQNCGQ-MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKR 126
+ C CG + ++ D +H C KC+SC +GD + + + ++ C Y R
Sbjct: 5 WKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIR 64
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 29/154 (18%), Positives = 57/154 (37%), Gaps = 27/154 (17%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G G V + +G + +K + ++ + E
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNE-------------------- 92
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
V ++R H NV+ +L ++ E++ GG L +++ L Q
Sbjct: 93 -----VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIAT 145
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ + YLH+ +IHRD+ S + L+ G
Sbjct: 146 VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR 179
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 26/153 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G FG+V++ T +V+ +K +D E ++ +++ +Q
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQ----------------- 69
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ VL V ++ G KD KL ++ EY+ GG+ +LL+ PL Q
Sbjct: 70 ----EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIAT 123
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R+I G+ YLHS IHRD+ + N L+ E G
Sbjct: 124 ILREILKGLDYLHSEKKIHRDIKAANVLLSEHG 156
|
| >2l4z_A DNA endonuclease RBBP8, LIM domain transcription LMO4; protein-protein interaction, LIM-interaction DOM LMO4, RBBP8/CTIP, LIM-only protein; HET: DNA; NMR {Homo sapiens} Length = 123 | Back alignment and structure |
|---|
Score = 82.5 bits (203), Expect = 5e-19
Identities = 20/71 (28%), Positives = 32/71 (45%), Gaps = 3/71 (4%)
Query: 1 MEDSETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW---YFEKDGLL 57
S CAGC I + + A+ WH+ C +CS+C L + + K G++
Sbjct: 53 HMGSGGLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMI 112
Query: 58 FCKEDYNGKYG 68
C+ DY +G
Sbjct: 113 LCRNDYIRLFG 123
|
| >2l4z_A DNA endonuclease RBBP8, LIM domain transcription LMO4; protein-protein interaction, LIM-interaction DOM LMO4, RBBP8/CTIP, LIM-only protein; HET: DNA; NMR {Homo sapiens} Length = 123 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 3e-08
Identities = 17/74 (22%), Positives = 29/74 (39%), Gaps = 1/74 (1%)
Query: 54 DGLLFCKEDYNGKYGEACQNCGQ-MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYAL 112
G G + C CG + ++ D +H C KC+SC +GD + +
Sbjct: 47 GGGSGGHMGSGGLSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSY 106
Query: 113 VERSILYCGLCYKR 126
+ ++ C Y R
Sbjct: 107 TKSGMILCRNDYIR 120
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 8e-19
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 23/154 (14%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G FG VY EV+ +K++ +++ + + I
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-----------------QDIIK- 103
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+V L+ L H N I++ G ++ LV EY G +LL+ +PL +
Sbjct: 104 ----EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLEVHKKPLQEVEIAA 158
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
G+ YLHS N+IHRD+ + N L+ E G
Sbjct: 159 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 192
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 37/185 (20%), Positives = 80/185 (43%), Gaps = 31/185 (16%)
Query: 460 SRTRSRSFRVEASKSRIFRASDL-VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE 518
S +++ F++ + L+G+G +G V + +++TG ++ +K+ +
Sbjct: 4 HHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKF-LESD 62
Query: 519 EAE---KNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR 575
+ + K ++E + +L+ L H N++ + V K +
Sbjct: 63 DDKMVKKIAMRE-------------------------IKLLKQLRHENLVNLLEVCKKKK 97
Query: 576 KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ LV E++ T+ + L+ L + + I G+ + HS N+IHRD+ +N L
Sbjct: 98 RWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156
Query: 636 VREVG 640
V + G
Sbjct: 157 VSQSG 161
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 2e-18
Identities = 29/148 (19%), Positives = 59/148 (39%), Gaps = 25/148 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G FG V+R + TG V V K + + E
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNE-------------------- 98
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++++ LHH +I ++ L+ E+++GG L + + + + +N
Sbjct: 99 -----ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ R G+ ++H +++H D+ +N +
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIM 181
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 33/161 (20%), Positives = 54/161 (33%), Gaps = 34/161 (21%)
Query: 487 LLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
LLG+G F QVY T + + VLK + E
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ-------KPANPWEFY------------ 112
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD----PG 597
+ L L+ H ++F LV E + GTL + P
Sbjct: 113 -IGTQLM-----ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ +P G ++FA + + +H +IH D+ N ++
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGN 207
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 37/187 (19%), Positives = 74/187 (39%), Gaps = 29/187 (15%)
Query: 459 LSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR-VD 517
+S S ++ + F A DL +G+G +G V ++ H+ +G++M +K + VD
Sbjct: 1 MSIESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD 60
Query: 518 EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKL 577
E+ +K L + +D V+RS +++F G L+++
Sbjct: 61 EKEQKQLLMD--------LD----------------VVMRSSDCPYIVQFYGALFREGDC 96
Query: 578 NLVTEYIAGG---TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQN 633
+ E ++ K + +P + +L + +IHRD+ N
Sbjct: 97 WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSN 156
Query: 634 CLVREVG 640
L+ G
Sbjct: 157 ILLDRSG 163
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 2e-18
Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 32/159 (20%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G FG V R H++TGE + +K+ + ++++
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQC-------RQELSPKNRERW------------ 59
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQ 598
++ +++ L+H NV+ V +KL L EY GG L++ L
Sbjct: 60 -----CLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN 114
Query: 599 P--LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
L G DI++ + YLH +IHRDL +N +
Sbjct: 115 CCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIV 153
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 34/152 (22%), Positives = 66/152 (43%), Gaps = 30/152 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE---KNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G V++ +R+TG+++ +K+ E+ K L+E
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKF-LESEDDPVIKKIALRE----------------- 52
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+ +L+ L H N++ + V + R+L+LV EY T+ L + +P
Sbjct: 53 --------IRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHL 103
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + + H N IHRD+ +N L+
Sbjct: 104 VKSITWQTLQAVNFCHKHNCIHRDVKPENILI 135
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 38/168 (22%), Positives = 68/168 (40%), Gaps = 23/168 (13%)
Query: 469 VEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKES 528
+ R F D G LG+G FG VY ++ +M LK L++ + EK ++
Sbjct: 3 LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFK--SQLEKEGVEH- 59
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGT 588
++ + L H N++R + +++ L+ E+ G
Sbjct: 60 -------------------QLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGE 100
Query: 589 LKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
L + LQ G + F ++A + Y H +IHRD+ +N L+
Sbjct: 101 LYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM 147
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 6e-18
Identities = 41/192 (21%), Positives = 69/192 (35%), Gaps = 26/192 (13%)
Query: 448 SPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDL---VRGPLLGQGFFGQVYRVTHRET 504
P K+ P + + + + VRG LG+G F + + ++ +T
Sbjct: 6 DPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADT 65
Query: 505 GEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNV 564
EV K + + S L + ++++ RSL H +V
Sbjct: 66 KEVFAGKIVPK------------SL--------LLKPHQREKM--SMEISIHRSLAHQHV 103
Query: 565 IRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 624
+ F G + + +V E +L EL + R + R I G YLH +
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-YYLRQIVLGCQYLHRNRV 162
Query: 625 IHRDLNSQNCLV 636
IHRDL N +
Sbjct: 163 IHRDLKLGNLFL 174
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 6e-18
Identities = 27/196 (13%), Positives = 73/196 (37%), Gaps = 20/196 (10%)
Query: 449 PPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVM 508
P S++ LS + + + K + +D L QG F ++ + +
Sbjct: 2 PLGSMKDI--LSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKDNKFY 57
Query: 509 VLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFI 568
LK+ + E +++F K + + +++ ++ + + +
Sbjct: 58 ALKKYEKSLLEKKRDFTKSNNDKISIKSKYD--------DFKNELQIITDIKNEYCLTCE 109
Query: 569 GVLYKDRKLNLVTEYIAGGTLKELLQDPG-------QPLPWGQRVNFARDIAAGMTYLHS 621
G++ ++ ++ EY+ ++ + + +P + + +Y+H+
Sbjct: 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN 169
Query: 622 -MNLIHRDLNSQNCLV 636
N+ HRD+ N L+
Sbjct: 170 EKNICHRDVKPSNILM 185
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 8e-18
Identities = 27/158 (17%), Positives = 62/158 (39%), Gaps = 28/158 (17%)
Query: 488 LGQGF--FGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+GF V ++ TGE + ++ R++ E + +
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVR---RINLEACSNEMVTFLQG-------------- 75
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWG 603
++ V + +H N++ + D +L +VT ++A G+ K+L+ +
Sbjct: 76 -------ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNEL 128
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ + + Y+H M +HR + + + L+ G
Sbjct: 129 AIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK 166
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 8e-18
Identities = 36/154 (23%), Positives = 60/154 (38%), Gaps = 30/154 (19%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLK--ELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
LG G +G+V + T +K V + L+E
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEE--------------- 86
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLP 601
VAVL+ L H N+++ ++D++ LV E GG L + + +
Sbjct: 87 ----------VAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGGELFDEIIHRMK-FN 134
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ + +G+TYLH N++HRDL +N L
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLL 168
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 41/161 (25%), Positives = 72/161 (44%), Gaps = 34/161 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G +GQVY+ H +TG++ +K + V + E+ +E
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQE-------------------- 70
Query: 548 HCFSQVAVLRSL-HHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQD-PGQP 599
+ +L+ HH N+ + G K D +L LV E+ G++ +L+++ G
Sbjct: 71 -----INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT 125
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L R+I G+++LH +IHRD+ QN L+ E
Sbjct: 126 LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA 166
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 38/168 (22%), Positives = 74/168 (44%), Gaps = 28/168 (16%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR-VDEEAEKNFLKESKQGLIYL 535
+A DL LG+G +G V ++ H +G++M +K + V+ + +K L +
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD-------- 55
Query: 536 IDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLK--ELL 593
+D +R++ + F G L+++ + + E + K + +
Sbjct: 56 LD----------------ISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQV 99
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREVG 640
D GQ +P A I + +LHS +++IHRD+ N L+ +G
Sbjct: 100 IDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG 147
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 9e-18
Identities = 34/155 (21%), Positives = 65/155 (41%), Gaps = 31/155 (20%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQGLIYLIDLGSH 541
+LG+G FG+V + TG+ +K + + + +++ L+E
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE-------------- 76
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPL 600
V +L+ L H N+++ ++D+ LV E GG L + + +
Sbjct: 77 -----------VQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKR-F 123
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
R + +G+TY+H ++HRDL +N L
Sbjct: 124 SEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLL 158
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 1e-17
Identities = 31/160 (19%), Positives = 55/160 (34%), Gaps = 31/160 (19%)
Query: 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
+LG G G + + +K R+ E +E
Sbjct: 27 CPKDVLGHGAEGTIVYR-GMFDNRDVAVK---RILPECFSFADRE--------------- 67
Query: 543 LINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
V +LR H NVIR+ + + E TL+E ++
Sbjct: 68 ----------VQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL-CAATLQEYVEQKDFAHL 116
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ + + +G+ +LHS+N++HRDL N L+ +
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNA 156
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 37/155 (23%), Positives = 64/155 (41%), Gaps = 5/155 (3%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G V + +K L + + F + G
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 545 NNLHCFSQ-VAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
+ Q +A+L+ L H NV++ + VL + L +V E + G + E+ +PL
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLS 135
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
Q + +D+ G+ YLH +IHRD+ N LV
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 2e-17
Identities = 34/151 (22%), Positives = 60/151 (39%), Gaps = 25/151 (16%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G FG V+RVT R TG K + E ++ KE
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE----------------- 204
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+ + L H ++ D ++ ++ E+++GG L E + D + +
Sbjct: 205 --------IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE 256
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
V + R + G+ ++H N +H DL +N +
Sbjct: 257 AVEYMRQVCKGLCHMHENNYVHLDLKPENIM 287
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 28/151 (18%), Positives = 58/151 (38%), Gaps = 26/151 (17%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG+G FG V+R + + + K + +V + KE
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKE----------------- 51
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+++L H N++ +L ++ E+I+G + E + L +
Sbjct: 52 --------ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE 103
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
V++ + + +LHS N+ H D+ +N +
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENII 134
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 30/156 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE---KNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G V++ +RET E++ LK + R+D++ E + L+E
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSALRE----------------- 51
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+ +L+ L H N++R VL+ D+KL LV E+ LK+ L
Sbjct: 52 --------ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEI 102
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+F + G+ + HS N++HRDL QN L+ G
Sbjct: 103 VKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG 138
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 38/152 (25%), Positives = 61/152 (40%), Gaps = 20/152 (13%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G LG G F V + + TG E A K K + + +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGL-----------EYAAKFIKKRQSRASRRGVSR--EEIE 63
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+V++LR + HHNVI V + L+ E ++GG L + L L +
Sbjct: 64 R------EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEE 116
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+F + I G+ YLH+ + H DL +N ++
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 38/182 (20%), Positives = 60/182 (32%), Gaps = 34/182 (18%)
Query: 463 RSRSFRVEASKSRIFRASDL-----VRGPLLGQGFFGQVYRVTHRETGEVMVLKELY--R 515
S + + + LG+G F V + + TG+ K L R
Sbjct: 7 HSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR 66
Query: 516 VDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKD 574
++ L E +AVL VI V
Sbjct: 67 RGQDCRAEILHE-------------------------IAVLELAKSCPRVINLHEVYENT 101
Query: 575 RKLNLVTEYIAGGTLKE-LLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
++ L+ EY AGG + L + + + + + I G+ YLH N++H DL QN
Sbjct: 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQN 161
Query: 634 CL 635
L
Sbjct: 162 IL 163
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 36/151 (23%), Positives = 58/151 (38%), Gaps = 20/151 (13%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G LG G F V + + TG E A K K + +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGL-----------EYAAKFIKKRQSRASRRGVCREE---- 61
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+V++LR + H N+I V + L+ E ++GG L + L L +
Sbjct: 62 ----IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEEE 116
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+F + I G+ YLH+ + H DL +N +
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIM 147
|
| >1nyp_A Pinch protein; LIM domain, protein recognition, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 PDB: 1u5s_B Length = 66 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-17
Identities = 17/60 (28%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGE 69
C C +E V A+ ++WH + F C+ C+ ++E+ GL +C+ YN +G+
Sbjct: 7 ICGAC-RRPIEGRVVNAMGKQWHVEHFVCAKCEKPFLGHRHYERKGLAYCETHYNQLFGD 65
|
| >1nyp_A Pinch protein; LIM domain, protein recognition, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 PDB: 1u5s_B Length = 66 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-08
Identities = 13/61 (21%), Positives = 22/61 (36%), Gaps = 2/61 (3%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130
C C + + G V+ ++H E F C C Y + + YC Y +
Sbjct: 8 CGACRRPIEGRVVNAMGKQWHVEHFVCAKCEKPFLGHRHY--ERKGLAYCETHYNQLFGD 65
Query: 131 L 131
+
Sbjct: 66 V 66
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 34/170 (20%), Positives = 65/170 (38%), Gaps = 27/170 (15%)
Query: 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR-VDEEAEKNFLKESKQG 531
+ +DL +G G GQV+++ R+TG V+ +K++ R ++E K L +
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---- 73
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
++ + +S +++ G + + + E + K
Sbjct: 74 ------------LDVVL--------KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKL 113
Query: 592 LLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCLVREVG 640
+ G P+P I + YL +IHRD+ N L+ E G
Sbjct: 114 KKRMQG-PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG 162
|
| >1v6g_A Actin binding LIM protein 2; LIM domain, zinc binding domain, ablim2, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 81 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-17
Identities = 18/65 (27%), Positives = 25/65 (38%), Gaps = 1/65 (1%)
Query: 62 DYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCG 121
DY YG C +C Q + G V+ +HP+CF C C G+ + C
Sbjct: 9 DYQRLYGTRCFSCDQFIEGEVVSALGKTYHPDCFVCAVCRLPFPPGDRVTFNGKEC-MCQ 67
Query: 122 LCYKR 126
C
Sbjct: 68 KCSLP 72
|
| >1v6g_A Actin binding LIM protein 2; LIM domain, zinc binding domain, ablim2, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 81 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 4e-09
Identities = 14/55 (25%), Positives = 22/55 (40%), Gaps = 3/55 (5%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN--WYFEKDGLLFCKEDYN 64
C C + +E E V AL + +H DCF C+ C + C++
Sbjct: 18 CFSC-DQFIEGEVVSALGKTYHPDCFVCAVCRLPFPPGDRVTFNGKECMCQKCSL 71
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 33/154 (21%), Positives = 60/154 (38%), Gaps = 30/154 (19%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLK--ELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
+LG+G FG+V + R T + +K + L+E
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE--------------- 71
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLP 601
V +L+ L H N+++ + +D +V E GG L + + +
Sbjct: 72 ----------VELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKR-FS 119
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ + +G+TY+H N++HRDL +N L
Sbjct: 120 EHDAARIIKQVFSGITYMHKHNIVHRDLKPENIL 153
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 5e-17
Identities = 37/153 (24%), Positives = 61/153 (39%), Gaps = 23/153 (15%)
Query: 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
RG LG+G F + + ++ +T EV K + + S L
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVFAGKIVPK------------SL--------LLKPHQ 58
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
+ ++++ RSL H +V+ F G + + +V E +L EL + L
Sbjct: 59 REKM--SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEP 115
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + R I G YLH +IHRDL N +
Sbjct: 116 EARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL 148
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 6e-17
Identities = 34/153 (22%), Positives = 67/153 (43%), Gaps = 21/153 (13%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G F VY+ + T +++ +K++ ++ E+K G+ N
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKI-KLGHR------SEAKDGI-------------NR 57
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
++ +L+ L H N+I + ++LV +++ L+ +++D L
Sbjct: 58 TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKA 116
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ G+ YLH ++HRDL N L+ E G
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG 149
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 7e-17
Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 35/158 (22%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G FG V+ V R +G V+K + K+ + + +
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTI-------NKDRSQVPMEQI------------ 67
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWG 603
+++ VL+SL H N+I+ V ++D + +V E GG ELL+ G
Sbjct: 68 -----EAEIEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGG---ELLERIVSAQARG 118
Query: 604 QR------VNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ + + + Y HS +++H+DL +N L
Sbjct: 119 KALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 36/151 (23%), Positives = 57/151 (37%), Gaps = 20/151 (13%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G LG G F V + + TG+ E A K K +
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGK-----------EYAAKFIKKRRLSSSRRGVSREE---- 54
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+V +LR + H N+I + + L+ E ++GG L + L + L +
Sbjct: 55 ----IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTEDE 109
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
F + I G+ YLHS + H DL +N +
Sbjct: 110 ATQFLKQILDGVHYLHSKRIAHFDLKPENIM 140
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 31/161 (19%), Positives = 61/161 (37%), Gaps = 31/161 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G V E + +K R++ E + + E +
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLK----------------- 62
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ-------DPGQPL 600
++ + HH N++ + +L LV + ++GG++ ++++ L
Sbjct: 63 ----EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
R++ G+ YLH IHRD+ + N L+ E GS
Sbjct: 119 DESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 20/152 (13%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G LG G F V + + TG + A K K + +
Sbjct: 16 GEELGSGQFAVVKKCREKSTGL-----------QYAAKFIKKRRTKSSRRGVSRED---- 60
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+V++L+ + H NVI V + L+ E +AGG L + L + L +
Sbjct: 61 ----IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEE 115
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
F + I G+ YLHS+ + H DL +N ++
Sbjct: 116 ATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 41/159 (25%), Positives = 70/159 (44%), Gaps = 37/159 (23%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEE------AEKNFLKESKQGLIYLIDLGSH 541
LG+G + VY+ + T ++ LKE+ R++ E A ++E
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTA----IRE-------------- 50
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
V++L+ L H N++ +++ ++ L LV EY+ LK+ L D G +
Sbjct: 51 -----------VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIIN 98
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F + G+ Y H ++HRDL QN L+ E G
Sbjct: 99 MHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG 137
|
| >1x62_A C-terminal LIM domain protein 1; PDZ and LIM domain protein 1, LIM domain protein CLP-36, contractIle protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 79 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-16
Identities = 10/70 (14%), Positives = 26/70 (37%), Gaps = 2/70 (2%)
Query: 3 DSETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKE 61
++ C C + +V+ + H +C+ C+ C L +F + ++C++
Sbjct: 9 IGNAQKLPMCDKC-GTGIVGVFVKLRDRHRHPECYVCTDCGTNLKQKGHFFVEDQIYCEK 67
Query: 62 DYNGKYGEAC 71
+
Sbjct: 68 HARERVSGPS 77
|
| >1x62_A C-terminal LIM domain protein 1; PDZ and LIM domain protein 1, LIM domain protein CLP-36, contractIle protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 79 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-11
Identities = 15/70 (21%), Positives = 29/70 (41%), Gaps = 2/70 (2%)
Query: 62 DYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCG 121
N + C CG + G + + D HPEC+ CT C + + + ++ +YC
Sbjct: 9 IGNAQKLPMCDKCGTGIVGVFVKLRDRHRHPECYVCTDCGTNLKQKGHFFVEDQ--IYCE 66
Query: 122 LCYKRQMQPL 131
+ ++
Sbjct: 67 KHARERVSGP 76
|
| >2dar_A PDZ and LIM domain protein 5; enigma homolog protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 90 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-16
Identities = 24/83 (28%), Positives = 36/83 (43%), Gaps = 3/83 (3%)
Query: 49 WYFEKDGLLFCKEDY-NGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDG 107
++D L+ E GK C +C Q++ GP +V +HPE F C C +
Sbjct: 5 SSGDQDTLVQRAEHIPAGKRTPMCAHCNQVIRGPFLVALGKSWHPEEFNCAHCKNTMAYI 64
Query: 108 ESYALVERSILYCGLCYKRQMQP 130
E+ LYC LCY++
Sbjct: 65 GFV--EEKGALYCELCYEKFFAS 85
|
| >2dar_A PDZ and LIM domain protein 5; enigma homolog protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 90 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 5e-15
Identities = 16/61 (26%), Positives = 29/61 (47%), Gaps = 2/61 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYNGKYGEA 70
CA C N ++ ++ AL + WH + F C+ C + + E+ G L+C+ Y +
Sbjct: 28 CAHC-NQVIRGPFLVALGKSWHPEEFNCAHCKNTMAYIGFVEEKGALYCELCYEKFFASG 86
Query: 71 C 71
Sbjct: 87 P 87
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 33/195 (16%), Positives = 59/195 (30%), Gaps = 69/195 (35%)
Query: 485 GPLLGQGFFGQVYRVTHRETGE-----VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
+GQG +G V +T +M ++ +++ + + E
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTE------------ 78
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
V +++ LHH N+ R V ++ + LV E GG L + L
Sbjct: 79 -------------VRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 600 LPWGQRV---------------------------------------NFARDIAAGMTYLH 620
+ N R I + + YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 621 SMNLIHRDLNSQNCL 635
+ + HRD+ +N L
Sbjct: 186 NQGICHRDIKPENFL 200
|
| >1x64_A Alpha-actinin-2 associated LIM protein; LIM domain, PDZ and LIM domain 3, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 89 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 3e-16
Identities = 15/69 (21%), Positives = 28/69 (40%), Gaps = 2/69 (2%)
Query: 4 SETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKED 62
+ C C + + V+A + H +CF C+ C++ L YF +G L+C+
Sbjct: 20 GSAQRMPLCDKC-GSGIVGAVVKARDKYRHPECFVCADCNLNLKQKGYFFVEGELYCETH 78
Query: 63 YNGKYGEAC 71
+
Sbjct: 79 ARARTSGPS 87
|
| >1x64_A Alpha-actinin-2 associated LIM protein; LIM domain, PDZ and LIM domain 3, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 Length = 89 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 2e-11
Identities = 16/69 (23%), Positives = 26/69 (37%), Gaps = 2/69 (2%)
Query: 63 YNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGL 122
+ + C CG + G V+ D HPECF C C+ + + + LYC
Sbjct: 20 GSAQRMPLCDKCGSGIVGAVVKARDKYRHPECFVCADCNLNLKQKGYFFVEGE--LYCET 77
Query: 123 CYKRQMQPL 131
+ +
Sbjct: 78 HARARTSGP 86
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 33/152 (21%), Positives = 58/152 (38%), Gaps = 28/152 (18%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G+V + T K++ + E F +E
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQE----------------- 56
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQPLPWG 603
+ +++SL H N+IR ++D + LV E GG L E +
Sbjct: 57 --------IEIMKSLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRV-FRES 106
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+D+ + + Y H +N+ HRDL +N L
Sbjct: 107 DAARIMKDVLSAVAYCHKLNVAHRDLKPENFL 138
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 33/167 (19%), Positives = 61/167 (36%), Gaps = 37/167 (22%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+L +G F VY +G LK L +EE + ++E
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE------------------- 75
Query: 547 LHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLN--------LVTEYIAGGTLKELLQ-DP 596
V ++ L H N+++F ++ + L+TE G ++ L + +
Sbjct: 76 ------VCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES 129
Query: 597 GQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLVREVGS 641
PL + + ++H +IHRDL +N L+ G+
Sbjct: 130 RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 29/152 (19%), Positives = 62/152 (40%), Gaps = 19/152 (12%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G G+V R+T + + ++ + + + F S + +++
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISK------RKFAIGSAREADPALNV------ 187
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+++ +L+ L+H +I+ + +V E + GG L + + + L
Sbjct: 188 -----ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR-LKEAT 240
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + + YLH +IHRDL +N L+
Sbjct: 241 CKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 272
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-16
Identities = 32/161 (19%), Positives = 61/161 (37%), Gaps = 42/161 (26%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+LG G F +V+ V R TG++ LK + + + + E
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENE----------------- 56
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+AVL+ + H N++ + LV + ++GG L + + +
Sbjct: 57 --------IAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRIL---------E 99
Query: 605 RVNF--------ARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
R + + + + + YLH ++HRDL +N L
Sbjct: 100 RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYL 140
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 36/164 (21%), Positives = 57/164 (34%), Gaps = 54/164 (32%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELY-RVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
LG+G VYR + T + LK L VD++ +
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT-------------------- 97
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
++ VL L H N+I+ + +++LV E + GG EL
Sbjct: 98 --------EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGG---ELF---------- 136
Query: 604 QR------------VNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
R + + I + YLH ++HRDL +N L
Sbjct: 137 DRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLL 180
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-16
Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 31/157 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE---KNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G VY+ ++ TGEV+ LK++ R+D E E ++E
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIRE----------------- 52
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWG 603
+++L+ L+H N+++ + V++ + KL LV E++ LK+ + +P
Sbjct: 53 --------ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLP 103
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
++ + G+ + HS ++HRDL QN L+ G
Sbjct: 104 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG 140
|
| >1a7i_A QCRP2 (LIM1); LIM domain containing proteins, metal-binding protein, zinc finger; NMR {Coturnix japonica} SCOP: g.39.1.3 g.39.1.3 PDB: 2o10_A Length = 81 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 9e-16
Identities = 21/66 (31%), Positives = 27/66 (40%), Gaps = 1/66 (1%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEA 70
C C + E VQ + +H CF C C LD+ D ++CK Y KYG
Sbjct: 10 CGACGRTVYHAEEVQCDGRSFHRCCFLCMVCRKNLDSTTVAIHDAEVYCKSCYGKKYGPK 69
Query: 71 CQNCGQ 76
GQ
Sbjct: 70 GYGYGQ 75
|
| >1a7i_A QCRP2 (LIM1); LIM domain containing proteins, metal-binding protein, zinc finger; NMR {Coturnix japonica} SCOP: g.39.1.3 g.39.1.3 PDB: 2o10_A Length = 81 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-08
Identities = 17/73 (23%), Positives = 27/73 (36%), Gaps = 3/73 (4%)
Query: 68 GEACQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKR 126
G C CG+ + FH CF C C + + A+ + + +YC CY +
Sbjct: 7 GNKCGACGRTVYHAEEVQCDGRSFHRCCFLCMVCRKNLDST-TVAIHD-AEVYCKSCYGK 64
Query: 127 QMQPLGRAKDAAF 139
+ P G
Sbjct: 65 KYGPKGYGYGQGA 77
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 38/152 (25%), Positives = 62/152 (40%), Gaps = 29/152 (19%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
L+G G FG+VY+ R+ +V + K + + F E
Sbjct: 46 LIGHGVFGKVYKGVLRDGAKVAL-KRRTPESSQGIEEFETE------------------- 85
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL---QDPGQPLPWG 603
+ L H +++ IG + ++ L+ +Y+ G LK L P + W
Sbjct: 86 ------IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
QR+ A G+ YLH+ +IHRD+ S N L
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINIL 171
|
| >1x3h_A Leupaxin; paxillin family, protein-protein interaction, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-15
Identities = 21/62 (33%), Positives = 29/62 (46%), Gaps = 2/62 (3%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYNGKYGE 69
C GC N V + Y+ A+ WH +CF C C +FE DG FC+ Y+ + G
Sbjct: 17 KCGGC-NRPVLENYLSAMDTVWHPECFVCGDCFTSFSTGSFFELDGRPFCELHYHHRRGS 75
Query: 70 AC 71
Sbjct: 76 GP 77
|
| >1x3h_A Leupaxin; paxillin family, protein-protein interaction, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-13
Identities = 17/73 (23%), Positives = 27/73 (36%), Gaps = 2/73 (2%)
Query: 55 GLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVE 114
+D+ + C C + + + D +HPECF C C G + L
Sbjct: 2 SSGSSGKDFLAMFSPKCGGCNRPVLENYLSAMDTVWHPECFVCGDCFTSFSTGSFFELDG 61
Query: 115 RSILYCGLCYKRQ 127
R +C L Y +
Sbjct: 62 R--PFCELHYHHR 72
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 35/161 (21%), Positives = 62/161 (38%), Gaps = 44/161 (27%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKEL--YRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
+LG+G FG+V + R T + +K + + L+E
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE--------------- 71
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
V +L+ L H N+++ +L +V E GG L + +
Sbjct: 72 ----------VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII-------- 113
Query: 603 GQRVNF--------ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+R F + + +G+TY+H N++HRDL +N L
Sbjct: 114 -KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENIL 153
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 31/165 (18%), Positives = 54/165 (32%), Gaps = 43/165 (26%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G G+V R+T + + A K K + +
Sbjct: 15 SKTLGSGACGEVKLAFERKTCK-----------KVAIKIISKRKFAIGSAREADPALNVE 63
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
++ +L+ L+H +I+ + +V E + GG EL
Sbjct: 64 T------EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG---ELFD---------- 103
Query: 605 RV------------NFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
+V + + + YLH +IHRDL +N L+
Sbjct: 104 KVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLS 148
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 31/152 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE---KNFLKESKQGLIYLIDLGSHGLI 544
LG+G +G+VY+ T E + +K + R++ E E ++E
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTAIRE----------------- 83
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
V++L+ L H N+I V++ + +L+L+ EY LK+ + D +
Sbjct: 84 --------VSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYM-DKNPDVSMRV 133
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+F + G+ + HS +HRDL QN L+
Sbjct: 134 IKSFLYQLINGVNFCHSRRCLHRDLKPQNLLL 165
|
| >2dlo_A Thyroid receptor-interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 81 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-15
Identities = 16/62 (25%), Positives = 29/62 (46%), Gaps = 3/62 (4%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN--WYFEKDGLLFCKEDYNGKYGE 69
CA C + + D ++A+ + +H CF C C LD + + + C ED++ K+
Sbjct: 18 CATC-SQPILDRILRAMGKAYHPGCFTCVVCHRGLDGIPFTVDATSQIHCIEDFHRKFAS 76
Query: 70 AC 71
Sbjct: 77 GP 78
|
| >2dlo_A Thyroid receptor-interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 81 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 5e-13
Identities = 15/69 (21%), Positives = 26/69 (37%), Gaps = 1/69 (1%)
Query: 59 CKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSIL 118
E E C C Q + ++ +HP CF C C + G + + S +
Sbjct: 6 SGEGCYVATLEKCATCSQPILDRILRAMGKAYHPGCFTCVVCHRGLD-GIPFTVDATSQI 64
Query: 119 YCGLCYKRQ 127
+C + R+
Sbjct: 65 HCIEDFHRK 73
|
| >1wig_A KIAA1808 protein; LIM domain, zinc finger, metal-binding protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 73 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 2e-15
Identities = 14/60 (23%), Positives = 27/60 (45%), Gaps = 1/60 (1%)
Query: 66 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYK 125
C +C + ++G V+ G+ +HP C C C +GE ++ S ++ C +
Sbjct: 3 SGSSGCDSCEKYITGRVLEAGEKHYHPSCALCVRCGQMFAEGEEM-YLQGSSIWHPACRQ 61
|
| >1wig_A KIAA1808 protein; LIM domain, zinc finger, metal-binding protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 73 | Back alignment and structure |
|---|
Score = 40.5 bits (94), Expect = 9e-05
Identities = 9/61 (14%), Positives = 18/61 (29%), Gaps = 3/61 (4%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW--YFEKDGLLFCKEDYNGKYG 68
C C + ++A + +H C C C M + + ++
Sbjct: 7 GCDSC-EKYITGRVLEAGEKHYHPSCALCVRCGQMFAEGEEMYLQGSSIWHPACRQAART 65
Query: 69 E 69
E
Sbjct: 66 E 66
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 2e-15
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 31/156 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE---KNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G VY+ + GE LK++ R+++E E ++E
Sbjct: 10 IGEGTYGVVYKAQNN-YGETFALKKI-RLEKEDEGIPSTTIRE----------------- 50
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+++L+ L H N+++ V++ ++L LV E++ LK+LL L
Sbjct: 51 --------ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVT 101
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+F + G+ Y H ++HRDL QN L+ G
Sbjct: 102 AKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG 137
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 36/161 (22%), Positives = 67/161 (41%), Gaps = 40/161 (24%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNF----LKESKQGLIYLIDLGSHGL 543
+GQG FG+V++ HR+TG+ + LK++ ++ E E F L+E
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKV-LMENEKE-GFPITALRE---------------- 66
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR--------KLNLVTEYIAGGTLKELLQD 595
+ +L+ L H NV+ I + + LV ++ L LL +
Sbjct: 67 ---------IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN 116
Query: 596 PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + + G+ Y+H ++HRD+ + N L+
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI 157
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 40/156 (25%), Positives = 71/156 (45%), Gaps = 31/156 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE---KNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G VY+ G ++ LK + R+D E E ++E
Sbjct: 29 VGEGTYGVVYKAKDS-QGRIVALKRI-RLDAEDEGIPSTAIRE----------------- 69
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+++L+ LHH N++ I V++ +R L LV E++ LK++L + L Q
Sbjct: 70 --------ISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQ 120
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ + G+ + H ++HRDL QN L+ G
Sbjct: 121 IKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG 156
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A Length = 192 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 4e-15
Identities = 21/66 (31%), Positives = 30/66 (45%), Gaps = 1/66 (1%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEA 70
C C + E V + WH CFRC+ C L++ +KDG ++CK Y +G
Sbjct: 118 CPRCGQAVYAAEKVIGAGKSWHKSCFRCAKCGKSLESTTLADKDGEIYCKGCYAKNFGPK 177
Query: 71 CQNCGQ 76
GQ
Sbjct: 178 GFGFGQ 183
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A Length = 192 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 23/116 (19%), Positives = 33/116 (28%), Gaps = 2/116 (1%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGE 69
C C + E VQ +H CF C C LD+ ++CK Y KYG
Sbjct: 9 KCGVCQKAVYFAEEVQCEGSSFHKSCFLCMVCKKNLDSTTVAVHGDEIYCKSCYGKKYGP 68
Query: 70 ACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYK 125
+ G G+ + + A C C +
Sbjct: 69 KGKGKGMGAGTLSTDKGESLGIKYEEGQS-HRPTNPNASRMAQKVGGSDGCPRCGQ 123
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A Length = 192 | Back alignment and structure |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 17/101 (16%), Positives = 33/101 (32%), Gaps = 3/101 (2%)
Query: 33 HTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQ-MMSGPVMVVGDHKFH 91
+ S + + + C CGQ + + ++ +H
Sbjct: 80 LSTDKGESLGIKYEEGQSHRPTNPNASRMAQKVGGSDGCPRCGQAVYAAEKVIGAGKSWH 139
Query: 92 PECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132
CF+C C + + + A + +YC CY + P G
Sbjct: 140 KSCFRCAKCGKSL-ESTTLADKD-GEIYCKGCYAKNFGPKG 178
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A Length = 192 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 19/115 (16%), Positives = 31/115 (26%), Gaps = 4/115 (3%)
Query: 68 GEACQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKR 126
G+ C C + + FH CF C C + + +YC CY +
Sbjct: 7 GKKCGVCQKAVYFAEEVQCEGSSFHKSCFLCMVCKKNLDSTTVAVHGDE--IYCKSCYGK 64
Query: 127 QMQPLGRAKDAAFPMMRKPHCIRLVEIQPSAHCSQGIKLALDTSQPAPPVFSNLC 181
+ P G + I+ S + S+ C
Sbjct: 65 KYGPKG-KGKGMGAGTLSTDKGESLGIKYEEGQSHRPTNPNASRMAQKVGGSDGC 118
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 5e-15
Identities = 40/161 (24%), Positives = 60/161 (37%), Gaps = 37/161 (22%)
Query: 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
V +LG G G V G + +K R+ + L E
Sbjct: 18 VSEKILGYGSSGTVV-FQGSFQGRPVAVK---RMLIDFCDIALME--------------- 58
Query: 543 LINNLHCFSQVAVLR-SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
+ +L S H NVIR+ DR L + E L++L++
Sbjct: 59 ----------IKLLTESDDHPNVIRYYCSETTDRFLYIALEL-CNLNLQDLVESKNVSDE 107
Query: 602 WGQRV------NFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + R IA+G+ +LHS+ +IHRDL QN LV
Sbjct: 108 NLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILV 148
|
| >1wyh_A SLIM 2, skeletal muscle LIM-protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-15
Identities = 15/62 (24%), Positives = 25/62 (40%), Gaps = 2/62 (3%)
Query: 12 CAGCLNNIVE-DEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGE 69
C+ C ++ ++ Q WH CF CS C+ L + + G +C Y K+
Sbjct: 8 CSACGETVMPGSRKLEYGGQTWHEHCFLCSGCEQPLGSRSFVPDKGAHYCVPCYENKFAS 67
Query: 70 AC 71
Sbjct: 68 GP 69
|
| >1wyh_A SLIM 2, skeletal muscle LIM-protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 5e-08
Identities = 16/64 (25%), Positives = 26/64 (40%), Gaps = 4/64 (6%)
Query: 66 KYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
C CG+ M + G +H CF C+ C +G S+ + + YC C
Sbjct: 3 SGSSGCSACGETVMPGSRKLEYGGQTWHEHCFLCSGCEQPLGSR-SFVPDKGAH-YCVPC 60
Query: 124 YKRQ 127
Y+ +
Sbjct: 61 YENK 64
|
| >1x61_A Thyroid receptor interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 9e-15
Identities = 19/67 (28%), Positives = 30/67 (44%), Gaps = 3/67 (4%)
Query: 11 TCAGCLNNIVEDE-YVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68
C GC ++V D V AL + +H CF CS C L ++ + +C+ Y
Sbjct: 7 GCGGCGEDVVGDGAGVVALDRVFHVGCFVCSTCRAQLRGQHFYAVERRAYCEGCYVATL- 65
Query: 69 EACQNCG 75
E+ + G
Sbjct: 66 ESGPSSG 72
|
| >1x61_A Thyroid receptor interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 5e-07
Identities = 19/59 (32%), Positives = 25/59 (42%), Gaps = 4/59 (6%)
Query: 71 CQNCGQMMSGPVMVVG--DHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQ 127
C CG+ + G V D FH CF C++C + YA+ R YC CY
Sbjct: 8 CGGCGEDVVGDGAGVVALDRVFHVGCFVCSTCRAQLRGQHFYAVERR--AYCEGCYVAT 64
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 1e-14
Identities = 40/162 (24%), Positives = 62/162 (38%), Gaps = 26/162 (16%)
Query: 477 FRASDLVRGP-LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYL 535
F + G +G+G FG VY+ T V V K+L +++
Sbjct: 27 FDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAV-KKL-------AAMVDITTEEL---- 73
Query: 536 IDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
++ V+ H N++ +G L LV Y+ G+L + L
Sbjct: 74 ----------KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC 123
Query: 596 PG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
PL W R A+ A G+ +LH + IHRD+ S N L
Sbjct: 124 LDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL 165
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 32/163 (19%), Positives = 51/163 (31%), Gaps = 41/163 (25%)
Query: 487 LLGQGFFGQVYRVTHRETGE---VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
L+G+G G VY + ++ E D +E
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQRE---------------- 84
Query: 544 INNLHCFSQVAVLRSLHHHNVI------RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
++ A L +V+ G LY + I G L +L+ G
Sbjct: 85 -------ARTAG--RLQEPHVVPIHDFGEIDGQLY------VDMRLINGVDLAAMLRRQG 129
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
PL + V R I + + H+ HRD+ +N LV
Sbjct: 130 -PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD 171
|
| >2d8z_A Four and A half LIM domains 2; skeletal muscle LIM-protein 3, LIM-domain protein DRAL, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 70 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-14
Identities = 15/62 (24%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGE 69
C C + V Q WH +CF C+AC L + +D +C + Y
Sbjct: 7 GCVQC-KKPITTGGVTYREQPWHKECFVCTACRKQLSGQRFTARDDFAYCLNCFCDLYAS 65
Query: 70 AC 71
Sbjct: 66 GP 67
|
| >2d8z_A Four and A half LIM domains 2; skeletal muscle LIM-protein 3, LIM-domain protein DRAL, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 70 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-10
Identities = 13/62 (20%), Positives = 25/62 (40%), Gaps = 2/62 (3%)
Query: 66 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYK 125
C C + ++ + + +H ECF CT+C + G+ + + YC C+
Sbjct: 3 SGSSGCVQCKKPITTGGVTYREQPWHKECFVCTACRKQLS-GQRFTARDDFA-YCLNCFC 60
Query: 126 RQ 127
Sbjct: 61 DL 62
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 33/153 (21%), Positives = 62/153 (40%), Gaps = 19/153 (12%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G FG V+ +E + +V+K F+K+ K I+ G
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNKEVVVK------------FIKKEKVLEDCWIEDPKLG-- 74
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTE-YIAGGTLKELLQDPGQPLPWG 603
++A+L + H N+I+ + + LV E + +G L + + L
Sbjct: 75 ---KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEP 130
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
R + + + YL ++IHRD+ +N ++
Sbjct: 131 LASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI 163
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 32/158 (20%), Positives = 59/158 (37%), Gaps = 31/158 (19%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEV----MVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
++G+G F V R +RETG+ +V + LK
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLK-------------- 74
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL-KELLQDPGQP 599
+ ++ L H +++ + D L +V E++ G L E+++
Sbjct: 75 ----------REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124
Query: 600 LPWGQRV--NFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ + V ++ R I + Y H N+IHRD+ L
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 37/201 (18%), Positives = 71/201 (35%), Gaps = 37/201 (18%)
Query: 447 NSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE 506
++ PK S A+ ++ D ++G+G V R HR TG
Sbjct: 63 DAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDP--KDVIGRGVSSVVRRCVHRATGH 120
Query: 507 VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVI 565
E A K +++ ++ + +LR + H ++I
Sbjct: 121 -----------EFAVKIMEVTAERLSPEQLEEVREATRR------ETHILRQVAGHPHII 163
Query: 566 RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF--------ARDIAAGMT 617
I + LV + + G L + L ++V R + ++
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYLT---------EKVALSEKETRSIMRSLLEAVS 214
Query: 618 YLHSMNLIHRDLNSQNCLVRE 638
+LH+ N++HRDL +N L+ +
Sbjct: 215 FLHANNIVHRDLKPENILLDD 235
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 33/151 (21%), Positives = 63/151 (41%), Gaps = 25/151 (16%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG+G +G+V +R T E + +K + + + + +
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENI------------ 52
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
++ + + L+H NV++F G + L EY +GG L + ++ +P
Sbjct: 53 -----KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD 106
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
F + AG+ YLH + + HRD+ +N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 33/151 (21%), Positives = 63/151 (41%), Gaps = 25/151 (16%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG+G +G+V +R T E + +K + + + + +
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENI------------ 52
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
++ + + L+H NV++F G + L EY +GG L + ++ +P
Sbjct: 53 -----KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPD 106
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
F + AG+ YLH + + HRD+ +N L
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLL 137
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 36/166 (21%), Positives = 72/166 (43%), Gaps = 26/166 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G F +V H TG + +K + +K L + +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKII-------DKTQLNPTSLQKL-------------- 61
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
F +V +++ L+H N+++ V+ ++ L L+ EY +GG + + L G + + +
Sbjct: 62 --FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARS 118
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIY 651
R I + + Y H ++HRDL ++N L+ + DF +
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 34/160 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNF--LKESKQGLIYLIDLGSHGLIN 545
LG G + VY+ ++ TG + LKE+ ++D E ++E
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIRE------------------ 53
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-----GQPL 600
+++++ L H N++R V++ + KL LV E++ LK+ + + L
Sbjct: 54 -------ISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGL 105
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F + G+ + H ++HRDL QN L+ + G
Sbjct: 106 ELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG 145
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 35/161 (21%), Positives = 56/161 (34%), Gaps = 40/161 (24%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG+G F V R H+ TG K + K Q L
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKIINT------KKLSARDFQKL------------ 52
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+ + R L H N++R + ++ LV + + GG EL +D
Sbjct: 53 -----EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG---ELFED------IVA 98
Query: 605 RVNF--------ARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
R + + I + Y HS ++HR+L +N L+
Sbjct: 99 REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 34/161 (21%), Positives = 55/161 (34%), Gaps = 40/161 (24%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG+G F V R H+ TG K + K Q L
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINT------KKLSARDFQKL------------ 75
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+ + R L H N++R + ++ LV + + GG L E +
Sbjct: 76 -----EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV---------A 121
Query: 605 RVNF--------ARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637
R + + I + Y HS ++HR+L +N L+
Sbjct: 122 REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 5e-14
Identities = 36/165 (21%), Positives = 63/165 (38%), Gaps = 47/165 (28%)
Query: 487 LLGQGFFGQVYRVT-HRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+ G G +Y G +VLK L + D EA+ + E +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQ--------------- 131
Query: 545 NNLHCFSQVAVLRSLHHHNVIR-----------FIGVLYKDRKLNLVTEYIAGGTLKELL 593
L + H ++++ V Y +V EY+ G +LK
Sbjct: 132 ----------FLAEVVHPSIVQIFNFVEHTDRHGDPVGY------IVMEYVGGQSLKRSK 175
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
GQ LP + + + +I ++YLHS+ L++ DL +N ++ E
Sbjct: 176 ---GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE 217
|
| >2cuq_A Four and A half LIM domains 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-14
Identities = 13/62 (20%), Positives = 22/62 (35%), Gaps = 2/62 (3%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGE 69
CA C + + V Q WH +C C+ C L + +D +C + +
Sbjct: 17 RCARC-SKTLTQGGVTYRDQPWHRECLVCTGCQTPLAGQQFTSRDEDPYCVACFGELFAS 75
Query: 70 AC 71
Sbjct: 76 GP 77
|
| >2cuq_A Four and A half LIM domains 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 80 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-11
Identities = 15/71 (21%), Positives = 26/71 (36%), Gaps = 2/71 (2%)
Query: 57 LFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERS 116
Y K+ C C + ++ + D +H EC CT C + G+ + +
Sbjct: 4 GSSGPCYENKFAPRCARCSKTLTQGGVTYRDQPWHRECLVCTGCQTPLA-GQQFTSRDED 62
Query: 117 ILYCGLCYKRQ 127
YC C+
Sbjct: 63 P-YCVACFGEL 72
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 5e-14
Identities = 41/159 (25%), Positives = 61/159 (38%), Gaps = 31/159 (19%)
Query: 487 LLGQGFFGQVYR----VTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
LG G VY + + + + + R EE K F +E
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVA-IKAIFIPPREKEETLKRFEREVHN------------ 64
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
+ L H N++ I V +D LV EYI G TL E ++ G PL
Sbjct: 65 ----------SS---QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSV 110
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+NF I G+ + H M ++HRD+ QN L+ +
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT 149
|
| >1iml_A CRIP, cysteine rich intestinal protein; metal-binding protein, LIM domain protein; NMR {Rattus rattus} SCOP: g.39.1.3 g.39.1.3 Length = 76 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-14
Identities = 18/70 (25%), Positives = 29/70 (41%), Gaps = 2/70 (2%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKED-YNGKYGE 69
C C + E V +L ++WH C +C C L + + E +G +C Y+ +G
Sbjct: 3 CPKCDKEVYFAERVTSLGKDWHRPCLKCEKCGKTLTSGGHAEHEGKPYCNHPCYSAMFGP 62
Query: 70 ACQNCGQMMS 79
G S
Sbjct: 63 KGFGRGGAES 72
|
| >1iml_A CRIP, cysteine rich intestinal protein; metal-binding protein, LIM domain protein; NMR {Rattus rattus} SCOP: g.39.1.3 g.39.1.3 Length = 76 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-05
Identities = 12/57 (21%), Positives = 17/57 (29%), Gaps = 2/57 (3%)
Query: 71 CQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKR 126
C C + + +H C KC C + G +A E CY
Sbjct: 3 CPKCDKEVYFAERVTSLGKDWHRPCLKCEKCGKTLTSG-GHAEHEGKPYCNHPCYSA 58
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 32/199 (16%), Positives = 63/199 (31%), Gaps = 45/199 (22%)
Query: 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGL 532
SR +D +G+G FG V+ ++ +K + E A + ++E K
Sbjct: 2 SRY--LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKA-- 57
Query: 533 IYLIDLGSHGLINNLHCFSQ------------------------------------VAVL 556
L L G++ + + + + +
Sbjct: 58 --LAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRM 115
Query: 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL--QDPGQPLPWGQRVNFARDIAA 614
N + + L + + LK+ + + + G ++ IA
Sbjct: 116 DPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAE 175
Query: 615 GMTYLHSMNLIHRDLNSQN 633
+ +LHS L+HRDL N
Sbjct: 176 AVEFLHSKGLMHRDLKPSN 194
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 8e-14
Identities = 28/156 (17%), Positives = 57/156 (36%), Gaps = 43/156 (27%)
Query: 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
++ +LG+G +V + T + +K + + +E
Sbjct: 16 LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE--------------- 60
Query: 543 LINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
V +L H NV+ I ++ + LV E + GG++ +
Sbjct: 61 ----------VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIH------- 103
Query: 602 WGQRVNF--------ARDIAAGMTYLHSMNLIHRDL 629
+R +F +D+A+ + +LH+ + HRDL
Sbjct: 104 --KRRHFNELEASVVVQDVASALDFLHNKGIAHRDL 137
|
| >2cur_A Skeletal muscle LIM-protein 1; four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 69 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-14
Identities = 14/63 (22%), Positives = 20/63 (31%), Gaps = 2/63 (3%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGE 69
C C N + + Q WH DCF C C L + + +C + Y
Sbjct: 7 GCVKC-NKAITSGGITYQDQPWHADCFVCVTCSKKLAGQRFTAVEDQYYCVDCYKNFVSG 65
Query: 70 ACQ 72
Sbjct: 66 PSS 68
|
| >2cur_A Skeletal muscle LIM-protein 1; four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 69 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-10
Identities = 17/60 (28%), Positives = 28/60 (46%), Gaps = 2/60 (3%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130
C C + ++ + D +H +CF C +CS + G+ + VE YC CYK +
Sbjct: 8 CVKCNKAITSGGITYQDQPWHADCFVCVTCSKKLA-GQRFTAVEDQY-YCVDCYKNFVSG 65
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 33/159 (20%)
Query: 485 GPLLGQGFFGQVYRVTHRETGE---VMVL-KELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
G LLG+G +G+V V ET V +L K+ R E N KE
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE------------- 56
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQD-PG 597
+ +LR L H NVI+ + VLY +K+ +V EY G ++E+L P
Sbjct: 57 ------------IQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPE 103
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ P Q + + G+ YLHS ++H+D+ N L+
Sbjct: 104 KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL 142
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 30/164 (18%), Positives = 56/164 (34%), Gaps = 50/164 (30%)
Query: 485 GPLLGQGFFGQVYRVTHRETGE-----VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
LG+G F V R G+ ++ K+L D + +
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---------------- 59
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
+ + R L H N++R + ++ L+ + + GG EL +D
Sbjct: 60 ------------EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG---ELFED---- 100
Query: 600 LPWGQRVNF--------ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
R + + I + + H M ++HR+L +N L
Sbjct: 101 --IVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLL 142
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 33/163 (20%), Positives = 59/163 (36%), Gaps = 34/163 (20%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+LG+G V R H+ T + E A K + G ++
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCK-----------EYAVKIIDV-TGGGSFSAEEVQE---- 65
Query: 545 NNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
+V +LR + H N+I+ + LV + + G L + L
Sbjct: 66 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--------- 116
Query: 604 QRVNF--------ARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
++V R + + LH +N++HRDL +N L+ +
Sbjct: 117 EKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDD 159
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 27/162 (16%), Positives = 60/162 (37%), Gaps = 46/162 (28%)
Query: 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
++ LG+G F + H+++ + +K + + E
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEAN---------------------- 51
Query: 543 LINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
++ L+ H N+++ V + LV E + GG EL +
Sbjct: 52 ------TQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG---ELFER------ 96
Query: 602 WGQRVNF--------ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
++ +F R + + ++++H + ++HRDL +N L
Sbjct: 97 IKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138
|
| >1x4k_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-13
Identities = 14/62 (22%), Positives = 21/62 (33%), Gaps = 2/62 (3%)
Query: 12 CAGCLNNIVEDEY-VQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYNGKYGE 69
C C I+ ++ WH CF C C + + KD FC Y ++
Sbjct: 8 CQECKKTIMPGTRKMEYKGSSWHETCFICHRCQQPIGTKSFIPKDNQNFCVPCYEKQHAS 67
Query: 70 AC 71
Sbjct: 68 GP 69
|
| >1x4k_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-08
Identities = 17/64 (26%), Positives = 24/64 (37%), Gaps = 4/64 (6%)
Query: 66 KYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLC 123
CQ C + M M +H CF C C IG S+ + +C C
Sbjct: 3 SGSSGCQECKKTIMPGTRKMEYKGSSWHETCFICHRCQQPIGTK-SFIPKDNQN-FCVPC 60
Query: 124 YKRQ 127
Y++Q
Sbjct: 61 YEKQ 64
|
| >2d8x_A Protein pinch; LIM domain, pinch protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 70 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-13
Identities = 16/65 (24%), Positives = 29/65 (44%), Gaps = 3/65 (4%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYNGKYGEA 70
C C + ++A++ WH +CFRC C +L D + + G C+ +N +
Sbjct: 8 CHQC-GEFIIGRVIKAMNNSWHPECFRCDLCQEVLADIGFVKNAGRHLCRPCHNREKASG 66
Query: 71 CQNCG 75
+ G
Sbjct: 67 P-SSG 70
|
| >2d8x_A Protein pinch; LIM domain, pinch protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 70 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-12
Identities = 17/58 (29%), Positives = 27/58 (46%), Gaps = 2/58 (3%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQM 128
C CG+ + G V+ ++ +HPECF+C C + D R C C+ R+
Sbjct: 8 CHQCGEFIIGRVIKAMNNSWHPECFRCDLCQEVLADIGFVKNAGR--HLCRPCHNREK 63
|
| >1x63_A Skeletal muscle LIM-protein 1; LIM domain, four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 82 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-13
Identities = 19/63 (30%), Positives = 27/63 (42%), Gaps = 2/63 (3%)
Query: 11 TCAGCLNNIV-EDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68
C GC IV D+ V+ WH DCF CS C ++ +F K +C + K+
Sbjct: 17 KCKGCFKAIVAGDQNVEYKGTVWHKDCFTCSNCKQVIGTGSFFPKGEDFYCVTCHETKFA 76
Query: 69 EAC 71
Sbjct: 77 SGP 79
|
| >1x63_A Skeletal muscle LIM-protein 1; LIM domain, four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 82 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-10
Identities = 14/75 (18%), Positives = 28/75 (37%), Gaps = 4/75 (5%)
Query: 55 GLLFCKEDYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYAL 112
+ + C+ C + + + +H +CF C++C IG G S+
Sbjct: 2 SSGSSGKCTTREDSPKCKGCFKAIVAGDQNVEYKGTVWHKDCFTCSNCKQVIGTG-SFFP 60
Query: 113 VERSILYCGLCYKRQ 127
YC C++ +
Sbjct: 61 KGEDF-YCVTCHETK 74
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 48/187 (25%), Positives = 72/187 (38%), Gaps = 42/187 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL---- 543
+G G +G VY+ +G + LK + RV G GL
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV-RVPNGGG-----------------GGGGLPIST 58
Query: 544 ---INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQD 595
+ L L + H NV+R + V R K+ LV E++ L+ L
Sbjct: 59 VREVALLR------RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK 111
Query: 596 -PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS---GFDFHLGQIY 651
P LP + R G+ +LH+ ++HRDL +N LV G+ DF L +IY
Sbjct: 112 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA-DFGLARIY 170
Query: 652 LIYVPYT 658
+ T
Sbjct: 171 SYQMALT 177
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 35/158 (22%), Positives = 64/158 (40%), Gaps = 39/158 (24%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G FG VY+ ++GE++ +K +V ++ +E
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIK---KVLQDKRFK-NRE-------------------- 97
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLY------KDRKLNLVTEYIAGGTLKELLQD---PGQ 598
+ ++R L H N++R Y + LNLV +Y+ T+ + + Q
Sbjct: 98 -----LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQ 151
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
LP + + + Y+HS + HRD+ QN L+
Sbjct: 152 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL 189
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 37/152 (24%), Positives = 66/152 (43%), Gaps = 27/152 (17%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G G FG + + T E++ +K + R G
Sbjct: 25 VKDIGSGNFGVARLMRDKLTKELVAVKYIER--------------------------GAA 58
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+ + ++ RSL H N++RF V+ L ++ EY +GG L E + + G+ +
Sbjct: 59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR-FSEDE 117
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
F + + +G++Y HSM + HRDL +N L+
Sbjct: 118 ARFFFQQLLSGVSYCHSMQICHRDLKLENTLL 149
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 34/151 (22%), Positives = 62/151 (41%), Gaps = 23/151 (15%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G LG G FG+V H+ TG + +K L K + S ++
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGHKVAVK------------ILNRQK--------IRSLDVV 55
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+ ++ L+ H ++I+ V+ +V EY++GG L + + G + +
Sbjct: 56 GKI--KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEME 112
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ I + + Y H ++HRDL +N L
Sbjct: 113 ARRLFQQILSAVDYCHRHMVVHRDLKPENVL 143
|
| >3f6q_B LIM and senescent cell antigen-like-containing domain protein 1; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 2kbx_B 3ixe_B Length = 72 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-12
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 11 TCAGCLNNIVEDE-YVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68
TC C E V + + +H CF C+ C ++E +G +C+ D+ +
Sbjct: 13 TCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGLFYEFEGRKYCEHDFQMLFA 72
|
| >3f6q_B LIM and senescent cell antigen-like-containing domain protein 1; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 2kbx_B 3ixe_B Length = 72 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 3e-09
Identities = 13/68 (19%), Positives = 23/68 (33%), Gaps = 4/68 (5%)
Query: 62 DYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILY 119
+ G C+ C + ++ +H +CF C C +G Y R Y
Sbjct: 5 YFQGSASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGLFYEFEGR--KY 62
Query: 120 CGLCYKRQ 127
C ++
Sbjct: 63 CEHDFQML 70
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 37/174 (21%), Positives = 65/174 (37%), Gaps = 39/174 (22%)
Query: 469 VEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKES 528
++ K+ I + +LG G G+V ++ ++ T E LK L +E
Sbjct: 8 LQIKKNAIIDDYKVT-SQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE- 60
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGV----LYKDRKLNLVTEY 583
V + +++R + V + L +V E
Sbjct: 61 ------------------------VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 96
Query: 584 IAGGTLKELLQDPGQPLPWGQR--VNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ GG L +QD G + +R + I + YLHS+N+ HRD+ +N L
Sbjct: 97 LDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 149
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 35/158 (22%), Positives = 51/158 (32%), Gaps = 55/158 (34%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEV----MVLKELYRVDEEAEKNFLKESKQGLIYLIDLGS 540
+G G + R H+ T ++ K EE E
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE------------------- 67
Query: 541 HGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRK-LNLVTEYIAGGTLKELLQDPGQP 599
+LR H N+I V Y D K + +VTE + GG ELL
Sbjct: 68 -------------ILLRYGQHPNIITLKDV-YDDGKYVYVVTELMKGG---ELLDK---- 106
Query: 600 LPWGQRVNF--------ARDIAAGMTYLHSMNLIHRDL 629
++ F I + YLH+ ++HRDL
Sbjct: 107 --ILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDL 142
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 31/168 (18%), Positives = 59/168 (35%), Gaps = 47/168 (27%)
Query: 487 LLGQGFFGQVYRVT----HRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
+LG G +V+ HR+ V VL+ D F +E++
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVA-VKVLRADLARDPSFYLRFRREAQN------------ 65
Query: 543 LINNLHCFSQVAVLRSLHHHNVI----------RFIGVLYKDRKLNLVTEYIAGGTLKEL 592
A +L+H ++ + Y +V EY+ G TL+++
Sbjct: 66 ----------AA---ALNHPAIVAVYDTGEAETPAGPLPY------IVMEYVDGVTLRDI 106
Query: 593 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ G P+ + + D + + H +IHRD+ N ++
Sbjct: 107 VHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN 153
|
| >2cor_A Pinch protein; LIM domain, particularly interesting NEW Cys- His protein, LIM and senescent cell antigen-like domains 1, structural genomics; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 79 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-12
Identities = 16/64 (25%), Positives = 30/64 (46%), Gaps = 2/64 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEAC 71
C C + I++++ + + +H D F C+ C L E G L+C ++ K G +
Sbjct: 18 CQKC-HAIIDEQPLIFKNDPYHPDHFNCANCGKELTADARELKGELYCLPCHD-KMGVSG 75
Query: 72 QNCG 75
+ G
Sbjct: 76 PSSG 79
|
| >2cor_A Pinch protein; LIM domain, particularly interesting NEW Cys- His protein, LIM and senescent cell antigen-like domains 1, structural genomics; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 79 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-08
Identities = 13/54 (24%), Positives = 24/54 (44%), Gaps = 3/54 (5%)
Query: 71 CQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCY 124
CQ C ++ ++ + +HP+ F C +C + A + LYC C+
Sbjct: 18 CQKCHAIIDEQPLIFKNDPYHPDHFNCANCGKELTAD---ARELKGELYCLPCH 68
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 34/158 (21%), Positives = 62/158 (39%), Gaps = 40/158 (25%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G FG V++ E+ EV +K++ D+ + +E
Sbjct: 48 IGNGSFGVVFQAKLVESDEV-AIKKV-LQDKRFK---NRE-------------------- 82
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLY------KDRKLNLVTEYIAGGTLKELLQD---PGQ 598
+ ++R + H NV+ Y + LNLV EY+ T+ + Q
Sbjct: 83 -----LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQ 136
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+P + + + Y+HS+ + HRD+ QN L+
Sbjct: 137 TMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL 174
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 42/221 (19%), Positives = 71/221 (32%), Gaps = 51/221 (23%)
Query: 428 KGPVAARVLSSRNRRDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPL 487
P A + A + P + P ++ K+ I + +
Sbjct: 11 PVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVT-SQV 69
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G G+V ++ ++ T E LK L +E
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARRE-------------------- 104
Query: 548 HCFSQVAVLRSLHHH-NVIRFIGV----LYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
V + +++R + V + L +V E + GG L +QD G
Sbjct: 105 -----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---- 155
Query: 603 GQRVNF--------ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
F + I + YLHS+N+ HRD+ +N L
Sbjct: 156 ---QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
|
| >2ehe_A Four and A half LIM domains 3; FHL-3, skeletal muscle LIM- protein 2, SLIM 2, FHL3, SLIM2, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 82 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-12
Identities = 17/63 (26%), Positives = 25/63 (39%), Gaps = 2/63 (3%)
Query: 11 TCAGCLNNIVEDE-YVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYNGKYG 68
TCA C I D + + +H CFRC C L + + +D L C + Y +
Sbjct: 17 TCAECQQLIGHDSRELFYEDRHFHEGCFRCCRCQRSLADEPFTCQDSELLCNDCYCSAFS 76
Query: 69 EAC 71
Sbjct: 77 SGP 79
|
| >2ehe_A Four and A half LIM domains 3; FHL-3, skeletal muscle LIM- protein 2, SLIM 2, FHL3, SLIM2, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 82 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-11
Identities = 16/75 (21%), Positives = 21/75 (28%), Gaps = 4/75 (5%)
Query: 58 FCKEDYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVER 115
Y+ + C C Q + D FH CF+C C + D
Sbjct: 5 SSGPCYDNTFANTCAECQQLIGHDSRELFYEDRHFHEGCFRCCRCQRSLADEPFTCQDSE 64
Query: 116 SILYCGLCYKRQMQP 130
L C CY
Sbjct: 65 --LLCNDCYCSAFSS 77
|
| >1x4l_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-12
Identities = 17/65 (26%), Positives = 27/65 (41%), Gaps = 4/65 (6%)
Query: 11 TCAGCLNNIV---EDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYNGK 66
CAGC N I +Y+ ++WH DCF C C + L + + + C +
Sbjct: 7 GCAGCTNPISGLGGTKYISFEERQWHNDCFNCKKCSLSLVGRGFLTERDDILCPDCGKDI 66
Query: 67 YGEAC 71
G +
Sbjct: 67 SGPSS 71
|
| >1x4l_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 72 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-09
Identities = 16/69 (23%), Positives = 24/69 (34%), Gaps = 6/69 (8%)
Query: 66 KYGEACQNCGQMMSGP----VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCG 121
C C +SG + + ++H +CF C CS + ER + C
Sbjct: 3 SGSSGCAGCTNPISGLGGTKYISFEERQWHNDCFNCKKCSLSLVGRGFL--TERDDILCP 60
Query: 122 LCYKRQMQP 130
C K P
Sbjct: 61 DCGKDISGP 69
|
| >1g47_A Pinch protein; LIM domain, Zn finger, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 77 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-12
Identities = 14/60 (23%), Positives = 25/60 (41%), Gaps = 2/60 (3%)
Query: 11 TCAGCLNNIVEDE-YVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68
TC C E V + + +H CF C+ C ++E +G +C+ D+ +
Sbjct: 13 TCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGLFYEFEGRKYCEHDFQMLFA 72
|
| >1g47_A Pinch protein; LIM domain, Zn finger, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 77 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-09
Identities = 14/74 (18%), Positives = 24/74 (32%), Gaps = 4/74 (5%)
Query: 59 CKEDYNGKYGEACQNCGQ--MMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERS 116
+ N C+ C + ++ +H +CF C C +G Y R
Sbjct: 2 SEFMANALASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGLFYEFEGR- 60
Query: 117 ILYCGLCYKRQMQP 130
YC ++ P
Sbjct: 61 -KYCEHDFQMLFAP 73
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 37/176 (21%), Positives = 58/176 (32%), Gaps = 27/176 (15%)
Query: 462 TRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE 521
S + R R D G +LG+G F V T +K L E
Sbjct: 12 AGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL-------E 64
Query: 522 KNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVT 581
K + + + + + + V+ L H ++ D KL
Sbjct: 65 KRHIIKENK-----VP----------YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 109
Query: 582 EYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
Y G L + ++ G F +I + + YLH +IHRDL +N L
Sbjct: 110 SYAKNGELLKYIRKIGSFDET---CTRFYTAEIVSALEYLHGKGIIHRDLKPENIL 162
|
| >2d8y_A Eplin protein; LIM domain, epithelial protein LOST in neoplasm, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 91 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-12
Identities = 22/72 (30%), Positives = 30/72 (41%), Gaps = 1/72 (1%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGE 69
TC C + E + A Q +H CFRCS C+ L Y G ++CK +N +
Sbjct: 17 TCVECQKTVYPMERLLANQQVFHISCFRCSYCNNKLSLGTYASLHGRIYCKPHFNQLFKS 76
Query: 70 ACQNCGQMMSGP 81
SGP
Sbjct: 77 KGNYDEGFGSGP 88
|
| >2d8y_A Eplin protein; LIM domain, epithelial protein LOST in neoplasm, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 91 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 4e-07
Identities = 16/71 (22%), Positives = 29/71 (40%), Gaps = 11/71 (15%)
Query: 68 GEACQNCGQMMSGPV-----MVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGL 122
E C C + V ++ FH CF+C+ C+ + G +YA + +YC
Sbjct: 15 RETCVECQK----TVYPMERLLANQQVFHISCFRCSYCNNKLSLG-TYASLH-GRIYCKP 68
Query: 123 CYKRQMQPLGR 133
+ + + G
Sbjct: 69 HFNQLFKSKGN 79
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 42/230 (18%), Positives = 82/230 (35%), Gaps = 39/230 (16%)
Query: 447 NSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE 506
+S R + + ++ K + S GPLLG G FG VY
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 507 VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH--NV 564
+ +K V+++ ++ + + + +V +L+ + V
Sbjct: 70 PVAIK---HVEKDRISDWGELPNGTRVPM----------------EVVLLKKVSSGFSGV 110
Query: 565 IRFIGVLYKDRKLNLVTEYIAGGTLKEL---LQDPGQPLPWGQRVNFARDIAAGMTYLHS 621
IR + + L+ E ++L + + G L +F + + + H+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPV--QDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN 167
Query: 622 MNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKTKKTYY 671
++HRD+ +N L+ D + G++ LI F A K T Y
Sbjct: 168 CGVLHRDIKDENILI-------DLNRGELKLID-----FGSGALLKDTVY 205
|
| >2egq_A FHL1 protein; LIM domain, four and A half LIM domains protein 1, skeletal muscle LIM- protein 1, SLIM 1, structural genomics NPPSFA; NMR {Homo sapiens} Length = 77 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 6e-12
Identities = 16/77 (20%), Positives = 27/77 (35%), Gaps = 7/77 (9%)
Query: 55 GLLFCKEDYNGKYGEACQNCGQMMSGP-----VMVVGDHKFHPECFKCTSCSCCIGDGES 109
+ Y + C C ++G V+ +H CF C CS + +
Sbjct: 2 SSGSSGDCYKNFVAKKCAGCKNPITGFGKGSSVVAYEGQSWHDYCFHCKKCSVNLANKRF 61
Query: 110 YALVERSILYCGLCYKR 126
E+ +YC C K+
Sbjct: 62 VFHQEQ--VYCPDCAKK 76
|
| >2egq_A FHL1 protein; LIM domain, four and A half LIM domains protein 1, skeletal muscle LIM- protein 1, SLIM 1, structural genomics NPPSFA; NMR {Homo sapiens} Length = 77 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 1e-10
Identities = 17/59 (28%), Positives = 22/59 (37%), Gaps = 5/59 (8%)
Query: 11 TCAGCLNNIV----EDEYVQALSQEWHTDCFRCSACDVML-DNWYFEKDGLLFCKEDYN 64
CAGC N I V Q WH CF C C V L + + ++C +
Sbjct: 17 KCAGCKNPITGFGKGSSVVAYEGQSWHDYCFHCKKCSVNLANKRFVFHQEQVYCPDCAK 75
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 7e-12
Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 24/151 (15%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG+G FG+V TH +T + + LK + + LK+S
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQKVALKFI-------SRQLLKKSDM-------------- 52
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
++ +++ L+ L H ++I+ V+ + +V EY AGG L + + + + +
Sbjct: 53 -HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKK-RMTEDE 109
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
F + I + Y H ++HRDL +N L
Sbjct: 110 GRRFFQQIICAIEYCHRHKIVHRDLKPENLL 140
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 46/223 (20%), Positives = 71/223 (31%), Gaps = 37/223 (16%)
Query: 454 RPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKEL 513
+P K R ++ GPLLG+G FG V+ + +K
Sbjct: 5 KPLQGPPAPPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIK-- 62
Query: 514 YRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH----HHNVIRFIG 569
+ + S L +VA+L + H VIR +
Sbjct: 63 -VIPRNRVLGWSPLSDSVTCPL----------------EVALLWKVGAGGGHPGVIRLLD 105
Query: 570 VLYKDRKLNLVTEY-IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628
LV E + L + + + G PL G F + A + + HS ++HRD
Sbjct: 106 WFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRD 164
Query: 629 LNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKTKKTYY 671
+ +N L+ D G LI F A Y
Sbjct: 165 IKDENILI-------DLRRGCAKLID-----FGSGALLHDEPY 195
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 21/157 (13%), Positives = 45/157 (28%), Gaps = 31/157 (19%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL---YRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
G Q ++ + L + + ++ + L +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTL-------------- 83
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
L + V R + V++ +V E+I GG+L+E+ P+
Sbjct: 84 -----------RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV--- 129
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ + +AA H + + V G
Sbjct: 130 GAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG 166
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 38/181 (20%), Positives = 64/181 (35%), Gaps = 48/181 (26%)
Query: 467 FRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLK 526
F+ K + +LG G G+V HR TG+ LK LY +
Sbjct: 16 FQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQ 70
Query: 527 ESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGV----LYKDRKLNLVTE 582
E +++ ++ +++ + V + R L ++ E
Sbjct: 71 E----------------VDHHW--------QASGGPHIVCILDVYENMHHGKRCLLIIME 106
Query: 583 YIAGGTLKELLQDPGQPLPWGQRVNF--------ARDIAAGMTYLHSMNLIHRDLNSQNC 634
+ GG L +Q+ G F RDI + +LHS N+ HRD+ +N
Sbjct: 107 CMEGGELFSRIQERGD-------QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENL 159
Query: 635 L 635
L
Sbjct: 160 L 160
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 23/151 (15%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G LG G FG+V H TG + +K L ++Q + L +G
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGHKVAVKIL--------------NRQKIRSLDVVG----- 61
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
++ L+ H ++I+ V+ + +V EY++GG L + + G L +
Sbjct: 62 ---KIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKE 117
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ I +G+ Y H ++HRDL +N L
Sbjct: 118 SRRLFQQILSGVDYCHRHMVVHRDLKPENVL 148
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 45/190 (23%), Positives = 71/190 (37%), Gaps = 50/190 (26%)
Query: 488 LGQGFFGQVYRVTH-RETGEVMVLKELYRVDEEA---------EKNFLKESKQGLIYLID 537
+G+G +G+V++ + G + LK + RV E L+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRH---------- 67
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLY-----KDRKLNLVTEYIAGGTLKEL 592
L + H NV+R V ++ KL LV E++ L
Sbjct: 68 ------------------LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTY 108
Query: 593 LQDPGQP-LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS---GFDFHLG 648
L +P +P + + G+ +LHS ++HRDL QN LV G DF L
Sbjct: 109 LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLA-DFGLA 167
Query: 649 QIYLIYVPYT 658
+IY + T
Sbjct: 168 RIYSFQMALT 177
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 40/185 (21%), Positives = 70/185 (37%), Gaps = 45/185 (24%)
Query: 461 RTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLK-----ELYR 515
+R + + R+ +A D ++G+G FG+V V H+ T +V +K E+ +
Sbjct: 51 LSRYKDTINKIRDLRM-KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIK 109
Query: 516 VDE----EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVL 571
+ E++ + + + L Q
Sbjct: 110 RSDSAFFWEERDIMAFAN-----------SPWVVQLFYAFQ------------------- 139
Query: 572 YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLN 630
DR L +V EY+ GG L L+ + P W + F ++ + +HSM IHRD+
Sbjct: 140 -DDRYLYMVMEYMPGGDLVNLMSNYDVPEKWAR---FYTAEVVLALDAIHSMGFIHRDVK 195
Query: 631 SQNCL 635
N L
Sbjct: 196 PDNML 200
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 31/155 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+LG+G FG+VY+ + V V K +E QG
Sbjct: 37 ILGRGGFGKVYKGRLADGTLVAV------------KRLKEERTQG-------------GE 71
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ---PLPWG 603
L ++V ++ H N++R G + LV Y+A G++ L++ + PL W
Sbjct: 72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWP 131
Query: 604 QRVNFARDIAAGMTYLH---SMNLIHRDLNSQNCL 635
+R A A G+ YLH +IHRD+ + N L
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANIL 166
|
| >1x68_A FHL5 protein; four-and-A-half LIM protein 5, zinc finger domain, AN actin- interacting protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 76 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-11
Identities = 14/69 (20%), Positives = 28/69 (40%), Gaps = 4/69 (5%)
Query: 11 TCAGCLNNIV---EDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEKDGLLFCKEDYNGK 66
C C I +++ +WH++CF C C V L + ++ +FC++ +G
Sbjct: 7 GCVACSKPISGLTGAKFICFQDSQWHSECFNCGKCSVSLVGKGFLTQNKEIFCQKCGSGM 66
Query: 67 YGEACQNCG 75
+
Sbjct: 67 DTDISGPSS 75
|
| >1x68_A FHL5 protein; four-and-A-half LIM protein 5, zinc finger domain, AN actin- interacting protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 76 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 2e-08
Identities = 14/65 (21%), Positives = 23/65 (35%), Gaps = 6/65 (9%)
Query: 66 KYGEACQNCGQMMSGP----VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCG 121
C C + +SG + D ++H ECF C CS + + ++C
Sbjct: 3 SGSSGCVACSKPISGLTGAKFICFQDSQWHSECFNCGKCSVSLVGKGFLTQNKE--IFCQ 60
Query: 122 LCYKR 126
C
Sbjct: 61 KCGSG 65
|
| >2cu8_A Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein, zinc-binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 76 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-11
Identities = 16/54 (29%), Positives = 23/54 (42%), Gaps = 1/54 (1%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD-NWYFEKDGLLFCKEDY 63
C C + E V +L ++WH C +C C L + E DG FC +
Sbjct: 11 KCPKCDKTVYFAEKVSSLGKDWHKFCLKCERCSKTLTPGGHAEHDGKPFCHKPC 64
|
| >2cu8_A Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein, zinc-binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 76 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 3e-05
Identities = 13/69 (18%), Positives = 21/69 (30%), Gaps = 4/69 (5%)
Query: 68 GEACQNCGQM-MSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCG-LCYK 125
C C + + +H C KC CS + G +A + +C CY
Sbjct: 9 ASKCPKCDKTVYFAEKVSSLGKDWHKFCLKCERCSKTLTPG-GHAEHD-GKPFCHKPCYA 66
Query: 126 RQMQPLGRA 134
+
Sbjct: 67 TLFGSGPSS 75
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 38/178 (21%), Positives = 70/178 (39%), Gaps = 33/178 (18%)
Query: 463 RSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK 522
+ V + R+ + D ++G+G F +V V ++TG+V +K +
Sbjct: 45 WAEPIVVRLKEVRL-QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM--------- 94
Query: 523 NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLY----KDRKLN 578
+K ++ ++ + VL + R+I L+ + L
Sbjct: 95 -----NKWDMLKRGEVS--------CFREERDVLVNGDR----RWITQLHFAFQDENYLY 137
Query: 579 LVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
LV EY GG L LL G+ +P + F +I + +H + +HRD+ N L
Sbjct: 138 LVMEYYVGGDLLTLLSKFGERIP-AEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL 194
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 27/170 (15%)
Query: 468 RVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKE 527
+ E + R LG G FG+V V H+E+G +K L +K + +
Sbjct: 29 KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVK 81
Query: 528 SKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGG 587
KQ I+ H ++ +L++++ +++ + L +V EY+AGG
Sbjct: 82 LKQ-----IE----------HTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 588 TLKELLQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ L+ G+ P F A I YLHS++LI+RDL +N L
Sbjct: 127 EMFSHLRRIGRFSEP---HARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-10
Identities = 39/183 (21%), Positives = 65/183 (35%), Gaps = 43/183 (23%)
Query: 463 RSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEV--M-VLK--ELYRVD 517
++ F + + R+ D ++G+G FG+V V + +V M +L E+ +
Sbjct: 58 WAKPFTSKVKQMRL-HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA 116
Query: 518 E----EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYK 573
E E++ L I LH Q
Sbjct: 117 ETACFREERDVLVNGD-----------SKWITTLHYAFQ--------------------D 145
Query: 574 DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQ 632
D L LV +Y GG L LL LP + F ++ + +H ++ +HRD+
Sbjct: 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLP-EEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204
Query: 633 NCL 635
N L
Sbjct: 205 NIL 207
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 49/186 (26%), Positives = 72/186 (38%), Gaps = 43/186 (23%)
Query: 465 RSFRVEASKSRIFRASDL--VRGPLLGQGFFGQVYRVTHRE--TGEVMVLKELYRVDEEA 520
F+V+ S R R DL G +G+G +G VY+ ++ + LK++
Sbjct: 5 YDFKVKLSSERE-RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI------- 56
Query: 521 EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVL--YKDRKLN 578
E + S I L LR L H NVI V + DRK+
Sbjct: 57 EGTGISMSACREIAL--------------------LRELKHPNVISLQKVFLSHADRKVW 96
Query: 579 LVTEYIAGGTLKELL--------QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630
L+ +Y A L ++ LP G + I G+ YLH+ ++HRDL
Sbjct: 97 LLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLK 155
Query: 631 SQNCLV 636
N LV
Sbjct: 156 PANILV 161
|
| >2yub_A LIMK-2, LIM domain kinase 2; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 118 | Back alignment and structure |
|---|
Score = 57.5 bits (138), Expect = 2e-10
Identities = 21/67 (31%), Positives = 36/67 (53%)
Query: 260 LTISLVQVTYRYCTGMTNNPSVPRLDPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLI 319
++++ + Y T + + ++H GDRILE+NGTPVR ++EVE I
Sbjct: 31 FSVTVESASSNYATTVQVKEVNRMHISPNNRNAIHPGDRILEINGTPVRTLRVEEVEDAI 90
Query: 320 RNTTDTV 326
+ T+ T+
Sbjct: 91 KQTSQTL 97
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 37/181 (20%), Positives = 66/181 (36%), Gaps = 46/181 (25%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G + +V+ + E +V+K L V + K +E K
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIK------------------ 82
Query: 548 HCFSQVAVLRSLHHH-NVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+L +L N+I ++ R LV E++ K+L Q L
Sbjct: 83 -------ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYD 131
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDL-------NSQNCLVREVGSGFDFHLGQIYLIYVPY 657
+ +I + Y HSM ++HRD+ + ++ +R D+ L + Y Y
Sbjct: 132 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL----IDWGLAEFYHPGQEY 187
Query: 658 T 658
Sbjct: 188 N 188
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 36/163 (22%), Positives = 55/163 (33%), Gaps = 43/163 (26%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELY--RVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
GQG FG V + TG + +K++ E +++
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD------------------ 72
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLY-------KDRKLNLVTEYIAGGTLKELL---QD 595
L LHH N+++ Y +D LN+V EY+ TL
Sbjct: 73 ----------LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYR 121
Query: 596 PGQPLPWGQRVNFARDIAAGMTYLH--SMNLIHRDLNSQNCLV 636
P F + + LH S+N+ HRD+ N LV
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV 164
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 6e-10
Identities = 36/155 (23%), Positives = 66/155 (42%), Gaps = 32/155 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G +G V + V+ +K++ RV E+ LI+
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKILRVFED-----------------------LIDCK 97
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLY-----KDRKLNLVTEYIAGGT-LKELLQDPGQPLP 601
++A+L L+H +V++ + ++ K +L +V E + K+L + P L
Sbjct: 98 RILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTP-VYLT 154
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
++ G+ Y+HS ++HRDL NCLV
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV 189
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 7e-10
Identities = 38/212 (17%), Positives = 63/212 (29%), Gaps = 51/212 (24%)
Query: 476 IFRASDLVRGPLLGQGFFGQVYR-----VTHRETGEVMVLKELYRV-DEEAEKNFLKESK 529
R L G LG+G FGQV + T + +K L + + E K
Sbjct: 19 FPR-DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 77
Query: 530 ---------------------QGLIYLI-DLGSHG-----LINNLHCFSQVAVLRSLHHH 562
G + +I + G L + + F +
Sbjct: 78 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY-KTKGARFR 136
Query: 563 NVIRFIGVLYKDRKLNLVT----------------EYIAGGTLKELLQDPGQPLPWGQRV 606
++G + D K L + + L +
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI 196
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
++ +A GM +L S IHRDL ++N L+ E
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSE 228
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 40/154 (25%), Positives = 62/154 (40%), Gaps = 31/154 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+LG+G FG+V R TG++ K+L EK +K+ K
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKG---------------E 228
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
++ +L ++ RF+ L L LV + GG LK + GQ
Sbjct: 229 AMALNEKQILEKVNS----RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP 284
Query: 603 GQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
R F A +I G+ LH +++RDL +N L
Sbjct: 285 EARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318
|
| >2co8_A NEDD9 interacting protein with calponin homology and LIM domains; zinc finger protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 82 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-09
Identities = 14/57 (24%), Positives = 21/57 (36%), Gaps = 3/57 (5%)
Query: 11 TCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW---YFEKDGLLFCKEDYN 64
CA C ++ E + +H CFRC C+ L DG +C +
Sbjct: 17 LCALCGEHLYVLERLCVNGHFFHRSCFRCHTCEATLWPGGYEQHPGDGHFYCLQHLP 73
|
| >2co8_A NEDD9 interacting protein with calponin homology and LIM domains; zinc finger protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 Length = 82 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 8e-05
Identities = 15/64 (23%), Positives = 23/64 (35%), Gaps = 9/64 (14%)
Query: 68 GEACQNCGQMMSGPV-----MVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGL 122
G+ C CG+ + + V H FH CF+C +C + G YC
Sbjct: 15 GDLCALCGE----HLYVLERLCVNGHFFHRSCFRCHTCEATLWPGGYEQHPGDGHFYCLQ 70
Query: 123 CYKR 126
+
Sbjct: 71 HLPQ 74
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 6e-09
Identities = 40/157 (25%), Positives = 64/157 (40%), Gaps = 35/157 (22%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+LG+G FG+V+ + TG++ K+L K LK+ K
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKL-------NKKRLKKRKG---------------Y 229
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLY-----KDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
+ +L +H RFI L K L LV + GG ++ + + + P
Sbjct: 230 QGAMVEKKILAKVHS----RFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 602 W--GQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
R F I +G+ +LH N+I+RDL +N L
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVL 321
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 35/164 (21%), Positives = 61/164 (37%), Gaps = 40/164 (24%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL------YRVDEE---AEKNFLKESKQGLIYLID 537
++G+G FG+VY +TG++ +K L + E E+ L L+
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS--------LVS 247
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
G I + KL+ + + + GG L L G
Sbjct: 248 TGDCPFIVCMSYAFHT--------------------PDKLSFILDLMNGGDLHYHLSQHG 287
Query: 598 QPLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ F A +I G+ ++H+ +++RDL N L+ E G
Sbjct: 288 VFSE--ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG 329
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 9e-09
Identities = 39/155 (25%), Positives = 66/155 (42%), Gaps = 27/155 (17%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
+ D LG G FG+V+ + R G +K L +K + KQ +
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQ-----V 50
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP 596
+ H + +L + H +IR G +++ ++ +YI GG L LL+
Sbjct: 51 E----------HTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS 100
Query: 597 GQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDL 629
+ P P F A ++ + YLHS ++I+RDL
Sbjct: 101 QRFPNP---VAKFYAAEVCLALEYLHSKDIIYRDL 132
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 33/161 (20%), Positives = 66/161 (40%), Gaps = 13/161 (8%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA--EKNFLKESK-------QGLIYLIDL 538
LG G FG V V E+G+ LK++ + E + +K Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGD 74
Query: 539 GSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---D 595
+++ + +++ I +++ LN++ EY+ TL ++L+
Sbjct: 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIR 133
Query: 596 PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
G+ +P + + + ++HS+ + HRD+ QN LV
Sbjct: 134 SGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLV 174
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 55.7 bits (133), Expect = 2e-08
Identities = 34/206 (16%), Positives = 65/206 (31%), Gaps = 27/206 (13%)
Query: 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGL 532
S L R +G+G FG+V++ + +K + + + K ++ L
Sbjct: 14 SHCLPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEIL 71
Query: 533 IYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVI---------------------RFIGVL 571
+I L++ C + H V
Sbjct: 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDF 131
Query: 572 YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH-SMNLIHRDLN 630
+KD +L +V E+ GG L Q + + + A + S+ HRDL+
Sbjct: 132 FKDDQLFIVLEFEFGGID--LEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 631 SQNCLVREVGSGFDFHLGQIYLIYVP 656
N L+++ + +P
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIP 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 32/159 (20%), Positives = 60/159 (37%), Gaps = 28/159 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLI---YLIDLGSHGL 543
++G+G FGQV + + + + LK + +N + +Q L L
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV--------RNEKRFHRQAAEEIRILEHLRKQDK 155
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL-QDPGQPLPW 602
N ++ + +L + N + + E + L EL+ ++ Q
Sbjct: 156 DNTMNV---IHMLENFTFRN------------HICMTFELL-SMNLYELIKKNKFQGFSL 199
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
FA I + LH +IH DL +N L+++ G
Sbjct: 200 PLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR 238
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 4e-08
Identities = 38/160 (23%), Positives = 59/160 (36%), Gaps = 45/160 (28%)
Query: 487 LLGQGFFGQVYRVTHRETGEV--M-VL-KELYRVDEE-----AEKNFLKESKQGLIYLID 537
LLG+G FG+V V + TG M +L KE+ +E E L+ ++
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-------- 63
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
H + L Q +L V EY GG L L
Sbjct: 64 ---HPFLTALKYAFQT--------------------HDRLCFVMEYANGGELFFHLSRER 100
Query: 598 Q-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
R F +I + + YLHS ++++RD+ +N +
Sbjct: 101 VFTEE---RARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 48/199 (24%), Positives = 77/199 (38%), Gaps = 44/199 (22%)
Query: 448 SPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEV 507
P+ + S+ + S + + SD ++G+G FG+V H+
Sbjct: 6 QEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVF 65
Query: 508 --M-VLK--ELYRVDEE----AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558
+ VL+ + + EE +E+N L ++ H + LH Q
Sbjct: 66 YAVKVLQKKAILKKKEEKHIMSERNVLLKN----------VKHPFLVGLHFSFQT----- 110
Query: 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-ARDIAAGM 616
KL V +YI GG L LQ P R F A +IA+ +
Sbjct: 111 ---------------ADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIASAL 152
Query: 617 TYLHSMNLIHRDLNSQNCL 635
YLHS+N+++RDL +N L
Sbjct: 153 GYLHSLNIVYRDLKPENIL 171
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 5e-08
Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 44/160 (27%)
Query: 487 LLGQGFFGQVYRVTHRETGEV--M-VL-KELYRVDEE-----AEKNFLKESKQGLIYLID 537
++G+G + +V V ++T + M V+ KEL DE+ EK+ +++
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA--------- 109
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
+H + LH Q + +L V EY+ GG L +Q
Sbjct: 110 -SNHPFLVGLHSCFQT--------------------ESRLFFVIEYVNGGDLMFHMQRQR 148
Query: 598 Q-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ P F + +I+ + YLH +I+RDL N L
Sbjct: 149 KLPEE---HARFYSAEISLALNYLHERGIIYRDLKLDNVL 185
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 39/160 (24%), Positives = 64/160 (40%), Gaps = 44/160 (27%)
Query: 487 LLGQGFFGQVYRVTHRETGEV--M-VL-KELYRVDEE-----AEKNFLKESKQGLIYLID 537
+LG+G FG+V +ETG++ + VL K++ D++ EK L +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA--------- 80
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
+H + L C Q +L V E++ GG L +Q
Sbjct: 81 -RNHPFLTQLFCCFQT--------------------PDRLFFVMEFVNGGDLMFHIQKSR 119
Query: 598 Q-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ R F A +I + + +LH +I+RDL N L
Sbjct: 120 RFDEA---RARFYAAEIISALMFLHDKGIIYRDLKLDNVL 156
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 30/155 (19%), Positives = 60/155 (38%), Gaps = 35/155 (22%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+G+G FG+V V +T ++ +K + K E + +
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNE-----VR--------- 60
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPGQ-PLP 601
+ F ++ +++ L H F+ L+ + + +V + + GG L+ LQ
Sbjct: 61 -NVFKELQIMQGLEH----PFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE 115
Query: 602 WGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
V ++ + YL + +IHRD+ N L
Sbjct: 116 ---TVKLFICELVMALDYLQNQRIIHRDMKPDNIL 147
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 44/160 (27%)
Query: 487 LLGQGFFGQVYRVTHRETGEV--M-VL-KELYRVDEE-----AEKNFLKESKQGLIYLID 537
++G+G + +V V ++T + M V+ KEL DE+ EK+ +++
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA--------- 66
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
+H + LH Q + +L V EY+ GG L +Q
Sbjct: 67 -SNHPFLVGLHSCFQT--------------------ESRLFFVIEYVNGGDLMFHMQRQR 105
Query: 598 Q-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ P F + +I+ + YLH +I+RDL N L
Sbjct: 106 KLPEE---HARFYSAEISLALNYLHERGIIYRDLKLDNVL 142
|
| >2ejy_A 55 kDa erythrocyte membrane protein; GPC, maguk, PDZ, membrane protein; NMR {Homo sapiens} PDB: 2ev8_A Length = 97 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 6e-08
Identities = 12/34 (35%), Positives = 22/34 (64%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
LH+GD ILE+NGT V + + +++ ++ T +
Sbjct: 55 LHVGDEILEINGTNVTNHSVDQLQKAMKETKGMI 88
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 7e-08
Identities = 38/160 (23%), Positives = 64/160 (40%), Gaps = 44/160 (27%)
Query: 487 LLGQGFFGQVYRVTHRETGEV--M-VL-KELYRVDEE-----AEKNFLKESKQGLIYLID 537
+LG+G FG+V+ ++T + + L K++ +D++ EK L +
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA--------- 74
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
H + ++ C Q L V EY+ GG L +Q
Sbjct: 75 -WEHPFLTHMFCTFQT--------------------KENLFFVMEYLNGGDLMYHIQSCH 113
Query: 598 Q-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ L R F A +I G+ +LHS +++RDL N L
Sbjct: 114 KFDLS---RATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 150
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 9e-08
Identities = 33/158 (20%), Positives = 61/158 (38%), Gaps = 38/158 (24%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +G VY + T + + +K++ R+ E + +
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE--------------------------DLI 67
Query: 548 HC---FSQVAVLRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGT-LKELLQDPGQ 598
C ++ +L L +IR ++ D L +V E + LK+L + P
Sbjct: 68 DCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP-I 124
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
L ++ G ++H +IHRDL NCL+
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL 162
|
| >1va8_A Maguk P55 subfamily member 5; PDZ domain, palmitoylated 5, PALS1 protein, structural genomics, riken structural genomics/proteomics initiative; NMR {Mus musculus} SCOP: b.36.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 9e-08
Identities = 14/34 (41%), Positives = 21/34 (61%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
LH GD +LE+NG +R K + EV L+ + T+
Sbjct: 67 LHEGDEVLEINGIEIRGKDVNEVFDLLSDMHGTL 100
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 40/160 (25%), Positives = 62/160 (38%), Gaps = 44/160 (27%)
Query: 487 LLGQGFFGQVYRVTHRETGEV--M-VL-KELYRVDEE-----AEKNFLKESKQGLIYLID 537
+LG+G FG+V + T E+ + +L K++ D++ EK L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP--------- 77
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
G + LH Q +L V EY+ GG L +Q G
Sbjct: 78 -GKPPFLTQLHSCFQT--------------------MDRLYFVMEYVNGGDLMYHIQQVG 116
Query: 598 Q-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ P F A +IA G+ +L S +I+RDL N +
Sbjct: 117 RFKEP---HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM 153
|
| >3o46_A Maguk P55 subfamily member 7; PDZ domain, structural genomics consortium, SGC, protein BIN; 1.30A {Homo sapiens} Length = 93 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-07
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+H+GD + EVNG PV DK +E+ ++ + +
Sbjct: 47 IHVGDELREVNGIPVEDKRPEEIIQILAQSQGAI 80
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 43/182 (23%), Positives = 74/182 (40%), Gaps = 34/182 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLK-ESKQGLIYLIDLGSHGLINN 546
+G G FG++Y T+ +T E + +K + + + L ESK IY I G G I N
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLLYESK---IYRILQGGTG-IPN 67
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+ F +NV LV + + G +L++L + L +
Sbjct: 68 VRWFGVE------GDYNV--------------LVMDLL-GPSLEDLFNFCSRKLSLKTVL 106
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAKT 666
A + + ++HS + +HRD+ N L +G G + Q+Y+I T
Sbjct: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFL---MGLGRRAN--QVYIIDFGLAKKYRDTST 161
Query: 667 KK 668
+
Sbjct: 162 HQ 163
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 36/167 (21%), Positives = 69/167 (41%), Gaps = 32/167 (19%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLK-ESKQGLIYLIDLGSHGLINN 546
+G+G FG ++ T+ + + +K ++ L+ E + Y + G G I N
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAPQLRDEYR---TYKLLAGCTG-IPN 70
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
++ F Q HNV LV + + G +L++LL G+
Sbjct: 71 VYYFGQE------GLHNV--------------LVIDLL-GPSLEDLLDLCGRKFSVKTVA 109
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLI 653
A+ + A + +H +L++RD+ N L +G + IY++
Sbjct: 110 MAAKQMLARVQSIHEKSLVYRDIKPDNFL---IGRPNSKNANMIYVV 153
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 44/205 (21%), Positives = 71/205 (34%), Gaps = 44/205 (21%)
Query: 442 RDAWYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTH 501
R + + A + + S + +D +LG+G FG+V
Sbjct: 303 RQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSER 362
Query: 502 RETGEVM---VL-KELYRVDEE-----AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552
+ T E+ +L K++ D++ EK L G + LH Q
Sbjct: 363 KGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP----------GKPPFLTQLHSCFQ 412
Query: 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNF-AR 610
+L V EY+ GG L +Q G+ P F A
Sbjct: 413 T--------------------MDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAA 449
Query: 611 DIAAGMTYLHSMNLIHRDLNSQNCL 635
+IA G+ +L S +I+RDL N +
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVM 474
|
| >1v62_A KIAA1719 protein; structural genomics, synaptic transmission, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 117 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-07
Identities = 12/34 (35%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
LH GD IL ++GT + L E L+ + ++ V
Sbjct: 61 LHPGDHILSIDGTSMEHCSLLEATKLLASISEKV 94
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 41/161 (25%), Positives = 59/161 (36%), Gaps = 46/161 (28%)
Query: 487 LLGQGFFGQVYRVTHRETGEV--M-VL-KELYRVDEE-----AEKNFLKESKQGLIYLID 537
LLG+G FG+V V + TG M +L KE+ +E E L+ S+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-------- 206
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
H + L Q +L V EY GG L L
Sbjct: 207 ---HPFLTALKYSFQT--------------------HDRLCFVMEYANGGELFFHLSRER 243
Query: 598 Q-PLPWGQRVNF-ARDIAAGMTYLHS-MNLIHRDLNSQNCL 635
R F +I + + YLHS N+++RDL +N +
Sbjct: 244 VFSED---RARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281
|
| >2yuy_A RHO GTPase activating protein 21; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 126 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 4e-07
Identities = 16/39 (41%), Positives = 22/39 (56%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L GDRI++VNG V K +V LI+N+ T+
Sbjct: 74 AFEAGLCTGDRIIKVNGESVIGKTYSQVIALIQNSDTTL 112
|
| >2yt7_A Amyloid beta A4 precursor protein-binding family A member 3; neuron-specific X11L2 protein, neuronal MUNC18-1-interacting protein 3, MINT-3; NMR {Homo sapiens} Length = 101 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-07
Identities = 11/34 (32%), Positives = 17/34 (50%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDR+ +NGT + PL + +R T
Sbjct: 56 LSIGDRLTAINGTSLVGLPLAACQAAVRETKSQT 89
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 33/159 (20%), Positives = 57/159 (35%), Gaps = 37/159 (23%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
+G G +G V + +GE + +K+L R E K +E
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELL---------------- 75
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQP 599
+L+ + H NVI + V L LV ++ L++++
Sbjct: 76 ---------LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMG---LK 122
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ + G+ Y+HS ++HRDL N V E
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE 161
|
| >1kwa_A Hcask/LIN-2 protein; PDZ domain, neurexin, syndecan, receptor clustering, kinase; 1.93A {Homo sapiens} SCOP: b.36.1.1 Length = 88 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-07
Identities = 10/34 (29%), Positives = 23/34 (67%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
LH+GD I E+NG V ++ +++++ ++R ++
Sbjct: 44 LHVGDEIREINGISVANQTVEQLQKMLREMRGSI 77
|
| >2kv8_A RGS12, regulator of G-protein signaling 12; PDZ domain, signaling protein; NMR {Homo sapiens} Length = 83 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 6e-07
Identities = 13/39 (33%), Positives = 20/39 (51%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
AD + L GD+IL VN V+ ++V LI + +
Sbjct: 36 ADFVGLRAGDQILAVNEINVKKASHEDVVKLIGKCSGVL 74
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 38/159 (23%), Positives = 62/159 (38%), Gaps = 36/159 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
+G G +G V TG + +K+LYR E K +E +
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR---------------- 76
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQP 599
+L+ + H NVI + V D L+ LV ++ G L +L++ +
Sbjct: 77 ---------LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK--HEK 124
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L + + G+ Y+H+ +IHRDL N V E
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE 163
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 7e-07
Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 39/158 (24%)
Query: 487 LLGQGFFGQVYRVTH---RETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
+LGQG FG+V+ V + ++ +K L +K LK +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDR------------- 70
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPGQ- 598
+ + +L ++H FI L+ + KL L+ +++ GG L L
Sbjct: 71 ---VRTKMERDILVEVNHP----FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123
Query: 599 PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
V F ++A + +LHS+ +I+RDL +N L
Sbjct: 124 TEE---DVKFYLAELALALDHLHSLGIIYRDLKPENIL 158
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 39/159 (24%), Positives = 60/159 (37%), Gaps = 36/159 (22%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAE--KNFLKESKQGLIYLIDLGSHGLIN 545
+G G +G V +TG + +K+L R + K +E +
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR---------------- 80
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQP 599
+L+ + H NVI + V R L LVT + G L +++ Q
Sbjct: 81 ---------LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVK--CQK 128
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L I G+ Y+HS ++IHRDL N V E
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE 167
|
| >1nf3_C PAR-6B; semi-CRIB motif, switch I and II, PDZ domain, GTPase binding domain, signaling protein; HET: GNP; 2.10A {Mus musculus} SCOP: b.36.1.1 PDB: 2lc6_A 1ry4_A 1x8s_A 2lc7_A 1rzx_A Length = 128 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 9e-07
Identities = 11/34 (32%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L + D +LEVNG V K L +V ++ + +
Sbjct: 84 LAVNDEVLEVNGIEVSGKSLDQVTDMMIANSRNL 117
|
| >2vsp_A PDZ domain-containing protein 1; membrane, cytoplasm, phosphoprotein, transport protein, CAsp; 2.60A {Homo sapiens} PDB: 2eej_A Length = 91 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-06
Identities = 16/39 (41%), Positives = 23/39 (58%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
ADL L D I+EVNG V D+P ++V I+++ V
Sbjct: 40 ADLAGLEDEDVIIEVNGVNVLDEPYEKVVDRIQSSGKNV 78
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 37/192 (19%), Positives = 69/192 (35%), Gaps = 47/192 (24%)
Query: 460 SRTRSRSFRVEASKSRIF----RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR 515
S+ + + VE S F R +L +G G G V + +K+L R
Sbjct: 5 SKRDNNFYSVEIGDST-FTVLKRYQNLKP---IGSGAQGIVCAAYDAILERNVAIKKLSR 60
Query: 516 VDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHC---FSQVAVLRSLHHHNVIRFIGVLY 572
+ N H + ++ +++ ++H N+I + V
Sbjct: 61 PFQ--------------------------NQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 94
Query: 573 KDRKLN------LVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626
+ L +V E + L +++Q L + + G+ +LHS +IH
Sbjct: 95 PQKSLEEFQDVYIVMELM-DANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIH 150
Query: 627 RDLNSQNCLVRE 638
RDL N +V+
Sbjct: 151 RDLKPSNIVVKS 162
|
| >1n7e_A AMPA receptor interacting protein GRIP; PDZ, protein binding; 1.50A {Rattus norvegicus} SCOP: b.36.1.1 PDB: 1n7f_A Length = 97 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-06
Identities = 14/34 (41%), Positives = 23/34 (67%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+H+GDRIL +N + ++ KPL E L++ +TV
Sbjct: 49 IHIGDRILAINSSSLKGKPLSEAIHLLQMAGETV 82
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 35/166 (21%), Positives = 63/166 (37%), Gaps = 30/166 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G FG++ + T E + +K L + A E + Y G I +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA-PQLHLEYR---FYKQLGSGDG-IPQV 70
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ F +N +V E + G +L++L + +
Sbjct: 71 YYFGPC------GKYNA--------------MVLELL-GPSLEDLFDLCDRTFSLKTVLM 109
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLI 653
A + + M Y+HS NLI+RD+ +N L +G + I++I
Sbjct: 110 IAIQLISRMEYVHSKNLIYRDVKPENFL---IGRPGNKTQQVIHII 152
|
| >2eaq_A LIM domain only protein 7; conserved hypothetical protein, structural genomics, NPPSFA; 1.46A {Homo sapiens} Length = 90 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-06
Identities = 9/39 (23%), Positives = 16/39 (41%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L + D I+ +N T +E E + +T
Sbjct: 41 AEFSQLQVDDEIIAINNTKFSYNDSKEWEEAMAKAQETG 79
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 42/165 (25%), Positives = 69/165 (41%), Gaps = 51/165 (30%)
Query: 487 LLGQGFFGQVYRVTH---RETGEV--M-VLKE---LYRVDE----EAEKNFLKESKQGLI 533
+LG+G +G+V++V TG++ M VLK+ + + +AE+N L+E K
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK---- 79
Query: 534 YLIDLGSHGLINNLH-CFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL 592
H I +L F Q KL L+ EY++GG L
Sbjct: 80 -------HPFIVDLIYAF-QT--------------------GGKLYLILEYLSGGELFMQ 111
Query: 593 LQDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
L+ G F +I+ + +LH +I+RDL +N +
Sbjct: 112 LEREGIFMED---TACFYLAEISMALGHLHQKGIIYRDLKPENIM 153
|
| >1m5z_A GRIP, AMPA receptor interacting protein; six beta-strands and two alpha-helices, protein binding; NMR {Rattus norvegicus} SCOP: b.36.1.1 Length = 91 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-06
Identities = 13/39 (33%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
DL L DR+L+VN RD V LI + + +
Sbjct: 45 GDLGGLKPYDRLLQVNHVRTRDFDCCLVVPLIAESGNKL 83
|
| >1vae_A Rhophilin 2, rhophilin, RHO GTPase binding protein 2; PDZ domain, intracellular signaling cascade, signal transduction; NMR {Mus musculus} SCOP: b.36.1.1 Length = 111 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 2e-06
Identities = 13/54 (24%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQIL 332
V LDP A L GD I+ + G + + EV L+++ ++ +++
Sbjct: 40 VHFLDPHCSASLAGAKEGDYIVSIQGVDCKWLTVSEVMKLLKSFGGEEVEMKVV 93
|
| >2dls_A PDZ-rhogef, RHO guanine nucleotide exchange factor 11; PDZ domain, arhgef11, KIAA0380, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2omj_A 2os6_A Length = 93 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-06
Identities = 15/40 (37%), Positives = 21/40 (52%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
A + GDRI++VNGT V + EV LI++ L
Sbjct: 42 AMKAGVKEGDRIIKVNGTMVTNSSHLEVVKLIKSGAYVAL 81
|
| >2f5y_A Regulator of G-protein signalling 3 isoform 1; PDZ domain, RGS-3, human, structural genomics, structural GE consortium, SGC, signaling protein; 2.39A {Homo sapiens} SCOP: b.36.1.1 Length = 91 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-06
Identities = 12/49 (24%), Positives = 21/49 (42%), Gaps = 2/49 (4%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
V +D A+ L D +L++N PV E+ IR+ ++
Sbjct: 28 VQAVDSGGPAERAGLQQLDTVLQLNERPVEHWKCVELAHEIRSCPSEII 76
|
| >1g9o_A NHE-RF; PDZ domain, complex, signaling protein; 1.50A {Homo sapiens} SCOP: b.36.1.1 PDB: 1i92_A 1gq4_A 1gq5_A 2ocs_A Length = 91 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-06
Identities = 15/39 (38%), Positives = 21/39 (53%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L GDR++EVNG V + Q+V IR + V
Sbjct: 40 AEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAV 78
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 28/158 (17%), Positives = 60/158 (37%), Gaps = 33/158 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+G G FG+V H + + +K + +N K ++ I
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV--------RNIKKYTRSAKI------------- 80
Query: 547 LHCFSQVAVLRSL-----HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPL 600
+ +L+ + +++N++++ G + L+ E G +L E++
Sbjct: 81 -----EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGF 134
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ +I + YL M+L H DL +N L+ +
Sbjct: 135 HIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 37/156 (23%), Positives = 66/156 (42%), Gaps = 37/156 (23%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G +G V++ R TGEV+ +K+++ + N+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ--------------------------NST 50
Query: 548 HC---FSQVAVLRSLHHH-NVIRFIGVLY--KDRKLNLVTEYIAGGT-LKELLQDPGQPL 600
F ++ +L L H N++ + VL DR + LV +Y+ T L +++ L
Sbjct: 51 DAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIR--ANIL 106
Query: 601 PWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + + YLHS L+HRD+ N L+
Sbjct: 107 EPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL 142
|
| >1whd_A RGS3, regulator of G-protein signaling 3; PDZ domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, signaling protein; NMR {Mus musculus} SCOP: b.36.1.1 Length = 100 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-06
Identities = 12/48 (25%), Positives = 20/48 (41%), Gaps = 2/48 (4%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
V +D A+ L D +L++N PV E+ IR+ +
Sbjct: 40 VQAVDSGGPAERAGLQQLDTVLQLNERPVEHWKCVELAHEIRSCPSEI 87
|
| >2rcz_A Tight junction protein ZO-1; PDZ, domain-swapping, cell junction, membrane, phosphorylati domain, protein binding; 1.70A {Homo sapiens} PDB: 2jwe_A 2osg_A Length = 81 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-06
Identities = 11/42 (26%), Positives = 22/42 (52%), Gaps = 3/42 (7%)
Query: 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV---LQRQ 330
++ GD +L++NGT + L + + LI + + +QR
Sbjct: 39 NIQEGDVVLKINGTVTENMSLTDAKTLIERSKGKLKMVVQRD 80
|
| >3r0h_A INAD, inactivation-NO-after-potential D protein; protein-protein complex, PDZ domain, peptide binding protein; 2.60A {Drosophila melanogaster} Length = 206 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 10/34 (29%), Positives = 13/34 (38%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD I + NG + P Q L + V
Sbjct: 155 LQRGDIITKFNGDALEGLPFQVCYALFKGANGKV 188
|
| >1w9e_A Syntenin 1; cell adhesion, adhesion/complex, PDZ domain, scaffolding protein signaling protein; 1.56A {Homo sapiens} SCOP: b.36.1.1 b.36.1.1 PDB: 1n99_A 1v1t_A 1obz_A 1w9o_A 1w9q_A 1ybo_A Length = 166 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 4e-06
Identities = 16/130 (12%), Positives = 37/130 (28%), Gaps = 16/130 (12%)
Query: 285 DPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQ---RQILKECRIKDLI 341
+ A L+ L GD++L++NG + +++ + R E I
Sbjct: 37 NSPASLVGLRFGDQVLQINGENCAGWSSDKAHKVLKQAFGEKITMTIRDRPFERTITMHK 96
Query: 342 IEVCLERFSCSVEVKQMLCVVSPFCWLFLAPLRLGE----------GNMRRQEAVEWRVK 391
F + S L ++ + +
Sbjct: 97 DSTGHVGFIFKNGKITSIVKDSSAA---RNGLLTEHNICEINGQNVIGLKDSQIADILST 153
Query: 392 PLSLKTLTVI 401
++ T+T++
Sbjct: 154 SGTVVTITIM 163
|
| >3e17_A Tight junction protein ZO-2; domain swapping, alternative promoter usage, alternative splicing, cell junction, cell membrane, disease mutation; 1.75A {Homo sapiens} Length = 88 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-06
Identities = 12/35 (34%), Positives = 19/35 (54%)
Query: 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+LH GD IL++NGT + L + LI + +
Sbjct: 39 NLHEGDIILKINGTVTENMSLTDARKLIEKSRGKL 73
|
| >2qkv_A Inactivation-NO-after-potential D protein; PDZ domain, scaffolding protein, membrane, sensory transduction, vision; 1.55A {Drosophila melanogaster} PDB: 2qkt_A 2qku_A Length = 96 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-06
Identities = 10/34 (29%), Positives = 13/34 (38%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD I + NG + P Q L + V
Sbjct: 50 LQRGDIITKFNGDALEGLPFQVSYALFKGANGKV 83
|
| >3cyy_A Tight junction protein ZO-1; protein-ligand complex, cell junction, membrane, phosphoprot domain, tight junction, transmembrane; 2.40A {Homo sapiens} Length = 92 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 5e-06
Identities = 9/35 (25%), Positives = 19/35 (54%)
Query: 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
++ GD +L++NGT + L + + LI + +
Sbjct: 41 NIQEGDVVLKINGTVTENMSLTDAKTLIERSKGKL 75
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 6e-06
Identities = 34/157 (21%), Positives = 56/157 (35%), Gaps = 29/157 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMV-LKELYRVDEEAEKNFLKESKQGLI---YLIDLGSHG 542
LG+G FG+V + G V +K + KN + + L L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV--------KNVDRYCEAARSEIQVLEHLNTTD 72
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLP 601
+ C V +L HH + +V E + G + + +++ G P
Sbjct: 73 PNSTFRC---VQMLEWFEHHG------------HICIVFE-LLGLSTYDFIKENGFLPFR 116
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
A I + +LHS L H DL +N L +
Sbjct: 117 LDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 6e-06
Identities = 31/160 (19%), Positives = 57/160 (35%), Gaps = 39/160 (24%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G G G V + +K+L R + N
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--------------------------NQT 103
Query: 548 HC---FSQVAVLRSLHHHNVIRFIGVLYKDRKLN------LVTEYIAGGTLKELLQDPGQ 598
H + ++ +++ ++H N+I + V + L LV E L +++Q
Sbjct: 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MDANLCQVIQ---M 159
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L + + G+ +LHS +IHRDL N +V+
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 199
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 36/164 (21%), Positives = 63/164 (38%), Gaps = 48/164 (29%)
Query: 487 LLGQGFFGQVYRVTH---RETGEV--M-VLK--ELYRVDEE-----AEKNFLKESKQGLI 533
+LG G +G+V+ V +TG++ M VLK + + + E+ L+ +Q
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ--- 117
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
+ LH Q + KL+L+ +YI GG L L
Sbjct: 118 -------SPFLVTLHYAFQT--------------------ETKLHLILDYINGGELFTHL 150
Query: 594 QDPGQ-PLPWGQRVNF-ARDIAAGMTYLHSMNLIHRDLNSQNCL 635
+ V +I + +LH + +I+RD+ +N L
Sbjct: 151 SQRERFTEH---EVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 7e-06
Identities = 62/441 (14%), Positives = 129/441 (29%), Gaps = 117/441 (26%)
Query: 284 LDPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKDLIIE 343
+D D IL V D + +C ++ D + + IL + I +I+
Sbjct: 7 MDFETGEHQYQYKD-ILSVF----EDAFVDNFDC--KDVQD--MPKSILSKEEIDHIIMS 57
Query: 344 -----------VCLERFSCSVEVKQML-CVVSP-FCWLFLAPLR--LGEGNMRRQEAVEW 388
L + V++ + V+ + +L ++P++ + +M + +E
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEM-VQKFVEEVLRINYKFL-MSPIKTEQRQPSMMTRMYIEQ 115
Query: 389 R------VKPLS------LKTLTVIGTVMINLGQNIQVVLGTTIGCYRGLIKGPVAARVL 436
R + + L+ + ++ L V++ +G G K VA V
Sbjct: 116 RDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS--G--KTWVALDVC 171
Query: 437 SSRNRRDA------W-----YNSPPKSLRPACDL---------------SRTRSRSFRVE 470
S + W NSP L L S + R ++
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ 231
Query: 471 ASKSRIFRASDLVRGPLL----------GQGF-FG-QVYRVTHRETGEVMVLKELYRVD- 517
A R+ ++ LL F ++ +T R L
Sbjct: 232 AELRRLLKSKPYENC-LLVLLNVQNAKAWNAFNLSCKIL-LTTRFKQVTDFLSAATTTHI 289
Query: 518 --EEAEKNFLK-ESKQGLIYLIDLGSHGL------INNLHCFSQVAVLRSLHHHNVIRFI 568
+ E K L+ +D L N S +A S+ + +
Sbjct: 290 SLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRL-SIIA--ESIRDG-LATWD 345
Query: 569 GVLY--KDRKLNLVT---EYIAGGTLKELLQD-----PGQPLP-------WGQRV-NFAR 610
+ D+ ++ + +++ P +P W + +
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 611 DIAAGMTYLHSMNLIHRDLNS 631
+ + LH +L+ +
Sbjct: 406 VV---VNKLHKYSLVEKQPKE 423
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 81/567 (14%), Positives = 165/567 (29%), Gaps = 169/567 (29%)
Query: 148 IRLVEIQPSAHCSQGIKLALDTSQPAPPVFSNLCISEWKLREETRTCVFYVR--LYLVLS 205
I+ + QPS I+ D VF+ +S + + R + +R +++
Sbjct: 98 IKTEQRQPSMMTRMYIE-QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLI- 155
Query: 206 VIVSATEPYLSRIKFASSGNRGLSGSCKGLMAEIALGNNHALL--------WL------- 250
G+ GS K +A ++ + WL
Sbjct: 156 --------------------DGVLGSGKTWVALDVC-LSYKVQCKMDFKIFWLNLKNCNS 194
Query: 251 -WSLLMSLVCLTISLVQVTYRYCTGMTNNPSVPRL-----DPRADLMSLHLGDRILEV-- 302
++L L L L Q+ + + ++ ++ L+ + L V
Sbjct: 195 PETVLEMLQKL---LYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251
Query: 303 NGTPVRDKPLQE---VEC--LI--RNT--TDTV------------------------LQR 329
N V++ + C L+ R TD + L
Sbjct: 252 N---VQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 330 QILKECRIKDLIIEVCLERFSCSVEVKQMLCVVSPF-CWLFLAPLRLGEGNMRRQEAVEW 388
+ L +CR +DL EV +P + +R +G W
Sbjct: 309 KYL-DCRPQDLPREVLT---------------TNPRRLSIIAESIR--DGLATWD---NW 347
Query: 389 RVKPLSLKTLTVIGTVMINLGQNIQVVLGTTIGCYRGL-I--KG-PVAARVLSSRNRRDA 444
+ K T+I + + L + L + + +LS
Sbjct: 348 K-HVNCDKLTTIIESSLNVLEPAEYR------KMFDRLSVFPPSAHIPTILLSL-----I 395
Query: 445 WYNSPPKSLRPACDLSRTRSRSFRVEASKSRIFRASDL---VRGPLLGQGFFGQVYRVTH 501
W++ +++ S + K + ++ L + H
Sbjct: 396 WFDVIKSD--VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENE-------YALH 446
Query: 502 RETGEVMVLKELYRVDEEAEKN-FLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560
R + + Y + + + + + Y +G H L N H ++ + R +
Sbjct: 447 RS------IVDHYNIPKTFDSDDLIPPYLDQYFYSH-IGHH-LKNIEH-PERMTLFRMVF 497
Query: 561 HHNVIRFIGVLYKDRKLNLV-TEYIAGGTLKELLQD---------PGQPLPWGQRVN--- 607
RF+ ++K+ T + A G++ LQ P + VN
Sbjct: 498 LD--FRFL-----EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY-ERLVNAIL 549
Query: 608 -FARDIAAGMTYLHSMNLIHRDLNSQN 633
F I + +L+ L +++
Sbjct: 550 DFLPKIEENLICSKYTDLLRIALMAED 576
|
| >3gsl_A Disks large homolog 4; PDZ domain, tandem, PSD-95, DLG4, SAP-90, GLUR6, cell juncti membrane, lipoprotein, membrane, palmitate, phosphoprotein; 2.05A {Rattus norvegicus} PDB: 3zrt_A 2ka9_A Length = 196 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 7e-06
Identities = 12/35 (34%), Positives = 19/35 (54%)
Query: 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GD+IL VN + D ++ ++NT D V
Sbjct: 148 RLQIGDKILAVNSVGLEDVMHEDAVAALKNTYDVV 182
|
| >3gsl_A Disks large homolog 4; PDZ domain, tandem, PSD-95, DLG4, SAP-90, GLUR6, cell juncti membrane, lipoprotein, membrane, palmitate, phosphoprotein; 2.05A {Rattus norvegicus} PDB: 3zrt_A 2ka9_A Length = 196 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 6e-05
Identities = 9/34 (26%), Positives = 13/34 (38%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L + D IL VN VR+ ++ V
Sbjct: 54 LRVNDSILFVNEVDVREVTHSAAVEALKEAGSIV 87
|
| >2vsv_A Rhophilin-2; scaffold protein, RHO GTPase binding, protein-binding, RHOB, nitration, cytoplasm, PDZ domain, CAsp8; 1.82A {Homo sapiens} Length = 109 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 7e-06
Identities = 12/54 (22%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQIL 332
V LDP A + GD I+ + + L EV L+++ + ++ +++
Sbjct: 48 VHFLDPYCSASVAGAREGDYIVSIQLVDCKWLTLSEVMKLLKSFGEDEIEMKVV 101
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 41/168 (24%), Positives = 65/168 (38%), Gaps = 36/168 (21%)
Query: 488 LGQGFFGQVYRVTHRETGE-VMVLKELYRVDEEAEKNFLK-ESKQGLIYLIDLGSHGLIN 545
+G G FG +Y T GE V + E + + L ESK IY + G G I
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLE----CVKTKHPQLHIESK---IYKMMQGGVG-IP 68
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
+ +NV +V E + G +L++L +
Sbjct: 69 TIRWCGAE------GDYNV--------------MVMELL-GPSLEDLFNFCSRKFSLKTV 107
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLI 653
+ A + + + Y+HS N IHRD+ N L +G G + +Y+I
Sbjct: 108 LLLADQMISRIEYIHSKNFIHRDVKPDNFL---MGLGKKGN--LVYII 150
|
| >1uit_A Human discs large 5 protein; PDZ domain, HDLG5, maguk family, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 117 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 7e-06
Identities = 13/39 (33%), Positives = 19/39 (48%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L GD++LE NG +R Q+ +I DT+
Sbjct: 55 AHQAGLEYGDQLLEFNGINLRSATEQQARLIIGQQCDTI 93
|
| >2v90_A PDZ domain-containing protein 3; membrane, protein-binding; 2.00A {Homo sapiens} Length = 96 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-06
Identities = 10/39 (25%), Positives = 15/39 (38%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A + GDR++ V G V +E I+ V
Sbjct: 43 AKKAGMQAGDRLVAVAGESVEGLGHEETVSRIQGQGSCV 81
|
| >1v5l_A PDZ and LIM domain 3; actinin alpha 2 associated LIM protein; PDZ domain, cytoskeleton, actin binding, structural genomics; NMR {Mus musculus} SCOP: b.36.1.1 Length = 103 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-06
Identities = 10/48 (20%), Positives = 20/48 (41%), Gaps = 2/48 (4%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ R+ P A +L GD IL ++G + + I+ + +
Sbjct: 33 ITRITPGSKAAAANLCPGDVILAIDGFGTESMTHADAQDRIKAASYQL 80
|
| >2la8_A Inactivation-NO-after-potential D protein, KON-TI peptide; peptide binding protein; NMR {Drosophila melanogaster} Length = 106 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 9e-06
Identities = 10/34 (29%), Positives = 13/34 (38%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD I + NG + P Q L + V
Sbjct: 44 LQRGDIITKFNGDALEGLPFQVCYALFKGANGKV 77
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 29/156 (18%), Positives = 52/156 (33%), Gaps = 32/156 (20%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+G+G +G V + +K++ F
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKI--------SPFEH----------------QTYCQ 70
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQPLPW 602
++ +L H N+I ++ +V + + L +LL+ Q L
Sbjct: 71 RTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLK--TQHLSN 127
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
F I G+ Y+HS N++HRDL N L+
Sbjct: 128 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT 163
|
| >1ujd_A KIAA0559 protein; PDZ domain, structural genomics, human cDNA, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 117 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-05
Identities = 11/34 (32%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L G ++LE NG P+ K +EV+ +I +
Sbjct: 68 LMEGMQVLEWNGIPLTSKTYEEVQSIISQQSGEA 101
|
| >2edv_A FERM and PDZ domain-containing protein 1; cytoskeletal-associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 96 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-05
Identities = 10/34 (29%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+IL++N P D + ++R D++
Sbjct: 48 LFPGDQILQMNNEPAEDLSWERAVDILREAEDSL 81
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 36/155 (23%), Positives = 60/155 (38%), Gaps = 34/155 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG+G +G V TH+ TGE++ +K++ + F K + L
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKI--------EPFDK----------------PLFAL 54
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGT-LKELLQDPGQPLP 601
++ +L+ H N+I + D N ++ E + T L ++ Q L
Sbjct: 55 RTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIS--TQMLS 110
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
F + LH N+IHRDL N L+
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI 145
|
| >2eei_A PDZ domain-containing protein 1; regulatory factor, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 106 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-05
Identities = 11/39 (28%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A + D ++EVNG V D +EV ++ + V
Sbjct: 45 AMRAGVLADDHLIEVNGENVEDASHEEVVEKVKKSGSRV 83
|
| >2z17_A Pleckstrin homology SEC7 and coiled-coil domains- binding protein; PDZ domain, cytoplasm, membrane, polymorphism, protein binding; 2.70A {Homo sapiens} Length = 104 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 1e-05
Identities = 10/39 (25%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L GD + +NG ++V LIR++ + +
Sbjct: 61 AHCAGLQAGDVLANINGVSTEGFTYKQVVDLIRSSGNLL 99
|
| >1vb7_A PDZ and LIM domain 2; PDZ domain PDZ-LIM protein, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.36.1.1 Length = 94 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-05
Identities = 12/48 (25%), Positives = 21/48 (43%), Gaps = 2/48 (4%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
V ++ R A+ L GD I+ +NG + E + IR + +
Sbjct: 34 VTKVTERGKAEAADLRPGDIIVAINGQSAENMLHAEAQSKIRQSASPL 81
|
| >2jxo_A Ezrin-radixin-moesin-binding phosphoprotein 50; nherf-1, PDZ domain, PDZ2, acetylation, cell projection, membrane, polymorphism; NMR {Homo sapiens} Length = 98 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-05
Identities = 14/39 (35%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L DRI+EVNG + K +V IR D
Sbjct: 46 AEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDET 84
|
| >2eeg_A PDZ and LIM domain protein 4; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-05
Identities = 12/48 (25%), Positives = 19/48 (39%), Gaps = 2/48 (4%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ R+ A L +L GD I +NG E + I+ D +
Sbjct: 36 ISRVHAGSKAALAALCPGDLIQAINGESTELMTHLEAQNRIKGCHDHL 83
|
| >1uez_A KIAA1526 protein; PDZ domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 101 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-05
Identities = 11/40 (27%), Positives = 18/40 (45%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
A+ L +GD+IL VN + E ++ + VL
Sbjct: 48 AEKEGLRVGDQILRVNDKSLARVTHAEAVKALKGSKKLVL 87
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 26/156 (16%), Positives = 52/156 (33%), Gaps = 21/156 (13%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
+ G +G V G + +K ++ + +
Sbjct: 30 ISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSD--------------SFLCK 74
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQPLPW 602
++ +L HH N++ + + LVTE + L +++ D +
Sbjct: 75 RVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISP 133
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
F I G+ LH ++HRDL+ N L+ +
Sbjct: 134 QHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD 169
|
| >2pkt_A PDZ and LIM domain protein 1; PDZ domain, structural genomics, structural genomics consort unknown function; HET: PG4; 1.50A {Homo sapiens} PDB: 2v1w_A* Length = 91 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-05
Identities = 14/55 (25%), Positives = 25/55 (45%), Gaps = 5/55 (9%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV---LQRQ 330
+ R+ P A L +L +GD I ++G + E + I+ TD + + R
Sbjct: 31 ISRVTPGSKAALANLCIGDVITAIDGENTSNMTHLEAQNRIKGCTDNLTLTVARS 85
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 33/157 (21%), Positives = 53/157 (33%), Gaps = 29/157 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMV-LKELYRVDEEAEKNFLKESKQGLI---YLIDLGSHG 542
LG+G FG+V G+ V LK + +N K + + L +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII--------RNVGKYREAARLEINVLKKIKEKD 77
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLP 601
N C V + + H + + E + G E L++ QP P
Sbjct: 78 KENKFLC---VLMSDWFNFHG------------HMCIAFE-LLGKNTFEFLKENNFQPYP 121
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ A + + +LH L H DL +N L
Sbjct: 122 LPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158
|
| >1wf7_A Enigma homologue protein; PDZ domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.36.1.1 Length = 103 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-05
Identities = 9/48 (18%), Positives = 20/48 (41%), Gaps = 2/48 (4%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ L A + +GD +L ++G + E + I+ T ++
Sbjct: 33 ISSLKDGGKASQAHVRIGDVVLSIDGISAQGMTHLEAQNKIKACTGSL 80
|
| >1y7n_A Amyloid beta A4 precursor protein-binding family A member 1; copper chaperone for superoxide dismutase, neuronal adaptor, protein transport; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 90 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-05
Identities = 10/39 (25%), Positives = 21/39 (53%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ + +G RI+E+NG V P +++ ++ N +
Sbjct: 44 AERGGVRVGHRIIEINGQSVVATPHEKIVHILSNAVGEI 82
|
| >3khf_A Microtubule-associated serine/threonine-protein kinase 3; MAST3, microtubule associated serine/threonine kinase 3, PDZ domain, structural genomics; 1.20A {Homo sapiens} PDB: 2w7r_A 2kqf_A 2kyl_A 3ps4_A Length = 99 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-05
Identities = 10/39 (25%), Positives = 16/39 (41%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L GD I +NG V +V L+ + + +
Sbjct: 47 AQEAGLRAGDLITHINGESVLGLVHMDVVELLLKSGNKI 85
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 35/172 (20%), Positives = 67/172 (38%), Gaps = 51/172 (29%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G G V+ + + + +K++ D ++ K+ L+E K
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIK------------------ 60
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN--------------LVTEYIAGGT-LKEL 592
++R L H N+++ +L +V EY+ T L +
Sbjct: 61 -------IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANV 111
Query: 593 LQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL-------NSQNCLVR 637
L+ PL F + G+ Y+HS N++HRDL N+++ +++
Sbjct: 112 LE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 28/159 (17%), Positives = 55/159 (34%), Gaps = 24/159 (15%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLK-----ELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
LG G F V+ + +K ++Y E E L+ + D
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ-----RVNDADNTKE 80
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPL 600
+ H + +L +H + +V E + G L L++ + +
Sbjct: 81 DSMGANHI---LKLLDHFNHKGP--------NGVHVVMVFE-VLGENLLALIKKYEHRGI 128
Query: 601 PWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQNCLVRE 638
P ++ + G+ Y+H +IH D+ +N L+
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEI 167
|
| >2d90_A PDZ domain containing protein 1; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} Length = 102 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-05
Identities = 11/39 (28%), Positives = 15/39 (38%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L D ++ VNG V V +IR D
Sbjct: 43 AEAAGLKNNDLVVAVNGKSVEALDHDGVVEMIRKGGDQT 81
|
| >1p1d_A PDZ45, glutamate receptor interacting protein; PDZ domain, tandem repeats, scaffold protein, protein binding; NMR {Rattus norvegicus} SCOP: b.36.1.1 b.36.1.1 PDB: 1p1e_A 1x5r_A Length = 196 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 7/35 (20%), Positives = 19/35 (54%)
Query: 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+L LGD++L ++ + +++ +++ D V
Sbjct: 153 TLELGDKLLAIDNIRLDSCSMEDAVQILQQCEDLV 187
|
| >1p1d_A PDZ45, glutamate receptor interacting protein; PDZ domain, tandem repeats, scaffold protein, protein binding; NMR {Rattus norvegicus} SCOP: b.36.1.1 b.36.1.1 PDB: 1p1e_A 1x5r_A Length = 196 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDR++ +NG P D +E L+R+++ T
Sbjct: 55 LQIGDRVMAINGIPTEDSTFEEANQLLRDSSITS 88
|
| >1uf1_A KIAA1526 protein; PDZ domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 128 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 13/40 (32%), Positives = 22/40 (55%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
A+ L +GD+ILEVNG + E L++++ +L
Sbjct: 59 AEGSGLKVGDQILEVNGRSFLNILHDEAVRLLKSSRHLIL 98
|
| >2vwr_A Ligand of NUMB protein X 2; protein-binding, metal-binding, zinc, LNX2_human, zinc-finger, polymorphism, ring finger protein 1; 1.3A {Homo sapiens} Length = 95 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-05
Identities = 8/34 (23%), Positives = 17/34 (50%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L DR+L +NG ++ + +I+ + + V
Sbjct: 48 LSSNDRVLAINGHDLKYGTPELAAQIIQASGERV 81
|
| >2dkr_A LIN-7 homolog B; LIN-7B, PDZ, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 93 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 2e-05
Identities = 10/34 (29%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD++L VNG V + ++ L++ +V
Sbjct: 49 LKRGDQLLSVNGVSVEGEQHEKAVELLKAAQGSV 82
|
| >2qt5_A Glutamate receptor-interacting protein 1; PDZ-peptide complex, PDZ tandem, alternative splicing, cell junction, cytoplasm; 2.30A {Rattus norvegicus} Length = 200 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 7/34 (20%), Positives = 14/34 (41%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ GDR+L V+G + E +++
Sbjct: 154 IKPGDRLLSVDGIRLLGTTHAEAMSILKQCGQEA 187
|
| >2qt5_A Glutamate receptor-interacting protein 1; PDZ-peptide complex, PDZ tandem, alternative splicing, cell junction, cytoplasm; 2.30A {Rattus norvegicus} Length = 200 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 15/63 (23%), Positives = 26/63 (41%), Gaps = 7/63 (11%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV-------LQRQILKECRIKDLIIEVC 345
L +GD I VNG + E+ L++N + V L ++ + +EV
Sbjct: 52 LDVGDYIKAVNGINLAKFRHDEIISLLKNVGERVVLEVEYELPPVSIQGSSVMFRTVEVT 111
Query: 346 LER 348
L +
Sbjct: 112 LHK 114
|
| >2uzc_A Human pdlim5, PDZ and LIM domain 5; metal-binding, enigma homolog, phosphorylation, signaling PR LIM domain, PDZ domain; 1.5A {Homo sapiens} Length = 88 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-05
Identities = 12/55 (21%), Positives = 25/55 (45%), Gaps = 5/55 (9%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV---LQRQ 330
+ L A ++ +GD +L ++G + E + I+ T ++ LQR+
Sbjct: 31 ISSLKDGGKAAQANVRIGDVVLSIDGINAQGMTHLEAQNKIKGCTGSLNMTLQRE 85
|
| >2ego_A General receptor for phosphoinositides 1- associated scaffold protein; PDZ domain, ligand-free, protein binding; 1.80A {Rattus norvegicus} PDB: 2egn_A 2egk_A 2pnt_A Length = 96 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-05
Identities = 12/39 (30%), Positives = 19/39 (48%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L L GD I VNG V +E+ +I+ + + +
Sbjct: 50 AQLAGLTPGDTIASVNGLNVEGIRHREIVDIIKASGNVL 88
|
| >2he4_A Na(+)/H(+) exchange regulatory cofactor NHE-RF2; phosphorylation, structural genomics, structural genomics consortium, SGC, unknown function; 1.45A {Homo sapiens} PDB: 2ozf_A Length = 90 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-05
Identities = 13/39 (33%), Positives = 16/39 (41%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L DR++EVNG V EV I+ D
Sbjct: 41 AARSGLRAQDRLIEVNGQNVEGLRHAEVVASIKAREDEA 79
|
| >2edz_A PDZ domain-containing protein 1; CFTR-associated protein of 70 kDa, Na/PI cotransporter C- terminal-associated protein, NAPI-CAP1; NMR {Mus musculus} Length = 114 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-05
Identities = 13/39 (33%), Positives = 22/39 (56%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L GDR+L +NG V + +V L+R + ++V
Sbjct: 51 AEKAGLLDGDRVLRINGVFVDKEEHAQVVELVRKSGNSV 89
|
| >2e7k_A Maguk P55 subfamily member 2; PDZ domain, MPP2 protein, discs large homolog 2, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 91 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 3e-05
Identities = 16/34 (47%), Positives = 23/34 (67%), Gaps = 1/34 (2%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
LH+GD I EVNG PV P + ++ L+RN + +V
Sbjct: 48 LHVGDIIKEVNGQPVGSDP-RALQELLRNASGSV 80
|
| >2q3g_A PDZ and LIM domain protein 7; structural genomics, structural genomics consortium, SGC; 1.11A {Homo sapiens} Length = 89 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-05
Identities = 11/48 (22%), Positives = 20/48 (41%), Gaps = 2/48 (4%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ RL P A + +GD +L ++G E + IR + +
Sbjct: 31 ISRLTPGGKAAQAGVAVGDWVLSIDGENAGSLTHIEAQNKIRACGERL 78
|
| >1rgw_A ZAsp protein; PDZ, cypher, oracle, muscle, Z-DISK, sarcomere, structural protein; NMR {Homo sapiens} SCOP: b.36.1.1 PDB: 1wjl_A Length = 85 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-05
Identities = 9/48 (18%), Positives = 20/48 (41%), Gaps = 2/48 (4%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ R+ P A L GD ++ ++G E + I++ + +
Sbjct: 29 ISRITPGSKAAQSQLSQGDLVVAIDGVNTDTMTHLEAQNKIKSASYNL 76
|
| >1uew_A Membrane associated guanylate kinase inverted-2 (MAGI-2); atrophin-1 interacting protein 1, PDZ domain, structural genomics; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 114 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-05
Identities = 13/34 (38%), Positives = 21/34 (61%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDRIL VNG + + P ++ LI++ +V
Sbjct: 62 LKVGDRILAVNGQSIINMPHADIVKLIKDAGLSV 95
|
| >3bpu_A Membrane-associated guanylate kinase, WW and PDZ containing protein 1; structural genomi consortium, SGC, ATP-binding, cell junction; 1.60A {Homo sapiens} Length = 88 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-05
Identities = 10/43 (23%), Positives = 18/43 (41%)
Query: 281 VPRLDPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTT 323
V ++ L GD I+EVN V+ +V ++ +
Sbjct: 31 VKQIVDSPRSRGLKEGDLIVEVNKKNVQALTHNQVVDMLVESP 73
|
| >3soe_A Membrane-associated guanylate kinase, WW and PDZ containing protein 3; structural genomics consortium, SGC, PDZ domain, signaling P; 1.60A {Homo sapiens} Length = 113 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 8/51 (15%), Positives = 16/51 (31%)
Query: 273 TGMTNNPSVPRLDPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTT 323
V + L GD I E+ V++ +V +++
Sbjct: 30 ADSPTGQKVKMILDSQWCQGLQKGDIIKEIYHQNVQNLTHLQVVEVLKQFP 80
|
| >1ufx_A KIAA1526 protein; PDZ domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 103 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-05
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQI 331
L +G ILEVNG +R K +E +I T + I
Sbjct: 51 LKVGHVILEVNGLTLRGKEHREAARIIAEAFKTKDRDYI 89
|
| >2pa1_A PDZ and LIM domain protein 2; PDZ domain, structural genomics, structural genomics consort metal binding protein; 1.70A {Homo sapiens} PDB: 3pdv_A Length = 87 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-05
Identities = 12/48 (25%), Positives = 19/48 (39%), Gaps = 2/48 (4%)
Query: 281 VPRLDPR--ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
V ++ R A L GD I+ +NG E + IR + +
Sbjct: 30 VTKVAERGKAKDADLRPGDIIVAINGESAEGMLHAEAQSKIRQSPSPL 77
|
| >2iyb_E Testin, TESS, TES; LIM domain, SH3-binding, tumour supressor LIM domain EVH1 DO cell motility, phosphorylation, cytoskeleton; 2.35A {Homo sapiens} Length = 65 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 4e-05
Identities = 17/56 (30%), Positives = 27/56 (48%), Gaps = 4/56 (7%)
Query: 11 TCAGCLNNI-VEDEYVQALSQEWHT--DCFRCSACDV-MLDNWYFEKDGLLFCKED 62
C GC N I E + V + WH +CF CS C ++ + +G++FC +
Sbjct: 4 VCQGCHNAIDPEVQRVTYNNFSWHASTECFLCSCCSKCLIGQKFMPVEGMVFCSVE 59
|
| >3ngh_A PDZ domain-containing protein 1; adaptor protein, SR-BI, signaling protein; 1.80A {Mus musculus} Length = 106 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-05
Identities = 13/39 (33%), Positives = 22/39 (56%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L GDR+L +NG V + +V L+R + ++V
Sbjct: 39 AEKAGLLDGDRVLRINGVFVDKEEHAQVVELVRKSGNSV 77
|
| >3r68_A Na(+)/H(+) exchange regulatory cofactor NHE-RF3; PDZ domain, adaptor protein, SR-BI, signaling protein; 1.30A {Mus musculus} PDB: 3r69_A* Length = 95 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-05
Identities = 11/39 (28%), Positives = 15/39 (38%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L D ++ VNG V V +IR D
Sbjct: 42 AEAAGLKNNDLVVAVNGKSVEALDHDGVVEMIRKGGDQT 80
|
| >2kjd_A Sodium/hydrogen exchange regulatory cofactor NHE- RF1; PDZ domain, protein, acetylation, cell projection, disease mutation, membrane; NMR {Homo sapiens} Length = 128 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 5e-05
Identities = 14/39 (35%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L DRI+EVNG + K +V IR D
Sbjct: 46 AEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDET 84
|
| >2jil_A GRIP1 protein, glutamate receptor interacting protein-1; endoplasmic reticulum, postsynaptic membrane, membrane, MEMB protein; 1.5A {Homo sapiens} Length = 97 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 5e-05
Identities = 7/34 (20%), Positives = 14/34 (41%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ GDR+L V+G + E +++
Sbjct: 51 IKPGDRLLSVDGIRLLGTTHAEAMSILKQCGQEA 84
|
| >2gzv_A PRKCA-binding protein; protein kinase C, PDZ domain, structural genomics, structura genomics consortium, SGC, signaling protein; 1.12A {Homo sapiens} PDB: 2pku_A Length = 114 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 5e-05
Identities = 11/34 (32%), Positives = 16/34 (47%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ GD I VNG ++ K EV +I+ V
Sbjct: 69 VAAGDEITGVNGRSIKGKTKVEVAKMIQEVKGEV 102
|
| >1x5q_A LAP4 protein; PDZ domain, scribble homolog protein, hscrib, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 110 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-05
Identities = 11/39 (28%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A + +GD++LEVNG ++ E +R V
Sbjct: 59 AARAGVRVGDKLLEVNGVALQGAEHHEAVEALRGAGTAV 97
|
| >2djt_A Unnamed protein product; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 104 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 5e-05
Identities = 8/34 (23%), Positives = 14/34 (41%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GD +L +NG + + IR +
Sbjct: 57 LEVGDLVLHINGESTQGLTHAQAVERIRAGGPQL 90
|
| >2lob_A Golgi-associated PDZ and coiled-coil motif-contai protein; structural protein-hydrolase complex, peptide binding protei; NMR {Homo sapiens} Length = 112 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-05
Identities = 12/34 (35%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
LH+GD IL VNG +RD +E ++ +
Sbjct: 72 LHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEI 105
|
| >2dlu_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} Length = 111 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-05
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD IL++ GT V+ ++V ++RN ++V
Sbjct: 57 LQTGDHILKIGGTNVQGMTSEQVAQVLRNCGNSV 90
|
| >1q3o_A Shank1; PDZ, GKAP, peptide binding protein; 1.80A {Rattus norvegicus} SCOP: b.36.1.1 PDB: 1q3p_A 3qjm_A 3qjn_A 3o5n_A* Length = 109 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 6e-05
Identities = 13/39 (33%), Positives = 21/39 (53%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L +GD ++EVNG V ++V +IR +T+
Sbjct: 58 AWRAGLRMGDFLIEVNGQNVVKVGHRQVVNMIRQGGNTL 96
|
| >1v5q_A GRIP1 homolog, glutamate receptor interacting protein 1A-L homolog; PDZ domain, cellular signaling, structural genomics; NMR {Mus musculus} SCOP: b.36.1.1 Length = 122 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-05
Identities = 12/34 (35%), Positives = 21/34 (61%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDR++ +NG P D +E L+R+++ T
Sbjct: 64 LQIGDRVMAINGIPTEDSTFEEANQLLRDSSITS 97
|
| >2dc2_A GOPC, golgi associated PDZ and coiled-coil motif containing isoform B; GOPC PDZ domain, structural protein; NMR {Homo sapiens} Length = 103 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 6e-05
Identities = 12/34 (35%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
LH+GD IL VNG +RD +E ++ +
Sbjct: 54 LHVGDAILAVNGVNLRDTKHKEAVTILSQQRGEI 87
|
| >2r4h_A Membrane-associated guanylate kinase, WW and PDZ containing protein 1; transferase, STRU genomics, structural genomics consortium, SGC, ATP-binding; HET: HIS; 2.05A {Homo sapiens} Length = 112 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-05
Identities = 11/34 (32%), Positives = 17/34 (50%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ +GD ILE+NG ++ LI+N V
Sbjct: 68 MRIGDEILEINGETTKNMKHSRAIELIKNGGRRV 101
|
| >3l4f_D SH3 and multiple ankyrin repeat domains protein 1; coiled-coil, PDZ, guanine-nucleotide releasing factor, phosphoprotein, SH3 domain; 2.80A {Rattus norvegicus} Length = 132 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 7e-05
Identities = 13/39 (33%), Positives = 21/39 (53%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L +GD ++EVNG V ++V +IR +T+
Sbjct: 78 AWRAGLRMGDFLIEVNGQNVVKVGHRQVVNMIRQGGNTL 116
|
| >1r6j_A Syntenin 1; PDZ, membrane protein; 0.73A {Homo sapiens} SCOP: b.36.1.1 PDB: 1nte_A 1obx_A 1oby_A Length = 82 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 7e-05
Identities = 8/39 (20%), Positives = 14/39 (35%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L I E+NG V ++ ++ + V
Sbjct: 36 AARNGLLTEHNICEINGQNVIGLKDSQIADILSTSGTVV 74
|
| >3suz_A Amyloid beta A4 precursor protein-binding family 2; APP binding; 2.70A {Rattus norvegicus} PDB: 1u3b_A 1u39_A 1x45_A 1u37_A 1u38_A 2yt8_A Length = 388 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 8e-05
Identities = 9/39 (23%), Positives = 20/39 (51%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ + +G RI+E+NG V +++ + N+ +
Sbjct: 328 AERGGVRVGHRIIEINGQSVVATAHEKIVQALSNSVGEI 366
|
| >3suz_A Amyloid beta A4 precursor protein-binding family 2; APP binding; 2.70A {Rattus norvegicus} PDB: 1u3b_A 1u39_A 1x45_A 1u37_A 1u38_A 2yt8_A Length = 388 | Back alignment and structure |
|---|
Score = 42.7 bits (99), Expect = 3e-04
Identities = 12/41 (29%), Positives = 21/41 (51%)
Query: 286 PRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
P A L +GD+I+ +NGT + PL + +I+ +
Sbjct: 244 PAARSGKLSIGDQIMSINGTSLVGLPLATCQGIIKGLKNQT 284
|
| >1wi2_A Riken cDNA 2700099C19; structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.36.1.1 Length = 104 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-05
Identities = 8/40 (20%), Positives = 17/40 (42%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
A L GD++L VN +D + +++ + +
Sbjct: 54 AHRAGLQEGDQVLAVNDVDFQDIEHSKAVEILKTAREISM 93
|
| >1ihj_A INAD; intermolecular disulfide bond, PDZ domain, signaling protein; 1.80A {Drosophila melanogaster} SCOP: b.36.1.1 Length = 98 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 8e-05
Identities = 14/34 (41%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDRIL +NG VR+ Q V LI+ +
Sbjct: 56 LKVGDRILSLNGKDVRNSTEQAVIDLIKEADFKI 89
|
| >3hpk_A Protein interacting with PRKCA 1; oxidized, PDZ domain, kinase, protein binding; 2.20A {Rattus norvegicus} PDB: 3hpm_A Length = 125 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 8e-05
Identities = 11/34 (32%), Positives = 16/34 (47%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ GD I VNG ++ K EV +I+ V
Sbjct: 64 VAAGDEITGVNGRSIKGKTKVEVAKMIQEVKGEV 97
|
| >2d8i_A T-cell lymphoma invasion and metastasis 1 variant; PDZ domain, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 114 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 8e-05
Identities = 10/42 (23%), Positives = 16/42 (38%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQR 329
A L GD ILE+N ++ + + +L R
Sbjct: 57 ASKKGLKAGDEILEINNRAADALNSSMLKDFLSQPSLGLLVR 98
|
| >1x5n_A Harmonin; PDZ domain, usher syndrome 1C protein, autoimmune enteropathy-related antigen AIE-75 ,antigen NY-CO-38/NY-CO- 37, PDZ-73 protein; NMR {Homo sapiens} SCOP: b.36.1.1 PDB: 2kbs_A Length = 114 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 9/40 (22%), Positives = 22/40 (55%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
+ + L +GD+I+EVNG + +E +++++ +
Sbjct: 54 SAEVGLEIGDQIVEVNGVDFSNLDHKEAVNVLKSSRSLTI 93
|
| >2w4f_A Protein LAP4; structural protein, phosphoprotein, UBL conjugation, leucine-rich repeat, alternative splicing, cytoplasm, circletail, coiled coil; 1.30A {Homo sapiens} Length = 97 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 1e-04
Identities = 11/39 (28%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A + +GD++LEVNG ++ E +R V
Sbjct: 47 AARAGVRVGDKLLEVNGVALQGAEHHEAVEALRGAGTAV 85
|
| >1ujv_A Membrane associated guanylate kinase inverted-2 (MAGI-2); atrophin-1 interacting protein 1, PDZ domain, structural genomics, KIAA0705 protein; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 96 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 1e-04
Identities = 10/50 (20%), Positives = 20/50 (40%)
Query: 273 TGMTNNPSVPRLDPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNT 322
V ++ L GD I+E+N V++ EV ++++
Sbjct: 28 ADSPTGQRVKQILDIQGCPGLCEGDLIVEINQQNVQNLSHTEVVDILKDC 77
|
| >1q7x_A PDZ2B domain of PTP-BAS (HPTP1E); phosphatase, structural proteomics in europe, spine, structural genomics, hydrolase; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 108 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 1e-04
Identities = 12/34 (35%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+H GDR+L VNG + ++ +RNT V
Sbjct: 61 IHKGDRVLAVNGVSLEGATHKQAVETLRNTGQVV 94
|
| >2eeh_A PDZ domain-containing protein 7; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 100 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 1e-04
Identities = 9/40 (22%), Positives = 20/40 (50%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
A+ L +GD+I EVNG + + ++ +++ +
Sbjct: 49 AERAGLCVGDKITEVNGLSLESTTMGSAVKVLTSSSRLHM 88
|
| >2iwn_A Multiple PDZ domain protein; SGC, MPDZ, MUPP1, MUPP- 1, HOST-virus interaction, structural genomics consortium, synaptosome, tight junction; 1.35A {Homo sapiens} Length = 97 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 1e-04
Identities = 11/34 (32%), Positives = 22/34 (64%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ +GD+I+ V+GT ++ Q+ ++R+T TV
Sbjct: 52 IQIGDQIIAVDGTNLQGFTNQQAVEVLRHTGQTV 85
|
| >1d5g_A Human phosphatase HPTP1E; protein-peptide complex, hydrolase; NMR {Homo sapiens} SCOP: b.36.1.1 PDB: 3lnx_A 3lny_A 3pdz_A 1vj6_A 1gm1_A 1ozi_A Length = 96 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 1e-04
Identities = 12/34 (35%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+H GDR+L VNG + ++ +RNT V
Sbjct: 52 IHKGDRVLAVNGVSLEGATHKQAVETLRNTGQVV 85
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 23/171 (13%), Positives = 48/171 (28%), Gaps = 16/171 (9%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+ G +Y T + + + + + + + +
Sbjct: 47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFF-QRAAKPLQV 105
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN-LVTEYIAGGTLKELLQD-PGQPLPW 602
N L S + +G K LV + G +L+ L P L
Sbjct: 106 NKWK------KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSE 158
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLI 653
+ A + + +LH +H ++ ++N V Q+ L
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIF---VDPE---DQSQVTLA 203
|
| >2iwo_A Multiple PDZ domain protein; SGC, MPDZ, MUPP1, MUPP-1, HOST-virus interaction, structural genomics consortium, synaptosome, tight junction; 1.7A {Homo sapiens} PDB: 2iwp_A Length = 120 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 9/34 (26%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDRI+ + GT + L++N + ++
Sbjct: 72 LRVGDRIVTICGTSTEGMTHTQAVNLLKNASGSI 105
|
| >3i4w_A Disks large homolog 4; alpha and beta protein, alternative splicing, cell junction, cell membrane, lipoprotein, membrane, palmitate, phosphoprotein; 1.35A {Homo sapiens} PDB: 3k82_A* 3jxt_A* 2he2_A 1pdr_A 2i0i_A Length = 104 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 1e-04
Identities = 12/34 (35%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+IL VNG +R+ ++ ++N TV
Sbjct: 54 LRKGDQILSVNGVDLRNASHEQAAIALKNAGQTV 87
|
| >1qau_A Neuronal nitric oxide synthase (residues 1-130); beta-finger, oxidoreductase; 1.25A {Rattus norvegicus} SCOP: b.36.1.1 PDB: 1qav_B Length = 112 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 1e-04
Identities = 9/34 (26%), Positives = 13/34 (38%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ GD IL VN P+ D ++R
Sbjct: 45 IQAGDIILAVNDRPLVDLSYDSALEVLRGIASET 78
|
| >1v6b_A Harmonin isoform A1; structural genomics, usher syndrome, USH1, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Mus musculus} SCOP: b.36.1.1 Length = 118 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 1e-04
Identities = 10/30 (33%), Positives = 15/30 (50%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNT 322
+ GD I+ +NG V D L E E ++
Sbjct: 62 VVKGDEIMAINGKIVTDYTLAEAEAALQKA 91
|
| >1wfv_A Membrane associated guanylate kinase inverted-2; atrophin-1 interacting protein 1, activin receptor interacting protein 1; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 103 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 1e-04
Identities = 11/34 (32%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ +GD+I+E+NG RD LI++ V
Sbjct: 55 MRVGDQIIEINGESTRDMTHARAIELIKSGGRRV 88
|
| >1um1_A KIAA1849 protein, RSGI RUH-007; PDZ domain, human cDNA, structural genomics, riken structural genomics/proteomics initiative, unknown function; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 110 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 14/34 (41%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L LGDRILEVNG+ + LIR+ +
Sbjct: 55 LSLGDRILEVNGSSLLGLGYLRAVDLIRHGGKKM 88
|
| >1uep_A Membrane associated guanylate kinase inverted-2 (MAGI-2); atrophin-1 interacting protein 1, PDZ domain, structural genomics; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 103 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 13/45 (28%), Positives = 23/45 (51%), Gaps = 5/45 (11%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDT-----VLQRQIL 332
LH GD ++ V+G PV K + V L+ + ++R++L
Sbjct: 53 LHPGDELVYVDGIPVAGKTHRYVIDLMHHAARNGQVNLTVRRKVL 97
|
| >1um7_A Synapse-associated protein 102; PDZ, discs large homolog 3, DLG3-human presynaptic protein, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 113 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 2e-04
Identities = 11/34 (32%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GDRIL VNG +R+ ++ ++ +V
Sbjct: 58 LRRGDRILSVNGVNLRNATHEQAAAALKRAGQSV 91
|
| >2opg_A Multiple PDZ domain protein; structural protein, structural genomics, structural genomics consortium, SGC; 1.50A {Homo sapiens} Length = 98 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 2e-04
Identities = 14/34 (41%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+ILEVNG +R E ++R T V
Sbjct: 49 LWAGDQILEVNGIDLRKATHDEAINVLRQTPQRV 82
|
| >2fcf_A Multiple PDZ domain protein; adaptor molecule, protein linker, structural genomics, struc genomics consortium, SGC, structural protein; 1.76A {Homo sapiens} SCOP: b.36.1.1 Length = 103 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 2e-04
Identities = 13/34 (38%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GDRI+EV+G +RD ++ IR + V
Sbjct: 58 LKPGDRIVEVDGMDLRDASHEQAVEAIRKAGNPV 91
|
| >2dm8_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} Length = 116 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 14/34 (41%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+ILEVNG +R+ +E +R T V
Sbjct: 62 LWAGDQILEVNGVDLRNSSHEEAITALRQTPQKV 95
|
| >2fe5_A Presynaptic protein SAP102; PDZ domain, DLG3, human, structural genomics, structural GEN consortium, SGC, structural protein; HET: GOL; 1.10A {Homo sapiens} SCOP: b.36.1.1 PDB: 2x7z_A 2oqs_A 1qlc_A 2i0l_A Length = 94 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 2e-04
Identities = 14/34 (41%), Positives = 22/34 (64%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDR+L VN T ++D +E ++NT+D V
Sbjct: 52 LQIGDRLLAVNNTNLQDVRHEEAVASLKNTSDMV 85
|
| >2ehr_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} Length = 117 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 12/34 (35%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+ILEV+G +++ E I+N + V
Sbjct: 69 LKTGDKILEVSGVDLQNASHSEAVEAIKNAGNPV 102
|
| >2dmz_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} Length = 129 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 8/34 (23%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ + D+I+ V+G ++ +V ++RN V
Sbjct: 65 IQVNDKIVAVDGVNIQGFANHDVVEVLRNAGQVV 98
|
| >1qav_A Alpha-1 syntrophin (residues 77-171); beta-finger, heterodimer, membrane protein-oxidoreductase CO; 1.90A {Mus musculus} SCOP: b.36.1.1 PDB: 1z86_A 2pdz_A 2vrf_A Length = 90 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 3e-04
Identities = 11/34 (32%), Positives = 15/34 (44%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GD IL VNG + E ++ T V
Sbjct: 49 LFVGDAILSVNGEDLSSATHDEAVQALKKTGKEV 82
|
| >2jre_A C60-1 PDZ domain peptide; de novo protein; NMR {Synthetic} Length = 108 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 3e-04
Identities = 11/42 (26%), Positives = 21/42 (50%), Gaps = 3/42 (7%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV---LQRQI 331
+ D+IL V+ V+ +V ++RN + V L R++
Sbjct: 63 IEPNDKILRVDDVNVQGMAQSDVVEVLRNAGNPVRLLLIRRL 104
|
| >1x6d_A Interleukin-16; PDZ domain, lymphocyte chemoattractant factor (LCF), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.36.1.2 Length = 119 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 5/34 (14%), Positives = 15/34 (44%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ G+ +L +NG ++ + ++R +
Sbjct: 61 IQKGNEVLSINGKSLKGTTHHDALAILRQAREPR 94
|
| >1uhp_A Hypothetical protein KIAA1095; PDZ domain, semaphorin cytoplasmic domain associated protein, structural genomics; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 107 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 3e-04
Identities = 8/34 (23%), Positives = 15/34 (44%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L + DRI+EVNG + + + + +
Sbjct: 60 LQIHDRIIEVNGRDLSRATHDQAVEAFKTAKEPI 93
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 35/158 (22%), Positives = 60/158 (37%), Gaps = 30/158 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLI---YLIDLGSHGL 543
L+G+G FGQV + R E + +K + KN Q I L + H
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKII--------KNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPW 602
+ V + R N L LV E + L +LL++ + +
Sbjct: 113 EMKYYI---VHLKRHFMFRN------------HLCLVFEML-SYNLYDLLRNTNFRGVSL 156
Query: 603 GQRVNFARDIAAGMTYLHS--MNLIHRDLNSQNCLVRE 638
FA+ + + +L + +++IH DL +N L+
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194
|
| >2krg_A Na(+)/H(+) exchange regulatory cofactor NHE-RF1; acetylation, cell projection, disease mutation, membrane, phosphoprotein, polymorphism; NMR {Homo sapiens} Length = 216 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 3e-04
Identities = 14/39 (35%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L DRI+EVNG + K +V IR D
Sbjct: 46 AEASGLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDET 84
|
| >1tp5_A Presynaptic density protein 95; PDZ-peptide ligand complex, peptide binding protein; 1.54A {Rattus norvegicus} SCOP: b.36.1.1 PDB: 1tp3_A 1tq3_A 1be9_A 1bfe_A Length = 119 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 12/34 (35%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+IL VNG +R+ ++ ++N TV
Sbjct: 57 LRKGDQILSVNGVDLRNASHEQAAIALKNAGQTV 90
|
| >2qg1_A Multiple PDZ domain protein; MPDZ, MUPP1, structural genomics, structural genomics consortium, SGC, signaling protein; 1.40A {Homo sapiens} Length = 92 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 3e-04
Identities = 14/34 (41%), Positives = 20/34 (58%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+IL VNG VR+ + V L++ + TV
Sbjct: 48 LMQGDQILMVNGEDVRNATQEAVAALLKCSLGTV 81
|
| >2eno_A Synaptojanin-2-binding protein; mitochondrial outer membrane protein 25, structural genomics, NPPSFA; NMR {Homo sapiens} Length = 120 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 3e-04
Identities = 13/34 (38%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+IL VNG +++ Q+ L RN V
Sbjct: 66 LQEGDKILSVNGQDLKNLLHQDAVDLFRNAGYAV 99
|
| >2iwq_A Multiple PDZ domain protein; SGC, MPDZ, MUPP1, MUPP- 1, membrane, HOST- interaction, structural genomics consortium, synaptosome, T junction; 1.80A {Homo sapiens} Length = 123 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 4e-04
Identities = 13/34 (38%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GDRI+EV+G +RD ++ IR + V
Sbjct: 78 LKPGDRIVEVDGMDLRDASHEQAVEAIRKAGNPV 111
|
| >2i1n_A Discs, large homolog 3; DLG3, PDZ, PDZ domain, signal transduction, structural genom structural genomics consortium, SGC, signaling protein; 1.85A {Homo sapiens} PDB: 2wl7_A 3rl7_B 1rgr_A* 1kef_A 1zok_A 1iu0_A 1iu2_A Length = 102 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 4e-04
Identities = 7/34 (20%), Positives = 12/34 (35%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L + D +L VN V + ++ V
Sbjct: 53 LGVNDCVLRVNEVDVSEVVHSRAVEALKEAGPVV 86
|
| >1b8q_A Protein (neuronal nitric oxide synthase); PDZ domain, NNOS, nitric oxide synthase, oxidoreductase; NMR {Rattus norvegicus} SCOP: b.36.1.1 Length = 127 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 4e-04
Identities = 9/34 (26%), Positives = 13/34 (38%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ GD IL VN P+ D ++R
Sbjct: 52 IQAGDIILAVNDRPLVDLSYDSALEVLRGIASET 85
|
| >2xkx_A Disks large homolog 4; structural protein, scaffold protein, membrane associated GU kinase; 22.9A {Rattus norvegicus} Length = 721 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 4e-04
Identities = 9/35 (25%), Positives = 13/35 (37%)
Query: 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L + D IL VN VR+ ++ V
Sbjct: 107 RLRVNDSILFVNEVDVREVTHSAAVEALKEAGSIV 141
|
| >2xkx_A Disks large homolog 4; structural protein, scaffold protein, membrane associated GU kinase; 22.9A {Rattus norvegicus} Length = 721 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 4e-04
Identities = 12/34 (35%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+IL VNG +R+ ++ ++N TV
Sbjct: 350 LRKGDQILSVNGVDLRNASHEQAAIALKNAGQTV 383
|
| >2awx_A Synapse associated protein 97; membrane protein, synaptic signaling, trafficking protein; HET: HIS; 1.80A {Rattus norvegicus} PDB: 2g2l_A 2awu_A 2aww_A 3rl8_A Length = 105 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 4e-04
Identities = 11/34 (32%), Positives = 20/34 (58%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GD++L VN + + +E ++NT+D V
Sbjct: 52 LQIGDKLLAVNSVSLEEVTHEEAVTALKNTSDFV 85
|
| >1uju_A Scribble; PDZ domain, cellular signaling, structural genomics, riken structural genomics/proteomics initiative, RSGI, signaling protein; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 111 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 4e-04
Identities = 12/34 (35%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +G R+LEVN + E L+R+ DT+
Sbjct: 63 LRVGLRLLEVNQQSLLGLTHGEAVQLLRSVGDTL 96
|
| >2daz_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} Length = 124 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 4e-04
Identities = 8/34 (23%), Positives = 16/34 (47%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ +GD +LE+N + + Q +I+ V
Sbjct: 70 MRIGDELLEINNQILYGRSHQNASAIIKTAPSKV 103
|
| >2jik_A Synaptojanin-2 binding protein; transmembrane, outer membrane, mitochondria distribution, PDZ, membrane, scaffold, mitochondrion, membrane protein; 1.35A {Homo sapiens} PDB: 2jin_A Length = 101 | Back alignment and structure |
|---|
Score = 38.8 bits (91), Expect = 5e-04
Identities = 13/34 (38%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+IL VNG +++ Q+ L RN V
Sbjct: 56 LQEGDKILSVNGQDLKNLLHQDAVDLFRNAGYAV 89
|
| >3k1r_A Harmonin; protein-protein complex, alternative splicing, coiled coil, deafness, hearing, non-syndromic deafness, polymorphism; 2.30A {Homo sapiens} PDB: 2kbq_A 2kbr_A Length = 192 | Back alignment and structure |
|---|
Score = 40.7 bits (95), Expect = 5e-04
Identities = 13/40 (32%), Positives = 20/40 (50%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
AD + L +GD I+ +NG + +EV LIR +
Sbjct: 123 ADSVGLQVGDEIVRINGYSISSCTHEEVINLIRTEKTVSI 162
|
| >2byg_A Channel associated protein of synapse-110; DLG2, PDZ, PDZ domain, structural genomics, structural genom consortium, SGC, phosphorylation; 1.85A {Homo sapiens} SCOP: b.36.1.1 Length = 117 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 5e-04
Identities = 11/34 (32%), Positives = 21/34 (61%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDR+L VN + + +E +++NT++ V
Sbjct: 73 LQVGDRLLMVNNYSLEEVTHEEAVAILKNTSEVV 106
|
| >1wfg_A Regulating synaptic membrane exocytosis protein 2; PDZ domain, RAB3-interacting molecule, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.36.1.1 PDB: 2css_A 1zub_A Length = 131 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 5e-04
Identities = 10/34 (29%), Positives = 16/34 (47%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD +LE NG ++ +EV +I +
Sbjct: 84 LRPGDEVLEWNGRLLQGATFEEVYNIILESKPEP 117
|
| >1wf8_A Neurabin-I; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 107 | Back alignment and structure |
|---|
Score = 39.2 bits (92), Expect = 5e-04
Identities = 9/34 (26%), Positives = 17/34 (50%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ + D+I+EV+G + ++RNT V
Sbjct: 59 IQVNDQIVEVDGISLVGVTQNFAATVLRNTKGNV 92
|
| >3gge_A PDZ domain-containing protein GIPC2; structural genomics, structural genomics consort protein binding; 2.60A {Homo sapiens} Length = 95 | Back alignment and structure |
|---|
Score = 38.6 bits (90), Expect = 5e-04
Identities = 6/34 (17%), Positives = 13/34 (38%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ +GD I +NG + +V ++
Sbjct: 47 ICVGDHIESINGENIVGWRHYDVAKKLKELKKEE 80
|
| >1wif_A RSGI RUH-020, riken cDNA 4930408O21; PDZ domain, structural genomics, mouse cDNA, riken structural genomics/proteomics initiative; NMR {Mus musculus} SCOP: b.36.1.1 Length = 126 | Back alignment and structure |
|---|
Score = 39.5 bits (92), Expect = 5e-04
Identities = 10/31 (32%), Positives = 15/31 (48%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTT 323
L GD ++ V V L+E L++N T
Sbjct: 68 LQPGDVLISVGHANVLGYTLREFLKLLQNIT 98
|
| >3tsz_A Tight junction protein ZO-1; PDZ3-SH3-GUK, scaffolding, JAM, tight junction, cell adhesio; 2.50A {Homo sapiens} PDB: 3tsw_A 3lh5_A Length = 391 | Back alignment and structure |
|---|
Score = 41.7 bits (97), Expect = 5e-04
Identities = 10/42 (23%), Positives = 15/42 (35%)
Query: 285 DPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
D A L GD+IL VN + +E + +
Sbjct: 41 DSPAAKEGLEEGDQILRVNNVDFTNIIREEAVLFLLDLPKGE 82
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 30/175 (17%), Positives = 58/175 (33%), Gaps = 24/175 (13%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKN--FLKESKQGLIYLIDLGSHG 542
G +GQG FG +Y + E + V E N E K Y
Sbjct: 40 GLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPLFTELK---FYQR------ 89
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIG---VLYKDRKLN-LVTEYIAGGTLKELLQDPGQ 598
+ R L + V ++ G + ++ + G L+++ + +
Sbjct: 90 -AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK 147
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLI 653
+ + I + Y+H +H D+ + N L + + Q+YL+
Sbjct: 148 RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL---LNYK---NPDQVYLV 196
|
| >1wha_A KIAA0147 protein, scribble; PDZ domain, cellular signaling, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 105 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 6e-04
Identities = 10/34 (29%), Positives = 17/34 (50%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDR+L +NG V + L+ + T+
Sbjct: 57 LQVGDRVLSINGVDVTEARHDHAVSLLTAASPTI 90
|
| >2cs5_A Tyrosine-protein phosphatase, non-receptor type 4; PDZ domain, ptpase, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.36.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 39.1 bits (91), Expect = 7e-04
Identities = 7/34 (20%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L+ GD+++ +NG + + +V I+ + +
Sbjct: 61 LNEGDQVVLINGRDIAEHTHDQVVLFIKASCERH 94
|
| >2fne_A Multiple PDZ domain protein; structural protein, structural genomics, SGC, structural genomics consortium, unknown function; 1.83A {Homo sapiens} SCOP: b.36.1.1 Length = 117 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 7e-04
Identities = 11/34 (32%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+I+ VNG + +E +++ T TV
Sbjct: 72 LKRGDQIIAVNGQSLEGVTHEEAVAILKRTKGTV 105
|
| >3b76_A E3 ubiquitin-protein ligase LNX; PDZ, bound ligand, structural genomics, structural genomics consortium, SGC, metal-binding; 1.75A {Homo sapiens} Length = 118 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 8e-04
Identities = 11/47 (23%), Positives = 24/47 (51%), Gaps = 4/47 (8%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIKD 339
+ GD +L V+G + + E L++ T+ ++ +LK +K+
Sbjct: 72 IKTGDILLNVDGVELTEVSRSEAVALLKRTSSSI----VLKALEVKE 114
|
| >2g5m_B Neurabin-2; spinophilin, PDZ domain, CNS, synaptic transmission, protein binding; NMR {Rattus norvegicus} Length = 113 | Back alignment and structure |
|---|
Score = 38.5 bits (90), Expect = 8e-04
Identities = 9/34 (26%), Positives = 17/34 (50%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ + D ++EV+GT + ++RNT V
Sbjct: 54 IQVNDLLVEVDGTSLVGVTQSFAASVLRNTKGRV 87
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 681 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.96 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.96 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.96 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.96 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.96 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.96 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.96 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.96 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.96 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.96 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.96 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.96 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.96 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.96 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.95 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.95 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.95 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.95 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.95 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.95 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.95 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.95 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.95 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.95 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.95 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.95 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.95 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.95 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.95 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.95 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.95 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.95 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.95 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.95 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.95 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.95 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.95 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.95 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.95 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.95 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.95 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.95 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.95 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.95 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.95 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.95 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.95 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.95 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.95 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.95 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.95 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.95 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.95 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.95 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.95 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.95 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.95 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.95 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.95 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.95 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.95 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.95 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.94 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.94 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.94 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.94 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.94 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.94 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.94 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.94 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.94 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.94 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.94 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.94 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.94 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.94 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.94 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.94 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.94 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.94 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.94 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.94 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.94 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.94 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.94 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.94 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.94 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.94 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.94 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.94 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.94 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.94 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.94 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.94 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.94 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.94 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.94 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.94 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.94 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.94 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.94 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.94 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.94 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.94 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.94 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.94 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.94 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.94 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.94 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.94 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.94 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.94 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.94 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.94 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.94 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.94 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.93 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.93 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.93 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.93 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.93 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.93 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.93 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.93 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.93 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.93 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.93 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.93 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.93 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.93 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.93 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.93 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.93 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.93 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.93 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.93 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.93 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 2jtn_A | 182 | LIM domain-binding protein 1, LIM/homeobox protein | 99.93 | |
| 2xjy_A | 131 | Rhombotin-2; oncoprotein, T-cell leukemia, proto-o | 99.93 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.93 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.93 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.93 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.93 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.93 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.93 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.93 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.93 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.93 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.93 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.93 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.93 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.93 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.93 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.93 | |
| 2rgt_A | 169 | Fusion of LIM/homeobox protein LHX3, linker, INSU | 99.93 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.93 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.93 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.93 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.93 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.93 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.93 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.92 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.92 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.92 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.92 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.92 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.92 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.92 | |
| 1rut_X | 188 | Flinc4, fusion protein of LMO4 protein and LIM dom | 99.92 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.92 | |
| 2xqn_T | 126 | Testin, TESS; metal-binding protein, cytoskeleton, | 99.92 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.92 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.92 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.92 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.92 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.92 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.92 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.92 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.92 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.91 | |
| 1b8t_A | 192 | Protein (CRP1); LIM domain, muscle differentiation | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.9 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.88 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.88 | |
| 2cup_A | 101 | Skeletal muscle LIM-protein 1; four and half LIM d | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1m3v_A | 122 | FLIN4, fusion of the LIM interacting domain of LDB | 99.76 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 1j2o_A | 114 | FLIN2, fusion of rhombotin-2 and LIM domain-bindin | 99.73 | |
| 1x6a_A | 81 | LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc fi | 99.68 | |
| 2dlo_A | 81 | Thyroid receptor-interacting protein 6; LIM domain | 99.67 | |
| 2ehe_A | 82 | Four and A half LIM domains 3; FHL-3, skeletal mus | 99.65 | |
| 2cuq_A | 80 | Four and A half LIM domains 3; structural genomics | 99.64 | |
| 1x3h_A | 80 | Leupaxin; paxillin family, protein-protein interac | 99.63 | |
| 1x63_A | 82 | Skeletal muscle LIM-protein 1; LIM domain, four an | 99.61 | |
| 2dj7_A | 80 | Actin-binding LIM protein 3; LIM domain, Zn bindin | 99.57 | |
| 1iml_A | 76 | CRIP, cysteine rich intestinal protein; metal-bind | 99.57 | |
| 2egq_A | 77 | FHL1 protein; LIM domain, four and A half LIM doma | 99.56 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.55 | |
| 1a7i_A | 81 | QCRP2 (LIM1); LIM domain containing proteins, meta | 99.54 | |
| 1v6g_A | 81 | Actin binding LIM protein 2; LIM domain, zinc bind | 99.54 | |
| 1x68_A | 76 | FHL5 protein; four-and-A-half LIM protein 5, zinc | 99.52 | |
| 2cu8_A | 76 | Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein | 99.48 | |
| 2cor_A | 79 | Pinch protein; LIM domain, particularly interestin | 99.46 | |
| 2cur_A | 69 | Skeletal muscle LIM-protein 1; four and A half LIM | 99.46 | |
| 1g47_A | 77 | Pinch protein; LIM domain, Zn finger, cell adhesio | 99.45 | |
| 1wyh_A | 72 | SLIM 2, skeletal muscle LIM-protein 2; structural | 99.45 | |
| 1x4k_A | 72 | Skeletal muscle LIM-protein 3; LIM domain, structu | 99.44 | |
| 2dar_A | 90 | PDZ and LIM domain protein 5; enigma homolog prote | 99.44 | |
| 2ehe_A | 82 | Four and A half LIM domains 3; FHL-3, skeletal mus | 99.43 | |
| 2d8z_A | 70 | Four and A half LIM domains 2; skeletal muscle LIM | 99.43 | |
| 1nyp_A | 66 | Pinch protein; LIM domain, protein recognition, ce | 99.43 | |
| 1x4l_A | 72 | Skeletal muscle LIM-protein 3; LIM domain, structu | 99.42 | |
| 1x64_A | 89 | Alpha-actinin-2 associated LIM protein; LIM domain | 99.41 | |
| 1x62_A | 79 | C-terminal LIM domain protein 1; PDZ and LIM domai | 99.4 | |
| 1x3h_A | 80 | Leupaxin; paxillin family, protein-protein interac | 99.4 | |
| 2d8y_A | 91 | Eplin protein; LIM domain, epithelial protein LOST | 99.39 | |
| 2dar_A | 90 | PDZ and LIM domain protein 5; enigma homolog prote | 99.37 | |
| 2cuq_A | 80 | Four and A half LIM domains 3; structural genomics | 99.37 | |
| 2d8x_A | 70 | Protein pinch; LIM domain, pinch protein, structur | 99.37 | |
| 1x61_A | 72 | Thyroid receptor interacting protein 6; LIM domain | 99.37 | |
| 2dlo_A | 81 | Thyroid receptor-interacting protein 6; LIM domain | 99.36 | |
| 2co8_A | 82 | NEDD9 interacting protein with calponin homology a | 99.36 | |
| 1b8t_A | 192 | Protein (CRP1); LIM domain, muscle differentiation | 99.35 | |
| 1x68_A | 76 | FHL5 protein; four-and-A-half LIM protein 5, zinc | 99.35 | |
| 1x63_A | 82 | Skeletal muscle LIM-protein 1; LIM domain, four an | 99.34 | |
| 2l4z_A | 123 | DNA endonuclease RBBP8, LIM domain transcription L | 99.34 | |
| 1wig_A | 73 | KIAA1808 protein; LIM domain, zinc finger, metal-b | 99.33 | |
| 2d8z_A | 70 | Four and A half LIM domains 2; skeletal muscle LIM | 99.32 | |
| 1nyp_A | 66 | Pinch protein; LIM domain, protein recognition, ce | 99.31 | |
| 1x4k_A | 72 | Skeletal muscle LIM-protein 3; LIM domain, structu | 99.31 | |
| 1wyh_A | 72 | SLIM 2, skeletal muscle LIM-protein 2; structural | 99.31 | |
| 2cur_A | 69 | Skeletal muscle LIM-protein 1; four and A half LIM | 99.31 | |
| 1wig_A | 73 | KIAA1808 protein; LIM domain, zinc finger, metal-b | 99.3 | |
| 1x4l_A | 72 | Skeletal muscle LIM-protein 3; LIM domain, structu | 99.29 | |
| 3f6q_B | 72 | LIM and senescent cell antigen-like-containing dom | 99.28 | |
| 2cor_A | 79 | Pinch protein; LIM domain, particularly interestin | 99.27 | |
| 1x6a_A | 81 | LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc fi | 99.26 | |
| 2d8x_A | 70 | Protein pinch; LIM domain, pinch protein, structur | 99.25 | |
| 2cu8_A | 76 | Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein | 99.24 | |
| 2l3k_A | 123 | Rhombotin-2, linker, LIM domain-binding protein 1; | 99.24 | |
| 2l3k_A | 123 | Rhombotin-2, linker, LIM domain-binding protein 1; | 99.23 | |
| 1x64_A | 89 | Alpha-actinin-2 associated LIM protein; LIM domain | 99.22 | |
| 1g47_A | 77 | Pinch protein; LIM domain, Zn finger, cell adhesio | 99.21 | |
| 2iyb_E | 65 | Testin, TESS, TES; LIM domain, SH3-binding, tumour | 99.2 | |
| 2egq_A | 77 | FHL1 protein; LIM domain, four and A half LIM doma | 99.19 | |
| 1x62_A | 79 | C-terminal LIM domain protein 1; PDZ and LIM domai | 99.19 | |
| 3f6q_B | 72 | LIM and senescent cell antigen-like-containing dom | 99.17 | |
| 1iml_A | 76 | CRIP, cysteine rich intestinal protein; metal-bind | 99.17 | |
| 2d8y_A | 91 | Eplin protein; LIM domain, epithelial protein LOST | 99.17 | |
| 2dj7_A | 80 | Actin-binding LIM protein 3; LIM domain, Zn bindin | 99.16 | |
| 1a7i_A | 81 | QCRP2 (LIM1); LIM domain containing proteins, meta | 99.15 | |
| 2jtn_A | 182 | LIM domain-binding protein 1, LIM/homeobox protein | 99.14 | |
| 2l4z_A | 123 | DNA endonuclease RBBP8, LIM domain transcription L | 99.14 | |
| 2cup_A | 101 | Skeletal muscle LIM-protein 1; four and half LIM d | 99.14 | |
| 1x61_A | 72 | Thyroid receptor interacting protein 6; LIM domain | 99.12 | |
| 1m3v_A | 122 | FLIN4, fusion of the LIM interacting domain of LDB | 99.12 | |
| 2co8_A | 82 | NEDD9 interacting protein with calponin homology a | 99.12 | |
| 2xqn_T | 126 | Testin, TESS; metal-binding protein, cytoskeleton, | 99.11 | |
| 1j2o_A | 114 | FLIN2, fusion of rhombotin-2 and LIM domain-bindin | 99.1 | |
| 2iyb_E | 65 | Testin, TESS, TES; LIM domain, SH3-binding, tumour | 99.09 | |
| 1rut_X | 188 | Flinc4, fusion protein of LMO4 protein and LIM dom | 99.07 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.06 | |
| 1v6g_A | 81 | Actin binding LIM protein 2; LIM domain, zinc bind | 98.97 | |
| 2xjy_A | 131 | Rhombotin-2; oncoprotein, T-cell leukemia, proto-o | 98.97 | |
| 2rgt_A | 169 | Fusion of LIM/homeobox protein LHX3, linker, INSU | 98.89 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.82 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.74 | |
| 2yub_A | 118 | LIMK-2, LIM domain kinase 2; PDZ domain, structura | 98.49 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.2 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 97.97 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.94 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.69 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.62 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.43 | |
| 2kv8_A | 83 | RGS12, regulator of G-protein signaling 12; PDZ do | 97.42 | |
| 1ujv_A | 96 | Membrane associated guanylate kinase inverted-2 (M | 97.35 | |
| 1ujd_A | 117 | KIAA0559 protein; PDZ domain, structural genomics, | 97.32 | |
| 2dkr_A | 93 | LIN-7 homolog B; LIN-7B, PDZ, structural genomics, | 97.27 | |
| 1m5z_A | 91 | GRIP, AMPA receptor interacting protein; six beta- | 97.26 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.26 | |
| 2yt7_A | 101 | Amyloid beta A4 precursor protein-binding family A | 97.26 | |
| 3soe_A | 113 | Membrane-associated guanylate kinase, WW and PDZ c | 97.25 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.25 | |
| 1r6j_A | 82 | Syntenin 1; PDZ, membrane protein; 0.73A {Homo sap | 97.23 | |
| 1d5g_A | 96 | Human phosphatase HPTP1E; protein-peptide complex, | 97.21 | |
| 2jil_A | 97 | GRIP1 protein, glutamate receptor interacting prot | 97.2 | |
| 3e17_A | 88 | Tight junction protein ZO-2; domain swapping, alte | 97.2 | |
| 2vsp_A | 91 | PDZ domain-containing protein 1; membrane, cytopla | 97.15 | |
| 1v62_A | 117 | KIAA1719 protein; structural genomics, synaptic tr | 97.15 | |
| 2jik_A | 101 | Synaptojanin-2 binding protein; transmembrane, out | 97.13 | |
| 2pa1_A | 87 | PDZ and LIM domain protein 2; PDZ domain, structur | 97.12 | |
| 2q3g_A | 89 | PDZ and LIM domain protein 7; structural genomics, | 97.12 | |
| 4e34_A | 87 | Golgi-associated PDZ and coiled-coil motif-contai | 97.11 | |
| 2db5_A | 128 | INAD-like protein; PDZ domain, hinadl, PALS1- asso | 97.11 | |
| 2uzc_A | 88 | Human pdlim5, PDZ and LIM domain 5; metal-binding, | 97.1 | |
| 1rgw_A | 85 | ZAsp protein; PDZ, cypher, oracle, muscle, Z-DISK, | 97.09 | |
| 1vb7_A | 94 | PDZ and LIM domain 2; PDZ domain PDZ-LIM protein, | 97.09 | |
| 2he4_A | 90 | Na(+)/H(+) exchange regulatory cofactor NHE-RF2; p | 97.09 | |
| 1kwa_A | 88 | Hcask/LIN-2 protein; PDZ domain, neurexin, syndeca | 97.08 | |
| 3gge_A | 95 | PDZ domain-containing protein GIPC2; structural ge | 97.07 | |
| 2d92_A | 108 | INAD-like protein; PDZ domain, inadl protein, hina | 97.07 | |
| 1wi4_A | 109 | Synip, syntaxin binding protein 4; syntaxin4-inter | 97.07 | |
| 1wi2_A | 104 | Riken cDNA 2700099C19; structural genomics, riken | 97.05 | |
| 1wha_A | 105 | KIAA0147 protein, scribble; PDZ domain, cellular s | 97.05 | |
| 2f5y_A | 91 | Regulator of G-protein signalling 3 isoform 1; PDZ | 97.05 | |
| 2i04_A | 85 | Membrane-associated guanylate kinase, WW and PDZ d | 97.05 | |
| 2v90_A | 96 | PDZ domain-containing protein 3; membrane, protein | 97.05 | |
| 1n7e_A | 97 | AMPA receptor interacting protein GRIP; PDZ, prote | 97.03 | |
| 2rcz_A | 81 | Tight junction protein ZO-1; PDZ, domain-swapping, | 97.03 | |
| 2ejy_A | 97 | 55 kDa erythrocyte membrane protein; GPC, maguk, P | 97.0 | |
| 2pkt_A | 91 | PDZ and LIM domain protein 1; PDZ domain, structur | 96.99 | |
| 1mfg_A | 95 | ERB-B2 interacting protein; PDZ domain, protein-pe | 96.99 | |
| 1v5l_A | 103 | PDZ and LIM domain 3; actinin alpha 2 associated L | 96.99 | |
| 4amh_A | 106 | Disks large homolog 1; permutation, protein foldin | 96.98 | |
| 2jxo_A | 98 | Ezrin-radixin-moesin-binding phosphoprotein 50; nh | 96.98 | |
| 2edv_A | 96 | FERM and PDZ domain-containing protein 1; cytoskel | 96.97 | |
| 3nfk_A | 107 | Tyrosine-protein phosphatase non-receptor type 4; | 96.97 | |
| 2qg1_A | 92 | Multiple PDZ domain protein; MPDZ, MUPP1, structur | 96.96 | |
| 1ihj_A | 98 | INAD; intermolecular disulfide bond, PDZ domain, s | 96.95 | |
| 2eeg_A | 94 | PDZ and LIM domain protein 4; PDZ domain, structur | 96.95 | |
| 2byg_A | 117 | Channel associated protein of synapse-110; DLG2, P | 96.95 | |
| 1um7_A | 113 | Synapse-associated protein 102; PDZ, discs large h | 96.94 | |
| 1n7t_A | 103 | 99-MER peptide of densin-180-like protein; PDZ dom | 96.94 | |
| 1ueq_A | 123 | Membrane associated guanylate kinase inverted-2 (M | 96.94 | |
| 1uep_A | 103 | Membrane associated guanylate kinase inverted-2 (M | 96.93 | |
| 2eno_A | 120 | Synaptojanin-2-binding protein; mitochondrial oute | 96.92 | |
| 1y7n_A | 90 | Amyloid beta A4 precursor protein-binding family A | 96.92 | |
| 1v6b_A | 118 | Harmonin isoform A1; structural genomics, usher sy | 96.91 | |
| 2dlu_A | 111 | INAD-like protein; PDZ domain, inadl protein, hina | 96.91 | |
| 2djt_A | 104 | Unnamed protein product; PDZ domain, structural ge | 96.91 | |
| 2fcf_A | 103 | Multiple PDZ domain protein; adaptor molecule, pro | 96.9 | |
| 2opg_A | 98 | Multiple PDZ domain protein; structural protein, s | 96.9 | |
| 1zfo_A | 31 | LAsp-1; LIM domain, zinc-finger, metal-binding pro | 96.9 | |
| 1uhp_A | 107 | Hypothetical protein KIAA1095; PDZ domain, semapho | 96.9 | |
| 1qav_A | 90 | Alpha-1 syntrophin (residues 77-171); beta-finger, | 96.89 | |
| 1whd_A | 100 | RGS3, regulator of G-protein signaling 3; PDZ doma | 96.89 | |
| 2iwo_A | 120 | Multiple PDZ domain protein; SGC, MPDZ, MUPP1, MUP | 96.89 | |
| 2dc2_A | 103 | GOPC, golgi associated PDZ and coiled-coil motif c | 96.89 | |
| 1uew_A | 114 | Membrane associated guanylate kinase inverted-2 (M | 96.89 | |
| 1i16_A | 130 | Interleukin 16, LCF; cytokine, lymphocyte chemoatt | 96.88 | |
| 2fe5_A | 94 | Presynaptic protein SAP102; PDZ domain, DLG3, huma | 96.88 | |
| 3cbz_A | 108 | Dishevelled-2; PDZ domain, phage derived high affi | 96.88 | |
| 2vwr_A | 95 | Ligand of NUMB protein X 2; protein-binding, metal | 96.88 | |
| 2qkv_A | 96 | Inactivation-NO-after-potential D protein; PDZ dom | 96.88 | |
| 2ego_A | 96 | General receptor for phosphoinositides 1- associat | 96.88 | |
| 3bpu_A | 88 | Membrane-associated guanylate kinase, WW and PDZ c | 96.88 | |
| 3cyy_A | 92 | Tight junction protein ZO-1; protein-ligand comple | 96.87 | |
| 2i1n_A | 102 | Discs, large homolog 3; DLG3, PDZ, PDZ domain, sig | 96.87 | |
| 3i4w_A | 104 | Disks large homolog 4; alpha and beta protein, alt | 96.87 | |
| 2iwq_A | 123 | Multiple PDZ domain protein; SGC, MPDZ, MUPP1, MUP | 96.86 | |
| 2o2t_A | 117 | Multiple PDZ domain protein; structural protein, s | 96.86 | |
| 3axa_A | 106 | Afadin, nectin-3, protein AF-6; PDZ domain, fusion | 96.86 | |
| 1v5q_A | 122 | GRIP1 homolog, glutamate receptor interacting prot | 96.85 | |
| 1wfg_A | 131 | Regulating synaptic membrane exocytosis protein 2; | 96.85 | |
| 3qe1_A | 107 | Sorting nexin-27, G protein-activated inward RECT | 96.84 | |
| 2q9v_A | 90 | Membrane-associated guanylate kinase, WW and PDZ c | 96.84 | |
| 2koj_A | 111 | Partitioning defective 3 homolog; PDZ domain, stru | 96.83 | |
| 2r4h_A | 112 | Membrane-associated guanylate kinase, WW and PDZ c | 96.83 | |
| 1wfv_A | 103 | Membrane associated guanylate kinase inverted-2; a | 96.83 | |
| 2kpk_A | 129 | Membrane-associated guanylate kinase, WW and PDZ c | 96.83 | |
| 3o46_A | 93 | Maguk P55 subfamily member 7; PDZ domain, structur | 96.82 | |
| 2d8i_A | 114 | T-cell lymphoma invasion and metastasis 1 variant; | 96.81 | |
| 2dm8_A | 116 | INAD-like protein; PDZ domain, inadl protein, hina | 96.81 | |
| 3b76_A | 118 | E3 ubiquitin-protein ligase LNX; PDZ, bound ligand | 96.81 | |
| 2ehr_A | 117 | INAD-like protein; PDZ domain, inadl protein, hina | 96.81 | |
| 1ufx_A | 103 | KIAA1526 protein; PDZ domain, structural genomics, | 96.8 | |
| 2kom_A | 121 | Partitioning defective 3 homolog; PAR-3B, PDZ doma | 96.79 | |
| 1vae_A | 111 | Rhophilin 2, rhophilin, RHO GTPase binding protein | 96.78 | |
| 3khf_A | 99 | Microtubule-associated serine/threonine-protein ki | 96.78 | |
| 3tsv_A | 124 | Tight junction protein ZO-1; PDZ, scaffolding, JAM | 96.78 | |
| 2jre_A | 108 | C60-1 PDZ domain peptide; de novo protein; NMR {Sy | 96.77 | |
| 1nf3_C | 128 | PAR-6B; semi-CRIB motif, switch I and II, PDZ doma | 96.77 | |
| 3ngh_A | 106 | PDZ domain-containing protein 1; adaptor protein, | 96.76 | |
| 1wf8_A | 107 | Neurabin-I; PDZ domain, structural genomics, NPPSF | 96.76 | |
| 2awx_A | 105 | Synapse associated protein 97; membrane protein, s | 96.75 | |
| 3kzd_A | 94 | TIAM-1, T-lymphoma invasion and metastasis-inducin | 96.75 | |
| 1va8_A | 113 | Maguk P55 subfamily member 5; PDZ domain, palmitoy | 96.74 | |
| 1wf7_A | 103 | Enigma homologue protein; PDZ domain, structural g | 96.74 | |
| 1uit_A | 117 | Human discs large 5 protein; PDZ domain, HDLG5, ma | 96.73 | |
| 1g9o_A | 91 | NHE-RF; PDZ domain, complex, signaling protein; 1. | 96.73 | |
| 2vsv_A | 109 | Rhophilin-2; scaffold protein, RHO GTPase binding, | 96.73 | |
| 2d90_A | 102 | PDZ domain containing protein 1; structural genomi | 96.73 | |
| 3sfj_A | 104 | TAX1-binding protein 3; PDZ:peptide complex, signa | 96.73 | |
| 2la8_A | 106 | Inactivation-NO-after-potential D protein, KON-TI | 96.72 | |
| 2iwn_A | 97 | Multiple PDZ domain protein; SGC, MPDZ, MUPP1, MUP | 96.71 | |
| 1um1_A | 110 | KIAA1849 protein, RSGI RUH-007; PDZ domain, human | 96.71 | |
| 2csj_A | 117 | TJP2 protein; PDZ domain, structural genomics, NPP | 96.7 | |
| 2fne_A | 117 | Multiple PDZ domain protein; structural protein, s | 96.67 | |
| 1uju_A | 111 | Scribble; PDZ domain, cellular signaling, structur | 96.67 | |
| 2e7k_A | 91 | Maguk P55 subfamily member 2; PDZ domain, MPP2 pro | 96.66 | |
| 2edz_A | 114 | PDZ domain-containing protein 1; CFTR-associated p | 96.65 | |
| 2yuy_A | 126 | RHO GTPase activating protein 21; PDZ domain, stru | 96.65 | |
| 1q7x_A | 108 | PDZ2B domain of PTP-BAS (HPTP1E); phosphatase, str | 96.65 | |
| 2eeh_A | 100 | PDZ domain-containing protein 7; structural genomi | 96.64 | |
| 2edp_A | 100 | Fragment, shroom family member 4; APX/shroom famil | 96.63 | |
| 2dmz_A | 129 | INAD-like protein; PDZ domain, inadl protein, hina | 96.62 | |
| 2vz5_A | 139 | TAX1-binding protein 3; WNT signaling pathway, pro | 96.62 | |
| 2g5m_B | 113 | Neurabin-2; spinophilin, PDZ domain, CNS, synaptic | 96.61 | |
| 3r68_A | 95 | Na(+)/H(+) exchange regulatory cofactor NHE-RF3; P | 96.61 | |
| 2daz_A | 124 | INAD-like protein; PDZ domain, inadl protein, hina | 96.58 | |
| 1x5q_A | 110 | LAP4 protein; PDZ domain, scribble homolog protein | 96.57 | |
| 2eei_A | 106 | PDZ domain-containing protein 1; regulatory factor | 96.56 | |
| 1q3o_A | 109 | Shank1; PDZ, GKAP, peptide binding protein; 1.80A | 96.56 | |
| 1wif_A | 126 | RSGI RUH-020, riken cDNA 4930408O21; PDZ domain, s | 96.56 | |
| 3gsl_A | 196 | Disks large homolog 4; PDZ domain, tandem, PSD-95, | 96.54 | |
| 3egg_C | 170 | Spinophilin; PP1, serine/threonine phosphatase, po | 96.54 | |
| 1qau_A | 112 | Neuronal nitric oxide synthase (residues 1-130); b | 96.54 | |
| 2cs5_A | 119 | Tyrosine-protein phosphatase, non-receptor type 4; | 96.52 | |
| 1x6d_A | 119 | Interleukin-16; PDZ domain, lymphocyte chemoattrac | 96.51 | |
| 1wg6_A | 127 | Hypothetical protein (riken cDNA 2810455B10); stru | 96.5 | |
| 2w4f_A | 97 | Protein LAP4; structural protein, phosphoprotein, | 96.5 | |
| 2dls_A | 93 | PDZ-rhogef, RHO guanine nucleotide exchange factor | 96.48 | |
| 3l4f_D | 132 | SH3 and multiple ankyrin repeat domains protein 1; | 96.46 | |
| 2eaq_A | 90 | LIM domain only protein 7; conserved hypothetical | 96.44 | |
| 1b8q_A | 127 | Protein (neuronal nitric oxide synthase); PDZ doma | 96.43 | |
| 3r0h_A | 206 | INAD, inactivation-NO-after-potential D protein; p | 96.43 | |
| 2qt5_A | 200 | Glutamate receptor-interacting protein 1; PDZ-pept | 96.4 | |
| 2kjd_A | 128 | Sodium/hydrogen exchange regulatory cofactor NHE- | 96.39 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.32 | |
| 3qik_A | 101 | Phosphatidylinositol 3,4,5-trisphosphate-dependen | 96.31 | |
| 1tp5_A | 119 | Presynaptic density protein 95; PDZ-peptide ligand | 96.25 | |
| 1zfo_A | 31 | LAsp-1; LIM domain, zinc-finger, metal-binding pro | 96.17 | |
| 2h2b_A | 107 | Tight junction protein ZO-1; PDZ domain, phage der | 96.17 | |
| 2z17_A | 104 | Pleckstrin homology SEC7 and coiled-coil domains- | 96.17 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=337.63 Aligned_cols=180 Identities=22% Similarity=0.258 Sum_probs=155.8
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..+||+++++||+|+||+||+|+++.+|+.||+|++.+........ ...+.+|+++|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~----------------------~~~~~~E~~il~ 87 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----------------------VPYVTRERDVMS 87 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHHT
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHH----------------------HHHHHHHHHHHH
Confidence 3468999999999999999999999999999999996532111000 012356799999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++|||||+++++|.+++.+||||||++||+|.+++.+.+ .+++..+..++.||+.||+|||+++||||||||+||||+
T Consensus 88 ~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~ 166 (311)
T 4aw0_A 88 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 166 (311)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc
Confidence 9999999999999999999999999999999999998654 599999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+|.+ +|||+|+.+..........+.+||+.|||||++.++.|
T Consensus 167 ~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y 211 (311)
T 4aw0_A 167 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211 (311)
T ss_dssp TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCB
T ss_pred CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCC
Confidence 99998 99999998765444444556789999999999988876
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=328.00 Aligned_cols=181 Identities=30% Similarity=0.465 Sum_probs=147.2
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
..+..+||.+.++||+|+||+||+|+++ .+++.||||++........+.|.+|
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E---------------------- 93 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQRE---------------------- 93 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHH----------------------
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHH----------------------
Confidence 3456678999999999999999999875 3688999999987766666666555
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC--------------CCCCHHHHHHHHHHHHHH
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--------------QPLPWGQRVNFARDIAAG 615 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--------------~~l~~~~~~~i~~QIa~g 615 (681)
+++|+.++|||||+++|++.+++.+||||||+++|+|.+++.... .+++|.++..|+.||+.|
T Consensus 94 ---~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 170 (329)
T 4aoj_A 94 ---AELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAG 170 (329)
T ss_dssp ---HHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHH
T ss_pred ---HHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999999999997532 358999999999999999
Q ss_pred HHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 616 MTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 616 L~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.|||+++||||||||+||||++++.+ +|||+|+...............||+.|||||++.+..|
T Consensus 171 l~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~ 237 (329)
T 4aoj_A 171 MVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF 237 (329)
T ss_dssp HHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC
T ss_pred HHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC
Confidence 999999999999999999999999988 99999998765443444445679999999999998876
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=331.43 Aligned_cols=173 Identities=21% Similarity=0.305 Sum_probs=151.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+.|+..+.||+|+||+||+|+++.+|+.||||++........ ..+.+|+.+|+.
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~-------------------------~~~~~Ei~il~~ 127 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR-------------------------ELLFNEVVIMRD 127 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSG-------------------------GGGHHHHHHHHH
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHH-------------------------HHHHHHHHHHHh
Confidence 3569999999999999999999999999999999864321111 124578999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|||||+++++|.+++.+||||||++||+|.+++.+. .+++.++..|+.||+.||+|||+++||||||||+||||+.
T Consensus 128 l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 205 (346)
T 4fih_A 128 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 205 (346)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC
Confidence 99999999999999999999999999999999999763 5999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|.+ +|||+|+...... ....+.+||+.|||||++.+..|
T Consensus 206 ~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y 247 (346)
T 4fih_A 206 DGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPY 247 (346)
T ss_dssp TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCB
T ss_pred CCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCC
Confidence 9998 9999999876433 22345689999999999998877
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=329.33 Aligned_cols=175 Identities=24% Similarity=0.374 Sum_probs=146.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+ .+|+.+|
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~-------------------------~~E~~il 77 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREES-------------------------RREVAVL 77 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHH-------------------------HHHHHHH
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHH-------------------------HHHHHHH
Confidence 478999999999999999999999999999999997543 2222333 3569999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++|||||++++++.+++.+||||||++||+|.++|... ...+++.++..|+.||+.||+|||++|||||||||+|||
T Consensus 78 ~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NIL 157 (350)
T 4b9d_A 78 ANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIF 157 (350)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEE
T ss_pred HHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEE
Confidence 9999999999999999999999999999999999999643 345799999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+.+|.+ +|||+|+...... .......||+.|||||++.++.|
T Consensus 158 l~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y 202 (350)
T 4b9d_A 158 LTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPY 202 (350)
T ss_dssp ECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCC
T ss_pred ECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCC
Confidence 9999998 9999999765432 12234569999999999999887
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=327.61 Aligned_cols=180 Identities=28% Similarity=0.424 Sum_probs=152.2
Q ss_pred eecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
.+..++|.+++.||+|+||.||+|++. .++..||||.+........+.|.+|
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E----------------------- 65 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHRE----------------------- 65 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHH-----------------------
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHH-----------------------
Confidence 356688999999999999999999975 3578999999987766665656555
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC------------CCCCCHHHHHHHHHHHHHHHHH
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP------------GQPLPWGQRVNFARDIAAGMTY 618 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~------------~~~l~~~~~~~i~~QIa~gL~y 618 (681)
+++|+.++|||||+++|++.+++.+|||||||++|+|.++|... ...++|.++..++.||+.||.|
T Consensus 66 --~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 143 (299)
T 4asz_A 66 --AELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVY 143 (299)
T ss_dssp --HHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHH
T ss_pred --HHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999643 2469999999999999999999
Q ss_pred HHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 619 LHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 619 LHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+++||||||||+||||++++.+ +|||+|+...............||+.|||||++.+..|
T Consensus 144 LH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~ 207 (299)
T 4asz_A 144 LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF 207 (299)
T ss_dssp HHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC
T ss_pred HHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC
Confidence 999999999999999999999988 99999987654333333233458999999999988776
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.91 Aligned_cols=173 Identities=21% Similarity=0.313 Sum_probs=151.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.+.|+..+.||+|+||.||+|+++.+|+.||||++........+ .+.+|+.+|+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~-------------------------~~~~Ei~il~~ 204 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRE-------------------------LLFNEVVIMRD 204 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGG-------------------------GHHHHHHHHHH
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHH-------------------------HHHHHHHHHHh
Confidence 35799999999999999999999999999999998654322111 23567999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|||||+++++|.+++.+|||||||+||+|.+++... .+++.++..|+.||+.||+|||++|||||||||+||||+.
T Consensus 205 l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~ 282 (423)
T 4fie_A 205 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 282 (423)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECT
T ss_pred CCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcC
Confidence 99999999999999999999999999999999999753 4999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|.+ +|||+|+.+.... ....+.+||+.|||||++.+..|
T Consensus 283 ~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y 324 (423)
T 4fie_A 283 DGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPY 324 (423)
T ss_dssp TCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCB
T ss_pred CCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCC
Confidence 9998 9999999875433 22335679999999999998877
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=319.35 Aligned_cols=178 Identities=29% Similarity=0.394 Sum_probs=145.0
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
...|.+..++|++++.||+|+||.||+|+++. .||||+++... .+..+.|.+
T Consensus 28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~----------------------- 81 (307)
T 3omv_A 28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRN----------------------- 81 (307)
T ss_dssp -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHH-----------------------
T ss_pred CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHH-----------------------
Confidence 34577888999999999999999999998753 58999886432 333444444
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
|+.+|+.++|||||+++|++. ++.+|||||||++|+|.++|......+++.++..|+.||+.||+|||+++||||||
T Consensus 82 --E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDl 158 (307)
T 3omv_A 82 --EVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158 (307)
T ss_dssp --HHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCC
T ss_pred --HHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCcc
Confidence 599999999999999999875 45789999999999999999876667999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
||+||||++++.+ +|||+|+...............||+.|||||++.+.
T Consensus 159 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 209 (307)
T 3omv_A 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209 (307)
T ss_dssp CSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCC
T ss_pred CHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhcc
Confidence 9999999999988 999999877654433444556799999999999654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=314.61 Aligned_cols=175 Identities=22% Similarity=0.316 Sum_probs=136.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|++.+.||+|+||+||+|+++.+|+.||+|.+.+........ . ..+.+|+++|+.
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~-~---------------------~~~~~Ei~il~~ 69 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDM-Q---------------------GRIEREISYLRL 69 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------C-H---------------------HHHHHHHHHHHH
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHH-H---------------------HHHHHHHHHHHH
Confidence 368999999999999999999999999999999997543211110 0 012456999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|||||++++++.+++.+|+||||+ +|+|.+++.+.+ .+++.++..++.||+.||+|||++||+||||||+|||++.
T Consensus 70 l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~ 147 (275)
T 3hyh_A 70 LRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDE 147 (275)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECT
T ss_pred CCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECC
Confidence 99999999999999999999999999 689999997654 5999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|.+ +|||+|+...... ...+..||+.|||||++.++.|
T Consensus 148 ~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y 188 (275)
T 3hyh_A 148 HLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLY 188 (275)
T ss_dssp TCCEEECCSSCC------------------CTTSCHHHHSSSSC
T ss_pred CCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCC
Confidence 9988 9999998765432 2334679999999999998876
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.70 Aligned_cols=176 Identities=20% Similarity=0.254 Sum_probs=138.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+||+..+.||+|+||+||+|+++.+|+.||+|++...... ..+.+. +|+.+|+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~-------------------------~E~~il~~ 59 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-------------------------REVKALAK 59 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHH-------------------------HHHHHHTT
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHH-------------------------HHHHHHHh
Confidence 4799999999999999999999999999999999754432 233333 45999999
Q ss_pred CCCCceeeEEEEEEeCC------------eEEEEEeccCCCCHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy5063 559 LHHHNVIRFIGVLYKDR------------KLNLVTEYIAGGTLKELLQDPGQ--PLPWGQRVNFARDIAAGMTYLHSMNL 624 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~------------~l~LV~Ey~~gGsL~~~L~~~~~--~l~~~~~~~i~~QIa~gL~yLHs~~I 624 (681)
++|||||+++++|.+.+ .+|+||||+++|+|.+++..... ..++..+..++.||+.||+|||+++|
T Consensus 60 l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~I 139 (299)
T 4g31_A 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGL 139 (299)
T ss_dssp CCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcC
Confidence 99999999999997544 47999999999999999986532 34567788999999999999999999
Q ss_pred cccCCCCCcEEEecCCCe--EEeeeeeEeeecccc----------eeeeecCCCccccchhhccCCCC
Q psy5063 625 IHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPY----------TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~----------~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||||+||||+.+|.+ +|||+|+........ ......+||+.|||||++.+++|
T Consensus 140 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y 207 (299)
T 4g31_A 140 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY 207 (299)
T ss_dssp CCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCC
T ss_pred ccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC
Confidence 999999999999999998 999999987643221 11234569999999999998877
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=320.27 Aligned_cols=171 Identities=20% Similarity=0.321 Sum_probs=146.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|+++.+|+.||||++.... ...+|+.+|+.
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~------------------------------~~~~E~~il~~ 106 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV------------------------------FRVEELVACAG 106 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT------------------------------CCTHHHHTTTT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH------------------------------hHHHHHHHHHh
Confidence 467889999999999999999999999999999985321 11357999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++|||||++++++.+++.+||||||++||+|.++|+..+ .+++..+..|+.||+.||+|||+++||||||||+||||+.
T Consensus 107 l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 185 (336)
T 4g3f_A 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS 185 (336)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT
T ss_pred CCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC
Confidence 999999999999999999999999999999999998654 5999999999999999999999999999999999999999
Q ss_pred CCC-e--EEeeeeeEeeecccce---eeeecCCCccccchhhccCCCC
Q psy5063 639 VGS-G--FDFHLGQIYLIYVPYT---LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~-~--~DFGLa~~~~~~~~~~---~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|. + +|||+|+....+.... .....+||+.|||||++.+++|
T Consensus 186 ~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y 233 (336)
T 4g3f_A 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233 (336)
T ss_dssp TSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCC
T ss_pred CCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCC
Confidence 984 5 9999999876432111 1223469999999999999877
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=318.48 Aligned_cols=180 Identities=27% Similarity=0.325 Sum_probs=149.7
Q ss_pred eecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
.+..+++++.+.||+|+||.||+|++. .+++.||||.+.... ....+.|.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~----------------------- 78 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH----------------------- 78 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHH-----------------------
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHH-----------------------
Confidence 355677888999999999999999864 467899999986432 222334444
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------------CCCCCHHHHHHHHHHHHH
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAA 614 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------------~~~l~~~~~~~i~~QIa~ 614 (681)
|+.+|+.++|||||+++|++.+++.++||||||++|+|.++|... ...++|..+..|+.||+.
T Consensus 79 --E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~ 156 (308)
T 4gt4_A 79 --EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 156 (308)
T ss_dssp --HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHH
T ss_pred --HHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHH
Confidence 599999999999999999999999999999999999999999643 135899999999999999
Q ss_pred HHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 615 GMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 615 gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||+++||||||||+||||++++.+ +|||+|+...............||+.|||||++.+..|
T Consensus 157 gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~ 224 (308)
T 4gt4_A 157 GMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF 224 (308)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC
Confidence 9999999999999999999999999998 99999987654443333445679999999999987766
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=319.65 Aligned_cols=177 Identities=21% Similarity=0.293 Sum_probs=144.9
Q ss_pred cCCCeeecceecccCcEEEEEEEEc---CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
..++|++++.||+|+||+||+|++. .+++.||+|.+.+..... .....+.+|++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-----------------------~~~~~~~~E~~ 78 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-----------------------RDRVRTKMERD 78 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-----------------------EECC------C
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-----------------------HHHHHHHHHHH
Confidence 4478999999999999999999984 468899999986432100 00113356789
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+|+.++|||||++++++.+++.+||||||++||+|.+++.+.+ .+++.++..++.||+.||+|||++|||||||||+||
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 157 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 157 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHe
Confidence 9999999999999999999999999999999999999998654 599999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.+|.+ +|||+|+...... ....+..||+.|||||++.+..|
T Consensus 158 Ll~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y 203 (304)
T 3ubd_A 158 LLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGH 203 (304)
T ss_dssp EECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCC
T ss_pred EEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCC
Confidence 99999998 9999998654332 22334679999999999998877
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=307.32 Aligned_cols=165 Identities=25% Similarity=0.375 Sum_probs=140.4
Q ss_pred eecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
+..++||+|+||.||+|+++.++..||+|++... .....+.+. +|+++|+.++
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~-------------------------~E~~il~~l~ 83 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-------------------------EEAEMLKGLQ 83 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHH-------------------------HHHHHHHTCC
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHH-------------------------HHHHHHHhCC
Confidence 5677899999999999999999999999999653 233333333 4599999999
Q ss_pred CCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCcE
Q psy5063 561 HHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNC 634 (681)
Q Consensus 561 HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~--IIHRDLKp~NI 634 (681)
|||||+++++|.+ ++.+||||||++||+|.+++.+. ..+++..+..|+.||+.||+|||+++ ||||||||+||
T Consensus 84 HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NI 162 (290)
T 3fpq_A 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 162 (290)
T ss_dssp CTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGE
T ss_pred CCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhe
Confidence 9999999999975 35689999999999999999864 35999999999999999999999998 99999999999
Q ss_pred EEec-CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 635 LVRE-VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 635 Ll~~-~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||+. +|.+ +|||+|+.... ....+..||+.|||||++.+
T Consensus 163 Ll~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~ 204 (290)
T 3fpq_A 163 FITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp EESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT
T ss_pred eEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcCC
Confidence 9984 7877 99999985432 22345679999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-35 Score=314.45 Aligned_cols=183 Identities=23% Similarity=0.302 Sum_probs=153.7
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCC-----CeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRET-----GEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINN 546 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t-----g~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~ 546 (681)
..|.+..++|++++.||+|+||.||+|++..+ ++.||+|.+.... ....+.+.+
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~-------------------- 116 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS-------------------- 116 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHH--------------------
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHH--------------------
Confidence 45788899999999999999999999998754 3689999987543 233344444
Q ss_pred ccchHHHHHHHhCCC-CceeeEEEEEEeC-CeEEEEEeccCCCCHHHHHhCC---------------CCCCCHHHHHHHH
Q psy5063 547 LHCFSQVAVLRSLHH-HNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFA 609 (681)
Q Consensus 547 ~~~~~Ei~iL~~L~H-pnIV~l~g~~~~~-~~l~LV~Ey~~gGsL~~~L~~~---------------~~~l~~~~~~~i~ 609 (681)
|+++|+.++| ||||+++|++.++ +.++||||||++|+|.++|+.. ...+++..+..|+
T Consensus 117 -----E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 191 (353)
T 4ase_A 117 -----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191 (353)
T ss_dssp -----HHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHH
T ss_pred -----HHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHH
Confidence 4999999955 8999999999764 5799999999999999999642 2348999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 610 ~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.||+.||+|||+++||||||||+|||+++++.+ +|||+|+....+..+.......||+.|||||++.+..|
T Consensus 192 ~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence 999999999999999999999999999999988 99999997765544444445668999999999988776
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=299.50 Aligned_cols=169 Identities=27% Similarity=0.388 Sum_probs=138.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.+|.+.+.||+|+||.||+|++ +|+.||||++..... +.+..| .|+..+..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~---~~~~~e-----------------------~Ei~~~~~l 54 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFRE-----------------------AEIYQTVML 54 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHH-----------------------HHHHTSTTC
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hhHHHH-----------------------HHHHHHhcC
Confidence 4688999999999999999998 489999999864332 223333 246677789
Q ss_pred CCCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------Ccccc
Q psy5063 560 HHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--------NLIHR 627 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~--------~IIHR 627 (681)
+|||||+++|++.+++ .+||||||+++|+|.++|+.. .++|..+..++.|++.||+|||++ +||||
T Consensus 55 ~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHR 132 (303)
T 3hmm_A 55 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECS
T ss_pred CCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeec
Confidence 9999999999998653 689999999999999999864 589999999999999999999987 99999
Q ss_pred CCCCCcEEEecCCCe--EEeeeeeEeeecccce--eeeecCCCccccchhhccCC
Q psy5063 628 DLNSQNCLVREVGSG--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 628 DLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~~ 678 (681)
||||+||||+.++.+ +|||+|+......... ......||+.|||||++.+.
T Consensus 133 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 187 (303)
T 3hmm_A 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred cCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccc
Confidence 999999999999998 9999999876543222 12235699999999999764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.12 Aligned_cols=174 Identities=21% Similarity=0.308 Sum_probs=145.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+ ++|+++|+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~-------------------------~~Ei~il~ 108 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT-------------------------LRELKILK 108 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHH-------------------------HHHHHHHH
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHH-------------------------HHHHHHHH
Confidence 57999999999999999999999999999999996532 2222223 35699999
Q ss_pred hCCCCceeeEEEEEEe------CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 558 SLHHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~------~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
.++|||||++++++.. .+.+||||||++ |+|.+++...+ .+++..+..|+.||+.||+|||++|||||||||
T Consensus 109 ~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP 186 (398)
T 4b99_A 109 HFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKP 186 (398)
T ss_dssp HCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred hcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCc
Confidence 9999999999999764 367999999996 68999998654 699999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecc--cceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYV--PYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~--~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.+|.+ +|||+|+.+.... ......+.+||+.|||||++.+..|
T Consensus 187 ~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~ 239 (398)
T 4b99_A 187 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHE 239 (398)
T ss_dssp GGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSC
T ss_pred cccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCC
Confidence 99999999998 9999998764321 1222345679999999999988655
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-33 Score=323.47 Aligned_cols=177 Identities=22% Similarity=0.303 Sum_probs=150.8
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH---HHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA---EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~---~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+..+||+++++||+|+||.||+|+++.+|+.||||++.+..... ......| ..++
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E----------------------~~~l 243 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE----------------------RIML 243 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHH----------------------HHHH
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHH----------------------HHHH
Confidence 45679999999999999999999999999999999996532111 1112222 2347
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+++.++|||||+++++|.+++.+||||||++||+|.++|...+ .+++..+..|+.||+.||+|||++|||||||||+|
T Consensus 244 ~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeN 322 (689)
T 3v5w_A 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPAN 322 (689)
T ss_dssp HHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred HHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHH
Confidence 78888999999999999999999999999999999999998654 59999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC-CCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK-ASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~-~~Y 680 (681)
|||+.+|.+ +|||+|+.+.... ..+.+||+.|||||++.+ ..|
T Consensus 323 ILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y 368 (689)
T 3v5w_A 323 ILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGVAY 368 (689)
T ss_dssp EEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTCCC
T ss_pred eEEeCCCCEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCCCC
Confidence 999999998 9999998775433 234689999999999964 455
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-33 Score=317.75 Aligned_cols=173 Identities=21% Similarity=0.332 Sum_probs=153.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|++++.||+|+||.||+|+++.+|+.||+|.+........+.+. +|+.+|+.+
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~-------------------------~Ei~il~~l 211 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR-------------------------KEIQTMSVL 211 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHH-------------------------HHHHHHHHT
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHH-------------------------HHHHHHHhC
Confidence 5899999999999999999999999999999999776554444443 459999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|||||+++++|.+++.+||||||++||+|.++|......+++.++..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 212 ~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~ 291 (573)
T 3uto_A 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK 291 (573)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred CCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC
Confidence 99999999999999999999999999999999997766679999999999999999999999999999999999999865
Q ss_pred --CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 --GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 --g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.+ +|||+|+.+.... .....+||+.|||||++.+++|
T Consensus 292 ~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y 333 (573)
T 3uto_A 292 RSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPV 333 (573)
T ss_dssp SCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCB
T ss_pred CCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCC
Confidence 666 9999999875433 3345689999999999999877
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=292.26 Aligned_cols=169 Identities=19% Similarity=0.258 Sum_probs=140.0
Q ss_pred CCeeecceecccCcEEEEEEEEc---CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+.|++.+.||+|+||+||+|+++ .+++.||+|.+.+.... ..+ .+|+++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~--~~~-------------------------~~E~~~l 73 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHP--IRI-------------------------AAELQCL 73 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCH--HHH-------------------------HHHHHHH
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCH--HHH-------------------------HHHHHHH
Confidence 57999999999999999999975 46789999988654321 112 3468999
Q ss_pred HhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.+ +||||++++++|.+++.+|+||||+++|+|.+++. .+++.++..++.||+.||+|||++|||||||||+|||
T Consensus 74 ~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiL 149 (361)
T 4f9c_A 74 TVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFL 149 (361)
T ss_dssp HHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeE
Confidence 988 79999999999999999999999999999999995 3899999999999999999999999999999999999
Q ss_pred EecC-CCe--EEeeeeeEeeeccc--------------------------ceeeeecCCCccccchhhccCCC
Q psy5063 636 VREV-GSG--FDFHLGQIYLIYVP--------------------------YTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~-g~~--~DFGLa~~~~~~~~--------------------------~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.+ +.+ +|||+|+....... .......+||+.|||||++.+.+
T Consensus 150 l~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 222 (361)
T 4f9c_A 150 YNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP 222 (361)
T ss_dssp EETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred EeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 9987 565 99999986542110 01123456999999999998764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=271.76 Aligned_cols=182 Identities=53% Similarity=0.885 Sum_probs=158.1
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.+.+..++|..++.||+|+||.||++++..+++.||+|.+...+....+.+.+| +
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E-------------------------~ 58 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE-------------------------V 58 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHH-------------------------H
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHH-------------------------H
Confidence 456778899999999999999999999999999999999877766666666655 9
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++|+.++||||+++++++.+++..++||||+++|+|.+++......+++..+..++.|++.||+|||+++|+||||||+|
T Consensus 59 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~N 138 (310)
T 3s95_A 59 KVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN 138 (310)
T ss_dssp HHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred HHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCe
Confidence 99999999999999999999999999999999999999998766679999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccce------------eeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYT------------LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~------------~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.++.+ +|||+++......... ......||+.|+|||++.+..|
T Consensus 139 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 199 (310)
T 3s95_A 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY 199 (310)
T ss_dssp EEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCC
T ss_pred EEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCC
Confidence 999999988 9999998775432211 0113568999999999987765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=270.40 Aligned_cols=174 Identities=20% Similarity=0.340 Sum_probs=150.8
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
..++|.+.+.||+|+||.||+|++..+|+.||+|++.+. .....+.+. +|+.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------~E~~~ 67 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-------------------------REVRI 67 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHH-------------------------HHHHH
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHH-------------------------HHHHH
Confidence 356899999999999999999999999999999998654 223333333 45999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
|+.++||||+++++++.+++.+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIl 146 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL 146 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEE
Confidence 999999999999999999999999999999999999997644 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||+++...... ......||+.|+|||++.+..|
T Consensus 147 l~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 190 (328)
T 3fe3_A 147 LDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKY 190 (328)
T ss_dssp ECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCC
T ss_pred EcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCc
Confidence 9999988 9999997654332 2234579999999999988765
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-30 Score=272.68 Aligned_cols=178 Identities=23% Similarity=0.298 Sum_probs=149.9
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|+..+.||+|+||.||+++++.+|+.||+|.+.+........ .....+|+.+|+
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----------------------~~~~~~E~~~l~ 60 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----------------------VAHTVTESRVLQ 60 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHHH
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhH----------------------HHHHHHHHHHHH
Confidence 4578999999999999999999999999999999986432111000 012345699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 61 ~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 139 (337)
T 1o6l_A 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139 (337)
T ss_dssp SCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred hCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC
Confidence 9999999999999999999999999999999999997643 589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 140 ~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 182 (337)
T 1o6l_A 140 KDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDY 182 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCB
T ss_pred CCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCC
Confidence 99998 9999998643322 12234568999999999987765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.9e-30 Score=274.95 Aligned_cols=181 Identities=20% Similarity=0.282 Sum_probs=144.4
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
..+..++|+..++||+|+||.||+|+++.+++.||+|++.+......... ....+|..
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~----------------------~~~~~E~~ 75 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDV----------------------ECTMTEKR 75 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTH----------------------HHHHHHHH
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHH----------------------HHHHHHHH
Confidence 34567899999999999999999999999999999999865321111100 11245688
Q ss_pred HHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 555 VLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 555 iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
+|+.+ +||||+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|
T Consensus 76 il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 154 (353)
T 3txo_A 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDN 154 (353)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred HHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHH
Confidence 89888 79999999999999999999999999999999997653 59999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.+|.+ +|||+++...... .......||+.|||||++.+..|
T Consensus 155 ILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 201 (353)
T 3txo_A 155 VLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLY 201 (353)
T ss_dssp EEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHC
T ss_pred EEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCc
Confidence 999999998 9999998643222 22334679999999999876543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=280.27 Aligned_cols=177 Identities=22% Similarity=0.286 Sum_probs=151.1
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..++||+|+||.||+|+++.+++.||+|++.+... .++. ....+.+|+.+|
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~------~~~~----------------~~~~~~~E~~il 128 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM------LKRA----------------ETACFREERDVL 128 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHH------HHTT----------------TTCCHHHHHHHH
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHh------hhHH----------------HHHHHHHHHHHH
Confidence 456789999999999999999999999999999999864211 1110 011345679999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+++.+|+||||+++|+|.+++......+++..+..++.||+.||+|||+++||||||||+||||
T Consensus 129 ~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl 208 (437)
T 4aw2_A 129 VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208 (437)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE
Confidence 99999999999999999999999999999999999998755679999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+.+|.+ +|||+|+....... .......||+.|||||++.
T Consensus 209 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 209 DMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp CTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHH
T ss_pred cCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHh
Confidence 999998 99999987654332 2223457999999999986
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=267.23 Aligned_cols=176 Identities=24% Similarity=0.352 Sum_probs=149.7
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..+.||+|+||.||+++++.+|+.||+|.+.+......+. .....+|+.+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~----------------------~~~~~~E~~~l 60 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ----------------------VEHTNDERLML 60 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHH
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhH----------------------HHHHHHHHHHH
Confidence 34578999999999999999999999999999999986532111000 01223568999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+...+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 61 ~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 139 (318)
T 1fot_A 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 139 (318)
T ss_dssp HSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred hhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE
Confidence 99999999999999999999999999999999999998654 59999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+|.+ +|||+++..... .....||+.|+|||++.+..|
T Consensus 140 ~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 180 (318)
T 1fot_A 140 DKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPY 180 (318)
T ss_dssp CTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCB
T ss_pred cCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCC
Confidence 999998 999999875431 224569999999999987765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=262.70 Aligned_cols=173 Identities=23% Similarity=0.371 Sum_probs=149.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|.+..+++.||+|.+........+.+. +|+.+|+.
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~E~~~l~~ 73 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-------------------------NEILVMRE 73 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHH-------------------------HHHHHHHH
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHH-------------------------HHHHHHhc
Confidence 35789999999999999999999999999999998654333333333 35899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..++..++||||+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 74 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~ 151 (297)
T 3fxz_A 74 NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (297)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred CCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC
Confidence 99999999999999999999999999999999999764 4899999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 193 (297)
T 3fxz_A 152 DGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 193 (297)
T ss_dssp TCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCB
T ss_pred CCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcCCCC
Confidence 9998 9999998765433 22334569999999999987765
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=267.59 Aligned_cols=176 Identities=21% Similarity=0.292 Sum_probs=150.1
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+..++|+..+.||+|+||.||+++++.+++.||+|.+.+.. ......+. +|+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~-------------------------~E~ 60 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ-------------------------TEK 60 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHH-------------------------HHH
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHH-------------------------HHH
Confidence 44578999999999999999999999999999999997542 22222233 358
Q ss_pred HHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.+|+.+ +||||+++++++.+++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+
T Consensus 61 ~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 139 (345)
T 3a8x_A 61 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLD 139 (345)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred HHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 888887 89999999999999999999999999999999997643 5999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||++.+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 140 NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 187 (345)
T 3a8x_A 140 NVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDY 187 (345)
T ss_dssp GEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCB
T ss_pred HEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCC
Confidence 9999999998 9999998643222 22334679999999999988765
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=270.53 Aligned_cols=179 Identities=22% Similarity=0.320 Sum_probs=148.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|.+.+.||+|+||.||+|+++.+|+.||+|.+.+........ .....+|..+|
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----------------------~~~~~~E~~il 71 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD----------------------VECTMVEKRVL 71 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHH
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhh----------------------HHHHHHHHHHH
Confidence 55789999999999999999999999999999999986532111000 00123457788
Q ss_pred HhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.+ +||||+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 72 ~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 150 (345)
T 1xjd_A 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL 150 (345)
T ss_dssp HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred HhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEE
Confidence 776 99999999999999999999999999999999997643 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 151 l~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 195 (345)
T 1xjd_A 151 LDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKY 195 (345)
T ss_dssp ECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCB
T ss_pred ECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCC
Confidence 9999988 9999998654322 22334679999999999988765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=275.70 Aligned_cols=179 Identities=20% Similarity=0.279 Sum_probs=150.0
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|++.++||+|+||.||+++++.+++.||+|++.+........ ...+.+|..+|
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~----------------------~~~~~~E~~il 106 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED----------------------IDWVQTEKHVF 106 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC--------------------------CCHHHHHHHHH
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHH----------------------HHHHHHHHHHH
Confidence 45678999999999999999999999999999999997542111110 01223467888
Q ss_pred HhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.+ +||||+++++++.+++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 107 ~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL 185 (396)
T 4dc2_A 107 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 185 (396)
T ss_dssp HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred HhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE
Confidence 776 89999999999999999999999999999999997643 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 186 l~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~ 230 (396)
T 4dc2_A 186 LDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDY 230 (396)
T ss_dssp ECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCB
T ss_pred ECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCC
Confidence 9999998 9999998643222 22345679999999999988765
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=265.18 Aligned_cols=176 Identities=26% Similarity=0.371 Sum_probs=150.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH-HHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA-EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~-~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|++.+.||+|+||.||+|++..+++.||+|.+....... .+. +.+|+.+++
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~-------------------------~~~E~~~l~ 60 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-------------------------IKKEICINK 60 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------C-------------------------HHHHHHHHH
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHH-------------------------HHHHHHHHH
Confidence 478999999999999999999999999999999986433211 111 235699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 61 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 139 (323)
T 3tki_A 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 139 (323)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred hCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEe
Confidence 9999999999999999999999999999999999997653 599999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||+++.+.............||+.|+|||++.+..|
T Consensus 140 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 184 (323)
T 3tki_A 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184 (323)
T ss_dssp TTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSB
T ss_pred CCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCC
Confidence 99988 99999988765443333445679999999999987664
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=262.21 Aligned_cols=173 Identities=17% Similarity=0.246 Sum_probs=149.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|.+++.||+|+||.||+|.+..+++.+|+|.+..... ....+. +|+.+|+.
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~-------------------------~E~~~l~~ 57 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVK-------------------------KEISILNI 57 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHH-------------------------HHHHHHHH
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHH-------------------------HHHHHHHh
Confidence 3689999999999999999999999999999998865432 222233 35999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++.+.+.+++||||+++|+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 58 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~ 137 (321)
T 1tki_A 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp SCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred CCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc
Confidence 99999999999999999999999999999999999876667999999999999999999999999999999999999997
Q ss_pred --CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 --VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 --~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...... ......+|+.|+|||++.+..|
T Consensus 138 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 180 (321)
T 1tki_A 138 RRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp SSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEE
T ss_pred CCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCC
Confidence 5666 9999998875432 2334568999999999987643
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=268.30 Aligned_cols=178 Identities=20% Similarity=0.282 Sum_probs=147.5
Q ss_pred ceecCCCeeecceecccCcEEEEEE-----EEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRV-----THRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~-----~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
..+..++|...+.||+|+||.||+| .+..+++.||+|.+...... .+..|
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~e---------------------- 114 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIG---------------------- 114 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH---HHHHH----------------------
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh---HHHHH----------------------
Confidence 3455678999999999999999999 46778999999998654432 23333
Q ss_pred hHHHHHHHhCC---CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy5063 550 FSQVAVLRSLH---HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD----PGQPLPWGQRVNFARDIAAGMTYLHSM 622 (681)
Q Consensus 550 ~~Ei~iL~~L~---HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~----~~~~l~~~~~~~i~~QIa~gL~yLHs~ 622 (681)
+++++.++ |+||+++++++..++..++||||+++|+|.+++.. ....+++..+..++.||+.||+|||++
T Consensus 115 ---~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~ 191 (365)
T 3e7e_A 115 ---TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191 (365)
T ss_dssp ---HHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ---HHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 56666665 99999999999999999999999999999999963 345699999999999999999999999
Q ss_pred CccccCCCCCcEEEec-----------CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 623 NLIHRDLNSQNCLVRE-----------VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~-----------~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+||||||||+||||+. ++.+ +|||+|+.+.............||+.|||||++.+..|
T Consensus 192 ~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 262 (365)
T 3e7e_A 192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW 262 (365)
T ss_dssp TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB
T ss_pred CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC
Confidence 9999999999999998 7777 99999987654444455566779999999999988765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=274.11 Aligned_cols=180 Identities=26% Similarity=0.323 Sum_probs=145.4
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
....++|+..++||+|+||.||+++++.+++.||+|++.+......... ....+|..+
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~----------------------~~~~~e~~~ 91 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEE----------------------KHIMSERNV 91 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-----------------------------------C
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHH----------------------HHHHHHHHH
Confidence 3556799999999999999999999999999999999975432111100 011233444
Q ss_pred -HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 -LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 -L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
++.++||||+++++++.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 92 ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 170 (373)
T 2r5t_A 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 170 (373)
T ss_dssp CBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 567899999999999999999999999999999999997643 589999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 171 ll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 216 (373)
T 2r5t_A 171 LLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPY 216 (373)
T ss_dssp EECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCC
T ss_pred EECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCC
Confidence 99999998 9999998543221 22334679999999999988765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=272.32 Aligned_cols=176 Identities=19% Similarity=0.305 Sum_probs=150.2
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|.+.+.||+|+||.||++++..+++.||+|.+.+........ ...+.+|+.+
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~----------------------~~~~~~E~~i 68 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE----------------------VRNVFKELQI 68 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHH
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHH----------------------HHHHHHHHHH
Confidence 355678999999999999999999999999999999986432111100 0123457999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
|+.++||||+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl 147 (384)
T 4fr4_A 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNIL 147 (384)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeE
Confidence 999999999999999999999999999999999999998754 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++.+|.+ +|||+++...... ......||+.|+|||++.+
T Consensus 148 l~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 148 LDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp ECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCC
T ss_pred ECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeecc
Confidence 9999998 9999998765332 2334679999999999964
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=270.18 Aligned_cols=183 Identities=27% Similarity=0.377 Sum_probs=151.2
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEc-------CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHR-------ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLI 544 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-------~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~ 544 (681)
..+.+..++|.+++.||+|+||.||+|++. .++..||+|.+.... ......+.
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------------------- 134 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV------------------- 134 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHH-------------------
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHH-------------------
Confidence 345567789999999999999999999975 345689999986543 22233333
Q ss_pred ccccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHHH
Q psy5063 545 NNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNF 608 (681)
Q Consensus 545 ~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~i 608 (681)
+|+++|+.+ +||||+++++++.+++.+|+||||+++|+|.+++.... ..+++..+..+
T Consensus 135 ------~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 208 (370)
T 2psq_A 135 ------SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208 (370)
T ss_dssp ------HHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHH
T ss_pred ------HHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHH
Confidence 459999999 89999999999999999999999999999999997532 34889999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 609 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 609 ~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.||+.||.|||+++|+||||||+|||++.+|.+ +|||+++...............+|+.|+|||++.+..|
T Consensus 209 ~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 282 (370)
T 2psq_A 209 TYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 282 (370)
T ss_dssp HHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC
Confidence 9999999999999999999999999999999988 99999987654332222233456789999999987765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-29 Score=267.40 Aligned_cols=179 Identities=23% Similarity=0.309 Sum_probs=149.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|.+++.||+|+||.||+|+++.+|+.||+|.+.+........ ......+.+|+.+|+.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~-------------------~~~~~~~~~E~~il~~ 71 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR-------------------GVCREEIEREVSILRQ 71 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSS-------------------SBCHHHHHHHHHHHTT
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccc-------------------hhHHHHHHHHHHHHHh
Confidence 357999999999999999999999999999999987643211000 0000122356999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++.++..+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 72 l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 150 (361)
T 2yab_A 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLD 150 (361)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESC
T ss_pred CCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeC
Confidence 999999999999999999999999999999999997654 5999999999999999999999999999999999999998
Q ss_pred CC----Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VG----SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g----~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++ .+ +|||+++...... ......||+.|+|||++.+..|
T Consensus 151 ~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 195 (361)
T 2yab_A 151 KNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPL 195 (361)
T ss_dssp TTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCC
T ss_pred CCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCC
Confidence 87 44 9999998765432 2234569999999999987765
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=276.80 Aligned_cols=177 Identities=23% Similarity=0.291 Sum_probs=150.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..++||+|+||.||+++++.+|+.||+|++.+....... + ...+.+|..+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~----~------------------~~~~~~E~~il 115 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRG----E------------------VSCFREERDVL 115 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHG----G------------------GCCHHHHHHHH
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHH----H------------------HHHHHHHHHHH
Confidence 4567899999999999999999999999999999998653211110 0 11335679999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
..++||||+++++++.+++.+|+||||+++|+|.+++...+..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 116 ~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl 195 (412)
T 2vd5_A 116 VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195 (412)
T ss_dssp HHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee
Confidence 99999999999999999999999999999999999998655569999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+.+|.+ +|||+++....... .......||+.|||||++.
T Consensus 196 d~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 196 DRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp CTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHH
T ss_pred cCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHh
Confidence 999998 99999987654322 1223457999999999986
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=268.84 Aligned_cols=175 Identities=25% Similarity=0.356 Sum_probs=149.5
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|+..+.||+|+||.||+++++.+|+.||+|.+.+......+. ...+.+|+.+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~----------------------~~~~~~E~~~l~ 96 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ----------------------IEHTLNEKRILQ 96 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHHT
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHH----------------------HHHHHHHHHHHH
Confidence 4578999999999999999999999999999999986532111110 012345799999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 97 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 175 (350)
T 1rdq_E 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175 (350)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred hCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEEC
Confidence 9999999999999999999999999999999999998644 599999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+|.+ +|||+++..... .....||+.|+|||++.+..|
T Consensus 176 ~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 215 (350)
T 1rdq_E 176 QQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGY 215 (350)
T ss_dssp TTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCB
T ss_pred CCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCC
Confidence 99988 999999876432 123468999999999987765
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-29 Score=269.34 Aligned_cols=180 Identities=22% Similarity=0.263 Sum_probs=149.2
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|...++||+|+||.||+|+++.+++.||+|.+.+........ .....+|..+
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~----------------------~~~~~~E~~~ 73 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----------------------VECTMVEKRV 73 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHH
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchH----------------------HHHHHHHHHH
Confidence 356789999999999999999999999999999999986532111000 0112456888
Q ss_pred HHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 LRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
|+.+ +||||+++++++.+.+.+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 152 (353)
T 2i0e_A 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152 (353)
T ss_dssp HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence 8887 89999999999999999999999999999999997644 499999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 153 ll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 198 (353)
T 2i0e_A 153 MLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPY 198 (353)
T ss_dssp EECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCB
T ss_pred EEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCc
Confidence 99999998 9999998643222 22334679999999999987765
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=274.80 Aligned_cols=178 Identities=24% Similarity=0.349 Sum_probs=150.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|...++||+|+||.||+|+++.+++.||+|.+.+... ... .....+.+|+.+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~------~~~----------------~~~~~~~~E~~il 123 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM------IKR----------------SDSAFFWEERDIM 123 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH------HHT----------------CCCSTHHHHHHHH
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh------hhh----------------HHHHHHHHHHHHH
Confidence 456789999999999999999999999999999999864211 111 0112345679999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+++.+|+||||++||+|.+++... .+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 124 ~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl 201 (410)
T 3v8s_A 124 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201 (410)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE
Confidence 9999999999999999999999999999999999999763 48999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+.+|.+ +|||+++...... ........||+.|||||++.+..
T Consensus 202 ~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~ 245 (410)
T 3v8s_A 202 DKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQG 245 (410)
T ss_dssp CTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTT
T ss_pred CCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccC
Confidence 999998 9999998765332 22233567999999999997653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=256.85 Aligned_cols=175 Identities=27% Similarity=0.361 Sum_probs=144.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.++|++.+.||+|+||.||++++..+++.||+|.+.... ....+.+. +|+.+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~-------------------------~e~~~ 64 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFE-------------------------REVHN 64 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHH-------------------------HHHHH
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHH-------------------------HHHHH
Confidence 468999999999999999999999999999999985432 23333333 35999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++.++||||+++++++..++..|+||||+++|+|.+++.... ++++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil 143 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL 143 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 999999999999999999999999999999999999997654 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||+++...... ........||+.|+|||++.+..|
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 189 (294)
T 4eqm_A 144 IDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEAT 189 (294)
T ss_dssp ECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCC
T ss_pred ECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCC
Confidence 9999988 9999998664322 122233458999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-28 Score=266.24 Aligned_cols=173 Identities=20% Similarity=0.334 Sum_probs=150.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|.+.+.||+|+||.||+|.++.+|+.+|+|.+..........+.+ |+.+|+.+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~-------------------------E~~il~~l 105 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN-------------------------EISIMNQL 105 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHH-------------------------HHHHHTTC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHH-------------------------HHHHHHhC
Confidence 57999999999999999999999999999999997665444444433 59999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++.+....++||||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 106 ~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~ 185 (387)
T 1kob_A 106 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185 (387)
T ss_dssp CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST
T ss_pred CCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC
Confidence 99999999999999999999999999999999998766679999999999999999999999999999999999999854
Q ss_pred --CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 --GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 --g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++...... ......||+.|+|||++.+..|
T Consensus 186 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 227 (387)
T 1kob_A 186 KASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPV 227 (387)
T ss_dssp TCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCB
T ss_pred CCCceEEEecccceecCCCc---ceeeeccCCCccCchhccCCCC
Confidence 445 9999998775432 2234579999999999987654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=257.89 Aligned_cols=176 Identities=19% Similarity=0.250 Sum_probs=143.2
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|+..+.||+|+||.||+|+++.+|+.||+|++..... ...+.+. +|+.+|+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~-------------------------~E~~~l~~ 60 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM-------------------------REVKALAK 60 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHH-------------------------HHHHHHTS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHH-------------------------HHHHHHHh
Confidence 578999999999999999999999999999999875432 2333333 35999999
Q ss_pred CCCCceeeEEEEEEeCC---------------------------------------------------------eEEEEE
Q psy5063 559 LHHHNVIRFIGVLYKDR---------------------------------------------------------KLNLVT 581 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~---------------------------------------------------------~l~LV~ 581 (681)
++||||+++++++.+.. ..++||
T Consensus 61 l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 140 (332)
T 3qd2_B 61 LEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140 (332)
T ss_dssp CCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEEEEEE
T ss_pred CCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEE
Confidence 99999999999986643 389999
Q ss_pred eccCCCCHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccc
Q psy5063 582 EYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPY 657 (681)
Q Consensus 582 Ey~~gGsL~~~L~~~~--~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~ 657 (681)
||+++|+|.+++.... ...++..+..++.|++.||.|||+++|+||||||+|||++.++.+ +|||+++........
T Consensus 141 e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 220 (332)
T 3qd2_B 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220 (332)
T ss_dssp ECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC---
T ss_pred EecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhh
Confidence 9999999999998653 235667789999999999999999999999999999999999988 999999887643211
Q ss_pred ----------eeeeecCCCccccchhhccCCCC
Q psy5063 658 ----------TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 658 ----------~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.......||+.|+|||++.+..|
T Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 253 (332)
T 3qd2_B 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253 (332)
T ss_dssp -----------CCCSCC-CGGGSCHHHHHCCCC
T ss_pred ccccccccccccccccCCCcCccChHHhcCCCC
Confidence 12233469999999999987665
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=261.49 Aligned_cols=181 Identities=27% Similarity=0.376 Sum_probs=148.4
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCe---EEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGE---VMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~---~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
..+..++|.+.+.||+|+||.||+|.+..+++ .||+|.+... .....+.+.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------------------------ 99 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLS------------------------ 99 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHH------------------------
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHH------------------------
Confidence 34567889999999999999999999986554 5999998754 3333344444
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+.+|+.++||||+++++++.+++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+|||||
T Consensus 100 -E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlk 178 (325)
T 3kul_A 100 -EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLA 178 (325)
T ss_dssp -HHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred -HHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 4999999999999999999999999999999999999999998766679999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.++.+ +|||+++......... ......+|..|+|||++.+..|
T Consensus 179 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 231 (325)
T 3kul_A 179 ARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF 231 (325)
T ss_dssp GGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEE
T ss_pred cceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCC
Confidence 999999999988 9999999875432211 2223346778999999875543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-29 Score=272.21 Aligned_cols=182 Identities=27% Similarity=0.390 Sum_probs=150.4
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
..+.+..++|.+++.||+|+||.||+|++..+++.||+|.+.... ..... .+.+
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~-------------------------~~~~ 161 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA-------------------------KFLQ 161 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHT-------------------------TTTH
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHH-------------------------HHHH
Confidence 456677889999999999999999999999999999999886432 11111 2345
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
|+++|+.++||||+++++++..++..++||||+++|+|.+++......+++..+..++.|++.||+|||+++|+||||||
T Consensus 162 E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp 241 (377)
T 3cbl_A 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAA 241 (377)
T ss_dssp HHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCH
Confidence 79999999999999999999999999999999999999999986555699999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||++.++.+ +|||+++...............++..|+|||++.+..
T Consensus 242 ~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 291 (377)
T 3cbl_A 242 RNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291 (377)
T ss_dssp GGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE
T ss_pred HHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC
Confidence 99999999988 9999998644221111101122467799999987554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-29 Score=257.87 Aligned_cols=180 Identities=31% Similarity=0.492 Sum_probs=147.0
Q ss_pred eecCCCeeecceecccCcEEEEEEE----EcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVT----HRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~----~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.+..++|++.+.||+|+||.||+++ +..+++.||+|.+........+.+.+|
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E------------------------ 61 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE------------------------ 61 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHH------------------------
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHH------------------------
Confidence 3556789999999999999999999 567899999999977665555555554
Q ss_pred HHHHHHhCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
+++|+.++||||+++++++... ..+++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||
T Consensus 62 -~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Di 140 (295)
T 3ugc_A 62 -IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 140 (295)
T ss_dssp -HHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -HHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence 9999999999999999998653 5689999999999999999876656999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccc-eeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPY-TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~-~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.++.+ +|||+++........ .......++..|+|||++.+..|
T Consensus 141 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (295)
T 3ugc_A 141 ATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194 (295)
T ss_dssp SGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCC
T ss_pred CHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCC
Confidence 9999999999988 999999887543322 12223446778999999876654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=262.61 Aligned_cols=172 Identities=23% Similarity=0.281 Sum_probs=147.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|...+.||+|+||.||+|.++.+|+.||+|.+.... ......+. +|+.+|+
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~-------------------------~E~~il~ 83 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-------------------------REARICR 83 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHH-------------------------HHHHHHH
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHH-------------------------HHHHHHH
Confidence 57999999999999999999999999999999986543 22222333 4599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 84 ~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~ 162 (362)
T 2bdw_A 84 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 162 (362)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEES
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence 9999999999999999999999999999999999997654 599999999999999999999999999999999999998
Q ss_pred cCCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++. + +|||+++...... ......||+.|+|||++.+..|
T Consensus 163 ~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 207 (362)
T 2bdw_A 163 SKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPY 207 (362)
T ss_dssp CSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCC
T ss_pred cCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCC
Confidence 7654 4 9999998765322 2234579999999999988765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=259.97 Aligned_cols=180 Identities=23% Similarity=0.319 Sum_probs=142.6
Q ss_pred ecCCCeeecceecccCcEEEEEEEEc---CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+..++|++.+.||+|+||.||++++. .+++.||+|.+.+......... .....+|+
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~---------------------~~~~~~E~ 72 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD---------------------TAHTKAER 72 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC-----------------------------------HH
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhH---------------------HHHHHHHH
Confidence 45678999999999999999999985 6899999999865432111100 01224579
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+|+.++||||+++++++..++.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 73 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~N 151 (327)
T 3a62_A 73 NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPEN 151 (327)
T ss_dssp HHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTT
T ss_pred HHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHH
Confidence 99999999999999999999999999999999999999997643 58999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 152 ill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 198 (327)
T 3a62_A 152 IMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGH 198 (327)
T ss_dssp EEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCC
T ss_pred eEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCC
Confidence 999999988 9999998654322 12234568999999999987654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=257.11 Aligned_cols=172 Identities=24% Similarity=0.360 Sum_probs=147.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH------HHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE------AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~------~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+.|..++.||+|+||.||++++..+|+.||+|.+...... ....+ .+|+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~-------------------------~~E~ 65 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI-------------------------EREV 65 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHH-------------------------HHHH
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHH-------------------------HHHH
Confidence 4688999999999999999999999999999998654321 12222 3569
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+|+.++||||+++++++.++...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 66 ~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 144 (326)
T 2y0a_A 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPEN 144 (326)
T ss_dssp HHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHH
Confidence 9999999999999999999999999999999999999999764 459999999999999999999999999999999999
Q ss_pred EEEecCC----Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVG----SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g----~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.++ .+ +|||+++....... .....||+.|+|||++.+..|
T Consensus 145 Ill~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 194 (326)
T 2y0a_A 145 IMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPL 194 (326)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCC
T ss_pred EEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCC
Confidence 9999888 44 99999987753322 233569999999999987665
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=251.63 Aligned_cols=172 Identities=29% Similarity=0.429 Sum_probs=145.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||+|++..+++.||+|.+.... ......+. +|+.+|+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------------------------~E~~~l~ 56 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-------------------------REICLLK 56 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHH-------------------------HHHHHHT
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHH-------------------------HHHHHHh
Confidence 57999999999999999999999999999999986532 22223333 4599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++..++||||+++ +|.+++......+++..+..++.|++.||+|||++||+||||||+|||++
T Consensus 57 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~ 135 (292)
T 3o0g_A 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 99999999999999999999999999976 66666655455699999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
.+|.+ +|||+++...... .......+|+.|+|||++.+..
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~ 177 (292)
T 3o0g_A 136 RNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp TTSCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCS
T ss_pred CCCCEEEeecccceecCCcc--ccccCCccccCCcChHHHcCCC
Confidence 99988 9999998765322 2233456899999999997754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-29 Score=264.47 Aligned_cols=184 Identities=24% Similarity=0.331 Sum_probs=150.5
Q ss_pred cccceecCCCeeecceecccCcEEEEEEE-----EcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVT-----HRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~-----~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
...+.+..++|.+++.||+|+||.||+|+ +..+++.||+|.+.... ....+.+.+
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------------------- 74 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS------------------- 74 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHH-------------------
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHH-------------------
Confidence 34556778899999999999999999999 45567899999997543 223333444
Q ss_pred cccchHHHHHHHhC-CCCceeeEEEEEEeCC-eEEEEEeccCCCCHHHHHhCCCC-------------------------
Q psy5063 546 NLHCFSQVAVLRSL-HHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPGQ------------------------- 598 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~-~l~LV~Ey~~gGsL~~~L~~~~~------------------------- 598 (681)
|+++|+.+ +||||+++++++.+.+ .+++||||+++|+|.+++.....
T Consensus 75 ------E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 148 (359)
T 3vhe_A 75 ------ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148 (359)
T ss_dssp ------HHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------
T ss_pred ------HHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchh
Confidence 48999999 8999999999998754 59999999999999999976432
Q ss_pred ----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 599 ----------------------------------------PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 599 ----------------------------------------~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
.+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~ 228 (359)
T 3vhe_A 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 228 (359)
T ss_dssp -----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred hhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcC
Confidence 2889999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...............+|+.|+|||++.+..|
T Consensus 229 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 272 (359)
T 3vhe_A 229 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272 (359)
T ss_dssp GGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCC
T ss_pred CCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCC
Confidence 9988 99999987654443334444567889999999876654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=262.06 Aligned_cols=180 Identities=18% Similarity=0.229 Sum_probs=146.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|++.+.||+|+||.||+|+++.+++.||+|.+......... ......+.+|+.+|+.
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~--------------------~~~~~~~~~E~~~l~~ 82 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP--------------------GLSTEDLKREASICHM 82 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS--------------------SCCHHHHHHHHHHHHH
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc--------------------cchHHHHHHHHHHHHh
Confidence 45799999999999999999999999999999998542111000 0000123456999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++||||+++++++.+++.+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 83 l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl 162 (351)
T 3c0i_A 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162 (351)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeE
Confidence 99999999999999999999999999999998887532 345899999999999999999999999999999999999
Q ss_pred EecCCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++. + +|||+++...... .......||+.|+|||++.+..|
T Consensus 163 ~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 210 (351)
T 3c0i_A 163 LASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPY 210 (351)
T ss_dssp ECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCB
T ss_pred EecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCC
Confidence 987765 4 9999998775432 12234569999999999987765
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=278.86 Aligned_cols=179 Identities=22% Similarity=0.298 Sum_probs=151.3
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|...++||+|+||.||+|+++.+|+.||+|++.+........ ...+.+|+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~----------------------~~~~~~E~~iL 238 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKG----------------------EAMALNEKQIL 238 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHH
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHH----------------------HHHHHHHHHHH
Confidence 44578999999999999999999999999999999986432111000 01234579999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++||||+++++++.+.+.+|+||||++||+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 239 ~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNIL 318 (576)
T 2acx_A 239 EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENIL 318 (576)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEE
Confidence 99999999999999999999999999999999999997643 34999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+|.+ +|||+++...... ......||+.|||||++.+..|
T Consensus 319 ld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~ 362 (576)
T 2acx_A 319 LDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERY 362 (576)
T ss_dssp ECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEE
T ss_pred EeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCCCC
Confidence 9999998 9999998765432 2234579999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-28 Score=252.80 Aligned_cols=199 Identities=22% Similarity=0.279 Sum_probs=145.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhcccee-eeccCCCCccccccchHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIY-LIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~-~~~~~~~~~~~~~~~~~Ei~i 555 (681)
+..++|.+.+.||+|+||.||+|++..+++.||+|.+..........+.......... ..............+.+|+++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3457899999999999999999999999999999998764322211111000000000 000000000112245678999
Q ss_pred HHhCCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 556 LRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
|+.++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999986 5789999999999999887654 459999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||++.+|.+ +|||+++...... .......||+.|+|||++.+..
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 213 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETR 213 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTC
T ss_pred EEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCC
Confidence 999999988 9999998765432 2233456999999999997654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=255.36 Aligned_cols=170 Identities=21% Similarity=0.326 Sum_probs=146.4
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
|...+.||+|+||.||+|++..+|+.||+|.+........+.+. +|+.+|+.++|
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~-------------------------~E~~~l~~l~h 101 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLF-------------------------NEVVIMRDYQH 101 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHH-------------------------HHHHHHTTCCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHH-------------------------HHHHHHHhCCC
Confidence 56667899999999999999999999999998654433333333 35999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
|||+++++++...+..++||||+++|+|.+++... .+++..+..++.|++.||.|||+++|+||||||+|||++.++.
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc
Confidence 99999999999999999999999999999998753 5999999999999999999999999999999999999999998
Q ss_pred e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 642 G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+ +|||+++....... ......||+.|+|||++.+..|
T Consensus 180 ~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLY 218 (321)
T ss_dssp EEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCB
T ss_pred EEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCC
Confidence 8 99999987654332 2234569999999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.95 E-value=3.9e-28 Score=276.08 Aligned_cols=180 Identities=20% Similarity=0.275 Sum_probs=151.6
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|...++||+|+||.||+|+++.+|+.||+|++.+......+. ...+.+|+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~----------------------~~~~~~E~~iL 239 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKG----------------------YQGAMVEKKIL 239 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHH
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHH----------------------HHHHHHHHHHH
Confidence 44578999999999999999999999999999999986432111100 01234569999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
+.++||||+++++++.+...+|+||||++||+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 240 ~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~N 319 (543)
T 3c4z_A 240 AKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319 (543)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHH
Confidence 9999999999999999999999999999999999998754 2359999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.+|.+ +|||+++....... ......||+.|||||++.+..|
T Consensus 320 ILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~ 366 (543)
T 3c4z_A 320 VLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEY 366 (543)
T ss_dssp EEECTTSCEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCB
T ss_pred EEEeCCCCEEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCC
Confidence 999999998 99999987654322 2233579999999999988765
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=268.12 Aligned_cols=173 Identities=19% Similarity=0.228 Sum_probs=145.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|++++.||+|+||.||+|.++.+|+.+|+|.+...... ..+.+ .+|+.+|+
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~-------------------------~~E~~il~ 65 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL-------------------------EREARICR 65 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHH-------------------------HHHHHHHH
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHH-------------------------HHHHHHHH
Confidence 5789999999999999999999999999999998754322 22222 34599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 66 ~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~ 144 (444)
T 3soa_A 66 LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLA 144 (444)
T ss_dssp HCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEES
T ss_pred hCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEe
Confidence 9999999999999999999999999999999999987654 599999999999999999999999999999999999998
Q ss_pred c---CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 E---VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~---~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
. ++.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 145 ~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~ 190 (444)
T 3soa_A 145 SKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPY 190 (444)
T ss_dssp BSSTTCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCB
T ss_pred ccCCCCcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCC
Confidence 5 4555 9999998765332 22234679999999999988765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-28 Score=272.35 Aligned_cols=179 Identities=23% Similarity=0.301 Sum_probs=144.0
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..+.||+|+||.||++++..+|+.||+|.+.+........ .....+|+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----------------------~~~~~~e~~~l 202 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDE----------------------VAHTLTENRVL 202 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-----------------------------------CC
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHH----------------------HHHHHHHHHHH
Confidence 44578999999999999999999999999999999986421111110 01224568889
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NIL 635 (681)
+.++||||+++++++.+.+.+++||||+++|+|.+++.... .+++..+..++.||+.||+|||+ ++|+||||||+|||
T Consensus 203 ~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIl 281 (446)
T 4ejn_A 203 QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281 (446)
T ss_dssp CCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEE
T ss_pred HhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEE
Confidence 99999999999999999999999999999999999997643 59999999999999999999998 99999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+.+|.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 282 l~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 326 (446)
T 4ejn_A 282 LDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDY 326 (446)
T ss_dssp ECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCC
T ss_pred ECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCC
Confidence 9999988 9999998543222 22334679999999999987765
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=260.94 Aligned_cols=175 Identities=22% Similarity=0.347 Sum_probs=147.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|.+.+.||+|+||.||+|++..+++.||+|.+.+....... ....+.+|+.+|+.
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~----------------------~~~~~~~E~~~l~~ 65 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSD----------------------MHMRVEREISYLKL 65 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTT----------------------CSHHHHHHHHHHTT
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchh----------------------HHHHHHHHHHHHHh
Confidence 46899999999999999999999999999999998642111100 01123467999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++.+++..++||||+ +|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.
T Consensus 66 l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~ 143 (336)
T 3h4j_B 66 LRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD 143 (336)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT
T ss_pred CCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcC
Confidence 99999999999999999999999999 789999887643 5999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...... ......||+.|+|||++.+..|
T Consensus 144 ~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 184 (336)
T 3h4j_B 144 NLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLY 184 (336)
T ss_dssp TCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGG
T ss_pred CCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCC
Confidence 9988 9999998654322 2234579999999999988765
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=259.35 Aligned_cols=176 Identities=16% Similarity=0.215 Sum_probs=148.3
Q ss_pred ecCCCeeecceeccc--CcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 477 FRASDLVRGPLLGQG--FFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G--~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
...++|++.+.||+| +||.||+++++.+++.||+|++.... ....+.+. +|
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------------------------~E 76 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ-------------------------GE 76 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHH-------------------------HH
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHH-------------------------HH
Confidence 445789999999999 99999999999999999999997532 22223333 35
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.+|+.++||||+++++++.+++.+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||
T Consensus 77 ~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp 156 (389)
T 3gni_B 77 LHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKA 156 (389)
T ss_dssp HHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 99999999999999999999999999999999999999999754 34599999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccc-----eeeeecCCCccccchhhccC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPY-----TLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~-----~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||++.+|.+ +|||++......... .......||+.|+|||++.+
T Consensus 157 ~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 157 SHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp GGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred HHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhc
Confidence 99999999988 999998766432211 11122368899999999977
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=262.04 Aligned_cols=187 Identities=28% Similarity=0.349 Sum_probs=153.7
Q ss_pred eeccccceecCCCeeecceecccCcEEEEEEEEcCC-------CeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCC
Q psy5063 469 VEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRET-------GEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGS 540 (681)
Q Consensus 469 ~~~~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t-------g~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~ 540 (681)
......+.+..++|.+++.||+|+||.||+|++..+ +..||+|++.... ......+.
T Consensus 58 ~~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--------------- 122 (382)
T 3tt0_A 58 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI--------------- 122 (382)
T ss_dssp CCCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHH---------------
T ss_pred cccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHH---------------
Confidence 334455667778999999999999999999997643 3589999986543 22333333
Q ss_pred CCccccccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHH
Q psy5063 541 HGLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQ 604 (681)
Q Consensus 541 ~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~ 604 (681)
+|+++++.+ +||||+++++++.+++..++||||+++|+|.+++.... ..+++..
T Consensus 123 ----------~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~ 192 (382)
T 3tt0_A 123 ----------SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192 (382)
T ss_dssp ----------HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHH
T ss_pred ----------HHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHH
Confidence 359999999 99999999999999999999999999999999997543 3589999
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 605 ~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+..++.|++.||.|||+++|+||||||+|||++.++.+ +|||+++...............+|+.|+|||++.+..|
T Consensus 193 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 270 (382)
T 3tt0_A 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 270 (382)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC
Confidence 99999999999999999999999999999999999988 99999987654332233334457889999999987654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=254.83 Aligned_cols=187 Identities=28% Similarity=0.381 Sum_probs=152.7
Q ss_pred eeeccccceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCC
Q psy5063 468 RVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSH 541 (681)
Q Consensus 468 ~~~~~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~ 541 (681)
.......+.+..++|.+++.||+|+||.||++++. .+++.||+|.+.... ....+.+.+
T Consensus 11 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--------------- 75 (314)
T 2ivs_A 11 KILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLS--------------- 75 (314)
T ss_dssp ---CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHH---------------
T ss_pred eccCCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHH---------------
Confidence 33345566677889999999999999999999983 456899999986533 333333333
Q ss_pred CccccccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-----------------------C
Q psy5063 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-----------------------Q 598 (681)
Q Consensus 542 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-----------------------~ 598 (681)
|+++|+.++||||+++++++.+++..++||||+++|+|.+++.... .
T Consensus 76 ----------E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (314)
T 2ivs_A 76 ----------EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145 (314)
T ss_dssp ----------HHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------C
T ss_pred ----------HHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccccc
Confidence 5999999999999999999999999999999999999999997532 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 599 ~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+ +|||+++...............+++.|+|||++.
T Consensus 146 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 225 (314)
T 2ivs_A 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF 225 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhc
Confidence 38899999999999999999999999999999999999999988 9999998775443333333445788899999987
Q ss_pred CCC
Q psy5063 677 KAS 679 (681)
Q Consensus 677 ~~~ 679 (681)
+..
T Consensus 226 ~~~ 228 (314)
T 2ivs_A 226 DHI 228 (314)
T ss_dssp HCE
T ss_pred CCC
Confidence 654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=261.19 Aligned_cols=174 Identities=24% Similarity=0.357 Sum_probs=140.8
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++|...+.||+|+||.||++++..+++.||+|.+.+.... .+.+ .+|+.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~-------------------------~~E~~~l 70 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENV-------------------------QREIINH 70 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHH-------------------------HHHHHHH
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHH-------------------------HHHHHHH
Confidence 3457899999999999999999999999999999998653221 1222 3459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+.+.+++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 71 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill 149 (361)
T 3uc3_A 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL 149 (361)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEE
T ss_pred HhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 99999999999999999999999999999999999997644 59999999999999999999999999999999999999
Q ss_pred ecCCC--e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGS--G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~--~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++. + +|||+++...... ......||+.|+|||++.+..|
T Consensus 150 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 194 (361)
T 3uc3_A 150 DGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEY 194 (361)
T ss_dssp CSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSC
T ss_pred cCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCC
Confidence 98775 4 9999998544322 2233569999999999987765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.5e-28 Score=258.94 Aligned_cols=180 Identities=26% Similarity=0.408 Sum_probs=148.9
Q ss_pred eecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
.+..++|...+.||+|+||.||+|++. .+++.||+|.+.... ......+.+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~----------------------- 99 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR----------------------- 99 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHH-----------------------
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHH-----------------------
Confidence 455678999999999999999999997 455899999987543 233333433
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-----------------------CCCCHHHHH
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-----------------------QPLPWGQRV 606 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-----------------------~~l~~~~~~ 606 (681)
|+.+|+.++||||+++++++.+++..++||||+++|+|.+++.... ..+++..+.
T Consensus 100 --E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 177 (343)
T 1luf_A 100 --EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 177 (343)
T ss_dssp --HHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHH
T ss_pred --HHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHH
Confidence 5999999999999999999999999999999999999999997531 468999999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 607 ~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.||+.||.|||+++|+||||||+|||++.++.+ +|||+++...............+|+.|+|||++.+..|
T Consensus 178 ~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 253 (343)
T 1luf_A 178 CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 253 (343)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc
Confidence 999999999999999999999999999999999988 99999986654332333344567899999999876554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-28 Score=262.65 Aligned_cols=171 Identities=23% Similarity=0.375 Sum_probs=141.1
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
+...+.||+|+||.||+|++..+|+.||+|++........+.+.+ |+++|+.++|
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~-------------------------E~~~l~~l~h 145 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN-------------------------EISVMNQLDH 145 (373)
T ss_dssp EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHH-------------------------HHHHHTTCCC
T ss_pred eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHH-------------------------HHHHHHhCCC
Confidence 445678999999999999999999999999998765544444444 4999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe--cC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR--EV 639 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~--~~ 639 (681)
|||+++++++...+..++||||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||++ .+
T Consensus 146 pnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 225 (373)
T 2x4f_A 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA 225 (373)
T ss_dssp TTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTT
T ss_pred CCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCC
Confidence 9999999999999999999999999999999876555699999999999999999999999999999999999994 44
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++....... .....||+.|+|||++.+..|
T Consensus 226 ~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 265 (373)
T 2x4f_A 226 KQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFV 265 (373)
T ss_dssp TEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBC
T ss_pred CcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCC
Confidence 555 99999987754322 233569999999999977654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=270.51 Aligned_cols=178 Identities=22% Similarity=0.352 Sum_probs=151.7
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|.+++.||+|+||.||+|++..+|+.||+|++.+....... .. ..+.+|+.+|
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~-~~---------------------~~~~~Ei~~l 70 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLD-VV---------------------GKIRREIQNL 70 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTT-TH---------------------HHHHHHHHHH
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHH-HH---------------------HHHHHHHHHH
Confidence 4457899999999999999999999999999999998653211100 00 1234579999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 71 ~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll 149 (476)
T 2y94_A 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL 149 (476)
T ss_dssp TTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE
T ss_pred HhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE
Confidence 99999999999999999999999999999999999997654 59999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++.+ +|||+++...... ......||+.|+|||++.+..|
T Consensus 150 ~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 192 (476)
T 2y94_A 150 DAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLY 192 (476)
T ss_dssp CTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCB
T ss_pred ecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCC
Confidence 999988 9999998765422 2234679999999999988765
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-28 Score=250.02 Aligned_cols=179 Identities=24% Similarity=0.353 Sum_probs=149.9
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.+.+..++|+..+.||+|+||.||++.+. +++.||+|.+...... .+.+. +|+
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~-------------------------~E~ 56 (269)
T 4hcu_A 4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-EEDFI-------------------------EEA 56 (269)
T ss_dssp -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC-HHHHH-------------------------HHH
T ss_pred cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC-HHHHH-------------------------HHH
Confidence 45677789999999999999999999987 4778999998654322 12233 359
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++++.++||||+++++++.+++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 57 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~N 136 (269)
T 4hcu_A 57 EVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN 136 (269)
T ss_dssp HHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchhe
Confidence 99999999999999999999999999999999999999998776679999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.++.+ +|||+++...... ........+|..|+|||++.+..|
T Consensus 137 il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 184 (269)
T 4hcu_A 137 CLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRY 184 (269)
T ss_dssp EEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred EEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCC
Confidence 999999988 9999998665432 122223446778999999876544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=265.88 Aligned_cols=181 Identities=28% Similarity=0.406 Sum_probs=146.9
Q ss_pred ceecCCCeeecceecccCcEEEEEEE-----EcCCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVT-----HRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~-----~~~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
..+..++|.+.+.||+|+||.||+|+ ...+++.||+|.+... .......+.+
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---------------------- 123 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM---------------------- 123 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHH----------------------
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHH----------------------
Confidence 34556789999999999999999999 4457789999998653 2333333444
Q ss_pred chHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy5063 549 CFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG------QPLPWGQRVNFARDIAAGMTYLHSM 622 (681)
Q Consensus 549 ~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~------~~l~~~~~~~i~~QIa~gL~yLHs~ 622 (681)
|+.+|+.++||||+++++++.++...++||||+++|+|.+++.... ..+++..++.++.||+.||.|||++
T Consensus 124 ---E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 200 (367)
T 3l9p_A 124 ---EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN 200 (367)
T ss_dssp ---HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ---HHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 4899999999999999999999999999999999999999997532 3589999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 623 NLIHRDLNSQNCLVREVGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|+||||||+|||++.+|. + +|||+++...............+|+.|+|||++.+..|
T Consensus 201 ~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 263 (367)
T 3l9p_A 201 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF 263 (367)
T ss_dssp TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC
T ss_pred CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCC
Confidence 9999999999999997664 4 99999986544333333334557899999999876654
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=253.14 Aligned_cols=170 Identities=22% Similarity=0.322 Sum_probs=146.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCC-------eEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETG-------EVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg-------~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
+..++|...+.||+|+||.||+|++..++ ..||+|.+........+.+.+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~----------------------- 61 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE----------------------- 61 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHH-----------------------
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHH-----------------------
Confidence 45678999999999999999999998877 479999986654444444444
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
|+.+|+.++||||+++++++.+++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||
T Consensus 62 --E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dl 139 (289)
T 4fvq_A 62 --AASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNV 139 (289)
T ss_dssp --HHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred --HHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCc
Confidence 499999999999999999999999999999999999999999876656999999999999999999999999999999
Q ss_pred CCCcEEEecCCC--------e--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 630 NSQNCLVREVGS--------G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 630 Kp~NILl~~~g~--------~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||+|||++.++. + +|||+++..... ....+|..|+|||++.+
T Consensus 140 kp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIEN 191 (289)
T ss_dssp CGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHC
T ss_pred CcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCC
Confidence 999999999886 5 899998654322 12347889999999976
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=255.83 Aligned_cols=176 Identities=18% Similarity=0.229 Sum_probs=139.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.++|++.+.||+|+||.||++++..+++.||+|.+.... ......+. +|+.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~-------------------------~E~~~ 65 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR-------------------------REAQN 65 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHH-------------------------HHHTT
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHH-------------------------HHHHH
Confidence 468999999999999999999999999999999986532 22223333 35888
Q ss_pred HHhCCCCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 556 LRSLHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
++.++||||+++++++.... ..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||
T Consensus 66 l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 144 (311)
T 3ork_A 66 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144 (311)
T ss_dssp CCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 99999999999999987653 3599999999999999997643 599999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++.+ +|||+++....... ........||+.|+|||++.+..|
T Consensus 145 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 196 (311)
T 3ork_A 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 196 (311)
T ss_dssp GGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCC
T ss_pred HHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCC
Confidence 99999999988 99999987654321 122223458999999999987765
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=267.81 Aligned_cols=171 Identities=25% Similarity=0.368 Sum_probs=131.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|++++.||+|+||.||+|+++.+++.||+|++.+. +....+.+. +|+.+|
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~-------------------------~E~~~l 106 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL-------------------------REIAIL 106 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHH-------------------------HHHHHH
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHH-------------------------HHHHHH
Confidence 47899999999999999999999999999999998653 222333333 459999
Q ss_pred HhCCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.++||||+++++++... ..+|+||||+ +|+|.+++.... .+++..+..++.||+.||.|||+++||||||||
T Consensus 107 ~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp 184 (458)
T 3rp9_A 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKP 184 (458)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCG
T ss_pred HhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCCh
Confidence 999999999999999543 5799999998 579999998654 599999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccc-------------------------eeeeecCCCccccchhhcc
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPY-------------------------TLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~-------------------------~~~~~~~gt~~Y~APEvL~ 676 (681)
+||||+.++.+ +|||+|+........ .......||+.|+|||++.
T Consensus 185 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp GGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred hhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 99999999988 999999875421110 1223456899999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-28 Score=253.11 Aligned_cols=170 Identities=24% Similarity=0.266 Sum_probs=140.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|+..+.||+|+||.||+|++..+++.||+|++.... ......+..| +..+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e-------------------------~~~~ 110 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAE-------------------------VGSH 110 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHH-------------------------HHHH
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHH-------------------------HHHH
Confidence 367999999999999999999999999999999886532 2222222222 4444
Q ss_pred H-hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 R-SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~-~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
. ..+||||+++++++.+++.+++||||+ +++|.+++......+++..+..++.|++.||+|||+++|+||||||+|||
T Consensus 111 ~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 189 (311)
T 3p1a_A 111 EKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF 189 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 4 449999999999999999999999999 77999998776667999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++.++.+ +|||+++...... ......||+.|+|||++.+
T Consensus 190 l~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 190 LGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG 230 (311)
T ss_dssp ECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT
T ss_pred ECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC
Confidence 9999988 9999998765432 2234568999999999876
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=252.76 Aligned_cols=179 Identities=32% Similarity=0.474 Sum_probs=140.6
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
....+..++|.+.+.||+|+||.||+|++ +|+.||+|.+.... ....+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~------------------------- 82 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFL------------------------- 82 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHH-------------------------
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHH-------------------------
Confidence 34446678999999999999999999987 48899999986543 23333333
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ--PLPWGQRVNFARDIAAGMTYLHSMN--LIH 626 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~--~l~~~~~~~i~~QIa~gL~yLHs~~--IIH 626 (681)
+|+++|+.++||||+++++++.+.+..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++ |+|
T Consensus 83 ~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH 162 (309)
T 3p86_A 83 REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVH 162 (309)
T ss_dssp HHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred HHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEEC
Confidence 459999999999999999999999999999999999999999986532 3899999999999999999999999 999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||+|||++.++.+ +|||+++...... .......||+.|+|||++.+..|
T Consensus 163 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 216 (309)
T 3p86_A 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPS 216 (309)
T ss_dssp TTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCC
T ss_pred CCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCC
Confidence 9999999999999988 9999998654322 22234568999999999987754
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=263.09 Aligned_cols=180 Identities=26% Similarity=0.392 Sum_probs=139.0
Q ss_pred eecCCCeeecceecccCcEEEEEEEEc---CCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.+..++|...+.||+|+||.||+|++. .++..||+|.+... .....+.+.+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------------------- 95 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG------------------------- 95 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHH-------------------------
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHH-------------------------
Confidence 345678999999999999999999987 46778999998654 2333334444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
|+.+|+.++||||+++++++.+++..++||||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||
T Consensus 96 E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 175 (373)
T 2qol_A 96 EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAA 175 (373)
T ss_dssp HHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCc
Confidence 49999999999999999999999999999999999999999988766799999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++.+ +|||+++......... ......++..|+|||++.+..|
T Consensus 176 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (373)
T 2qol_A 176 RNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227 (373)
T ss_dssp GGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCC
T ss_pred ceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCc
Confidence 99999999988 9999998776432111 1122335678999999876654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-28 Score=254.99 Aligned_cols=177 Identities=24% Similarity=0.361 Sum_probs=148.6
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.+...+..++|++.+.||+|+||.||+|++. ++.||+|++....... ... .+
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-~~~-------------------------~~ 67 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQS-WQN-------------------------EY 67 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHH-HHH-------------------------HH
T ss_pred ccccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHH-HHH-------------------------HH
Confidence 4456678889999999999999999999876 8999999986543221 111 23
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM----- 622 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~----- 622 (681)
|+.+|+.++||||+++++++.... .+++||||+++|+|.+++... .+++..+..++.|++.||.|||+.
T Consensus 68 E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~ 145 (322)
T 3soc_A 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLK 145 (322)
T ss_dssp HHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEET
T ss_pred HHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 588899999999999999998743 489999999999999999763 499999999999999999999999
Q ss_pred -----CccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 623 -----NLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 623 -----~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|+||||||+|||++.++.+ +|||+++...............||+.|+|||++.+.
T Consensus 146 ~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 208 (322)
T 3soc_A 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208 (322)
T ss_dssp TEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC
T ss_pred cccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccc
Confidence 99999999999999999988 999999887654433333345689999999999764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.7e-28 Score=282.44 Aligned_cols=180 Identities=22% Similarity=0.263 Sum_probs=150.1
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|.+.++||+|+||.||+|+++.+++.||+|++.+........ .....+|..+
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~----------------------~~~~~~E~~~ 394 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD----------------------VECTMVEKRV 394 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTT----------------------THHHHHHHHH
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHH----------------------HHHHHHHHHH
Confidence 356789999999999999999999999999999999986421111000 1123456888
Q ss_pred HHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 LRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
|..+ +||||+++++++.+.+.+||||||+++|+|.+++...+ .+++..+..++.||+.||+|||+++||||||||+||
T Consensus 395 l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NI 473 (674)
T 3pfq_A 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473 (674)
T ss_dssp HTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTE
T ss_pred HHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhE
Confidence 8887 79999999999999999999999999999999998654 599999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+.+|.+ +|||+|+...... .......||+.|||||++.+..|
T Consensus 474 Ll~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~ 519 (674)
T 3pfq_A 474 MLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPY 519 (674)
T ss_dssp EECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCB
T ss_pred EEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCC
Confidence 99999998 9999998654332 22345679999999999988766
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7.7e-28 Score=255.55 Aligned_cols=189 Identities=26% Similarity=0.367 Sum_probs=152.8
Q ss_pred cceeeccccceecCCCeeecceecccCcEEEEEEEEc-------CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeec
Q psy5063 466 SFRVEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHR-------ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLID 537 (681)
Q Consensus 466 s~~~~~~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-------~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~ 537 (681)
.+.....+.+.+..++|.+++.||+|+||.||+|++. .++..||+|.+.... ......+.
T Consensus 21 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------------ 88 (334)
T 2pvf_A 21 EYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV------------ 88 (334)
T ss_dssp --CCCCCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHH------------
T ss_pred cccCCCCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHH------------
Confidence 4444556667788899999999999999999999986 456789999986543 22233333
Q ss_pred cCCCCccccccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCC
Q psy5063 538 LGSHGLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLP 601 (681)
Q Consensus 538 ~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~ 601 (681)
+|+++|+.+ +||||+++++++..++..++||||+++|+|.+++.... ..++
T Consensus 89 -------------~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 155 (334)
T 2pvf_A 89 -------------SEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155 (334)
T ss_dssp -------------HHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCC
T ss_pred -------------HHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCC
Confidence 358999999 99999999999999999999999999999999997643 2488
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 602 ~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+..+..++.|++.||.|||+++|+||||||+|||++.++.+ +|||+++...............+|+.|+|||++.+..
T Consensus 156 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 235 (334)
T 2pvf_A 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235 (334)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC
Confidence 99999999999999999999999999999999999999988 9999998766443333333445788899999986554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.1e-28 Score=255.90 Aligned_cols=176 Identities=19% Similarity=0.180 Sum_probs=149.1
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+-.++|.+.+.||+|+||.||+|++..+++.||+|.+...... . .+.+|+.+|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------------------------~~~~E~~~l 58 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--P-------------------------QLHLEYRFY 58 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS--C-------------------------CHHHHHHHH
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch--H-------------------------HHHHHHHHH
Confidence 3457899999999999999999999999999999988543210 1 234569999
Q ss_pred HhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.+ +||||+++++++..++..++||||+ +++|.+++......+++..+..++.|++.||+|||+++|+||||||+|||
T Consensus 59 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil 137 (330)
T 2izr_A 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFL 137 (330)
T ss_dssp HHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence 999 9999999999999999999999999 99999999865567999999999999999999999999999999999999
Q ss_pred EecCCC-----e--EEeeeeeEeeecccce-----eeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGS-----G--FDFHLGQIYLIYVPYT-----LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~-----~--~DFGLa~~~~~~~~~~-----~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++. + +|||+++......... ......||+.|+|||++.+..|
T Consensus 138 l~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 194 (330)
T 2izr_A 138 IGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ 194 (330)
T ss_dssp ECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred eccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCC
Confidence 999886 6 9999999875432211 1234669999999999988765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=256.17 Aligned_cols=171 Identities=26% Similarity=0.364 Sum_probs=134.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|++..+++.||+|.+.... ..+.+ .+|+++|+.
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~-------------------------~~E~~~l~~ 104 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIV-------------------------RTEIGVLLR 104 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------------------------------CHHHHH
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHH-------------------------HHHHHHHHh
Confidence 467999999999999999999999999999999986532 11122 245899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 105 l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~ 183 (349)
T 2w4o_A 105 LSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYAT 183 (349)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESS
T ss_pred CCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEec
Confidence 999999999999999999999999999999999997654 5999999999999999999999999999999999999975
Q ss_pred ---CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 ---VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ---~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...... ......||+.|+|||++.+..|
T Consensus 184 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 227 (349)
T 2w4o_A 184 PAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAY 227 (349)
T ss_dssp SSTTCCEEECCCC-------------------CGGGSCHHHHTTCCC
T ss_pred CCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCC
Confidence 6666 9999998765322 2234568999999999987655
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=257.17 Aligned_cols=184 Identities=24% Similarity=0.341 Sum_probs=150.4
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
...+.+..++|..++.||+|+||.||+|++. .++..||+|.+..... .....+
T Consensus 37 ~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------- 95 (344)
T 1rjb_A 37 DLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL--------------------- 95 (344)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHH---------------------
T ss_pred CcCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHH---------------------
Confidence 3446677889999999999999999999973 4567899999864321 112222
Q ss_pred cccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCC----------------------CCCH
Q psy5063 546 NLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ----------------------PLPW 602 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~----------------------~l~~ 602 (681)
.+|+.+|+.+ +||||+++++++..++..++||||+++|+|.+++..... .+++
T Consensus 96 ----~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 171 (344)
T 1rjb_A 96 ----MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171 (344)
T ss_dssp ----HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred ----HHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCH
Confidence 3469999999 999999999999999999999999999999999976532 3789
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 603 ~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
..+..++.||+.||.|||+++|+||||||+|||++.++.+ +|||+++...............+|+.|+|||++.+..|
T Consensus 172 ~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 172 EDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence 9999999999999999999999999999999999999988 99999987665443333334457889999999876554
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-27 Score=251.15 Aligned_cols=171 Identities=25% Similarity=0.406 Sum_probs=142.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|+..+.||+|+||.||+|++. +|+.||+|++...... ....+ .+|+++|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~-------------------------~~E~~~l 73 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTA-------------------------IREISLL 73 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHH-------------------------HHHHHHH
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHH-------------------------HHHHHHH
Confidence 468999999999999999999985 4899999998543211 11222 3469999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+++..++||||+++ +|.+++......+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 74 ~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~ 152 (311)
T 3niz_A 74 KELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152 (311)
T ss_dssp HHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred HHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence 999999999999999999999999999975 8888888766679999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.++.+ +|||+++..... ........+|+.|+|||++.+.
T Consensus 153 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~ 194 (311)
T 3niz_A 153 NSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGS 194 (311)
T ss_dssp CTTCCEEECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTTC
T ss_pred CCCCCEEEccCcCceecCCC--cccccCCcccCCcCCHHHhcCC
Confidence 999988 999999876432 2223345689999999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-28 Score=258.06 Aligned_cols=180 Identities=24% Similarity=0.362 Sum_probs=140.6
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEE----EEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVM----VLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~v----AiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
..+..++|...+.||+|+||.||+|++..+++.+ |+|.+.... ....+.+
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~------------------------- 64 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI------------------------- 64 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHH-------------------------
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHH-------------------------
Confidence 4566788999999999999999999998888765 666653321 1122223
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
.+|+.+|+.++||||+++++++..+ ..++|+||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||
T Consensus 65 ~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Di 143 (327)
T 3poz_A 65 LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 143 (327)
T ss_dssp HHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCC
Confidence 3459999999999999999999875 488999999999999999876667999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.++.+ +|||+++...............+|..|+|||++.+..|
T Consensus 144 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3poz_A 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp CGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCC
T ss_pred ChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCC
Confidence 9999999999988 99999987654433333334557889999999876654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-28 Score=247.81 Aligned_cols=178 Identities=23% Similarity=0.338 Sum_probs=146.6
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|++.+.||+|+||.||+|.+..+++.||+|.+......... .. ..+.+|+.+
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~-~~---------------------~~~~~e~~~ 62 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-VE---------------------HQLRREVEI 62 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHT-CH---------------------HHHHHHHHH
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhh-HH---------------------HHHHHHHHH
Confidence 45567899999999999999999999999999999998653221110 00 012356999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++.++||||+++++++.+.+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nil 141 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL 141 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEE
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEE
Confidence 999999999999999999999999999999999999997643 4899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||++....... .....+++.|+|||++.+..|
T Consensus 142 i~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 184 (279)
T 3fdn_A 142 LGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMH 184 (279)
T ss_dssp ECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCC
T ss_pred EcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCC
Confidence 9999998 9999986554322 233568999999999977654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=244.81 Aligned_cols=175 Identities=26% Similarity=0.391 Sum_probs=150.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+. +|+.+++.
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-------------------------~e~~~l~~ 61 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-------------------------KEICINKM 61 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHH-------------------------HHHHHHHT
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHH-------------------------HHHHHHHh
Confidence 57899999999999999999999999999999986432 22223333 35899999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 62 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~ 140 (276)
T 2yex_A 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE 140 (276)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred cCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEcc
Confidence 99999999999999999999999999999999999764 35999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||++................+|+.|+|||++.+..|
T Consensus 141 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 184 (276)
T 2yex_A 141 RDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184 (276)
T ss_dssp TCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSB
T ss_pred CCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCC
Confidence 9988 99999987765433333345668999999999987654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=246.03 Aligned_cols=178 Identities=24% Similarity=0.338 Sum_probs=132.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||+|++..+++.||+|.+......... .. ..+.+|+.+++.
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~---------------------~~~~~e~~~l~~ 67 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG-MV---------------------QRVQNEVKIHCQ 67 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT-CH---------------------HHHHHHHHHHTT
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhh-HH---------------------HHHHHHHHHHHh
Confidence 35799999999999999999999999999999998643211100 00 012456999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++.+.+..++||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 68 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~ 147 (278)
T 3cok_A 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTR 147 (278)
T ss_dssp BCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECT
T ss_pred CCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 99999999999999999999999999999999999887667999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++...... .......+|+.|+|||++.+..|
T Consensus 148 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 189 (278)
T 3cok_A 148 NMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAH 189 (278)
T ss_dssp TCCEEECCCTTCEECC----------------------------
T ss_pred CCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCC
Confidence 9988 9999998765322 12223568999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.8e-28 Score=249.46 Aligned_cols=180 Identities=29% Similarity=0.406 Sum_probs=147.8
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..+.+..++|+..+.||+|+||.||++.+. ++..||+|.+...... .+.+. +|
T Consensus 17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~-------------------------~E 69 (283)
T 3gen_A 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFI-------------------------EE 69 (283)
T ss_dssp CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC-HHHHH-------------------------HH
T ss_pred CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC-HHHHH-------------------------HH
Confidence 455677789999999999999999999886 5778999998654322 12333 35
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
+++|+.++||||+++++++.+++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+
T Consensus 70 ~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~ 149 (283)
T 3gen_A 70 AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAAR 149 (283)
T ss_dssp HHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGG
T ss_pred HHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccc
Confidence 99999999999999999999999999999999999999999875556999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||++.++.+ +|||+++...... ........+|+.|+|||++.+..|
T Consensus 150 Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 198 (283)
T 3gen_A 150 NCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKF 198 (283)
T ss_dssp GEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCC
T ss_pred eEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCC
Confidence 9999999988 9999998665432 122223446788999999876554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=252.96 Aligned_cols=183 Identities=25% Similarity=0.341 Sum_probs=151.7
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEE-----cCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCcccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTH-----RETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINN 546 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~-----~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~ 546 (681)
..+.+..++|..++.||+|+||.||+|++ ..+++.||+|.+..... ...+.+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~--------------------- 74 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM--------------------- 74 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHH---------------------
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHH---------------------
Confidence 34556778999999999999999999995 45678999999875432 2233333
Q ss_pred ccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCC-----------------CCCHHHHHHH
Q psy5063 547 LHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ-----------------PLPWGQRVNF 608 (681)
Q Consensus 547 ~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~-----------------~l~~~~~~~i 608 (681)
+|+.+|+.+ +||||+++++++..++..++||||+++|+|.+++..... .+++..+..+
T Consensus 75 ----~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (313)
T 1t46_A 75 ----SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150 (313)
T ss_dssp ----HHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred ----HHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHH
Confidence 358999999 999999999999999999999999999999999975432 4899999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 609 ARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 609 ~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.|++.||.|||+++|+||||||+|||++.++.+ +|||+++...............+|+.|+|||++.+..|
T Consensus 151 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence 9999999999999999999999999999999987 99999987765443333334456788999999866544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.4e-28 Score=254.52 Aligned_cols=176 Identities=25% Similarity=0.390 Sum_probs=148.1
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||+|++. +++.||+|.+........+.+.+ |+.+|+.
T Consensus 38 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~-------------------------E~~~l~~ 91 (321)
T 2qkw_B 38 TNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFET-------------------------EIETLSF 91 (321)
T ss_dssp CCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHH-------------------------HHHGGGS
T ss_pred HhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHH-------------------------HHHHHHh
Confidence 468999999999999999999964 68999999886654444444444 4889999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++||||+++++++..++..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 92 l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil 171 (321)
T 2qkw_B 92 CRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINIL 171 (321)
T ss_dssp CCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEE
T ss_pred CCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEE
Confidence 999999999999999999999999999999999997543 35899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||+++...............||+.|+|||++.+..|
T Consensus 172 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2qkw_B 172 LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL 218 (321)
T ss_dssp ECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC
T ss_pred ECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCC
Confidence 9999988 99999987553322222233458999999999876544
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=251.59 Aligned_cols=171 Identities=21% Similarity=0.346 Sum_probs=143.1
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
..++|.+.+.||+|+||.||+|++..+++.||+|.+...... ..+.+ .+|+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------------------------~~E~~~l 61 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-------------------------MREFEVL 61 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHH-------------------------HHHHHHH
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHH-------------------------HHHHHHH
Confidence 346799999999999999999999999999999998653221 12222 3459999
Q ss_pred HhCCCCceeeEEEEEEeCC--eEEEEEeccCCCCHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKDR--KLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~--~l~LV~Ey~~gGsL~~~L~~~~--~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
+.++||||+++++++.... ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+
T Consensus 62 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 141 (319)
T 4euu_A 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPG 141 (319)
T ss_dssp HHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHH
Confidence 9999999999999998765 8899999999999999998643 23899999999999999999999999999999999
Q ss_pred cEEE----ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 633 NCLV----REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 633 NILl----~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
|||+ +.++.+ +|||+++....... .....||+.|+|||++.
T Consensus 142 NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 142 NIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp GEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHH
T ss_pred HEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHhh
Confidence 9998 555555 99999987754332 22356899999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=253.44 Aligned_cols=182 Identities=28% Similarity=0.457 Sum_probs=152.8
Q ss_pred ccceecCCCeeecceecccCcEEEEEEE----EcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVT----HRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~----~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
...++..++|+..+.||+|+||.||+++ +..+++.||+|.+........+.+.+|
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E--------------------- 74 (327)
T 3lxl_A 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQRE--------------------- 74 (327)
T ss_dssp -CCBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHH---------------------
T ss_pred hhhhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHH---------------------
Confidence 3456778899999999999999999999 467899999999977665555555554
Q ss_pred chHHHHHHHhCCCCceeeEEEEEE--eCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 549 CFSQVAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 549 ~~~Ei~iL~~L~HpnIV~l~g~~~--~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
+++|+.++||||+++++++. +....++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+|
T Consensus 75 ----~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 150 (327)
T 3lxl_A 75 ----IQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 150 (327)
T ss_dssp ----HHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred ----HHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 99999999999999999987 456799999999999999999865456999999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||||+|||++.++.+ +|||+++......... ......+|..|+|||++.+..
T Consensus 151 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 206 (327)
T 3lxl_A 151 RDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI 206 (327)
T ss_dssp SCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE
T ss_pred CCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCC
Confidence 9999999999999988 9999998775433221 222344788899999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-28 Score=258.66 Aligned_cols=182 Identities=23% Similarity=0.350 Sum_probs=146.8
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeE----EEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEV----MVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~----vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
..++..++|+..+.||+|+||.||+|++..+++. +|+|.+..... ......+
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~------------------------~~~~~~~ 62 (325)
T 3kex_A 7 ARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG------------------------RQSFQAV 62 (325)
T ss_dssp CCBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS------------------------CSCBCSC
T ss_pred HhhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc------------------------HHHHHHH
Confidence 3457788999999999999999999999988876 55565532110 0011234
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
.+|+.+++.++||||+++++++. ++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||
T Consensus 63 ~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Di 141 (325)
T 3kex_A 63 TDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNL 141 (325)
T ss_dssp CHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 57899999999999999999886 56799999999999999999876567999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.++.+ +|||+++...............++..|+|||++.+..|
T Consensus 142 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (325)
T 3kex_A 142 AARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194 (325)
T ss_dssp SSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCC
T ss_pred chheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCC
Confidence 9999999999988 99999987765443333444567889999999876554
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=247.58 Aligned_cols=179 Identities=20% Similarity=0.310 Sum_probs=136.4
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCC---CeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRET---GEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t---g~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
..+..++|++++.||+|+||.||+|.+..+ +..+|+|.+.... ....+.+.+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------------------ 65 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ------------------------ 65 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHH------------------------
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHH------------------------
Confidence 345567899999999999999999998654 4579999876533 223333333
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+.+|+.++||||+++++++ .++..|+||||+++|+|.+++......+++..+..++.|++.||.|||+++|+|||||
T Consensus 66 -e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 143 (281)
T 1mp8_A 66 -EALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 143 (281)
T ss_dssp -HHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred -HHHHHHhCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 58999999999999999998 4567899999999999999998766679999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.++.+ +|||+++....... .......+++.|+|||++.+..|
T Consensus 144 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 194 (281)
T 1mp8_A 144 ARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRF 194 (281)
T ss_dssp GGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCC
T ss_pred HHHEEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCC
Confidence 999999999988 99999987754321 12223446788999999876554
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.7e-28 Score=253.88 Aligned_cols=183 Identities=23% Similarity=0.357 Sum_probs=151.4
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCe-----EEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE-----VMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINN 546 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~-----~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~ 546 (681)
....+..++|..++.||+|+||.||+|.+..+++ .||+|.+.... ......+.+
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------------------- 98 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS-------------------- 98 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHH--------------------
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHH--------------------
Confidence 3456778999999999999999999999987664 79999986543 223333333
Q ss_pred ccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-------------CCCCCHHHHHHHHHHH
Q psy5063 547 LHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-------------GQPLPWGQRVNFARDI 612 (681)
Q Consensus 547 ~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-------------~~~l~~~~~~~i~~QI 612 (681)
|+.+|+.+ +||||+++++++..++..++||||+++|+|.+++... ...+++..+..++.|+
T Consensus 99 -----E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 173 (333)
T 2i1m_A 99 -----ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173 (333)
T ss_dssp -----HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHH
T ss_pred -----HHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHH
Confidence 59999999 8999999999999999999999999999999998642 2358999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 613 AAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 613 a~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.||.|||+++|+||||||+|||++.++.+ +|||+++...............+|+.|+|||++.+..|
T Consensus 174 ~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 243 (333)
T 2i1m_A 174 AQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243 (333)
T ss_dssp HHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC
T ss_pred HHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC
Confidence 999999999999999999999999999987 99999987654443333333456788999999876544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=261.42 Aligned_cols=172 Identities=24% Similarity=0.372 Sum_probs=142.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|.+.+.||+|+||.||+|++..+++.||+|++.+. .....+.+. +|+.+|
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~-------------------------~E~~~l 79 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL-------------------------REITIL 79 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHH-------------------------HHHHHH
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHH-------------------------HHHHHH
Confidence 57899999999999999999999999999999999653 222333333 459999
Q ss_pred HhCCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.++||||+++++++... ..+|+||||++ |+|.+++... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 80 ~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp 157 (432)
T 3n9x_A 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKP 157 (432)
T ss_dssp HHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999766 57999999996 5999999875 3599999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccc--------------------eeeeecCCCccccchhhccC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPY--------------------TLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~--------------------~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||++.++.+ +|||+|+........ .......||+.|+|||++..
T Consensus 158 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp GGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT
T ss_pred HHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 99999999988 999999987543211 12245678999999998643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-27 Score=248.23 Aligned_cols=170 Identities=26% Similarity=0.407 Sum_probs=140.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH--HHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA--EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~--~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||+|++ .+++.+|+|++....... ... +.+|+.+|+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~-------------------------~~~E~~~l~ 55 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPST-------------------------TIREISILK 55 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHH-------------------------HHHHHHGGG
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchh-------------------------HHHHHHHHH
Confidence 5799999999999999999998 678999999986433211 122 235699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++..++||||+++ +|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 56 ~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 134 (288)
T 1ob3_A 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134 (288)
T ss_dssp GCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred hcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 99999999999999999999999999975 99999987666799999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.+|.+ +|||+++...... .......+|+.|+|||++.+.
T Consensus 135 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 175 (288)
T 1ob3_A 135 REGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGS 175 (288)
T ss_dssp TTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTC
T ss_pred CCCCEEEeECccccccCccc--cccccccccccccCchheeCC
Confidence 99988 9999997654221 222345689999999999764
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=249.18 Aligned_cols=178 Identities=29% Similarity=0.415 Sum_probs=145.5
Q ss_pred ecCCCeeecceecccCcEEEEEEE----EcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVT----HRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~----~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
+....|+..+.||+|+||.||+|+ +..+++.||+|.+...... ....+ .+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------------------------~~ 72 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADL-------------------------KK 72 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHH-------------------------HH
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHH-------------------------HH
Confidence 455678999999999999999999 5678999999998643211 11222 34
Q ss_pred HHHHHHhCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
|+.+|+.++||||+++++++..+ ..+++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||
T Consensus 73 E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di 152 (302)
T 4e5w_A 73 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDL 152 (302)
T ss_dssp HHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCC
Confidence 59999999999999999999876 6799999999999999999665566999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccc-eeeeecCCCccccchhhccCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPY-TLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~-~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||+|||++.++.+ +|||+++........ .......+|..|+|||++.+..
T Consensus 153 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 205 (302)
T 4e5w_A 153 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205 (302)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE
T ss_pred chheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC
Confidence 9999999999988 999999887654322 2223455788899999986654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=242.24 Aligned_cols=173 Identities=23% Similarity=0.284 Sum_probs=147.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||+|.+..+++.||+|.+.... ......+. +|+.++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------------------------~e~~~l 59 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE-------------------------REARIC 59 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHH-------------------------HHHHHH
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHH-------------------------HHHHHH
Confidence 478999999999999999999999999999999986532 22223333 459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~ 138 (284)
T 3kk8_A 60 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLL 138 (284)
T ss_dssp HHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred HHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEE
Confidence 99999999999999999999999999999999998887643 59999999999999999999999999999999999999
Q ss_pred ecCCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++. + +|||++........ .....+|+.|+|||++.+..|
T Consensus 139 ~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 184 (284)
T 3kk8_A 139 ASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPY 184 (284)
T ss_dssp SSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCB
T ss_pred ecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCC
Confidence 87765 4 99999987654322 233568999999999987764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=257.47 Aligned_cols=186 Identities=16% Similarity=0.158 Sum_probs=148.2
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCC-----CeEEEEEEeeccCHHHHH--HHHHHhhccceeeeccCCCCccccccch
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRET-----GEVMVLKELYRVDEEAEK--NFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~t-----g~~vAiK~l~~~~~~~~~--~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
..++|.+++.||+|+||.||+|.+..+ ++.||+|.+......... .++++. .....+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~----------------~~~~~~ 96 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA----------------AKPEQI 96 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHH----------------CCHHHH
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhh----------------hhhHHH
Confidence 356899999999999999999998765 578999998765533222 222221 112335
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeC----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKD----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
.|+..++.++||||+++++++... ...++||||+ +++|.+++......+++..+..++.||+.||.|||+++|+|
T Consensus 97 ~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiH 175 (364)
T 3op5_A 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVH 175 (364)
T ss_dssp HHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEE
Confidence 678889999999999999998764 4589999999 99999999876667999999999999999999999999999
Q ss_pred cCCCCCcEEEe--cCCCe--EEeeeeeEeeeccccee-----eeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVR--EVGSG--FDFHLGQIYLIYVPYTL-----FILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~--~~g~~--~DFGLa~~~~~~~~~~~-----~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||+|||++ .++.+ +|||+++.+........ .....||+.|||||++.+..|
T Consensus 176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 238 (364)
T 3op5_A 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP 238 (364)
T ss_dssp CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC
T ss_pred ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC
Confidence 99999999999 77777 99999988764322111 123449999999999988765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=245.22 Aligned_cols=176 Identities=26% Similarity=0.370 Sum_probs=147.9
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|+..+.||+|+||.||++.+. ++..||+|.+...... .+.+. +|+++
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~-------------------------~E~~~ 56 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS-EDEFF-------------------------QEAQT 56 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC-HHHHH-------------------------HHHHH
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc-HHHHH-------------------------HHHHH
Confidence 456788999999999999999999886 5778999998654322 22233 35999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++.++||||+++++++.+++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 136 (268)
T 3sxs_A 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136 (268)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEE
T ss_pred HHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEE
Confidence 99999999999999999999999999999999999999876556999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.++.+ +|||+++...... ........+|+.|+|||++.+..
T Consensus 137 ~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 181 (268)
T 3sxs_A 137 VDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFK 181 (268)
T ss_dssp ECTTCCEEECCTTCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSE
T ss_pred ECCCCCEEEccCccceecchhh-hhcccCCCcCcccCCHHHHhccC
Confidence 9999988 9999998765432 22223344677899999986543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-27 Score=246.39 Aligned_cols=171 Identities=22% Similarity=0.373 Sum_probs=141.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||+|++..+|+.||+|++..... ...+.+. +|+++|+
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------------------------~E~~~l~ 57 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL-------------------------REIRMLK 57 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHH-------------------------HHHHHHH
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHH-------------------------HHHHHHH
Confidence 679999999999999999999999999999998865432 2223233 4599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++...+..++||||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++
T Consensus 58 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~ 136 (311)
T 4agu_A 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILIT 136 (311)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred hCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEc
Confidence 9999999999999999999999999999999999887654 599999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.++.+ +|||+++...... .......+|+.|+|||++.+.
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~ 177 (311)
T 4agu_A 137 KHSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGD 177 (311)
T ss_dssp TTSCEEECCCTTCEECC--------------GGGCCHHHHHTC
T ss_pred CCCCEEEeeCCCchhccCcc--cccCCCcCCccccChHHHhcC
Confidence 99988 9999998765322 222345689999999998763
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-27 Score=263.53 Aligned_cols=172 Identities=20% Similarity=0.299 Sum_probs=139.3
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
...++|+..+.||+|+||.||+|.+..+++.||+|++.+. .....+.+ .+|+.
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~-------------------------~~E~~ 113 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-------------------------YRELV 113 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHH-------------------------HHHHH
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHH-------------------------HHHHH
Confidence 3357899999999999999999999999999999999754 22223333 34599
Q ss_pred HHHhCCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 555 VLRSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
+|+.++||||+++++++... ..+|+||||+++ +|.+.+.. .+++..+..++.||+.||+|||++||+|||
T Consensus 114 ~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~iiHrD 189 (464)
T 3ttj_A 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 189 (464)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 99999999999999999654 468999999976 57777654 389999999999999999999999999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+|||++.++.+ +|||+|+...... ......||+.|+|||++.+..|
T Consensus 190 lkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 240 (464)
T 3ttj_A 190 LKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGY 240 (464)
T ss_dssp CCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCC
T ss_pred CChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCC
Confidence 99999999999988 9999998765432 2234568999999999988776
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=250.37 Aligned_cols=172 Identities=25% Similarity=0.350 Sum_probs=147.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH------HHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE------AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~------~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
++|.+++.||+|+||.||++++..+|+.||+|.+...... ..+.+ .+|+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~-------------------------~~E~ 66 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI-------------------------EREV 66 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHH-------------------------HHHH
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHH-------------------------HHHH
Confidence 5689999999999999999999999999999998654321 12222 3469
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+|+.++||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 67 ~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~N 145 (321)
T 2a2a_A 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145 (321)
T ss_dssp HHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHH
Confidence 99999999999999999999999999999999999999998653 58999999999999999999999999999999999
Q ss_pred EEEecCC----Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVG----SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g----~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.++ .+ +|||+++....... .....||+.|+|||++.+..|
T Consensus 146 Il~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 195 (321)
T 2a2a_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPL 195 (321)
T ss_dssp EEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCC
T ss_pred EEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCC
Confidence 9999988 45 99999987654322 233568999999999987654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=253.24 Aligned_cols=172 Identities=27% Similarity=0.429 Sum_probs=131.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|+..+.||+|+||.||+|.++.+|+.||+|.+...... ....+ .+|+.+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~E~~~l~ 58 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-------------------------IREISLMK 58 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHH-------------------------HHHHHHHT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHH-------------------------HHHHHHHH
Confidence 46899999999999999999999999999999998654311 11222 34699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-----GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-----~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.++||||+++++++..++..++||||++ |+|.+++... ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 59 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~ 137 (317)
T 2pmi_A 59 ELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQ 137 (317)
T ss_dssp TCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChH
Confidence 9999999999999999999999999998 5999988642 235899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||++.+|.+ +|||+++...... .......+|+.|+|||++.+.
T Consensus 138 NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 183 (317)
T 2pmi_A 138 NLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGS 183 (317)
T ss_dssp GEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTC
T ss_pred HeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCC
Confidence 9999999988 9999998764322 223345689999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.4e-28 Score=252.91 Aligned_cols=182 Identities=26% Similarity=0.381 Sum_probs=130.7
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCe---EEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE---VMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~---~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
...+..++|..++.||+|+||.||+|++..++. .||+|.+... .....+.+.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~----------------------- 73 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL----------------------- 73 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHH-----------------------
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHH-----------------------
Confidence 344667889999999999999999999887765 8999988543 122223333
Q ss_pred chHHHHHHHhCCCCceeeEEEEEEeCCeE------EEEEeccCCCCHHHHHhCC-----CCCCCHHHHHHHHHHHHHHHH
Q psy5063 549 CFSQVAVLRSLHHHNVIRFIGVLYKDRKL------NLVTEYIAGGTLKELLQDP-----GQPLPWGQRVNFARDIAAGMT 617 (681)
Q Consensus 549 ~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l------~LV~Ey~~gGsL~~~L~~~-----~~~l~~~~~~~i~~QIa~gL~ 617 (681)
+|+++++.++||||+++++++...... ++||||+++|+|.+++... ...+++..+..++.|++.||.
T Consensus 74 --~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 151 (323)
T 3qup_A 74 --REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151 (323)
T ss_dssp --HHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHH
Confidence 459999999999999999999877655 9999999999999998532 225899999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 618 YLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 618 yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++|+||||||+|||++.++.+ +|||+++...............+++.|+|||++.+..|
T Consensus 152 ~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 216 (323)
T 3qup_A 152 YLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY 216 (323)
T ss_dssp HHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCC
T ss_pred HHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCC
Confidence 9999999999999999999999988 99999987765443333334557888999999876654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=243.13 Aligned_cols=168 Identities=20% Similarity=0.322 Sum_probs=141.2
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|+..+.||+|+||.||+|++..+++.||+|.+.... ......+. +|+..+.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------~e~~~~~ 65 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL-------------------------REVYAHA 65 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHH-------------------------HHHHHHH
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHH-------------------------HHHHHHH
Confidence 57899999999999999999999999999999987532 22233333 3488888
Q ss_pred hC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 558 SL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 558 ~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+ +||||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 66 ~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N 145 (289)
T 1x8b_A 66 VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSN 145 (289)
T ss_dssp HSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHH
Confidence 88 9999999999999999999999999999999999753 2458999999999999999999999999999999999
Q ss_pred EEEecCC-------------------Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 634 CLVREVG-------------------SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 634 ILl~~~g-------------------~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
||++.++ .+ +|||+++...... ...+|+.|+|||++.+.
T Consensus 146 Il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 146 IFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQEN 205 (289)
T ss_dssp EEEC--------------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTC
T ss_pred EEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCC
Confidence 9998655 34 8999998765322 24589999999999765
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=244.16 Aligned_cols=170 Identities=22% Similarity=0.316 Sum_probs=146.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||+|.+..++..+|+|.+........+.+.+ |+++++.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~-------------------------E~~~l~~l 63 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ-------------------------EIEIMKSL 63 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHH-------------------------HHHHHHTC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHH-------------------------HHHHHHhC
Confidence 46889999999999999999999999999999987643333333444 49999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV--- 636 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl--- 636 (681)
+||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 142 (277)
T 3f3z_A 64 DHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD 142 (277)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred CCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC
Confidence 99999999999999999999999999999999987643 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+.++.+ +|||++....... ......+|+.|+|||++.+.
T Consensus 143 ~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~ 183 (277)
T 3f3z_A 143 SPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL 183 (277)
T ss_dssp STTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC
T ss_pred CCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhccc
Confidence 667777 9999998765432 22345689999999998654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-27 Score=243.78 Aligned_cols=174 Identities=25% Similarity=0.311 Sum_probs=148.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.++|..++.||+|+||.||++.+..+++.+|+|.+.... ......+. +|+.+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~-------------------------~e~~~ 68 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------------------------MEISI 68 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHH-------------------------HHHHH
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHH-------------------------HHHHH
Confidence 457899999999999999999999999999999986532 22333333 35999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++.++||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil 147 (294)
T 2rku_A 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 147 (294)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE
Confidence 999999999999999999999999999999999999987643 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||+++...... .......+|+.|+|||++.+..|
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 192 (294)
T 2rku_A 148 LNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGH 192 (294)
T ss_dssp ECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCB
T ss_pred EcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCC
Confidence 9999988 9999998765332 12233568999999999977654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=251.46 Aligned_cols=165 Identities=19% Similarity=0.328 Sum_probs=123.9
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC-CCc
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH-HHN 563 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hpn 563 (681)
++.||+|+||.||+|.++.+++.||+|.+.+.. ...+. +|+.+|+.+. |||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~-------------------------~e~~~l~~l~~h~n 67 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQ-------------------------KEITALKLCEGHPN 67 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG---HHHHH-------------------------HHHHHHHHTTTCTT
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChhh---hhhHH-------------------------HHHHHHHHhcCCCC
Confidence 478999999999999999999999999986532 12222 3588899996 999
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC---
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG--- 640 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g--- 640 (681)
|+++++++.++...|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 68 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~ 146 (325)
T 3kn6_A 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNL 146 (325)
T ss_dssp BCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----C
T ss_pred eeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcc
Confidence 999999999999999999999999999999875 4599999999999999999999999999999999999998876
Q ss_pred Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 641 SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 641 ~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ +|||+++...... .......+|+.|+|||++.+..|
T Consensus 147 ~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~ 186 (325)
T 3kn6_A 147 EIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGY 186 (325)
T ss_dssp EEEECCCTTCEECCC------------------------CCC
T ss_pred cEEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCC
Confidence 34 9999998765332 22334568999999999987765
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=249.87 Aligned_cols=174 Identities=25% Similarity=0.320 Sum_probs=149.1
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc---CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV---DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~---~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.++|..++.||+|+||.||++++..+++.+|+|.+... .......+. +|+.+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~-------------------------~E~~~ 94 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS-------------------------MEISI 94 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHH-------------------------HHHHH
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHH-------------------------HHHHH
Confidence 45799999999999999999999999999999998653 222333333 35999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++.++||||+++++++.+.+..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 173 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEE
Confidence 999999999999999999999999999999999999987643 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||+++...... .......+|..|+|||++.+..|
T Consensus 174 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 218 (335)
T 2owb_A 174 LNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGH 218 (335)
T ss_dssp ECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCB
T ss_pred EcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhccCCC
Confidence 9999988 9999998765332 12234568999999999977654
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=256.61 Aligned_cols=171 Identities=24% Similarity=0.391 Sum_probs=133.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|+..+.||+|+||.||+|.+..+|+.||+|++.+. .......+ ++|+.+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~-------------------------~~E~~~l 62 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-------------------------FREIMIL 62 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHH-------------------------HHHHHHH
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHH-------------------------HHHHHHH
Confidence 36899999999999999999999999999999998543 22222223 3458999
Q ss_pred HhCC-CCceeeEEEEEEeCC--eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 557 RSLH-HHNVIRFIGVLYKDR--KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 557 ~~L~-HpnIV~l~g~~~~~~--~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
+.+. ||||+++++++..++ .+|+||||++ |+|.+++... .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 63 ~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~N 139 (388)
T 3oz6_A 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSN 139 (388)
T ss_dssp HHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHH
Confidence 9996 999999999998654 7999999997 5999998763 58999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeec-------------------ccceeeeecCCCccccchhhccC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIY-------------------VPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~-------------------~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||++.++.+ +|||+|+..... ..........||+.|+|||++.+
T Consensus 140 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 140 ILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp EEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred eEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 999999988 999999876321 01112234569999999999976
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=256.43 Aligned_cols=169 Identities=24% Similarity=0.349 Sum_probs=134.7
Q ss_pred CCCeeec-ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH-
Q psy5063 479 ASDLVRG-PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL- 556 (681)
Q Consensus 479 ~~d~~~~-~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL- 556 (681)
.++|... ++||+|+||.||+++++.+++.||+|++.... .+.+ |++++
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~-----~~~~-------------------------E~~~~~ 109 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARR-------------------------EVELHW 109 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-----HHHH-------------------------HHHHHH
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch-----hHHH-------------------------HHHHHH
Confidence 3567766 78999999999999999999999999986421 1222 36665
Q ss_pred HhCCCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 557 RSLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+..+||||+++++++.. ...+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||
T Consensus 110 ~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 189 (400)
T 1nxk_A 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189 (400)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCc
Confidence 55689999999999876 567999999999999999998753 3599999999999999999999999999999999
Q ss_pred CcEEEec---CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVRE---VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~---~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++. ++.+ +|||+++...... ......||+.|+|||++.+..|
T Consensus 190 ~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 240 (400)
T 1nxk_A 190 ENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 240 (400)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCS
T ss_pred ceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCC
Confidence 9999998 5666 9999998765322 2234668999999999987765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=243.40 Aligned_cols=176 Identities=18% Similarity=0.152 Sum_probs=149.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..+.||+|+||.||+|++..+++.||+|.+...... . .+.+|+.++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------------------------~~~~e~~~~ 59 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--P-------------------------QLRDEYRTY 59 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--C-------------------------CHHHHHHHH
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc--H-------------------------HHHHHHHHH
Confidence 4467899999999999999999999999999999988543211 1 223468889
Q ss_pred HhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.+ +|+|++++++++..+...++||||+ +++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 60 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl 138 (298)
T 1csn_A 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFL 138 (298)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred HHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 999 8999999999999999999999999 99999999876667999999999999999999999999999999999999
Q ss_pred EecCCC-----e--EEeeeeeEeeecccc-----eeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGS-----G--FDFHLGQIYLIYVPY-----TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~-----~--~DFGLa~~~~~~~~~-----~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++. + +|||+++........ .......||+.|+|||++.+..|
T Consensus 139 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 195 (298)
T 1csn_A 139 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ 195 (298)
T ss_dssp ECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred eccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCC
Confidence 988775 5 999999987653221 12234569999999999987664
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-28 Score=270.56 Aligned_cols=181 Identities=27% Similarity=0.407 Sum_probs=151.5
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..+.+..++|.+.+.||+|+||.||+|+++.++..||+|.+...... .+.+.+ |
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~-------------------------E 266 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK-------------------------E 266 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC-HHHHHH-------------------------H
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc-hHHHHH-------------------------H
Confidence 34556778999999999999999999999999999999998653322 233444 4
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.+|+.++||||+++++++..++.+++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++|+||||||
T Consensus 267 ~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 346 (495)
T 1opk_A 267 AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAA 346 (495)
T ss_dssp HHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 99999999999999999999999999999999999999999753 34589999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++.+ +|||+++...... +.......++..|+|||++.+..|
T Consensus 347 ~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 396 (495)
T 1opk_A 347 RNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKF 396 (495)
T ss_dssp GGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEE
T ss_pred hhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCC
Confidence 99999999988 9999998764322 222223446778999999875543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=245.44 Aligned_cols=167 Identities=22% Similarity=0.324 Sum_probs=143.4
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
....++|++.+.||+|+||.||+|++..+++.||+|.+..... +.+. +|+.+
T Consensus 32 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~-------------------------~E~~~ 83 (330)
T 3nsz_A 32 WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIK-------------------------REIKI 83 (330)
T ss_dssp CEEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH---HHHH-------------------------HHHHH
T ss_pred ccCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch---HHHH-------------------------HHHHH
Confidence 3446789999999999999999999999999999999865432 2233 35889
Q ss_pred HHhCC-CCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 556 LRSLH-HHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 556 L~~L~-HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
|+.++ ||||+++++++.. ....++||||+++++|.+++.. +++..+..++.|++.||.|||+++|+||||||+
T Consensus 84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~ 159 (330)
T 3nsz_A 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPH 159 (330)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 99996 9999999999987 6789999999999999999864 889999999999999999999999999999999
Q ss_pred cEEEecCC-Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 633 NCLVREVG-SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g-~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|||++.++ .+ +|||+++....... .....+|..|+|||++.+
T Consensus 160 Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 160 NVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVD 204 (330)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTT
T ss_pred HEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcC
Confidence 99999877 44 99999987654332 234568999999999876
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=247.04 Aligned_cols=172 Identities=19% Similarity=0.287 Sum_probs=138.3
Q ss_pred CCeee-cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVR-GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~-~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+.|.+ .+.||+|+||.||+|++..+++.||+|.+..........+. +|+++|+.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------------------------~E~~~l~~ 66 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF-------------------------REVEMLYQ 66 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHH-------------------------HHHHHHHH
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHH-------------------------HHHHHHHH
Confidence 56777 47899999999999999999999999998765433333333 35888888
Q ss_pred C-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 L-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
+ +||||+++++++.+++..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 67 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 145 (316)
T 2ac3_A 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE 145 (316)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred hcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEc
Confidence 5 79999999999999999999999999999999997643 589999999999999999999999999999999999999
Q ss_pred cCCC---e--EEeeeeeEeeeccc-----ceeeeecCCCccccchhhccC
Q psy5063 638 EVGS---G--FDFHLGQIYLIYVP-----YTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 638 ~~g~---~--~DFGLa~~~~~~~~-----~~~~~~~~gt~~Y~APEvL~~ 677 (681)
.++. + +|||+++....... ........||+.|+|||++.+
T Consensus 146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHH
T ss_pred cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhc
Confidence 8875 4 99999987653211 111223458999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-27 Score=255.12 Aligned_cols=168 Identities=20% Similarity=0.292 Sum_probs=142.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|++.+.||+|+||.||+|+++.+++.||+|.+.+... ...+|+++|..
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----------------------------~~~~E~~~l~~ 71 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----------------------------DPTEEIEILLR 71 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----------------------------CCHHHHHHHHH
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----------------------------ChHHHHHHHHH
Confidence 3579999999999999999999999999999999865321 11345777777
Q ss_pred C-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 L-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
+ +||||+++++++.+++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||+.
T Consensus 72 ~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~ 150 (342)
T 2qr7_A 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYV 150 (342)
T ss_dssp HTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred hcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEe
Confidence 7 89999999999999999999999999999999998654 599999999999999999999999999999999999985
Q ss_pred cC-CC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EV-GS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~-g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.+ +. + +|||+++...... .......+|+.|+|||++.+.
T Consensus 151 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~ 195 (342)
T 2qr7_A 151 DESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQ 195 (342)
T ss_dssp SSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHH
T ss_pred cCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCC
Confidence 43 32 4 9999998765432 223346789999999998654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-27 Score=254.74 Aligned_cols=166 Identities=18% Similarity=0.287 Sum_probs=134.4
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--------HHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--------AEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--------~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
+..++|+..+.||+|+||.||+|++ +|+.||+|++...... ..+.+.
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~----------------------- 71 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEIL----------------------- 71 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHH-----------------------
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHH-----------------------
Confidence 3456788999999999999999998 6899999999754211 112233
Q ss_pred chHHHHHHHhCC---------CCceeeEEEEEE------------------------------eCCeEEEEEeccCCCCH
Q psy5063 549 CFSQVAVLRSLH---------HHNVIRFIGVLY------------------------------KDRKLNLVTEYIAGGTL 589 (681)
Q Consensus 549 ~~~Ei~iL~~L~---------HpnIV~l~g~~~------------------------------~~~~l~LV~Ey~~gGsL 589 (681)
+|+.+|+.++ ||||+++.+++. .++.+|+||||+++|++
T Consensus 72 --~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~l 149 (336)
T 2vuw_A 72 --PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID 149 (336)
T ss_dssp --HHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEE
T ss_pred --HHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCcc
Confidence 3466666664 888888888754 26789999999999977
Q ss_pred HHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCcEEEecCC--------------------Ce--EEee
Q psy5063 590 KELLQDPGQPLPWGQRVNFARDIAAGMTYLH-SMNLIHRDLNSQNCLVREVG--------------------SG--FDFH 646 (681)
Q Consensus 590 ~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLH-s~~IIHRDLKp~NILl~~~g--------------------~~--~DFG 646 (681)
.+.+.+ ..+++..+..++.||+.||.||| +++|+||||||+|||++.+| .+ +|||
T Consensus 150 l~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG 227 (336)
T 2vuw_A 150 LEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYT 227 (336)
T ss_dssp TGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCT
T ss_pred HHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeecc
Confidence 766654 45899999999999999999999 99999999999999999987 55 9999
Q ss_pred eeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 647 LGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 647 La~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|+..... ...||+.|||||++.+.
T Consensus 228 ~a~~~~~~-------~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 228 LSRLERDG-------IVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp TCBEEETT-------EEECCCCTTCSGGGCCC
T ss_pred ccEecCCC-------cEEEeecccChhhhcCC
Confidence 99977632 23589999999999765
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=243.24 Aligned_cols=178 Identities=24% Similarity=0.365 Sum_probs=149.5
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|...+.||+|+||.||+|++..+++.||+|.+......... . ...+.+|+++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~-~---------------------~~~~~~e~~~ 67 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-V---------------------EHQLRREIEI 67 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTT-C---------------------HHHHHHHHHH
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHH-H---------------------HHHHHHHHHH
Confidence 45567899999999999999999999999999999998653211100 0 0012356999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++.++||||+++++++.+.+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil 146 (284)
T 2vgo_A 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKVIHRDIKPENLL 146 (284)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEE
T ss_pred HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence 999999999999999999999999999999999999997644 5899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||++....... .....+++.|+|||++.+..|
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 189 (284)
T 2vgo_A 147 MGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTH 189 (284)
T ss_dssp ECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCB
T ss_pred EcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCC
Confidence 9999988 9999997654322 223568999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=248.72 Aligned_cols=172 Identities=17% Similarity=0.316 Sum_probs=144.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.-.++|.+.+.||+|+||.||+|++..+++.||+|.+... ......+.. |+.++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~-------------------------e~~~l 85 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKI-------------------------EADIL 85 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHH-------------------------HHHHH
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHH-------------------------HHHHH
Confidence 3457899999999999999999999999999999998643 222222223 47788
Q ss_pred HhCC-----CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLH-----HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~-----HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++ ||||+++++++...+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+++|+|||||
T Consensus 86 ~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlk 164 (360)
T 3llt_A 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLK 164 (360)
T ss_dssp HHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 8886 999999999999999999999999 999999997643 358999999999999999999999999999999
Q ss_pred CCcEEEec-------------------------CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVRE-------------------------VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~-------------------------~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++. ++.+ +|||+++..... .....||+.|+|||++.+..|
T Consensus 165 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 236 (360)
T 3llt_A 165 PENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGW 236 (360)
T ss_dssp GGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCC
T ss_pred cccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCC
Confidence 99999975 5666 999999864432 123568999999999988765
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=261.58 Aligned_cols=174 Identities=28% Similarity=0.431 Sum_probs=145.3
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..+.+..++|++.+.||+|+||.||+|.+. ++.||+|.+.... ..+.+. +|
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~-------------------------~E 236 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFL-------------------------AE 236 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHH-------------------------HH
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHH-------------------------HH
Confidence 446677889999999999999999999986 7899999986532 223333 45
Q ss_pred HHHHHhCCCCceeeEEEEEEeCC-eEEEEEeccCCCCHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~-~l~LV~Ey~~gGsL~~~L~~~~~-~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.+|+.++||||+++++++.+.. .+++||||+++|+|.+++..... .+++..+..++.|++.||+|||+++|+|||||
T Consensus 237 ~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlk 316 (450)
T 1k9a_A 237 ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316 (450)
T ss_dssp HHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 99999999999999999987765 79999999999999999986433 47999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.++.+ +|||+++..... .....++..|+|||++.+..|
T Consensus 317 p~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~ 363 (450)
T 1k9a_A 317 ARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKF 363 (450)
T ss_dssp GGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCC
T ss_pred HhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCC
Confidence 999999999988 999999865422 122357889999999987665
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=247.76 Aligned_cols=183 Identities=21% Similarity=0.252 Sum_probs=149.7
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.....+..++|+..+.||+|+||.||++.+..+++.||+|.+........+.+.+|
T Consensus 21 g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E------------------------ 76 (317)
T 2buj_A 21 GHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE------------------------ 76 (317)
T ss_dssp EEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHH------------------------
T ss_pred ccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHH------------------------
Confidence 34455677889999999999999999999999999999999877665555555444
Q ss_pred HHHHHHhCCCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNL 624 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~I 624 (681)
+.+++.++||||+++++++.. ....++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++|
T Consensus 77 -~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i 155 (317)
T 2buj_A 77 -ADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGY 155 (317)
T ss_dssp -HHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred -HHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 899999999999999999873 3578999999999999999875 34569999999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCe--EEeeeeeEeeecccc-------eeeeecCCCccccchhhccCCC
Q psy5063 625 IHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPY-------TLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~-------~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+||||||+|||++.++.+ +|||+++........ .......||+.|+|||++.+..
T Consensus 156 vH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 219 (317)
T 2buj_A 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS 219 (317)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS
T ss_pred ccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCC
Confidence 999999999999999988 999998875432111 0112234799999999987553
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-27 Score=255.36 Aligned_cols=180 Identities=19% Similarity=0.253 Sum_probs=149.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||+|++..+++.||+|.+......... +. .......+.+|+.+|+.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~-~~----------------~~~~~~~~~~E~~~l~~l 86 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDC-WI----------------EDPKLGKVTLEIAILSRV 86 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTS-EE----------------EETTTEEEEHHHHHHTTC
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhccccc-cc----------------chHHHHHHHHHHHHHHhC
Confidence 5799999999999999999999999999999998653211000 00 000112446789999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCC-CHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGG-TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gG-sL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
+||||+++++++.+.+..++||||+.+| +|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 87 ~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~ 165 (335)
T 3dls_A 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE 165 (335)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred CCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcC
Confidence 9999999999999999999999999777 9999998754 5999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +|||+++....... .....||+.|+|||++.+..|
T Consensus 166 ~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 206 (335)
T 3dls_A 166 DFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPY 206 (335)
T ss_dssp TSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCB
T ss_pred CCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCC
Confidence 9988 99999987654322 233568999999999988765
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-27 Score=251.02 Aligned_cols=183 Identities=25% Similarity=0.383 Sum_probs=149.0
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCcccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINN 546 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~ 546 (681)
..+.+..++|...+.||+|+||.||+|++. .+++.||+|.+..... .....+.
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--------------------- 76 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFL--------------------- 76 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHH---------------------
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHH---------------------
Confidence 344556678999999999999999999887 4578999999865432 2223333
Q ss_pred ccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------CCCCCHHHHHHHHHHHHHHHH
Q psy5063 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------GQPLPWGQRVNFARDIAAGMT 617 (681)
Q Consensus 547 ~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------~~~l~~~~~~~i~~QIa~gL~ 617 (681)
+|+.+|+.++||||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||.
T Consensus 77 ----~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 152 (322)
T 1p4o_A 77 ----NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152 (322)
T ss_dssp ----HHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHH
Confidence 4599999999999999999999999999999999999999998642 135789999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 618 YLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 618 yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++|+||||||+|||++.++.+ +|||+++...............+|+.|+|||++.+..|
T Consensus 153 ~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 217 (322)
T 1p4o_A 153 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 217 (322)
T ss_dssp HHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred HHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC
Confidence 9999999999999999999999988 99999986543332222223346888999999876554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=241.62 Aligned_cols=178 Identities=22% Similarity=0.331 Sum_probs=141.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|.+++.||+|+||.||+|.+..+++.||+|.+......... .. ..+.+|+.++
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~---------------------~~~~~e~~~l 65 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLD-VV---------------------GKIKREIQNL 65 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT-CH---------------------HHHHHHHHHH
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchh-HH---------------------HHHHHHHHHH
Confidence 4457899999999999999999999999999999998643211100 00 0123569999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 66 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 144 (276)
T 2h6d_A 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL 144 (276)
T ss_dssp HTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE
T ss_pred hcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE
Confidence 99999999999999999999999999999999999997643 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++.+ +|||+++...... ......+++.|+|||++.+..|
T Consensus 145 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~ 187 (276)
T 2h6d_A 145 DAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLY 187 (276)
T ss_dssp CTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCC
T ss_pred CCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCC
Confidence 999988 9999998765322 1233568999999999987654
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=254.58 Aligned_cols=177 Identities=23% Similarity=0.365 Sum_probs=142.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||+|++..+|+.||+|.+............ ...+.+|+.+|+.
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~--------------------~~~~~~E~~~l~~ 68 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--------------------NRTALREIKLLQE 68 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------------------CTHHHHHHHHHHH
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhh--------------------hHHHHHHHHHHhh
Confidence 46899999999999999999999999999999998643221111000 1123567999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++...+..++||||+++ +|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 69 l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 147 (346)
T 1ua2_A 69 LSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 147 (346)
T ss_dssp CCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECT
T ss_pred CCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcC
Confidence 9999999999999999999999999976 899999876667999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|.+ +|||+++...... .......+|+.|+|||++.+.
T Consensus 148 ~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 187 (346)
T 1ua2_A 148 NGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGA 187 (346)
T ss_dssp TCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTC
T ss_pred CCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCC
Confidence 9988 9999998654321 223345689999999999764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=252.17 Aligned_cols=180 Identities=25% Similarity=0.365 Sum_probs=139.9
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEE----EEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVM----VLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~v----AiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
..+..++|+..+.||+|+||.||+|++..+++.+ |+|.+.... ....+.+.
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~------------------------ 65 (327)
T 3lzb_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL------------------------ 65 (327)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHH------------------------
T ss_pred cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHH------------------------
Confidence 4466789999999999999999999998888765 556553321 12223333
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
+|+.+|+.++||||+++++++..+. .++|+||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||
T Consensus 66 -~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 143 (327)
T 3lzb_A 66 -DEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 143 (327)
T ss_dssp -HHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -HHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCC
Confidence 4599999999999999999998654 88999999999999999876667999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.++.+ +|||+++...............+|..|+|||++.+..|
T Consensus 144 kp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3lzb_A 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp CGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCC
T ss_pred CHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCC
Confidence 9999999999988 99999988765443333344557889999999877654
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=245.85 Aligned_cols=171 Identities=22% Similarity=0.385 Sum_probs=144.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||++++..+|+.||+|.+..........+. +|+.+|+.+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~e~~~l~~l 63 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE-------------------------NEIAVLKKI 63 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHH-------------------------HHHHHHHHC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHH-------------------------HHHHHHHhC
Confidence 5788999999999999999999999999999999765433333333 359999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE---
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV--- 636 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl--- 636 (681)
+||||+++++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 64 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~ 142 (304)
T 2jam_A 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP 142 (304)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS
T ss_pred CCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC
Confidence 99999999999999999999999999999999987543 58999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++.+ +|||+++...... .....||+.|+|||++.+..|
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 184 (304)
T 2jam_A 143 EENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPY 184 (304)
T ss_dssp STTCCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSC
T ss_pred CCCCCEEEccCCcceecCCCc----cccccCCCCccChHHhccCCC
Confidence 667776 9999997654321 123458999999999987665
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=242.54 Aligned_cols=178 Identities=25% Similarity=0.364 Sum_probs=149.2
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
+.+..++|...+.||+|+||.||++.+. +++.||+|.+...... .+.+. +|++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~-------------------------~e~~ 55 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS-EEDFI-------------------------EEAE 55 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC-HHHHH-------------------------HHHH
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC-HHHHH-------------------------HHHH
Confidence 4567789999999999999999999986 5788999998654322 12333 3599
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+++.++||||+++++++.+++..++||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 135 (267)
T 3t9t_A 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 135 (267)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred HHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence 99999999999999999999999999999999999999987666799999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.++.+ +|||+++...... ........++..|+|||++.+..|
T Consensus 136 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 182 (267)
T 3t9t_A 136 LVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRY 182 (267)
T ss_dssp EECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCC
T ss_pred EECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCc
Confidence 99999988 9999998664322 112223446788999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-27 Score=251.50 Aligned_cols=172 Identities=27% Similarity=0.413 Sum_probs=140.2
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|...+.||+|+||.||+|++..+++.||+|.+........ ...+.+|+.+|+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~E~~~l~~l 57 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA------------------------PCTAIREVSLLKDL 57 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------------------------------CCCCCCCHHHHSCC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccccc------------------------chhHHHHHHHHHhc
Confidence 579999999999999999999999999999998854321100 11234579999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++..++..++||||++ |+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 58 ~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~ 136 (324)
T 3mtl_A 58 KHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER 136 (324)
T ss_dssp CCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT
T ss_pred CCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC
Confidence 99999999999999999999999997 59999988766679999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|.+ +|||+++...... .......+|+.|+|||++.+.
T Consensus 137 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 175 (324)
T 3mtl_A 137 GELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGS 175 (324)
T ss_dssp CCEEECSSSEEECC--------------CGGGCCHHHHTTC
T ss_pred CCEEEccCcccccccCCc--cccccccCcccccChhhhcCC
Confidence 988 9999998654322 223345689999999998763
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.8e-27 Score=252.58 Aligned_cols=175 Identities=23% Similarity=0.408 Sum_probs=149.1
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.+..++|+..+.||+|+||.||++.+..+++.||+|.+... .....+.+.+ |+.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~-------------------------E~~ 83 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-------------------------ELQ 83 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHH-------------------------HHG
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHH-------------------------HHH
Confidence 45567899999999999999999999999999999998754 2333333444 488
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCc
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNSQN 633 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~-~IIHRDLKp~N 633 (681)
+|+.++||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+|
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~N 162 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 162 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHH
Confidence 9999999999999999999999999999999999999997654 589999999999999999999996 99999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.++.+ +|||+++...... .....||+.|+|||++.+..|
T Consensus 163 il~~~~~~~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 207 (360)
T 3eqc_A 163 ILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY 207 (360)
T ss_dssp EEECTTCCEEECCCCCCHHHHHHC--------CCCCTTCCHHHHTTCCC
T ss_pred EEECCCCCEEEEECCCCccccccc----ccCCCCCCCeECHHHHcCCCC
Confidence 999999988 9999997554322 223568999999999987765
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=241.19 Aligned_cols=172 Identities=23% Similarity=0.353 Sum_probs=143.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH------HHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE------AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~------~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
++|...+.||+|+||.||++++..+++.+|+|.+...... ..+.+ .+|+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~-------------------------~~E~ 59 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI-------------------------EREV 59 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHH-------------------------HHHH
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHH-------------------------HHHH
Confidence 4688999999999999999999999999999998654221 12223 3459
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.+|+.++||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 60 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N 138 (283)
T 3bhy_A 60 NILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPEN 138 (283)
T ss_dssp HHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHH
Confidence 99999999999999999999999999999999999999997643 59999999999999999999999999999999999
Q ss_pred EEEecCC----Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVG----SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g----~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++.++ .+ +|||+++....... .....+++.|+|||++.+..|
T Consensus 139 il~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 188 (283)
T 3bhy_A 139 IMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPL 188 (283)
T ss_dssp EEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCC
T ss_pred EEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCC
Confidence 9999887 44 99999987654322 233568999999999977654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=244.53 Aligned_cols=175 Identities=19% Similarity=0.211 Sum_probs=139.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.++|.+.+.||+|+||.||++++..+++.||+|.+.... ....+.+. +|+.+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~-------------------------~e~~~ 87 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQ-------------------------REART 87 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHH-------------------------HHHHH
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHH-------------------------HHHHH
Confidence 578999999999999999999999999999999986432 22223333 45999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++.++||||+++++++..++..|+||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl 166 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL 166 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEE
Confidence 999999999999999999999999999999999999997643 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||+++...... ........+++.|+|||++.+..|
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 212 (309)
T 2h34_A 167 VSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHA 212 (309)
T ss_dssp ECTTSCEEECSCCC-----------------CCGGGCCGGGTCC---
T ss_pred EcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCC
Confidence 9999988 9999998765432 122234568999999999976644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-27 Score=244.13 Aligned_cols=173 Identities=27% Similarity=0.424 Sum_probs=139.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-----HHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-----AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-----~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.++|+..+.||+|+||.||+|++..+++.||+|.+...... ....+. +|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~-------------------------~e~ 62 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-------------------------REV 62 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHH-------------------------HHH
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHH-------------------------HHH
Confidence 56899999999999999999999999999999998642210 011222 335
Q ss_pred HHHHh---CCCCceeeEEEEEEeCC-----eEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy5063 554 AVLRS---LHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNL 624 (681)
Q Consensus 554 ~iL~~---L~HpnIV~l~g~~~~~~-----~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~I 624 (681)
++++. ++||||+++++++.... ..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+++|
T Consensus 63 ~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 141 (308)
T 3g33_A 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCI 141 (308)
T ss_dssp HHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 55544 46999999999998765 5899999996 59999998654 348999999999999999999999999
Q ss_pred cccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 625 IHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+||||||+|||++.++.+ +|||+++...... ......+|+.|+|||++.+..|
T Consensus 142 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 196 (308)
T 3g33_A 142 VHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTY 196 (308)
T ss_dssp CCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCC
T ss_pred ccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCC
Confidence 999999999999999988 9999998654322 1233568999999999977665
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=249.29 Aligned_cols=182 Identities=25% Similarity=0.329 Sum_probs=148.6
Q ss_pred cceecCCCeeecceecccCcEEEEEEEE-----cCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccc
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTH-----RETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNL 547 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~-----~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~ 547 (681)
.+.+..++|.+++.||+|+||.||+|.+ ..+++.||+|.+..... ...+.+.+
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--------------------- 79 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS--------------------- 79 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHH---------------------
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHH---------------------
Confidence 4456678999999999999999999985 35678999999865432 22333333
Q ss_pred cchHHHHHHHhC-CCCceeeEEEEEEeCC-eEEEEEeccCCCCHHHHHhCCCC---------------CCCHHHHHHHHH
Q psy5063 548 HCFSQVAVLRSL-HHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPGQ---------------PLPWGQRVNFAR 610 (681)
Q Consensus 548 ~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~-~l~LV~Ey~~gGsL~~~L~~~~~---------------~l~~~~~~~i~~ 610 (681)
|+.+|+.+ +||||+++++++...+ ..++||||+++|+|.+++..... .+++..+..++.
T Consensus 80 ----E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (316)
T 2xir_A 80 ----ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155 (316)
T ss_dssp ----HHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHH
T ss_pred ----HHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHH
Confidence 58899999 7999999999987754 59999999999999999986532 278999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 611 DIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 611 QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.||.|||+++|+||||||+|||++.++.+ +|||+++...............+|+.|+|||++.+..|
T Consensus 156 qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 156 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 99999999999999999999999999999988 99999987654433333334457889999999876554
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-27 Score=245.59 Aligned_cols=180 Identities=27% Similarity=0.406 Sum_probs=151.5
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.+.+..++|...+.||+|+||.||+|.+..+++.||+|.+..... ..+.+.+ |+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~-------------------------E~ 60 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLK-------------------------EA 60 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHH-------------------------HH
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHH-------------------------HH
Confidence 445667889999999999999999999999999999999865432 2333444 49
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.+++.++||||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+
T Consensus 61 ~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~ 140 (288)
T 3kfa_A 61 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 140 (288)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGG
T ss_pred HHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcc
Confidence 9999999999999999999999999999999999999999753 345899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||++.++.+ +|||+++...... ........+|+.|+|||++.+..|
T Consensus 141 Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 189 (288)
T 3kfa_A 141 NCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKF 189 (288)
T ss_dssp GEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCC
T ss_pred eEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCC
Confidence 9999999988 9999998665332 222233446788999999876554
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.4e-27 Score=250.44 Aligned_cols=165 Identities=27% Similarity=0.375 Sum_probs=142.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+.|...+.||+|+||.||+|++..+++.||+|++...... ..+.+. +|+++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~-------------------------~E~~~l 108 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII-------------------------KEVRFL 108 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHH-------------------------HHHHHH
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHH-------------------------HHHHHH
Confidence 3488889999999999999999999999999998654322 222333 459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++.+++..++||||++ |+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 109 ~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 187 (348)
T 1u5q_A 109 QKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 187 (348)
T ss_dssp HHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE
T ss_pred HhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 99999999999999999999999999997 68888886555679999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+.+|.+ +|||+++..... ....||+.|+|||++.
T Consensus 188 ~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~ 223 (348)
T 1u5q_A 188 SEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVIL 223 (348)
T ss_dssp ETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHH
T ss_pred CCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhc
Confidence 999988 999999765421 2356899999999985
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=248.68 Aligned_cols=172 Identities=19% Similarity=0.284 Sum_probs=136.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
...++|...+.||+|+||.||+|.+..+++.||+|++... .....+.+. +|+.
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------------------------~E~~ 76 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY-------------------------RELV 76 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHH-------------------------HHHH
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHH-------------------------HHHH
Confidence 3457899999999999999999999999999999998653 222233333 4599
Q ss_pred HHHhCCCCceeeEEEEEEeCC------eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~------~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
+|+.++||||+++++++...+ ..|+||||+++ +|.+++.. .+++..+..++.||+.||.|||+++|+|||
T Consensus 77 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 152 (371)
T 2xrw_A 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 152 (371)
T ss_dssp HHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 999999999999999997664 78999999974 78888864 489999999999999999999999999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+|||++.++.+ +|||+++...... ......||+.|+|||++.+..|
T Consensus 153 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 203 (371)
T 2xrw_A 153 LKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGY 203 (371)
T ss_dssp CCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCC
T ss_pred CCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCC
Confidence 99999999999988 9999998765322 1233568999999999987765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-27 Score=250.80 Aligned_cols=174 Identities=23% Similarity=0.303 Sum_probs=140.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-----HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-----EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-----~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.++|.+.+.||+|+||.||+|.+..+++.+|+|.+.+.. ....+.+ .+|+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~-------------------------~~E~ 79 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI-------------------------KTEV 79 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHH-------------------------HHHH
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHH-------------------------HHHH
Confidence 467999999999999999999999999999999986432 1122222 3469
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-------------------------------------
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP------------------------------------- 596 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~------------------------------------- 596 (681)
.+|+.++||||+++++++.+++..++||||+++|+|.+++...
T Consensus 80 ~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (345)
T 3hko_A 80 RLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159 (345)
T ss_dssp HHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEE
T ss_pred HHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999999999998520
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCC--Ce--EEeeeeeEeeeccc--ceeeeecCCCcc
Q psy5063 597 --GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG--SG--FDFHLGQIYLIYVP--YTLFILSAKTKK 668 (681)
Q Consensus 597 --~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g--~~--~DFGLa~~~~~~~~--~~~~~~~~gt~~ 668 (681)
...+++..+..++.|++.||.|||+++|+||||||+|||++.++ .+ +|||+++....... ........||+.
T Consensus 160 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~ 239 (345)
T 3hko_A 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239 (345)
T ss_dssp ECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGG
T ss_pred cccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcc
Confidence 11235777888999999999999999999999999999998877 45 99999987643221 112334569999
Q ss_pred ccchhhccC
Q psy5063 669 TYYPNILKK 677 (681)
Q Consensus 669 Y~APEvL~~ 677 (681)
|+|||++.+
T Consensus 240 y~aPE~~~~ 248 (345)
T 3hko_A 240 FVAPEVLNT 248 (345)
T ss_dssp GCCHHHHTC
T ss_pred ccCchhhcc
Confidence 999999965
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=247.50 Aligned_cols=180 Identities=29% Similarity=0.421 Sum_probs=141.7
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCC----eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETG----EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg----~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
.+..++|...+.||+|+||.||+|.+..++ ..||+|.+.... ......+.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------------------------- 94 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFL------------------------- 94 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHH-------------------------
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHH-------------------------
Confidence 456788999999999999999999987553 469999986543 22333333
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+|+.+++.++||||+++++++...+..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+|||||
T Consensus 95 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 174 (333)
T 1mqb_A 95 GEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 174 (333)
T ss_dssp HHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 35999999999999999999999999999999999999999998766679999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.++.+ +|||+++......... ......+|..|+|||++.+..|
T Consensus 175 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (333)
T 1mqb_A 175 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227 (333)
T ss_dssp GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred hheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC
Confidence 999999999988 9999998775432111 1122345788999999977654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=241.10 Aligned_cols=176 Identities=22% Similarity=0.393 Sum_probs=137.6
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc---CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV---DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~---~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++... +......+.+ |+.
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~-------------------------E~~ 84 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK-------------------------EID 84 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHH-------------------------HHH
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHH-------------------------HHH
Confidence 346799999999999999999999999999999998652 2333333333 599
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+++.++||||+++++++..++..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++|+||||||
T Consensus 85 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p 164 (310)
T 2wqm_A 85 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164 (310)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcH
Confidence 99999999999999999999999999999999999999864 345689999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.+|.+ +|||+++...... .......+++.|+|||++.+..|
T Consensus 165 ~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 213 (310)
T 2wqm_A 165 ANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGY 213 (310)
T ss_dssp GGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCC
T ss_pred HHEEEcCCCCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCC
Confidence 99999999988 9999998765432 12223468999999999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.5e-27 Score=242.39 Aligned_cols=173 Identities=27% Similarity=0.372 Sum_probs=139.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||+|++..+++.||+|.+... ......+. +|+.+++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~-------------------------~E~~~l~~l 59 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTIL-------------------------SEVMLLASL 59 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHH-------------------------HHHHHHTTC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHH-------------------------HHHHHHHhc
Confidence 5789999999999999999999999999999998643 22223333 359999999
Q ss_pred CCCceeeEEEEEEe-------------CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 560 HHHNVIRFIGVLYK-------------DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 560 ~HpnIV~l~g~~~~-------------~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
+||||+++++++.+ .+..|+||||+++|+|.+++......+++..+..++.|++.||.|||+++|+|
T Consensus 60 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H 139 (303)
T 1zy4_A 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIH 139 (303)
T ss_dssp CCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred CchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeec
Confidence 99999999999865 35789999999999999999866556888999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecc------------cceeeeecCCCccccchhhccCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYV------------PYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~------------~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||||+|||++.++.+ +|||+++...... .........+|+.|+|||++.+.
T Consensus 140 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 140 RDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred ccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 9999999999999988 9999997653211 01122345589999999999764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-27 Score=242.48 Aligned_cols=174 Identities=26% Similarity=0.394 Sum_probs=133.2
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
...+..++|.+++.||+|+||.||+|++.. .+|+|.+.... ....+.+.+
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~------------------------- 69 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKN------------------------- 69 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHH-------------------------
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHH-------------------------
Confidence 345667899999999999999999998653 59999886432 333333444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
|+.+|+.++||||++++++. .....++||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||
T Consensus 70 E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp 148 (289)
T 3og7_A 70 EVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKS 148 (289)
T ss_dssp HHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 59999999999999999964 56678999999999999999987666799999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+|||++.++.+ +|||+++...............||+.|+|||++.
T Consensus 149 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 149 NNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp GGEEEETTTEEEECCCC------------------CCCTTCCHHHHC
T ss_pred ceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhc
Confidence 99999999988 9999998765433333344456899999999986
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=248.05 Aligned_cols=179 Identities=30% Similarity=0.459 Sum_probs=149.0
Q ss_pred eecCCCeeecceecccCcEEEEEEEE----cCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTH----RETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~----~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.+..++|++.+.||+|+||.||++++ ..+++.||+|.+........+.+.+|
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E------------------------ 92 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFERE------------------------ 92 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHH------------------------
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHH------------------------
Confidence 45567899999999999999999994 56899999999976555544445444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCC--eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDR--KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~--~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
+.+|+.++||||+++++++...+ ..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||
T Consensus 93 -~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~di 171 (326)
T 2w1i_A 93 -IEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171 (326)
T ss_dssp -HHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred -HHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCC
Confidence 99999999999999999987643 789999999999999999876666999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeeccccee-eeecCCCccccchhhccCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTL-FILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~-~~~~~gt~~Y~APEvL~~~~ 679 (681)
||+|||++.++.+ +|||+++.......... .....++..|+|||++.+..
T Consensus 172 kp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 224 (326)
T 2w1i_A 172 ATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224 (326)
T ss_dssp CGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE
T ss_pred CcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC
Confidence 9999999999988 99999998765432221 12234677899999986554
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=246.40 Aligned_cols=173 Identities=24% Similarity=0.373 Sum_probs=142.0
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++|++.+.||+|+||.||+|++..+++.+|+|.+..........+.+ |+.+|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~-------------------------e~~~l 70 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIV-------------------------EIEIL 70 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHH-------------------------HHHHH
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHH-------------------------HHHHH
Confidence 34568999999999999999999999999999999986543333333333 58999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++..++..++||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 71 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~ 150 (302)
T 2j7t_A 71 ATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM 150 (302)
T ss_dssp HHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred hcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE
Confidence 99999999999999999999999999999999999987655569999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+.++.+ +|||++....... .......+|+.|+|||++.
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 151 TLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp CTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHH
T ss_pred CCCCCEEEEECCCCccccccc--cccccccCChhhcCCeeec
Confidence 999988 9999976433211 1122346899999999983
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=242.27 Aligned_cols=176 Identities=23% Similarity=0.410 Sum_probs=144.5
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|+..+.||+|+||.||+|++..+++.||+|.+.............. ...+.+|+.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------------~~~~~~E~~~ 76 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK------------------FQEFQREVFI 76 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCC------------------SHHHHHHHHH
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHH------------------HHHHHHHHHH
Confidence 3556899999999999999999999999999999999865332211111000 0123456999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCc
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQN 633 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~--IIHRDLKp~N 633 (681)
++.++||||+++++++.+.. ++||||+++|+|.+++......+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~N 154 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPN 154 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGG
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcce
Confidence 99999999999999987655 7999999999999999877777999999999999999999999999 9999999999
Q ss_pred EEEecCCC-----e--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 634 CLVREVGS-----G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 634 ILl~~~g~-----~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
||++.++. + +|||+++.... ......+|+.|+|||++.
T Consensus 155 il~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 155 IFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIG 199 (287)
T ss_dssp EEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSS
T ss_pred EEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhc
Confidence 99998776 5 99999975432 233456899999999984
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=245.18 Aligned_cols=173 Identities=24% Similarity=0.404 Sum_probs=143.0
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
..++|+..+.||+|+||.||+|++..+|+.||+|++.... ....+.+. +|+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------------------------~E~~~ 77 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM-------------------------REIKL 77 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHH-------------------------HHHHH
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHH-------------------------HHHHH
Confidence 4578999999999999999999999999999999986543 22223333 35999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++.++||||+++++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil 156 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEE
Confidence 999999999999999999999999999999999998876544 5999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
++.++.+ +|||+++...... .......+|+.|+|||++.+.
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 157 VSQSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp ECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTC
T ss_pred EcCCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCC
Confidence 9999988 9999998765322 222345689999999999765
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=242.36 Aligned_cols=170 Identities=25% Similarity=0.408 Sum_probs=138.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
++|...+.||+|+||.||++++..+++.+|+|.+..... ...+.+ .+|+++|+.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~-------------------------~~E~~~l~~ 76 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI-------------------------EAEIEVLKS 76 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHH-------------------------HHHHHHHHT
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHH-------------------------HHHHHHHHh
Confidence 578899999999999999999999999999999865321 112223 345999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++||||+++++++.+....++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 77 l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl 156 (285)
T 3is5_A 77 LDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENIL 156 (285)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred CCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEE
Confidence 99999999999999999999999999999999988532 356999999999999999999999999999999999999
Q ss_pred Eec---CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 636 VRE---VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 636 l~~---~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++. ++.+ +|||+++....... .....+|+.|+|||++.+
T Consensus 157 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 157 FQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFKR 200 (285)
T ss_dssp ESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTT
T ss_pred EecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhcc
Confidence 954 4555 99999987654322 234568999999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=243.13 Aligned_cols=175 Identities=21% Similarity=0.392 Sum_probs=143.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++|...+.||+|+||.||+|.+..+|+.||+|.+..... ...+ .+|+.+|
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~-------------------------~~e~~~l 78 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEI-------------------------IKEISIM 78 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC--CHHH-------------------------HHHHHHH
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH--HHHH-------------------------HHHHHHH
Confidence 345789999999999999999999999999999999865321 1222 3459999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||+++++++..++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 79 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 158 (314)
T 3com_A 79 QQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158 (314)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred HhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE
Confidence 99999999999999999999999999999999999997545569999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+|.+ +|||+++...... .......+++.|+|||++.+..|
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 202 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGY 202 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCB
T ss_pred CCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCC
Confidence 999988 9999998765432 12234568999999999977654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=257.67 Aligned_cols=177 Identities=20% Similarity=0.256 Sum_probs=136.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||+|.+..+++.||+|.+.+........... .....+.+|+.+|+.
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~-----------------~~~~~~~~E~~~l~~ 196 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREA-----------------DPALNVETEIEILKK 196 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC-------------------------CCHHHHHHHHHH
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccc-----------------hhHHHHHHHHHHHHh
Confidence 468999999999999999999999999999999986532110000000 001134567999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++. .+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++.
T Consensus 197 l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 197 LNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSS 274 (419)
T ss_dssp CCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred CCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 99999999999975 566899999999999999987654 5999999999999999999999999999999999999986
Q ss_pred CCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 639 VGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 639 ~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++. + +|||+++..... .......||+.|+|||++.+
T Consensus 275 ~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 275 QEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp SSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC-
T ss_pred CCCcceEEEeecccceecCCC---ccccccCCCCCccCceeeec
Confidence 554 5 999999876532 22234568999999999854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=260.06 Aligned_cols=183 Identities=23% Similarity=0.380 Sum_probs=143.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|..++.||+|+||.||+|+++.+++.+|+|.+.+....... ...... ........+.+|+.+|+.
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~-~~~~~~-----------~~~~~~~~~~~E~~~l~~ 102 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGR-YSDDNK-----------NIEKFHEEIYNEISLLKS 102 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------------------CTHHHHHHHHHHHHT
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhccccc-ccccch-----------hhHHHHHHHHHHHHHHHh
Confidence 46799999999999999999999999999999998754322110 000000 000001124567999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++.+....|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 103 l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 181 (504)
T 3q5i_A 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLEN 181 (504)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESS
T ss_pred CCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEec
Confidence 999999999999999999999999999999999987643 5999999999999999999999999999999999999998
Q ss_pred CCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 639 VGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 639 ~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++. + +|||+++...... ......||+.|+|||++.+
T Consensus 182 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 182 KNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp TTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT
T ss_pred CCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc
Confidence 873 4 9999998775432 2234569999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-27 Score=239.87 Aligned_cols=169 Identities=26% Similarity=0.374 Sum_probs=144.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||++.+..+++.||+|.+..... ...+|+++++.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----------------------------~~~~e~~~l~~l 61 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-----------------------------KAEREVKALAKL 61 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG-----------------------------GGHHHHHHHHHC
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH-----------------------------HHHHHHHHHHhC
Confidence 578999999999999999999999999999999865431 123469999999
Q ss_pred CCCceeeEEEEEEe----------------CCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy5063 560 HHHNVIRFIGVLYK----------------DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSM 622 (681)
Q Consensus 560 ~HpnIV~l~g~~~~----------------~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~ 622 (681)
+||||+++++++.. ...+++||||+++|+|.+++... ...+++..+..++.|++.||.|||++
T Consensus 62 ~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 141 (284)
T 2a19_B 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK 141 (284)
T ss_dssp CCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 99999999999864 45589999999999999999653 34689999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 623 NLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|+||||||+|||++.++.+ +|||+++....... .....+|+.|+|||++.+..|
T Consensus 142 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 198 (284)
T 2a19_B 142 KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDY 198 (284)
T ss_dssp TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCC
T ss_pred CeeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCC
Confidence 99999999999999999988 99999987654322 223568999999999987654
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=239.37 Aligned_cols=168 Identities=29% Similarity=0.393 Sum_probs=138.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||+|++ +++.||+|.+..... ..+..| .+++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~---~~~~~e-------------------------~~~~~~ 56 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE---KSWFRE-------------------------TELYNT 56 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH---HHHHHH-------------------------HHHHHH
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc---hhhHHH-------------------------HHHHHH
Confidence 46899999999999999999987 589999999865322 222333 444444
Q ss_pred --CCCCceeeEEEEEEeC----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCc
Q psy5063 559 --LHHHNVIRFIGVLYKD----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH--------SMNL 624 (681)
Q Consensus 559 --L~HpnIV~l~g~~~~~----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLH--------s~~I 624 (681)
++||||+++++++... ..+++||||+++|+|.++++.. .+++..+..++.|++.||.||| +++|
T Consensus 57 ~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 57 VMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp TCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE
T ss_pred hhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe
Confidence 8999999999997542 5689999999999999999653 5999999999999999999999 9999
Q ss_pred cccCCCCCcEEEecCCCe--EEeeeeeEeeeccccee--eeecCCCccccchhhccCC
Q psy5063 625 IHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTL--FILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 625 IHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~--~~~~~gt~~Y~APEvL~~~ 678 (681)
+||||||+|||++.++.+ +|||+++.......... .....||+.|+|||++.+.
T Consensus 135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred ecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCc
Confidence 999999999999999988 99999987765432211 1234689999999999765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.8e-27 Score=248.84 Aligned_cols=176 Identities=23% Similarity=0.370 Sum_probs=144.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+|+.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~~E~~~l~~ 72 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-----------------------GFPITALREIKILQL 72 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-----------------------SSCHHHHHHHHHHHH
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-----------------------cchHHHHHHHHHHHh
Confidence 468999999999999999999999999999999885432110 001122456999999
Q ss_pred CCCCceeeEEEEEEe--------CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 559 LHHHNVIRFIGVLYK--------DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 559 L~HpnIV~l~g~~~~--------~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
++||||+++++++.. .+.+++||||+++ +|.+.+......+++..+..++.|++.||.|||++||+|||||
T Consensus 73 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 151 (351)
T 3mi9_A 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 151 (351)
T ss_dssp CCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred ccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 999999999999987 4578999999975 8888887766679999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeeccc--ceeeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVP--YTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~--~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|+|||++.++.+ +|||+++....... ........||+.|+|||++.+.
T Consensus 152 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (351)
T 3mi9_A 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 203 (351)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC
T ss_pred HHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCC
Confidence 999999999988 99999987653221 1223345689999999998764
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=240.03 Aligned_cols=178 Identities=24% Similarity=0.371 Sum_probs=144.9
Q ss_pred eecCCCeeecc-eecccCcEEEEEEEEc--CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 476 IFRASDLVRGP-LLGQGFFGQVYRVTHR--ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 476 ~~~~~d~~~~~-~LG~G~FG~Vyk~~~~--~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.+..++|.+.+ .||+|+||.||+|.+. .++..||+|.+.... ....+.+.+
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------------------------- 59 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR------------------------- 59 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHH-------------------------
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHH-------------------------
Confidence 34556777766 9999999999999864 468899999987643 333333444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
|+++|+.++||||+++++++ ..+..++||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||
T Consensus 60 E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 138 (287)
T 1u59_A 60 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 138 (287)
T ss_dssp HHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCch
Confidence 49999999999999999999 56679999999999999999987666799999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||++.++.+ +|||+++......... ......+|+.|+|||++.+..
T Consensus 139 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (287)
T 1u59_A 139 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189 (287)
T ss_dssp GGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE
T ss_pred heEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCC
Confidence 99999999987 9999998775432211 122334688999999986543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=238.51 Aligned_cols=171 Identities=24% Similarity=0.389 Sum_probs=132.7
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
+..++|+..+.||+|+||.||++++..+++.||+|.+.... .........+ +...
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~------------------------~~~~ 59 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD------------------------LDIS 59 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHH------------------------HHHH
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHH------------------------HHHH
Confidence 45678999999999999999999999999999999986532 2222222222 2455
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNS 631 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~-~IIHRDLKp 631 (681)
++.++||||+++++++.+++..++||||++ |+|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp 138 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSG
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH
Confidence 788899999999999999999999999997 588777653 345699999999999999999999998 999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhc
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNIL 675 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL 675 (681)
+|||++.++.+ +|||+++....... .....+|+.|+|||++
T Consensus 139 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~ 181 (290)
T 3fme_A 139 SNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERI 181 (290)
T ss_dssp GGCEECTTCCEEBCCC------------------CCCCCCSCHHHH
T ss_pred HHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhc
Confidence 99999999988 99999987654322 2234689999999997
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.7e-27 Score=238.72 Aligned_cols=170 Identities=22% Similarity=0.292 Sum_probs=142.9
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.+..++|...+.||+|+||.||+|++. ++.+|+|.+.... ....+.+.+ |+
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~-------------------------E~ 58 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNE-------------------------EC 58 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHH-------------------------HG
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHH-------------------------HH
Confidence 355678999999999999999999985 8899999986542 333344444 48
Q ss_pred HHHHhCCCCceeeEEEEEEeC--CeEEEEEeccCCCCHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccC
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKD--RKLNLVTEYIAGGTLKELLQDPGQ-PLPWGQRVNFARDIAAGMTYLHSMN--LIHRD 628 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~--~~l~LV~Ey~~gGsL~~~L~~~~~-~l~~~~~~~i~~QIa~gL~yLHs~~--IIHRD 628 (681)
.+|+.++||||+++++++.+. +..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++ |+|||
T Consensus 59 ~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~d 138 (271)
T 3kmu_A 59 PRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA 138 (271)
T ss_dssp GGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCC
T ss_pred HHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCC
Confidence 889999999999999999877 789999999999999999987543 5899999999999999999999999 99999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||+|||++.+|.+ .|||++..... ....+|+.|+|||++.+..
T Consensus 139 ikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~ 184 (271)
T 3kmu_A 139 LNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKP 184 (271)
T ss_dssp CSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCG
T ss_pred CccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCC
Confidence 99999999999887 77777654221 1245899999999998754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-27 Score=246.60 Aligned_cols=175 Identities=29% Similarity=0.431 Sum_probs=143.0
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEE--EEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVM--VLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~v--AiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+..++|.+.+.||+|+||.||+|++..++..+ |+|.+..... ...+.+ .+|+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~-------------------------~~E~ 76 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-------------------------AGEL 76 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHH-------------------------HHHH
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHH-------------------------HHHH
Confidence 45578999999999999999999999888865 8898864321 122222 3469
Q ss_pred HHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHHHHHHHHHHHH
Q psy5063 554 AVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMT 617 (681)
Q Consensus 554 ~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~i~~QIa~gL~ 617 (681)
++|+.+ +||||+++++++.+++..++||||+++|+|.+++.... ..+++..+..++.|++.||.
T Consensus 77 ~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 156 (327)
T 1fvr_A 77 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 156 (327)
T ss_dssp HHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH
T ss_pred HHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 999999 99999999999999999999999999999999997643 36899999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 618 YLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 618 yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||+++|+||||||+|||++.++.+ +|||+++...... ......+++.|+|||++.+..
T Consensus 157 ~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~ 217 (327)
T 1fvr_A 157 YLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSV 217 (327)
T ss_dssp HHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCE
T ss_pred HHHhCCccCCCCccceEEEcCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhcccc
Confidence 9999999999999999999999888 9999997443222 112244688999999986554
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=238.23 Aligned_cols=175 Identities=29% Similarity=0.446 Sum_probs=132.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|...+.||+|+||.||+|.+. ++.+|+|.+............+ .+.+|++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~---------------------~~~~e~~~l 60 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIE---------------------NVRQEAKLF 60 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHH---------------------HHHHHHHHH
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHH---------------------HHHHHHHHH
Confidence 45678999999999999999999975 8899999886533222111111 123469999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCc
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN---LIHRDLNSQN 633 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~---IIHRDLKp~N 633 (681)
+.++||||+++++++.+++..++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||||+|
T Consensus 61 ~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~N 138 (271)
T 3dtc_A 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSN 138 (271)
T ss_dssp HHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGG
T ss_pred HhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHH
Confidence 999999999999999999999999999999999999965 35999999999999999999999999 8999999999
Q ss_pred EEEec--------CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVRE--------VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~--------~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||++. ++.+ +|||+++....... ....+|+.|+|||++.+..|
T Consensus 139 il~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~ 191 (271)
T 3dtc_A 139 ILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMF 191 (271)
T ss_dssp EEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCC
T ss_pred EEEecccccccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCC
Confidence 99986 4555 99999987654322 23468999999999876654
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-26 Score=239.31 Aligned_cols=173 Identities=26% Similarity=0.401 Sum_probs=148.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.+.|...+.||+|+||.||+|++..+++.||+|.+..... ...+.+. +|+.+++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~e~~~l~ 75 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-------------------------QEITVLS 75 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHH-------------------------HHHHHHH
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHH-------------------------HHHHHHH
Confidence 4568999999999999999999999999999999865432 1222333 4589999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.++...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 76 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 153 (303)
T 3a7i_A 76 QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS 153 (303)
T ss_dssp HCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred hCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEEC
Confidence 99999999999999999999999999999999999975 3599999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||+++...... .......+|+.|+|||++.+..|
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~ 196 (303)
T 3a7i_A 154 EHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAY 196 (303)
T ss_dssp TTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCB
T ss_pred CCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCC
Confidence 99988 9999998765432 12234568999999999977654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-26 Score=238.07 Aligned_cols=173 Identities=21% Similarity=0.265 Sum_probs=146.2
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-----HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-----EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-----~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.++|...+.||+|+||.||+|.++.+++.||+|.+.... ......... .+.+|+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~---------------------~~~~e~ 74 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE---------------------ATLKEV 74 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHH---------------------HHHHHH
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHH---------------------HHHHHH
Confidence 578999999999999999999999999999999986542 111111111 124569
Q ss_pred HHHHhCC-CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
++|+.+. ||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+
T Consensus 75 ~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 153 (298)
T 1phk_A 75 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 153 (298)
T ss_dssp HHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcc
Confidence 9999995 999999999999999999999999999999999764 35999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
|||++.++.+ +|||++....... ......+++.|+|||++.
T Consensus 154 Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 154 NILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHH
T ss_pred eEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhc
Confidence 9999999988 9999998765332 223356899999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-26 Score=242.94 Aligned_cols=183 Identities=26% Similarity=0.386 Sum_probs=137.7
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcC---CCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRE---TGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~---tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~ 547 (681)
....+..++|.+++.||+|+||.||+|.+.. +++.||+|.+... .....+.+.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~---------------------- 84 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFL---------------------- 84 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHH----------------------
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHH----------------------
Confidence 3445667889999999999999999998765 5668999998643 223333333
Q ss_pred cchHHHHHHHhCCCCceeeEEEEEEeCC-----eEEEEEeccCCCCHHHHHhC-----CCCCCCHHHHHHHHHHHHHHHH
Q psy5063 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQD-----PGQPLPWGQRVNFARDIAAGMT 617 (681)
Q Consensus 548 ~~~~Ei~iL~~L~HpnIV~l~g~~~~~~-----~l~LV~Ey~~gGsL~~~L~~-----~~~~l~~~~~~~i~~QIa~gL~ 617 (681)
+|+.+|+.++||||+++++++.... ..++||||+++|+|.+++.. ....+++..+..++.|++.||.
T Consensus 85 ---~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 161 (313)
T 3brb_A 85 ---SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161 (313)
T ss_dssp ---HHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHH
Confidence 3599999999999999999998654 35999999999999999842 2346999999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 618 YLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 618 yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++|+||||||+|||++.++.+ +|||+++...............+++.|+|||++.+..|
T Consensus 162 ~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 226 (313)
T 3brb_A 162 YLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY 226 (313)
T ss_dssp HHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCC
T ss_pred HHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCc
Confidence 9999999999999999999999988 99999987765433333334557889999999987654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=248.64 Aligned_cols=174 Identities=26% Similarity=0.375 Sum_probs=137.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||+|++..+++.||+|.+........ . ...+.+|+.+|+.
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~---------------------~~~~~~E~~~l~~ 89 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEG--V---------------------PGTAIREVSLLKE 89 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC-------------------------------CHHHHHHGGG
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccc--c---------------------chhHHHHHHHHHH
Confidence 4689999999999999999999999999999999865432111 0 0123467999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++..++..++||||++ |+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 90 l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~ 167 (329)
T 3gbz_A 90 LQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSV 167 (329)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC
T ss_pred cCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEec
Confidence 999999999999999999999999997 59999998654 4999999999999999999999999999999999999965
Q ss_pred CC-----Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 639 VG-----SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 639 ~g-----~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++ .+ +|||+++...... .......+|+.|+|||++.+..
T Consensus 168 ~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~ 213 (329)
T 3gbz_A 168 SDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSR 213 (329)
T ss_dssp -----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCC
T ss_pred CCCCccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCC
Confidence 44 35 9999998654321 2233456899999999997743
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=240.95 Aligned_cols=175 Identities=25% Similarity=0.410 Sum_probs=143.8
Q ss_pred CeeecceecccCcEEEEEEEEcCCCe---EEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGE---VMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~---~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.|..++.||+|+||.||+|.+..+++ .+|+|.+..... ...+.+.+ |+.+|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~-------------------------E~~~l 76 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLR-------------------------EGLLM 76 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHH-------------------------HHHHH
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHH-------------------------HHHHH
Confidence 45667899999999999999766554 799998865432 33333444 49999
Q ss_pred HhCCCCceeeEEEEEEeCCeE-EEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKL-NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l-~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++||||+++++++.+.+.. ++||||+.+|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 77 ~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil 156 (298)
T 3pls_A 77 RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCM 156 (298)
T ss_dssp HTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEE
Confidence 999999999999999876655 9999999999999999886677999999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeeccc--ceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVP--YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~--~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||+++....... ........+++.|+|||++.+..|
T Consensus 157 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 205 (298)
T 3pls_A 157 LDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205 (298)
T ss_dssp ECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC
T ss_pred EcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCC
Confidence 9999988 99999986543221 122233457889999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.6e-27 Score=249.43 Aligned_cols=185 Identities=17% Similarity=0.193 Sum_probs=144.3
Q ss_pred cCCCeeecceecccCcEEEEEEEEcC---CCeEEEEEEeeccCHHH--HHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRE---TGEVMVLKELYRVDEEA--EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~---tg~~vAiK~l~~~~~~~--~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..++|.+++.||+|+||.||+|++.. ++..+|+|.+....... +..++++. ....+.+|
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~----------------~~~~~~~e 98 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV----------------AKKDCIKK 98 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHH----------------CCHHHHHH
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHH----------------hhhHHHHH
Confidence 35789999999999999999999987 78899999987653222 22222221 11234678
Q ss_pred HHHHHhCCCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
+..++.++||||+++++++.. ....|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+++|+|||
T Consensus 99 ~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 176 (345)
T 2v62_A 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGD 176 (345)
T ss_dssp HHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 999999999999999999988 78899999999 999999998654 699999999999999999999999999999
Q ss_pred CCCCcEEEecCC--Ce--EEeeeeeEeeeccccee-----eeecCCCccccchhhccCCCC
Q psy5063 629 LNSQNCLVREVG--SG--FDFHLGQIYLIYVPYTL-----FILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 629 LKp~NILl~~~g--~~--~DFGLa~~~~~~~~~~~-----~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+|||++.++ .+ +|||+++.+........ .....||+.|+|||++.+..|
T Consensus 177 lkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 237 (345)
T 2v62_A 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL 237 (345)
T ss_dssp CSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC
T ss_pred cCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC
Confidence 999999999887 66 99999988754321111 133468999999999987754
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=9.7e-27 Score=242.10 Aligned_cols=176 Identities=23% Similarity=0.352 Sum_probs=141.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCC---eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETG---EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg---~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+|...+.||+|+||.||+|++..++ ..+|+|.+.... ....+.+.+ |+.+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~-------------------------E~~~ 79 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT-------------------------EGII 79 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHH-------------------------HHHH
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHH-------------------------HHHH
Confidence 35888999999999999999976433 468999886533 333334444 4899
Q ss_pred HHhCCCCceeeEEEEEE-eCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 LRSLHHHNVIRFIGVLY-KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~-~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
|+.++||||+++++++. .++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Ni 159 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNC 159 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence 99999999999999864 45688999999999999999987666789999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccc--eeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPY--TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~--~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++.++.+ +|||+++........ .......+|+.|+|||++.+..|
T Consensus 160 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (298)
T 3f66_A 160 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209 (298)
T ss_dssp EECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCC
T ss_pred EECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCC
Confidence 99999988 999999876543211 12233457788999999876554
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=4.8e-27 Score=252.55 Aligned_cols=178 Identities=21% Similarity=0.296 Sum_probs=146.8
Q ss_pred ecCCCeeecceecccCcEEEEEEEEc---CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHR---ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~---~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+..++|.+.+.||+|+||.||++++. .+++.||+|++.+...... ......+.+|+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~---------------------~~~~~~~~~E~ 109 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK---------------------AKTTEHTRTER 109 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEE---------------------ESSGGGCCCHH
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhh---------------------hhHHHHHHHHH
Confidence 34578999999999999999999984 5899999998854211000 00011234679
Q ss_pred HHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
++|+.+ +||||+++++++..++..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+
T Consensus 110 ~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~ 188 (355)
T 1vzo_A 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188 (355)
T ss_dssp HHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 999999 79999999999999999999999999999999997643 5999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|||++.++.+ +|||+++........ ......||+.|+|||++.+
T Consensus 189 NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 189 NILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp GEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTT
T ss_pred HEEECCCCcEEEeeCCCCeecccCCCC-cccCcccCcCccChhhhcC
Confidence 9999999988 999999876543221 2223569999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.1e-27 Score=254.04 Aligned_cols=171 Identities=21% Similarity=0.352 Sum_probs=142.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|.+.+.||+|+||.||+|++..+|+.||+|.+...... ....+ .+|+++|+
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~E~~~l~ 62 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-------------------------MREFEVLK 62 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHH-------------------------HHHHHHHH
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHH-------------------------HHHHHHHH
Confidence 46799999999999999999999999999999998643211 12222 34599999
Q ss_pred hCCCCceeeEEEEEEeCC--eEEEEEeccCCCCHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 558 SLHHHNVIRFIGVLYKDR--KLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~--~l~LV~Ey~~gGsL~~~L~~~~--~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
.++||||+++++++...+ ..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+|
T Consensus 63 ~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N 142 (396)
T 4eut_A 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGN 142 (396)
T ss_dssp HCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred hcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHH
Confidence 999999999999998755 7899999999999999997643 238999999999999999999999999999999999
Q ss_pred EEE----ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 634 CLV----REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 634 ILl----~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
||+ +.++.+ +|||+++....... .....||+.|+|||++.+
T Consensus 143 Ill~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 143 IMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp EEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHH
T ss_pred EEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhc
Confidence 999 555555 99999987754332 223568999999999854
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=260.16 Aligned_cols=169 Identities=24% Similarity=0.345 Sum_probs=139.9
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
+.|...+.||+|+||.||+|+++.++..+|+|.+.+.... .... +.+|+.+|+
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~-------------------------~~~E~~~l~ 91 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-------------------------LLEEVAVLK 91 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHH-------------------------HHHHHHHHT
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHH-------------------------HHHHHHHHH
Confidence 4689999999999999999999999999999998654211 1122 245699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 92 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~ 170 (494)
T 3lij_A 92 LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLE 170 (494)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred hCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEe
Confidence 9999999999999999999999999999999999887643 599999999999999999999999999999999999998
Q ss_pred cCCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 638 EVGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 638 ~~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
..+. + +|||+++...... ......||+.|+|||++.+
T Consensus 171 ~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~ 212 (494)
T 3lij_A 171 SKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRK 212 (494)
T ss_dssp CSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHTT
T ss_pred CCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHcc
Confidence 7543 4 9999998776432 2234569999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=251.48 Aligned_cols=166 Identities=25% Similarity=0.361 Sum_probs=136.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||+|.+..+|+.||+|++.... ....+.+ .+|+.+|
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~~E~~~l 78 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-------------------------YRELRLL 78 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHH-------------------------HHHHHHH
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHH-------------------------HHHHHHH
Confidence 468999999999999999999999999999999985432 2222223 3459999
Q ss_pred HhCCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++..+ ..+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus 79 ~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlk 155 (367)
T 1cm8_A 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 155 (367)
T ss_dssp HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcC
Confidence 999999999999999765 3469999999 8899999976 358999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|+|||++.+|.+ +|||+++..... .....+|+.|+|||++.+
T Consensus 156 p~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 156 PGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHT
T ss_pred HHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhC
Confidence 999999999988 999999876432 223568999999999876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=248.19 Aligned_cols=180 Identities=28% Similarity=0.402 Sum_probs=140.9
Q ss_pred eecCCCeeecceecccCcEEEEEEE-----EcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVT-----HRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~-----~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
.+..++|.+.+.||+|+||.||+|+ ...+++.||+|.+.... ......+.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~----------------------- 82 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM----------------------- 82 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHH-----------------------
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHH-----------------------
Confidence 4566789999999999999999999 55678899999986432 333333443
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG------QPLPWGQRVNFARDIAAGMTYLHSMN 623 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~------~~l~~~~~~~i~~QIa~gL~yLHs~~ 623 (681)
|+.+++.++||||+++++++..+...|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++
T Consensus 83 --E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 160 (327)
T 2yfx_A 83 --EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160 (327)
T ss_dssp --HHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred --HHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence 4899999999999999999999999999999999999999997543 34889999999999999999999999
Q ss_pred ccccCCCCCcEEEecCCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 624 LIHRDLNSQNCLVREVGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 624 IIHRDLKp~NILl~~~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+||||||+|||++.++. + +|||+++...............+|+.|+|||++.+..|
T Consensus 161 i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 222 (327)
T 2yfx_A 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF 222 (327)
T ss_dssp CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC
T ss_pred eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC
Confidence 999999999999996553 4 99999976543332222233457889999999876554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=246.66 Aligned_cols=172 Identities=16% Similarity=0.233 Sum_probs=137.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
+..++|++.+.||+|+||.||++.+. +++.||+|.+.... ....+.+.+ |+.
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~-------------------------E~~ 59 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRN-------------------------EIA 59 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHH-------------------------HHH
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHH-------------------------HHH
Confidence 34567999999999999999999884 58999999986532 233333333 599
Q ss_pred HHHhCCC--CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 555 VLRSLHH--HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 555 iL~~L~H--pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
+|+.++| |||+++++++..++.+++|||| .+|+|.+++.... .+++..+..++.|++.||.|||+++|+||||||+
T Consensus 60 ~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~ 137 (343)
T 3dbq_A 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 137 (343)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 9999976 9999999999999999999995 5889999998754 5999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|||++ ++.+ +|||+++...............||+.|+|||++.+
T Consensus 138 NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 138 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp GEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHH
T ss_pred eEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhh
Confidence 99997 4666 99999987765443333345679999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=261.42 Aligned_cols=179 Identities=25% Similarity=0.379 Sum_probs=147.2
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..+.+..++|.+.+.||+|+||.||+|.+.. +..||+|.+..... ..+.+.+ |
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~-------------------------E 233 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSM-SVEAFLA-------------------------E 233 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSB-CHHHHHH-------------------------H
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCc-cHHHHHH-------------------------H
Confidence 4456778899999999999999999999864 77899999865332 2333444 5
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.+|+.++||||+++++++. ++.+++||||+++|+|.+++.... ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 234 ~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp 312 (454)
T 1qcf_A 234 ANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRA 312 (454)
T ss_dssp HHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG
T ss_pred HHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCH
Confidence 99999999999999999986 667999999999999999998642 3588999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++.+ +|||+++...... +.......++..|+|||++....|
T Consensus 313 ~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 362 (454)
T 1qcf_A 313 ANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSF 362 (454)
T ss_dssp GGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCC
T ss_pred HHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCC
Confidence 99999999988 9999998765322 122223446788999999876554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=260.64 Aligned_cols=170 Identities=22% Similarity=0.372 Sum_probs=142.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|.+.+.||+|+||.||+|+++.+++.||+|.+.+... ..... +.+|+++|+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~-------------------------~~~E~~~l~ 76 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTST-------------------------ILREVELLK 76 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHH-------------------------HHHHHHHHH
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHH-------------------------HHHHHHHHH
Confidence 578999999999999999999999999999999854211 11122 245699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+...+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 77 ~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~ 155 (486)
T 3mwu_A 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (486)
T ss_dssp HCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEES
T ss_pred hCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEe
Confidence 9999999999999999999999999999999999887643 599999999999999999999999999999999999996
Q ss_pred cC---CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EV---GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~---g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.. +.+ +|||+++...... ......||+.|+|||++.+.
T Consensus 156 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 198 (486)
T 3mwu_A 156 SKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGT 198 (486)
T ss_dssp SSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGSC
T ss_pred cCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCCC
Confidence 53 445 9999998665432 22345699999999999763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=240.18 Aligned_cols=178 Identities=22% Similarity=0.326 Sum_probs=142.7
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcC---CCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRE---TGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~---tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.+..++|...+.||+|+||.||+|++.. ++..||+|.+... .....+.+.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------------------------- 62 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS------------------------- 62 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHH-------------------------
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHH-------------------------
Confidence 4556789999999999999999999754 3456999988654 2333333444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
|+.+++.++||||+++++++.+ +..|+||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||
T Consensus 63 E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 141 (281)
T 3cc6_A 63 EAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAV 141 (281)
T ss_dssp HHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred HHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCcc
Confidence 4899999999999999999864 467999999999999999987656699999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++.+ +|||+++....... .......++..|+|||++.+..|
T Consensus 142 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~ 191 (281)
T 3cc6_A 142 RNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRF 191 (281)
T ss_dssp GGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCC
T ss_pred ceEEECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCC
Confidence 99999999987 99999987654321 12233456888999999876554
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=259.20 Aligned_cols=170 Identities=22% Similarity=0.363 Sum_probs=144.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.++|...+.||+|+||.||+|++..+++.||+|.+.+.. ......+ .+|+.+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~-------------------------~~E~~~ 79 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL-------------------------LREVQL 79 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHH-------------------------HHHHHH
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHH-------------------------HHHHHH
Confidence 357899999999999999999999999999999986432 1122223 345999
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
|+.++||||+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 80 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil 158 (484)
T 3nyv_A 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLL 158 (484)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence 999999999999999999999999999999999999997654 5999999999999999999999999999999999999
Q ss_pred Ee---cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 636 VR---EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 636 l~---~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++ .++.+ +|||+++....... .....||+.|+|||++.+
T Consensus 159 ~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 159 LESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp ESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT
T ss_pred EecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC
Confidence 94 55666 99999986654322 223569999999999876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.2e-26 Score=237.20 Aligned_cols=174 Identities=21% Similarity=0.346 Sum_probs=143.7
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..+++....+||+|+||.||+|.+..+++.||+|.+...+....+.+.+ |+.++
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------e~~~l 73 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE-------------------------EIALH 73 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHH-------------------------HHHHH
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHH-------------------------HHHHH
Confidence 44556666678999999999999999999999999987655444444444 48999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~--~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+.++||||+++++++...+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 74 ~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 153 (295)
T 2clq_A 74 KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNV 153 (295)
T ss_dssp HTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhE
Confidence 99999999999999999999999999999999999997643 2467888999999999999999999999999999999
Q ss_pred EEec-CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 635 LVRE-VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 635 Ll~~-~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|++. ++.+ +|||+++...... .......+|+.|+|||++.+
T Consensus 154 l~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~ 197 (295)
T 2clq_A 154 LINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDK 197 (295)
T ss_dssp EEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHH
T ss_pred EEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcC
Confidence 9998 7777 9999998765322 11234568999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=250.39 Aligned_cols=172 Identities=16% Similarity=0.243 Sum_probs=139.6
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
+...+|.+.+.||+|+||.||++.+.. ++.||+|.+... +......+. +|+.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~-------------------------~Ei~ 106 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYR-------------------------NEIA 106 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHH-------------------------HHHH
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHH-------------------------HHHH
Confidence 344569999999999999999999865 899999998653 233333343 4599
Q ss_pred HHHhCC--CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 555 VLRSLH--HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 555 iL~~L~--HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
+|+.++ ||||+++++++..++.+|+||| +.+++|.+++.... .+++..+..++.||+.||.|||+++|+||||||+
T Consensus 107 ~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~ 184 (390)
T 2zmd_A 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184 (390)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGG
T ss_pred HHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 999996 5999999999999999999999 56889999998754 5899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|||+++ +.+ +|||+++...............||+.|||||++.+
T Consensus 185 NIll~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 185 NFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp GEEESS-SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHC
T ss_pred HEEEEC-CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhh
Confidence 999964 666 99999987764433333345679999999999875
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-27 Score=246.61 Aligned_cols=179 Identities=25% Similarity=0.394 Sum_probs=146.8
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
.....++|...+.||+|+||.||+|++. +++.||+|.+........ ...+.+|++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------------------------~~~~~~e~~ 79 (326)
T 3uim_A 25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGG------------------------ELQFQTEVE 79 (326)
T ss_dssp HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----C------------------------CCHHHHHHH
T ss_pred HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchH------------------------HHHHHHHHH
Confidence 3345678999999999999999999854 689999998864321110 112345699
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccC
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---QPLPWGQRVNFARDIAAGMTYLHSM---NLIHRD 628 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---~~l~~~~~~~i~~QIa~gL~yLHs~---~IIHRD 628 (681)
+++.++||||+++++++..++..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+|||
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~D 159 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRD 159 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCC
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Confidence 9999999999999999999999999999999999999998643 3489999999999999999999999 999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||+|||++.++.+ +|||+++....... .......||+.|+|||++.+..
T Consensus 160 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~ 211 (326)
T 3uim_A 160 VKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGK 211 (326)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSE
T ss_pred CchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCC
Confidence 99999999999988 99999987754332 2233455899999999986543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=242.12 Aligned_cols=175 Identities=25% Similarity=0.369 Sum_probs=132.3
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
..+...+|.+.++||+|+||.||++++..+++.||+|.+..........+.+| +.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e-------------------------~~ 77 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQE-------------------------VC 77 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHH-------------------------HH
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHH-------------------------HH
Confidence 34556689999999999999999999999999999999877665555555554 88
Q ss_pred HHHhCC-CCceeeEEEEEE--------eCCeEEEEEeccCCCCHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy5063 555 VLRSLH-HHNVIRFIGVLY--------KDRKLNLVTEYIAGGTLKELLQD--PGQPLPWGQRVNFARDIAAGMTYLHSMN 623 (681)
Q Consensus 555 iL~~L~-HpnIV~l~g~~~--------~~~~l~LV~Ey~~gGsL~~~L~~--~~~~l~~~~~~~i~~QIa~gL~yLHs~~ 623 (681)
+++.+. ||||+++++++. ....+++||||++ |+|.+++.. ....+++..+..++.||+.||.|||+++
T Consensus 78 ~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 156 (337)
T 3ll6_A 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK 156 (337)
T ss_dssp HHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 899995 999999999994 3446899999995 799998864 3346999999999999999999999999
Q ss_pred --ccccCCCCCcEEEecCCCe--EEeeeeeEeeecccce----------eeeecCCCccccchhhc
Q psy5063 624 --LIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYT----------LFILSAKTKKTYYPNIL 675 (681)
Q Consensus 624 --IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~----------~~~~~~gt~~Y~APEvL 675 (681)
|+||||||+|||++.++.+ +|||+++......... ......+|+.|+|||++
T Consensus 157 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~ 222 (337)
T 3ll6_A 157 PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII 222 (337)
T ss_dssp SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC------------------------------
T ss_pred CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence 9999999999999999988 9999998765432111 11134589999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=238.93 Aligned_cols=173 Identities=27% Similarity=0.431 Sum_probs=142.1
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH----HHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE----AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~----~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
++|.+++.||+|+||.||++.+..+++.+|+|.+...... ....+ .+|+.+
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~-------------------------~~E~~~ 59 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANV-------------------------KKEIQL 59 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHH-------------------------HHHHHH
T ss_pred cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHH-------------------------HHHHHH
Confidence 6899999999999999999999999999999998643211 12222 346999
Q ss_pred HHhCCCCceeeEEEEEE--eCCeEEEEEeccCCCCHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 556 LRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~--~~~~l~LV~Ey~~gGsL~~~L~~-~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
++.++||||+++++++. +....++||||++++ |.+++.. ....+++..+..++.|++.||.|||+++|+||||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 138 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG 138 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcc
Confidence 99999999999999985 456899999999876 7676654 3456999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||++.++.+ +|||+++...............+|+.|+|||++.+.
T Consensus 139 NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (305)
T 2wtk_C 139 NLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGL 186 (305)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCC
T ss_pred cEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCc
Confidence 9999999988 999999876543333334456699999999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=249.44 Aligned_cols=166 Identities=25% Similarity=0.344 Sum_probs=125.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||+|.+..+|+.||+|++... .....+.+ .+|+.+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~~E~~~l 82 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------------------------YRELRLL 82 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHH-------------------------HHHHHHH
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHH-------------------------HHHHHHH
Confidence 47899999999999999999999999999999998653 22233333 3459999
Q ss_pred HhCCCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++... ...|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+|||||
T Consensus 83 ~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlk 159 (367)
T 2fst_X 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLK 159 (367)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred HhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 999999999999999754 5689999999 7899999875 359999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|+|||++.++.+ +|||+++..... .....+|+.|+|||++.+
T Consensus 160 p~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 160 PSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp GGGEEECTTCCEEECC--------------------CCCTTCCHHHHTT
T ss_pred HhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcC
Confidence 999999999988 999999876532 223568999999999876
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=246.12 Aligned_cols=172 Identities=22% Similarity=0.273 Sum_probs=145.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC----HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD----EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~----~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
++|...+.||+|+||.||+|++..+|+.||+|++.... ......+.+ .+.+|+.+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~---------------------~~~~E~~~ 152 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE---------------------ATRRETHI 152 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHH---------------------HHHHHHHH
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHH---------------------HHHHHHHH
Confidence 46889999999999999999999999999999986532 111111111 12456999
Q ss_pred HHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 LRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
++.+ +||||+++++++......++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 153 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NI 231 (365)
T 2y7j_A 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENI 231 (365)
T ss_dssp HHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 9998 89999999999999999999999999999999997643 599999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
|++.+|.+ +|||++....... ......||+.|+|||++.
T Consensus 232 l~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~ 272 (365)
T 2y7j_A 232 LLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILK 272 (365)
T ss_dssp EECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHH
T ss_pred EECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhcc
Confidence 99999988 9999998765432 223467999999999985
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.9e-26 Score=248.64 Aligned_cols=169 Identities=24% Similarity=0.423 Sum_probs=138.6
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|..++.||+|+||.||+|++..+|+.||+|++..... ...+|+++|+
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----------------------------~~~~E~~il~ 55 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----------------------------YKNRELDIMK 55 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----------------------------SCCHHHHHHT
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----------------------------hHHHHHHHHH
Confidence 35689999999999999999999999999999998854311 1125799999
Q ss_pred hCCCCceeeEEEEEEeC--------------------------------------CeEEEEEeccCCCCHHHHHhC---C
Q psy5063 558 SLHHHNVIRFIGVLYKD--------------------------------------RKLNLVTEYIAGGTLKELLQD---P 596 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~--------------------------------------~~l~LV~Ey~~gGsL~~~L~~---~ 596 (681)
.++||||+++++++... ..+++||||++ |+|.+.+.. .
T Consensus 56 ~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~ 134 (383)
T 3eb0_A 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS 134 (383)
T ss_dssp TCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT
T ss_pred HcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc
Confidence 99999999999999543 34899999998 587777652 3
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe-cCCCe--EEeeeeeEeeecccceeeeecCCCccccchh
Q psy5063 597 GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPN 673 (681)
Q Consensus 597 ~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~-~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APE 673 (681)
...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+ +|||+|+....... .....+|+.|+|||
T Consensus 135 ~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE 211 (383)
T 3eb0_A 135 GRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPE 211 (383)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHH
Confidence 45699999999999999999999999999999999999998 56766 99999987754332 22356899999999
Q ss_pred hccCCC
Q psy5063 674 ILKKAS 679 (681)
Q Consensus 674 vL~~~~ 679 (681)
++.+..
T Consensus 212 ~~~~~~ 217 (383)
T 3eb0_A 212 LMLGAT 217 (383)
T ss_dssp HHTTCS
T ss_pred HhcCCC
Confidence 987654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=265.02 Aligned_cols=180 Identities=24% Similarity=0.373 Sum_probs=141.7
Q ss_pred ceecCCCeeecc-eecccCcEEEEEEEEc--CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 475 RIFRASDLVRGP-LLGQGFFGQVYRVTHR--ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 475 ~~~~~~d~~~~~-~LG~G~FG~Vyk~~~~--~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
..+..+++.+.+ .||+|+||.||+|.++ .++..||+|.+.... ....+.+.+
T Consensus 330 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~------------------------ 385 (613)
T 2ozo_A 330 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR------------------------ 385 (613)
T ss_dssp SBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHH------------------------
T ss_pred eeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHH------------------------
Confidence 345566776666 8999999999999876 346679999986532 222333444
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+++|+.++||||+++++++.. +.+++||||+++|+|.+++......+++..+..++.||+.||+|||+++|+|||||
T Consensus 386 -E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlk 463 (613)
T 2ozo_A 386 -EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLA 463 (613)
T ss_dssp -HHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred -HHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCC
Confidence 5999999999999999999875 56999999999999999998766679999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+||||+.++.+ +|||+++....... +.......+++.|+|||++.+..|
T Consensus 464 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~ 516 (613)
T 2ozo_A 464 ARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516 (613)
T ss_dssp GGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCC
T ss_pred HHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCC
Confidence 999999999988 99999987643321 122222345688999999976554
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=8.9e-27 Score=258.90 Aligned_cols=179 Identities=29% Similarity=0.390 Sum_probs=141.5
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..+.+..++|.+.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+ |
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~-------------------------E 229 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQ-------------------------E 229 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC-HHHHHH-------------------------H
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC-HHHHHH-------------------------H
Confidence 3456677889999999999999999999975 467999998653321 233444 5
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.+|+.++||||+++++++.+ +..++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||
T Consensus 230 ~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp 308 (452)
T 1fmk_A 230 AQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 308 (452)
T ss_dssp HHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 999999999999999999865 6799999999999999999743 24589999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++.+ +|||+++...... +.......++..|+|||++.+..|
T Consensus 309 ~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 358 (452)
T 1fmk_A 309 ANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF 358 (452)
T ss_dssp GGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCC
T ss_pred hhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCC
Confidence 99999999888 9999998765432 222233456788999999876554
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=241.17 Aligned_cols=180 Identities=28% Similarity=0.412 Sum_probs=145.2
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEE----cCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTH----RETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNL 547 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~----~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~ 547 (681)
...++....|+..+.||+|+||.||++.+ ..+++.||+|.+.... ......+.+
T Consensus 24 ~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~--------------------- 82 (318)
T 3lxp_A 24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ--------------------- 82 (318)
T ss_dssp CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHH---------------------
T ss_pred CCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHH---------------------
Confidence 34445555569999999999999988764 4578999999987543 233333433
Q ss_pred cchHHHHHHHhCCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy5063 548 HCFSQVAVLRSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 625 (681)
Q Consensus 548 ~~~~Ei~iL~~L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~II 625 (681)
|+++|+.++||||+++++++.+ ...+++||||+++|+|.+++... .+++..+..++.|++.||.|||+++|+
T Consensus 83 ----E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~iv 156 (318)
T 3lxp_A 83 ----EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHYI 156 (318)
T ss_dssp ----HHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred ----HHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 5999999999999999999987 46899999999999999999764 389999999999999999999999999
Q ss_pred ccCCCCCcEEEecCCCe--EEeeeeeEeeecccc-eeeeecCCCccccchhhccCCC
Q psy5063 626 HRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPY-TLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~-~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||||||+|||++.++.+ +|||+++........ .......+|..|+|||++.+..
T Consensus 157 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 213 (318)
T 3lxp_A 157 HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213 (318)
T ss_dssp CSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE
T ss_pred CCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC
Confidence 99999999999999988 999999887643322 1223445788899999987654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=235.00 Aligned_cols=169 Identities=25% Similarity=0.357 Sum_probs=141.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..|...+.||+|+||.||+|.+..++..||+|.+... .....+.+.+ |+.+|+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~-------------------------e~~~l~ 80 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE-------------------------EAEMLK 80 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHH-------------------------HHHHHT
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHH-------------------------HHHHHH
Confidence 3478888999999999999999999999999998653 2333333333 599999
Q ss_pred hCCCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCC
Q psy5063 558 SLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNS 631 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~--IIHRDLKp 631 (681)
.++||||+++++++.. ...+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++ |+||||||
T Consensus 81 ~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp 159 (290)
T 1t4h_A 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKC 159 (290)
T ss_dssp TCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCG
T ss_pred hCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCH
Confidence 9999999999999875 45699999999999999999764 35899999999999999999999999 99999999
Q ss_pred CcEEEe-cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 632 QNCLVR-EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 632 ~NILl~-~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|||++ .++.+ +|||++....... .....||+.|+|||++.+.
T Consensus 160 ~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~ 205 (290)
T 1t4h_A 160 DNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEEK 205 (290)
T ss_dssp GGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGTC
T ss_pred HHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHhcc
Confidence 999998 67777 9999997544322 2335689999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-26 Score=238.48 Aligned_cols=178 Identities=22% Similarity=0.302 Sum_probs=142.3
Q ss_pred ceecCCCeeecc-eecccCcEEEEEEEE--cCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 475 RIFRASDLVRGP-LLGQGFFGQVYRVTH--RETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 475 ~~~~~~d~~~~~-~LG~G~FG~Vyk~~~--~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
..+..++|.+.+ .||+|+||.||+|.+ ..+++.||+|.+..... ...+.+.
T Consensus 11 ~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------------------------ 66 (291)
T 1xbb_A 11 VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL------------------------ 66 (291)
T ss_dssp CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHH------------------------
T ss_pred eeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHH------------------------
Confidence 345567888888 999999999999954 56678999999865321 1122333
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
+|+.+++.++||||+++++++ ..+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||
T Consensus 67 -~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~di 143 (291)
T 1xbb_A 67 -AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDL 143 (291)
T ss_dssp -HHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred -HHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeEcCCC
Confidence 459999999999999999999 6678999999999999999998654 5999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||+|||++.++.+ +|||+++......... ......++..|+|||++.+..
T Consensus 144 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 196 (291)
T 1xbb_A 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196 (291)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE
T ss_pred CcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC
Confidence 9999999999987 9999998775433221 122234678899999986543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.5e-26 Score=238.91 Aligned_cols=169 Identities=28% Similarity=0.435 Sum_probs=141.2
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC----HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD----EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~----~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
|..++.||+|+||.||+|.+ +++.+|+|.+.... ....+.+. +|+.+++
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~-------------------------~E~~~l~ 85 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFD-------------------------QEIKVMA 85 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHH-------------------------HHHHHHH
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHH-------------------------HHHHHHH
Confidence 44568999999999999986 58899999986432 22233333 3599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP--GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~--~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
.++||||+++++++.+++..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 86 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil 165 (307)
T 2nru_A 86 KCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL 165 (307)
T ss_dssp HCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred hcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence 999999999999999999999999999999999998743 345899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
++.++.+ +|||+++...............||+.|+|||++.+
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG 209 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC
Confidence 9999988 99999987664333333334568999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=238.15 Aligned_cols=175 Identities=23% Similarity=0.353 Sum_probs=143.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|+..+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+ |+.++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~-------------------------e~~~l 59 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS-------------------------EVNLL 59 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHH-------------------------HHHHH
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHH-------------------------HHHHH
Confidence 468999999999999999999999999999999987532 233333333 59999
Q ss_pred HhCCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccc
Q psy5063 557 RSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDP---GQPLPWGQRVNFARDIAAGMTYLHSMN-----LIH 626 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~---~~~l~~~~~~~i~~QIa~gL~yLHs~~-----IIH 626 (681)
+.++||||+++++++.. ....++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++ |+|
T Consensus 60 ~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH 139 (279)
T 2w5a_A 60 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 139 (279)
T ss_dssp HHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CC
T ss_pred HhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEE
Confidence 99999999999998864 57899999999999999998642 345899999999999999999999999 999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||+|||++.++.+ +|||+++....... ......+++.|+|||++.+..|
T Consensus 140 ~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~ 193 (279)
T 2w5a_A 140 RDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSY 193 (279)
T ss_dssp CCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-C
T ss_pred eccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCC
Confidence 9999999999999988 99999986653221 1123458999999999987654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=251.04 Aligned_cols=175 Identities=23% Similarity=0.344 Sum_probs=133.2
Q ss_pred CeeecceecccCcEEEEEEEEcCCC---eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETG---EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg---~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.|...+.||+|+||.||+|++..++ ..+|+|.+.... ....+.+.+| +.+|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E-------------------------~~il 144 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE-------------------------GIIM 144 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHH-------------------------HTTS
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHH-------------------------HHHH
Confidence 4677899999999999999976433 468999886532 2333444444 8899
Q ss_pred HhCCCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 557 RSLHHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+.++||||+++++++.. ++..++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+||||||+|||
T Consensus 145 ~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 224 (373)
T 3c1x_A 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 224 (373)
T ss_dssp TTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEE
Confidence 99999999999998754 56889999999999999999887667899999999999999999999999999999999999
Q ss_pred EecCCCe--EEeeeeeEeeecccce--eeeecCCCccccchhhccCCCC
Q psy5063 636 VREVGSG--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~g~~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.++.+ +|||+++......... ......+|+.|+|||++.+..|
T Consensus 225 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 273 (373)
T 3c1x_A 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273 (373)
T ss_dssp ECTTCCEEECCC---------------------CCGGGSCHHHHHHCCC
T ss_pred ECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCC
Confidence 9999988 9999998765432111 1123446788999999876654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-26 Score=236.90 Aligned_cols=171 Identities=25% Similarity=0.343 Sum_probs=135.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|...+.||+|+||.||+|.+..+++.||+|.+...+....+.+.+| +++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e-------------------------~~~l~~ 64 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE-------------------------IKIIRR 64 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHH-------------------------HHHHHT
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHH-------------------------HHHHHh
Confidence 4789999999999999999999999999999999977665555555444 999999
Q ss_pred CCCCceeeEEEEEE--------------eCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy5063 559 LHHHNVIRFIGVLY--------------KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNL 624 (681)
Q Consensus 559 L~HpnIV~l~g~~~--------------~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~I 624 (681)
++||||+++++++. .....++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+++|
T Consensus 65 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i 141 (320)
T 2i6l_A 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANV 141 (320)
T ss_dssp CCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCE
Confidence 99999999999873 3478999999997 699999975 358999999999999999999999999
Q ss_pred cccCCCCCcEEEec-CCCe--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccC
Q psy5063 625 IHRDLNSQNCLVRE-VGSG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 625 IHRDLKp~NILl~~-~g~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+||||||+|||++. ++.+ +|||+++....... ........+|..|+|||++.+
T Consensus 142 ~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp BCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred ecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC
Confidence 99999999999985 4455 99999987643211 112223457899999999865
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-27 Score=242.65 Aligned_cols=178 Identities=19% Similarity=0.272 Sum_probs=130.1
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
..+..++|...+.||+|+||.||++.+..+++.||+|.+...... .... +.+|+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~-------------------------~~~e~ 64 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE-------------------------LLKEI 64 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------------------------------
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHH-------------------------HHHHH
Confidence 345678999999999999999999999889999999987543211 1111 23468
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIH 626 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~-------~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIH 626 (681)
.+++.++||||+++++++..++..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+++|+|
T Consensus 65 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 144 (303)
T 2vwi_A 65 QAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH 144 (303)
T ss_dssp -CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 889999999999999999999999999999999999999863 2345899999999999999999999999999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeeccc---ceeeeecCCCccccchhhccC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVP---YTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~---~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|||||+|||++.++.+ +|||+++....... ........+|+.|+|||++.+
T Consensus 145 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp CCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHH
T ss_pred CCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence 9999999999999988 99999876543211 111223468999999999854
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.2e-26 Score=239.64 Aligned_cols=177 Identities=20% Similarity=0.348 Sum_probs=131.0
Q ss_pred ccccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 471 ASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 471 ~~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
....+.+..++|...+.||+|+||.||+|.+..+|+.||+|.+.... ......+..|
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e---------------------- 70 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---------------------- 70 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHH----------------------
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHH----------------------
Confidence 44556677899999999999999999999999999999999997643 3333333333
Q ss_pred hHHHH-HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC----CCCCCCHHHHHHHHHHHHHHHHHHHhC-C
Q psy5063 550 FSQVA-VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD----PGQPLPWGQRVNFARDIAAGMTYLHSM-N 623 (681)
Q Consensus 550 ~~Ei~-iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~----~~~~l~~~~~~~i~~QIa~gL~yLHs~-~ 623 (681)
+. +++.++||||+++++++..++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||++ +
T Consensus 71 ---~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 146 (327)
T 3aln_A 71 ---LDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146 (327)
T ss_dssp ---HHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred ---HHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC
Confidence 44 67788999999999999999999999999975 88877752 245689999999999999999999999 9
Q ss_pred ccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 624 LIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 624 IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
|+||||||+|||++.++.+ +|||+++....... .....||+.|+|||++.
T Consensus 147 ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERID 198 (327)
T ss_dssp CCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------
T ss_pred EeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeec
Confidence 9999999999999999988 99999987654321 22346899999999983
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-26 Score=242.58 Aligned_cols=175 Identities=21% Similarity=0.264 Sum_probs=139.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|.+.+.||+|+||.||+|++..+++.||+|.+............. .....+.+|+++|+.+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-----------------~~~~~~~~E~~~l~~l 72 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREA-----------------DPALNVETEIEILKKL 72 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC--------------------------------CHHHHHHHHHHC
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccc-----------------hhhhhHHHHHHHHHhC
Confidence 57899999999999999999999999999999986532211000000 0011235679999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++++++..+. .|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 73 ~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 73 NHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp CCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred CCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecC
Confidence 9999999999987654 89999999999999998764 459999999999999999999999999999999999999987
Q ss_pred CC---e--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 640 GS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 640 g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+. + +|||+++...... ......||+.|+|||++.
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp SSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHH
T ss_pred CCCCeEEEccCccceeccccc---ccccccCCcCccCchhhc
Confidence 65 4 9999998765322 112345899999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=236.66 Aligned_cols=177 Identities=25% Similarity=0.372 Sum_probs=144.6
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.+.+..++|...+.||+|+||.||+|.+. ++..||+|.+...... .+.+. +|+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~-------------------------~E~ 59 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS-PDAFL-------------------------AEA 59 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC-HHHHH-------------------------HHH
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc-HHHHH-------------------------HHH
Confidence 45566788999999999999999999976 5778999988653321 22333 359
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
++|+.++||||+++++++. ++..++||||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+
T Consensus 60 ~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~ 138 (279)
T 1qpc_A 60 NLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138 (279)
T ss_dssp HHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHh
Confidence 9999999999999999986 456899999999999999997542 25899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||++.++.+ +|||+++...... ........++..|+|||++.+..
T Consensus 139 Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~ 186 (279)
T 1qpc_A 139 NILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGT 186 (279)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCE
T ss_pred hEEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhhhccCC
Confidence 9999999988 9999998765422 22222344678899999986543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=246.12 Aligned_cols=170 Identities=18% Similarity=0.249 Sum_probs=139.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|.+.+.||+|+||.||+|++..+++.||+|.+... ....+.+.+ |+.+|+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~-------------------------E~~~l~~ 89 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALD-------------------------EIRLLKS 89 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHH-------------------------HHHHHHH
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHH-------------------------HHHHHHH
Confidence 57899999999999999999999999999999998643 222333333 4777777
Q ss_pred CC--------CCceeeEEEEEE----eCCeEEEEEeccCCCCHHHHHh-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q psy5063 559 LH--------HHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQ-DPGQPLPWGQRVNFARDIAAGMTYLHSM-NL 624 (681)
Q Consensus 559 L~--------HpnIV~l~g~~~----~~~~l~LV~Ey~~gGsL~~~L~-~~~~~l~~~~~~~i~~QIa~gL~yLHs~-~I 624 (681)
++ |+||+++++++. ....+++||||+ +++|.+++. .....+++..+..++.||+.||.|||++ ||
T Consensus 90 l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~gi 168 (397)
T 1wak_A 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRI 168 (397)
T ss_dssp HHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred HhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 74 888999999997 456899999999 556655554 4345699999999999999999999998 99
Q ss_pred cccCCCCCcEEEecCC-------------------------------------------------Ce--EEeeeeeEeee
Q psy5063 625 IHRDLNSQNCLVREVG-------------------------------------------------SG--FDFHLGQIYLI 653 (681)
Q Consensus 625 IHRDLKp~NILl~~~g-------------------------------------------------~~--~DFGLa~~~~~ 653 (681)
+||||||+|||++.++ .+ +|||+++....
T Consensus 169 vHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~ 248 (397)
T 1wak_A 169 IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK 248 (397)
T ss_dssp ECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB
T ss_pred ecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc
Confidence 9999999999999875 45 99999987653
Q ss_pred cccceeeeecCCCccccchhhccCCCC
Q psy5063 654 YVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 654 ~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
. .....||+.|+|||++.+..|
T Consensus 249 ~-----~~~~~gt~~y~aPE~~~~~~~ 270 (397)
T 1wak_A 249 H-----FTEDIQTRQYRSLEVLIGSGY 270 (397)
T ss_dssp C-----SCSCCSCGGGCCHHHHHTSCC
T ss_pred c-----CccCCCCCcccCChhhcCCCC
Confidence 2 233568999999999987765
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-26 Score=249.88 Aligned_cols=169 Identities=15% Similarity=-0.015 Sum_probs=124.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH---HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE---EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~---~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.+|...+.||+|+||.||+|++..+++.||+|++..... .....+.+|. ..+..|
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~----------------------~~~~~l 119 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEAT----------------------FAAARL 119 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHH----------------------HHHHHH
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHH----------------------HHHHHh
Confidence 358899999999999999999999999999999977542 2222233331 114556
Q ss_pred HhCCCCceeeEE-------EEEEeC-----------------CeEEEEEeccCCCCHHHHHhCCCCCCCHHHH------H
Q psy5063 557 RSLHHHNVIRFI-------GVLYKD-----------------RKLNLVTEYIAGGTLKELLQDPGQPLPWGQR------V 606 (681)
Q Consensus 557 ~~L~HpnIV~l~-------g~~~~~-----------------~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~------~ 606 (681)
+. +||||++++ +++..+ ..+|+||||++ |+|.+++...+..+++..+ .
T Consensus 120 ~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~ 197 (371)
T 3q60_A 120 LG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALH 197 (371)
T ss_dssp HC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHH
T ss_pred cc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHH
Confidence 66 799988865 555443 34899999998 8999999864444555555 6
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 607 ~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
.++.||+.||+|||+++|+||||||+|||++.+|.+ +|||+|+..... .....+|+.|+|||++.+
T Consensus 198 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 198 ILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNA 265 (371)
T ss_dssp HHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTC
T ss_pred HHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccC
Confidence 778999999999999999999999999999999988 999999865421 113457799999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-26 Score=240.27 Aligned_cols=168 Identities=25% Similarity=0.423 Sum_probs=136.6
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH--
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR-- 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~-- 557 (681)
++|++.+.||+|+||.||+|++. ++.||+|.+...... .+..+ .+++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~---~~~~e-------------------------~~~~~~~ 86 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEA---SWFRE-------------------------TEIYQTV 86 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHH---HHHHH-------------------------HHHHTST
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccc---hhhhH-------------------------HHHHHHH
Confidence 57999999999999999999886 899999998654321 22222 33343
Q ss_pred hCCCCceeeEEEEEEeC----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------Ccc
Q psy5063 558 SLHHHNVIRFIGVLYKD----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM--------NLI 625 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~--------~II 625 (681)
.++||||+++++++... ...++||||+++|+|.+++... .+++..+..++.|++.||.|||++ +|+
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 164 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIA 164 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEE
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEE
Confidence 35999999999999887 7899999999999999999764 489999999999999999999999 999
Q ss_pred ccCCCCCcEEEecCCCe--EEeeeeeEeeeccccee--eeecCCCccccchhhccCCC
Q psy5063 626 HRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTL--FILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~--~~~~~gt~~Y~APEvL~~~~ 679 (681)
||||||+|||++.++.+ +|||+++.......... .....||+.|+|||++.+..
T Consensus 165 H~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 222 (337)
T 3mdy_A 165 HRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222 (337)
T ss_dssp CSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC
T ss_pred ecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc
Confidence 99999999999999988 99999987654332211 12346899999999997654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-26 Score=240.70 Aligned_cols=172 Identities=24% Similarity=0.322 Sum_probs=140.0
Q ss_pred Ceeec-ceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRG-PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~-~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.|.+. +.||+|+||.||+|++..+++.||+|.+..... .....+ .+|+.+++
T Consensus 29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~-------------------------~~e~~~l~ 83 (327)
T 3lm5_A 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEI-------------------------LHEIAVLE 83 (327)
T ss_dssp HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHH-------------------------HHHHHHHH
T ss_pred EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHH-------------------------HHHHHHHH
Confidence 45554 889999999999999999999999999865321 112233 34588899
Q ss_pred hC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 558 SL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 558 ~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
.+ +||||+++++++.+.+..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||
T Consensus 84 ~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl 163 (327)
T 3lm5_A 84 LAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163 (327)
T ss_dssp HTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred hccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEE
Confidence 88 5799999999999999999999999999999998653 356999999999999999999999999999999999999
Q ss_pred Eec---CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VRE---VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~---~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++. ++.+ +|||+++....... .....||+.|+|||++.+..|
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 210 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPI 210 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCC
T ss_pred EecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCC
Confidence 998 6666 99999987654322 233569999999999987665
|
| >2jtn_A LIM domain-binding protein 1, LIM/homeobox protein LHX3; intramolecular (fusion) protein-protein complex, protein binding/transcription complex; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=227.47 Aligned_cols=124 Identities=32% Similarity=0.754 Sum_probs=113.0
Q ss_pred CCCCCccccccccccccCceEEecCccccccCcccccCcCccCCceEeeCCeeeeccccccccCCcccccCCcccc--Ce
Q psy5063 5 ETPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSG--PV 82 (681)
Q Consensus 5 ~~~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~g--~~ 82 (681)
.....+.|++|+++|.+.+++.|+++.||++||+|..|+++|.+.+|.+||++||+.||.++|+++|.+|+++|.+ .+
T Consensus 56 ~~~~~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~f~~~g~~yC~~~y~~~f~~kC~~C~~~I~~~~~v 135 (182)
T 2jtn_A 56 GTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQVV 135 (182)
T ss_dssp CCCSCCBCBTSSSBCCCSEEEEETTEEECSSTTSCTTTCCCCSSCCEEETTEEECHHHHHHTTSCCCTTTCCCCCSSCCC
T ss_pred CCCCCCcCccCCCCccCceeEEecCCeEccccCccCCCCCccCCCceeECCEeeecCccccccccccccCCCccCCCceE
Confidence 3455689999999999877889999999999999999999998877899999999999999999999999999975 36
Q ss_pred EEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhc
Q psy5063 83 MVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQM 128 (681)
Q Consensus 83 ~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~ 128 (681)
+.|.++.||++||+|..|++.|..|+.|+...++++||..||++++
T Consensus 136 ~~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~~g~~yC~~cy~~~~ 181 (182)
T 2jtn_A 136 RRAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYETAK 181 (182)
T ss_dssp CEETTEECCTTTCCCTTTCCCCCTTCEEEECTTSCEECHHHHHHHT
T ss_pred EecCCCCEEeCCCcCCCCCCCCCCCCceEEccCCEEECHHHHHHhh
Confidence 7899999999999999999999888888887788899999998754
|
| >2xjy_A Rhombotin-2; oncoprotein, T-cell leukemia, proto-oncogene, transcription, developmental protein; 2.40A {Homo sapiens} PDB: 2xjz_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-27 Score=217.35 Aligned_cols=122 Identities=32% Similarity=0.710 Sum_probs=111.4
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccC---CceEeeCCeeeeccccccccCC--cccccCCcccc--C
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD---NWYFEKDGLLFCKEDYNGKYGE--ACQNCGQMMSG--P 81 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~---~~~~~~dg~~yC~~cY~~~f~~--~C~~C~~~I~g--~ 81 (681)
.+.|++|+++|.+.+.+.|+++.||++||+|+.|+.+|+ ..||.+||++||+.||.++|++ +|..|+++|.+ .
T Consensus 2 ~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~g~~yC~~~y~~~~~~~~~C~~C~~~I~~~e~ 81 (131)
T 2xjy_A 2 LLTCGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLRLFGQDGLCASCDKRIRAYEM 81 (131)
T ss_dssp CCBBTTTCCBCCSSEEEEETTEEEETTTCBCTTTCCBCSSTTCCEEEETTEEECHHHHHHHHCCCEECTTTCCEECTTSE
T ss_pred cccCcCCCCEeCCcEEEEECCCcccHHHcccCcCCCccccCCCeEEEECCEEeecCchhhhCCCccChhhcCCccCccce
Confidence 478999999998777899999999999999999999995 3799999999999999999999 99999999975 5
Q ss_pred eEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCC
Q psy5063 82 VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPL 131 (681)
Q Consensus 82 ~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~ 131 (681)
+|.|.++.||++||+|..|+++|..|+.|+.. ++++||..||+++++++
T Consensus 82 ~~~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~-~~~~~C~~c~~~~~~~~ 130 (131)
T 2xjy_A 82 TMRVKDKVYHLECFKCAACQKHFCVGDRYLLI-NSDIVCEQDIYEWTKIN 130 (131)
T ss_dssp EEEETTEEEEGGGCBCTTTCCBCCTTCEEEEE-TTEEEEGGGHHHHHHHH
T ss_pred eEeeCCceECccCcccCCCCCCCCCCCEEEEE-CCEEEcHHHHHHHhhcc
Confidence 78999999999999999999999778878765 57899999999988764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-27 Score=255.25 Aligned_cols=168 Identities=18% Similarity=0.190 Sum_probs=134.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc---CHHHHHHHHHHhhccceeeeccCCCCccccccchHHH--
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV---DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV-- 553 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~---~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei-- 553 (681)
.++|...+.||+|+||.||+|++..+|+.||+|.+... .....+.+.+| +
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E-------------------------~~~ 126 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE-------------------------VLR 126 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHH-------------------------HHG
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHH-------------------------HHH
Confidence 46799999999999999999999999999999998743 23334444444 6
Q ss_pred -HHHHhCCCCceeeEE-------EEEEeCC-----------------eEEEEEeccCCCCHHHHHhCCCC------CCCH
Q psy5063 554 -AVLRSLHHHNVIRFI-------GVLYKDR-----------------KLNLVTEYIAGGTLKELLQDPGQ------PLPW 602 (681)
Q Consensus 554 -~iL~~L~HpnIV~l~-------g~~~~~~-----------------~l~LV~Ey~~gGsL~~~L~~~~~------~l~~ 602 (681)
.+|+.++||||++++ +++..++ ..|+||||+ +|+|.+++..... .+++
T Consensus 127 l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~ 205 (377)
T 3byv_A 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVH 205 (377)
T ss_dssp GGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHH
T ss_pred HHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccH
Confidence 456667899999998 7766553 289999999 6899999975321 2335
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 603 ~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
..+..++.||+.||+|||+++|+||||||+|||++.+|.+ +|||+++.... ......| +.|+|||++.+.
T Consensus 206 ~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 206 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhccc
Confidence 8888899999999999999999999999999999999988 99999985332 2334557 999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=248.85 Aligned_cols=170 Identities=21% Similarity=0.277 Sum_probs=141.5
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
..+|++.+.||+|+||.||+|.+..+++.||+|++... ......+..| +.+++.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E-------------------------~~~l~~ 149 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEE-------------------------IRILEH 149 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHH-------------------------HHHHHH
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHH-------------------------HHHHHH
Confidence 46799999999999999999999999999999998643 2223333333 555554
Q ss_pred C------CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 559 L------HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 559 L------~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+ +|+||+++++++...+.+++||||++ ++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 150 l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp 228 (429)
T 3kvw_A 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKP 228 (429)
T ss_dssp HHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSG
T ss_pred HhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 4 68899999999999999999999996 69999887543 4599999999999999999999999999999999
Q ss_pred CcEEEecCCC--e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGS--G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~--~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++. + +|||+++..... .....+|+.|+|||++.+..|
T Consensus 229 ~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 276 (429)
T 3kvw_A 229 ENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARY 276 (429)
T ss_dssp GGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCC
T ss_pred HHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCC
Confidence 9999999987 5 999999764422 223568999999999987765
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.9e-26 Score=238.62 Aligned_cols=168 Identities=23% Similarity=0.398 Sum_probs=134.6
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|+..+.||+|+||.||++++. ++.||+|.+.... ..+.+.+ |+.+|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~-------------------------E~~~l 55 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES--ERKAFIV-------------------------ELRQL 55 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT--HHHHHHH-------------------------HHHHH
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh--HHHHHHH-------------------------HHHHH
Confidence 45678999999999999999999985 7899999885432 2233444 48999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQ--PLPWGQRVNFARDIAAGMTYLHS---MNLIHRDLNS 631 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~--~l~~~~~~~i~~QIa~gL~yLHs---~~IIHRDLKp 631 (681)
+.++||||+++++++. +..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+ ++|+||||||
T Consensus 56 ~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp 133 (307)
T 2eva_A 56 SRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133 (307)
T ss_dssp HHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSG
T ss_pred hcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCCh
Confidence 9999999999999876 348999999999999999986542 47889999999999999999999 8999999999
Q ss_pred CcEEEecCCC-e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGS-G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~-~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++. + +|||+++...... ....||+.|+|||++.+..|
T Consensus 134 ~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~ 180 (307)
T 2eva_A 134 PNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNY 180 (307)
T ss_dssp GGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCC
T ss_pred hHEEEeCCCCEEEEccccccccccccc-----ccCCCCCceEChhhhCCCCC
Confidence 9999999886 3 9999998664322 23458999999999987654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.6e-26 Score=237.94 Aligned_cols=171 Identities=27% Similarity=0.430 Sum_probs=139.3
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|++.+.||+|+||.||+|++..+++.||+|.+...... ...+. +|+.+++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~-------------------------~e~~~l~ 75 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIK-------------------------QEINMLK 75 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST-THHHH-------------------------HHHHHHH
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc-HHHHH-------------------------HHHHHHH
Confidence 467899999999999999999999999999999998653321 12233 3588899
Q ss_pred hC-CCCceeeEEEEEEe------CCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 558 SL-HHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 558 ~L-~HpnIV~l~g~~~~------~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
.+ +||||+++++++.. .+.+++||||+++|+|.+++... ...+++..+..++.|++.||.|||+++|+||||
T Consensus 76 ~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dl 155 (326)
T 2x7f_A 76 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 155 (326)
T ss_dssp HHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred hccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 88 89999999999987 56899999999999999999754 246899999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
||+|||++.++.+ +|||++....... .......+|+.|+|||++.
T Consensus 156 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 156 KGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp SGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC
T ss_pred cHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhc
Confidence 9999999999988 9999998765322 1223356899999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=9.7e-26 Score=242.63 Aligned_cols=172 Identities=20% Similarity=0.303 Sum_probs=143.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|+..+.||+|+||.||++++..+++.||+|.+.... ......+. +|+++|+
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~E~~~l~ 80 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-------------------------REIKILL 80 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHH-------------------------HHHHHHH
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHH-------------------------HHHHHHH
Confidence 468999999999999999999999999999999986533 22223333 4599999
Q ss_pred hCCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 558 SLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.++||||+++++++... ...|+||||++ |+|.+++... .+++..+..++.|++.||.|||++||+||||||+
T Consensus 81 ~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 157 (364)
T 3qyz_A 81 RFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 157 (364)
T ss_dssp HCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChH
Confidence 99999999999999754 47999999997 5999999763 4999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeeccccee-eeecCCCccccchhhccCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTL-FILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~-~~~~~gt~~Y~APEvL~~~ 678 (681)
|||++.++.+ +|||+++.......... .....||+.|+|||++.+.
T Consensus 158 NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 206 (364)
T 3qyz_A 158 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206 (364)
T ss_dssp GEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTB
T ss_pred hEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCC
Confidence 9999999988 99999987764332221 2334689999999987543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=238.35 Aligned_cols=172 Identities=27% Similarity=0.388 Sum_probs=137.6
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|++.+.||+|+||.||+|++ +++.||+|.+...... .+..+ .|+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~e-----------------------~~~~~ 60 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ---NFINE-----------------------KNIYR 60 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH---HHHHH-----------------------HHHHT
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh---hHHHH-----------------------HHHHH
Confidence 46678999999999999999999976 5899999998654322 22222 12444
Q ss_pred HHhCCCCceeeEEEEEEe-----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------
Q psy5063 556 LRSLHHHNVIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-------- 622 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~-----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~-------- 622 (681)
++.++||||+++++.+.. ...+++||||+++|+|.+++.... .++..+..++.|++.||.|||++
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~ 138 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLHTELPRGDHYK 138 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCB
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 556899999999986643 236799999999999999997643 68999999999999999999999
Q ss_pred -CccccCCCCCcEEEecCCCe--EEeeeeeEeeeccc------ceeeeecCCCccccchhhccC
Q psy5063 623 -NLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVP------YTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 623 -~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~------~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|+||||||+|||++.++.+ +|||+++....... ........||+.|+|||++.+
T Consensus 139 ~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 139 PAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp CCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred cceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 99999999999999999988 99999987653211 112224569999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=239.14 Aligned_cols=171 Identities=25% Similarity=0.365 Sum_probs=141.1
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|.+.+.||+|+||.||+|++..+|+.||+|.+.... ......+. +|+.+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~-------------------------~E~~~l~ 64 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-------------------------REIKILK 64 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHH-------------------------HHHHHHH
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHH-------------------------HHHHHHH
Confidence 468999999999999999999999999999999986533 22233333 3599999
Q ss_pred hCCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 558 SLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.++||||+++++++..+ ...++||||++ |+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+
T Consensus 65 ~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~ 141 (353)
T 2b9h_A 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPS 141 (353)
T ss_dssp HCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred hCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 99999999999998754 68999999997 699999876 35999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccce--------eeeecCCCccccchhhccC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYT--------LFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~--------~~~~~~gt~~Y~APEvL~~ 677 (681)
|||++.++.+ +|||+++......... ......||+.|+|||++.+
T Consensus 142 Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 142 NLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp GEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS
T ss_pred HeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc
Confidence 9999999988 9999998765322111 1223468999999999764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=242.85 Aligned_cols=185 Identities=15% Similarity=0.217 Sum_probs=146.7
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCcc---ccccchHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI---NNLHCFSQV 553 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~---~~~~~~~Ei 553 (681)
...++|...+.||+|+||.||+|.+ +++.||+|.+.......... .......... ....+.+|+
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~E~ 94 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRD-----------FTKSNNDKISIKSKYDDFKNEL 94 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEE-----------ECCCSSSSCCEEEHHHHHHHHH
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhh-----------hccccchhhhHHhHHHHHHHHH
Confidence 3457999999999999999999999 79999999986421110000 0000000000 001234579
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHH------HhCC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL------LQDP-GQPLPWGQRVNFARDIAAGMTYLHS-MNLI 625 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~------L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs-~~II 625 (681)
.+|+.++||||+++++++.+++..++||||+++|+|.++ +... ...+++..+..++.|++.||.|||+ +||+
T Consensus 95 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~ 174 (348)
T 2pml_X 95 QIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC 174 (348)
T ss_dssp HHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEE
T ss_pred HHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEe
Confidence 999999999999999999999999999999999999998 6542 4569999999999999999999999 9999
Q ss_pred ccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 626 HRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
||||||+|||++.++.+ +|||+++..... ......++..|+|||++.+.
T Consensus 175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp CCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSC
T ss_pred ecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCC
Confidence 99999999999999988 999999876532 23445689999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=250.00 Aligned_cols=166 Identities=23% Similarity=0.376 Sum_probs=136.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.+|...++||+|+||.||+|++..+|+.||+|++..... ...+|+++|+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----------------------------~~~~E~~il~~l 104 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------------------------FKNRELQIMRKL 104 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----------------------------SCCHHHHHHHTC
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----------------------------hHHHHHHHHHHc
Confidence 468999999999999999999999999999998854210 113579999999
Q ss_pred CCCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 560 HHHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQ---DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~---~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+||||+++++++... ..+++||||+++ +|.+++. .....+++..+..++.||+.||.|||+++|+|||||
T Consensus 105 ~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk 183 (420)
T 1j1b_A 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK 183 (420)
T ss_dssp CCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCS
T ss_pred CCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 999999999998642 247799999976 6666554 234569999999999999999999999999999999
Q ss_pred CCcEEEecCCC-e--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVREVGS-G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~~g~-~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|+||||+.++. + +|||+++........ ....+|+.|+|||++.+.
T Consensus 184 p~NILl~~~~~~~kl~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~ 231 (420)
T 1j1b_A 184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYICSRYYRAPELIFGA 231 (420)
T ss_dssp GGGEEEETTTTEEEECCCTTCEECCTTCCC---CSCCSCTTSCCHHHHTTC
T ss_pred hhhEEEeCCCCeEEeccchhhhhcccCCCc---eeeeeCCCcCCHHHHcCC
Confidence 99999997653 3 999999976543322 235689999999999765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=236.05 Aligned_cols=173 Identities=28% Similarity=0.423 Sum_probs=136.9
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.+.+..++|+..+.||+|+||.||++.+. |+.||+|.+.... ..+.+.+ |+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~-------------------------E~ 65 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLA-------------------------EA 65 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHH-------------------------TH
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHH-------------------------HH
Confidence 34566789999999999999999999875 8899999886433 2233334 48
Q ss_pred HHHHhCCCCceeeEEEEEEeC-CeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~-~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
.+++.++||||+++++++... +..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||
T Consensus 66 ~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp 145 (278)
T 1byg_A 66 SVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAA 145 (278)
T ss_dssp HHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCc
Confidence 999999999999999997654 57999999999999999997542 2378999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++.+ +|||+++...... ....+++.|+|||++.+..|
T Consensus 146 ~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~ 191 (278)
T 1byg_A 146 RNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF 191 (278)
T ss_dssp GGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC
T ss_pred ceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCC
Confidence 99999999988 9999998655322 22357889999999876544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=9.9e-26 Score=241.47 Aligned_cols=169 Identities=21% Similarity=0.298 Sum_probs=133.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-----------HHHHHHHHHhhccceeeeccCCCCccccc
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-----------EAEKNFLKESKQGLIYLIDLGSHGLINNL 547 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-----------~~~~~~~~E~k~~~~~~~~~~~~~~~~~~ 547 (681)
.++|.+++.||+|+||.||+|.+.. |+.||+|++..... ...+.+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~----------------------- 76 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRV----------------------- 76 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHH-----------------------
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHH-----------------------
Confidence 5789999999999999999999865 89999998854221 111222
Q ss_pred cchHHHHHHHhCCCCceeeEEEEEEe-----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy5063 548 HCFSQVAVLRSLHHHNVIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM 622 (681)
Q Consensus 548 ~~~~Ei~iL~~L~HpnIV~l~g~~~~-----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~ 622 (681)
.+|+++|+.++||||+++++++.. ...+|+||||++ |+|.+++......+++..+..++.|++.||.|||++
T Consensus 77 --~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 153 (362)
T 3pg1_A 77 --LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA 153 (362)
T ss_dssp --HHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred --HHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456999999999999999999854 247899999997 689888887666799999999999999999999999
Q ss_pred CccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 623 NLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|+||||||+|||++.++.+ +|||+++....... .....+|+.|+|||++.+
T Consensus 154 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 154 GVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp TCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTT
T ss_pred cCEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcC
Confidence 99999999999999999988 99999986554322 223568999999999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=233.14 Aligned_cols=174 Identities=20% Similarity=0.200 Sum_probs=140.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|++..+++.||+|.+...... . .+.+|+.+++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~-------------------------~~~~e~~~l~~ 60 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--P-------------------------QLHIESKIYKM 60 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--C-------------------------CHHHHHHHHHH
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--h-------------------------HHHHHHHHHHH
Confidence 46899999999999999999999999999999976432111 1 12346889999
Q ss_pred CCCCceeeEEEEE-EeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-
Q psy5063 559 LHHHNVIRFIGVL-YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV- 636 (681)
Q Consensus 559 L~HpnIV~l~g~~-~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl- 636 (681)
++|++++..++.+ ...+..++||||+ +++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 61 MQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp HTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred hcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 9887776665554 6778899999999 999999998655679999999999999999999999999999999999999
Q ss_pred --ecCCCe--EEeeeeeEeeecccc-----eeeeecCCCccccchhhccCCCC
Q psy5063 637 --REVGSG--FDFHLGQIYLIYVPY-----TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 --~~~g~~--~DFGLa~~~~~~~~~-----~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++.+ +|||+++........ .......||+.|+|||++.+..|
T Consensus 140 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 192 (296)
T 4hgt_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 192 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC
T ss_pred ccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCC
Confidence 777877 999999987654321 12234568999999999987665
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=231.63 Aligned_cols=174 Identities=20% Similarity=0.199 Sum_probs=142.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+..+.||+|+||.||+|++..+++.||+|.+...... ..+ .+|+.+++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~-------------------------~~e~~~l~~ 60 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQL-------------------------HIESKIYKM 60 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHH-------------------------HHHHHHHHH
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHH-------------------------HHHHHHHHH
Confidence 57899999999999999999999999999999987543211 112 345889999
Q ss_pred CCCCceeeEEEEE-EeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHHHNVIRFIGVL-YKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~HpnIV~l~g~~-~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++|++++..+..+ ...+..++||||+ +++|.+++......+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 61 l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 139 (296)
T 3uzp_A 61 MQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp HTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred hhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence 9888766655554 6678899999999 9999999986556799999999999999999999999999999999999994
Q ss_pred ---cCCCe--EEeeeeeEeeecccc-----eeeeecCCCccccchhhccCCCC
Q psy5063 638 ---EVGSG--FDFHLGQIYLIYVPY-----TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ---~~g~~--~DFGLa~~~~~~~~~-----~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||+++........ .......||+.|+|||++.+..|
T Consensus 140 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 192 (296)
T 3uzp_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 192 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC
T ss_pred cCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCC
Confidence 77777 999999987654321 11234568999999999987654
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=240.76 Aligned_cols=180 Identities=23% Similarity=0.342 Sum_probs=140.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++|.+++.||+|+||.||+|.+..+++.||+|.+............. ...+.+|+.++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~-------------------~~~~~~e~~~l 88 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSD-------------------SVTCPLEVALL 88 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC---------------------------CCCCHHHHHH
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchh-------------------hHHHHHHHHHH
Confidence 34578999999999999999999999999999999986543222111111 12345678999
Q ss_pred HhC----CCCceeeEEEEEEeCCeEEEEEec-cCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 557 RSL----HHHNVIRFIGVLYKDRKLNLVTEY-IAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 557 ~~L----~HpnIV~l~g~~~~~~~l~LV~Ey-~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.+ +||||+++++++..++..++|||| +++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||
T Consensus 89 ~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 167 (312)
T 2iwi_A 89 WKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKD 167 (312)
T ss_dssp HHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSG
T ss_pred HhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh
Confidence 988 899999999999999999999999 78999999997643 599999999999999999999999999999999
Q ss_pred CcEEEe-cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVR-EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~-~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++ .++.+ +|||+++...... .....++..|+|||++.+..|
T Consensus 168 ~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~ 215 (312)
T 2iwi_A 168 ENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQY 215 (312)
T ss_dssp GGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCB
T ss_pred hhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCC
Confidence 999999 77776 9999998775432 233568999999999876544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=242.32 Aligned_cols=165 Identities=23% Similarity=0.338 Sum_probs=137.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||+|.+..+|+.||+|++.... ....+.+. +|+.++
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------~E~~~l 95 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-------------------------RELLLL 95 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHH-------------------------HHHHHH
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHH-------------------------HHHHHH
Confidence 478999999999999999999999999999999986532 22233333 459999
Q ss_pred HhCCCCceeeEEEEEEeCCeE------EEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKL------NLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l------~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++...+.. ++||||++ ++|.+++.. .+++..+..++.|++.||.|||+++|+|||||
T Consensus 96 ~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 171 (371)
T 4exu_A 96 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK 171 (371)
T ss_dssp HHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcC
Confidence 999999999999999877654 99999997 689888753 48999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|+|||++.++.+ +|||+++..... .....+|+.|+|||++.+
T Consensus 172 p~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 172 PGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp GGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSC
T ss_pred HHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcC
Confidence 999999999988 999999866432 233568999999999876
|
| >2rgt_A Fusion of LIM/homeobox protein LHX3, linker, INSU enhancer protein ISL-1; protein-protein complex, LIM domain, Zn finger, activator, D binding; 2.05A {Mus musculus} PDB: 3mmk_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=224.39 Aligned_cols=125 Identities=33% Similarity=0.758 Sum_probs=112.3
Q ss_pred CCCCccccccccccccCceEEecCccccccCcccccCcCccCCceEeeCCeeeeccccccccCCcccccCCccccC--eE
Q psy5063 6 TPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGP--VM 83 (681)
Q Consensus 6 ~~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~g~--~~ 83 (681)
+++.+.|++|+++|.+.+++.|+|+.||++||+|+.|+.+|++.+|++||++||+.||.++|+++|.+|+++|.+. ++
T Consensus 3 ~~~~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~f~~~g~~yC~~~y~~~f~~~C~~C~~~I~~~~~v~ 82 (169)
T 2rgt_A 3 TPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAERCFSRGESVYCKDDFFKRFGTKCAACQLGIPPTQVVR 82 (169)
T ss_dssp ----CBBSSSSSBCCSSSCEECSSCEECTTTSBCTTTCCBCCSCCEESSSCEECHHHHHHHHSCBCTTTCCBCCTTSEEE
T ss_pred CCCCCccccCCCccCCcEEEEECCcEEccccCccCCCCCcCCCCCcccCCeeeecccccccccccccccccccCCCcEEE
Confidence 3456899999999998778999999999999999999999988778999999999999999999999999999753 67
Q ss_pred EecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCC
Q psy5063 84 VVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130 (681)
Q Consensus 84 ~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p 130 (681)
.|.++.||++||+|..|++.|..|+.|+...++++||..||++.++.
T Consensus 83 ~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~~g~~~C~~c~~~~~~~ 129 (169)
T 2rgt_A 83 RAQDFVYHLHCFACVVCKRQLATGDEFYLMEDSRLVCKADYETAKQG 129 (169)
T ss_dssp EETTEEEEGGGCBCTTTCCBCCTTCEEEECTTSCEEEHHHHHHHHHC
T ss_pred EcCCceEeeCCCcCCCCCCCCCCCCceEEccCCeEECHHHHHHHhhc
Confidence 89999999999999999999987888888778889999999988765
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=234.53 Aligned_cols=170 Identities=19% Similarity=0.283 Sum_probs=139.8
Q ss_pred CCCeeecceecccCcEEEEEEEE-cCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTH-RETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~-~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|++.+.||+|+||.||++.+ ..+++.||+|.+.... .....+.+ |+.+++
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~-------------------------e~~~l~ 66 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARS-------------------------EIQVLE 66 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHH-------------------------HHHHHH
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHH-------------------------HHHHHH
Confidence 56899999999999999999998 5678999999986432 22233333 466676
Q ss_pred hCCCC------ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 558 SLHHH------NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 558 ~L~Hp------nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
.++|+ +|+++++++...+..++||||+ +++|.+++.... .++++..+..++.|++.||+|||+++|+|||||
T Consensus 67 ~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 145 (339)
T 1z57_A 67 HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLK 145 (339)
T ss_dssp HHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 66554 5999999999999999999999 889999987643 368999999999999999999999999999999
Q ss_pred CCcEEEec-------------------CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVRE-------------------VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~-------------------~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++. ++.+ +|||+++..... .....||+.|+|||++.+..|
T Consensus 146 p~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 211 (339)
T 1z57_A 146 PENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGW 211 (339)
T ss_dssp GGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCC
T ss_pred HHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCC
Confidence 99999987 4455 999999864422 223568999999999987664
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=262.01 Aligned_cols=179 Identities=29% Similarity=0.390 Sum_probs=146.6
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
..+.+..++|.+.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+ |
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~-------------------------E 312 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS-PEAFLQ-------------------------E 312 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC-HHHHHH-------------------------H
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC-HHHHHH-------------------------H
Confidence 4456777899999999999999999999975 467999998653321 233444 5
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+++|+.++||||+++++++.+ +.+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||
T Consensus 313 ~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 391 (535)
T 2h8h_A 313 AQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRA 391 (535)
T ss_dssp HHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCH
Confidence 999999999999999999865 6799999999999999999753 24589999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+||||+.++.+ +|||+++...... +.......++..|+|||++.+..|
T Consensus 392 ~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~ 441 (535)
T 2h8h_A 392 ANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF 441 (535)
T ss_dssp GGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCC
T ss_pred hhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCC
Confidence 99999999887 9999998765321 122223446788999999876554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=239.56 Aligned_cols=168 Identities=26% Similarity=0.349 Sum_probs=121.8
Q ss_pred CCCeeec-ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRG-PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~-~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|.+. ++||+|+||.||+|+++.+++.||+|.+.... .. .++ ....++
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~----~~e------------------------~~~~~~ 77 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KA----RQE------------------------VDHHWQ 77 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HH----HHH------------------------HHHHHH
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HH----HHH------------------------HHHHHH
Confidence 4678884 57999999999999999999999999986532 11 111 033466
Q ss_pred hCCCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 558 SLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.++||||+++++++.. ...+++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+
T Consensus 78 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~ 157 (336)
T 3fhr_A 78 ASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157 (336)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred hcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 7799999999999976 456899999999999999998753 46999999999999999999999999999999999
Q ss_pred cEEEecCCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 633 NCLVREVGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 633 NILl~~~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||++.++. + +|||+++...... .....+|+.|+|||++.+..
T Consensus 158 NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~ 205 (336)
T 3fhr_A 158 NLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEK 205 (336)
T ss_dssp GEEESCSSTTCCEEECCCTTCEEC--------------------------CH
T ss_pred HEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCC
Confidence 999987543 4 9999998765322 23356899999999986654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=235.87 Aligned_cols=179 Identities=28% Similarity=0.330 Sum_probs=135.9
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcC-CCe--EEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRE-TGE--VMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~-tg~--~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
..+..++|+..+.||+|+||.||+|++.. +++ .||+|.+.... ....+.+
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~------------------------ 68 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF------------------------ 68 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHH------------------------
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHH------------------------
Confidence 34556789999999999999999998753 333 68999875432 1222233
Q ss_pred chHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 549 CFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 549 ~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
.+|+.+++.++||||+++++++..+. .++||||+++|+|.+++......+++..+..++.|++.||.|||+++|+|||
T Consensus 69 -~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 146 (291)
T 1u46_A 69 -IREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRD 146 (291)
T ss_dssp -HHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred -HHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 34599999999999999999998765 8999999999999999986555699999999999999999999999999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~ 679 (681)
|||+|||++.++.+ +|||+++......... ......+|..|+|||++.+..
T Consensus 147 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (291)
T 1u46_A 147 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200 (291)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred CchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCC
Confidence 99999999999987 9999998875433221 222345778899999986554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=244.23 Aligned_cols=171 Identities=13% Similarity=0.104 Sum_probs=139.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcCC--------CeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRET--------GEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~t--------g~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
.++|.+.+.||+|+||.||+|++..+ ++.||+|.+.... .+ .
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~-----~~-------------------------~ 90 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDG-----RL-------------------------F 90 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTS-----TH-------------------------H
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccc-----hH-------------------------H
Confidence 47899999999999999999999874 8899999886431 12 3
Q ss_pred HHHHHHHhCCCCceee---------------EEEEEEe-CCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHH
Q psy5063 551 SQVAVLRSLHHHNVIR---------------FIGVLYK-DRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIA 613 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~---------------l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa 613 (681)
+|+++++.++||||++ +++++.. +...++||||+ +++|.+++... ...+++..+..++.||+
T Consensus 91 ~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~ 169 (352)
T 2jii_A 91 NEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLL 169 (352)
T ss_dssp HHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHH
Confidence 4588888888888877 6777776 78999999999 99999999864 34699999999999999
Q ss_pred HHHHHHHhCCccccCCCCCcEEEecCC--Ce--EEeeeeeEeeecccce-----eeeecCCCccccchhhccCCCC
Q psy5063 614 AGMTYLHSMNLIHRDLNSQNCLVREVG--SG--FDFHLGQIYLIYVPYT-----LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 614 ~gL~yLHs~~IIHRDLKp~NILl~~~g--~~--~DFGLa~~~~~~~~~~-----~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.||.|||+++|+||||||+|||++.++ .+ +|||+++......... ......||+.|+|||++.+..|
T Consensus 170 ~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 245 (352)
T 2jii_A 170 DALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP 245 (352)
T ss_dssp HHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC
T ss_pred HHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC
Confidence 999999999999999999999999988 55 9999998765432111 1123468999999999987655
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-26 Score=262.67 Aligned_cols=175 Identities=23% Similarity=0.318 Sum_probs=136.0
Q ss_pred CCCeee-cceecccCcEEEEEEEE--cCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 479 ASDLVR-GPLLGQGFFGQVYRVTH--RETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 479 ~~d~~~-~~~LG~G~FG~Vyk~~~--~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
...+.+ .+.||+|+||.||+|.+ +.+++.||+|++.... ....+.+. +|+
T Consensus 367 ~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~-------------------------~E~ 421 (635)
T 4fl3_A 367 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-------------------------AEA 421 (635)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHH-------------------------HHH
T ss_pred chhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHH-------------------------HHH
Confidence 334444 34799999999999965 4567899999986532 22233343 459
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
++|+.++||||+++++++. .+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++||||||||+|
T Consensus 422 ~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~N 499 (635)
T 4fl3_A 422 NVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 499 (635)
T ss_dssp HHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCCCCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHh
Confidence 9999999999999999986 456899999999999999997643 59999999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccCCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+.++.+ +|||+++....... +.......+|..|+|||++.+..|
T Consensus 500 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~ 549 (635)
T 4fl3_A 500 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 549 (635)
T ss_dssp EEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCC
T ss_pred EEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCC
Confidence 999999987 99999987643322 122223446788999999976654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=260.53 Aligned_cols=179 Identities=20% Similarity=0.306 Sum_probs=143.6
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCC---CeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRET---GEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t---g~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
..+..++|.+++.||+|+||.||+|.+..+ +..+|+|.+.... ....+.+.+
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~------------------------ 440 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ------------------------ 440 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHH------------------------
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHH------------------------
Confidence 345567899999999999999999998653 4679999876533 333333444
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+.+|+.++||||+++++++. ++..|+||||+++|+|.+++......+++..+..++.|++.||.|||+++|+|||||
T Consensus 441 -E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDik 518 (656)
T 2j0j_A 441 -EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIA 518 (656)
T ss_dssp -HHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred -HHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccc
Confidence 499999999999999999984 567899999999999999998766679999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.+|.+ +|||+++....... .......+|+.|||||++.+..|
T Consensus 519 p~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~ 569 (656)
T 2j0j_A 519 ARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRF 569 (656)
T ss_dssp GGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCC
T ss_pred hHhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCC
Confidence 999999999988 99999987653321 12223446789999999876554
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=235.24 Aligned_cols=167 Identities=27% Similarity=0.409 Sum_probs=140.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh-
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS- 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~- 558 (681)
++|.+.+.||+|+||.||++++ +++.||+|.+.... ...+.+ |+++++.
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~-------------------------e~~~~~~~ 91 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFR-------------------------EAEIYQTV 91 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG---HHHHHH-------------------------HHHHHHHS
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh---HHHHHH-------------------------HHHHHHHh
Confidence 5789999999999999999998 48999999985432 222333 3677776
Q ss_pred -CCCCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcc
Q psy5063 559 -LHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH--------SMNLI 625 (681)
Q Consensus 559 -L~HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLH--------s~~II 625 (681)
++||||+++++++.... ..++||||+++|+|.+++... .+++..+..++.|++.||.||| +++|+
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~iv 169 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEE
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCee
Confidence 79999999999998876 899999999999999999763 4899999999999999999999 89999
Q ss_pred ccCCCCCcEEEecCCCe--EEeeeeeEeeecccce--eeeecCCCccccchhhccCC
Q psy5063 626 HRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 626 HRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~~ 678 (681)
||||||+|||++.++.+ +|||+++......... ......||+.|+|||++.+.
T Consensus 170 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp CSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred eCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence 99999999999999988 9999998876543221 12334689999999998765
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=244.28 Aligned_cols=169 Identities=22% Similarity=0.379 Sum_probs=135.2
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
...+|...++||+|+||.||+|++..+++ +|+|++..... ...+|+++|+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----------------------------~~~~E~~il~ 87 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----------------------------FKNRELQIMR 87 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----------------------------SCCHHHHHHH
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----------------------------hHHHHHHHHH
Confidence 34579999999999999999999987766 78887753211 1125799999
Q ss_pred hCCCCceeeEEEEEEeCC------eEEEEEeccCCCCHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 558 SLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQ--DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~------~l~LV~Ey~~gGsL~~~L~--~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
.++||||+++++++...+ .+++||||++++.+..+.. .....+++..+..++.||+.||.|||+++|+||||
T Consensus 88 ~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 167 (394)
T 4e7w_A 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDI 167 (394)
T ss_dssp TCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred hCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCC
Confidence 999999999999996543 3889999998754443321 22346999999999999999999999999999999
Q ss_pred CCCcEEEe-cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 630 NSQNCLVR-EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 630 Kp~NILl~-~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||+|||++ .++.+ +|||+|+........ ....+|+.|+|||++.+..
T Consensus 168 kp~Nill~~~~~~~kL~DFG~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~ 217 (394)
T 4e7w_A 168 KPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYICSRYYRAPELIFGAT 217 (394)
T ss_dssp SGGGEEEETTTTEEEECCCTTCEECCTTCCC---CSSCSCGGGCCHHHHTTCS
T ss_pred CHHHEEEcCCCCcEEEeeCCCcccccCCCCC---cccccCcCccCHHHHcCCC
Confidence 99999999 67776 999999887543322 2356899999999987653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=238.71 Aligned_cols=165 Identities=22% Similarity=0.331 Sum_probs=137.1
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|...+.||+|+||.||+|++..+|+.||+|.+.... ....+.+. +|+.+|
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------~E~~~l 77 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-------------------------RELLLL 77 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHH-------------------------HHHHHH
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHH-------------------------HHHHHH
Confidence 468999999999999999999999999999999986532 22233333 459999
Q ss_pred HhCCCCceeeEEEEEEeCCe------EEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKDRK------LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~------l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||+++++++..... .++||||++ |+|.+++.. .+++..+..++.||+.||.|||++||+|||||
T Consensus 78 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlk 153 (353)
T 3coi_A 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLK 153 (353)
T ss_dssp HHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred HhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 99999999999999987654 599999997 688888753 48999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|+|||++.++.+ +|||+++..... .....+|+.|+|||++.+
T Consensus 154 p~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 154 PGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp GGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSC
T ss_pred HHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhC
Confidence 999999999988 999999865432 223468999999999876
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=234.54 Aligned_cols=175 Identities=29% Similarity=0.422 Sum_probs=140.2
Q ss_pred CCCeeecceecccCcEEEEEEEEc-CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHR-ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~-~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|+..+.||+|+||.||+|++. .+++.||+|.+........ ......+|+.+++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~e~~~l~ 66 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-----------------------MPLSTIREVAVLR 66 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-----------------------CBCTHHHHHHHHH
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccccc-----------------------CCchhhHHHHHHH
Confidence 368999999999999999999995 6789999998864321100 0111233455555
Q ss_pred hC---CCCceeeEEEEEE-----eCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy5063 558 SL---HHHNVIRFIGVLY-----KDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRD 628 (681)
Q Consensus 558 ~L---~HpnIV~l~g~~~-----~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRD 628 (681)
.+ +||||+++++++. .....++||||++ |+|.+++.... ..+++..+..++.|++.||.|||++||+|||
T Consensus 67 ~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~d 145 (326)
T 1blx_A 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRD 145 (326)
T ss_dssp HHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred hhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 54 8999999999987 4568999999997 69999987543 3489999999999999999999999999999
Q ss_pred CCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 629 LNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 629 LKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+|||++.+|.+ +|||+++....... .....+|..|+|||++.+..|
T Consensus 146 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~ 196 (326)
T 1blx_A 146 LKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSY 196 (326)
T ss_dssp CCGGGEEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCC
T ss_pred CCHHHeEEcCCCCEEEecCcccccccCCCC---ccccccccceeCHHHHhcCCC
Confidence 99999999999988 99999987653321 223568999999999987654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=231.45 Aligned_cols=175 Identities=23% Similarity=0.321 Sum_probs=131.2
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
......++|+..+.||+|+||.||+|++..+|+.||+|.+..... ........+ +
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~------------------------~ 74 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD------------------------L 74 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHH------------------------H
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHH------------------------H
Confidence 344556889999999999999999999999999999999976432 222222222 2
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM-NLIHRDLNS 631 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~-~IIHRDLKp 631 (681)
..+++.++||||+++++++.+++..++||||+ ++.+..+.......+++..+..++.|++.||.|||++ +|+||||||
T Consensus 75 ~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp 153 (318)
T 2dyl_A 75 DVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 153 (318)
T ss_dssp HHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCG
T ss_pred HHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCH
Confidence 45688889999999999999999999999999 5667666654445699999999999999999999995 999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
+|||++.++.+ +|||+++....... .....+|+.|+|||++.
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 154 SNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERID 197 (318)
T ss_dssp GGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC
T ss_pred HHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcc
Confidence 99999999988 99999987654321 22356899999999985
|
| >1rut_X Flinc4, fusion protein of LMO4 protein and LIM domain- binding protein 1; B-tandem zipper, protein binding; 1.30A {Mus musculus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 2dfy_X 2xjz_I 2xjy_B | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-26 Score=225.55 Aligned_cols=123 Identities=28% Similarity=0.706 Sum_probs=109.9
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccC---CceEeeCCeeeeccccccccCC--cccccCCcccc--C
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD---NWYFEKDGLLFCKEDYNGKYGE--ACQNCGQMMSG--P 81 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~---~~~~~~dg~~yC~~cY~~~f~~--~C~~C~~~I~g--~ 81 (681)
.+.|++|+++|.+.+.+.|+++.||++||+|..|+.+|. ..||.+||++||+.||.++|++ +|..|+++|.+ .
T Consensus 5 ~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~g~~~~~~~g~~yC~~cy~~~~~~~~~C~~C~~~I~~~e~ 84 (188)
T 1rut_X 5 WKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFGNSGACSACGQSIPASEL 84 (188)
T ss_dssp CCBBTTTCCBCCCSEEEEETTEEECGGGCBCTTTCCBHHHHCSEEEEETTEEECHHHHHHHHSCCEECTTTCCEECTTSE
T ss_pred CCcCccCCCEeCCceeEEecCcEecccCcccCCCCcccccCCceEEEeCCccccccccccccccCCccccCCCccccCcE
Confidence 478999999998777899999999999999999999996 3899999999999999999999 79999999974 5
Q ss_pred eEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 82 VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 82 ~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
+|.|.++.||++||+|..|++.|..|..|+.. ++++||..||.+.++|.+
T Consensus 85 ~i~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~-~g~~yC~~c~~~~~~~~~ 134 (188)
T 1rut_X 85 VMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYI-NGSLFCEHDRPTALINGH 134 (188)
T ss_dssp EEEETTEEECGGGCBCTTTCCBCCTTCEEEEE-TTEEEEGGGCCTTTC---
T ss_pred EEEcCCCEEeCCCCeECCCCCCCCCCCeEEEE-CCeEECHHHHHHHhcccc
Confidence 78999999999999999999999778878765 567999999999998875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=231.92 Aligned_cols=170 Identities=22% Similarity=0.382 Sum_probs=142.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCH--HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDE--EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~--~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|.+.+.||+|+||.||+|++..+++.||+|.+..... .....+ .+|+++++
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~-------------------------~~e~~~l~ 76 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI-------------------------LREVELLK 76 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHH-------------------------HHHHHHHH
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHH-------------------------HHHHHHHH
Confidence 579999999999999999999999999999999864321 122223 34599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+|||++
T Consensus 77 ~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~ 155 (287)
T 2wei_A 77 KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155 (287)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEES
T ss_pred hccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEe
Confidence 9999999999999999999999999999999999886543 589999999999999999999999999999999999998
Q ss_pred cCC---Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 638 EVG---SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 638 ~~g---~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
.++ .+ +|||+++....... .....+|+.|+|||++.+.
T Consensus 156 ~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~ 198 (287)
T 2wei_A 156 SKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRGT 198 (287)
T ss_dssp CSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTCCHHHHTTC
T ss_pred cCCCcccEEEeccCcceeecCCCc---cccccCcccccChHHhcCC
Confidence 755 34 99999986653321 1223478999999998653
|
| >2xqn_T Testin, TESS; metal-binding protein, cytoskeleton, focal adhesion, acrosom; 2.62A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.8e-26 Score=207.88 Aligned_cols=118 Identities=31% Similarity=0.698 Sum_probs=108.1
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccccCCccc--cCeEEe
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCGQMMS--GPVMVV 85 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~--g~~~~a 85 (681)
.+.|++|+++|.+++.+.|+|+.||++||+|+.|+++|++ .|+++||++||+.||.++|+++|.+|+++|. +.+|.|
T Consensus 3 ~~~C~~C~~~I~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~g~~yC~~cy~~~~~~~C~~C~~~I~~~~~~~~a 82 (126)
T 2xqn_T 3 KPRCAGCDELIFSNEYTQAENQNWHLKHFCCFDCDSILAGEIYVMVNDKPVCKPCYVKNHAVVCQGCHNAIDPEVQRVTY 82 (126)
T ss_dssp CCBBTTTSSBCCSSCEEEETTEEECGGGSBCTTTCCBCTTSEEEEETTEEEEHHHHHHHSCCBCTTTCSBCCTTSCEEEE
T ss_pred CCCCccCCCEeCCceEEeeCCCCccCCCCCcCCCCCCCCcCEEEeECCEEechHHhCcCcCccCcccCCcCCcCceEEEC
Confidence 3689999999998889999999999999999999999976 7899999999999999999999999999998 578999
Q ss_pred cCccCC--CCceecCCCCcccCCCCceeeecCCeeeeccchhhhc
Q psy5063 86 GDHKFH--PECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQM 128 (681)
Q Consensus 86 ~~~~yH--~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~ 128 (681)
.++.|| ++||+|..|+++|. |+.|+.. ++++||..+|.++|
T Consensus 83 ~~~~~H~~~~CF~C~~C~~~l~-~~~f~~~-~~~~yC~~~~~~~f 125 (126)
T 2xqn_T 83 NNFSWHASTECFLCSCCSKCLI-GQKFMPV-EGMVFCSVECKKRM 125 (126)
T ss_dssp TTEEEESSTTTSBCTTTCCBCT-TSEEEEE-TTEEESSHHHHHSC
T ss_pred CCCEeeCCCCCcCcCCCCCccC-CCeeEeE-CCEEcchHHhhhhc
Confidence 999999 99999999999995 7777664 67899998887765
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.5e-25 Score=232.80 Aligned_cols=170 Identities=19% Similarity=0.259 Sum_probs=138.1
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCC-eEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETG-EVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg-~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|.+.+.||+|+||.||+|.+..++ +.||+|.+... ......+.+ |+.+|+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~-------------------------E~~~l~ 71 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARL-------------------------EINVLK 71 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHH-------------------------HHHHHH
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHH-------------------------HHHHHH
Confidence 578999999999999999999998777 78999988643 222233333 477777
Q ss_pred hCCCCc------eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 558 SLHHHN------VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 558 ~L~Hpn------IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
.++|++ ++.+++++...+..++||||+ +++|.+++... ...+++..+..++.||+.||.|||+++|+|||||
T Consensus 72 ~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlk 150 (355)
T 2eu9_A 72 KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLK 150 (355)
T ss_dssp HHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred HHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 776655 999999999999999999999 56676666543 3569999999999999999999999999999999
Q ss_pred CCcEEE-------------------ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLV-------------------REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl-------------------~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||+ +.++.+ +|||+++..... .....||+.|+|||++.+..|
T Consensus 151 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 216 (355)
T 2eu9_A 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGW 216 (355)
T ss_dssp GGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCC
T ss_pred HHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCC
Confidence 999999 556666 999999864322 223568999999999987665
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=239.18 Aligned_cols=179 Identities=21% Similarity=0.289 Sum_probs=147.4
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|++++.||+|+||.||+|++..+++.||+|.+........ ........+.+|+.+++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~~~~E~~~l~ 101 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW-------------------GELPNGTRVPMEVVLLK 101 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCE-------------------EECTTCCEEEHHHHHHH
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhh-------------------hhhhhhhHHHHHHHHHH
Confidence 35789999999999999999999999999999999864321100 00011234567899999
Q ss_pred hCC--CCceeeEEEEEEeCCeEEEEEeccCC-CCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 558 SLH--HHNVIRFIGVLYKDRKLNLVTEYIAG-GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 558 ~L~--HpnIV~l~g~~~~~~~l~LV~Ey~~g-GsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
.++ |+||+++++++..++..++||||+.+ ++|.+++.... .+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 102 ~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 180 (320)
T 3a99_A 102 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180 (320)
T ss_dssp HHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred hhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHE
Confidence 996 59999999999999999999999976 89999997643 589999999999999999999999999999999999
Q ss_pred EEe-cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVR-EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~-~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++ +++.+ +|||+++...... .....||+.|+|||++.+..|
T Consensus 181 ll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 225 (320)
T 3a99_A 181 LIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRY 225 (320)
T ss_dssp EEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCB
T ss_pred EEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCC
Confidence 999 66776 9999998765422 233568999999999876554
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.3e-26 Score=260.17 Aligned_cols=166 Identities=13% Similarity=0.038 Sum_probs=125.2
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccC------HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVD------EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~------~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
...+.|++|.+..++....|+.+|+|.+.+.. ....+.-.+ .+.+|+++|+.+
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~---------------------~~~~E~~~l~~~ 298 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKY---------------------ELHNEIKFLTQP 298 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHH---------------------HHHHHHHHHHSC
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHH---------------------HHHHHHHHHHhc
Confidence 45778889988888888889999999986532 111111111 235679999999
Q ss_pred -CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 560 -HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 560 -~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
+|+||+++++++.+++.+||||||++||+|.++|...+ +++.. .|+.||+.||+|+|++|||||||||+||||+.
T Consensus 299 ~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~ 374 (569)
T 4azs_A 299 PAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDA 374 (569)
T ss_dssp CTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECT
T ss_pred CCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECC
Confidence 79999999999999999999999999999999998754 57654 47899999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|.+ +|||+|+....+. ....+..||+.|||||++.+.
T Consensus 375 dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g~ 414 (569)
T 4azs_A 375 RQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAEN 414 (569)
T ss_dssp TSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC---
T ss_pred CCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCCC
Confidence 9998 9999998765432 222346699999999999775
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=238.12 Aligned_cols=173 Identities=23% Similarity=0.286 Sum_probs=127.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
...++|.+.+.||+|+||.||+|++..+++.||+|++...... ...+ .+|+..+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~-------------------------~~~~~~l 73 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRE-------------------------LQIMQDL 73 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHH-------------------------HHHHHHH
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHH-------------------------HHHHHHH
Confidence 3457899999999999999999999999999999988543211 1111 2347778
Q ss_pred HhCCCCceeeEEEEEEeCCe-------EEEEEeccCCCCHHHHHh---CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCc
Q psy5063 557 RSLHHHNVIRFIGVLYKDRK-------LNLVTEYIAGGTLKELLQ---DPGQPLPWGQRVNFARDIAAGMTYLH--SMNL 624 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~-------l~LV~Ey~~gGsL~~~L~---~~~~~l~~~~~~~i~~QIa~gL~yLH--s~~I 624 (681)
+.++||||+++++++...+. +++||||+++ +|.+.+. .....+++..+..++.|++.||.||| +++|
T Consensus 74 ~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~i 152 (360)
T 3e3p_A 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV 152 (360)
T ss_dssp HHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCC
T ss_pred HhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence 88899999999999976433 8999999986 5544332 23456899999999999999999999 9999
Q ss_pred cccCCCCCcEEEec-CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 625 IHRDLNSQNCLVRE-VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 625 IHRDLKp~NILl~~-~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+||||||+|||++. ++.+ +|||+++....... .....||+.|+|||++.+..
T Consensus 153 vH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~ 207 (360)
T 3e3p_A 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQ 207 (360)
T ss_dssp BCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCS
T ss_pred ecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCC
Confidence 99999999999997 7777 99999987654332 22356899999999986654
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=234.31 Aligned_cols=179 Identities=24% Similarity=0.329 Sum_probs=141.6
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
...+.+..++|+.++.||+|+||.||+|.+.. .+|+|.+....... .....+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-----------------------~~~~~~~~ 78 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-----------------------DQLKAFKR 78 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-----------------------CCCCCCCT
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-----------------------HHHHHHHH
Confidence 34555778899999999999999999999864 38999875421100 01123346
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
|+.+++.++||||+++++++.+++..++||||+++++|.+++......+++..+..++.|++.||.|||+++|+||||||
T Consensus 79 e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp 158 (319)
T 2y4i_B 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKS 158 (319)
T ss_dssp TGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCS
T ss_pred HHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCh
Confidence 78899999999999999999999999999999999999999988766799999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecc---cceeeeecCCCccccchhhccC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYV---PYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~---~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||++ ++.+ +|||+++...... .........||+.|+|||++.+
T Consensus 159 ~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 159 KNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp TTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSC
T ss_pred hhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhh
Confidence 999998 4555 9999987654211 1122234558999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-25 Score=241.96 Aligned_cols=171 Identities=27% Similarity=0.377 Sum_probs=123.9
Q ss_pred Ceee-cceecccCcEEEEEEEEc--CCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVR-GPLLGQGFFGQVYRVTHR--ETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~-~~~LG~G~FG~Vyk~~~~--~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.|.. +++||+|+||.||+|+++ .+++.||+|.+...... ..+ .+|+.+|+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~-------------------------~~E~~~l~ 73 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSA-------------------------CREIALLR 73 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHH-------------------------HHHHHHHH
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHH-------------------------HHHHHHHH
Confidence 3444 668999999999999976 46889999988543211 122 34699999
Q ss_pred hCCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q psy5063 558 SLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQD--------PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHR 627 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~--------~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHR 627 (681)
.++||||+++++++.. +..+|+||||++ |+|.+++.. ....+++..+..++.||+.||.|||+++|+||
T Consensus 74 ~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~ 152 (405)
T 3rgf_A 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR 152 (405)
T ss_dssp HCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred hcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCC
Confidence 9999999999999965 678999999996 588887752 12248999999999999999999999999999
Q ss_pred CCCCCcEEE----ecCCCe--EEeeeeeEeeecc-cceeeeecCCCccccchhhccCCC
Q psy5063 628 DLNSQNCLV----REVGSG--FDFHLGQIYLIYV-PYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 628 DLKp~NILl----~~~g~~--~DFGLa~~~~~~~-~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||||+|||| +.++.+ +|||+|+...... .........||+.|+|||++.+..
T Consensus 153 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 211 (405)
T 3rgf_A 153 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR 211 (405)
T ss_dssp CCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCC
T ss_pred CcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCC
Confidence 999999999 566777 9999998775432 112233456899999999998754
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.5e-25 Score=245.92 Aligned_cols=174 Identities=20% Similarity=0.230 Sum_probs=144.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|.+++.||+|+||.||+|++..+++.||||.+...... ..+.+|+++++.
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---------------------------~~~~~E~~il~~ 58 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------------------------PQLLYESKIYRI 58 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---------------------------CCHHHHHHHHHH
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---------------------------HHHHHHHHHHHH
Confidence 47899999999999999999999999999999987542211 123456889999
Q ss_pred CCC-CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE-
Q psy5063 559 LHH-HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV- 636 (681)
Q Consensus 559 L~H-pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl- 636 (681)
++| ++|..+..++...+..+|||||+ +++|.+++......+++..++.++.||+.||.|||+++|+||||||+||||
T Consensus 59 L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~ 137 (483)
T 3sv0_A 59 LQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137 (483)
T ss_dssp TTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred hcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEe
Confidence 976 56666777777889999999999 999999998655679999999999999999999999999999999999999
Q ss_pred --ecCCCe--EEeeeeeEeeeccc-----ceeeeecCCCccccchhhccCCCC
Q psy5063 637 --REVGSG--FDFHLGQIYLIYVP-----YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 --~~~g~~--~DFGLa~~~~~~~~-----~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.++.+ +|||+++.+..... +.......||..|+|||++.+..|
T Consensus 138 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 190 (483)
T 3sv0_A 138 LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ 190 (483)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred cCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCC
Confidence 577777 99999998765432 112224569999999999988765
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-25 Score=229.86 Aligned_cols=173 Identities=17% Similarity=0.239 Sum_probs=137.0
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.+..++|.+.+.||+|+||.||++.+. +++.||+|.+... .......+.+ |+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~-------------------------E~ 77 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRN-------------------------EI 77 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHH-------------------------HH
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHH-------------------------HH
Confidence 355668999999999999999999986 4889999998643 2333333444 48
Q ss_pred HHHHhCC--CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 554 AVLRSLH--HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 554 ~iL~~L~--HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
++++.++ |+||+++++++..++..++||| +.+++|.+++.... .+++..+..++.|++.||.|||+++|+||||||
T Consensus 78 ~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 155 (313)
T 3cek_A 78 AYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155 (313)
T ss_dssp HHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCc
Confidence 8999986 5999999999999999999999 56889999998654 589999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
+|||+++ +.+ +|||+++...............||+.|+|||++.+
T Consensus 156 ~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 156 ANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp GGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTT
T ss_pred ccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhh
Confidence 9999975 666 99999987765433333334568999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-25 Score=258.37 Aligned_cols=165 Identities=22% Similarity=0.340 Sum_probs=137.3
Q ss_pred CCCeeecceecccCcEEEEEEEEcC-CCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRE-TGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~-tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|.+.+.||+|+||.||++.+.. +++.||+|.+... +......+.+ |+.+|
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~-------------------------E~~~l 133 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMA-------------------------ERQFL 133 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHH-------------------------HHGGG
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHH-------------------------HHHHH
Confidence 4789999999999999999999976 7899999988643 3333334444 48889
Q ss_pred HhCCCCceeeEEEEEEeCCe-----EEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKDRK-----LNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~-----l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.++||||+++++++...+. .||||||++|++|.+++.. .+++..+..++.||+.||.|||++|||||||||
T Consensus 134 ~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp 210 (681)
T 2pzi_A 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKP 210 (681)
T ss_dssp GGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccCh
Confidence 99999999999999987655 7999999999999988765 599999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+|||++.+ .+ +|||+++..... ....||+.|||||++.+.
T Consensus 211 ~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~ 252 (681)
T 2pzi_A 211 ENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG 252 (681)
T ss_dssp GGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC
T ss_pred HHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC
Confidence 99999986 55 999999876432 234589999999998643
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=236.49 Aligned_cols=173 Identities=17% Similarity=0.286 Sum_probs=141.2
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+..++|.+.+.||+|+||.||+|++..+++.||+|.+... ......+.+ |+.+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~-------------------------e~~~ 68 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAED-------------------------EIKL 68 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHH-------------------------HHHH
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhH-------------------------HHHH
Confidence 35567899999999999999999999999999999998643 222333333 3666
Q ss_pred HHhCC-----------CCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHH
Q psy5063 556 LRSLH-----------HHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYL 619 (681)
Q Consensus 556 L~~L~-----------HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yL 619 (681)
++.++ ||||+++++++...+ .+++||||+ +++|.+++... ...+++..+..++.||+.||.||
T Consensus 69 l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l 147 (373)
T 1q8y_A 69 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM 147 (373)
T ss_dssp HHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHH
Confidence 66664 899999999998654 799999999 89999998753 34599999999999999999999
Q ss_pred HhC-CccccCCCCCcEEEecCC------Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 620 HSM-NLIHRDLNSQNCLVREVG------SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 620 Hs~-~IIHRDLKp~NILl~~~g------~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|++ +|+||||||+|||++.++ .+ +|||+++..... .....+|+.|+|||++.+..|
T Consensus 148 H~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~ 212 (373)
T 1q8y_A 148 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPW 212 (373)
T ss_dssp HHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCC
T ss_pred HhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCC
Confidence 998 999999999999996543 34 999999876532 223468999999999988765
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=235.13 Aligned_cols=170 Identities=19% Similarity=0.275 Sum_probs=139.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|.+.+.||+|+||.||+|++..+++.||+|++.... .....+.. |+.+++.
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~-------------------------e~~~l~~ 106 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQI-------------------------EVRLLEL 106 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHH-------------------------HHHHHHH
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHH-------------------------HHHHHHH
Confidence 578999999999999999999999999999999986432 22222222 3666666
Q ss_pred CC-CC-----ceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCC
Q psy5063 559 LH-HH-----NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLH--SMNLIHRDL 629 (681)
Q Consensus 559 L~-Hp-----nIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLH--s~~IIHRDL 629 (681)
++ |+ +|+++++++...+..++||||++ |+|.+++.... ..+++..+..++.|++.||.||| +.+|+||||
T Consensus 107 l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDl 185 (382)
T 2vx3_A 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDL 185 (382)
T ss_dssp HHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCC
T ss_pred HHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCC
Confidence 63 44 59999999999999999999996 59999987643 45899999999999999999999 578999999
Q ss_pred CCCcEEEec--CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVRE--VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~--~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++. ++.+ +|||+++..... .....+|+.|+|||++.+..|
T Consensus 186 kp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~ 235 (382)
T 2vx3_A 186 KPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPY 235 (382)
T ss_dssp SGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCC
T ss_pred CcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCC
Confidence 999999964 5555 999999876432 223568999999999988765
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.8e-24 Score=239.42 Aligned_cols=172 Identities=22% Similarity=0.242 Sum_probs=133.5
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.+...+|...++||+|+||.|+. ....+++.||||++..... ....+|+.+
T Consensus 20 ~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~----------------------------~~~~~E~~~ 70 (432)
T 3p23_A 20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF----------------------------SFADREVQL 70 (432)
T ss_dssp EETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE----------------------------EECHHHHHH
T ss_pred EEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH----------------------------HHHHHHHHH
Confidence 34455789999999999999664 3345789999998853211 013467999
Q ss_pred HHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 556 LRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
|+.+ +||||+++++++.+....|+||||++ |+|.+++......+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 71 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NI 149 (432)
T 3p23_A 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNI 149 (432)
T ss_dssp HHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSE
T ss_pred HHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHE
Confidence 9999 89999999999999999999999996 699999987665566667789999999999999999999999999999
Q ss_pred EEecC---C--C--eEEeeeeeEeeeccc-ceeeeecCCCccccchhhccC
Q psy5063 635 LVREV---G--S--GFDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 635 Ll~~~---g--~--~~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|++.+ + . .+|||+++....... ........||+.|+|||++.+
T Consensus 150 ll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 150 LISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp EECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSC
T ss_pred EEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhc
Confidence 99643 3 2 299999987654321 122334569999999999974
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.9e-24 Score=212.49 Aligned_cols=125 Identities=27% Similarity=0.626 Sum_probs=111.6
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCc----------------
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEA---------------- 70 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~---------------- 70 (681)
+.+.|++|+++|..++.+.|+++.||++||+|..|+.+|.+ .||.+||++||+.||.++|+++
T Consensus 6 ~~~~C~~C~~~I~~~~~v~a~g~~wH~~CF~C~~C~~~L~~~~~~~~~g~~yC~~cy~~~f~~~c~~c~~~~g~~~~~~~ 85 (192)
T 1b8t_A 6 GGKKCGVCQKAVYFAEEVQCEGSSFHKSCFLCMVCKKNLDSTTVAVHGDEIYCKSCYGKKYGPKGKGKGMGAGTLSTDKG 85 (192)
T ss_dssp CCEECTTTCCEECSSCCEEETTEEECTTTCBCTTTCCBCCSSSEEEETTEEEEHHHHHHHHSCCCCCCCCCCCCCCCCCC
T ss_pred CCCcCccCCCeecceeEEEeCCceecCCCCcCcccCCcCCCCeeEecCCEeeChhhhHhhcCccccccccccccEecCCC
Confidence 35789999999988888999999999999999999999965 6899999999999999999876
Q ss_pred --------------------------------ccccCCccc-cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCe
Q psy5063 71 --------------------------------CQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSI 117 (681)
Q Consensus 71 --------------------------------C~~C~~~I~-g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~ 117 (681)
|.+|+++|. +..+.|.++.||++||+|..|+++|..+. |+ ..+++
T Consensus 86 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~-~~-~~~g~ 163 (192)
T 1b8t_A 86 ESLGIKYEEGQSHRPTNPNASRMAQKVGGSDGCPRCGQAVYAAEKVIGAGKSWHKSCFRCAKCGKSLESTT-LA-DKDGE 163 (192)
T ss_dssp CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECTTTSCEECSSSCEEETTEEECTTTCBCTTTCCBCCSSS-EE-EETTE
T ss_pred cccccccccccccCCCCcCccccccccCCCCcCCCCCCEecCcEEEecCCCccchhcCCccccCCCCCCCc-cc-ccCCE
Confidence 778999996 46788999999999999999999996554 54 55778
Q ss_pred eeeccchhhhcCCCCCC
Q psy5063 118 LYCGLCYKRQMQPLGRA 134 (681)
Q Consensus 118 lyC~~Cy~~~~~p~~~~ 134 (681)
+||..||.++|+|+|..
T Consensus 164 ~yC~~cy~~~f~~kc~~ 180 (192)
T 1b8t_A 164 IYCKGCYAKNFGPKGFG 180 (192)
T ss_dssp EEEHHHHHHHTCCCCCC
T ss_pred EeCHHHHHHhcCCcCCC
Confidence 99999999999999754
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-23 Score=216.37 Aligned_cols=137 Identities=15% Similarity=0.083 Sum_probs=120.4
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
-.++|++.+.||+|+||.||+|++..+++.||+|.+.... ....+.+.+ |+.
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~-------------------------e~~ 83 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLS-------------------------RTL 83 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHH-------------------------HHH
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHH-------------------------HHH
Confidence 3467999999999999999999999999999999986532 233333444 488
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+++.++||||+++++++..++..|+||||++|++|.++++.. ....++..++.|++.||+|||++||+||||||+||
T Consensus 84 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NI 160 (286)
T 3uqc_A 84 RLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRV 160 (286)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred HHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccE
Confidence 999999999999999999999999999999999999999642 35567888999999999999999999999999999
Q ss_pred EEecCCCe
Q psy5063 635 LVREVGSG 642 (681)
Q Consensus 635 Ll~~~g~~ 642 (681)
|++.+|.+
T Consensus 161 ll~~~g~~ 168 (286)
T 3uqc_A 161 RVSIDGDV 168 (286)
T ss_dssp EEETTSCE
T ss_pred EEcCCCCE
Confidence 99999987
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-24 Score=251.98 Aligned_cols=174 Identities=24% Similarity=0.337 Sum_probs=143.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|.+.+.||+|+||.||+|.+..+|+.||+|.+... .......+.+ |+++|+
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~-------------------------Ei~iL~ 67 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-------------------------EIQIMK 67 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHH-------------------------HHHHHH
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHH-------------------------HHHHHH
Confidence 36899999999999999999999999999999988653 3333333444 599999
Q ss_pred hCCCCceeeEEEEEEe------CCeEEEEEeccCCCCHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 558 SLHHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQDPG--QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~------~~~l~LV~Ey~~gGsL~~~L~~~~--~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
.++||||+++++++.. .+..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||
T Consensus 68 ~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDL 147 (676)
T 3qa8_A 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDL 147 (676)
T ss_dssp HCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCC
T ss_pred hCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 9999999999999765 677899999999999999998643 25899999999999999999999999999999
Q ss_pred CCCcEEEecCCC---e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGS---G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~---~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.++. + +|||+++...... ......||+.|+|||++.+..|
T Consensus 148 KP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~ 200 (676)
T 3qa8_A 148 KPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKY 200 (676)
T ss_dssp CSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCC
T ss_pred CHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCC
Confidence 999999998875 3 9999998764332 2233568999999999987655
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=232.66 Aligned_cols=168 Identities=26% Similarity=0.250 Sum_probs=125.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+-|...++||+|+||.||.+ ...+|+.||+|.+..... ..+. +|+.+|+.+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~---~~~~-------------------------~E~~~l~~l 65 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC---DIAL-------------------------MEIKLLTES 65 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGH---HHHH-------------------------HHHHHHHHH
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHH---HHHH-------------------------HHHHHHHhc
Confidence 34566789999999999875 445799999998864321 2222 358888876
Q ss_pred -CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCC------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 560 -HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP------LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 560 -~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~------l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
+||||+++++++.+++.+|+||||++ |+|.+++...... .++..+..++.||+.||+|||+++|+||||||+
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 89999999999999999999999995 6999999864321 122345679999999999999999999999999
Q ss_pred cEEEecCC-------------Ce--EEeeeeeEeeecccce--eeeecCCCccccchhhccC
Q psy5063 633 NCLVREVG-------------SG--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g-------------~~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~ 677 (681)
|||++.+| .+ +|||+++......... ......||+.|+|||++.+
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 99998754 34 9999999876432211 1224569999999999965
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=212.25 Aligned_cols=143 Identities=27% Similarity=0.404 Sum_probs=123.2
Q ss_pred CCeeec-ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH-H
Q psy5063 480 SDLVRG-PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL-R 557 (681)
Q Consensus 480 ~d~~~~-~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL-~ 557 (681)
++|... ++||+|+||.||++.+..+++.||+|.+.... .+.+ |++++ +
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~-------------------------e~~~~~~ 66 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARR-------------------------EVELHWR 66 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH-----HHHH-------------------------HHHHHHH
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH-----HHHH-------------------------HHHHHHH
Confidence 467666 78999999999999999999999999986421 1222 36666 6
Q ss_pred hCCCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 558 SLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.++||||+++++++.. +...++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+++|+||||||+
T Consensus 67 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~ 146 (299)
T 3m2w_A 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 146 (299)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence 6699999999999987 678999999999999999997643 46999999999999999999999999999999999
Q ss_pred cEEEec---CCCe--EEeeeeeEee
Q psy5063 633 NCLVRE---VGSG--FDFHLGQIYL 652 (681)
Q Consensus 633 NILl~~---~g~~--~DFGLa~~~~ 652 (681)
|||++. ++.+ +|||++....
T Consensus 147 Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 147 NLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECT
T ss_pred HEEEecCCCCCcEEEeccccccccc
Confidence 999998 5666 9999998765
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.9e-24 Score=241.80 Aligned_cols=162 Identities=19% Similarity=0.251 Sum_probs=118.6
Q ss_pred eecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
...++||+|+||.||++.. .++.+++|+..... .........+ .+.+|+++|+.+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~--------------------~~~~E~~il~~l 396 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKS--------------------RTAREARYLALV 396 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHH--------------------HHHHHHHHHHHG
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHH--------------------HHHHHHHHHHhc
Confidence 3466899999999999944 47888999864321 1111111111 235679999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||+++..+....+..||||||+++|+|.+++.. +..++.|++.||.|||+++|+||||||+|||++.
T Consensus 397 ~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~- 466 (540)
T 3en9_A 397 KDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK- 466 (540)
T ss_dssp GGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS-
T ss_pred CCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC-
Confidence 999999655555577788999999999999999875 4579999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccce-----eeeecCCCccccchhhccC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYT-----LFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~-----~~~~~~gt~~Y~APEvL~~ 677 (681)
.+ +|||+++......... ......||+.|||||++.+
T Consensus 467 -~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 467 -DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp -SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred -eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 55 9999999876532211 1134568999999999865
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.6e-23 Score=226.38 Aligned_cols=164 Identities=19% Similarity=0.172 Sum_probs=120.2
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH---HHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA---EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~---~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.+|..+++||+|+||.||+|++..+|+.||||++....... .+.+.+ |+.++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~-------------------------E~~~~ 132 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKE-------------------------EVLRL 132 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHH-------------------------HHHGG
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHH-------------------------HHHHH
Confidence 45888899999999999999999999999999886332221 223333 35556
Q ss_pred HhCCC-C---------------------ceeeEEEEEEe-----CCeEEEEEeccCCCCHHHHHh------CCCCCCCHH
Q psy5063 557 RSLHH-H---------------------NVIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQ------DPGQPLPWG 603 (681)
Q Consensus 557 ~~L~H-p---------------------nIV~l~g~~~~-----~~~l~LV~Ey~~gGsL~~~L~------~~~~~l~~~ 603 (681)
+.++| + +...+..++.. ....+++|+++ +++|.++++ .....+++.
T Consensus 133 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~ 211 (413)
T 3dzo_A 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHH 211 (413)
T ss_dssp GGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHH
T ss_pred HhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHH
Confidence 66654 1 11112222221 23467788766 689999984 234457888
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhc
Q psy5063 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNIL 675 (681)
Q Consensus 604 ~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL 675 (681)
.+..++.|++.||+|||+++|+||||||+||||+.+|.+ +|||+++..... .....| +.|||||++
T Consensus 212 ~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~ 279 (413)
T 3dzo_A 212 ARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETT 279 (413)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHH
T ss_pred HHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhh
Confidence 999999999999999999999999999999999999998 999999865432 334567 999999998
|
| >2cup_A Skeletal muscle LIM-protein 1; four and half LIM domains protein 1, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.6e-22 Score=178.95 Aligned_cols=94 Identities=23% Similarity=0.511 Sum_probs=87.5
Q ss_pred CCcccccccccccc-CceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccccCCccc--cCeE
Q psy5063 8 EILTCAGCLNNIVE-DEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCGQMMS--GPVM 83 (681)
Q Consensus 8 ~~~~C~~C~~~I~~-~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~--g~~~ 83 (681)
..+.|++|+++|.. ++.+.++++.||++||+|..|+++|.+ .|+.+||++||+.||.++|+++|.+|+++|. +.+|
T Consensus 4 ~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~cy~~~~~~~C~~C~~~I~~~~~~~ 83 (101)
T 2cup_A 4 GSSGCVECRKPIGADSKEVHYKNRFWHDTCFRCAKCLHPLANETFVAKDNKILCNKCTTREDSPKCKGCFKAIVAGDQNV 83 (101)
T ss_dssp CCCBCSSSCCBCCSSSCEEEETTEEEETTTCCCSSSCCCTTSSCCEEETTEEECHHHHTTCCCCBCSSSCCBCCSSSCEE
T ss_pred CCCcCcccCCcccCCceEEEECccChhhcCCcccccCCCCCcCeeECcCCEEEChhHhhhhcCCccccCCCccccCCeEE
Confidence 34789999999974 789999999999999999999999966 6899999999999999999999999999997 5789
Q ss_pred EecCccCCCCceecCCCC
Q psy5063 84 VVGDHKFHPECFKCTSCS 101 (681)
Q Consensus 84 ~a~~~~yH~~CF~C~~C~ 101 (681)
.|.++.||++||+|..|+
T Consensus 84 ~a~~~~~H~~CF~C~~C~ 101 (101)
T 2cup_A 84 EYKGTVWHKDCFSGPSSG 101 (101)
T ss_dssp ESSSCEEETTTCCCTTCC
T ss_pred EeCCcchHHhCCCCCCCC
Confidence 999999999999999995
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.3e-21 Score=202.51 Aligned_cols=159 Identities=17% Similarity=0.118 Sum_probs=112.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHH--HHHHHhhccceeeeccCCCCc--cccccchHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEK--NFLKESKQGLIYLIDLGSHGL--INNLHCFSQVA 554 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~--~~~~E~k~~~~~~~~~~~~~~--~~~~~~~~Ei~ 554 (681)
...|.+++.||+|+||.||+|.+ .+|+.||+|.+......... .... .+ ...+ .....+.+|++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~-------~~----~~~w~~~~~~~~~~E~~ 156 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRD-------YG----DLHFSVLAIRSARNEFR 156 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC------------------CHHHHHHHHHHHHHH
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhh-------hc----chhhHHHHHHHHHHHHH
Confidence 34566789999999999999999 88999999998543211000 0000 00 0000 00112346799
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+|+.++| +++++++.. +..|+||||++||+|.+ +.. .....++.|++.||.|||++||+||||||+||
T Consensus 157 ~l~~l~~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NI 224 (282)
T 1zar_A 157 ALQKLQG---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNV 224 (282)
T ss_dssp HHHHTTT---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred HHHhccC---CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHE
Confidence 9999984 555554433 55699999999999998 432 12446999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|++ +|.+ +|||+|+. +..|+|||++.+
T Consensus 225 Ll~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp EEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred EEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 999 8877 99999863 445788988753
|
| >1m3v_A FLIN4, fusion of the LIM interacting domain of LDB1 and the N-terminal LIM domain of LMO4...; fusion protein, LMO proteins, metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-19 Score=164.75 Aligned_cols=107 Identities=26% Similarity=0.486 Sum_probs=91.4
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccC---CceEeeCCeeeeccccccccCC--cccccCCccccCeE
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD---NWYFEKDGLLFCKEDYNGKYGE--ACQNCGQMMSGPVM 83 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~---~~~~~~dg~~yC~~cY~~~f~~--~C~~C~~~I~g~~~ 83 (681)
.+.|++|+++|.+.+.+.|+++.||++||+|+.|+.+|. ..||.+||++||+.||.++|++ +|++|+++|.+..+
T Consensus 5 ~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~g~~yC~~cy~~~f~~~~~C~~C~~~I~~~~~ 84 (122)
T 1m3v_A 5 WKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFGNSGAGGSGGHMGSGGDV 84 (122)
T ss_dssp CCCBSSSSSCCCSSCCEEETTEEECHHHHCCSSSCCCTTTSEECCEEETTEEECHHHHHHHHCCCCSSSCSSCCSCCEES
T ss_pred CCCCcccCCEeCCcEEEEECCceeHhhCCCcCCCCCcccccCCeEEEECCeeecHHHHHHHcCCCCccccCCCCcCchhe
Confidence 478999999998877799999999999999999999996 3799999999999999999999 99999999987665
Q ss_pred EecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCC
Q psy5063 84 VVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130 (681)
Q Consensus 84 ~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p 130 (681)
.+.++ ++..|+.|+.. ++++||..||.+.+..
T Consensus 85 ~~~g~--------------~~l~g~~f~~~-~~~~yC~~~~~~~~~~ 116 (122)
T 1m3v_A 85 MVVGE--------------PTLMGGEFGDE-DERLITRLENTQFDAA 116 (122)
T ss_dssp SSSSS--------------SSCCSCTTCCT-TCCCCEECTTTTTTCC
T ss_pred EEcCC--------------cCCCCCccEec-CCEeEccCcchhchhh
Confidence 55553 23367888655 5669999999887544
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.1e-18 Score=176.16 Aligned_cols=159 Identities=19% Similarity=0.092 Sum_probs=104.9
Q ss_pred eeecceecccCcEEEEEEEEcCCCeE--EEEEEeeccCHHHHHHHHHHhhccceeeeccC-CCCccccccchHHHHHHHh
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEV--MVLKELYRVDEEAEKNFLKESKQGLIYLIDLG-SHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~--vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~-~~~~~~~~~~~~Ei~iL~~ 558 (681)
|.+++.||+|+||.||+|.+..+|+. ||+|.+.......... .+............ +........+.+|+.+|+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKM--DEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC---------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhH--HHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 56788999999999999999778999 9999875432111100 00000000000000 0000001134578999999
Q ss_pred CCCCce--eeEEEEEEeCCeEEEEEeccCC-C----CHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCC
Q psy5063 559 LHHHNV--IRFIGVLYKDRKLNLVTEYIAG-G----TLKELLQDPGQPLPWGQRVNFARDIAAGMTYLH-SMNLIHRDLN 630 (681)
Q Consensus 559 L~HpnI--V~l~g~~~~~~~l~LV~Ey~~g-G----sL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLH-s~~IIHRDLK 630 (681)
++|+++ ...++. +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.||+|||||
T Consensus 127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlk 198 (258)
T 1zth_A 127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLS 198 (258)
T ss_dssp HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCS
T ss_pred HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCC
Confidence 987754 444442 356899999942 4 77776543 234567789999999999999 9999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEee
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYL 652 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~ 652 (681)
|+|||++. .+ +|||+|....
T Consensus 199 p~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 199 EYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp TTSEEESS--SEEECCCTTCEETT
T ss_pred HHHEEEcC--cEEEEECcccccCC
Confidence 99999998 55 9999997653
|
| >1j2o_A FLIN2, fusion of rhombotin-2 and LIM domain-binding protein 1; LIM-interaction-domain (LID), metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.73 E-value=1.2e-18 Score=157.91 Aligned_cols=103 Identities=28% Similarity=0.481 Sum_probs=87.2
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccC---CceEeeCCeeeeccccccccCCcccccCCccccCeEEe
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD---NWYFEKDGLLFCKEDYNGKYGEACQNCGQMMSGPVMVV 85 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~---~~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a 85 (681)
.+.|++|+++|.+.+.+.|+++.||++||+|+.|+.+|. ..||.+||++||+.||.++|+++|..|. .+.+|+
T Consensus 3 ~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~g~~~~~~~g~~yC~~~y~~~f~~~c~~c~---~~~~~~- 78 (114)
T 1j2o_A 3 LLTCGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLRLGGSGGHMGS---GGDVMV- 78 (114)
T ss_dssp CBCBSSSCSCBCSSEEEECSSSEECTTTCCCSSSCSCCCCSSSCCCCBTTBCCCHHHHHHHHTSCCSSCB---SCSCCC-
T ss_pred CCCCcCCCCeeCCcEEEEECchhHHHhcCcccccCCchhcCCCeeEEECCeeechHHHHHHhCcccCcCC---CCceeE-
Confidence 578999999999777899999999999999999999996 3799999999999999999999999886 233432
Q ss_pred cCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCC
Q psy5063 86 GDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130 (681)
Q Consensus 86 ~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p 130 (681)
|.+++..|+.|+.. ++++||..||.+..++
T Consensus 79 --------------~~~~~~~g~~f~~~-~~~~~C~~~~~~~~~~ 108 (114)
T 1j2o_A 79 --------------VGEPTLMGGEFGDE-DERLITRLENTQFDAA 108 (114)
T ss_dssp --------------SSCSSTTSSBCCCS-SSCCCEEEECTTCCCT
T ss_pred --------------cCCccCCCCeeEEc-CCEeecchhhhccccc
Confidence 45666678888555 5669999999886555
|
| >1x6a_A LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.68 E-value=1.6e-17 Score=140.96 Aligned_cols=79 Identities=44% Similarity=0.959 Sum_probs=73.0
Q ss_pred CCeeeeccccccccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 54 DGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 54 dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
++.+||++||.++|+++|++|+++|.+..|.|.++.||++||+|..|+++|.+|..|++..++++||..||.+++++.+
T Consensus 1 g~~~yC~~~y~~~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~~~~~~C~~c~~~~~~~~~ 79 (81)
T 1x6a_A 1 GSSGSSGKDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLYCGKCHNEVVSGPS 79 (81)
T ss_dssp CCCCCCCCCSSCCSSCBCTTTCCBCCSCCBCCTTCCBCTTSCBCTTTCCBCCTTSCEEECSSSCEEEHHHHHHHHCTTS
T ss_pred CCCccchhHHhhhcCCcCccCCCCcCceEEEECCceeccccCCccCCCCccCCCCcEEEeeCCEEECHHHHHHHhcCCC
Confidence 4689999999999999999999999999999999999999999999999998888887666788999999999998854
|
| >2dlo_A Thyroid receptor-interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.67 E-value=3.2e-17 Score=139.12 Aligned_cols=78 Identities=19% Similarity=0.379 Sum_probs=71.4
Q ss_pred CCeeeeccccccccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 54 DGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 54 dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
||++||++||. +++++|++|+++|.+++|.|.++.||++||+|..|+++|. +..|+...++++||..||.++|+|+|.
T Consensus 2 ~g~~yC~~~y~-~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~f~~~~~g~~yC~~cy~~~f~~~C~ 79 (81)
T 2dlo_A 2 SSGSSGEGCYV-ATLEKCATCSQPILDRILRAMGKAYHPGCFTCVVCHRGLD-GIPFTVDATSQIHCIEDFHRKFASGPS 79 (81)
T ss_dssp CCCCCCCCCCC-SSCCBCTTTCCBCCSCCEEETTEEECTTTCBCSSSCCBCT-TSCEECCTTCCCEEHHHHHHHTTSSSC
T ss_pred cCCEECHHHhh-cCCCccccCCCeecceeEEECCccccHHhcCcccCCCccC-CCeeEECCCCEEECHHHHHHHhcCcCC
Confidence 78999999999 7999999999999999999999999999999999999995 667766657789999999999999863
|
| >2ehe_A Four and A half LIM domains 3; FHL-3, skeletal muscle LIM- protein 2, SLIM 2, FHL3, SLIM2, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=7.6e-17 Score=137.02 Aligned_cols=78 Identities=22% Similarity=0.554 Sum_probs=70.1
Q ss_pred CCeeeeccccccccCCcccccCCccc--cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCC
Q psy5063 54 DGLLFCKEDYNGKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPL 131 (681)
Q Consensus 54 dg~~yC~~cY~~~f~~~C~~C~~~I~--g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~ 131 (681)
||++||++||.++|+++|++|+++|. +.++.|.++.||++||+|..|+++|. +..|+. .++++||..||.++++|+
T Consensus 1 ~g~~yC~~~y~~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~f~~-~~~~~~C~~c~~~~~~~~ 78 (82)
T 2ehe_A 1 GSSGSSGPCYDNTFANTCAECQQLIGHDSRELFYEDRHFHEGCFRCCRCQRSLA-DEPFTC-QDSELLCNDCYCSAFSSG 78 (82)
T ss_dssp CCCCCCCCCCCCCCSCBCTTTCCBCCSSCCBCCCSSCCCBTTTSBCTTTCCBCS-SCCEEE-ETTEEEETTTSSCCGGGS
T ss_pred CCceechhHhCcccCCcCccCCCccccCcEEEEeCCccccccCCeecCCCCccC-CCccEe-eCCEEECHHHHhhhcCCC
Confidence 68999999999999999999999998 77899999999999999999999995 445644 467899999999999998
Q ss_pred CC
Q psy5063 132 GR 133 (681)
Q Consensus 132 ~~ 133 (681)
|.
T Consensus 79 C~ 80 (82)
T 2ehe_A 79 PS 80 (82)
T ss_dssp SC
T ss_pred CC
Confidence 64
|
| >2cuq_A Four and A half LIM domains 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-16 Score=135.14 Aligned_cols=77 Identities=19% Similarity=0.486 Sum_probs=70.3
Q ss_pred CCeeeeccccccccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 54 DGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 54 dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
+|++||++||.++|+++|++|+++|.+..|.|.++.||++||+|..|+++|. +..|+. .++.+||..||.++++|++
T Consensus 1 gg~~yC~~cy~~~~~~~C~~C~~~I~~~~v~a~~~~~H~~CF~C~~C~~~L~-~~~~~~-~~~~~yC~~cy~~~f~~~c 77 (80)
T 2cuq_A 1 GSSGSSGPCYENKFAPRCARCSKTLTQGGVTYRDQPWHRECLVCTGCQTPLA-GQQFTS-RDEDPYCVACFGELFASGP 77 (80)
T ss_dssp CCCCSCCCCCCCCSSCCCTTTCCCCCSCCEESSSSEECTTTCBCSSSCCBCT-TCCEEE-CSSSEEEHHHHHHHTTCST
T ss_pred CCcEEcHHHHccccCCcCCCCCCEecCcEEEECCchhhhhhCCcccCCCcCC-CCeeEe-ECCEEECHHHHHHHcCCCC
Confidence 5899999999999999999999999999999999999999999999999994 556655 4667999999999999976
|
| >1x3h_A Leupaxin; paxillin family, protein-protein interaction, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.63 E-value=1.3e-16 Score=134.79 Aligned_cols=78 Identities=19% Similarity=0.427 Sum_probs=70.6
Q ss_pred CCeeeeccccccccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 54 DGLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 54 dg~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
+|++||++||.++|+++|++|+++|.++.|.|.++.||++||+|..|+++|.++. |+. .++++||..||.++++|+|.
T Consensus 1 gg~~yC~~~y~~~~~~~C~~C~~~I~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~-~~~-~~~~~yC~~~y~~~f~~~C~ 78 (80)
T 1x3h_A 1 GSSGSSGKDFLAMFSPKCGGCNRPVLENYLSAMDTVWHPECFVCGDCFTSFSTGS-FFE-LDGRPFCELHYHHRRGSGPS 78 (80)
T ss_dssp CCCCCCCCCCCCCCSCBCTTTCCBCCSSCEEETTEEECTTTCBCSSSCCBSCSSC-CEE-SSSCEECHHHHHHHHSSSCC
T ss_pred CCCccchhHHhhhcCCccccCCCeecceeEEECCCeEecCcCChhhCCCCCCCCc-EEe-ECCEEECHHHHHHHcCCCCC
Confidence 5889999999999999999999999999999999999999999999999996654 544 46779999999999999863
|
| >1x63_A Skeletal muscle LIM-protein 1; LIM domain, four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.61 E-value=3.1e-16 Score=133.17 Aligned_cols=77 Identities=18% Similarity=0.405 Sum_probs=69.1
Q ss_pred CCeeeeccccccccCCcccccCCccc--cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCC
Q psy5063 54 DGLLFCKEDYNGKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPL 131 (681)
Q Consensus 54 dg~~yC~~cY~~~f~~~C~~C~~~I~--g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~ 131 (681)
++.+||++||.++|+++|.+|+++|. +.+|.|.++.||++||+|..|+++|.++ .|+. .++.+||..||.++++|+
T Consensus 1 ~~~~yC~~cy~~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~-~~~~-~~~~~yC~~cy~~~f~~~ 78 (82)
T 1x63_A 1 GSSGSSGKCTTREDSPKCKGCFKAIVAGDQNVEYKGTVWHKDCFTCSNCKQVIGTG-SFFP-KGEDFYCVTCHETKFASG 78 (82)
T ss_dssp CCSCCCCCCCSCCCSCBCSSSCCBCCSSSCEEECSSCEEETTTCCCSSSCCCCTTS-CEEE-ETTEEEEHHHHHHHTSCC
T ss_pred CCCcCchhHHccccCCcCccCCcccccCceEEEECccccccccCchhhCCCccCCC-ccEe-eCCEEECHHHHHHHhCCC
Confidence 47899999999999999999999997 6789999999999999999999999665 5544 467899999999999997
Q ss_pred C
Q psy5063 132 G 132 (681)
Q Consensus 132 ~ 132 (681)
+
T Consensus 79 ~ 79 (82)
T 1x63_A 79 P 79 (82)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >2dj7_A Actin-binding LIM protein 3; LIM domain, Zn binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.57 E-value=1.2e-15 Score=129.24 Aligned_cols=66 Identities=35% Similarity=0.899 Sum_probs=62.0
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCCceEeeCCeeeeccccccccCCcccc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
..+.|++|+++|.+++.+.++++.||++||+|..|+.+|.+.||++||++||+.||.++|+++|..
T Consensus 14 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~~g~~yC~~~y~~~fg~~C~~ 79 (80)
T 2dj7_A 14 GPSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQTCSVILTGEYISKDGVPYCESDYHAQFGSGPSS 79 (80)
T ss_dssp SCSCCTTTCCCCSSSCCEEETTEEECTTTCBCSSSCCBCSSCCEEETTEEECTTHHHHHTTCCSTT
T ss_pred CCCCCcCcCCeeCCCeEEEECCcccccccCCcCcCCCCcCCCeEEECCEEECHHHHHHHcCCCCCC
Confidence 346899999999888999999999999999999999999888999999999999999999999974
|
| >1iml_A CRIP, cysteine rich intestinal protein; metal-binding protein, LIM domain protein; NMR {Rattus rattus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.57 E-value=1.5e-15 Score=127.14 Aligned_cols=70 Identities=26% Similarity=0.586 Sum_probs=64.7
Q ss_pred ccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeec-cccccccCCcccccCCccc
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCK-EDYNGKYGEACQNCGQMMS 79 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~-~cY~~~f~~~C~~C~~~I~ 79 (681)
|.|++|+++|..++.+.++++.||++||+|..|+.+|.+ .|+.+||++||+ .||.++|+++|.+|++.+.
T Consensus 1 p~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~cy~~~f~~~C~~C~~~~~ 72 (76)
T 1iml_A 1 PKCPKCDKEVYFAERVTSLGKDWHRPCLKCEKCGKTLTSGGHAEHEGKPYCNHPCYSAMFGPKGFGRGGAES 72 (76)
T ss_dssp CBCTTTSSBCCGGGEEEETTEEEETTTCBCTTTCCBCCTTTEEEETTEEEETTTHHHHHSSCCCSSCCCSSS
T ss_pred CcCCCCCCEEECceEEEECCccccCCCCCccccCccCCCCceECcCCeEeeCHHHHHHHhCccCCCcCCcee
Confidence 579999999987889999999999999999999999965 799999999999 6999999999999996553
|
| >2egq_A FHL1 protein; LIM domain, four and A half LIM domains protein 1, skeletal muscle LIM- protein 1, SLIM 1, structural genomics NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.4e-15 Score=127.56 Aligned_cols=71 Identities=21% Similarity=0.579 Sum_probs=63.4
Q ss_pred CCeeeeccccccccCCcccccCCcccc-----CeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhh
Q psy5063 54 DGLLFCKEDYNGKYGEACQNCGQMMSG-----PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKR 126 (681)
Q Consensus 54 dg~~yC~~cY~~~f~~~C~~C~~~I~g-----~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~ 126 (681)
++++||++||.++|+++|++|+++|.+ ..+.|.++.||++||+|..|+++|. +..|+. .++++||..||.+
T Consensus 1 g~~~yC~~cy~~~~~~~C~~C~~~I~~~g~~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~f~~-~~~~~yC~~cy~~ 76 (77)
T 2egq_A 1 GSSGSSGDCYKNFVAKKCAGCKNPITGFGKGSSVVAYEGQSWHDYCFHCKKCSVNLA-NKRFVF-HQEQVYCPDCAKK 76 (77)
T ss_dssp CCSSCCTTCCCSCCCCCCSSSCCCCCCCSSCCCEEEETTEEEETTTCBCSSSCCBCT-TSCCCE-ETTEECCHHHHHH
T ss_pred CCCeEchhHhchhhCccCcccCCcccCCCCCceeEEECcceeCcccCEehhcCCCCC-CCccEe-ECCEEEChHHhcc
Confidence 478999999999999999999999987 8899999999999999999999995 455644 4677999999975
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.55 E-value=7.3e-15 Score=159.71 Aligned_cols=131 Identities=19% Similarity=0.226 Sum_probs=91.8
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--------------HHHHHHHHhhccceeeeccCCCCccccc
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--------------AEKNFLKESKQGLIYLIDLGSHGLINNL 547 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--------------~~~~~~~E~k~~~~~~~~~~~~~~~~~~ 547 (681)
|.+++.||+|+||.||+|.+. +|+.||||+++..... ........ ..+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~-----------------~rl 158 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYL-----------------SRL 158 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHH-----------------HHH
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHH-----------------HHH
Confidence 788999999999999999985 5999999987431100 00001111 011
Q ss_pred cchHHHHHHHhCCCCcee--eEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q psy5063 548 HCFSQVAVLRSLHHHNVI--RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLI 625 (681)
Q Consensus 548 ~~~~Ei~iL~~L~HpnIV--~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~II 625 (681)
...+|...|..+.+.++. ..++. . ..+|||||++|++|.++... .....++.|++.+|.|||++|||
T Consensus 159 ~A~kE~~nL~rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~~-------~~~~~l~~qll~~l~~lH~~gIV 227 (397)
T 4gyi_A 159 AAIKEFAFMKALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSSV-------PDPASLYADLIALILRLAKHGLI 227 (397)
T ss_dssp HHHHHHHHHHHHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCCC-------SCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhccc-------HHHHHHHHHHHHHHHHHHHCCCc
Confidence 223567777777555442 22222 2 23799999999998765432 12456889999999999999999
Q ss_pred ccCCCCCcEEEecCCC
Q psy5063 626 HRDLNSQNCLVREVGS 641 (681)
Q Consensus 626 HRDLKp~NILl~~~g~ 641 (681)
||||||.|||++++|.
T Consensus 228 HrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 228 HGDFNEFNILIREEKD 243 (397)
T ss_dssp CSCCSTTSEEEEEEEC
T ss_pred CCCCCHHHEEEeCCCC
Confidence 9999999999999873
|
| >1a7i_A QCRP2 (LIM1); LIM domain containing proteins, metal-binding protein, zinc finger; NMR {Coturnix japonica} SCOP: g.39.1.3 g.39.1.3 PDB: 2o10_A | Back alignment and structure |
|---|
Probab=99.54 E-value=1.5e-15 Score=128.81 Aligned_cols=72 Identities=29% Similarity=0.487 Sum_probs=56.3
Q ss_pred CCCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccccCCcc
Q psy5063 7 PEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCGQMM 78 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I 78 (681)
...+.|++|+++|.+++.+.++++.||++||+|..|+++|.+ .|+.+||++||+.||.++|+++|.+|++..
T Consensus 5 ~~~~~C~~C~~~I~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~c~gcg~g~ 77 (81)
T 1a7i_A 5 GGGNKCGACGRTVYHAEEVQCDGRSFHRCCFLCMVCRKNLDSTTVAIHDAEVYCKSCYGKKYGPKGYGYGQGA 77 (81)
T ss_dssp ---CBCSSSCCBCSSTTEEEETTEEEESSSEECSSSCCEECSSCCEEETTEEECSHHHHHHCC----------
T ss_pred CCCCcCcCcCccccCceeEEeCCcccccccCccCCCCCCCCCCCeEeeCCEEECHHHHHHHhCCcccccCCcc
Confidence 345789999999988889999999999999999999999965 699999999999999999999999998754
|
| >1v6g_A Actin binding LIM protein 2; LIM domain, zinc binding domain, ablim2, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.54 E-value=3.7e-15 Score=126.29 Aligned_cols=74 Identities=24% Similarity=0.530 Sum_probs=65.4
Q ss_pred CeeeeccccccccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 55 GLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 55 g~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
+.+||++||.++|+++|+.|+++|.+++|.|.++.||++||+|..|+++|.++..|.. ++..+||..||.+.+.
T Consensus 2 ~~~yC~~dy~~~~~~~C~~C~~~I~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~~-~~~~~~C~~C~~~~~~ 75 (81)
T 1v6g_A 2 SSGSSGLDYQRLYGTRCFSCDQFIEGEVVSALGKTYHPDCFVCAVCRLPFPPGDRVTF-NGKECMCQKCSLPVSV 75 (81)
T ss_dssp CCCCCCSCGGGSCCCBCTTTCCBCCSCCEEETTEEECTTTSSCSSSCCCCCSSSCEEE-ETTEEEEHHHHSCCSS
T ss_pred CCCcchHHHHhHhCCcCccccCEeccceEEECCceeCccCCccccCCCCCCCCCEEEe-CCCCEEChhhhcccCC
Confidence 5689999999999999999999999999999999999999999999999987776655 4455899999976543
|
| >1x68_A FHL5 protein; four-and-A-half LIM protein 5, zinc finger domain, AN actin- interacting protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.52 E-value=9.1e-15 Score=122.42 Aligned_cols=67 Identities=21% Similarity=0.580 Sum_probs=61.8
Q ss_pred Ccccccccccccc---CceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccccC
Q psy5063 9 ILTCAGCLNNIVE---DEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCG 75 (681)
Q Consensus 9 ~~~C~~C~~~I~~---~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~ 75 (681)
.+.|++|+++|.+ ++.+.++++.||++||+|..|+.+|.+ .|+.+||++||+.||.++|+++|+.++
T Consensus 5 ~~~C~~C~~~I~~~g~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~f~~~~g~~yC~~cy~~~f~~~C~~~s 75 (76)
T 1x68_A 5 SSGCVACSKPISGLTGAKFICFQDSQWHSECFNCGKCSVSLVGKGFLTQNKEIFCQKCGSGMDTDISGPSS 75 (76)
T ss_dssp CCCCTTTCCCCCTTTTCCEEEETTEEEEGGGCBCTTTCCBCSSSCEEEETTEEEETTTTCCCCCCSSSSSC
T ss_pred CCCCccCCCcccCCCCceeEEECCcccCcccCChhhCCCcCCCCceEeECCEEECHHHhhhhhCCcCCCCC
Confidence 3689999999984 488999999999999999999999965 699999999999999999999999885
|
| >2cu8_A Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein, zinc-binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.48 E-value=2.3e-14 Score=119.86 Aligned_cols=66 Identities=27% Similarity=0.586 Sum_probs=61.0
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeec-cccccccCCcccc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCK-EDYNGKYGEACQN 73 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~-~cY~~~f~~~C~~ 73 (681)
..+.|++|+++|..++.+.|+++.||++||+|..|+++|.+ .|+++||++||+ .||.++|+++|.+
T Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~cy~~~f~~kc~g 75 (76)
T 2cu8_A 8 MASKCPKCDKTVYFAEKVSSLGKDWHKFCLKCERCSKTLTPGGHAEHDGKPFCHKPCYATLFGSGPSS 75 (76)
T ss_dssp CCCBCTTTCCBCCTTTEEEETTEEEETTTCBCSSSCCBCCTTSCEEETTEEECTTTHHHHHSCSSCSC
T ss_pred CCCCCcCCCCEeECCeEEEECCeEeeCCCCCCCCCCCccCCCceEeECCEEecchHHHHHhcccccCC
Confidence 34789999999998889999999999999999999999975 699999999999 7999999999974
|
| >2cor_A Pinch protein; LIM domain, particularly interesting NEW Cys- His protein, LIM and senescent cell antigen-like domains 1, structural genomics; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.46 E-value=2.8e-14 Score=120.45 Aligned_cols=65 Identities=20% Similarity=0.273 Sum_probs=59.3
Q ss_pred CCCccccccccccccCceEEecCccccccCcccccCcCccCCceEeeCCeeeeccccccccCCccc
Q psy5063 7 PEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDYNGKYGEACQ 72 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~dg~~yC~~cY~~~f~~~C~ 72 (681)
...+.|++|+++|. ++.+.|+++.||++||+|..|+.+|.+.+|++||++||+.||.++|++++.
T Consensus 13 ~~~~~C~~C~~~I~-~~~v~a~~~~~H~~CF~C~~C~~~L~~~~f~~~g~~yC~~cy~~~f~p~~s 77 (79)
T 2cor_A 13 LGKYICQKCHAIID-EQPLIFKNDPYHPDHFNCANCGKELTADARELKGELYCLPCHDKMGVSGPS 77 (79)
T ss_dssp CCCCBCTTTCCBCC-SCCCCCSSSCCCTTTSBCSSSCCBCCTTCEEETTEEECHHHHHTTSCCSSC
T ss_pred cCCCCCccCCCEec-ceEEEECcceeCCCCCEeCCCCCccCCCCEeECCEEeCHHHHHHhCCCCCC
Confidence 34578999999998 788999999999999999999999988788999999999999999998765
|
| >2cur_A Skeletal muscle LIM-protein 1; four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.46 E-value=2.6e-14 Score=117.22 Aligned_cols=65 Identities=22% Similarity=0.523 Sum_probs=59.5
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
..+.|++|+++|. ++.+.++++.||++||+|..|+++|.+ .|+++||++||+.||.++|+++|++
T Consensus 4 ~~~~C~~C~~~I~-~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~C~g 69 (69)
T 2cur_A 4 GSSGCVKCNKAIT-SGGITYQDQPWHADCFVCVTCSKKLAGQRFTAVEDQYYCVDCYKNFVSGPSSG 69 (69)
T ss_dssp CCCCCSSSCCCCC-TTCEEETTEEECTTTTBCTTTCCBCTTSCEEECSSCEEEHHHHHHHHTCSCCC
T ss_pred CcCCCcccCCEeC-cceEEECccccccCcCEECCCCCCCCCCccEeECCEEECHHHhHHHhcCCCCC
Confidence 3478999999997 568999999999999999999999965 7899999999999999999999974
|
| >1g47_A Pinch protein; LIM domain, Zn finger, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-14 Score=119.17 Aligned_cols=68 Identities=19% Similarity=0.549 Sum_probs=59.1
Q ss_pred CCCCCcccccccccccc-CceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCccc
Q psy5063 5 ETPEILTCAGCLNNIVE-DEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQ 72 (681)
Q Consensus 5 ~~~~~~~C~~C~~~I~~-~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~ 72 (681)
+....+.|++|+++|.. +.++.++|+.||++||+|..|+++|.+ .||.+||++||+.||.++|+++|.
T Consensus 7 ~~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~~f~~~C~ 76 (77)
T 1g47_A 7 NALASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGLFYEFEGRKYCEHDFQMLFAPCWI 76 (77)
T ss_dssp SCCCCCBCSSSCCBCCSTTTCEEETTEEECTTTCCCTTTCCCCGGGCSEEETTEEECHHHHHHHCCCC--
T ss_pred cCCCCCCchhcCCccCCCceEEEeCccEeccccCeECCCCCCCCCCCeEeECCeEeCHHHHHHHhhcccC
Confidence 34445789999999985 567899999999999999999999965 789999999999999999999996
|
| >1wyh_A SLIM 2, skeletal muscle LIM-protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.45 E-value=3.6e-14 Score=117.21 Aligned_cols=65 Identities=23% Similarity=0.611 Sum_probs=59.8
Q ss_pred CccccccccccccC-ceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccc
Q psy5063 9 ILTCAGCLNNIVED-EYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 9 ~~~C~~C~~~I~~~-~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
.+.|++|+++|..+ +.+.++++.||++||+|..|+.+|.+ .|+.+||++||+.||.++|+++|+.
T Consensus 5 ~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~C~~ 71 (72)
T 1wyh_A 5 SSGCSACGETVMPGSRKLEYGGQTWHEHCFLCSGCEQPLGSRSFVPDKGAHYCVPCYENKFASGPSS 71 (72)
T ss_dssp CCBCSSSCCBCCSSSCEECSTTCCEETTTCBCTTTCCBTTTSCEEEETTEEEEHHHHHHHTSCCCCC
T ss_pred CCCCccCCCccccCccEEEECccccCcccCeECCCCCcCCCCccCCcCCeEECHHHHHHHccCcCCC
Confidence 46899999999874 78999999999999999999999965 7899999999999999999999974
|
| >1x4k_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.44 E-value=4.6e-14 Score=116.58 Aligned_cols=65 Identities=22% Similarity=0.531 Sum_probs=59.7
Q ss_pred CccccccccccccC-ceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccc
Q psy5063 9 ILTCAGCLNNIVED-EYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 9 ~~~C~~C~~~I~~~-~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
.+.|++|+++|.++ ..+.++++.||++||+|..|+++|.+ .|+.+||++||+.||.++|+++|+.
T Consensus 5 ~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~C~~ 71 (72)
T 1x4k_A 5 SSGCQECKKTIMPGTRKMEYKGSSWHETCFICHRCQQPIGTKSFIPKDNQNFCVPCYEKQHASGPSS 71 (72)
T ss_dssp CCCBSSSCCCCCSSSCEEEETTEEEETTTTCCSSSCCCCCSSSEEEETTEEEEHHHHHHHTSSCCCC
T ss_pred CCCCccCCCcccCCceEEEECcCeecccCCcccccCCccCCCccCccCCeEECHHHHhHHhCCCCCC
Confidence 36899999999875 68999999999999999999999965 6899999999999999999999973
|
| >2dar_A PDZ and LIM domain protein 5; enigma homolog protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.44 E-value=5e-14 Score=121.82 Aligned_cols=65 Identities=25% Similarity=0.603 Sum_probs=59.5
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
..+.|++|+++|. ++.+.|+++.||++||+|..|+++|.+ .|+.+||++||+.||.++|+++|+.
T Consensus 24 ~~~~C~~C~~~I~-~~~v~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~g~~yC~~cy~~~f~~~c~s 89 (90)
T 2dar_A 24 RTPMCAHCNQVIR-GPFLVALGKSWHPEEFNCAHCKNTMAYIGFVEEKGALYCELCYEKFFASGPSS 89 (90)
T ss_dssp CCCBBSSSCCBCC-SCEEEETTEEECTTTCBCSSSCCBCSSSCBEESSSCEECHHHHHHHTSCCCCC
T ss_pred CCCCCccCCCEec-ceEEEECCccccccCCccCCCCCCCCCCEeEeECCEEECHHHHHHHcCCCCCC
Confidence 3478999999995 788999999999999999999999965 7899999999999999999999963
|
| >2ehe_A Four and A half LIM domains 3; FHL-3, skeletal muscle LIM- protein 2, SLIM 2, FHL3, SLIM2, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.43 E-value=1.1e-13 Score=117.30 Aligned_cols=65 Identities=25% Similarity=0.529 Sum_probs=59.7
Q ss_pred Cccccccccccc-cCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccc
Q psy5063 9 ILTCAGCLNNIV-EDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 9 ~~~C~~C~~~I~-~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
.+.|++|+++|. ++.++.|+++.||++||+|+.|+++|.+ .|+.+||++||+.||.++|+++|++
T Consensus 15 ~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~~~~~C~~c~~~~~~~~C~~ 81 (82)
T 2ehe_A 15 ANTCAECQQLIGHDSRELFYEDRHFHEGCFRCCRCQRSLADEPFTCQDSELLCNDCYCSAFSSGPSS 81 (82)
T ss_dssp SCBCTTTCCBCCSSCCBCCCSSCCCBTTTSBCTTTCCBCSSCCEEEETTEEEETTTSSCCGGGSSCC
T ss_pred CCcCccCCCccccCcEEEEeCCccccccCCeecCCCCccCCCccEeeCCEEECHHHHhhhcCCCCCC
Confidence 468999999998 4678899999999999999999999976 7889999999999999999999974
|
| >2d8z_A Four and A half LIM domains 2; skeletal muscle LIM-protein 3, LIM-domain protein DRAL, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.43 E-value=4.2e-14 Score=116.23 Aligned_cols=64 Identities=25% Similarity=0.594 Sum_probs=58.8
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccc
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
.+.|++|+++|. ++.+.++++.||++||+|..|+++|.+ .|+.+||++||+.||.++|+++|+.
T Consensus 5 ~~~C~~C~~~I~-~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~c~~ 69 (70)
T 2d8z_A 5 SSGCVQCKKPIT-TGGVTYREQPWHKECFVCTACRKQLSGQRFTARDDFAYCLNCFCDLYASGPSS 69 (70)
T ss_dssp CCBCSSSCCBCC-SSEEESSSSEEETTTSBCSSSCCBCTTSCCEESSSSEECHHHHHHHTCCCCTT
T ss_pred CCCCcccCCeec-cceEEECccccCCCCCccCCCCCcCCcCceEeeCCeEECHHHHHHHhccccCC
Confidence 468999999997 567999999999999999999999965 7889999999999999999999974
|
| >1nyp_A Pinch protein; LIM domain, protein recognition, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 PDB: 1u5s_B | Back alignment and structure |
|---|
Probab=99.43 E-value=5.3e-14 Score=114.35 Aligned_cols=61 Identities=28% Similarity=0.774 Sum_probs=56.7
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCc
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEA 70 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~ 70 (681)
.+.|++|+++|. ++.+.|+++.||++||+|..|+.+|.+ .|+.+||++||+.||.++|+++
T Consensus 5 ~~~C~~C~~~I~-~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~~f~~k 66 (66)
T 1nyp_A 5 VPICGACRRPIE-GRVVNAMGKQWHVEHFVCAKCEKPFLGHRHYERKGLAYCETHYNQLFGDV 66 (66)
T ss_dssp CCEETTTTEECC-SCEECCTTSBEETTTCBCTTTCCBCSSSCCEEETTEEECHHHHHHHCSCC
T ss_pred CCCCcccCCEec-ceEEEECccccccCcCEECCCCCCCCCCceEeECCcEECHHHHHHHhCCC
Confidence 468999999998 788999999999999999999999965 7999999999999999999875
|
| >1x4l_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.42 E-value=8.7e-14 Score=115.06 Aligned_cols=65 Identities=26% Similarity=0.638 Sum_probs=58.4
Q ss_pred CCcccccccccccc---CceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCccc
Q psy5063 8 EILTCAGCLNNIVE---DEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQ 72 (681)
Q Consensus 8 ~~~~C~~C~~~I~~---~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~ 72 (681)
..+.|++|+++|.+ ++++.++++.||++||+|..|+.+|.+ .|+.+||++||+.||.+.|++++.
T Consensus 4 ~~~~C~~C~~~I~~~~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~f~~~~g~~yC~~c~~~~~~p~~g 72 (72)
T 1x4l_A 4 GSSGCAGCTNPISGLGGTKYISFEERQWHNDCFNCKKCSLSLVGRGFLTERDDILCPDCGKDISGPSSG 72 (72)
T ss_dssp CSCSBTTTTBCCCCSSSCSCEECSSCEECTTTCBCSSSCCBCTTSCCEECSSSEECHHHHHTCCCSSCC
T ss_pred CCCCCcCCCccccCCCCcceEEECCcccCcccCEeccCCCcCCCCccEeECCEEEChhHcCcccCCCCC
Confidence 35789999999985 478999999999999999999999976 678899999999999999998863
|
| >1x64_A Alpha-actinin-2 associated LIM protein; LIM domain, PDZ and LIM domain 3, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.41 E-value=1.2e-13 Score=119.22 Aligned_cols=65 Identities=26% Similarity=0.595 Sum_probs=59.3
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
..+.|++|++.|.+ +++.|+++.||.+||+|..|++.|.+ .||.+||++||+.||.++|+++|.+
T Consensus 24 ~~~~C~~C~~~I~~-~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~~f~p~~~g 89 (89)
T 1x64_A 24 RMPLCDKCGSGIVG-AVVKARDKYRHPECFVCADCNLNLKQKGYFFVEGELYCETHARARTSGPSSG 89 (89)
T ss_dssp SCCBCTTTCCBCCS-CCEESSSCEECTTTCCCSSSCCCTTTSCCEEETTEEECHHHHHHHSSSCCCC
T ss_pred cCCCcccCCCEecc-cEEEECCceECccCCEecCCCCCCCCCCeEeECCEEECHHHHHHHhCCCCCC
Confidence 44689999999974 78999999999999999999999965 7999999999999999999999863
|
| >1x62_A C-terminal LIM domain protein 1; PDZ and LIM domain protein 1, LIM domain protein CLP-36, contractIle protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.40 E-value=6.5e-14 Score=118.12 Aligned_cols=65 Identities=18% Similarity=0.511 Sum_probs=59.3
Q ss_pred CCCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCccc
Q psy5063 7 PEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQ 72 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~ 72 (681)
...+.|++|+++|.+ +++.|+++.||++||+|..|+++|.+ .||.+||++||+.||.++|++++.
T Consensus 13 ~~~~~C~~C~~~I~~-~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~cy~~~~~p~g~ 78 (79)
T 1x62_A 13 QKLPMCDKCGTGIVG-VFVKLRDRHRHPECYVCTDCGTNLKQKGHFFVEDQIYCEKHARERVSGPSS 78 (79)
T ss_dssp CCCCCCSSSCCCCCS-SCEECSSCEECTTTTSCSSSCCCHHHHCCEESSSCEECHHHHHHHHSSCCC
T ss_pred CCCCccccCCCCccC-cEEEECcceeCcCcCeeCCCCCCCCCCCeEeECCEEECHHHHHHHhCCCCC
Confidence 445789999999975 68999999999999999999999965 699999999999999999999875
|
| >1x3h_A Leupaxin; paxillin family, protein-protein interaction, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-13 Score=116.39 Aligned_cols=64 Identities=31% Similarity=0.799 Sum_probs=59.3
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccc
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
.+.|++|+++|.+ +.+.|+++.||++||+|..|+++|.+ .|+.+||++||+.||.++|+++|++
T Consensus 15 ~~~C~~C~~~I~~-~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~~y~~~f~~~C~~ 79 (80)
T 1x3h_A 15 SPKCGGCNRPVLE-NYLSAMDTVWHPECFVCGDCFTSFSTGSFFELDGRPFCELHYHHRRGSGPSS 79 (80)
T ss_dssp SCBCTTTCCBCCS-SCEEETTEEECTTTCBCSSSCCBSCSSCCEESSSCEECHHHHHHHHSSSCCC
T ss_pred CCccccCCCeecc-eeEEECCCeEecCcCChhhCCCCCCCCcEEeECCEEECHHHHHHHcCCCCCC
Confidence 4789999999975 78999999999999999999999965 7999999999999999999999974
|
| >2d8y_A Eplin protein; LIM domain, epithelial protein LOST in neoplasm, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.39 E-value=1.1e-13 Score=120.06 Aligned_cols=68 Identities=28% Similarity=0.522 Sum_probs=61.9
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccccC
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCG 75 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~ 75 (681)
..+.|++|+++|.+.+.+.++++.||.+||+|..|+.+|.. .||.+||++||+.||.++|+++|.-+.
T Consensus 14 ~~~~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~~f~~kc~~~~ 82 (91)
T 2d8y_A 14 ARETCVECQKTVYPMERLLANQQVFHISCFRCSYCNNKLSLGTYASLHGRIYCKPHFNQLFKSKGNYDE 82 (91)
T ss_dssp SSCBCTTTCCBCCTTSEEECSSSEEETTTCBCTTTCCBCCTTTCCCSSSCCCCHHHHHHHSCCCSCCCS
T ss_pred CCCcCccCCCccCCceeEEECCCEECCCCCeeCCCCCCCCCCCcEeECCEEECHHHHHHHhCCCcCccC
Confidence 34689999999988788999999999999999999999975 699999999999999999999998443
|
| >2dar_A PDZ and LIM domain protein 5; enigma homolog protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.37 E-value=3e-13 Score=116.97 Aligned_cols=77 Identities=27% Similarity=0.597 Sum_probs=65.3
Q ss_pred CeeeeccccccccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 55 GLLFCKEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 55 g~~yC~~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
....++..+...++++|..|+++|.+++|.|.++.||++||+|..|++.|.+ ..|+ ..++++||..||.++|+|+|.
T Consensus 12 ~~~~~~~~~~~~~~~~C~~C~~~I~~~~v~a~~~~~H~~CF~C~~C~~~L~~-~~f~-~~~g~~yC~~cy~~~f~~~c~ 88 (90)
T 2dar_A 12 LVQRAEHIPAGKRTPMCAHCNQVIRGPFLVALGKSWHPEEFNCAHCKNTMAY-IGFV-EEKGALYCELCYEKFFASGPS 88 (90)
T ss_dssp SCBCCEEECTTTCCCBBSSSCCBCCSCEEEETTEEECTTTCBCSSSCCBCSS-SCBE-ESSSCEECHHHHHHHTSCCCC
T ss_pred hhhhcccCCCCCCCCCCccCCCEecceEEEECCccccccCCccCCCCCCCCC-CEeE-eECCEEECHHHHHHHcCCCCC
Confidence 3344555577788999999999999999999999999999999999999964 4564 456779999999999999863
|
| >2cuq_A Four and A half LIM domains 3; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.37 E-value=2.8e-13 Score=114.29 Aligned_cols=67 Identities=19% Similarity=0.492 Sum_probs=60.1
Q ss_pred CCCCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccc
Q psy5063 6 TPEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 6 ~~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
....+.|++|+++|.+ +.+.|+++.||++||+|..|+++|.+ .|+.+||++||+.||.++|+++|+.
T Consensus 12 ~~~~~~C~~C~~~I~~-~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~c~s 79 (80)
T 2cuq_A 12 NKFAPRCARCSKTLTQ-GGVTYRDQPWHRECLVCTGCQTPLAGQQFTSRDEDPYCVACFGELFASGPSS 79 (80)
T ss_dssp CCSSCCCTTTCCCCCS-CCEESSSSEECTTTCBCSSSCCBCTTCCEEECSSSEEEHHHHHHHTTCSTTC
T ss_pred cccCCcCCCCCCEecC-cEEEECCchhhhhhCCcccCCCcCCCCeeEeECCEEECHHHHHHHcCCCCCC
Confidence 3345789999999975 68999999999999999999999965 7999999999999999999999963
|
| >2d8x_A Protein pinch; LIM domain, pinch protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.37 E-value=2.4e-13 Score=111.76 Aligned_cols=64 Identities=23% Similarity=0.614 Sum_probs=57.7
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCccc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQ 72 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~ 72 (681)
..+.|++|+++|. ++.+.++++.||++||+|..|+.+|.+ .|+.+||++||+.||.++|++++.
T Consensus 4 ~~~~C~~C~~~I~-~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~g~~yC~~c~~~~~~~~~~ 68 (70)
T 2d8x_A 4 GSSGCHQCGEFII-GRVIKAMNNSWHPECFRCDLCQEVLADIGFVKNAGRHLCRPCHNREKASGPS 68 (70)
T ss_dssp CSSBCSSSCCBCC-SCCEEETTEEECTTTSBCSSSCCBCSSSCCEEETTEEECHHHHHHHHCCCSC
T ss_pred CCCcCccCCCEec-ceEEEECcccccccCCEeCCCCCcCCCCccEeECCeEECHHHhhhhcCCCCC
Confidence 4578999999997 578999999999999999999999965 678899999999999999987764
|
| >1x61_A Thyroid receptor interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.37 E-value=2.1e-13 Score=112.64 Aligned_cols=67 Identities=28% Similarity=0.641 Sum_probs=58.9
Q ss_pred CCccccccccccccC-ceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCcccccC
Q psy5063 8 EILTCAGCLNNIVED-EYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCG 75 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~-~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~ 75 (681)
..+.|++|+++|..+ ..+.++++.||++||+|..|+++|.+ .||.+||++||+.||.++| .+|..++
T Consensus 4 ~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~~-~~~~~~~ 72 (72)
T 1x61_A 4 GSSGCGGCGEDVVGDGAGVVALDRVFHVGCFVCSTCRAQLRGQHFYAVERRAYCEGCYVATL-ESGPSSG 72 (72)
T ss_dssp CCCCCSSSCSCCCSSSCCEECSSSEECTTTCBCSSSCCBCTTSCEEESSSCEEEHHHHHHHH-HTCSSCC
T ss_pred CCCCCccCCCccCCCceEEEECCCeEcccCCcccccCCcCCcCcCEeeCCeEECHHHHHHHH-ccCCCCC
Confidence 347899999999864 68999999999999999999999965 6999999999999999988 5676553
|
| >2dlo_A Thyroid receptor-interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.36 E-value=3.1e-13 Score=114.41 Aligned_cols=66 Identities=26% Similarity=0.653 Sum_probs=58.4
Q ss_pred CCCccccccccccccCceEEecCccccccCcccccCcCccCCc-eEee-CCeeeeccccccccCCcccc
Q psy5063 7 PEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDNW-YFEK-DGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~-~~~~-dg~~yC~~cY~~~f~~~C~~ 73 (681)
...+.|++|+++|. ++.+.|+++.||++||+|..|+++|.+. |+.+ ||++||+.||.++|+++|++
T Consensus 13 ~~~~~C~~C~~~I~-~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~~g~~yC~~cy~~~f~~~C~~ 80 (81)
T 2dlo_A 13 ATLEKCATCSQPIL-DRILRAMGKAYHPGCFTCVVCHRGLDGIPFTVDATSQIHCIEDFHRKFASGPSS 80 (81)
T ss_dssp SSCCBCTTTCCBCC-SCCEEETTEEECTTTCBCSSSCCBCTTSCEECCTTCCCEEHHHHHHHTTSSSCC
T ss_pred cCCCccccCCCeec-ceeEEECCccccHHhcCcccCCCccCCCeeEECCCCEEECHHHHHHHhcCcCCC
Confidence 34578999999997 5789999999999999999999999764 5555 79999999999999999974
|
| >2co8_A NEDD9 interacting protein with calponin homology and LIM domains; zinc finger protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.36 E-value=4.6e-13 Score=113.82 Aligned_cols=66 Identities=23% Similarity=0.393 Sum_probs=57.4
Q ss_pred CCCccccccccccccCceEEecCccccccCcccccCcCccCC-ceE--eeCCeeeeccccccccCCccc
Q psy5063 7 PEILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLDN-WYF--EKDGLLFCKEDYNGKYGEACQ 72 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~--~~dg~~yC~~cY~~~f~~~C~ 72 (681)
...+.|++|+++|.+.+.+.++++.||.+||+|..|+++|.. .|+ ++||++||+.||.++|+.-+.
T Consensus 13 ~~~~~C~~C~~~I~~~e~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~g~~yC~~~y~~~~~~~~~ 81 (82)
T 2co8_A 13 GAGDLCALCGEHLYVLERLCVNGHFFHRSCFRCHTCEATLWPGGYEQHPGDGHFYCLQHLPQTDSGPSS 81 (82)
T ss_dssp CSSCBCSSSCCBCCTTTBCCBTTBCCBTTTCBCSSSCCBCCTTSEECCTTTCCCEETTTCCCCCCCCCC
T ss_pred CCCCCCcccCCCcccceEEEECCCeeCCCcCEEcCCCCCcCCCceeEeCcCCEEEChHHHHhhhcCCCC
Confidence 345789999999988888999999999999999999999976 455 579999999999999876543
|
| >1b8t_A Protein (CRP1); LIM domain, muscle differentiation, contractIle; NMR {Gallus gallus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 1ibi_A 1qli_A 1cxx_A 1ctl_A 2o13_A | Back alignment and structure |
|---|
Probab=99.35 E-value=3.6e-13 Score=132.76 Aligned_cols=70 Identities=30% Similarity=0.642 Sum_probs=65.5
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccC-CceEeeCCeeeeccccccccCCcccccCCcc
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD-NWYFEKDGLLFCKEDYNGKYGEACQNCGQMM 78 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~-~~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I 78 (681)
.+.|++|+++|.+++.+.++++.||.+||+|..|+.+|. +.|+.+||++||+.||.++|+++|.+|++++
T Consensus 115 ~~~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~cy~~~f~~kc~~C~~~~ 185 (192)
T 1b8t_A 115 SDGCPRCGQAVYAAEKVIGAGKSWHKSCFRCAKCGKSLESTTLADKDGEIYCKGCYAKNFGPKGFGFGQGA 185 (192)
T ss_dssp CEECTTTSCEECSSSCEEETTEEECTTTCBCTTTCCBCCSSSEEEETTEEEEHHHHHHHTCCCCCCCCCCC
T ss_pred CCcCCCCCCEecCcEEEecCCCccchhcCCccccCCCCCCCcccccCCEEeCHHHHHHhcCCcCCCCCCcc
Confidence 357999999998888899999999999999999999995 4799999999999999999999999999986
|
| >1x68_A FHL5 protein; four-and-A-half LIM protein 5, zinc finger domain, AN actin- interacting protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.35 E-value=6.6e-13 Score=111.02 Aligned_cols=68 Identities=22% Similarity=0.610 Sum_probs=60.1
Q ss_pred cccCCcccccCCcccc----CeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCCC
Q psy5063 65 GKYGEACQNCGQMMSG----PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGRA 134 (681)
Q Consensus 65 ~~f~~~C~~C~~~I~g----~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~~ 134 (681)
++|+++|.+|+++|.+ .++.|.++.||++||+|..|+++|. +..|+. .++++||..||.++++|+|..
T Consensus 2 ~~~~~~C~~C~~~I~~~g~~~~~~a~~~~wH~~CF~C~~C~~~L~-~~~f~~-~~g~~yC~~cy~~~f~~~C~~ 73 (76)
T 1x68_A 2 SSGSSGCVACSKPISGLTGAKFICFQDSQWHSECFNCGKCSVSLV-GKGFLT-QNKEIFCQKCGSGMDTDISGP 73 (76)
T ss_dssp TTCCCCCTTTCCCCCTTTTCCEEEETTEEEEGGGCBCTTTCCBCS-SSCEEE-ETTEEEETTTTCCCCCCSSSS
T ss_pred CccCCCCccCCCcccCCCCceeEEECCcccCcccCChhhCCCcCC-CCceEe-ECCEEECHHHhhhhhCCcCCC
Confidence 4688999999999997 8999999999999999999999995 556655 467899999999999998754
|
| >1x63_A Skeletal muscle LIM-protein 1; LIM domain, four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.34 E-value=7.5e-13 Score=112.17 Aligned_cols=66 Identities=27% Similarity=0.676 Sum_probs=59.2
Q ss_pred CCCccccccccccccC-ceEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccCCccc
Q psy5063 7 PEILTCAGCLNNIVED-EYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQ 72 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~-~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~ 72 (681)
...+.|++|+++|..+ .++.|+++.||++||+|..|+++|.+ .|+.+||++||+.||.++|+++|.
T Consensus 13 ~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~~~~~~~~~yC~~cy~~~f~~~~~ 80 (82)
T 1x63_A 13 EDSPKCKGCFKAIVAGDQNVEYKGTVWHKDCFTCSNCKQVIGTGSFFPKGEDFYCVTCHETKFASGPS 80 (82)
T ss_dssp CCSCBCSSSCCBCCSSSCEEECSSCEEETTTCCCSSSCCCCTTSCEEEETTEEEEHHHHHHHTSCCCS
T ss_pred ccCCcCccCCcccccCceEEEECccccccccCchhhCCCccCCCccEeeCCEEECHHHHHHHhCCCCC
Confidence 3347899999999864 56999999999999999999999965 799999999999999999999885
|
| >2l4z_A DNA endonuclease RBBP8, LIM domain transcription LMO4; protein-protein interaction, LIM-interaction DOM LMO4, RBBP8/CTIP, LIM-only protein; HET: DNA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.34 E-value=2.9e-13 Score=124.08 Aligned_cols=60 Identities=32% Similarity=0.834 Sum_probs=55.3
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccC---CceEeeCCeeeeccccccccC
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD---NWYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~---~~~~~~dg~~yC~~cY~~~f~ 68 (681)
.+.|++|+++|.+.+.+.|+++.||++||+|..|+.+|. ..||.+||++||+.||.++|+
T Consensus 61 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~~~g~~f~~~dg~~yC~~cy~~~Fg 123 (123)
T 2l4z_A 61 WKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFG 123 (123)
T ss_dssp CSBBSSSSSBCCSSSEEEETTEEEETTTSBCTTTCCBGGGTTCCCBCSSSCCBCHHHHHHHCC
T ss_pred CCcCcCCCCCcCCcEEEEeCCcEEcccccCcCcCCCcccccCCceEEECCEEeCHHHhhhhcC
Confidence 368999999999777899999999999999999999995 479999999999999999885
|
| >1wig_A KIAA1808 protein; LIM domain, zinc finger, metal-binding protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.33 E-value=6.7e-13 Score=110.26 Aligned_cols=65 Identities=23% Similarity=0.608 Sum_probs=57.9
Q ss_pred cccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCC
Q psy5063 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130 (681)
Q Consensus 65 ~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p 130 (681)
.+|+++|++|+++|.+++|.|.++.||++||+|..|+++|.++..|+.. ++.+||..||.+.++.
T Consensus 2 s~~~~~C~~C~~~I~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~f~~~-~~~~yC~~C~~~~~~~ 66 (73)
T 1wig_A 2 SSGSSGCDSCEKYITGRVLEAGEKHYHPSCALCVRCGQMFAEGEEMYLQ-GSSIWHPACRQAARTE 66 (73)
T ss_dssp CCSCCSCSSSCCCCSSCCBCCSSCCBCTTTSCCSSSCCCCCSSCCCEEE-TTEEECTTHHHHTSSS
T ss_pred CcCcCCcccCCCEecCeeEEeCCCCCCCCcCEeCCCCCCCCCCCeeEee-CCEEEChHHChHhhcc
Confidence 4688999999999999999999999999999999999999767777665 6779999999988765
|
| >2d8z_A Four and A half LIM domains 2; skeletal muscle LIM-protein 3, LIM-domain protein DRAL, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.32 E-value=9.8e-13 Score=108.00 Aligned_cols=67 Identities=19% Similarity=0.501 Sum_probs=58.6
Q ss_pred cccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 65 ~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
..++++|..|+++|.++.|.|.++.||++||+|..|+++|. +..|+.. ++++||..||.++++|+|.
T Consensus 2 ~~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~~~~~-~~~~yC~~cy~~~f~~~c~ 68 (70)
T 2d8z_A 2 SSGSSGCVQCKKPITTGGVTYREQPWHKECFVCTACRKQLS-GQRFTAR-DDFAYCLNCFCDLYASGPS 68 (70)
T ss_dssp CCCCCBCSSSCCBCCSSEEESSSSEEETTTSBCSSSCCBCT-TSCCEES-SSSEECHHHHHHHTCCCCT
T ss_pred CCCCCCCcccCCeeccceEEECccccCCCCCccCCCCCcCC-cCceEee-CCeEECHHHHHHHhccccC
Confidence 35789999999999999999999999999999999999995 5566554 6679999999999999863
|
| >1nyp_A Pinch protein; LIM domain, protein recognition, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 PDB: 1u5s_B | Back alignment and structure |
|---|
Probab=99.31 E-value=7.1e-13 Score=107.63 Aligned_cols=65 Identities=18% Similarity=0.383 Sum_probs=57.0
Q ss_pred cccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCC
Q psy5063 65 GKYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPL 131 (681)
Q Consensus 65 ~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~ 131 (681)
++|+++|++|+++|.++.+.|.++.||++||+|..|+++|.+ ..|+. .++.+||..||.++|+|+
T Consensus 2 ~~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~~-~~~~~-~~g~~yC~~~y~~~f~~k 66 (66)
T 1nyp_A 2 SMGVPICGACRRPIEGRVVNAMGKQWHVEHFVCAKCEKPFLG-HRHYE-RKGLAYCETHYNQLFGDV 66 (66)
T ss_dssp CCCCCEETTTTEECCSCEECCTTSBEETTTCBCTTTCCBCSS-SCCEE-ETTEEECHHHHHHHCSCC
T ss_pred CcCCCCCcccCCEecceEEEECccccccCcCEECCCCCCCCC-CceEe-ECCcEECHHHHHHHhCCC
Confidence 457899999999999999999999999999999999999954 45544 467799999999999884
|
| >1x4k_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.31 E-value=1.3e-12 Score=107.85 Aligned_cols=67 Identities=24% Similarity=0.520 Sum_probs=58.3
Q ss_pred cccCCcccccCCccc--cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 65 GKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 65 ~~f~~~C~~C~~~I~--g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
++|+++|..|+++|. +.+|.|.++.||++||+|..|+++|.++ .|+. .++.+||..||.++++|+|.
T Consensus 2 ~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~-~~~~-~~~~~yC~~cy~~~f~~~C~ 70 (72)
T 1x4k_A 2 SSGSSGCQECKKTIMPGTRKMEYKGSSWHETCFICHRCQQPIGTK-SFIP-KDNQNFCVPCYEKQHASGPS 70 (72)
T ss_dssp CSCCCCBSSSCCCCCSSSCEEEETTEEEETTTTCCSSSCCCCCSS-SEEE-ETTEEEEHHHHHHHTSSCCC
T ss_pred CccCCCCccCCCcccCCceEEEECcCeecccCCcccccCCccCCC-ccCc-cCCeEECHHHHhHHhCCCCC
Confidence 468899999999997 4689999999999999999999999665 5554 46789999999999999863
|
| >1wyh_A SLIM 2, skeletal muscle LIM-protein 2; structural genomics, riken structural genomics/proteomics initiative, RSGI, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.31 E-value=1.2e-12 Score=108.07 Aligned_cols=67 Identities=22% Similarity=0.638 Sum_probs=58.4
Q ss_pred cccCCcccccCCccc--cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 65 GKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 65 ~~f~~~C~~C~~~I~--g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
++|+++|..|+++|. +.+|.|.++.||++||+|..|+++|..+ .|+. .++.+||..||.++++|+|.
T Consensus 2 ~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~-~~~~-~~~~~yC~~cy~~~f~~~C~ 70 (72)
T 1wyh_A 2 SSGSSGCSACGETVMPGSRKLEYGGQTWHEHCFLCSGCEQPLGSR-SFVP-DKGAHYCVPCYENKFASGPS 70 (72)
T ss_dssp CCCCCBCSSSCCBCCSSSCEECSTTCCEETTTCBCTTTCCBTTTS-CEEE-ETTEEEEHHHHHHHTSCCCC
T ss_pred CccCCCCccCCCccccCccEEEECccccCcccCeECCCCCcCCCC-ccCC-cCCeEECHHHHHHHccCcCC
Confidence 467899999999997 6789999999999999999999999654 5554 46789999999999999863
|
| >2cur_A Skeletal muscle LIM-protein 1; four and A half LIM domains protein 1, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.31 E-value=1.2e-12 Score=107.19 Aligned_cols=65 Identities=25% Similarity=0.642 Sum_probs=57.9
Q ss_pred ccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 66 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 66 ~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
.++++|..|+++|.++.+.|.++.||++||+|..|+++|. +..|+.. ++++||..||.++++|+|
T Consensus 3 ~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~~~~~-~~~~yC~~cy~~~f~~~C 67 (69)
T 2cur_A 3 SGSSGCVKCNKAITSGGITYQDQPWHADCFVCVTCSKKLA-GQRFTAV-EDQYYCVDCYKNFVSGPS 67 (69)
T ss_dssp CCCCCCSSSCCCCCTTCEEETTEEECTTTTBCTTTCCBCT-TSCEEEC-SSCEEEHHHHHHHHTCSC
T ss_pred CCcCCCcccCCEeCcceEEECccccccCcCEECCCCCCCC-CCccEeE-CCEEECHHHhHHHhcCCC
Confidence 5678999999999999999999999999999999999995 5566554 567999999999999976
|
| >1wig_A KIAA1808 protein; LIM domain, zinc finger, metal-binding protein, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.30 E-value=1.1e-12 Score=108.88 Aligned_cols=61 Identities=16% Similarity=0.347 Sum_probs=55.1
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccC-C-ceEeeCCeeeeccccccccCCc
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD-N-WYFEKDGLLFCKEDYNGKYGEA 70 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~-~-~~~~~dg~~yC~~cY~~~f~~~ 70 (681)
.+.|++|+++|.+ +++.|+++.||++||+|..|+.+|. + .|+.++|++||+.||.+.+++.
T Consensus 5 ~~~C~~C~~~I~~-~~v~a~~~~wH~~CF~C~~C~~~L~~~~~f~~~~~~~yC~~C~~~~~~~~ 67 (73)
T 1wig_A 5 SSGCDSCEKYITG-RVLEAGEKHYHPSCALCVRCGQMFAEGEEMYLQGSSIWHPACRQAARTED 67 (73)
T ss_dssp CCSCSSSCCCCSS-CCBCCSSCCBCTTTSCCSSSCCCCCSSCCCEEETTEEECTTHHHHTSSSS
T ss_pred cCCcccCCCEecC-eeEEeCCCCCCCCcCEeCCCCCCCCCCCeeEeeCCEEEChHHChHhhccc
Confidence 4789999999975 7899999999999999999999996 4 7889999999999999887654
|
| >1x4l_A Skeletal muscle LIM-protein 3; LIM domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.29 E-value=1.9e-12 Score=106.97 Aligned_cols=65 Identities=26% Similarity=0.630 Sum_probs=56.6
Q ss_pred ccCCcccccCCcccc----CeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 66 KYGEACQNCGQMMSG----PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 66 ~f~~~C~~C~~~I~g----~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
+++++|.+|+++|.+ .+|.|.++.||++||+|..|+++|. +..|+. .++++||..||.++++|+.
T Consensus 3 ~~~~~C~~C~~~I~~~~~~~~~~a~~~~wH~~CF~C~~C~~~L~-~~~f~~-~~g~~yC~~c~~~~~~p~~ 71 (72)
T 1x4l_A 3 SGSSGCAGCTNPISGLGGTKYISFEERQWHNDCFNCKKCSLSLV-GRGFLT-ERDDILCPDCGKDISGPSS 71 (72)
T ss_dssp SCSCSBTTTTBCCCCSSSCSCEECSSCEECTTTCBCSSSCCBCT-TSCCEE-CSSSEECHHHHHTCCCSSC
T ss_pred CCCCCCcCCCccccCCCCcceEEECCcccCcccCEeccCCCcCC-CCccEe-ECCEEEChhHcCcccCCCC
Confidence 567899999999986 7899999999999999999999995 556654 4677999999999999863
|
| >3f6q_B LIM and senescent cell antigen-like-containing domain protein 1; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 2kbx_B 3ixe_B | Back alignment and structure |
|---|
Probab=99.28 E-value=1.4e-12 Score=107.35 Aligned_cols=61 Identities=23% Similarity=0.628 Sum_probs=54.5
Q ss_pred CCccccccccccccCc-eEEecCccccccCcccccCcCccCC-ceEeeCCeeeeccccccccC
Q psy5063 8 EILTCAGCLNNIVEDE-YVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~-~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~ 68 (681)
..+.|++|+++|..++ .+.++++.||++||+|..|+++|.. .|+.+||++||+.||.++|+
T Consensus 10 ~~~~C~~C~~~i~~~e~~~~~~~~~~H~~CF~C~~C~~~L~~~~~~~~~g~~yC~~~y~~lf~ 72 (72)
T 3f6q_B 10 ASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGLFYEFEGRKYCEHDFQMLFA 72 (72)
T ss_dssp TTCBCTTTCCBCCTTCEEEEETTEEEETTTSSCTTTCCCCGGGCCEEETTEEECHHHHHHHTC
T ss_pred CCccchhcCccccCCceEEEeCcCeeCcCCCcccCCCCCCCCCCeEeECCeEeCHHHHHHhhC
Confidence 3468999999998665 5789999999999999999999965 68999999999999998875
|
| >2cor_A Pinch protein; LIM domain, particularly interesting NEW Cys- His protein, LIM and senescent cell antigen-like domains 1, structural genomics; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.27 E-value=2.5e-12 Score=108.44 Aligned_cols=64 Identities=19% Similarity=0.443 Sum_probs=56.7
Q ss_pred ccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 66 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 66 ~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
.+.++|.+|+++|.++.|.|.++.||++||+|..|+++|.++ .| ..++.+||..||.++|+|..
T Consensus 13 ~~~~~C~~C~~~I~~~~v~a~~~~~H~~CF~C~~C~~~L~~~-~f--~~~g~~yC~~cy~~~f~p~~ 76 (79)
T 2cor_A 13 LGKYICQKCHAIIDEQPLIFKNDPYHPDHFNCANCGKELTAD-AR--ELKGELYCLPCHDKMGVSGP 76 (79)
T ss_dssp CCCCBCTTTCCBCCSCCCCCSSSCCCTTTSBCSSSCCBCCTT-CE--EETTEEECHHHHHTTSCCSS
T ss_pred cCCCCCccCCCEecceEEEECcceeCCCCCEeCCCCCccCCC-CE--eECCEEeCHHHHHHhCCCCC
Confidence 456899999999999999999999999999999999999644 44 55788999999999999953
|
| >1x6a_A LIMK-2, LIM domain kinase 2; LIM-kinase 2, zinc finger domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.26 E-value=2.4e-12 Score=108.82 Aligned_cols=65 Identities=22% Similarity=0.485 Sum_probs=57.6
Q ss_pred CCccccccccccccCceEEecCccccccCcccccCcCccC-C-ceE-eeCCeeeeccccccccCCcccc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD-N-WYF-EKDGLLFCKEDYNGKYGEACQN 73 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~-~-~~~-~~dg~~yC~~cY~~~f~~~C~~ 73 (681)
-.+.|++|+++|. ++.+.|+++.||++||+|..|+++|. + .|+ ++||++||+.||.++|++.|.+
T Consensus 14 ~~~~C~~C~~~I~-~~~~~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~~~~~~C~~c~~~~~~~~~sg 81 (81)
T 1x6a_A 14 FGEFCHGCSLLMT-GPFMVAGEFKYHPECFACMSCKVIIEDGDAYALVQHATLYCGKCHNEVVSGPSSG 81 (81)
T ss_dssp SSCBCTTTCCBCC-SCCBCCTTCCBCTTSCBCTTTCCBCCTTSCEEECSSSCEEEHHHHHHHHCTTSCC
T ss_pred cCCcCccCCCCcC-ceEEEECCceeccccCCccCCCCccCCCCcEEEeeCCEEECHHHHHHHhcCCCCC
Confidence 3468999999998 78899999999999999999999995 4 555 5899999999999999988864
|
| >2d8x_A Protein pinch; LIM domain, pinch protein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.25 E-value=3.4e-12 Score=104.83 Aligned_cols=65 Identities=25% Similarity=0.635 Sum_probs=57.0
Q ss_pred ccCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 66 KYGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 66 ~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
.+.++|..|+++|.+++|.|.++.||++||+|..|+++|.++ .|+. .++++||..||.++++|..
T Consensus 3 ~~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~~~-~f~~-~~g~~yC~~c~~~~~~~~~ 67 (70)
T 2d8x_A 3 SGSSGCHQCGEFIIGRVIKAMNNSWHPECFRCDLCQEVLADI-GFVK-NAGRHLCRPCHNREKASGP 67 (70)
T ss_dssp CCSSBCSSSCCBCCSCCEEETTEEECTTTSBCSSSCCBCSSS-CCEE-ETTEEECHHHHHHHHCCCS
T ss_pred CCCCcCccCCCEecceEEEECcccccccCCEeCCCCCcCCCC-ccEe-ECCeEECHHHhhhhcCCCC
Confidence 356899999999999999999999999999999999999766 4544 5778999999999998853
|
| >2cu8_A Cysteine-rich protein 2; CRP2, CRIP2, ESP1 protein, zinc-binding, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.24 E-value=5.6e-12 Score=105.27 Aligned_cols=68 Identities=18% Similarity=0.383 Sum_probs=58.5
Q ss_pred cccccCCcccccCCccc-cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeec-cchhhhcCCCC
Q psy5063 63 YNGKYGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCG-LCYKRQMQPLG 132 (681)
Q Consensus 63 Y~~~f~~~C~~C~~~I~-g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~-~Cy~~~~~p~~ 132 (681)
....++++|..|+++|. ++.+.|.++.||++||+|..|+++|.+ ..|+. .++++||. .||.++|+|+|
T Consensus 4 ~~~~~~~~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~-~~~~~-~~g~~yC~~~cy~~~f~~kc 73 (76)
T 2cu8_A 4 GSSGMASKCPKCDKTVYFAEKVSSLGKDWHKFCLKCERCSKTLTP-GGHAE-HDGKPFCHKPCYATLFGSGP 73 (76)
T ss_dssp SCCCCCCBCTTTCCBCCTTTEEEETTEEEETTTCBCSSSCCBCCT-TSCEE-ETTEEECTTTHHHHHSCSSC
T ss_pred ccCCCCCCCcCCCCEeECCeEEEECCeEeeCCCCCCCCCCCccCC-CceEe-ECCEEecchHHHHHhccccc
Confidence 34567899999999997 788899999999999999999999964 45554 46789999 79999999976
|
| >1x64_A Alpha-actinin-2 associated LIM protein; LIM domain, PDZ and LIM domain 3, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.22 E-value=6.5e-12 Score=108.25 Aligned_cols=64 Identities=28% Similarity=0.597 Sum_probs=56.5
Q ss_pred cCCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 67 YGEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 67 f~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
..++|..|+++|.+++|.|.++.||++||+|..|++.|.++. |+.. ++.+||..||.++|+|++
T Consensus 24 ~~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~-~~~~-~g~~yC~~~y~~~f~p~~ 87 (89)
T 1x64_A 24 RMPLCDKCGSGIVGAVVKARDKYRHPECFVCADCNLNLKQKG-YFFV-EGELYCETHARARTSGPS 87 (89)
T ss_dssp SCCBCTTTCCBCCSCCEESSSCEECTTTCCCSSSCCCTTTSC-CEEE-TTEEECHHHHHHHSSSCC
T ss_pred cCCCcccCCCEecccEEEECCceECccCCEecCCCCCCCCCC-eEeE-CCEEECHHHHHHHhCCCC
Confidence 457899999999999999999999999999999999996654 5444 678999999999999975
|
| >1g47_A Pinch protein; LIM domain, Zn finger, cell adhesion; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.21 E-value=5.1e-12 Score=105.59 Aligned_cols=66 Identities=17% Similarity=0.420 Sum_probs=56.4
Q ss_pred cccCCcccccCCccc--cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 65 GKYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 65 ~~f~~~C~~C~~~I~--g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
..++++|.+|+++|. +.++.|.++.||++||+|..|+++|.++. |+ ..++.+||..||.++++|+|
T Consensus 8 ~~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~-~~-~~~g~~yC~~~y~~~f~~~C 75 (77)
T 1g47_A 8 ALASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEGL-FY-EFEGRKYCEHDFQMLFAPCW 75 (77)
T ss_dssp CCCCCBCSSSCCBCCSTTTCEEETTEEECTTTCCCTTTCCCCGGGC-SE-EETTEEECHHHHHHHCCCC-
T ss_pred CCCCCCchhcCCccCCCceEEEeCccEeccccCeECCCCCCCCCCC-eE-eECCeEeCHHHHHHHhhccc
Confidence 356789999999995 67889999999999999999999997664 54 44678999999999999976
|
| >2iyb_E Testin, TESS, TES; LIM domain, SH3-binding, tumour supressor LIM domain EVH1 DO cell motility, phosphorylation, cytoskeleton; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.20 E-value=5.5e-12 Score=102.22 Aligned_cols=57 Identities=33% Similarity=0.710 Sum_probs=51.2
Q ss_pred cccccccccccc-CceEEecCcccc--ccCcccccCcCccCC-ceEeeCCeeee-ccccccc
Q psy5063 10 LTCAGCLNNIVE-DEYVQALSQEWH--TDCFRCSACDVMLDN-WYFEKDGLLFC-KEDYNGK 66 (681)
Q Consensus 10 ~~C~~C~~~I~~-~~~v~a~~~~wH--~~CF~C~~C~~~L~~-~~~~~dg~~yC-~~cY~~~ 66 (681)
+.|++|+++|.. ++.+.++++.|| ++||+|+.|+++|.+ .|+.+||++|| ++||.+.
T Consensus 3 ~~C~~C~~~I~~~~~~v~a~~~~wH~~~~CF~C~~C~~~L~~~~f~~~~g~~yC~~~C~~k~ 64 (65)
T 2iyb_E 3 VVCQGCHNAIDPEVQRVTYNNFSWHASTECFLCSCCSKCLIGQKFMPVEGMVFCSVECKKRM 64 (65)
T ss_dssp EECTTTSSEECTTSCEEEETTEEEETTTTTSBCTTTCCBCTTSCCEEETTEEESSHHHHHTT
T ss_pred CCCcCCCCeeccCceEEEECCCccCCCCCCEECCCCCCcCCCCceEEECCEEecCHHHhhhh
Confidence 579999999987 489999999999 999999999999976 68999999999 7888643
|
| >2egq_A FHL1 protein; LIM domain, four and A half LIM domains protein 1, skeletal muscle LIM- protein 1, SLIM 1, structural genomics NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.19 E-value=8e-12 Score=104.46 Aligned_cols=58 Identities=31% Similarity=0.658 Sum_probs=52.1
Q ss_pred CCcccccccccccc----CceEEecCccccccCcccccCcCccCC-ceEeeCCeeeecccccc
Q psy5063 8 EILTCAGCLNNIVE----DEYVQALSQEWHTDCFRCSACDVMLDN-WYFEKDGLLFCKEDYNG 65 (681)
Q Consensus 8 ~~~~C~~C~~~I~~----~~~v~a~~~~wH~~CF~C~~C~~~L~~-~~~~~dg~~yC~~cY~~ 65 (681)
..+.|++|+++|.+ .+.+.|+++.||++||+|+.|+++|.+ .|+.+||++||+.||.+
T Consensus 14 ~~~~C~~C~~~I~~~g~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~~f~~~~~~~yC~~cy~~ 76 (77)
T 2egq_A 14 VAKKCAGCKNPITGFGKGSSVVAYEGQSWHDYCFHCKKCSVNLANKRFVFHQEQVYCPDCAKK 76 (77)
T ss_dssp CCCCCSSSCCCCCCCSSCCCEEEETTEEEETTTCBCSSSCCBCTTSCCCEETTEECCHHHHHH
T ss_pred hCccCcccCCcccCCCCCceeEEECcceeCcccCEehhcCCCCCCCccEeECCEEEChHHhcc
Confidence 34789999999983 488999999999999999999999976 68899999999999964
|
| >1x62_A C-terminal LIM domain protein 1; PDZ and LIM domain protein 1, LIM domain protein CLP-36, contractIle protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.19 E-value=3.9e-12 Score=107.12 Aligned_cols=63 Identities=22% Similarity=0.559 Sum_probs=55.4
Q ss_pred CCcccccCCccccCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 68 GEACQNCGQMMSGPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 68 ~~~C~~C~~~I~g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
.++|..|+++|.+++|.|.++.||++||+|..|++.|.+ ..|+. .++++||..||.++|+|++
T Consensus 15 ~~~C~~C~~~I~~~~~~a~~~~~H~~CF~C~~C~~~L~~-~~~~~-~~g~~yC~~cy~~~~~p~g 77 (79)
T 1x62_A 15 LPMCDKCGTGIVGVFVKLRDRHRHPECYVCTDCGTNLKQ-KGHFF-VEDQIYCEKHARERVSGPS 77 (79)
T ss_dssp CCCCSSSCCCCCSSCEECSSCEECTTTTSCSSSCCCHHH-HCCEE-SSSCEECHHHHHHHHSSCC
T ss_pred CCccccCCCCccCcEEEECcceeCcCcCeeCCCCCCCCC-CCeEe-ECCEEECHHHHHHHhCCCC
Confidence 579999999999999999999999999999999999954 44554 4677999999999999974
|
| >3f6q_B LIM and senescent cell antigen-like-containing domain protein 1; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 2kbx_B 3ixe_B | Back alignment and structure |
|---|
Probab=99.17 E-value=9.1e-12 Score=102.37 Aligned_cols=67 Identities=18% Similarity=0.471 Sum_probs=55.5
Q ss_pred ccc-ccccCCcccccCCccccC--eEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 61 EDY-NGKYGEACQNCGQMMSGP--VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 61 ~cY-~~~f~~~C~~C~~~I~g~--~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
++| ...++++|.+|+++|.+. ++.|.++.||++||+|..|+++|.++ .|+. .++++||..||.++|+
T Consensus 3 n~yy~~~~~~~C~~C~~~i~~~e~~~~~~~~~~H~~CF~C~~C~~~L~~~-~~~~-~~g~~yC~~~y~~lf~ 72 (72)
T 3f6q_B 3 NLYFQGSASATCERCKGGFAPAEKIVNSNGELYHEQCFVCAQCFQQFPEG-LFYE-FEGRKYCEHDFQMLFA 72 (72)
T ss_dssp EEECCCCTTCBCTTTCCBCCTTCEEEEETTEEEETTTSSCTTTCCCCGGG-CCEE-ETTEEECHHHHHHHTC
T ss_pred CccccCcCCccchhcCccccCCceEEEeCcCeeCcCCCcccCCCCCCCCC-CeEe-ECCeEeCHHHHHHhhC
Confidence 344 447889999999999743 67899999999999999999999776 4544 4578999999998875
|
| >1iml_A CRIP, cysteine rich intestinal protein; metal-binding protein, LIM domain protein; NMR {Rattus rattus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.17 E-value=2.4e-11 Score=101.38 Aligned_cols=65 Identities=23% Similarity=0.584 Sum_probs=56.5
Q ss_pred CcccccCCccc-cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeec-cchhhhcCCCCCCc
Q psy5063 69 EACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCG-LCYKRQMQPLGRAK 135 (681)
Q Consensus 69 ~~C~~C~~~I~-g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~-~Cy~~~~~p~~~~~ 135 (681)
++|.+|+++|. ++.+.|.++.||++||+|..|+++|.++ .|+. .++.+||. .||.++++|+|..+
T Consensus 1 p~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~~-~~~~-~~g~~yC~~~cy~~~f~~~C~~C 67 (76)
T 1iml_A 1 PKCPKCDKEVYFAERVTSLGKDWHRPCLKCEKCGKTLTSG-GHAE-HEGKPYCNHPCYSAMFGPKGFGR 67 (76)
T ss_dssp CBCTTTSSBCCGGGEEEETTEEEETTTCBCTTTCCBCCTT-TEEE-ETTEEEETTTHHHHHSSCCCSSC
T ss_pred CcCCCCCCEEECceEEEECCccccCCCCCccccCccCCCC-ceEC-cCCeEeeCHHHHHHHhCccCCCc
Confidence 58999999997 7889999999999999999999999665 5544 57789999 69999999997643
|
| >2d8y_A Eplin protein; LIM domain, epithelial protein LOST in neoplasm, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.17 E-value=2.4e-11 Score=105.15 Aligned_cols=70 Identities=21% Similarity=0.558 Sum_probs=58.8
Q ss_pred cccCCcccccCCcccc-CeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCCCcC
Q psy5063 65 GKYGEACQNCGQMMSG-PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGRAKD 136 (681)
Q Consensus 65 ~~f~~~C~~C~~~I~g-~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~~~~ 136 (681)
....++|..|+++|.+ ..+.|.++.||++||+|..|++.|.++. |+. .++.+||..||.++++|++....
T Consensus 12 ~~~~~~C~~C~~~I~~~~~v~a~~~~~H~~CF~C~~C~~~L~~~~-~~~-~~g~~yC~~~y~~~f~~kc~~~~ 82 (91)
T 2d8y_A 12 APARETCVECQKTVYPMERLLANQQVFHISCFRCSYCNNKLSLGT-YAS-LHGRIYCKPHFNQLFKSKGNYDE 82 (91)
T ss_dssp SSSSCBCTTTCCBCCTTSEEECSSSEEETTTCBCTTTCCBCCTTT-CCC-SSSCCCCHHHHHHHSCCCSCCCS
T ss_pred CCCCCcCccCCCccCCceeEEECCCEECCCCCeeCCCCCCCCCCC-cEe-ECCEEECHHHHHHHhCCCcCccC
Confidence 3456899999999965 7788999999999999999999997665 544 46779999999999999876433
|
| >2dj7_A Actin-binding LIM protein 3; LIM domain, Zn binding protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.16 E-value=1.9e-11 Score=103.37 Aligned_cols=62 Identities=29% Similarity=0.692 Sum_probs=54.5
Q ss_pred CCcccccCCccc-cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 68 GEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 68 ~~~C~~C~~~I~-g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
.++|..|+++|. ++.+.|.++.||++||+|..|+++|. +. |+ ..++++||..||.++|+|+|
T Consensus 15 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~-~~-~~-~~~g~~yC~~~y~~~fg~~C 77 (80)
T 2dj7_A 15 PSHCAGCKEEIKHGQSLLALDKQWHVSCFKCQTCSVILT-GE-YI-SKDGVPYCESDYHAQFGSGP 77 (80)
T ss_dssp CSCCTTTCCCCSSSCCEEETTEEECTTTCBCSSSCCBCS-SC-CE-EETTEEECTTHHHHHTTCCS
T ss_pred CCCCcCcCCeeCCCeEEEECCcccccccCCcCcCCCCcC-CC-eE-EECCEEECHHHHHHHcCCCC
Confidence 468999999996 77899999999999999999999995 54 54 45678999999999999976
|
| >1a7i_A QCRP2 (LIM1); LIM domain containing proteins, metal-binding protein, zinc finger; NMR {Coturnix japonica} SCOP: g.39.1.3 g.39.1.3 PDB: 2o10_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.9e-11 Score=103.32 Aligned_cols=65 Identities=26% Similarity=0.649 Sum_probs=52.6
Q ss_pred cCCcccccCCccc-cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 67 YGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 67 f~~~C~~C~~~I~-g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
..++|..|+++|. +..+.|.++.||++||+|..|+++|..+ .|+.. ++++||..||.++++|++.
T Consensus 6 ~~~~C~~C~~~I~~~~~~~a~~~~~H~~CF~C~~C~~~L~~~-~~~~~-~~~~yC~~cy~~~f~~~c~ 71 (81)
T 1a7i_A 6 GGNKCGACGRTVYHAEEVQCDGRSFHRCCFLCMVCRKNLDST-TVAIH-DAEVYCKSCYGKKYGPKGY 71 (81)
T ss_dssp --CBCSSSCCBCSSTTEEEETTEEEESSSEECSSSCCEECSS-CCEEE-TTEEECSHHHHHHCC----
T ss_pred CCCcCcCcCccccCceeEEeCCcccccccCccCCCCCCCCCC-CeEee-CCEEECHHHHHHHhCCccc
Confidence 4689999999994 7789999999999999999999999655 45544 7789999999999999874
|
| >2jtn_A LIM domain-binding protein 1, LIM/homeobox protein LHX3; intramolecular (fusion) protein-protein complex, protein binding/transcription complex; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=99.14 E-value=3.8e-11 Score=117.29 Aligned_cols=79 Identities=16% Similarity=0.348 Sum_probs=66.7
Q ss_pred CCeeeeccccc---cccCCcccccCCccccC-eEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 54 DGLLFCKEDYN---GKYGEACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 54 dg~~yC~~cY~---~~f~~~C~~C~~~I~g~-~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
++..||..++. ....++|.+|+++|.+. ++.|.++.||++||+|..|+++|.++ .| ..++++||..||.++++
T Consensus 43 ~~~~~~~~~~~~~~~~~~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~-~f--~~~g~~yC~~~y~~~f~ 119 (182)
T 2jtn_A 43 DDEGGSGGHMGSGGTPEIPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAER-CF--SRGESVYCKDDFFKRFG 119 (182)
T ss_dssp SSSCSSSSSCCCCCCCSCCBCBTSSSBCCCSEEEEETTEEECSSTTSCTTTCCCCSSC-CE--EETTEEECHHHHHHTTS
T ss_pred ccccccccccccCCCCCCCcCccCCCCccCceeEEecCCeEccccCccCCCCCccCCC-ce--eECCEeeecCccccccc
Confidence 56789998875 45568999999999877 57899999999999999999999654 45 35788999999999999
Q ss_pred CCCCCc
Q psy5063 130 PLGRAK 135 (681)
Q Consensus 130 p~~~~~ 135 (681)
|+|..+
T Consensus 120 ~kC~~C 125 (182)
T 2jtn_A 120 TKCAAC 125 (182)
T ss_dssp CCCTTT
T ss_pred cccccC
Confidence 998643
|
| >2l4z_A DNA endonuclease RBBP8, LIM domain transcription LMO4; protein-protein interaction, LIM-interaction DOM LMO4, RBBP8/CTIP, LIM-only protein; HET: DNA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.14 E-value=2.6e-11 Score=111.07 Aligned_cols=101 Identities=23% Similarity=0.485 Sum_probs=71.4
Q ss_pred cCceEEecCccccccCcccccCcCccCCceEeeCCeeeecccc---------------ccccCCcccccCCccccC-eEE
Q psy5063 21 EDEYVQALSQEWHTDCFRCSACDVMLDNWYFEKDGLLFCKEDY---------------NGKYGEACQNCGQMMSGP-VMV 84 (681)
Q Consensus 21 ~~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~dg~~yC~~cY---------------~~~f~~~C~~C~~~I~g~-~~~ 84 (681)
..+-+.+.+..||.+. +..|++.+.. +-.+-+.... ...+.++|.+|+++|.+. ++.
T Consensus 6 ~~~~~~~~~~~~~~~~------ga~l~~~km~-~~~~~~~~~s~s~~~~~~~~~~~~~~~~~~~~C~~C~~~I~~~~~v~ 78 (123)
T 2l4z_A 6 NNQDVSFENIQWSIDP------GADLSQYKMD-VTVIDTKDGSQSKLGGGGSGGHMGSGGLSWKRCAGCGGKIADRFLLY 78 (123)
T ss_dssp CCCCSSSGGGCCCCCT------TSTTTTTBCC-CCEECCCSSSCTTSCBTTTBSCCCCSCSSCSBBSSSSSBCCSSSEEE
T ss_pred cCcccccccceeEecc------Ccccccceee-ecccccccccccccCCCCCCCcccccCccCCcCcCCCCCcCCcEEEE
Confidence 3344566788899873 5556553321 1122222211 134567999999999887 589
Q ss_pred ecCccCCCCceecCCCCcccCC-CCceeeecCCeeeeccchhhhcC
Q psy5063 85 VGDHKFHPECFKCTSCSCCIGD-GESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 85 a~~~~yH~~CF~C~~C~~~l~~-g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
|.++.||++||+|..|++.|.+ |..|+. .++++||..||.++|+
T Consensus 79 a~~~~wH~~CF~C~~C~~~L~~~g~~f~~-~dg~~yC~~cy~~~Fg 123 (123)
T 2l4z_A 79 AMDSYWHSRCLKCSSCQAQLGDIGTSSYT-KSGMILCRNDYIRLFG 123 (123)
T ss_dssp ETTEEEETTTSBCTTTCCBGGGTTCCCBC-SSSCCBCHHHHHHHCC
T ss_pred eCCcEEcccccCcCcCCCcccccCCceEE-ECCEEeCHHHhhhhcC
Confidence 9999999999999999999963 556654 4677999999998874
|
| >2cup_A Skeletal muscle LIM-protein 1; four and half LIM domains protein 1, LIM domain, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.14 E-value=3.6e-11 Score=105.79 Aligned_cols=67 Identities=18% Similarity=0.536 Sum_probs=58.4
Q ss_pred ccCCcccccCCccc--cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCCC
Q psy5063 66 KYGEACQNCGQMMS--GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGRA 134 (681)
Q Consensus 66 ~f~~~C~~C~~~I~--g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~~ 134 (681)
.++++|..|+++|. +.++.|.++.||++||+|..|+++|. +..|+. .++++||..||.++++|+|..
T Consensus 3 ~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~~~~-~~g~~yC~~cy~~~~~~~C~~ 71 (101)
T 2cup_A 3 SGSSGCVECRKPIGADSKEVHYKNRFWHDTCFRCAKCLHPLA-NETFVA-KDNKILCNKCTTREDSPKCKG 71 (101)
T ss_dssp SCCCBCSSSCCBCCSSSCEEEETTEEEETTTCCCSSSCCCTT-SSCCEE-ETTEEECHHHHTTCCCCBCSS
T ss_pred CCCCcCcccCCcccCCceEEEECccChhhcCCcccccCCCCC-cCeeEC-cCCEEEChhHhhhhcCCcccc
Confidence 56789999999996 68899999999999999999999994 555644 567899999999999999764
|
| >1x61_A Thyroid receptor interacting protein 6; LIM domain, OPA-interacting protein 1, zyxin related protein 1 (ZRP-1), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.12 E-value=3.1e-11 Score=99.55 Aligned_cols=63 Identities=29% Similarity=0.703 Sum_probs=54.2
Q ss_pred ccCCcccccCCcccc--CeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCC
Q psy5063 66 KYGEACQNCGQMMSG--PVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130 (681)
Q Consensus 66 ~f~~~C~~C~~~I~g--~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p 130 (681)
.++++|.+|+++|.+ .++.|.++.||++||+|..|+++| .+..|+.. ++.+||..||.++++.
T Consensus 3 ~~~~~C~~C~~~I~~~~~~~~a~~~~~H~~CF~C~~C~~~L-~~~~~~~~-~~~~yC~~cy~~~~~~ 67 (72)
T 1x61_A 3 SGSSGCGGCGEDVVGDGAGVVALDRVFHVGCFVCSTCRAQL-RGQHFYAV-ERRAYCEGCYVATLES 67 (72)
T ss_dssp SCCCCCSSSCSCCCSSSCCEECSSSEECTTTCBCSSSCCBC-TTSCEEES-SSCEEEHHHHHHHHHT
T ss_pred CCCCCCccCCCccCCCceEEEECCCeEcccCCcccccCCcC-CcCcCEee-CCeEECHHHHHHHHcc
Confidence 467899999999974 589999999999999999999999 56667554 5679999999998764
|
| >1m3v_A FLIN4, fusion of the LIM interacting domain of LDB1 and the N-terminal LIM domain of LMO4...; fusion protein, LMO proteins, metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.12 E-value=2.6e-11 Score=110.77 Aligned_cols=76 Identities=24% Similarity=0.496 Sum_probs=61.2
Q ss_pred ccCCcccccCCccccC-eEEecCccCCCCceecCCCCcccCC-CCceeeecCCeeeeccchhhhcCCCCCCcCCCCCCC
Q psy5063 66 KYGEACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGD-GESYALVERSILYCGLCYKRQMQPLGRAKDAAFPMM 142 (681)
Q Consensus 66 ~f~~~C~~C~~~I~g~-~~~a~~~~yH~~CF~C~~C~~~l~~-g~~~~l~~~~~lyC~~Cy~~~~~p~~~~~~~~~p~~ 142 (681)
.+.++|++|+++|.+. ++.|.++.||++||+|..|+++|.+ +..|+ ..++++||..||.++|+|..+|..+..|+.
T Consensus 3 ~~~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~~~~~-~~~g~~yC~~cy~~~f~~~~~C~~C~~~I~ 80 (122)
T 1m3v_A 3 LSWKRCAGCGGKIADRFLLYAMDSYWHSRCLKCSSCQAQLGDIGTSSY-TKSGMILCRNDYIRLFGNSGAGGSGGHMGS 80 (122)
T ss_dssp SCCCCBSSSSSCCCSSCCEEETTEEECHHHHCCSSSCCCTTTSEECCE-EETTEEECHHHHHHHHCCCCSSSCSSCCSC
T ss_pred CCCCCCcccCCEeCCcEEEEECCceeHhhCCCcCCCCCcccccCCeEE-EECCeeecHHHHHHHcCCCCccccCCCCcC
Confidence 4678999999999887 5899999999999999999999964 45565 456789999999999999433344444444
|
| >2co8_A NEDD9 interacting protein with calponin homology and LIM domains; zinc finger protein, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.12 E-value=3e-11 Score=102.52 Aligned_cols=63 Identities=25% Similarity=0.581 Sum_probs=53.1
Q ss_pred CCcccccCCccc-cCeEEecCccCCCCceecCCCCcccCCCCceee-ecCCeeeeccchhhhcCCC
Q psy5063 68 GEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYAL-VERSILYCGLCYKRQMQPL 131 (681)
Q Consensus 68 ~~~C~~C~~~I~-g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l-~~~~~lyC~~Cy~~~~~p~ 131 (681)
.++|..|+++|. ++.+.|.++.||++||+|..|++.|..+. |+. ..++++||..||.+++++.
T Consensus 15 ~~~C~~C~~~I~~~e~v~a~~~~wH~~CF~C~~C~~~L~~~~-~~~~~~~g~~yC~~~y~~~~~~~ 79 (82)
T 2co8_A 15 GDLCALCGEHLYVLERLCVNGHFFHRSCFRCHTCEATLWPGG-YEQHPGDGHFYCLQHLPQTDSGP 79 (82)
T ss_dssp SCBCSSSCCBCCTTTBCCBTTBCCBTTTCBCSSSCCBCCTTS-EECCTTTCCCEETTTCCCCCCCC
T ss_pred CCCCcccCCCcccceEEEECCCeeCCCcCEEcCCCCCcCCCc-eeEeCcCCEEEChHHHHhhhcCC
Confidence 468999999994 56778999999999999999999996555 443 4678899999999988764
|
| >2xqn_T Testin, TESS; metal-binding protein, cytoskeleton, focal adhesion, acrosom; 2.62A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.11 E-value=5.2e-11 Score=109.11 Aligned_cols=66 Identities=18% Similarity=0.498 Sum_probs=57.9
Q ss_pred cCCcccccCCccc-cCeEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCCC
Q psy5063 67 YGEACQNCGQMMS-GPVMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGRA 134 (681)
Q Consensus 67 f~~~C~~C~~~I~-g~~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~~ 134 (681)
|+++|.+|+++|. +.++.|.|+.||++||+|..|+++|. +..|+. .++++||..||.++++|+|..
T Consensus 2 ~~~~C~~C~~~I~~~~~~~a~~~~~H~~CF~C~~C~~~L~-~~~f~~-~~g~~yC~~cy~~~~~~~C~~ 68 (126)
T 2xqn_T 2 EKPRCAGCDELIFSNEYTQAENQNWHLKHFCCFDCDSILA-GEIYVM-VNDKPVCKPCYVKNHAVVCQG 68 (126)
T ss_dssp CCCBBTTTSSBCCSSCEEEETTEEECGGGSBCTTTCCBCT-TSEEEE-ETTEEEEHHHHHHHSCCBCTT
T ss_pred cCCCCccCCCEeCCceEEeeCCCCccCCCCCcCCCCCCCC-cCEEEe-ECCEEechHHhCcCcCccCcc
Confidence 6789999999997 56899999999999999999999995 556654 567899999999999999764
|
| >1j2o_A FLIN2, fusion of rhombotin-2 and LIM domain-binding protein 1; LIM-interaction-domain (LID), metal binding protein; NMR {Mus musculus} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=99.10 E-value=4e-11 Score=108.21 Aligned_cols=67 Identities=22% Similarity=0.505 Sum_probs=58.2
Q ss_pred CcccccCCccccC-eEEecCccCCCCceecCCCCcccCC-CCceeeecCCeeeeccchhhhcCCCCCCcC
Q psy5063 69 EACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGD-GESYALVERSILYCGLCYKRQMQPLGRAKD 136 (681)
Q Consensus 69 ~~C~~C~~~I~g~-~~~a~~~~yH~~CF~C~~C~~~l~~-g~~~~l~~~~~lyC~~Cy~~~~~p~~~~~~ 136 (681)
++|.+|+++|.+. ++.|.++.||++||+|..|+++|.+ |..|+. .++++||..||.++|+|+|.++.
T Consensus 4 ~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~g~~~~~-~~g~~yC~~~y~~~f~~~c~~c~ 72 (114)
T 1j2o_A 4 LTCGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYY-KLGRKLCRRDYLRLGGSGGHMGS 72 (114)
T ss_dssp BCBSSSCSCBCSSEEEECSSSEECTTTCCCSSSCSCCCCSSSCCCC-BTTBCCCHHHHHHHHTSCCSSCB
T ss_pred CCCcCCCCeeCCcEEEEECchhHHHhcCcccccCCchhcCCCeeEE-ECCeeechHHHHHHhCcccCcCC
Confidence 6899999999887 7899999999999999999999975 556644 46779999999999999976543
|
| >2iyb_E Testin, TESS, TES; LIM domain, SH3-binding, tumour supressor LIM domain EVH1 DO cell motility, phosphorylation, cytoskeleton; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.09 E-value=3.9e-11 Score=97.16 Aligned_cols=59 Identities=27% Similarity=0.711 Sum_probs=50.3
Q ss_pred cCCcccccCCccc--cCeEEecCccCC--CCceecCCCCcccCCCCceeeecCCeeee-ccchhhh
Q psy5063 67 YGEACQNCGQMMS--GPVMVVGDHKFH--PECFKCTSCSCCIGDGESYALVERSILYC-GLCYKRQ 127 (681)
Q Consensus 67 f~~~C~~C~~~I~--g~~~~a~~~~yH--~~CF~C~~C~~~l~~g~~~~l~~~~~lyC-~~Cy~~~ 127 (681)
|+++|.+|+++|. +..|.|.++.|| ++||+|..|+++|. +..|+. .++++|| ..||.++
T Consensus 1 fa~~C~~C~~~I~~~~~~v~a~~~~wH~~~~CF~C~~C~~~L~-~~~f~~-~~g~~yC~~~C~~k~ 64 (65)
T 2iyb_E 1 HAVVCQGCHNAIDPEVQRVTYNNFSWHASTECFLCSCCSKCLI-GQKFMP-VEGMVFCSVECKKRM 64 (65)
T ss_dssp -CEECTTTSSEECTTSCEEEETTEEEETTTTTSBCTTTCCBCT-TSCCEE-ETTEEESSHHHHHTT
T ss_pred CcCCCcCCCCeeccCceEEEECCCccCCCCCCEECCCCCCcCC-CCceEE-ECCEEecCHHHhhhh
Confidence 5789999999998 689999999999 99999999999994 555655 4578999 8999764
|
| >1rut_X Flinc4, fusion protein of LMO4 protein and LIM domain- binding protein 1; B-tandem zipper, protein binding; 1.30A {Mus musculus} SCOP: g.39.1.3 g.39.1.3 g.39.1.3 g.39.1.3 PDB: 2dfy_X 2xjz_I 2xjy_B | Back alignment and structure |
|---|
Probab=99.07 E-value=1.3e-10 Score=114.09 Aligned_cols=87 Identities=26% Similarity=0.454 Sum_probs=64.5
Q ss_pred cccccccccccC-ceEEecCccccccCcccccCcCccC-C-ceEeeCCeeeeccccccccCCcccccCCcc-----ccCe
Q psy5063 11 TCAGCLNNIVED-EYVQALSQEWHTDCFRCSACDVMLD-N-WYFEKDGLLFCKEDYNGKYGEACQNCGQMM-----SGPV 82 (681)
Q Consensus 11 ~C~~C~~~I~~~-~~v~a~~~~wH~~CF~C~~C~~~L~-~-~~~~~dg~~yC~~cY~~~f~~~C~~C~~~I-----~g~~ 82 (681)
.|++|+++|... .++.|+++.||++||+|..|+++|. + .|+.+||++||+.||.+.|+++|..++..- ...+
T Consensus 71 ~C~~C~~~I~~~e~~i~a~~~~~H~~CF~C~~C~~~L~~g~~f~~~~g~~yC~~c~~~~~~~~~~~~g~~~~~~~~~~~v 150 (188)
T 1rut_X 71 ACSACGQSIPASELVMRAQGNVYHLKCFTCSTCRNRLVPGDRFHYINGSLFCEHDRPTALINGHLNSGGSGGSGGSGGDV 150 (188)
T ss_dssp ECTTTCCEECTTSEEEEETTEEECGGGCBCTTTCCBCCTTCEEEEETTEEEEGGGCCTTTC----------------CCC
T ss_pred ccccCCCccccCcEEEEcCCCEEeCCCCeECCCCCCCCCCCeEEEECCeEECHHHHHHHhcccccccCCCCcccccCCcc
Confidence 699999999864 4689999999999999999999994 4 688999999999999999999998887521 1233
Q ss_pred E-----EecCccCCCCceec
Q psy5063 83 M-----VVGDHKFHPECFKC 97 (681)
Q Consensus 83 ~-----~a~~~~yH~~CF~C 97 (681)
| ...+..||+++.++
T Consensus 151 ~vvgep~l~g~~~~~~~~r~ 170 (188)
T 1rut_X 151 MVVGEPTLMGGEFGDEDERL 170 (188)
T ss_dssp EECCCCEETTCCCCCTTEEE
T ss_pred cccCCCcccCCCCCCCCCce
Confidence 3 34566788888876
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.06 E-value=2.8e-10 Score=115.83 Aligned_cols=140 Identities=16% Similarity=0.047 Sum_probs=105.2
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
..|.....++.|+++.||++... +..+++|........... .+.+|+++|+.+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~-------------------------~~~~E~~~l~~l 66 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTY-------------------------DVEREKDMMLWL 66 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTT-------------------------CHHHHHHHHHHH
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHH-------------------------HHHHHHHHHHHH
Confidence 35777778888999999998754 678999987532111111 123458888887
Q ss_pred -CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------
Q psy5063 560 -HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS----------------- 621 (681)
Q Consensus 560 -~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs----------------- 621 (681)
++..+.+++++....+..|+||||++|.+|.+.+.. ......++.+++.+|..||+
T Consensus 67 ~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~ 140 (263)
T 3tm0_A 67 EGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLA 140 (263)
T ss_dssp TTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHH
T ss_pred hcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHH
Confidence 467788999999999999999999999999876421 12234678899999999998
Q ss_pred ------------------------------------------CCccccCCCCCcEEEecCCCe--EEeeeeeEee
Q psy5063 622 ------------------------------------------MNLIHRDLNSQNCLVREVGSG--FDFHLGQIYL 652 (681)
Q Consensus 622 ------------------------------------------~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~ 652 (681)
..++|+|++|.|||++.++.. +||+.+....
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~gd 215 (263)
T 3tm0_A 141 ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp HHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccCC
Confidence 348999999999999875433 8999887654
|
| >1v6g_A Actin binding LIM protein 2; LIM domain, zinc binding domain, ablim2, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.39.1.3 g.39.1.3 | Back alignment and structure |
|---|
Probab=98.97 E-value=2.3e-10 Score=96.62 Aligned_cols=59 Identities=25% Similarity=0.425 Sum_probs=50.7
Q ss_pred CccccccccccccCceEEecCccccccCcccccCcCccC-CceEeeCC-eeeeccccccccC
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCFRCSACDVMLD-NWYFEKDG-LLFCKEDYNGKYG 68 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF~C~~C~~~L~-~~~~~~dg-~~yC~~cY~~~f~ 68 (681)
.+.|++|+++|. ++.+.|+++.||++||+|..|+++|. +.+|..++ .+||+.||.+.++
T Consensus 15 ~~~C~~C~~~I~-~~~v~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~~~~~~C~~C~~~~~~ 75 (81)
T 1v6g_A 15 GTRCFSCDQFIE-GEVVSALGKTYHPDCFVCAVCRLPFPPGDRVTFNGKECMCQKCSLPVSV 75 (81)
T ss_dssp CCBCTTTCCBCC-SCCEEETTEEECTTTSSCSSSCCCCCSSSCEEEETTEEEEHHHHSCCSS
T ss_pred CCcCccccCEec-cceEEECCceeCccCCccccCCCCCCCCCEEEeCCCCEEChhhhcccCC
Confidence 368999999998 68899999999999999999999995 56676665 5799999987664
|
| >2xjy_A Rhombotin-2; oncoprotein, T-cell leukemia, proto-oncogene, transcription, developmental protein; 2.40A {Homo sapiens} PDB: 2xjz_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.9e-10 Score=103.85 Aligned_cols=64 Identities=23% Similarity=0.551 Sum_probs=55.6
Q ss_pred CcccccCCccccC-eEEecCccCCCCceecCCCCcccCC-CCceeeecCCeeeeccchhhhcCC--CCC
Q psy5063 69 EACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGD-GESYALVERSILYCGLCYKRQMQP--LGR 133 (681)
Q Consensus 69 ~~C~~C~~~I~g~-~~~a~~~~yH~~CF~C~~C~~~l~~-g~~~~l~~~~~lyC~~Cy~~~~~p--~~~ 133 (681)
++|.+|+++|.+. ++.|.++.||++||+|..|+++|.+ |..|+. .++++||..||.++++| +|.
T Consensus 3 ~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~~~~~~~-~~g~~yC~~~y~~~~~~~~~C~ 70 (131)
T 2xjy_A 3 LTCGGCQQNIGDRYFLKAIDQYWHEDCLSCDLCGCRLGEVGRRLYY-KLGRKLCRRDYLRLFGQDGLCA 70 (131)
T ss_dssp CBBTTTCCBCCSSEEEEETTEEEETTTCBCTTTCCBCSSTTCCEEE-ETTEEECHHHHHHHHCCCEECT
T ss_pred ccCcCCCCEeCCcEEEEECCCcccHHHcccCcCCCccccCCCeEEE-ECCEEeecCchhhhCCCccChh
Confidence 6899999999887 6889999999999999999999964 456654 56789999999999999 554
|
| >2rgt_A Fusion of LIM/homeobox protein LHX3, linker, INSU enhancer protein ISL-1; protein-protein complex, LIM domain, Zn finger, activator, D binding; 2.05A {Mus musculus} PDB: 3mmk_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.1e-09 Score=105.68 Aligned_cols=65 Identities=18% Similarity=0.490 Sum_probs=55.7
Q ss_pred CCcccccCCccccC-eEEecCccCCCCceecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCCCc
Q psy5063 68 GEACQNCGQMMSGP-VMVVGDHKFHPECFKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGRAK 135 (681)
Q Consensus 68 ~~~C~~C~~~I~g~-~~~a~~~~yH~~CF~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~~~ 135 (681)
.++|.+|+++|.+. ++.|.|+.||++||+|..|+++|.++ .| ..++++||..||.++++|+|..+
T Consensus 6 ~~~C~~C~~~I~~~~~~~a~~~~wH~~CF~C~~C~~~L~~~-~f--~~~g~~yC~~~y~~~f~~~C~~C 71 (169)
T 2rgt_A 6 IPMCAGCDQHILDRFILKALDRHWHSKCLKCSDCHVPLAER-CF--SRGESVYCKDDFFKRFGTKCAAC 71 (169)
T ss_dssp -CBBSSSSSBCCSSSCEECSSCEECTTTSBCTTTCCBCCSC-CE--ESSSCEECHHHHHHHHSCBCTTT
T ss_pred CCccccCCCccCCcEEEEECCcEEccccCccCCCCCcCCCC-Cc--ccCCeeeeccccccccccccccc
Confidence 47899999999876 67899999999999999999999554 45 45788999999999999998643
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.82 E-value=5.9e-09 Score=104.87 Aligned_cols=133 Identities=16% Similarity=0.079 Sum_probs=93.0
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
+....+.+.|..+.||++.. .+|..+++|....... . ...+|+++|+.+.+
T Consensus 22 ~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~---~-------------------------~~~~E~~~l~~l~~ 72 (264)
T 1nd4_A 22 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL---N-------------------------ELQDEAARLSWLAT 72 (264)
T ss_dssp CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT---S-------------------------CHHHHHHHHHHHHT
T ss_pred CceEecccCCCCceEEEEec-CCCCeEEEEeCCcccc---h-------------------------hhhHHHHHHHHHHh
Confidence 33333334666799999865 4577889997643210 1 12345778887754
Q ss_pred Cc--eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------
Q psy5063 562 HN--VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN---------------- 623 (681)
Q Consensus 562 pn--IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~---------------- 623 (681)
.+ +.+++++...++..++||||++|.+|. ... .. ...++.+++..|..||+..
T Consensus 73 ~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~ 143 (264)
T 1nd4_A 73 TGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIER 143 (264)
T ss_dssp TTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHH
T ss_pred CCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Confidence 34 566888888888899999999998884 221 22 1256677888888888643
Q ss_pred ------------------------------------------ccccCCCCCcEEEecCCCe--EEeeeeeEee
Q psy5063 624 ------------------------------------------LIHRDLNSQNCLVREVGSG--FDFHLGQIYL 652 (681)
Q Consensus 624 ------------------------------------------IIHRDLKp~NILl~~~g~~--~DFGLa~~~~ 652 (681)
++|+|++|.|||++.++.. +|||.+....
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 144 ARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp HHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 9999999999999876543 8999987654
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.74 E-value=1.7e-08 Score=107.85 Aligned_cols=138 Identities=12% Similarity=0.199 Sum_probs=100.3
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEee--ccCH-HHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC-
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELY--RVDE-EAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH- 560 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~--~~~~-~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~- 560 (681)
.+.|+.|.++.||+.... +..+++|... .... .... ...+|.++|+.+.
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~-------------------------~~~~E~~~l~~L~~ 95 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAH-------------------------AIEREYRVMDALAG 95 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC-----------------------------------CHHHHHHHHHHHTT
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHH-------------------------HHHHHHHHHHHhhc
Confidence 456889999999998764 4677888654 2110 0011 2235688888886
Q ss_pred -CCceeeEEEEEEeC---CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---------------
Q psy5063 561 -HHNVIRFIGVLYKD---RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS--------------- 621 (681)
Q Consensus 561 -HpnIV~l~g~~~~~---~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs--------------- 621 (681)
+..+.+++.++.+. +..|+||||++|..+.+.. ...++......++.+++..|..||+
T Consensus 96 ~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~ 172 (359)
T 3dxp_A 96 TDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPG 172 (359)
T ss_dssp SSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCS
T ss_pred CCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCC
Confidence 45678888888765 4589999999998875421 1236788888899999999999997
Q ss_pred -------------------------------------------CCccccCCCCCcEEEecCCC-e---EEeeeeeEee
Q psy5063 622 -------------------------------------------MNLIHRDLNSQNCLVREVGS-G---FDFHLGQIYL 652 (681)
Q Consensus 622 -------------------------------------------~~IIHRDLKp~NILl~~~g~-~---~DFGLa~~~~ 652 (681)
..++|+|+++.|||++.++. + .||+++....
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 173 NYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp CHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred CchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 35899999999999998764 2 8999988654
|
| >2yub_A LIMK-2, LIM domain kinase 2; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=98.49 E-value=8.2e-07 Score=80.37 Aligned_cols=44 Identities=48% Similarity=0.654 Sum_probs=40.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
-|++||+|++|||.+|.+++++++..++++. .+.+.|+++++..
T Consensus 63 GL~~GD~Il~Vng~~v~~~~~~dl~~~l~~~-g~~v~l~v~R~g~ 106 (118)
T 2yub_A 63 AIHPGDRILEINGTPVRTLRVEEVEDAIKQT-SQTLQLLIEHDPV 106 (118)
T ss_dssp HCCTTCCEEEESSSBTTTSCHHHHHHHHHCC-SSCEEEEEEECSS
T ss_pred CCCCCCEEEEECCEECCCcCHHHHHHHHHhC-CCEEEEEEEECCE
Confidence 5999999999999999999999999999955 8899999999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=4.6e-05 Score=79.63 Aligned_cols=133 Identities=21% Similarity=0.178 Sum_probs=86.6
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCC--
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-- 562 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-- 562 (681)
.+.++.|....||+. |..+++|.-. .......+. +|.++|+.+.+.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~-------------------------~E~~~L~~L~~~~~ 71 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELN-------------------------KEIQLLPLLVGCVK 71 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHH-------------------------HHHHHHHHHTTTCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHH-------------------------HHHHHHHHHHhcCC
Confidence 345788999999987 4567778642 222222333 358888888642
Q ss_pred -ceeeEEEEEE-eCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------
Q psy5063 563 -NVIRFIGVLY-KDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM------------------ 622 (681)
Q Consensus 563 -nIV~l~g~~~-~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~------------------ 622 (681)
.+.+.+.+.. ..+..|+||||++|.+|.+..-. .++......++.|+...|..||+.
T Consensus 72 v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~ 148 (306)
T 3tdw_A 72 VNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNK 148 (306)
T ss_dssp SBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHH
T ss_pred CCCCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHH
Confidence 3556666654 34567899999999888763211 134444555555555555555532
Q ss_pred ------------------------------------------CccccCCCCCcEEEec---CCCe---EEeeeeeEee
Q psy5063 623 ------------------------------------------NLIHRDLNSQNCLVRE---VGSG---FDFHLGQIYL 652 (681)
Q Consensus 623 ------------------------------------------~IIHRDLKp~NILl~~---~g~~---~DFGLa~~~~ 652 (681)
.++|+|+++.|||++. ++.+ +||+.+....
T Consensus 149 ~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 149 ILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999997 4554 8998877654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=97.97 E-value=9.1e-06 Score=84.51 Aligned_cols=132 Identities=22% Similarity=0.233 Sum_probs=89.5
Q ss_pred ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC-CCCc-
Q psy5063 486 PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL-HHHN- 563 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~Hpn- 563 (681)
+.++.|.+..||+.. ..+++|..... .....+. +|.++|+.+ .+..
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~-------------------------~E~~~l~~l~~~~~v 73 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLF-------------------------NEVNILKRIHNKLPL 73 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHH-------------------------HHHHHHHHHTTSSSS
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHH-------------------------HHHHHHHHHHhcCCC
Confidence 458999999999863 45778865322 2222233 347788776 3332
Q ss_pred -eeeEEEEEEeCC---eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q psy5063 564 -VIRFIGVLYKDR---KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS------------------ 621 (681)
Q Consensus 564 -IV~l~g~~~~~~---~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs------------------ 621 (681)
+.+.+......+ ..|+|||+++|.+|.+.... .++..+...++.|++..|..||+
T Consensus 74 ~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~ 150 (304)
T 3sg8_A 74 PIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKI 150 (304)
T ss_dssp CCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHH
T ss_pred CCCceEeecCCCCCCCcceEEEcccCCeECCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHH
Confidence 344544433332 35899999999888653321 36777778888888888888886
Q ss_pred ----------------------------------------CCccccCCCCCcEEEecC-CCe---EEeeeeeEee
Q psy5063 622 ----------------------------------------MNLIHRDLNSQNCLVREV-GSG---FDFHLGQIYL 652 (681)
Q Consensus 622 ----------------------------------------~~IIHRDLKp~NILl~~~-g~~---~DFGLa~~~~ 652 (681)
..++|+|++|.|||++.+ +.. +||+.+....
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~ 225 (304)
T 3sg8_A 151 NEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISD 225 (304)
T ss_dssp HHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEEC
T ss_pred HHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCC
Confidence 136999999999999985 433 8999887653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=5.3e-05 Score=76.78 Aligned_cols=132 Identities=19% Similarity=0.145 Sum_probs=88.0
Q ss_pred ecccCcE-EEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC-CCcee
Q psy5063 488 LGQGFFG-QVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH-HHNVI 565 (681)
Q Consensus 488 LG~G~FG-~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV 565 (681)
+..|..| .||+......+..+++|.-... ....+.. |...|+.+. +--+.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~-------------------------E~~~l~~l~~~vPVP 83 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTD-------------------------EMVRLNWLTAFMPLP 83 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHH-------------------------HHHHHHHHTTTSCCC
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHH-------------------------HHHHHHHhccCCCcC
Confidence 4445555 6899887777778888975432 2222333 467777663 33467
Q ss_pred eEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------
Q psy5063 566 RFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSM----------------------- 622 (681)
Q Consensus 566 ~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~----------------------- 622 (681)
+.+++..+++..|+|||+++|.++.+..... ......+..+++..|.-||+.
T Consensus 84 ~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (272)
T 4gkh_A 84 TIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMN 158 (272)
T ss_dssp CEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHH
T ss_pred eEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHH
Confidence 7888888899999999999998887654321 111223444555555555521
Q ss_pred -----------------------------------CccccCCCCCcEEEecCCCe--EEeeeeeEee
Q psy5063 623 -----------------------------------NLIHRDLNSQNCLVREVGSG--FDFHLGQIYL 652 (681)
Q Consensus 623 -----------------------------------~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~ 652 (681)
.++|+|+.+.|||++.++.. +||+.+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gd 225 (272)
T 4gkh_A 159 NGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIAD 225 (272)
T ss_dssp TTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCC
Confidence 16899999999999976654 7998887654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00015 Score=78.14 Aligned_cols=83 Identities=12% Similarity=0.067 Sum_probs=46.0
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC--C
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH--H 562 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--p 562 (681)
.+.||.|.++.||++....+++.+++|............ . ........+|.++|+.+.. +
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~---~---------------~~~~~r~~~E~~~L~~l~~~~~ 96 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGES---W---------------PLTIDRARIESSALIRQGEHVP 96 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC----------C---------------CCCTTHHHHHHHHHHHHHTTCG
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCC---C---------------cCcHHHHHHHHHHHHHhhhhCC
Confidence 457899999999999766567889999764321100000 0 0000112346777776632 3
Q ss_pred -ceeeEEEEEEeCCeEEEEEeccCCC
Q psy5063 563 -NVIRFIGVLYKDRKLNLVTEYIAGG 587 (681)
Q Consensus 563 -nIV~l~g~~~~~~~l~LV~Ey~~gG 587 (681)
.+.+++.+ +.+..++||||+++.
T Consensus 97 ~~vP~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 97 HLVPRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp GGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred CCcCeEEEE--cCCccEEEEEeCCCc
Confidence 34456543 445568999999764
|
| >2kv8_A RGS12, regulator of G-protein signaling 12; PDZ domain, signaling protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00018 Score=60.10 Aligned_cols=43 Identities=33% Similarity=0.404 Sum_probs=38.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+++++++..+++ ...+.++|++++++
T Consensus 40 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~-~~~~~v~l~v~R~~ 82 (83)
T 2kv8_A 40 GLRAGDQILAVNEINVKKASHEDVVKLIG-KCSGVLHMVIAEGV 82 (83)
T ss_dssp TCCTTCEEEEETTEECSSCCHHHHHHHHT-TCSSCEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEcCC
Confidence 59999999999999999999999999998 55677999999887
|
| >1ujv_A Membrane associated guanylate kinase inverted-2 (MAGI-2); atrophin-1 interacting protein 1, PDZ domain, structural genomics, KIAA0705 protein; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00035 Score=60.37 Aligned_cols=45 Identities=22% Similarity=0.265 Sum_probs=40.3
Q ss_pred cccccCCeEEEEcCeecCCCChHHHHHhhhcCC-CceeeeeeeccC
Q psy5063 291 MSLHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILKEC 335 (681)
Q Consensus 291 ~~~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 335 (681)
.-|++||+|++|||.+|.+.+++++..+|++.. ++.+.|+++++-
T Consensus 46 aGL~~GD~I~~vng~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~g 91 (96)
T 1ujv_A 46 PGLCEGDLIVEINQQNVQNLSHTEVVDILKDCPIGSETSLIIHRGS 91 (96)
T ss_dssp TTCCSSCEEEEETTEECSSCCHHHHHHHHHHSCTTSEEEEEEECCS
T ss_pred CCCCCCCEEEEECCEECCCCCHHHHHHHHHcCCCCCEEEEEEEECC
Confidence 379999999999999999999999999999553 789999999875
|
| >1ujd_A KIAA0559 protein; PDZ domain, structural genomics, human cDNA, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00024 Score=63.61 Aligned_cols=44 Identities=25% Similarity=0.354 Sum_probs=40.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
.|++||+|++|||.++.+.+.+++..+++ ...+.++|++++++.
T Consensus 67 ~L~~GD~Il~vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~R~~~ 110 (117)
T 1ujd_A 67 KLMEGMQVLEWNGIPLTSKTYEEVQSIIS-QQSGEAEICVRLDLN 110 (117)
T ss_dssp SCCTTCEEEEETTEECTTCCHHHHHHHHS-CCSSCEEEEEESSCC
T ss_pred CCCCCCEEEEECCEEcCCCCHHHHHHHHh-cCCCEEEEEEEECCc
Confidence 39999999999999999999999999999 578899999999984
|
| >2dkr_A LIN-7 homolog B; LIN-7B, PDZ, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00026 Score=60.35 Aligned_cols=42 Identities=21% Similarity=0.348 Sum_probs=38.5
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ...+.+.|++.++|
T Consensus 49 l~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~r~~ 90 (93)
T 2dkr_A 49 LKRGDQLLSVNGVSVEGEQHEKAVELLK-AAQGSVKLVVRSGP 90 (93)
T ss_dssp CCTTCBEEEETTEECTTSCHHHHHHHHH-HCCSEEEEEECCCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCcEEEEEEeCC
Confidence 9999999999999999999999999998 45568999999998
|
| >1m5z_A GRIP, AMPA receptor interacting protein; six beta-strands and two alpha-helices, protein binding; NMR {Rattus norvegicus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00034 Score=59.33 Aligned_cols=43 Identities=30% Similarity=0.233 Sum_probs=38.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.++..+++..+++ ...+.+.|+++++|
T Consensus 49 Gl~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~p 91 (91)
T 1m5z_A 49 GLKPYDRLLQVNHVRTRDFDCCLVVPLIA-ESGNKLDLVISRNP 91 (91)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-TSTTEEEEEEEECC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEeCc
Confidence 59999999999999999998888878887 56788999999886
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00014 Score=76.91 Aligned_cols=84 Identities=13% Similarity=0.101 Sum_probs=50.3
Q ss_pred ccee-cccCcEEEEEEEEc---C---CCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 485 GPLL-GQGFFGQVYRVTHR---E---TGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 485 ~~~L-G~G~FG~Vyk~~~~---~---tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.+.| +.|....+|+.... + ++..+++|.......... .......+|.++|+
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~----------------------~~~~~~~~E~~~l~ 82 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPV----------------------FPTYRLDHQFEVIR 82 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCS----------------------SSCCCHHHHHHHHH
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCcccc----------------------CchhHHHHHHHHHH
Confidence 4567 88999999988753 1 156788886532110000 00012235577777
Q ss_pred hCC-C--CceeeEEEEEEeC---CeEEEEEeccCCCCHH
Q psy5063 558 SLH-H--HNVIRFIGVLYKD---RKLNLVTEYIAGGTLK 590 (681)
Q Consensus 558 ~L~-H--pnIV~l~g~~~~~---~~l~LV~Ey~~gGsL~ 590 (681)
.+. + -.+.+++.+..+. +..|+||||++|..+.
T Consensus 83 ~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 83 LVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp HHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred HHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 763 2 3567777776554 3578999999986654
|
| >2yt7_A Amyloid beta A4 precursor protein-binding family A member 3; neuron-specific X11L2 protein, neuronal MUNC18-1-interacting protein 3, MINT-3; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00028 Score=61.40 Aligned_cols=44 Identities=30% Similarity=0.508 Sum_probs=40.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+.+++..+|++. .++.++|++.+.|
T Consensus 55 gl~~GD~I~~Ing~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~~ 99 (101)
T 2yt7_A 55 ALSIGDRLTAINGTSLVGLPLAACQAAVRETKSQTSVTLSIVHCP 99 (101)
T ss_dssp SCCTTCEEEEESSCBCTTSCHHHHHHHHHHTTTSSEEEEEECCCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCeEEEEEEeCC
Confidence 4999999999999999999999999999953 6789999999987
|
| >3soe_A Membrane-associated guanylate kinase, WW and PDZ containing protein 3; structural genomics consortium, SGC, PDZ domain, signaling P; 1.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0003 Score=62.94 Aligned_cols=44 Identities=20% Similarity=0.218 Sum_probs=39.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC-CceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.+|.+.+++|+..+|++.. ++.+.|+|.++-
T Consensus 49 GL~~GD~Il~VNG~~v~~~~h~evv~~lk~~~~G~~v~L~V~R~g 93 (113)
T 3soe_A 49 GLQKGDIIKEIYHQNVQNLTHLQVVEVLKQFPVGADVPLLILRGG 93 (113)
T ss_dssp TCCTTCEEEEETTEECTTSCHHHHHHHHHHSCTTCEEEEEEEESS
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHcCCCCCEEEEEEEECC
Confidence 69999999999999999999999999999543 679999999876
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0012 Score=68.56 Aligned_cols=30 Identities=27% Similarity=0.265 Sum_probs=24.8
Q ss_pred CCccccCCCCCcEEEecCCCe--EEeeeeeEe
Q psy5063 622 MNLIHRDLNSQNCLVREVGSG--FDFHLGQIY 651 (681)
Q Consensus 622 ~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~ 651 (681)
..++|+|+++.|||++.++.. +||+.+...
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g 253 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSFD 253 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEEC
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcccC
Confidence 579999999999999766655 899987654
|
| >1r6j_A Syntenin 1; PDZ, membrane protein; 0.73A {Homo sapiens} SCOP: b.36.1.1 PDB: 1nte_A 1obx_A 1oby_A | Back alignment and structure |
|---|
Probab=97.23 E-value=0.00029 Score=59.37 Aligned_cols=40 Identities=25% Similarity=0.315 Sum_probs=36.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (681)
-|.+||+|+||||.++...+++|+-.+|+ .....+.|++.
T Consensus 40 Gl~~GD~Il~VNG~~v~~~~~~evv~llr-~~g~~V~L~v~ 79 (82)
T 1r6j_A 40 GLLTEHNICEINGQNVIGLKDSQIADILS-TSGTVVTITIM 79 (82)
T ss_dssp TCCSSEEEEEETTEECTTCCHHHHHHHHH-HSCSEEEEEEE
T ss_pred CCCCCCEEEEECCEEcCCCCHHHHHHHHh-cCCCEEEEEEE
Confidence 47799999999999999999999999999 78888888875
|
| >1d5g_A Human phosphatase HPTP1E; protein-peptide complex, hydrolase; NMR {Homo sapiens} SCOP: b.36.1.1 PDB: 3lnx_A 3lny_A 3pdz_A 1vj6_A 1gm1_A 1ozi_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00043 Score=59.36 Aligned_cols=42 Identities=29% Similarity=0.433 Sum_probs=39.1
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+++.+++..+++ ..++.++|++++++
T Consensus 52 l~~GD~I~~vng~~v~~~~~~~~~~~l~-~~g~~v~l~v~R~~ 93 (96)
T 1d5g_A 52 IHKGDRVLAVNGVSLEGATHKQAVETLR-NTGQVVHLLLEKGQ 93 (96)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-SCCSEEEEEEECCS
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEcCC
Confidence 9999999999999999999999999999 57889999999877
|
| >2jil_A GRIP1 protein, glutamate receptor interacting protein-1; endoplasmic reticulum, postsynaptic membrane, membrane, MEMB protein; 1.5A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00036 Score=59.99 Aligned_cols=43 Identities=19% Similarity=0.292 Sum_probs=40.3
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+.+.+++..++++ .++.+.|++++++.
T Consensus 51 l~~GD~I~~ing~~v~~~~~~~~~~~l~~-~g~~v~l~v~R~~~ 93 (97)
T 2jil_A 51 IKPGDRLLSVDGIRLLGTTHAEAMSILKQ-CGQEAALLIEYDVS 93 (97)
T ss_dssp CCTTCEEEEETTEECSSCCHHHHHHHHHH-SCSEEEEEEEEECC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCeEEEEEEeCCC
Confidence 99999999999999999999999999995 88999999999873
|
| >3e17_A Tight junction protein ZO-2; domain swapping, alternative promoter usage, alternative splicing, cell junction, cell membrane, disease mutation; 1.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00036 Score=59.19 Aligned_cols=44 Identities=34% Similarity=0.514 Sum_probs=38.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
.|++||+|++|||.++.+.+.+++..+|+ .....+.|++...|.
T Consensus 39 ~L~~GD~Il~ing~~v~~~~~~~~~~~i~-~~~~~v~L~v~~~~~ 82 (88)
T 3e17_A 39 NLHEGDIILKINGTVTENMSLTDARKLIE-KSRGKLQLVVLRDLE 82 (88)
T ss_dssp CCCTTCEEEEETTEECTTCCHHHHHHHHH-HTTTEEEEEECCC--
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEeCCCc
Confidence 39999999999999999999999999999 566789999988873
|
| >2vsp_A PDZ domain-containing protein 1; membrane, cytoplasm, phosphoprotein, transport protein, CAsp; 2.60A {Homo sapiens} PDB: 2eej_A | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00049 Score=58.47 Aligned_cols=43 Identities=28% Similarity=0.331 Sum_probs=37.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..++++ .++.++|++.++-
T Consensus 44 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~~-~g~~v~l~v~r~~ 86 (91)
T 2vsp_A 44 GLEDEDVIIEVNGVNVLDEPYEKVVDRIQS-SGKNVTLLVCGKK 86 (91)
T ss_dssp TCCTTCEEEEETTEECTTSCHHHHHHHHTT-SCSEEEEEEEC--
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCEEEEEEEeCC
Confidence 499999999999999998999999999994 4899999998865
|
| >1v62_A KIAA1719 protein; structural genomics, synaptic transmission, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.00057 Score=61.17 Aligned_cols=42 Identities=31% Similarity=0.452 Sum_probs=40.1
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+++++..+++ ...+.++|++.++.
T Consensus 61 l~~GD~Il~Ing~~v~~~~~~~~~~~l~-~~g~~v~l~v~r~~ 102 (117)
T 1v62_A 61 LHPGDHILSIDGTSMEHCSLLEATKLLA-SISEKVRLEILPVP 102 (117)
T ss_dssp CCTTCBEEEETTEETTSCCHHHHHHHHH-SCSSEEEEEECCBT
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEECC
Confidence 9999999999999999999999999999 68899999999987
|
| >2jik_A Synaptojanin-2 binding protein; transmembrane, outer membrane, mitochondria distribution, PDZ, membrane, scaffold, mitochondrion, membrane protein; 1.35A {Homo sapiens} PDB: 2jin_A | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0005 Score=59.59 Aligned_cols=42 Identities=26% Similarity=0.397 Sum_probs=38.6
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.++..+++..+++ ..++.++|++++++
T Consensus 56 L~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~ 97 (101)
T 2jik_A 56 LQEGDKILSVNGQDLKNLLHQDAVDLFR-NAGYAVSLRVQHRL 97 (101)
T ss_dssp CCTTCEEEEETTEECSSCCHHHHHHHHH-TCCSEEEEEEEEES
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEeCC
Confidence 9999999999999999999999988988 56788999999887
|
| >2pa1_A PDZ and LIM domain protein 2; PDZ domain, structural genomics, structural genomics consort metal binding protein; 1.70A {Homo sapiens} PDB: 3pdv_A | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00054 Score=57.64 Aligned_cols=43 Identities=26% Similarity=0.340 Sum_probs=38.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..++++. .+.++|++.++-
T Consensus 43 GL~~GD~I~~ing~~v~~~~~~~~~~~l~~~-~~~v~l~v~R~~ 85 (87)
T 2pa1_A 43 DLRPGDIIVAINGESAEGMLHAEAQSKIRQS-PSPLRLQLDRIT 85 (87)
T ss_dssp TCCTTCEEEEETTEESTTCCHHHHHHHHHTC-CSSEEEEEEECC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHcC-CCeEEEEEEecC
Confidence 5999999999999999999999999999944 489999998875
|
| >2q3g_A PDZ and LIM domain protein 7; structural genomics, structural genomics consortium, SGC; 1.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.12 E-value=0.00041 Score=58.64 Aligned_cols=43 Identities=19% Similarity=0.285 Sum_probs=38.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+++.+++..+++ ...+.++|+++++.
T Consensus 44 Gl~~GD~I~~ing~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~ 86 (89)
T 2q3g_A 44 GVAVGDWVLSIDGENAGSLTHIEAQNKIR-ACGERLSLGLSRAI 86 (89)
T ss_dssp TCCTTCEEEEETTEEGGGCCHHHHHHHHH-TCTTEEEEEEEEEC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCEEEEEEEeCC
Confidence 59999999999999999999999999998 55788999998865
|
| >4e34_A Golgi-associated PDZ and coiled-coil motif-contai protein; PDZ-peptide complex, protein transport-inhibitor complex; 1.40A {Homo sapiens} PDB: 4e35_A | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00042 Score=58.24 Aligned_cols=41 Identities=29% Similarity=0.515 Sum_probs=36.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
.|++||+|++|||.++.+.+.+++..+++ ...+.+.|++++
T Consensus 46 gl~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~~ 86 (87)
T 4e34_A 46 GLHVGDAILAVNGVNLRDTKHKEAVTILS-QQRGEIEFEVVY 86 (87)
T ss_dssp CCCTTEEEEEETTEECTTCCHHHHHHHHH-HCCSEEEEEEEE
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEE
Confidence 69999999999999999999999999998 567788888875
|
| >2db5_A INAD-like protein; PDZ domain, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.00041 Score=63.01 Aligned_cols=43 Identities=28% Similarity=0.370 Sum_probs=40.1
Q ss_pred cccCCeEEEEcCeecC-CCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVR-DKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++. +...+++..+++ ...+.++|++.+++.
T Consensus 73 L~~GD~Il~ing~~v~~~~~~~~~~~~l~-~~~~~v~l~v~r~~~ 116 (128)
T 2db5_A 73 LKENDQILAINHTPLDQNISHQQAIALLQ-QTTGSLRLIVAREPV 116 (128)
T ss_dssp CCSSCBEEEESSCBCSTTSCHHHHHHHHH-HCCSEEEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCCHHHHHHHHH-cCCCeEEEEEEcCCC
Confidence 9999999999999997 999999999999 578999999999983
|
| >2uzc_A Human pdlim5, PDZ and LIM domain 5; metal-binding, enigma homolog, phosphorylation, signaling PR LIM domain, PDZ domain; 1.5A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.10 E-value=0.00063 Score=57.30 Aligned_cols=43 Identities=19% Similarity=0.351 Sum_probs=38.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.++.++++..+++ ...+.+.|+++++-
T Consensus 44 Gl~~GD~I~~ing~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~g 86 (88)
T 2uzc_A 44 NVRIGDVVLSIDGINAQGMTHLEAQNKIK-GCTGSLNMTLQRES 86 (88)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEeCC
Confidence 49999999999999999999999999988 45889999998864
|
| >1rgw_A ZAsp protein; PDZ, cypher, oracle, muscle, Z-DISK, sarcomere, structural protein; NMR {Homo sapiens} SCOP: b.36.1.1 PDB: 1wjl_A | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00061 Score=56.93 Aligned_cols=42 Identities=19% Similarity=0.284 Sum_probs=37.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
-|++||+|++|||.++.++..+++..+++ ...+.+.|+++++
T Consensus 42 Gl~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~ 83 (85)
T 1rgw_A 42 QLSQGDLVVAIDGVNTDTMTHLEAQNKIK-SASYNLSLTLQKS 83 (85)
T ss_dssp SCCCCSBEEEETTEECTTCCHHHHHHHHT-TCSSCEEEEEESC
T ss_pred CCCCCCEEEEECCEECCCcCHHHHHHHHH-cCCCeEEEEEEeC
Confidence 59999999999999999999999998888 5566799999875
|
| >1vb7_A PDZ and LIM domain 2; PDZ domain PDZ-LIM protein, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00059 Score=58.39 Aligned_cols=43 Identities=26% Similarity=0.387 Sum_probs=38.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..++++ ..+.++|+++++.
T Consensus 47 GL~~GD~I~~ing~~v~~~~~~~~~~~l~~-~~~~v~l~v~R~g 89 (94)
T 1vb7_A 47 DLRPGDIIVAINGQSAENMLHAEAQSKIRQ-SASPLRLQLDRSS 89 (94)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHHT-CCSSEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHh-CCCcEEEEEEECC
Confidence 599999999999999999999999999994 4489999999876
|
| >2he4_A Na(+)/H(+) exchange regulatory cofactor NHE-RF2; phosphorylation, structural genomics, structural genomics consortium, SGC, unknown function; 1.45A {Homo sapiens} PDB: 2ozf_A | Back alignment and structure |
|---|
Probab=97.09 E-value=0.00065 Score=57.53 Aligned_cols=43 Identities=26% Similarity=0.346 Sum_probs=38.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..+++ ..++.+.|++.+.-
T Consensus 45 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~-~~~~~v~l~v~r~~ 87 (90)
T 2he4_A 45 GLRAQDRLIEVNGQNVEGLRHAEVVASIK-AREDEARLLVVGPS 87 (90)
T ss_dssp TCCTTCEEEEETTEECTTSCHHHHHHHHT-TSSSEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCcEEEEEEccC
Confidence 49999999999999999999999999999 45889999998764
|
| >1kwa_A Hcask/LIN-2 protein; PDZ domain, neurexin, syndecan, receptor clustering, kinase; 1.93A {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.00042 Score=58.80 Aligned_cols=43 Identities=26% Similarity=0.556 Sum_probs=37.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+++++..++++..+ .++|++.+.-
T Consensus 43 gL~~GD~I~~Ing~~v~~~~~~~~~~~l~~~~~-~v~l~v~r~~ 85 (88)
T 1kwa_A 43 TLHVGDEIREINGISVANQTVEQLQKMLREMRG-SITFKIVPSY 85 (88)
T ss_dssp CCCTTCEEEEETTEEGGGSCHHHHHHHHHHCCE-EEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHhcCCC-cEEEEEECCc
Confidence 499999999999999999999999999995544 8888887643
|
| >3gge_A PDZ domain-containing protein GIPC2; structural genomics, structural genomics consort protein binding; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00057 Score=59.15 Aligned_cols=41 Identities=15% Similarity=0.343 Sum_probs=34.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 332 (681)
.||+||.|+||||+++..++++|+.+++++. .+.++.|.+.
T Consensus 46 ~L~vGD~I~~VNG~~v~g~~h~evv~lLk~~~~g~~~~L~lv 87 (95)
T 3gge_A 46 TICVGDHIESINGENIVGWRHYDVAKKLKELKKEELFTMKLI 87 (95)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHHHSCTTCEEEEEEE
T ss_pred CCCCCCEEEEECCEEccCCCHHHHHHHHHhCCCCCEEEEEEE
Confidence 6999999999999999999999999999953 3345666554
|
| >2d92_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00057 Score=60.19 Aligned_cols=44 Identities=20% Similarity=0.273 Sum_probs=39.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+.+++-.++++...+.+.|++.+.+
T Consensus 62 ~L~~GD~Il~Vng~~v~~~~~~~~~~~l~~~~~~~v~l~v~R~~ 105 (108)
T 2d92_A 62 GLLPGDRLVSVNEYCLDNTSLAEAVEILKAVPPGLVHLGICSGP 105 (108)
T ss_dssp CCCTTCEEEEESSCBCTTCCHHHHHHHHHHSCSEEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCeEEEEEEcCC
Confidence 39999999999999999999999999999555678999999877
|
| >1wi4_A Synip, syntaxin binding protein 4; syntaxin4-interacting protein, STXBP4 protein, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00052 Score=60.71 Aligned_cols=44 Identities=14% Similarity=0.347 Sum_probs=40.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC---CceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT---DTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+++++..+|++.. .+.++|++.++-
T Consensus 59 ~l~~GD~Il~Vng~~~~~~~~~~~~~~l~~~~~r~~~~~~l~v~R~~ 105 (109)
T 1wi4_A 59 RLKPGDQLVSINKESMIGVSFEEAKSIITRAKLRSESPWEIAFIRSG 105 (109)
T ss_dssp SCCTTCBEEEETTSCCTTCCHHHHHHHHHHSCCSSSSCEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHccccCCCceEEEEEEeCC
Confidence 39999999999999999999999999999776 788999998875
|
| >1wi2_A Riken cDNA 2700099C19; structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00059 Score=59.62 Aligned_cols=43 Identities=16% Similarity=0.232 Sum_probs=39.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
-|++||+|++|||.+|.+.+.+++..++++ .+.+.|+++++|.
T Consensus 58 GL~~GD~I~~ing~~v~~~~~~~~~~~l~~--~~~v~l~v~r~~~ 100 (104)
T 1wi2_A 58 GLQEGDQVLAVNDVDFQDIEHSKAVEILKT--AREISMRVRFFSG 100 (104)
T ss_dssp TCCTTCEEEEETTEECSSCCHHHHHHHHHH--SSSEEEEEECCCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHhC--CCEEEEEEEECCC
Confidence 599999999999999999999999999995 6889999999984
|
| >1wha_A KIAA0147 protein, scribble; PDZ domain, cellular signaling, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00064 Score=59.44 Aligned_cols=42 Identities=24% Similarity=0.472 Sum_probs=39.2
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ...+.+.|++.+++
T Consensus 57 L~~GD~I~~vng~~v~~~~~~~~~~~l~-~~g~~v~l~v~R~~ 98 (105)
T 1wha_A 57 LQVGDRVLSINGVDVTEARHDHAVSLLT-AASPTIALLLEREA 98 (105)
T ss_dssp CCTTCEEEEESSCBCTTCCHHHHHHHHT-SCCSCEEEEEEECC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 9999999999999999999999999999 55888999999987
|
| >2f5y_A Regulator of G-protein signalling 3 isoform 1; PDZ domain, RGS-3, human, structural genomics, structural GE consortium, SGC, signaling protein; 2.39A {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00073 Score=57.44 Aligned_cols=43 Identities=21% Similarity=0.252 Sum_probs=38.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.++..+++..+++ .....+.|++.++.
T Consensus 41 Gl~~GD~I~~vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~R~~ 83 (91)
T 2f5y_A 41 GLQQLDTVLQLNERPVEHWKCVELAHEIR-SCPSEIILLVWRMV 83 (91)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-TCSSEEEEEEEECC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 59999999999999999999999999998 45668999998865
|
| >2i04_A Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1; PDZ, E6 binding, tumor suppressor, peptide binding protein; 2.15A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00074 Score=56.44 Aligned_cols=41 Identities=20% Similarity=0.293 Sum_probs=35.5
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCC-Cceeeeeeec
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILK 333 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 333 (681)
|++||+|++|||.++.+++.+++..++++.. ++.++|++++
T Consensus 44 l~~GD~I~~vng~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R 85 (85)
T 2i04_A 44 METGDVIVSVNDTCVLGHTHAQVVKIFQSIPIGASVDLELCR 85 (85)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHHTSCTTCEEEEEEEC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCeEEEEEEC
Confidence 9999999999999999999999999998443 6788888753
|
| >2v90_A PDZ domain-containing protein 3; membrane, protein-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.05 E-value=0.00062 Score=58.37 Aligned_cols=43 Identities=19% Similarity=0.320 Sum_probs=39.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..+++ ..++.++|++.++-
T Consensus 47 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~-~~g~~v~l~v~r~~ 89 (96)
T 2v90_A 47 GMQAGDRLVAVAGESVEGLGHEETVSRIQ-GQGSCVSLTVVDPE 89 (96)
T ss_dssp TCCTTEEEEEETTEECTTCCHHHHHHHHH-TTTTEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEECCC
Confidence 49999999999999999999999999999 45899999999876
|
| >1n7e_A AMPA receptor interacting protein GRIP; PDZ, protein binding; 1.50A {Rattus norvegicus} SCOP: b.36.1.1 PDB: 1n7f_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00077 Score=57.97 Aligned_cols=42 Identities=33% Similarity=0.634 Sum_probs=38.8
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+++++..+++ ..++.+.|++.++-
T Consensus 49 l~~GD~I~~vng~~v~~~~~~~~~~~l~-~~g~~v~l~v~R~~ 90 (97)
T 1n7e_A 49 IHIGDRILAINSSSLKGKPLSEAIHLLQ-MAGETVTLKIKKQT 90 (97)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 9999999999999999999999999998 67889999998865
|
| >2rcz_A Tight junction protein ZO-1; PDZ, domain-swapping, cell junction, membrane, phosphorylati domain, protein binding; 1.70A {Homo sapiens} PDB: 2jwe_A 2osg_A | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0008 Score=55.37 Aligned_cols=41 Identities=24% Similarity=0.482 Sum_probs=35.8
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
|++||+|++|||.++.+.+.+++..++++ ....++|+++++
T Consensus 40 l~~GD~I~~ing~~v~~~~~~~~~~~l~~-~~~~v~l~v~R~ 80 (81)
T 2rcz_A 40 IQEGDVVLKINGTVTENMSLTDAKTLIER-SKGKLKMVVQRD 80 (81)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHHT-STTEEEEEEEC-
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHC-CCCeEEEEEEeC
Confidence 99999999999999998899999999994 455888888764
|
| >2ejy_A 55 kDa erythrocyte membrane protein; GPC, maguk, PDZ, membrane protein; NMR {Homo sapiens} PDB: 2ev8_A | Back alignment and structure |
|---|
Probab=97.00 E-value=0.00057 Score=59.40 Aligned_cols=41 Identities=29% Similarity=0.631 Sum_probs=36.3
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
|++||+|++|||.+|.+.+++++..+++ ...+.++|++...
T Consensus 55 L~~GD~Il~ING~~v~~~~~~~~~~~l~-~~~~~v~L~V~~~ 95 (97)
T 2ejy_A 55 LHVGDEILEINGTNVTNHSVDQLQKAMK-ETKGMISLKVIPN 95 (97)
T ss_dssp CCTTCEEEEETTBCCCSSCSHHHHHHHH-HCCEEEEEEEECC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEEC
Confidence 8999999999999999999999999999 4567888888743
|
| >2pkt_A PDZ and LIM domain protein 1; PDZ domain, structural genomics, structural genomics consort unknown function; HET: PG4; 1.50A {Homo sapiens} PDB: 2v1w_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00081 Score=57.06 Aligned_cols=43 Identities=19% Similarity=0.280 Sum_probs=39.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+...+++..++++ .++.+.|++.++-
T Consensus 44 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~~-~g~~v~l~v~R~g 86 (91)
T 2pkt_A 44 NLCIGDVITAIDGENTSNMTHLEAQNRIKG-CTDNLTLTVARSE 86 (91)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHHT-CSSEEEEEEEEEC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCeEEEEEEECC
Confidence 599999999999999999999999999994 8899999999876
|
| >1mfg_A ERB-B2 interacting protein; PDZ domain, protein-peptide complex, erbin., signaling protein; 1.25A {Homo sapiens} SCOP: b.36.1.1 PDB: 1mfl_A | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00069 Score=57.99 Aligned_cols=43 Identities=23% Similarity=0.384 Sum_probs=39.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+...+++..+++ ...+.++|++++++
T Consensus 51 gL~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~ 93 (95)
T 1mfg_A 51 LLQPGDKIIQANGYSFINIEHGQAVSLLK-TFQNTVELIIVREV 93 (95)
T ss_dssp TCCTTCEEEEETTEECTTCBHHHHHHHHH-HCCSEEEEEEEEEC
T ss_pred CCCCCCEEEEECCEEcCCCCHHHHHHHhh-cCCCeEEEEEEeCC
Confidence 69999999999999999988888888888 67889999999987
|
| >1v5l_A PDZ and LIM domain 3; actinin alpha 2 associated LIM protein; PDZ domain, cytoskeleton, actin binding, structural genomics; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00071 Score=58.96 Aligned_cols=43 Identities=21% Similarity=0.219 Sum_probs=39.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..++++ ..+.+.|+++++-
T Consensus 46 GL~~GD~I~~ing~~v~~~~~~~~~~~l~~-~g~~v~l~v~R~g 88 (103)
T 1v5l_A 46 NLCPGDVILAIDGFGTESMTHADAQDRIKA-ASYQLCLKIDRAE 88 (103)
T ss_dssp TCCTTCBEEEETTEECSSCCHHHHHHHHTT-CCSEEECEECCCT
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHh-CCCeEEEEEEECC
Confidence 699999999999999999999999999994 4899999999876
|
| >4amh_A Disks large homolog 1; permutation, protein folding, structural protein; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00091 Score=58.75 Aligned_cols=42 Identities=21% Similarity=0.406 Sum_probs=38.8
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.+|.+...+++..+++ .....++|+++++.
T Consensus 51 L~~GD~Il~Vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~R~~ 92 (106)
T 4amh_A 51 LQIGDKLLAVNNVALEEVTHEEAVTALK-NTSDFVYLKVAKPG 92 (106)
T ss_dssp CCTTCEEEEETTEECSSCCHHHHHHHHH-SCCSEEEEEEECCS
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHh-CCCCeEEEEEEeCC
Confidence 9999999999999999999999999998 56779999999976
|
| >2jxo_A Ezrin-radixin-moesin-binding phosphoprotein 50; nherf-1, PDZ domain, PDZ2, acetylation, cell projection, membrane, polymorphism; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.00063 Score=58.60 Aligned_cols=44 Identities=32% Similarity=0.349 Sum_probs=38.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..++++..++.+.|+++++-
T Consensus 50 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~~~~~~~~~l~v~R~g 93 (98)
T 2jxo_A 50 GLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRET 93 (98)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHHTTTTEEEEEECCHHH
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCcEEEEEEECCc
Confidence 49999999999999999999999999999666667788888764
|
| >2edv_A FERM and PDZ domain-containing protein 1; cytoskeletal-associated protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0007 Score=58.31 Aligned_cols=44 Identities=23% Similarity=0.397 Sum_probs=40.0
Q ss_pred cccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 291 MSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 291 ~~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.-|++||+|++|||.+|.+...+++..+++ ..++.+.|+++++.
T Consensus 46 agL~~GD~Il~ing~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~ 89 (96)
T 2edv_A 46 GKLFPGDQILQMNNEPAEDLSWERAVDILR-EAEDSLSITVVRCT 89 (96)
T ss_dssp TTSCTTCBEEEESSCBSTTCCHHHHHHHHH-HCSSCEEEEEEECC
T ss_pred hCCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 469999999999999999999999999998 47889999999987
|
| >3nfk_A Tyrosine-protein phosphatase non-receptor type 4; PDZ-PDZ-binding site complex, protein binding; 1.43A {Homo sapiens} SCOP: b.36.1.1 PDB: 3nfl_A 2vph_A | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0008 Score=58.91 Aligned_cols=42 Identities=19% Similarity=0.366 Sum_probs=36.3
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCC---ceeeeeeecc
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTD---TVLQRQILKE 334 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 334 (681)
|++||+|++|||.++.++..+++..++++..+ +.+.|++++|
T Consensus 63 L~~GD~Il~ing~~v~~~~~~~~~~~i~~~~~~~~~~v~l~v~r~ 107 (107)
T 3nfk_A 63 LNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRPN 107 (107)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHHCGGGSBTTBEEEEEECC
T ss_pred cCCCCEEEEECCEECCCCCHHHHHHHHHhccccCCcEEEEEEEcC
Confidence 99999999999999999999999999984432 4889988764
|
| >2qg1_A Multiple PDZ domain protein; MPDZ, MUPP1, structural genomics, structural genomics consortium, SGC, signaling protein; 1.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00096 Score=56.65 Aligned_cols=42 Identities=29% Similarity=0.417 Sum_probs=38.0
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ...+.++|++.+..
T Consensus 48 L~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~ 89 (92)
T 2qg1_A 48 LMQGDQILMVNGEDVRNATQEAVAALLK-CSLGTVTLEVGRIS 89 (92)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-HCCSEEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEccc
Confidence 9999999999999999988999999998 56778999998875
|
| >1ihj_A INAD; intermolecular disulfide bond, PDZ domain, signaling protein; 1.80A {Drosophila melanogaster} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00085 Score=57.68 Aligned_cols=41 Identities=39% Similarity=0.527 Sum_probs=38.1
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
|++||+|++|||.++.+.+.+++..+++ ...+.+.|++.++
T Consensus 56 L~~GD~I~~ing~~v~~~~~~~~~~~l~-~~g~~v~l~v~R~ 96 (98)
T 1ihj_A 56 LKVGDRILSLNGKDVRNSTEQAVIDLIK-EADFKIELEIQTF 96 (98)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-HSCSEEEEEEEEC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHh-cCCCeEEEEEEeC
Confidence 9999999999999999999999999998 4888999999886
|
| >2eeg_A PDZ and LIM domain protein 4; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00097 Score=57.04 Aligned_cols=43 Identities=21% Similarity=0.176 Sum_probs=38.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.++..+++..+++ ...+.+.|+++++-
T Consensus 49 Gl~~GD~I~~ing~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~g 91 (94)
T 2eeg_A 49 ALCPGDLIQAINGESTELMTHLEAQNRIK-GCHDHLTLSVSSGP 91 (94)
T ss_dssp TCCTTCEEEEETTEETTTCCHHHHHHHHH-TCCSCEEEEEECCS
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 59999999999999999998888888888 46788999998865
|
| >2byg_A Channel associated protein of synapse-110; DLG2, PDZ, PDZ domain, structural genomics, structural genom consortium, SGC, phosphorylation; 1.85A {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.95 E-value=0.00087 Score=60.06 Aligned_cols=42 Identities=26% Similarity=0.435 Sum_probs=38.7
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+.+++..+++ ...+.++|++.++.
T Consensus 73 L~~GD~Il~Vng~~v~~~~~~~~~~~l~-~~g~~v~l~v~R~~ 114 (117)
T 2byg_A 73 LQVGDRLLMVNNYSLEEVTHEEAVAILK-NTSEVVYLKVGKPT 114 (117)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEEEEE
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 9999999999999999999999999999 66889999998864
|
| >1um7_A Synapse-associated protein 102; PDZ, discs large homolog 3, DLG3-human presynaptic protein, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00077 Score=59.51 Aligned_cols=43 Identities=23% Similarity=0.349 Sum_probs=39.7
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.++..+++..+++ ...+.+.|++++++.
T Consensus 58 L~~GD~Il~Vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~r~~~ 100 (113)
T 1um7_A 58 LRRGDRILSVNGVNLRNATHEQAAAALK-RAGQSVTIVAQYRPE 100 (113)
T ss_dssp CCTTCEEEEESSCBCTTCCHHHHHHHHH-SCCSEEEEEEECCHH
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCcEEEEEEECcc
Confidence 9999999999999999999999988888 678899999999984
|
| >1n7t_A 99-MER peptide of densin-180-like protein; PDZ domain, C-terminal peptide complex, high affnity ligand, signaling protein; NMR {Homo sapiens} SCOP: b.36.1.1 PDB: 2h3l_A | Back alignment and structure |
|---|
Probab=96.94 E-value=0.00091 Score=58.17 Aligned_cols=43 Identities=23% Similarity=0.384 Sum_probs=39.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+...+++..+++ ...+.++|++++++
T Consensus 59 gL~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~ 101 (103)
T 1n7t_A 59 LLQPGDKIIQANGYSFINIEHGQAVSLLK-TFQNTVELIIVREV 101 (103)
T ss_dssp SCCTTCEEEEETTEECSSCCHHHHHHHHH-HCCSEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHhh-cCCCeEEEEEEecC
Confidence 69999999999999999999999888888 67889999999987
|
| >1ueq_A Membrane associated guanylate kinase inverted-2 (MAGI-2); atrophin-1 interacting protein 1, PDZ domain, structural genomics; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.94 E-value=0.001 Score=60.00 Aligned_cols=43 Identities=16% Similarity=0.203 Sum_probs=39.3
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+.+++..+|++. .++.++|+++++.
T Consensus 63 L~~GD~Il~Vng~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~~ 106 (123)
T 1ueq_A 63 METGDVIVYINEVCVLGHTHADVVKLFQSVPIGQSVNLVLCRGY 106 (123)
T ss_dssp CCTTCEEEEETTEECTTSCHHHHHHHHHTSCTTCEEEEEEEESC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCeEEEEEEeCC
Confidence 999999999999999999999999999954 3789999999987
|
| >1uep_A Membrane associated guanylate kinase inverted-2 (MAGI-2); atrophin-1 interacting protein 1, PDZ domain, structural genomics; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.93 E-value=0.00055 Score=59.70 Aligned_cols=44 Identities=25% Similarity=0.419 Sum_probs=38.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC-CceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.+|.+...+++..++++.. .+.++|++.++-
T Consensus 52 ~L~~GD~Il~ing~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~~ 96 (103)
T 1uep_A 52 RLHPGDELVYVDGIPVAGKTHRYVIDLMHHAARNGQVNLTVRRKV 96 (103)
T ss_dssp CCCTTCEEEEETTEECTTSCHHHHHHHHHHHHHHTEEEEEEEEEC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCcEEEEEEeCC
Confidence 39999999999999999999999999998433 689999999876
|
| >2eno_A Synaptojanin-2-binding protein; mitochondrial outer membrane protein 25, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00062 Score=61.10 Aligned_cols=42 Identities=26% Similarity=0.397 Sum_probs=38.9
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.+|.+...+++..+++ ...+.++|++++++
T Consensus 66 L~~GD~Il~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~ 107 (120)
T 2eno_A 66 LQEGDKILSVNGQDLKNLLHQDAVDLFR-NAGYAVSLRVQHRL 107 (120)
T ss_dssp SCTTCEEEEETTEECCSCCHHHHHHHHH-HHCSEEEEEEEEEE
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 9999999999999999999999999998 45788999999988
|
| >1y7n_A Amyloid beta A4 precursor protein-binding family A member 1; copper chaperone for superoxide dismutase, neuronal adaptor, protein transport; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.92 E-value=0.00087 Score=57.24 Aligned_cols=41 Identities=20% Similarity=0.459 Sum_probs=36.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
-|++||+|++|||.++.+.+.+++..+++ ..++.++|++..
T Consensus 48 GL~~GD~Il~Ing~~v~~~~~~~~~~~l~-~~g~~v~l~v~p 88 (90)
T 1y7n_A 48 GVRVGHRIIEINGQSVVATPHEKIVHILS-NAVGEIHMKTMP 88 (90)
T ss_dssp TCCSSCEEEEETTEECTTSCHHHHHHHHH-HCCEEEEEEEEC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEE
Confidence 59999999999999999999999999998 568888888863
|
| >1v6b_A Harmonin isoform A1; structural genomics, usher syndrome, USH1, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00067 Score=60.87 Aligned_cols=44 Identities=23% Similarity=0.305 Sum_probs=38.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC---CCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT---TDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+++++++..+|++. .++.++|++.+.|
T Consensus 61 gL~~GD~Il~Ing~~v~~~~~~~~~~~l~~~~~~~g~~v~l~v~r~~ 107 (118)
T 1v6b_A 61 GVVKGDEIMAINGKIVTDYTLAEAEAALQKAWNQGGDWIDLVVAVCP 107 (118)
T ss_dssp SSCTTCEEEEESSCBCTTCBHHHHHHHHHHHHHHTCSEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHHhhhcCCCeEEEEEEeCC
Confidence 5999999999999999999999998888743 2678999999966
|
| >2dlu_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00072 Score=59.66 Aligned_cols=43 Identities=23% Similarity=0.429 Sum_probs=39.2
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+.+.+++..+++ ..++.+.|++.+++.
T Consensus 57 l~~GD~I~~vng~~v~~~~~~~~~~~l~-~~g~~v~l~v~R~~~ 99 (111)
T 2dlu_A 57 LQTGDHILKIGGTNVQGMTSEQVAQVLR-NCGNSVRMLVARDPA 99 (111)
T ss_dssp CCSSCEEEEESSCCCTTSCHHHHHHHHH-HHCSEEEEEEEESCT
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEeCCC
Confidence 9999999999999999999999999998 467889999999883
|
| >2djt_A Unnamed protein product; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.91 E-value=0.00086 Score=58.38 Aligned_cols=42 Identities=24% Similarity=0.317 Sum_probs=38.3
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.+|.++..+++..+++ ...+.++|+++++-
T Consensus 57 l~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~g 98 (104)
T 2djt_A 57 LEVGDLVLHINGESTQGLTHAQAVERIR-AGGPQLHLVIRRPL 98 (104)
T ss_dssp CCTTCBEEEETTEECTTCCHHHHHHHHH-HTCSEEEEEECCCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 9999999999999999999999988888 47789999998876
|
| >2fcf_A Multiple PDZ domain protein; adaptor molecule, protein linker, structural genomics, struc genomics consortium, SGC, structural protein; 1.76A {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0011 Score=57.50 Aligned_cols=42 Identities=29% Similarity=0.383 Sum_probs=38.4
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+.+++..++++ ....+.|++.++.
T Consensus 58 l~~GD~I~~ing~~v~~~~~~~~~~~l~~-~~~~v~l~v~r~~ 99 (103)
T 2fcf_A 58 LKPGDRIVEVDGMDLRDASHEQAVEAIRK-AGNPVVFMVQSII 99 (103)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHHT-CCSSEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHh-CCCcEEEEEEECC
Confidence 99999999999999999999999999994 4569999999877
|
| >2opg_A Multiple PDZ domain protein; structural protein, structural genomics, structural genomics consortium, SGC; 1.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0012 Score=56.71 Aligned_cols=43 Identities=30% Similarity=0.455 Sum_probs=38.6
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+...+++..+++ ...+.++|++.++..
T Consensus 49 l~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~~ 91 (98)
T 2opg_A 49 LWAGDQILEVNGIDLRKATHDEAINVLR-QTPQRVRLTLYRDEA 91 (98)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEEECSS
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEcCCC
Confidence 9999999999999999999999988888 556899999998773
|
| >1zfo_A LAsp-1; LIM domain, zinc-finger, metal-binding protein; NMR {Sus scrofa} SCOP: g.39.1.4 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.00025 Score=48.42 Aligned_cols=28 Identities=36% Similarity=0.767 Sum_probs=26.3
Q ss_pred ccccccccccccCceEEecCccccccCc
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
+.|+.|++.++..+.+.+.|+.||..||
T Consensus 4 ~~C~~C~k~Vy~~Ek~~~~g~~~Hk~CF 31 (31)
T 1zfo_A 4 PNCARCGKIVYPTEKVNCLDKFWHKACF 31 (31)
T ss_dssp CBCSSSCSBCCGGGCCCSSSSCCCGGGC
T ss_pred CcCCccCCEEecceeEEECCeEecccCC
Confidence 4799999999999999999999999998
|
| >1uhp_A Hypothetical protein KIAA1095; PDZ domain, semaphorin cytoplasmic domain associated protein, structural genomics; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.90 E-value=0.001 Score=58.27 Aligned_cols=43 Identities=26% Similarity=0.408 Sum_probs=38.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+...+++-.+++ ...+.+.|++.++.
T Consensus 59 gL~~GD~Il~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~ 101 (107)
T 1uhp_A 59 GLQIHDRIIEVNGRDLSRATHDQAVEAFK-TAKEPIVVQVLRRT 101 (107)
T ss_dssp CCCSSCEEEEETTEECTTCCHHHHHHHHH-HCCSSEEEEEEECC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCcEEEEEEeCC
Confidence 49999999999999999999999988888 56788999998866
|
| >1qav_A Alpha-1 syntrophin (residues 77-171); beta-finger, heterodimer, membrane protein-oxidoreductase CO; 1.90A {Mus musculus} SCOP: b.36.1.1 PDB: 1z86_A 2pdz_A 2vrf_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.001 Score=56.29 Aligned_cols=41 Identities=24% Similarity=0.349 Sum_probs=36.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
-|++||+|++|||.++.+.+.+++..+++ ...+.+.|++++
T Consensus 48 gl~~GD~I~~ing~~v~~~~~~~~~~~~~-~~~~~v~l~v~r 88 (90)
T 1qav_A 48 ALFVGDAILSVNGEDLSSATHDEAVQALK-KTGKEVVLEVKY 88 (90)
T ss_dssp CCCTTEEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEEE
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEE
Confidence 59999999999999999999999999998 567788888875
|
| >1whd_A RGS3, regulator of G-protein signaling 3; PDZ domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, signaling protein; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0011 Score=57.58 Aligned_cols=43 Identities=21% Similarity=0.249 Sum_probs=37.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.++..+++..+++. ....+.|+++++.
T Consensus 53 GL~~GD~I~~vng~~v~~~~~~~~~~~l~~-~~~~v~l~v~R~~ 95 (100)
T 1whd_A 53 GLQQLDTVLQLNERPVEHWKCVELAHEIRS-CPSEIILLVWRVS 95 (100)
T ss_dssp TCCSSCEEEEETTEECTTCCHHHHHHHHHH-CSSEEEEEEEECC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCeEEEEEEECC
Confidence 599999999999999999999999999984 4555999999876
|
| >2iwo_A Multiple PDZ domain protein; SGC, MPDZ, MUPP1, MUPP-1, HOST-virus interaction, structural genomics consortium, synaptosome, tight junction; 1.7A {Homo sapiens} PDB: 2iwp_A | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00086 Score=60.39 Aligned_cols=43 Identities=21% Similarity=0.394 Sum_probs=38.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+...+++..+++ .....+.|+++++-
T Consensus 71 gL~~GD~Il~VnG~~v~~~~~~~~~~~l~-~~~~~v~l~v~r~g 113 (120)
T 2iwo_A 71 KLRVGDRIVTICGTSTEGMTHTQAVNLLK-NASGSIEMQVVAGG 113 (120)
T ss_dssp CCCTTCEEEEETTEECTTCBHHHHHHHHH-HCCSEEEEEEECCT
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 58999999999999999999999999999 55667999999876
|
| >2dc2_A GOPC, golgi associated PDZ and coiled-coil motif containing isoform B; GOPC PDZ domain, structural protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.89 E-value=0.0009 Score=58.41 Aligned_cols=43 Identities=28% Similarity=0.481 Sum_probs=38.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+.+++..+++ .....++|++....
T Consensus 53 gL~~GD~Il~Ing~~v~~~~~~~~~~~l~-~~~~~v~l~v~~~~ 95 (103)
T 2dc2_A 53 GLHVGDAILAVNGVNLRDTKHKEAVTILS-QQRGEIEFEVVYVA 95 (103)
T ss_dssp CCCSSEEEEEETTEESTTSCHHHHHHHHH-HCCSEEEEEEEECC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCcEEEEEEecC
Confidence 58999999999999999999999999999 56668999998876
|
| >1uew_A Membrane associated guanylate kinase inverted-2 (MAGI-2); atrophin-1 interacting protein 1, PDZ domain, structural genomics; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00085 Score=59.59 Aligned_cols=43 Identities=30% Similarity=0.544 Sum_probs=39.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+++++..++++ .++.+.|++.++-
T Consensus 61 gL~~GD~I~~ing~~v~~~~~~~~~~~l~~-~g~~v~l~v~r~~ 103 (114)
T 1uew_A 61 KLKVGDRILAVNGQSIINMPHADIVKLIKD-AGLSVTLRIIPQE 103 (114)
T ss_dssp SCCTTCBEEEETTBCTTTSCHHHHHHHHHH-TTTEEEEEECCCS
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCeEEEEEEeCC
Confidence 599999999999999999999999999994 8899999999876
|
| >1i16_A Interleukin 16, LCF; cytokine, lymphocyte chemoattractant factor, PDZ domain; NMR {Homo sapiens} SCOP: b.36.1.2 | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00058 Score=62.37 Aligned_cols=44 Identities=23% Similarity=0.325 Sum_probs=40.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+++++++-.+|++..++.+.|++.++.
T Consensus 75 gL~~GD~Il~Vng~~v~~~~~~~~~~~l~~~~~~~v~l~v~r~~ 118 (130)
T 1i16_A 75 TVQPGDEILQLGGTAMQGLTRFEAWNIIKALPDGPVTIVIRRKS 118 (130)
T ss_dssp CCCTTCCEEECSSCBGGGSCHHHHHHHHHTSCSSEEEEEEEEES
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCceEEEEEEeCC
Confidence 69999999999999999999999999999666778999998876
|
| >2fe5_A Presynaptic protein SAP102; PDZ domain, DLG3, human, structural genomics, structural GEN consortium, SGC, structural protein; HET: GOL; 1.10A {Homo sapiens} SCOP: b.36.1.1 PDB: 2x7z_A 2oqs_A 1qlc_A 2i0l_A | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0011 Score=56.36 Aligned_cols=41 Identities=29% Similarity=0.489 Sum_probs=36.5
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
|++||+|++|||.++.+...+++..+++ .....+.|+++++
T Consensus 52 l~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~ 92 (94)
T 2fe5_A 52 LQIGDRLLAVNNTNLQDVRHEEAVASLK-NTSDMVYLKVAKP 92 (94)
T ss_dssp CCTTCEEEEETTEECTTCBHHHHHHHHH-TCCSEEEEEEECC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEcC
Confidence 9999999999999999999999988888 5566899998875
|
| >3cbz_A Dishevelled-2; PDZ domain, phage derived high affinity ligand, cytoplasm, developmental protein, phosphoprotein, WNT signaling pathway; 1.38A {Homo sapiens} PDB: 3cby_A 3cc0_A 3cbx_A 2rey_A 2f0a_A 1l6o_A 3fy5_A 2kaw_A* 1mc7_A | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00094 Score=58.87 Aligned_cols=44 Identities=16% Similarity=0.249 Sum_probs=38.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC--CCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT--TDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+++++..++++. ....++|++.++-
T Consensus 51 ~L~~GD~Il~Vng~~v~~~~~~~~~~~l~~~~~~~~~v~l~v~R~~ 96 (108)
T 3cbz_A 51 RIEPGDMLLQVNDMNFENMSNDDAVRVLRDIVHKPGPIVLTVAKSG 96 (108)
T ss_dssp CCCTTCEEEEETTEETTSCCHHHHHHHHHHHHTSSSCEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhcccCCCeEEEEEEeCC
Confidence 3999999999999999999999999999854 3457999998864
|
| >2vwr_A Ligand of NUMB protein X 2; protein-binding, metal-binding, zinc, LNX2_human, zinc-finger, polymorphism, ring finger protein 1; 1.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.00096 Score=57.06 Aligned_cols=42 Identities=19% Similarity=0.302 Sum_probs=38.6
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+.+++..+++ ..++.++|++.++.
T Consensus 48 L~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~ 89 (95)
T 2vwr_A 48 LSSNDRVLAINGHDLKYGTPELAAQIIQ-ASGERVNLTIARPG 89 (95)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-HCCSEEEEEEEEES
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEcCC
Confidence 9999999999999999999999888888 56899999999876
|
| >2qkv_A Inactivation-NO-after-potential D protein; PDZ domain, scaffolding protein, membrane, sensory transduction, vision; 1.55A {Drosophila melanogaster} PDB: 2qkt_A 2qku_A | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0013 Score=56.55 Aligned_cols=42 Identities=21% Similarity=0.349 Sum_probs=37.7
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ...+.+.|++.+.+
T Consensus 50 L~~GD~I~~Ing~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~ 91 (96)
T 2qkv_A 50 LQRGDIITKFNGDALEGLPFQVSYALFK-GANGKVSMEVTRPK 91 (96)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-TCSSEEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHh-cCCCcEEEEEEeCC
Confidence 9999999999999999988999988888 56678999999864
|
| >2ego_A General receptor for phosphoinositides 1- associated scaffold protein; PDZ domain, ligand-free, protein binding; 1.80A {Rattus norvegicus} PDB: 2egn_A 2egk_A 2pnt_A | Back alignment and structure |
|---|
Probab=96.88 E-value=0.001 Score=57.06 Aligned_cols=41 Identities=32% Similarity=0.413 Sum_probs=36.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
-|++||+|++|||.++.+.+++++..++++. ...+.|++.+
T Consensus 54 GL~~GD~I~~ing~~v~~~~~~~~~~~l~~~-~~~v~l~v~~ 94 (96)
T 2ego_A 54 GLTPGDTIASVNGLNVEGIRHREIVDIIKAS-GNVLRLETLY 94 (96)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHHHT-TTEEEEEEEC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhC-CCeEEEEEEE
Confidence 4999999999999999999999999999944 6688888865
|
| >3bpu_A Membrane-associated guanylate kinase, WW and PDZ containing protein 1; structural genomi consortium, SGC, ATP-binding, cell junction; 1.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0012 Score=55.65 Aligned_cols=45 Identities=20% Similarity=0.250 Sum_probs=39.0
Q ss_pred cccccCCeEEEEcCeecCCCChHHHHHhhhc-CCCceeeeeeeccC
Q psy5063 291 MSLHLGDRILEVNGTPVRDKPLQEVECLIRN-TTDTVLQRQILKEC 335 (681)
Q Consensus 291 ~~~~~~d~~levng~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 335 (681)
.-|++||+|++|||.++.++.++++..++++ ..++.++|+++++-
T Consensus 41 aGl~~GD~I~~vng~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~g 86 (88)
T 3bpu_A 41 RGLKEGDLIVEVNKKNVQALTHNQVVDMLVESPKGSEVTLLVQRQT 86 (88)
T ss_dssp TTCCTTCEEEEETTEECTTSCHHHHHHHHHTSCTTCEEEEEEEEEC
T ss_pred hCCCCCCEEEEECCEEcCCCCHHHHHHHHHhCCCCCEEEEEEEeCC
Confidence 4699999999999999999999999998883 35788999998764
|
| >3cyy_A Tight junction protein ZO-1; protein-ligand complex, cell junction, membrane, phosphoprot domain, tight junction, transmembrane; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.87 E-value=0.0013 Score=55.78 Aligned_cols=42 Identities=24% Similarity=0.447 Sum_probs=36.4
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+.+++..++++ ....++|+++++.
T Consensus 42 l~~GD~I~~ing~~v~~~~~~~~~~~l~~-~~~~v~l~v~r~g 83 (92)
T 3cyy_A 42 IQEGDVVLKINGTVTENMSLTDAKTLIER-SKGKLKMVVQRDE 83 (92)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHHT-TTTEEEEEEEC--
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCcEEEEEEeCC
Confidence 99999999999999998899999999994 5568999998876
|
| >2i1n_A Discs, large homolog 3; DLG3, PDZ, PDZ domain, signal transduction, structural genom structural genomics consortium, SGC, signaling protein; 1.85A {Homo sapiens} PDB: 2wl7_A 3rl7_B 1rgr_A* 1kef_A 1zok_A 1iu0_A 1iu2_A | Back alignment and structure |
|---|
Probab=96.87 E-value=0.001 Score=57.70 Aligned_cols=43 Identities=16% Similarity=0.200 Sum_probs=39.3
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+...+++..+++ ..++.+.|++.++..
T Consensus 53 L~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~~ 95 (102)
T 2i1n_A 53 LGVNDCVLRVNEVDVSEVVHSRAVEALK-EAGPVVRLVVRRRQP 95 (102)
T ss_dssp CCTTCEEEEETTEECSSCCHHHHHHHHH-HSCSEEEEEEEEECC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCCC
Confidence 9999999999999999999999999888 578899999999873
|
| >3i4w_A Disks large homolog 4; alpha and beta protein, alternative splicing, cell junction, cell membrane, lipoprotein, membrane, palmitate, phosphoprotein; 1.35A {Homo sapiens} SCOP: b.36.1.1 PDB: 3k82_A* 3jxt_A* 2he2_A 1pdr_A 2i0i_A | Back alignment and structure |
|---|
Probab=96.87 E-value=0.00097 Score=57.93 Aligned_cols=43 Identities=21% Similarity=0.333 Sum_probs=39.7
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+...+++..+++ ...+.+.|++.+++.
T Consensus 54 l~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~r~~~ 96 (104)
T 3i4w_A 54 LRKGDQILSVNGVDLRNASHEQAAIALK-NAGQTVTIIAQYKPE 96 (104)
T ss_dssp CCTTEEEEEETTEECTTCCHHHHHHHHH-TSCSEEEEEEEECHH
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECcc
Confidence 9999999999999999999999998988 578899999999983
|
| >2iwq_A Multiple PDZ domain protein; SGC, MPDZ, MUPP1, MUPP- 1, membrane, HOST- interaction, structural genomics consortium, synaptosome, T junction; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.001 Score=60.25 Aligned_cols=42 Identities=29% Similarity=0.377 Sum_probs=38.5
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.+|.+.+.+++..+++ .....++|++.+.+
T Consensus 78 L~~GD~Il~Vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~r~~ 119 (123)
T 2iwq_A 78 LKPGDRIVEVDGMDLRDASHEQAVEAIR-KAGNPVVFMVQSII 119 (123)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-HCCSSEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 9999999999999999999999999998 44669999999877
|
| >2o2t_A Multiple PDZ domain protein; structural protein, structural genomics, structural genomics consortium, SGC; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0011 Score=59.10 Aligned_cols=43 Identities=21% Similarity=0.311 Sum_probs=39.8
Q ss_pred cccCCeEEEEcCeecC-CCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVR-DKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++. +.+.+++..+++ ..++.++|++.++..
T Consensus 68 l~~GD~Il~ing~~v~~~~~~~~~~~~l~-~~~~~v~l~v~R~~~ 111 (117)
T 2o2t_A 68 LKETDQILAINGQALDQTITHQQAISILQ-KAKDTVQLVIARGSL 111 (117)
T ss_dssp CCTTCEEEEETTEECCTTSCHHHHHHHHH-HCCSEEEEEEESSCC
T ss_pred CCCCCEEEEECCEECCCCCCHHHHHHHHH-cCCCEEEEEEEeCCc
Confidence 9999999999999998 899999999999 578899999999874
|
| >3axa_A Afadin, nectin-3, protein AF-6; PDZ domain, fusion protein, cell adhesion; 2.78A {Mus musculus} PDB: 1xz9_A 2exg_A* 1t2m_A 2ain_A | Back alignment and structure |
|---|
Probab=96.86 E-value=0.0013 Score=57.49 Aligned_cols=43 Identities=23% Similarity=0.385 Sum_probs=39.5
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+...+++..+++ ...+.++|++.++-.
T Consensus 57 L~~GD~I~~ing~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~~ 99 (106)
T 3axa_A 57 LAAGDQLLSVDGRSLVGLSQERAAELMT-RTSSVVTLEVAKQGA 99 (106)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEECCCS
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCCc
Confidence 9999999999999999999999999998 578999999998763
|
| >1v5q_A GRIP1 homolog, glutamate receptor interacting protein 1A-L homolog; PDZ domain, cellular signaling, structural genomics; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.00079 Score=60.67 Aligned_cols=43 Identities=28% Similarity=0.621 Sum_probs=39.6
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCC-CceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+++++..++++.. .+.+.|+++++.
T Consensus 64 L~~GD~I~~ing~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~~ 107 (122)
T 1v5q_A 64 LQIGDRVMAINGIPTEDSTFEEANQLLRDSSITSKVTLEIEFDV 107 (122)
T ss_dssp CCTTCCEEEETTEESSSSCHHHHHHHHHHHTTTTCEEEEEEEEC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCeEEEEEEECC
Confidence 9999999999999999999999999999554 789999999987
|
| >1wfg_A Regulating synaptic membrane exocytosis protein 2; PDZ domain, RAB3-interacting molecule, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.36.1.1 PDB: 2css_A 1zub_A | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0011 Score=60.69 Aligned_cols=43 Identities=23% Similarity=0.384 Sum_probs=38.5
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+.+++..+|++. .++.+.|++.++-
T Consensus 84 L~~GD~Il~ing~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~g 127 (131)
T 1wfg_A 84 LRPGDEVLEWNGRLLQGATFEEVYNIILESKPEPQVELVVSRSG 127 (131)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHHHTSSSSEEEEEEEEEC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHhcCCCCEEEEEEEcCC
Confidence 999999999999999999999999999854 4588999998864
|
| >2q9v_A Membrane-associated guanylate kinase, WW and PDZ containing protein 1; Cys Ser mutant, S genomics consortium, SGC, transferase; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.84 E-value=0.00076 Score=57.04 Aligned_cols=42 Identities=29% Similarity=0.430 Sum_probs=36.2
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCC-ceeeeeeecc
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTD-TVLQRQILKE 334 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 334 (681)
|++||+|++|||.++.+.+.+++..++++..+ ..++|++.++
T Consensus 46 L~~GD~I~~ing~~v~~~~~~~~~~~l~~~~~~~~v~l~v~R~ 88 (90)
T 2q9v_A 46 LRSGDELISVDGTPVIGKSHQLVVQLMQQAAKQGHVNLTVRQT 88 (90)
T ss_dssp CCTTCEEEEETTEECTTSCHHHHHHHHHHHHHHTEEEEEEEEC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCeEEEEEEec
Confidence 99999999999999999999999999984332 3889998875
|
| >2koj_A Partitioning defective 3 homolog; PDZ domain, structural genomics, alternative splicing, cell cycle, cell division, cell junction, coiled coil; NMR {Mus musculus} PDB: 2ogp_A | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0011 Score=58.32 Aligned_cols=43 Identities=33% Similarity=0.563 Sum_probs=38.6
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+++++..++++. .++.++|+++++.
T Consensus 58 l~~GD~I~~ing~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~~ 101 (111)
T 2koj_A 58 LKAGDRLIEVNGVDLAGKSQEEVVSLLRSTKMEGTVSLLVFRQE 101 (111)
T ss_dssp SCTTCEEEEETTEECTTSCHHHHHHHHHHCCCSSEEEEEEEECC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCeEEEEEEeCC
Confidence 999999999999999999999999999853 3788999998876
|
| >2r4h_A Membrane-associated guanylate kinase, WW and PDZ containing protein 1; transferase, STRU genomics, structural genomics consortium, SGC, ATP-binding; HET: HIS; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0014 Score=58.13 Aligned_cols=42 Identities=21% Similarity=0.359 Sum_probs=37.8
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.+|.+...+++..+++ ..++.++|+++++-
T Consensus 68 L~~GD~Il~Vng~~v~~~~~~~~~~~l~-~~g~~v~l~v~R~~ 109 (112)
T 2r4h_A 68 MRIGDEILEINGETTKNMKHSRAIELIK-NGGRRVRLFLKRGE 109 (112)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-TTTTEEEEEEECCE
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 9999999999999999999999989998 57788999998754
|
| >1wfv_A Membrane associated guanylate kinase inverted-2; atrophin-1 interacting protein 1, activin receptor interacting protein 1; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.83 E-value=0.00091 Score=57.99 Aligned_cols=42 Identities=24% Similarity=0.427 Sum_probs=38.5
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ..++.+.|+++++.
T Consensus 55 l~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~ 96 (103)
T 1wfv_A 55 MRVGDQIIEINGESTRDMTHARAIELIK-SGGRRVRLLLKRGT 96 (103)
T ss_dssp SCTTCEEEEETTEECSSCCHHHHHHHHH-HHCSEECEEEECTT
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 9999999999999999999999988888 67789999999876
|
| >2kpk_A Membrane-associated guanylate kinase, WW and PDZ containing protein 1; PDZ domain, ATP-binding, cell junction, cell membrane; NMR {Homo sapiens} PDB: 2kpl_A | Back alignment and structure |
|---|
Probab=96.83 E-value=0.0012 Score=60.14 Aligned_cols=44 Identities=18% Similarity=0.256 Sum_probs=39.6
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCC-CceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.+|.+...+++..+|++.. ++.++|++.++..
T Consensus 62 L~~GD~Il~vng~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~~~ 106 (129)
T 2kpk_A 62 METGDVIVSVNDTCVLGHTHAQVVKIFQSIPIGASVDLELCRGYP 106 (129)
T ss_dssp CCTTCEEEEETTEECTTSCHHHHHHHHHHSCTTEEEEEEEEECSC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCeEEEEEEeCCC
Confidence 9999999999999999999999999998554 7889999998763
|
| >3o46_A Maguk P55 subfamily member 7; PDZ domain, structural genomics consortium, SGC, protein BIN; 1.30A {Homo sapiens} SCOP: b.36.1.0 | Back alignment and structure |
|---|
Probab=96.82 E-value=0.0012 Score=56.27 Aligned_cols=43 Identities=30% Similarity=0.549 Sum_probs=36.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+.+++..++++ ....+.|++....
T Consensus 46 ~L~~GD~I~~ing~~v~~~~~~~~~~~l~~-~~~~v~l~v~~~~ 88 (93)
T 3o46_A 46 LIHVGDELREVNGIPVEDKRPEEIIQILAQ-SQGAITFKIIPGS 88 (93)
T ss_dssp CCCTTCEEEEETTEESTTSCHHHHHHHHHH-CCEEEEEEEECC-
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHh-CCCeEEEEEEeCC
Confidence 399999999999999999999999999994 4458888887654
|
| >2d8i_A T-cell lymphoma invasion and metastasis 1 variant; PDZ domain, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00094 Score=59.73 Aligned_cols=42 Identities=19% Similarity=0.209 Sum_probs=38.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
-|++||+|++|||.+|.++.++++..+++. +.+.|+++++|.
T Consensus 61 GL~~GD~Il~Ing~~v~~~~~~~~~~~l~~---~~v~l~v~R~p~ 102 (114)
T 2d8i_A 61 GLKAGDEILEINNRAADALNSSMLKDFLSQ---PSLGLLVRTYPE 102 (114)
T ss_dssp TCCTTCCEEEESSCBGGGCCHHHHHHHHTS---SEEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCcCHHHHHHHHhC---CcEEEEEEECCC
Confidence 599999999999999999989999999983 489999999994
|
| >2dm8_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0014 Score=58.27 Aligned_cols=43 Identities=30% Similarity=0.465 Sum_probs=38.9
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.+|.++.++++..+++ ...+.++|++.++..
T Consensus 62 L~~GD~I~~vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~R~~~ 104 (116)
T 2dm8_A 62 LWAGDQILEVNGVDLRNSSHEEAITALR-QTPQKVRLVVYRDEA 104 (116)
T ss_dssp CCTTCEEEEETTEECSSSCHHHHHHHHH-TCCSEEEEEEECCSS
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEeCCc
Confidence 9999999999999999999999999998 556899999998773
|
| >3b76_A E3 ubiquitin-protein ligase LNX; PDZ, bound ligand, structural genomics, structural genomics consortium, SGC, metal-binding; 1.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0011 Score=59.65 Aligned_cols=43 Identities=21% Similarity=0.363 Sum_probs=39.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+.+++..+++ ...+.+.|++.+..
T Consensus 71 ~L~~GD~Il~VNg~~v~~~~~~~~~~~l~-~~~~~v~L~v~R~~ 113 (118)
T 3b76_A 71 RIKTGDILLNVDGVELTEVSRSEAVALLK-RTSSSIVLKALEVK 113 (118)
T ss_dssp SSCTTCEEEEETTEEGGGSCHHHHHHHHH-SCCSEEEEEEEEEE
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 39999999999999999999999999999 66788999998755
|
| >2ehr_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0012 Score=58.79 Aligned_cols=42 Identities=24% Similarity=0.328 Sum_probs=39.0
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ...+.+.|++++..
T Consensus 69 L~~GD~Il~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~r~~ 110 (117)
T 2ehr_A 69 LKTGDKILEVSGVDLQNASHSEAVEAIK-NAGNPVVFIVQSLS 110 (117)
T ss_dssp CCTTCEEEEESSCBCTTCCHHHHHHHHH-TSCSSEEEEECCBS
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 9999999999999999999999999998 67889999999876
|
| >1ufx_A KIAA1526 protein; PDZ domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, protein binding; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.00076 Score=59.06 Aligned_cols=44 Identities=27% Similarity=0.370 Sum_probs=38.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC----CCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT----TDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+.+++-.+|++. ..+.+++++++.-
T Consensus 50 ~L~~GD~Il~Vng~~v~~~~~~~~~~~l~~~~~~~~~~~i~l~v~r~~ 97 (103)
T 1ufx_A 50 QLKVGHVILEVNGLTLRGKEHREAARIIAEAFKTKDRDYIDFLVTEFN 97 (103)
T ss_dssp SSCTTCBCCEETTEECTTCBHHHHHHHHHHHHHCSSCSEEEEEECCCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHHhcccCCCCeEEEEEEEcc
Confidence 3999999999999999999999999999854 5778888888765
|
| >2kom_A Partitioning defective 3 homolog; PAR-3B, PDZ domain, PSI, structural genomics, alternative splicing, cell cycle, cell division, cell junction; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.79 E-value=0.0014 Score=58.95 Aligned_cols=42 Identities=33% Similarity=0.589 Sum_probs=37.5
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeeecc
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQILKE 334 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 334 (681)
|++||+|++|||.++.+++++++..++++. .++.++|+++++
T Consensus 77 L~~GD~Il~Ing~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~ 119 (121)
T 2kom_A 77 LKAGDRLIEVNGVDLVGKSQEEVVSLLRSTKMEGTVSLLVFRQ 119 (121)
T ss_dssp CCSSSEEEEETTEECTTSCHHHHHHHHHHCCSSCEEEEEEEEC
T ss_pred CCCCCEEEEECCEEcCCCCHHHHHHHHhcCCCCCEEEEEEEeC
Confidence 999999999999999999999999999854 378899999875
|
| >1vae_A Rhophilin 2, rhophilin, RHO GTPase binding protein 2; PDZ domain, intracellular signaling cascade, signal transduction; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0013 Score=58.49 Aligned_cols=44 Identities=16% Similarity=0.237 Sum_probs=38.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.+|.+...+++..+|++..++.++|++++.-
T Consensus 53 GL~~GD~Il~InG~~v~~~~~~d~~~~i~~~~~~~v~l~V~~~~ 96 (111)
T 1vae_A 53 GAKEGDYIVSIQGVDCKWLTVSEVMKLLKSFGGEEVEMKVVSLL 96 (111)
T ss_dssp HCCTTCEEEEETTEECSSCCHHHHHHHHHHTTTSEECEEEECEE
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCceEEEEEEecC
Confidence 59999999999999999889999999999666777888887643
|
| >3khf_A Microtubule-associated serine/threonine-protein kinase 3; MAST3, microtubule associated serine/threonine kinase 3, PDZ domain, structural genomics; 1.20A {Homo sapiens} PDB: 2w7r_A 2kqf_A 2kyl_A 3ps4_A | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0014 Score=56.44 Aligned_cols=43 Identities=21% Similarity=0.194 Sum_probs=39.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..+++ ..++.++|++.++-
T Consensus 51 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~-~~g~~v~l~v~r~~ 93 (99)
T 3khf_A 51 GLRAGDLITHINGESVLGLVHMDVVELLL-KSGNKISLRTTALE 93 (99)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-HSCSEEEEEEECSC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHh-cCCCEEEEEEEECC
Confidence 59999999999999999999999999999 78899999998865
|
| >3tsv_A Tight junction protein ZO-1; PDZ, scaffolding, JAM, cell adhesion; 1.99A {Homo sapiens} PDB: 3shu_A | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0011 Score=60.20 Aligned_cols=45 Identities=20% Similarity=0.203 Sum_probs=40.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhc-CCCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRN-TTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 336 (681)
-|++||+|++|||.+|.+++.+++..++.+ ..++.++|++++++.
T Consensus 68 GL~~GD~Il~Vng~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~~~ 113 (124)
T 3tsv_A 68 GLEEGDQILRVNNVDFTNIIREEAVLFLLDLPKGEEVTILAQKKKD 113 (124)
T ss_dssp TCCTTEEEEEETTEECSSCCHHHHHHHHHHSCTTCEEEEEEEECHH
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhcCCCCEEEEEEEECCc
Confidence 599999999999999999999999887774 577899999999983
|
| >2jre_A C60-1 PDZ domain peptide; de novo protein; NMR {Synthetic} | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0011 Score=58.08 Aligned_cols=42 Identities=19% Similarity=0.357 Sum_probs=38.7
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.+|.+++.+++..++++ .++.+.|++.++.
T Consensus 63 l~~GD~I~~vng~~v~~~~~~~~~~~l~~-~g~~v~l~v~R~~ 104 (108)
T 2jre_A 63 IEPNDKILRVDDVNVQGMAQSDVVEVLRN-AGNPVRLLLIRRL 104 (108)
T ss_dssp CCSSEEEEEETTEECTTSCHHHHHHHHHH-HCSEEEEEEEECC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCeEEEEEEeCC
Confidence 99999999999999999999999999984 7889999998876
|
| >1nf3_C PAR-6B; semi-CRIB motif, switch I and II, PDZ domain, GTPase binding domain, signaling protein; HET: GNP; 2.10A {Mus musculus} SCOP: b.36.1.1 PDB: 2lc6_A 1ry4_A 1x8s_A 2lc7_A 1rzx_A | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0012 Score=59.93 Aligned_cols=42 Identities=29% Similarity=0.381 Sum_probs=38.1
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.+|.+.+++++..+++ .....++|++.++-
T Consensus 84 L~~GD~Il~vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~r~~ 125 (128)
T 1nf3_C 84 LAVNDEVLEVNGIEVSGKSLDQVTDMMI-ANSRNLIITVRPAN 125 (128)
T ss_dssp CCTTCEEEEETTEESTTCCHHHHHHHHH-HTTTSEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 8999999999999999999999999998 56667999998865
|
| >3ngh_A PDZ domain-containing protein 1; adaptor protein, SR-BI, signaling protein; 1.80A {Mus musculus} SCOP: b.36.1.0 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0012 Score=57.63 Aligned_cols=43 Identities=28% Similarity=0.379 Sum_probs=39.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+..++++..+++ ..++.+.|++.++.
T Consensus 43 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~-~~g~~v~l~v~r~~ 85 (106)
T 3ngh_A 43 GLLDGDRVLRINGVFVDKEEHAQVVELVR-KSGNSVTLLVLDGD 85 (106)
T ss_dssp TCCTTCEEEEETTEECTTSCHHHHHHHHH-HTTTEEEEEEECHH
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCEEEEEEEECC
Confidence 48999999999999999999999999998 67889999999866
|
| >1wf8_A Neurabin-I; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0012 Score=57.85 Aligned_cols=42 Identities=21% Similarity=0.304 Sum_probs=38.7
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ...+.++|++.++.
T Consensus 59 L~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~ 100 (107)
T 1wf8_A 59 IQVNDQIVEVDGISLVGVTQNFAATVLR-NTKGNVRFVIGREK 100 (107)
T ss_dssp SCTTCBEEEETTEECBSCCHHHHHHHHH-HCCSEEEEEEEEEC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHh-cCCCeEEEEEEeCC
Confidence 9999999999999999999999988888 56889999999876
|
| >2awx_A Synapse associated protein 97; membrane protein, synaptic signaling, trafficking protein; HET: HIS; 1.80A {Rattus norvegicus} PDB: 2g2l_A 2awu_A 2aww_A 3rl8_A | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0016 Score=56.83 Aligned_cols=43 Identities=21% Similarity=0.407 Sum_probs=39.2
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+...+++..+++ ..++.++|++.++..
T Consensus 52 L~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~~ 94 (105)
T 2awx_A 52 LQIGDKLLAVNSVSLEEVTHEEAVTALK-NTSDFVYLKVAKPTS 94 (105)
T ss_dssp CCTTCEEEEETTEECTTCBHHHHHHHHH-SCCSEEEEEEECCCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEcCCC
Confidence 9999999999999999999999988888 568899999999873
|
| >3kzd_A TIAM-1, T-lymphoma invasion and metastasis-inducing prote; PDZ, cell junction, cell adhesion, signaling protein, nucleotide exchange factor; 1.30A {Homo sapiens} PDB: 3kze_A | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0014 Score=56.65 Aligned_cols=41 Identities=20% Similarity=0.212 Sum_probs=37.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|+.||+|++|||.+|.++.++++..+++ .+.+.|++..-|
T Consensus 52 GL~~GD~Il~vng~~v~~~~~~~l~~~l~---~~~l~ltV~~~p 92 (94)
T 3kzd_A 52 GLKAGDEILEINNRAADALNSSMLKDFLS---QPSLGLLVRTYP 92 (94)
T ss_dssp TCCTTCEEEEETTEEGGGCCHHHHHHHHH---SSEEEEEEEECC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHh---CCeEEEEEEecC
Confidence 69999999999999999999999999998 467888888766
|
| >1va8_A Maguk P55 subfamily member 5; PDZ domain, palmitoylated 5, PALS1 protein, structural genomics, riken structural genomics/proteomics initiative; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0014 Score=58.23 Aligned_cols=43 Identities=33% Similarity=0.505 Sum_probs=37.5
Q ss_pred cc-ccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SL-HLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~-~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-| ++||+|++|||.+|.+..++++..+++ .....+.|++.++-
T Consensus 65 Gll~~GD~I~~vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~r~~ 108 (113)
T 1va8_A 65 GLLHEGDEVLEINGIEIRGKDVNEVFDLLS-DMHGTLTFVLIPSS 108 (113)
T ss_dssp TCCCTTCEEEEETTEECTTCCHHHHHHHHH-HCCEEEEEEEECCC
T ss_pred CCCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 35 999999999999999999999999998 45568899988765
|
| >1wf7_A Enigma homologue protein; PDZ domain, structural genomics, riken structural genomics/proteomics initiative, RSGI, unknown function; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.74 E-value=0.0014 Score=56.99 Aligned_cols=43 Identities=16% Similarity=0.338 Sum_probs=38.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.++...++..+++ ...+.+.|+++++-
T Consensus 46 GL~~GD~I~~ing~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~g 88 (103)
T 1wf7_A 46 HVRIGDVVLSIDGISAQGMTHLEAQNKIK-ACTGSLNMTLQRAS 88 (103)
T ss_dssp TCCTTCBEEEETTEECSSCCHHHHHHHHH-HCSSEEEEEECCCS
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 59999999999999999998888888888 45788999998876
|
| >1uit_A Human discs large 5 protein; PDZ domain, HDLG5, maguk family, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0018 Score=57.62 Aligned_cols=44 Identities=23% Similarity=0.301 Sum_probs=38.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
-|++||+|++|||.+|.++...+...++. ...+.++|++++++.
T Consensus 59 GL~~GD~Il~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~r~~~ 102 (117)
T 1uit_A 59 GLEYGDQLLEFNGINLRSATEQQARLIIG-QQCDTITILAQYNPH 102 (117)
T ss_dssp TCCTTCEECEETTEETTTCCHHHHHHHTT-SCCSEEEEEECCCSC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECCc
Confidence 49999999999999999988777766666 678899999999985
|
| >1g9o_A NHE-RF; PDZ domain, complex, signaling protein; 1.50A {Homo sapiens} SCOP: b.36.1.1 PDB: 1i92_A 1gq4_A 1gq5_A 2ocs_A | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0018 Score=54.85 Aligned_cols=44 Identities=34% Similarity=0.409 Sum_probs=35.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..++++..++...+++.++.
T Consensus 44 GL~~GD~I~~ing~~v~~~~~~~~~~~l~~~~~~~~~~~~~r~~ 87 (91)
T 1g9o_A 44 GLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAVRLLVVDPET 87 (91)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHHTCSSEEEEEEECCCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHcCCCcEEEEEEcCCc
Confidence 49999999999999999999999999999554555555555543
|
| >2vsv_A Rhophilin-2; scaffold protein, RHO GTPase binding, protein-binding, RHOB, nitration, cytoplasm, PDZ domain, CAsp8; 1.82A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0017 Score=57.62 Aligned_cols=44 Identities=16% Similarity=0.199 Sum_probs=38.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.+|.+++.+++..+|++..++.+.|++.+..
T Consensus 61 GL~~GD~Il~VnG~~v~~~~~~dv~~~i~~~~~~~v~l~V~~~~ 104 (109)
T 2vsv_A 61 GAREGDYIVSIQLVDCKWLTLSEVMKLLKSFGEDEIEMKVVSLL 104 (109)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHHTTTTSCEEEEEESCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCeEEEEEEECC
Confidence 58999999999999999999999999998655666888887654
|
| >2d90_A PDZ domain containing protein 1; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0026 Score=55.15 Aligned_cols=43 Identities=23% Similarity=0.244 Sum_probs=38.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+...+++..+++ ..++.+.|++.++-
T Consensus 47 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~-~~g~~v~l~v~r~~ 89 (102)
T 2d90_A 47 GLKNNDLVVAVNGKSVEALDHDGVVEMIR-KGGDQTTLLVLDKE 89 (102)
T ss_dssp TCCTTCEEEEESSCBCTTSCHHHHHHHHH-HSTTEEEEEECSTT
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEECC
Confidence 59999999999999999998999999998 46789999998765
|
| >3sfj_A TAX1-binding protein 3; PDZ:peptide complex, signaling protein-inhibitor complex; 1.24A {Homo sapiens} PDB: 3dj3_A | Back alignment and structure |
|---|
Probab=96.73 E-value=0.0019 Score=56.10 Aligned_cols=43 Identities=19% Similarity=0.388 Sum_probs=38.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
-|++||+|++|||.++.+..++++..++++..++.+.|++.++
T Consensus 62 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~~~~g~~v~l~v~R~ 104 (104)
T 3sfj_A 62 GLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQ 104 (104)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHTCTTCSEEEEEEEEC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCEEEEEEEcC
Confidence 5999999999999999999999999999866678899988763
|
| >2la8_A Inactivation-NO-after-potential D protein, KON-TI peptide; peptide binding protein; NMR {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=96.72 E-value=0.0016 Score=57.26 Aligned_cols=42 Identities=21% Similarity=0.357 Sum_probs=37.8
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ...+.+.|++.+..
T Consensus 44 L~~GD~Il~Ing~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~ 85 (106)
T 2la8_A 44 LQRGDIITKFNGDALEGLPFQVCYALFK-GANGKVSMEVTRPK 85 (106)
T ss_dssp CCTTCEEEEESSCBCSSSCHHHHHHHHH-SCBSCEEEEEEECC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHh-CCCCeEEEEEEeCC
Confidence 9999999999999999988999988888 56677999999865
|
| >2iwn_A Multiple PDZ domain protein; SGC, MPDZ, MUPP1, MUPP- 1, HOST-virus interaction, structural genomics consortium, synaptosome, tight junction; 1.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0018 Score=55.22 Aligned_cols=42 Identities=21% Similarity=0.424 Sum_probs=37.6
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.++..+++..+++ ..++.+.|++.++-
T Consensus 52 l~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~r~g 93 (97)
T 2iwn_A 52 IQIGDQIIAVDGTNLQGFTNQQAVEVLR-HTGQTVLLTLMRRG 93 (97)
T ss_dssp CCTTCEEEEETTEECTTSCHHHHHHHHH-TCCSEEEEEEEEEE
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 9999999999999999999999888888 47888999998754
|
| >1um1_A KIAA1849 protein, RSGI RUH-007; PDZ domain, human cDNA, structural genomics, riken structural genomics/proteomics initiative, unknown function; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0017 Score=57.06 Aligned_cols=42 Identities=36% Similarity=0.416 Sum_probs=38.9
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ...+.++|++.++.
T Consensus 55 L~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~ 96 (110)
T 1um1_A 55 LSLGDRILEVNGSSLLGLGYLRAVDLIR-HGGKKMRFLVAKSD 96 (110)
T ss_dssp CCTTCEEEEESSCBCSSCCHHHHHHHHH-TCCSEEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 9999999999999999999999999998 56889999999876
|
| >2csj_A TJP2 protein; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0013 Score=58.68 Aligned_cols=44 Identities=23% Similarity=0.250 Sum_probs=39.7
Q ss_pred cccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 291 MSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 291 ~~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
..|++||+|++|||.++.+...+++..+++ ...+.+.|+++++.
T Consensus 61 ~gL~~GD~I~~Vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~R~~ 104 (117)
T 2csj_A 61 GLLQENDRVVMVNGTPMEDVLHSFAVQQLR-KSGKIAAIVVKRPR 104 (117)
T ss_dssp HHBCTTCEEEEESSCBCBTCCHHHHHHHHH-HSCSEEEEEEEEEE
T ss_pred ccCCCCCEEEEECCEECCCcCHHHHHHHHh-cCCCeEEEEEEECC
Confidence 469999999999999999999999989988 57889999999876
|
| >2fne_A Multiple PDZ domain protein; structural protein, structural genomics, SGC, structural genomics consortium, unknown function; 1.83A {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0017 Score=58.24 Aligned_cols=42 Identities=24% Similarity=0.412 Sum_probs=37.5
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+.+++..+++ .....++|++.++.
T Consensus 72 L~~GD~Il~Vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~R~g 113 (117)
T 2fne_A 72 LKRGDQIIAVNGQSLEGVTHEEAVAILK-RTKGTVTLMVLSSD 113 (117)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-HCCSSEEEEEEECS
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 9999999999999999999999999998 44556999998875
|
| >1uju_A Scribble; PDZ domain, cellular signaling, structural genomics, riken structural genomics/proteomics initiative, RSGI, signaling protein; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.67 E-value=0.00075 Score=59.61 Aligned_cols=42 Identities=26% Similarity=0.310 Sum_probs=39.2
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+...+++..+++ ...+.++|+++++.
T Consensus 63 L~~GD~Il~vng~~v~~~~~~~~~~~l~-~~g~~v~l~v~r~~ 104 (111)
T 1uju_A 63 LRVGLRLLEVNQQSLLGLTHGEAVQLLR-SVGDTLTVLVCDGF 104 (111)
T ss_dssp CCTTCBCCBBSSCBCTTSCHHHHHHHHS-SCSSEEEECCCCCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 9999999999999999999999999999 57899999998876
|
| >2e7k_A Maguk P55 subfamily member 2; PDZ domain, MPP2 protein, discs large homolog 2, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.0018 Score=55.19 Aligned_cols=41 Identities=37% Similarity=0.526 Sum_probs=36.2
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++ +.+++++..+++ ...+.+.|++.+..
T Consensus 48 L~~GD~I~~ing~~v-~~~~~~~~~~l~-~~~~~v~l~v~~~~ 88 (91)
T 2e7k_A 48 LHVGDIIKEVNGQPV-GSDPRALQELLR-NASGSVILKILSGP 88 (91)
T ss_dssp CCTTCEEEEETTEEC-TTCHHHHHHHHH-TCCSSBCEEEECCS
T ss_pred CCCCCEEEEECCEEC-CCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 899999999999999 889999999999 45778888887654
|
| >2edz_A PDZ domain-containing protein 1; CFTR-associated protein of 70 kDa, Na/PI cotransporter C- terminal-associated protein, NAPI-CAP1; NMR {Mus musculus} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0014 Score=58.14 Aligned_cols=43 Identities=28% Similarity=0.379 Sum_probs=39.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.+|.+..++++..+++ ..++.+.|++.++-
T Consensus 55 GL~~GD~I~~ing~~v~~~~~~~~~~~l~-~~g~~v~l~v~R~~ 97 (114)
T 2edz_A 55 GLLDGDRVLRINGVFVDKEEHAQVVELVR-KSGNSVTLLVLDGD 97 (114)
T ss_dssp TCCTTCEEEEESSSBCSSSCHHHHHHHHH-HTCSEEEEEEECHH
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEECC
Confidence 49999999999999999999999999998 45899999999876
|
| >2yuy_A RHO GTPase activating protein 21; PDZ domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0013 Score=59.68 Aligned_cols=43 Identities=37% Similarity=0.567 Sum_probs=39.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.+|.+.+++++..+|+ ...+.+.|++.++.
T Consensus 78 GL~~GD~I~~ing~~v~~~~~~~~~~~l~-~~g~~v~l~v~r~~ 120 (126)
T 2yuy_A 78 GLCTGDRIIKVNGESVIGKTYSQVIALIQ-NSDTTLELSVMPKD 120 (126)
T ss_dssp TCCSSCCCCEETTEECSSCCHHHHHHHHH-TCTTEEEEECCCCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEECC
Confidence 59999999999999999999999999999 56899999998876
|
| >1q7x_A PDZ2B domain of PTP-BAS (HPTP1E); phosphatase, structural proteomics in europe, spine, structural genomics, hydrolase; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0015 Score=57.32 Aligned_cols=43 Identities=28% Similarity=0.421 Sum_probs=39.1
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+.+.+++..+++ ..++.+.|++.++..
T Consensus 61 L~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~~ 103 (108)
T 1q7x_A 61 IHKGDRVLAVNGVSLEGATHKQAVETLR-NTGQVVHLLLEKGQS 103 (108)
T ss_dssp CCSSCEEEEETTEECBSCTTSHHHHHHH-HTTSEEEEEEECCCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCCc
Confidence 9999999999999999989999999998 568999999999763
|
| >2eeh_A PDZ domain-containing protein 7; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0021 Score=55.51 Aligned_cols=42 Identities=21% Similarity=0.365 Sum_probs=37.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+..++++-.++++ ++.+.|+++++-
T Consensus 53 GL~~GD~I~~ing~~v~~~~~~~~~~~~~~--~~~v~l~v~R~g 94 (100)
T 2eeh_A 53 GLCVGDKITEVNGLSLESTTMGSAVKVLTS--SSRLHMMVRRMG 94 (100)
T ss_dssp TCCSSCEEEEETTEECSSCCHHHHHHHHHS--CSSEEEEEEECS
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHhhcC--CCEEEEEEEECC
Confidence 499999999999999999889999888884 688999999876
|
| >2edp_A Fragment, shroom family member 4; APX/shroom family member, KIAA1202 protein, structural genomics, NPPSFA; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0018 Score=56.16 Aligned_cols=42 Identities=26% Similarity=0.450 Sum_probs=36.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+. .+++..+++ ...+.+.|+++++.
T Consensus 53 GL~~GD~I~~ing~~v~~~-~~~~~~~~~-~~~~~v~l~v~R~~ 94 (100)
T 2edp_A 53 KMRTGDELVNINGTPLYGS-RQEALILIK-GSFRILKLIVRRRN 94 (100)
T ss_dssp SCCTTCEEEEETTEECCSC-SHHHHHHHH-TCCSSCEEEEEECC
T ss_pred CCCCCCEEEEECCEEccch-HHHHHHHHH-hCCCeEEEEEEeCC
Confidence 4999999999999999986 788888888 45788999999876
|
| >2dmz_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0016 Score=59.00 Aligned_cols=42 Identities=19% Similarity=0.435 Sum_probs=39.4
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.++.+.+.+++..++++ .++.++|++.++-
T Consensus 65 L~~GD~I~~vng~~v~~~~~~~~~~~l~~-~~~~v~l~v~R~~ 106 (129)
T 2dmz_A 65 IQVNDKIVAVDGVNIQGFANHDVVEVLRN-AGQVVHLTLVRRK 106 (129)
T ss_dssp CCSSCBEEEETTBCCTTCCHHHHHHHHHH-CCSSEEEEEEEES
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCeEEEEEEeCC
Confidence 99999999999999999999999999995 8889999999876
|
| >2vz5_A TAX1-binding protein 3; WNT signaling pathway, protein binding, nucleus, cytoplasm, PDZ domain; 1.74A {Homo sapiens} PDB: 3dj1_A 3diw_A 2l4s_A 2l4t_A 3gj9_A 2kg2_A 3dj3_A | Back alignment and structure |
|---|
Probab=96.62 E-value=0.0022 Score=59.29 Aligned_cols=44 Identities=18% Similarity=0.380 Sum_probs=40.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..++++..++.++|++.++.
T Consensus 81 GL~~GD~I~~vng~~v~~~~~~~~~~~l~~~~g~~v~l~v~R~g 124 (139)
T 2vz5_A 81 GLQIGDKIMQVNGWDMTMVTHDQARKRLTKRSEEVVRLLVTRQS 124 (139)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHCCTTCSEEEEEEEECC
T ss_pred CCCCCCEEEEECCEEcCCCCHHHHHHHHHhCCCCEEEEEEEECC
Confidence 49999999999999999999999999999656789999999987
|
| >2g5m_B Neurabin-2; spinophilin, PDZ domain, CNS, synaptic transmission, protein binding; NMR {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0017 Score=57.33 Aligned_cols=43 Identities=21% Similarity=0.287 Sum_probs=39.2
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+.+.+++..+++ ..++.+.|++.++..
T Consensus 54 l~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~~ 96 (113)
T 2g5m_B 54 IQVNDLLVEVDGTSLVGVTQSFAASVLR-NTKGRVRFMIGRERP 96 (113)
T ss_dssp SCTTCBEEEETTEECSSCCHHHHHHHHH-HSCSSCEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHh-cCCCeEEEEEEeCCC
Confidence 9999999999999999999999988888 568899999999873
|
| >3r68_A Na(+)/H(+) exchange regulatory cofactor NHE-RF3; PDZ domain, adaptor protein, SR-BI, signaling protein; 1.30A {Mus musculus} SCOP: b.36.1.0 PDB: 3r69_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0023 Score=54.58 Aligned_cols=43 Identities=23% Similarity=0.250 Sum_probs=35.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+++++++..++++ ....+.+++.+..
T Consensus 46 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~~-~~~~~~~~~~r~~ 88 (95)
T 3r68_A 46 GLKNNDLVVAVNGKSVEALDHDGVVEMIRK-GGDQTTLLVLDKE 88 (95)
T ss_dssp TCCTTEEEEEETTEECTTCCHHHHHHHHHT-TTTEEEEEEEECC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHh-CCCeEEEEEECCc
Confidence 499999999999999999999999999994 5556666655443
|
| >2daz_A INAD-like protein; PDZ domain, inadl protein, hinadl, PALS1- associated tight junction protein, protein associated to tight junctions, PATJ; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.0017 Score=58.61 Aligned_cols=43 Identities=19% Similarity=0.421 Sum_probs=38.7
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.+|.+...+++..+++ .....++|++.++..
T Consensus 70 L~~GD~Il~Ing~~v~~~~~~~~~~~~~-~~~~~v~l~v~R~~~ 112 (124)
T 2daz_A 70 MRIGDELLEINNQILYGRSHQNASAIIK-TAPSKVKLVFIRNED 112 (124)
T ss_dssp CCTTCEECEESSCBCTTSCHHHHHHHHH-HSCSEEEEEEEECTT
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCCC
Confidence 9999999999999999999999988888 556799999999873
|
| >1x5q_A LAP4 protein; PDZ domain, scribble homolog protein, hscrib, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0027 Score=55.80 Aligned_cols=43 Identities=28% Similarity=0.507 Sum_probs=38.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+....++..+++ ..++.++|+++++-
T Consensus 63 GL~~GD~I~~ing~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~g 105 (110)
T 1x5q_A 63 GVRVGDKLLEVNGVALQGAEHHEAVEALR-GAGTAVQMRVWRES 105 (110)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-SCCSEEEEEEEECS
T ss_pred CCCCCCEEEEECCEECCCcCHHHHHHHhh-CCCCeEEEEEEECC
Confidence 49999999999999999988888877887 58899999999876
|
| >2eei_A PDZ domain-containing protein 1; regulatory factor, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0017 Score=56.64 Aligned_cols=43 Identities=21% Similarity=0.320 Sum_probs=37.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+...+++..+++ ...+.+.|++.++.
T Consensus 49 Gl~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~r~~ 91 (106)
T 2eei_A 49 GVLADDHLIEVNGENVEDASHEEVVEKVK-KSGSRVMFLLVDKE 91 (106)
T ss_dssp TCCSSEEEEEETTEECTTCCHHHHHHHHH-HHCSEEEEEECCTT
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEcCc
Confidence 49999999999999999999999988888 55778899988765
|
| >1q3o_A Shank1; PDZ, GKAP, peptide binding protein; 1.80A {Rattus norvegicus} SCOP: b.36.1.1 PDB: 1q3p_A 3qjm_A 3qjn_A 3o5n_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0023 Score=56.27 Aligned_cols=43 Identities=28% Similarity=0.406 Sum_probs=37.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.+|.++.++++..+++ ...+.+.|++.+..
T Consensus 62 Gl~~GD~I~~vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~~~~ 104 (109)
T 1q3o_A 62 GLRMGDFLIEVNGQNVVKVGHRQVVNMIR-QGGNTLMVKVVMVT 104 (109)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-HTTTEEEEEEEEEE
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCEEEEEEEECC
Confidence 59999999999999999999999999998 45778888887643
|
| >1wif_A RSGI RUH-020, riken cDNA 4930408O21; PDZ domain, structural genomics, mouse cDNA, riken structural genomics/proteomics initiative; NMR {Mus musculus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0024 Score=58.20 Aligned_cols=42 Identities=33% Similarity=0.397 Sum_probs=38.4
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhc-CCCceeeeeeecc
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRN-TTDTVLQRQILKE 334 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 334 (681)
|++||+|++|||.+|...+.+++..++++ ..++.++|+++++
T Consensus 68 L~~GD~Il~VnG~~v~~~s~~d~~~~l~~~~~G~~v~l~V~R~ 110 (126)
T 1wif_A 68 LQPGDVLISVGHANVLGYTLREFLKLLQNITIGTVLQIKAYRG 110 (126)
T ss_dssp SCTTCBEEEESSSCCTTCCHHHHHHHHTSCCSSCEEEEEEESS
T ss_pred CCCCCEEEEECCEEcCCCCHHHHHHHHhcCCCCCEEEEEEEEC
Confidence 99999999999999988899999999995 3578999999998
|
| >3gsl_A Disks large homolog 4; PDZ domain, tandem, PSD-95, DLG4, SAP-90, GLUR6, cell juncti membrane, lipoprotein, membrane, palmitate, phosphoprotein; 2.05A {Rattus norvegicus} PDB: 3zrt_A 2ka9_A | Back alignment and structure |
|---|
Probab=96.54 E-value=0.002 Score=62.10 Aligned_cols=42 Identities=26% Similarity=0.414 Sum_probs=39.1
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.+|.+.+.+++..+++ ...+.+.|+++++-
T Consensus 149 L~~GD~Il~Vng~~v~~~~~~~~~~~l~-~~~~~v~l~v~R~~ 190 (196)
T 3gsl_A 149 LQIGDKILAVNSVGLEDVMHEDAVAALK-NTYDVVYLKVAKPS 190 (196)
T ss_dssp CCTTCEEEEETTEECSSCBHHHHHHHHH-SCCEEEEEEEEEES
T ss_pred CCCCCEEEEECCCcCCCCCHHHHHHHHH-cCCCeEEEEEeCCC
Confidence 9999999999999999999999999999 67889999999876
|
| >3egg_C Spinophilin; PP1, serine/threonine phosphatase, post synapti density, glutametergic receptors, carbohydrate metabolism, cycle, cell division; HET: MES; 1.85A {Rattus norvegicus} PDB: 3egh_C* 3hvq_C 2fn5_A | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0021 Score=61.67 Aligned_cols=42 Identities=21% Similarity=0.317 Sum_probs=38.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
.|++||+||+|||.+|.+.+.+++..+|+ .....+.|+|.++
T Consensus 129 ~L~~GD~Il~VNG~~v~~~~~~~~~~~l~-~~g~~v~L~V~R~ 170 (170)
T 3egg_C 129 RIQVNDLLVEVDGTSLVGVTQSFAASVLR-NTKGRVRFMIGRE 170 (170)
T ss_dssp CCCTTCEEEEETTEECTTBCHHHHHHHHH-HCCSEEEEEEEEC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEeC
Confidence 39999999999999999999999999999 5778999999875
|
| >1qau_A Neuronal nitric oxide synthase (residues 1-130); beta-finger, oxidoreductase; 1.25A {Rattus norvegicus} SCOP: b.36.1.1 PDB: 1qav_B | Back alignment and structure |
|---|
Probab=96.54 E-value=0.0026 Score=56.06 Aligned_cols=45 Identities=27% Similarity=0.331 Sum_probs=40.2
Q ss_pred cc-ccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 292 SL-HLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~-~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
-| ++||+|++|||.++.+.+.+++..++++..++.+.|+++++..
T Consensus 43 Gll~~GD~I~~ing~~v~~~~~~~~~~~l~~~~g~~v~l~v~R~g~ 88 (112)
T 1qau_A 43 GLIQAGDIILAVNDRPLVDLSYDSALEVLRGIASETHVVLILRGPE 88 (112)
T ss_dssp TCCCTTCEEEEETTEECTTSCHHHHHHHHHHSCSSSEEEEEEECCT
T ss_pred CCCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCcEEEEEEeCCc
Confidence 45 9999999999999999999999999996667899999999873
|
| >2cs5_A Tyrosine-protein phosphatase, non-receptor type 4; PDZ domain, ptpase, structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.52 E-value=0.0016 Score=58.24 Aligned_cols=44 Identities=18% Similarity=0.352 Sum_probs=38.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCC---ceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTD---TVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+...+++..++++..+ +.+.|++.++.
T Consensus 60 GL~~GD~Il~ing~~v~~~~~~~~~~~~~~~~~~~~~~v~l~v~R~~ 106 (119)
T 2cs5_A 60 RLNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRPNA 106 (119)
T ss_dssp CCCTTCEEEEETTBCTTSSCHHHHHHHHHHHHHCCSSCEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhccccCCCEEEEEEEccc
Confidence 599999999999999999999999999984332 58999999987
|
| >1x6d_A Interleukin-16; PDZ domain, lymphocyte chemoattractant factor (LCF), structural genomics, NPPSFA; NMR {Homo sapiens} SCOP: b.36.1.2 | Back alignment and structure |
|---|
Probab=96.51 E-value=0.0025 Score=56.95 Aligned_cols=44 Identities=11% Similarity=0.361 Sum_probs=38.7
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.+|.+...+++..+++...++.+.+++.++..
T Consensus 61 L~~GD~Il~ing~~v~~~~~~~~~~~l~~~~~~~~~l~v~R~~~ 104 (119)
T 1x6d_A 61 IQKGNEVLSINGKSLKGTTHHDALAILRQAREPRQAVIVTRKLT 104 (119)
T ss_dssp SCTTCBCCEETTEECSSCCHHHHHHHHHHTTSSSEEEEEEECCC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCeEEEEEEcCCC
Confidence 99999999999999999999999999986667777788888774
|
| >1wg6_A Hypothetical protein (riken cDNA 2810455B10); structural genomics, PDZ domain, riken structural genomics/proteomics initiative, RSGI; NMR {Mus musculus} SCOP: b.36.1.1 PDB: 2koh_A 2k1z_A 2k20_A | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0022 Score=58.22 Aligned_cols=44 Identities=25% Similarity=0.410 Sum_probs=38.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC------CCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT------TDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+..++++-.+|++. ....+.|+|.++.
T Consensus 73 ~L~~GD~Il~Vng~~v~~~~~~~~~~~l~~~~~~~g~~~~~v~l~v~R~~ 122 (127)
T 1wg6_A 73 RLRMNDQLIAVNGETLLGKSNHEAMETLRRSMSMEGNIRGMIQLVILRRS 122 (127)
T ss_dssp TSCSCCBEEEETTEESTTSCHHHHHHHHHHHHHHHHHHTCEEEEEEEECS
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHHhhccccCCCCEEEEEEEeCC
Confidence 4999999999999999999999999999843 2678999999876
|
| >2w4f_A Protein LAP4; structural protein, phosphoprotein, UBL conjugation, leucine-rich repeat, alternative splicing, cytoplasm, circletail, coiled coil; 1.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0034 Score=53.64 Aligned_cols=43 Identities=28% Similarity=0.489 Sum_probs=37.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+....+....++ ..++.+.|++.++-
T Consensus 51 Gl~~GD~I~~ing~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~g 93 (97)
T 2w4f_A 51 GVRVGDKLLEVNGVALQGAEHHEAVEALR-GAGTAVQMRVWRER 93 (97)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-TSCSEEEEEEECCS
T ss_pred CCCCCCEEEEECCEECCCcCHHHHHHHHh-CCCCeEEEEEEeCC
Confidence 49999999999999999988777777777 57889999999875
|
| >2dls_A PDZ-rhogef, RHO guanine nucleotide exchange factor 11; PDZ domain, arhgef11, KIAA0380, structural genomics, NPPSFA; NMR {Homo sapiens} PDB: 2omj_A 2os6_A | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0036 Score=53.35 Aligned_cols=42 Identities=33% Similarity=0.476 Sum_probs=36.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+....++-.+++ ..+.+.|++.++.
T Consensus 46 GL~~GD~I~~ing~~v~~~~~~~~~~~~~--~g~~v~l~v~R~~ 87 (93)
T 2dls_A 46 GVKEGDRIIKVNGTMVTNSSHLEVVKLIK--SGAYVALTLLGSS 87 (93)
T ss_dssp TCCSSCEEEEETTEECSSSCHHHHHHHHT--SSSEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHhhc--CCCEEEEEEEECC
Confidence 49999999999999999987777777776 4789999999987
|
| >3l4f_D SH3 and multiple ankyrin repeat domains protein 1; coiled-coil, PDZ, guanine-nucleotide releasing factor, phosphoprotein, SH3 domain; 2.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0026 Score=58.23 Aligned_cols=43 Identities=28% Similarity=0.406 Sum_probs=39.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.+|.+...+++..+++ ...+.++|++....
T Consensus 82 GL~~GD~Il~Vng~~v~~~~~~~~~~~l~-~~g~~v~l~v~~~~ 124 (132)
T 3l4f_D 82 GLRMGDFLIEVNGQNVVKVGHRQVVNMIR-QGGNTLMVKVVMVT 124 (132)
T ss_dssp TCCTTCEEEEESSSBCTTSCHHHHHHHHH-HTTTEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEECC
Confidence 59999999999999999999999999999 57788999988765
|
| >2eaq_A LIM domain only protein 7; conserved hypothetical protein, structural genomics, NPPSFA; 1.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.44 E-value=0.002 Score=54.32 Aligned_cols=43 Identities=19% Similarity=0.215 Sum_probs=36.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhc-CCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRN-TTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 334 (681)
-|++||+|++|||.++.+.+.+++..++++ ..++.+.|++.++
T Consensus 45 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~~~~~g~~v~l~v~R~ 88 (90)
T 2eaq_A 45 QLQVDDEIIAINNTKFSYNDSKEWEEAMAKAQETGHLVMDVRRY 88 (90)
T ss_dssp TCCTTCEEEEETTEECCTTCHHHHHHHHHHHHHHTEEEEEEEEE
T ss_pred CCCCCCEEEEECCEEccCCCHHHHHHHHHhcCCCCEEEEEEEeC
Confidence 499999999999999987889999998884 2577889998875
|
| >1b8q_A Protein (neuronal nitric oxide synthase); PDZ domain, NNOS, nitric oxide synthase, oxidoreductase; NMR {Rattus norvegicus} SCOP: b.36.1.1 | Back alignment and structure |
|---|
Probab=96.43 E-value=0.0022 Score=57.93 Aligned_cols=45 Identities=27% Similarity=0.331 Sum_probs=40.3
Q ss_pred cc-ccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 292 SL-HLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~-~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
-| ++||+|++|||.++.+.+.+++..++++..++.+.|++.++-.
T Consensus 50 Gll~~GD~I~~ing~~v~~~~~~~~~~~l~~~~g~~v~l~v~R~g~ 95 (127)
T 1b8q_A 50 GLIQAGDIILAVNDRPLVDLSYDSALEVLRGIASETHVVLILRGPE 95 (127)
T ss_dssp SSCCTTTCCCEETTEECSSSCHHHHHHHHHSCCSSCEEEEEECCCC
T ss_pred CCCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCeEEEEEEeCCc
Confidence 45 9999999999999999999999999997667899999998774
|
| >3r0h_A INAD, inactivation-NO-after-potential D protein; protein-protein complex, PDZ domain, peptide binding protein; 2.60A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.003 Score=61.70 Aligned_cols=42 Identities=21% Similarity=0.357 Sum_probs=38.8
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
|++||+|++|||.+|.++..+++..+++ ...+.+.|++++.+
T Consensus 155 L~~GD~Il~VNg~~v~~~~~~~~~~~l~-~~~~~v~L~V~R~~ 196 (206)
T 3r0h_A 155 LQRGDIITKFNGDALEGLPFQVCYALFK-GANGKVSMEVTRPK 196 (206)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEEEEC
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 9999999999999999999999999998 57789999999865
|
| >2qt5_A Glutamate receptor-interacting protein 1; PDZ-peptide complex, PDZ tandem, alternative splicing, cell junction, cytoplasm; 2.30A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0026 Score=61.98 Aligned_cols=43 Identities=19% Similarity=0.294 Sum_probs=40.3
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.+.+.+++..++++ .++.+.|+++++..
T Consensus 154 l~~GD~I~~ing~~v~~~~~~~~~~~l~~-~~~~v~l~v~R~~~ 196 (200)
T 2qt5_A 154 IKPGDRLLSVDGIRLLGTTHAEAMSILKQ-CGQEATLLIEYDVS 196 (200)
T ss_dssp CCTTCEEEEETTEECTTCCHHHHHHHHHT-TCSEEEEEEEEEEE
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCeEEEEEEECCc
Confidence 99999999999999999999999999995 88999999999874
|
| >2kjd_A Sodium/hydrogen exchange regulatory cofactor NHE- RF1; PDZ domain, protein, acetylation, cell projection, disease mutation, membrane; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0029 Score=57.13 Aligned_cols=44 Identities=32% Similarity=0.349 Sum_probs=39.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+.+.+++..++++..++.+.|+++++-
T Consensus 50 Gl~~GD~I~~ing~~v~~~~~~~~~~~l~~~~~~~~~l~v~R~g 93 (128)
T 2kjd_A 50 GLRAQDRIVEVNGVCMEGKQHGDVVSAIRAGGDETKLLVVDRET 93 (128)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHHTTCSEEEEEEECHHH
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCEEEEEEEeCC
Confidence 49999999999999999999999999999766778889998875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.027 Score=59.09 Aligned_cols=76 Identities=16% Similarity=0.093 Sum_probs=54.1
Q ss_pred ecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC---
Q psy5063 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH--- 560 (681)
Q Consensus 484 ~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--- 560 (681)
..+.|+.|.+..+|+... ++..+++|...... ...+.. |.+.|+.|.
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~---~~~~~~-------------------------E~~~L~~L~~~~ 89 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSY---RSMFRA-------------------------EADQLALLAKTN 89 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG---HHHHHH-------------------------HHHHHHHHHHTT
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCccc---HHHHHH-------------------------HHHHHHHHHhhC
Confidence 345689999999999875 36778888765432 222333 366666652
Q ss_pred CCceeeEEEEEEeCCeEEEEEeccCCCCH
Q psy5063 561 HHNVIRFIGVLYKDRKLNLVTEYIAGGTL 589 (681)
Q Consensus 561 HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL 589 (681)
...+.+.+.+....+..|+||||++|..+
T Consensus 90 ~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 90 SINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp SSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 35678888888777899999999998764
|
| >3qik_A Phosphatidylinositol 3,4,5-trisphosphate-dependen exchanger 1 protein; PDZ domain, structural genomics consortium, SGC, hydrolase R; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0038 Score=54.52 Aligned_cols=44 Identities=23% Similarity=0.414 Sum_probs=38.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhc--CCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRN--TTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.+|...+.+|+..+++. ...+.+.|++--.|
T Consensus 56 GL~~GD~I~~Ing~~v~~~s~~dv~~~i~~~~~~g~~v~LLV~~~~ 101 (101)
T 3qik_A 56 GLQVGRKIYSINEDLVFLRPFSEVESILNQSFCSRRPLRLLVATKA 101 (101)
T ss_dssp TCCTTCBEEEETTEESTTSCHHHHHHHHHHHHHTTCCEEEEEECCC
T ss_pred CCCCCCEEEEECCEEcCcCCHHHHHHHHHHhhccCCeEEEEEecCC
Confidence 699999999999999988899999999984 36889998886543
|
| >1tp5_A Presynaptic density protein 95; PDZ-peptide ligand complex, peptide binding protein; 1.54A {Rattus norvegicus} SCOP: b.36.1.1 PDB: 1tp3_A 1tq3_A 1be9_A 1bfe_A | Back alignment and structure |
|---|
Probab=96.25 E-value=0.0039 Score=55.55 Aligned_cols=43 Identities=21% Similarity=0.333 Sum_probs=38.4
Q ss_pred cccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCC
Q psy5063 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECR 336 (681)
Q Consensus 293 ~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 336 (681)
|++||+|++|||.++.++..++...+++ ...+.+.|++.+++.
T Consensus 57 L~~GD~I~~vng~~v~~~~~~~~~~~~~-~~~~~v~l~v~r~~~ 99 (119)
T 1tp5_A 57 LRKGDQILSVNGVDLRNASHEQAAIALK-NAGQTVTIIAQYKPE 99 (119)
T ss_dssp CCTTEEEEEETTEECTTCCHHHHHHHHH-TSCSEEEEEEEECHH
T ss_pred CCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECCc
Confidence 9999999999999999998888877777 578899999999883
|
| >1zfo_A LAsp-1; LIM domain, zinc-finger, metal-binding protein; NMR {Sus scrofa} SCOP: g.39.1.4 | Back alignment and structure |
|---|
Probab=96.17 E-value=0.0014 Score=44.62 Aligned_cols=28 Identities=25% Similarity=0.645 Sum_probs=24.0
Q ss_pred CCcccccCCccc-cCeEEecCccCCCCce
Q psy5063 68 GEACQNCGQMMS-GPVMVVGDHKFHPECF 95 (681)
Q Consensus 68 ~~~C~~C~~~I~-g~~~~a~~~~yH~~CF 95 (681)
.++|..|++.+. .+.+.+.|+.||..||
T Consensus 3 ~~~C~~C~k~Vy~~Ek~~~~g~~~Hk~CF 31 (31)
T 1zfo_A 3 NPNCARCGKIVYPTEKVNCLDKFWHKACF 31 (31)
T ss_dssp CCBCSSSCSBCCGGGCCCSSSSCCCGGGC
T ss_pred CCcCCccCCEEecceeEEECCeEecccCC
Confidence 479999999883 4677799999999998
|
| >2h2b_A Tight junction protein ZO-1; PDZ domain, phage derived high affinity ligand, cell adhesio; 1.60A {Homo sapiens} PDB: 2h2c_A 2h3m_A 2rrm_A | Back alignment and structure |
|---|
Probab=96.17 E-value=0.0059 Score=53.24 Aligned_cols=44 Identities=18% Similarity=0.157 Sum_probs=36.9
Q ss_pred cccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 291 MSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 291 ~~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.-|++||+|++|||.++.++...+...++. ...+.+.|+++++-
T Consensus 54 agl~~GD~I~~vng~~v~~~~~~~~~~~~~-~~g~~v~l~v~R~~ 97 (107)
T 2h2b_A 54 GQLQENDRVAMVNGVSMDNVEHAFAVQQLR-KSGKNAKITIRRKK 97 (107)
T ss_dssp TTBCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEEEES
T ss_pred hCCCCCCEEEEECCEECCCccHHHHHHHhh-CCCCEEEEEEEECC
Confidence 569999999999999999987776666666 56788999998876
|
| >2z17_A Pleckstrin homology SEC7 and coiled-coil domains- binding protein; PDZ domain, cytoplasm, membrane, polymorphism, protein binding; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.17 E-value=0.0033 Score=54.67 Aligned_cols=39 Identities=26% Similarity=0.421 Sum_probs=33.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQI 331 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (681)
-|++||+|++|||.++.+.+++++..++++. ...+.|++
T Consensus 65 Gl~~GD~I~~vng~~v~~~~~~~~~~~l~~~-~~~v~l~v 103 (104)
T 2z17_A 65 GLQAGDVLANINGVSTEGFTYKQVVDLIRSS-GNLLTIET 103 (104)
T ss_dssp TCCTTCBCCEETTEECTTCCHHHHHHHHHHT-TTEEEEEC
T ss_pred CCCCCCEEEEECCEEcCCCCHHHHHHHHHhC-CCcEEEEE
Confidence 4999999999999999999999999999955 44777765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 681 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-32 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-29 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-29 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-28 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-28 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-28 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-27 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-26 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-26 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-26 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-26 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-26 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-25 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-25 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-25 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-25 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 9e-25 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-24 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-24 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-24 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-24 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-23 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-23 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-23 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-22 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-22 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-22 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-22 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-22 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-21 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-21 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-21 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-21 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-21 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-20 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-20 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-20 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-20 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-19 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-19 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-19 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-19 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-19 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-19 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-17 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-17 | |
| d1x6aa1 | 34 | g.39.1.3 (A:8-41) Lim domain kinase 2 {Human (Homo | 6e-15 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-13 | |
| d1v6ga1 | 41 | g.39.1.3 (A:1-41) Actin-binding LIM protein 2, abL | 3e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-12 | |
| d1x6aa2 | 34 | g.39.1.3 (A:42-75) Lim domain kinase 2 {Human (Hom | 3e-11 | |
| d1x3ha1 | 35 | g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [ | 6e-09 | |
| d1x3ha1 | 35 | g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [ | 8e-04 | |
| d1vb7a_ | 94 | b.36.1.1 (A:) PDZ-LIM protein mystique {Mouse (Mus | 3e-06 | |
| d1rgwa_ | 85 | b.36.1.1 (A:) Zasp (Cypher, Oracle 1) {Human (Homo | 5e-06 | |
| d1m5za_ | 91 | b.36.1.1 (A:) Glutamate receptor interacting prote | 6e-06 | |
| d2f5ya1 | 77 | b.36.1.1 (A:19-95) Regulator of G-protein signalin | 7e-06 | |
| d1ujda_ | 117 | b.36.1.1 (A:) Hypothetical protein KIAA0559 {Human | 9e-06 | |
| d1g9oa_ | 91 | b.36.1.1 (A:) Na+/H+ exchanger regulatory factor, | 1e-05 | |
| d1ufxa_ | 103 | b.36.1.1 (A:) KIAA1526 protein {Human (Homo sapien | 2e-05 | |
| d1n7ea_ | 95 | b.36.1.1 (A:) Glutamate receptor-interacting prote | 3e-05 | |
| d2cs5a1 | 106 | b.36.1.1 (A:8-113) Tyrosine-protein phosphatase no | 7e-05 | |
| d1x5qa1 | 97 | b.36.1.1 (A:8-104) Scribble (KIAA0147) {Human (Hom | 7e-05 | |
| d2fcfa1 | 96 | b.36.1.1 (A:1148-1243) Multiple PDZ domain protein | 9e-05 | |
| d2dj7a1 | 31 | g.39.1.3 (A:44-74) Actin-binding LIM protein 3, ab | 1e-04 | |
| d1wf7a_ | 103 | b.36.1.1 (A:) Enigma homolog ENH {Mouse (Mus muscu | 1e-04 | |
| d1va8a1 | 100 | b.36.1.1 (A:8-107) Maguk p55 subfamily member 5 {M | 1e-04 | |
| d1q3oa_ | 104 | b.36.1.1 (A:) Shank1, PDZ domain {Rat (Rattus norv | 1e-04 | |
| d1x5ra1 | 99 | b.36.1.1 (A:8-106) Glutamate receptor interacting | 1e-04 | |
| d2csja1 | 104 | b.36.1.1 (A:8-111) Tight junction protein ZO-2, Tj | 2e-04 | |
| d1v5la_ | 103 | b.36.1.1 (A:) Alpha-actinin-2 associated LIM prote | 3e-04 | |
| d1qava_ | 90 | b.36.1.1 (A:) Syntrophin {Mouse (Mus musculus) [Ta | 3e-04 | |
| d1wi2a_ | 104 | b.36.1.1 (A:) PDZ domain containing protein 11, Pd | 3e-04 | |
| d1uf1a_ | 128 | b.36.1.1 (A:) KIAA1526 protein {Human (Homo sapien | 3e-04 | |
| d1x5na1 | 101 | b.36.1.1 (A:8-108) Harmonin {Human (Homo sapiens) | 4e-04 | |
| d1rzxa_ | 98 | b.36.1.1 (A:) GTPase-binding domain of the cell po | 5e-04 | |
| d1wi4a1 | 96 | b.36.1.1 (A:8-103) Syntaxin binding protein 4 {Mou | 6e-04 | |
| d1p1da2 | 99 | b.36.1.1 (A:115-213) Glutamate receptor interactin | 6e-04 | |
| d1ueza_ | 101 | b.36.1.1 (A:) KIAA1526 protein {Human (Homo sapien | 7e-04 | |
| d1y7na1 | 79 | b.36.1.1 (A:12-90) Amyloid beta A4 precursor prote | 8e-04 | |
| d1kwaa_ | 88 | b.36.1.1 (A:) Cask/Lin-2 {Human (Homo sapiens) [Ta | 9e-04 | |
| d1x45a1 | 85 | b.36.1.1 (A:8-92) Amyloid beta A4 precursor protei | 0.001 | |
| d1ihja_ | 94 | b.36.1.1 (A:) Inad {Fruit fly (Drosophila melanoga | 0.001 | |
| d1uepa_ | 103 | b.36.1.1 (A:) Membrane associated guanylate kinase | 0.001 | |
| d1j2oa1 | 30 | g.39.1.3 (A:1-30) Rhombotin-2 (Lmo2) {Mouse (Mus m | 0.002 | |
| d2h3la1 | 103 | b.36.1.1 (A:1310-1412) Erbin {Human (Homo sapiens) | 0.002 | |
| d1vaea_ | 111 | b.36.1.1 (A:) Rhophilin-2 {Mouse (Mus musculus) [T | 0.002 | |
| d1wg6a_ | 127 | b.36.1.1 (A:) Partitioning-defective 3-like protei | 0.002 | |
| d2cssa1 | 108 | b.36.1.1 (A:8-115) Regulating synaptic membrane ex | 0.002 | |
| d1wf8a1 | 94 | b.36.1.1 (A:8-101) Neurabin-i {Human (Homo sapiens | 0.002 | |
| d1v6ba_ | 118 | b.36.1.1 (A:) Harmonin {Mouse (Mus musculus) [TaxI | 0.002 | |
| d2fnea1 | 88 | b.36.1.1 (A:1955-2042) Multiple PDZ domain protein | 0.003 | |
| d2fe5a1 | 92 | b.36.1.1 (A:223-314) Synapse-associated protein 10 | 0.004 | |
| d1ujva_ | 96 | b.36.1.1 (A:) Membrane associated guanylate kinase | 0.004 | |
| d1b8ta4 | 49 | g.39.1.3 (A:144-192) Cysteine-rich (intestinal) pr | 0.004 | |
| d1ueqa_ | 123 | b.36.1.1 (A:) Membrane associated guanylate kinase | 0.004 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (316), Expect = 9e-33
Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 25/154 (16%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL 547
LG G FG+VY+ ++ET + K + EE ++++ E
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVE-------------------- 59
Query: 548 HCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVN 607
+ +L S H N+++ + Y + L ++ E+ AGG + ++ + +PL Q
Sbjct: 60 -----IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 114
Query: 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ + YLH +IHRDL + N L G
Sbjct: 115 VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD 148
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 126 bits (317), Expect = 2e-32
Identities = 35/183 (19%), Positives = 71/183 (38%), Gaps = 31/183 (16%)
Query: 469 VEASKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKES 528
VE + ++ D++ LG G FG V+R + TG V V K + + E
Sbjct: 20 VEVKQGSVYDYYDILE--ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNE- 76
Query: 529 KQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGT 588
++++ LHH +I ++ L+ E+++GG
Sbjct: 77 ------------------------ISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112
Query: 589 LKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG----FD 644
L + + + + +N+ R G+ ++H +++H D+ +N + + D
Sbjct: 113 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 172
Query: 645 FHL 647
F L
Sbjct: 173 FGL 175
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 122 bits (308), Expect = 3e-31
Identities = 38/165 (23%), Positives = 64/165 (38%), Gaps = 29/165 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG G FG V+RVT R TG K + E ++ KE
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE------------------- 73
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+ + L H ++ D ++ ++ E+++GG L E + D + + V
Sbjct: 74 ------IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 127
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF----DFHL 647
+ R + G+ ++H N +H DL +N + S DF L
Sbjct: 128 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGL 172
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 2e-29
Identities = 30/165 (18%), Positives = 62/165 (37%), Gaps = 30/165 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG+G FG V+R + + + K + +V + KE
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKE------------------- 51
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+++L H N++ +L ++ E+I+G + E + L + V
Sbjct: 52 ------ISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV 105
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG----FDFHL 647
++ + + +LHS N+ H D+ +N + + S +F
Sbjct: 106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 36/156 (23%), Positives = 68/156 (43%), Gaps = 28/156 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR-VDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
LG G G V++V+H+ +G VM K ++ + ++E
Sbjct: 13 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE------------------ 54
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
+ VL + ++ F G Y D ++++ E++ GG+L ++L+ G +P
Sbjct: 55 -------LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQIL 106
Query: 606 VNFARDIAAGMTYLHSMN-LIHRDLNSQNCLVREVG 640
+ + G+TYL + ++HRD+ N LV G
Sbjct: 107 GKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 142
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 1e-28
Identities = 39/169 (23%), Positives = 67/169 (39%), Gaps = 29/169 (17%)
Query: 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV---DEEAEKNFLKESKQG 531
R + D G LG+G FG VY +++ ++ LK L++ E +E
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE---- 56
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
V + L H N++R G + ++ L+ EY GT+
Sbjct: 57 ---------------------VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95
Query: 592 LLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
LQ + + ++A ++Y HS +IHRD+ +N L+ G
Sbjct: 96 ELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG 143
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-28
Identities = 41/159 (25%), Positives = 63/159 (39%), Gaps = 27/159 (16%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
+ G +G G FG VY+ V +L + + + F E
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLN-VTAPTPQQLQAFKNE------------ 54
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
V VLR H N++ F+G +L +VT++ G +L L
Sbjct: 55 -------------VGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETK 100
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ ++ AR A GM YLH+ ++IHRDL S N + E
Sbjct: 101 FEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHE 139
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 112 bits (282), Expect = 4e-28
Identities = 41/156 (26%), Positives = 62/156 (39%), Gaps = 29/156 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKEL---YRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G G FG VY EV+ +K++ + E ++ +KE
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKE----------------- 65
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
V L+ L H N I++ G ++ LV EY G L +PL +
Sbjct: 66 --------VRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH-KKPLQEVE 116
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
G+ YLHS N+IHRD+ + N L+ E G
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 152
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 9e-28
Identities = 37/163 (22%), Positives = 69/163 (42%), Gaps = 29/163 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+GQG G VY TG+ + ++++ + ++ + E
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE------------------- 67
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+ V+R + N++ ++ +L +V EY+AGG+L +++ + GQ
Sbjct: 68 ------ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIA 119
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS--GFDFHL 647
R+ + +LHS +IHRD+ S N L+ GS DF
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGF 162
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 41/162 (25%), Positives = 66/162 (40%), Gaps = 29/162 (17%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
L LG G FG+V+ + +V V K L + + FL E
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAV-KSL-KQGSMSPDAFLAE------------ 58
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQ 598
+++ L H ++R V + ++TEY+ G+L + L+ P G
Sbjct: 59 -------------ANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGI 104
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L + ++ A IA GM ++ N IHRDL + N LV +
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL 146
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 37/187 (19%), Positives = 67/187 (35%), Gaps = 29/187 (15%)
Query: 488 LGQGFFGQVYRVTHRETGEVMV--LKELYR-VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G FG V + +R + + +K L + ++ + ++E
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMRE----------------- 59
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
++ L + ++R IGV + L LV E GG L + L + +P
Sbjct: 60 --------AQIMHQLDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSN 110
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSA 664
++ GM YL N +HRDL ++N L+ G + + + +
Sbjct: 111 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170
Query: 665 KTKKTYY 671
K
Sbjct: 171 AGKWPLK 177
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-26
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 31/163 (19%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
+L +G+G FG V +R G + +K + ++ + FL E
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK--NDATAQAFLAE------------ 50
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR-KLNLVTEYIAGGTLKELLQDPG- 597
+V+ L H N+++ +GV+ +++ L +VTEY+A G+L + L+ G
Sbjct: 51 -------------ASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 97
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L + F+ D+ M YL N +HRDL ++N LV E
Sbjct: 98 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN 140
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 4e-26
Identities = 37/155 (23%), Positives = 66/155 (42%), Gaps = 27/155 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
LG+G +G+V +R T E + +K + + + +N KE
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKE------------------ 53
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
+ + + L+H NV++F G + L EY +GG L + ++ +P
Sbjct: 54 -------ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDA 105
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
F + AG+ YLH + + HRD+ +N L+ E
Sbjct: 106 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD 140
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 105 bits (264), Expect = 6e-26
Identities = 42/160 (26%), Positives = 74/160 (46%), Gaps = 27/160 (16%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
+D+ LG G +G+VY ++ + +K L + D + FLKE
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKE------------ 63
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-Q 598
AV++ + H N+++ +GV ++ ++TE++ G L + L++ Q
Sbjct: 64 -------------AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 110
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ + A I++ M YL N IHRDL ++NCLV E
Sbjct: 111 EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGE 150
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 7e-26
Identities = 40/207 (19%), Positives = 64/207 (30%), Gaps = 31/207 (14%)
Query: 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQG 531
R R D G +LG+G F V T +K L + + E +E
Sbjct: 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD-- 60
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
V+ L H ++ D KL Y G L +
Sbjct: 61 -----------------------VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 592 LLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIY 651
++ G + +I + + YLH +IHRDL +N L+ E G
Sbjct: 98 YIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK 156
Query: 652 LIYVPYTLFILSAKTKKTYY--PNILK 676
++ ++ Y P +L
Sbjct: 157 VLSPESKQARANSFVGTAQYVSPELLT 183
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 1e-25
Identities = 45/229 (19%), Positives = 79/229 (34%), Gaps = 44/229 (19%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
F +L G +LG G FG+V T + V ++ A K +++
Sbjct: 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV------AVKMLKEKADSS----- 82
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD 595
S++ ++ L H N++ +G + L+ EY G L L+
Sbjct: 83 --------EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134
Query: 596 PGQ----------------------PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633
+ L + + FA +A GM +L + +HRDL ++N
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194
Query: 634 CLVREVGSGF--DFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680
LV DF L + + Y + + K P L + +
Sbjct: 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 104 bits (260), Expect = 3e-25
Identities = 30/151 (19%), Positives = 58/151 (38%), Gaps = 27/151 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL-YRVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
+LG G F +V + T +++ +K + + E E + E
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE------------------ 57
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
+AVL + H N++ + L L+ + ++GG L + + + G
Sbjct: 58 -------IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDA 109
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+ + YLH + ++HRDL +N L
Sbjct: 110 SRLIFQVLDAVKYLHDLGIVHRDLKPENLLY 140
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 105 bits (262), Expect = 5e-25
Identities = 31/158 (19%), Positives = 64/158 (40%), Gaps = 26/158 (16%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQGLIYLIDLGSHGL 543
++G+G FG+VY +TG++ +K L + ++ E L E
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIM------------- 57
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
++++ + ++ + KL+ + + + GG L L G
Sbjct: 58 ---------LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEA 107
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+A +I G+ ++H+ +++RDL N L+ E G
Sbjct: 108 DMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 145
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 8e-25
Identities = 41/188 (21%), Positives = 64/188 (34%), Gaps = 49/188 (26%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYR-VDEEAEKNFLKESKQ 530
F + L G LG G FG+V T + + +K L + + E
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE--- 76
Query: 531 GLIYLIDLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTL 589
+ VL L +H N++ +G ++TEY G L
Sbjct: 77 ----------------------LKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 590 KELLQ-----------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632
L+ D L ++F+ +A GM +L S N IHRDL ++
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174
Query: 633 NCLVREVG 640
N L+
Sbjct: 175 NILLTHGR 182
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 102 bits (256), Expect = 8e-25
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 29/169 (17%)
Query: 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE----VMVLKELYRVDEEAEKNFLKESK 529
++ S + ++G G FG+V + G+ V + E+ ++FL E
Sbjct: 20 AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSE-- 77
Query: 530 QGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL 589
+++ H NVI GV+ K + ++TE++ G+L
Sbjct: 78 -----------------------ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL 114
Query: 590 KELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L+ Q V R IAAGM YL MN +HRDL ++N LV
Sbjct: 115 DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNS 163
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 9e-25
Identities = 42/159 (26%), Positives = 67/159 (42%), Gaps = 27/159 (16%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
DL LG G FG V R +V + K + + +E F++E
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAI-KMI-KEGSMSEDEFIEE------------ 49
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
V+ +L H +++ GV K R + ++TEY+A G L L++
Sbjct: 50 -------------AKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR 96
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
Q + +D+ M YL S +HRDL ++NCLV +
Sbjct: 97 FQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 35/175 (20%), Positives = 63/175 (36%), Gaps = 37/175 (21%)
Query: 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYL 535
RA D +G G +G+ ++ + G+++V KEL + E ++ + E
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSE-------- 53
Query: 536 IDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLY--KDRKLNLVTEYIAGGTLKELL 593
V +LR L H N++R+ + + L +V EY GG L ++
Sbjct: 54 -----------------VNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI 96
Query: 594 QDPG---QPLPWGQRVNFARDIAAGMTYLH-----SMNLIHRDLNSQNCLVREVG 640
Q L + + + H ++HRDL N +
Sbjct: 97 TKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 151
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 2e-24
Identities = 36/159 (22%), Positives = 61/159 (38%), Gaps = 34/159 (21%)
Query: 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHG 542
V +LG G G+V ++ ++ T E LK L + +E +
Sbjct: 15 VTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVE------------- 56
Query: 543 LINNLHCFSQVAVLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPG- 597
R+ +++R + V + L +V E + GG L +QD G
Sbjct: 57 -----------LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD 105
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
Q + + I + YLHS+N+ HRD+ +N L
Sbjct: 106 QAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLY 144
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 101 bits (252), Expect = 2e-24
Identities = 26/159 (16%), Positives = 52/159 (32%), Gaps = 33/159 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL---YRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
+LG G +V+ + +K L D F +E
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRRE---------------- 57
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN----LVTEYIAGGTLKELLQDPGQP 599
+L+H ++ + +V EY+ G TL++++ G P
Sbjct: 58 ---------AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-P 107
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ + + D + + H +IHRD+ N ++
Sbjct: 108 MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 146
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 3e-24
Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 27/159 (16%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
S+L +G G FG V+ +V + K + R +E++F++E
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAI-KTI-REGAMSEEDFIEE------------ 50
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
V+ L H +++ GV + + LV E++ G L + L+
Sbjct: 51 -------------AEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL 97
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ D+ GM YL +IHRDL ++NCLV E
Sbjct: 98 FAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 100 bits (251), Expect = 3e-24
Identities = 35/155 (22%), Positives = 61/155 (39%), Gaps = 18/155 (11%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+LG+G V R H+ T + +K +D +F E Q L
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVK---IIDVTGGGSFSAEEVQELRE------------ 54
Query: 547 LHCFSQVAVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
+V +LR + H N+I+ + LV + + G L + L + L +
Sbjct: 55 -ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKET 112
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
R + + LH +N++HRDL +N L+ +
Sbjct: 113 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDM 147
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 1e-23
Identities = 28/161 (17%), Positives = 59/161 (36%), Gaps = 22/161 (13%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
+ G +G+G FG V++ + + + + ++ Q
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ--------- 57
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQP 599
+ +R H ++++ IGV + + ++ E G L+ LQ
Sbjct: 58 ------------EALTMRQFDHPHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS 104
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L + +A ++ + YL S +HRD+ ++N LV
Sbjct: 105 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND 145
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 2e-23
Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 31/169 (18%)
Query: 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGE-----VMVLKELYRVDEEAEKNFLKESK 529
RI + ++ + +LG G FG VY+ GE V + + +A K L E
Sbjct: 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE-- 61
Query: 530 QGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTL 589
V+ S+ + +V R +G+ + L+T+ + G L
Sbjct: 62 -----------------------AYVMASVDNPHVCRLLGI-CLTSTVQLITQLMPFGCL 97
Query: 590 KELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ +++ + +N+ IA GM YL L+HRDL ++N LV+
Sbjct: 98 LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 146
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.4 bits (247), Expect = 2e-23
Identities = 37/199 (18%), Positives = 68/199 (34%), Gaps = 28/199 (14%)
Query: 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKEL---YRVDEEAEKNFLKESKQGLIYLID 537
D + +LG+G FG+V+ ++T + +K L + ++ + + E +
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR-------- 54
Query: 538 LGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG 597
+ + H + L V EY+ GG L +Q
Sbjct: 55 ----------------VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH 98
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPY 657
+ +A +I G+ +LHS +++RDL N L+ + G G +
Sbjct: 99 -KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157
Query: 658 TLFILSAKTKKTYYPNILK 676
T P IL
Sbjct: 158 AKTNTFCGTPDYIAPEILL 176
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 6e-23
Identities = 44/178 (24%), Positives = 69/178 (38%), Gaps = 44/178 (24%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETG---EVMVLKELYRVDEEAEKNFLKESKQGLIYLI 536
+D+ ++G+G FGQV + ++ G + + + ++ ++F E
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGE--------- 60
Query: 537 DLGSHGLINNLHCFSQVAVLRSLHHH-NVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ- 594
+ VL L HH N+I +G L L EY G L + L+
Sbjct: 61 ----------------LEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104
Query: 595 --------------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
L Q ++FA D+A GM YL IHRDL ++N LV E
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 162
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 97.2 bits (241), Expect = 8e-23
Identities = 41/191 (21%), Positives = 76/191 (39%), Gaps = 54/191 (28%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYR-VDEEAEKNFLKESKQ 530
+ +++ +G+G FG+V++ E ++ +K L + + +F +E
Sbjct: 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE--- 66
Query: 531 GLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLK 590
A++ + N+++ +GV + + L+ EY+A G L
Sbjct: 67 ----------------------AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 104
Query: 591 ELLQDPG-----------------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHR 627
E L+ PL +++ AR +AAGM YL +HR
Sbjct: 105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 164
Query: 628 DLNSQNCLVRE 638
DL ++NCLV E
Sbjct: 165 DLATRNCLVGE 175
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.2 bits (239), Expect = 8e-23
Identities = 37/157 (23%), Positives = 63/157 (40%), Gaps = 34/157 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELY--RVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
+G+G F VY+ ET + EL ++ + + F +E
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEE------------------ 58
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLY----KDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
+L+ L H N++RF + + LVTE + GTLK L+ + +
Sbjct: 59 -------AEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMK 110
Query: 602 WGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQNCLV 636
++ R I G+ +LH+ +IHRDL N +
Sbjct: 111 IKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 1e-22
Identities = 34/158 (21%), Positives = 59/158 (37%), Gaps = 31/158 (19%)
Query: 488 LGQGFFGQVYRVTHR--ETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGL 543
LG G FG V + ++ + + + +K L D + L E
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE---------------- 58
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
V++ L + ++R IG+ + + LV E G L + LQ +
Sbjct: 59 ---------ANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNR-HVKDK 107
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641
+ ++ GM YL N +HRDL ++N L+
Sbjct: 108 NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY 145
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 1e-22
Identities = 46/190 (24%), Positives = 67/190 (35%), Gaps = 32/190 (16%)
Query: 488 LGQGFFGQVYRVTHRETGE------VMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSH 541
LG G FG V R V LK EA +F++E
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE-------------- 61
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
V + SL H N+IR GV + +VTE G+L + L+
Sbjct: 62 -----------VNAMHSLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFL 109
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFI 661
G +A +A GM YL S IHRDL ++N L+ G + + ++
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 662 LSAKTKKTYY 671
+ K +
Sbjct: 170 MQEHRKVPFA 179
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 1e-22
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 29/162 (17%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
L LGQG FG+V+ T T V + K L + + + FL+E
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAI-KTL-KPGTMSPEAFLQE------------ 62
Query: 540 SHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKEL-LQDPGQ 598
V++ L H +++ V+ ++ + +VTEY++ G+L + + G+
Sbjct: 63 -------------AQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGK 108
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L Q V+ A IA+GM Y+ MN +HRDL + N LV E
Sbjct: 109 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL 150
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 1e-22
Identities = 47/169 (27%), Positives = 74/169 (43%), Gaps = 30/169 (17%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGE----VMVLKELYR-VDEEAEKNFLKESKQG 531
S + R ++G G FG+VY+ + + + +K L E+ +FL E
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE---- 59
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
++ HHN+IR GV+ K + + ++TEY+ G L +
Sbjct: 60 ---------------------AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 98
Query: 592 LLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L++ Q V R IAAGM YL +MN +HRDL ++N LV
Sbjct: 99 FLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL 147
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 3e-22
Identities = 35/172 (20%), Positives = 66/172 (38%), Gaps = 40/172 (23%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
++G G FG VY+ ++GE++ +K++ + ++ +E
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRE------------------- 63
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLY------KDRKLNLVTEYIAGGTLKELLQ--DPGQ 598
+ ++R L H N++R Y + LNLV +Y+ + Q
Sbjct: 64 ------LQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF---DFHL 647
LP + + + Y+HS + HRD+ QN L+ + DF
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 169
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.9 bits (235), Expect = 4e-22
Identities = 29/159 (18%), Positives = 52/159 (32%), Gaps = 27/159 (16%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G +G G FG +Y T GE + +K + E
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIE----------------- 52
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+ + + I I + N++ + G +L++L +
Sbjct: 53 --------SKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKT 104
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF 643
+ A + + + Y+HS N IHRD+ N L+ G
Sbjct: 105 VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN 143
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.8 bits (232), Expect = 1e-21
Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 40/174 (22%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYR-VDEEAEKNFLKESKQGLI 533
+ LGQG FG VY + E + +K + FL E
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE------ 73
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
+V++ + H+V+R +GV+ + + ++ E + G LK L
Sbjct: 74 -------------------ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114
Query: 594 QDPG---------QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+ P + + A +IA GM YL++ +HRDL ++NC+V E
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 168
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (230), Expect = 2e-21
Identities = 36/194 (18%), Positives = 69/194 (35%), Gaps = 31/194 (15%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKEL-----YRVDEEAEKNFLKESKQGLIYLIDLGSH 541
LG+G F VY+ + T +++ +K++ + + L+E
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE-------------- 50
Query: 542 GLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
+ +L+ L H N+I + ++LV +++ +++D L
Sbjct: 51 -----------IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV-IIKDNSLVLT 98
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFI 661
+ G+ YLH ++HRDL N L+ E G G P +
Sbjct: 99 PSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 158
Query: 662 LSAKTKKTYYPNIL 675
T+ P +L
Sbjct: 159 HQVVTRWYRAPELL 172
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.2 bits (231), Expect = 2e-21
Identities = 38/167 (22%), Positives = 66/167 (39%), Gaps = 29/167 (17%)
Query: 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQGLI 533
+ D LG G FG+V+ + R G +K L + V + ++ E
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE------ 54
Query: 534 YLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELL 593
+L + H +IR G +++ ++ +YI GG L L
Sbjct: 55 -------------------RLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL- 94
Query: 594 QDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
Q P +A ++ + YLHS ++I+RDL +N L+ + G
Sbjct: 95 LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG 141
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 5e-21
Identities = 41/174 (23%), Positives = 71/174 (40%), Gaps = 42/174 (24%)
Query: 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDL 538
A +V +G+G FG+V+R GE + +K E+++ +E+
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVK---IFSSREERSWFREA---------- 46
Query: 539 GSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQ 594
++ L H N++ FI KD +L LV++Y G+L + L
Sbjct: 47 -------------EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN 93
Query: 595 DPGQPLPWGQRVNFARDIAAGMTYLHS--------MNLIHRDLNSQNCLVREVG 640
+ + A A+G+ +LH + HRDL S+N LV++ G
Sbjct: 94 R--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 145
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.5 bits (226), Expect = 6e-21
Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 33/173 (19%)
Query: 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLG 539
LV G LG+G FGQV + + RV + A K ++ + +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDK----DKPNRVTKVAVKMLKSDATEKDL------ 62
Query: 540 SHGLINNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQ---- 594
S++ +++ + H N+I +G +D L ++ EY + G L+E LQ
Sbjct: 63 -------SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRP 115
Query: 595 -----------DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636
+P + L V+ A +A GM YL S IHRDL ++N LV
Sbjct: 116 PGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 7e-21
Identities = 37/193 (19%), Positives = 68/193 (35%), Gaps = 34/193 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
+G+G +G V + +K++ + + L+E
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLRE------------------ 56
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVL----YKDRKLNLVTEYIAGGTLKELLQDPGQPLP 601
+ +L H N+I ++ + K + ++ G L +LL+ Q L
Sbjct: 57 -------IKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--QHLS 107
Query: 602 WGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTL 659
F I G+ Y+HS N++HRDL N L+ DF L ++ +T
Sbjct: 108 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 167
Query: 660 FILSAKTKKTYYP 672
F+ + Y
Sbjct: 168 FLTEYVATRWYRA 180
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 91.4 bits (226), Expect = 1e-20
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 29/156 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
LG G FG+V V H+E+G +K L + V + ++ L E
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE----------------- 91
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+L++++ +++ + L +V EY+AGG + L+ G
Sbjct: 92 --------KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPH 142
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+A I YLHS++LI+RDL +N L+ + G
Sbjct: 143 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG 178
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.4 bits (221), Expect = 2e-20
Identities = 28/156 (17%), Positives = 51/156 (32%), Gaps = 21/156 (13%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
GPLLG G FG VY + +K + D ++ L +
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHV-EKDRISDWGELPNGTR-------------- 53
Query: 545 NNLHCFSQVAVLRSLH--HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
+V +L+ + VIR + + L+ E L
Sbjct: 54 ----VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE 109
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
+F + + + H+ ++HRD+ +N L+
Sbjct: 110 ELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDL 145
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.2 bits (220), Expect = 4e-20
Identities = 36/156 (23%), Positives = 71/156 (45%), Gaps = 27/156 (17%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G VY+ ++ TGEV+ LK++ E ++E
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----------------- 51
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
+++L+ L+H N+++ + V++ + KL LV E++ K + +P
Sbjct: 52 --------ISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPL 103
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
++ + G+ + HS ++HRDL QN L+ G
Sbjct: 104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG 139
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 5e-20
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 24/169 (14%)
Query: 476 IFRASDL----VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQG 531
+FR ++ G LG G F V + + TG K + +K K S++G
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFI-------KKRRTKSSRRG 54
Query: 532 LIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKE 591
++ +V++L+ + H NVI V + L+ E +AGG L +
Sbjct: 55 ------------VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102
Query: 592 LLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
L + L + F + I G+ YLHS+ + H DL +N ++ +
Sbjct: 103 FLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRN 150
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 1e-19
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 32/177 (18%)
Query: 469 VEASKSRIFRASDLVR--GPLLGQGFFGQVYRVTHRE---TGEVMVLKELYRV-DEEAEK 522
V+A + + S L+ ++G+G FG VY T + +K L R+ D
Sbjct: 14 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 73
Query: 523 NFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYK-DRKLNLVT 581
FL E +++ H NV+ +G+ + + +V
Sbjct: 74 QFLTE-------------------------GIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108
Query: 582 EYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638
Y+ G L+ +++ + F +A GM +L S +HRDL ++NC++ E
Sbjct: 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.5 bits (216), Expect = 2e-19
Identities = 33/157 (21%), Positives = 62/157 (39%), Gaps = 29/157 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR---VDEEAEKNFLKESKQGLIYLIDLGSHGL 543
LLG+G FG+V V + TG +K L + + ++ + + E
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTE---------------- 55
Query: 544 INNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
VL++ H + +L V EY GG L L +
Sbjct: 56 ---------SRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEE 105
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+ + +I + + YLHS ++++RD+ +N ++ + G
Sbjct: 106 RARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 142
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 3e-19
Identities = 39/179 (21%), Positives = 63/179 (35%), Gaps = 34/179 (18%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G G +G V TG + +K+LYR E K +E
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----------------- 67
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYI-----AGGTLKELLQDPGQP 599
+ +L+ + H NVI + V D L+ T++ G L +L++ +
Sbjct: 68 --------LRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EK 117
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYT 658
L + + G+ Y+H+ +IHRDL N V E G T
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (211), Expect = 5e-19
Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 28/190 (14%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
+G+G +G V++ +RET E++ LK + DE + L+E
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE------------------ 51
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
+ +L+ L H N++R VL+ D+KL LV E+ K G
Sbjct: 52 -------ICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIV 103
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFILSAK 665
+F + G+ + HS N++HRDL QN L+ G + G +P +
Sbjct: 104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV 163
Query: 666 TKKTYYPNIL 675
T P++L
Sbjct: 164 TLWYRPPDVL 173
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 85.3 bits (210), Expect = 6e-19
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 31/164 (18%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELY--RVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
+G+G +G VY+ + GE LK++ + DE ++E
Sbjct: 10 IGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIRE------------------ 50
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQR 605
+++L+ L H N+++ V++ ++L LV E++ K L G L
Sbjct: 51 -------ISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTA 102
Query: 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHL 647
+F + G+ Y H ++HRDL QN L+ G DF L
Sbjct: 103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 85.6 bits (211), Expect = 7e-19
Identities = 25/161 (15%), Positives = 54/161 (33%), Gaps = 27/161 (16%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
+G+G FG ++ T+ + + +K R E
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDE------------------- 50
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+ L I + ++ N++ + G +L++LL G+
Sbjct: 51 ------YRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVA 104
Query: 607 NFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHL 647
A+ + A + +H +L++RD+ N L+ S +
Sbjct: 105 MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMI 145
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 86.0 bits (212), Expect = 8e-19
Identities = 34/171 (19%), Positives = 62/171 (36%), Gaps = 38/171 (22%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG+G + +V+ + E +V+K L +K +E
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKRE------------------- 79
Query: 547 LHCFSQVAVLRSLHHH-NVIRFIGVLY--KDRKLNLVTEYIAGGTLKELLQDPGQPLPWG 603
+ +L +L N+I ++ R LV E++ K+L Q L
Sbjct: 80 ------IKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDY 129
Query: 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS---GFDFHLGQIY 651
+ +I + Y HSM ++HRD+ N ++ D+ L + Y
Sbjct: 130 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 180
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 4e-18
Identities = 38/161 (23%), Positives = 65/161 (40%), Gaps = 30/161 (18%)
Query: 488 LGQGFFGQVYRVTHRET-GEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G+G +G+V++ + G + LK + +E + ++E + + H
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--------VAVLRH--- 63
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDR-----KLNLVTEYIAGGTLKELLQDPGQP 599
L + H NV+R V R KL LV E++ L + P
Sbjct: 64 -----------LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 112
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
+P + + G+ +LHS ++HRDL QN LV G
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG 153
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 8e-18
Identities = 37/176 (21%), Positives = 68/176 (38%), Gaps = 38/176 (21%)
Query: 488 LGQGFFGQVYRVTHRETGEVMVLKELY--RVDEEAEKNFLKESKQGLIYLIDLGSHGLIN 545
+GQG FG+V++ HR+TG+ + LK++ E L+E
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE------------------ 59
Query: 546 NLHCFSQVAVLRSLHHHNVIRFIGVLY--------KDRKLNLVTEYIAGGTLKELLQDPG 597
+ +L+ L H NV+ I + + LV ++ LL +
Sbjct: 60 -------IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-GLLSNVL 111
Query: 598 QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGF--DFHLGQIY 651
+ + + G+ Y+H ++HRD+ + N L+ G DF L + +
Sbjct: 112 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.2 bits (202), Expect = 9e-18
Identities = 43/193 (22%), Positives = 65/193 (33%), Gaps = 47/193 (24%)
Query: 470 EASKSRIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYR-VDEEAEKN 523
+ASK R L G LG+G FGQV T + +K L +
Sbjct: 4 DASKWEFPR-DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 524 FLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHNVIRFIGVLYKD-RKLNLVTE 582
+ E K ++ HH NV+ +G K L ++ E
Sbjct: 63 LMSELKI------------------------LIHIGHHLNVVNLLGACTKPGGPLMVIVE 98
Query: 583 YIAGGTLKELLQDPG---------------QPLPWGQRVNFARDIAAGMTYLHSMNLIHR 627
+ G L L+ L + ++ +A GM +L S IHR
Sbjct: 99 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 158
Query: 628 DLNSQNCLVREVG 640
DL ++N L+ E
Sbjct: 159 DLAARNILLSEKN 171
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 4e-17
Identities = 33/191 (17%), Positives = 66/191 (34%), Gaps = 26/191 (13%)
Query: 487 LLGQGFFGQVYRVTH---RETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGL 543
+LG G +G+V+ V +TG++ +K L + + + ++
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT------------- 77
Query: 544 INNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPW 602
+ VL + ++ + KL+L+ +YI GG L L +
Sbjct: 78 --------ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTE 128
Query: 603 GQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLGQIYLIYVPYTLFIL 662
+ + +I + +LH + +I+RD+ +N L+ G G T
Sbjct: 129 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 188
Query: 663 SAKTKKTYYPN 673
Y
Sbjct: 189 DFCGTIEYMAP 199
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.7 bits (198), Expect = 5e-17
Identities = 37/169 (21%), Positives = 59/169 (34%), Gaps = 34/169 (20%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G G +G V +TG + +K+L R K +E
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----------------- 67
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLN-----LVTEYIAGGTLKELLQDPGQP 599
+ +L+ + H NVI + V R L + ++ G L +++ Q
Sbjct: 68 --------LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QK 117
Query: 600 LPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSGFDFHLG 648
L I G+ Y+HS ++IHRDL N V E G
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 166
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (197), Expect = 7e-17
Identities = 32/185 (17%), Positives = 65/185 (35%), Gaps = 39/185 (21%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYR--VDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
+G G G V + +K+L R ++ K +E
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE----------------- 66
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGV------LYKDRKLNLVTEYIAGGTLKELLQDPGQ 598
+ +++ ++H N+I + V L + + + LV E + + + +
Sbjct: 67 --------LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-- 116
Query: 599 PLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS--GFDFHLGQIYLIYVP 656
+ + G+ +LHS +IHRDL N +V+ + DF L +
Sbjct: 117 --DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM 174
Query: 657 YTLFI 661
T ++
Sbjct: 175 MTPYV 179
|
| >d1x6aa1 g.39.1.3 (A:8-41) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 34 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.7 bits (163), Expect = 6e-15
Identities = 19/34 (55%), Positives = 25/34 (73%)
Query: 61 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPEC 94
+DY GK+GE C C +M+GP MV G+ K+HPEC
Sbjct: 1 KDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPEC 34
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.3 bits (161), Expect = 4e-13
Identities = 26/156 (16%), Positives = 49/156 (31%), Gaps = 20/156 (12%)
Query: 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLI 544
G L+G+G V+ E V+K ++V + K ++ G ++ L
Sbjct: 5 GKLMGEGKESAVFNCYS-EKFGECVVK-FHKVGHTSFKKVKEKRDYGDLHFSVL------ 56
Query: 545 NNLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQ 604
++ L+ L V + ++ E I +
Sbjct: 57 AIRSARNEFRALQKLQGLAVPKVYAW----EGNAVLMELID--------AKELYRVRVEN 104
Query: 605 RVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVG 640
I + + ++H DL+ N LV E G
Sbjct: 105 PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG 140
|
| >d1v6ga1 g.39.1.3 (A:1-41) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} Length = 41 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (143), Expect = 3e-12
Identities = 12/33 (36%), Positives = 17/33 (51%)
Query: 62 DYNGKYGEACQNCGQMMSGPVMVVGDHKFHPEC 94
DY YG C +C Q + G V+ +HP+C
Sbjct: 9 DYQRLYGTRCFSCDQFIEGEVVSALGKTYHPDC 41
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 65.8 bits (159), Expect = 4e-12
Identities = 29/155 (18%), Positives = 54/155 (34%), Gaps = 12/155 (7%)
Query: 487 LLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINN 546
LG G F V+ + +K + R D+ + E I L+ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDE-----IKLLQRVNDADNTK 73
Query: 547 LHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRV 606
+L+ L H N GV +V E + L + + + +P
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHV-----VMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 607 NFARDIAAGMTYL-HSMNLIHRDLNSQNCLVREVG 640
++ + G+ Y+ +IH D+ +N L+ V
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 163
|
| >d1x6aa2 g.39.1.3 (A:42-75) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} Length = 34 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (135), Expect = 3e-11
Identities = 16/32 (50%), Positives = 21/32 (65%)
Query: 95 FKCTSCSCCIGDGESYALVERSILYCGLCYKR 126
F C SC I DG++YALV+ + LYCG C+
Sbjct: 1 FACMSCKVIIEDGDAYALVQHATLYCGKCHNE 32
|
| >d1x3ha1 g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} Length = 35 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.6 bits (119), Expect = 6e-09
Identities = 9/35 (25%), Positives = 16/35 (45%)
Query: 61 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 95
+D+ + C C + + + D +HPECF
Sbjct: 1 KDFLAMFSPKCGGCNRPVLENYLSAMDTVWHPECF 35
|
| >d1x3ha1 g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} Length = 35 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.4 bits (82), Expect = 8e-04
Identities = 11/26 (42%), Positives = 15/26 (57%), Gaps = 1/26 (3%)
Query: 12 CAGCLNNIVEDEYVQALSQEWHTDCF 37
C GC N V + Y+ A+ WH +CF
Sbjct: 11 CGGC-NRPVLENYLSAMDTVWHPECF 35
|
| >d1vb7a_ b.36.1.1 (A:) PDZ-LIM protein mystique {Mouse (Mus musculus) [TaxId: 10090]} Length = 94 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: PDZ-LIM protein mystique species: Mouse (Mus musculus) [TaxId: 10090]
Score = 43.8 bits (103), Expect = 3e-06
Identities = 10/39 (25%), Positives = 17/39 (43%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L GD I+ +NG + E + IR + +
Sbjct: 43 AEAADLRPGDIIVAINGQSAENMLHAEAQSKIRQSASPL 81
|
| >d1rgwa_ b.36.1.1 (A:) Zasp (Cypher, Oracle 1) {Human (Homo sapiens) [TaxId: 9606]} Length = 85 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Zasp (Cypher, Oracle 1) species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.9 bits (101), Expect = 5e-06
Identities = 7/39 (17%), Positives = 16/39 (41%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L GD ++ ++G E + I++ + +
Sbjct: 38 AAQSQLSQGDLVVAIDGVNTDTMTHLEAQNKIKSASYNL 76
|
| >d1m5za_ b.36.1.1 (A:) Glutamate receptor interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 91 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.0 bits (101), Expect = 6e-06
Identities = 13/39 (33%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
DL L DR+L+VN RD V LI + + +
Sbjct: 45 GDLGGLKPYDRLLQVNHVRTRDFDCCLVVPLIAESGNKL 83
|
| >d2f5ya1 b.36.1.1 (A:19-95) Regulator of G-protein signaling 3, RGS3 {Human (Homo sapiens) [TaxId: 9606]} Length = 77 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Regulator of G-protein signaling 3, RGS3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (99), Expect = 7e-06
Identities = 10/39 (25%), Positives = 17/39 (43%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L D +L++N PV E+ IR+ +
Sbjct: 31 AERAGLQQLDTVLQLNERPVEHWKCVELAHEIRSCPSEI 69
|
| >d1ujda_ b.36.1.1 (A:) Hypothetical protein KIAA0559 {Human (Homo sapiens) [TaxId: 9606]} Length = 117 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Hypothetical protein KIAA0559 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (101), Expect = 9e-06
Identities = 11/34 (32%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L G ++LE NG P+ K +EV+ +I +
Sbjct: 68 LMEGMQVLEWNGIPLTSKTYEEVQSIISQQSGEA 101
|
| >d1g9oa_ b.36.1.1 (A:) Na+/H+ exchanger regulatory factor, NHERF {Human (Homo sapiens) [TaxId: 9606]} Length = 91 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Na+/H+ exchanger regulatory factor, NHERF species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (99), Expect = 1e-05
Identities = 15/42 (35%), Positives = 21/42 (50%)
Query: 285 DPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ L GDR++EVNG V + Q+V IR + V
Sbjct: 37 GSPAEKAGLLAGDRLVEVNGENVEKETHQQVVSRIRAALNAV 78
|
| >d1ufxa_ b.36.1.1 (A:) KIAA1526 protein {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: KIAA1526 protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (97), Expect = 2e-05
Identities = 14/39 (35%), Positives = 19/39 (48%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQI 331
L +G ILEVNG +R K +E +I T + I
Sbjct: 51 LKVGHVILEVNGLTLRGKEHREAARIIAEAFKTKDRDYI 89
|
| >d1n7ea_ b.36.1.1 (A:) Glutamate receptor-interacting protein 1, GRIP1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 95 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor-interacting protein 1, GRIP1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.0 bits (96), Expect = 3e-05
Identities = 14/34 (41%), Positives = 23/34 (67%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+H+GDRIL +N + ++ KPL E L++ +TV
Sbjct: 47 IHIGDRILAINSSSLKGKPLSEAIHLLQMAGETV 80
|
| >d2cs5a1 b.36.1.1 (A:8-113) Tyrosine-protein phosphatase non-receptor type 4, PTPN4 {Human (Homo sapiens) [TaxId: 9606]} Length = 106 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Tyrosine-protein phosphatase non-receptor type 4, PTPN4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (94), Expect = 7e-05
Identities = 7/34 (20%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L+ GD+++ +NG + + +V I+ + +
Sbjct: 54 LNEGDQVVLINGRDIAEHTHDQVVLFIKASCERH 87
|
| >d1x5qa1 b.36.1.1 (A:8-104) Scribble (KIAA0147) {Human (Homo sapiens) [TaxId: 9606]} Length = 97 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Scribble (KIAA0147) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (93), Expect = 7e-05
Identities = 12/46 (26%), Positives = 21/46 (45%), Gaps = 3/46 (6%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV---LQRQ 330
A + +GD++LEVNG ++ E +R V + R+
Sbjct: 52 AARAGVRVGDKLLEVNGVALQGAEHHEAVEALRGAGTAVQMRVWRE 97
|
| >d2fcfa1 b.36.1.1 (A:1148-1243) Multiple PDZ domain protein {Human (Homo sapiens) [TaxId: 9606]} Length = 96 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Multiple PDZ domain protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (92), Expect = 9e-05
Identities = 15/42 (35%), Positives = 22/42 (52%), Gaps = 3/42 (7%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV---LQRQI 331
L GDRI+EV+G +RD ++ IR + V +Q I
Sbjct: 55 LKPGDRIVEVDGMDLRDASHEQAVEAIRKAGNPVVFMVQSII 96
|
| >d2dj7a1 g.39.1.3 (A:44-74) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 31 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (87), Expect = 1e-04
Identities = 12/31 (38%), Positives = 20/31 (64%)
Query: 38 RCSACDVMLDNWYFEKDGLLFCKEDYNGKYG 68
+C C V+L Y KDG+ +C+ DY+ ++G
Sbjct: 1 KCQTCSVILTGEYISKDGVPYCESDYHAQFG 31
|
| >d1wf7a_ b.36.1.1 (A:) Enigma homolog ENH {Mouse (Mus musculus) [TaxId: 10090]} Length = 103 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Enigma homolog ENH species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.6 bits (92), Expect = 1e-04
Identities = 8/39 (20%), Positives = 18/39 (46%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A + +GD +L ++G + E + I+ T ++
Sbjct: 42 ASQAHVRIGDVVLSIDGISAQGMTHLEAQNKIKACTGSL 80
|
| >d1va8a1 b.36.1.1 (A:8-107) Maguk p55 subfamily member 5 {Mouse (Mus musculus) [TaxId: 10090]} Length = 100 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Maguk p55 subfamily member 5 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.5 bits (92), Expect = 1e-04
Identities = 14/34 (41%), Positives = 21/34 (61%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
LH GD +LE+NG +R K + EV L+ + T+
Sbjct: 60 LHEGDEVLEINGIEIRGKDVNEVFDLLSDMHGTL 93
|
| >d1q3oa_ b.36.1.1 (A:) Shank1, PDZ domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 104 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Shank1, PDZ domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 39.6 bits (92), Expect = 1e-04
Identities = 13/39 (33%), Positives = 21/39 (53%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A L +GD ++EVNG V ++V +IR +T+
Sbjct: 56 AWRAGLRMGDFLIEVNGQNVVKVGHRQVVNMIRQGGNTL 94
|
| >d1x5ra1 b.36.1.1 (A:8-106) Glutamate receptor interacting protein 2, GRIP2 (KIAA1719) {Human (Homo sapiens) [TaxId: 9606]} Length = 99 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor interacting protein 2, GRIP2 (KIAA1719) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (91), Expect = 1e-04
Identities = 11/34 (32%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDR+L +NG D ++E L+R+
Sbjct: 57 LQVGDRVLSINGIATEDGTMEEANQLLRDAALAH 90
|
| >d2csja1 b.36.1.1 (A:8-111) Tight junction protein ZO-2, Tjp2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 104 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Tight junction protein ZO-2, Tjp2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 39.1 bits (91), Expect = 2e-04
Identities = 10/34 (29%), Positives = 15/34 (44%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L DR++ VNGTP+ D +R +
Sbjct: 56 LQENDRVVMVNGTPMEDVLHSFAVQQLRKSGKIA 89
|
| >d1v5la_ b.36.1.1 (A:) Alpha-actinin-2 associated LIM protein {Mouse (Mus musculus) [TaxId: 10090]} Length = 103 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Alpha-actinin-2 associated LIM protein species: Mouse (Mus musculus) [TaxId: 10090]
Score = 38.5 bits (89), Expect = 3e-04
Identities = 8/39 (20%), Positives = 16/39 (41%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A +L GD IL ++G + + I+ + +
Sbjct: 42 AAAANLCPGDVILAIDGFGTESMTHADAQDRIKAASYQL 80
|
| >d1qava_ b.36.1.1 (A:) Syntrophin {Mouse (Mus musculus) [TaxId: 10090]} Length = 90 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Syntrophin species: Mouse (Mus musculus) [TaxId: 10090]
Score = 38.3 bits (89), Expect = 3e-04
Identities = 11/35 (31%), Positives = 16/35 (45%)
Query: 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+L +GD IL VNG + E ++ T V
Sbjct: 48 ALFVGDAILSVNGEDLSSATHDEAVQALKKTGKEV 82
|
| >d1wi2a_ b.36.1.1 (A:) PDZ domain containing protein 11, Pdzk11 {Mouse (Mus musculus) [TaxId: 10090]} Length = 104 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: PDZ domain containing protein 11, Pdzk11 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 38.4 bits (89), Expect = 3e-04
Identities = 8/40 (20%), Positives = 17/40 (42%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
A L GD++L VN +D + +++ + +
Sbjct: 54 AHRAGLQEGDQVLAVNDVDFQDIEHSKAVEILKTAREISM 93
|
| >d1uf1a_ b.36.1.1 (A:) KIAA1526 protein {Human (Homo sapiens) [TaxId: 9606]} Length = 128 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: KIAA1526 protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (90), Expect = 3e-04
Identities = 13/40 (32%), Positives = 22/40 (55%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
A+ L +GD+ILEVNG + E L++++ +L
Sbjct: 59 AEGSGLKVGDQILEVNGRSFLNILHDEAVRLLKSSRHLIL 98
|
| >d1x5na1 b.36.1.1 (A:8-108) Harmonin {Human (Homo sapiens) [TaxId: 9606]} Length = 101 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Harmonin species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.9 bits (88), Expect = 4e-04
Identities = 9/40 (22%), Positives = 22/40 (55%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
+ + L +GD+I+EVNG + +E +++++ +
Sbjct: 47 SAEVGLEIGDQIVEVNGVDFSNLDHKEAVNVLKSSRSLTI 86
|
| >d1rzxa_ b.36.1.1 (A:) GTPase-binding domain of the cell polarity protein par6 (Par-6B) {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 98 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: GTPase-binding domain of the cell polarity protein par6 (Par-6B) species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.6 bits (87), Expect = 5e-04
Identities = 10/41 (24%), Positives = 18/41 (43%)
Query: 286 PRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L + D ++EVNG V K L +V ++ + +
Sbjct: 50 LAESTGLLAVNDEVIEVNGIEVAGKTLDQVTDMMVANSSNL 90
|
| >d1wi4a1 b.36.1.1 (A:8-103) Syntaxin binding protein 4 {Mouse (Mus musculus) [TaxId: 10090]} Length = 96 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Syntaxin binding protein 4 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 37.6 bits (87), Expect = 6e-04
Identities = 6/30 (20%), Positives = 14/30 (46%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNT 322
L GD+++ +N + +E + +I
Sbjct: 53 LKPGDQLVSINKESMIGVSFEEAKSIITRA 82
|
| >d1p1da2 b.36.1.1 (A:115-213) Glutamate receptor interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 99 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.6 bits (87), Expect = 6e-04
Identities = 7/34 (20%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L LGD++L ++ + +++ +++ D V
Sbjct: 57 LELGDKLLAIDNIRLDSCSMEDAVQILQQCEDLV 90
|
| >d1ueza_ b.36.1.1 (A:) KIAA1526 protein {Human (Homo sapiens) [TaxId: 9606]} Length = 101 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: KIAA1526 protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (86), Expect = 7e-04
Identities = 11/40 (27%), Positives = 18/40 (45%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVL 327
A+ L +GD+IL VN + E ++ + VL
Sbjct: 48 AEKEGLRVGDQILRVNDKSLARVTHAEAVKALKGSKKLVL 87
|
| >d1y7na1 b.36.1.1 (A:12-90) Amyloid beta A4 precursor protein-binding family A member 1 (APBA1, X11) {Human (Homo sapiens) [TaxId: 9606]} Length = 79 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Amyloid beta A4 precursor protein-binding family A member 1 (APBA1, X11) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (85), Expect = 8e-04
Identities = 10/39 (25%), Positives = 21/39 (53%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
A+ + +G RI+E+NG V P +++ ++ N +
Sbjct: 33 AERGGVRVGHRIIEINGQSVVATPHEKIVHILSNAVGEI 71
|
| >d1kwaa_ b.36.1.1 (A:) Cask/Lin-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 88 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Cask/Lin-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (85), Expect = 9e-04
Identities = 10/41 (24%), Positives = 24/41 (58%)
Query: 286 PRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+LH+GD I E+NG V ++ +++++ ++R ++
Sbjct: 37 MIHRQGTLHVGDEIREINGISVANQTVEQLQKMLREMRGSI 77
|
| >d1x45a1 b.36.1.1 (A:8-92) Amyloid beta A4 precursor protein-binding family A member 1 (APBA1, X11) {Human (Homo sapiens) [TaxId: 9606]} Length = 85 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Amyloid beta A4 precursor protein-binding family A member 1 (APBA1, X11) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.4 bits (84), Expect = 0.001
Identities = 10/34 (29%), Positives = 20/34 (58%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L++GD+I+ +NGT + PL + +I+ +
Sbjct: 45 LNIGDQIMSINGTSLVGLPLSTCQSIIKGLKNQS 78
|
| >d1ihja_ b.36.1.1 (A:) Inad {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 94 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Inad species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 36.4 bits (84), Expect = 0.001
Identities = 14/34 (41%), Positives = 19/34 (55%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDRIL +NG VR+ Q V LI+ +
Sbjct: 54 LKVGDRILSLNGKDVRNSTEQAVIDLIKEADFKI 87
|
| >d1uepa_ b.36.1.1 (A:) Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.4 bits (84), Expect = 0.001
Identities = 13/46 (28%), Positives = 23/46 (50%), Gaps = 5/46 (10%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDT-----VLQRQILK 333
LH GD ++ V+G PV K + V L+ + ++R++L
Sbjct: 53 LHPGDELVYVDGIPVAGKTHRYVIDLMHHAARNGQVNLTVRRKVLS 98
|
| >d1j2oa1 g.39.1.3 (A:1-30) Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 10090]} Length = 30 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Rhombotin-2 (Lmo2) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 34.4 bits (79), Expect = 0.002
Identities = 13/28 (46%), Positives = 19/28 (67%)
Query: 9 ILTCAGCLNNIVEDEYVQALSQEWHTDC 36
+LTC GC NI + +++A+ Q WH DC
Sbjct: 3 LLTCGGCQQNIGDRYFLKAIDQYWHEDC 30
|
| >d2h3la1 b.36.1.1 (A:1310-1412) Erbin {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Erbin species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.4 bits (84), Expect = 0.002
Identities = 10/43 (23%), Positives = 21/43 (48%), Gaps = 3/43 (6%)
Query: 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV---LQRQI 331
L GD+I++ NG + + L++ +TV + R++
Sbjct: 59 LLQPGDKIIQANGYSFINIEHGQAVSLLKTFQNTVELIIVREV 101
|
| >d1vaea_ b.36.1.1 (A:) Rhophilin-2 {Mouse (Mus musculus) [TaxId: 10090]} Length = 111 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Rhophilin-2 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 36.5 bits (84), Expect = 0.002
Identities = 9/46 (19%), Positives = 21/46 (45%)
Query: 288 ADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333
A L GD I+ + G + + EV L+++ ++ +++
Sbjct: 49 ASLAGAKEGDYIVSIQGVDCKWLTVSEVMKLLKSFGGEEVEMKVVS 94
|
| >d1wg6a_ b.36.1.1 (A:) Partitioning-defective 3-like protein, PAR3-L (RIKEN cDNA 2810455b10) {Mouse (Mus musculus) [TaxId: 10090]} Length = 127 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Partitioning-defective 3-like protein, PAR3-L (RIKEN cDNA 2810455b10) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 36.6 bits (84), Expect = 0.002
Identities = 8/34 (23%), Positives = 15/34 (44%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L + D+++ VNG + K E +R +
Sbjct: 74 LRMNDQLIAVNGETLLGKSNHEAMETLRRSMSME 107
|
| >d2cssa1 b.36.1.1 (A:8-115) Regulating synaptic membrane exocytosis protein 1, RIMS1 {Human (Homo sapiens) [TaxId: 9606]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Regulating synaptic membrane exocytosis protein 1, RIMS1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.1 bits (83), Expect = 0.002
Identities = 11/34 (32%), Positives = 16/34 (47%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD +LE NG P+ +EV +I +
Sbjct: 66 LRAGDEVLEWNGKPLPGATNEEVYNIILESKSEP 99
|
| >d1wf8a1 b.36.1.1 (A:8-101) Neurabin-i {Human (Homo sapiens) [TaxId: 9606]} Length = 94 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Neurabin-i species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.6 bits (82), Expect = 0.002
Identities = 9/34 (26%), Positives = 17/34 (50%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
+ + D+I+EV+G + ++RNT V
Sbjct: 52 IQVNDQIVEVDGISLVGVTQNFAATVLRNTKGNV 85
|
| >d1v6ba_ b.36.1.1 (A:) Harmonin {Mouse (Mus musculus) [TaxId: 10090]} Length = 118 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Harmonin species: Mouse (Mus musculus) [TaxId: 10090]
Score = 36.1 bits (83), Expect = 0.002
Identities = 10/30 (33%), Positives = 15/30 (50%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNT 322
+ GD I+ +NG V D L E E ++
Sbjct: 62 VVKGDEIMAINGKIVTDYTLAEAEAALQKA 91
|
| >d2fnea1 b.36.1.1 (A:1955-2042) Multiple PDZ domain protein {Human (Homo sapiens) [TaxId: 9606]} Length = 88 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Multiple PDZ domain protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.2 bits (81), Expect = 0.003
Identities = 11/34 (32%), Positives = 18/34 (52%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L GD+I+ VNG + +E +++ T TV
Sbjct: 49 LKRGDQIIAVNGQSLEGVTHEEAVAILKRTKGTV 82
|
| >d2fe5a1 b.36.1.1 (A:223-314) Synapse-associated protein 102 {Human (Homo sapiens) [TaxId: 9606]} Length = 92 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Synapse-associated protein 102 species: Human (Homo sapiens) [TaxId: 9606]
Score = 34.9 bits (80), Expect = 0.004
Identities = 14/34 (41%), Positives = 22/34 (64%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV 326
L +GDR+L VN T ++D +E ++NT+D V
Sbjct: 50 LQIGDRLLAVNNTNLQDVRHEEAVASLKNTSDMV 83
|
| >d1ujva_ b.36.1.1 (A:) Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) {Human (Homo sapiens) [TaxId: 9606]} Length = 96 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) species: Human (Homo sapiens) [TaxId: 9606]
Score = 34.9 bits (80), Expect = 0.004
Identities = 10/51 (19%), Positives = 20/51 (39%)
Query: 273 TGMTNNPSVPRLDPRADLMSLHLGDRILEVNGTPVRDKPLQEVECLIRNTT 323
V ++ L GD I+E+N V++ EV ++++
Sbjct: 28 ADSPTGQRVKQILDIQGCPGLCEGDLIVEINQQNVQNLSHTEVVDILKDCP 78
|
| >d1b8ta4 g.39.1.3 (A:144-192) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} Length = 49 | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Score = 33.6 bits (77), Expect = 0.004
Identities = 13/40 (32%), Positives = 20/40 (50%), Gaps = 1/40 (2%)
Query: 38 RCSACDVMLDNW-YFEKDGLLFCKEDYNGKYGEACQNCGQ 76
RC+ C L++ +KDG ++CK Y +G GQ
Sbjct: 1 RCAKCGKSLESTTLADKDGEIYCKGCYAKNFGPKGFGFGQ 40
|
| >d1ueqa_ b.36.1.1 (A:) Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) {Human (Homo sapiens) [TaxId: 9606]} Length = 123 | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) species: Human (Homo sapiens) [TaxId: 9606]
Score = 35.7 bits (82), Expect = 0.004
Identities = 7/30 (23%), Positives = 13/30 (43%)
Query: 293 LHLGDRILEVNGTPVRDKPLQEVECLIRNT 322
+ GD I+ +N V +V L ++
Sbjct: 63 METGDVIVYINEVCVLGHTHADVVKLFQSV 92
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 681 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.98 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.98 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.98 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.98 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.97 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.97 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.97 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.97 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.97 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.97 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.97 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.96 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.96 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.96 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.95 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.95 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.9 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1x3ha1 | 35 | Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | 99.12 | |
| d1x6aa1 | 34 | Lim domain kinase 2 {Human (Homo sapiens) [TaxId: | 98.97 | |
| d1v6ga1 | 41 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 98.79 | |
| d2dloa1 | 35 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 98.63 | |
| d1x6aa2 | 34 | Lim domain kinase 2 {Human (Homo sapiens) [TaxId: | 98.44 | |
| d2cuqa2 | 35 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 98.42 | |
| d1g47a2 | 35 | Pinch (particularly interesting new Cys-His) prote | 98.4 | |
| d2dara2 | 45 | PDZ and LIM domain protein 5, Enigma {Human (Homo | 98.27 | |
| d2dj7a1 | 31 | Actin-binding LIM protein 3, abLIM-3 {Human (Homo | 98.26 | |
| d1x3ha1 | 35 | Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | 98.19 | |
| d1b8ta4 | 49 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 98.18 | |
| d2dara2 | 45 | PDZ and LIM domain protein 5, Enigma {Human (Homo | 98.13 | |
| d2d8xa2 | 26 | Pinch (particularly interesting new Cys-His) prote | 98.13 | |
| d1x63a1 | 37 | Four and a half LIM domains protein 1, FHL-1 {Huma | 98.12 | |
| d1j2oa1 | 30 | Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 1 | 97.97 | |
| d2dj7a2 | 36 | Actin-binding LIM protein 3, abLIM-3 {Human (Homo | 97.93 | |
| d1u5sb1 | 31 | Pinch (particularly interesting new Cys-His) prote | 97.89 | |
| d1u5sb1 | 31 | Pinch (particularly interesting new Cys-His) prote | 97.87 | |
| d1rutx1 | 30 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 97.84 | |
| d1rgwa_ | 85 | Zasp (Cypher, Oracle 1) {Human (Homo sapiens) [Tax | 97.83 | |
| d1m5za_ | 91 | Glutamate receptor interacting protein {Rat (Rattu | 97.83 | |
| d2dloa1 | 35 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 97.79 | |
| d2d8xa2 | 26 | Pinch (particularly interesting new Cys-His) prote | 97.78 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.78 | |
| d1wf7a_ | 103 | Enigma homolog ENH {Mouse (Mus musculus) [TaxId: 1 | 97.77 | |
| d1g47a2 | 35 | Pinch (particularly interesting new Cys-His) prote | 97.76 | |
| d1tp5a1 | 102 | Synaptic protein PSD-95 {Rat (Rattus norvegicus) [ | 97.76 | |
| d1vb7a_ | 94 | PDZ-LIM protein mystique {Mouse (Mus musculus) [Ta | 97.75 | |
| d1ozia_ | 99 | Phosphatase hPTP1e {Mouse (Mus musculus) [TaxId: 1 | 97.74 | |
| d2fcfa1 | 96 | Multiple PDZ domain protein {Human (Homo sapiens) | 97.72 | |
| d1whaa_ | 105 | Scribble (KIAA0147) {Human (Homo sapiens) [TaxId: | 97.71 | |
| d2dloa2 | 33 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 97.7 | |
| d1uita_ | 117 | Discs large 5 protein KIAA0583 {Human (Homo sapien | 97.68 | |
| d1n7ea_ | 95 | Glutamate receptor-interacting protein 1, GRIP1 {R | 97.64 | |
| d1v62a_ | 117 | Glutamate receptor interacting protein 2, GRIP2 (K | 97.62 | |
| d1p1da2 | 99 | Glutamate receptor interacting protein {Rat (Rattu | 97.61 | |
| d1qava_ | 90 | Syntrophin {Mouse (Mus musculus) [TaxId: 10090]} | 97.61 | |
| d2fnea1 | 88 | Multiple PDZ domain protein {Human (Homo sapiens) | 97.59 | |
| d1u5sb2 | 35 | Pinch (particularly interesting new Cys-His) prote | 97.57 | |
| d1um1a_ | 110 | Hypothetical protein KIAA1849 {Human (Homo sapiens | 97.56 | |
| d1y7na1 | 79 | Amyloid beta A4 precursor protein-binding family A | 97.56 | |
| d2d8za2 | 32 | Four and a half LIM domains protein 2, FHL2 {Human | 97.54 | |
| d1t2ma1 | 92 | Afadin {Human (Homo sapiens) [TaxId: 9606]} | 97.54 | |
| d1r6ja_ | 82 | Syntenin 1 {Human (Homo sapiens) [TaxId: 9606]} | 97.53 | |
| d1ihja_ | 94 | Inad {Fruit fly (Drosophila melanogaster) [TaxId: | 97.52 | |
| d2h3la1 | 103 | Erbin {Human (Homo sapiens) [TaxId: 9606]} | 97.52 | |
| d1ujda_ | 117 | Hypothetical protein KIAA0559 {Human (Homo sapiens | 97.52 | |
| d2f5ya1 | 77 | Regulator of G-protein signaling 3, RGS3 {Human (H | 97.51 | |
| d1wfva_ | 103 | Membrane associated guanylate kinase inverted-2 (M | 97.51 | |
| d1rgra_ | 93 | Synaptic protein PSD-95 {Rat (Rattus norvegicus) [ | 97.5 | |
| d1wf8a1 | 94 | Neurabin-i {Human (Homo sapiens) [TaxId: 9606]} | 97.48 | |
| d1uewa_ | 114 | Membrane associated guanylate kinase inverted-2 (M | 97.48 | |
| d1q3oa_ | 104 | Shank1, PDZ domain {Rat (Rattus norvegicus) [TaxId | 97.48 | |
| d1vaea_ | 111 | Rhophilin-2 {Mouse (Mus musculus) [TaxId: 10090]} | 97.48 | |
| d1kwaa_ | 88 | Cask/Lin-2 {Human (Homo sapiens) [TaxId: 9606]} | 97.48 | |
| d1uhpa_ | 107 | Hypothetical protein KIAA1095 {Human (Homo sapiens | 97.47 | |
| d2fe5a1 | 92 | Synapse-associated protein 102 {Human (Homo sapien | 97.46 | |
| d1va8a1 | 100 | Maguk p55 subfamily member 5 {Mouse (Mus musculus) | 97.45 | |
| d1w9ea1 | 85 | Syntenin 1 {Human (Homo sapiens) [TaxId: 9606]} | 97.44 | |
| d1rzxa_ | 98 | GTPase-binding domain of the cell polarity protein | 97.43 | |
| d1ujua_ | 111 | Scribble (KIAA0147) {Human (Homo sapiens) [TaxId: | 97.43 | |
| d1imla2 | 48 | Cysteine-rich (intestinal) protein, CRP, CRIP {Rat | 97.43 | |
| d1x3ha2 | 32 | Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | 97.42 | |
| d1ujva_ | 96 | Membrane associated guanylate kinase inverted-2 (M | 97.41 | |
| d1g9oa_ | 91 | Na+/H+ exchanger regulatory factor, NHERF {Human ( | 97.41 | |
| d1x5qa1 | 97 | Scribble (KIAA0147) {Human (Homo sapiens) [TaxId: | 97.41 | |
| d1ibia2 | 31 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 97.39 | |
| d1wiga1 | 32 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 97.37 | |
| d1ueqa_ | 123 | Membrane associated guanylate kinase inverted-2 (M | 97.36 | |
| d2csja1 | 104 | Tight junction protein ZO-2, Tjp2 {Mouse (Mus musc | 97.35 | |
| d1x5ra1 | 99 | Glutamate receptor interacting protein 2, GRIP2 (K | 97.34 | |
| d1v5la_ | 103 | Alpha-actinin-2 associated LIM protein {Mouse (Mus | 97.34 | |
| d1v5qa_ | 122 | Glutamate receptor interacting protein {Mouse (Mus | 97.34 | |
| d2d8za1 | 26 | Four and a half LIM domains protein 2, FHL2 {Human | 97.3 | |
| d1fc6a3 | 92 | Photosystem II D1 C-terminal processing protease { | 97.3 | |
| d1i16a_ | 130 | Interleukin 16 {Human (Homo sapiens) [TaxId: 9606] | 97.28 | |
| d2cuqa1 | 32 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 97.26 | |
| d1x62a2 | 35 | PDZ and LIM domain protein 1 Elfin {Human (Homo sa | 97.26 | |
| d1ueza_ | 101 | KIAA1526 protein {Human (Homo sapiens) [TaxId: 960 | 97.24 | |
| d1zfoa_ | 30 | LASP-1 {Pig (Sus scrofa) [TaxId: 9823]} | 97.2 | |
| d1b8ta2 | 65 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 97.2 | |
| d1rutx3 | 31 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 97.19 | |
| d1x4la1 | 29 | Four and a half LIM domains protein 2, FHL2 {Human | 97.18 | |
| d1uepa_ | 103 | Membrane associated guanylate kinase inverted-2 (M | 97.18 | |
| d1v6ba_ | 118 | Harmonin {Mouse (Mus musculus) [TaxId: 10090]} | 97.17 | |
| d1wi2a_ | 104 | PDZ domain containing protein 11, Pdzk11 {Mouse (M | 97.17 | |
| d1x45a1 | 85 | Amyloid beta A4 precursor protein-binding family A | 97.17 | |
| d1wi4a1 | 96 | Syntaxin binding protein 4 {Mouse (Mus musculus) [ | 97.15 | |
| d2cura2 | 26 | Four and a half LIM domains protein 1, FHL-1 {Huma | 97.14 | |
| d1wyha1 | 32 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 97.14 | |
| d2cs5a1 | 106 | Tyrosine-protein phosphatase non-receptor type 4, | 97.14 | |
| d1x4ka1 | 32 | Four and a half LIM domains protein 2, FHL2 {Human | 97.12 | |
| d2cu8a1 | 30 | Cysteine-rich (intestinal) protein, CRP, CRIP {Hum | 97.12 | |
| d1x64a1 | 45 | PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus m | 97.11 | |
| d2cssa1 | 108 | Regulating synaptic membrane exocytosis protein 1, | 97.11 | |
| d1wifa_ | 126 | hypothetical PDZ domain containing protein Uqcrc2 | 97.1 | |
| d2f0aa1 | 92 | Segment polarity protein dishevelled homolog Dvl-2 | 97.07 | |
| d1x4la1 | 29 | Four and a half LIM domains protein 2, FHL2 {Human | 97.02 | |
| d1x63a1 | 37 | Four and a half LIM domains protein 1, FHL-1 {Huma | 97.01 | |
| d2dj7a2 | 36 | Actin-binding LIM protein 3, abLIM-3 {Human (Homo | 97.0 | |
| d2d8ya2 | 42 | Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | 96.99 | |
| d2dara1 | 32 | PDZ and LIM domain protein 5, Enigma {Human (Homo | 96.97 | |
| d1ufxa_ | 103 | KIAA1526 protein {Human (Homo sapiens) [TaxId: 960 | 96.92 | |
| d2d8za2 | 32 | Four and a half LIM domains protein 2, FHL2 {Human | 96.9 | |
| d1x5na1 | 101 | Harmonin {Human (Homo sapiens) [TaxId: 9606]} | 96.89 | |
| d1uf1a_ | 128 | KIAA1526 protein {Human (Homo sapiens) [TaxId: 960 | 96.87 | |
| d1x68a1 | 29 | Four and a half LIM domains protein 5, FHL-5 {Huma | 96.86 | |
| d2dara1 | 32 | PDZ and LIM domain protein 5, Enigma {Human (Homo | 96.86 | |
| d1x6da1 | 107 | Interleukin 16 {Human (Homo sapiens) [TaxId: 9606] | 96.84 | |
| d2cu8a2 | 33 | Cysteine-rich (intestinal) protein, CRP, CRIP {Hum | 96.83 | |
| d1x68a1 | 29 | Four and a half LIM domains protein 5, FHL-5 {Huma | 96.79 | |
| d2d8za1 | 26 | Four and a half LIM domains protein 2, FHL2 {Human | 96.77 | |
| d1wg6a_ | 127 | Partitioning-defective 3-like protein, PAR3-L (RIK | 96.74 | |
| d2cura2 | 26 | Four and a half LIM domains protein 1, FHL-1 {Huma | 96.71 | |
| d2cuqa1 | 32 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 96.71 | |
| d1rutx1 | 30 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 96.69 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.62 | |
| d1b8ta4 | 49 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 96.5 | |
| d1a7ia2 | 32 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 96.49 | |
| d1x4ka1 | 32 | Four and a half LIM domains protein 2, FHL2 {Human | 96.49 | |
| d2cuqa2 | 35 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 96.49 | |
| d2dj7a1 | 31 | Actin-binding LIM protein 3, abLIM-3 {Human (Homo | 96.46 | |
| d1b8ta3 | 43 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 96.43 | |
| d1j2oa1 | 30 | Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 1 | 96.42 | |
| d1qaua_ | 112 | Neuronal nitric oxide synthase, NNOS {Rat (Rattus | 96.42 | |
| d1x62a2 | 35 | PDZ and LIM domain protein 1 Elfin {Human (Homo sa | 96.39 | |
| d2d8ya1 | 35 | Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | 96.37 | |
| d1wyha1 | 32 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 96.31 | |
| d1k32a1 | 91 | Tricorn protease {Archaeon Thermoplasma acidophilu | 96.3 | |
| d1imla2 | 48 | Cysteine-rich (intestinal) protein, CRP, CRIP {Rat | 96.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.21 | |
| d2co8a2 | 36 | Nedd9 interacting protein with calponin homology, | 96.17 | |
| d1x61a2 | 32 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 96.15 | |
| d2dloa2 | 33 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 96.14 | |
| d1x4ka2 | 27 | Four and a half LIM domains protein 2, FHL2 {Human | 96.12 | |
| d1x64a1 | 45 | PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus m | 96.11 | |
| d1x4ka2 | 27 | Four and a half LIM domains protein 2, FHL2 {Human | 96.06 | |
| d1ibia2 | 31 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 96.05 | |
| d2cura1 | 31 | Four and a half LIM domains protein 1, FHL-1 {Huma | 96.05 | |
| d1x63a2 | 32 | Four and a half LIM domains protein 1, FHL-1 {Huma | 96.0 | |
| d2d8ya2 | 42 | Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | 95.99 | |
| d1wyha2 | 27 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 95.97 | |
| d1ky9b2 | 88 | Protease Do (DegP, HtrA), C-terminal domains {Esch | 95.95 | |
| d1wyha2 | 27 | Four and a half LIM domains 3, FHL3 {Human (Homo s | 95.93 | |
| d2cupa3 | 27 | Four and a half LIM domains protein 1, FHL-1 {Huma | 95.92 | |
| d1rutx2 | 34 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 95.87 | |
| d1wh1a_ | 124 | Hypothetical protein KIAA1095 {Human (Homo sapiens | 95.78 | |
| d2hgaa1 | 103 | Uncharacterized protein MTH1368 {Methanobacterium | 95.77 | |
| d1rutx3 | 31 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 95.73 | |
| d2cura1 | 31 | Four and a half LIM domains protein 1, FHL-1 {Huma | 95.59 | |
| d1b8ta2 | 65 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 95.56 | |
| d1b8ta3 | 43 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 95.48 | |
| d1x63a2 | 32 | Four and a half LIM domains protein 1, FHL-1 {Huma | 95.45 | |
| d1x61a1 | 27 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 95.23 | |
| d2i6va1 | 87 | General secretion pathway protein C, EpsC {Vibrio | 95.21 | |
| d2d8ya1 | 35 | Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | 95.21 | |
| d1lcya1 | 100 | Mitochondrial serine protease HtrA2 {Human (Homo s | 95.2 | |
| d1ibia1 | 28 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 95.16 | |
| d1v6ga1 | 41 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 95.15 | |
| d1a7ia1 | 28 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 95.05 | |
| d1zfoa_ | 30 | LASP-1 {Pig (Sus scrofa) [TaxId: 9823]} | 94.86 | |
| d2co8a2 | 36 | Nedd9 interacting protein with calponin homology, | 94.84 | |
| d1x3ha2 | 32 | Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | 94.82 | |
| d1b8ta1 | 35 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 94.66 | |
| d1a7ia2 | 32 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 94.61 | |
| d2cu8a1 | 30 | Cysteine-rich (intestinal) protein, CRP, CRIP {Hum | 94.6 | |
| d2cupa3 | 27 | Four and a half LIM domains protein 1, FHL-1 {Huma | 94.59 | |
| d2z9ia1 | 88 | Protease PepD {Mycobacterium tuberculosis [TaxId: | 94.59 | |
| d1ky9a1 | 94 | Protease Do (DegP, HtrA), C-terminal domains {Esch | 94.4 | |
| d1u5sb2 | 35 | Pinch (particularly interesting new Cys-His) prote | 94.39 | |
| d1x61a1 | 27 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 93.93 | |
| d1x61a2 | 32 | Thyroid receptor interacting protein 6, TRIP6 {Hum | 93.37 | |
| d2cu8a2 | 33 | Cysteine-rich (intestinal) protein, CRP, CRIP {Hum | 93.36 | |
| d1b8ta1 | 35 | Cysteine-rich (intestinal) protein, CRP, CRIP {Chi | 93.03 | |
| d1a7ia1 | 28 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 92.99 | |
| d1x64a2 | 31 | PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus m | 92.93 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.69 | |
| d1sota1 | 99 | Stress sensor protease DegS, C-terminal domain {Es | 92.65 | |
| d1rutx4 | 33 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 92.23 | |
| d1wiga1 | 32 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 92.09 | |
| d1ibia1 | 28 | Cysteine-rich (intestinal) protein, CRP, CRIP {Jap | 91.25 | |
| d2cora2 | 35 | Pinch (particularly interesting new Cys-His) prote | 91.23 | |
| d2cora1 | 31 | Pinch (particularly interesting new Cys-His) prote | 91.18 | |
| d2cupa2 | 31 | Four and a half LIM domains protein 1, FHL-1 {Huma | 90.98 | |
| d1x62a1 | 31 | PDZ and LIM domain protein 1 Elfin {Human (Homo sa | 90.22 | |
| d2cora1 | 31 | Pinch (particularly interesting new Cys-His) prote | 88.3 | |
| d1wiga2 | 41 | Actin-binding LIM protein 2, abLIM2 {Human (Homo s | 88.27 | |
| d2cora2 | 35 | Pinch (particularly interesting new Cys-His) prote | 86.9 | |
| d1j2oa2 | 33 | Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 1 | 84.4 | |
| d1g47a1 | 35 | Pinch (particularly interesting new Cys-His) prote | 84.37 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 84.28 | |
| d1rutx4 | 33 | LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10 | 84.12 | |
| d1x6aa2 | 34 | Lim domain kinase 2 {Human (Homo sapiens) [TaxId: | 83.8 | |
| d1x6aa1 | 34 | Lim domain kinase 2 {Human (Homo sapiens) [TaxId: | 83.24 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-37 Score=315.32 Aligned_cols=176 Identities=25% Similarity=0.368 Sum_probs=153.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|++++.||+|+||.||+|+++.+|+.||+|++...... ..+ .+.+|+++|+
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~-------------------------~~~~Ei~~l~ 58 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-------------------------NIKKEICINK 58 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------------------------CHHHHHHHHH
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHH-------------------------HHHHHHHHHH
Confidence 46899999999999999999999999999999998654321 111 2345799999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 59 ~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~ 137 (271)
T d1nvra_ 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD 137 (271)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred hCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC
Confidence 9999999999999999999999999999999999997644 599999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++|.+ +|||+|+...............||+.|||||++.+.+|
T Consensus 138 ~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 182 (271)
T d1nvra_ 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182 (271)
T ss_dssp TTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSB
T ss_pred CCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCC
Confidence 99988 99999998775544444455679999999999988765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-36 Score=308.03 Aligned_cols=176 Identities=23% Similarity=0.350 Sum_probs=151.2
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..++|++++.||+|+||.||+|+++.+++.||+|++.+....... . ...+.+|+++|+
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~-~---------------------~~~~~~E~~il~ 61 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAG-V---------------------EHQLRREVEIQS 61 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTT-C---------------------HHHHHHHHHHHH
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChH-H---------------------HHHHHHHHHHHH
Confidence 457899999999999999999999999999999998653211100 0 012345699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++.+|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 62 ~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~ 140 (263)
T d2j4za1 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLG 140 (263)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred hcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceec
Confidence 9999999999999999999999999999999999997644 599999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+|.+ +|||+|+...... .....||+.|||||++.+.+|
T Consensus 141 ~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~ 181 (263)
T d2j4za1 141 SAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMH 181 (263)
T ss_dssp TTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCC
T ss_pred CCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCC
Confidence 99988 9999998665332 234679999999999998876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-36 Score=312.06 Aligned_cols=180 Identities=22% Similarity=0.258 Sum_probs=149.6
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
+.++|++++.||+|+||+||+|+++.+|+.||+|++.+........ ...+.+|+++|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~----------------------~~~~~~E~~il~ 63 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK----------------------VPYVTRERDVMS 63 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHHH
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHH----------------------HHHHHHHHHHHH
Confidence 3468999999999999999999999999999999986432111000 012346799999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++.+|+||||++||+|.+++...+ .+++..+..++.|++.||+|||+++||||||||+|||++
T Consensus 64 ~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142 (288)
T ss_dssp HCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred HcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC
Confidence 9999999999999999999999999999999999987654 599999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++|.+ +|||+|+...............||+.|||||++.+..|
T Consensus 143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~ 187 (288)
T d1uu3a_ 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187 (288)
T ss_dssp TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCC
T ss_pred CCceEEecccccceecccCCcccccccccCCccccCceeeccCCC
Confidence 99998 99999998765443444445679999999999998876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=309.71 Aligned_cols=172 Identities=23% Similarity=0.374 Sum_probs=150.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||+|+++.+|+.||+|++........+.+. +|+++|+.+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~-------------------------~E~~il~~l 74 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII-------------------------NEILVMREN 74 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHH-------------------------HHHHHHHHC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHH-------------------------HHHHHHHhC
Confidence 4699999999999999999999999999999998754333333333 459999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|||||++++++.+++.+|+||||++||+|.+++.+. .+++.++..++.||+.||+|||++|||||||||+|||++.+
T Consensus 75 ~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~ 152 (293)
T d1yhwa1 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152 (293)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCC
Confidence 9999999999999999999999999999999988753 59999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|.+ +|||+|+...... .......||+.|||||++.+.+|
T Consensus 153 ~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~ 193 (293)
T d1yhwa1 153 GSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAY 193 (293)
T ss_dssp CCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCB
T ss_pred CcEeeccchhheeecccc--ccccccccCCCccChhhhcCCCC
Confidence 998 9999999875433 22334679999999999998876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-35 Score=307.53 Aligned_cols=170 Identities=24% Similarity=0.346 Sum_probs=148.2
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|++.+.||+|+||.||+|+++.+|+.||+|++........+. +.+|+++|+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~-------------------------~~~E~~il~~l 66 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED-------------------------YMVEIDILASC 66 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGG-------------------------THHHHHHHHHC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHH-------------------------HHHHHHHHHhC
Confidence 46899999999999999999999999999999986543332222 34569999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|||||++++++.+++.+|+||||+++|+|.+++.+....+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus 67 ~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~ 146 (288)
T d2jfla1 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD 146 (288)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred CCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC
Confidence 99999999999999999999999999999999987655679999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhcc
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILK 676 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~ 676 (681)
|.+ +|||+|+...... .......||+.|||||++.
T Consensus 147 ~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~ 183 (288)
T d2jfla1 147 GDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVM 183 (288)
T ss_dssp SCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHT
T ss_pred CCEEEEechhhhccCCCc--ccccccccccccCCHHHHh
Confidence 988 9999998765322 1223466999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-35 Score=313.19 Aligned_cols=174 Identities=24% Similarity=0.410 Sum_probs=150.2
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
+..++|++.+.||+|+||.||+|+++.+|+.||+|++... +......+. +|+.+
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~-------------------------~Ei~i 57 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII-------------------------RELQV 57 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHH-------------------------HHGGG
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHH-------------------------HHHHH
Confidence 3467899999999999999999999999999999998653 222233333 45899
Q ss_pred HHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCcE
Q psy5063 556 LRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS-MNLIHRDLNSQNC 634 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs-~~IIHRDLKp~NI 634 (681)
|+.++|||||+++++|.+++.+|+||||++||+|.+++.+.+ .+++..+..++.|++.||.|||+ ++|+||||||+||
T Consensus 58 l~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NI 136 (322)
T d1s9ja_ 58 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136 (322)
T ss_dssp GGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHe
Confidence 999999999999999999999999999999999999997654 59999999999999999999997 5999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+.+|.+ +|||+|+...... .....||+.|||||++.+.+|
T Consensus 137 Ll~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APEvl~~~~y 180 (322)
T d1s9ja_ 137 LVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHY 180 (322)
T ss_dssp EECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHHHHHCSCC
T ss_pred eECCCCCEEEeeCCCccccCCCc----cccccCCccccCchHHcCCCC
Confidence 99999998 9999998765432 234579999999999998876
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-34 Score=309.04 Aligned_cols=173 Identities=22% Similarity=0.340 Sum_probs=152.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|++++.||+|+||.||+|+++.+|+.||+|++.+......+.+.+ |+.+|+.+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~-------------------------E~~il~~l 80 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK-------------------------EIQTMSVL 80 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHH-------------------------HHHHHHHT
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHH-------------------------HHHHHHhC
Confidence 58999999999999999999999999999999997766554444444 59999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec-
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE- 638 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~- 638 (681)
+|||||++++++.+++.+|+||||++||+|.+++.+....+++..+..++.||+.||.|||++|||||||||+|||++.
T Consensus 81 ~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~ 160 (350)
T d1koaa2 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK 160 (350)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST
T ss_pred CCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC
Confidence 9999999999999999999999999999999999766667999999999999999999999999999999999999965
Q ss_pred -CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 -VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 -~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|.+ +|||+|+...... ......||+.|||||++.+.+|
T Consensus 161 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~ 202 (350)
T d1koaa2 161 RSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPV 202 (350)
T ss_dssp TSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCB
T ss_pred CCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCC
Confidence 4556 9999998775433 2345679999999999998876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-35 Score=310.36 Aligned_cols=178 Identities=23% Similarity=0.298 Sum_probs=152.4
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..+||+++++||+|+||.||+|+++.+|+.||+|++.+........ ...+.+|+.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~----------------------~~~~~~E~~il~ 60 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE----------------------VAHTVTESRVLQ 60 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHHH
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHH----------------------HHHHHHHHHHHH
Confidence 4578999999999999999999999999999999986432111100 012356799999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++.+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||++|||||||||+|||++
T Consensus 61 ~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~ 139 (337)
T d1o6la_ 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139 (337)
T ss_dssp SCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred hCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec
Confidence 9999999999999999999999999999999999998654 599999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+|.+ +|||+|+...... ......+||+.|||||++.+.+|
T Consensus 140 ~~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y 182 (337)
T d1o6la_ 140 KDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDY 182 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCB
T ss_pred CCCCEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCC
Confidence 99988 9999998765332 22234679999999999998876
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-35 Score=301.59 Aligned_cols=176 Identities=26% Similarity=0.367 Sum_probs=143.3
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.|.+..++|++++.||+|+||.||+|+++ ..||||++... +....+.+.+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~------------------------- 53 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKN------------------------- 53 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHH-------------------------
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHH-------------------------
Confidence 46678899999999999999999999864 35999998643 2333444444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
|+++|+.++|||||++++++. ++.+++||||+++|+|.+++......+++..+..++.||+.||+|||+++||||||||
T Consensus 54 E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp 132 (276)
T d1uwha_ 54 EVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKS 132 (276)
T ss_dssp HHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred HHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCH
Confidence 499999999999999999864 4678999999999999999987666799999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
+||||+.++.+ +|||+|+...............||+.|||||++.+.
T Consensus 133 ~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 181 (276)
T d1uwha_ 133 NNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181 (276)
T ss_dssp GGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTC
T ss_pred HHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcc
Confidence 99999999988 999999887654444444556799999999999653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-34 Score=298.27 Aligned_cols=176 Identities=24% Similarity=0.339 Sum_probs=141.9
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
+..++|++++.||+|+||.||+|.++ +++.||||++..... ..+.+.+ |+++|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~-------------------------E~~~l 54 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIE-------------------------EAEVM 54 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS-CHHHHHH-------------------------HHHHH
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC-cHHHHHH-------------------------HHHHH
Confidence 45678999999999999999999986 477899999865332 2233444 49999
Q ss_pred HhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEE
Q psy5063 557 RSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLV 636 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl 636 (681)
+.++||||++++|++..++.+++||||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 55 ~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill 134 (263)
T d1sm2a_ 55 MKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134 (263)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE
T ss_pred HhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee
Confidence 99999999999999999999999999999999999998777779999999999999999999999999999999999999
Q ss_pred ecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 637 REVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 637 ~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++++.+ +|||+|+....... .......||+.|||||++.+..|
T Consensus 135 ~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~ 179 (263)
T d1sm2a_ 135 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRY 179 (263)
T ss_dssp CGGGCEEECSCC-------------------CTTSCCHHHHTTCCC
T ss_pred cCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCC
Confidence 999988 99999988765332 22234568999999999988776
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-35 Score=301.26 Aligned_cols=175 Identities=23% Similarity=0.361 Sum_probs=138.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.+||++.+.||+|+||.||+|+++.+|+.||+|.+.... ....+.+. +|+++|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~-------------------------~E~~il 57 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-------------------------SEVNLL 57 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHH-------------------------HHHHHT
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHH-------------------------HHHHHH
Confidence 578999999999999999999999999999999986543 22223333 459999
Q ss_pred HhCCCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccc
Q psy5063 557 RSLHHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQD---PGQPLPWGQRVNFARDIAAGMTYLHSMN-----LIH 626 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~---~~~~l~~~~~~~i~~QIa~gL~yLHs~~-----IIH 626 (681)
+.++|||||++++++.+ ++.+|+||||+++|+|.+++.+ ....+++..+..++.||+.||.|||+++ |||
T Consensus 58 ~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiH 137 (269)
T d2java1 58 RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLH 137 (269)
T ss_dssp TSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-------
T ss_pred HHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEe
Confidence 99999999999999864 4679999999999999999864 2356999999999999999999999976 999
Q ss_pred cCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 627 RDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 627 RDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||||+||||+.+|.+ +|||+|+...... .......||+.|||||++.+.+|
T Consensus 138 rDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~ 191 (269)
T d2java1 138 RDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSY 191 (269)
T ss_dssp --CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCC
T ss_pred CcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCC
Confidence 9999999999999998 9999998765432 22334679999999999988776
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-34 Score=306.56 Aligned_cols=173 Identities=20% Similarity=0.340 Sum_probs=152.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+........+. +|+.+|+.+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~-------------------------~Ei~il~~l 83 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK-------------------------NEISIMNQL 83 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHH-------------------------HHHHHHTTC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHH-------------------------HHHHHHHhC
Confidence 5799999999999999999999999999999999776544444333 459999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe--
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-- 637 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~-- 637 (681)
+|||||+++++|.+++.+|+||||++||+|.+++......+++.++..++.||+.||.|||++|||||||||+||||+
T Consensus 84 ~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~ 163 (352)
T d1koba_ 84 HHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 163 (352)
T ss_dssp CSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST
T ss_pred CCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc
Confidence 999999999999999999999999999999998877666799999999999999999999999999999999999998
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+|.+ +|||+|+....+. ......||+.|||||++.+..|
T Consensus 164 ~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~ 205 (352)
T d1koba_ 164 KASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPV 205 (352)
T ss_dssp TCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCB
T ss_pred CCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCC
Confidence 45666 9999999876433 2344679999999999988876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-35 Score=304.20 Aligned_cols=180 Identities=27% Similarity=0.411 Sum_probs=154.2
Q ss_pred cceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 474 SRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 474 ~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.+.+..++|++++.||+|+||.||+|+++.+++.||||++...... .+.+. +|+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~-------------------------~E~ 64 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFL-------------------------KEA 64 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC-HHHHH-------------------------HHH
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch-HHHHH-------------------------HHH
Confidence 4567778999999999999999999999999999999998643322 23344 459
Q ss_pred HHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQD-PGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~-~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
++|+.++|||||+++|++.+++.+|+||||+++|+|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+
T Consensus 65 ~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~ 144 (287)
T d1opja_ 65 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR 144 (287)
T ss_dssp HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred HHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccC
Confidence 999999999999999999999999999999999999999864 3456899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||||++++.+ +|||+|+...... ........|++.|||||++.+..|
T Consensus 145 NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~ 193 (287)
T d1opja_ 145 NCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKF 193 (287)
T ss_dssp GEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCC
T ss_pred eEEECCCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcCCCC
Confidence 9999999988 9999998765432 223333457899999999987765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-34 Score=304.41 Aligned_cols=175 Identities=24% Similarity=0.349 Sum_probs=150.5
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..+||++++.||+|+||+||+|+++.+|+.||+|++.+......+. ...+.+|+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~----------------------~~~~~~E~~il~ 59 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ----------------------VEHTNDERLMLS 59 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHHH
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHH----------------------HHHHHHHHHHHH
Confidence 4578999999999999999999999999999999986432111000 012345799999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+++.+|+||||++||+|.+++.... .+++..+..++.||+.||+|||+++||||||||+||||+
T Consensus 60 ~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~ 138 (316)
T d1fota_ 60 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 138 (316)
T ss_dssp SCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred hccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc-cccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc
Confidence 9999999999999999999999999999999999988654 489999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+|.+ +|||+|+...... ....||+.|||||++.+.+|
T Consensus 139 ~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y 178 (316)
T d1fota_ 139 KNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPY 178 (316)
T ss_dssp TTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCB
T ss_pred CCCCEEEecCccceEecccc-----ccccCcccccCHHHHcCCCC
Confidence 99998 9999998865322 24579999999999998876
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-34 Score=301.81 Aligned_cols=173 Identities=20% Similarity=0.307 Sum_probs=135.3
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|++++.||+|+||+||+|+++.+|+.||+|.+.+....... ..+.+|+++|+.+
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~------------------------~~~~~Ei~il~~l 64 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE------------------------GSMENEIAVLHKI 64 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------------------------------CHHHHHHHTC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHH------------------------HHHHHHHHHHHhC
Confidence 5699999999999999999999999999999998654322111 1234679999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe--
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR-- 637 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~-- 637 (681)
+||||+++++++.+++.+|+||||++||+|.+++...+ .+++..+..++.||+.||+|||+++|+||||||+|||+.
T Consensus 65 ~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~ 143 (307)
T d1a06a_ 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL 143 (307)
T ss_dssp CCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred CCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc
Confidence 99999999999999999999999999999999998754 599999999999999999999999999999999999995
Q ss_pred -cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 -EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 -~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++|.+ +|||+|+...... ......||+.|||||++.+.+|
T Consensus 144 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~ 186 (307)
T d1a06a_ 144 DEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPY 186 (307)
T ss_dssp STTCCEEECCC---------------------CTTSCHHHHTTCCC
T ss_pred CCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCC
Confidence 46666 9999998765432 2234679999999999988876
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-34 Score=299.67 Aligned_cols=179 Identities=27% Similarity=0.391 Sum_probs=139.4
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCe---EEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGE---VMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~---~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
+..++|++.++||+|+||.||+|+++.+++ .||+|.+... .....+.|.+ |
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~-------------------------E 77 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLS-------------------------E 77 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHH-------------------------H
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHH-------------------------H
Confidence 445789999999999999999999987665 5888887553 3334444544 4
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
+++|+.++|||||+++|++.+++.+|+||||+++|+|.+++......+++.++..++.||+.||.|||+++|+||||||+
T Consensus 78 ~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~ 157 (299)
T d1jpaa_ 78 ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAAR 157 (299)
T ss_dssp HHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred HHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccc
Confidence 99999999999999999999999999999999999999999887667999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeeccccee---eeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTL---FILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~---~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||||+.++.+ +|||+|+.......... .....+|+.|||||++.+..|
T Consensus 158 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 210 (299)
T d1jpaa_ 158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 210 (299)
T ss_dssp GEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCC
T ss_pred eEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCC
Confidence 9999999988 99999998765332221 122347899999999987765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.7e-34 Score=299.28 Aligned_cols=165 Identities=26% Similarity=0.347 Sum_probs=143.7
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.|+..+.||+|+||.||+|+++.+|+.||||++...... ..+.+ .+|+.+|+
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~-------------------------~~Ei~il~ 70 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI-------------------------IKEVRFLQ 70 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHH-------------------------HHHHHHHT
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHH-------------------------HHHHHHHH
Confidence 388899999999999999999999999999998764322 22223 34599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++|||||++++++.+++.+|+||||+++|+|..++... .++++..+..++.||+.||.|||++|||||||||+||||+
T Consensus 71 ~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~ 149 (309)
T d1u5ra_ 71 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 149 (309)
T ss_dssp TCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred HCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC
Confidence 999999999999999999999999999999998776554 4699999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
.+|.+ +|||+|+..... ....||+.|||||++.+
T Consensus 150 ~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 150 EPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILA 185 (309)
T ss_dssp TTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHTT
T ss_pred CCCCEEEeecccccccCCC------CccccCccccCHHHHhc
Confidence 99988 999999865432 23569999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-34 Score=303.37 Aligned_cols=183 Identities=24% Similarity=0.342 Sum_probs=151.4
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcCCCe-----EEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGE-----VMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINN 546 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~-----~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~ 546 (681)
..+.++.++|+++++||+|+||+||+|+++.+++ .||+|.+.... ......+
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------- 87 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL---------------------- 87 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHH----------------------
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHH----------------------
Confidence 4466788999999999999999999999876554 68999885432 2222223
Q ss_pred ccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC----------------------CCCCHH
Q psy5063 547 LHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG----------------------QPLPWG 603 (681)
Q Consensus 547 ~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~----------------------~~l~~~ 603 (681)
.+|+.+|+.+ +|||||++++++.+.+.+|+||||+++|+|.++|.... ..+++.
T Consensus 88 ---~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 164 (325)
T d1rjba_ 88 ---MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 164 (325)
T ss_dssp ---HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHH
T ss_pred ---HHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHH
Confidence 3458899888 89999999999999999999999999999999997542 248899
Q ss_pred HHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 604 QRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 604 ~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.++.||+.||.|||+++||||||||+|||++.++.+ +|||+|+...............||+.|||||++.+..|
T Consensus 165 ~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 243 (325)
T d1rjba_ 165 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 243 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC
Confidence 999999999999999999999999999999999999988 99999998765554444445568999999999987665
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-33 Score=292.14 Aligned_cols=180 Identities=29% Similarity=0.418 Sum_probs=143.8
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCC----eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETG----EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg----~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
.+..++|+..++||+|+||.||+|.++.++ ..||||.+.... ......+.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~------------------------ 58 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG------------------------ 58 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHH------------------------
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHH------------------------
Confidence 355678999999999999999999987655 479999986533 333334444
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+++|+.++|||||+++|++.+.+.+++||||+.+|++.+++......+++.++..++.||+.||+|||+++|+|||||
T Consensus 59 -E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlK 137 (283)
T d1mqba_ 59 -EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLA 137 (283)
T ss_dssp -HHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred -HHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccc
Confidence 4999999999999999999999999999999999999999988766679999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+||||+.++.+ +|||+|+......... ......||+.|||||++.+..|
T Consensus 138 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~ 190 (283)
T d1mqba_ 138 ARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190 (283)
T ss_dssp GGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC
T ss_pred cceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCC
Confidence 999999999988 9999999876433222 2223458999999999988765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-33 Score=293.66 Aligned_cols=178 Identities=24% Similarity=0.328 Sum_probs=148.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|++++.||+|+||+||+|+++.+|+.||+|.+.+........ ......+.+|+++|+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~-------------------~~~~~~~~~E~~il~~l 70 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRR-------------------GVSREDIEREVSILKEI 70 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSS-------------------SBCHHHHHHHHHHHHHC
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhh-------------------hHHHHHHHHHHHHHHhC
Confidence 46999999999999999999999999999999986532111000 00001234569999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|||||++++++.+++.+|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||+|||++.+
T Consensus 71 ~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~ 149 (293)
T d1jksa_ 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDR 149 (293)
T ss_dssp CCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS
T ss_pred CCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecC
Confidence 99999999999999999999999999999999997654 59999999999999999999999999999999999999988
Q ss_pred CC----e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GS----G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~----~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|. + +|||+|+...... ......+|+.|||||++.+..|
T Consensus 150 ~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~ 193 (293)
T d1jksa_ 150 NVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPL 193 (293)
T ss_dssp SSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCB
T ss_pred CCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCC
Confidence 74 4 9999998765332 2234568999999999988765
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-33 Score=293.03 Aligned_cols=179 Identities=24% Similarity=0.380 Sum_probs=147.2
Q ss_pred eecCCCeeecce-ecccCcEEEEEEEEcC--CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 476 IFRASDLVRGPL-LGQGFFGQVYRVTHRE--TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 476 ~~~~~d~~~~~~-LG~G~FG~Vyk~~~~~--tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
.+..++|...+. ||+|+||.||+|.++. ++..||||.+.+.. ....+.+.+
T Consensus 4 ~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~------------------------- 58 (285)
T d1u59a_ 4 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR------------------------- 58 (285)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHH-------------------------
T ss_pred eecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHH-------------------------
Confidence 455678888885 9999999999998764 35589999986543 333444444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
|+++|+.++|||||+++|++.+ +.+|+||||+++|+|.+++......+++..+..++.||+.||+|||+++|+||||||
T Consensus 59 E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp 137 (285)
T d1u59a_ 59 EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAA 137 (285)
T ss_dssp HHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCch
Confidence 4999999999999999999864 568999999999999999877666799999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeeccccee-eeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTL-FILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~-~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+||||+.++.+ +|||+|+.......... .....||+.|||||++.+..|
T Consensus 138 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 189 (285)
T d1u59a_ 138 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189 (285)
T ss_dssp GGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred hheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCC
Confidence 99999999988 99999998764332222 223458899999999876554
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-34 Score=293.04 Aligned_cols=180 Identities=26% Similarity=0.379 Sum_probs=149.2
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
...+.+..++|++++.||+|+||.||+|+++ +++.||||++..... ..+.+.+
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~-~~~~~~~------------------------- 57 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM-SPDAFLA------------------------- 57 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS-CHHHHHH-------------------------
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC-CHHHHHH-------------------------
Confidence 4556677889999999999999999999986 578899999865332 2233444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+++|+.++|||||+++|++. ++.+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+|||||
T Consensus 58 E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiK 136 (272)
T d1qpca_ 58 EANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLR 136 (272)
T ss_dssp HHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccc
Confidence 599999999999999999875 467899999999999999876532 358999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+||||++++.+ +|||+|+...... ........||+.|||||++.+..|
T Consensus 137 p~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~ 187 (272)
T d1qpca_ 137 AANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTF 187 (272)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEE
T ss_pred hhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCC
Confidence 999999999988 9999999875432 222234568999999999976654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-33 Score=301.82 Aligned_cols=174 Identities=25% Similarity=0.355 Sum_probs=150.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|++.+.||+|+||.||+|+++.+|+.||+|++.+........ ...+.+|+.+|+.
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~----------------------~~~~~~E~~il~~ 97 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ----------------------IEHTLNEKRILQA 97 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTC----------------------HHHHHHHHHHHTT
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHH----------------------HHHHHHHHHHHHH
Confidence 468999999999999999999999999999999986432111100 0123467999999
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++.+...+++||||+.+|+|.+++...+ .+++..+..++.||+.||.|||+++||||||||+||||+.
T Consensus 98 l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~ 176 (350)
T d1rdqe_ 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ 176 (350)
T ss_dssp CCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred cCCCcEeecccccccccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCC
Confidence 999999999999999999999999999999999997654 5999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|.+ +|||+|+..... .....||+.|||||++.+..|
T Consensus 177 ~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~ 215 (350)
T d1rdqe_ 177 QGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGY 215 (350)
T ss_dssp TSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCB
T ss_pred CCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCC
Confidence 9998 999999976532 223569999999999998876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-33 Score=288.00 Aligned_cols=167 Identities=26% Similarity=0.363 Sum_probs=140.2
Q ss_pred eeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 482 LVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 482 ~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
|+..+.||+|+||+||+|++..+++.||+|.+... .....+.+. +|+++|+.+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~-------------------------~E~~il~~l 65 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK-------------------------EEAEMLKGL 65 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHH-------------------------HHHHHHTTC
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHH-------------------------HHHHHHHhC
Confidence 35667899999999999999999999999998653 233333333 459999999
Q ss_pred CCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCc
Q psy5063 560 HHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMN--LIHRDLNSQN 633 (681)
Q Consensus 560 ~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~--IIHRDLKp~N 633 (681)
+|||||++++++.+ +..+|+||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|
T Consensus 66 ~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~N 144 (270)
T d1t4ha_ 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 144 (270)
T ss_dssp CCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGG
T ss_pred CCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhh
Confidence 99999999999875 456899999999999999997643 5999999999999999999999998 9999999999
Q ss_pred EEEe-cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 634 CLVR-EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 634 ILl~-~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
||++ +++.+ +|||+|+...... .....||+.|||||++.+.
T Consensus 145 ILl~~~~~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~~ 188 (270)
T d1t4ha_ 145 IFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEEK 188 (270)
T ss_dssp EEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGTC
T ss_pred ceeeCCCCCEEEeecCcceeccCCc----cCCcccCccccCHHHhCCC
Confidence 9997 46777 9999998644322 2346799999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-33 Score=292.94 Aligned_cols=172 Identities=17% Similarity=0.247 Sum_probs=149.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|++++.||+|+||+||+|+++.+|+.||+|.+....... ..+ .+|+++|+.+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~-~~~-------------------------~~Ei~il~~l 58 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLV-------------------------KKEISILNIA 58 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH-HHH-------------------------HHHHHHHHHS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH-HHH-------------------------HHHHHHHHhC
Confidence 67999999999999999999999999999999997654322 222 2459999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+||||++++++|.+++.+|+||||++||+|.+++...+..+++.++..++.||+.||+|||++||+||||||+|||++.+
T Consensus 59 ~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~ 138 (321)
T d1tkia_ 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR 138 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred CCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCC
Confidence 99999999999999999999999999999999998766679999999999999999999999999999999999999876
Q ss_pred C--Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 G--SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g--~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+ .+ +|||+++...... ......+|+.|||||++.+..|
T Consensus 139 ~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~ 180 (321)
T d1tkia_ 139 RSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVV 180 (321)
T ss_dssp SCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEE
T ss_pred CceEEEEcccchhhccccCC---cccccccccccccchhccCCCC
Confidence 5 44 8999998765432 2344668999999999987765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.8e-33 Score=300.97 Aligned_cols=174 Identities=22% Similarity=0.296 Sum_probs=148.4
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH---HHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE---AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~---~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
..++|++.++||+|+||.||+|+++.+|+.||+|.+.+.... ....+.+| ..|+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e----------------------~~~~~ 59 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE----------------------RIMLS 59 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHH----------------------HHHHH
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHH----------------------HHHHH
Confidence 468999999999999999999999999999999998643211 11222222 23477
Q ss_pred HHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 555 VLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
+++.++|||||++++++.+++.+|+||||++||+|.+++.... .+++..+..++.||+.||+|||+++||||||||+||
T Consensus 60 ~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NI 138 (364)
T d1omwa3 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138 (364)
T ss_dssp HHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeecccee
Confidence 8888999999999999999999999999999999999997654 589999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|++.+|.+ +|||+|+...... .....||+.|||||++.+.
T Consensus 139 Ll~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~ 180 (364)
T d1omwa3 139 LLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKG 180 (364)
T ss_dssp EECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTT
T ss_pred EEcCCCcEEEeeeceeeecCCCc----ccccccccccchhHHhhcC
Confidence 99999988 9999999765432 2345699999999999643
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=4.7e-33 Score=285.35 Aligned_cols=175 Identities=29% Similarity=0.424 Sum_probs=151.4
Q ss_pred cCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
..+||++++.||+|+||.||+|+++ +++.||||++++.... .+.+.+ |+++|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~-~~~~~~-------------------------Ev~~~~ 54 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS-EDEFIE-------------------------EAKVMM 54 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC-HHHHHH-------------------------HHHHHH
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC-HHHHHH-------------------------HHHHHH
Confidence 4579999999999999999999985 6889999998764332 234444 499999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||++++|++.+++.+++||||+++|+|.+++......+++..+..++.|+++||.|||+++|+||||||+|||++
T Consensus 55 ~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~ 134 (258)
T d1k2pa_ 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 134 (258)
T ss_dssp TCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC
T ss_pred hcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc
Confidence 99999999999999999999999999999999999887666799999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+++.+ +|||+++...... ........+|+.|||||++.+..|
T Consensus 135 ~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~ 178 (258)
T d1k2pa_ 135 DQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKF 178 (258)
T ss_dssp TTCCEEECCCSSCCBCSSSS-CCCCCCSCCCGGGCCHHHHHHCCC
T ss_pred CCCcEEECcchhheeccCCC-ceeecccCCCCCcCCcHHhcCCCC
Confidence 99998 9999998765433 223334668999999999987765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.2e-33 Score=293.74 Aligned_cols=176 Identities=22% Similarity=0.326 Sum_probs=147.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH-Hh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL-RS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL-~~ 558 (681)
++|+++++||+|+||+||+|+++.+|+.||+|++.+......... ....+|+.+| +.
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~----------------------~~~~~e~~~l~~~ 59 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV----------------------ECTMVEKRVLSLA 59 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCH----------------------HHHHHHHHHHHHH
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHH----------------------HHHHHHHHHHHHh
Confidence 689999999999999999999999999999999965321111000 0113345555 47
Q ss_pred CCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 559 LHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
++||||+++++++.+++.+|+||||+++|+|.+++.... .+++.++..++.||+.||+|||+++|+||||||+|||+++
T Consensus 60 ~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~ 138 (320)
T d1xjda_ 60 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 138 (320)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecC
Confidence 899999999999999999999999999999999997654 5999999999999999999999999999999999999999
Q ss_pred CCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 639 VGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|.+ +|||+|+...... .......||+.|||||++.+..|
T Consensus 139 ~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~ 180 (320)
T d1xjda_ 139 DGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKY 180 (320)
T ss_dssp TSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCB
T ss_pred CCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCC
Confidence 9988 9999998665432 22334579999999999998876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=5.1e-33 Score=293.02 Aligned_cols=180 Identities=25% Similarity=0.364 Sum_probs=144.3
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCe----EEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGE----VMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~----~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
++++.+||+..++||+|+||.||+|++..+|+ .||+|.+.... ....+.+.
T Consensus 4 ~~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~------------------------ 59 (317)
T d1xkka_ 4 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEIL------------------------ 59 (317)
T ss_dssp EECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHH------------------------
T ss_pred ccCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHH------------------------
Confidence 46677899999999999999999999988876 47778775422 22233344
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
+|+++|+.++|||||+++|++.+ +..+++|||+.+|+|.+++......+++..+..++.||+.||+|||+++||||||
T Consensus 60 -~E~~~l~~l~HpnIv~l~g~~~~-~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDl 137 (317)
T d1xkka_ 60 -DEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 137 (317)
T ss_dssp -HHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred -HHHHHHHhCCCCCEeeEEEEEec-CCeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcc
Confidence 45999999999999999999976 4678889999999999998877777999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+||||+.++.+ +|||+|+...............||+.|||||++.+..|
T Consensus 138 Kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 190 (317)
T d1xkka_ 138 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190 (317)
T ss_dssp CGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCC
T ss_pred hhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCC
Confidence 9999999999988 99999987654443333344568999999999987765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.98 E-value=1.3e-32 Score=284.03 Aligned_cols=176 Identities=18% Similarity=0.227 Sum_probs=141.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.++|++.+.||+|+||.||+|++..+|+.||+|++.+.. ......+. +|+.+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~-------------------------~E~~~ 60 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR-------------------------REAQN 60 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHH-------------------------HHHHH
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHH-------------------------HHHHH
Confidence 357999999999999999999999999999999996532 22233333 45999
Q ss_pred HHhCCCCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 556 LRSLHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 556 L~~L~HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
|+.++||||+++++++..++ .+|+||||++||+|.+++...+ .+++.++..++.||+.||+|||++||+||||||
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP 139 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 139 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHhCCccCccccC
Confidence 99999999999999997653 4899999999999999987654 599999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeeccc-ceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVP-YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~-~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.++.. +|||+++....... ........||+.|||||++.+..|
T Consensus 140 ~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~ 191 (277)
T d1o6ya_ 140 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 191 (277)
T ss_dssp GGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCC
T ss_pred cccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCC
Confidence 99999999988 89999887654321 223334569999999999988776
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=2.1e-32 Score=283.46 Aligned_cols=174 Identities=21% Similarity=0.252 Sum_probs=149.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH-----HHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE-----AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~-----~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
.++|++.+.||+|+||+||+|+++.+|+.||+|++.+.... ..+... + .+.+|+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~-~--------------------~~~~E~ 60 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELR-E--------------------ATLKEV 60 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHH-H--------------------HHHHHH
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHH-H--------------------HHHHHH
Confidence 46899999999999999999999999999999999764321 111111 1 235679
Q ss_pred HHHHhCC-CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 554 AVLRSLH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 554 ~iL~~L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
.+|+.++ ||||+++++++.+++.+||||||+++|+|.+++...+ ++++.++..++.||+.||+|||++||+||||||+
T Consensus 61 ~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~ 139 (277)
T d1phka_ 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 139 (277)
T ss_dssp HHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 9999996 9999999999999999999999999999999997654 6999999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKK 677 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~ 677 (681)
|||++.++.+ +|||+++....... .....||+.|+|||++.+
T Consensus 140 Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~ 183 (277)
T d1phka_ 140 NILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIEC 183 (277)
T ss_dssp GEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHH
T ss_pred eEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhc
Confidence 9999999988 99999998754322 233569999999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-32 Score=284.74 Aligned_cols=168 Identities=24% Similarity=0.323 Sum_probs=135.9
Q ss_pred ceecccCcEEEEEEEEcC--CCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCC
Q psy5063 486 PLLGQGFFGQVYRVTHRE--TGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHH 561 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~--tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H 561 (681)
+.||+|+||.||+|.++. +++.||+|++.... ....+.+. +|+++|+.++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~-------------------------~E~~il~~l~H 67 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL-------------------------AEANVMQQLDN 67 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHH-------------------------HHHHHHHTCCC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHH-------------------------HHHHHHHhCCC
Confidence 479999999999998753 45789999985432 22233333 45999999999
Q ss_pred CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCC
Q psy5063 562 HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGS 641 (681)
Q Consensus 562 pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~ 641 (681)
||||+++|++.+ +..+|||||+++|+|.+++.... .+++..+..++.||+.||+|||+++||||||||+||||+.+|.
T Consensus 68 pnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~ 145 (277)
T d1xbba_ 68 PYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY 145 (277)
T ss_dssp TTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE
T ss_pred CCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc
Confidence 999999999864 56789999999999999998654 5999999999999999999999999999999999999999998
Q ss_pred e--EEeeeeeEeeecccce-eeeecCCCccccchhhccCCCC
Q psy5063 642 G--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 642 ~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+ +|||+|+......... ......||+.|||||++.+..|
T Consensus 146 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 187 (277)
T d1xbba_ 146 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187 (277)
T ss_dssp EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEE
T ss_pred ccccchhhhhhccccccccccccccCCCceecCchhhcCCCC
Confidence 8 9999999876443222 2233468999999999876554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-32 Score=283.85 Aligned_cols=179 Identities=20% Similarity=0.304 Sum_probs=138.5
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCC---eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccch
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETG---EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCF 550 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg---~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~ 550 (681)
+.+..++|++++.||+|+||.||+|++..++ ..||+|.+.... ....+.+.+
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~------------------------ 57 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ------------------------ 57 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHH------------------------
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHH------------------------
Confidence 4566789999999999999999999987543 568888885433 333334444
Q ss_pred HHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 551 SQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 551 ~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+.+|+.++||||++++|++. ++.+|+||||+++|+|.+++......+++..+..++.||+.||.|||+++|||||||
T Consensus 58 -E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlK 135 (273)
T d1mp8a_ 58 -EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 135 (273)
T ss_dssp -HHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred -HHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccc
Confidence 499999999999999999985 568999999999999999987766679999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.++.+ +|||+|+....... .......||+.|||||++.+..|
T Consensus 136 p~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~ 186 (273)
T d1mp8a_ 136 ARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRF 186 (273)
T ss_dssp GGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCC
T ss_pred hhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCC
Confidence 999999999988 99999987654332 22334568899999999987665
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.4e-33 Score=288.84 Aligned_cols=173 Identities=21% Similarity=0.337 Sum_probs=139.4
Q ss_pred ecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCCCCc
Q psy5063 484 RGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLHHHN 563 (681)
Q Consensus 484 ~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hpn 563 (681)
.+++||+|+||+||+|+++.+|+.||||++........+... ...+.+|+.+|+.++|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~--------------------~~~~~~Ei~il~~l~hpn 61 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--------------------NRTALREIKLLQELSHPN 61 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC--------------------------------CTHHHHHHHHHHHCCCTT
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHH--------------------HHHHHHHHHHHHhCCCCC
Confidence 467899999999999999999999999998543221111100 112457799999999999
Q ss_pred eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe-
Q psy5063 564 VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG- 642 (681)
Q Consensus 564 IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~- 642 (681)
||++++++.+++.+|+||||++++++..+... ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+
T Consensus 62 Iv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~K 140 (299)
T d1ua2a_ 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLK 140 (299)
T ss_dssp BCCEEEEECCTTCCEEEEECCSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred EeEEEeeeccCCceeehhhhhcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccc
Confidence 99999999999999999999998877766654 4569999999999999999999999999999999999999999998
Q ss_pred -EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 643 -FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 643 -~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
+|||+|+...... .......||+.|||||++.+..
T Consensus 141 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~ 176 (299)
T d1ua2a_ 141 LADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGAR 176 (299)
T ss_dssp ECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCS
T ss_pred cccCccccccCCCc--ccccceecChhhccHHHHccCC
Confidence 9999998655332 2223456999999999987553
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.2e-32 Score=285.18 Aligned_cols=183 Identities=25% Similarity=0.325 Sum_probs=140.8
Q ss_pred ccceecCCCeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccc
Q psy5063 473 KSRIFRASDLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINN 546 (681)
Q Consensus 473 ~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~ 546 (681)
..+.+..++|++++.||+|+||.||+|++.. +++.||+|++.... ....+.+.+|
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e------------------- 66 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE------------------- 66 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHH-------------------
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHH-------------------
Confidence 3455777899999999999999999999764 34789999986432 3333334443
Q ss_pred ccchHHHHHHHhC-CCCceeeEEEEEEeC-CeEEEEEeccCCCCHHHHHhCC---------------CCCCCHHHHHHHH
Q psy5063 547 LHCFSQVAVLRSL-HHHNVIRFIGVLYKD-RKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFA 609 (681)
Q Consensus 547 ~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~-~~l~LV~Ey~~gGsL~~~L~~~---------------~~~l~~~~~~~i~ 609 (681)
+..+..+ +|+||+.+++++..+ ..+++||||+++|+|.+++... ...+++.++..++
T Consensus 67 ------~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (299)
T d1ywna1 67 ------LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140 (299)
T ss_dssp ------HHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHH
T ss_pred ------HHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHH
Confidence 5666655 799999999998764 5689999999999999998642 2348899999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 610 RDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 610 ~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.||+.||.|||+++||||||||+||||+.++.+ +|||+|+...............||+.|||||++.+..|
T Consensus 141 ~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 141 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence 999999999999999999999999999999998 99999998765444444445679999999999987765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.3e-32 Score=286.21 Aligned_cols=180 Identities=29% Similarity=0.399 Sum_probs=143.2
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchH
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFS 551 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~ 551 (681)
..++.+..++|++++.||+|+||+||+|+++.+ +.||||++..... ..+.|.+
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~-~~~~~~~------------------------- 61 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQ------------------------- 61 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS-CHHHHHH-------------------------
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC-CHHHHHH-------------------------
Confidence 345567778999999999999999999999765 5699999864332 2234444
Q ss_pred HHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 552 QVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-GQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 552 Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
|+.+|+.++|||||+++|++. ++..|+||||+++|+|..++... ...+++.++..++.||+.||.|||+++|+|||||
T Consensus 62 E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlK 140 (285)
T d1fmka3 62 EAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLR 140 (285)
T ss_dssp HHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheeccccc
Confidence 499999999999999999985 56689999999999999888643 2459999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+||||++++.+ +|||+|+...... ........+|+.|||||++.+..|
T Consensus 141 p~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~ 191 (285)
T d1fmka3 141 AANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRF 191 (285)
T ss_dssp GGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCC
T ss_pred ceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCCC
Confidence 999999999988 9999998765432 222334568999999999977655
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.7e-32 Score=282.91 Aligned_cols=176 Identities=24% Similarity=0.412 Sum_probs=144.7
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
++|+..+.||+|+||.||+|+++.+|+.||+|++....... .. ...+.+|+++|+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~---------------------~~~~~~Ei~il~~l 58 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE--GV---------------------PSTAIREISLLKEL 58 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------C---------------------CHHHHHHHHHHTTC
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcCh--HH---------------------HHHHHHHHHHHHhC
Confidence 68999999999999999999999999999999985432110 00 01234579999999
Q ss_pred CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 560 HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
+|||||++++++.+++.+|+||||+.++.+..........+++..+..++.||+.||+|||++|||||||||+|||++.+
T Consensus 59 ~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~ 138 (298)
T d1gz8a_ 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 138 (298)
T ss_dssp CCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeeccc
Confidence 99999999999999999999999997655554445555679999999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.. +|||+|+...... .......||+.|+|||++....|
T Consensus 139 ~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~ 179 (298)
T d1gz8a_ 139 GAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKY 179 (298)
T ss_dssp SCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSS
T ss_pred CcceeccCCcceeccCCc--ccceeecccceeeehhhhccccC
Confidence 987 9999998664322 22234569999999999887765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=3.7e-32 Score=284.23 Aligned_cols=181 Identities=25% Similarity=0.398 Sum_probs=150.7
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCcccccc
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLH 548 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~ 548 (681)
..++.++|++.+.||+|+||.||+|+++ .+++.||||++.... ....+.+.+
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~---------------------- 65 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---------------------- 65 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHH----------------------
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHH----------------------
Confidence 4466789999999999999999999986 356899999986533 333344444
Q ss_pred chHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC-----------------------CCCCCHHHH
Q psy5063 549 CFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP-----------------------GQPLPWGQR 605 (681)
Q Consensus 549 ~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~-----------------------~~~l~~~~~ 605 (681)
|+++|+.++||||+++++++.+.+..++||||+++|+|.+++... ...+++..+
T Consensus 66 ---E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 142 (301)
T d1lufa_ 66 ---EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ 142 (301)
T ss_dssp ---HHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHH
T ss_pred ---HHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHH
Confidence 599999999999999999999999999999999999999998532 124889999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 606 VNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 606 ~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
..++.|++.||+|||+++||||||||+||||+.++.+ +|||+|+...............+|+.|||||++.+..|
T Consensus 143 ~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 219 (301)
T d1lufa_ 143 LCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY 219 (301)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC
Confidence 9999999999999999999999999999999999988 99999987655444444445678999999999987765
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-31 Score=285.13 Aligned_cols=168 Identities=24% Similarity=0.333 Sum_probs=141.1
Q ss_pred CCeeec-ceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH-
Q psy5063 480 SDLVRG-PLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR- 557 (681)
Q Consensus 480 ~d~~~~-~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~- 557 (681)
++|.+. ++||+|+||.||+|+++.+++.||||++.+.. .+. +|++++.
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-----~~~-------------------------~E~~~~~~ 60 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KAR-------------------------REVELHWR 60 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH-----HHH-------------------------HHHHHHHH
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH-----HHH-------------------------HHHHHHHH
Confidence 578775 57999999999999999999999999986431 122 3477754
Q ss_pred hCCCCceeeEEEEEEe----CCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 558 SLHHHNVIRFIGVLYK----DRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~----~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
..+|||||+++++|.+ +..+|+|||||+||+|.+++...+ ..+++.++..++.||+.||+|||++||+||||||+
T Consensus 61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~ 140 (335)
T d2ozaa1 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 140 (335)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 5589999999999975 467999999999999999998653 46999999999999999999999999999999999
Q ss_pred cEEEecCC---Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVG---SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g---~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||++.++ .+ +|||+|+...... ......||+.|||||++.+.+|
T Consensus 141 NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y 190 (335)
T d2ozaa1 141 NLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKY 190 (335)
T ss_dssp GEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGG
T ss_pred ccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCC
Confidence 99998743 34 9999998776433 2334679999999999988766
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.3e-32 Score=281.85 Aligned_cols=184 Identities=28% Similarity=0.355 Sum_probs=149.1
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcCCC-------eEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRETG-------EVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGL 543 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg-------~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~ 543 (681)
.+.+.+..++|++++.||+|+||.||+|++..++ ..||+|++.+.. ......+..
T Consensus 5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~----------------- 67 (299)
T d1fgka_ 5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLIS----------------- 67 (299)
T ss_dssp CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHH-----------------
T ss_pred CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHH-----------------
Confidence 4557788899999999999999999999987654 479999986533 223333433
Q ss_pred cccccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC---------------CCCCHHHHHH
Q psy5063 544 INNLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG---------------QPLPWGQRVN 607 (681)
Q Consensus 544 ~~~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~---------------~~l~~~~~~~ 607 (681)
|...+..+ +|||||++++++.+++.+++||||+++|+|.+++.... ..+++..++.
T Consensus 68 --------e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 139 (299)
T d1fgka_ 68 --------EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139 (299)
T ss_dssp --------HHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHH
T ss_pred --------HHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHH
Confidence 47777777 89999999999999999999999999999999996542 3589999999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 608 i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.||+.||+|||+++||||||||+|||++.++.. +|||+++...............+|+.|||||++.+.+|
T Consensus 140 ~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y 214 (299)
T d1fgka_ 140 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 214 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC
T ss_pred HHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC
Confidence 99999999999999999999999999999999988 99999998766544444445668999999999987766
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.3e-32 Score=280.86 Aligned_cols=178 Identities=21% Similarity=0.286 Sum_probs=146.8
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|+++++||+|+||.||+|++..+|+.||+|++.+..... .........+.+|+.+|+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-------------------~~~~~~~~~~~~E~~il~~ 63 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD-------------------WGELPNGTRVPMEVVLLKK 63 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCC-------------------EEECTTCCEEEHHHHHHHH
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccc-------------------hhhhhHHHHHHHHHHHHHH
Confidence 367999999999999999999999999999999986421100 0001112345688999999
Q ss_pred CC--CCceeeEEEEEEeCCeEEEEEeccCC-CCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 559 LH--HHNVIRFIGVLYKDRKLNLVTEYIAG-GTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L~--HpnIV~l~g~~~~~~~l~LV~Ey~~g-GsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
++ ||||+++++++.+++..|+||||+.+ +++.+++.... .+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 64 l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIl 142 (273)
T d1xwsa_ 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENIL 142 (273)
T ss_dssp HCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred hccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceE
Confidence 86 89999999999999999999999976 68888887543 5999999999999999999999999999999999999
Q ss_pred EecC-CCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 636 VREV-GSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 636 l~~~-g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.+ +.+ +|||+|+..... ......||+.|||||++.+..|
T Consensus 143 l~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~ 186 (273)
T d1xwsa_ 143 IDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRY 186 (273)
T ss_dssp EETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCB
T ss_pred EecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCC
Confidence 9965 555 999999875432 2334679999999999987655
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.1e-31 Score=281.97 Aligned_cols=184 Identities=24% Similarity=0.323 Sum_probs=154.4
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEc-----CCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHR-----ETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~-----~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
...|.+..++|+++++||+|+||.||+|++. .+++.||||++.... ......+.+
T Consensus 15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~------------------- 75 (311)
T d1t46a_ 15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS------------------- 75 (311)
T ss_dssp CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHH-------------------
T ss_pred cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHH-------------------
Confidence 3456788899999999999999999999864 466799999997543 223333444
Q ss_pred cccchHHHHHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCC-----------------CCCCHHHHHH
Q psy5063 546 NLHCFSQVAVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPG-----------------QPLPWGQRVN 607 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~-----------------~~l~~~~~~~ 607 (681)
|+.+++.+ +|||||+++|++.+++..++||||+++|+|.+++.... ..+++..+..
T Consensus 76 ------E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 149 (311)
T d1t46a_ 76 ------ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149 (311)
T ss_dssp ------HHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred ------HHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHH
Confidence 48899988 79999999999999999999999999999999986422 2588999999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 608 FARDIAAGMTYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 608 i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
++.||+.||.|||+++||||||||+|||++.++.+ +|||+++...............||+.|||||++.+..|
T Consensus 150 ~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 224 (311)
T d1t46a_ 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (311)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC
Confidence 99999999999999999999999999999999988 99999998765444444445668999999999976554
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.1e-31 Score=278.27 Aligned_cols=176 Identities=28% Similarity=0.437 Sum_probs=144.5
Q ss_pred ecCCCeeecceecccCcEEEEEEEEcCCCeE--EEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHH
Q psy5063 477 FRASDLVRGPLLGQGFFGQVYRVTHRETGEV--MVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQV 553 (681)
Q Consensus 477 ~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~--vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei 553 (681)
+..++|+++++||+|+||.||+|+++.+|.. ||||.+.... ....+.+ .+|+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~-------------------------~~E~ 61 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-------------------------AGEL 61 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHH-------------------------HHHH
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHH-------------------------HHHH
Confidence 4457899999999999999999999988874 6777765432 2222233 3459
Q ss_pred HHHHhC-CCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------------CCCCCHHHHHHHHHHHHHHHH
Q psy5063 554 AVLRSL-HHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------------GQPLPWGQRVNFARDIAAGMT 617 (681)
Q Consensus 554 ~iL~~L-~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------------~~~l~~~~~~~i~~QIa~gL~ 617 (681)
++|+.+ +|||||+++|++.+++.+|+||||+++|+|.++|... ...+++..+..++.||+.||.
T Consensus 62 ~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~ 141 (309)
T d1fvra_ 62 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 141 (309)
T ss_dssp HHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHH
T ss_pred HHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHH
Confidence 999998 7999999999999999999999999999999999643 346999999999999999999
Q ss_pred HHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 618 YLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 618 yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||+++|+||||||+|||++.++.+ +|||+|+....... .....||..|+|||.+.+..|
T Consensus 142 ~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~ 203 (309)
T d1fvra_ 142 YLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY 203 (309)
T ss_dssp HHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEE
T ss_pred hhhcCCccccccccceEEEcCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCC
Confidence 9999999999999999999999988 99999986554322 123558999999999987665
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=280.04 Aligned_cols=184 Identities=24% Similarity=0.369 Sum_probs=153.6
Q ss_pred cccceecCCCeeecceecccCcEEEEEEEEcC-----CCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccc
Q psy5063 472 SKSRIFRASDLVRGPLLGQGFFGQVYRVTHRE-----TGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLIN 545 (681)
Q Consensus 472 ~~~~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~-----tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~ 545 (681)
...|++..++|++++.||+|+||.||+|+++. +++.||||++.+.. ......+.+
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~------------------- 72 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN------------------- 72 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHH-------------------
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHH-------------------
Confidence 34577888999999999999999999999863 35789999986543 233333444
Q ss_pred cccchHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCC---------CCCCCHHHHHHHHHHHHHHH
Q psy5063 546 NLHCFSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDP---------GQPLPWGQRVNFARDIAAGM 616 (681)
Q Consensus 546 ~~~~~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~---------~~~l~~~~~~~i~~QIa~gL 616 (681)
|+.+|+.++||||++++|++..++..++||||+++|+|.+++... ...+++..+..++.|+++||
T Consensus 73 ------E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl 146 (308)
T d1p4oa_ 73 ------EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146 (308)
T ss_dssp ------HHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHH
T ss_pred ------HHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHH
Confidence 599999999999999999999999999999999999999988531 23478999999999999999
Q ss_pred HHHHhCCccccCCCCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 617 TYLHSMNLIHRDLNSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 617 ~yLHs~~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.|||+++|+||||||+|||++.++.+ +|||+|+...............+|+.|||||.+.+..|
T Consensus 147 ~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~ 212 (308)
T d1p4oa_ 147 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF 212 (308)
T ss_dssp HHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC
T ss_pred HHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCC
Confidence 99999999999999999999999988 99999987765443333334458999999999987765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=273.83 Aligned_cols=172 Identities=28% Similarity=0.421 Sum_probs=138.5
Q ss_pred ceecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 475 RIFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 475 ~~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
|.+..+||++++.||+|+||.||+|+++ |..||+|++.+.. ..+.+.+ |++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~-------------------------E~~ 52 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLA-------------------------EAS 52 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHH-------------------------THH
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHH-------------------------HHH
Confidence 5677889999999999999999999985 7889999986533 2233444 499
Q ss_pred HHHhCCCCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 555 VLRSLHHHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPG-QPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 555 iL~~L~HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~~-~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
+|+.++||||++++|++.+ ++.+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+
T Consensus 53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~ 132 (262)
T d1byga_ 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 132 (262)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchH
Confidence 9999999999999999865 467899999999999999996532 35899999999999999999999999999999999
Q ss_pred cEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 633 NCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 633 NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|||++.+|.+ +|||+++...... ....+|..|||||++.+..|
T Consensus 133 Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~ 177 (262)
T d1byga_ 133 NVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKF 177 (262)
T ss_dssp GEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCC
T ss_pred hheecCCCCEeecccccceecCCCC-----ccccccccCCChHHHhCCCC
Confidence 9999999988 9999998765322 23457899999999977665
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=274.24 Aligned_cols=179 Identities=29% Similarity=0.348 Sum_probs=137.8
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCC-C--eEEEEEEeeccC---HHHHHHHHHHhhccceeeeccCCCCccccccc
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRET-G--EVMVLKELYRVD---EEAEKNFLKESKQGLIYLIDLGSHGLINNLHC 549 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~t-g--~~vAiK~l~~~~---~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~ 549 (681)
.+..+||++.+.||+|+||.||+|++..+ + ..||+|++.+.. .+..+.+.
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~------------------------ 59 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI------------------------ 59 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHH------------------------
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHH------------------------
Confidence 34567899999999999999999987533 3 368999886432 22223333
Q ss_pred hHHHHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 550 FSQVAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 550 ~~Ei~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
+|+.+|+.++||||++++|++.+ +.+++||||+++|+|.+++......+++..+..++.||+.||.|||+++|+||||
T Consensus 60 -~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDi 137 (273)
T d1u46a_ 60 -REVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 137 (273)
T ss_dssp -HHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred -HHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeee
Confidence 45999999999999999999965 5778999999999999988766667999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceee-eecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLF-ILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~-~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+||||+.++.+ +|||+++........... ....++..|||||++.+..|
T Consensus 138 kp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 191 (273)
T d1u46a_ 138 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191 (273)
T ss_dssp CGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred cHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCC
Confidence 9999999999988 999999987654332222 23346788999999977654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1e-30 Score=272.70 Aligned_cols=176 Identities=28% Similarity=0.400 Sum_probs=141.7
Q ss_pred CCCeeecceecccCcEEEEEEEEcCC-CeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRET-GEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~t-g~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
.++|++.+.||+|+||+||+|++..+ ++.||+|++........ ......+|+.+|+
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-----------------------~~~~~~~E~~~l~ 62 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-----------------------MPLSTIREVAVLR 62 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-----------------------CBCTHHHHHHHHH
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccch-----------------------HHHHHHHHHHHHH
Confidence 36899999999999999999999765 67899999864221100 0111234466555
Q ss_pred h---CCCCceeeEEEEEEe-----CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy5063 558 S---LHHHNVIRFIGVLYK-----DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDL 629 (681)
Q Consensus 558 ~---L~HpnIV~l~g~~~~-----~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDL 629 (681)
. ++||||++++++|.. ...++++|||+++|++..........+++..+..++.|++.||+|||+++||||||
T Consensus 63 ~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDi 142 (305)
T d1blxa_ 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 142 (305)
T ss_dssp HHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCC
Confidence 4 589999999999863 35789999999998887666666667999999999999999999999999999999
Q ss_pred CCCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 630 NSQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 630 Kp~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
||+|||++.+|.. +|||+++....... .....||+.|||||++.+.+|
T Consensus 143 Kp~NILi~~~~~~kl~dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y 192 (305)
T d1blxa_ 143 KPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSY 192 (305)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCC
T ss_pred CccEEEEcCCCCeeecchhhhhhhccccc---CCCcccChhhcCcchhcCCCC
Confidence 9999999999988 99999987654332 334679999999999988876
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-30 Score=270.59 Aligned_cols=169 Identities=27% Similarity=0.388 Sum_probs=138.8
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
.+|.+.+.||+|+||.||+|++ +|+.||||++.... .+.+..| +|+..++.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~---~~~~~~e-----------------------~ei~~~~~~ 54 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE---ERSWFRE-----------------------AEIYQTVML 54 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG---HHHHHHH-----------------------HHHHTSTTC
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc---hhHHHHH-----------------------HHHHHHhhC
Confidence 4688899999999999999987 48999999885432 2223333 246666778
Q ss_pred CCCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccc
Q psy5063 560 HHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS--------MNLIHR 627 (681)
Q Consensus 560 ~HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs--------~~IIHR 627 (681)
+||||+++++++.+++ .+|+||||+++|+|.+++++. .++|..+..++.|++.||+|||+ ++||||
T Consensus 55 ~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHr 132 (303)
T d1vjya_ 55 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp CCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred CCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecc
Confidence 9999999999998653 689999999999999999864 48999999999999999999996 599999
Q ss_pred CCCCCcEEEecCCCe--EEeeeeeEeeecccce--eeeecCCCccccchhhccCC
Q psy5063 628 DLNSQNCLVREVGSG--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 628 DLKp~NILl~~~g~~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~~ 678 (681)
||||+||||+.++.+ +|||+++......... ......||+.|||||++.+.
T Consensus 133 DlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (303)
T d1vjya_ 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred ccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhcccc
Confidence 999999999999998 9999999886543222 22345699999999998765
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.96 E-value=2.1e-30 Score=268.26 Aligned_cols=172 Identities=24% Similarity=0.357 Sum_probs=141.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHH--HHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEE--AEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~--~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|++.++||+|+||.||+|+++ +|+.||+|++...... ..+. +.+|+.+|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~-------------------------~~~E~~il~ 55 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPST-------------------------TIREISILK 55 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHH-------------------------HHHHHHGGG
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHH-------------------------HHHHHHHHH
Confidence 58999999999999999999986 7899999998654221 1222 245699999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++..++..+++|||+.++.+..+.... ..+++..+..++.||+.||+|||+++||||||||+|||++
T Consensus 56 ~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~ 134 (286)
T d1ob3a_ 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134 (286)
T ss_dssp GCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred hCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEc
Confidence 999999999999999999999999999887777666544 5699999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||+|....... .......+++.|+|||++.+..|
T Consensus 135 ~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~ 177 (286)
T d1ob3a_ 135 REGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKK 177 (286)
T ss_dssp TTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCS
T ss_pred CCCCEEecccccceecccCc--cccceecccchhhhHHHHhCCCC
Confidence 99998 9999998765322 22233458999999999977654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.96 E-value=4.6e-30 Score=270.81 Aligned_cols=166 Identities=22% Similarity=0.331 Sum_probs=140.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|++++.||+|+||+||+|+++.+|+.||+|++..... +.+. +|+++|+.
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~-------------------------~Ei~il~~ 85 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIK-------------------------REIKILEN 85 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH---HHHH-------------------------HHHHHHHH
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH---HHHH-------------------------HHHHHHHh
Confidence 4689999999999999999999999999999999865432 2223 45999999
Q ss_pred C-CCCceeeEEEEEEe--CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEE
Q psy5063 559 L-HHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCL 635 (681)
Q Consensus 559 L-~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NIL 635 (681)
+ +||||++++++|.. ...+++||||+++|+|..+.+ .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 86 l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL 161 (328)
T d3bqca1 86 LRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 161 (328)
T ss_dssp HTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc----CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence 9 49999999999974 357999999999999987643 4899999999999999999999999999999999999
Q ss_pred EecCCC-e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 636 VREVGS-G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 636 l~~~g~-~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
++.++. + +|||+|+....... .....+|+.|+|||++.+..
T Consensus 162 i~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~ 205 (328)
T d3bqca1 162 IDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQ 205 (328)
T ss_dssp EETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCC
T ss_pred EcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCC
Confidence 997765 4 99999987764332 23466899999999987654
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.5e-30 Score=273.00 Aligned_cols=169 Identities=24% Similarity=0.345 Sum_probs=138.0
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeecc--CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRV--DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~--~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.+.|+..+.||+|+||+||+|+++.+|+.||||++.+. .....+.+ .+|+.+|
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~-------------------------~~Ei~il 71 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-------------------------YRELRLL 71 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHH-------------------------HHHHHHH
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHH-------------------------HHHHHHH
Confidence 47899999999999999999999999999999998653 22222333 3569999
Q ss_pred HhCCCCceeeEEEEEEeCC------eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKDR------KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~~------~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++|||||+++++|...+ .+|+||||+ +.+|..+++.. .+++..+..++.||+.||.|||++||+|||||
T Consensus 72 ~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiK 148 (346)
T d1cm8a_ 72 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLK 148 (346)
T ss_dssp HHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccC
Confidence 9999999999999997654 579999999 66888887653 59999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.++.. +|||+|+...... ....+|+.|||||++.+..|
T Consensus 149 p~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~ 195 (346)
T d1cm8a_ 149 PGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMR 195 (346)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTC
T ss_pred cchhhcccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCC
Confidence 999999999998 9999998765322 34569999999999977544
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.5e-30 Score=268.77 Aligned_cols=171 Identities=24% Similarity=0.375 Sum_probs=141.7
Q ss_pred cceecccCcEEEEEEEEcCCC---eEEEEEEeecc-CHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 485 GPLLGQGFFGQVYRVTHRETG---EVMVLKELYRV-DEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg---~~vAiK~l~~~-~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
.++||+|+||+||+|++..++ ..||||++.+. +....+.+.+| +++|++++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E-------------------------~~~l~~l~ 86 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE-------------------------GIIMKDFS 86 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHH-------------------------HHHHHTCC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHH-------------------------HHHHHhCC
Confidence 678999999999999987643 36899998653 44444555555 99999999
Q ss_pred CCceeeEEEEEEe-CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEecC
Q psy5063 561 HHNVIRFIGVLYK-DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVREV 639 (681)
Q Consensus 561 HpnIV~l~g~~~~-~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~~ 639 (681)
||||++++|++.+ ++..++||||+++|+|.+++......+++..+..++.|++.||.|||+.+|+||||||+||||+++
T Consensus 87 HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~ 166 (311)
T d1r0pa_ 87 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 166 (311)
T ss_dssp CTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCC
Confidence 9999999999876 568999999999999999998877778899999999999999999999999999999999999999
Q ss_pred CCe--EEeeeeeEeeecccce--eeeecCCCccccchhhccCCCC
Q psy5063 640 GSG--FDFHLGQIYLIYVPYT--LFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 640 g~~--~DFGLa~~~~~~~~~~--~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+.+ +|||+++......... ......||..|+|||++....|
T Consensus 167 ~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 211 (311)
T d1r0pa_ 167 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211 (311)
T ss_dssp CCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCC
T ss_pred CCEEEecccchhhccccccccceecccccccccccChHHHhcCCC
Confidence 988 9999998765432111 1123458899999999876554
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.1e-30 Score=272.31 Aligned_cols=166 Identities=22% Similarity=0.355 Sum_probs=136.9
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
+|...++||+|+||+||+|+++.+|+.||||++.+... ...+|+++|+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----------------------------~~~~Ei~il~~l~ 71 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----------------------------FKNRELQIMRKLD 71 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----------------------------SCCHHHHHHHHCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----------------------------HHHHHHHHHHhcC
Confidence 68889999999999999999999999999999864321 1135799999999
Q ss_pred CCceeeEEEEEEeC------CeEEEEEeccCCCCHHHHHh--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 561 HHNVIRFIGVLYKD------RKLNLVTEYIAGGTLKELLQ--DPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 561 HpnIV~l~g~~~~~------~~l~LV~Ey~~gGsL~~~L~--~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
||||++++++|... ..+||||||+++|.+..+.. .....+++.++..++.||+.||+|||++||+||||||+
T Consensus 72 h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~ 151 (350)
T d1q5ka_ 72 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 151 (350)
T ss_dssp CTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred CCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcc
Confidence 99999999999643 35899999998764444332 23446999999999999999999999999999999999
Q ss_pred cEEEecCC-Ce--EEeeeeeEeeecccceeeeecCCCccccchhhccCC
Q psy5063 633 NCLVREVG-SG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 633 NILl~~~g-~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|||++.++ .+ +|||+++....... .....||+.|+|||++.+.
T Consensus 152 NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~ 197 (350)
T d1q5ka_ 152 NLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGA 197 (350)
T ss_dssp GEEECTTTCCEEECCCTTCEECCTTSC---CCSCCSCTTSCCHHHHTTC
T ss_pred eEEEecCCCceeEecccchhhccCCcc---cccccccccccChHHhhcc
Confidence 99999876 44 89999987754332 2335799999999998754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=1.6e-29 Score=263.09 Aligned_cols=174 Identities=18% Similarity=0.174 Sum_probs=145.6
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|++++.||+|+||+||+|++..+|+.||+|.+...... . ...+|++.++.
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~-------------------------~~~~e~~~~~~ 56 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--P-------------------------QLRDEYRTYKL 56 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS--C-------------------------CHHHHHHHHHH
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc--H-------------------------HHHHHHHHHHH
Confidence 46899999999999999999999999999999987543211 1 12345888888
Q ss_pred CCC-CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 559 LHH-HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 559 L~H-pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
++| +|++.+++++..+...++||||+ +|+|.+++......+++..+..++.|++.||+|||++|||||||||+|||++
T Consensus 57 l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 57 LAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp TTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred hcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence 865 89999999999999999999999 7899999987766799999999999999999999999999999999999997
Q ss_pred c-----CCCe--EEeeeeeEeeeccc-----ceeeeecCCCccccchhhccCCCC
Q psy5063 638 E-----VGSG--FDFHLGQIYLIYVP-----YTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~-----~g~~--~DFGLa~~~~~~~~-----~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
. ++.+ +|||+|+.+..... ........||+.|||||++.+..|
T Consensus 136 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~ 190 (293)
T d1csna_ 136 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ 190 (293)
T ss_dssp CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred CcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCC
Confidence 5 3455 99999998764321 122234569999999999988766
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.4e-29 Score=259.87 Aligned_cols=173 Identities=28% Similarity=0.397 Sum_probs=148.0
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHH
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLR 557 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 557 (681)
++|++.+.||+|+||+||+|+++.+++.||+|+++... ......+. +|+.+|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~-------------------------~E~~il~ 56 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-------------------------REICLLK 56 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHH-------------------------HHHHHHT
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHH-------------------------HHHHHHH
Confidence 57999999999999999999999999999999986432 22233333 4599999
Q ss_pred hCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEe
Q psy5063 558 SLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVR 637 (681)
Q Consensus 558 ~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~ 637 (681)
.++||||+++++++.+....++|+||+.+++|..++... ..+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 57 ~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~ 135 (292)
T d1unla_ 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLIN 135 (292)
T ss_dssp TCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred hcCcCCEEeeccccccccceeEEeeeccccccccccccc-cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccc
Confidence 999999999999999999999999999999998888764 4589999999999999999999999999999999999999
Q ss_pred cCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 638 EVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 638 ~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.++.+ +|||+|+...... .......++..|+|||++.+..|
T Consensus 136 ~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~ 178 (292)
T d1unla_ 136 RNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKL 178 (292)
T ss_dssp TTCCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSC
T ss_pred cCCceeeeecchhhcccCCC--ccceeeccccchhhhhHhccCCC
Confidence 99888 9999999876433 22223457788889999987654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.7e-30 Score=270.75 Aligned_cols=172 Identities=21% Similarity=0.300 Sum_probs=138.4
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC-HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD-EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~-~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+. +|+++|+.
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~-------------------------~Ei~il~~ 62 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTL-------------------------REIKILLR 62 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHH-------------------------HHHHHHHH
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHH-------------------------HHHHHHHH
Confidence 46999999999999999999999999999999996543 22333333 45999999
Q ss_pred CCCCceeeEEEEEEeCC----eEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcE
Q psy5063 559 LHHHNVIRFIGVLYKDR----KLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNC 634 (681)
Q Consensus 559 L~HpnIV~l~g~~~~~~----~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NI 634 (681)
++||||+++++++..+. ..+++++|+.+|+|.+++... .+++..+..++.|++.||+|||++|||||||||+||
T Consensus 63 l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NI 140 (345)
T d1pmea_ 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 140 (345)
T ss_dssp CCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred cCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceE
Confidence 99999999999997643 234445566799999999764 599999999999999999999999999999999999
Q ss_pred EEecCCCe--EEeeeeeEeeecccce-eeeecCCCccccchhhccCC
Q psy5063 635 LVREVGSG--FDFHLGQIYLIYVPYT-LFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 635 Ll~~~g~~--~DFGLa~~~~~~~~~~-~~~~~~gt~~Y~APEvL~~~ 678 (681)
|++.+|.+ +|||+|+......... ......||+.|+|||++...
T Consensus 141 Ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 187 (345)
T d1pmea_ 141 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187 (345)
T ss_dssp EECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTB
T ss_pred EECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcC
Confidence 99999987 9999998876532221 22345689999999998554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.4e-29 Score=265.66 Aligned_cols=176 Identities=22% Similarity=0.338 Sum_probs=139.4
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
.++|++.+.||+|+||+||+|+++.+|+.||||++....... .....+.+|+.+|+.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-----------------------~~~~~~~~E~~il~~ 65 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-----------------------GFPITALREIKILQL 65 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-----------------------SSCHHHHHHHHHHHH
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcch-----------------------HHHHHHHHHHHHHHH
Confidence 468999999999999999999999999999999874421100 001123467999999
Q ss_pred CCCCceeeEEEEEEe--------CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 559 LHHHNVIRFIGVLYK--------DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 559 L~HpnIV~l~g~~~~--------~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
++||||+++++++.. ++.+|+||||++++.+..+.. ....+++..+..++.|++.||.|||++||+|||||
T Consensus 66 l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~-~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlK 144 (318)
T d3blha1 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 144 (318)
T ss_dssp CCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred hcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh-cccccccHHHHHHHHHHHHHHHHhccCCEEecCcC
Confidence 999999999999855 346899999998776655444 44569999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeeccc--ceeeeecCCCccccchhhccCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVP--YTLFILSAKTKKTYYPNILKKA 678 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~--~~~~~~~~gt~~Y~APEvL~~~ 678 (681)
|+|||++.++.+ +|||+++....... ........||+.|+|||++.+.
T Consensus 145 p~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 145 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred chheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCC
Confidence 999999999998 99999987664321 1222345699999999998765
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.3e-29 Score=266.69 Aligned_cols=170 Identities=19% Similarity=0.259 Sum_probs=131.9
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|++.++||+|+||+||+|+++.+|+.||||++.+.. ......+. +|+.+|
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~-------------------------~Ei~il 70 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-------------------------RELVLM 70 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHH-------------------------HHHHHH
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHH-------------------------HHHHHH
Confidence 367999999999999999999999999999999997532 22223333 459999
Q ss_pred HhCCCCceeeEEEEEEe------CCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy5063 557 RSLHHHNVIRFIGVLYK------DRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLN 630 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~------~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLK 630 (681)
+.++||||++++++|.. ...+|+||||+.++.+ +.+.. .+++..++.++.||+.||.|||++||+|||||
T Consensus 71 ~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~~---~~~~~~i~~~~~qil~gl~~LH~~giiHrDlK 146 (355)
T d2b1pa1 71 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLK 146 (355)
T ss_dssp HHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHTS---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhhhc---CCCHHHHHHHHHHHHHHHHHhhhcccccccCC
Confidence 99999999999999964 3689999999976544 44432 48999999999999999999999999999999
Q ss_pred CCcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 631 SQNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 631 p~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
|+|||++.++.. +|||+++....... .....+|+.|+|||++.+..|
T Consensus 147 P~Nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~y~aPE~l~~~~~ 195 (355)
T d2b1pa1 147 PSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGY 195 (355)
T ss_dssp GGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCC
T ss_pred ccccccccccceeeechhhhhccccccc---cccccccccccChhhhcCCCC
Confidence 999999999987 99999987765432 233568999999999988765
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=9.7e-30 Score=268.69 Aligned_cols=179 Identities=21% Similarity=0.309 Sum_probs=148.0
Q ss_pred cCCCeeecceecccCcEEEEEEEE---cCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHH
Q psy5063 478 RASDLVRGPLLGQGFFGQVYRVTH---RETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVA 554 (681)
Q Consensus 478 ~~~d~~~~~~LG~G~FG~Vyk~~~---~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~ 554 (681)
..++|++++.||+|+||+||+|++ +.+|+.||+|++.+....... .....+.+|++
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~---------------------~~~~~~~~E~~ 80 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA---------------------KTTEHTRTERQ 80 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE---------------------SSGGGCCCHHH
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch---------------------HHHHHHHHHHH
Confidence 457899999999999999999997 457899999998542110000 00123457899
Q ss_pred HHHhCCC-CceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q psy5063 555 VLRSLHH-HNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQN 633 (681)
Q Consensus 555 iL~~L~H-pnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~N 633 (681)
+|+.++| |||+++++++.+...++++|||+.+|+|.+++.... .+++..+..++.||+.||+|||+++|+||||||+|
T Consensus 81 il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~N 159 (322)
T d1vzoa_ 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 159 (322)
T ss_dssp HHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccc
Confidence 9999966 899999999999999999999999999999997654 47889999999999999999999999999999999
Q ss_pred EEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCC
Q psy5063 634 CLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKAS 679 (681)
Q Consensus 634 ILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~ 679 (681)
||++.+|.+ +|||+|+.+..... .......|++.|+|||++.+..
T Consensus 160 ill~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~ 206 (322)
T d1vzoa_ 160 ILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGD 206 (322)
T ss_dssp EEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC
T ss_pred eeecCCCCEEEeeccchhhhccccc-ccccccccccccchhHHhhcCC
Confidence 999999998 99999988754332 2234466999999999997654
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.95 E-value=8e-29 Score=257.86 Aligned_cols=173 Identities=18% Similarity=0.171 Sum_probs=139.5
Q ss_pred CCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhC
Q psy5063 480 SDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSL 559 (681)
Q Consensus 480 ~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 559 (681)
+.|++++.||+|+||.||+|++..+|+.||||.+...... . .+.+|+++|+.+
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~-------------------------~~~~E~~i~~~l 59 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--P-------------------------QLHIESKIYKMM 59 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--C-------------------------CHHHHHHHHHHS
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--H-------------------------HHHHHHHHHHHc
Confidence 4699999999999999999999999999999987543211 1 234569999999
Q ss_pred CCCc-eeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcEEEec
Q psy5063 560 HHHN-VIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQNCLVRE 638 (681)
Q Consensus 560 ~Hpn-IV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~NILl~~ 638 (681)
+|+| |+.+.+++.+.+..++||||+ +|+|.+.+......+++..+..++.|++.||+|||++|||||||||+|||++.
T Consensus 60 ~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~ 138 (299)
T d1ckia_ 60 QGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 138 (299)
T ss_dssp TTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred cCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccc
Confidence 7666 555566677888999999999 56777776655667999999999999999999999999999999999999875
Q ss_pred CC---Ce--EEeeeeeEeeecccc-----eeeeecCCCccccchhhccCCCC
Q psy5063 639 VG---SG--FDFHLGQIYLIYVPY-----TLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 639 ~g---~~--~DFGLa~~~~~~~~~-----~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
.+ .+ +|||+|+.+...... .......||+.|||||++.+..|
T Consensus 139 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 190 (299)
T d1ckia_ 139 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 190 (299)
T ss_dssp GGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC
T ss_pred cCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCC
Confidence 43 34 899999987653321 22234569999999999988765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.3e-29 Score=265.91 Aligned_cols=170 Identities=22% Similarity=0.264 Sum_probs=139.2
Q ss_pred CCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccC--HHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHH
Q psy5063 479 ASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVD--EEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVL 556 (681)
Q Consensus 479 ~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~--~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL 556 (681)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+.. ....+.+ .+|+.+|
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~-------------------------~~Ei~il 71 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT-------------------------YRELRLL 71 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHH-------------------------HHHHHHH
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHH-------------------------HHHHHHH
Confidence 467999999999999999999999999999999986532 2222233 3469999
Q ss_pred HhCCCCceeeEEEEEEeC-----CeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC
Q psy5063 557 RSLHHHNVIRFIGVLYKD-----RKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNS 631 (681)
Q Consensus 557 ~~L~HpnIV~l~g~~~~~-----~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp 631 (681)
+.++||||+++++++... ...+++|||+.+|+|.+++... .+++..+..++.||+.||+|||++||+||||||
T Consensus 72 ~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp 149 (348)
T d2gfsa1 72 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKP 149 (348)
T ss_dssp HHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred HhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHHhCCCcccccCC
Confidence 999999999999998643 3456677788899999999653 599999999999999999999999999999999
Q ss_pred CcEEEecCCCe--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 632 QNCLVREVGSG--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 632 ~NILl~~~g~~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+|||++.+|.. +|||+|...... .....||+.|||||++.+..|
T Consensus 150 ~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~ 195 (348)
T d2gfsa1 150 SNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMH 195 (348)
T ss_dssp GGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSC
T ss_pred ccccccccccccccccchhcccCcc-----cccccccccccCchhhcCCcc
Confidence 99999999988 999999765432 233568999999999877654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.90 E-value=2.2e-24 Score=229.12 Aligned_cols=174 Identities=16% Similarity=0.242 Sum_probs=132.2
Q ss_pred eecCCCeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHH
Q psy5063 476 IFRASDLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAV 555 (681)
Q Consensus 476 ~~~~~d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~i 555 (681)
.|..++|+++++||+|+||+||+|+++.+|+.||||++.+.. ...+.+.+| +.+
T Consensus 9 ~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~E-------------------------i~~ 62 (362)
T d1q8ya_ 9 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDE-------------------------IKL 62 (362)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHH-------------------------HHH
T ss_pred CccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHH-------------------------HHH
Confidence 344456999999999999999999999999999999986532 222233333 555
Q ss_pred HHhC-----------CCCceeeEEEEEEe--CCeEEEEEeccCCCCHHH--HHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy5063 556 LRSL-----------HHHNVIRFIGVLYK--DRKLNLVTEYIAGGTLKE--LLQDPGQPLPWGQRVNFARDIAAGMTYLH 620 (681)
Q Consensus 556 L~~L-----------~HpnIV~l~g~~~~--~~~l~LV~Ey~~gGsL~~--~L~~~~~~l~~~~~~~i~~QIa~gL~yLH 620 (681)
|+.+ .|+||+++++++.. ....+++|+++..+.... ........+++..+..++.||+.||+|||
T Consensus 63 l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh 142 (362)
T d1q8ya_ 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH 142 (362)
T ss_dssp HHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh
Confidence 5544 46899999988864 467777777765544322 22334456899999999999999999999
Q ss_pred h-CCccccCCCCCcEEEecCCC------e--EEeeeeeEeeecccceeeeecCCCccccchhhccCCCC
Q psy5063 621 S-MNLIHRDLNSQNCLVREVGS------G--FDFHLGQIYLIYVPYTLFILSAKTKKTYYPNILKKASF 680 (681)
Q Consensus 621 s-~~IIHRDLKp~NILl~~~g~------~--~DFGLa~~~~~~~~~~~~~~~~gt~~Y~APEvL~~~~Y 680 (681)
+ +||+||||||+||||+.++. + +|||.+...... .....||+.|+|||++....|
T Consensus 143 ~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~ 206 (362)
T d1q8ya_ 143 RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPW 206 (362)
T ss_dssp HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCC
T ss_pred hhcCcccccCChhHeeeeccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCC
Confidence 8 89999999999999987664 2 899988765432 234569999999999987765
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=1.7e-20 Score=181.97 Aligned_cols=140 Identities=18% Similarity=0.106 Sum_probs=104.6
Q ss_pred eecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHH----------HHHHHHHhhccceeeeccCCCCccccccchHH
Q psy5063 483 VRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEA----------EKNFLKESKQGLIYLIDLGSHGLINNLHCFSQ 552 (681)
Q Consensus 483 ~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~----------~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~E 552 (681)
.+++.||+|+||.||+|++. +|+.||+|.+....... ...+..+ ......+|
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~e 64 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL-----------------AIRSARNE 64 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHH-----------------HHHHHHHH
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHH-----------------HHHHHHHH
Confidence 46889999999999999985 68999999864321110 0001111 11223457
Q ss_pred HHHHHhCCCCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy5063 553 VAVLRSLHHHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHSMNLIHRDLNSQ 632 (681)
Q Consensus 553 i~iL~~L~HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs~~IIHRDLKp~ 632 (681)
...|..+.|.+++..+++. ..+++|||++++.+.+ ++...+..++.|++.||.|||++||+||||||+
T Consensus 65 ~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~ 132 (191)
T d1zara2 65 FRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQY 132 (191)
T ss_dssp HHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred HHHHHHccCCCcceEEEec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChh
Confidence 8899999999999988663 2379999998876543 333445678999999999999999999999999
Q ss_pred cEEEecCCCe-EEeeeeeEee
Q psy5063 633 NCLVREVGSG-FDFHLGQIYL 652 (681)
Q Consensus 633 NILl~~~g~~-~DFGLa~~~~ 652 (681)
|||+++++.. +|||+|....
T Consensus 133 NILv~~~~~~liDFG~a~~~~ 153 (191)
T d1zara2 133 NVLVSEEGIWIIDFPQSVEVG 153 (191)
T ss_dssp SEEEETTEEEECCCTTCEETT
T ss_pred heeeeCCCEEEEECCCcccCC
Confidence 9999987755 9999997654
|
| >d1x3ha1 g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.12 E-value=9.9e-12 Score=85.76 Aligned_cols=35 Identities=26% Similarity=0.673 Sum_probs=34.1
Q ss_pred cccccccCCcccccCCccccCeEEecCccCCCCce
Q psy5063 61 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 95 (681)
Q Consensus 61 ~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF 95 (681)
+||.++|+++|++|+++|.|.+|+|+|+.|||+||
T Consensus 1 ~DY~~~fapkC~~C~~~I~g~~v~Al~~~wHpeCF 35 (35)
T d1x3ha1 1 KDFLAMFSPKCGGCNRPVLENYLSAMDTVWHPECF 35 (35)
T ss_dssp CCCCCCCSCBCTTTCCBCCSSCEEETTEEECTTTC
T ss_pred CcHHHHhChhhhhcCCcccchheeecCCccCcccC
Confidence 58999999999999999999999999999999998
|
| >d1x6aa1 g.39.1.3 (A:8-41) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.97 E-value=8.4e-11 Score=77.62 Aligned_cols=34 Identities=56% Similarity=1.304 Sum_probs=33.0
Q ss_pred cccccccCCcccccCCccccCeEEecCccCCCCc
Q psy5063 61 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPEC 94 (681)
Q Consensus 61 ~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~C 94 (681)
+|||.+|++.|++|++.|+|++|+|++++|||+|
T Consensus 1 kdYw~kfge~C~~C~~~itGpvMvAG~~K~HPEC 34 (34)
T d1x6aa1 1 KDYWGKFGEFCHGCSLLMTGPFMVAGEFKYHPEC 34 (34)
T ss_dssp CCSSCCSSCBCTTTCCBCCSCCBCCTTCCBCTTS
T ss_pred CcHHHHHHHHhhhhHhhcccceeeecccccCCCC
Confidence 5899999999999999999999999999999998
|
| >d1v6ga1 g.39.1.3 (A:1-41) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.79 E-value=9.2e-10 Score=77.04 Aligned_cols=34 Identities=35% Similarity=0.871 Sum_probs=33.2
Q ss_pred cccccccCCcccccCCccccCeEEecCccCCCCc
Q psy5063 61 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPEC 94 (681)
Q Consensus 61 ~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~C 94 (681)
.||+++|+.+|..|++.|+|++|+|++++|||+|
T Consensus 8 ~DYq~~fG~~C~~C~~~ItG~V~~Ag~~~yHP~C 41 (41)
T d1v6ga1 8 LDYQRLYGTRCFSCDQFIEGEVVSALGKTYHPDC 41 (41)
T ss_dssp SCGGGSCCCBCTTTCCBCCSCCEEETTEEECTTT
T ss_pred ccHHHHhCcccccccCEeeeeeeEecCcccCCCC
Confidence 5999999999999999999999999999999998
|
| >d2dloa1 g.39.1.3 (A:8-42) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.63 E-value=5.4e-09 Score=70.26 Aligned_cols=35 Identities=26% Similarity=0.642 Sum_probs=32.0
Q ss_pred ccccccccCCcccccCCccccCeEEecCccCCCCce
Q psy5063 60 KEDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 95 (681)
Q Consensus 60 ~~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF 95 (681)
+.||.... ++|..|+++|.+++++|.|+.|||.||
T Consensus 1 E~Cy~~tl-EkC~~C~~~I~driLrA~Gk~yHP~CF 35 (35)
T d2dloa1 1 EGCYVATL-EKCATCSQPILDRILRAMGKAYHPGCF 35 (35)
T ss_dssp CCCCCSSC-CBCTTTCCBCCSCCEEETTEEECTTTC
T ss_pred ChhHHHHH-HHHHHhchHHHHHHHHHhCCCCCCCCC
Confidence 46887664 899999999999999999999999998
|
| >d1x6aa2 g.39.1.3 (A:42-75) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.44 E-value=3.9e-08 Score=64.65 Aligned_cols=33 Identities=48% Similarity=1.067 Sum_probs=31.5
Q ss_pred eecCCCCcccCCCCceeeecCCeeeeccchhhh
Q psy5063 95 FKCTSCSCCIGDGESYALVERSILYCGLCYKRQ 127 (681)
Q Consensus 95 F~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~ 127 (681)
|.|..|+..|+||+.|++++.+++||+.||.+.
T Consensus 1 F~C~~C~~fIgdgdsyaLVerskLYCG~Cy~~~ 33 (34)
T d1x6aa2 1 FACMSCKVIIEDGDAYALVQHATLYCGKCHNEV 33 (34)
T ss_dssp CBCTTTCCBCCTTSCEEECSSSCEEEHHHHHHH
T ss_pred CcccccccEEecCceEEEEeeceeeeecchhcc
Confidence 889999999999999999999999999999874
|
| >d2cuqa2 g.39.1.3 (A:8-42) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.42 E-value=4.3e-08 Score=65.47 Aligned_cols=35 Identities=23% Similarity=0.634 Sum_probs=33.5
Q ss_pred cccccccCCcccccCCccccCeEEecCccCCCCce
Q psy5063 61 EDYNGKYGEACQNCGQMMSGPVMVVGDHKFHPECF 95 (681)
Q Consensus 61 ~cY~~~f~~~C~~C~~~I~g~~~~a~~~~yH~~CF 95 (681)
.||.++|+++|..|+++|+..-+.+.++.||.+||
T Consensus 1 PCyE~kfa~~C~~Ckk~It~GGvtY~dqpWHkeCF 35 (35)
T d2cuqa2 1 PCYENKFAPRCARCSKTLTQGGVTYRDQPWHRECL 35 (35)
T ss_dssp CCCCCCSSCCCTTTCCCCCSCCEESSSSEECTTTC
T ss_pred CchHHHHHHHHhhcCCccccCceeecCCcchhhhC
Confidence 48999999999999999998899999999999998
|
| >d1g47a2 g.39.1.3 (A:36-70) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.40 E-value=2.7e-08 Score=68.19 Aligned_cols=33 Identities=21% Similarity=0.678 Sum_probs=30.7
Q ss_pred cccccCcCccCC-ceEeeCCeeeeccccccccCC
Q psy5063 37 FRCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGE 69 (681)
Q Consensus 37 F~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~ 69 (681)
|+|+.|+++|.+ .||++||++||+.||.++|+|
T Consensus 1 F~C~~C~~~f~~~~F~e~~G~pYCe~~Y~~lFAP 34 (35)
T d1g47a2 1 FVCAQCFQQFPEGLFYEFEGRKYCEHDFQMLFAP 34 (35)
T ss_dssp CCCTTTCCCCGGGCSEEETTEEECHHHHHHHCCC
T ss_pred CCCCCCcCCCCCCCeEEECCEecChHhHHhhcCC
Confidence 799999999965 899999999999999999976
|
| >d2dara2 g.39.1.3 (A:8-52) PDZ and LIM domain protein 5, Enigma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 5, Enigma species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.27 E-value=1.3e-07 Score=67.15 Aligned_cols=28 Identities=36% Similarity=0.839 Sum_probs=27.0
Q ss_pred CCcccccCCccccCeEEecCccCCCCce
Q psy5063 68 GEACQNCGQMMSGPVMVVGDHKFHPECF 95 (681)
Q Consensus 68 ~~~C~~C~~~I~g~~~~a~~~~yH~~CF 95 (681)
.+.|+.|+++|.|++++|+|+.||||||
T Consensus 18 ~P~C~~C~~pI~g~~vtAlgk~WHPEhF 45 (45)
T d2dara2 18 TPMCAHCNQVIRGPFLVALGKSWHPEEF 45 (45)
T ss_dssp CCBBSSSCCBCCSCEEEETTEEECTTTC
T ss_pred CeeccccCCcccCceeeecCCccCcCCC
Confidence 5889999999999999999999999998
|
| >d2dj7a1 g.39.1.3 (A:44-74) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=1.5e-07 Score=60.98 Aligned_cols=31 Identities=39% Similarity=1.089 Sum_probs=29.3
Q ss_pred ccccCcCccCCceEeeCCeeeeccccccccC
Q psy5063 38 RCSACDVMLDNWYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~~~~~~~dg~~yC~~cY~~~f~ 68 (681)
+|..|++.|.+.|..+||.|||+.||+..|+
T Consensus 1 kC~~C~~vL~gEYm~kdG~PyCe~DY~~~FG 31 (31)
T d2dj7a1 1 KCQTCSVILTGEYISKDGVPYCESDYHAQFG 31 (31)
T ss_dssp BCSSSCCBCSSCCEEETTEEECTTHHHHHTT
T ss_pred CccccCccccceeecCCCCcccHHHHHHhcC
Confidence 6899999999999999999999999999885
|
| >d1x3ha1 g.39.1.3 (A:8-42) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.19 E-value=4.1e-07 Score=62.27 Aligned_cols=34 Identities=29% Similarity=0.779 Sum_probs=28.6
Q ss_pred CCCCCCCccccccccccccCceEEecCccccccCc
Q psy5063 3 DSETPEILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 3 ~~~~~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
|-...-.+.|++|+++|. ++++.|+|+.||++||
T Consensus 2 DY~~~fapkC~~C~~~I~-g~~v~Al~~~wHpeCF 35 (35)
T d1x3ha1 2 DFLAMFSPKCGGCNRPVL-ENYLSAMDTVWHPECF 35 (35)
T ss_dssp CCCCCCSCBCTTTCCBCC-SSCEEETTEEECTTTC
T ss_pred cHHHHhChhhhhcCCccc-chheeecCCccCcccC
Confidence 334444589999999995 7899999999999998
|
| >d1b8ta4 g.39.1.3 (A:144-192) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=98.18 E-value=3.1e-07 Score=66.98 Aligned_cols=40 Identities=33% Similarity=0.659 Sum_probs=36.5
Q ss_pred ccccCcCccCC-ceEeeCCeeeeccccccccCCcccccCCc
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCGQM 77 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~~~ 77 (681)
+|..|++.|++ ..+++||++||+.||.++|++++.+.++.
T Consensus 1 KC~~C~k~Lds~t~~ehdg~~YCk~CY~k~fGPKG~g~G~g 41 (49)
T d1b8ta4 1 RCAKCGKSLESTTLADKDGEIYCKGCYAKNFGPKGFGFGQG 41 (49)
T ss_dssp BCTTTCCBCCSSSEEEETTEEEEHHHHHHHTCCCCCCCCCC
T ss_pred ChhhcCCccCCCcccccCCcccchhhhhhccCCCccCcccC
Confidence 69999999976 78999999999999999999999998753
|
| >d2dara2 g.39.1.3 (A:8-52) PDZ and LIM domain protein 5, Enigma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 5, Enigma species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=5.9e-07 Score=63.79 Aligned_cols=29 Identities=31% Similarity=0.677 Sum_probs=26.4
Q ss_pred CCccccccccccccCceEEecCccccccCc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
-.|+|++|+++|. +.+++|+|+.||++||
T Consensus 17 r~P~C~~C~~pI~-g~~vtAlgk~WHPEhF 45 (45)
T d2dara2 17 RTPMCAHCNQVIR-GPFLVALGKSWHPEEF 45 (45)
T ss_dssp CCCBBSSSCCBCC-SCEEEETTEEECTTTC
T ss_pred CCeeccccCCccc-CceeeecCCccCcCCC
Confidence 3589999999995 7899999999999998
|
| >d1x63a1 g.39.1.3 (A:8-44) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.12 E-value=4.9e-07 Score=62.15 Aligned_cols=35 Identities=14% Similarity=0.373 Sum_probs=32.0
Q ss_pred cccccccCCcccccCCccc--cCeEEecCccCCCCce
Q psy5063 61 EDYNGKYGEACQNCGQMMS--GPVMVVGDHKFHPECF 95 (681)
Q Consensus 61 ~cY~~~f~~~C~~C~~~I~--g~~~~a~~~~yH~~CF 95 (681)
+||.+.|+++|.+|+++|. ...|.+.|+.||.+||
T Consensus 1 kCy~~~~a~~C~~C~k~I~~G~k~veykg~~WHe~CF 37 (37)
T d1x63a1 1 KCTTREDSPKCKGCFKAIVAGDQNVEYKGTVWHKDCF 37 (37)
T ss_dssp CCCSCCCSCBCSSSCCBCCSSSCEEECSSCEEETTTC
T ss_pred CccccccCcccccCCCccCCCCeEeEeCCccchhccC
Confidence 5899999999999999994 4689999999999998
|
| >d1j2oa1 g.39.1.3 (A:1-30) Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Rhombotin-2 (Lmo2) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.97 E-value=1.6e-06 Score=56.13 Aligned_cols=28 Identities=46% Similarity=1.107 Sum_probs=26.2
Q ss_pred CccccccccccccCceEEecCccccccC
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDC 36 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~C 36 (681)
+..|++|+++|.+.+++.|+++.||.+|
T Consensus 3 ~~~CaGC~~~I~DRflL~a~Dr~WH~~C 30 (30)
T d1j2oa1 3 LLTCGGCQQNIGDRYFLKAIDQYWHEDC 30 (30)
T ss_dssp CBCBSSSCSCBCSSEEEECSSSEECTTT
T ss_pred CcccCCCCCcchHHHHHHHHHHHHhcCC
Confidence 5689999999999999999999999987
|
| >d2dj7a2 g.39.1.3 (A:8-43) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.93 E-value=2.8e-06 Score=56.42 Aligned_cols=29 Identities=38% Similarity=0.905 Sum_probs=27.2
Q ss_pred CccccccccccccCceEEecCccccccCc
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
...|++|++.|..++.+.|+++.||.+||
T Consensus 8 ~~~CagCg~eik~gQaL~ALdkqWH~~CF 36 (36)
T d2dj7a2 8 PSHCAGCKEEIKHGQSLLALDKQWHVSCF 36 (36)
T ss_dssp CSCCTTTCCCCSSSCCEEETTEEECTTTC
T ss_pred CccccccchhhhCCceeeeeecceeeeeC
Confidence 35799999999999999999999999998
|
| >d1u5sb1 g.39.1.3 (B:72-102) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.89 E-value=1.9e-06 Score=55.87 Aligned_cols=29 Identities=24% Similarity=0.623 Sum_probs=25.7
Q ss_pred CCCccccccccccccCceEEecCccccccC
Q psy5063 7 PEILTCAGCLNNIVEDEYVQALSQEWHTDC 36 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~~~v~a~~~~wH~~C 36 (681)
-..|+|+.|+++|. ++++.|+|+.||+++
T Consensus 3 mg~p~C~~C~~PI~-~~~vtAlgk~WHpEH 31 (31)
T d1u5sb1 3 MGVPICGACRRPIE-GRVVNAMGKQWHVEH 31 (31)
T ss_dssp CCCCEETTTTEECC-SCEECCTTSBEETTT
T ss_pred cCCcchhhcCCchh-hhHhhhhccccCCCC
Confidence 35689999999996 699999999999985
|
| >d1u5sb1 g.39.1.3 (B:72-102) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.87 E-value=1.5e-06 Score=56.46 Aligned_cols=29 Identities=21% Similarity=0.345 Sum_probs=26.7
Q ss_pred ccCCcccccCCccccCeEEecCccCCCCc
Q psy5063 66 KYGEACQNCGQMMSGPVMVVGDHKFHPEC 94 (681)
Q Consensus 66 ~f~~~C~~C~~~I~g~~~~a~~~~yH~~C 94 (681)
.+.++|+.|.+||.++++.|+|+.||||+
T Consensus 3 mg~p~C~~C~~PI~~~~vtAlgk~WHpEH 31 (31)
T d1u5sb1 3 MGVPICGACRRPIEGRVVNAMGKQWHVEH 31 (31)
T ss_dssp CCCCEETTTTEECCSCEECCTTSBEETTT
T ss_pred cCCcchhhcCCchhhhHhhhhccccCCCC
Confidence 45689999999999999999999999985
|
| >d1rutx1 g.39.1.3 (X:19-48) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.84 E-value=3.5e-06 Score=54.70 Aligned_cols=28 Identities=32% Similarity=0.801 Sum_probs=26.1
Q ss_pred ccccccccccccCceEEecCccccccCc
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
..|++|+++|.+..++.++++.||..|+
T Consensus 3 ~~CaGC~~~I~DRflL~v~dr~WH~~CL 30 (30)
T d1rutx1 3 KRCAGCGGKIADRFLLYAMDSYWHSRCL 30 (30)
T ss_dssp CBBTTTCCBCCCSEEEEETTEEECGGGC
T ss_pred cccCCCCCccchhhhhccchhhhhhhhC
Confidence 4799999999999999999999999985
|
| >d1rgwa_ b.36.1.1 (A:) Zasp (Cypher, Oracle 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Zasp (Cypher, Oracle 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.83 E-value=9.6e-06 Score=66.90 Aligned_cols=43 Identities=19% Similarity=0.256 Sum_probs=39.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||+++.+.+.+|+..+|+ .+.+.++|++.++.
T Consensus 42 ~L~~GD~Il~VNg~~v~~~s~~ev~~~i~-~~~~~v~L~V~R~~ 84 (85)
T d1rgwa_ 42 QLSQGDLVVAIDGVNTDTMTHLEAQNKIK-SASYNLSLTLQKSK 84 (85)
T ss_dssp SCCCCSBEEEETTEECTTCCHHHHHHHHT-TCSSCEEEEEESCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEECC
Confidence 69999999999999999999999999999 67788999999875
|
| >d1m5za_ b.36.1.1 (A:) Glutamate receptor interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.83 E-value=9.8e-06 Score=67.76 Aligned_cols=43 Identities=30% Similarity=0.233 Sum_probs=40.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+++.+++..+|+ +....+.|+|.+||
T Consensus 49 gL~~GD~Il~VNg~~v~~~t~~~~~~~l~-~~~~~v~L~v~R~P 91 (91)
T d1m5za_ 49 GLKPYDRLLQVNHVRTRDFDCCLVVPLIA-ESGNKLDLVISRNP 91 (91)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-TSTTEEEEEEEECC
T ss_pred cCCCCCEEEEECCEECCCCCHHHHHHHHH-CCCCEEEEEEEECc
Confidence 59999999999999999999999999999 77888999999998
|
| >d2dloa1 g.39.1.3 (A:8-42) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.79 E-value=6.7e-06 Score=55.03 Aligned_cols=35 Identities=29% Similarity=0.693 Sum_probs=30.4
Q ss_pred CCCCCCCCccccccccccccCceEEecCccccccCc
Q psy5063 2 EDSETPEILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 2 ~~~~~~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
|+.....+..|..|+++|. +.+++|+|+.||+.||
T Consensus 1 E~Cy~~tlEkC~~C~~~I~-driLrA~Gk~yHP~CF 35 (35)
T d2dloa1 1 EGCYVATLEKCATCSQPIL-DRILRAMGKAYHPGCF 35 (35)
T ss_dssp CCCCCSSCCBCTTTCCBCC-SCCEEETTEEECTTTC
T ss_pred ChhHHHHHHHHHHhchHHH-HHHHHHhCCCCCCCCC
Confidence 3456677889999999996 6899999999999998
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.78 E-value=5.3e-05 Score=73.97 Aligned_cols=139 Identities=16% Similarity=0.053 Sum_probs=84.6
Q ss_pred CeeecceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC
Q psy5063 481 DLVRGPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH 560 (681)
Q Consensus 481 d~~~~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 560 (681)
.|...+..+.++.+.||+... .++.+++|......... .....+|...++.+.
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~-------------------------~~~~~~E~~~l~~l~ 67 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT-------------------------TYDVEREKDMMLWLE 67 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS-------------------------TTCHHHHHHHHHHHT
T ss_pred ceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc-------------------------hhhHHHHHHHHHHHh
Confidence 333333333344568998763 46677788764332111 112234566666653
Q ss_pred -CCceeeEEEEEEeCCeEEEEEeccCCCCHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q psy5063 561 -HHNVIRFIGVLYKDRKLNLVTEYIAGGTLKELLQDPGQPLPWGQRVNFARDIAAGMTYLHS------------------ 621 (681)
Q Consensus 561 -HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL~~~L~~~~~~l~~~~~~~i~~QIa~gL~yLHs------------------ 621 (681)
+--+.+++.+...++..++||++++|.++.+..... .. ...++.+++..+..||+
T Consensus 68 ~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~ 141 (263)
T d1j7la_ 68 GKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp TTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHH
T ss_pred ccCCCCcEEEEEecCCceEEEEEeccccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhh
Confidence 434677888888889999999999998886543221 11 11223333333444442
Q ss_pred -----------------------------------C------CccccCCCCCcEEEecCCCe--EEeeeeeEee
Q psy5063 622 -----------------------------------M------NLIHRDLNSQNCLVREVGSG--FDFHLGQIYL 652 (681)
Q Consensus 622 -----------------------------------~------~IIHRDLKp~NILl~~~g~~--~DFGLa~~~~ 652 (681)
. .++|+|+.|.|||+++++.. .||+.+....
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~ 215 (263)
T d1j7la_ 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp HHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccCC
Confidence 1 27899999999999986654 8998887654
|
| >d1wf7a_ b.36.1.1 (A:) Enigma homolog ENH {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Enigma homolog ENH species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.77 E-value=1.4e-05 Score=68.39 Aligned_cols=43 Identities=16% Similarity=0.338 Sum_probs=40.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||+++.+.+++|+-.+|+ .....++|+|.+..
T Consensus 46 ~L~~GD~Il~INg~~v~~~t~~eav~li~-~~~~~v~L~v~R~~ 88 (103)
T d1wf7a_ 46 HVRIGDVVLSIDGISAQGMTHLEAQNKIK-ACTGSLNMTLQRAS 88 (103)
T ss_dssp TCCTTCBEEEETTEECSSCCHHHHHHHHH-HCSSEEEEEECCCS
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 79999999999999999999999999999 57788999999977
|
| >d1g47a2 g.39.1.3 (A:36-70) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.76 E-value=3.3e-06 Score=57.57 Aligned_cols=34 Identities=21% Similarity=0.401 Sum_probs=29.7
Q ss_pred eecCCCCcccCCCCceeeecCCeeeeccchhhhcCC
Q psy5063 95 FKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130 (681)
Q Consensus 95 F~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p 130 (681)
|+|..|+++++++.. ...+|++||..||+++|||
T Consensus 1 F~C~~C~~~f~~~~F--~e~~G~pYCe~~Y~~lFAP 34 (35)
T d1g47a2 1 FVCAQCFQQFPEGLF--YEFEGRKYCEHDFQMLFAP 34 (35)
T ss_dssp CCCTTTCCCCGGGCS--EEETTEEECHHHHHHHCCC
T ss_pred CCCCCCcCCCCCCCe--EEECCEecChHhHHhhcCC
Confidence 799999999976653 4568899999999999998
|
| >d1tp5a1 b.36.1.1 (A:302-403) Synaptic protein PSD-95 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Synaptic protein PSD-95 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.76 E-value=1e-05 Score=69.07 Aligned_cols=43 Identities=21% Similarity=0.332 Sum_probs=41.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||+++.+.+++|+..+|+ .....++|++.++|
T Consensus 51 ~l~~GD~Il~INg~~v~~~~~~ev~~~l~-~~~~~v~L~v~~~~ 93 (102)
T d1tp5a1 51 ELRKGDQILSVNGVDLRNASHEQAAIALK-NAGQTVTIIAQYKP 93 (102)
T ss_dssp CCCTTEEEEEETTEECTTCCHHHHHHHHH-TSCSEEEEEEEECH
T ss_pred CCcccCEEEEECCeEcCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 59999999999999999999999999999 67889999999998
|
| >d1vb7a_ b.36.1.1 (A:) PDZ-LIM protein mystique {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: PDZ-LIM protein mystique species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.75 E-value=1.5e-05 Score=67.05 Aligned_cols=43 Identities=26% Similarity=0.382 Sum_probs=40.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+.+|+..+|+ .....+.|+|.++.
T Consensus 47 gL~~GD~Il~VNg~~v~~~~~~~~~~~l~-~~~~~v~L~V~R~~ 89 (94)
T d1vb7a_ 47 DLRPGDIIVAINGQSAENMLHAEAQSKIR-QSASPLRLQLDRSS 89 (94)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSSEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 79999999999999999999999999999 57788999999865
|
| >d1ozia_ b.36.1.1 (A:) Phosphatase hPTP1e {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Phosphatase hPTP1e species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.74 E-value=1.3e-05 Score=67.79 Aligned_cols=43 Identities=28% Similarity=0.421 Sum_probs=40.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||||||.++.+.+.+|+-.+|+ .+...++|++.+++
T Consensus 55 ~L~~GD~Il~VNg~~v~~~s~~~a~~~lk-~~~~~v~L~v~R~~ 97 (99)
T d1ozia_ 55 RIHKGDRVLAVNGVSLEGATHKQAVETLR-NTGQVVHLLLEKGQ 97 (99)
T ss_dssp CCCTTCEEEEETTEECSSCCHHHHHHHHH-HSCSEEEEEEECCC
T ss_pred CCCccCEEEEECCEEcCCCCHHHHHHHHH-CCCCeEEEEEEeCC
Confidence 59999999999999999999999999999 57789999999987
|
| >d2fcfa1 b.36.1.1 (A:1148-1243) Multiple PDZ domain protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Multiple PDZ domain protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.72 E-value=1.6e-05 Score=67.04 Aligned_cols=41 Identities=29% Similarity=0.430 Sum_probs=37.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
.|++||+||+|||+++.+.+++|+-.+|+ .+...++|++++
T Consensus 54 ~L~~GD~Il~VNg~~v~~~t~~ea~~~lk-~~~~~v~L~V~r 94 (96)
T d2fcfa1 54 TLKPGDRIVEVDGMDLRDASHEQAVEAIR-KAGNPVVFMVQS 94 (96)
T ss_dssp CCCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSSEEEEEEC
T ss_pred CCcCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEE
Confidence 59999999999999999999999999999 667789998874
|
| >d1whaa_ b.36.1.1 (A:) Scribble (KIAA0147) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Scribble (KIAA0147) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.71 E-value=1.6e-05 Score=68.11 Aligned_cols=43 Identities=23% Similarity=0.473 Sum_probs=40.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+-.+|+ .+...+.|++.+++
T Consensus 56 ~L~~GD~Il~INg~~v~~~~~~ev~~~l~-~~~~~v~l~v~R~~ 98 (105)
T d1whaa_ 56 TLQVGDRVLSINGVDVTEARHDHAVSLLT-AASPTIALLLEREA 98 (105)
T ss_dssp SCCTTCEEEEESSCBCTTCCHHHHHHHHT-SCCSCEEEEEEECC
T ss_pred CccCCCEEEEECCEEcCCCcHHHHHHHHH-cCCCeEEEEEEECC
Confidence 59999999999999999999999999999 67788999999977
|
| >d2dloa2 g.39.1.3 (A:43-75) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.70 E-value=7.3e-06 Score=54.03 Aligned_cols=33 Identities=21% Similarity=0.497 Sum_probs=30.8
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
+|..|++.| +|.+|+++..+++||..+|+++||
T Consensus 1 tCvvC~~~L-DGvPFtvD~~n~i~Cv~DyHrkfA 33 (33)
T d2dloa2 1 TCVVCHRGL-DGIPFTVDATSQIHCIEDFHRKFA 33 (33)
T ss_dssp BCSSSCCBC-TTSCEECCTTCCCEEHHHHHHHTT
T ss_pred CeeEcCccc-CCCcEEEcCCCCEeehhhhhhhcC
Confidence 588999999 999999999999999999999886
|
| >d1uita_ b.36.1.1 (A:) Discs large 5 protein KIAA0583 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Discs large 5 protein KIAA0583 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.68 E-value=2.1e-05 Score=68.71 Aligned_cols=46 Identities=22% Similarity=0.315 Sum_probs=42.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccCCcc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKECRIK 338 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 338 (681)
.|++||+||+|||.++.+.+++++..+|+ .....+.|++.++|...
T Consensus 59 gL~~GD~Il~INg~~v~~~~~~~~~~~l~-~~~~~v~l~v~~~p~~~ 104 (117)
T d1uita_ 59 GLEYGDQLLEFNGINLRSATEQQARLIIG-QQCDTITILAQYNPHVH 104 (117)
T ss_dssp TCCTTCEECEETTEETTTCCHHHHHHHTT-SCCSEEEEEECCCSCCC
T ss_pred CCCCCCEeeeECCcccCCCCHHHHHHHHH-CCCCeEEEEEEECCcce
Confidence 59999999999999999999999999999 67888999999999643
|
| >d1n7ea_ b.36.1.1 (A:) Glutamate receptor-interacting protein 1, GRIP1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor-interacting protein 1, GRIP1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.64 E-value=2.9e-05 Score=65.27 Aligned_cols=43 Identities=33% Similarity=0.628 Sum_probs=40.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+..+|+ ..+..+.|++.+.+
T Consensus 46 ~L~~GD~Il~INg~~v~~~~~~ev~~~l~-~~~~~v~l~v~r~~ 88 (95)
T d1n7ea_ 46 AIHIGDRILAINSSSLKGKPLSEAIHLLQ-MAGETVTLKIKKQT 88 (95)
T ss_dssp CCCTTCEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 59999999999999999999999999999 56788999999876
|
| >d1v62a_ b.36.1.1 (A:) Glutamate receptor interacting protein 2, GRIP2 (KIAA1719) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor interacting protein 2, GRIP2 (KIAA1719) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.62 E-value=2.7e-05 Score=68.07 Aligned_cols=43 Identities=30% Similarity=0.450 Sum_probs=40.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++++.+++|+..+|+ .....++|++.+.+
T Consensus 60 ~L~~GD~Il~VNg~~v~~~~~~~v~~~l~-~~~~~v~l~v~~~~ 102 (117)
T d1v62a_ 60 ALHPGDHILSIDGTSMEHCSLLEATKLLA-SISEKVRLEILPVP 102 (117)
T ss_dssp CCCTTCBEEEETTEETTSCCHHHHHHHHH-SCSSEEEEEECCBT
T ss_pred CCChhheeeeECCEecCCCCHHHHHHHHH-cCCCcEEEEEEECC
Confidence 59999999999999999999999999999 57788999999887
|
| >d1p1da2 b.36.1.1 (A:115-213) Glutamate receptor interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.61 E-value=1.9e-05 Score=66.91 Aligned_cols=43 Identities=16% Similarity=0.434 Sum_probs=39.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+-.+|+ .....++|++.++.
T Consensus 56 ~L~~GD~Il~VNg~~v~~~s~~e~~~ll~-~~~~~v~L~V~r~~ 98 (99)
T d1p1da2 56 TLELGDKLLAIDNIRLDSCSMEDAVQILQ-QCEDLVKLKIRKDE 98 (99)
T ss_dssp CCCTTCEEEEETTEEGGGCCHHHHHHHHH-HCTTCEEEEEECCC
T ss_pred CCCCCCEEEeeCCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 49999999999999999999999999999 45667999998875
|
| >d1qava_ b.36.1.1 (A:) Syntrophin {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Syntrophin species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.61 E-value=2.8e-05 Score=64.74 Aligned_cols=41 Identities=24% Similarity=0.349 Sum_probs=37.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
.|++||+||+|||+++.+.+.+++..+|+ .....+.|++.|
T Consensus 48 ~L~~GD~Il~INg~~v~~~~~~~~~~~l~-~~~~~v~l~v~~ 88 (90)
T d1qava_ 48 ALFVGDAILSVNGEDLSSATHDEAVQALK-KTGKEVVLEVKY 88 (90)
T ss_dssp CCCTTEEEEEETTEECTTCCHHHHHHHHH-TCCSEEEEEEEE
T ss_pred CCCccCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEE
Confidence 59999999999999999999999999999 556789999876
|
| >d2fnea1 b.36.1.1 (A:1955-2042) Multiple PDZ domain protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Multiple PDZ domain protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.59 E-value=2.8e-05 Score=64.44 Aligned_cols=40 Identities=25% Similarity=0.455 Sum_probs=36.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (681)
.|++||+||+|||.++++.+++++..+|+ .+.+.+.|+|.
T Consensus 48 ~l~~GD~Il~INg~~v~~~~~~~v~~~l~-~~~~~v~L~Vl 87 (88)
T d2fnea1 48 RLKRGDQIIAVNGQSLEGVTHEEAVAILK-RTKGTVTLMVL 87 (88)
T ss_dssp CCCTTCEEEEETTEECTTCCHHHHHHHHH-HCCSSEEEEEE
T ss_pred CCcCCcEEEEECCEECCCCCHHHHHHHHH-cCCCcEEEEEE
Confidence 59999999999999999999999999999 66778888874
|
| >d1u5sb2 g.39.1.3 (B:103-137) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.57 E-value=1e-05 Score=52.95 Aligned_cols=33 Identities=30% Similarity=0.899 Sum_probs=29.8
Q ss_pred cccccCcCcc-CCceEeeCCeeeeccccccccCC
Q psy5063 37 FRCSACDVML-DNWYFEKDGLLFCKEDYNGKYGE 69 (681)
Q Consensus 37 F~C~~C~~~L-~~~~~~~dg~~yC~~cY~~~f~~ 69 (681)
|+|+.|.+|. +.+.|++.|..||+.+|.++|+.
T Consensus 1 FvCA~CekPF~G~rhyE~~g~ayCe~Hy~qLfg~ 34 (35)
T d1u5sb2 1 FVCAKCEKPFLGHRHYERKGLAYCETHYNQLFGD 34 (35)
T ss_dssp CBCTTTCCBCSSSCCEEETTEEECHHHHHHHCSC
T ss_pred CcccccCCccCCchhhhhcCchHHHHHHHHHhcc
Confidence 8999999987 55899999999999999999874
|
| >d1um1a_ b.36.1.1 (A:) Hypothetical protein KIAA1849 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Hypothetical protein KIAA1849 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.56 E-value=3.6e-05 Score=66.42 Aligned_cols=43 Identities=35% Similarity=0.405 Sum_probs=40.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++++.+++|+-.+|+ .....++|++.+.+
T Consensus 54 ~L~~GD~Il~INg~~v~~~~~~ev~~llk-~~~~~v~l~v~r~~ 96 (110)
T d1um1a_ 54 RLSLGDRILEVNGSSLLGLGYLRAVDLIR-HGGKKMRFLVAKSD 96 (110)
T ss_dssp CCCTTCEEEEESSCBCSSCCHHHHHHHHH-TCCSEEEEEEECCC
T ss_pred CCccCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 49999999999999999999999999999 56788999998877
|
| >d1y7na1 b.36.1.1 (A:12-90) Amyloid beta A4 precursor protein-binding family A member 1 (APBA1, X11) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Amyloid beta A4 precursor protein-binding family A member 1 (APBA1, X11) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.56 E-value=3.1e-05 Score=62.88 Aligned_cols=40 Identities=20% Similarity=0.475 Sum_probs=36.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (681)
.|++||+|++|||.++.+.+.+|+-.+|+ .+...+.|++.
T Consensus 37 gL~~GD~Il~INg~~v~~~~~~~~~~ll~-~~~~~v~l~vi 76 (79)
T d1y7na1 37 GVRVGHRIIEINGQSVVATPHEKIVHILS-NAVGEIHMKTM 76 (79)
T ss_dssp TCCSSCEEEEETTEECTTSCHHHHHHHHH-HCCEEEEEEEE
T ss_pred CCCCCCEEEEECCEEeCCCCHHHHHHHHH-cCCCEEEEEEE
Confidence 79999999999999999999999999999 56677888773
|
| >d2d8za2 g.39.1.3 (A:33-64) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.54 E-value=8.9e-06 Score=53.35 Aligned_cols=31 Identities=23% Similarity=0.626 Sum_probs=27.7
Q ss_pred ccccCcCccCC-ceEeeCCeeeeccccccccC
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~ 68 (681)
.|..|+++|++ +|..+|++|||-+||..+|+
T Consensus 1 ~C~~C~~~L~GQry~~rd~~PyC~~Cf~~lfA 32 (32)
T d2d8za2 1 VCTACRKQLSGQRFTARDDFAYCLNCFCDLYA 32 (32)
T ss_dssp BCSSSCCBCTTSCCEESSSSEECHHHHHHHTC
T ss_pred CcccCCccccCceeeecCCCeehHHhhHhhcC
Confidence 48899999976 78899999999999998874
|
| >d1t2ma1 b.36.1.1 (A:2-93) Afadin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Afadin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.54 E-value=4.1e-05 Score=63.88 Aligned_cols=42 Identities=24% Similarity=0.413 Sum_probs=38.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
.|++||+||+|||.++.+.+.+|+-.+|+ .....++|++.+.
T Consensus 49 ~L~~GD~Il~VNg~~v~~~s~~ea~~~l~-~~~~~v~L~v~R~ 90 (92)
T d1t2ma1 49 RLAAGDQLLSVDGRSLVGLSQERAAELMT-RTSSVVTLEVAKQ 90 (92)
T ss_dssp CCCSSEEEEEETTEECTTCCHHHHHHHHH-SCCSEEEEEEEEC
T ss_pred CCCcccEeeeeCCeecCCCCHHHHHHHHH-cCCCeEEEEEEeC
Confidence 59999999999999999999999999999 6778899998764
|
| >d1r6ja_ b.36.1.1 (A:) Syntenin 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Syntenin 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.53 E-value=3.6e-05 Score=62.90 Aligned_cols=40 Identities=25% Similarity=0.315 Sum_probs=36.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (681)
-|++||+||||||.++.+.+.+|+-.+|+ .....+.|+|.
T Consensus 40 Gl~~GD~Il~INg~~v~~~t~~~~~~ll~-~~~~~v~l~v~ 79 (82)
T d1r6ja_ 40 GLLTEHNICEINGQNVIGLKDSQIADILS-TSGTVVTITIM 79 (82)
T ss_dssp TCCSSEEEEEETTEECTTCCHHHHHHHHH-HSCSEEEEEEE
T ss_pred CcCCCCEEEEeCCeEEeeCCHHHHHHHHH-cCCCEEEEEEE
Confidence 48999999999999999999999999999 66788888885
|
| >d1ihja_ b.36.1.1 (A:) Inad {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Inad species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=97.52 E-value=4.1e-05 Score=64.09 Aligned_cols=41 Identities=39% Similarity=0.557 Sum_probs=37.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
.|++||+||+|||.++.+.+.+++-.+|+ .+...++|+|.+
T Consensus 53 ~L~~GD~Il~VNg~~v~~~~~~~~~~ll~-~~~~~v~L~V~R 93 (94)
T d1ihja_ 53 RLKVGDRILSLNGKDVRNSTEQAVIDLIK-EADFKIELEIQT 93 (94)
T ss_dssp SCCTTCEEEEETTEECTTCCHHHHHHHHH-HSCSEEEEEEEE
T ss_pred CCChhcEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEe
Confidence 59999999999999999999999999999 567789998864
|
| >d2h3la1 b.36.1.1 (A:1310-1412) Erbin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Erbin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.52 E-value=6.2e-05 Score=64.19 Aligned_cols=43 Identities=23% Similarity=0.384 Sum_probs=39.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+.+|+-.+|+ .....+.|++.+..
T Consensus 59 ~L~~GD~Il~VNg~~v~~~t~~eav~~l~-~~~~~v~L~V~R~~ 101 (103)
T d2h3la1 59 LLQPGDKIIQANGYSFINIEHGQAVSLLK-TFQNTVELIIVREV 101 (103)
T ss_dssp TCCTTCEEEEETTEECSSCCHHHHHHHHH-HCCSEEEEEEEEEE
T ss_pred ccCCCCEEEEECCEECCCCCHHHHHHHHH-hCCCeEEEEEEEEC
Confidence 69999999999999999999999999999 56778999998764
|
| >d1ujda_ b.36.1.1 (A:) Hypothetical protein KIAA0559 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Hypothetical protein KIAA0559 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.52 E-value=4.7e-05 Score=66.47 Aligned_cols=43 Identities=26% Similarity=0.360 Sum_probs=39.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+++++|+..+|+ .....+.|+|.++.
T Consensus 67 ~L~~GD~Il~INg~~v~~~s~~e~~~~i~-~~~~~v~l~v~r~~ 109 (117)
T d1ujda_ 67 KLMEGMQVLEWNGIPLTSKTYEEVQSIIS-QQSGEAEICVRLDL 109 (117)
T ss_dssp SCCTTCEEEEETTEECTTCCHHHHHHHHS-CCSSCEEEEEESSC
T ss_pred CCCCCCEEEEECCEECCCCcHHHHHHHHH-cCCCeEEEEEEECC
Confidence 59999999999999999999999999999 56667999999887
|
| >d2f5ya1 b.36.1.1 (A:19-95) Regulator of G-protein signaling 3, RGS3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Regulator of G-protein signaling 3, RGS3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=5.3e-05 Score=61.08 Aligned_cols=41 Identities=22% Similarity=0.281 Sum_probs=38.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
-|++||+|++|||.++.+++.+|+..+++ .....++|++.+
T Consensus 35 GL~~GD~Il~Vng~~v~~~~~~~v~~~i~-~~~~~v~L~v~R 75 (77)
T d2f5ya1 35 GLQQLDTVLQLNERPVEHWKCVELAHEIR-SCPSEIILLVWR 75 (77)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-TCSSEEEEEEEE
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-CCCCEEEEEEEE
Confidence 59999999999999999999999999999 777889999875
|
| >d1wfva_ b.36.1.1 (A:) Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.51 E-value=3.4e-05 Score=65.86 Aligned_cols=43 Identities=23% Similarity=0.415 Sum_probs=40.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+.+|+-.+|+ ...+.++|++.+.+
T Consensus 54 ~L~~GD~Il~INg~~v~~~s~~ev~~~l~-~~~~~v~l~v~R~~ 96 (103)
T d1wfva_ 54 RMRVGDQIIEINGESTRDMTHARAIELIK-SGGRRVRLLLKRGT 96 (103)
T ss_dssp SSCTTCEEEEETTEECSSCCHHHHHHHHH-HHCSEECEEEECTT
T ss_pred CCCCCCEEEEECCEECCCCcHHHHHHHHH-cCCCEEEEEEEECC
Confidence 59999999999999999999999999999 57789999999987
|
| >d1rgra_ b.36.1.1 (A:) Synaptic protein PSD-95 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Synaptic protein PSD-95 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.50 E-value=4.7e-05 Score=63.58 Aligned_cols=43 Identities=19% Similarity=0.301 Sum_probs=39.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+.+++-.+|+ .+...++|++.+..
T Consensus 49 ~L~~GD~Il~VNg~~v~~~s~~e~~~~l~-~~~~~v~L~v~R~~ 91 (93)
T d1rgra_ 49 RLRVNDSILFVNEVDVREVTHSAAVEALK-EAGSIVRLYVMRRK 91 (93)
T ss_dssp CCCTTCEEEEETTEECSSSCHHHHHHHHH-HTTTEEEEEEECSC
T ss_pred CCCcCcEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEeCC
Confidence 59999999999999999999999999999 57788999998754
|
| >d1wf8a1 b.36.1.1 (A:8-101) Neurabin-i {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Neurabin-i species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.48 E-value=4.2e-05 Score=64.08 Aligned_cols=42 Identities=21% Similarity=0.324 Sum_probs=38.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
.|++||+||+|||.++.+.+.+++-.+|+ .+...++|++.++
T Consensus 51 ~L~~GD~Il~VNg~~v~~~~~~~~~~~l~-~~~~~v~L~V~R~ 92 (94)
T d1wf8a1 51 RIQVNDQIVEVDGISLVGVTQNFAATVLR-NTKGNVRFVIGRE 92 (94)
T ss_dssp SSCTTCBEEEETTEECBSCCHHHHHHHHH-HCCSEEEEEEEEE
T ss_pred CCCcCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEeC
Confidence 59999999999999999999999999999 5667899999764
|
| >d1uewa_ b.36.1.1 (A:) Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.48 E-value=4.2e-05 Score=66.32 Aligned_cols=43 Identities=30% Similarity=0.527 Sum_probs=39.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.+|.+.+.+|+..+|+ .....++|++.+..
T Consensus 61 ~L~~GD~Il~VNg~~v~~~~~~ev~~ll~-~~~~~v~l~V~r~~ 103 (114)
T d1uewa_ 61 KLKVGDRILAVNGQSIINMPHADIVKLIK-DAGLSVTLRIIPQE 103 (114)
T ss_dssp SCCTTCBEEEETTBCTTTSCHHHHHHHHH-HTTTEEEEEECCCS
T ss_pred cCCcCcEEeEeCCcccCCCcHHHHHHHHH-cCCCeEEEEEEeCC
Confidence 59999999999999999999999999999 66788999998876
|
| >d1q3oa_ b.36.1.1 (A:) Shank1, PDZ domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Shank1, PDZ domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.48 E-value=4.1e-05 Score=65.26 Aligned_cols=43 Identities=28% Similarity=0.406 Sum_probs=39.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+++.+++..+|+ .++..+.|++...|
T Consensus 60 GL~~GD~Il~INg~~v~~~~h~evv~~ik-~~~~~v~L~V~~~~ 102 (104)
T d1q3oa_ 60 GLRMGDFLIEVNGQNVVKVGHRQVVNMIR-QGGNTLMVKVVMVT 102 (104)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-HTTTEEEEEEEEEE
T ss_pred CCCCCCEEEEEcCeEcCCCCHHHHHHHHH-cCCCeEEEEEEecC
Confidence 59999999999999999999999999999 67888999987655
|
| >d1vaea_ b.36.1.1 (A:) Rhophilin-2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Rhophilin-2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.48 E-value=4.7e-05 Score=65.88 Aligned_cols=42 Identities=17% Similarity=0.283 Sum_probs=37.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
-|++||+||+|||.+|++++++|+-.+|++.....++|++..
T Consensus 53 GL~~GD~Il~INg~~v~~~~~~ev~~llk~~~~~~v~l~v~~ 94 (111)
T d1vaea_ 53 GAKEGDYIVSIQGVDCKWLTVSEVMKLLKSFGGEEVEMKVVS 94 (111)
T ss_dssp HCCTTCEEEEETTEECSSCCHHHHHHHHHHTTTSEECEEEEC
T ss_pred ccCcccEEEEECCEEcCCCCHHHHHHHHHcCCCCeEEEEEEC
Confidence 499999999999999999999999999996667788888765
|
| >d1kwaa_ b.36.1.1 (A:) Cask/Lin-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Cask/Lin-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.48 E-value=4.2e-05 Score=63.32 Aligned_cols=40 Identities=28% Similarity=0.586 Sum_probs=36.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (681)
.|++||+|++|||+++.+.+++++..+++ .+...+.|+|.
T Consensus 43 ~l~~GD~Il~INg~~v~~~~~~~~~~ll~-~~~~~v~L~i~ 82 (88)
T d1kwaa_ 43 TLHVGDEIREINGISVANQTVEQLQKMLR-EMRGSITFKIV 82 (88)
T ss_dssp CCCTTCEEEEETTEEGGGSCHHHHHHHHH-HCCEEEEEEEE
T ss_pred CCccCcEEEEECCEECCCCCHHHHHHHHH-cCCCcEEEEEE
Confidence 59999999999999999999999999999 55667888886
|
| >d1uhpa_ b.36.1.1 (A:) Hypothetical protein KIAA1095 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Hypothetical protein KIAA1095 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.47 E-value=5.6e-05 Score=64.88 Aligned_cols=43 Identities=26% Similarity=0.408 Sum_probs=39.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+-.+|+ .....+.|++.+.+
T Consensus 59 ~L~~GD~Il~VNg~~v~~~t~~eav~~lk-~~~~~v~l~v~r~~ 101 (107)
T d1uhpa_ 59 GLQIHDRIIEVNGRDLSRATHDQAVEAFK-TAKEPIVVQVLRRT 101 (107)
T ss_dssp CCCSSCEEEEETTEECTTCCHHHHHHHHH-HCCSSEEEEEEECC
T ss_pred CCcceeEEeEECCEECCCCCHHHHHHHHH-hCCCcEEEEEEECC
Confidence 59999999999999999999999999999 56778899998876
|
| >d2fe5a1 b.36.1.1 (A:223-314) Synapse-associated protein 102 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Synapse-associated protein 102 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.46 E-value=6e-05 Score=62.83 Aligned_cols=41 Identities=29% Similarity=0.491 Sum_probs=37.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
.|++||+||+|||+++.+.+.+|+-.+|+ .....+.|++.+
T Consensus 49 ~L~~GD~Il~VNg~~v~~~~~~e~~~~lk-~~~~~v~L~v~R 89 (92)
T d2fe5a1 49 RLQIGDRLLAVNNTNLQDVRHEEAVASLK-NTSDMVYLKVAK 89 (92)
T ss_dssp CCCTTCEEEEETTEECTTCBHHHHHHHHH-TCCSEEEEEEEC
T ss_pred CCCCCCEEEEeCCeecCCCCHHHHHHHHH-cCCCEEEEEEEC
Confidence 59999999999999999999999999999 566788888874
|
| >d1va8a1 b.36.1.1 (A:8-107) Maguk p55 subfamily member 5 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Maguk p55 subfamily member 5 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.45 E-value=0.00018 Score=60.80 Aligned_cols=39 Identities=36% Similarity=0.514 Sum_probs=34.3
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQI 331 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (681)
.|++||+|++|||+++.+.+++|+..+|+ .+...+.|++
T Consensus 59 ~l~~GD~Il~VNg~~v~~~~~~~~~~ll~-~~~~~v~L~v 97 (100)
T d1va8a1 59 LLHEGDEVLEINGIEIRGKDVNEVFDLLS-DMHGTLTFVL 97 (100)
T ss_dssp CCCTTCEEEEETTEECTTCCHHHHHHHHH-HCCEEEEEEE
T ss_pred ccCccCEEEEECCEEEcCCCHHHHHHHHH-cCCCeEEEEE
Confidence 49999999999999999999999999999 4555677765
|
| >d1w9ea1 b.36.1.1 (A:110-194) Syntenin 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Syntenin 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.44 E-value=7.4e-05 Score=61.28 Aligned_cols=44 Identities=16% Similarity=0.309 Sum_probs=39.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+|++|||.++.+.+.+++..+|++..+..+.|++...|
T Consensus 42 GL~~GD~Il~Vng~~v~~~~~~~v~~~lk~~~~~~v~l~v~~rP 85 (85)
T d1w9ea1 42 GLRFGDQVLQINGENCAGWSSDKAHKVLKQAFGEKITMTIRDRP 85 (85)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHHHCCSSEEEEEEECCT
T ss_pred CCCCccEEEEECCEEeCCCCHHHHHHHHhcCCCCEEEEEEeCCC
Confidence 58999999999999999999999999999777788999887665
|
| >d1rzxa_ b.36.1.1 (A:) GTPase-binding domain of the cell polarity protein par6 (Par-6B) {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: GTPase-binding domain of the cell polarity protein par6 (Par-6B) species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=97.43 E-value=6.1e-05 Score=63.61 Aligned_cols=40 Identities=28% Similarity=0.404 Sum_probs=36.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (681)
.|++||+|++|||.++.+.+++|+..+|+ .+...++|++.
T Consensus 56 ~l~~GD~Il~VNg~~v~~~~~~~~~~~l~-~~~~~v~l~v~ 95 (98)
T d1rzxa_ 56 LLAVNDEVIEVNGIEVAGKTLDQVTDMMV-ANSSNLIITVK 95 (98)
T ss_dssp CCCTTCEEEEETTEECTTCCHHHHHHHHH-HTCTEEEEEEE
T ss_pred cCCCCcEEeeECCEECCCCCHHHHHHHHH-cCCCeEEEEEE
Confidence 59999999999999999999999999999 66777888774
|
| >d1ujua_ b.36.1.1 (A:) Scribble (KIAA0147) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Scribble (KIAA0147) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.43 E-value=2.6e-05 Score=67.46 Aligned_cols=43 Identities=26% Similarity=0.302 Sum_probs=39.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+-.+|+ .....+.|+|.+..
T Consensus 62 ~L~~GD~Il~VNg~~v~~~t~~ea~~~lk-~~~~~v~L~V~r~~ 104 (111)
T d1ujua_ 62 RLRVGLRLLEVNQQSLLGLTHGEAVQLLR-SVGDTLTVLVCDGF 104 (111)
T ss_dssp SCCTTCBCCBBSSCBCTTSCHHHHHHHHS-SCSSEEEECCCCCC
T ss_pred CCccceeeeeeCCcccCCCCHHHHHHHHH-cCCCeEEEEEEECC
Confidence 49999999999999999999999999999 67788999998876
|
| >d1imla2 g.39.1.3 (A:29-76) Cysteine-rich (intestinal) protein, CRP, CRIP {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Rat (Rattus rattus) [TaxId: 10117]
Probab=97.43 E-value=2.9e-05 Score=55.76 Aligned_cols=36 Identities=22% Similarity=0.526 Sum_probs=31.0
Q ss_pred ccccCcCccCC-ceEeeCCeeee-ccccccccCCcccc
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFC-KEDYNGKYGEACQN 73 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC-~~cY~~~f~~~C~~ 73 (681)
+|..|++.|+. ..-++||++|| +.||.++|+|+=.+
T Consensus 1 kC~~C~K~L~sg~~aeHdg~pYC~k~CY~~~FGPkG~g 38 (48)
T d1imla2 1 KCEKCGKTLTSGGHAEHEGKPYCNHPCYSAMFGPKGFG 38 (48)
T ss_dssp BCTTTCCBCCTTTEEEETTEEEETTTHHHHHSSCCCSS
T ss_pred CchhcCcCcCCCChhhcCCcccccccchhhccCCCccc
Confidence 68999999965 78899999999 77999999987443
|
| >d1x3ha2 g.39.1.3 (A:43-74) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.42 E-value=1.5e-05 Score=52.46 Aligned_cols=30 Identities=30% Similarity=0.678 Sum_probs=26.5
Q ss_pred ccccCcCccC-CceEeeCCeeeecccccccc
Q psy5063 38 RCSACDVMLD-NWYFEKDGLLFCKEDYNGKY 67 (681)
Q Consensus 38 ~C~~C~~~L~-~~~~~~dg~~yC~~cY~~~f 67 (681)
+|.+|.++.. +.||+.||+|||+.+|.++.
T Consensus 1 VC~~C~~PF~~~~Fy~~~g~PyCe~HyH~~~ 31 (32)
T d1x3ha2 1 VCGDCFTSFSTGSFFELDGRPFCELHYHHRR 31 (32)
T ss_dssp BCSSSCCBSCSSCCEESSSCEECHHHHHHHH
T ss_pred CcCccCCcCCCCCeEeECCccchHHhhhhhc
Confidence 5899999995 58999999999999998764
|
| >d1ujva_ b.36.1.1 (A:) Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.41 E-value=8.2e-05 Score=62.53 Aligned_cols=44 Identities=23% Similarity=0.289 Sum_probs=39.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC-CceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+-.+|++.+ ...+.|++.+.+
T Consensus 47 ~L~~GD~Il~VNg~~v~~~t~~evv~~lk~~~~g~~v~l~v~R~~ 91 (96)
T d1ujva_ 47 GLCEGDLIVEINQQNVQNLSHTEVVDILKDCPIGSETSLIIHRGS 91 (96)
T ss_dssp TCCSSCEEEEETTEECSSCCHHHHHHHHHHSCTTSEEEEEEECCS
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHcCCCCCEEEEEEEECC
Confidence 69999999999999999999999999999654 468999998866
|
| >d1g9oa_ b.36.1.1 (A:) Na+/H+ exchanger regulatory factor, NHERF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Na+/H+ exchanger regulatory factor, NHERF species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.41 E-value=8.4e-05 Score=61.89 Aligned_cols=41 Identities=32% Similarity=0.466 Sum_probs=37.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (681)
-|++||+||+|||.++.+.+++|+-.+|+ .....++|++..
T Consensus 44 Gl~~GD~Il~VNg~~v~~~t~~e~~~ll~-~~~~~v~L~v~~ 84 (91)
T d1g9oa_ 44 GLLAGDRLVEVNGENVEKETHQQVVSRIR-AALNAVRLLVVD 84 (91)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-TCSSEEEEEEEC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCeEEEEEEC
Confidence 58999999999999999999999999999 677789998864
|
| >d1x5qa1 b.36.1.1 (A:8-104) Scribble (KIAA0147) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Scribble (KIAA0147) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.41 E-value=8.4e-05 Score=62.53 Aligned_cols=42 Identities=29% Similarity=0.518 Sum_probs=39.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
-|++||+|++|||+.+.+.+.+++-.+|+ ..+..+.|+|.+|
T Consensus 56 GL~~GD~Il~VNg~~v~~~~~~~~~~~l~-~~~~~v~l~v~R~ 97 (97)
T d1x5qa1 56 GVRVGDKLLEVNGVALQGAEHHEAVEALR-GAGTAVQMRVWRE 97 (97)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHH-SCCSEEEEEEEEC
T ss_pred cccCCCEEEEECCEECCCCCHHHHHHHHh-CCCCEEEEEEEEC
Confidence 49999999999999999999999999999 6788999999875
|
| >d1ibia2 g.39.1.3 (A:145-175) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=97.39 E-value=1.8e-05 Score=50.07 Aligned_cols=29 Identities=38% Similarity=0.834 Sum_probs=25.8
Q ss_pred cccccCcCccCC-ceEeeCCeeeecccccc
Q psy5063 37 FRCSACDVMLDN-WYFEKDGLLFCKEDYNG 65 (681)
Q Consensus 37 F~C~~C~~~L~~-~~~~~dg~~yC~~cY~~ 65 (681)
|+|+.|++.|.+ ..-.+||.+||+.||.+
T Consensus 1 frca~cgk~lestt~adkdgeiyck~cyak 30 (31)
T d1ibia2 1 FRCAKCGKSLESTTLTEKEGEIYCKGCYAK 30 (31)
T ss_dssp EECSSSCCEECSSCSEEETTEEECHHHHHH
T ss_pred CccccccCccccceeeccCCcEEEeeeeec
Confidence 899999999976 56799999999999964
|
| >d1wiga1 g.39.1.3 (A:1-32) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.37 E-value=2.5e-05 Score=49.81 Aligned_cols=26 Identities=31% Similarity=1.037 Sum_probs=24.6
Q ss_pred CcccccCCccccCeEEecCccCCCCc
Q psy5063 69 EACQNCGQMMSGPVMVVGDHKFHPEC 94 (681)
Q Consensus 69 ~~C~~C~~~I~g~~~~a~~~~yH~~C 94 (681)
.-|..|.+.|+|.++.|++++|||.|
T Consensus 6 sgC~~C~~~ItGkVLEAG~khYHP~C 31 (32)
T d1wiga1 6 SGCDSCEKYITGRVLEAGEKHYHPSC 31 (32)
T ss_dssp CSCSSSCCCCSSCCBCCSSCCBCTTT
T ss_pred chhhhhhhhhhhhhhhccccccCCCC
Confidence 46999999999999999999999998
|
| >d1ueqa_ b.36.1.1 (A:) Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.36 E-value=0.00013 Score=64.23 Aligned_cols=44 Identities=16% Similarity=0.205 Sum_probs=39.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC-CceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.+|.+.+++|+..+|++.. ...++|++.+..
T Consensus 62 ~L~~GD~Il~INg~~v~~~t~~eav~~l~~~~~g~~v~L~v~R~~ 106 (123)
T d1ueqa_ 62 KMETGDVIVYINEVCVLGHTHADVVKLFQSVPIGQSVNLVLCRGY 106 (123)
T ss_dssp CCCTTCEEEEETTEECTTSCHHHHHHHHHTSCTTCEEEEEEEESC
T ss_pred CCeeCCEEEEECCEECCCCCHHHHHHHHHcCCCCCEEEEEEEcCC
Confidence 59999999999999999999999999999543 578999998754
|
| >d2csja1 b.36.1.1 (A:8-111) Tight junction protein ZO-2, Tjp2 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Tight junction protein ZO-2, Tjp2 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.35 E-value=7.2e-05 Score=63.83 Aligned_cols=43 Identities=23% Similarity=0.288 Sum_probs=38.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||+++.+.+++|+-.+|++ +...+.|+|.+..
T Consensus 55 ~L~~GD~Il~INg~~v~~~~~~ev~~ll~~-~~~~v~l~V~R~~ 97 (104)
T d2csja1 55 LLQENDRVVMVNGTPMEDVLHSFAVQQLRK-SGKIAAIVVKRPR 97 (104)
T ss_dssp HBCTTCEEEEESSCBCBTCCHHHHHHHHHH-SCSEEEEEEEEEE
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHc-CCCEEEEEEEeCC
Confidence 699999999999999999999999999994 5678999998753
|
| >d1x5ra1 b.36.1.1 (A:8-106) Glutamate receptor interacting protein 2, GRIP2 (KIAA1719) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor interacting protein 2, GRIP2 (KIAA1719) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.34 E-value=4.6e-05 Score=64.51 Aligned_cols=43 Identities=26% Similarity=0.485 Sum_probs=36.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 334 (681)
.|++||+|++|||.++.+.+++|+..+|+|. ....|.|+++.|
T Consensus 56 ~l~~GD~Il~INg~~v~~~t~~e~~~~lr~~~~~~~l~l~v~~~ 99 (99)
T d1x5ra1 56 LLQVGDRVLSINGIATEDGTMEEANQLLRDAALAHKVVLEVEFD 99 (99)
T ss_dssp SCCTTCBCSEETTEESTTSBHHHHHHHHHHHHTTTCEEEEEEEC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCEEEEEEEcC
Confidence 5999999999999999999999999999854 345577777765
|
| >d1v5la_ b.36.1.1 (A:) Alpha-actinin-2 associated LIM protein {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Alpha-actinin-2 associated LIM protein species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.34 E-value=9.1e-05 Score=63.11 Aligned_cols=43 Identities=21% Similarity=0.226 Sum_probs=39.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+-.+|+ .....+.|+|.++.
T Consensus 46 ~L~~GD~Il~VNg~~v~~~~~~e~v~ll~-~~~~~v~l~V~R~~ 88 (103)
T d1v5la_ 46 NLCPGDVILAIDGFGTESMTHADAQDRIK-AASYQLCLKIDRAE 88 (103)
T ss_dssp TCCTTCBEEEETTEECSSCCHHHHHHHHT-TCCSEEECEECCCT
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHH-cCCCEEEEEEEECC
Confidence 69999999999999999999999999999 66778999999865
|
| >d1v5qa_ b.36.1.1 (A:) Glutamate receptor interacting protein {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Glutamate receptor interacting protein species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.34 E-value=4.6e-05 Score=67.09 Aligned_cols=43 Identities=28% Similarity=0.585 Sum_probs=35.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCce--eeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTV--LQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+++++|+..+|+ ..... |+|.+..+.
T Consensus 63 ~L~~GD~Il~INg~~v~~~~~~e~~~~lk-~~~~~~~l~l~~~~~~ 107 (122)
T d1v5qa_ 63 VLQIGDRVMAINGIPTEDSTFEEANQLLR-DSSITSKVTLEIEFDV 107 (122)
T ss_dssp CCCTTCCEEEETTEESSSSCHHHHHHHHH-HHTTTTCEEEEEEEEC
T ss_pred CCCcCCEEEEECCCcCCCCCHHHHHHHHH-cCCCceEEEEEEeccC
Confidence 59999999999999999999999999998 44433 555555554
|
| >d1fc6a3 b.36.1.3 (A:157-248) Photosystem II D1 C-terminal processing protease {Algae (Scenedesmus obliquus) [TaxId: 3088]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: Tail specific protease PDZ domain domain: Photosystem II D1 C-terminal processing protease species: Algae (Scenedesmus obliquus) [TaxId: 3088]
Probab=97.30 E-value=0.00014 Score=60.58 Aligned_cols=44 Identities=25% Similarity=0.388 Sum_probs=40.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+|++|||.++.+++++++..+|+...+..+.|+|.++-
T Consensus 36 Gl~~GD~I~~Ing~~v~~~~~~~~~~~l~g~~g~~v~l~i~R~g 79 (92)
T d1fc6a3 36 GARAGDVIVTVDGTAVKGMSLYDVSDLLQGEADSQVEVVLHAPG 79 (92)
T ss_dssp TCCTTCEEEEETTEECTTCCHHHHHHHHCBSTTCEEEEEEEETT
T ss_pred hhHcCCcceecCceEcCCCCHHHHHHHhhCCCCCEEEEEEEECC
Confidence 59999999999999999999999999999778889999999865
|
| >d1i16a_ b.36.1.2 (A:) Interleukin 16 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: Interleukin 16 domain: Interleukin 16 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.28 E-value=7.2e-05 Score=66.41 Aligned_cols=44 Identities=23% Similarity=0.325 Sum_probs=40.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+++++|+-.+|++..+..+.|+|.+.+
T Consensus 75 ~L~~GD~Il~VNg~~~~~~t~~eav~~l~~~~~~~v~l~v~r~~ 118 (130)
T d1i16a_ 75 TVQPGDEILQLGGTAMQGLTRFEAWNIIKALPDGPVTIVIRRKS 118 (130)
T ss_dssp CCCTTCCEEECSSCBGGGSCHHHHHHHHHTSCSSEEEEEEEEES
T ss_pred CcccCceeeeECCeecCCCcHHHHHHHHHcCCCCeEEEEEEcCC
Confidence 59999999999999999999999999999666778999999887
|
| >d2cuqa1 g.39.1.3 (A:43-74) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.26 E-value=3.9e-05 Score=49.55 Aligned_cols=31 Identities=16% Similarity=0.498 Sum_probs=27.4
Q ss_pred ccccCcCccCC-ceEeeCCeeeeccccccccC
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~ 68 (681)
.|..|+++|++ +|-.+|.++||-+||..+|+
T Consensus 1 vCt~Ck~~LaGqrFTSrde~pYC~~Cfg~LfA 32 (32)
T d2cuqa1 1 VCTGCQTPLAGQQFTSRDEDPYCVACFGELFA 32 (32)
T ss_dssp BCSSSCCBCTTCCEEECSSSEEEHHHHHHHTT
T ss_pred CccccCccccCCccccCCCCccHHHHhHhhcC
Confidence 48999999977 67799999999999988774
|
| >d1x62a2 g.39.1.3 (A:8-42) PDZ and LIM domain protein 1 Elfin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 1 Elfin species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.26 E-value=4.9e-05 Score=49.81 Aligned_cols=27 Identities=33% Similarity=0.866 Sum_probs=26.1
Q ss_pred CcccccCCccccCeEEecCccCCCCce
Q psy5063 69 EACQNCGQMMSGPVMVVGDHKFHPECF 95 (681)
Q Consensus 69 ~~C~~C~~~I~g~~~~a~~~~yH~~CF 95 (681)
+.|..|+..|.|.++.+.++.+||+||
T Consensus 9 p~CdkCg~GIVG~~VK~rDk~rHPeCf 35 (35)
T d1x62a2 9 PMCDKCGTGIVGVFVKLRDRHRHPECY 35 (35)
T ss_dssp CCCSSSCCCCCSSCEECSSCEECTTTT
T ss_pred ccccccCCCcEeEEEEeccccCCCCCC
Confidence 789999999999999999999999998
|
| >d1ueza_ b.36.1.1 (A:) KIAA1526 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: KIAA1526 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.24 E-value=0.00011 Score=62.26 Aligned_cols=42 Identities=21% Similarity=0.309 Sum_probs=36.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+||+|||.+|.+.+++++..+|++ +. .+.|++...+
T Consensus 52 gL~~GD~Il~ING~~v~~~~~~~v~~ll~~-~~-~~~l~V~~~~ 93 (101)
T d1ueza_ 52 GLRVGDQILRVNDKSLARVTHAEAVKALKG-SK-KLVLSVYSAG 93 (101)
T ss_dssp TCCSSCCEEEETTEECSSCCHHHHHHHSSS-SS-SCCEEECCCC
T ss_pred CCCCCcEEEEECCEECCCCCHHHHHHHHhc-CC-CEEEEEEECC
Confidence 499999999999999999999999999994 44 3667777766
|
| >d1zfoa_ g.39.1.4 (A:) LASP-1 {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LASP-1 domain: LASP-1 species: Pig (Sus scrofa) [TaxId: 9823]
Probab=97.20 E-value=4.4e-05 Score=48.49 Aligned_cols=28 Identities=36% Similarity=0.767 Sum_probs=26.5
Q ss_pred ccccccccccccCceEEecCccccccCc
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
+.|++|++.++..+-+..+++.||..||
T Consensus 3 ~~CaRC~k~VYp~Ekl~ClDk~WHK~CF 30 (30)
T d1zfoa_ 3 PNCARCGKIVYPTEKVNCLDKFWHKACF 30 (30)
T ss_dssp CBCSSSCSBCCGGGCCCSSSSCCCGGGC
T ss_pred CcccccCCccccHHHhhhhHHHHhhccC
Confidence 5799999999999999999999999998
|
| >d1b8ta2 g.39.1.3 (A:36-100) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.20 E-value=5.1e-05 Score=58.19 Aligned_cols=38 Identities=29% Similarity=0.545 Sum_probs=32.8
Q ss_pred ccccCcCccCC-ceEeeCCeeeeccccccccCCcccccC
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYNGKYGEACQNCG 75 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~~~C~~C~ 75 (681)
.|..|++.|++ ..-++|+++||+.||.++|+++=.+=+
T Consensus 1 ~C~~C~K~LdS~~~~eh~~e~YCk~CY~k~fGPkG~G~G 39 (65)
T d1b8ta2 1 LCMVCKKNLDSTTVAVHGDEIYCKSCYGKKYGPKGKGKG 39 (65)
T ss_dssp BCTTTCCBCCSSSEEEETTEEEEHHHHHHHHSCCCCCCC
T ss_pred CchhcCCccCCCccccCCCcccchhhhccccCCCccccc
Confidence 38899999976 678999999999999999998865554
|
| >d1rutx3 g.39.1.3 (X:83-113) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.19 E-value=4.2e-05 Score=49.84 Aligned_cols=27 Identities=41% Similarity=0.826 Sum_probs=24.2
Q ss_pred CcccccCCcc--ccCeEEecCccCCCCce
Q psy5063 69 EACQNCGQMM--SGPVMVVGDHKFHPECF 95 (681)
Q Consensus 69 ~~C~~C~~~I--~g~~~~a~~~~yH~~CF 95 (681)
..|++|++.| .+.+|+|.++.||.+||
T Consensus 3 g~Ca~C~~~I~~~e~VmRA~~~VyHl~CF 31 (31)
T d1rutx3 3 GACSACGQSIPASELVMRAQGNVYHLKCF 31 (31)
T ss_dssp EECTTTCCEECTTSEEEEETTEEECGGGC
T ss_pred cccccccCcCChhHhheecccceeeeccC
Confidence 4699999988 56799999999999998
|
| >d1x4la1 g.39.1.3 (A:8-36) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.18 E-value=7.2e-05 Score=47.21 Aligned_cols=26 Identities=46% Similarity=1.156 Sum_probs=23.3
Q ss_pred cccccccccc---CceEEecCccccccCc
Q psy5063 12 CAGCLNNIVE---DEYVQALSQEWHTDCF 37 (681)
Q Consensus 12 C~~C~~~I~~---~~~v~a~~~~wH~~CF 37 (681)
|++|.+||.. .+++...++.||.+||
T Consensus 1 C~~C~kPItg~gg~kyisFE~R~WH~~CF 29 (29)
T d1x4la1 1 CAGCTNPISGLGGTKYISFEERQWHNDCF 29 (29)
T ss_dssp BTTTTBCCCCSSSCSCEECSSCEECTTTC
T ss_pred CCccCCcccccCCceEEEeecccccccCC
Confidence 8999999953 4789999999999998
|
| >d1uepa_ b.36.1.1 (A:) Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Membrane associated guanylate kinase inverted-2 (MAGI-2, KIAA0705) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.18 E-value=0.00012 Score=62.38 Aligned_cols=44 Identities=25% Similarity=0.419 Sum_probs=37.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC-CceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+-.+|++.. ...+.|++.++.
T Consensus 52 ~L~~GD~Il~VNg~~v~~~t~~e~~~~l~~~~~~~~v~l~v~r~~ 96 (103)
T d1uepa_ 52 RLHPGDELVYVDGIPVAGKTHRYVIDLMHHAARNGQVNLTVRRKV 96 (103)
T ss_dssp CCCTTCEEEEETTEECTTSCHHHHHHHHHHHHHHTEEEEEEEEEC
T ss_pred CCCcCCEEEEECCEECCCCCHHHHHHHHHhCCCCCEEEEEEEeCC
Confidence 59999999999999999999999999999432 346888888765
|
| >d1v6ba_ b.36.1.1 (A:) Harmonin {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Harmonin species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.17 E-value=0.00013 Score=63.60 Aligned_cols=45 Identities=22% Similarity=0.292 Sum_probs=39.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC---CCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT---TDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 336 (681)
.|++||+||+|||.++.+.+++++..+|++. ....++|++.++|.
T Consensus 61 ~L~~GD~Il~VNg~~v~~~s~~e~~~~l~~~~~~~~~~V~L~v~r~pp 108 (118)
T d1v6ba_ 61 GVVKGDEIMAINGKIVTDYTLAEAEAALQKAWNQGGDWIDLVVAVCPP 108 (118)
T ss_dssp SSCTTCEEEEESSCBCTTCBHHHHHHHHHHHHHHTCSEEEEEEECCCS
T ss_pred CCCCCCEEeeECCEECCCCcHHHHHHHHHhcccCCCCEEEEEEEeCCC
Confidence 5999999999999999999999999999832 36679999999884
|
| >d1wi2a_ b.36.1.1 (A:) PDZ domain containing protein 11, Pdzk11 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: PDZ domain containing protein 11, Pdzk11 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.17 E-value=0.00018 Score=61.30 Aligned_cols=42 Identities=17% Similarity=0.252 Sum_probs=35.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+||+|||+++.+.+++|+-.+|++ .+ .+.|+|.+-+
T Consensus 58 GL~~GD~Il~VNg~~v~~~~~~ev~~llk~-~~-~v~l~V~~~~ 99 (104)
T d1wi2a_ 58 GLQEGDQVLAVNDVDFQDIEHSKAVEILKT-AR-EISMRVRFFS 99 (104)
T ss_dssp TCCTTCEEEEETTEECSSCCHHHHHHHHHH-SS-SEEEEEECCC
T ss_pred ccccCCEEEEECCEECCCCCHHHHHHHHhc-CC-eEEEEEEECC
Confidence 499999999999999999999999999994 43 5777876644
|
| >d1x45a1 b.36.1.1 (A:8-92) Amyloid beta A4 precursor protein-binding family A member 1 (APBA1, X11) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Amyloid beta A4 precursor protein-binding family A member 1 (APBA1, X11) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.17 E-value=0.00023 Score=58.31 Aligned_cols=40 Identities=28% Similarity=0.588 Sum_probs=33.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC-Cceeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQI 331 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 331 (681)
.|++||+||+|||.++.+.+++|+..+|++.. ...+.|+|
T Consensus 44 ~l~~GD~Il~VNg~~v~~~s~~e~~~~l~~~~~~~~v~L~V 84 (85)
T d1x45a1 44 KLNIGDQIMSINGTSLVGLPLSTCQSIIKGLKNQSRVKLNI 84 (85)
T ss_dssp SCCTTCEEEEETTEECTTCCHHHHHHHHHTTTTCSEEEEEE
T ss_pred CCCcCCEEEEECCEECCCCCHHHHHHHHHcCCCCCEEEEEE
Confidence 59999999999999999999999999999532 33466654
|
| >d1wi4a1 b.36.1.1 (A:8-103) Syntaxin binding protein 4 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Syntaxin binding protein 4 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.15 E-value=0.00018 Score=60.31 Aligned_cols=41 Identities=15% Similarity=0.376 Sum_probs=34.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC---CCceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT---TDTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 332 (681)
.|++||+||+|||+++.+.+.+|+-.+|++. .+.++++++.
T Consensus 52 ~L~~GD~Il~VNg~~v~~~~~~ea~~~l~~~~~~~~~~vel~~~ 95 (96)
T d1wi4a1 52 RLKPGDQLVSINKESMIGVSFEEAKSIITRAKLRSESPWEIAFI 95 (96)
T ss_dssp SCCTTCBEEEETTSCCTTCCHHHHHHHHHHSCCSSSSCEEEEEE
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhccCCCCCeEEEEEE
Confidence 5999999999999999999999999999843 3556776654
|
| >d1wyha1 g.39.1.3 (A:35-66) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.14 E-value=0.00011 Score=47.54 Aligned_cols=32 Identities=22% Similarity=0.675 Sum_probs=26.5
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
.|..|+++|+... ++.+++..||..||+++||
T Consensus 1 ~C~~C~qPIGtkS--Fip~~~~~yCvpCYE~kfA 32 (32)
T d1wyha1 1 LCSGCEQPLGSRS--FVPDKGAHYCVPCYENKFA 32 (32)
T ss_dssp BCTTTCCBTTTSC--EEEETTEEEEHHHHHHHTS
T ss_pred CcccccCcccccc--cccCCCcEEEEeccccccC
Confidence 3889999996654 5777888999999999886
|
| >d2cs5a1 b.36.1.1 (A:8-113) Tyrosine-protein phosphatase non-receptor type 4, PTPN4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Tyrosine-protein phosphatase non-receptor type 4, PTPN4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.14 E-value=0.00021 Score=61.09 Aligned_cols=44 Identities=18% Similarity=0.335 Sum_probs=36.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC---CceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT---DTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+..+|++.. ..++.|++..++
T Consensus 53 ~L~~GD~Il~VNg~~v~~~~~~e~~~ll~~~~~~~~~~v~L~vrp~~ 99 (106)
T d2cs5a1 53 RLNEGDQVVLINGRDIAEHTHDQVVLFIKASCERHSGELMLLVRPNA 99 (106)
T ss_dssp CCCTTCEEEEETTBCTTSSCHHHHHHHHHHHHHCCSSCEEEEEECCC
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHHhCCCCCCcEEEEEECCCC
Confidence 59999999999999999999999999998532 335777777655
|
| >d1x4ka1 g.39.1.3 (A:35-66) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.12 E-value=0.00012 Score=47.52 Aligned_cols=32 Identities=25% Similarity=0.582 Sum_probs=26.4
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
.|..|+++|+... ++..++..||..||+++||
T Consensus 1 ~C~~C~qPIGtks--fipk~~~~yCvpCyE~kfA 32 (32)
T d1x4ka1 1 ICHRCQQPIGTKS--FIPKDNQNFCVPCYEKQHA 32 (32)
T ss_dssp CCSSSCCCCCSSS--EEEETTEEEEHHHHHHHTS
T ss_pred CcccccCcccccc--cccCCCCceEeecchhhcC
Confidence 3889999997654 5677788999999999886
|
| >d2cu8a1 g.39.1.3 (A:8-37) Cysteine-rich (intestinal) protein, CRP, CRIP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.12 E-value=0.0001 Score=47.49 Aligned_cols=28 Identities=29% Similarity=0.707 Sum_probs=26.2
Q ss_pred ccccccccccccCceEEecCccccccCc
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
+.|++|+++++..|-+.++|+.||..|+
T Consensus 3 ~~CprC~K~VYfaEk~~~lgk~WHk~Cl 30 (30)
T d2cu8a1 3 SKCPKCDKTVYFAEKVSSLGKDWHKFCL 30 (30)
T ss_dssp CBCTTTCCBCCTTTEEEETTEEEETTTC
T ss_pred CcCCCCCCceeeHHhhccCCcccccccC
Confidence 5799999999999999999999999985
|
| >d1x64a1 g.39.1.3 (A:8-52) PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 3, PDLIM3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.11 E-value=8e-05 Score=52.06 Aligned_cols=27 Identities=41% Similarity=0.898 Sum_probs=26.2
Q ss_pred CcccccCCccccCeEEecCccCCCCce
Q psy5063 69 EACQNCGQMMSGPVMVVGDHKFHPECF 95 (681)
Q Consensus 69 ~~C~~C~~~I~g~~~~a~~~~yH~~CF 95 (681)
+.|..|+..|.|.++.+.++.+||+||
T Consensus 19 P~CdkCg~GIVG~~VK~rDK~rHPeCf 45 (45)
T d1x64a1 19 PLCDKCGSGIVGAVVKARDKYRHPECF 45 (45)
T ss_dssp CBCTTTCCBCCSCCEESSSCEECTTTC
T ss_pred ccccccCCCcEEEEEEeccccCCCCCC
Confidence 789999999999999999999999998
|
| >d2cssa1 b.36.1.1 (A:8-115) Regulating synaptic membrane exocytosis protein 1, RIMS1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Regulating synaptic membrane exocytosis protein 1, RIMS1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.11 E-value=0.0002 Score=61.49 Aligned_cols=41 Identities=27% Similarity=0.421 Sum_probs=34.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC-Cceeeeeee
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQIL 332 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 332 (681)
.|++||+||+|||.++.+.+++|+-.+|++.. ...++|++.
T Consensus 65 ~L~~GD~Il~VNg~~~~~~t~~ea~~~l~~~~~~~~v~l~v~ 106 (108)
T d2cssa1 65 HLRAGDEVLEWNGKPLPGATNEEVYNIILESKSEPQVEIIVS 106 (108)
T ss_dssp CCCTTCEEEEESSCBCTTSCHHHHHHHHHHGGGCSCEEEEEE
T ss_pred CCCcCCEEEEECCEECCCCCHHHHHHHHHhCCCCCEEEEEEe
Confidence 59999999999999999999999999998532 346777764
|
| >d1wifa_ b.36.1.1 (A:) hypothetical PDZ domain containing protein Uqcrc2 (4930408O21Rik) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: hypothetical PDZ domain containing protein Uqcrc2 (4930408O21Rik) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.10 E-value=0.00023 Score=62.81 Aligned_cols=44 Identities=32% Similarity=0.360 Sum_probs=39.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC-CceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT-DTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+.+++|+-.+|++.+ +..++|++.++-
T Consensus 67 ~l~~GD~Il~Ing~~v~~~~~~e~~~llr~~~~g~~v~L~v~R~~ 111 (126)
T d1wifa_ 67 ILQPGDVLISVGHANVLGYTLREFLKLLQNITIGTVLQIKAYRGF 111 (126)
T ss_dssp SSCTTCBEEEESSSCCTTCCHHHHHHHHTSCCSSCEEEEEEESSS
T ss_pred CCCCCCEEEEECCEEeEeccHHHHHHHHhCCCCCCEEEEEEEeCC
Confidence 59999999999999999999999999999644 578999999864
|
| >d2f0aa1 b.36.1.1 (A:251-342) Segment polarity protein dishevelled homolog Dvl-2 {African clawed frog (Xenopus laevis) [TaxId: 8355]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Segment polarity protein dishevelled homolog Dvl-2 species: African clawed frog (Xenopus laevis) [TaxId: 8355]
Probab=97.07 E-value=0.00024 Score=59.06 Aligned_cols=42 Identities=17% Similarity=0.275 Sum_probs=35.0
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC--CCceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT--TDTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 333 (681)
.|++||+||+|||+++.+.+.+|+-.++++. +...+.|+|.+
T Consensus 47 ~L~~GD~Il~VNg~~l~~~s~~eav~llk~~~~~~~~v~L~V~R 90 (92)
T d2f0aa1 47 RIEPGDMLLQVNDINFENMSNDDAVRVLRDIVHKPGPIVLTVAK 90 (92)
T ss_dssp CCCTTCEEEEETTEECTTCCHHHHHHHHHHHHHSSSCEEEEEEC
T ss_pred CCCCccEEEEECCEECCCCCHHHHHHHHHhccCCCCcEEEEEEe
Confidence 5999999999999999999999999999743 23457777754
|
| >d1x4la1 g.39.1.3 (A:8-36) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.02 E-value=0.00011 Score=46.29 Aligned_cols=25 Identities=28% Similarity=0.873 Sum_probs=22.8
Q ss_pred ccccCCcccc----CeEEecCccCCCCce
Q psy5063 71 CQNCGQMMSG----PVMVVGDHKFHPECF 95 (681)
Q Consensus 71 C~~C~~~I~g----~~~~a~~~~yH~~CF 95 (681)
|++|.+||+| .++.+.++.||.+||
T Consensus 1 C~~C~kPItg~gg~kyisFE~R~WH~~CF 29 (29)
T d1x4la1 1 CAGCTNPISGLGGTKYISFEERQWHNDCF 29 (29)
T ss_dssp BTTTTBCCCCSSSCSCEECSSCEECTTTC
T ss_pred CCccCCcccccCCceEEEeecccccccCC
Confidence 8999999975 589999999999998
|
| >d1x63a1 g.39.1.3 (A:8-44) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.01 E-value=0.0002 Score=48.92 Aligned_cols=29 Identities=38% Similarity=0.899 Sum_probs=25.9
Q ss_pred CccccccccccccC-ceEEecCccccccCc
Q psy5063 9 ILTCAGCLNNIVED-EYVQALSQEWHTDCF 37 (681)
Q Consensus 9 ~~~C~~C~~~I~~~-~~v~a~~~~wH~~CF 37 (681)
.+.|.+|+++|..+ +.+.+.|+.||..||
T Consensus 8 a~~C~~C~k~I~~G~k~veykg~~WHe~CF 37 (37)
T d1x63a1 8 SPKCKGCFKAIVAGDQNVEYKGTVWHKDCF 37 (37)
T ss_dssp SCBCSSSCCBCCSSSCEEECSSCEEETTTC
T ss_pred CcccccCCCccCCCCeEeEeCCccchhccC
Confidence 46899999999855 679999999999998
|
| >d2dj7a2 g.39.1.3 (A:8-43) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.00 E-value=0.00012 Score=48.49 Aligned_cols=27 Identities=26% Similarity=0.772 Sum_probs=24.8
Q ss_pred CcccccCCcc-ccCeEEecCccCCCCce
Q psy5063 69 EACQNCGQMM-SGPVMVVGDHKFHPECF 95 (681)
Q Consensus 69 ~~C~~C~~~I-~g~~~~a~~~~yH~~CF 95 (681)
..|++|++.| .|..+.|.++.||.+||
T Consensus 9 ~~CagCg~eik~gQaL~ALdkqWH~~CF 36 (36)
T d2dj7a2 9 SHCAGCKEEIKHGQSLLALDKQWHVSCF 36 (36)
T ss_dssp SCCTTTCCCCSSSCCEEETTEEECTTTC
T ss_pred ccccccchhhhCCceeeeeecceeeeeC
Confidence 5799999988 67899999999999998
|
| >d2d8ya2 g.39.1.3 (A:44-85) Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Eplin, LIMA1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.99 E-value=5.6e-05 Score=53.09 Aligned_cols=33 Identities=30% Similarity=0.689 Sum_probs=29.4
Q ss_pred ccccCcCccC-CceEeeCCeeeeccccccccCCc
Q psy5063 38 RCSACDVMLD-NWYFEKDGLLFCKEDYNGKYGEA 70 (681)
Q Consensus 38 ~C~~C~~~L~-~~~~~~dg~~yC~~cY~~~f~~~ 70 (681)
+|..|++.|. +.|-..+|.+||+.||.++|.++
T Consensus 1 rC~~C~~~Ls~~~yas~~G~lYCkpHf~qLF~~k 34 (42)
T d2d8ya2 1 RCSYCNNKLSLGTYASLHGRIYCKPHFNQLFKSK 34 (42)
T ss_dssp BCTTTCCBCCTTTCCCSSSCCCCHHHHHHHSCCC
T ss_pred CcCcCCCCccCCcchhhCCEeccHHHHHHHHHhh
Confidence 6999999996 57889999999999999999765
|
| >d2dara1 g.39.1.3 (A:53-84) PDZ and LIM domain protein 5, Enigma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 5, Enigma species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.97 E-value=9.6e-05 Score=47.88 Aligned_cols=31 Identities=23% Similarity=0.645 Sum_probs=26.8
Q ss_pred ccccCcCccCC-ceEeeCCeeeeccccccccC
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~ 68 (681)
.|+.|+.+|.. .|.+.+|.+||+.||.+.|+
T Consensus 1 nCa~C~~sL~d~gFVEE~g~lYCe~Cye~ffA 32 (32)
T d2dara1 1 NCAHCKNTMAYIGFVEEKGALYCELCYEKFFA 32 (32)
T ss_dssp BCSSSCCBCSSSCBEESSSCEECHHHHHHHTS
T ss_pred CcccccccHhhcceeeecCcEeHHHHHHHhcC
Confidence 38999999976 78899999999999987663
|
| >d1ufxa_ b.36.1.1 (A:) KIAA1526 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: KIAA1526 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.92 E-value=0.0003 Score=59.77 Aligned_cols=42 Identities=29% Similarity=0.415 Sum_probs=33.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC----Cceeeeeeec
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT----DTVLQRQILK 333 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 333 (681)
.|++||+||+|||.++.+.+++|+..+|++.. ...++|.+..
T Consensus 50 ~L~~GD~Il~VNg~~v~~~s~~e~~~~l~~a~~~~~~~~~~l~v~~ 95 (103)
T d1ufxa_ 50 QLKVGHVILEVNGLTLRGKEHREAARIIAEAFKTKDRDYIDFLVTE 95 (103)
T ss_dssp SSCTTCBCCEETTEECTTCBHHHHHHHHHHHHHCSSCSEEEEEECC
T ss_pred CCCCCCEEEEECCEECCCCcHHHHHHHHHHccCCCccceEEEEEeC
Confidence 59999999999999999999999999999421 2345555544
|
| >d2d8za2 g.39.1.3 (A:33-64) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.90 E-value=0.00022 Score=46.62 Aligned_cols=32 Identities=22% Similarity=0.592 Sum_probs=26.2
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
.|..|+++| .|+.|+.. +++|||..||+.+||
T Consensus 1 ~C~~C~~~L-~GQry~~r-d~~PyC~~Cf~~lfA 32 (32)
T d2d8za2 1 VCTACRKQL-SGQRFTAR-DDFAYCLNCFCDLYA 32 (32)
T ss_dssp BCSSSCCBC-TTSCCEES-SSSEECHHHHHHHTC
T ss_pred CcccCCccc-cCceeeec-CCCeehHHhhHhhcC
Confidence 488999999 57788654 567999999998875
|
| >d1x5na1 b.36.1.1 (A:8-108) Harmonin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Harmonin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.89 E-value=0.00056 Score=57.82 Aligned_cols=42 Identities=26% Similarity=0.461 Sum_probs=34.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+||+|||.++.+++++++-.+|++.. .+.+++....
T Consensus 51 gL~~GD~Il~VNg~~v~~~~~~~v~~~lk~~~--~~~l~v~~~~ 92 (101)
T d1x5na1 51 GLEIGDQIVEVNGVDFSNLDHKEAVNVLKSSR--SLTISIVAAA 92 (101)
T ss_dssp TCCTTCEEEEETTEETTSCCTTHHHHHHHHCS--SEEEEECSST
T ss_pred CCCcccEEEEECCEECCCCCHHHHHHHHhCCC--CEEEEEEECC
Confidence 59999999999999999999999999999543 3556665443
|
| >d1uf1a_ b.36.1.1 (A:) KIAA1526 protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: KIAA1526 protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.87 E-value=0.00055 Score=60.39 Aligned_cols=42 Identities=29% Similarity=0.372 Sum_probs=36.4
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||+||+|||.++.+++.+|+..+|++ . ..+.|++....
T Consensus 63 gL~~GD~Il~INg~~v~~~s~~evv~~lr~-~-~~v~l~v~~~~ 104 (128)
T d1uf1a_ 63 GLKVGDQILEVNGRSFLNILHDEAVRLLKS-S-RHLILTVKDVG 104 (128)
T ss_dssp TCCTTCEEEEETTEECSSCCHHHHHHHHTT-C-SEEEEEEECCS
T ss_pred CCCCCCEEEEECCEECCCCCHHHHHHHHhc-C-CcEEEEEEECC
Confidence 599999999999999999999999999994 4 35778887654
|
| >d1x68a1 g.39.1.3 (A:8-36) Four and a half LIM domains protein 5, FHL-5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 5, FHL-5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.86 E-value=0.0002 Score=45.10 Aligned_cols=26 Identities=27% Similarity=0.919 Sum_probs=23.1
Q ss_pred cccccccccc---CceEEecCccccccCc
Q psy5063 12 CAGCLNNIVE---DEYVQALSQEWHTDCF 37 (681)
Q Consensus 12 C~~C~~~I~~---~~~v~a~~~~wH~~CF 37 (681)
|.+|.+||.. .+++...++.||.+||
T Consensus 1 C~~C~kPItg~gG~k~isFedR~WH~~CF 29 (29)
T d1x68a1 1 CVACSKPISGLTGAKFICFQDSQWHSECF 29 (29)
T ss_dssp CTTTCCCCCTTTTCCEEEETTEEEEGGGC
T ss_pred CccccccccccCCceEEEeehhhcccccC
Confidence 8899999953 4789999999999998
|
| >d2dara1 g.39.1.3 (A:53-84) PDZ and LIM domain protein 5, Enigma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 5, Enigma species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.86 E-value=0.00024 Score=45.95 Aligned_cols=32 Identities=28% Similarity=0.718 Sum_probs=26.7
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
.|..|+++|.+-. ++.+++.+||..||++.||
T Consensus 1 nCa~C~~sL~d~g--FVEE~g~lYCe~Cye~ffA 32 (32)
T d2dara1 1 NCAHCKNTMAYIG--FVEEKGALYCELCYEKFFA 32 (32)
T ss_dssp BCSSSCCBCSSSC--BEESSSCEECHHHHHHHTS
T ss_pred CcccccccHhhcc--eeeecCcEeHHHHHHHhcC
Confidence 4889999996644 6788899999999998765
|
| >d1x6da1 b.36.1.2 (A:8-114) Interleukin 16 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: Interleukin 16 domain: Interleukin 16 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.84 E-value=0.00039 Score=59.34 Aligned_cols=43 Identities=12% Similarity=0.394 Sum_probs=34.1
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (681)
.|++||+||+|||..+.+++++|+-.+|++..+....+.+...
T Consensus 53 ~L~~GD~Il~VNg~~v~~~~~~ea~~~l~~~~~~~~l~v~~r~ 95 (107)
T d1x6da1 53 TIQKGNEVLSINGKSLKGTTHHDALAILRQAREPRQAVIVTRK 95 (107)
T ss_dssp SSCTTCBCCEETTEECSSCCHHHHHHHHHHTTSSSEEEEEEEC
T ss_pred CCCcCCEEEEECCEecCCCCHHHHHHHHHcCCCCEEEEEEECC
Confidence 5999999999999999999999999999954444444444333
|
| >d2cu8a2 g.39.1.3 (A:38-70) Cysteine-rich (intestinal) protein, CRP, CRIP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.83 E-value=0.00022 Score=46.32 Aligned_cols=31 Identities=32% Similarity=0.684 Sum_probs=26.9
Q ss_pred ccccCcCccC-CceEeeCCeeeecc-ccccccC
Q psy5063 38 RCSACDVMLD-NWYFEKDGLLFCKE-DYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~-~~~~~~dg~~yC~~-cY~~~f~ 68 (681)
+|..|++.|. +..-++||+|||.. ||..+|+
T Consensus 1 kCekC~ktL~~G~HaEH~gkPYC~~PCY~aLFG 33 (33)
T d2cu8a2 1 KCERCSKTLTPGGHAEHDGKPFCHKPCYATLFG 33 (33)
T ss_dssp BCSSSCCBCCTTSCEEETTEEECTTTHHHHHSC
T ss_pred CchhcccccCCCCccccCCCcCcCcchHHhhcC
Confidence 5889999995 68899999999986 9988775
|
| >d1x68a1 g.39.1.3 (A:8-36) Four and a half LIM domains protein 5, FHL-5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 5, FHL-5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.79 E-value=0.00019 Score=45.20 Aligned_cols=25 Identities=36% Similarity=0.949 Sum_probs=22.6
Q ss_pred ccccCCcccc----CeEEecCccCCCCce
Q psy5063 71 CQNCGQMMSG----PVMVVGDHKFHPECF 95 (681)
Q Consensus 71 C~~C~~~I~g----~~~~a~~~~yH~~CF 95 (681)
|.+|.+||+| .++.+.++.||.+||
T Consensus 1 C~~C~kPItg~gG~k~isFedR~WH~~CF 29 (29)
T d1x68a1 1 CVACSKPISGLTGAKFICFQDSQWHSECF 29 (29)
T ss_dssp CTTTCCCCCTTTTCCEEEETTEEEEGGGC
T ss_pred CccccccccccCCceEEEeehhhcccccC
Confidence 8899999976 588999999999998
|
| >d1wg6a_ b.36.1.1 (A:) Partitioning-defective 3-like protein, PAR3-L (RIKEN cDNA 2810455b10) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Partitioning-defective 3-like protein, PAR3-L (RIKEN cDNA 2810455b10) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.74 E-value=0.00057 Score=60.24 Aligned_cols=44 Identities=25% Similarity=0.410 Sum_probs=36.6
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCC------CceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTT------DTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~ 335 (681)
.|++||+||+|||+++.+++++|+-.+|++.. ...++|+|.+..
T Consensus 73 ~L~~GD~Il~VNg~~v~~~~~~e~~~~lr~a~~~~~~~~~~V~L~V~R~~ 122 (127)
T d1wg6a_ 73 RLRMNDQLIAVNGETLLGKSNHEAMETLRRSMSMEGNIRGMIQLVILRRS 122 (127)
T ss_dssp TSCSCCBEEEETTEESTTSCHHHHHHHHHHHHHHHHHHTCEEEEEEEECS
T ss_pred CCCCCCEEEeECCEECCCCCHHHHHHHHHhcccccCCCCCEEEEEEeeCC
Confidence 69999999999999999999999999998432 346788887643
|
| >d2cuqa1 g.39.1.3 (A:43-74) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.71 E-value=0.00045 Score=44.49 Aligned_cols=32 Identities=22% Similarity=0.601 Sum_probs=26.2
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
.|..|+++| .|+.|+-. +..+||..||..+||
T Consensus 1 vCt~Ck~~L-aGqrFTSr-de~pYC~~Cfg~LfA 32 (32)
T d2cuqa1 1 VCTGCQTPL-AGQQFTSR-DEDPYCVACFGELFA 32 (32)
T ss_dssp BCSSSCCBC-TTCCEEEC-SSSEEEHHHHHHHTT
T ss_pred CccccCccc-cCCccccC-CCCccHHHHhHhhcC
Confidence 489999999 68888755 456999999988775
|
| >d1rutx1 g.39.1.3 (X:19-48) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.69 E-value=0.00031 Score=45.41 Aligned_cols=27 Identities=22% Similarity=0.685 Sum_probs=23.9
Q ss_pred CcccccCCccccCe-EEecCccCCCCce
Q psy5063 69 EACQNCGQMMSGPV-MVVGDHKFHPECF 95 (681)
Q Consensus 69 ~~C~~C~~~I~g~~-~~a~~~~yH~~CF 95 (681)
.+|++|+++|.+++ +.+.++.||..|.
T Consensus 3 ~~CaGC~~~I~DRflL~v~dr~WH~~CL 30 (30)
T d1rutx1 3 KRCAGCGGKIADRFLLYAMDSYWHSRCL 30 (30)
T ss_dssp CBBTTTCCBCCCSEEEEETTEEECGGGC
T ss_pred cccCCCCCccchhhhhccchhhhhhhhC
Confidence 58999999999985 6799999999883
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.62 E-value=0.0025 Score=61.25 Aligned_cols=73 Identities=16% Similarity=0.144 Sum_probs=46.2
Q ss_pred ecccCc-EEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHhCC--CCce
Q psy5063 488 LGQGFF-GQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRSLH--HHNV 564 (681)
Q Consensus 488 LG~G~F-G~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpnI 564 (681)
+..|.. +.||+.... ++..+++|........ .+ ..|.+.|+.+. .-.+
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~---~l-------------------------~~E~~~l~~L~~~gvpv 68 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALN---EL-------------------------QDEAARLSWLATTGVPC 68 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCTTS---CH-------------------------HHHHHHHHHHHTTTCCB
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccCHh---HH-------------------------HHHHHHHHHHHhcCCCC
Confidence 344443 578988754 4666788865432211 11 22455565552 2336
Q ss_pred eeEEEEEEeCCeEEEEEeccCCCCH
Q psy5063 565 IRFIGVLYKDRKLNLVTEYIAGGTL 589 (681)
Q Consensus 565 V~l~g~~~~~~~l~LV~Ey~~gGsL 589 (681)
.+++.+..+++..++|||+++|.++
T Consensus 69 P~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 69 AAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CCEEEEEECSSCEEEEEECCSSEET
T ss_pred CceeeecccccceEEEEEeeecccc
Confidence 6788888888899999999988665
|
| >d1b8ta4 g.39.1.3 (A:144-192) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.50 E-value=0.00074 Score=48.82 Aligned_cols=36 Identities=22% Similarity=0.633 Sum_probs=29.2
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
+|..|++.|.... . .+.++++||..||.+.|.|++-
T Consensus 1 KC~~C~k~Lds~t-~-~ehdg~~YCk~CY~k~fGPKG~ 36 (49)
T d1b8ta4 1 RCAKCGKSLESTT-L-ADKDGEIYCKGCYAKNFGPKGF 36 (49)
T ss_dssp BCTTTCCBCCSSS-E-EEETTEEEEHHHHHHHTCCCCC
T ss_pred ChhhcCCccCCCc-c-cccCCcccchhhhhhccCCCcc
Confidence 5899999995543 3 3467889999999999999863
|
| >d1a7ia2 g.39.1.3 (A:36-67) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=96.49 E-value=0.00035 Score=44.72 Aligned_cols=30 Identities=37% Similarity=0.709 Sum_probs=26.4
Q ss_pred cccCcCccCC-ceEeeCCeeeeccccccccC
Q psy5063 39 CSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 39 C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~ 68 (681)
|-.|++.|++ ..-.+++.+||+.||.++|+
T Consensus 2 C~~C~K~LdStTva~h~~eiYCKsCygkkyg 32 (32)
T d1a7ia2 2 CMVCRKNLDSTTVAIHDAEVYCKSCYGKKYG 32 (32)
T ss_dssp CSSSCCEECSSCCEEETTEEECSHHHHHHCC
T ss_pred chhhhhccCcceeeeecceEEehhhccccCC
Confidence 7889999987 56789999999999998875
|
| >d1x4ka1 g.39.1.3 (A:35-66) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.49 E-value=0.00049 Score=44.57 Aligned_cols=31 Identities=23% Similarity=0.503 Sum_probs=27.4
Q ss_pred ccccCcCccCC-ceEeeCCeeeeccccccccC
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~ 68 (681)
.|..|.++++. .|..+|+..||..||.++|+
T Consensus 1 ~C~~C~qPIGtksfipk~~~~yCvpCyE~kfA 32 (32)
T d1x4ka1 1 ICHRCQQPIGTKSFIPKDNQNFCVPCYEKQHA 32 (32)
T ss_dssp CCSSSCCCCCSSSEEEETTEEEEHHHHHHHTS
T ss_pred CcccccCcccccccccCCCCceEeecchhhcC
Confidence 38899999976 68899999999999999884
|
| >d2cuqa2 g.39.1.3 (A:8-42) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.49 E-value=0.00075 Score=44.73 Aligned_cols=31 Identities=26% Similarity=0.590 Sum_probs=25.6
Q ss_pred CCCCccccccccccccCceEEecCccccccCc
Q psy5063 6 TPEILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 6 ~~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
+.-.+.|..|+++|..+ -++..++.||.+||
T Consensus 5 ~kfa~~C~~Ckk~It~G-GvtY~dqpWHkeCF 35 (35)
T d2cuqa2 5 NKFAPRCARCSKTLTQG-GVTYRDQPWHRECL 35 (35)
T ss_dssp CCSSCCCTTTCCCCCSC-CEESSSSEECTTTC
T ss_pred HHHHHHHhhcCCccccC-ceeecCCcchhhhC
Confidence 33447899999999754 58889999999998
|
| >d2dj7a1 g.39.1.3 (A:44-74) Actin-binding LIM protein 3, abLIM-3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 3, abLIM-3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.46 E-value=0.00075 Score=43.40 Aligned_cols=31 Identities=32% Similarity=0.729 Sum_probs=25.9
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
+|..|++.| .|+ ++..++.|||..+|+.+|.
T Consensus 1 kC~~C~~vL-~gE--Ym~kdG~PyCe~DY~~~FG 31 (31)
T d2dj7a1 1 KCQTCSVIL-TGE--YISKDGVPYCESDYHAQFG 31 (31)
T ss_dssp BCSSSCCBC-SSC--CEEETTEEECTTHHHHHTT
T ss_pred CccccCccc-cce--eecCCCCcccHHHHHHhcC
Confidence 588999988 666 5778899999999998763
|
| >d1b8ta3 g.39.1.3 (A:101-143) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.43 E-value=0.00054 Score=48.51 Aligned_cols=28 Identities=29% Similarity=0.698 Sum_probs=26.7
Q ss_pred ccccccccccccCceEEecCccccccCc
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
..|..|++.++..|.+.+.|+.||..||
T Consensus 16 ~kC~~C~k~VY~~E~~~~~g~~~Hk~CF 43 (43)
T d1b8ta3 16 DGCPRCGQAVYAAEKVIGAGKSWHKSCF 43 (43)
T ss_dssp EECTTTSCEECSSSCEEETTEEECTTTC
T ss_pred CcCccCCCEeeHHHHhhcCCCccccCCC
Confidence 5799999999999999999999999998
|
| >d1j2oa1 g.39.1.3 (A:1-30) Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Rhombotin-2 (Lmo2) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.42 E-value=0.00067 Score=43.62 Aligned_cols=26 Identities=23% Similarity=0.571 Sum_probs=23.2
Q ss_pred CcccccCCccccCe-EEecCccCCCCc
Q psy5063 69 EACQNCGQMMSGPV-MVVGDHKFHPEC 94 (681)
Q Consensus 69 ~~C~~C~~~I~g~~-~~a~~~~yH~~C 94 (681)
..|++|+++|.+++ +.|.++.||.+|
T Consensus 4 ~~CaGC~~~I~DRflL~a~Dr~WH~~C 30 (30)
T d1j2oa1 4 LTCGGCQQNIGDRYFLKAIDQYWHEDC 30 (30)
T ss_dssp BCBSSSCSCBCSSEEEECSSSEECTTT
T ss_pred cccCCCCCcchHHHHHHHHHHHHhcCC
Confidence 47999999999985 679999999987
|
| >d1qaua_ b.36.1.1 (A:) Neuronal nitric oxide synthase, NNOS {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Neuronal nitric oxide synthase, NNOS species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.42 E-value=0.0012 Score=56.41 Aligned_cols=31 Identities=29% Similarity=0.427 Sum_probs=28.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT 322 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~ 322 (681)
.|++||+||+|||.++.+.+++|+..+|++.
T Consensus 44 ~L~~GD~Il~INg~~v~~~s~~e~~~~l~~~ 74 (112)
T d1qaua_ 44 LIQAGDIILAVNDRPLVDLSYDSALEVLRGI 74 (112)
T ss_dssp CCCTTCEEEEETTEECTTSCHHHHHHHHHHS
T ss_pred hcccccEeEEECCcCccCCCHHHHHHHHHcC
Confidence 4999999999999999999999999999943
|
| >d1x62a2 g.39.1.3 (A:8-42) PDZ and LIM domain protein 1 Elfin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 1 Elfin species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.39 E-value=0.00073 Score=44.18 Aligned_cols=30 Identities=23% Similarity=0.638 Sum_probs=26.8
Q ss_pred CCCccccccccccccCceEEecCccccccCc
Q psy5063 7 PEILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
..+|+|.+|+.-|. +-++.+.++.+|++||
T Consensus 6 qklp~CdkCg~GIV-G~~VK~rDk~rHPeCf 35 (35)
T d1x62a2 6 QKLPMCDKCGTGIV-GVFVKLRDRHRHPECY 35 (35)
T ss_dssp CCCCCCSSSCCCCC-SSCEECSSCEECTTTT
T ss_pred ccCccccccCCCcE-eEEEEeccccCCCCCC
Confidence 34689999999996 6789999999999998
|
| >d2d8ya1 g.39.1.3 (A:9-43) Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Eplin, LIMA1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.37 E-value=0.00092 Score=44.99 Aligned_cols=30 Identities=30% Similarity=0.536 Sum_probs=27.6
Q ss_pred CCccccccccccccCceEEecCccccccCc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
....|..|++.++.-+.+.|.|+.||..||
T Consensus 6 ~~~kC~~C~K~VY~~E~~~a~g~~~Hk~CF 35 (35)
T d2d8ya1 6 ARETCVECQKTVYPMERLLANQQVFHISCF 35 (35)
T ss_dssp SSCBCTTTCCBCCTTSEEECSSSEEETTTC
T ss_pred CCcccccCCCEEeeeeeEecCCeehhhccC
Confidence 346899999999999999999999999998
|
| >d1wyha1 g.39.1.3 (A:35-66) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.31 E-value=0.0007 Score=43.77 Aligned_cols=31 Identities=26% Similarity=0.670 Sum_probs=27.3
Q ss_pred ccccCcCccCC-ceEeeCCeeeeccccccccC
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~~~f~ 68 (681)
.|..|.++++. .|..+++..||-.||.++|+
T Consensus 1 ~C~~C~qPIGtkSFip~~~~~yCvpCYE~kfA 32 (32)
T d1wyha1 1 LCSGCEQPLGSRSFVPDKGAHYCVPCYENKFA 32 (32)
T ss_dssp BCTTTCCBTTTSCEEEETTEEEEHHHHHHHTS
T ss_pred CcccccCcccccccccCCCcEEEEeccccccC
Confidence 38899999976 67899999999999999885
|
| >d1k32a1 b.36.1.3 (A:763-853) Tricorn protease {Archaeon Thermoplasma acidophilum [TaxId: 2303]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: Tail specific protease PDZ domain domain: Tricorn protease species: Archaeon Thermoplasma acidophilum [TaxId: 2303]
Probab=96.30 E-value=0.0038 Score=51.45 Aligned_cols=66 Identities=12% Similarity=0.112 Sum_probs=47.4
Q ss_pred eeEEEeEeeecCCCCCCCCCccCCCCCcc-cc-ccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 263 SLVQVTYRYCTGMTNNPSVPRLDPRADLM-SL-HLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
..++|. ++..|..-++.- -||--. -| ++||+|+.|||.+|.+ .+++-.++++..++.+.|+|+++-
T Consensus 12 ~~~~I~-~i~~G~~~~~~~----~sPa~~aGl~k~GD~I~~IdG~~v~~--~~~~~~~l~g~~G~~V~L~i~R~g 79 (91)
T d1k32a1 12 DHYVVA-KAYAGDYSNEGE----KSPIFEYGIDPTGYLIEDIDGETVGA--GSNIYRVLSEKAGTSARIRLSGKG 79 (91)
T ss_dssp TEEEEE-EECBSCTTSTTC----BCGGGGGTCCCTTCEEEEETTEECBT--TBCHHHHHHTTTTSEEEEEEECSS
T ss_pred CeEEEE-EEecCCCCCccc----CChhHhcCCCCCCCEEEEECCEeecC--cceeEEEEecCCCCEEEEEEEeCC
Confidence 356666 666676433211 133222 44 8999999999999975 457778888899999999999865
|
| >d1imla2 g.39.1.3 (A:29-76) Cysteine-rich (intestinal) protein, CRP, CRIP {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Rat (Rattus rattus) [TaxId: 10117]
Probab=96.21 E-value=0.0017 Score=46.38 Aligned_cols=35 Identities=29% Similarity=0.670 Sum_probs=29.2
Q ss_pred ecCCCCcccCCCCceeeecCCeeee-ccchhhhcCCCC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYC-GLCYKRQMQPLG 132 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC-~~Cy~~~~~p~~ 132 (681)
+|..|++.|..+. ....++++|| ..||.++|.|++
T Consensus 1 kC~~C~K~L~sg~--~aeHdg~pYC~k~CY~~~FGPkG 36 (48)
T d1imla2 1 KCEKCGKTLTSGG--HAEHEGKPYCNHPCYSAMFGPKG 36 (48)
T ss_dssp BCTTTCCBCCTTT--EEEETTEEEETTTHHHHHSSCCC
T ss_pred CchhcCcCcCCCC--hhhcCCcccccccchhhccCCCc
Confidence 5899999997665 4566788999 779999999975
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.21 E-value=0.0044 Score=64.44 Aligned_cols=83 Identities=14% Similarity=0.153 Sum_probs=46.3
Q ss_pred cceecccCcEEEEEEEEcCCCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccc-cchHHHHHHHhC-CC-
Q psy5063 485 GPLLGQGFFGQVYRVTHRETGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNL-HCFSQVAVLRSL-HH- 561 (681)
Q Consensus 485 ~~~LG~G~FG~Vyk~~~~~tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~-~~~~Ei~iL~~L-~H- 561 (681)
.+.||.|....||++....+++.+++|.-...-... .+.+.... ...+|.+.|+.+ .+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~-------------------g~~~~~~~~R~~~E~~~L~~~~~~~ 91 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVV-------------------GESWPLTIDRARIESSALIRQGEHV 91 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC---------------------CCCCCCTTHHHHHHHHHHHHHTTC
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhccc-------------------CCCCCCCHHHHHHHHHHHHHhhhhC
Confidence 446899999999999987778889999643210000 00000001 123456666655 22
Q ss_pred -CceeeEEEEEEeCCeEEEEEeccCCCC
Q psy5063 562 -HNVIRFIGVLYKDRKLNLVTEYIAGGT 588 (681)
Q Consensus 562 -pnIV~l~g~~~~~~~l~LV~Ey~~gGs 588 (681)
..+.+++.+ ++...++|||++++..
T Consensus 92 p~~vP~v~~~--d~~~~~lvmE~L~~~~ 117 (392)
T d2pula1 92 PHLVPRVFYS--DTEMAVTVMEDLSHLK 117 (392)
T ss_dssp GGGSCCEEEE--ETTTTEEEECCCTTSE
T ss_pred CCCcceEEEE--cCCCCEEEEeccCCcc
Confidence 345666644 4556679999997654
|
| >d2co8a2 g.39.1.3 (A:8-43) Nedd9 interacting protein with calponin homology, NICAL (MICAL1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Nedd9 interacting protein with calponin homology, NICAL (MICAL1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.17 E-value=0.0015 Score=44.15 Aligned_cols=31 Identities=23% Similarity=0.297 Sum_probs=28.1
Q ss_pred CCCccccccccccccCceEEecCccccccCc
Q psy5063 7 PEILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 7 ~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
.....|..|++.++.-+.+.|.|+.||..||
T Consensus 6 g~~~~C~~C~K~VY~~Erl~a~g~~yHk~CF 36 (36)
T d2co8a2 6 GAGDLCALCGEHLYVLERLCVNGHFFHRSCF 36 (36)
T ss_dssp CSSCBCSSSCCBCCTTTBCCBTTBCCBTTTC
T ss_pred CCCCcccccCCEEeeeeEEEecCcEeccccC
Confidence 3446899999999999999999999999998
|
| >d1x61a2 g.39.1.3 (A:35-66) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.15 E-value=0.00096 Score=42.53 Aligned_cols=28 Identities=21% Similarity=0.627 Sum_probs=24.6
Q ss_pred ccccCcCccCC-ceEeeCCeeeecccccc
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYNG 65 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~~ 65 (681)
.|..|+..|.+ .||..+.+.||+.||..
T Consensus 1 vC~tC~~kLRGqpFYAvekkayCE~CYi~ 29 (32)
T d1x61a2 1 VCSTCRAQLRGQHFYAVERRAYCEGCYVA 29 (32)
T ss_dssp BCSSSCCBCTTSCEEESSSCEEEHHHHHH
T ss_pred CeeEeCceecCCcceEeeccccccceeee
Confidence 48999999966 78999999999999964
|
| >d2dloa2 g.39.1.3 (A:43-75) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.14 E-value=0.00069 Score=44.45 Aligned_cols=31 Identities=29% Similarity=0.654 Sum_probs=26.1
Q ss_pred ccccCcCccCCceEe--eCCeeeeccccccccC
Q psy5063 38 RCSACDVMLDNWYFE--KDGLLFCKEDYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~~~~~~--~dg~~yC~~cY~~~f~ 68 (681)
+|..|++.|+|.-|. .++++||-+||+++|+
T Consensus 1 tCvvC~~~LDGvPFtvD~~n~i~Cv~DyHrkfA 33 (33)
T d2dloa2 1 TCVVCHRGLDGIPFTVDATSQIHCIEDFHRKFA 33 (33)
T ss_dssp BCSSSCCBCTTSCEECCTTCCCEEHHHHHHHTT
T ss_pred CeeEcCcccCCCcEEEcCCCCEeehhhhhhhcC
Confidence 588999999996554 4699999999999885
|
| >d1x4ka2 g.39.1.3 (A:8-34) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.12 E-value=0.0012 Score=40.53 Aligned_cols=26 Identities=27% Similarity=0.809 Sum_probs=23.2
Q ss_pred ccccccccccC-ceEEecCccccccCc
Q psy5063 12 CAGCLNNIVED-EYVQALSQEWHTDCF 37 (681)
Q Consensus 12 C~~C~~~I~~~-~~v~a~~~~wH~~CF 37 (681)
|..|.+.|.++ ..+...|..||..||
T Consensus 1 C~~C~ktiMPGsrKme~kG~~WHEtCF 27 (27)
T d1x4ka2 1 CQECKKTIMPGTRKMEYKGSSWHETCF 27 (27)
T ss_dssp BSSSCCCCCSSSCEEEETTEEEETTTT
T ss_pred CccccccccCCceeecccCCccccccC
Confidence 88999999887 458999999999998
|
| >d1x64a1 g.39.1.3 (A:8-52) PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 3, PDLIM3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=96.11 E-value=0.0012 Score=46.08 Aligned_cols=29 Identities=31% Similarity=0.625 Sum_probs=26.3
Q ss_pred CCccccccccccccCceEEecCccccccCc
Q psy5063 8 EILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 8 ~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
.+|.|.+|+.-|. +-++.+.++.+|++||
T Consensus 17 kLP~CdkCg~GIV-G~~VK~rDK~rHPeCf 45 (45)
T d1x64a1 17 RMPLCDKCGSGIV-GAVVKARDKYRHPECF 45 (45)
T ss_dssp SCCBCTTTCCBCC-SCCEESSSCEECTTTC
T ss_pred cCccccccCCCcE-EEEEEeccccCCCCCC
Confidence 3689999999996 6789999999999998
|
| >d1x4ka2 g.39.1.3 (A:8-34) Four and a half LIM domains protein 2, FHL2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 2, FHL2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.06 E-value=0.0011 Score=40.83 Aligned_cols=25 Identities=28% Similarity=0.680 Sum_probs=22.1
Q ss_pred ccccCCcccc--CeEEecCccCCCCce
Q psy5063 71 CQNCGQMMSG--PVMVVGDHKFHPECF 95 (681)
Q Consensus 71 C~~C~~~I~g--~~~~a~~~~yH~~CF 95 (681)
|..|.+.|.+ +.|.+.|..||..||
T Consensus 1 C~~C~ktiMPGsrKme~kG~~WHEtCF 27 (27)
T d1x4ka2 1 CQECKKTIMPGTRKMEYKGSSWHETCF 27 (27)
T ss_dssp BSSSCCCCCSSSCEEEETTEEEETTTT
T ss_pred CccccccccCCceeecccCCccccccC
Confidence 8899998843 689999999999998
|
| >d1ibia2 g.39.1.3 (A:145-175) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=96.05 E-value=0.0012 Score=41.52 Aligned_cols=30 Identities=23% Similarity=0.757 Sum_probs=24.0
Q ss_pred eecCCCCcccCCCCceeeecCCeeeeccchhh
Q psy5063 95 FKCTSCSCCIGDGESYALVERSILYCGLCYKR 126 (681)
Q Consensus 95 F~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~ 126 (681)
|+|..|++.|.. .. .-+.++.+||+.||.+
T Consensus 1 frca~cgk~les-tt-~adkdgeiyck~cyak 30 (31)
T d1ibia2 1 FRCAKCGKSLES-TT-LTEKEGEIYCKGCYAK 30 (31)
T ss_dssp EECSSSCCEECS-SC-SEEETTEEECHHHHHH
T ss_pred CccccccCcccc-ce-eeccCCcEEEeeeeec
Confidence 899999999943 32 4567888999999965
|
| >d2cura1 g.39.1.3 (A:33-63) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.05 E-value=0.0017 Score=41.34 Aligned_cols=29 Identities=38% Similarity=0.875 Sum_probs=24.9
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhh
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKR 126 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~ 126 (681)
.|..|++.| .|..|+.+++. .||..||..
T Consensus 1 vC~~C~K~L-ag~rFTa~eDq-~yCVdCYK~ 29 (31)
T d2cura1 1 VCVTCSKKL-AGQRFTAVEDQ-YYCVDCYKN 29 (31)
T ss_dssp BCTTTCCBC-TTSCEEECSSC-EEEHHHHHH
T ss_pred Ccccccchh-cCceeEEecce-EEEeeeecc
Confidence 489999999 68889988876 899999964
|
| >d1x63a2 g.39.1.3 (A:45-76) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.00 E-value=0.002 Score=40.53 Aligned_cols=32 Identities=25% Similarity=0.704 Sum_probs=26.2
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQ 129 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~ 129 (681)
+|+.|+..|+.|.+| .++...||..|++.+|+
T Consensus 1 tcs~ckq~igsgsff--pkg~d~ycvtche~kfa 32 (32)
T d1x63a2 1 TCSNCKQVIGTGSFF--PKGEDFYCVTCHETKFA 32 (32)
T ss_dssp CCSSSCCCCTTSCEE--EETTEEEEHHHHHHHTS
T ss_pred Ccchhhhhccccccc--CCCCcEEEEEeeccccC
Confidence 489999999988855 34556999999999875
|
| >d2d8ya2 g.39.1.3 (A:44-85) Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Eplin, LIMA1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.99 E-value=0.0012 Score=46.06 Aligned_cols=36 Identities=22% Similarity=0.591 Sum_probs=29.0
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCCC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLGR 133 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~~ 133 (681)
+|..|++.|.-+. |+ ..++.+||..||.++|.|++.
T Consensus 1 rC~~C~~~Ls~~~-ya-s~~G~lYCkpHf~qLF~~kGn 36 (42)
T d2d8ya2 1 RCSYCNNKLSLGT-YA-SLHGRIYCKPHFNQLFKSKGN 36 (42)
T ss_dssp BCTTTCCBCCTTT-CC-CSSSCCCCHHHHHHHSCCCSC
T ss_pred CcCcCCCCccCCc-ch-hhCCEeccHHHHHHHHHhhcC
Confidence 5999999996654 54 346789999999999999763
|
| >d1wyha2 g.39.1.3 (A:8-34) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.97 E-value=0.0013 Score=40.30 Aligned_cols=26 Identities=27% Similarity=0.809 Sum_probs=23.0
Q ss_pred ccccccccccC-ceEEecCccccccCc
Q psy5063 12 CAGCLNNIVED-EYVQALSQEWHTDCF 37 (681)
Q Consensus 12 C~~C~~~I~~~-~~v~a~~~~wH~~CF 37 (681)
|..|.+.|.++ ..+...|..||..||
T Consensus 1 C~~C~ktiMPGsrKmey~G~sWHE~CF 27 (27)
T d1wyha2 1 CSACGETVMPGSRKLEYGGQTWHEHCF 27 (27)
T ss_dssp CSSSCCBCCSSSCEECSTTCCEETTTC
T ss_pred CccccceecCCcccccccCcccccccC
Confidence 88999999877 458889999999998
|
| >d1ky9b2 b.36.1.4 (B:359-446) Protease Do (DegP, HtrA), C-terminal domains {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: HtrA-like serine proteases domain: Protease Do (DegP, HtrA), C-terminal domains species: Escherichia coli [TaxId: 562]
Probab=95.95 E-value=0.0032 Score=51.38 Aligned_cols=41 Identities=24% Similarity=0.373 Sum_probs=36.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||.|++|||.++. +.+++..+++ ...+.+.|+|+++-
T Consensus 42 Gl~~GDvI~~ing~~v~--~~~~~~~~l~-~~~~~v~l~v~R~~ 82 (88)
T d1ky9b2 42 GLKKGDVIIGANQQAVK--NIAELRKVLD-SKPSVLALNIQRGD 82 (88)
T ss_dssp TCCSSCEEEEETTEECS--SHHHHHHHTT-TCCSCCCEEEESSS
T ss_pred CCCCCcEEEEECCEEcC--CHHHHHHHHH-hCCCEEEEEEEECC
Confidence 69999999999999995 6789999998 67778999999876
|
| >d1wyha2 g.39.1.3 (A:8-34) Four and a half LIM domains 3, FHL3 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains 3, FHL3 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.93 E-value=0.0012 Score=40.58 Aligned_cols=25 Identities=28% Similarity=0.832 Sum_probs=21.7
Q ss_pred ccccCCcccc--CeEEecCccCCCCce
Q psy5063 71 CQNCGQMMSG--PVMVVGDHKFHPECF 95 (681)
Q Consensus 71 C~~C~~~I~g--~~~~a~~~~yH~~CF 95 (681)
|..|.+.|.+ +.|.+.|..||..||
T Consensus 1 C~~C~ktiMPGsrKmey~G~sWHE~CF 27 (27)
T d1wyha2 1 CSACGETVMPGSRKLEYGGQTWHEHCF 27 (27)
T ss_dssp CSSSCCBCCSSSCEECSTTCCEETTTC
T ss_pred CccccceecCCcccccccCcccccccC
Confidence 8899988843 678999999999998
|
| >d2cupa3 g.39.1.3 (A:8-34) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.92 E-value=0.0018 Score=39.60 Aligned_cols=26 Identities=35% Similarity=0.787 Sum_probs=22.3
Q ss_pred ccccccccccC-ceEEecCccccccCc
Q psy5063 12 CAGCLNNIVED-EYVQALSQEWHTDCF 37 (681)
Q Consensus 12 C~~C~~~I~~~-~~v~a~~~~wH~~CF 37 (681)
|..|+++|..+ +-+...++.||..||
T Consensus 1 c~ecrkpigad~ke~h~knr~wh~~cf 27 (27)
T d2cupa3 1 CVECRKPIGADSKEVHYKNRFWHDTCF 27 (27)
T ss_dssp CSSSCCBCCSSSCEEEETTEEEETTTC
T ss_pred CccccCCcCcchHHhhccccccccccC
Confidence 88999999644 568889999999998
|
| >d1rutx2 g.39.1.3 (X:49-82) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.87 E-value=0.0011 Score=43.28 Aligned_cols=31 Identities=32% Similarity=0.910 Sum_probs=27.3
Q ss_pred ccccCcCccC---CceEeeCCeeeeccccccccC
Q psy5063 38 RCSACDVMLD---NWYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~---~~~~~~dg~~yC~~cY~~~f~ 68 (681)
+|+-|+..|. ..+|.+.|.+.|+.||.+.|+
T Consensus 1 KCscC~~~LgeiG~s~ytk~~mILCk~DY~rlFG 34 (34)
T d1rutx2 1 KCSSCQAQLGDIGTSSYTKSGMILCRNDYIRLFG 34 (34)
T ss_dssp BCTTTCCBHHHHCSEEEEETTEEECHHHHHHHHS
T ss_pred CCcchhcChhhccchheecCCEEEEchhHHHhcC
Confidence 5888999884 479999999999999998885
|
| >d1wh1a_ b.36.1.1 (A:) Hypothetical protein KIAA1095 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: PDZ domain domain: Hypothetical protein KIAA1095 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.78 E-value=0.005 Score=53.62 Aligned_cols=42 Identities=24% Similarity=0.430 Sum_probs=34.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
.|++||+||+|||.++.+ +++...+++...+..+.|++.+.+
T Consensus 66 ~L~~GD~Il~INg~~v~~--~~~~~~~l~~~~~~~v~l~v~r~~ 107 (124)
T d1wh1a_ 66 RIREGDRIIQINGIEVQN--REEAVALLTSEENKNFSLLIARPE 107 (124)
T ss_dssp CCCTTCEEEEESSCBCCS--HHHHHHHHTCSSCCSCCEEEEECS
T ss_pred ccCCCCEEEEECCEECCC--HHHHHHHHhhCCCCcEEEEEEeCC
Confidence 599999999999999974 677777777566777888887754
|
| >d2hgaa1 b.36.1.6 (A:23-125) Uncharacterized protein MTH1368 {Methanobacterium thermoautotrophicum [TaxId: 145262]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: MTH1368 C-terminal domain-like domain: Uncharacterized protein MTH1368 species: Methanobacterium thermoautotrophicum [TaxId: 145262]
Probab=95.77 E-value=0.0073 Score=50.77 Aligned_cols=43 Identities=19% Similarity=0.220 Sum_probs=36.6
Q ss_pred cccccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeeeccC
Q psy5063 291 MSLHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQILKEC 335 (681)
Q Consensus 291 ~~~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 335 (681)
..|++||+|+.|||.+|. +.+++..+|.+. .++.+.|+++++-
T Consensus 18 ~~L~~GD~I~~ing~~v~--~~~~l~~~i~~~~~G~~v~l~v~R~~ 61 (103)
T d2hgaa1 18 KVLTPGLVIESINGMPTS--NLTTYSAALKTISVGEVINITTDQGT 61 (103)
T ss_dssp GTSCTTCEEEEETTEECS--SHHHHHHHHTTCCTTCEEEEEETTEE
T ss_pred hcCCCCCEEEEECCEEcC--CHHHHHHHHhhCCCCCEEEEEEEECC
Confidence 369999999999999995 578998888743 5899999999874
|
| >d1rutx3 g.39.1.3 (X:83-113) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=95.73 E-value=0.002 Score=41.74 Aligned_cols=27 Identities=30% Similarity=0.736 Sum_probs=24.3
Q ss_pred cccccccccccCce-EEecCccccccCc
Q psy5063 11 TCAGCLNNIVEDEY-VQALSQEWHTDCF 37 (681)
Q Consensus 11 ~C~~C~~~I~~~~~-v~a~~~~wH~~CF 37 (681)
.|++|++.|...+. .+|.+..||.+||
T Consensus 4 ~Ca~C~~~I~~~e~VmRA~~~VyHl~CF 31 (31)
T d1rutx3 4 ACSACGQSIPASELVMRAQGNVYHLKCF 31 (31)
T ss_dssp ECTTTCCEECTTSEEEEETTEEECGGGC
T ss_pred ccccccCcCChhHhheecccceeeeccC
Confidence 59999999987775 6899999999998
|
| >d2cura1 g.39.1.3 (A:33-63) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.59 E-value=0.0023 Score=40.65 Aligned_cols=28 Identities=18% Similarity=0.552 Sum_probs=24.3
Q ss_pred ccccCcCccCC-ceEeeCCeeeecccccc
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYNG 65 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~~ 65 (681)
.|..|++.|++ +|-..+++.||-+||..
T Consensus 1 vC~~C~K~Lag~rFTa~eDq~yCVdCYK~ 29 (31)
T d2cura1 1 VCVTCSKKLAGQRFTAVEDQYYCVDCYKN 29 (31)
T ss_dssp BCTTTCCBCTTSCEEECSSCEEEHHHHHH
T ss_pred CcccccchhcCceeEEecceEEEeeeecc
Confidence 48999999987 67789999999999953
|
| >d1b8ta2 g.39.1.3 (A:36-100) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.56 E-value=0.0032 Score=48.01 Aligned_cols=35 Identities=26% Similarity=0.687 Sum_probs=27.7
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhhcCCCC
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQMQPLG 132 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p~~ 132 (681)
.|..|++.|.. ....- .++.+||+.||.++|.|++
T Consensus 1 ~C~~C~K~LdS-~~~~e-h~~e~YCk~CY~k~fGPkG 35 (65)
T d1b8ta2 1 LCMVCKKNLDS-TTVAV-HGDEIYCKSCYGKKYGPKG 35 (65)
T ss_dssp BCTTTCCBCCS-SSEEE-ETTEEEEHHHHHHHHSCCC
T ss_pred CchhcCCccCC-Ccccc-CCCcccchhhhccccCCCc
Confidence 38899999944 44544 4558999999999999975
|
| >d1b8ta3 g.39.1.3 (A:101-143) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=95.48 E-value=0.0021 Score=45.40 Aligned_cols=27 Identities=26% Similarity=0.781 Sum_probs=23.5
Q ss_pred CcccccCCccc-cCeEEecCccCCCCce
Q psy5063 69 EACQNCGQMMS-GPVMVVGDHKFHPECF 95 (681)
Q Consensus 69 ~~C~~C~~~I~-g~~~~a~~~~yH~~CF 95 (681)
++|..|++.+. -+.+.+.|+.||..||
T Consensus 16 ~kC~~C~k~VY~~E~~~~~g~~~Hk~CF 43 (43)
T d1b8ta3 16 DGCPRCGQAVYAAEKVIGAGKSWHKSCF 43 (43)
T ss_dssp EECTTTSCEECSSSCEEETTEEECTTTC
T ss_pred CcCccCCCEeeHHHHhhcCCCccccCCC
Confidence 68999999884 4577899999999998
|
| >d1x63a2 g.39.1.3 (A:45-76) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.45 E-value=0.003 Score=39.70 Aligned_cols=31 Identities=23% Similarity=0.596 Sum_probs=26.9
Q ss_pred ccccCcCccC-CceEeeCCeeeeccccccccC
Q psy5063 38 RCSACDVMLD-NWYFEKDGLLFCKEDYNGKYG 68 (681)
Q Consensus 38 ~C~~C~~~L~-~~~~~~dg~~yC~~cY~~~f~ 68 (681)
+|+.|++.++ +.||.++...||-.|+..+|+
T Consensus 1 tcs~ckq~igsgsffpkg~d~ycvtche~kfa 32 (32)
T d1x63a2 1 TCSNCKQVIGTGSFFPKGEDFYCVTCHETKFA 32 (32)
T ss_dssp CCSSSCCCCTTSCEEEETTEEEEHHHHHHHTS
T ss_pred CcchhhhhcccccccCCCCcEEEEEeeccccC
Confidence 5899999995 589999999999999887763
|
| >d1x61a1 g.39.1.3 (A:8-34) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.23 E-value=0.0043 Score=37.29 Aligned_cols=26 Identities=42% Similarity=0.920 Sum_probs=22.6
Q ss_pred ccccccccccC-ceEEecCccccccCc
Q psy5063 12 CAGCLNNIVED-EYVQALSQEWHTDCF 37 (681)
Q Consensus 12 C~~C~~~I~~~-~~v~a~~~~wH~~CF 37 (681)
|.+|++.+..+ .-+.|+++.||..||
T Consensus 1 cggcgedvvgdgagvvaldrvfhvgcf 27 (27)
T d1x61a1 1 CGGCGEDVVGDGAGVVALDRVFHVGCF 27 (27)
T ss_dssp CSSSCSCCCSSSCCEECSSSEECTTTC
T ss_pred CCCcccccccCCcceEEEeeeEEeccC
Confidence 89999988754 458999999999998
|
| >d2i6va1 b.36.1.5 (A:219-305) General secretion pathway protein C, EpsC {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: EpsC C-terminal domain-like domain: General secretion pathway protein C, EpsC species: Vibrio cholerae [TaxId: 666]
Probab=95.21 E-value=0.011 Score=48.10 Aligned_cols=43 Identities=16% Similarity=0.259 Sum_probs=35.5
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhc-CCCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRN-TTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 336 (681)
-|++||.|+.|||+|+. ..+++..+++. .+++.+.+++++|-.
T Consensus 36 Gl~~GDiI~~ing~~v~--~~~~~~~~~~~~~~~~~~~l~v~R~g~ 79 (87)
T d2i6va1 36 GLQDGDMAVALNGLDLT--DPNVMNTLFQSMNEMTEMSLTVERDGQ 79 (87)
T ss_dssp TCCTTCEEEEETTEETT--CHHHHHHHHHTGGGCSEEEEEEEETTE
T ss_pred CCCCCCEEEEECCEEee--cHHHHHHHHHhhccccccEEEEEECCE
Confidence 69999999999999995 56677777764 467889999999763
|
| >d2d8ya1 g.39.1.3 (A:9-43) Eplin, LIMA1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Eplin, LIMA1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.21 E-value=0.0046 Score=41.48 Aligned_cols=28 Identities=25% Similarity=0.663 Sum_probs=24.6
Q ss_pred CCcccccCCcccc-CeEEecCccCCCCce
Q psy5063 68 GEACQNCGQMMSG-PVMVVGDHKFHPECF 95 (681)
Q Consensus 68 ~~~C~~C~~~I~g-~~~~a~~~~yH~~CF 95 (681)
.++|..|++.+.. +.+.|.|+.||..||
T Consensus 7 ~~kC~~C~K~VY~~E~~~a~g~~~Hk~CF 35 (35)
T d2d8ya1 7 RETCVECQKTVYPMERLLANQQVFHISCF 35 (35)
T ss_dssp SCBCTTTCCBCCTTSEEECSSSEEETTTC
T ss_pred CcccccCCCEEeeeeeEecCCeehhhccC
Confidence 5799999998844 678999999999998
|
| >d1lcya1 b.36.1.4 (A:226-325) Mitochondrial serine protease HtrA2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: HtrA-like serine proteases domain: Mitochondrial serine protease HtrA2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.20 E-value=0.0099 Score=49.35 Aligned_cols=40 Identities=30% Similarity=0.345 Sum_probs=34.9
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcCCCceeeeeeeccC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNTTDTVLQRQILKEC 335 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (681)
-|++||.|++|||.+|. +.+++..+++ .++.+.+++++|-
T Consensus 48 Gl~~GDiI~~ing~~V~--s~~dl~~~l~--~g~~v~l~v~R~g 87 (100)
T d1lcya1 48 GLRPGDVILAIGEQMVQ--NAEDVYEAVR--TQSQLAVQIRRGR 87 (100)
T ss_dssp TCCTTCEEEEETTEECC--SHHHHHHHHT--TCSSEEEEEEETT
T ss_pred CCCCCcEEEEECCEEcC--CHHHHHHHhc--CCCEEEEEEEECC
Confidence 69999999999999995 5788888886 4678999999986
|
| >d1ibia1 g.39.1.3 (A:117-144) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=95.16 E-value=0.0039 Score=38.71 Aligned_cols=26 Identities=27% Similarity=0.786 Sum_probs=24.1
Q ss_pred cccccccccccCceEEecCccccccC
Q psy5063 11 TCAGCLNNIVEDEYVQALSQEWHTDC 36 (681)
Q Consensus 11 ~C~~C~~~I~~~~~v~a~~~~wH~~C 36 (681)
.|.+|++.++..+.+...|+.||..|
T Consensus 3 ~CpRC~~~VyaAEkviGaG~~WHk~C 28 (28)
T d1ibia1 3 KCSRCGDSVYAAEKVIGAGKPWHKNC 28 (28)
T ss_dssp ECTTTSSEESSSSCEESSSSEECSSC
T ss_pred cCcccchhHHHHHHHhcCCCccccCC
Confidence 69999999999999999999999987
|
| >d1v6ga1 g.39.1.3 (A:1-41) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.15 E-value=0.0041 Score=42.94 Aligned_cols=26 Identities=42% Similarity=0.790 Sum_probs=23.7
Q ss_pred ccccccccccccCceEEecCccccccC
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDC 36 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~C 36 (681)
..|..|++-| .++++.|.++.||++|
T Consensus 16 ~~C~~C~~~I-tG~V~~Ag~~~yHP~C 41 (41)
T d1v6ga1 16 TRCFSCDQFI-EGEVVSALGKTYHPDC 41 (41)
T ss_dssp CBCTTTCCBC-CSCCEEETTEEECTTT
T ss_pred cccccccCEe-eeeeeEecCcccCCCC
Confidence 3699999988 5899999999999998
|
| >d1a7ia1 g.39.1.3 (A:8-35) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=95.05 E-value=0.0056 Score=37.56 Aligned_cols=27 Identities=30% Similarity=0.653 Sum_probs=25.5
Q ss_pred cccccccccccCceEEecCccccccCc
Q psy5063 11 TCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 11 ~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
.|+.|.+.++..+-++..|+.||..||
T Consensus 2 kcg~c~ktvy~aeevqc~grsfhk~cf 28 (28)
T d1a7ia1 2 KCGACGRTVYHAEEVQCDGRSFHRCCF 28 (28)
T ss_dssp BCSSSCCBCSSTTEEEETTEEEESSSE
T ss_pred ccccccceEeeeeeeeecCceeccccC
Confidence 599999999999999999999999998
|
| >d1zfoa_ g.39.1.4 (A:) LASP-1 {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LASP-1 domain: LASP-1 species: Pig (Sus scrofa) [TaxId: 9823]
Probab=94.86 E-value=0.0038 Score=39.45 Aligned_cols=28 Identities=25% Similarity=0.640 Sum_probs=23.6
Q ss_pred CCcccccCCcccc-CeEEecCccCCCCce
Q psy5063 68 GEACQNCGQMMSG-PVMVVGDHKFHPECF 95 (681)
Q Consensus 68 ~~~C~~C~~~I~g-~~~~a~~~~yH~~CF 95 (681)
.+.|+.|++.+.. +.+.-.++.||..||
T Consensus 2 n~~CaRC~k~VYp~Ekl~ClDk~WHK~CF 30 (30)
T d1zfoa_ 2 NPNCARCGKIVYPTEKVNCLDKFWHKACF 30 (30)
T ss_dssp CCBCSSSCSBCCGGGCCCSSSSCCCGGGC
T ss_pred CCcccccCCccccHHHhhhhHHHHhhccC
Confidence 3689999998844 567889999999998
|
| >d2co8a2 g.39.1.3 (A:8-43) Nedd9 interacting protein with calponin homology, NICAL (MICAL1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Nedd9 interacting protein with calponin homology, NICAL (MICAL1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.84 E-value=0.0052 Score=41.38 Aligned_cols=28 Identities=36% Similarity=0.835 Sum_probs=24.1
Q ss_pred CCcccccCCcccc-CeEEecCccCCCCce
Q psy5063 68 GEACQNCGQMMSG-PVMVVGDHKFHPECF 95 (681)
Q Consensus 68 ~~~C~~C~~~I~g-~~~~a~~~~yH~~CF 95 (681)
+.+|..|++.+.. +.+.|.|+.||..||
T Consensus 8 ~~~C~~C~K~VY~~Erl~a~g~~yHk~CF 36 (36)
T d2co8a2 8 GDLCALCGEHLYVLERLCVNGHFFHRSCF 36 (36)
T ss_dssp SCBCSSSCCBCCTTTBCCBTTBCCBTTTC
T ss_pred CCcccccCCEEeeeeEEEecCcEeccccC
Confidence 4799999998844 567899999999998
|
| >d1x3ha2 g.39.1.3 (A:43-74) Leupaxin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Leupaxin species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.82 E-value=0.0062 Score=39.79 Aligned_cols=30 Identities=23% Similarity=0.627 Sum_probs=24.6
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhh
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQ 127 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~ 127 (681)
+|..|.+++.++++|.+ +++|||..+|+++
T Consensus 1 VC~~C~~PF~~~~Fy~~--~g~PyCe~HyH~~ 30 (32)
T d1x3ha2 1 VCGDCFTSFSTGSFFEL--DGRPFCELHYHHR 30 (32)
T ss_dssp BCSSSCCBSCSSCCEES--SSCEECHHHHHHH
T ss_pred CcCccCCcCCCCCeEeE--CCccchHHhhhhh
Confidence 58999999988876644 6779999999874
|
| >d1b8ta1 g.39.1.3 (A:1-35) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.66 E-value=0.0068 Score=39.20 Aligned_cols=29 Identities=28% Similarity=0.513 Sum_probs=26.8
Q ss_pred CccccccccccccCceEEecCccccccCc
Q psy5063 9 ILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 9 ~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
-..|+.|.+.++..+-++..|+.||..||
T Consensus 7 g~kcg~c~ktvy~aeevqc~g~sfhk~cf 35 (35)
T d1b8ta1 7 GKKCGVCQKAVYFAEEVQCEGSSFHKSCF 35 (35)
T ss_dssp CEECTTTCCEECSSCCEEETTEEECTTTC
T ss_pred CceeccccceEeeeeeeeecCcccccccC
Confidence 35799999999999999999999999998
|
| >d1a7ia2 g.39.1.3 (A:36-67) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=94.61 E-value=0.0071 Score=38.54 Aligned_cols=30 Identities=27% Similarity=0.769 Sum_probs=24.1
Q ss_pred cCCCCcccCCCCceeeecCCeeeeccchhhhc
Q psy5063 97 CTSCSCCIGDGESYALVERSILYCGLCYKRQM 128 (681)
Q Consensus 97 C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~ 128 (681)
|..|.+.| |....+..+ +.+||+.||.+++
T Consensus 2 C~~C~K~L-dStTva~h~-~eiYCKsCygkky 31 (32)
T d1a7ia2 2 CMVCRKNL-DSTTVAIHD-AEVYCKSCYGKKY 31 (32)
T ss_dssp CSSSCCEE-CSSCCEEET-TEEECSHHHHHHC
T ss_pred chhhhhcc-Ccceeeeec-ceEEehhhccccC
Confidence 88999999 666666665 5599999999875
|
| >d2cu8a1 g.39.1.3 (A:8-37) Cysteine-rich (intestinal) protein, CRP, CRIP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.60 E-value=0.0076 Score=38.57 Aligned_cols=28 Identities=14% Similarity=0.441 Sum_probs=24.1
Q ss_pred CCcccccCCcc-ccCeEEecCccCCCCce
Q psy5063 68 GEACQNCGQMM-SGPVMVVGDHKFHPECF 95 (681)
Q Consensus 68 ~~~C~~C~~~I-~g~~~~a~~~~yH~~CF 95 (681)
.++|+.|++++ ..+.+.+.|+.||..|.
T Consensus 2 ~~~CprC~K~VYfaEk~~~lgk~WHk~Cl 30 (30)
T d2cu8a1 2 ASKCPKCDKTVYFAEKVSSLGKDWHKFCL 30 (30)
T ss_dssp CCBCTTTCCBCCTTTEEEETTEEEETTTC
T ss_pred CCcCCCCCCceeeHHhhccCCcccccccC
Confidence 47899999998 56788999999999884
|
| >d2cupa3 g.39.1.3 (A:8-34) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.59 E-value=0.007 Score=36.95 Aligned_cols=25 Identities=20% Similarity=0.608 Sum_probs=21.2
Q ss_pred ccccCCcccc--CeEEecCccCCCCce
Q psy5063 71 CQNCGQMMSG--PVMVVGDHKFHPECF 95 (681)
Q Consensus 71 C~~C~~~I~g--~~~~a~~~~yH~~CF 95 (681)
|..|.+||.. ..+...++.||..||
T Consensus 1 c~ecrkpigad~ke~h~knr~wh~~cf 27 (27)
T d2cupa3 1 CVECRKPIGADSKEVHYKNRFWHDTCF 27 (27)
T ss_dssp CSSSCCBCCSSSCEEEETTEEEETTTC
T ss_pred CccccCCcCcchHHhhccccccccccC
Confidence 7889999943 568899999999998
|
| >d2z9ia1 b.36.1.4 (A:227-314) Protease PepD {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: HtrA-like serine proteases domain: Protease PepD species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=94.59 E-value=0.023 Score=46.00 Aligned_cols=41 Identities=10% Similarity=0.233 Sum_probs=33.2
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhc-CCCceeeeeeecc
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRN-TTDTVLQRQILKE 334 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 334 (681)
-|++||+|++|||.++.+ .+++..++.. ..++.+.|++.+.
T Consensus 33 Gl~~GD~I~~ing~~i~~--~~~~~~~i~~~~~g~~v~l~v~r~ 74 (88)
T d2z9ia1 33 GVPKGVVVTKVDDRPINS--ADALVAAVRSKAPGATVALTFQDP 74 (88)
T ss_dssp TCCTTCEEEEETTEECCS--HHHHHHHHHTSCTTCEEEEEEEET
T ss_pred CCCCCCEEEEeCCCcCCc--HHHHHHHHHhCCCCCEEEEEEEEC
Confidence 699999999999999964 5677777753 4568899999873
|
| >d1ky9a1 b.36.1.4 (A:260-353) Protease Do (DegP, HtrA), C-terminal domains {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: HtrA-like serine proteases domain: Protease Do (DegP, HtrA), C-terminal domains species: Escherichia coli [TaxId: 562]
Probab=94.40 E-value=0.0084 Score=49.37 Aligned_cols=43 Identities=19% Similarity=0.439 Sum_probs=35.8
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhhcC-CCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIRNT-TDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 336 (681)
-|++||.|++|||+||. +.+++..++.+. .++.+.|++++|-+
T Consensus 44 Gl~~gDvI~~i~g~~v~--~~~~l~~~l~~~~~g~~v~l~v~R~g~ 87 (94)
T d1ky9a1 44 GIKAGDVITSLNGKPIS--SFAALRAQVGTMPVGSKLTLGLLRDGK 87 (94)
T ss_dssp TCCTTCEECBSSSSBCC--SSHHHHHHTTSSBTTCCCEEEEESSSC
T ss_pred CCCcccEEEEECCEEeC--CHHHHHHHHHhCCCCCEEEEEEEECCE
Confidence 59999999999999995 567888888743 47889999999863
|
| >d1u5sb2 g.39.1.3 (B:103-137) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.39 E-value=0.013 Score=38.14 Aligned_cols=34 Identities=21% Similarity=0.531 Sum_probs=27.3
Q ss_pred eecCCCCcccCCCCceeeecCCeeeeccchhhhcCC
Q psy5063 95 FKCTSCSCCIGDGESYALVERSILYCGLCYKRQMQP 130 (681)
Q Consensus 95 F~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~~~p 130 (681)
|+|..|.+++.....| ..++..||...|+++|+-
T Consensus 1 FvCA~CekPF~G~rhy--E~~g~ayCe~Hy~qLfg~ 34 (35)
T d1u5sb2 1 FVCAKCEKPFLGHRHY--ERKGLAYCETHYNQLFGD 34 (35)
T ss_dssp CBCTTTCCBCSSSCCE--EETTEEECHHHHHHHCSC
T ss_pred CcccccCCccCCchhh--hhcCchHHHHHHHHHhcc
Confidence 7899999999544444 557889999999998764
|
| >d1x61a1 g.39.1.3 (A:8-34) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.93 E-value=0.012 Score=35.22 Aligned_cols=25 Identities=40% Similarity=0.868 Sum_probs=21.4
Q ss_pred ccccCCccc--cCeEEecCccCCCCce
Q psy5063 71 CQNCGQMMS--GPVMVVGDHKFHPECF 95 (681)
Q Consensus 71 C~~C~~~I~--g~~~~a~~~~yH~~CF 95 (681)
|.+|++-+. |.-++|.++.||..||
T Consensus 1 cggcgedvvgdgagvvaldrvfhvgcf 27 (27)
T d1x61a1 1 CGGCGEDVVGDGAGVVALDRVFHVGCF 27 (27)
T ss_dssp CSSSCSCCCSSSCCEECSSSEECTTTC
T ss_pred CCCcccccccCCcceEEEeeeEEeccC
Confidence 889998774 4578999999999998
|
| >d1x61a2 g.39.1.3 (A:35-66) Thyroid receptor interacting protein 6, TRIP6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Thyroid receptor interacting protein 6, TRIP6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.37 E-value=0.022 Score=36.11 Aligned_cols=29 Identities=34% Similarity=0.872 Sum_probs=22.0
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhh
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKR 126 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~ 126 (681)
.|..|+..| .|++|+-++.. -||..||-.
T Consensus 1 vC~tC~~kL-RGqpFYAvekk-ayCE~CYi~ 29 (32)
T d1x61a2 1 VCSTCRAQL-RGQHFYAVERR-AYCEGCYVA 29 (32)
T ss_dssp BCSSSCCBC-TTSCEEESSSC-EEEHHHHHH
T ss_pred CeeEeCcee-cCCcceEeecc-ccccceeee
Confidence 488999999 56666666544 799999954
|
| >d2cu8a2 g.39.1.3 (A:38-70) Cysteine-rich (intestinal) protein, CRP, CRIP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.36 E-value=0.026 Score=36.40 Aligned_cols=31 Identities=26% Similarity=0.598 Sum_probs=25.2
Q ss_pred ecCCCCcccCCCCceeeecCCeeeecc-chhhhc
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGL-CYKRQM 128 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~-Cy~~~~ 128 (681)
+|..|++.|..|. ....++++||.. ||..+|
T Consensus 1 kCekC~ktL~~G~--HaEH~gkPYC~~PCY~aLF 32 (33)
T d2cu8a2 1 KCERCSKTLTPGG--HAEHDGKPFCHKPCYATLF 32 (33)
T ss_dssp BCSSSCCBCCTTS--CEEETTEEECTTTHHHHHS
T ss_pred CchhcccccCCCC--ccccCCCcCcCcchHHhhc
Confidence 5899999998887 446678999977 998766
|
| >d1b8ta1 g.39.1.3 (A:1-35) Cysteine-rich (intestinal) protein, CRP, CRIP {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=93.03 E-value=0.016 Score=37.43 Aligned_cols=28 Identities=25% Similarity=0.647 Sum_probs=24.1
Q ss_pred CCcccccCCcc-ccCeEEecCccCCCCce
Q psy5063 68 GEACQNCGQMM-SGPVMVVGDHKFHPECF 95 (681)
Q Consensus 68 ~~~C~~C~~~I-~g~~~~a~~~~yH~~CF 95 (681)
+.+|..|.+.+ ..+.++..|+.||..||
T Consensus 7 g~kcg~c~ktvy~aeevqc~g~sfhk~cf 35 (35)
T d1b8ta1 7 GKKCGVCQKAVYFAEEVQCEGSSFHKSCF 35 (35)
T ss_dssp CEECTTTCCEECSSCCEEETTEEECTTTC
T ss_pred CceeccccceEeeeeeeeecCcccccccC
Confidence 46899999877 56778999999999998
|
| >d1a7ia1 g.39.1.3 (A:8-35) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=92.99 E-value=0.023 Score=34.76 Aligned_cols=26 Identities=27% Similarity=0.730 Sum_probs=22.8
Q ss_pred cccccCCcc-ccCeEEecCccCCCCce
Q psy5063 70 ACQNCGQMM-SGPVMVVGDHKFHPECF 95 (681)
Q Consensus 70 ~C~~C~~~I-~g~~~~a~~~~yH~~CF 95 (681)
+|..|.+.+ ..+.++..|+.||..||
T Consensus 2 kcg~c~ktvy~aeevqc~grsfhk~cf 28 (28)
T d1a7ia1 2 KCGACGRTVYHAEEVQCDGRSFHRCCF 28 (28)
T ss_dssp BCSSSCCBCSSTTEEEETTEEEESSSE
T ss_pred ccccccceEeeeeeeeecCceeccccC
Confidence 799999877 56788999999999998
|
| >d1x64a2 g.39.1.3 (A:53-83) PDZ and LIM domain protein 3, PDLIM3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 3, PDLIM3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.93 E-value=0.022 Score=36.05 Aligned_cols=26 Identities=31% Similarity=0.774 Sum_probs=22.2
Q ss_pred ccccCcCccCC-ceEeeCCeeeecccc
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDY 63 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY 63 (681)
.|+.|+..|.. .||..++++||+++-
T Consensus 1 vC~dCg~NLKqrG~Ffv~~~lyCE~HA 27 (31)
T d1x64a2 1 VCADCNLNLKQKGYFFVEGELYCETHA 27 (31)
T ss_dssp CCSSSCCCTTTSCCEEETTEEECHHHH
T ss_pred CccccccChhhcceEEeccEEeehhhh
Confidence 48999999954 688899999999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.69 E-value=0.021 Score=57.34 Aligned_cols=29 Identities=24% Similarity=0.211 Sum_probs=23.4
Q ss_pred CccccCCCCCcEEEecCCCe-EEeeeeeEee
Q psy5063 623 NLIHRDLNSQNCLVREVGSG-FDFHLGQIYL 652 (681)
Q Consensus 623 ~IIHRDLKp~NILl~~~g~~-~DFGLa~~~~ 652 (681)
++||+|+.+.|||++. |.. +||+-+....
T Consensus 193 ~liHgDlh~~NvL~~~-~~~~IDFdd~~~g~ 222 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-GPMFVDLDDARNGP 222 (325)
T ss_dssp EECCSSCSGGGEEESS-SEEECCCTTCCEEC
T ss_pred eeecCCCCcccEEEeC-CceEEechhcccCc
Confidence 5899999999999975 444 8999887543
|
| >d1sota1 b.36.1.4 (A:255-353) Stress sensor protease DegS, C-terminal domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: PDZ domain-like superfamily: PDZ domain-like family: HtrA-like serine proteases domain: Stress sensor protease DegS, C-terminal domain species: Escherichia coli [TaxId: 562]
Probab=92.65 E-value=0.023 Score=47.06 Aligned_cols=43 Identities=14% Similarity=0.285 Sum_probs=30.7
Q ss_pred ccccCCeEEEEcCeecCCCChHHHHHhhh-cCCCceeeeeeeccCC
Q psy5063 292 SLHLGDRILEVNGTPVRDKPLQEVECLIR-NTTDTVLQRQILKECR 336 (681)
Q Consensus 292 ~~~~~d~~levng~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 336 (681)
-|++||.|++|||.+|.+ .+++..++. ...++.+.+++.+|-.
T Consensus 43 Gl~~GDiI~~ing~~v~~--~~~l~~~l~~~~~g~~v~l~v~R~g~ 86 (99)
T d1sota1 43 GIQVNDLIISVDNKPAIS--ALETMDQVAEIRPGSVIPVVVMRDDK 86 (99)
T ss_dssp SCCTTCEECBSSSSBCCC--SHHHHHHHHHSCTTCEEEECC-----
T ss_pred CCCcceEEEEECCEeccc--HHHHHHHHHcCCCCCEEEEEEEECCE
Confidence 599999999999999975 466666664 3567889999998863
|
| >d1rutx4 g.39.1.3 (X:114-146) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=92.23 E-value=0.054 Score=34.44 Aligned_cols=26 Identities=35% Similarity=0.769 Sum_probs=21.8
Q ss_pred ccccCcCcc--CCceEeeCCeeeecccc
Q psy5063 38 RCSACDVML--DNWYFEKDGLLFCKEDY 63 (681)
Q Consensus 38 ~C~~C~~~L--~~~~~~~dg~~yC~~cY 63 (681)
.|+.|...| +.+|...+|.+||+.|-
T Consensus 1 tC~tC~n~LVPGDRFHyvNG~lfCE~D~ 28 (33)
T d1rutx4 1 TCSTCRNRLVPGDRFHYINGSLFCEHDR 28 (33)
T ss_dssp BCTTTCCBCCTTCEEEEETTEEEEGGGC
T ss_pred CcccccccccCCceeEEecCEEEEecCC
Confidence 489998887 34888999999999874
|
| >d1wiga1 g.39.1.3 (A:1-32) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.09 E-value=0.025 Score=35.80 Aligned_cols=26 Identities=23% Similarity=0.585 Sum_probs=23.0
Q ss_pred ccccccccccccCceEEecCccccccC
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDC 36 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~C 36 (681)
.-|..|.+-| .+.++.|.++.||+.|
T Consensus 6 sgC~~C~~~I-tGkVLEAG~khYHP~C 31 (32)
T d1wiga1 6 SGCDSCEKYI-TGRVLEAGEKHYHPSC 31 (32)
T ss_dssp CSCSSSCCCC-SSCCBCCSSCCBCTTT
T ss_pred chhhhhhhhh-hhhhhhccccccCCCC
Confidence 4599998888 4789999999999988
|
| >d1ibia1 g.39.1.3 (A:117-144) Cysteine-rich (intestinal) protein, CRP, CRIP {Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Cysteine-rich (intestinal) protein, CRP, CRIP species: Japanese quail (Coturnix coturnix japonica), CRP2 [TaxId: 93934]
Probab=91.25 E-value=0.035 Score=34.31 Aligned_cols=26 Identities=23% Similarity=0.695 Sum_probs=19.9
Q ss_pred CcccccCCccc-cCeEEecCccCCCCc
Q psy5063 69 EACQNCGQMMS-GPVMVVGDHKFHPEC 94 (681)
Q Consensus 69 ~~C~~C~~~I~-g~~~~a~~~~yH~~C 94 (681)
.+|..|++.+. .+.+.-.|+.||..|
T Consensus 2 d~CpRC~~~VyaAEkviGaG~~WHk~C 28 (28)
T d1ibia1 2 EKCSRCGDSVYAAEKVIGAGKPWHKNC 28 (28)
T ss_dssp EECTTTSSEESSSSCEESSSSEECSSC
T ss_pred CcCcccchhHHHHHHHhcCCCccccCC
Confidence 57999999884 345556678999987
|
| >d2cora2 g.39.1.3 (A:8-42) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.23 E-value=0.062 Score=35.10 Aligned_cols=33 Identities=18% Similarity=0.372 Sum_probs=26.9
Q ss_pred CCCCCCccccccccccccCceEEecCccccccCc
Q psy5063 4 SETPEILTCAGCLNNIVEDEYVQALSQEWHTDCF 37 (681)
Q Consensus 4 ~~~~~~~~C~~C~~~I~~~~~v~a~~~~wH~~CF 37 (681)
..+.+..+|.+|...| +++-+...+..||+.+|
T Consensus 3 A~glGk~vC~KCh~iI-dd~pL~Fr~d~YHp~HF 35 (35)
T d2cora2 3 ARGLGKYICQKCHAII-DEQPLIFKNDPYHPDHF 35 (35)
T ss_dssp CCCCCCCBCTTTCCBC-CSCCCCCSSSCCCTTTS
T ss_pred ccchhhHHHHHHHhhh-hcCcceecCCCCCCCCC
Confidence 4455668999997777 56888999999999987
|
| >d2cora1 g.39.1.3 (A:43-73) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.18 E-value=0.054 Score=34.08 Aligned_cols=29 Identities=24% Similarity=0.574 Sum_probs=22.5
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccchhhh
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCYKRQ 127 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy~~~ 127 (681)
.|..|++.| ..+ +....+.+||..|+.++
T Consensus 1 nC~~Cgkel-tad--ArEl~geLyCLpChdKm 29 (31)
T d2cora1 1 NCANCGKEL-TAD--ARELKGELYCLPCHDKM 29 (31)
T ss_dssp BCSSSCCBC-CTT--CEEETTEEECHHHHHTT
T ss_pred Ccccccccc-chh--HHHhcCCEEEEeccccc
Confidence 488999998 444 45667889999999764
|
| >d2cupa2 g.39.1.3 (A:35-65) Four and a half LIM domains protein 1, FHL-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Four and a half LIM domains protein 1, FHL-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.98 E-value=0.052 Score=34.17 Aligned_cols=27 Identities=30% Similarity=0.607 Sum_probs=23.1
Q ss_pred ccccCcCccCC-ceEeeCCeeeeccccc
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYN 64 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~ 64 (681)
+|..|-.+|.+ .|..+|+++.|.+|-.
T Consensus 1 RCaKC~hpLA~E~F~aKd~kI~C~Kc~s 28 (31)
T d2cupa2 1 RCAKCLHPLANETFVAKDNKILCNKCTT 28 (31)
T ss_dssp CCSSSCCCTTSSCCEEETTEEECHHHHT
T ss_pred CchhhccccccCcccccCCeEeeccccc
Confidence 68999999965 7889999999998843
|
| >d1x62a1 g.39.1.3 (A:43-73) PDZ and LIM domain protein 1 Elfin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: PDZ and LIM domain protein 1 Elfin species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.22 E-value=0.025 Score=35.93 Aligned_cols=27 Identities=19% Similarity=0.519 Sum_probs=22.3
Q ss_pred ccccCcCccCC-ceEeeCCeeeeccccc
Q psy5063 38 RCSACDVMLDN-WYFEKDGLLFCKEDYN 64 (681)
Q Consensus 38 ~C~~C~~~L~~-~~~~~dg~~yC~~cY~ 64 (681)
.|+.|+..|.. .||..++++||+++-.
T Consensus 1 vC~dCg~NLKqrG~Ffve~~lyCE~HAr 28 (31)
T d1x62a1 1 VCTDCGTNLKQKGHFFVEDQIYCEKHAR 28 (31)
T ss_dssp SCSSSCCCHHHHCCEESSSCEECHHHHH
T ss_pred CccccccChhhcceEEeccEEehhhhhh
Confidence 48999999954 6888999999998743
|
| >d2cora1 g.39.1.3 (A:43-73) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.30 E-value=0.093 Score=32.96 Aligned_cols=28 Identities=25% Similarity=0.395 Sum_probs=24.2
Q ss_pred ccccCcCccCCceEeeCCeeeecccccc
Q psy5063 38 RCSACDVMLDNWYFEKDGLLFCKEDYNG 65 (681)
Q Consensus 38 ~C~~C~~~L~~~~~~~dg~~yC~~cY~~ 65 (681)
.|+.|++.|...--+..|.+||-.|..+
T Consensus 1 nC~~CgkeltadArEl~geLyCLpChdK 28 (31)
T d2cora1 1 NCANCGKELTADARELKGELYCLPCHDK 28 (31)
T ss_dssp BCSSSCCBCCTTCEEETTEEECHHHHHT
T ss_pred CccccccccchhHHHhcCCEEEEecccc
Confidence 3889999998878889999999999754
|
| >d1wiga2 g.39.1.3 (A:33-73) Actin-binding LIM protein 2, abLIM2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Actin-binding LIM protein 2, abLIM2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.27 E-value=0.066 Score=36.19 Aligned_cols=28 Identities=29% Similarity=0.529 Sum_probs=20.8
Q ss_pred cccccccccccCceEEe-cCccccccCcc
Q psy5063 11 TCAGCLNNIVEDEYVQA-LSQEWHTDCFR 38 (681)
Q Consensus 11 ~C~~C~~~I~~~~~v~a-~~~~wH~~CF~ 38 (681)
+|++|++.+.+++-+-. .+..||+.|-+
T Consensus 1 ~C~rC~~mF~EGEEMYLQGs~IWHP~C~~ 29 (41)
T d1wiga2 1 LCVRCGQMFAEGEEMYLQGSSIWHPACRQ 29 (41)
T ss_dssp CCSSSCCCCCSSCCCEEETTEEECTTHHH
T ss_pred CcchhhccccccceeeecCCceeCCcccc
Confidence 59999999988765433 45689998744
|
| >d2cora2 g.39.1.3 (A:8-42) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.90 E-value=0.11 Score=33.86 Aligned_cols=27 Identities=22% Similarity=0.717 Sum_probs=24.1
Q ss_pred CcccccCCccccCeEEecCccCCCCce
Q psy5063 69 EACQNCGQMMSGPVMVVGDHKFHPECF 95 (681)
Q Consensus 69 ~~C~~C~~~I~g~~~~a~~~~yH~~CF 95 (681)
..|..|...|.+.-+.+.+..|||.+|
T Consensus 9 ~vC~KCh~iIdd~pL~Fr~d~YHp~HF 35 (35)
T d2cora2 9 YICQKCHAIIDEQPLIFKNDPYHPDHF 35 (35)
T ss_dssp CBCTTTCCBCCSCCCCCSSSCCCTTTS
T ss_pred HHHHHHHhhhhcCcceecCCCCCCCCC
Confidence 369999999988888999999999887
|
| >d1j2oa2 g.39.1.3 (A:31-63) Rhombotin-2 (Lmo2) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Rhombotin-2 (Lmo2) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=84.40 E-value=0.098 Score=33.24 Aligned_cols=29 Identities=28% Similarity=0.631 Sum_probs=23.7
Q ss_pred cccccCcCccCC---ceEeeCCeeeecccccc
Q psy5063 37 FRCSACDVMLDN---WYFEKDGLLFCKEDYNG 65 (681)
Q Consensus 37 F~C~~C~~~L~~---~~~~~dg~~yC~~cY~~ 65 (681)
++|.-|+..|++ ..|.+.+...|+.||.+
T Consensus 1 LkC~cC~cRLGEVG~tlytk~nliLCkrDYlR 32 (33)
T d1j2oa2 1 LSCDLCGCRLGEVGRRLYYKLGRKLCRRDYLR 32 (33)
T ss_dssp CCCSSSCSCCCCSSSCCCCBTTBCCCHHHHHH
T ss_pred CccccccccccchhhHHHhhcceeeehhhhhc
Confidence 367778888853 68999999999999964
|
| >d1g47a1 g.39.1.3 (A:1-35) Pinch (particularly interesting new Cys-His) protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Pinch (particularly interesting new Cys-His) protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.37 E-value=0.4 Score=31.11 Aligned_cols=28 Identities=21% Similarity=0.535 Sum_probs=22.9
Q ss_pred CccccccccccccC-ceEEecCccccccC
Q psy5063 9 ILTCAGCLNNIVED-EYVQALSQEWHTDC 36 (681)
Q Consensus 9 ~~~C~~C~~~I~~~-~~v~a~~~~wH~~C 36 (681)
...|.+|+..+... +++.-.|..||+.|
T Consensus 7 ~~~C~RC~~gF~p~EkiVNSnGEl~H~qC 35 (35)
T d1g47a1 7 SATCERCKGGFAPAEKIVNSNGELYHEQC 35 (35)
T ss_dssp CCBCSSSCCBCCSTTTCEEETTEEECTTT
T ss_pred HHHHHHHccCCCchHHhhcCCCccccccC
Confidence 46899999888665 46888899999987
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=84.28 E-value=0.64 Score=47.11 Aligned_cols=73 Identities=15% Similarity=0.306 Sum_probs=43.4
Q ss_pred ceecccCcEEEEEEEEcC-------CCeEEEEEEeeccCHHHHHHHHHHhhccceeeeccCCCCccccccchHHHHHHHh
Q psy5063 486 PLLGQGFFGQVYRVTHRE-------TGEVMVLKELYRVDEEAEKNFLKESKQGLIYLIDLGSHGLINNLHCFSQVAVLRS 558 (681)
Q Consensus 486 ~~LG~G~FG~Vyk~~~~~-------tg~~vAiK~l~~~~~~~~~~~~~E~k~~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 558 (681)
+.|+.|---.+|++.... ..+.+++++....... . .. .+|..+++.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-i-dr-------------------------~~E~~i~~~ 100 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-S-HL-------------------------VAESVIFTL 100 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-H-HH-------------------------HHHHHHHHH
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-h-HH-------------------------HHHHHHHHH
Confidence 457778888999988753 2345666655322111 1 11 134666666
Q ss_pred CC-CCceeeEEEEEEeCCeEEEEEeccCCCCH
Q psy5063 559 LH-HHNVIRFIGVLYKDRKLNLVTEYIAGGTL 589 (681)
Q Consensus 559 L~-HpnIV~l~g~~~~~~~l~LV~Ey~~gGsL 589 (681)
+. +.-..++++++.+ ++|+||++|..|
T Consensus 101 ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 101 LSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 63 4334577777642 689999987544
|
| >d1rutx4 g.39.1.3 (X:114-146) LIM only 4 (Lmo4) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: LIM only 4 (Lmo4) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=84.12 E-value=0.47 Score=30.02 Aligned_cols=28 Identities=18% Similarity=0.584 Sum_probs=23.3
Q ss_pred ecCCCCcccCCCCceeeecCCeeeeccch
Q psy5063 96 KCTSCSCCIGDGESYALVERSILYCGLCY 124 (681)
Q Consensus 96 ~C~~C~~~l~~g~~~~l~~~~~lyC~~Cy 124 (681)
.|+.|...|-.|+.|... ++.+||..+.
T Consensus 1 tC~tC~n~LVPGDRFHyv-NG~lfCE~D~ 28 (33)
T d1rutx4 1 TCSTCRNRLVPGDRFHYI-NGSLFCEHDR 28 (33)
T ss_dssp BCTTTCCBCCTTCEEEEE-TTEEEEGGGC
T ss_pred CcccccccccCCceeEEe-cCEEEEecCC
Confidence 489999999999999776 5679998764
|
| >d1x6aa2 g.39.1.3 (A:42-75) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.80 E-value=0.21 Score=32.30 Aligned_cols=29 Identities=28% Similarity=0.699 Sum_probs=22.7
Q ss_pred cccccCcCccC-C-ceE-eeCCeeeecccccc
Q psy5063 37 FRCSACDVMLD-N-WYF-EKDGLLFCKEDYNG 65 (681)
Q Consensus 37 F~C~~C~~~L~-~-~~~-~~dg~~yC~~cY~~ 65 (681)
|.|..|+..++ + .|- ....++||..||.+
T Consensus 1 F~C~~C~~fIgdgdsyaLVerskLYCG~Cy~~ 32 (34)
T d1x6aa2 1 FACMSCKVIIEDGDAYALVQHATLYCGKCHNE 32 (34)
T ss_dssp CBCTTTCCBCCTTSCEEECSSSCEEEHHHHHH
T ss_pred CcccccccEEecCceEEEEeeceeeeecchhc
Confidence 78999999994 3 564 45589999999864
|
| >d1x6aa1 g.39.1.3 (A:8-41) Lim domain kinase 2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Glucocorticoid receptor-like (DNA-binding domain) superfamily: Glucocorticoid receptor-like (DNA-binding domain) family: LIM domain domain: Lim domain kinase 2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.24 E-value=0.38 Score=31.10 Aligned_cols=26 Identities=23% Similarity=0.566 Sum_probs=22.7
Q ss_pred ccccccccccccCceEEecCccccccC
Q psy5063 10 LTCAGCLNNIVEDEYVQALSQEWHTDC 36 (681)
Q Consensus 10 ~~C~~C~~~I~~~~~v~a~~~~wH~~C 36 (681)
..|.+|.+.| .+-++.|.+..||++|
T Consensus 9 e~C~~C~~~i-tGpvMvAG~~K~HPEC 34 (34)
T d1x6aa1 9 EFCHGCSLLM-TGPFMVAGEFKYHPEC 34 (34)
T ss_dssp CBCTTTCCBC-CSCCBCCTTCCBCTTS
T ss_pred HHhhhhHhhc-ccceeeecccccCCCC
Confidence 5799998866 5888999999999998
|